<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005">
<channel xmlns:cfi="http://www.microsoft.com/schemas/rss/core/2005/internal" cfi:lastdownloaderror="None">
<title cf:type="text"><![CDATA[International Journal of Ophthalmology Press -->Clinical Research]]></title>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Standard coaxial phaco microincision cataract
surgery: a corneal endothelium study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200804013]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[To assess whether the new microincision cataract surgery (MICS) induces less endothelium damages than the standard coaxial phacoemulsification.
· METHODS: Two hundred consecutive patients affected by age-related cataract were randomly assigned to undergo phacoemulsification using either standard coaxial phaco (SCP) or MICS. Central cornea and 12 o'clock endothelial cell count, cell size variation coefficient, percentage of hexagonality and central cornea thickness were measured before and up to one year after surgery.
· RESULTS: One hundred and seventy-three patients completed the trial. At the one-year follow-up visit, the loss of endothelium cells was 6.5204% in the MICS group and 8.726% in the SCP group (P <0.00005). There were no significant differences between the two groups in terms of coefficient of variation in cell size, percentage of hexagonal cells, corneal thickness the day after surgery and variation of endothelial cell density measured both at the incision site and at the central cornea. In patients with hard cataracts, the increase in endothelial cell density loss was higher indepen- dently of the procedure.
· CONCLUSION: MICS induces a significant lower endothelial cell density loss than SCP.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Alessandro Franchini,Saverio Frosini and Vieri Boddi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Alessandro Franchini,Saverio Frosini and Vieri Boddi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200804013]]></guid><cfi:id>1546</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Risk factors for anterior chamber membrane forma-
tion after phacoemulsification]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200804014]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[To investigate the risk factors for the development of
membrane formation in the anterior chamber after phacoemulsification.
METHODS: A total of 1 356 patients who underwent
phacoemulsification with implantation of single piece
polymethyl methacrylate (PMMA) IOL were prospectively
evaluated. Presence of pseudoexfoliation syndrome, nuclear
hardness, pupil size, phaco time, effective phaco time,
systemic diseases, postoperative complications (capsulorhexis
rupture, zonular dialysis, posterior capsule rupture with
vitreous loss), location of IOL placement and postoperative
complications(intraocular pressurechanges, synechiaformation)
were analyzed as risk factors for development of membrane
formation.
·RESULTS: In 111 (8.1%) patients postoperative fibrinous
anterior uveitis with membrane formation was observed. The
mean time for membrane formation was postoperative second
day (range postoperative 1<sup>st</sup> and 7<sup>th</sup> day). Mean duration of
the presence of membrane was 5.2 days (range 1 to 48
days). Among the patients who had membrane formation, +4
hardness of the nucleus was present in 45%, while it was
present in only 13.5% of patients who did not have
membrane formation. The difference was statistically significant
( <0.05). In the membrane-forming group, mean phaco
time was 2.4 minutes and mean effective phaco time was
32.8 seconds, compared to 1.8 minutes and 22.1 seconds in
the membrane-free group. Both parameters were significantly
longer in the membrane-forming group ( <0.05). Posterior
capsule rupture with vitreous loss and sulcus implantation of
IOL was seen in 33% of membrane-forming patients and in
11%of membrane-free patients ( <0.05). Other risk factors
were not statistically different between membrane-forming
and membrane-free patients. On postoperative first and 7<sup>th</sup>
day, the mean best corrected visual acuity in the membraneforming
group was 0.2 and 0.4 respectively, versus 0.4 and
0.6 in the membrane-free group on Snellen chard ( <0.05).
But three months after surgery, the best corrected visual
acuity was similar between the membrane-forming and
membrane- free patients (0.8 and 0.9 respectively).
·CONCLUSION: Higher nucleus hardness, longer phaco time
and effective phaco time, and posterior capsule rupture
during surgery are risk factors which significantly associated
with postoperative fibrinous membrane formation in the
anterior chamber.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ayse Gul Kocak Altintas,M Alpaslan Anayol and aban Simsek]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ayse Gul Kocak Altintas,M Alpaslan Anayol and aban Simsek</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200804014]]></guid><cfi:id>1545</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Vitrectomy results in proliferative diabetic retinopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200804015]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[To evaluate the effectiveness of vitrectomy on eyes with proliferative diabetic retinopathy (PDR).
· METHODS: A total of 139 eyes of 93 cases with PDR underwent vitrectomy and were followed up for 3-24 months (16.72±8.53 months; mean±SD). The visual acuity and the factors causing recurrence of operation were analyzed.
· RESULTS: The visual acuity was improved in 98 eyes (70.50%) after vitrectomy. The mean postoperative visual acuity was significantly better than the mean preoperative visual acuity. The main reasons for the failure of operation were retinal detachment and maculopathy. 
· CONCLUSION: These results demonstrate that vitrectomy is generally an effective procedure in treating PDR]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jie Luan,Fumitaka Ando,Hirosi Hirose and Osumu Yasui]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jie Luan,Fumitaka Ando,Hirosi Hirose and Osumu Yasui</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200804015]]></guid><cfi:id>1544</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Low vision aid in exudative macular degeneration
treated by photodynamic therapy and thermal laser
photocoagulation]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200804016]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[To determine the efficacy of low vision rehabilitation (LVR) in patients with age-related macular degeneration (AMD) treated by photodynamic therapy (PDT) compared to those treated by thermal laser photocoagulation (TLP).
· METHODS: A retrospective study was performed examining the files of 42 patients (42 eyes) with AMD who had been treated either by TLP (Group 1) and PDT (Group 2). Once AMD was considered to be inactive they underwent visual rehabilitation in the LVR Unit in order to increase their ability for distant and near vision.
· RESULTS: Eighteen eyes had received PDT and 24 had received TLP. Average corrected visual acuity after laser therapy was 0.14 in Group 1, and 0.16 in Group 2. No statistically significant differences were found between both groups before and after laser therapy. Both groups showed improvement after LVR; however, statistically significant differences between both groups were found only for near vision.
· CONCLUSION: Our findings suggest that even though both PDT and TLP are associated to a decreased visual acuity after treatment, LVR may be more successful for near vision among patients treated by PDT]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Montero JA,Ruiz-Moreno JM,Sanchez -de Castro MJ and Fabiani C]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Montero JA,Ruiz-Moreno JM,Sanchez -de Castro MJ and Fabiani C</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200804016]]></guid><cfi:id>1543</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Pterygium surgery: amniotic membrane or conjunc-
tival autograft transplantation]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200804017]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[To compare the outcomes of amniotic membrane transplantation (AMT) with conjunctival autograft transplantation (CAT) in primary and recurrent pterygium. 
· METHODS: This study was designed as a prospective study on consecutive cases of pterygium from April 2004 to February 2006. The cases were randomly divided into two groups of AMT (26 cases) and CAT (24 cases). All subjects were operated with an extensive excision of the fibro vascular tissues with AMT or CAT approach. Patients were followed for recurrence and complications for 24 months. The surgical procedures were performed by a single surgeon. The associations between demographic variables, surgical techniques (AMT, CAT), recurrences and postoperative complications were analyzed.
· RESULTS: The patients' male to female ratio was 4:1. Involvement of right to left eye ratio was 3:2. Pterygium in 70% of cases was primary and in 30% was recurrent. The most common clinical signs were red eye and reduced visual acuity while the most common complications were recurrence and corneal scar. In the first month of follow up, the recurrence rates in AMT and CAT approaches were 3.8% vs 8.3% respectively and these rates increased to 46.2% vs 25% respectively after 24 months of follow up.
· CONCLUSION: The success rate of 2 years follow up was better in CAT technique. The AMT technique for pterygium surgery has an unacceptably high recurrence rate.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mohammad Reza Besharati,Seyed Ali Mohammad Miratashi and Amir Bahrami Ahmadi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mohammad Reza Besharati,Seyed Ali Mohammad Miratashi and Amir Bahrami Ahmadi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200804017]]></guid><cfi:id>1542</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Ｍacular hole surgery ｗithor ｗithout internal  liｍiting ｍeｍbrane peeling]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200803012]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[to comParethe anatomical and visualoutcome in Primary idioPathic macular hole surgery withor without indocyanine green (ICG) stained internal limiting membrane (ILM) Peeling.
·METHODS:the medical recordsofthe 40 consecutive eyes receiving Primary idioPathic macular hole surgery with gas as internaltamPonade Performed by a single surgeon were retrosPectively reviewed and analyzed. All eyes had a follow-uPof at least 6 months. Inthe initial 22 consecutive eyes, no ILM Peeling was Performed (non-ILM Peeling grouP).the subsequent 18 eyes underwent surgery with ICG stained ILM Peeling (ILM Peeling grouP).
·RESULTS:the Primary anatomical closure rates were 88.9% and 59.1% inthe ILM Peeling grouP and non-ILM Peeling grouP, resPectively.the difference was statistically significant (Fisher's exacttest, P =0.038). ImProvement in visual acuity was more marked inthe ILM Peeling grouPthan inthe non-ILM Peeling grouP, with a mean imProvementof 3.6 and 1.3 lines resPectively (two-tailedt -test, P =0.036).there were significantly more cases with imProvementoftwoor more linesof visual acuity after surgery, with 66.7% inthe ILM Peeling grouP and 31.8% non-ILM Peeling grouP (Chi-squaretest, P = 0.028). However,there was no significant difference inthe final PostoPerative logMAR best corrected visual acuity(BCVA) betweenthetwo grouPs (two-tailedt -test, P =0.073).
·CONCLUSION: Basedonthis study, ICG stained ILM Peeling seemsto imProvethe anatomical and visualoutcome in Primary idioPathic macular hole surgery. Further studies inthis asPect are warranted.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Alvin K H Kwok and timothy Y Y Lai]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Alvin K H Kwok and timothy Y Y Lai</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200803012]]></guid><cfi:id>1541</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Neuroprotective effects of erigeron breviscapus (vant.) hand-ｍazzon glaucoｍa—a ｍulti-center clinicaltrial]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200803013]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[to evaluatethe neuroProtective effectsof a Chinese herbal drug, erigeron breviscaPus (vant.) hand-mazz (EBHM),on glaucoma Patients with controlled intraocular Pressure (IOP) after surgical and/or medicaltheraPies.
·METHODS: Atotalof 99 Primary glaucoma Patients (113 eyes) with medicallyor surgically controlled IOP were givenorally either EBHMor Placebo for 6 months andthen evaluated in a multi-center, ProsPective, randomized and double masked clinicaltrial by quantifyingthe visual field changes using visual field defect scoring (VFDS). 
·RESULTS: After 2, 4, 6 monthsoftreatment,the VFDS in EBHM GrouP (66 eyes/55 Patients) decreased by 0.44±1.60, 1.27±2.16 and 1.42±2.37 resPectively, indicating atime-    dePendent imProvementof visual field uPon EBHMtreatment, whereasthe VFDS in Placebo Control GrouP  (47 eyes/47 Patients) decreased by -0.02±1.5, 0.68±1.73 and 0.40±1.57 resPectively. Statistically,the differencesof VFDS betweenthetwo grouPs were significant (P <0.05) at 2 and 4 months, and highly significant at 6 monthsoftreatment (P = 0.007).the average IOP in both grouPs was 15mmHg (range 8-18mmHg) duringthe Periodofthe study (P >0.05). No serious side effects were rePorted in glaucoma Patientson EBHM.
·CONCLUSION: EBHM aPPearedto be safe and effective in neuroProtection for Patients with glaucoma. More studies are neededto determinethe safety and effectivenessof longer-term EBHMtreatment.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ning-Li Wang,Xing-Huai Sun,Jing-Zhen Li,Jing-Hua Wang,Xiao-Ming Chen,Ding Lin,Jian-Hua Lü,Yi-Sheng Zhong,Chun Zhang and Wen-Yi Guo]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ning-Li Wang,Xing-Huai Sun,Jing-Zhen Li,Jing-Hua Wang,Xiao-Ming Chen,Ding Lin,Jian-Hua Lü,Yi-Sheng Zhong,Chun Zhang and Wen-Yi Guo</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200803013]]></guid><cfi:id>1540</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Risk factors for corneal graft failure and rejection in penetrating ｋeratoplasty]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200803014]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[to evaluate risk factorsof graft failure and allograft rejection after Penetrating keratoPlasty (PK).
·METHODS: Clinical dataof PKson 224 eyes (212 Patients) from 1996to 2006 were studied retrosPectively.the graft survival rate and rejection-free survival rateover 10 years were estimated with KaPlan-Meir's lifetable, and differences between levelsof each factor were comPared with log-ranktest. Cox regression was also Performedto further assessthe imPactof related clinical factorsonthe Prognosisofthe corneal graft.
·RESULTS:theoverall ratesof graft survival and rejection-free graft survival at 10 years after PK were 81.4% and 78.2% resPectively. Relatively higher riskof graft failure was associated with corneal vascularization, regraft, aPhakiaor PseudoPhakia, Presenceof anterioror Posterior synechia, long (≥90 minutes )oPerationtime andolder (≥60 years) ageof reciPient. Relatively higher riskof rejection was associated with corneal vascularization and longoPerationtime. Cox regression analysis showed corneal vascularization（RR = 2.46, P =0.04）, regraft (RR =5.67,P <0.01), aPhakia (RR = 3.64,P <0.05),or PseudoPhakia (RR =6.83,P <0.01), Presenceof anterior (RR =2.76,P = 0.05)or Posterior synechia (RR =3.12, P =0.05) were indePendent risk factors for corneal graft failure.
·CONCLUSION:the risk factors for graft failure after PK were corneal vascularization, regraft, aPhakiaor PseudoPhakia, Presenceof anterioror Posterior synechia.the risk factors after PK for allograft rejection were corneal   vascularization and longoPerationtime.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yan-Feng Yang,Yi-Fei Huang,Li-Qiang Wang,Dong-Fang Yin and Kun Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yan-Feng Yang,Yi-Fei Huang,Li-Qiang Wang,Dong-Fang Yin and Kun Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200803014]]></guid><cfi:id>1539</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Stress and continuous relaxation spectrum of porcine cornea after LASIK]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200802005]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To explore the characteristic of relaxation of porcine cornea after LASIK.
· METHODS: Usual LASIK was performed on fresh porcine corneas with stable intraoculer pressure(IOP) maintained through optic nerve irrigation . The ablation depth on stroma is 30%, 50% and 70% respectively. Then the dumbbell- shaped corneal strip specimens were cut and stored in 20% Human Albumin solution for use (4oC).Sip up the Albumin solution on specimens, and fixed them on homemade jig. Stress relaxation tests were performed on Tytron250 Dynamics  Experiment System. The loading speed was 385mm/min，extending rate was 1.5, and relaxation time was 1 000s. The data were collected electronically and automatically.
· RESULTS: In LASIK procedure, though a single flap-cutting can cause a little reduction of corneal stress relaxation (P < 0.05, P =0.49), the cornea may  still remain its property of visco-elasticity. When ablation depth was 30% or more, corneal stress relaxation decreased to almost one half (P < 0.01).The change of corneal stress relaxation degree in vertical meridian specimen was lower than that in  horizontal  specimen, especially when ablation depth was 70%, and it's statistically significant（P <0.001）. In LASIK operation, the more depth the ablation, the more reduce the stress relaxation degree, and it’s easy to cause deformation and creep deformation. 
· CONCLUSION: The changes of the stress relaxation in vertical and longitudinal meridian specimens are similar, and slightly obvious in longitudinal specimen, especially in 70% ablation group.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xue-Jun Fang,Yan-Chun Xu,Tian-Yu Shi,Li Zhang and Zi-Fan Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xue-Jun Fang,Yan-Chun Xu,Tian-Yu Shi,Li Zhang and Zi-Fan Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200802005]]></guid><cfi:id>1538</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Combined scleral buckle and vitrectomy as a primary surgery for pseudophakic and aphakic retinal detachments]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200802006]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine whether a combined scleral buckle and pars plana vitrectomy, as a primary surgery, owns any advantage over a single scleral buckling in pseudophakic and aphakic retinal detachments.
· METHODS: Thirty consecutive pseudophakic/aphakic retinal detachments were included in this retrospective study. Each patient underwent combined scleral buckle and pars plana vitrectomy, and was followed up for 3 to 14 months. Patients were examined with respect to anatomic reattachment, visual acuity improvement, and surgical complications.
· RESULTS: All eyes were anatomically reattached after the first operation. All patients had an increase in their visual acuity, and there were no complications attributable to the vitrectomy procedure.
· CONCLUSION: A combined surgery for primary pseudophakic/ aphakic retinal detachments offers significant benefits to scleral buckling alone. The improved success rate is contributing to the function of vitrectomy, which improves peripheral visibility and reduces the occurrence of proliferative vitreoretinopathy (PVR).]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Bo Qin,Li-Na Huang,Tie-Ying Zhao and Hong-Bo Cheng]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Bo Qin,Li-Na Huang,Tie-Ying Zhao and Hong-Bo Cheng</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200802006]]></guid><cfi:id>1537</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Application of a modified pars plana lensectomy within traumatic eyes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200802007]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate a surgical method of modified lensectomy within combined lensectomy and vitrectomy surgery in traumatic eyes. 
· METHODS: Clinical records were studied retrospectively for a series of consecutive 27 traumatic patients who were performed vitrectomy combined with lensectomy surgery. A modified lensectomy through pars plana incision of sclera was performed to these cases and lens capsule was reserved. It was then combined with vitreous and retinal operations. 
· RESULTS: All lens were removed completely with lens capsule remained. All cases achieved improved visual acuity. Intraocular pressure (IOP) in all eyes was in normal range after surgery. 
· CONCLUSION: The modified lensectomy is a safe and effective surgery manner which has few complications and is more suitable for traumatic eyes in the combined lensectomy and vitrectomy surgery.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yue Zhang,Wan-Rong Huang and Shi Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yue Zhang,Wan-Rong Huang and Shi Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200802007]]></guid><cfi:id>1536</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Improving quality of vision with an anterior surface modified prolate intraocular lens: A prospective clinical trial]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200802008]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the optical performance of the anterior surface modified prolate Tecnis Z9000 IOL with the standard 911A IOL in terms of contrast sensitivity outcomes.
· METHODS: The Tecnis Z9000 silicone IOL shares the same basic characteristics with the 911A IOL including a 12.0mm overall diameter, 3-piece equiconvex 6.0mm optic and angulated cap C polyvinylidene fluoride haptics. This is a randomized prospective study that involved ten consecutive patients (20 eyes) with bilateral cataracts. Each patient underwent phacoemulsification and received randomly the Tecnis Z9000 IOL in one eye and the control (911A IOL) in the fellow eye within 6 weeks period of one another. Contrast sensitivity was measured after six postoperative weeks. The collected data were analyzed through using Mann Whitney U test. 
· RESULTS: The mean pre-operative best spectacle corrected Snellen visual acuity in the eyes that were randomly selected to receive the Tecnis IOL was 6/8.5 (0.70) and in the eye selected to receive the 911A IOL was 6/9.4(0.64). Postoperatively all 20 eyes achieved best corrected Snellen visual acuity of 6/6 (1.0). Postoperative contrast sensitivity testing showed statistically significant differences (P <0.05) between the two IOLs at 12 and 18 cpd under photopic, at 1.5 and 3 cpd under mesopic, and at 1.5 and 3 cpd under mesopic with glare conditions. 
· CONCLUSION: The Tecnis Z9000 IOL proved to have statistically significant superior contrast sensitivity to the 911A IOL at high spatial frequencies under photopic conditions and at low spatial frequencies under mesopic and mesopic with glare conditions.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[V Subrayan,E Mavrikakis and J A Bell]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>V Subrayan,E Mavrikakis and J A Bell</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200802008]]></guid><cfi:id>1535</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Indications for penetrating keratoplasty in west Malaysia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200802009]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the indications for penetrating keratoplasty in Malaysia and to compare the leading indications with recently published data from other countries.
· METHODS: A retrospective review of the medical records of all patients who underwent penetrating keratoplasty at Medical Centre, University of Malaya, Kuala Lumpur, Malaysia over a period of fifteen years (1991/2005) was done. The gender, age, race of patients, eye operated, indication for surgery were noted from the records, and analyzed.
· RESULTS: A total of 125 penetrating keratoplasties were performed in 105 patients (male 71 and female 34; Chinese 55, Indians 33, and Malays 17; unilateral 85 and bilateral 20) during the study period. The mean age of patients was 51.3 years (range 13-79 years). The indications for penetrating keratoplasty were pseudophakic bullous keratopathy (28.8%), corneal scar (20.0%), keratoconus (17.6%), regrafts (9.6%), corneal dystrophies (8.8%) and corneal perforations (7.2%).
· CONCLUSION: Pseudophakic bullous keratopathy is the most common indication for penetrating keratoplasty in Malaysia. The three leading indications (pseudophakic bullous keratopathy, corneal scar and keratoconus) in our study are similar to many countries in the world, but they differ in the order of frequency from some countries.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[S C Reddy and I Tajunisah]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>S C Reddy and I Tajunisah</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200802009]]></guid><cfi:id>1534</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Primary chronic angle-closure glaucoma in younger
patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200802010]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the clinical outcomes of management in
younger patients with primary chronic angle-closure glaucoma
(PCACG).
·METHODS: Thirty-eight patients (50 eyes) aged 40 or
younger with confirmed diagnosis of PCACG in advanced or
late stage who received surgical treatment in Zhongshan
Ophthalmic Center from January 2000 to December 2005
were retrospectively investigated. All patients underwent
trabeculectomy. The mean follow-up was 23.6± 7.5 months.
Full ophthalmic examinations were performed. The clinical
outcomes including clinical presentations, surgical results and
complications were evaluated.
·RESULTS: The mean age of patients was 33.5± 6.1 years
old. There was a female preponderance (60.5%). The mean
axial length was 22.4 ± 3.5mm with 18.0% short axis of
eyeball and 14% nanophthalmos. There was 60.0% flat
anterior chamber depth (<1.9mm). Ultrasonic Biomicroscopy
identified that plateau iris was the most common underlying
etiology (80.6% ). There was a statistically significant
differenceinintraocular pressure(IOP) reductionpostoperatively
preoperatively ( <0.001). Four eyes failed to control IOP
and received second filtration surgery. The main
postoperative complications included shallow anterior
chamber (20.0%) and malignant glaucoma (12.0%).
·CONCLUSION: The younger PCACG patients in advanced or
late stage can be effectively managed by trabeculectomy.
They have more frequency of postoperative sustained shallow
anterior chamber and malignant glaucoma. Careful ophthalmic
examinations, delicate surgical procedures and well-managed
technique of complications were suggested on younger
PCACG patients]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xiu-Lan Zhang,Ang Li,Lei-Lei Teng,Shao-Lin Du,Yun-Yun Zhu and Jian Ge]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiu-Lan Zhang,Ang Li,Lei-Lei Teng,Shao-Lin Du,Yun-Yun Zhu and Jian Ge</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200802010]]></guid><cfi:id>1533</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Recombinant tissue plasminogen activator for treatment of fibrinous membranes after cataract surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200802011]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the efficacy of recombinant tissue plasminogen activator (TPA) for treatment of fibrinous membranes following cataract surgery.
· METHODS: 25μg of TPA was injected into the anterior chamber of 15 pseudophakic eyes with moderate to severe fibrinous membranes that developed after cataract surgery. Simultaneously, topical corticosteroid and cycloplegic therapy was continued. Routine follow-up included slit-lamp examination and intraocular pressure measurement.
· RESULTS: Injection of the solution of tissue plasminogen activator into anterior chamber of 15 eyes resulted in complete dissolution of the fibrinous membranes in 9 (60.0%) eyes after 2 hours, and 11 (73.3%) eyes within 1 day. In 3 eyes, within a few days after injection, fibrinous membrane recurred. Increased anterior chamber reaction (P =0.54) and corneal edema (P =0.083) were seen after 24 hours. No evidence of toxicity was observed as measured by slit-lamp biomicroscopy and intraocular pressure. Finally, expectable stable result was obtained in all of the eyes.
· CONCLUSION: Safety and high efficacy of TPA in the treatment of fibrinous membranes after cataract surgery are confirmed.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Heydar Siatiri,Bahram Eshraghi,Mohammad Taher Rajabi,Firoozeh Rahimi and Nasim Siatiri]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Heydar Siatiri,Bahram Eshraghi,Mohammad Taher Rajabi,Firoozeh Rahimi and Nasim Siatiri</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200802011]]></guid><cfi:id>1532</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Changes of intraocular pressure after intravitreal
injection of 4mg triamcinolone acetonide in treatment
of macular edema]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200802012]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the changes of intraocular pressure
(IOP) and associated factors of IOP elevation after 4mg
intravitreal injection of triamcinolone acetonide (IVTA) in
treatment of macular edema.
·METHODS: The study is prospective, consecutive, and
non-comparative interventional case series including 93 eyes
with macular edema associated with retinal vein occlusion
( =54 eyes) or diabetic retinopathy ( =39 eyes), which
received 4mg IVTA injection. The change in IOP was followed
for all cases at pre-operation and 14 days, 1, 2, 3, 4, 5, and 6
months post-operation. Associated factors of IOP elevation
were examined regarding baseline IOP, causal disease, age
and gender.
·RESULTS: IOP increased significantly ( <0.001) at 14 days
16.02 ± 2.45mmHg after injection and peaked at 18.80 ±
6.20mmHg at 2 months post-injection ( <0.001) from
14.85± 2.55 mmHg preoperatively. An IOP rise to the value
higher than 21mmHg was observed in 2 (2.2%) eyes 14 days
after injection and which was observed in 14 (15.1%), 18
(19.5%), 9(9.6%), 4(4.3%), 0, and 0 eyes respectively at 1,
2, 3, 4, 5, and 6 months after injection. One eye (1.07%)
showed pressure elevation of over 5mmHg than baseline 14
days after injection and IOP peaked to 22mmHg (23.7%) at 2
months after injection. Five (5.3%) eyes had an increase of
10mmHg at 1 month and IOP peaked to 12mmHg (12.9%) at
2 months after injection. The rise in IOP was statistically
associated with younger age (correlation coefficient -0.18-
-0.29, <0.05), high baseline IOP (correlation coefficient
0.52-0.79, all <0.001), and the presence of diabetes
mellitus (correlation coefficient 0.23, <0.001) but
independent of gender (correlation coefficient -0.002-0.04, all
>0.05). In all eyes, IOP could be lowered to the normal
range with topical medication, without development of
glaucomatous optic nerve head changes.
·CONCLUSION: Elevated IOP after 4mg IVTA injection is
common and patients should be monitored beyond 6 months
post-injection. In all the cases, IOP can be normalized by
topical medication. Patients with high baseline IOP, diabetic
retinopathy, and younger age should be carefully monitored
for an elevated IOP.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Li-Li Wang,Hu-Ping Song and Bei Liu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Li-Li Wang,Hu-Ping Song and Bei Liu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200802012]]></guid><cfi:id>1531</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Retinopathy of prematurity in a tertiary center in south of Brazil]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200802013]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the incidence of retinopathy of prematurity(ROP) in the southern Brazil, the rate of treatment and outcomes in all premature infants born at Hospital de Clinicas de Porto Alegre, Brazil, from October 2002 to October 2006. 
· METHODS: A prospective cohort study was conducted on 323 premature children born at Hospital de Clinicas de Porto Alegre, Brazil, from October 2002 to October 2006 with birth weight equal to or less than 1 500g or a gestational age at birth of 32 weeks or less. All of the newborns were examined by indirect binocular ophthalmoscopy with the 28 diopters lens after pupil's dilation and a lid speculum after the sixth week of life with examinations repeated depending on the disease classification. The main clinical outcome was the occurrence of ROP at any stage.
· RESULTS: ROP occurred in 82 infants with an incidence rate of 25.7%. Threshold disease occurred in only 17 of the patients (5.3%), all of them had the disease affecting posterior Zone II needing laser treatment. None of the treated children had Zone I or aggressive posterior disease despite that three of the treated children needed a second laser session. One patient of the re-treated group needed scleral buckling with an equatorial silicon band after progression to stage 4 of ROP.
· CONCLUSION: The incidence of retinopathy and the threshold disease in this study was similar to the international results reported. This study showed a high survival rate (70.1%), high incidence of retinopathy, and high laser treatment necessity among newborns under 28 weeks of gestational age or under 1 000g of birth weight. This study drove attention about the no identification of any Zone I posterior disease in this cohort of patients.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Joao Borges Fortes Filho,Cristiano Koch Barros,Gabriela Unchalo Eckert,Leticia Procianoy and Renato S Procianoy]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Joao Borges Fortes Filho,Cristiano Koch Barros,Gabriela Unchalo Eckert,Leticia Procianoy and Renato S Procianoy</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200802013]]></guid><cfi:id>1530</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Vitrectomy for the treatment of posttraumatic endophthalmitis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200802014]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the efficacy of vitrectomy in combination with intravitreal dexamethasone and vancomycin perfusion in the management of severe posttraumatic endophthalmitis. 
· METHODS: Thirty eyes of 30 cases diagnosed as posttraumatic infectious endophthalmitis were analyzed retrospectively  from April 2004 to April 2006. All the patients underwent vitrectomy in combination with intravitreal drugs perfusion and were followed up for 12 to 24 weeks. The visual acuity, traumatic causes and microorganisms culture were analyzed.
· RESULTS: There are significant reduction in inflammation at 3 months after surgery. Infectious symptoms were completely controlled in 97% of the cases(29/30). Final visual acuity were improved in 93% of cases (28/30). Among traumatic causes, foreign body is the most common cause (57%). Staphylococcus aureus is the commonest microorganism.
· CONCLUSION: Vitrectomy in combination with intravitreal dexamethasone and vancomycin perfusion is the most effective method in the treatment of severe posttraumatic endophthalmitis.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xiao Ma,Zao-Xia Liu,Yi-Fei Huang and Zhao-Hui Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiao Ma,Zao-Xia Liu,Yi-Fei Huang and Zhao-Hui Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200802014]]></guid><cfi:id>1529</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[The measurement of anterior chamber depth and
axial length with the IOLMaster compared with
contact ultrasonic axial scan]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200802015]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the measurement of anterior chamber depth (ACD) and axial length (AL) by IOLMaster and contact ultrasonic (US) axial scan (A-scan).
· METHODS: Measurements of ACD and AL were prospectively obtained in 137 eyes of 121 subjects with the IOLMaster compared with measurements with the US.
· RESULTS: There was an excellent correlation between IOL Master and US measurements for the ACD (r =0.823;P < 0.001) and AL (r =0.996;P <0.001). The mean values of the parameters measured by IOLMaster and US were, respectively, as follows: ACD, 2.94±0.49mm, 2.58±0.51mm; AL, 24.37±3.04mm, 23.81±2.83mm. The mean differences of ACD and AL values between IOLMaster and US measurements were 0.36±0.30mm, 0.56±0.34 mm respectively, and they proved to be statistically significant (P < 0.001), with the 95% limits of agreement (LoA) from -0.08mm to +0.38mm for ACD and from -0.09mm to +0.69mm for AL.
· CONCLUSION: As noncontact biometry, IOLMaster provides accurate values. A high degree of agreement between US and IOLMaster was noted. It not only has the advantage of performing noncontact examinations, but also produces various additional data simultaneously and may thus obviate the need for multiple examinations. Further studies are needed to assess the interchangeability of measurements in clinical practice.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Quan-Hao Bai,Jun-Li Wang,Qing-Qiang Wang,Qi-Chang Yan and Jin-Song Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Quan-Hao Bai,Jun-Li Wang,Qing-Qiang Wang,Qi-Chang Yan and Jin-Song Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200802015]]></guid><cfi:id>1528</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical study on "one-stitch anastomosis through the skin" repair of canalicular laceration]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200802016]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM：To evaluate the efficacy and safety of  "one-stitch anastomosis through the skin" repair of canalicular laceration.
METHODS：The data of 32 cases (32 eyes) of canalicular laceration who underwent repair of lacerated canaliculi with one-stitch anastomosis through the skin were retrospectively reviewed, inferior canalicular laceration in 29 patients, superior canalicular laceration in 1 patient, 2 cases involving both the inferior and superior canalicular laceration. All the operations were performed under surgical microscope, 5-0 silk sutures were used and silicone tube of 0.8mm diameter was employed in intubation. The stents were left in place for 3 months postoperatively and then removed. The follow-up period was 1 to 36 months.
· RESULTS: In 32 patients, 28(88%) patients were cured entirely, 3 (9%)patients were meliorated, and 1(3%) patient had no effects. A total of 29 patients complied with scheduled follow up 1-36 months (average 12 months) after stent removal, and 3 patients were lost in follow-up. All the patients had got good recovery of eyelid laceration with no traumatic deformity in eyelid and canthus.   
· CONCLUSION: In "one-stitch anastomosis through the skin" repair of canalicular laceration, the cut ends could be anastomosed directly，for there was no suture remained in the wound permanently, so there was no suture-related granuloma which might cause obstruction or stenosis of canaliculi. It was simple, economical，effective and safe.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hai Tao,Wei Wang,Peng Wang,Jie Zhao,Wei-Qun Yu,Hai-Yang Wu,Chuan Liu,Bao-Jie Hou and Qing Xu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hai Tao,Wei Wang,Peng Wang,Jie Zhao,Wei-Qun Yu,Hai-Yang Wu,Chuan Liu,Bao-Jie Hou and Qing Xu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200802016]]></guid><cfi:id>1527</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Dry eye in post-menopausal Asian women on hormone replacement therapy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200802017]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the occurrence of dry eye in post- menopausal women between those with hormone replacement therapy and those without hormone replacement therapy (HRT). 
· METHODS: A comparative cross-sectional study was carried out to determine the occurrence of dry eye in control subjects and those on HRT. Schirmer's test, tear film break-up time and Rose Bengal staining were performed on all participants. 
· RESULTS: Fifty-four women were examined. Among them 30 (55.6%) were on hormone replacement therapy (Group 2), while the control group consisted of 24 (44.4%) women without any hormone replacement therapy (Group 1). In Group 2 (HRT), 11 patients were on estrogen (Group 2A) and 19 patients were on combined estrogen and progesterone (Group 2B). Dry eye was found in 29.2% of patients in Group 1 (Control) and in 70.0% of patients in Group 2 (HRT) (P = 0.003). In Group 2 (HRT), dry eye was more common in Group 2B, 84.2% compared to Group 2A, 45.5% (P =0.042). 
· CONCLUSION: Dry eye was found more commonly in post-menopausal women who took HRT in our study. Our finding has negated the previous assumption that HRT is a protective factor against dry eye.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[B Shaharuddin,S F Ismail-Mokhtar and E Hussein]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>B Shaharuddin,S F Ismail-Mokhtar and E Hussein</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200802017]]></guid><cfi:id>1526</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Study of the indications and changing trends of
enucleation and evisceration in West Malaysia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200802018]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To study the demographic pattern and indications for enucleation and evisceration in West Malaysia, and to evaluate the changing trends of the same over the past three decades.
· METHODS: In a retrospective hospital based study, case records of all patients who underwent enucleation and evisceration at University of Malaya Medical Centre over a period of 20 years (1985/2004) were reviewed. Age, gender, ethnicity of patients, indications for enucleation and evisceration were evaluated.
· RESULTS: Out of 160 patients, enucleation was done in one eye in 85 patients and evisceration was done in one eye in 75 patients during the study period. The mean age of patients was 36.4 years with a range of 6 months to 90 years. In our study, panophthalmitis (26.9%) and retinoblastoma (18.8%) were the most common causes of evisceration and enucleation respectively. Infections of the eye contributed to 72.0% of eviscerations while tumors contributed to 51.8% of enucleations. There was a significant decrease in the removal of eyes over the past three decades in our hospital. The number of removal of eyes for glaucoma and trauma-related causes significantly reduced while removal for infection- related causes and painful blind eyes significantly increased when compared to the figures reported three decades ago from our hospital.
· CONCLUSION: Panophthalmitis and intraocular tumors are the major indications for the removal of eyes. Although the frequency of removal of eye has significantly decreased over time in our country, the indications for the same suggest that there is a need of further improvement of eye care services in Malaysia.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[I Tajunisah,S C Reddy and S Mas-Ayu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>I Tajunisah,S C Reddy and S Mas-Ayu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200802018]]></guid><cfi:id>1525</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical features of Graves' ophthalmopathy in Iran]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200802019]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the clinical characteristics of a prospective study of patients with Graves' ophthalmopathy(GO). 
· METHODS: We reviewed clinical manifestations, and medical records of 103 patients in whom GO was diagnosed between 2003 and 2005. 
· RESULTS: Among 103 patients with GO, 48 (46.6%) male and 55 (53.3%) female, with mean age of 45 (range; 18-73) years, 95 (92.2%) patients had Graves' hyperthyroidism, 3 (2.9%) had primary hypothyroidism, and 5 (4.8%) were euthyroid. The mean duration of ocular symptoms was 13.2 (range 2-95) months while the mean duration of dysthyroid symptoms was 39.4 (range 6-180) months. Unilaterality occurred in 12 patients.  Eyelid retraction was presented in 90 patients (87%), whereas the approximate frequency of exophthalmos was 77.6% (80 patients); restrictive extraocular myopathy, 29% (30 patients); evidence of extraocular enlargement on CT-scan in 52 patients of 70 patients (74%) that was evaluated, and optic nerve dysfunction, 5.8% (6 patients). 22 (21%) patients had glaucoma associated with GO that 7 (6.7%) of them were normal-tension glaucoma. 
· CONCLUSION: Eyelid retraction was the most common clinical sign of GO in our patients. Larger prospective studies are suggested to evaluate both the prevalence and possible racial difference in its clinical presentation in Iranian population.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ali Sadeghi Tari,Mohammad Taher Rajabi,Khalil Hamzedust,Seyed Ziaeddin Tabatabaie and Abolfazl Kasai]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ali Sadeghi Tari,Mohammad Taher Rajabi,Khalil Hamzedust,Seyed Ziaeddin Tabatabaie and Abolfazl Kasai</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200802019]]></guid><cfi:id>1524</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Contrast sensitivity after excimer laser photorefractive keratectomy for myopia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200802020]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate contrast sensitivity in patients who had undergone uncomplicated excimer laser photorefractive keratectomy (PRK) for myopia.
· METHODS: Monocular contrast sensitivity function was measured with the CSV-I000E chart in 41 patients who had received PRK by the Nidek EC-5000 excimer laser system. Mean preoperative refractive error was -2.62±1.33 D (range, -0.75 to -4.00 D). Contrast sensitivity function was measured preoperatively, 1week, 1, 3 and 6 months after surgery through the CSV-1000E contrast sensitivity unit (VectorVision).  · RESULTS: Logarithmic values of contrast sensitivity at each spatial frequency were used for statistical analysis and normalized values were used for graphical representation. Contrast sensitivity decreased 1 week and 1 month postoperatively. Starting from the first month, there was rapid recovery of contrast sensitivity especially at low spatial frequencies, and at the third month, only at 6 and 12 cycles per degree (cpd) statistically significant decrease was seen. Six months after surgery, there was an increase in contrast sensitivity values at all spatial frequencies. 
· CONCLUSION: Photorefractive keratectomy can induce significant reductions in contrast sensitivity in the first month after surgery; these values returned to the preopereative values at 6 months after surgery.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mahmoud Jabbarvand,Javad Bakhshi and Mohammad Taher Rajabi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mahmoud Jabbarvand,Javad Bakhshi and Mohammad Taher Rajabi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200802020]]></guid><cfi:id>1523</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Early phototherapeutic keratectomy in recurrent corneal erosion]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200802021]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the morphological and functional outcomes of earlier excimer laser phototherapeutic keratectomy (PTK) for treatment of recurrent corneal erosion (RCE). 
· METHODS: A total of 25 eyes of 23 patients with RCE were enrolled in a prospective non-randomized consecutive study. In all cases, RCEs were unresponsive to conventional treatment methods. No one had experienced stromal puncture or tried contact lens previously. After complete ophthalmologic examination, central excimer laser PTK with ablation depth of 10μm and optical zones of 4-8 mm was performed. Uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), spherical equivalents (SE) and refractive cylinder (RC) were compared before and after phototherapeutic keratectomy.
· RESULTS: Previously 2 patients had undergone epithelial scraping. Duration of disease ranged from 2 months to 3 years prior to PTK (mean=9.3 months). The mean follow-up time was 10.1±5.5 months (4.2-19.2 months). Success rate after PTK, regarding prevention of recurrence was 96% when they were under follow-up. BCVA was also increased from 0.69±0.30 to 0.90±0.23 (P <0.001). Mean SE remained constant with values of 0.41±1.67D preoperatively and 0.35?.63D postoperatively (P =0.26). Mean RC was also improved from -1.22±0.90D preoperatively to -0.57±0.57D postoper- atively (P <0.001).
· CONCLUSION: PTK using 193nm excimer laser is an effective and safe choice of treatment for a fast epithelial closure, an increase of visual acuity and alleviating symptoms in most patients with RCE in earlier course of the disease.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[M N Hashemian,S Moghimi,F Rahimi,B Dehsarvi,Z Najmi and M T Rajabi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>M N Hashemian,S Moghimi,F Rahimi,B Dehsarvi,Z Najmi and M T Rajabi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200802021]]></guid><cfi:id>1522</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A comparison study of the clinical features between
Chinese and Indian primary congenital glaucoma
patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200801013]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[To summarize the clinical features of Chinese primary congenital glaucoma(PCG) and to investigate the discrepancies of the clinical features between the Chinese and Indian patients.
· METHODS: Clinical records of 40 Chinese PCG patients were reviewed. The clinical features were summarized as several quantifiable clinical parameters and the severity of the disease was evaluated. Both the quantified clinical features and severity were statistically compared with those of the Indian patients, which were cited from the previously published articles.
· RESULTS: Forty Chinese and 43 Indian patients were included in the study. In Chinese patients, sex ratio (male to female )was about 2:1, family history was presented in 3 patients(7.5%) and consanguinity was found in one patient (2.5%). The main symptoms and signs observed in Chinese patients spanned a wide spectrum of manifestations. The most frequent signs noted in the initial examination were enlarged eyeball (42.5%) and decreased visual acuity(VA)(35.0%). Compared with Indian patients, Chinese patients had a later onset, a delayed diagnosis , more severe corneal changes and more severe optic nerve damages(P  <0.01). The combined trabeculectomy and trabeculotomy operation was preferred by both Chinese and Indian doctors whereas a higher proportion of Indian patients received the combined operation (P <0.01). The proportions of the severity grade were different between Chinese and Indian patients. Most Chinese patients were in the severe grade while most Indian patients were in the very severe grade (P  <0.01). 
· CONCLUSION: Chinese PCG patients were sporadic and non-consanguineous. Compared with Indian patients, Chinese patients had a relative later onset, a delayed diagnosis and treatment. More attempts are needed in Chinese PCG prevention and treatment.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mao Li,Xiao-Ming Chen,Ya-Li Liu,Ru-Gang Pan,Dong-Jing Liu and Ni Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mao Li,Xiao-Ming Chen,Ya-Li Liu,Ru-Gang Pan,Dong-Jing Liu and Ni Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200801013]]></guid><cfi:id>1521</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Changes in intraocular pressure after topical
anaesthetic instillation]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200801014]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[To determine the influence of topical anaesthetic drops, age and central corneal thickness (CCT) in the determination of intraocular pressure (IOP) by non contact tonometry (NCT).
· METHODS: Ninety-three eyes from 47 patients were examined for CCT and IOP by NCT before and after the instillation of topical anaesthetic drops.
· RESULTS: Average age was 66.4 (SD 16, range 34 to 88 years-of-age). Thirty one patients were female and 16 were male. Average basal IOP was 16.0mmHg (SD 4.0, range 8.5 to 26.1). IOP one minute after topical anesthesia instillation was 15.0mmHg (SD 3.8, range 7.7 to 26.7), and 14.9mmHg (SD 3.9, range 7.6 to 26.3) five minutes after the instillation. The differences were statistically significant for the 0 to 1 minute lapse(P =0.0007) and for the 0 to 5 minute lapse (P = 0.0003), but not for the 1 to 5 minute lapse (P =0.27) (Student's t test for paired data). Average CCT before topical anaesthetic drops was 565.4 microns. Simple linear regression analysis demonstrated absence of significant variation between age and IOP changes and between CCT and IOP changes.
· CONCLUSION: Our study confirms that the instillation of topical anaesthetics causes a reduction in IOP, which is progressive during the first 5 minutes after instillation. This IOP reduction does not seem to be associated with basal CCT or age.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Javier A Montero,Jose M Ruiz-Moreno,Marta Fernandez-Munoz and M.Isabel Rodriguez-Palacios]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Javier A Montero,Jose M Ruiz-Moreno,Marta Fernandez-Munoz and M.Isabel Rodriguez-Palacios</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200801014]]></guid><cfi:id>1520</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Early changes of retinal function in diabetic patients
detected by multifocal electroretinogram]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200801015]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[To investigate the early changes of retinal function in
diabetic patients detected by multifocal electroretinogram
(mfERG).
·METHODS: The first-order kernel responses of mfERG were
recorded fromeyes of 33 normal control subjects, 63 diabetic
patients without retinopathy and 43 diabetic patients with
background retinopathy. The response densities and implicit
times of N<sub>1</sub> and P<sub>1</sub> were compared among the control, diabetic
patients without retinopathy and diabetic patients with
retinopathy.
·RESULTS: The response densities of N1 and P1 in central 3
rings were reduced significantly in diabetic eyes with and
without retinopathy. And the implicit times of N<sub>1</sub> and P<sub>1</sub> were
delayed significantly only in diabetic eyes with retinopathy.
·CONCLUSION: mfERG can detect the early changes of
retinal function quantitatively in diabetic patients. Analysis of
response densities and implicit times of N<sub>1</sub> and P<sub>1</sub> can reflect
the progress of local retinal dysfunction in diabetes]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mei Wang,Yu-Qing Lan,Yan-Fen Liu,Hui Guo,Zhao-Xia Xia and Zi-Li Zhou]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mei Wang,Yu-Qing Lan,Yan-Fen Liu,Hui Guo,Zhao-Xia Xia and Zi-Li Zhou</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200801015]]></guid><cfi:id>1519</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[PFCL and ILM peeling in macular hole with retinal detachment]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200801016]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[To investigate the early changes of retinal function in
diabetic patients detected by multifocal electroretinogram
(mfERG).
·METHODS: The first-order kernel responses of mfERG were
recorded fromeyes of 33 normal control subjects, 63 diabetic
patients without retinopathy and 43 diabetic patients with
background retinopathy. The response densities and implicit
times of N<sub>1</sub> and P<sub>1</sub> were compared among the control, diabetic
patients without retinopathy and diabetic patients with
retinopathy.
·RESULTS: The response densities of N1 and P1 in central 3
rings were reduced significantly in diabetic eyes with and
without retinopathy. And the implicit times of N<sub>1</sub> and P<sub>1</sub> were
delayed significantly only in diabetic eyes with retinopathy.
·CONCLUSION: mfERG can detect the early changes of
retinal function quantitatively in diabetic patients. Analysis of
response densities and implicit times of N<sub>1</sub> and P<sub>1</sub> can reflect
the progress of local retinal dysfunction in diabetes]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Nazimul Hussain,Anjli Hussain and Sundaram Natarajan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Nazimul Hussain,Anjli Hussain and Sundaram Natarajan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200801016]]></guid><cfi:id>1518</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Evaluation of the acute effect of Sildenafil citrate on
visual function in patients with early -stage age
related macular degeneration]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200801017]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[To assess the effect of a single dose of Sildenafil citrate on the visual function in men with early-stage age related macular degeneration(AMD).
· METHODS: Forty men (mean age 71, range from 55-86 years)with early-stage AMD were prospectively randomized to receive either placebo or Sildenafil citrate (Viagra; Pfizer Inc, New York, NY) 100mg as a single oral dose. Subjects underwent visual acuity, Amsler grid and color discrimination in each eye before and at specific intervals within 9 hours after dosing.
· RESULTS: Compared with placebo, no pattern of errors were evident in any visual function test following Sildenafil administration. No statistically or clinically relevant changes from baseline were observed in visual acuity or color discrimination. No clinically relevant changes were observed in the Amsler grid. Sildenafil treatment was associated with transient mild or moderate headache and flushing. 
· CONCLUSION: A single 100mg dose of Sildenafil was well tolerated and produced no significant acute visual effects in a sample of men with early-stage AMD.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Neveen Mostafa Sabra Ibrahim,Hisham Aly Hashem and Ahmed Youssef Helal]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Neveen Mostafa Sabra Ibrahim,Hisham Aly Hashem and Ahmed Youssef Helal</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200801017]]></guid><cfi:id>1517</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Visual outcome after optimized aspheric transition
zone laser keratomileusis compared to
conventional LASIK]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200801018]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[To compare the visual effects of optimized aspheric
transition zone Laser keratomileusis （OATｚ-LASIK ）
versus conventional Laser in situ keratomileusis (con. LASIK).
METHODS: In a prospective study 44 patients (88 eyes)
underwent OAT<sub>ｚ</sub>-LASIK and 50 patients (92 eyes) received
conventional LASIK surgery. Visual acuity,refractions、contrast
sensitivity （CS）,
glare sensitivity （GS）, and increment of
Q-value after surgery were studied.
RESULTS: All of operations on 94 cases were successful
without severe complication after 3 months' follow-up. There
was no significant difference in term of postoperative
refractions between the two groups ( -test). The uncorrected
visual acuity (UCVA), CS, GS, and increment of Q-value of
OAT<sub>ｚ</sub>group were significantly better compared to the
tradition group 3 months after the surgery ( <0.05).
CONCLUSION: OATｚ- LASIK is a more effective procedure
to improve visual quality compared to conventional LASIK]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Li Xu,Tao Qian and Yi-Zhuang Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Li Xu,Tao Qian and Yi-Zhuang Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200801018]]></guid><cfi:id>1516</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Topographic changes at the optic disc in 33 patients
with primary open angle glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200904018]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To show frequency of progression and the progression at the optic disc in primary open angle glaucoma (POAG).
 METHODS: A total of 33 patients (66 eyes), 14 male and 19 female, aged 14 to 79 with POAG were imaged using the Heidelberg Retina Tomography II (HRT II) three or more times during follow-up periods of 6 years (2000-2006). Disc progression was determined by regression analysis of global and segmental changes in optic disc parameters. Every patient was tested by Octopus G1 once a year. Imaged optic disc parameters with scanning laser tomography were: rim area (ra), cup/disc (C/D), rim volume (rv), mean RNFL thickness (mRNFL). Imaged segments of the optic disc were global (G), temporal (T), temporal superior (TS), temporal inferior (TI), nasal (N), nasal superior (NS) and nasal inferior (NI).
 RESULTS: Global frequency of progression according to c/d ratio existed in 34 eyes (51%), but 32 eyes (48%) were without frequency of progression. Progression existed in 12 eyes (18%) in temporal, 7 eyes (10.6%) in TS, 14 eyes (21%) in TI, 8 eyes (12%) in N, 7 eyes (10.6%) in NS, and 13 eyes (20%) in NI segment. Without progression were 5 eyes (8%).
 CONCLUSION: Disc progression in our study is mostly in N and TI segments. Most frequently are stricken TI and NI, but most infrequently NS segment. Most sensitive parameter is c/d ratio. Segmental scanning is of importance in POAG progression analysis.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ivan Marjanovic,Djordje Kontic,Paraskeva Hentova-Sencanic,Vujica Markovic,Marija Bozic and Natasa Milic]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ivan Marjanovic,Djordje Kontic,Paraskeva Hentova-Sencanic,Vujica Markovic,Marija Bozic and Natasa Milic</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200904018]]></guid><cfi:id>1515</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Corneal topography and hyperopia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200904019]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate Orbscan II corneal topography in hyperopic cases.
 METHODS: A retrospective, observational, consecutive, clinical case series in 295 eyes of hyperopic patients who undergo a LASIK evaluation. The information that was reviewed included age, sex of the patients and the Orbscan II corneal topographic maps. Refractive powers and the following test indices produced by Orbscan II were analyzed: keratometry, corneal diameter, pupil diameter and anterior chamber depth. 
· RESULTS: The total mean corneal thickness was 546.3±35.5μm. It was found; 547.3±38.4μm in 17-29 years old, 553.4±38.3μm in 30-44 years old and 546.2±29.3μm in older than 45 years old. The mean corneal thickness was found 551.5±35.9μm in female, and 542.6±34.7μm in male. The total mean depth of anterior chamber was 2.57±0.40mm and in 17-29 years old patients was 2.82±0.39mm. In 30- 44 years old patients was 2.49±0.39mm and in patients older than 45 years old was 2.37±0.40mm. The mean depth of anterior chamber was 2.53±0.40mm in female and 2.60±0.40mm in male. A reverse significant relation between corneal thickness and keratometry were found. Refractive error severity had a reverse correlation with depth of anterior chamber and a correlation with keratometry (P =0.061, r = 0.108).Corneal thickness had a reverse correlation with keratometry (P =0.005, r =0.160), and correlation with pupil diameter (P =0.013, r =0.144).
· CONCLUSION: We provides a description and analysis of Orbscan II findings in hyperopic patients These show mean corneal thickness 546.3±35.5μm and anterior chamber depth 2.57±0.40mm in hyperopic patients.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Masoud Reza Manaviat,Mohammad Reza Besharati,Maryam Kheirandish and Maryam Dehyadegari]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Masoud Reza Manaviat,Mohammad Reza Besharati,Maryam Kheirandish and Maryam Dehyadegari</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200904019]]></guid><cfi:id>1514</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Hospital -base epidemiology, risk factors and
microbiological diagnosis of bacterial corneal ulcer]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200904020]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the predisposing factors, clinical and microbial characteristics of bacterial corneal ulcer.
 METHODS: Three hundred patients (300 eyes) of clinically suspected microbial corneal ulcer were included in the study. Data was collected through history and slit lamp examination. Using standard techniques, corneal scraping was performed. A portion of each scraping was examined by direct microscopy for the presence of bacteria, fungi and acanthamoeba by using 100g/L potassium hydroxideand also by Gramand staining. Another portion was inoculated directly on the surface of solid media such as blood agar, Mac-Conkey agar, chocolate agar and Sabouraud's agar. A bacterial corneal ulcer was defined as a suppurative corneal infiltrate and overlying epithelial defect associated with presence of bacteria on corneal scraping examination and cured with antibacterial therapy. 
 RESULTS: Of the 300 patients, sixty were lost in follow up, they were excluded from study. Of the remaining 240, bacterial corneal ulcer was identified in 156 (65.0%) patients. The age of patients ranged from 14 to 74 (mean age of 48) years. Majority of them were male (102). Corneal localization of the ulcers was distributed as central in 96 (61.5%) patients and peripheral in 60 (38.5%) patients. Ulcer depth in 82 (52.6%) patients was less than 1/3 of corneal thickness. In 64 (41.0%) patients, anterior chamber inflammation was 1+ to 2+ Tyndall effect with 1+ to 2+ cells present. Bacteria were isolated in 125 (80.0%) patients from the corneal smears. Sixty-nine percent of isolated bacteria were Grams' positive, and 39% were Grams' negative. Gram negative bacteria were associated with severe anterior chamber inflammation (P =0.003) and depth more than 2/3 of cornea (P =0.001). The most frequent organism isolated was Staphylococcus aureus. Forty percent of patients had good visual outcome with visual acuity same or better than the level at admission. Among the others 60% patients, final outcome was poor.
 CONCLUSION: Bacterial corneal ulcer is aserious ocular infectious disease that remains a therapeutic challenge and vision threatening ocular condition. Rapid isolation of bacteria and treatment with intensive ocular antibiotics represent decisive steps in the management of such pathologies.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ashok Kumar Narsani,Shafi Muhammad Jatoi,Mahesh Kumar Lohana,Syed Asher Dabir,Siddiqa Gul and Mahtab Alam Khanzada]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ashok Kumar Narsani,Shafi Muhammad Jatoi,Mahesh Kumar Lohana,Syed Asher Dabir,Siddiqa Gul and Mahtab Alam Khanzada</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200904020]]></guid><cfi:id>1513</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Reappraisal of the capsulorhexis: tearing angle in
capsulorhexis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200903019]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the tearing angle and tearing force, and effects of associated pressures in tearing of various materials and human lens capsule in continuous curvilinear capsulorhexis (CCC). 
 METHODS: Tearing was done on different materials such as aluminum-laminated paper, different types of thin transplant plastics and human lens capsule with blunt tip needle. During the procedure, angle and direction of force were measured. Effects of increased underlying pressure on tearing of tearable materials and effect of anterior chamber depth and vitreous pressure on 24 postmortem human eyes with different ages (range from10 to 75 years), was evaluated. RESULTS: Tearing angle in every material was unique for that material Angle and force of tearing was decreased reversely with increasing age (from 85 degree in a 10-years-old to 10 degree in older than 50 years). Increasing vitreous pressure and decrease in AC depth causes higher pressure on point of tearing. Safe methods in controlling CCC were discussed in the context.
· CONCLUSION: Understanding the physics and vector of forces during CCC is necessary in good performance and avoidance of radial tears. Change in capsular properties between different ages and different type of cataract causes different tearing angle and tearing force that should be considered during CCC.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mohammad Taher Rajabi,Ali Sadeghi Tari,Mahmood Jabbarvand and Mohammad Bagher Rajabi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mohammad Taher Rajabi,Ali Sadeghi Tari,Mahmood Jabbarvand and Mohammad Bagher Rajabi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200903019]]></guid><cfi:id>1512</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Study on dominant eye measurement]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200903020]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To examine a new performance test for detecting eye
dominance by testing and re-testing with two different
methods of the same subjects for comparing and discussing
the reliabilities of these tests.
 METHODS: A total of 179 university students (mean± SD:
19.37± 1.62 years) were voluntarily participate in this survey
consisting of 110 females (61.5%) and 69 males (38.5%).
Eye dominances were determined by two different methods
which were named McManus and a Gündoğan tests. The
reliability of the survey was examined using a test-retest
method.
 RESULTS: Without sex difference, right eyes were found
dominant in 128 (71.5 %) participants by McManus test. The
same subjects were re-tested by Gündo an method, the right
eye dominance were found in 110 (61.5%) subjects. The
results of these two methods were related significantly by
Fisher exact test(P<0.01), with an agreement score( k=0.256,
P<0.001). In females, the right eye dominance was found in
74 (67.3%) and left eye was found in 36 (32.7%) by
McManus test. When the same subjects were re-tested by G
ndo an method, the right eye dominance was found in 62
(56.4%) and the left eye dominance was found in 48 (43.6%)
subjects.McManus and Gündoğan methods results for females
were related significantly by Fisher exact test ( P<0.05), with
a weak agreement score ( k=0.239, P<0.01). In males, the
right/left eye dominances were found respectively 54
(78.3%), 15(21.7%) by McManus test as they were found 48
(69.6 %), 21 (30.4 %) in the same participants when they
were re-tested by Gündoğan method.χ <sup>2</sup> test and Fisher exact
test were used for the analysis of categorical data. The
agreement between different methods was analyzed with
Kappa statistics. Comparison of proportions was made by two
proportions test. value less than 0.05 was considered as
significant.
 CONCLUSION: Without gender difference and also in both
females and males marked right eye dominance is observed.
The right eye dominance is considering functional laterality
may due to the dominance of left hemisphere instead of right
hemisphere. It is an important topic for future research in
laterality, and it may well become an important model system
for future research."]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Nimet ünay Gündo?an,Ay?e Canan Yazlcl and Ayten ?im?ek]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Nimet ünay Gündo?an,Ay?e Canan Yazlcl and Ayten ?im?ek</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200903020]]></guid><cfi:id>1511</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparative incidence of posterior capsular opacification
in AcrySof and PMMA intraocular lenses]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200902012]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the extent of significant posterior capsular
opacification (PCO) after implanting polyme-thylmethacrylate
(PMMA) and soft acrylic intraocular lenses.
 METHODS: A total of one hundred patients (110 eyes)
undergoingintraocular lens(IOL) implant surgerywererandomly
divided into two groups based on the type of IOL implanted:
Group I: AcrySof (SA60AT) and Group II: PMMA (LX10BD).
The density of posterior capsular opacification (PCO) was
assessed 3, 6, 12 and 18 months after surgery by taking best
corrected visual acuity (BCVA) and the digital photographs.
 RESULTS: At the end of 3 months postoperatively, the PCO
density in the Group I (PMMA) increased significantly (3.6%)
while no increase was found in the Group II (Acrylic). By the
end of 18 months follow-up, the incidence of significant PCO
was found to be less in the acrylic group (14.5%) as
compared to the PMMA group (34.5%).On the basis of
density, the PCO was more extensive with the PMMA lens
than the AcrySof lens, which led to more severe visual loss.
 CONCLUSION: The intraocular implantation of the AcrySof
IOL helps to reduce the incidence of PCO to a greater degree
as compared to the PMMA IOL.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mahtab Alam Khanzada,Siddiqa Gul,Syed Asher Dabir,Shafi Muhammad Jatoi and Ashok Kumar Narsani]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mahtab Alam Khanzada,Siddiqa Gul,Syed Asher Dabir,Shafi Muhammad Jatoi and Ashok Kumar Narsani</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200902012]]></guid><cfi:id>1510</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Fungal keratitis:84 cases report in Southern Pakistan]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200902013]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To identify the predisposing factors, causative fungi and to improve the facilities for the laboratory diagnosis of fungal keratitis.
  METHODS: Two hundred and forty eyes of 240 patients of clinically suspected microbial corneal ulcer were included in the study. Data was collected through history and slit lamp examination. Using standard techniques, corneal scraping was performed.A portion of each scraping was examined by direct microscopy for the presence of fungi, bacteria and acanthamoeba by using 100g/L potassium hydroxide and also by Gram and Giemsa stainings. Another portion was inoculated directly on the surface of solid media such as blood agar, Mac-Conkey agar, chocolate agar and Sabouraud agar in C-shaped streaks for culture.
  RESULTS: A total of 240 patients with suppurative corneal ulcer were enrolled in the study, out of which fungi were identified in 84 (35%) patients. Of these, 48 (57.1%) were males and 36 (42.9%) females. The age ranged between 22-80 years. Sixty patients (71.4%) belonged to rural population and twenty four (28.6%) to urban population. Trauma with vegetative material was the most frequent cause noted in eighteen (21.4%) patients. Peak incidence was in the months of October-November. Out of 84 eyes with fungal keratitis, fungi alone were the etiologic agents in 74 (80.10%) cases and bacteria with fungi were identified in 10 (11.90%). The most frequently isolated organism was Candida albicans which was found in 66 (78.6%) patients.
  CONCLUSION: Fungal keratitis is the leading cause of infective corneal ulcer and Candida albicans being the most commonly isolated pathogen in the patients belonging to Southern Pakistan. The direct microscopic examination with potassium hydroxide 100g/L method is a simple, rapid, inexpensive and reliable method in the diagnosis of this infection.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ashok Kumar Narsani, , , , ,,Siddiqa Gul,Syed Asher Dabir,Shafi Muhammad Jatoi,Mahtab Alam Khanzada and Mahesh Kumar]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ashok Kumar Narsani, , , , ,,Siddiqa Gul,Syed Asher Dabir,Shafi Muhammad Jatoi,Mahtab Alam Khanzada and Mahesh Kumar</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200902013]]></guid><cfi:id>1509</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Bacterial colonization of hydrogel disposable contact
lenses]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200902014]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the rate of bacterial colonization in hydrogel disposable contact lenses and solutions and to identify the contaminating organisms.
  METHODS: A cross sectional study with purposive sampling was carried out. One hundred hydrogel contact lenses were collected from wearers among undergraduate students of Health Campus, University Sains Malaysia. All lenses and storage solutions were sent for microbiological culture and gram staining.
  RESULTS: The majority of study participants were females (98%). The mean age was 21.36±1.63 years. Forty-one subject participants (82%) showed positive bacterial colonization of the lenses. From storage solutions 32% yielded positive colonization by bacteria. The most common organisms were coagulase negative staphylococcus,  Staph aureus  and streptococci while Pseudomonas sp. and Serratia sp. were isolated more frequently from contact lenses.
  CONCLUSION: Contact lens wearing is potentially dangerous as a result of high rate of bacterial colonization of the lenses and its storage solutions. Extreme precaution and adherence to strict hygienic practice is recommended during lens handling and wearing.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Bakiah Shaharuddin 1, 2,  1,  1,K Wei Chan,Siti Suraiya Mohd Noor and Zunaina Embong]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Bakiah Shaharuddin 1, 2,  1,  1,K Wei Chan,Siti Suraiya Mohd Noor and Zunaina Embong</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200902014]]></guid><cfi:id>1508</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Anterior single flap external dacryocystorhinostomy:
outcome in 200 Sudanese patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200902015]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To present the outcome of anterior single flap external dacryocystorhinostomy (DCR) in Sudanese patients.
  METHODS: The data of 200 consecutive patients were retrospectively analyzed, who had anterior single flap external DCR with a minimum of one year follow-up. The surgeries were performed by the same surgeon (the first author) and patients were followed up for one year postoperatively. Presence of epiphora at the end of one year and no response to syringing and probing was considered failure. 
  RESULTS: The mean age of the study sample was 29.7 years (ranged 4-65 years). The ratio of male to female was 1∶2. The success rate was 98%. Failure was reported in 4 patients, two of them were traumatic cases with preexisting orbital disfigurement. 
  CONCLUSION: This study adds on to the evidence of the usefulness of anterior single flap DCR. Although it is simpler and easier to master the technique, this procedure showed a success rate comparable to that of the conventional method in literature.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Kamal Hashim Bennawi,Nadir Ali Mohamed Ali,Ehab Yusri Subhi Al-Sirhy and Nabila Radi Elias]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Kamal Hashim Bennawi,Nadir Ali Mohamed Ali,Ehab Yusri Subhi Al-Sirhy and Nabila Radi Elias</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200902015]]></guid><cfi:id>1507</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Traumatic visual loss of inpatients in Yazd, Iran
from 2005 to 2006]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200902016]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the conditions of traumatic visual loss of inpatients in Yazd, Iran from 2005 to 2006, and to explore the possible causes and preventive methods.
  METHODS: We retrospectively analyzed data on all patients with eye injuries (70 cases) hospitalized at Shahid Sadoughi Hospital between August 2005 and August 2006, including age, gender, causes, type of injury, time of initial treatment, visual acuity during admission and discharge, surgical procedures, and final outcome. Furthermore, standardized international classification of ocular trauma (Birmingham Eye Trauma Terminology) was used for eye injury categorization. 
· RESULTS: A total of 70 inpatients with ocular injuries were selected by simple approach. The male/female ratio was 2.8 to 1. The most frequent causes of eye injury were metallic objects (34.3%) especially in age group of ≤10 and ≥30 years old, accidents (22.8%) and assaults (17.2%). Waiting time to initial treatment was 6-24 hours in most cases (51.4%). Trauma was blunt in 38.6% and penetrating in 61.4%. The most and the least final visual acuity in blunt and penetrating trauma was LP (51.8%, 41.8%) and HM (7.5%, 4.7%) respectively. Surgery outcome was globe saving with acceptable visual acuity in 72.9% and enucleation in 24.2%.
  CONCLUSION: With regard to the high incidence of ocular trauma and consequent severe visual loss, parents' attention, eye safety protection and early treatment should be considered as final preserving globe in most accidents.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mohammad Reza Besharati,Mohammad Reza Shoja,Maryam Kheirandish,Leila Shirani and Ziba Parizi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mohammad Reza Besharati,Mohammad Reza Shoja,Maryam Kheirandish,Leila Shirani and Ziba Parizi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200902016]]></guid><cfi:id>1506</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Evaluation of computerized image analysis system
for quantification of posterior capsular opacification]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200901012]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Li-Wei Ma,Jin-Song Zhang,Jun Xu,Jiao Zhang and Ping Zhao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Li-Wei Ma,Jin-Song Zhang,Jun Xu,Jiao Zhang and Ping Zhao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200901012]]></guid><cfi:id>1505</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Multifocal VEP in patients with optic nerve disease]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200901011]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM:To determine whether the multifocal visual evoked
potential (mfVEP) can be used as a clinical method to assess
the patients with optic nerve disease.
METHODS:Fifteen patients with optic nerve disease were
examined in this study. All patients underwent visual acuity
examination, slit-lamp inspection, ophthalmoscopy, Goldmann
perimeter, fundus fluorescein angiography, visual field and
mfVEP. Although these patients with unilateral optic nerve
damage,data from both eyes were included in the analysis.
 RESULTS:In all patients the visual fields defect was
demonstrated on the mfVEPand showed good correspondence
in location of the scotoma. However, we also found some
slight difference between visual field and mfVEP. In some
locations, when the local visual fields were normal, mfVEP
showed that its amplitude reduced. In reverse, when the
local mfVEPseemed normal, visual field showed abnormity.
CONCLUSION:Multifocal visual evoked potential could be
used as a clinical diagnosis option in patients with optic nerve
disease. Local monocular damage to the optic nerve can be
measured by an interocular comparison of the mfVEP]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xiao-Peng Hu,Shi-Zhou Huang and Le-Zheng Wu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiao-Peng Hu,Shi-Zhou Huang and Le-Zheng Wu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200901011]]></guid><cfi:id>1504</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Long-term efficacy of transpupillary thermotherapy for subfoveal choroidal neovascularization in age-related macular degeneration]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200901013]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the long-term efficacy of transpupillary thermotherapy (TTT) in the treatment of subfoveal choroidal neovascularization (CNV) in age-related macular degeneration (AMD). 
METHODS: Fourteen eyes of 14 patients with subfoveal CNV secondary to AMD were treated with diode laser (810nm) TTT. The mean age was 67.1 years. Complete ophthalmic examination was done, color fundus photographs and macular optical coherence tomography scans were taken, fluorescein and indocyanine green angiography were performed during initial and at subsequent follow-up examinations. Treatment was given in one minute using 2-3mm spot sizes, and laser power settings were between 650-800mW. The follow-up period was between 5 and 64 months and the mean was 28.6 months. 
RESULTS: There was subfoveal classic CNV in 10, predominantly classic CNV in 2, minimally classic CNV in 1, and type 1 occult CNV in one of the fourteen eyes. Four patients were noted to have post-treatment hemorrhage which was absorbed in a short time. Macular non-perfusion occurred in one patient immediately after treatment. Most of the eyes demonstrated a decrease in exudation during the follow-up. With a mean follow-up of 28.6 months, visual acuity improved in 5, remained the same in 8 and decreased in 1 of the 14 eyes. 
CONCLUSION: Transpupillary thermotherapy is shown to close subfoveal CNV with rapid resolution of subretinal fluid while maintaining visual function in patients with AMD. It may be performed as an alternative laser treatment in classic and predominantly classic subfoveal choroidal neovascularization due to AMD.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Leyla S Atmaca and Figen Batioglu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Leyla S Atmaca and Figen Batioglu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200901013]]></guid><cfi:id>1503</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Neuropathy and retinopathy in diabetes: Is there any association?]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200901014]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate correlation of retinopathy and diabetic peripheral neuropathy (DPN) as microvascular complications of diabetes and also to identify their risk factors in patients with type 2 diabetes.
 METHODS: We conducted a cross-sectional study in an outpatient diabetes clinic during an 18-month period. 100 patients (51 male and 49 female), all affected by non-insulin- dependent diabetes mellitus (NIDDM), were examined for the presence of diabetic neuropathy and diabetic retinopathy. 
 RESULTS: 78.1% of patients with retinopathy had DPN; and 79.1% of patients with DPN had retinopathy. Analysis of the association between DPN and retinopathy showed no significant correlation between them. 90.9% of patients with proliferative diabetic retinopathy (PDR) had DPN; and 27.8 % of patients with DPN had PDR. Both the univariate analysis and multiple logistic regression analysis revealed significant correlation between them (r  =0.42, P  =0.02).
 CONCLUSION: A severe diabetic retinopathy is associated with diabetic neuropathy. Our study further supports that diabetic neuropathy might be used as a tell-tale sign of diabetic retinopathy, necessitating more intensive ophthalmic care, especially in long-lasting diabetes.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ali Abdollahi,Sasan Moghimi,Abdolreza Tabasi,Mohammad Taher Rajabi and Baharak Sabet]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ali Abdollahi,Sasan Moghimi,Abdolreza Tabasi,Mohammad Taher Rajabi and Baharak Sabet</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200901014]]></guid><cfi:id>1502</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Combined lens and vitreoretinal surgery in patients with traumatic cataract and intraocular foreign body]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200901015]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyze the postoperative anatomical and functional outcomes as well as complications after combined phacoemul- sification, pars plana vitrectomy (PPV), removal of the intraocular foreign body (IOFB) and intraocular lens (IOL) implantation in patients with traumatic cataract and intraocular foreign body.
METHODS: Medical records of 13 patients(13 eyes) with traumatic cataract and IOFB who had undergone combined phacoemulsification, PPV, foreign body extraction and IOL implantation were retrospectively analyzed. The postoperative follow-up ranged from 2 to 12 months. The main measure- ments of outcomes were the extraction success of cataract and intraocular foreign body, intraoperative and postoperative complications and the final best corrected visual acuity (BCVA).
·RESULTS: The mean age of 13 patients(10 male, 3 female )was 36.8 years (range: 17-65 years). All eight IOFBs were removed. Four intraocular lenses were implanted after vitrectomy intraoperatively. In 5 cases, intraocular lenses were implanted during the second operation. Intraocular lenses were not implanted in 4 cases. BCVA at last ranged from 0.8 to hand movement. BCVA was 0.5 or better in four eyes, 0.1 to 0.4 in five eyes, less than 0.1 in four eyes. Intraoperative complications were encountered in 3 patients. They had vitreous hemorrhage. Postoperative complications were encounter- ed in 2 patients. They had retinal detachment. The reoperations of the two patients were successful.
 CONCLUSION: The combined phacoemulsification, PPV, removal of IOFB and IOL implantation is safe and effective for patients with traumatic cataract and intraocular foreign body. The visual outcome depended primarily on the corneal or scleral wound and underlying posterior segment pathology and sites.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Shi-Hong Zhao,Yuan Zhang,Jin-Hui Wu,Dong-Yan Pan,Xin Liu and Yu Xu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Shi-Hong Zhao,Yuan Zhang,Jin-Hui Wu,Dong-Yan Pan,Xin Liu and Yu Xu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200901015]]></guid><cfi:id>1501</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Bovine bone xenograft as orbital implants in rabbit eyes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200901016]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the biocompatibility of bovine bone as orbital implants in rabbits. 
 METHODS: Bovine bone graft was used as an ocular im- plant in rabbits to determine whether it could be successfully used in the anophthalmic socket as an alternative to the expensive synthetic alloplastics. Evisceration of eyes with and without bovine bone orbital implantation was performed in the right eyes of 12 New Zealand white rabbits. Group Y (n = 6) was eviscerated without implant, meanwhile Group X (n = 6) was eviscerated with insertion of an orbital implant using bovine bone. Observation was carried out on day 1, day 7, day 14, day 28 and day 42. Serial clinical examination was carried out based on a few fixed criteria, which included rate of infection, implant migration, evidence of wound breakdown and any restriction of intraocular movements. The implanted eyes were then enucleated on day 42. The enucleated eyes were sent for histopathological evaluation to record the type of inflammatory reaction and rate of fibrovascular ingrowth. 
 RESULTS : Serial clinical examination showed presence of mini- mal infection in all eyes, both in Group X (implanted) and Group Y (control) on first postoperative day, which responded well with antibiotics. Infection occurred in the implanted group after first postoperative day, but there was no evidence of orbital migration or extrusion of implant, wound breakdown, restriction of extraocular movement, severe infection or any physical abnormality. Histopathological examination revealed good fibrovascular ingrowth in the implanted group, with minimal rejecting reaction of rabbit eye towards bovine bone implant. 
 CONCLUSION: This study shows that bovine orbital implant has a good biocompatibility in rabbit eyes and its cost is acceptable.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[S Mohd Mansor,H K Tan,I Shatriah,W H Wan Hazabbah and J Hasnan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>S Mohd Mansor,H K Tan,I Shatriah,W H Wan Hazabbah and J Hasnan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200901016]]></guid><cfi:id>1500</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Efficacy of probing in the treatment of congenital nasolacrimal duct obstruction in three age groups]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200901017]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the success rates of probing for the treatment of congenital nasolacrimal duct obstruction in children divided into three age groups.
 METHODS: One hundred and eighty children with uncomplicated congenital nasolacrimal duct obstruction underwent probing in  Eye Hospital of Liaquat University of Medical and Health Sciences Hyderabad, Sindh, Pakistan from March 2005 to January 2008. The children were divided into three groups: Group I (aged 4-6 months), Group II (aged 7-12 months) and Group III (aged 13-24 months). Success was defined as complete resolution of signs and symptoms. The chi-square test was used to analyze the results.
 RESULTS: The success rate was 100.0% in Group I, 88.5% in Group II and 82.3% in Group III. The overall cure rate for the entire study was 90.7%.
 CONCLUSION: The efficacy of probing decreases with the increasing age. However, when probing is done within six months of age, it is highly effective and results in complete resolution of symptoms.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Siddiqa Gul,Syed Asher Dabir,Shafi Muhammad Jatoi,Ashok Kumar Narsani and Mahatab Alam]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Siddiqa Gul,Syed Asher Dabir,Shafi Muhammad Jatoi,Ashok Kumar Narsani and Mahatab Alam</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/200901017]]></guid><cfi:id>1499</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of fibrin glue and suture technique in pterygium surgery performed with limbal autograft]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201004009]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the efficiency and safety of fibrin glue to suture technique in pterygium surgery performed with limbal autograft.
METHODS: A prospective randomised clinical trial was carried out in 58 eyes of 58 patients operated for primary nasal pterygium. Autologous conjunctival graft taken from the superotemporal limbus was used to cover the sclera after pterygium excision. In 29 eyes, the transplant was attached to the sclera with a fibrin tissue adhesive (Beriplast P) and in 29 eyes with 8-0 Virgin silk sutures. The Mann-Whitney U test was used for statistical analysis. Postoperative patient discomfort (pain, stinging, watering) and biomicroscopic findings (hyperemia, edema) were graded. Patients were followed up at least for six months.
RESULTS: Subconjunctival hemorrhage occured under the graft in one patient in group 1. In seven cases of group 2, sutures were removed at the 15th day because of granulomatous tissue reaction. Patient symptoms were significantly less and biomicroscopic findings were better in group 1. Pterygium recurrence was seen in one case of group 1, and 2 cases of group 2. Average surgery cost was higher (P<0.05) and surgery time was shorter (P<0.05) in fibrin group. 
CONCLUSION: Using fibrin glue for graft fixation in pterygium surgery causes significantly less postoperative pain and shortens surgery time significantly.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Bora Yüksel,Sultan Kaya ünsal and Sevgi Onat]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Bora Yüksel,Sultan Kaya ünsal and Sevgi Onat</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201004009]]></guid><cfi:id>1498</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Chronic macular edema associated with extrafoveal vitreoretinal traction]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201004010]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To describe an association between extrafoveal vitreoretinal traction and chronic macular edema, either diffuse (DiME) or cystoid (CME), by the use of optical coherence tomography (OCT).
METHODS: Charts and OCT findings of two patients with persistent DiME or persistent DiME accompanied by CME, both associated with extrafoveal vitreous traction membranes were analyzed. Excluded were eyes that either had another vitreoretinopathy that could affect the analysis, had undergone pars plana vitrectomy or that had been treated by intravitreal medications. An age-matched normal control group for OCT (n=12) allowed for the quantification of the normal macular thicknesses.
RESULTS: One patient (one eye) following perforating ocular injury and one patient (one eye) of idiopathic origin, both with chronic macular edema refractive to conventional treatment, were found to be associated with extrafoveal vitreoretinal traction in each eye. Retinal edema that was underlying the traction site in each eye was in continuum with the central macular edema, thus manifesting as diffuse macular edema. The automatic central 6-radial lines program in the OCT enabled the detection of the traction site in one eye, while in the other eye the diagnosis was achieved only with the additional use of the Line group program. 
CONCLUSION: Chronic diffuse macular edema might be related to extrafoveal vitreoretinal traction. Careful search with the diverse OCT programs should be made in order to detect extrafoveal traction sites. Further studies and a larger cohort are required to compare the efficacy of early vitrectomy or pharmacologic vitreolysis versus the current therapeutic approaches in these situations.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Aaron Trevino,Michael R Martinez and Avinoam Ophir]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Aaron Trevino,Michael R Martinez and Avinoam Ophir</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201004010]]></guid><cfi:id>1497</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Intraocular pressure as indicator of sympathetic asymmetry in the eyes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201004011]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the asymmetry in the sympathetic activity in the eyes as indicated by intraocular pressure(IOP). 
METHODS: In a prospective cross sectional study, the IOP in 150 newborns, 80 young adults and 159 old people was measured with Tono-Pen under topical anaesthesia. 
RESULTS: The mean IOP in the newborns was 16.16mmHg in right eye and 15.79mmHg in left eye; in young adults 15.04mmHg in right eye and 14.71 in left eye; in old people 15.16 in right eye and 15.03 in left eye. A statistically significant higher IOP was noted in the right eye in the newborns (P=0.03) and in young adults (P=0.02), but not in the old people (P=0.26). The higher IOP in the right eye indicates the lowered sympathetic activity in that eye.
CONCLUSION: We hypothesize that the sympathetic asy- mmetry in the bilaterally placed organs helps to establish the dominant pattern of  the organ in the body.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Sagili Chandrasekhara Reddy and Satagopam Mitti Mohan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Sagili Chandrasekhara Reddy and Satagopam Mitti Mohan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201004011]]></guid><cfi:id>1496</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Assessing amblyogenic factors in 100 patients with congenital ptosis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201004012]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM:  To study the frequency of amblyogenic factors in patients with congenital ptosis.
METHODS:  In this cross-sectional study, 114 eyes of 100 patients with congenital ptosis more than 1 year old were included. Amblyopia was defined as best-corrected visual acuity (BCVA) less than 10/10 or a difference between the two eyes of at least 2/10. In patients too young to be measured by the linear Snellen E test, fixation behavior was observed. Different types of amblyopia were assessed for each patient as: 1) anisometropic amblyopia: astigmatic anisometropia ≥1 dpt, hyperopic spherical anisometropia ≥1 dpt, myopic spherical anisometropia ≥-3 dpt (with cycloplegia); 2) strabismic amblyopia, and 3) stimulus deprivation amblyopia (SDA). Then the total incidence of amblyopia and each type of it were obtained. Patients with uni- and bi-lateral ptosis were also compared. 
RESULTS: The incidence of amblyopia in ptotic eyes was 39/114 (34.2 %), and for each specific cause was: refractive amblyopia in 29.8%, SDA in 10.5%, strabismic amblyopia in 4.3%. Amblyopia was more frequent in severe ptosis, 76% in patients with covered optical axes (OA), compared to non-covered OA (22.5%). In unilateral ptosis with covered OA, astigmatic anisometropic amblyopia was more frequent, and in bilateral ptosis with at least one eye covered OA, spherical anisometropic amblyopia was more frequent. In both unilateral and bilateral ptosis, SDA was more common if the OA was covered. 
CONCLUSION:  As refractive anisometropic amblyopia is more prevalent than SDA, paying attention to all causes of amblyopia may be important in preventing amblyopia in a child with a ptotic eye.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Abolfazl Kasaee,Alireza Yazdani-Abyaneh,Syed Ziaeddin Tabatabaie,Alireza K.Jafari,Ahmad Ameri,Bahram Eshraghi,Vafa Samarai,Meysam Mireshghi and Mohammad Taher Rajabi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Abolfazl Kasaee,Alireza Yazdani-Abyaneh,Syed Ziaeddin Tabatabaie,Alireza K.Jafari,Ahmad Ameri,Bahram Eshraghi,Vafa Samarai,Meysam Mireshghi and Mohammad Taher Rajabi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201004012]]></guid><cfi:id>1495</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical spectrum of 15 patients with HIV-related ocular involvement in Tehran]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201004013]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the frequency of HIV-related ocular involvement and to describe the characteristics of involvement in a special clinic in Tehran.
METHODS: In this cross sectional study, 141 patients (125 male and 16 female, 282 eyes) of HIV-infected patients with various stages of HIV infection that were referred to Center of behavioral diseases were evaluated during a period of 7 months. Every patient had a complete profile including demographic data, method of HIV transmission, recent CD4 T cell lymphocyte count, serological studies for common sexual or blood-born viruses and toxoplasmosis, history of antiretroviral therapy, and associated systemic disease. 
RESULTS: A total of 141 patients were evaluated. HIV-related ocular involvement was detected in 15 patients (10.6%), including 3 mycobacterium tuberculosis-related choroiditis, 2 cytomegalovirus  retinitis, 2 retinal toxoplas- mosis, 2 herpes simplex virus-related lesions, 1 HIV- associated retinopathy, 1 herpes zoster ophthalmicus, 1 undetermined vitritis, and 3 cases of cranial nerve involvement including 2 cases of gaze palsy and 1 case of papilitis. In our study, mean CD4 T cell lymphocyte count was fewer in patients with ocular involvement than in patients without ocular involvement (204.7±123.8 vs 403.7±339.7, P=0.029), but there was no difference in other possible associated factors between two groups.
CONCLUSION: Mycobacterium tuberculosis-related choroiditis and neurophthalmic lesions are the most common HIV-related ocular involvements in Tehran that is different from those of recent publications in developed countries.  
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ali Abdollahi,Giv Heidari-Bateni,Reza Zarei,Parastou Kheirandish,Mohammadhosein Malekmadani,Minoo Mohraz,Maryam Abdollahi and Mohammad Taher Rajabi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ali Abdollahi,Giv Heidari-Bateni,Reza Zarei,Parastou Kheirandish,Mohammadhosein Malekmadani,Minoo Mohraz,Maryam Abdollahi and Mohammad Taher Rajabi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201004013]]></guid><cfi:id>1494</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Practical method to calculate post-LASIK corneal power: the Actual Ka+p method]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201004014]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the accuracy of a practical method (the Actual Ka+p method) of corneal power measurement for post-LASIK eyes undergoing cataract surgery.
METHODS: Ten eyes of 7 patients (4 male, 3 female, average age 50.10±4.01 years, with -11.01±3.55D mean refraction before LASIK), underwent post-LASIK phaco+IOL cataract surgery. We used the posterior corneal curvature as measured by the Pentacam in a method we named Actual Ka+p to calculate the post-LASIK corneal power for IOL calculation. The refractive outcomes after cataract surgery were evaluated. The Actual Ka+p was compared with the back- calculated corneal power (BCK), which was thought to be the benchmark of true corneal power. The corneal power estimated by other published methods, including Maloney, Shammas, Koch-Maloney, Savini, and McCulley, together with the true net power and equivalent K reading (EKR) as found by the Pentacam were also compared with the BCK.
RESULTS: All eyes achieved satisfied refractive status after cataract surgery. The difference between the postoperative refraction and the target refraction was 0.04±0.40D, range from -0.63D and +0.85D. Among all the methods we studied, although the Bonferroni multiple comparison tests did not detect significant differences between any two of them, the Actual Ka+p yielded the highest agreement with the BCK, with 80% of the eyes falling within ±0.5D and 100% within ±1.0D from the BCK values. 
CONCLUSION: The Actual Ka+p method can provide encour- aging results in post-LASIK eyes undergoing cataract surgery.	
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yi-Qian Hu,Xiang-Yu Ye,Xiu-Li Zhou,Yin Li,Cheng-Hui Xu,Lin-Lu Tian,Huang Zhu and Yao-Hua Sheng]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yi-Qian Hu,Xiang-Yu Ye,Xiu-Li Zhou,Yin Li,Cheng-Hui Xu,Lin-Lu Tian,Huang Zhu and Yao-Hua Sheng</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201004014]]></guid><cfi:id>1493</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Management of morderate-to-severe Marcus-Gunn syndrome by anastomosis of levator and frontal muscles]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201004015]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To study the effect of clinical management of moderate-to-severe Marcus-Gunn syndrome (MGS) by anastomosis of levator and frontal muscles.
METHODS: The medical records of 13 patients with moderate-to-severe MGS who underwent surgeries in our institute between 2000 and 2007 were reviewed retrospectively. They underwent unilateral anastomosis of levator and frontal muscles under local anesthesia. 
RESULTS: Postoperative follow-up periods ranged from 6 to 36 months, with an average of 12 months.  All eyelids (100%) showed complete resolution of jaw-winking, ten eyelids (76.9%) had good correction of ptosis, with equal plapebral apertures and symmetrical contours, three (23.1%) showed residual mild ptosis (<2mm). 
CONCLUSION: For moderate-to-severe MGS, unilateral ana- stomosis of levator and frontal muscles provides satisfied correction of jaw-winking and ptosis.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Nan Xiang,Wei-Kun Hu,Bin Li and Rong Liu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Nan Xiang,Wei-Kun Hu,Bin Li and Rong Liu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201004015]]></guid><cfi:id>1492</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Prevention of exposure keratopathy in intensive care unit]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201004016]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the efficacy for preventing exposure keratopathy of three forms of eye care (artificial tear, moist chamber and polyethylene covers) for intensive care patients.
METHODS: Eighty-four patients in Intensive Care Unit (ICU) were randomized to three treatment groups, including artificial tears group, moist chambers group and polyethylene film group. Patients of artificial tear group received two drops of carboxymethylcellulose drops to each eye every 2 hours. The moist chambers and the polyethylene were changed every 12 hours or as needed if they became unclean or torn. The corneal fluorescein stains were performed daily.
RESULTS: No of 28 patients (0%) in the polyethylene group and one of the 27 patients (3.70%) in the moist chamber group had exposure keratopathy, compared to 8 of the 29 patients (27.59%) in the artificial tear group. There were statistical significance between the artificial tear group and the moist chamber group (P=0.02), and the artificial tear group and the polyethylene group (P =0.003). The time on eye care every day of the artificial tear group, the moist chamber group and the polyethylene group was 26.69±2.39 minutes, 35.33±2.63 minutes and 7.48±0.87 minutes, respectively. The eye care of the polyethylene group were statistically more time-save than that of the artificial tear group (P<0.001) and the moist chamber group (P<0.001). 
CONCLUSION: Polyethylene covers are more effective and more time-saving in reducing the incidence of corneal damage in intensive care patients 
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hua Shan and Du Min]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hua Shan and Du Min</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201004016]]></guid><cfi:id>1491</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Alteration of anterior chamber in 81 glaucomatous eyes using Pentacam Scheimpflug system]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201004017]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To study the effects of gender, eye side and age on anterior chamber measurements; To compare the anterior chamber parameters between glaucoma and normal subjects.
METHODS: A total of 169 patients (299 eyes), of which 122 normal subjects (218 eyes), 24 cases (39 eyes) with primary angle-closure glaucoma (PACG) and 22 cases (42 eyes) with primary open-angle glaucoma (POAG) visiting our hospital from Apr. 2008 to Oct. 2008 were enrolled. The parameters measured by Pentacam between different sexes, eye sides, ages and different groups were compared. 
RESULTS: The mean central anterior chamber depth (CACD), anterior chamber volume (ACV) and anterior chamber angle (ACA) measurements of normal eyes were 2.82±0.43mm, 159.74±43.64mm3 and 35.47±7.92°. There were no significant differences between different eye sides. There was a negative correlation between age and anterior chamber parameters (all P <0.001); The mean CACD, ACV and ACA were 1.87±0.29mm, 82.00±24.17mm3 and 21.94±7.11° in PACG group, and 2.67±0.34mm, 147.24±43.40mm3 and 31.19±6.34° in POAG group. The differences between PACG and age-matched normal subjects were significant (all P <0.05), but there was no significant difference between POAG and age-matched normal subjects (P >0.05). 
CONCLUSION: CACD, ACV and ACA decrease mildly with age. Anterior chamber parameters of PACG are smaller than that of normal eyes, but there is no difference between POAG and normal eyes.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xuan Zou,Xuan-Chu Duan and Qian Zhong]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xuan Zou,Xuan-Chu Duan and Qian Zhong</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201004017]]></guid><cfi:id>1490</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effectiveness of amniotic membrane transplantation combined with mitomycin C in the treatment of pterygium: a meta-analysis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201004018]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the recurrence rate and safety of amniotic membrane transplantation (AMT) augmented with mitomycin C (MMC) compared with amniotic membrane transplantation alone during the pterygium excision. 
METHODS: We took a meta-analysis on this program. Pertinent studies were selected through extensive searches of the Cochrane Library, MEDLINE, EMBASE, CBMdisc, CNKI. Pooled estimates were carried out in RevMan software v.4.2. 
RESULTS: Six trials reported postoperative recurrence rate of pterygium, included 882 eyes, three trials reported the complications. The results of meta-analysis showed that recurrence rate of AMT plus MMC group was 5.41%, AMT alone group was 16.89%, RR was 0.32, 95%CI ranged from 0.19 to 0.56, Z was 4.06, P <0.001. Two trials reported early complication as punctata keratitis, the incidence rate of AMT plus MMC group and AMT alone group were 17.14% and 0.00%, RR was 12.11, 95%CI ranged from 1.62 to 90.76. 
CONCLUSION: Amniotic membrane transplantation with MMC was associated with lower recurrence rate compared with amniotic membrane transplantation alone in pterygium excision，whether accompanied a higher risk with adverse events need more investigation.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yin-Wei Song,Ai-Hua Yu and Xiao-Jun Cai]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yin-Wei Song,Ai-Hua Yu and Xiao-Jun Cai</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201004018]]></guid><cfi:id>1489</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Cost-effectiveness of autologous retinal pigment epithelium and choroid translocation in neovascular AMD]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201003011]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the cost-effectiveness of autologous retinal pigment epithelium and choroid translocation (PATCH) in neovascular age-related macular degeneration (AMD).
METHODS: Visual acuity and complication rates of published patient series were used to determine the incremental utility of treatment for the patient. The utility data applied assume that the better eye was affected. Comparator was a meta-analysis of recent control groups, in which patients received best supportive care. To assess cost-effectiveness, costs per quality adjusted life years (QALYs) and costs of avoiding low vision ("legal blindness", i.e. ≤20/200) were calculated. Costs were based on a German sick fund perspective and in a scenario on US costs. Robustness of the model was investigated by univariate and probabilistic multivariate sensitivity analysis (PSA).
RESULTS: Cost-utility analysis showed surgery to be the dominant ("cost-saving") strategy for Germany and for the US in both, cost-effectiveness and cost-utility analysis (costs per QALY). In the sensitivity analysis the intervention remained dominant or cost-effective in all scenarios investigated. Clinical outcomes and duration of modeling were the most influential factors in the sensitivity analyses. 
CONCLUSION: Therapy of neovascular AMD by PATCH is a cost-effective treatment option for selected patients, who are not well suitable for other current treatment options. 
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Aljoscha S Neubauer,Sandra Liakopoulos,Jan C van Meurs and Bernd Kirchhof]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Aljoscha S Neubauer,Sandra Liakopoulos,Jan C van Meurs and Bernd Kirchhof</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201003011]]></guid><cfi:id>1488</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Corneal changes in type II diabetes mellitus in Malaysia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201003012]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare corneal endothelial structure and central corneal thickness (CCT) between type II diabetics and non-diabetic control patients. To look for correlations between diabetic status and corneal findings.
METHODS: Hospital-based, observational study. 200 eyes (from 100 type II diabetic patients and 100 controls) were included. Specular microscopy and pachymetry were used to measure endothelial cell density, size, coefficient of variation in cell area, hexagonality as well as corneal thickness. Independent t-tests were used to compare variables between diabetics and controls. Pearson correlation tests were used to evaluate correlations between corneal findings and diabetic status such as duration of diabetes, haemoglobin A1c (HbA1c) level and severity of diabetic retinopathy.
RESULTS: Endothelial cell density in the diabetic group (2541.6±516.4 cells/mm2) was significantly lower than that in the control group (2660.1±515.5 cells/mm2, P <0.05). The average size of endothelial cells, standard deviation (SD) of cell size and coefficient of variation (CV) of cell area were all significantly higher in diabetics. Hexagonality was significantly lower in diabetics (41.1%±19.6%) compared to non- diabetics (45.2%±20.6%). CCT was higher in diabetics but not significant (P >0.05). Duration of diabetes, HbA1c level and severity of diabetic retinopathy were not significantly correlated with corneal endothelial findings.
CONCLUSION: Type II diabetes causes a significant alteration in the state of the cornea including reduction in endothelial cell density and increased pleomorphism and polymegathism. Central corneal thickness is unaffected.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Choo MM,Prakash K,Samsudin A,Soong T,Ramli N and Kadir AJ]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Choo MM,Prakash K,Samsudin A,Soong T,Ramli N and Kadir AJ</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201003012]]></guid><cfi:id>1487</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Evaluation of efficacy and safety of botulinum toxin type A injection in patients requiring temporary tarsorrhaphy to improve corneal epithelial defects]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201003013]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the efficacy and safety of botulinum toxin type A (Dysport, (Ipsen Biopharm Ltd, Wrexham, UK)) injection in patients requiring temporary tarsorrhaphy to improve corneal epithelial defects.
METHODS: Thirty patients were enrolled into the prospective study between March 2007 and September 2009. Doses of 15 and 30U of Dysport were injected into the levator palpebrae superioris muscle through the eyelid. The patients were followed daily until completion of ptosis and then 1-2 weekly until complete resolution of levator function and improvement of corneal condition. 
RESULTS: Ptosis took 2.64±1.85 days to be completed (range 1-9 days) and lasted for 12±2.19 weeks. For patients with seventh nerve palsy, 30U Dysport was appropriate to produce sufficient ptosis whereas in other patients 15U of toxin was sufficient. In 83.3% of patients ptosis was sufficient for complete recovery of corneal epithelium and 16.7% required a second procedure (Amniotic membrane transplantation, conjunctival flap). There was a direct correlation between age and duration of ptosis. In patients with seventh nerve palsy, the amount of resultant ptosis was significantly lower than that of other patients. The only adverse effects of injection were superior rectus underaction (33.3%) and diplopia (16.7%) which resolved in all patients without any intervention.
CONCLUSION: Dysport injection is a safe and effective substitute for surgical tasorrhaphy with fewer complications. 
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Abolfazl Kasaee,Mohammad Reza Musavi,Syed Ziaeddin Tabatabaie,Mohammad Nasser Hashemian,Shahrzad Mohebbi,Alireza Khodabandeh and Mohammad Taher Rajabi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Abolfazl Kasaee,Mohammad Reza Musavi,Syed Ziaeddin Tabatabaie,Mohammad Nasser Hashemian,Shahrzad Mohebbi,Alireza Khodabandeh and Mohammad Taher Rajabi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201003013]]></guid><cfi:id>1486</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Sutureless large-incision manual cataract extraction using the kongsap technique: outcome of a prospective study ]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201003014]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report the short- and medium-term outcomes of sutureless large-incision manual cataract extraction using the Kongsap (SLIMCE-K) technique.
METHODS: This prospective study included 73 eyes of 73 patients who underwent cataract surgery performed by using the SLIMCE-K technique. The postoperative visual acuity, intraoperative and postoperative complications, and endothelial cell loss were evaluated. A follow-up visit, at least 6 months after the surgery, was included in the study.
RESULTS: All patients had improved visual acuity after surgery. Uncorrected visual acuity (UCVA) was 6/18 or better in 55 eyes (75.3%) at 1 week postoperatively and in 64 eyes (87.6%) at 6 weeks postoperatively (P=0.09). The best corrected visual acuity (BCVA) was 6/18 or better in 67 eyes (91.8%) at 1 week postoperatively and in 70 eyes (95.9%) at 6 weeks postoperatively. The results remained stable at 3 months and 6 months postoperatively. No significant intraoperative complications were encountered. The endothelial cell loss was 4.8% at the 3-month follow-up examination.
CONCLUSION: When performed by an experienced surgeon, SLIMCE-K is a safe and effective procedure that can be performed independent of phacoemulsification machines. It can be used in any nuclear grading of cataract hardness that is common in developing countries.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Pipat Kongsap]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Pipat Kongsap</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201003014]]></guid><cfi:id>1485</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Detection of 8-hydroxydeoxyguanosine enzyme in recurrent pterygium raising a question on its role on recurrence]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201003015]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To detect the presence of 8-hydroxydeoxyguanosine enzyme (8-OHdG) in recurrent pterygium and its role on recurrence.
METHODS: Ninty-two samples were collected of which 55 from primary pterygium, 12 from recurrent and 25 from normal conjunctiva. A cross sectional study was embarked to detect the presence of the 8-OHdG enzyme in primary, recurrent pterygium and the normal conjunctival tissue by immunohistochemistry test.
RESULTS: The immunohistochemistry test showed positive results: 35 in primary, 2 in recurrent pterygia and 4 in normal conjunctiva, respectively. Significant association between primary pterygium and 8-OHdG enzyme (63.6% of samples are positive) and no significant relation was detected with recurrent pterygium (16.7% of samples are positive).
CONCLUSION: 8-OHdG enzyme is associated with primary pterygium. It is also present in normal conjunctival tissue. For the first time it is detected in recurrent pterygia. This may raise question whether 8-OHdG enzyme has a role in recurrence of pterygium. 
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Omar M S Ismaeel,Hasnan Jaafar and Mohtar Ibrahim]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Omar M S Ismaeel,Hasnan Jaafar and Mohtar Ibrahim</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201003015]]></guid><cfi:id>1484</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Anterior segment complications after phacoemu-lsification combined vitrectomy and foldable intraocular lens implantation]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201003016]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the anterior segment complications of phacovitrectomy and foldable intraocular lens (IOL) implantation in eyes with significant cataract and co-existing vitreoretinal diseases. 
METHODS: This retrospective study was consisted of 285 eyes of 238 patients with various vitreoretinal abnormalities and visually significant cataracts. Vitreoretinal surgery was combined with phacoemulsification and foldable IOL implantation. Main outcome measures were visual acuity, the preoperative data, and the anterior segment complications at postoperative 6 to 72 months. 
RESULTS: The most common indications for surgery were non-diabetic vitreous hemorrhage, proliferative diabetic retinopathy. Preoperative vision ranged from 20/30 to light perception and postoperative vision ranged from 20/20 to no light perception. Postoperatively, in 245 eyes (85.9%), visual acuity improved by 3 lines or more on the Snellen chart. In 24 eyes (8.4%), vision remained within 3 lines of preoperative levels and in 16 eyes (5.6%), vision had decreased at the last follow-up. The most common anterior segment pathological change was PCO in 50 eyes (17.5%), the second was corneal edema in 32 eyes (11.2%) and the third was elevated IOP in 31 eyes (10.8%). 
CONCLUSION: The combined vitreoretinal surgery and phacoemulsification with foldable IOL implantation is safe and effective.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Qin-Xiang Zheng,Rong-Han Wu,Yuan-Ping Zhang,Ming Xu and Wen-Sheng Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Qin-Xiang Zheng,Rong-Han Wu,Yuan-Ping Zhang,Ming Xu and Wen-Sheng Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201003016]]></guid><cfi:id>1483</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical research of intraoperative image-guidance in endoscopic nasocular operation]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201003017]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the availability and our experience of intraoperative image-guidance in endoscopic nasocular operation.
METHODS: Seven cases of endoscopic nasal surgery with intraoperative image-guidance were retropectively reviewed, including 3 cases of optic nerve injury; 3 cases of foreign object of optic behind the eyeball; 1 case of retrobulbar tumor (angeioma).
RESULTS: The preoperative preparatory time would take 15 minutes, including coordination, head holder localization, conventional instrument registration. In our cases, the localization accuracy between 3-D image landmarks of navigation system and actual anatomical landmarks was less than 1.3mm. The optic nerve and other anatomical points could be orientated accurately in intraoperative procedures. No complication occurred.
CONCLUSION: Nasal endoscope combined with image- guidance systems provides accurate anatomical localization of anterior skull base with enlarged operation field. It is possible for surgeons to observe important anatomical structures during endoscopic surgery. It could increase the effectiveness and decrease surgical complications, especially in complicated cases.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xiao-Yan Dou,Jiang Guo,Yong-Tian Lu and Jing Sima]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiao-Yan Dou,Jiang Guo,Yong-Tian Lu and Jing Sima</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201003017]]></guid><cfi:id>1482</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Therapeutic efficacy of intracameral amphotericin B injection for 60 patients with keratomycosis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201003018]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[? AIM: To evaluate the therapeutic efficacy of intracameral amphotericin B (ICAMB) injection in the treatment of keratomycosis. 
? METHODS: The study design was a prospective controlled clinical trial. A total of 60 eyes of 60 patients were divided into two groups, 30 in the ICAMB injection group (group A) and 30 in the control group-topical application amphotericin B (group B). Serial measurements of the size of the keratomycosis-namely, two maximum linear dimensions perpendicular to each other, and the area and perimeter was done at start of therapy and follow up on day 3, 7, and 21. Rate of healing of the keratomycosis were measured as percentage decrease from the baseline parameter at each subsequent follow up. The data were analyzed by the non-parametric Wilcoxon rank sum test.
? RESULTS: The mean time to disappearance of hypopyon was 9.6±9.2 (range:1-26) days in group A and 26.8±20.8 (range:14-62) days in group B (P=0.03). The median percentage decrease in the size of the keratomycosis was significantly greater than that in the cord serum group at day 21(P＜0.05) when measured in terms of the area and perimeter. A greater number of patients showed complete re-epithelialization in group A (n=27) than in group B (n=14) (P＜0.05). None of the patients reported any side effects or discomfort with either treatment.
? CONCLUSION: ICAMB injection leads to faster healing of the keratomycosis refractory to all medical management and reducing time to disapperence of hypopyon compared to topical application amphotericin B.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yi Shao,Yao Yu,Chong-Gang Pei,Ye-Hui Tan,Qiong Zhou,Jing-Lin Yi and Gui-Ping Gao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yi Shao,Yao Yu,Chong-Gang Pei,Ye-Hui Tan,Qiong Zhou,Jing-Lin Yi and Gui-Ping Gao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201003018]]></guid><cfi:id>1481</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of intravitreal bevacizumab injection before vitrectomy on proliferative diabetic retinopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201003019]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the effect of intravitreal bevacizumab (IVB) injection 1 week before pars plana vitrectomy (PPV) in proliferative diabetic retinopathy (PDR) patients. 
METHODS: A retrospective research was done on 46 PDR patients who were divided into PPV group (n=28) and IVB group (n =18, PPV with preoperative IVB). Bevacizumab was injected 1 week before PPV. Main outcome measures were visual acuity, incidence of iatrogenic retinal breaks, intraoperative and postoperative bleeding. 
RESULTS: At 1 month after surgery, visual acuity in PPV (82.1%) and IVB group (88.9%) improved significantly (P＜0.01) and the difference between the two groups was not significant (P＞0.05). Iatrogenic retinal breaks were reported in 18 cases (64.3%) in PPV group and 4 cases (22.2%) in IVB group (P＜0.05). Intraoperative bleeding was encountered in all cases in PPV group and 7 cases (39%) in IVB group (P＜0.01). Postoperative bleeding was reported in 9 cases (32.1%) in PPV group and none in IVB group (P＜0.01). 
CONCLUSION: IVB injection before PPV is helpful in reducing iatrogenic retinal breaks, intraoperative and postoperative bleeding in PDR patients. 
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Cai-Rui Li,Shu-Guang Sun and Wei Hong]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Cai-Rui Li,Shu-Guang Sun and Wei Hong</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201003019]]></guid><cfi:id>1480</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Efficacy and tolerability of one-site versus two-site phacotrabeculectomy: a meta-analysis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201003020]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the efficacy and tolerability of one-site versus two-site phacotrabeculectomy in the treatment of patients with coexisting cataract and glaucoma.
METHODS: A comprehensive literature meta-analysis was performed according to the Cochrane Collaboration methodology to identify controlled clinical trials comparing one-site with two-site phacotrabeculectomy. The studies meeting the predefined criteria were reviewed systematically by meta-analysis. Efficacy estimates were measured by standardised mean difference (SMD) for the percentage intraocular pressure (IOP) reduction from baseline to end point, odds ratio (OR) for the percentage having a best-corrected visual acuity (BCVA) of 0.5 or better after surgery and relative risk (RR) for complete success rates. Tolerability estimates were measured by RR for adverse events. All of outcomes were reported with 95% confidence interval (CI). Data were synthesised by Stata 10.1 for Windows.
RESULTS: Two-site phacotrabeculectomy was associated with numerically greater, and significant efficacy than one-site in lowering IOP (SMD, -0.19; 95% CI, -0.33 to -0.04; P=0.01). Numerically greater, but nonsignificant proportions of two-site patients than one-site patients had a BCVA of 0.5 or better (OR, 0.65; 95% CI, 0.30 to 1.39; P=0.26).Numerically greater, but nonsignificant proportions of two-site patients than one-site patients achieved the target IOP without anti-glaucoma medication at the end point (RR, 0.94; 95% CI, 0.84 to 1.04; P=0.22). Furthermore, there was nonsignificant difference in adverse events between two surgical procedures.
CONCLUSION: The efficacy of two-site phacotrabecu- lectomy appears to be superior to one-site phacotrabecul- ectomy. One-site and two-site phacotrabeculectomy are similarly tolerable in postoperative adverse events.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[He-Nan Liu,Xun Li,Qing-Zhu Nie and Xiao-Long Chen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>He-Nan Liu,Xun Li,Qing-Zhu Nie and Xiao-Long Chen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201003020]]></guid><cfi:id>1479</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Application of sodium hyaluronate to the operation of suturing the corneal perforation]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201003021]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the effect of the application of sodium hyaluronate on the operation of suturing the corneal perforation.
METHODS: Sodium hyaluronate was used in the operation of suturing the corneal perforation in 76 patients to form the anterior chamber, protect eye tissues and separate the anterior iris synechia.
RESULTS: In the procedure of operation, the anterior chamber was stable, the prolapsed iris was easily restored, the corneal wound was easily sutured and there was no damage to the lens. Postoperatively, the corneal wound was closed well, the anterior chamber formed and there was no anterior iris synechia. Fifty-four cases had round pupils and the pupils of 22 cases were not round with defect of iris.
CONCLUSION: Sodium hyaluronate in the operation of suturing the corneal perforation can help form the anterior chamber, protect the eye tissues and make the suturing corneal wound easier. It can reduce the rate of complication and promote the wound healing.  
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Tao Jiang,Jing Jiang,Yang Zhou,Gui-Qiu Zhao,Shan-Shan Yang,Hui Li and Li Shen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Tao Jiang,Jing Jiang,Yang Zhou,Gui-Qiu Zhao,Shan-Shan Yang,Hui Li and Li Shen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201003021]]></guid><cfi:id>1478</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Hyphema due to blunt injury: a review of 118 patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201003022]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the causes, associated ocular findings and visual acuity on presentation, complications and visual outcome following treatment in patients of hyphema due to blunt injury
METHODS: A retrospective study was performed in 118 patients with  hyphema due to blunt injury  admitted in University of Malaya Medical Centre, Kuala Lumpur, Malaysia. The gender, age, race, cause of blunt injury resulting in hyphema, eye involved, vision at admission, other associated ophthalmological findings, complications and visual outcome were noted from the case records of patients. The data were analyzed using SPSS programme.
RESULTS: Males were more predominantly affected (93.2%). Two-thirds of patients (67.8%) were aged below 30 years.  Sports related injury (38.1%) was the most common cause for hyphema. Hyphema disappeared within 5 days in 66.9% of patients. Iris injuries were very commonly associated in the form of mydriasis, sphincter tear and iridodialysis.  Associated vitreous haemorrhage was noted in 11.9% of patients.  During the hospital stay, secondary haemorrhage was observed in 3.4% of patients. The best corrected vision of 6/18 or better was noted in 85.4% of patients at the last follow-up. The follow-up of these subjects was very poor and thus the incidence of secondary glaucoma could not be established. Moderate blood staining of cornea occurred in 0.8% of patients.
CONCLUSION: Sports related injury is the most common cause of hyphema in Malaysia. Good visual recovery, without serious complications, is possible with appropriate and in-time treatment in hyphema patients due to blunt injury.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[V Ulagantheran,M S Ahmad Fauzi and S C Reddy]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>V Ulagantheran,M S Ahmad Fauzi and S C Reddy</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201003022]]></guid><cfi:id>1477</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Ocular manifestations of Alport syndrome]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201002013]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM： To analyze the clinical manifestation of Alport syndrome, especially the ocular features.
METHODS: The physical, ophthalmologic and audiologic examination results of thirty-two patients with Alport syndrome were analyzed retrospectively.
RESULTS: Thirty (93.7%) patients had some family history. All patients had renal disease: eighteen (56.3%) patients with chronic renal failure, four (12.5%) patients with renal insufficiency, and the other ten (31.3%) patients with hematuria. Twenty (62.5%) patients had sensorineural deafness. Thirteen (40.6%) patients had ocular deformity, five (15.7%) patients had typical ocular changes: three patients with anterior lenticonus, and two patients with macular flecks.
CONCLUSION: Ocular anomalies are not requisite for the diagnosis of Alport syndrome. But its typical ocular features should be recognized by the ophthalmologists which supports the diagnosis.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jian-Min Xu,Shi-Sheng Zhang,Qiong Zhang,Ying-Ming Zhou,Cai-Hong Zhu,Jian Ge and Ling Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jian-Min Xu,Shi-Sheng Zhang,Qiong Zhang,Ying-Ming Zhou,Cai-Hong Zhu,Jian Ge and Ling Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201002013]]></guid><cfi:id>1476</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Damage patterns of retinal nerve fiber layer in acute and chronic intraocular pressure elevation in primary angle closure glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201002014]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To observe the differences of damage patterns of retinal nerve fiber layer (RNFL) between acute and chronic intraocular pressure (IOP) elevation in primary angle closure glaucoma (PACG) using optical coherence tomography (OCT).
METHODS: Twenty-four patients (48 eyes) with unilateral acute PACG (APACG) attack in the 6 months after admission and 36 patients (64 eyes) with chronic PACG (CPACG) were included in this prospective study. For all cases, IOP has been controlled under 21mmHg after treatment. Using stratus OCT, the RNFL thickness was assessed in eyes with PACG within 3 days, 2 weeks, 1, 3 and 6 months after IOP was controlled. Repeated measures ANOVA was used to examine the changes of RNFL thickness at different time after IOP being controlled in both acute attack eyes and unaffected fellow eyes of APACG and eyes with CPACG.
RESULTS: The mean RNFL thickness for the APACG- attacked eyes increased significantly within 3 days (121.49±23.84)μm after acute onset and then became thinner along with time [(107.22±24.72)μm at 2 weeks,(93.58±18.37)μm at 1 month, (84.10±19.89)μm at 3 months and (78.98±19.17)μm at 6 months]. In APACG-attacked eyes, there were significant differences of average RNFL thickness at 5 different times after IOP was controlled (P＜0.001). In the APACG unaffected fellow eyes and CPACG eyes, there were no significant differences in mean RNFL thickness at 5 different times(F=0.450, P=0.104 in APACG unaffected fellow eyes and F=1.558, P=0.200 in CPACG eyes). There was significant difference for interaction between time periods and groups (F=1.912, P=0.003). 
CONCLUSION: RNFL damage patterns are different under different IOP elevated courses. In APACG, RNFL was found to be swollen and thickening right after acute attack and then becomes thinning and atrophy along with the time, while RNFL was found to be diffused thinness in CPACG.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xing Liu,Mei Li,Yi-Min Zhong,Hui Xiao,Jing-Jing Huang and Xiang-Yun Kong]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xing Liu,Mei Li,Yi-Min Zhong,Hui Xiao,Jing-Jing Huang and Xiang-Yun Kong</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201002014]]></guid><cfi:id>1475</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effects of glycemic control on refraction in diabetic patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201002015]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the effects of glycemic control on refraction in diabetic patients. 
METHODS: Twenty newly diagnosed diabetic patients were included in this study. The random blood glucose, HbA1c levels, fasting C-peptide and postprandial 2h C-peptide were measured before treatment. The patients with random blood glucose higher than 12.0mmol/L and HbA1c level higher than 10.0% were selected. Refraction, intraocular pressure, radius of the anterior corneal curvature, depth of the anterior chamber, lens thickness, vitreous length, and axial length were measured on admission and at the end of week 1, 2, 3 and 4 during glycemic control.
RESULTS: A transient hyperopic change occurred in all the patients receiving glycemic control. The maximum hyperopic change was 1.60D (range 0.50±3.20D). Recovery of the previous refraction occurred between two and four weeks after insulin treatment. There was a positive correlation between the maximum hyperopic changes and the HbA1c levels on admission (r=0.84, P<0.05). There was a positive correlation between the maximum hyperopic changes and the daily rate of blood glucose reduction over the first 7 days of the treatment (r=0.53, P<0.05). During transient hyperopia, no significant changes were observed in the intraocular pre- ssure, radius of the anterior corneal curvature, depth of the anterior chamber, lens thickness, vitreous length and axial length.
CONCLUSION: Transient hyperopic changes occur after glycemic control in diabetic patients with severe hyperglycemia. The degrees of transient hyperopia are highly dependent on HbA1c levels before treatment and the rate of reduction of the blood glucose level.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hai-Yan Li,Guo-Chun Luo,Jiang Guo and Zhen Liang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hai-Yan Li,Guo-Chun Luo,Jiang Guo and Zhen Liang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201002015]]></guid><cfi:id>1474</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Macular atrophy after combined intravitreal triamcinolone and photodynamic therapy to treat choroidal neovascularization]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201002016]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report the appearance of choriocapillaris atrophy after combined high dose intravitreal triamcinolone acetonide (TA) and photodynamic therapy (PDT) to treat choroidal neovascularization (CNV) associated with age related macular degeneration (AMD). 
METHODS: The present study was retrospective about non-randomized interventional case series. Fifty-one consecutive eyes with subfoveal (all types) CNV associated with AMD were treated by PDT and intravitreal (19.4±2.1)mg per 0.1mL TA at the Alicante Institute of Ophthalmology. The appearance of macular choriocapillaris and retinal pigment epithelium (RPE) atrophy was considered at two years follow-up. Thirty consecutive eyes treated by PDT alone, matched for age, sex, and type and size of CNV were considered as control group.
RESULTS: Twenty-one of 47 eyes in the study group (45%) and 7 of 30 eyes in the control group (23%) developed macular RPE and choriocapillaris atrophy in the treated area at month 24 (P=0.04, Chi-square test). The greatest diameter of the atrophic areas averaged (5044±1666)μm in the study group vs (4345±1550)μm in the control group. Mean final best corrected visual acuity (logarithm of minimal angle of resolution) was (0.87±0.33) in the cases with RPE atrophy vs (0.66±0.26) in the cases with no RPE atrophy in the study group (P=0.11, Mann-Whitney U test).
CONCLUSION: The association of high doses of intravitreal TA and PDT may increase the risk for RPE and choriocapillaris atrophy.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[José M Ruiz-Moreno,Javier A Montero,Pedro Amat and Francisco Lugo]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>José M Ruiz-Moreno,Javier A Montero,Pedro Amat and Francisco Lugo</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201002016]]></guid><cfi:id>1473</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Cell culture isolation can miss the laboratory diagnosis of HSV ocular infection]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201002017]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: We compared polymerase chain reaction (PCR) to cell culture isolation for the laboratory diagnosis of ocular herpes simplex virus (HSV) disease. 
METHODS: Laboratory and medical records of consecutive patients were reviewed for results of 1) HSV PCR testing, 2) HSV cell culture isolation, and 3) clinical diagnosis. PCR results were statistically compared to cell culture isolation and patients initially diagnosed for ocular HSV infection. 
RESULTS: Of 581 cases submitted for laboratory testing, 520 were PCR negative, cell culture negative (89.6%); 0 were PCR negative, cell culture positive (0%); 27 were PCR positive, cell culture negative (4.6%); and 34 were PCR positive, cell culture positive (5.8%). PCR tested more positive than cell culture isolation (McNemar's,P=0.0001). Of 47 HSV PCR positive cases with complete medical records, 19 were cell culture negative for HSV and 28 were cell culture positive for HSV. Fourteen of 19 cell culture negative cases (74%) (Without PCR, 5 cases of HSV would be missed) and 25 of the 28 cell culture positive cases (89%) (Laboratory testing was necessary for diagnosing 3 cases) were clinically diagnosed with HSV at the initial examination. 
CONCLUSION: PCR was a more definitive test for diagnosing HSV ocular infection than cell culture isolation. Cell culture isolation alone can miss an atypical presentation of HSV ocular infection.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Regis P Kowalski,Paul P Thompson and Tara H Cronin]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Regis P Kowalski,Paul P Thompson and Tara H Cronin</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201002017]]></guid><cfi:id>1472</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Treatment review of sight threatening circumscribed choroidal haemangioma ]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201002018]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To describe our clinical experience in treating circumscribed choroidal haemangioma (CCH) in a tertiary referral centre over a fifteen year period prior to photodynamic therapy. 
METHODS: The departmental database and photographic records of a tertiary referral center were used to identify patients who were treated for CCH between 1992 and 2007. Their case records were reviewed. 
RESULTS: Visual acuity improved (>2 Snellen lines) in eleven patients (69%) remained stable in one patient (6%) and deteriorated in four patients (25%). Six of the seven treated with brachytherapy and three of the four treated with transpupillary thermotherapy achieved better visual acuity after treatment. 86% of patients treated within six months of onset of symptoms and 50% of patients treated after six months of onset of symptoms noted an improvement in visual acuity. Only one patient in our series had a final VA of 6/60 or worse. Mean follow-up was thirty-five months.
CONCLUSION: Visual outcome is better when treatment is performed within 6 months of symptoms. The majority of patients achieved an improvement in visual acuity without any adverse effect following treatment.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[James FT Li Yim,Teresa Sandinha,Jan M Kerr,Diana Ritchie and Ewan G Kemp]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>James FT Li Yim,Teresa Sandinha,Jan M Kerr,Diana Ritchie and Ewan G Kemp</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201002018]]></guid><cfi:id>1471</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[LASIK surgery in patients with residual refractive errors after radial keratotomy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201002019]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To study the results and complications of LASIK surgery after radial keratotomy.
METHODS: This descriptive study was carried out in Yazd LASIK Center, Yazd, Iran. Cases included all patients who had been operated between April 2003 and September 2006. Data were collected via a special questionnaire and analyzed by SPSS software and paired t-test. 
RESULTS: Samples included 33 eyes of 23 patients of whom 11 (47.8%) were women and 12 (52.2%) were men. Their age ranged from 28 to 49 years old and the mean age was 31.6 years old. Two cases (6.1%) had openings of the previous radial keratotomy incisions during flap lifting and one case (3%) had moderate non-infectious keratitis. The mean preoperative spherical equivalent (SE) was -2.17D±0.94SD, while the postoperative SE was -0.17D±0.19SD, the difference of which was significant (P =0.0001). Mean preoperative uncorrected visual acuity (UCVA) was 0.07±0.02SD (logMAR) and the postoperative was 0.880.16SD (log MAR), the difference of which was also significant (P=0.0001). The mean best spectacle corrected visual acuity prior to the operation was 0.930.08SD (log MAR) and 0.920.08SD (logMAR) after the operation, the difference of which was not significant (P=0.268).
CONCLUSION: LASIK surgery could improve residual myopia after the radial keratotomy without major complications during or post operation, but necessity of the second procedure must be pondering and require careful case selection and assessment. 
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Abolghasem Rastegar]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Abolghasem Rastegar</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201002019]]></guid><cfi:id>1470</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Traumatic optic neuropathy: a review of 24 patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201002020]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the clinical presentations of traumatic optic neuropathy and to assess the visual outcome of three groups of patients managed differently (conservative, intravenous corticosteroids only and combination of intravenous and oral corticosteroids) at an academic tertiary care referral centre.
METHODS: A retrospective study was conducted involving 24 consecutive patients (27 eyes) with traumatic optic neuropathy attending Hospital Universiti Sains Malaysia from January 2007 till December 2009.
RESULTS: Twenty-four patients (27 eyes) were included. All cases involved were males. Mean age was 33 years old. Motor vehicle accident was the major cause (83.3%). Both eyes were equally involved. Most of the eyes had poor vision on presentation (HM-NPL, 81.5%) with associated periorbital haematoma (22 eyes) and subconjunctival haemorrhage (20 eyes). Majority of patients (19 patients, 79.2%) presented with more than one bony fracture of skull or orbit and 5 patients (20.8%) had no fractures. None of the patients had evidence of optic nerve compression on CT scans or MRI done. Eleven patients (45.8%) had been treated with intravenous and oral corticosteroids. The other 7 patients (29.2%) were treated conservatively and the third group (6 patients, 25.0%) was on intravenous corticosteroids only. Eleven of 12 eyes (91.7%) treated with intravenous and oral corticosteroids had shown 1 line improvement of visual acuity. Those eyes treated conservatively (77.8%) had shown 1 line improvement of visual acuity. As for patients treated with intravenous corticosteroids only, four patients remained NPL, one patient had mild visual improvement and the other one's vision remained the same. The visual improvement in patients treated with conservative management was not significant (P=0.386). Patients treated with intravenous corticosteroids alone have shown no visual improvement statistically(P<0.05). Patients treated with intravenous followed by oral corticosteroids had significant visual improvement (P<0.05). There was no statistically significant difference in visual outcome between patients treated with corticosteroids and patients treated conservatively (P=0.368). No patient underwent surgical decompression of the optic nerve. In this series, the follow up ranges from 6 months to 3 years.
CONCLUSION: Most of the traumatic optic neuropathy patients presented with periorbital haematoma, subconjunctival haemorrhage and orbital wall fractures.  Patients treated with intravenous followed by oral corticosteroids have better visual outcome compared to conservative management.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Kok Foo Lee,Nor Idahriani Muhd Nor,Azhany Yaakub and Wan Hazabbah Wan Hitam]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Kok Foo Lee,Nor Idahriani Muhd Nor,Azhany Yaakub and Wan Hazabbah Wan Hitam</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201002020]]></guid><cfi:id>1469</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical presentation of retinoblastoma in Malaysia: a review of 64 patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201001015]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[ AIM: To analyze the demography, presenting clinical features, spread of the disease of retinoblastoma in patients who were treated in two tertiary hospitals in Malaysia.
·  METHODS: In this retrospective study, information of gender, age, race, presenting clinical features, findings of CT scan orbits and brain, lumbar puncture and bone marrow aspiration results were collected from the medical records of retinoblastoma patients diagnosed in Hospital of Universiti Sains Malaysia and General Hospital of Kuala Lumpur over a period of ten years. The data were collected in the same type of proforma from both hospitals.
·  RESULTS: A total of 64 patients were treated in both hospitals together, of whom boys and girls were almost equally affected. The mean age of children at presentation was 24.2 (range 3-84) months, 53 (82.8%) children were under 36 months old. The disease was unilateral in 39 (60.9%) patients. The most common presenting signs were leukocoria in 46 (71.8%), followed by proptosis in 21 (32.8%) patients. Routine screening of the siblings of affected children revealed retinoblastoma in 2 patients. There was intracranial extension in 8 (12.5%) and metastasis in bone marrow in 6 (9.3%) patients. 
·  CONCLUSION: Leukocoria is the most common presentation of retinoblastoma in Malaysia. However, the disease was intraocular in 40 (62.5%) and extraocular (orbital involvement, intracranial and distant metastasis) in 24 (37.5%) patients. 
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[S C Reddy and S Anusya]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>S C Reddy and S Anusya</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201001015]]></guid><cfi:id>1468</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Surgical outcome of 21 patients with congenital upper eyelid coloboma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201001016]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[ AIM: To evaluate the surgical outcome of congenital upper eyelid coloboma repair.
·  METHODS: All patients underwent complete ophthalmic and general examination before going to surgery, and then examination under anesthesia was performed to assess the site and size of eyelid defect, conjunctival involvement. The status of cornea and ocular motility with forced duction test was also being noted. The surgical procedure was performed according to the size of defect.
·  RESULTS: Out of 21 cases of congenital upper eyelid coloboma, 18 occurred in isolation with upper eyelid medial defect, 13 were bilateral and 5 were unilateral. Others were associated with Goldenhar syndrome and CHARGE syndrome with bilateral upper lid medial defects. All patients were presented for surgical corrections during age of 2.5-4.0 years except one that presented at 25 years of age. Cosmetically surgical results were acceptable, except one that was already presented with opaque corneal.
·  CONCLUSION: In this study, overall surgical results were satisfactory except one that was presented late with compromised cornea.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Arshad Ali Lodhi,Sameen Afzal Junejo,Mahtab Alam Khanzada,Imran Akram Sahaf and Zahid Kamal Siddique]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Arshad Ali Lodhi,Sameen Afzal Junejo,Mahtab Alam Khanzada,Imran Akram Sahaf and Zahid Kamal Siddique</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201001016]]></guid><cfi:id>1467</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Corneal topographic changes in healthy siblings of patients with keratoconus]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201001017]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To describe the involvement in relatives of keratoconus (KCN) patients with corneal topography map. 
·  METHODS: A total of 150 siblings of 300 eyes of 75 KCN patients referred to corneal clinic were studied and experienced complete slit-lamp, refraction examinations and topographic cornea maps provided by videophotoker- atography. ANOVA, Fisher exact and Chi-square tests performed to compare of results.
·  RESULTS: Of 150 siblings, 56% were female and 44% were male with average age of 21 (range 15-39) years. KCN and suspect KCN diagnosed in 12.3% and 6.6% respectively. The central keratometry (CK) was 46.5±4.51 dioptr (D) in KCN and 45.66±1.52D in suspect KCN. Inferior-superior value (I-S) was 3.51±2.5D in KCN and 1.56±1.22D in suspect KCN. In KCN condition the oval pattern was 67.6% (n = 25) and Round pattern detected 32.4% (n =12). In suspect KCN these patterns detected 90% and 10% respectively. Refractive errors in KCN were -7.5 to +1.25 dioptr (-1.25±1.83), in suspect KCN 0.45 to -4.2 dioptr (-0.68±0.76) and in healthy group 2.75 to -7.5 dioptr (-0.6±1.12). Astigmatism was mild in 22.7%, moderate and sever astigmatism in 18.3% in KCN and suspect KCN
·  CONCLUSION: Increasing KCN condition in healthy siblings of KCN patients shows require to screening plan to early diagnose and cautionly treatment of contact lens in these individuals.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mohammad Reza Besharati,Mohammad Reza Shoja,Masoud Reza Manaviat,Maryam Kheirandish and Maasome Zare Rad]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mohammad Reza Besharati,Mohammad Reza Shoja,Masoud Reza Manaviat,Maryam Kheirandish and Maasome Zare Rad</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201001017]]></guid><cfi:id>1466</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Corneal lymphangiogenesis correlates closely with hemangiogenesis after keratoplasty]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201001018]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[ AIM: To examine the relationship between corneal lymphangiogenesis and hemangiogenesis after keratoplasty.
·  METHODS: Nineteen human corneas were obtained from 19 patients undergoing a second corneal transplantation in Zhongshan Ophthalmic Center in 2005. Blood and lymphatic vessels in human transplanted corneas were identified by lymphatic vessel endothelial receptor (LYVE-1) and platelet endothelial cell adhesion modecule-1 (PECAM-1) immunohi- stochemistry, and double enzyme-histochemistry; then the association of corneal blood vessel counting (BVC) with lymphatic vessel counting (LVC) was examined.
·  RESULTS: Corneal hemangiogenesis was present in 12 cases (63%), and lymphangiogenesis occurred in 5 cases (26%) human transplanted corneas. In addition, corneal lymphangiogenesis was only present in vascularized corneas. LVC was strongly and positively correlated with BVC(r=0.725, P <0.01).
·  CONCLUSION: Corneal lymphangiogenesis develops after keratoplasty and strongly associates with hemangiogenesis.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Shi-Qi Ling,Can Liu,Wei-Hua Li,Jian-Gang Xu and Wen-Hui Kuang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Shi-Qi Ling,Can Liu,Wei-Hua Li,Jian-Gang Xu and Wen-Hui Kuang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201001018]]></guid><cfi:id>1465</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Risk factor analysis of 167 patients with high myopia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201001019]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyze the risk factors of age, sex, course, best corrected visual acuity (BCVA), diopter and fundus features of high myopes with progressive high myopia. 
·  METHODS: A total of 167 patients with high myopes were categorized into four groups: group 1, age 10-29 years; group 2, age 30-49 years; group 3, age 50-69 years and group 4, age 70-89 years. The refractive errors of all patients were measured without cycloplegia with an autorefractometer. Data of the spherical equivalent (SE) of the refractive errors in diopters (D) and fundus examined by direct ophthalmoscope were used in statistical analysis. 
·  RESULTS: The number of female was statistically larger than that of male (P＜0.01), also the disease course was correlated to the age. The visual acuity of high myopes significantly decreased as they grew older including the higher incidence of lacquer cracker, submacular hemorrhage, Fuchs spots, chorioretinal atrophy. 
·  CONCLUSION: Female maybe a risk factor of high myopia, advanced age is an important factor of visual acuity decreased. High myopes ought to be treated early to delay the progress of myopia and development of macular degeneration. 
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ya Mo,Ming-Fang Wang and Lu-Lu Zhou]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ya Mo,Ming-Fang Wang and Lu-Lu Zhou</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201001019]]></guid><cfi:id>1464</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Objective evaluation of the changes in the crystalline lens during accommodation in young and presbyopic populations using Pentacam HR system ]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201106007]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To quantify the changes in the lens profile with accommodation in different age groups.
METHODS: The Pentacam HR system was used to obtain the images of the anterior eye segment from 23 young and 15 presbyopic emmetropic subjects in unaccommodated (with an accommodation stimulus of 0.0D) and accommodated (with an accommodation stimulus of 5.0D for the young group and 1.0D for the presbyopic group) states. The phakic crystalline lens shape, including curvature of crystalline lens and central lens thickness (CLT), and the measurements of anterior segment length (ASL), central anterior chamber depth (CACD) were investigated. The anterior chamber volume (ACV) was also measured.
RESULTS: The reduction of CACD and ACV were significant in both groups after accommodation stimulus. From the profile of anterior eye segment, a significant decrease in anterior crystalline lens radii of curvature (-2.52mm) and a mean increase in CLT (0.222mm) and ASL (0.108mm) were found in the young group with an accommodation stimulus of 5.0D. However, no statistically significant changes of CLT, ASL, or crystalline lens radii of curvature were found in the presbyopic group.
CONCLUSION: Our data showed that the shallowing of anterior chamber during accommodation was caused by the forward bulging of the anterior lens surface, rather than by anterior shifting of lens position in either young or presbyopic subjects. 
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yao Ni,Xia-Lin Liu,Ming-Xing Wu,Ying Lin,Yu-Ying Sun,Chang He and Yi-Zhi Liu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yao Ni,Xia-Lin Liu,Ming-Xing Wu,Ying Lin,Yu-Ying Sun,Chang He and Yi-Zhi Liu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201106007]]></guid><cfi:id>1463</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Proteomic analysis of human serum from diabetic retinopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201106008]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To establish and compare serum proteomic of diabetic retinopathy(DR) patients in various phases and discuss pathogenesis of DR so as to find out possible serum specific molecular markers for early diagnosis of DR. 
METHODS: Thirty-two subjects were divided into four groups: one group of eight type 2 diabetes mellitus (T2DM) patients without apparent DR (No-DR, NDR), one group of eight T2DM patients with non-proliferative diabetic retinopathy(NPDR), one group of eight T2DM patients with proliferative diabetic retinopathy(PDR) and one group of eight healthy volunteer participants. Two dimensional fluorescence difference gel electrophoresis (2D-DIGE) was applied to establish differential protein expression profiles in four groups. Matrix-assisted laser desorption/ionization time of flight tandem mass spectrometry (MALDI-TOF-TOF MS) was applied to identify mass spectrometry of differential proteins and analyze follow-up bioinformatics.
RESULTS: 2D-DIGE maps of serum protein were satisfactory obtained from NDR, NPDR, PDR and normal control groups. Twenty-six different proteins spots were screened(the volume ratio was ＞1.5 based on DeCyder software analysis). Twenty-four of them were verified and two of them were not. Fifteen proteins were verified. Most of them were high-abundant proteins in serum. The four relatively low-abundant ones were beta 2-glycoprotein I (β2-GPI), alpha2-HS-glycoprotein(AHSG), alpha1-acid glycoprotein(α1-AGP) and apolipoprotein A-1(apo A-1). β2-GPI expression was gradually increased in the development of DR but unrelated to the severity of DR. The volume ratio of β2-GPI is 1.54, 2.43, and 2.84 in NDR, NPDR and PDR group respectively compared with normal control group.
CONCLUSION: Serum proteomic analysis of 2D-DIGE combined with MALDI-TOF-TOF MS is feasible to be applied in the study of DR. β2-GPI probably takes part in the process of DR occurrence and development and it could be a candidate biomarker on DR diagnosis in early phase.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yin-Ping Liu,Shui-Wang Hu,Zhen-Feng Wu,Li-Xin Mei,Ping Lang and Xiao-He Lu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yin-Ping Liu,Shui-Wang Hu,Zhen-Feng Wu,Li-Xin Mei,Ping Lang and Xiao-He Lu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201106008]]></guid><cfi:id>1462</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Blue-on-yellow perimetry and corneal thickness in patients with ocular hypertension]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201106009]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the frequency of blue-on-yellow perimetry (B/YP) deficits in ocular hypertension (OHT) patients and to correlate these findings with central corneal thickness (CCT), and to investigate the influence of age, refraction and gender on the B/YP results in OHT patients.
METHODS: The B/YP and CCT were checked respectively in 72 OHT patients with normal white-on-white perimetry(W/WP) and normal optic nerve head. The B/YP was tested by Octopus 101 automated perimetry using G2 strategy, while the CCT was checked with DGH-550 ultrasound pachymeter. All patients were chosen randomly one eye for statistical analysis, a binary regression model was used to determine the independent contribution of variables included in the model, and the differences of the intraocular pressure (IOP), CCT, age, refraction and gender between the normal B/YP group and abnormal B/YP group were compared.
RESULTS: Forty-nine out of 72 patients with OHT showed normal B/YP results, whereas 23 of 72 patients(31.9%) demonstrated abnormal B/YP results. CCT showed a correlation with the B/YP results (B=-0.038, SE=0.019, P=0.044), whereas none of the IOP, age, refraction and gender was found to be correlated with the B/YP results. The mean CCT in OHT patients with abnormal B/YP group was lower than that with normal B/YP group(t =2.066, P=0.043).There was a significant positive correlation between IOP and CCT (R2=0.513, P= 0.000).
CONCLUSION: The mean CCT in OHT patients with abnormal B/YP results was lower than that with normal B/YP results. There was a significant positive correlation between IOP and CCT in OHT patients. The age, refraction and gender didn't influence the B/YP results in OHT patients.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yi-Sheng Zhong,Li-Ping Chen and Yu Cheng]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yi-Sheng Zhong,Li-Ping Chen and Yu Cheng</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201106009]]></guid><cfi:id>1461</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Spectral-domain optical coherence tomography in patients with congenital nystagmus ]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201106010]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To study macular features in patients with congenital nystagmus and to assess the utility of spectral-domain optical coherence tomography (SD-OCT) in nystagmus.
METHODS: The macular areas of 51 outpatients with congenital nystagmus were examined using SD-OCT. Morphological changes in the retinal layers of the macular area were analysed.
RESULTS: Macular images were successfully obtained with SD-OCT from 50 (98%) patients. Patients with ocular albinism mainly have macular hypoplasia, abnormal foveal depression, and increased foveal thickness with persistence of an inner nuclear layer, an inner plexiform layer, a ganglion cell layer and a nerve fiber layer. Macular morphology similar to albinism was observed in three patients with idiopathic macular hypoplasia. The OCT findings of cone dystrophy included unclear, disrupted or invisible photoreceptor outer segment/inner segment in the fovea; fusion, thickening and uneven reflection of the outer segment/inner segment with external limiting membrane. Some patients with congenital idiopathic nystagmus showed normal macular morphology and structure, and others showed indistinct macular external limiting membrane reflection.
CONCLUSION: SD-OCT is an effective and reliable method to detect the macular morphology of congenital nystagmus patients. This technique has diagnostic value in particular for patients with macular hypoplasia and cone cell dystrophy with no distinct abnormality on fundoscopy. 
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hong Yang,Tao Yu,Cheng Sun,Xiao-Hong Meng,Yan-Ji Yu,Shu-Jia Huo and Jiu-Quan Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hong Yang,Tao Yu,Cheng Sun,Xiao-Hong Meng,Yan-Ji Yu,Shu-Jia Huo and Jiu-Quan Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201106010]]></guid><cfi:id>1460</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Analysis of risk factors for retinopathy of prematurity]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201106011]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyze the incidence and risk factors for retinopathy of prematurity (ROP).
METHODS: A retrospective analysis was conducted on 568 premature infants from September 2005 to December 2010 with birth weight(BW) equal to or less than 2 500g or a gestational age(GA) at birth of 34 weeks or less. All of the members were examined by indirect binocular ophthalmoscopy. 
RESULTS: ROP occurred with an incidence rate of 10.7% among 568 premature infants, and stages 3 and above ROP occurred with an incidence rate of 2.5%. This study showed the infants were more prone to develop ROP with short geststional age, low BW, long time of oxygen inhalation, and severe infants diseases. Twins had a significantly higher rate of ROP(18.3%) than singleton babies(9.8%), ROP were severer in twins than singleton babies . 
CONCLUSION: Short GA, low BW, long time of oxygen inhalation, severe infants diseases, and non-singleton babies were the most significant risk factors associated with ROP.  
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Wen-Lin Li,Li He,Xi-Hua Liu,Yu-Mei Wang and Jian-Qing Liu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Wen-Lin Li,Li He,Xi-Hua Liu,Yu-Mei Wang and Jian-Qing Liu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201106011]]></guid><cfi:id>1459</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[One-year experience in the retinopathy of prematurity: frequency and risk factors, short-term results and follow-up]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201106012]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: As a result of the increase in premature births and the advances in neonatal intensive care, retinopathy of prematurity (ROP) remains one of the most important causes of childhood blindness worldwide. The main factors in the development of ROP are gestational age, birth weight and oxygen therapy. ROP continues to gain importance due to the increasing survival rates of more immature babies. 
METHODS: Between January 2007 and October 2008, 203 premature infants treated at the Neonatal Intensive Care Unit (NNICU) were prospectively enrolled and the relationship between known risk factors and the occurance of ROP was studied.
RESULTS: ROP in various stages developed in 86 cases (42.4%). Statistically significant correlations were found between the development of ROP and birth weight (P<0.0001) gestational age (P<0.0001), oxygen treatment and its duration (P<0.0001 and P=0.002), mechanical ventilation (MV) and its duration (P=0,0001 and P=0.0001), apnea(P=0.001), intraventricular hemorrhage (IVH) (P=0.046), sepsis (P=0.0001), use of erythropoietin (EPO) (P=0.003), the number of blood transfusions and frequency (P=0.0001 and P=0.0001), surfactant application (P=0.0001), the presence of patent ductus arteriosus (PDA) (P=0.001) or bronchopu- lmonary dysplasia (BPD) (P=0.0001). No significant correlations were found between the occurance of ROP and maternal pre-eclampsia (P=0.293), multiple pregnancy (P=0.218), or hyperbilirubinemia (P=0.494). Severity of ROP was related significantly with birth weight (P=0.0001), but no significant correlation between severity of ROP and gestational age was present.
CONCLUSION: Early description and reduction of the risk factors related with the occurance of ROP with the help of routine screening programs may warrant the prevention of visual loss, however early ophthalmic diagnosis and treatment are still mandatory to provide better visual rehabilitation.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Sariaydin Mehmet,Atlihan Fusun,Calkavur Sebnem,Olukman Ozgur,Ercan Gulten,Ozturk Arif Taylan,Kaya Kilic Fatma,Gokaslan Filiz,Altinyaprak Derya and Malatyali Rana]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Sariaydin Mehmet,Atlihan Fusun,Calkavur Sebnem,Olukman Ozgur,Ercan Gulten,Ozturk Arif Taylan,Kaya Kilic Fatma,Gokaslan Filiz,Altinyaprak Derya and Malatyali Rana</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201106012]]></guid><cfi:id>1458</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Retinal manifestations of patients with human immun- odeficiency virus, a multiethnics study in Malaysia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201106013]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the fundus findings of patients infected with human immunodeficiency virus (HIV) in correlation to Highly Active Antiretroviral Therapy (HAART) and CD4 count.
METHODS:  Two hundred and two patients of the three major races (Chinese, Malay and Indian) in Malaysia were recruited in this population-based cross-sectional study. This consisted of confirmed HIV sero-positive patients with HAART treatment (n=95) or without HAART therapy (n=107) from December 2007 to March 2008. They were further classified into the HIV infected group, AIDS related complex (ARC) group and AIDS group. Each group was then subdivided according to their CD4 count. Clinical fundus findings were recorded. 
RESULTS: Sixty six patients (32.7%) showed presence of fundus manifestation, majority of which was HIV microangiopathy (89%) and the rest being Cytomegalovirus (CMV) retinitis (11%). The most common fundus lesion was cotton wool spot (34%). There was a higher incidence of fundus manifestation in the non HAART group than the HAART group (P=0.04) and in patients with CD4 count less than 200 cells/ml in both groups (P=0.01). The HAART therapy had remarkably reduced the percentage of fundus manifestation by 20% but CD4 count remains the marker for fundus manifestations. There were no significant differences noted in the retinal manifestation among the different races. (ANOVA, P=0.25).
CONCLUSION: The fundus manifestations were higher in patients with CD4<200 cells/ml and in the non HAART group. Hence the HAART therapy is capable of reducing the incidence of fundus manifestations, however the CD4 count determines the occurrence of fundus manifestations. 
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Loo A.V.P,Sujaya S,Peyman M,Florence S and Subrayan V]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Loo A.V.P,Sujaya S,Peyman M,Florence S and Subrayan V</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201106013]]></guid><cfi:id>1457</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Changes in endothelial cell density following penetrating keratoplasty and deep anterior lamellar keratoplasty]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201106014]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the corneal endothelial cell density (ECD) of clear grafts after penetrating keratoplasty (PK) and deep anterior lamellar keratoplasty (DALK). 
METHODS: The study included 44 and 54 patients treated with PK and DALK, respectively, between March 2006 and April 2010. Corneal ECD was examined using specular microscopy at postoperative 1, 3, 6, 12, and 18 months, and the values were compared. 
RESULTS: Corneal ECD reduction in the PK group was 7.4%, 15.2%, 23.5%, and 28.9% at 3, 6, 12 and 18 months respectively after surgery, compared with 4.2 % in the first month (P<0.01). These figures were 3.0%, 6.7%, 7.2%, and 7.7% at 3, 6, 12 and 18 months respectively, compared with 2.2 % in the first month in the DALK group (P>0.05). 
CONCLUSION: Compared with DALK,PK significantly reduced ECD of the clear grafts. These results suggest  that survival of endothelial cells in grafts is better after DALK than after PK.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Banu Torun Acar,Ece Turan Vural and Suphi Acar]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Banu Torun Acar,Ece Turan Vural and Suphi Acar</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201106014]]></guid><cfi:id>1456</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Trends in the indications for penetrating keratoplasty in Shandong, 2005-2010]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201105007]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To identify the current indications and the trend shifts for penetrating keratoplasty (PKP) in Shandong. 
METHODS: The medical charts of all patients who underwent PKP at Shandong Eye Institute from June 1, 2005 to May 31, 2010 were analysed retrospectively. 
RESULTS: A total of 875 patients (875 eyes) received PKP in this 5-year period, accounting for 61.6% of all corneal transplantation surgeries. The leading indications for PKP were infectious keratitis (37.1%), HSK (19.1%), keratoconus (11.2%), bullous keratopathy (8.5%), regrafting (6.7%) and corneal scarring (4.8%). The percentage of PKP for keratoconus declined year by year, whereas the percentage of bullous keratopathy had a mild annual increase. Fungal infections accounted for 65.2% of the infectious keratitis cases, remaining the leading cause of corneal infection. In addition, 54.1% of bullous keratopathy cases were associated with cataract surgery. The leading initial diagnoses associated with regrafting were infectious keratitis (38.9%), HSK (18.6%) and corneal burn (16.9%). The major causes of regrafting included graft endothelial dysfunction (39.0%), graft ulcer (28.8%) and primary disease recurrence (15.3%). 
CONCLUSION: Infectious keratitis remained the leading indication for PKP in Shandong, and fungal infections were still the major cause of corneal infections. There was an increasing trend in the percentage of PKP cases indicated for bullous keratopathy but a decline in the same for keratoconus. Even with a decline in the overall proportion among all corneal transplantation surgeries, PKP is still the major corneal transplant choice in Shandong.  
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jun-Yi Wang,Li-Xin Xie,Xiu-Sheng Song and Jing Zhao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jun-Yi Wang,Li-Xin Xie,Xiu-Sheng Song and Jing Zhao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201105007]]></guid><cfi:id>1455</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Aerocyst urethral catheter insertion compared to expansion sponges application in external dacryocystorhinostomy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201105008]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the clinical effect and complications of two different filling materials  (aerocyst urethral catheter and expansion sponges) applying in external dacryocystorhin- ostomy (EXT-DCR) and compare their advantages and disadvantages. 
METHODS: A retrospective study was made in the period from April, 1 2000 to April, 1 2005. Totally 180 patients (240 eyes) underwent the EX-DCR using different filling materials and divided into three groups randomly: negative control groups (group 1), expansion sponges group (group 2) and aerocyst urethral catheter group (group 3). The gender, etiology, clinical findings, surgical technique, filling materials, the condition of ocular surface and complications were analyzed. Filling materials were removed during day 7. Postoperative success was determined by lacrimal patency to irrigation, a positive dye test, hemorrhage and errhysis conditions after extubation and subjective resolution of epiphora and liquor puris.
RESULTS: During a mean follow-up of 5.14±1.69 years, the success rate were 73.7％ (group 1), 86.5％(group 2), 98.7％ (group 3) in three groups. There was significant statistical difference among three groups in the surgical success rate and the operative complications (including hemorrhage, errhysis, periorbital ecchymosis after extubation)(P<0.05). 
CONCLUSION: EXT-DCR with aerocyst urethral cathete intraoperatively have higher success rate，fewer operative complications and a high patient satisfaction ,and can be used to simplify and speed up traditional EXT-DCR. 
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yi Shao,Yao Yu,Chong-Gang Pei,Qiong Zhou,Wen-Jia Dong,Yangluowa Qu,Lu Yang and Gui-Ping Gao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yi Shao,Yao Yu,Chong-Gang Pei,Qiong Zhou,Wen-Jia Dong,Yangluowa Qu,Lu Yang and Gui-Ping Gao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201105008]]></guid><cfi:id>1454</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Corneal astigmatism correction with scleral flaps in trans-scleral suture-fixed posterior chamber lens implantation: a preliminary clinical observation]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201105009]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To study the impact of scleral flap position, under which the posterior chamber intraocular lenses (PC-IOL) were sulcus-fixed by trans-scleral suture, on cornea astigmatism. 
METHODS: Twenty-six aphakic or cataract eyes were comprised in this prospective noncomparative case series study. Eleven eyes had traumatic cataract removed without sufficient capsular support, 3 had blunt trauma with subluxated traumatic cataract, 8 had undergone vitreoretinal surgery and 4 had congenital cataract removed. The average age was 54 years (range 21-74 years), with 17 men and 7 women. The foldable PC-IOL was fixed in sulcus by trans-scleral suture. The incision for IOL implantation was made 1mm posterior to limbus along the steepest meridian of cornea, while scleral flaps to bury the knots of trans-scleral suture were made along the flattest meridian. All the surgeries were performed by a single doctor (Ma L), and the follow up was at least 13 months (range 13-28 months). The preoperative, 3 months and 1 year postoperative corneal curvature along the steepest and flattest cornea meridian and overall cornea astigmatism were compared.
RESULTS: The curvature along the steepest meridian changed from 44.25±2.22D preoperatively to 44.08±2.16D at 3 months postoperatively, and 43.65±5.23D at 1 year postoperatively (P>0.05); the curvature along the flattest meridian changed from 41.24±2.21D preoperatively to 43.15±3.94D at 3 months postoperatively, and 42.85±5.17D at 1 year postoperatively (P<0.05); and the surgery induced astigmatism (SIA) on cornea was calculated by vector analysis, which was 2.42±2.13D at 3 months postoperatively, and 2.18±3.42D at 1 year postoperatively, the difference was statistically significant (P<0.05).
CONCLUSION: The scleral flap made along the flattest meridian, under which the posterior chamber intraocular lenses (PCIOL) were sulcus-fixed by trans-scleral suture, can steepen the cornea in varying degrees, thus reducing preexisting corneal astigmatism.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Li-Wei Ma,Dwight Xuan,Xiao-Yan Li and Jin-Song Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Li-Wei Ma,Dwight Xuan,Xiao-Yan Li and Jin-Song Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201105009]]></guid><cfi:id>1453</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Idiopathic phacodonesis in senile cataract patients in Qinghai, China]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201105010]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the frequency of idiopathic phacodonesis (IP) in senile cataract subjects and the short-term clinical outcomes following cataract surgery.
METHODS：This institutional case-control study included 1301 consecutive low-income cataract subjects from June to November 2009. Anterior segment were carefully evaluated with dilated pupil under slit-lamp. IP were screened and graded by a criteria set by the authors. Risk factors, surgical outcomes, and operative complications were analyzed.
RESULTS：A total of 42 subjects (3.2%) with IP were diagnosed and classified as grade 1 (36 subjects), grade 2 (5 subjects) and grade 3 (1 subject). Harder lenses and intumescent cataracts were observed in the IP group than the control group (P<0.05). Logistics regression test also indicated the main risk factor was the hardness of the lens. The incidence of zonular dialysis during surgery was 23.8% (10 eyes), which was significantly higher than the controls (0.7%,P<0.001). Visual outcomes of the two groups were not statistically or clinically significant.
CONCLUSION: Hard nucleus and intumescent cataract are related to IP in senile cataract subjects in Qinghai, China. With more care being taken, grade 1 and some of the grade 2 IP subjects achieved similar surgical outcomes as compared to controls. 
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xiao-Wei Liu,Zheng Wang,Wei-Hong Yu,Zao-Wen Wang,Yan-Ning Zhang,Jian-Jun Liu and Rui-Fang Sui]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiao-Wei Liu,Zheng Wang,Wei-Hong Yu,Zao-Wen Wang,Yan-Ning Zhang,Jian-Jun Liu and Rui-Fang Sui</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201105010]]></guid><cfi:id>1452</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Cataract surgery in aged patients: phacoemul-sification or small-incision extracapsular cataract surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201105011]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the effects and safety of phacoemu- lsification (Phaco) or small-incision extracapsular cataract surgery (SICS) and intraocular lens (IOL) implantation for aged patients.
METHODS: Totally 137 aged patients (149 eyes) underwent cataract operation in the case of stable systemic condition, the blood pressure less than 160/95mmHg, blood glucose less than 8mmol/L, and under the help of electrocardiogram surveillance by anesthesiologists during the operation. 106 aged patients (114 eyes) underwent Phaco while 31 aged patients (35 eyes) underwent SICS. The postoperative visual acuity, corneal endothelial cell loss, surgery time and major complications were observed and analyzed retrospectively.
RESULTS: The best-corrected visual acuity(BCVA) of ≥0.6 was achieved in 135 eyes (92.6%) at 1 month postoperatively (χ2=259.730, P＜0.001). For aged patients, both Phaco and SICS could significantly improve visual acuity with no significant difference (χ2=4.535,P＞0.05). Postoperative corneal endothelial cell loss was 18.6%, in PHACO group, the rate was 18.5%; in SICS group, the rate was 19.0%, the difference of which was no significant (χ2=0.102, P>0.05). The surgery time was different in two groups. No severe complications occurred.
CONCLUSION: Both Phaco and SICS combined with IOL implantation for aged patients are effective and safe. Before surgery, detailed physical examination should be performed. When the systemic condition is stable, cataract surgery for aged patients is safe.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Tao Jiang,Jing Jiang,Yang Zhou,Gui-Qiu Zhao,Hui Li and Shan-Yao Zhao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Tao Jiang,Jing Jiang,Yang Zhou,Gui-Qiu Zhao,Hui Li and Shan-Yao Zhao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201105011]]></guid><cfi:id>1451</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Awareness of eye complications and prevalence of retinopathy in the first visit to eye clinic among type 2 diabetic patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201105012]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the awareness of eye complications and the prevalence of retinopathy, in the first visit to eye clinic, among type 2 diabetic patients attending a tertiary medical centre in Kuala Lumpur, Malaysia.
METHODS: An investigator-administered questionnaire was given to 137 patients with diabetes undergoing first time eye screening in the eye clinic. This was followed by a detailed fundus examination by a senior ophthalmologist to assess for presence of retinopathy. 
RESULTS: Almost 86% of respondents were aware of diabetic eye complications, especially in patients who had achieved tertiary educational level (96.3%). The majority of the patients (78.8%) were referred by their physicians and only 20.4% came on their own initiative. Many of the patients (43.8%) did not know how frequent they should go for an eye check-up and 72.3% did not know what treatments were available. Lack of understanding on diabetic eye diseases (68.6%) was the main barrier for most patients for not coming for eye screening earlier. Despite a high level of awareness, only 21.9% had recorded HbA1c level of <6.5% while 31.4% were under the erroneous assumption of having a good blood sugar control. A total of 29.2% had diabetic retinopathy in their first visit eye testing.
CONCLUSION: In the present study, 29.2% of type 2 diabetic patients had  retinopathy in their first time eye testing. Although the awareness of diabetic eye complications was high among first time eye screening patients, the appropriate eye care-seeking behavior was comparatively less and should be rectified to prevent the rise of this sight threatening eye disease. 
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[I Tajunisah,PS Wong,LT Tan,P Rokiah and SC Reddy]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>I Tajunisah,PS Wong,LT Tan,P Rokiah and SC Reddy</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201105012]]></guid><cfi:id>1450</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Rigid contact lens fitting based on keratometry readings in keratoconus patients: predicting formula]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201105013]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To find a simple mathematical correlation between the lens base curve (BC) and keratometry findings (krf).
METHODS: This retrospective study included 400 keratoconic eyes (350 patients) previously fit with rigid contact lenses at an academic eye center over a five year period. The patients were classified into five groups based on the keratometry findings (krf<7, krf:7-8, krf>8, krf-krs (difference between two keratometry; flat and steep)= 0.3-0.6, krf-krs >0.6mm as groups 1 to 5, respectively. Multivariate linear regression and Munro's correlation coefficient were employed to defer the formulas.
RESULTS: A linear correlation could be found in all groups except for patients in group 3. For group 1, BC=0.211×krf+ 5.904. For group 2, BC=0.456×krf+4.160. For group 4,BC= 0.321×krf+5.219. For group 5, BC=0.337×krf+ 5.090.
CONCLUSION: The development of new formulas for RGP fitting enables ophthalmologists to work with confidence and prevents unnecessary and frequent lens trials. The customary lens fitting methods are needed to be replaced by new formulas, which help to save time and costs.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mohammad Taher Rajabi,Zahra Mohajernezhad-fard,Seyede Khojaste Naseri,Fahimeh Jafari,Askar Doostdar,Parviz Zarrinbakhsh,Mohammad Bagher Rajabi and Sedigheh Kohansal]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mohammad Taher Rajabi,Zahra Mohajernezhad-fard,Seyede Khojaste Naseri,Fahimeh Jafari,Askar Doostdar,Parviz Zarrinbakhsh,Mohammad Bagher Rajabi and Sedigheh Kohansal</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201105013]]></guid><cfi:id>1449</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Immediate intraocular pressure rise after intravitreal injection of ranibizumab and two doses of triamcinolone acetonide]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201104016]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate prospectively immediate intraocular pressure (IOP) changes after the intravitreal injection of ranibizumab, 2 and 4mg triamcinolone acetonide.
METHODS: Patients who underwent intravitreal injection of 0.1mL (4mg) triamcinolone acetonide (TA, Group T4), 0.05mL (2mg) TA (Group T2) and 0.05mL (0.5mg) ranibizumab (Group R) comprised the study population. Overall, 229 eyes of 205 patients were injected. Fifty-four eyes (23.6%) were in Group T4, 69 eyes (30.1%) in Group T2 and 106 eyes (46.3%) in Group R. If IOP was less than 26mmHg immediately after the injection no further measurement was performed. If IOP was ≥26mmHg, IOP was remeasured till the reading was below 26mmHg at 5, 15 and 30 minutes.
RESULTS: Immediately after the injection, the IOP of 28 eyes (51.9%) in Group T4, 22 eyes (31.9%) in Group T2 and 51 eyes (48.1%) in Group R were over 25mmHg. At 30 minutes, IOP of one eye (1.9%) in group T4, two eyes (2.9%) in group T2 and two eyes (1.9 %) in Group R were over 25mmHg. Immediate post-injection IOP was significantly higher in Group T4 and Group R when compared to Group T2 (P<0.001 and P<0.001, respectively). IOP was significantly higher in eyes without vitreous reflux when compared to those with vitreous reflux in all groups (P<0.001). 
CONCLUSION: IOP may remarkably increase immediately after the intravitreal injection of 2 or 4mg  triamcinolone acetonide, and 0.5mg ranibizumab. Absence of vitreous reflux is the most important predicting factor for immediate IOP rise after the injection.   
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ali Osman Saatci,Ferit Hakan Oner and Gul Arikan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ali Osman Saatci,Ferit Hakan Oner and Gul Arikan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201104016]]></guid><cfi:id>1448</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Osteopontin expression in vitreous and proliferative retinal membranes of patients with proliferative vitreous retinopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201104017]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyze osteopontin (OPN) expression in vitreous and proliferative retinal membranes of patients with proliferative vitreous retinopathy (PVR). 
METHODS: A total of 54 vitreous fluid samples were obtained between 2009 and 2010, which contained 45 with PVR (group A) and 9 without PVR (group B). Enzyme-linked immunosorbent assay was applied to quantify the OPN concentrations in vitreous fluid. Four samples of proliferative retinal membrane were also obtained at the time of vitrectomy, and their contents of OPN were measured by Real-time RT-PCR.
RESULTS: The OPN levels in the vitreous fluid were 778.48±62.06ng/mL in group A and 452.99±32.52ng/mL in group B. The vitreous OPN levels in group A were significantly higher than those in group B and to rise by time in the early stages of PVR. The average OPN levels in the proliferative retinal membranes (F=0.14) were also higher than those in the retinal pigment cells (F=0) using Real-time RT-PCR. 
CONCLUSION: The high vitreous and proliferative retinal membrane OPN levels in PVR suggest that OPN might promote the development of PVR. The vitreous OPN concentrations are rising by the time in the early phases of PVR.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xiao-Yi Liu,Lei Li,Jia-Qi Yao,Xi Chen and Qing-Huai Liu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiao-Yi Liu,Lei Li,Jia-Qi Yao,Xi Chen and Qing-Huai Liu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201104017]]></guid><cfi:id>1447</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Pathogen characteristics and its sensitivity against antimicrobial agents in fatal bacterial granuloma after eyelid trauma in vitro]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201104018]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To understand the pathogen characteristics and its sensitivity against antimicrobial agents in fatal bacterial granuloma after eyelid trauma (FBGT) in vitro, and to provide laboratory evidence for diagnosis. 
METHODS: The FBGT pathogens were isolaated and cultured with reformed rabbit-brain anaerobic enriched broth (RRAB), and identified by ATB/API 20A system. The minimum inhibiting concentration (MIC) was determined by anaerobic broth dilution method. 
RESULTS: A total of 22 strains of pathogen were separated from 21 patients with FBGT and identified as Propionibacterium acnes (PA) by ATB/API 20A system. The MIC of ciprofloxacin for 22 PA strains was 0.0625-0.5mg/L, the MIC of penicillin, ampicillin, ampicillin/sulbactam, cefoperazone, lincomycin, and imipenem/cilastatin were 0.125-0.5mg/L, the MIC of ticarcillin/clavulanic acid was 0.250-1.000 mg/L ,and the MIC of metronidazole was 64-256mg/L. The pathogen of FBGT was strictly anaerobic PA, which growed slowly and better in nutritious RRAB broth. All PA were resistant to metronidazole, but susceptive to other routine antimicrobial agents, such as penicillin, ampicillin and lincomycin. 
CONCLUSSION: FBGT should not be treated with metronidazole. Clinicians should choose combined use of drugs or operation to treat FBGT according to patients’ individual condition and the results of drug sensitivity test. 
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jia-Yun Liu,Xiu-Li Xu,Tian-Wen Gao,Peng-Liang Zhang,Xian-Long Qi,Xiao-Dong Cheng and Xiao-Ke Hao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jia-Yun Liu,Xiu-Li Xu,Tian-Wen Gao,Peng-Liang Zhang,Xian-Long Qi,Xiao-Dong Cheng and Xiao-Ke Hao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201104018]]></guid><cfi:id>1446</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Validation of PCR for the detection of Pseudomonas aeruginosa from corneal samples]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201103010]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine a species-specific real-time polymerase chain reaction (PCR) assay to detect Pseudomonas aeruginosa (PA), a secondary DNA target for PA that may provide a universal target for other bacterial pathogens, and validate both assays for diagnostic testing.  
METHODS: PCR detection was established against the ecfX PA gene and the 16S rRNA gene using known PA keratitis isolates.  The outcome parameters for both assays were “limit of detection” (LOD), amplification efficiency (AE), and PAGE amplified product analysis.  Both assays were validated against 20 true-positive clinical samples positive for PA DNA and 20 true-negative samples containing no PA DNA.  Descriptive statistics and PAGE analysis were used as outcome parameters.     
RESULTS:  AE of the ecfX assay was 96.6%, and LOD was 33.6 copies of target DNA per microliter. AE of the 16S rRNA assay was 103.4%, and LOD was 8.12 copies per microliter.  The sensitivity, specificity, positive predictive value, negative predictive value, and efficiency for the ecfX and 16S rRNA assays were [75%, 95%, 94%, 79%, and 85%], and [70%, 100%, 100%, 77%, and 85%], respectively.  Both PCR assays were validated, followed by confirmation of DNA patterns from PAGE analysis. 
CONCLUSION: The PCR methodology described here may be a useful adjunct to standard methods in the diagnosis of PA keratitis.  
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Maria E. Hillenbrand,Paul P. Thompson,Robert M. Q. Shanks and Regis P. Kowalski]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Maria E. Hillenbrand,Paul P. Thompson,Robert M. Q. Shanks and Regis P. Kowalski</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201103010]]></guid><cfi:id>1445</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Correlation of leaking microaneurysms with retinal thickening in diabetic retinopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201103011]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the contribution of fluorescein angiographic leaking microaneurysms (leak-MA) versus non-leaking microaneurysms (non-leak-MA) to retinal thickening in diabetic retinopathy.
METHODS: A consecutive series of 38 eyes from 24 patients with diabetic retinopathy was included. Leak-MA and non-leak-MA in each eye were selected in pairs at corresponding topographic location. Leaking was defined by late phase fluorescein angiograms compared to early phase. Retinal thickness was measured with Heidelberg Spectralis OCT topographically aligned on early phase angiograms at the MA site and within a 1 mm circle. 
RESULTS: In all eyes, significant retinal thickening at the site of leaking compared to non-leaking microaneurysms was observed (356±69μm vs 318±56μm, P <0.001), showing a mean increase in thickness in the areas of leak-MA vs non-leak-MA of 38±39μm (95% confidence interval 25-51μm, P<0.001). All 1mm area measurements also showed significant (P<0.001) thickening of the leak-MA with average thickness of leak-MA vs non-leak-MA as 351±67μm vs 319±59μm; minimum thickness 311±62μm vs 284±60μm; maximum thickness 389±78μm vs 352±66μm; and retina volume 26.4±6.0mm vs 23.6±3.7mm3, respectively. 
CONCLUSION: Leaking of microaneurysms on fluorescein angiography appears to cause focal thickening of retina, which can be measured with high-resolution OCT. Therefore, targeting leaking microaneursyms in diabetic retinopathy has the potential to reduce retinal thickening.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Lukas Reznicek,Marcus Kernt,Christos Haritoglou,Michael Ulbig,Anselm Kampik and Aljoscha S Neubauer]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Lukas Reznicek,Marcus Kernt,Christos Haritoglou,Michael Ulbig,Anselm Kampik and Aljoscha S Neubauer</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201103011]]></guid><cfi:id>1444</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Non-arteritic anterior ischaemic optic neuropathy in Malaysia: a 5 years review]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201103012]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the clinical presentations and visual outcomes of non-arteritic anterior ischaemic optic neuropathy (NAION).
METHODS: A retrospective study was conducted involving 18 consecutive patients (20 eyes) with NAION attending Hospital Universiti Sains Malaysia from January 2005 until December 2009.
RESULTS: Most patients were Malay (94.4%), and followed by Chinese (5.6 %). The female-to-male ratio was 3.5:1. The age of patients ranged from 36 to 85 years (mean, 57.1 years). The main risk factors in systemic diseases were hypertension (55.5%), diabetes mellitus (44.4%), and ischaemic heart disease (11.1%). Most patients (77.8%) presented with acute loss of vision while gradual onset was in 22.3% of cases. Majority had visual acuity worse than 1/60 (80%). The most common fundoscopic findings were peripapillary splinter haemorrhage (90%), sectorial swollen optic disc (60%) and hyperemic disc (60%). During follow up, 20% of the patients showed stabilization in visual acuity, and 80% showed worsening of vision.
CONCLUSION: Majority of patients with NAION presented with acute poor vision involving middle-aged and elderly individuals. Hypertension and diabetes mellitus were among the main risk factors involved. NAION can lead to permanent visual loss despite treatment.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Abdulrahman Bawazir,Reza Gharebaghi,Adil Hussein and Wan Hazabbah Wan Hitam]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Abdulrahman Bawazir,Reza Gharebaghi,Adil Hussein and Wan Hazabbah Wan Hitam</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201103012]]></guid><cfi:id>1443</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[TGFBI gene mutation analysis in a Chinese pedigree of Avellino corneal dystrophy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201103013]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyze phenotype and genotype of a Chinese pedigree with Avellino corneal dystrophy (ACD).
METHODS: Complete ophthalmic examinations were per- formed on all the family members. Exons of TGFBI were amplified by polymerase chain reaction, sequenced, and compared with a reference database.
RESULTS: A single heterozygous G>A(R124H) point mutation was identified in exon 4 of TGFBI in three affected members and two unaffected children who were offsprings of the affected members, but not in the other family members. 
CONCLUSION: Mutation R124H in TGFBI was identified in this pedigree and appeared to be the disease causing mutation. Atypical phenotype and low penetrance was observed in this pedigree.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ai-Rui Xie,Su-Ping Cai,Yin Yang,Yin-Chuan Fan,Wen-Han Yu,Li-Heng Guo,Qiao-Na Yang,Jin Zhu and Xu-Yang Liu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ai-Rui Xie,Su-Ping Cai,Yin Yang,Yin-Chuan Fan,Wen-Han Yu,Li-Heng Guo,Qiao-Na Yang,Jin Zhu and Xu-Yang Liu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201103013]]></guid><cfi:id>1442</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Novel sutureless transplantation for primary pterygium associated with cysts]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201103014]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the efficacy and safety of a novel sutureless AMT (amniotic membrane transplantation) or CAT (conjunctivolimbal autograft transplantation) using fibrin glue for reconstructing corneoconjunctival surfaces for primary pterygium associated with cysts. 
METHODS: A prospective descriptive study was made of the period 1 January 2006-1 May 2009. Nine patients with primary pterygium associated with cysts underwent pterygium and cyst excision followed by sutureless AMT or CAT using fibrin glue. 
RESULTS: During a mean follow-up of 8.00±0.67 months, all eyes maintained a smooth and stable corneal epithelial surface without recurrent erosion or persistent epithelial defect. The limbal donor site showed the presence of mild depressions without the formation of pseudopterygium. All eyes have good tear secretion function, tear film stability and ocular motility.
CONCLUSION: Sutureless transplantation using fibrin glue is safe and effective for restoring a stable corneoconjunctival epithelium in primary pterygium associated with cysts. 
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yi Shao,Xin Zhou,Yao Yu,Chong-Gang Pei,Qiong Zhou,Juan Li,Lu Yang,Wen-Jia Dong and Jing-Lin Yi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yi Shao,Xin Zhou,Yao Yu,Chong-Gang Pei,Qiong Zhou,Juan Li,Lu Yang,Wen-Jia Dong and Jing-Lin Yi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201103014]]></guid><cfi:id>1441</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of the retinal modulation transfer function between amblyopes successfully corrected and normal subjects ]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201103015]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM：To analyze the retinal modulation transfer function between amblyopes whose visual acuity was corrected to 5.0 and normal subjects at the same age. 
METHODS： RM-800 used to detect contrast sensitivity was adopted to measure MTF of 96 amblyopes (96 eyes) whose visual acuity was corrected to 5.0 and 80 normal controls (80 eyes) at the same age under six interference fringes (IVA=0.06, 0.1, 0.2, 0.4, 0.6, 0.8).
RESULTS： The functional values of amblyopes were significantly lower than those of normal subjects in every fringe (P<0.01), especially in medium and high frequency.
CONCLUSION：For amblyopes, MTF was still abnormal after stopping the treatments.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xiao-Ming Huang,Xue-Gu Xu and Guo-Xing Xu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiao-Ming Huang,Xue-Gu Xu and Guo-Xing Xu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201103015]]></guid><cfi:id>1440</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of age-related changes between corneal and ocular aberration in young and mid-age myopic patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201103016]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To study the dynamic character of aberration between the cornea and the ocular with aging, and to evaluate the symmetry of the aberrations between right and left eye in order to supply the data for clinic to do the refractive surgery reasonably. 
METHODS: This is a comparative case series study. 82 normal cases (164 eyes) including 37 females (74 eyes) and 45 males (90 eyes) were recruited through the routine examinations、Topolyzer and wavefront analysis. The average age was 25.9±5.0 years old (range 18 to 49 years old), and the mean spherical equivalent (SE) is -3.82±2.21D (range -1.00 to -6.00D). The changes of aberrations regarding age, the relationship between anterior corneal and total aberrations were analyzed，as well as the symmetry between right and left eyes by using Zernike terms. 
RESULTS: The Z 3 1, RMS3 of corneal aberrations, Z 3 1, Z 4 0 , RMS3 and RMS4 of ocular aberrations had a positive correlation with age. The zernike terms both in corneal and whole eye were significantly correlated between right and left eyes. 
CONCLUSION: The corneal horizontal coma, ocular horizontal coma and ocular spherical aberrations become to increase at the age of more than 40 years old. The dynamic change of aberration with aging, balance between corneal and ocular, and the symmetric character between left eye and right eye should be designed carefully in the treatment nomogram before the refractive surgery.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Feng-Ju Zhang,Zheng Zhou,Fang-Lei Yu,Zhi-Li Lu,Ting Li and Meng-Meng Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Feng-Ju Zhang,Zheng Zhou,Fang-Lei Yu,Zhi-Li Lu,Ting Li and Meng-Meng Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201103016]]></guid><cfi:id>1439</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Confocal microscopic evaluation of cornea after AquaLase liquefaction cataract extraction]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201103017]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: The most recent and innovative AquaLase liquefaction technology has offered an alternative to lens extraction. Many studies have investigated its functions and advantages. This article focuses on evaluating the in vivo microscopic cornea changes after AquaLase liquefaction by using a laser confocal microscope. 
METHODS: In this perspective, randomized case study, 37 eyes of 35 patients submitted to cataract surgery were chosen to undergo AquaLase liquefaction cataract extraction. Each patient was assessed before the operation, on the 1st, 7th, and 30th postoperative days, and 6 months after the cataract extraction. The morphologies and quantitative comparisons of corneal cells and corneal nerves layer by layer were evaluated in vivo with the Heidelberg Retina Tomograph III-Rostock Cornea Module (HRT-III RCM) confocal microscope. ANOVA and Post-Hoc Bonferroni test were carried out to compare the results pre- and post-operation. 
RESULTS: ANOVA results indicated no post-operation changes for epithelium and anterior stroma cells. Irregular segments of sub-basal nerve fiber were most pronounced seven days post-operation. In the mid and posterior stroma, keratocytes were obvious compared with the preoperative condition. Corneal endothelium cells became obviously swollen in cytoplasm and nucleus. The mid and posterior stroma cell density decreased from the 1st to 7th postoperative days (P<0.05). The corneal endothelium cell density decreased (P<0.05) and did not revert to the preoperative level after six months (P<0.05).
CONCLUSION: Slight microstructural abnormalities were identified in the corneal recovery process after AquaLase liquefaction. AquaLase liquefaction cataract extraction is safe for cornea.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jiang-Yue Zhao,Ming-Wu Wang,Qi Sun and Jin-Song Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jiang-Yue Zhao,Ming-Wu Wang,Qi Sun and Jin-Song Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201103017]]></guid><cfi:id>1438</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Head trauma can cause transient elevation of intraocular pressure in patients with open angle glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201103018]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To describe a newly-recognized entity, illustrated by five cases of glaucoma in whom trauma to the head, but not the eye, resulted in marked, transient elevation of intraocular pressure (IOP).
METHODS: Retrospective case series.  Chart review.
RESULTS: All five cases had a diagnosis of primary open-angle glaucoma prior to the experience of trauma to the head. All cases had an unusual elevation of IOP (around 70 percent) for days to weeks following the trauma, after which the IOP fell to pre-accident levels.  No cause other than the trauma could be determined.  
CONCLUSION: The relationship between head trauma and elevation of IOP appears real.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hong Wei and George L. Spaeth]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hong Wei and George L. Spaeth</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201103018]]></guid><cfi:id>1437</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Application of Lutein and Zeaxanthin in nonproliferative diabetic retin]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201103019]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare serum Lutein and Zeaxanthin (L/Z) concentrations between patients with nonproliferative diabetic retinopathy (NDR) and normal subjects, and to explore the effect of L/Z supplementation on serum L/Z level and visual function in NDR patients
METHODS: Subjects were divided into three groups: 30 NDR patients supplied with Lutein 6mg/d and Zeaxanthin 0.5mg/d for three months (DR Group), 30 NDR patients without L/Z supplementation (DR Control Group) and 30 normal subjects (Control Group). Serum L/Z concentrations were measured by liquid high-resolution chromatography (HPLC). Visual acuity was recorded at baseline, 1 month, 2 months and 3 months post initial supplementation. Serum L/Z concentration were measured at baseline, 1 month and 2 months post initial supplementation. Contrast sensitivity (CS) and fovea thickness were recorded at baseline and 3 months post initial supplementation.  
RESULTS: Mean serum lutein concentrations in DR group were 0.0686±0.0296μg/mL and zeaxanthin concentration was 0.0137±0.0059μg/mL. The L/Z level of DR group was significantly lower compared to the control group( lutein: 0.2302±0.1308μg/mL，zeaxanthin: 0.0456±0.0266μg/m，P = 0.000). The concentration of lutein and zeaxanthin in the DR control group at base line was 0.0714±0.0357μg/mL and 0.0119±0.0072μg/mL, respectively. There was no significant change of L/Z concentration in the DR control group during the study. Serum L/Z concentrations of DR group increased significantly after supplementation（F=109.124，P=0.000；F=219.207，P=0.000）.Visual acuity improved significantly after medication. Compared with pre-medication, the average CS values of 1.5cpd, 3cpd and 6cpd after three months increased significantly (P=0.030,0.013,0.008) and the foveal thickness decreased. (P=0.05)
CONCLUSION: Serum L/Z concentrations in DR patients are significantly lower than those in normal subjects, and L/Z intake can improve the visual acuity, CS and macular edema in DR patients, suggesting that L/Z supplementation might be targeted as potential potential therapeutic agents in treating NDR. 
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Bo-Jie Hu,Ya-Nan Hu,Song Lin,Wen-Jiang Ma and Xiao-Rong Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Bo-Jie Hu,Ya-Nan Hu,Song Lin,Wen-Jiang Ma and Xiao-Rong Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201103019]]></guid><cfi:id>1436</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Vitrectomy for vitreous amyloidosis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201103020]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To study the clinical features of vitreous amyloidosis and the effect of vitrectomy for it.
METHODS: We treated 6 eyes (4 Patients) with vitreous amyloidosis from 2008 to 2009, and followed up for 18-30 months after vitrectomy.
RESULTS: The visual acuity ranged from counting fingers to 3/50 before surgery and 15/50-40/50 after vitrectomy.  No severe complication was observed.
CONCLUSION: Vitrectomy is an effective and safe treatment for eyes with vitreous amyloidosis. A long period of follow-up after surgery should be performed.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jiang You]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jiang You</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201103020]]></guid><cfi:id>1435</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinicopathological survey of 23 patients with lacrimal fossa lesions in Hong Kong]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201103021]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To survey the clinicopathological correlations of lacrimal fossa lesions in the Hong Kong population.
METHODS:  A total of 23 patients with lacrimal fossa lesions were identified radiologically.  The mean age at the time of diagnosis was 52 year-old. The medical records of patients diagnosed with lacrimal fossa lesions and subsequently underwent radiological investigations were collected and reviewed retrospectively throughout a six years period from 2000 to 2006 from three regional hospitals (Tung Wah Eastern Hospital, Pamela Youde Nethersole Eastern Hospital and Queen Mary Hospital) belonging to the Hong Kong Mega Cluster.  Patient demographics, presenting signs and symptoms, imaging modalities, pathological reports and subsequent management were recorded.
RESULTS:  The most common initial presenting symptom was upper lid swelling (83%) followed by proptosis (13%).  19 patients (83%) had benign lacrimal fossa lesion and 4 patients (17%) had malignancy.  Three of the malignancies were lymphomas and one was adenoid cystic carcinoma.  
CONCLUSION: Age is an important factor in considering the differential diagnosis of lacrimal fossa lesion.  Lymphoproliferative diseases have the highest incidence in patients over 60 years of age while inflammatory lesions are more common in younger patients in Hong Kong. 
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Danny Siu-Chun Ng,Edwin Chan, Kin Yau and Clement Wai-Nang Chan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Danny Siu-Chun Ng,Edwin Chan, Kin Yau and Clement Wai-Nang Chan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201103021]]></guid><cfi:id>1434</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinic study on silicone hydrogel contact lenses used as bandage contact lenses after LASEK surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201103022]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the clinical performance of two types of silicon hydrogel contact lenses used as bandage lenses after LASEK surgery. 
METHODS: A prospective, double-masked study was conducted on 42 eyes of 21 patients who received binocular LASEK surgeries. The interocular difference in spherical equivalent power was less than -1.50D. Patients were randomly assigned to wear Galyfilcon A (Lens A) bandage contact lens in one eye and Balafilcon A (Lens B) in the fellow eye after the surgery. The responses to a subjective questionnaire on comfort of wearing, corneal epithelial status, conjunctival hyperemia, limbal neovascularization, lens fitting and contact lens debris were assessed 1 and 5 days postoperatively. Corneal endothelium was assessed before and 5 days after the surgery upon bandage lens removal.
RESULTS: There was no difference between the two groups in terms of conjunctival hyperemia, limbal neovascularization, contact lens fitting, corneal epithelial status, corneal endothelium cell density (CD) and endothelium cell size (CS) at any postoperative visit. Complaints of discomfort, including foreign body sensation, pain and intolerance were statistically more among Lens B wearers at any postoperative visit (P<0.05). Lens B appeared to attract much more debris than Lens A at the 5-day post-operative follow-up visit (P<0.01).
CONCLUSION: The two types of silicon hydrogel lenses investigated in this study demonstrated similar clinical performance in terms of corneal responses and lens fitting. However, Lens A showed a better performance in terms of comfort of wearing and deposit resistance.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xiao-Mei Qu,Jin -Hui Dai,Zhen -Ying Jiang and Yi- Feng Qian]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiao-Mei Qu,Jin -Hui Dai,Zhen -Ying Jiang and Yi- Feng Qian</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201103022]]></guid><cfi:id>1433</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effects of propofol versus urapidil on perioperative hemodynamics and intraocular pressure during anesthesia and extubation in ophthalmic patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201102012]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the effect of propofol versus urapidil on hemodynamics and intraocular pressure during anesthesia and extubation for ophthalmic patients.
METHODS: Eighty-two surgical patients (Class: ASA I-Ⅱ) were randomly assigned to propofol (n=41) and urapidil groups (n=41). Their gender, age, body mass, operation time and dosage of anesthetics had no significant difference between the two groups (P>0.05). The patients of propofol and urapidil groups were given propofol (1.5mg/kg) and urapidil (2.5mg/kg) respectively; and two drugs were all diluted with normal saline to 8mL. Then the drugs were given to patients by slow intravenous injection. After treatment, the patients were conducted immediate suction, tracheal extubation, and then patients wore oxygen masks for 10 minutes. By double-blind methods, before the induction medication, at the suction, and 5, 10 minutes after the extubation, we recorded the systolic and diastolic blood pressure (BP), heart rate (HR), pH, PaO2, PaCO2, SaO2 and intraocular pressure (IOP) respectively. The complete recovery time of the patients with restlessness (on the command they could open eyes and shaking hands) was also recorded during the extubation. The data were analyzed by using a professional SPSS 15.0 statistical software.
RESULTS: The incidence of cough, restlessness and glossocoma was significantly lower in the propofol group than that in the urapidil group after extubation (P<0.05). There were no episodes of hypotension, laryngospasm, or severe respiratory depression. There was no statistical difference in recovery time between two groups (P>0.05). In propofol group, the BP and HR during extubation and thereafter had no significant difference compared with those before induction, while they were significantly lower than those before giving propofol (P<0.05), and had significant difference compared with those in urapidil group (P<0.05). Compared to preinduction, the BP of urapidil group showed no obvious increase during aspiration and extubation. The HR of urapidil group had little changes after being given urapidil, and it was obviously increased compared with that before induction. The stimulation of aspiration and extubation caused less cough and agitation in propofol group than that in urapidil group (P<0.05). The IOP of propofol group showed no obvious increase during extubation compared with that in preinduction, while in the urpidil group, extubation caused IOP significantly increased (P<0.05). The changes in these indicators between the two groups had no significant difference (P>0.05).
CONCLUSION: Compared to urapidil, propofol is superior for preventing the cardiovascular and stress responses and IOP increases during emergence and extubation for the ophthalmic patients. Moreover, it has no effects on patient's recovery.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yong-Chong Cheng,Yang Li,Chang-Tai Xu,Li-Xian Xu and Bo-Rong Pan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yong-Chong Cheng,Yang Li,Chang-Tai Xu,Li-Xian Xu and Bo-Rong Pan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201102012]]></guid><cfi:id>1432</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Distance vision after bilateral implantation of AcrySof toric intraocular lenses: a randomized, controlled, prospective trial]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201102013]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the distance vision of Chinese patients with cataracts and corneal astigmatism after implantation of bilateral AcrySof toric intraocular lens (IOL) versus bilateral AcrySof spherical IOL.
METHODS: This study randomized 60 patients into equal groups to receive toric IOL or spherical IOL. IOL powers targeting emmetropia were selected for 93% of toric IOL patients and for 90% of spherical IOL patients. Assessments included monocular and binocular distance vision, with and without best correction. Patients also completed surveys about their distance vision.
RESULTS: Preoperatively, the two study groups were similar in age, in distance visual acuity, and in the magnitude of corneal astigmatism. At 6 months postoperative, binocular uncorrected distance vision was 0.06±0.14 logMAR in the AcrySof toric IOL group, significantly better than the 0.14±0.11 logMAR in the spherical IOL group (P<0.05). For eyes with emmetropia as a target, the equivalent of 20/20 uncorrected vision was more likely (P<0.001) in the toric IOL group (36% of eyes) than in the spherical IOL group (4% of eyes). No patients in the emmetropia/toric IOL group used distance glasses, as compared to 52% of patients in the emmetropia/spherical IOL group. All patients were satisfied or highly satisfied. Quality of distance vision was rated higher by toric IOL patients than by spherical IOL patients (P<0.05).
CONCLUSION: Bilateral AcrySof toric IOL is superior to bilateral spherical IOL in providing uncorrected distance vision to cataract patients with corneal astigmatism.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jin-Song Zhang,Jiang-Yue Zhao,Qi Sun and Li-Wei Ma]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jin-Song Zhang,Jiang-Yue Zhao,Qi Sun and Li-Wei Ma</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201102013]]></guid><cfi:id>1431</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Minimally invasive botulinum toxin type A injection from the ocular surface to extraocular muscles]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201102014]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate a new, safe and effective injection method for strabismus patients. Botulinum toxin type A (BTXA) was injected by pulling the extraocular muscles with a minimally-invasive technique into the ocular surface, and it was ensured that the extraocular muscles was maintained in the suspended state.
METHODS: A total of 32 patients with different types of strabismus were treated at our institution from February to October 2010. A small conjunctival incision (≤2mm) was made under a microscope. The extraocular muscles were pulled out with a hook to ensure an elevated position compared with the wall of eyeball. The muscle fiber was clearly seen through the conjunctiva and BTXA was injected at a small angle under the microscope. The deviation angles before and after the injection were recorded. All patients were followed up at 5 and 30 days after the operation. Recovery was defined as abolition of diplopia in straight-ahead gaze and anteroinferior gaze and the symptoms of giddiness disappeared thoroughly. Eyeball position was essentially normal. Improvement was defined as basic disappearance of diplopia in straight-ahead gaze and anteroinferior gaze; restriction of action of paralytic muscle improved. If most of the symptoms and signs still existed and disturbed normal work and life, the treatment was determined to be invalid. The injection dose for patients of 5 to 10 prism diopter (PD), 11 to 20PD, and ≥21PD  was 1u, 3u and 4u to 5u, respectively.
RESULTS: Of the 32 treated patients, 11(34.4%) were cured, and 18(56.3%) were improved at 5 days after the operation; 12(40%) were cured, and 15(46.9%) were improved at 30 days. Five patients (15.6%) who had unsatisfactory response after BTXA injection at 30 days received repeated injections or underwent strabismus surgery. Ptosis was present in 2.5% of the injected eyes. No retrobulbar hemorrhage or ocular perforation was found in any eye.
CONCLUSION: It is safe and efficient to inject BTXA by pulling extraocular muscles with a minimally-invasive technique under the microscope to make the muscles separated from the wall of eyeball.  
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xiao-Mei Wan,Rui-Xue Chu and Hua-Qing Gong]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiao-Mei Wan,Rui-Xue Chu and Hua-Qing Gong</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201102014]]></guid><cfi:id>1430</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Risk factors associated with retinal neovasculari-zation of diabetic retinopathy in type 2 diabetes mellitus ]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201102015]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the risk factors associated with retinal neovascularization of diabetic retinopathy in northern Chinese Han patients with type 2 diabetes mellitus (T2DM). 
METHODS: The clinical characteristics of 200 patients with proliferative diabetic retinopathy (PDR) and 100 age-matched healthy individuals were compared. The univariate and multivariate logistic regression analysis were performed in the patients with PDR. 
RESULTS: Fasting blood glucose (FBG), triglyceride (TG), total cholesterol (TC), blood urea nitrogen (BUN), uric acid (UA), white blood cell count (WBC), absolute neutrophil count, hematocrit (HCT) and mean platelet volume (MPV) and mean platelet volume (MPV) were all significantly higher in patients with PDR than in the control group (P<0.05). The univariate and multivariate logistic regression analysis showed that risk factors independently associated with retinal neovascularization of DR were duration of diabetes mellitus (OR=1.112; P =0.000), BUN (OR=1.277; P=0.000), smoking (OR=3.967; P=0.000) and MPV(OR=2.472; P=0.000). On the other hand, panretinal photocoagulation was associated with reduced risk of retinal neovascularization (OR=0.983; P=0.000).  
CONCLUSION: Preventing and controlling T2DM in terms of risk factors, including duration of diabetes, BUN, smoking and MPV, might offer novel approaches to prevent or delay the onset of retinal neovascularization in patients with PDR.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ze-Long Zhong,Mei Han and Song Chen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ze-Long Zhong,Mei Han and Song Chen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201102015]]></guid><cfi:id>1429</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Radiofrequency ablation technique eradicating palpebral margin neoplasm]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201102016]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report the study on radiofrequency ablation technique for eradication of palpebral margin neoplasm and its clinical effects. 
METHODS: One hundred and six cases with the palpebral margin neoplasm were performed surgical removal with radiofrequency ablation technique. The 1-2 months postoperative follow-up was investigated and the lost cases were excluded from statistics. The continuing follow-up lasted about 6-16months. 
RESULTS: One hundred cases underwent one treatment and 6 cases underwent two treatments. Six cases were missed. All the cases followed up healed well without pigmentation or scar left, nor eyelash loss or palpebral margin deformation. No case was recurrent. 
CONCLUSION: Radiofrequency ablation has significant efficiency in eradicating the palpebral margin neoplasm. 
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Tian-Yu Jiang,Xing-Lin Wang,Wei Suo,Qing-Hua He and Hong-Yu Xiao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Tian-Yu Jiang,Xing-Lin Wang,Wei Suo,Qing-Hua He and Hong-Yu Xiao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201102016]]></guid><cfi:id>1428</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of latanoprost/timolol and dorzolamide/tiomolol on intraocular pressure after phacoemulsification surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201102017]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evalaute the effect of fixed-combination latanoprost 0.005%/timolol maleate 0.5% and dorzolamide hydrochloride 2%/timolol maleate 0.5% on postoperative intraocular pressure after phacoemulsification cataract surgery. 
METHODS: This study is a prospective, randomized, double-masked and placebo-controlled. The study included 90 eyes of 90 patients which were scheduled to have phacoemulsification surgery. Patients were randomly assigned preoperatively to 1 of 3 groups (30 eyes of 30 patients). Two hour before surgery, the patients received one drop latanoprost/timolol (group 1), dorzolamide/timolol (group 2) and placebo (group 3, control group). The IOPs were measured at preoperative and postoperative 4, 8, and 24 hours. 
RESULTS: The preoperative mean intraocular pressure was not statistically significant between both drug groups and control group. In group 1 and 2, the postoperative mean IOP [group1: (14.03±3.15)mmHg and group 2: (14.16±4.43)mmHg] at 24 hours were significantly lower than the control group [(16.93±3.70)mmHg, (P<0.05)]. In addition, the postoperative mean IOP of group 1 [(14.90±3.69)mmHg] at 8 hours was significantly lower than the control group [(17.70±3.89)mmHg, (P<0.05)], but there was no significant difference between group 2 [(16.16±5.23)mmHg] and control group at 8 hours (P>0.05). 
CONCLUSION: When compared with placebo, the use of preoperative fixed combination of latanoprost/ timolol and dorzolamide/timolol is an effective method for preventing intraocular pressure elevation in 24 hours after phacoemulsification surgery, but did not completely prevent IOP spikes.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Haydar Erdogan,Ayse Vural Ozec,Cengiz Caner,Mustafa Ilker Toker,Mustafa Kemal Arici and Aysen Topalkara]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Haydar Erdogan,Ayse Vural Ozec,Cengiz Caner,Mustafa Ilker Toker,Mustafa Kemal Arici and Aysen Topalkara</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201102017]]></guid><cfi:id>1427</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Adhesion of cavernous hemangioma in the orbit revealed by CT and MRI: analysis of 97 cases]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201102018]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess features of cavernous hemangioma (CH) in the orbit revealed by CT and MRI and summarize prediction of preoperative CT and MRI for the adhesion degree of CH in the orbit. 
METHODS: A total of 97 patients with pathologically confirmed CH in the orbit were examined with axial and coronal CT scan, and axial, coronal, sagittal, and enhanced fat suppression MRI scan. CT and MRI findings and intraoperative adhesion degrees were retrospectively analyzed. 
RESULTS: There were 47 patients with slight adhesion, for whom CT and MRI showed round masses with well defined margins in the extraocular muscles; 14 patients with mild adhesion, for whom CT and MRI revealed irregular masses with unclear boundary between CH and the optic nerve in coronal images, and emissary veins in the posterior region of masses in contrast-enhanced images; 36 patients with severe adhesion, for whom CT and MRI exhibited an irregular or ovoid mass filling the orbital apex, or showed distorted and even spiky margins in the posterior region of masses in contrast enhanced images at the presence of a transparent triangle between the mass and the orbital apex. 
CONCLUSION: Preoperative CT and MRI aid in accurate diagnosis, selection of the surgical approach, and assessment of the adhesion degree and surgical risks for CH.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yan-Ming Tian,Li-Hua Xiao and Xiao-Wei Gao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yan-Ming Tian,Li-Hua Xiao and Xiao-Wei Gao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201102018]]></guid><cfi:id>1426</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Ocular toxoplasmosis in Iran: 40 cases analysis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201102019]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report ocular symptoms, funduscopic findings and demographic distribution of ocular toxoplasmosis in Iran
METHODS: In this cross-sectional study, a total of 40 patients with ocular toxoplasmosis (24 female, 16 male) were enrolled. The distribution of symptoms and funduscopic findings were studied.
RESULTS: The patients' age was in the range of 13-52 with the most common age of 19 years old. Twenty-four patients were female (60.0%). The most common presenting sign was visual loss. There was anterior chamber (AC) inflammation in 23 patients (57.5%). Vitritis was presented in 36 patients (90.0%). In 35 patients (87.5%), the retinal lesion was central. In patients with peripheral lesion, 3 patients (60.0%) had flashing vs 12.5% chance of flashing in all patients. Older patients had larger lesion (P=0.04).
CONCLUSION: Ocular toxoplasmosis substantially varies among patients with different age, gender, status of immunity, site of lesion and other undetermined factors. One of ocular symptoms, flashing, may necessitate a more precise peripheral fundus examination. 
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Seidali Tabatabaei,Mohammad Soleimani,Alireza Foroutan,Mehdinili Ahmadabadi,Reza Zarei,Nilofar Piri and Arzhang Gordiz]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Seidali Tabatabaei,Mohammad Soleimani,Alireza Foroutan,Mehdinili Ahmadabadi,Reza Zarei,Nilofar Piri and Arzhang Gordiz</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201102019]]></guid><cfi:id>1425</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Epidemiological characteristics and risk factors of diabetic retinopathy in type 2 diabetes mellitus in Shandong Peninsula of China]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201102020]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the epidemiological characteristics and estimate the risk factors of diabetic retinopathy (DR) in patients with type 2 diabetes mellitus (T2DM) in Shandong Peninsula of China.
METHODS: The cases of T2DM admitted to Affiliated Hospital of Medical College of Qingdao University, Shandong Province, China, from January 2006 to December 2010 were retrospectively reviewed. The epidemiological characteristics of DR were estimated. The cases were divided into two groups according to degrees of retinopathy: non-DR group and DR group. Logistic regression analysis was used to study the related risk factors of DR.
RESULTS: The prevalence of DR in patients with T2DM was 25.08% (834/3326). There was significant difference between the average age for men (59.08±15.43 years) and for women (62.92±18.19 years,P=0.0021). The majority of DR occurred in women (female: male ratio=1.76:1,P<0.0001). The incidence rate of DR in urban (489/834) was higher than that in rural area (345/834, P<0.0001). In 834 DR patients, the mean duration of T2DM was 8.90±4.15 years (range: 0-16 years); 440 people (52.76%) had received varying degrees of health education about prevention and primary care of DM; and 473 people (56.71%) suffered from other DM complications confirmed at the same time. In addition, the incidence rate of monocular (551/3326) and binocular retinopathy (283/3326) were statistically different (P<0.0001). Factors associated (P<0.05) with the presence of DR included old age, lower health educational level, intraocular surgery history, longer duration of T2DM, accompanying with other DM complications, no standard treatment procedure, lower body mass index (BMI) and higher fasting plasma glucose (FPG), glycated hemoglobin A1C (HbA1C), urine albumin (UA), total cholesterol (TC), low-density-lipoprotein cholesterol (LDL-C). The risk factors (P<0.05) independently associated with the presence of DR were: longer duration of T2DM, lower health educational level, higher FPG, higher UA, lower BMI and higher TC.
CONCLUSION: DR is highly prevalent in the patients with T2DM in Shandong Peninsula of China. Besides blood glucose, many factors are associated with the present and development of DR.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Zhao-Dong Du,Li-Ting Hu,Gui-Qiu Zhao,Yan Ma,Zhan-Yu Zhou and Tao Jiang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zhao-Dong Du,Li-Ting Hu,Gui-Qiu Zhao,Yan Ma,Zhan-Yu Zhou and Tao Jiang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201102020]]></guid><cfi:id>1424</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Visual outcome of manual small-incision cataract surgery: comparison of modified Blumenthal and Ruit techniques]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201101014]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the efficacy and visual results of the modified Blumenthal and Ruit techniques for manual small-incision cataract surgery (MSICS).
METHODS: This was a prospective, non-randomized comparison of 129 patients with senile cataracts scheduled to undergo routine cataract surgery via either a superior scleral tunnel incision, i.e., the Blumenthal technique (group 1, n=64) or a temporal scleral tunnel incision, i.e., the Ruit technique (group 2, n=65). MSICS and intraocular lens implantation were performed through an unsutured 6.5- to 7.0-mm scleral tunnel incision. Uncorrected and corrected visual acuity, intraoperative and postoperative complications, and surgically induced astigmatism calculated by simple subtraction were compared. Patients were examined at 1 day, 1 week, 1 month, and 3 months after surgery.
RESULTS: Both groups achieved good visual outcome with minor complications. Three months after surgery, the corrected visual acuity was 0.73 in the Blumenthal group and 0.69 in the Ruit group (P=0.29). The average (SD) postoperative astigmatism was 0.87 (0.62) diopter (D) for the Blumenthal group and 0.86 (0.62) D for the Ruit group. The mean (SD) surgically induced astigmatism was 0.55 (0.45) D and 0.50 (0.44) D for the Blumenthal and Ruit groups, respectively (P=0.52). Common complications were minimal hyphema and corneal edema. There was no statistically significant difference in the complication rate between the groups (P>0.05).
CONCLUSION: In MSICS, both the Blumenthal and Ruit techniques achieved good visual outcomes, with low complication rates. 
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Pipat Kongsap]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Pipat Kongsap</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201101014]]></guid><cfi:id>1423</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Challenges in the management of paediatric cataract in a developing country]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201101015]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To review the management of cataract in children in a tertiary hospital in a developing country, and to highlight the challenges therein.
METHODS: The hospital records of children aged 15 years or less that had cataract surgery at University of Nigeria Teaching Hospital, Enugu from 2005 to 2008 were reviewed retrospectively. Information was obtained on bio-data, pre- and post-operative visual acuity (VA), biometry, and type of surgery, use of intraocular lens (IOL) and presence of co-morbidity. SPSS was used for data entry and analysis.
RESULTS:  The hospital records of 21 children (26 eyes) were analyzed. There were 12 males (57.1%) and 9 females (42.9%). Pre-operative VA could not be assessed in 11 eyes (42.3%), 14 eyes (53.9%) had VA <3/60 and 1 eye (3.8%) had VA 6/60. Biometry was done in only 5 eyes (19.2%). All eyes had standard extracapsular cataract extraction without primary posterior capsulectomy; 12 eyes (46.2%) had posterior chamber intraocular lens (PC-IOL) implant while 13 eyes (50.0%) had no IOL. After 12 weeks of follow up, vision assessment was available in only 15 eyes. With best correction, VA of 6/18 or better was achieved in only 5 eyes (33.3%).
CONCLUSION: Inadequate facilities and inadequate follow up after surgery are some of the challenges in managing paediatric cataract in the developing countries. If these challenges are not addressed, cataract will remain a major cause of childhood blindness and low vision in Africa for many years. There should be collaboration between Paediatric Ophthalmology Centres in industrialized and developing countries to enhance skill transfer. Governmental and International Non-governmental Organizations can go a long way to facilitate this exchange. 
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ifeoma R Ezegwui,Ada E Aghaji,Nkechi J Uche and Ernest N Onwasigwe]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ifeoma R Ezegwui,Ada E Aghaji,Nkechi J Uche and Ernest N Onwasigwe</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201101015]]></guid><cfi:id>1422</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Correlation of serum insulin like growth factor-I with retinopathy in Malaysian pregnant diabetics]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201101016]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To study the association of serum insulin-like growth factor-I (IGF-I) with diabetic retinopathy.
METHODS: Serum IGF-1 levels were measured in 25 pregnant diabetic patients and 25 pregnant non-diabetic patients who were matched for age, ethnicity, parity and period of gestation.  Fundus examination was performed in both groups at 28, 32 and 36 weeks of gestation. 
RESULTS: The serum IGF-I level was significantly elevated in pregnant diabetics compared to pregnant non-diabetics (366±199μg/L vs 184±89μg/L, (P=0.0001) at 24 weeks, 535±251μg/L vs 356±89μg/L, (P=0.007) at 32 weeks and 404±166μg/L vs 264±113μg/L, (P=0.003) at 36 weeks of gestation). The pregnant diabetics with established diabetes had significantly higher IGF-1 level than gestational diabetes at 28, 32 and 36 weeks of gestation. The serum IGF-I level in pregnant diabetics with retinopathy was significantly higher than that in those without retinopathy at all periods of gestation. 
CONCLUSION: Increased serum IGF-1 in pregnancy may increase the risks for retinopathy. 
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[S Adzura,M Muhaya,M Normalina,A M Zaleha,W P Sharifa Ezat and I Tajunisah]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>S Adzura,M Muhaya,M Normalina,A M Zaleha,W P Sharifa Ezat and I Tajunisah</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201101016]]></guid><cfi:id>1421</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Laser treatment in 341 patients with exudative age-related macular degeneration]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201101017]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To document the prognosis of laser treatment in patients with exudative age-related macular degeneration (AMD).
METHODS: Efficacy of the intervention was evaluated using a before-after method.
RESULTS: A total of 392 eyes of 341 patients with exudative AMD were examined. 77.6% had choroideal neovascularisation (CNV). Before the use of indocyanine green (ICG) angiography, occult CNV was detected in only 1.8% of the eyes, but after the use of ICG angiography, this increased to 19.5% (P<0.001). Of the 349 eyes which were followed up, visual acuity had remained stable in 68.2%. There was a statistically significant relationship between the localization of lesion and visual acuity changes on pre- and post-laser treatment (P<0.001). Also there was a statistically significant relationship between the localization of lesion and recurrence (P<0.05). The recurrence was less in subfoveal lesions than that in juxtafoveal and extrafoveal lesions.
CONCLUSION: ICG angiography is highly important in the treatment of occult CNV. 
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Leyla Atmaca,Aysun İdil and Pelin Atmaca-Sönmez]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Leyla Atmaca,Aysun İdil and Pelin Atmaca-Sönmez</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201101017]]></guid><cfi:id>1420</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Changes of corneal central thickness of aphakia following congenital cataract surgery under the first six months of life]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201101018]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To observe the central corneal thickness (CCT) changes in infants and young children who had been undergone bilateral congenital cataract surgery, and to compare the changes with normal control group which was selected from healthy population. 
METHODS: A cross section case-control study contained  28 cases (56 eyes) of bilateral aphakia (aphakic group) due to congenital cataract surgery combining with posterior continuous curvilinear capsulorhexis and with anterior vitrectomy during 2-6 months after birth. Fourteen children (28 eyes) of age-sex matched with the aphalic group were selected as normal control group. CCT and intraocular pressure (IOP) were measured postoperatively and the results were compared between groups. 
RESULTS: The mean CCT was 653.5±82.4μm in the aphakic group and 579.6±39.2μm in the control group, with a significant difference (P=0.000). The mean value of IOP in aphakic group (22.0±1.6mmHg) was greater than that of control group (16.9±2.1mmHg), P=0.023. There was a negative correlation between age and CCT in normal control group (r=-0.531, P=0.026), and there was no correlation in bilateral aphakia group (r=-0.324, P=0.165)
CONCLUSION: Aphakic children due to congenital cataract surgery have a greater CCT than normal children. It is necessary to consider CCT in evaluating IOP for children after congenital cataract surgery. 
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Wei Xiao,Xiao-Fang Liang and Jia-Jun Sun]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Wei Xiao,Xiao-Fang Liang and Jia-Jun Sun</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201101018]]></guid><cfi:id>1419</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Surgical treatment for 42 patients with traumatic annular ciliochoroidal detachment]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201101019]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyze the clinical features of traumatic annular ciliochoroidal detachment (CCD) with ultrasound biomicroscopy (UBM) images, to investigate the surgical outcomes of ciliary body suturing and the prognostic factors.
METHODS: Forty-two patients with traumatic annular CCD who had undergone ciliary body suturing were enrolled for complete ocular examinations, including visual acuity (VA), slitlamp microscopy, tonometer, indirect ophthalscopy and UBM. Comparisons of clinical features were performed among baseline and follow-ups, and the morphologic alterations on UBM images were analyzed between pre- and post-surgery.
RESULTS: The mean intraocular pressure (IOP) was 5.54mmHg, and the median VA was 0.1 in traumatic eyes at baseline. The pre-surgical morphological features on UBM images consisted of supraciliochoroidal effusion (33.33%), multilayer splits (40.48%) and CCD with cyclodialysis cleft (26.19%). After surgery, the median VA was 0.4 at the final follow-up. IOPs were significantly increased, which the mean final IOP was to 10.36mmHg (P<0.01). UBM images displayed complete reattachment in 40.48% of patients, partial reattachment in 50.00% of patients and 360-degree detachment in 9.52% of patients. Analyzing the prognostic factors, the significant factors were duration, VA at baseline, ocular laterality (P<0.01), gender, age and the presence of hypotonous maculopathy (P<0.05).
CONCLUSION: Ciliary body suturing is the optimized procedure for traumatic annular CCD. UBM is a useful equipment for diagnosis and monitoring post-surgical morphological changes. The periodical detection of IOP and UBM is necessary for the observation of surgical outcomes.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jian-Gang Yang,Guo-Min Yao,Shao-Peng Li,Xiao-Hua Wang and Bai-Chao Ren]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jian-Gang Yang,Guo-Min Yao,Shao-Peng Li,Xiao-Hua Wang and Bai-Chao Ren</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201101019]]></guid><cfi:id>1418</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of visual acuity outcomes between ranibizumab and bevacizumab treatment in neovascular age-related macular degeneration]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201101020]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare visual acuity (VA) outcomes between intravitreal injection of bevacizumab and ranibizumab in the treatment of neovascular age-related macular degeneration (AMD).  
METHODS:  We conducted a consecutive, retrospective case series study in patients with newly diagnosed all type choroidal neovascularization (CNV) secondary to AMD who received an intravitreal injection of bevacizumab (1.25mg) or ranibizumab (0.3mg) at Lions Eye Institute, Western Australia from Mar. 2006 to May 2008. All patients received injection at baseline with additional monthly injections given at the discretion of the treating physician. Main outcome measures were changes in VA. 
RESULTS: There were 371 consecutive patients received injection at least in one eye with at least 6 months of follow up (median of 12.0 months). Bevacizumab treatment prevented 221 out of 278 (79.5%) patients from losing < 15 letters in VA compared with 79 out of 93 (84.9%) of ranibizumab treated patients (P=0.25). While 68 (24.5%) of bevacizumab treated patients gained ≥15 letters of VA compared with 24 (25.8%) of ranibizumab treated patients (P=0.79). 75.3% and 66.2% patients benefited from ranibizumab and bevacizumab respectively with final VA better than 6/60 (P=0.10). Multivariate analysis showed that pre-treatment VA was negatively associated with benefit outcome. Assignment of injection was not associated with VA outcome of benefit after adjusting the covariate (P=0.857). 
CONCLUSION: There are no difference in treatment efficacy in terms of VA between bevacizumab and ranibizumab in routine clinical condition. 
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xue-Feng Feng,Ian J Constable,Ian L McAllister and Timothy Isaacs]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xue-Feng Feng,Ian J Constable,Ian L McAllister and Timothy Isaacs</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201101020]]></guid><cfi:id>1417</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Intravitreal injection of bevacizumab alone or with triamcinolone acetonide for treatment of macular edema caused by central retinal vein occlusion]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201101021]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the efficacy and safety of intravitreal bevacizumab alone versus bevacizumab combined with triamcinolone acetonide in eyes with macular edema caused by central retinal vein occlusion (CRVO) in Chinese patients.
METHODS: Seventy-five eyes of 75 patients were enrolled in this prospective, randomized, consecutive study. Thirty-six patients in group 1 were treated with an intravitreal injection of bevacizumab (1.25mg/0.05mL), and 39 patients in group 2 were treated with intravitreal bevacizumab (1.25mg/0.05mL) combined with triamcinolone acetonide (2mg/0.05mL). The main outcomes of the mean best corrected visual acuity (BCVA), central retinal thickness (CRT), and intraocular pressure (IOP) were measured.
RESULTS: In group 1, the mean BCVA improved from 37.78±6.14 (baseline) to 48.06±3.86, 46.48±4.77 and 44.18±5.78 at four, six and twelve weeks post-injection, respectively (P<0.01, P=0.03, P=0.04). In group 2, the mean BCVA improved from 35.92±6.20 (baseline) to 50.69±4.22, 48.76±5.59 and 45.70±6.56 at the same time points (P<0.01 each). However, there was no significant differences in the mean BCVA (F=0.043, P=0.836) and CRT (F=0.374, P=0.544) between these two groups. During the follow-up, five patients in group 1 and six patients in group 2 with high IOP were controlled with anti-glaucoma drugs. 
CONCLUSION: Intravitreal injection of bevacizumab alone or combined with triamcinolone acetonide has a short beneficial effect in Chinese patients with macular edema caused by CRVO, but there is no significant difference between the two groups.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hai-Yan Wang,Xiao Li,Yu-Sheng Wang,Zi-Feng Zhang,Man-Hong Li,Xiao-Na Su and Jin-Ting Zhu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hai-Yan Wang,Xiao Li,Yu-Sheng Wang,Zi-Feng Zhang,Man-Hong Li,Xiao-Na Su and Jin-Ting Zhu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201101021]]></guid><cfi:id>1416</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Endotamponades in pars plana vitrectomy for metallic intraocular foreign body associated with endophthalmitis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201101022]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To study the criterion-reference of endotamponades in pars plana vitrectomy for metallic intraocular foreign body (MIOFD) associated with endophthalmitis. 
METHODS: Thirty-six patients of MIOFD with endophthalmitis accorded with exclusion and inclusion criteria were retrospectively analyzed. A detailed analysis of the patients’ natural factors, preoperative examinations, intraoperative endotamponades choice, postoperative complications and therapeutic effects was performed. 
RESULTS: BSS was used in 4 eyes without obvious retinal damage. There was no postoperative complication and the visual acuity (VA) was improved. Sixteen eyes that had mild retinal damage filled with C3F8 gas. The postoperative VA improved in 10 eyes (62.5%), 4 eyes (25.0%) remained unchanged and 2 eyes (12.5%) decreased. Only 2 cases occurred postoperative retinal detachment in gas group. Another 16 eyes with serious retinal damage were treated with silicone oil. Postoperative VA of 9 eyes (56.3%) improved, 3 eyes (18.8%) remained unchanged and 4 eyes (25.0%) decreased. The silicone oil group had higher incidence of postoperative complications, but the incidence of secondary treatment had no significant different between silicone oil and gas group. 
CONCLUSION: An appropriate choice of endotamponades in vitrectomy surgery for MIOFB with endophthalmitis is important for prognosis.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Rui Wang,Xing-Li Wang,Yi Wang,Shao-Jun Chen,Xiao-Yong Huang,Nan Wu and Xi Ying]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Rui Wang,Xing-Li Wang,Yi Wang,Shao-Jun Chen,Xiao-Yong Huang,Nan Wu and Xi Ying</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201101022]]></guid><cfi:id>1415</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Laboratory diagnosis of infectious endophthalmitis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201101023]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyze the lab diagnosis and etiology of infectious endophthalmitis.  
METHODS: The medical and microbial records of 36 patients diagnosed with infectious endophthalmitis and 8 patients diagnosed with intraocular lens (IOL)-related inflammation between Nov. 1999 and Dec. 2009 were retrospectively reviewed for lab diagnosis and etiology.  
RESULTS: The inflammatory cell counts in all aqueous humor specimens from infectious endophthalmitis patients were more than in all aqueous humor specimens from patients with IOL-related inflammation. Sixteen of the 36 aqueous humor samples (44.4%) and 11 of the 24 vitreous humor samples (45.8%) from infectious endophthalmitis patients showed positive results in smears; while 17 aqueous humor samples (47.2%) and 15 vitreous humor samples (62.5%) from infectious endophthalmitis patients showed positive results in culture. 
CONCLUSION: The inflammatory cell count may be an important index for infectious endophthalmitis; while, smears can show etiological information earlier. 
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Wen-Jiang Ma,Hong Zhang and Shao-Zhen Zhao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Wen-Jiang Ma,Hong Zhang and Shao-Zhen Zhao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201101023]]></guid><cfi:id>1414</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of simulated dynamic intraocular pressure on retinal thickness measured by optical coherence tomography after cataract surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201206007]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the effect of simulated dynamic intraocular pressure (SDIOP) during uncomplicated phacoemulsification on postoperative macular and peripapillary retinal nerve fiber layer (RNFL) thickness.
METHODS: Macular and RNFL thicknesses in one eye of patients (n=30) undergoing uncomplicated phacoemulsification were measured by optical coherence tomography preoperatively and 1 week postoperatively. The best-corrected visual acuity, SDIOP, irrigation time (IT), effective phacoemulsification time, entire surgical duration, blood pressure, and heart rate were recorded.
RESULTS: The mean SDIOP and IT was (74.9 ± 27.4)cmH2O and (178.4 ± 21.6) seconds respectively. We divided our patients into two groups based upon IT with greater than 90cmH2O (P<sub>>90</sub>IT). In Group A (n=14), the P<sub>>90</sub>IT was greater than the mean P<sub>>90</sub>IT, and in Group B (n=16), the P<sub>></sub>90IT was less than the mean P<sub>>90</sub>IT. For all patients there was a significant increase in macular thickness one week after cataract surgery (P=0.001). While the RNFL thickness tended to increase, the change was not significant. The postoperative macular thickness of Group A, (277.8 ± 13.7)μm, was significantly thicker than that of Group B, (267.9 ± 15.0)μm (P=0.004). The postoperative peripapillary RNFL thickness of Group A, (96.8 ± 10.8) μm, was not significantly different from Group B. For Group A, the change in macular thickness was positively correlated with P<sub>>90</sub>IT (R2=0.524, P=0.02). There was no statistical difference in postoperative visual acuity between Groups A and B. 
CONCLUSION: After uncomplicated phacoemulsification, increased macular thickness is associated with the IT under high SDIOP. The effect of high SDIOP is limited to the sub-clinical level.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ding Chen,Jun Zhu,Jin Li,Xi-Xia Ding,Fan Lu and Yun-E Zhao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ding Chen,Jun Zhu,Jin Li,Xi-Xia Ding,Fan Lu and Yun-E Zhao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201206007]]></guid><cfi:id>1413</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Fundus changes in pregnancy induced hypertension]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201206008]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the prevalence of retinal changes in pregnancy induced hypertension (PIH) and any association between the retinal changes and blood pressure, proteinuria, and severity of the disease.
METHODS: All the patients admitted with diagnosis of PIH were included in this study. Age, race, gravida, gestation period, blood pressure, and proteinuria were noted from the case records. After taking history for any eye symptoms, fundus examination was done after dilating the pupils with direct ophthalmoscope in the ward itself. All the findings were noted on a data sheet, and were analyzed using SPSS programme. 
RESULTS: A total of 78 patients of PIH were examined. Majority (75.6%) were Malays. The mean age of patients was 30.2 years (range 21-45 years). The gestation period ranged from 25 weeks to 41 weeks; 34 (43.5%) were primi gravida. Thirty (38.4%) patients had mild preeclampsia, 46 (59%) had severe preeclampsia and 2 (2.5%) had eclampsia. Retinal changes (hypertensive retinopathy) were noted in 46 (59%) patients --- grade I in 41 (52.6%) and grade II in 5 (6.4%).  Haemorrhages or exudates or retinal detachment were not seen in any patient. There was statistically significant positive association of retinal changes and blood pressure (P =0.001), proteinuria (P =0.018) and severity of the PIH (P =0.024). 
CONCLUSION: Retinal changes (grade I and II hypertensive retinopathy) were seen in 59% of patients with PIH and they were significantly associated with blood pressure, proteinuria and severity of the disease. Fundus examination helps in assessing the severity of PIH.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Sagili Chandrasekhara Reddy,Sivalingam Nalliah,Sheila Rani a/pKovil George and Tham Seng Who]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Sagili Chandrasekhara Reddy,Sivalingam Nalliah,Sheila Rani a/pKovil George and Tham Seng Who</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201206008]]></guid><cfi:id>1412</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of corneal graft diameter on therapeutic penetrating keratoplasty for fungal keratitis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201206009]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the effect of corneal graft diameter on therapeutic penetrating keratoplasty (PKP) for fungal keratitis. 
METHODS: A total of 116 patients (116 eyes) suffered from fungal keratitis underwent PKP at the Affiliated Hospital of Medical College Qingdao University from May 2006 to May 2010. They were divided into two groups according to the corneal graft diameter. 64 eyes’ corneal graft diameter was 8.00mm or larger and 52 eyes’ graft diameter was smaller than 8.00mm. The follow-up time was 2 years. The postoperative visual acuity and complications were documented and compared. 
RESULTS: Sixty-two (96.88%) eyes and fifty (96.15%) eyes preserved eyeballs respectively in two groups. There was no statistical difference in postoperative visual acuity (P=0.961), corneal graft clear rate (P=0.132) or the incidence of recurred fungal infection (P=0.770) between two groups. But there was a higher incidence of graft rejection (P=0.020) and secondary glaucoma (P=0.039) in group with corneal graft diameter 8.00mm or larger. 
CONCLUSION: PKP is an effective treatment approach for fungal keratitis. There is a higher incidence of complications in large-diameter PKP for fungal keratitis. Effective, preventive and therapeutic measures can improve the prognosis.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Cui Li,Gui-Qiu Zhao,Cheng-Ye Che,Jing Lin,Na Li,Wen-Yan Jia,Qiu-Qiu Zhang,Nan Jiang and Li-Ting Hu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Cui Li,Gui-Qiu Zhao,Cheng-Ye Che,Jing Lin,Na Li,Wen-Yan Jia,Qiu-Qiu Zhang,Nan Jiang and Li-Ting Hu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201206009]]></guid><cfi:id>1411</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[New mucosal flap modification for endonasal endoscopic dacryocystorhinostomy in Asians]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201206010]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To describe a simple modification of fashioning the mucosal flap for endonasal endoscopic dacryocystorhinostomy (EES-DCR) in Asians and investigate its efficacy.
METHODS: A total of 120 patients with unilateral primary chronic dacryocystitis (PCD) were randomized into two groups: the new shaped nasal mucosal flap group (group A) and the removed nasal mucosal flap group (group B). All patients underwent standard EES-DCR. Patients in group A were performed a new shaped nasal mucosal flap covering the bared bone around the opened sac and those in group B was removed the nasal mucosal flap uncovering the bared bone. Patients were followed up for one year. The occurrence of granulation tissue, the proliferation of scar tissue and success rate of EES-DCR was compared.
RESULTS: In the present study, complete postoperative data were acquired from 54 patients in group A and from 57 patients in group B. During process of review, the occurrence of granulation tissue was at the ostium margins account for 15% (8/54) in group A and 39% (22/57) in group B (P<0.05). At the one-year review, scar tissue was present in 5 patients in group A compared with 18 in group B (P<0.05). The success rate of EES-DCR was 98% (53/54) in group A and 84% (48/57) in group B (P<0.05).
CONCLUSION: The simple modification of fashioning nasal mucosal flap can effectively cover the bared bone around the opened sac and reduce formation of granulation tissue, lessen the risk of scar tissue formation and closure of ostium, thus improve the success rate of EES-DCR in Asians.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Qing-Shan Ji,Jing-Xiang Zhong,Yun-Hai Tu and Wen-Can Wu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Qing-Shan Ji,Jing-Xiang Zhong,Yun-Hai Tu and Wen-Can Wu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201206010]]></guid><cfi:id>1410</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effects of major ozonated autohemotherapy in the treatment of dry age related macular degeneration: a randomized controlled clinical study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201206011]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM:  To evaluate the effect of systemic ozonated major autohaemotherapy (O<sub>3</sub>-AHT) in patients affected by dry age related macular degeneration (AMD). METHODS: This study was a randomized, controlled clinical study. One hundred and forty patients with the diagnosis of AMD in both eyes, with the study eye presenting dry AMD and soft drusen, were randomly assigned in a 1:1 ratio to either receive 27 major ozonated autohemotherapy treatments during 12-month period, or a standardized multi-vitamin therapy. Primary outcome was the change in best corrected visual acuity (mean logMar change) between the baseline and 6 and 12 months, end point of the study. In addition, to investigate the safety of prolonged ozonated autohaemotherapy, we measured the routine haematochemical parameters and biochemical oxidative stress values at baseline and after 12 months treatment time. RESULTS: The mean baseline best corrected visual acuity in study eyes was 0.36 in the treatment group and 0.38 in the control group (difference not statistically significant). At the primary endpoint, 6 months post-baseline, the mean logMAR change in the treated group improved by 0.1 and the values of the control group at the same time impaired by 0.2 respect to the baseline. Four percent and twenty-five percent of eyes in the group treated with  O3-AHT gained 1 or more  lines after  6 and 12 months respectively compared to 0% in  the eyes which received no treatment (P<0.05 at 12 months). None of the treated patients experienced a loss in visual acuity in their study eye at 6 and 12 months,  compared to 16% and 40 % of patients in the control group who lost 2 lines or more at 6 months and  12 months respectively (P<0.05 treated vs control group)). Major ozonated autohemotherapy was shown to be safe and well- tolerated by the patients. Moreover, the haematochemical parameters showed a decrease in the Reactive Oxygen Metabolites (300±10.1 UCARR at 12 months compared to a baseline value of 380±10.4 UCARR, P<0.05) and an increase in Biological Antioxidant Potential plasma values (2100±34.8 micromoles/ C vitamin after 12 months compared to the baseline value of 1610±36.2, P<0.05) in the treated patients when compared  to the control group. This data suggests that major ozonated autohaemotherapy may exert a role in reducing oxidative stress by endogenously stimulating the production of antioxidant molecules. 
CONCLUSION: The results of this study suggests that major ozonated autohaemotherapy could be a safe and effective therapeutic option for high-risk patients with dry AMD, and that a series of such treatments could improve the natural course of AMD.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Emma Borrell,Angelica Diadori,Alessandro Zalaffi and Velio Bocci]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Emma Borrell,Angelica Diadori,Alessandro Zalaffi and Velio Bocci</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201206011]]></guid><cfi:id>1409</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Short-term effect of topical brinzolamide-timolol fixed combination on ocular surface of glaucoma patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201206012]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the short-term effect of the fixed combination of brinzolamide-timolol on the ocular surface in glaucoma patients.
METHODS: This is a prospective study of 23 eyes of 23 patients with newly diagnosed glaucoma. Schirmer I test, tear break-up time (BUT) measurement, conjunctival impression cytology and central corneal thickness (CCT) measurements were performed in one of the eyes of each patients before and 4 weeks after brinzolamide-timolol fixed combination therapy. All patients were asked to answer the OSDI questionnaire form about the ocular surface symptoms at baseline and at 1 week and 4 weeks follow-up visits.
RESULTS: After brinzolamide-timolol fixed combination theraphy Schirmer I, BUT and CCT values decreased but the only statistically significant decrease was seen in BUT test (P=0.03). OSDI scores increased during the follow-up but this increase was not statistically significant (P=0.22, P=0.42 respectively). Impression cytology findings ranged from 0.78±0.42 to 0.95±0.36 according to the Nelson classification. There was no statistically significant difference between baseline and 4 weeks follow up in impression cytology grades (P=0.15).
CONCLUSION: The results of our study indicate that short-term use of brinzolamide-timolol fixed combination theraphy does not have a profound effect on ocular surface except BUT values.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Penpe Gul Firat,Emine Samdanci,Selim Doganay,Mufide Cavdar,Nurdan Sahin and Abuzer Gunduz]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Penpe Gul Firat,Emine Samdanci,Selim Doganay,Mufide Cavdar,Nurdan Sahin and Abuzer Gunduz</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201206012]]></guid><cfi:id>1408</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Complications of intravitreal triamcinolone acetonide for macular edema and predictive factors for intraocular pressure elevation]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201206013]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the complications of intravitreal triamcinolone acetonide (IVTA) for the treatment of macular edema, and to determine the risk factors for intraocular pressure (IOP) elevation.
METHODS: Charts of patients with macular edema secondary to branch retinal vein occlusion (BRVO), diabetic retinopathy and uveitis who had received IVTA injections were reviewed to document its complications. IOP elevation was defined as a pressure of ≥24mmHg at some point during follow-up. Multivariate logistic regression analysis was performed to characterize baseline risk factors for this elevation. 
RESULTS: The study included 111 eyes of 65 female and 46 male patients with a mean follow-up of (11.6±5.1) months. Of the 111 eyes, 52 (46.8%) had macular edema secondary to BRVO, 44 (39.6%) had clinically significant diabetic macular edema (CSDME) and 15 (13.5%) had non-infectious uveitis with macular edema. IOP was recorded ≥ 24mmHg in 38 eyes (34.2%) during the follow-up. Higher baseline IOP (P=0.022), younger age (P=0.003), and male gender (P=0.014) were significant risk factors for IOP elevation after IVTA injection. Eyes with prior vitrectomy were less likely to have IOP elevation (P=0.054). Two eyes (5.2% of eyes with increased IOP) underwent trabeculectomy, and 9 eyes (16.3% of the phakic eyes) necessitated cataract surgery. Other complications included branch vein occlusion (1.8%), sterile endophthalmitis (0.9%) and pseudohypopyon (0.9%).
CONCLUSION: IVTA has side effects with IOP elevation and cataract formation being the two most common. A subset of patients is more prone to developing increased IOP following IVTA, namely, younger male patients with higher baseline IOP.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Kenan Sonmez and Faruk Ozturk]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Kenan Sonmez and Faruk Ozturk</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201206013]]></guid><cfi:id>1407</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Angiogenesis-related cytokines in serum of proliferative diabetic retinopathy patients before and after vitrectomy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201206014]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate serum concentrations of angiogenesis-related cytokines in proliferative diabetic retinopathy (PDR) before and after vitrectomy. 
METHODS: Serum samples were collected from 30 PDR patients with varying severity before and after vitrectomy. Serum concentrations of vascular endothelial growth factor (VEGF), pigment epithelium-derived factor (PEDF), interleukin-8 (IL-8) and interferon-inducible protein-10 (IP-10) were determined by enzyme-linked immunosorbent assays (ELISA). 
RESULTS: Serum concentrations of VEGF, PEDF, IL-8 and IP-10 were significantly higher in PDR patients than that in controls, respectively (P<0.05). VEGF concentration decreased significantly in postoperative samples than that in preoperative samples (P<0.05). The concentrations of PEDF, IL-8 and IP-10 did not exhibit significant changes after vitrectomy. 
CONCLUSION: Elevated cytokines levels in serum may be diagnostically useful in PDR. Angiogenesis-related cytokines play important roles in the development of PDR, and would instruct the risk assessment of pathogenetic condition in PDR patients.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Shuang Li,Xun-An Fu,Xiao-Fang Zhou,You-Yan Chen and Wei-Qun Chen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Shuang Li,Xun-An Fu,Xiao-Fang Zhou,You-Yan Chen and Wei-Qun Chen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201206014]]></guid><cfi:id>1406</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of aerobic conjunctival bacterial flora in pregnant, reproductive-aged and postmenopausal women]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201206015]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the effect of hormonal status on aerobic conjunctival flora in women.
METHODS: One hundred fifty-eight women [reproductive-aged (n=55), pregnant (n=51), and postmenopausal (n=52)] who admitted to outpatient clinic of Obstetrics and Gynecology Department of Denizli State Hospital were enrolled. Age, body-mass index (BMI), obstetric history, cigarette smoking, drug usage, presence of systemic disease, and intraocular pressure (IOP) were recorded for each patient. The samples were taken from the lower fornix with two culture swabs and directly incubated in culture containing 5% sheep blood, eosin-methylene blue and chocolate agar. The other swab specimen was Gram stained. All growths and microscopic results were analyzed.
RESULTS: The coagulase-negative Staphylococcus was the predominant organism isolated in the conjunctival samples in both three groups. The aerobic microorganism growth rate for all isolated aerobic organisms revealed no significant change in the three groups (P >0.05).  The conjunctival culture positivity rates were similar in the three groups (49% in reproductive-aged, 57% in pregnant and 58% in postmenopausal women) (P >0.05). Age, IOP, BMI, gravidity, parity, cigarette smoking, drug usage, and presence of systemic diseases did not have an effect on culture positivity in three groups.
CONCLUSION: Results of this study showed that conjunctival aerobic flora and bacterial colonization did not differ between reproductive-aged, pregnant and postmenopausal women.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Melike Balikoglu-Yilmaz,Emine Sen,Osman Sevket,Yusuf Polat,Aysun Karabulut and Omer Uysal]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Melike Balikoglu-Yilmaz,Emine Sen,Osman Sevket,Yusuf Polat,Aysun Karabulut and Omer Uysal</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201206015]]></guid><cfi:id>1405</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of contrast sensitivity and visual acuity between deep anterior lamellar keratoplasty and penetrating keratoplasty in patients with keratoconus]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201206016]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate postoperative visual acuity and contrast sensitivity results following deep anterior lamellar keratoplasty (DALK) and penetrating keratoplasty (PK) in patients with keratoconus (KC). 
METHODS: All the patients’ records with KC who had PK or DALK surgery between May 2010 and May 2011 were retrospectively reviewed. Sixty patients who underwent successful corneal transplantation for KC: 30 eyes underwent DALK and 30 eyes underwent PK were included in this study. Preoperative and postoperative mean logarithm of the minimum angle of resolution (logMAR) uncorrected visual acuity (UCVA), logMAR best spectacle-corrected visual acuity (BSCVA) and intraocular pressure (IOP) were evaluated. Contrast sensitivity tests (CS) were done preoperative and 2 months after all sutures had removed. All surgeries were performed under regional anesthesia (retrobulbar anesthesia) by 1 surgeon (B.K.) who was experienced in penetrating and lamellar keratoplasty techniques.
RESULTS: The mean age of the DALK group was 29.67±4.95 (range 18-40) years and the PK group was 28.7±3.53 (range 18-39) years. Preoperatively there was no significant difference in the logMAR UCVA, logMAR BSCVA and IOP between the DALK (1.281±0.56; 0.97±0.85; 12.07±2.12mmHg) and PK (1.34±0.21; 0.98±0.21; 13±2.12mmHg) groups. One-year after surgery there was no significant difference in the mean logMAR UCVA and IOP between the DALK (0.46±0.37; 11.73±2.1mmHg) and PK (0.38±0.21; 12±2.12mmHg) groups. The mean contrast sensitivity was evaluated by CC-100 Topcon LCD at 1.5, 2.52, 4.23, 7.10 and 11.91 cycles per degree (cs/deg) spatial frequencies before and 2 months after the all sutures had removed. 
CONCLUSION: All patients with keratoconus in both DALK and PK groups performed good visual function postoperatively. The mean contrast sensitivity increased considerably at all spatial frequencies compared with preoperative levels in the DALK and PK groups. The mean post-operative evaluation of contrast sensitivity measurements was not significantly different between the two groups.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mehmet Orcun Akdemir,Baran Kandemir,Isil Bahar Sayman,Cem Selvi and Omer Kamil Dogan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mehmet Orcun Akdemir,Baran Kandemir,Isil Bahar Sayman,Cem Selvi and Omer Kamil Dogan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201206016]]></guid><cfi:id>1404</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Evaluation of the new OxyPlate<sup>TM</sup>Anaerobic System for the isolation of ocular anaerobic bacteria]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/ijo-5-582]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM: </b>Anaerobic bacteria can cause ocular infections. We tested the OxyPlate<sup>TM</sup> Anaerobic System (OXY) to isolate pertinent anaerobic bacteria that can cause ocular disease.<b>METHODS:</b> OXY, which does not require direct anaerobic conditions (<i>i.e.</i> bags, jars), was compared to conventional isolation of incubating culture media in anaerobic bags. Standard colonies counts were performed on anaerobic ocular bacterial isolates under aerobic and anaerobic conditions (anaerobic bags) using agar media: 1) OXY (aerobic only), 2) 5% sheep blood (SB), 3) Chocolate, and 4) Schaedler. The bacteria tested were de-identified ocular isolates cultured from endophthalmitis and dacryocystitis that include 10 <i>Propionibacterium acnes </i>and 3 <i>Actinomyces species.</i> The colony counts for each bacteria isolate, on each culturing condition, were ranked from largest to smallest, and non-parametrically compared to determine the best culturing condition.<b>RESULTS: </b>All anaerobic conditions were positive for all of the anaerobic isolates. SB and Schaedler’s agar under aerobic conditions did not support the growth of anaerobic bacteria. Sparse growth was noted on chocolate agar with <i>Propionibacterium acnes</i>. As an anaerobic system, SB in an anaerobic bag isolated higher colony counts than OXY (<i>P</i>=0.0028) and chocolate agar (<i>P</i>=0.0028).<b>CONCLUSION:</b> Although OXY did not test to be more efficient than other anaerobic systems, it appears to be a reasonable alternative for isolating anaerobic bacteria from ocular sites. The use of an agar medium in a specially designed plate, without the requirement of an anaerobic bag, rendered OXY as an advantage over other anaerobic systems.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Emily K. Deschler,Paul P. Thompson and Regis Paul Kowalski]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Emily K. Deschler,Paul P. Thompson and Regis Paul Kowalski</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/ijo-5-582]]></guid><cfi:id>1403</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Ferrara ring segments implantation for treating keratoconus]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/ijo-5-586]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM</b>: To investigate the efficacy of Ferrara rings (FR) implantation in the treatment of keratoconus.<b>METHODS</b>: It was a retrospective case series descriptive study. The sample was comprised of 50 patients 79 eyes diagnosed with progressive keratoconus. This included 24 (48%) males and 26 (52%) females between the age of 13 and 44 years. All participants underwent surgical implantation of FR in the period between January 2009 and September 2010 at Jordan University Hospital. Thorough ophthalmologic examinations were applied to measure vital variables for each pathological condition before and after surgery.<b>RESULTS:</b><i></i>Findings indicated an overall significant postoperative improvement in both uncorrected visual acuity (UCVA) and best spectacle corrected visual acuity (BSCVA) throughout follow up visits. Moreover, results illustrated a significant decrease in spherical equivalent (SE) and keratometric readings (lower, higher and the average).<b>CONCLUSION: </b>Surgical intervention strategies are being frequently developed to meet the needs of patients with keratoconus. The implantation of Ferrara rings has proven to be a safe and feasible alternative procedure for the treatment of mild-moderate keratoconus especially for patients with contact lenses intolerance. We have found that this procedure has improved visual outcomes in all eyes studied. Nevertheless, further research is needed to investigate long term outcomes.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mohammed Ali Abu Ameerh,Ghada Ismail Hamad,Osama  H. Ababneh,Almutez  M. Gharaibeh,Rola M.  Al Refai and Muawyah D. Al Bdour]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mohammed Ali Abu Ameerh,Ghada Ismail Hamad,Osama  H. Ababneh,Almutez  M. Gharaibeh,Rola M.  Al Refai and Muawyah D. Al Bdour</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/ijo-5-586]]></guid><cfi:id>1402</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Non-buckled vitrectomy for retinal detachment with inferior breaks and proliferative vitreoretinophathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/ijo-5-591]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM: </b>To investigate the efficacy of non-buckled vitrectomy with classical endotamponade agents in the treatment of primary retinal detachment (RD) complicated by inferior breaks and proliferative vitreoretinophathy (PVR).<b>METHODS:</b> A retrospective, consecutive and case series study of 40 patients with inferior break RD and PVR ≥C1 was conducted. All patients underwent a standard 3-port 20-gauge pars plana vitrectomy (PPV) with gas or silicone oil tamponade without supplementary scleral buckling. The vitreous and all proliferative membrane were completely removed, and retinectomy was performed when necessary. The mean follow-up was 12.5 months. The primary and final anatomic success rate, visual acuity and complications were recorded and analyzed.<b>RESULTS:</b> Primary anatomic success rate was achieved in 35 of 40 eyes (87.5%) and the final anatomic success rate was 100%. The most common cause of redetachment was recurrent PVR. The best-corrected visual acuity (BCVA) at final follow-up was improved in 34 eyes (85%), remained stable in 1 eye (2.5%), and worsened in 5 eyes (12.5%). The mean visual acuity at final follow-up was improved significantly (<i>P</i>=0.000).<b>CONCLUSION: </b>This retrospective study provides evidence that vitrectomy without scleral buckling seemed to be an effective treatment for inferior break RD with PVR. With complete removal of vitreous and proliferative membranes and timing of retinectomy, the inferior breaks which complicated with PVR could be closed successfully without additional scleral buckling.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yan Sheng,Wen Sun,Bin Mo,Ya-Jie Yu,Yang-Shun Gu and Wu Liu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yan Sheng,Wen Sun,Bin Mo,Ya-Jie Yu,Yang-Shun Gu and Wu Liu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/ijo-5-591]]></guid><cfi:id>1401</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of low molecular weight heparin (enoxaparin) on congenital cataract surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/ijo-5-596]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM: </b>To assess the efficacy of intracameral enoxaparin (a low-molecular-weight heparin) infusion, in variable doses on postoperative inflammatory response in congenital cataract surgery.<b>METHODS: </b>It is aprospective, randomized controlled trial. Eighty eyes of 53 children with congenital cataract were enrolled in this study. Every eye had primary posterior capsulorrhexis and intraocular lens (IOL) implantation after lens aspiration. The eyes were divided into 4 equal groups. In group 1 balanced salt solution (BSS) without enoxaparin was used as an irrigation solution. Whereas in group 2, 3 and 4, 40mg, 20mg and 10mg enoxaparin in 500mL BSS was used respectively. The inflammatory response in the anterior chamber was compared among the groups with slit-lamp biomicroscopy.<b>RESULTS:</b> The mean follow-up period was (17.75±3.95) months in group 1, (18.00±5.15) months in group 2, (19.20±5.47) months in group 3 and (18.65±5.16) months in group 4. Mean number of inflammatory cells in the anterior chamber in group 1 was significantly higher than that of group 2, 3, 4 (<i>P</i>&lt;0.001). There was fibrin formation in the anterior chambers of 3 eyes in group 1 and one eye in group 4. There was synechiae formation in 3 eyes of group 1 and one eye of group 4. There was no significant difference among the groups by means of fibrin or synechiae formation (<i>P</i>&gt;0.05). There were IOL precipitates in 4 eyes of group 1 and 2 eyes of group 4. IOL precipitate formation was significantly higher in group 1 than that of group 2 and 3 in which there was no IOL precipitate (<i>P</i>=0.048). There was IOL subluxation in only one eye of group 1, 3 and 4 while no subluxation was observed in group 2 (<i>P</i>&gt;0.05). There was no statistically significant difference detected about IOL subluxation occurance in all 4 groups (<i>P</i>&gt;0.05).<b>CONCLUSION:</b> Complications of cataract surgery in congenital cataract patients associated with postoperative inflammatory response found to be decreased with the use of enoxaparin in intraocular infusion solutions. Furthermore according to our results the anti-inflammatory effect of enoxaparin was dose dependant.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ihsan &#199;a&#231;a, Alparslan &#350;ahin, Abdullah Kürsat Cingü, &#350;eyhmus Ari, Fuat Alaku&#351; and Yasin &#199;inar]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ihsan &#199;a&#231;a, Alparslan &#350;ahin, Abdullah Kürsat Cingü, &#350;eyhmus Ari, Fuat Alaku&#351; and Yasin &#199;inar</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/ijo-5-596]]></guid><cfi:id>1400</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical presentation of a mixed 23-gauge infusion and 20-gauge pars plana technique for active silicone oil removal]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/ijo-5-600]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM: </b>To present with a clinical case series of a mixed 23-gauge infusion and 20-gauge pars plana technique for 5,700-centipoise silicone oil removal (SOR), and to discuss its efficacy and safety.<b>METHODS: </b>This is a retrospective, non-randomized controlled study. We performed SOR with   23-gauge infusion and 20-gauge active suction technique on 29 patients 29 eyes from April to October, 2011 (mixed group). During the surgeries, a 23-gauge sclerotomy was made for infusion and a 20-gauge sclerotomy was used for active silicone oil suction. Anterior segment optical coherence tomography (OCT) was applied for 23-gauge sclerotomy analysis 1 day  post-operation. Traditional 20-gauge SOR was performed on another consecutive 29 patients 29 eyes, the control group (20G group).<b>RESULTS:</b> There were 2 eyes (6.9%) in mixed group and 5 eyes (17.2%) in 20G group which had recurrent retinal detachment after surgery. Hopytony (IOP≤6mmHg) occurred in 8 eyes (27.6%) of mixed group and in 10 eyes (34.5%) of 20G group post-operation, but all of them recovered to the normal level finally. There were no statistical significant differences. Final visual acuity was significantly increased after surgery in both groups. Anterior segment OCT images were acquired from 13 eyes of mixed group, and all of them had a proper wound apposition. But local ciliary detachment was found in 9 eyes (69%). It was hard to define the OCT image of the sclerotomies and ciliary body because of the serious conjunctival hemorrhages and chemosis in 20G group.<b>CONCLUSION: </b>This mixed technique is a convenient and effective way to remove high viscosity silicone oil. Compared with traditional 20-gauge SOR, it does not increase the risk of post-operative complications and has less conjunctival reactions.. Transient postoperative hypotony is common for this procedure and subclinical ciliochoroidal detachment is a probable cause.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jian-Qin Lei,An-Ming Xie and Qiang Shi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jian-Qin Lei,An-Ming Xie and Qiang Shi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/ijo-5-600]]></guid><cfi:id>1399</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effects of body mass index on intraocular pressure and ocular pulse amplitude]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/ijo-5-605]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the effects of body mass index (BMI) on intraocular pressure (IOP) and ocular pulse amplitude (OPA).METHODS: Totally 140 healthy individuals without any systemic diseases were included in the study. BMI (kg/m<sup>2</sup>) was calculated for every individual. IOP and OPA were measured with Pascal Dynamic contour tonometer (DCT). Blood pressure was also measured along with the DCT. The patients were divided into three groups according to BMI as: Group1, BMI&lt;25; Group2, 25≤BMI&lt;30; Group3, BMI≥30. Mean values of IOP, OPA, systolic blood pressure (SBP) and diastolic blood pressure (DBP) were used in statistical analysis.RESULTS: In Group1, the means of IOP, OPA, were 16.8±2.3mmHg, 2.7±0.7mmHg respectively; and SBP, DBP were 120.0±6.1mmHg, and 77.4±5.6mmHg respectively. In group2, the mean IOP, OPA, SBP, and DBP were found to be 16.6±2.1mmHg, 2.4±0.7mmHg, 121.7±5.3mmHg, and 79.5±4.9mmHg respectively. In group3, the mean IOP, OPA, SBP, and DBP were found to be 17.3±1.7mmHg, 2.1±0.7mmHg, 122.4±5.7mmHg, and 79.7±5.2mmHg respectively. There were no statistically significant difference between groups in terms of IOP, SBP and DBP, while OPA values were significantly lower in group3 (<i>P</i>=0.001).CONCLUSION: Decreased OPA values in individuals with higher BMI may indicate that subjects with higher BMI have lower choroidal perfusion and lower ocular blood flow.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Remzi Karadag,Zeynel Arslanyilmaz,Bahri Aydin and Ibrahim F. Hepsen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Remzi Karadag,Zeynel Arslanyilmaz,Bahri Aydin and Ibrahim F. Hepsen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/ijo-5-605]]></guid><cfi:id>1398</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Magnetic resonance diffusion tensor imaging and diffusion tensor tractography of human visual pathway]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201204009]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the visual pathway in normal subjects and patients with lesion involved by diffusion tensor imaging (DTI) and diffusion tensor tractography (DTT).
METHODS: Thirty normal volunteers, 3 subjects with orbital tumors involved the optic nerve (ON) and 33 subjects with occipital lobe tumors involved the optic radiation (OR) (10 gliomas, 6 meningiomas and 17 cerebral metastases) undertook routine cranium magnetic resonance imaging (MRI), DTI and DTT. Visual pathway fibers were analyzed by DTI and DTT images. Test fractional anisotropy (FA) and mean diffusivity (MD) values in different part of the visual pathway.
RESULTS: The whole visual pathway but optic chiasm manifested as hyperintensity in FA maps and homogenous green signal in the direction encoded color maps. The optic chiasm did not display clearly. There was no significant difference between the bilateral FA values and MD values of normal visual pathway but optic chiasm, which the FA values tested were much too low(all P＞0.05). The ONs of subjects with orbital tumors were compressed and displaced. Only one subject had lower FA values and higher MD values. OR of 9 gliomas subjects were infiltrated, with displacement in 2 and disruption in 7 subjects. All OR in 6 meniongiomas subjects were displaced. OR in 17 cerebral metastases subjects all developed displacement while 7 of them had disruption also.
CONCLUSION: MR-DTI is highly sensitive in manifesting visual pathway. Visual pathway can be analyzed quantitatively in FA and MD values. DTT supplies accurate three dimensional conformations of visual pathway. But optic chiasm’s manifestation still needs to improve.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yan Zhang,Si-Hai Wan,Gui-Jun Wu and Xue-Lin Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yan Zhang,Si-Hai Wan,Gui-Jun Wu and Xue-Lin Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201204009]]></guid><cfi:id>1397</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Outcomes and possible risk factors associated with axis alignment and rotational stability after implantation of the Toric implantable collamer lens for high myopic astigmatism]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201204010]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the visual outcomes and possible risk factors associated with axis alignment and rotational stability after implantation of Toric implantable collamer lens (TICL) for the correction of high myopic astigmatism.
METHODS: In this prospective, nonrandomized clinical study, 54 consecutive eyes of 29 patients with high myopic astigmatism received TICL implantation. To evaluate postoperative axis deviation from the intended axis, a digital anterior segment photograph was taken. The ultrasound biomicroscopy(UBM) was used to observe footplate-position.
RESULTS: After mean follow-up of 8.6 months, mean manifest refractive cylinder (MRC) decreased 79.3% from (-1.88±1.49)D preoperatively to (0.39±0.61)D postoperatively. MRC within 1.00 D occurred in 68.5% (37/54) of eyes, whereas 48.1% (26/54) had MRC within 0.50 D. Mean manifest refraction spherical equivalent (MRSE) changed from (-12.08±4.22)D preoperatively to (-0.41±0.61)D postoperatively. Uncorrected binocular vision of 20/20 or better occurred in 72.2% (39/54) of patients compared with binocular best-corrected visual acuity (BCVA) of 20/20 or better in 44.4% (24/54) preoperatively. The mean difference between intended and achieved TICL axes was (6.96±8.37)°. Footplates of TICLs were in the ciliary sulcus in 22 eyes (46.3%), below the ciliary sulcus in 32 eyes (53.7%). The angle of TICL rotation had significant correlation with the footplates-position (t=2.127; P=0.045) and the postoperative TICL vaulting (r=-0.516; P=0.000). 
CONCLUSION: The results of our study further support the safety, efficacy and predictability of TICL for the correct high myopic astigmatism. The footplate-position of TICL and vault value should be taken into consideration as two possible risks factors for TICL rotation.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xun-Lun Sheng,Wei-Ning Rong,Qin Jia,Ya-Ni Liu,Wen-Juan Zhuang,Qing Gu,Yan Sun,Bo Pan and De-Jun Zhu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xun-Lun Sheng,Wei-Ning Rong,Qin Jia,Ya-Ni Liu,Wen-Juan Zhuang,Qing Gu,Yan Sun,Bo Pan and De-Jun Zhu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201204010]]></guid><cfi:id>1396</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical effect of improved viscocanalostomy for the treatment of primary congenital glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201204011]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the clinical effect of improved viscocanalostomy in patients with primary congenital glaucoma.
METHODS: Retrospective analysis of improved viscocanalostomy was performed on 51 eyes of 42 patients with primary congenital glaucoma. The outcome evaluation included postoperative intraocular pressure(IOP), corneal diameter, cup/disc ratio and complications. All patients were followed up at week 1, month 1, 3, 6 and 12.
RESULTS: The results revealed that postoperative IOP was decreased from (38.57±13.61)mmHg to (10.53±3.91)mmHg, (14.89±5.26)mmHg, (15.42±5.11)mmHg, (13.82±3.46)mmHg, (13.16±5.29)mmHg at follow-up time of 1 week, 1, 3, 6, 12 months (P<0.001). The postoperative corneal diameter was decreased significantly (P=0.002); The mean cup/dish ratio wasn’t significantly different (P=0.148) before and after the surgery, the cup/dish ratio of successful surgery was evidently decreased (preoperative 0.7±0.2, postoperative 0.6±0.3, P=0.007), but the complications like as unformed anterior chamber were not observed. The mean follow-up period was 12 months.
CONCLUSION: Improved viscocanalostomy improves the clinical effects of the patients with primary congenital glaucoma, such as higher success rates, lower postoperative mean IOP and fewer complications.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yong Yu,Zhi-Li Liu,Lei Cao and Qing-Zhu Nie]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yong Yu,Zhi-Li Liu,Lei Cao and Qing-Zhu Nie</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201204011]]></guid><cfi:id>1395</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Outcomes of 957 preterm neonatal fundus examinations in a Guangzhou NICU through 2008 to 2011]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201204012]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To take fundus examination in the preterm neonates to observe the common diseases and report the outcomes in a neonatal intensive care unit (NICU) in Guangzhou between May 2008 and May 2011. 
METHODS: Fundus examinations were performed with Retcam Ⅱ in 957 prematures. 
RESULTS: There were 957 prematures in this study, including 666 males and 291 females, 2 triple births, 152 twins and 803 singletons. During the three years, 86 infants with any stage retinopathy of prematurity (ROP) (9.0%), 123 infants with retinal hemorrhage(12.9%), 10 infants with neonatal fundual jaundice(1.0%) and 3 babies with congenital choroidal coloboma (0.3%) were found. 
CONCLUSION: Early detection and prompt treatment of ocular disorders in neonates is important to avoid lifelong visual impairment. Examination of the eyes should be performed in the newborn period and at all well-child visits.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Rui-Hong Ju,Xiao-Yun Ke,Jia-Qing Zhang and Min Fu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Rui-Hong Ju,Xiao-Yun Ke,Jia-Qing Zhang and Min Fu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201204012]]></guid><cfi:id>1394</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Refractive accuracy after intraocular lens implantation in pediatric cataract]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201204013]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyze the factors that influence the prediction error (PE) after intraocular lens (IOL) implantation in pediatric cataract.
METHODS: The medical records of cataract patients of no more than 14 years old who had primary IOL implantation were reviewed from 2006 to 2010. The PE, absolute value of PE (APE), and predictability between in different axial length, mean corneal curvature, corneal astigmatism, and age at the surgery were analyzed. 
RESULTS: Seventy-five children (119 eyes) were included, with a mean age of (5.09±2.54) years. At the follow-up of (1.19±0.69) months, the mean postoperative PE was (-0.22±1.12) D, and APE was (0.87±0.73)D. The PE in eyes with an axial length ＞20mm but ≤22mm were significantly under-corrected than that in eyes with longer axis, and the APE in eyes with an axial length ≤20mm was more obvious compared with the others. The correlations between PE and axial length, as well as corneal astigmatism, and between APE and axial length were significant. The predictability was significantly poorer in the eyes with an axial length ≤20mm than the others.
CONCLUSION: The axial length is closely related with the PE after IOL implantation in pediatric cataract patients, especially when it is ≤20mm, PE is more significant. The formula that is more suitable to very short axial length should be explored.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Tan Long,Yu-Sen Huang and Li-Xin Xie]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Tan Long,Yu-Sen Huang and Li-Xin Xie</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201204013]]></guid><cfi:id>1393</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of the SchirmerⅠtest with and without topical anesthesia for diagnosing dry eye]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201204014]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the value of Schirmer Ⅰtest (SⅠt) without anesthesia and with topical anesthesia for diagnosing dry eye (DE).
METHODS: Totally 220 eyes in 110 patients, male (44) and female (66), (39.56±12.67) years old diagnosed with DE were examined. SⅠt without anesthesia was performed firstly, and 15 minutes later, it was applied again in the same person after topical anesthesia with 0.5% proparacaine hydrochloride eye drops. The wetting strips counted <10mm per 5 minutes were defined positive, while ≤5mm per 5 minutes were defined strong positive.
RESULTS: The wetting length in SⅠt after topical anesthesia was significantly lower than that in SⅠt without anesthesia (P<0.001). The positive rate and strong positive rate of SⅠt after topical anesthesia were significantly higher than that of SⅠt without anesthesia (P<0.001). The positive rate and strong positive rate of SⅠt without anesthesia and the strong positive rate of SⅠt after topical anesthesia in patients with aqueous-deficiency dry eye (ADDE) were significantly higher than those in total patients whereas those in patients with evaporative dry eye (EDE) were significantly lower than those in total patients (P<0.001).
CONCLUSION: SⅠt after topical anesthesia with 0.5% proparacaine hydrochloride eye drops is more objective and reliable than that without anesthesia in reflecting the status of DE, and its diagnostic value in patients with ADDE was even higher, making itself a meaningful evidence for the diagnosis and treatment of DE.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Na Li,Xin-Guo Deng and Mei-Feng He]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Na Li,Xin-Guo Deng and Mei-Feng He</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201204014]]></guid><cfi:id>1392</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Efficacy and necessity of prophylactic vitrectomy for acute retinal necrosis syndrome]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201204015]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the efficacy of prophylactic vitrectomy for acute retinal necrosis syndrome(ARN) with routine treatment in Chinese patients, thereby investigate the necessity of prophylactic vitrectomy for ARN. 
METHODS: Thirty patients (37 eyes) were retrospectively included in this study. The eyes were divided into 2 groups by treatment, including routine treatment, which consisted of antiviral medication and vitrectomy after retinal detachment (RD) (n=21), and prophylactic vitrectomy, which consisted of antiviral medication and vitrectomy for the prevention of RD performed during the active in?ammatory phase (n=16). The extent of necrosis was determined by fundus photographs at the time of presentation (for eyes with mild vitreous opacity) or the drawings in the operation records. Necrosis of the 37 eyes was divided into 3 grades, including peripheral, middle-peripheral and extensive. The follow-up period ranged from 8 to 57 months. Differences in visual acuity and necrosis between groups were identified using independent samples t-test. 
RESULTS: Necrosis was more extensive in the routine treatment group than in the prophylactic vitrectomy group (P<0.05). In the routine treatment group, conservative treatment improved necrosis and prevented RD in 6 eyes (29%). Seven eyes (33%) obtained anatomical success, but retinal redetachment occurred in 8 eyes (57%). There were also 5 eyes (24%) developed ocular hypotony or atrophy. Ten eyes (48%) achieved equal or increased visual acuity. In the prophylactic vitrectomy group, RD occurred in 2 eyes (13%). Twelve eyes (75%) were completely anatomically successful, and 10 eyes underwent silicone oil removal. Only one eye (6%) became ocular hypotony. Fourteen eyes (88%) achieved equal or increased visual acuity. The prophylactic vitrectomy group achieved better vision trends than the routine treatment group (P<0.05). Eyes with peripheral necrosis had better visual outcomes than those with mid-peripheral (P<0.05) or extensive (P<0.05) necrosis. However, there was no significant difference between eyes with mid-peripheral and extensive necrosis (P=0.3008)
CONCLUSION: Prophylactic vitrectomy can prevent RD and improve the prognosis of ARN, making it an option for cases with rapidly progressing necrosis despite antiviral treatment and cases with moderate to extensive necrosis and severe vitreous opacity.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yong-Heng Luo,Xuan-Chu Duan,Bai-Hua Chen,Luo-Sheng Tang and Xiao-Jian Guo]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yong-Heng Luo,Xuan-Chu Duan,Bai-Hua Chen,Luo-Sheng Tang and Xiao-Jian Guo</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201204015]]></guid><cfi:id>1391</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Reconstruction of complex orbital fracture with titanium implants]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201204016]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the effectiveness and safety of complex orbital fracture reconstruction with titanium implants.
METHODS: A retrospective review of 46 patients treated with complex orbital fractures reconstruction using titanium implants from January 2005 to December 2008 was conducted. The following data were recorded: age, gender, mechanism of injury, preoperative and postoperative orbital CT, visual acuity, diplopia, ocular motility and Hertel exophthalmometer.
RESULTS: The most common cause was motor vehicle accident (47.8%), followed by industrial injury (30.4%). All patients had improved appearance after operation and CT scan at one week after operation showed the fracture defects of orbit and neighboring areas had been reconstructed. Forty-six cases had various degrees of enophthalmos before operation. Among them, 32 cases were completely corrected, 11 cases improved obviously and 3 cases had no improvement after operation. Thirty-six patients with visual acuity ≥20/60 revealed diplopia of various degrees, including 26 patients had diplopia in right ahead and/or reading positions. At the sixth month after operation, diplopia disappeared in five patients, 7 patients still had diplopia in right ahead and/or reading positions, 14 patients had diplopia in positions rather than right ahead and reading positions (<20°) and ten patients had diplopia only at peripheral gazing (>20°). All patients had various degrees of ocular motility disorders before operation. At the sixth month after operation, eyeball movement disorder disappeared in 9 patients, 31 patients showed improvement and 6 patients had no improvement. Complications of implant infection, rejection and displacement were not reported after operation.
CONCLUSION: The application of titanium implants in the repair of complex orbital fractures greatly improves the appearance and functional results, which is a favorable material for plastic surgery of complex orbital fracture.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Wen-Shu Yi,Xue-Liang Xu,Jian-Rong Ma and Xin-Rong Ou]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Wen-Shu Yi,Xue-Liang Xu,Jian-Rong Ma and Xin-Rong Ou</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201204016]]></guid><cfi:id>1390</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Oxidative stress-elevated high gamma glutamyl transferase levels, and aging, intake of tropical food plants, migration and visual disability in Central Africans]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201204017]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the independent pathogenic role of high serum gamma-glutamyl transferase (GGT) levels, sociodemographic data, dietary and environmental risk factors for visual disability (VD).
METHODS: This was a case-control study, run in 200 black Congolese patients managed in Saint Joseph Hospital Ophthalmology Division from Kinshasa town. Logistic regression model was used to identify determinants of VD (n=58) among sex, age, cigarette smoking, alcohol abuse, rural-urban migration, education levels, aging ≥60 years, intake of red Beans, Safou fruit and Taro leaves, lipid profile, residence, socioeconomic status, and GGT.
RESULTS: After adjusting for confounding factors, we identified migration (OR=3.7  95% CI:  1.2-11.3; P=0.023), low education level (OR=3.1  95% CI  1.1-8.5; P=0.026), no intake of Safou fruit (OR=34.2  95% CI  11.5-102; P<0.0001), age ≥ 60 years (OR=2.5  95% CI  1.01-6.5; P=0.049), and serum GGT ≥10 U/L (OR=3.6  95% CI  1.3-9.6; P=0.012) as the significant and independent determinants of VD.
CONCLUSION: VD appears as a major public health problem in Central Africa to be prevented or delayed by control of migration, lifestyle changes, antioxidant supplements, appropriate diet, nutrition education, and blocking of oxidative stress.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Benjamin Longo-Mbenza, Mo&#239;se Mvitu Muaka, Etienne Mokondjimobe, Dalida Kibokela Ndembe, Doris Tulomba Mona and Baudouin Buassabu-bu-Tsumbu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Benjamin Longo-Mbenza, Mo&#239;se Mvitu Muaka, Etienne Mokondjimobe, Dalida Kibokela Ndembe, Doris Tulomba Mona and Baudouin Buassabu-bu-Tsumbu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201204017]]></guid><cfi:id>1389</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Risk factors for clinically significant macular edema in a multi-ethnics population with type 2 diabetes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201204018]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the risk factors of clinically significant macular edema (CSME) in patients with non-proliferative diabetic retinopathy (NPDR) in a multi-ethnics Malaysian population.
METHODS: We performed a case control study in which 150 patients with bilateral NPDR and CSME in either eye were compared to 150 patients with bilateral NPDR and no CSME in both eyes. CSME and NPDR were graded according to Early Treatment of Diabetic Retinopathy Study criteria. Student’s t-test, odds ratio and multiple logistic regression analysis were performed to analyze the duration of diabetes, body mass index (BMI), blood pressure(BP), total cholesterol, low density lipoprotein (LDL), high density lipoprotein (HDL), triglycerides (TG), fasting blood glucose (FBG), HbA1c, full blood count, serum creatinine and proteinuria between the two groups.
RESULTS: Both groups were matched in terms of age, gender and ethnicity. Duration of diabetes, total serum cholesterol, serum LDL, FBG, HbA1c and serum creatinine were significantly higher in the CSME group (P<0.05). The hemoglobin, packed cell volume were significantly lower in the CSME group (p<0.05). There was no significant difference for serum HDL, TG, BMI, systolic and diastolic BP. Multiple logistic regression analysis showed that total serum cholesterol and HbA1c had significantly high odds of developing CSME.
CONCLUSION: HbA1c and total cholesterol are the two most important risk factors associated with CSME in patients with NPDR.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ong Ming Jew,Mohammadreza Peyman,Tan Chen Chen and Subrayan Visvaraja]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ong Ming Jew,Mohammadreza Peyman,Tan Chen Chen and Subrayan Visvaraja</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201204018]]></guid><cfi:id>1388</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Corneal white-to-white distance and mesopic pupil diameter]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201204019]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To study the relationship between corneal white-to-white (WTW) distance and mesopic pupil diameter.
METHODS: This study is composed of 30 cases that underwent photorefractive keratotomy (PRK). Pupil size measurements were performed with Schwind ORK wavefront analyzer in mesopic conditions. WTW distance was measured with a measuring caliper. Also, A-scan ultrasound examination was performed in all patients. The relationship among the mesopic pupil diameter and age, sex, axial length, lens thickness, anterior chamber depth(ACD), horizontal WTW distance, vertical WTW distance, spherical equivalent, and average keratometry were analyzed with univariate and multivariate regression analysis. 
RESULTS: Mean pupil diameter was (6.39±0.80)mm (range: 3.70mm-7.73mm). Horizontal WTW distance measurements were between 11.00mm and 12.50mm and mean horizontal WTW distance was (11.79±0.43)mm. On the other hand, vertical WTW distances ranged between 10.00mm and 13.00mm, and their mean was (11.42±0.72)mm. Bivariate correlation between pupil diameter and other variables showed that the axial length, ACD, spherical equivalent, and horizontal WTW distance had a moderate correlation with mesopic pupil diameter. Multiple regression analysis revealed that spherical equivalent and horizontal WTW distances were significantly associated with mesopic pupil diameter (R=0.598, R<sup>2</sup>=0.358 P=0.02).
CONCLUSION: This study shows that mesopic pupil diameter is closely related to horizontal WTW distance. These two factors must be taken in consideration together in preoperative ablation zone planning.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hasan Basri Cakmak,Nurullah Cagil,Huseyin Simavli and Sabri Raza]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hasan Basri Cakmak,Nurullah Cagil,Huseyin Simavli and Sabri Raza</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201204019]]></guid><cfi:id>1387</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Characteristics and clinical presentations of pediatric retinoblastoma in North-western Iran]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201204020]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report the characteristics and clinical presentations of retinoblastoma in a series of pediatric patients from Iran.
METHODS: In this retrospective study, profiles of pediatric patients with retinoblastoma archived in a referral eye hospital in north-west of Iran during 7 years (n=40 patients with 57 eyes) were reviewed. Demographics, as well as the laterality, clinical manifestations and the types of treatment were the major endpoints. The Student’s t test, Mann-Whitney U-test, Chi-square or Fishers’ Exact test was used for analysis where appropriate. 
RESULTS: There were 23 cases (57.7%) with unilateral and 17 cases (42.5%) with bilateral involvement. The male to female ratio was 1 to 1.4 with a mean admitting age of 24.0±11.3 (range: 5-62) months. The mean diagnosis delay was 7.4±9.6 months (range: 10 days to 13 months). The most common presenting sign was leukocoria (97.5%) followed by proptosis (7.5%), strabismus (7.5%), hyphema (5%), orbital cellulitis (5%) and glaucoma (2.5%). Enucleation was performed in 95.7% of the cases with unilateral involvement and at least one eye of the patients with bilateral disease. A second enucleation was performed in other 3 patients (17.6%) of the latter group.
CONCLUSION: This is the first study evaluating a series of Iranian children with retinoblastoma.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Reza Nabie,Nazli Taheri,Ali Mahdavi Fard and Rohollah Fadaei Fouladi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Reza Nabie,Nazli Taheri,Ali Mahdavi Fard and Rohollah Fadaei Fouladi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201204020]]></guid><cfi:id>1386</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Treatment of moderate to severe keratoconus with 6-mm Intacs SK]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201204021]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the effect of Intacs SK corneal ring segment implant for treatment of patients with moderate to severe keratoconus, who have clear central cornea and cannot tolerate contact lens.
METHODS: In this prospective, non-comparative, interventional case series study performed in Dena Hospital, Shiraz, Iran, thirty-seven eyes of thirty-six patients with moderate to severe keratoconus, clear central cornea, and contact lens intolerance were enrolled and underwent Intacs SK corneal ring segment implantation. Preoperatively, uncorrected distance visual acuity (UCDVA), best-corrected distance visual acuity (BCDVA), central corneal thickness(CCT) and average keratometry (Av-K) were measured and compared with post-operative results at one week, one month, three months, and six months.
RESULTS: Mean preoperative UCDVA and BCDVA were (1.32±0.31)logMAR and (1.07±0.27)logMAR, respectively. Av-K was (52.13±0.39)D, and the CCT was (432±39.5)μm. Post-operative examinations showed a clinically significant improvement in both UCDVA and BCDVA (P<0.001). There was also a significant effect based on the time of assessment on both UCDVA and BCDVA and both parameters had a continuous improvement during the follow-up period. Three months after operation there was a statistical significant reduction of Av-K (P=0.0001), but there were no significant changes in CCT (P=0.149). 
CONCLUSION: Intacs SK corneal ring segment implants seem to be a safe and effective treatment option for patients who have keratoconus, clear central cornea, and contact lens intolerance.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Sasan Niknam,Mehrdad Shamshiri,Seyed Sahabaldin Shahrzad,Abbas Alipour,Mohammad Bagher Rajabi and Mohammad Taher Rajabi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Sasan Niknam,Mehrdad Shamshiri,Seyed Sahabaldin Shahrzad,Abbas Alipour,Mohammad Bagher Rajabi and Mohammad Taher Rajabi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201204021]]></guid><cfi:id>1385</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Relations between lymphangiogenesis and the size of pterygium]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201203012]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To examine the relations between lymphangiogenesis and the size of pterygium.
METHODS: Tissues from 88 primary and 34 recurrent pterygia were evaluated, and those from 7 nasal epibulbar conjunctiva segments were used as controls. Pterygium slices from each patient were stained with LYVE-1 monoclonal antibodies to identify lymphatic microvessel for calculating lymph-vascular area (LVA), lymph-microvascular density (LMD) and lymph-vascular luminal diameter (LVL). Also, the relations between lymphangiogenesis (measuring by LVA, LMD and LVL) and the size of pterygium (extension, width and area) were explored.  
RESULTS: There were a few LYVE-1(+) lymphatic vessels in normal epibulbar conjunctiva segments. However, the number of lymphatic vessels slightly increased in primary pterygia and dramatically increased in recurrent pterygia. LVA, LMD and LVL significantly increased in recurrent pterygia in comparison with primary pterygia (all P<0.05). Both LMD and LVA were correlated with the width and area of pterygia (both P< 0.05), and LVA was also correlated with the extension of pterygia(P<0.05).
CONCLUSION: Lymphangiogenesis is correlated with the size of pterygium. The outgrowth of lymphatic vessels might contribute to the development of pterygia.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Lin Liu,Shi-Qi Ling,Qiao-Li Li,Tao Wang,Hui Ye,Jie-Zhen Yang and Xiu-Hua Jia]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Lin Liu,Shi-Qi Ling,Qiao-Li Li,Tao Wang,Hui Ye,Jie-Zhen Yang and Xiu-Hua Jia</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201203012]]></guid><cfi:id>1384</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Cigarette smoking, body mass index associated with the risks of age-related cataract in male patients in northeast China]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201203013]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the association between cigarettes smoking, body mass index (BMI) and the risk of age-related cataract (ARC) in middle-aged and elderly men in Northeast China.
METHODS: A hospital-based case control study was conducted. Cases (n =362) were men who had surgically treated ARC, 45-85 years old; controls frequency-matched (n =362) were men who had been admitted to the same hospital as cases for other diseases not related with eye diseases. Cases and controls were matched with 1:1. The cases and controls were interviewed during their hospital stay, using a structured interviewer-administrated questionnaire that included information on sociodemographic characteristics, socioeconomic, lifestyle habits (tobacco smoking and alcohol consumption, etc.), anthropometric measures, personal medical history, and family history of ARC in first-degree relatives, and simultaneously BMI was calculated. The odds ratios (OR) and 95% confidence intervals (CI) of ARC were estimated using multiple logistic regression models.
RESULTS: After adjusting for age and multiple potential confounders, higher BMI was associated with an increased risk of ARC. Cigarette smoking, years smoking or moderate cigarette smoking (1-29 cigarettes per day) had no relation with the risk of ARC (P >0.05), although patients smoking ≥30 cigarettes per day had an elevated risk of ARC as compared with the non-smokers (OR =1.55, 95% CI; 1.16-2.85, P =0.026). Higher BMI was associated with an increased risk of ARC. Both overweight and obesity was associated with an obviously increased risk for surgically ARC (OR=1.55, 95% CI: 1.02-1.98, P=0.015 and OR=1.71, 95% CI: 1.32-2.39, P=0.013 respectively) compared to normal BMI. Then participants were grouped into quartiles of BMI (Q1 to Q4), compared to controls in the lowest quartile, the OR for cases in the highest quartile of BMI was 1.54 (OR=1.54, 95% CI: 1.08-2.46, P=0.022). The results of univariate analysis showed cigarette smoking was not associated with ARC formation for men with lower or normal BMI (P >0.05). Compared to the non-smokers, for men of overweight or obesity, cigarette smoking was associated with a significantly increased risk for surgically ARC (OR=2.00, 95% CI: 1.49-6.65, P =0.003 and OR =1.66, 95% CI: 1.63-13.21, P =0.002 respectively). Similarly, smokers in the highest quartile of BMI had approximately 1.5 times the risk of ARC as non-smokers in the lowest quartile (OR=1.46, 95% CI: 1.06-5.29, P <0.001). Followed multivariate models revealed that the association had never changed. 
CONCLUSION: Current cigarette smoking is positively related to ARC only among those who smoking 30 or more cigarettes per day. For men who are both overweight and obesity, cigarette smoking is associated with a significantly increased risk for ARC.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Zhi-Quan Lu,Wen-Hui Sun,Jia Yan,Teng-Xuan Jiang,Shu-Na Zhai and Yan Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zhi-Quan Lu,Wen-Hui Sun,Jia Yan,Teng-Xuan Jiang,Shu-Na Zhai and Yan Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201203013]]></guid><cfi:id>1383</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Visual and optical performance of eyes with different corneal spherical aberration implanted with aspheric intraocular lens]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201203014]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the visual and optical performance of eyes with different corneal spherical aberration (SA) implanted with spherical aberration-free intraocular lens (IOLs). 
METHODS: Thirty-six patients with different corneal SA had phacoemulsification with implantation of spherical aberration-free IOLs. Patients were divided into 3 groups according to the value of preoperative corneal SA. Eyes with corneal SA <0.10μm were assigned to group A, those with 0.10 ≤corneal SA <0.20μm to Group B, and those with 0.20≤ corneal SA <0.35μm to Group C. Best-corrected visual acuity (BCVA), contrast sensitivity, corneal SA, total ocular aberrations, and depth of focus were recorded 3 months postoperatively. Distance-corrected near and intermediate visual acuity was studied to measure depth of focus.
RESULTS: BCVA and contrast sensitivity were similar between groups. There were no significant differences in distance-corrected near or intermediate visual acuity. Corneal SA was similar before and 3 months after surgery in the 3 groups. With a 5.0mm pupil diameter, root mean square values for total ocular higher-order aberrations (HOAs) were lower in groups A and B than in group C. Total ocular SA was lower in group A than in groups B and C. SA was also lower in group B than in group C. Coma and trefoil were similar between the groups. 
CONCLUSION: Implantation of spherical aberration-free IOLs in eyes with different corneal SA results in similar visual performance at BCVA, contrast sensitivity and depth of focus.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xian-Hui Gong,Qin-Xiang Zheng,Na Wang,Ding Chen,Juan Zhao,Jin Li and Yun-E Zhao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xian-Hui Gong,Qin-Xiang Zheng,Na Wang,Ding Chen,Juan Zhao,Jin Li and Yun-E Zhao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201203014]]></guid><cfi:id>1382</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Repeatability and agreement of CCT measurement in myopia using entacam and ultrasound pachymetry]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201203015]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the repeatability of central corneal thickness (CCT) measurement by entacam, and agreement of CCT measured by Pentacam and ultrasound pachymetry (USP) in Chinese myopia. Thereby investigate the possibility of Pentacam as a substitute for USP in CCT measurement before refractive surgery. The effects of corneal curvature measured by Pentacam on CCT were also evaluated.
METHODS: One hundred and forty-eight right eyes of 148 individual with myopia were included in this study. Three successive Pentacam CCT measurements followed by 10 successive ultrasound pachymetry were carried out in the 148 eyes. Mean of CCT taken by each device was calculated for comparison. According to the CCT measured by USP, all the 148 eyes were divided into 3 groups: <520μm, 520-560μm, >560μm. For all eyes and each group the CCT obtained by Pentacam and USP were compared. Anterior corneal curvature of the 148 eyes was also adopted for correlation analysis with CCT obtained by ultrasound pachymetry. In addition, CCT measurement using 60 random selected Scheimpflug images was performed by 3 skilled investigators at different time, and this was repeated for 3 times by a forth investigator to assess repeatability of Pentacam CCT measurement using Scheimpflug images.
RESULTS: Intraclass correlation coefficient (ICC) analysis revealed high intraobserver repeatability (ICC=0.994, F=158.60, P<0.001) for CCT measurement by Pentacam. The interobserver (ICC=0.998, F=494.73, P<0.001) and intraobserver (ICC=0.997, F=383.98, P<0.001) repeatability for Pentacam CCT measurements using Scheimpflug images were also excellent. There was high positive correlation between the CCT values measured by Pentacam and ultrasound pachymetry (r=0.963, P<0.001). Bland-altman plots showed that the Pentacam underestimate the CCT by 8.02μm compared with ultrasouond pachymetry. The differences between Pentacam and USP increased as the CCT readings by USP increased (Pentacam vs USP: slope=-0.04, P<0.05). The 95% upper and lower limits of agreement between CCT values obtained from the two devices were +9.33μm and -25.37μm. No significant association could be found between CCT and anterior corneal curvature.
CONCLUSION: Inter- and intraobserver variability for CCT measurements by Pentacam was considerably below clinically significant levels. CCT of myopia obtained by Scheimpflug camera, Pentacam, were highly correlated to that by ultrasound pachymetry. However, the values obtained are not directly interchangeable between Pentacam and ultrasound pachymetry as the 95% limits of agreement are relatively wide. Pentacam can be a useful instrument for measuring CCT in candidates to refractive surgery in clinic.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yong-Heng Luo,Qian Zhong,Ping-Bo Ouyang,Xiao-Jian Guo and Xuan-Chu Duan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yong-Heng Luo,Qian Zhong,Ping-Bo Ouyang,Xiao-Jian Guo and Xuan-Chu Duan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201203015]]></guid><cfi:id>1381</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Transepithelial photorefractive keratectomy mode using SCHWIND-ESIRIS excimer laser: initial clinical results]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201203016]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate postoperative pain, uncorrected visual acuity (UCVA), and cornea haze value after transepithelial photorefractive keratectomy (T-PRK) performed with aspherical ablation profile using SCHWIND ESIRIS excimer laser.
METHODS: Retrospective case series. Fifty-nice eyes (32 patients) with myopia associated with or without astigmatism underwent phototherapeutic keratectomy (PTK) followed by photorefractive keratectomy (PRK) which performed by Optimized Refractive Keratecomy (ORK)-CAM software based on aspherical ablation profile using SCHWIND ESIRIS excimer laser. Postoperative pain scale was measured on a questionnaire through five levels. Haze was graded by five grades, and UCVA, manifest refraction spherical equivalent (MRSE) were analyzed.
RESULTS: Mean pain level was (1.37±0.613) (range: 1 to 3), the mean time picking out the soft contact lens was (6.22±1.73) days, at 3 months, UCVA was 1.0 for 40 eyes (67.8%), 0.5 for all eyes (100.0%). The UCVA was significantly less than the preoperative best spectacle corrected visual acuity (BSCVA) (t=-2.84, P=0.006), haze value was (0.27±0.25), no patients had a haze grade up to 2. Mean MRSE was (0.76±0.96) diopter(D) by 3 months.
CONCLUSION: The outcomes from this study show that using the SCHWIND ESIRIS aspherical ablation profile for transepithelial PRK has a good visual result. The primary advantage is related to a spherical ablation profile, automatically considers the ablation volume of the stroma and the accurate and smooth removal of the epithelium with PTK. Additional studies are needed to determine long-term outcomes.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Dong-Mei Wang,Yi Du,Guang-Sheng Chen,Liu-Song Tang and Jian-Feng He]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Dong-Mei Wang,Yi Du,Guang-Sheng Chen,Liu-Song Tang and Jian-Feng He</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201203016]]></guid><cfi:id>1380</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparisons of morphologic characteristics between thin-flap LASIK and SBK]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201203017]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the morphologic characteristics between thin-flap laser in situ keratomileusis (LASIK) and Sub-Bowman keratomileusis (SBK), and to evaluate the uniformity of flap and to explore the correlative factors of corneal flap thickness.
METHODS: A prospective, randomized, comparative clinical study was performed in Department of Ophthalmology, West Hospital of China, Chengdu, Sichuan Province, China. Totally 59 patients 114 eyes underwent LASIK or SBK to correct myopia, 29 patients 57 eyes underwent SBK, 30 patients 57 eyes underwent LASIK. Anterior optical coherence tomography(OCT) was used to measure corneal flap thickness in all the patients 1 week after surgeries, 16 positions were set to be measured in each eye. Comparisons of flap thickness in each group and between 2 groups were evaluated. Correlative factors of flap thickness were evaluated.
RESULTS: Coefficient of variation（CV, s/x ×%）in SBK group were lesser than that in LASIK group, t test showed there was significant statistical difference between 2 groups(P=0.000). Comparisons of the difference of 2 paired positions(temporal-nasal; superior-inferior) showed there were no significant differences in each group, but between 2 groups , there were statistical significance of value of difference (D-value) of superior and inferior positions between SBK and LASIK group(P=0.036). Linear regression analysis of correlative factors of flap thickness showed there were no statistic significances related to central corneal thickness(CCT)(P=0.060, t=1.921) and corneal curvature(P=0.083, t=1.766).
CONCLUSION: SBK is better than LASIK in creating much uniform corneal flap. There was no evidence showing correlations between flap thickness and CCT or corneal curvature.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yi Sun,Ying-Ping Deng,Lin Wang,Yong-Zhi Huang and Le-Mei Qiu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yi Sun,Ying-Ping Deng,Lin Wang,Yong-Zhi Huang and Le-Mei Qiu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201203017]]></guid><cfi:id>1379</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparative study of bacterial status from conjunctival sac of the elder Qiang minority and Han people with dry eye in Sichuan, China]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201203018]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the status of bacteria in the conjunctival sac from the elder Qiang minority and Han people with dry eyes in Sichuan, China. 
METHODS: Total of 54 elder Qiang people with dry eyes (108 eyes) were examined by cluster sampling. In the similar habitation region of Han people, 80 (160 dry eyes) Han people were analyzed as the control group. The bacteria was separated from the inferior palpebral conjunctiva, then inoculated on blood plate for 48 hours and identified. 
RESULTS: Totally 24 strains of bacteria were cultured in either Qiang minority or Han c populations with 3 strains of them existed in both ethnic groups. The commonest bacteria in conjunctival sac in two ethnic groups were non-pathogenic bacterium. The composition of Corynebacterium in Han people (54.1%) was significantly higher than that in Qiang minority (27.4%) (χ2=11.6721, P=0.0006). The percentage of Sphingomonas Paucimobilis in Qiang people was higher than that in Han people (χ2=18.6442, P= 0.0000). However, there was no significant difference between Qiang minority and Han people either in bacterial positive rate in conjunctival sac, or the composition of bacteria species and strains, or the composition of staphylococcus epidemids between two ethnic populations. 
CONCLUSION: There was no significant difference of bacterial positive rate in conjunctival sac from the elder of Qiang minority and Han people with dry eye, but the species of bacteria were different.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yue Zhang,Zhi-Rong Liu,Hui Chen,Wan-Jiang Dong,Ying-Chuan Fan,Hua Yu,Guang-Jin Wang,Yu-Chan Li and Kui Cao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yue Zhang,Zhi-Rong Liu,Hui Chen,Wan-Jiang Dong,Ying-Chuan Fan,Hua Yu,Guang-Jin Wang,Yu-Chan Li and Kui Cao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201203018]]></guid><cfi:id>1378</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of choroidal thickness measured by two methods]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201203019]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To examine the profile of the choroidal thickness (CT) in healthy myopia subjects and emmetropic participants by Heidelberg Eye explore software and Image J software so as to compare the agreement and reproducibility of the two methods. 
METHODS: Thirty-six study participants (36 eyes) were enrolled in this research. The fovea and parafoveal region (the region of 6mm diameter of the fovea as center) of the images were selected by spectral domain optic coherence tomography (SD-OCT). The choroidal thickness was measured manually by the Heidelberg Eye explore software (version 5.3.3.0, Heidelberg Engineering) with a vertical line and the Image J software with a line vertical to the retinal  pigment  epithelial  layer. The agreement and reproducibility of the two methods were described by the Bland-Altmann analysis.
RESULTS: As compared with Heidelberg Eye explore software (39.9186), the repeatability coefficient is lower calculated by Image J software (27.3525). The Bland-Altmann analysis showed that the limits of 95% CI of agreement analysis is -18.437-63.949μm and the upper limits of  the precision of the 95% CI of agreement is between 16.102 and 111.796μm and the lower limits is range from -66.29-21.41μm, which reflected a great variations of the difference.
CONCLUSION: The repeatability and agreement of measurement implied by Image J software was better than the Heidelberg Eye explore software. The Image J software should be used for measuring the choroidal thickness in future study in China.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Wei Chen,Zhi-Tao Wang and Hong Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Wei Chen,Zhi-Tao Wang and Hong Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201203019]]></guid><cfi:id>1377</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of central macular thickness between two spectral-domain optical coherence tomography in elderly non-mydriatic eyes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201203020]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare central macular thickness (CMT) measurements obtained by two spectral-domain optical coherence tomography (SD-OCT) exams, and to evaluate measurement reproducibility and agreement between these two exams, and to investigate the relationship between CMT and possible influencing factors such as age, sex, eye (OD/OS), and operators in elderly non-mydriatic eyes. 
METHODS: Seventy-two normal subjects were included. Every subject underwent CMT measurement twice using one of two SD-OCT (OSE-2000, Moptim, Shenzhen, China & 3-D OCT-1000, Topcon, Tokyo, Japan) instruments respectively where we randomly chose one eye in each patient for the test; these exams were performed by two operators over an hour period with a brief rest between sessions. Comparison of the OSE-2000 and 3-D OCT-1000 CMT measurements was based on paired-t test. The mean difference between the CMT measurements was calculated. General linear model analyzed the relationships among eye (OD/OS), operator, sex, and CMT values using age as co-variant. All tests were considered statistically significant at P<0.05. The main outcome measures included CMT. 
RESULTS: When evaluated with general linear model analysis, CMT measurements were found to have high reproducibility across the two instruments between the two operators for the OSE-2000 single line scan and 3-D OCT-1000 macular scans (P=0.731; P=0.443). There was statistically significant difference in CMT values between the two instruments (P<0.001) and the mean difference was -46.83μm at 95% confidence limits (-49.15,-44.51). Age was positively correlated with CMT (beta coefficient = 0.516, P=0.001; beta coefficient = 0.453, P=0.009) and sex was correlated with CMT from the OSE-2000 (P=0.021) but not with the 3-D OCT-1000 (P=0.056). According to the actual thickness measurements, the CMT of the male was thicker than the female’s but there was no statistical difference. There was interaction between sex and eye in OSE-2000 and not in 3-D OCT-1000 (P=0.02; P=0.374). No significant correlation was found between CMT and the influencing factor of eye in both of the instruments (P=0.884; P=0.492).
CONCLUSION: Reproducibility of CMT measurement using the two SD-OCTs is excellent in normal eyes according to the operator factor analysis. OSE-2000 has a different posterior retinal boundary of CMT measurement, which results in the CMT value differences, compared with the 3-D OCT-1000. Age is positively correlated with CMT measurement while sex is correlated with CMT in the OSE-2000 but not in the 3-D OCT-1000 and eye (OD/OS) had no correlation with CMT values. Mydriatic drops may not be necessary for CMT measurement using high scan rate SD-OCT in normal eyes in dark room.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xiao-Gang Wang,Qing Peng and Qiang Wu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiao-Gang Wang,Qing Peng and Qiang Wu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201203020]]></guid><cfi:id>1376</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[AcrySof phakic angle-supported intraocular lens for the correction of high to extremely high myopia: one-year follow-up results]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201203021]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the safety, efficacy and predictability of the AcrySof phakic angle-supported intraocular lens (IOL) (Alcon Inc., U.S.A.) for correction of high-to-extremely high myopia in adults.
METHODS: In this prospective study performed in Tianjin Medical University Eye Center & College of Optometry, Tianjin, China, 25 eyes of 13 patients were implanted with AcrySof phakic angle-supported IOLs and followed for 1 year postoperatively. Preoperative manifest refractive sphere was (-12.08±2.44) diopters (D) and cylinder was (-1.35±0.62)D. Visual acuity, predictability and stability of manifest refraction spherical equivalent (MRSE), adverse events, and endothelial cell density were analyzed during 1-year of follow-up.
RESULTS: After 1 year of follow-up, no eyes lost≥1 line (best spectacle-corrected visual acuity)BSCVA; an uncorrected visual acuity (UCVA) of 20/20 or better was achieved in 60% of eyes; 100% had an UCVA of 20/40 or better; a BSCVA of 20/30 or better was achieved by 100% of eyes; 84% had a BSCVA of 20/20 or better. The overall mean percentage change in endothelial cell density 1 year after surgery was (-0.27±3.60)%. Two eyes (8%) had increased intraocular pressure (IOP) on the day of surgery. No pupil ovalization, pupillary block, or retinal detachment events were observed.
CONCLUSION: After 1 year of follow-up, the implantation of AcrySof phakic angle-supported IOL is proved to be safe, effective and predictable with minimal complications in patients with high-to-extremely high myopia. Due to the limitation of visiting time, long-term of clinical investigation is necessary to verify the safety and efficacy of this IOL.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Rui-Bo Yang and Shao-Zhen Zhao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Rui-Bo Yang and Shao-Zhen Zhao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201203021]]></guid><cfi:id>1375</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Data analysis of low dose multislice helical CT scan in orbital trauma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201203022]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To explore the optimal low dose of MSCT in orbital trauma examination. 
METHODS: Sixty transverse images of the fracture layer were selected. Low-dose images acquired at 30, 70, 100, 140, 170, and 200 milliampere (mA) were simulated by adding noise to the image space using software. After assessing the images according to the conditions of image quality and fracture, we found the optimal tube current that met diagnostic requirements and then applied it to clinical use. The CT Dose Index volume (CTDIvol), dose length product (DLP) and effective dose (ED) were recorded. The image quality was classified as good, fairly good, ordinary, poor, or very poor according to image level, noise, anatomic structure and whether the diagnostic requirements were met or not. The rank-sum test was used to perform statistical analysis on the ranked data. The Chi-square test was used for the numerical data. 
RESULTS: Under the scan conditions of a conventional dose of 300 mA, 60 cases of orbital fracture, 38 cases of orbital emphysema, 25 cases of ocular damage, and 3 cases of intraorbital foreign body were demonstrated in the images of the 60 orbital trauma patients. Among the low dose simulated images, the image quality difference of the different doses was of statistical significance (χ2 =15.678, P=0.016). When the dose was lowered to 70 mA, the above mentioned clinical signs were still clear and diagnostic, however the image quality assessment results indicated that 2 cases were good, 16 cases were fairly good, and 42 cases were ordinary, poor or very poor. When the simulated dose tube current was 100mA, the image quality assessment results were 18 cases good, 34 cases fairly good, and 8 cases ordinary, poor and very poor; compared with the conventional dose, there was no statistical significance (P >0.05). When using a 100 mA tube current to examine 40 cases of orbital trauma patients in the clinic, the acquired image quality was 10 cases good, 26 cases fairly good and 4 cases ordinary, without any cases of poor or very poor. The CTDIvol, DLP and ED were 20.72mGy, 124.97 mGy?cm and 0.26mSv, respectively, while the CTDIvol, DLP and ED were 62.53mGy, 375.18 mGy?GTtl and 0.86mSv, respectively, when using a conventional dose of 300 mA. Compared with the tube current of 100 mA for scanning, the ED declined 70%. 
CONCLUSION: When conducting an MSCT scan for orbital trauma, the acquired images using the 100 mA tube current can meet the clinical diagnostic requirements, and the radiation dose to the patients can be decreased.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ji-Wei Wang,Chong Tang and Bo-Rong Pan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ji-Wei Wang,Chong Tang and Bo-Rong Pan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201203022]]></guid><cfi:id>1374</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Analysis of the relationship between postoperative ophthalmic complications and dialysis time of pre-kidney transplantation]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201203023]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the influence of the dialysis time before kidney transplantation on postoperative ophthalmic complications. 
METHODS: One hundred and eighty three patients who were given the follow-up after kidney transplantation were selected, including 124 males and 59 females. The dialysis time before kidney transplantation was (2.9±2.1) years. Among them, there were 93 cases having cadaveric renal transplantation and 90 cases having living relative renal transplantation. The conditions of ophthalmic complications in all the patients after kidney transplantation were investigated and the incidence rate on ophthalmic complications having different dialysis time before kidney transplantation was given Chi-square test and Chi-square linear trend test. 
RESULTS: Among 183 patients with kidney transplantation, 95 patients (51.9%) had at least one ophthalmic complication and the rest 88 patients (48.1%) had no significant abnormality at the eye region. The most common ophthalmic complications were pinguecula/conjunctival degeneration (31 cases), the following was caligo lentis (24 cases). The main manifestations were grayish white granule and plaque turbidity occurred in posterior capsule at the posterior pole of crystaline lens. The angulus iridocornealis of 5 patients (5.3%) with cataract and glaucoma were all open-angle through the detection by gonioscope. Through visual field examination, there were 2 patients with paracentral scotoma, 2 patients with arcuate scotoma and one case with nasal step. 
CONCLUSION: The experiments verify that the incidence of glaucomawas relates to the dialysis time before kidney transplantation, and the incidence rate might be higher if the dialysis time is longer.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yao-Lei Wang,Fan Qi,Jin-Liang Xie,Lin Qi,Cheng Zhou,Xiang-Rong Zhu,Xiang Ding,Bo Yang and Peng Jin]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yao-Lei Wang,Fan Qi,Jin-Liang Xie,Lin Qi,Cheng Zhou,Xiang-Rong Zhu,Xiang Ding,Bo Yang and Peng Jin</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201203023]]></guid><cfi:id>1373</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of silicone oil removal on central corneal thickness]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201203024]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the effect of silicone oil removal(SOR) on central corneal thickness(CCT) in aphakic and pseudophakic eyes prospectively.
METHODS: Patients who underwent SOR surgery between June 2005 - August 2007 were included in this study. Silicon oil was actively removed behind the posterior capsule through the pars plana sclerotomy site (posterior approach) in pseudophakic eyes and through the pupil and the corneal tunnel incision  (anterior approach) in aphakic eyes with the 18-gauge cannula. CCT was assessed with Orbscan II corneal topography system preoperatively and at one month and three months postoperatively. A total of 34 eyes of 34  patients (26 males, 8 females) comprised the study group. Mean age was (55.6±12.3) years (Range: 25-80 years). Twenty-six eyes (76.5%) were pseudophakic and 8 (23.5%) aphakic. Mean time between silicone oil injection and removal was (15.1±13.6) months (Range: 5-54 months). At baseline, CCT was 576.4±46.0μm in pseudophakic eyes and  611.6±36.2μm  in aphakic eyes. 
RESULTS: At the first postoperative month CCT was (573.3±40.1)μm and (630.9±72.9)μm in pseudophakic and aphakic eyes respectively. At the third postoperative month, CCT was (582.7±49.5)μm and (614.5±82.4)μm in pseudophakic and aphakic eyes respectively. There was no statistically significant difference in CCT  measurements one month and 3 months after  SOR when compared to preoperative values in both  aphakic and pseudophakic eyes (P>0.05).   
CONCLUSION: Active SOR either by anterior or posterior approach did not affect the CCT.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Gul Arikan,Zeynep Ozbek,F Hakan Oner,Ismet  Durak and A Osman Saatci]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Gul Arikan,Zeynep Ozbek,F Hakan Oner,Ismet  Durak and A Osman Saatci</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201203024]]></guid><cfi:id>1372</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Low-fluence photodynamic therapy combinations in the treatment of exudative age-related macular degeneration]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201203025]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the efficacy of low-fluence photodynamic therapy (PDT) combinations in the treatment of age-related macular degeneration (AMD).
METHODS: Forty-five previously untreated eyes of 45 patients with exudative AMD whose best-corrected visual acuity (BCVA) was ≥0.3 (Snellen) were enrolled. 15 patients in Group I underwent low-fluence PDT (25J/cm2-300mW/cm2-83sec) and intravitreal pegaptanib combination, 15 patients in Group II underwent PDT (50J/cm2-600mW/cm2-83sec) and intravitreal pegaptanib combination while, 15 patients in Group III underwent intravitreal pegaptanib monotherapy. Complete ophthalmologic examinations were performed in pre and post treatment visits, and the results were statistically analised. A clinical activity score (CAS) was calculated by using changes in lesion size, amount of hemorrhage, staining pattern in FA and OCT measurement of intra/subretinal fluid. ≤ 3 logMAR lines of decrease in BCVA and decrease in CAS were considered as successful treatment.
RESULTS: The mean age of 19 female (42.2%) and 26 male (57.8%) patients was 72.82±8.02 years. Mean follow-up was 13.93±5.87 months. Lesion type was occult in 28 eyes (62.2%). Treatment success rates according to BCVA assessments were 86.7%, 80%, 60% and mean BCVA decrease were 0.3, 1.0, 2.2 logMAR lines in Group I, II and III, respectively (P>0.05). According to the changes in central macular thickness and CAS, no difference was found among the study groups (P=0.850 and P=0.811, respectively). Patients treated with combination regimens had lower intravitreal injection frequencies (P=0.015). 
CONCLUSION: Combination regimen with intravitreal pegaptanib and low-fluence PDT seems to be safe and effective in stabilizing the clinical activity and BCVA in exudative AMD.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Taylan Ozturk,Hakan Oner,Ali Osman Saatci and Suleyman Kaynak]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Taylan Ozturk,Hakan Oner,Ali Osman Saatci and Suleyman Kaynak</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201203025]]></guid><cfi:id>1371</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Outcome of trabeculectomy in hospital Melaka, Malaysia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201203026]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To study the success and outcome of trabeculectomy in Hospital Melaka.
METHODS: Medical records of all patients who underwent trabeculectomy between January 1, 2007 and October 31, 2010 whom were followed up for at least 6 months postoperatively in Hospital Melaka were retrospectively reviewed.
RESULTS: A total number of 117 eyes of 91 patients with the age range between 12 to 84 years underwent primary trabeculectomy (n=20, 17.1%), combine trabeculectomy with cataract surgery (n=90, 76.9%), repeat trabeculectomy (n=5, 4.3%), and combine repeat trabeculectomy with cataract surgery (n=2, 1.7%). The disease spectrum includes primary open-angle glaucoma (POAG) (54 patients, 59.3%), priamry angle-closure glaucoma (PACG) (14 patients, 15.4%), secondary glaucomas (19 patients, 20.9%) and juvenile glaucomas (4 patients, 4.4%). Preoperative mean intraocular pressure (IOP) was (24.69±8.67)mmHg as compared to postoperative mean IOP of (15.81±6.66)mmHg, (15.07±4.72)mmHg and (15.68 ±3.65)mmHg at 6-month, 12-month and 24-month respectively. Eighty-two point one percent of eyes (n=96) achieved complete success (CS), 12.8% (n=15) with qualified success (QS) and only 5.1% (n=6) failed at 6 month with two of them warrant other filtering surgery. At twelve months, trabeculectomy with CS was 71.6% (n=63), QS in 22.7% (n=20) and failure in 5.7% (n=5).  Sixty-seven point five percent (n=27) attained CS, 20.0% (n=8) with QS while 12.5% (n=5) failed at 24 month postoperative.
CONCLUSION: As the understanding of the lower the IOP, the better the patients retaining the visual function, trabeculectomy is significantly a choice of treatment in uncontrolled glaucoma. This study concluded that trabeculectomy performed in Hospital Melaka has produced significant success as compared to other studies.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Moon Heng Hah,,Raja Norliza Raja Omar,Juliana Jalaluddin,Nor Fadzillah Abd Jalil and Anusiah Selvathurai]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Moon Heng Hah,,Raja Norliza Raja Omar,Juliana Jalaluddin,Nor Fadzillah Abd Jalil and Anusiah Selvathurai</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201203026]]></guid><cfi:id>1370</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Hyaluronidase in sub-Tenon's anesthesia for phacoemulsification, a double-blind randomized clinical trial]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201203027]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the effect of hyaluronidase use on the quality of sub-Tenon's anaesthesia for phacoemulsification.
METHODS: This was a randomized, double-blind clinical trial which was conducted at Nikookari Eye Hospital for 5 months. Forty-two eyes of candidates for phacoemulsification under sub-Tenon's anaesthesia were randomly allocated to two equal groups and received either 2 mL of lidocaine 2% solution  with (LH), or without (L) addition of hyaluronidase (150IU/mL). Akinesia was assessed 15 minutes after sub-Tenon’s injection. Patients and surgeon’s satisfaction, as well as the postoperative pain (the visual analogue scale, VAS) were investigated after operation. The contingency tables (including the Chi-square or Fisher's exact tests, when appropriate) and parametric analysis (the independent samples t test) were used for statistical analysis.
RESULTS: Complete akinesia (33.3% vs 4.8%, P=0.04), as well as the patients (85.7% vs 57.1%, P=0.04) and surgeon’s satisfaction (87.5% vs 52.4%, P=0.02) were significantly more frequent in LH than in L group. The mean VAS was significantly lower in the same group (1.90±1.45 vs 3.00±1.55, P=0.04).
CONCLUSION: Addition of hyaluronidase to lidocaine solution for sub-Tenon's anesthesia significantly improves the ocular akinesia, enhances the intra-operative patients and surgeons' satisfaction, and attenuates the postoperative pain.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mohammadreza Sedghipour,Ali Mahdavifard,Rohollah Fadaei Fouladi,Davoud Gharabaghi,Mohammadbagher Rahbani,Ghasem Amiraslanzadeh and Mohammadreza Afhami]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mohammadreza Sedghipour,Ali Mahdavifard,Rohollah Fadaei Fouladi,Davoud Gharabaghi,Mohammadbagher Rahbani,Ghasem Amiraslanzadeh and Mohammadreza Afhami</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201203027]]></guid><cfi:id>1369</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Sensory-neural hearing loss in pseudoexfoliation syndrome]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201203028]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate relationship between ocular pseudoexfoliation syndrome(PXF) and sensory-neural hearing loss (SNHL). 
METHODS: This prospective case-control study was designed on patients who referred to a general ophthalmic clinic at Imam Khomeini Medical Center, Urmia, Iran (March 2010 through November 2010). On routine ophthalmic examination, patients diagnosed with ocular PXF were referred to the ENT department and, selected cases (after evaluating inclusion and exclusion criteria) were referred to Audiometric Department. Pure tone hearing threshold level(HTL) was measured at 1, 2, 3 kHz for each ear and was compared with International Standard (ISO 7029) median age associated hearing loss at 1, 2, 3 kHz (AAHL).
RESULTS : Overall 21 of 50 patients (42.0%) had a higher HTL than the ISO 7029 median AAHL at 1, 2 and 3kHz, which included 14 ears of 9 patients in the male group and 21 ears of 12 patients in the female group. Approximately 12.0% of patients had glaucoma at the same time, however; no significant correlation was found in SNHL prevalence and severity between PXF patient and patients with simultaneous glaucoma. SNHL was more common in patients with ocular PXF compared to their age- sex matched controls (P <0.05).
CONCLUSION: Most of patients with ocular PXF had SNHL compared to their age-sex matched controls, which could be due to PXF fibrils in the inner ear. These findings suggest PXF could be a systemic disease.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Vafa Samarai,Reza Samarei,Negar Haghighi and Elnaz Jalili]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Vafa Samarai,Reza Samarei,Negar Haghighi and Elnaz Jalili</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201203028]]></guid><cfi:id>1368</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical features of ankylosing spondylitis associated with acute anterior uveitis in Chinese patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201202009]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To characterize the clinical features, diagnosis, treatment and prognosis of uveitis associated with ankylosing spondylitis (AS) in Chinese patients. 
 METHODS: Two hundred and three patients with uveitis associated with AS followed-up in the Third Military Medical University Daping Hospital between 2005 and 2010 were retrospectively evaluated in this study. Complete ophthalmological examinations were evaluated at baseline and during the follow-up period. The gender, age, follow-up time, mean frequency of uveitis onset, and accompanying eye examination findings, history, demographical parameters were reviewed. All the patients presented complete clinical and radiologic (sacroiliac, lumbar, dorsal and cervical spine, knee, ankle, shoulder, hip, elbow) evaluation. HLA-B27 typing was also searched. 
RESULTS: There were 203 patients diagnosed with AS associated uveitis. All showed sacroiliac X-ray changes indicative of AS. There were 184 male and 19 female patients. The average age of patients was 35±12 (range 18–50).  Mean follow-up period was 2.4 years (1-5 years). Acute anterior uveitis was the most common type of uveitis in both genders. 121 eyes presented unilateral involvement (55.2%), and 92 eyes presented bilateral involvement (45.3%) with onset alternately. 22 eyes occurred hypopyon, 16 eyes were found anterior vitreous cells, 7 eyes were noted reactive macular edema or exudation, 29 eyes presented posterior synechiae of iris, and 14 eyes presented cataract, 9 eyes presented secondary glaucoma, 2 eyes presented bend corneal degeneration and 1 eyes presented atrophy of eyeball. At the final visit, uveitis was well controlled in most patients.
CONCLUSION: AS associated with uveitis in Chinese patients mainly manifests as acute anterior uveitis. A combination of corticosteroids with other mydriasis agents is effective for most AS associated with uveitis patients. In general, the prognosis is good in these cases.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Shu-Xing Ji,Xiao-Lei Yin,Rong-Di Yuan,Zheng Zheng,Yan Huo and Huan Zou]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Shu-Xing Ji,Xiao-Lei Yin,Rong-Di Yuan,Zheng Zheng,Yan Huo and Huan Zou</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201202009]]></guid><cfi:id>1367</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Implantation of Iakymenko keratoprosthesis in patients with severe ocular injury]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201202010]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To present the results of implantation of Iakymenko keratoprosthesis in five patients with vascularized corneal leukoma caused by severe ocular injury.
 METHODS: Iakymenko keratoprosthesis was implanted into 5 eyes of 5 patients: 4 patients were suffered from chemical burns and 1 patient from explosive injury. The preoperative visual acuity ranged from light perception to hand motion. The implantation surgery was composed of two-stage procedures. The follow-up period was from 9 months to 11 years. The outcome measures were visual acuity, retention, and complications of the keratoprosthesis.
RESULTS: Vision improvements were achieved in most patients. All keratoprosthesis were retained within the follow-up period. Corneal melting occurred in one patient and fibrous closure in another patient, both of which were successfully treated. Retinal detachment occurred in one patient after surgery.
 CONCLUSION: Iakymenko keratoprosthesis seems to be a promising alternative for the patients with severe corneal injury, but further investigation is needed to evaluate the role of Iakymenko keratoprosthesis.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hong-Wei Pan,Stanislav Iakymenko,Jin-Tang Xu,Guang-Hui Hou,Bing-Ji Sun and A-Ning Zheng]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hong-Wei Pan,Stanislav Iakymenko,Jin-Tang Xu,Guang-Hui Hou,Bing-Ji Sun and A-Ning Zheng</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201202010]]></guid><cfi:id>1366</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Characteristics of the macula in amblyopic eyes by optical coherence tomography]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201202011]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To test the hypothesis that amblyopic neuroretina may have an altered thickness when compared to the normal.
METHODS: Twenty-five amblyopic, young patients between the ages of 7 and 11 years old were studied. The interested neuroretina areas are defined into 10 sub-regions according to superior-inferior, nasal-temoral, and peri-para axis, which cross the fovela structure. The thicknesses of ten, defined macular regions were separately measured by optical coherence tomography (OCT) and analyzed by t-test. 
RESULTS: The average thickness of neuroretina in the exact foveola of the amblyopic eyes is larger than that of normal eyes (P<0.05), but the other nine regions have no significant difference. Interestingly, in both the normal and amblyopic eyes, the temporal area looks thinner than other quadrants (P<0.05).
 CONCLUSION: Thickness alteration may be associated with amblyopic disorders in young patients. Studying a larger volume of subjects of similar age is required to confirm this observation.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xin-Mei Wang,Dong-Mei Cui,Ling Zhen,Xiao Yang,Li-Jun Huo,Xing Liu and Jun-Wen Zeng]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xin-Mei Wang,Dong-Mei Cui,Ling Zhen,Xiao Yang,Li-Jun Huo,Xing Liu and Jun-Wen Zeng</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201202011]]></guid><cfi:id>1365</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A survey of high risk factors affecting retinopathy in full-term infants in China]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201202012]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the possible relationship between the influencing factors occurring before and during birth in full-term infants and the outcome of retinopathy.
METHODS: Totally 816 full-term infants admitted in the neonate intensive unit of Boai Hospital of Zhongshan between 1 May, 2008 and 30 June, 2011 were included in the study. Fundus examination was performed and evaluated individually on them at the age of 48 hours after delivery, 2 weeks and 1 month. Some possible risk factors happening prenatally or during delivery such as pregnant related hypertension, placenta previa, placental abruption etc, as well as some neonatal risk factors such as neonatal asphyxia, hypoxic-ischemic encephalopathy (HIE), low birth weight etc, were recorded and evacuated. Then the effect of the risk factors of full-term infants on retinopathy was studied.
RESULTS: The incidence of retinal hemorrhage of full-term infants with prenatal pregnant related hypertension (PRH) of the mother (43.6%) was significantly higher than that of full-term infants without (8.0%). (P<0.001). The incidence of retinal hemorrhage of full-term infants with neonatal asphyxia and /or hypoxic-ischemic encephalopathy (HIE)(29.3%) was significantly higher than that of those without (15.7%), but correlation was not found between the severity of retina hemorrhage and the degree of hypoxic disease. A pale color of optic disc was associated with a low birth weight of full-term infant. Full-term infants with birth weigh less than 2500g had a significant higher incidence of retinopathy than those with birth weight equal or more than 2500g ( P<0.001).  
CONCLUSION: The main influencing factors which lead to retinopathy of high risk full-term infants are prenatal factors such as PRH, and some neonatal risk factors such as asphyxia, hypoxic-ischemic encephalopathy, and low birth weight.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Li-Na Chen,Xiao-Ping He and Li-Ping Huang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Li-Na Chen,Xiao-Ping He and Li-Ping Huang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201202012]]></guid><cfi:id>1364</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A technique for periorbital syringomas: intralesional radiofrequency ablation]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201202013]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the efficacy of intralesional radiofrequency ablation in the treatment of periorbital syringomas. 
 METHODS: We tried the intralesional radiofrequency ablation for 64 patients with periorbital syringomas from 2007 to 2011. The operation was performed under 2.5 loupe magnifications. The handpiece was assembled with a needle electrode and connected to the radiofrequency ablation apparatus. The electrode was then inserted into the target lesions in dermis and delivering injury to the base of these tumors. Results were assessed clinically by comparing pre- and post-treatment photographs and patient satisfaction rates. 
 RESULTS: Clinical improvement increased with each subsequent treatment session. The percent of patients whose clinic improvement grade were≥3 after each session was respectively 71.9%(Session1), 83.3%(Session2), and 100%(Session3). The statistical results indicated the concordance of the clinical assessment and the satisfaction level of patients (kappa=0.78 of the session1; kappa=0.82 of the session2). The majority of patients had good or excellent cosmetic results. Postoperatively, there were no permanent side effects or recurrences.
 CONCLUSION: As a new technique of minimally invasion, the intralesional radiofrequency ablation was found to be an effective, inexpensive, highly precise and safe way of treating periorbital syringomas.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Li-Ping Huang,Leng Zhang,Xing-Lin Wang,Xiao-Cui Liu,Tian-Yu Jiang and Bi-Weng Lin]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Li-Ping Huang,Leng Zhang,Xing-Lin Wang,Xiao-Cui Liu,Tian-Yu Jiang and Bi-Weng Lin</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201202013]]></guid><cfi:id>1363</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Corneal endothelial cell density and morphology in Chinese patients with pseudoexfoliation syndrome]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201202014]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the corneal endothelial cell density and morphology in Chinese patients with pseudoexfoliation syndrome (PEX).
 METHODS: Medical records of 16 patients (20 eyes) with PEX who presented to our institution between July 2008 and June 2010 were retrospectively reviewed. Thirteen eyes had combined glaucoma. The information of five apparently normal fellow eyes in these patients was also recorded. Left eyes of 20 patients with bilateral senile cataracts but no other eye disease were included as controls. Specular microscopy was performed in all eyes to analyze for corneal endothelial cell density and morphology. Cell density, coefficient of variation in cell size, and percentage of hexagonal cells in corneal endothelium were evaluated. 
RESULTS: The mean corneal endothelial cell density in the PEX eyes was 2298±239 cells/mm<sup>2</sup>, significantly lower than that in the cataract eyes (2652±18 cells/mm<sup>2</sup>, P=0.026), but there were no significant differences in coefficient of variation of cell size and frequency of hexagonality between these two groups. No significant differences in the three parameters were found between the apparently normal fellow eyes and the PEX eyes or the cataract eyes, or between the PEX eyes with and without glaucoma.
 CONCLUSION: Corneal endothelial cell density may decrease in Chinese patients with PEX. The development of glaucoma in PEX eyes does not seem to be related with the change in corneal endothelial cell density or morphology.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Meng Wang,Wei Sun,Liang Ying and Xiao-Guang Dong]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Meng Wang,Wei Sun,Liang Ying and Xiao-Guang Dong</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201202014]]></guid><cfi:id>1362</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Corneal collagen crosslinking for corneal ectasia of post-LASIK: one-year results]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201202015]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the efficacy and safety of corneal collagen crosslinking (CXL) to prevent the progression of post-laser in situ keratomileusis (LASIK) corneal ectasia. 
 METHODS: In a prospective, nonrandomized, single-centre study, CXL was performed in 20 eyes of 11 patients who had LASIK for myopic astigmatism and subsequently developed keratectasia.The procedure included instillation of 0.1% riboflavin-20% dextrane solution 30 minutes before UVA irradiation and every 5 minutes for an additional 30 minutes during irradiation. The eyes were evaluated preoperatively and at 1-, 3-, 6-, and 12-month intervals. The complete ophthalmologic examination comprised uncorrected visual acuity, best spectacle-corrected visual acuity, endothelial cell count, ultrasound pachymetry, corneal topography, and in vivo confocal microscopy.
RESULTS: CXL appeared to stabilise or partially reverse the progression of post-LASIK corneal ectasia without apparent complication in our cohort. UCVA and BCVA improvements were statistically significant(P＜0.05) beyond 12 months after surgery (improvement of 0.07 and 0.13 logMAR at 1 year, respectively). Mean baseline flattest meridian keratometry and mean steepest meridian keratometry reduction (improvement of 2.00 and 1.50 diopters(D), respectively) were statistically significant (P＜0.05) at 12 months postoperatively. At 1 year after CXL, mean endothelial cell count did not deteriorate. Mean thinnest cornea pachymetry increased significantly.
 CONCLUSION: The results of the study showed a long-term stability of post-LASIK corneal ectasia after crosslinking without relevant side effects. It seems to be a safe and promising procedure to stop the progression of post-LASIK keratectasia, thereby avoiding or delaying keratoplasty.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Gang Li,Zheng-Jun Fan and Xiu-Jun Peng]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Gang Li,Zheng-Jun Fan and Xiu-Jun Peng</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201202015]]></guid><cfi:id>1361</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Analysis of the optical quality by determining the modulation transfer function for anterior corneal surface in myopes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201202016]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To describe the characteristics of modulation transfer function (MTF) of anterior corneal surface, and obtain the the normal reference range of MTF at different spatial frequencies and optical zones of the anterior corneal surface in myopes. 
 METHODS: Four hundred eyes from 200 patients were examined under SIRIUS corneal topography system. Phoenis analysis software was applied to simulate the MTF curves of anterior corneal surface at vertical and horizontal meridians at the 3, 4, 5 , 6, 7mm optical zones of cornea .The MTF values at spatial frequencies of 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55 and 60 cycles/degree (c/d) were selected.
 RESULTS: The MTF curve of anterior corneal surface decreased rapidly from low to intermediate frequency (0-15cpd) at various optical zones of cornea, the value decreased to 0 slowly at higher frequency (>15cpd). With the increase of the optical zones of cornea, MTF curve decreased gradually. 3) In the range of 3 mm- 6 mm optical zones of the cornea, the MTF values measured at horizontal meridian were greater than the corresponding values at horizontal meridian of each spatial frequency, the difference was statistically significant (P<0.05). At 7 mm optical zones of cornea, the MTF values measured at horizontal meridian were less than the corresponding values at vertical meridian at 10-60 spatial frequencies(cpd), and the difference was statistically significant in 25, 30, 35, 40, 45, 50 cpd (P<0.05). 
 CONCLUSION: MTF can be used to describe the imaging quality of optical systems at anterior corneal surface objectively in detail.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yan-Zhen Zheng,Yan-Peng Chen,Yan Qiu,Guo-Guang Zhai and Yao-Yu Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yan-Zhen Zheng,Yan-Peng Chen,Yan Qiu,Guo-Guang Zhai and Yao-Yu Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201202016]]></guid><cfi:id>1360</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Different expression pattern of serum soluble intercellular adhesion molecules-1 and neutrophilic expression of CD18 in patients with diabetic retinopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201202017]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the levels of serum soluble intercellular adhesion molecules-1(sICAM-1) and neutrophilic expression of CD18 in patients with various stages of diabetic retinopathy and to determine their different expression pattern in the development of diabetic retinopathy(DR).
 METHODS: Levels of serum sICAM-1 and CD18 on the surface of neutrophile were measured in 41 DR patients, they were classified in three subgroups according to the stage of retinopathy as determined by fund’s ophthalmoscopy; 10 control subjects were also studied. sICAM-1 were measured by enzyme-linked immunosorbent assay and CD18 by flow cytometry. 
 RESULTS: The neutrophilic CD18 expression and serum sICAM-1 level were all significantly elevated in all diabetic subgroups compared to control subjects (P<0.01). The differences of CD18 and sICAM-1 among the diabetic subgroups were significant in CD18 but not in sICAM-1. The progression of retinopathy was associated with an increase both in CD18 and in sICAM-1 levels by simple correlation analysis (β=0.74, P<0.001; β=0.38, P<0.01, respectively). But stepwise multiple regression analysis revealed that only CD18 was independent determinant of retinopathy (β=1.04, P<0.01). 
 CONCLUSION: Our results confirm the contribution of endothelial and neutrophilic activation in the development of DR as indicated by increased levels of CD18 and sICAM-1. However, a direct implication of CD18 and ICAM-1 in the progression of DR can be supported only in the CD18 but not ICAM-1. CD18 and  ICAM-1 may play different role in the development of diabetic retinopathy.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hua Ai and Hu-Ping Song]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hua Ai and Hu-Ping Song</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201202017]]></guid><cfi:id>1359</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Space-occupying lesions of the lacrimal gland at one tertiary eye center in China: a retrospective clinical study of 95 patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201202018]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the treatment status and prognosis of space-occupying lacrimal gland lesions at one tertiary eye center in China. 
 METHODS: A retrospective clinical study was performed on 95 patients with space-occupying lesions of the lacrimal gland surgically treated at the Eye & ENT Hospital of Fudan University from 2003 to 2007. The reviewed clinical data included age, gender, side of the lesion, duration of signs and symptoms, histopathological diagnosis, treatment modality, recurrence (local, regional, and distant metastasis) and survival.
 RESULTS: Of the 95 cases (99 eyes), pleomorphic adenomas were the most common lesions (43 cases), followed by lymphoid disorders (14), inflammatory pseudotumors (11), carcinoma ex-pleomorphic adenomas (11), and adenoid cystic carcinomas (ACC, 6). There were 8 patients with relapsed pleomorphic adenomas. Five of these 8 cases had malignant pathological changes. All patients with ACC had metastasis and three of them died during their follow-up. 
 CONCLUSION: Our study indicated that the most common lacrimal gland lesions were pleomorphic adenomas. Multiple recurrence and surgical procedures may increase the risk of tumor progression. ACC had a high incidence of tumor metastasis and a poor prognosis.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xiang-Ning Wang,Jiang Qian,Yi-Fei Yuan,Rui Zhang and Yan-Qing Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiang-Ning Wang,Jiang Qian,Yi-Fei Yuan,Rui Zhang and Yan-Qing Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201202018]]></guid><cfi:id>1358</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Transcranial surgery through pterional approach for removal of cranio-orbital tumors by an interdisciplinary team of nurosurgeons and ophthalmologists]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201202019]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the specialty of transcranial surgery through pterional approach for removal of cranio-orbital tumors, introduce the ophthalmological experiences of entering the orbit to reduce the incidence rate of associated complications of this operation.
 METHODS: We performed a retrospective analysis of a series of 37 cases involving patients who underwent transcranial surgery through pterional approach for treatment of cranio-orbital tumors in our department in the past 8 years. Pterion approach craniotomy was performed to all patients. After removing tumors in the skull by the neurosurgeon, ophthalmologist removed tumors in orbit. We took measures below to decrease complications, including grounding optic canal through an abrasive drilling when necessary, hanging various extraocular muscles to be exposed for protection, refrigerating by refrigeration heads to remove tumors, at last sewing up orbit septum after surgery.
? RESULTS: Tumors were removed completely in 32 cases, and incomplete in 5 cases due to extensive invasion into the cavernous sinus or sphenoid sinus. Of all the cases, benign tumors were demonstrated in 28 cases (75.6%, 28/37) and malignant in 9(24.3%, 9/37). The most common lesion type was meningioma in 11 cases (29.7%, 11/37). Extraocular muscles (EOM) impairment, occurring in 21 cases (56.7%, 21/37), was the most frequent postoperative complication. The most serious consequence was vision loss occurred in 4 cases (10.8%, 4/37). Other complications, such as 11 cases of transient blepharoptosis 29.7%(11/37), 5 cases of mydriasis in 13.5% (5/7); 2 cases of cerebrospinal rhinorrhea in 5.4% (2/37). 
 CONCLUSION: Cranio-orbital tumors can be removed completely using transcranial approach, and the pterional approach offers excellent exposure. Cooperation of interdisciplinary team of neurosurgeons and ophthalmologists conduces to full use of respective professional advantages. The experience of ophthalmic operation technology can decrease occurrence of ocular complications after surgery.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yan Liu,Jiang-Rong Ma and Xue-Liang Xu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yan Liu,Jiang-Rong Ma and Xue-Liang Xu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201202019]]></guid><cfi:id>1357</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Is laser photocoagulation still effective in diabetic macular edema? Assessment with optical coherence tomography in Nepal]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201202020]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To find out the outcome of laser photocoagulation in clinically significant macular edema (CSME) by optical coherence tomography (OCT)
 METHODS: It was a prospective, non-controlled, case series study enrolling 81 eyes of 64 patients with CSME between August 2008 and January 2010. All patients received modified grid photocoagulation with frequency doubled Nd: YAG laser. Each patient was evaluated in terms of best-corrected visual acuity (BCVA) and regression or progression of maculopathy after laser therapy at 1, 3 and 6 months. Spearman’s correlation test was used to show the correlation between BCVA and total macular volume (TMV). Analysis of variance (ANOVA) was used to compare among groups and independent t-test was used to compare in each group. 
 RESULTS: There is high correlation between BCVA and TMV (P≤0.001). BCVA improved in 50.6 %, remained static in 39.5% and deteriorated in 9.9% patients after 6 month of treatment.  The Baseline TMV (mean and SD) were 9.26±1.83, 10.4±2.38), 11.5±3.05), 8.89±0.75 and 9.47±1.98mm3 for different OCT patterns, ST (sponge like thickening), CMO (cystoid macular edema), SFD (subfoveal detachment), VMIA (Vitreo macular interface abnormality) and average TMV respectively (P=0.04). After 6 months of laser treatment, the mean TMV decreased from 9.47±1.98mm<sup>3</sup> to 8.77±1.31mm<sup>3</sup> (P=0.01). In ST there was significant decrease in TMV, P=0.01, Further within these groups at 6 months, they were significantly different, P=0.01. 
 CONCLUSION: OCT showed the different morphological variant of CSME while the response of treatment is different. TMV decreased the most and hence showed the improvement in vision after 6 months of laser treatment. In the era of Anti vascular endothelial growth factors (VEGFs), efficacy of laser seems to be in shadow but it is still first line of treatment in developing nation like Nepal where antiVEGFs may not be easily available and affordable.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Arjun Shrestha,Deepak Khadka,Angira Karmacharya,Nhukesh Maharjan,Anand Shrestha,Raba Thapa and Govinda Poudyal]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Arjun Shrestha,Deepak Khadka,Angira Karmacharya,Nhukesh Maharjan,Anand Shrestha,Raba Thapa and Govinda Poudyal</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201202020]]></guid><cfi:id>1356</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Ocular higher-order aberrations and mesopic pupil size in individuals screened for refractive surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201202021]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To study the distribution of ocular higher-order aberrations(HOAs) and mesopic pupil size in individuals screened for refractive surgery.
 METHODS: Ocular HOAs and mesopic pupil size were studied in 2 458 eyes of 1 240 patients with myopia, myopic astigmatism and compound myopic astigmatism and 215 eyes of 110 patients with hyperopia, hyperopic astigmatism and compound hyperopic astigmatism using the Zywave aberrometer (Busch& Lomb). All patients had correctable refractive errors without a history of refractive surgery or underlying diseases. Root-mean-square values of HOAs, total spherical aberration, total coma and mesopic pupil size were analyzed. Ocular HOAs were measured across a ≥ 6.0 mm pupil, and pupil size measurements were performed under the mesopic condition. 
 RESULTS: The mean values of HOAs, total spherical aberration and total coma in the myopic group were 0.369μm, ±0.233, 0.133± 0.112μm and 0.330±0.188μm, respectively. In the hyperopic group the mean values of HOAs, total spherical aberration and total coma were 0.418μm ±0.214, 0.202±0.209μm and 0.343±0.201μm, respectively. Hyperopes showed greater total HOAs (P<0.01) and total spherical aberration (P<0.01) compared to myopes. In age-matched analysis, only the amount of total spherical aberration was higher in the hyperopic group (P=0.05). Mesopic pupil size in the myopic group was larger (P≤0.05). 
 CONCLUSION: The results suggested that significant levels of HOAs were found in both groups which are important for planning refractive surgeries on Iranians. There were significantly higher levels of total spherical aberration in hyperopes compared to myopes. Mesopic pupil size was larger in myopic group.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Seyed Javad Hashemian,Mohammad Soleimani,Alireza Foroutan,Mahmood Joshaghani,Mohammad Jafar Ghaempanah,Mohammad Ebrahim Jafari and Mehdi Yaseri]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Seyed Javad Hashemian,Mohammad Soleimani,Alireza Foroutan,Mahmood Joshaghani,Mohammad Jafar Ghaempanah,Mohammad Ebrahim Jafari and Mehdi Yaseri</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201202021]]></guid><cfi:id>1355</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Primary 23-gauge vitreoretinal surgery for rhegmatogenous retinal detachment]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201202022]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report the effectiveness and safety of primary 23-Gauge (G) vitreoretinal surgery for rhegmatogenous retinal detachment (RRD).
 METHODS: In this retrospective study, 49 eyes of 49 consecutive patients who underwent primary 23-G transconjunctival sutureless vitrectomy (TSV) for RRD between January 2007 and July 2009 at our institution were evaluated. 
 RESULTS: Mean follow-up time was 8.9±7.7 months (1-28 months). Retinal reattachment was achieved with a single operation in 47(95.9%) of 49 eyes. In two eyes (4.1%), retinal redetachment due to new breaks was successfully treated with reoperation using the 23-G TSV system. Mean logMAR visual acuity was 2.01±0.47 preoperatively and 1.3±0.5 postoperatively (P<0.001, Paired t-test). Mean preoperative intraocular pressure (IOP) was 14.1±2.8mmHg. Mean postoperative IOP was 12.3±3.6mmHg at 1 day, 13.1±2.1mmHg at 1 week, 14.3±2.2mmHg at 1 month. Iatrogenic peripheral retinal break was observed in 1 eye (2.0%) intraoperatively. No sutures were required to close the scleral or conjunctival openings, and no eyes required convertion of surgery to 20-G vitrectomy. 
 CONCLUSION: Primary 23-G TSV system was observed to be effective and safe in the treatment of RRD.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ates Yanyali,Gokhan Celik,Alper Dincyildiz,Fatih Horozoglu and Ahmet F. Nohutcu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ates Yanyali,Gokhan Celik,Alper Dincyildiz,Fatih Horozoglu and Ahmet F. Nohutcu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201202022]]></guid><cfi:id>1354</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Role of Mediterranean diet, tropical vegetables rich in antioxidants, and sunlight exposure in blindness, cataract and glaucoma among African type 2 diabetics]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201202023]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess whether regular Mediterranean diet and regular intake of vegetables may reduce the risk of blindness, cataract, and glaucoma in these type 2 diabetics.
 METHODS: A cross-sectional design was carried out among known black diabetics admitted at the diabetic clinics of Kinshasa, between October 2008 and March 2009. The Mediterranean-style dietary score (MSDPS) was used to characterize a Mediterranean-style dietary pattern in the study population using the Harvard semi quantitative FFQ adapted for Africa.
 RESULTS: Five hundred Type 2 diabetic patients were included in this study (48% of males; 40% aged ≥60 years). There was a significant association between blindness, cataract and aging; between blindness (P<0.05), cataract (P<0.05), glaucoma (P<0.05), and physical inactivity; between blindness (P<0.05), cataract (P<0.0001), glaucoma (P<0.01) and high SES, and a very significant association between blindness (P<0.0001), cataract (P<0.0001), glaucoma (P<0.0001) and exposure to sunlight. There was also a significant association between blindness, glaucoma, and male sex. Regular intake of Mediterranean diet, Brassica Rapa, beans, Abelmoschus, Musa acuminata reduced significantly the risk of blindness, cataract and glaucoma.
 CONCLUSION: Regular intake of Mediterranean diet, Brassica Rapa, beans, Abelmoschus, and Musa acuminata may significantly reduce the risk of blindness or its major causes among type 2 diabetes mellitus in Africa.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mvitu Muaka Mo&#239;se, Longo-Mbenza Benjamin, Tulomba Mona Doris, Kibokela Ndembe Dalida and Nge Okwe Augustin]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mvitu Muaka Mo&#239;se, Longo-Mbenza Benjamin, Tulomba Mona Doris, Kibokela Ndembe Dalida and Nge Okwe Augustin</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201202023]]></guid><cfi:id>1353</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Outcomes of revision external dacryocystorhinostomy and nasal intubation by bicanalicular silicone tubing under endonasal endoscopic guidance]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201202024]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the long-term treatment outcomes in patients who underwent revision of external dacryocystorhinostomy (DCR) and nasal intubation by bicanalicular silicone tubing (BSTI) under endonasal endoscopic guidance. 
 METHODS: Data from 28 patients with recurrent dacryocystitis were retrospectively reviewed. Revision external DCR and bicanalicular nasal intubation by silicone tubing under endonasal endoscopic guidance was performed in 28 eyes of 28 patients. The patients were evaluated with respect to the reason of recurrence, time to recurrence, time to revision, duration of follow-up and surgical success.
RESULTS: Endoscopic endonasal examination detected an osteotomy-side obstruction by the excessive granulation tissue in 24 patients (86%), nasal septal deviation in three patients (10%) and nasal polyp in one patient (4%). Recurrence occurred after a mean duration of 5.3±3.7 months following the first operation. The mean time between the first DCR operation and the revision DCR was 11.5 ± 9.3 months. After a mean follow-up of 14.9±7.8 months, the rate of anatomic success alone was 85% (24/28); the rate of subjective success was 78% (22/28).  CONCLUSION: Revision external DCR and bicanalicular nasal intubation by silicone tubing under endonasal endoscopic guidance can be recommended in patients with recurrent dacryocystitis as a surgical approach that achieves satisfactory objective and subjective success rates.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[&#350;eyhmus Ari, Abdullah Kür&#351;at Cingü, Alparslan &#350;ahin, Ramazan Gün, Vefa Kini&#351; and &#304;hsan &#199;a&#231;a]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>&#350;eyhmus Ari, Abdullah Kür&#351;at Cingü, Alparslan &#350;ahin, Ramazan Gün, Vefa Kini&#351; and &#304;hsan &#199;a&#231;a</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201202024]]></guid><cfi:id>1352</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Corneal flap morphological analysis using anterior segment optical coherence tomography in laser in situ keratomileusis with femtosecond lasers versus mechanical microkeratome]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201201014]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess and compare the flap morphology using anterior segment optical coherence tomography (AS-OCT) in laser in situ keratomileusis(LASIK) with Femto LDV femtosecond lasers versus Hansatome mechanical Microkeratome.
METHODS: AS-OCT (Visante) was used to compare 1 month postoperatively the morphology of the flaps created with Femto LDV femtosecond lasers or Hansatome Microkeratome. The intended ?ap thickness was 110μm and 160μm respectively. The thickness of twenty-five points across each flap, which were 0mm, 1.5mm, 2.5mm, and 3.5mm to the corneal vertex on the horizontal, vertical, 45° and 135° meridian respectively, was evaluated. 
RESULTS: One month postoperative, the central flap thickness in the Femto LDV group was 107.43±4.70μm, while 125.90±17.50μm in the Hansatome group. The difference between the actual and the expected ?ap thickness was 5.61±3.84μm and 31.52±12.27μm, respectively. The Hansatome group had presented a statistically signi?cant result (P﹤0.001). Flap morphology showed a more regular planar shape in the Femto LDV group and a meniscus shape in the Hansatome group. 
CONCLUSION: AS-OCT is a direct and fast procedure to assess the flap morphology. The morphology by AS-OCT showed that the flaps created with Femto LDV femtosecond laser were more accurate and regular than the flaps created with Hansatome microkeratome. 
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xiao-Xiao Zhang,Xing-Wu Zhong,Jun-Shu Wu,Zheng Wang,Ke-Ming Yu,Quan Liu and Bin Yang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiao-Xiao Zhang,Xing-Wu Zhong,Jun-Shu Wu,Zheng Wang,Ke-Ming Yu,Quan Liu and Bin Yang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201201014]]></guid><cfi:id>1351</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical analysis of tear film after lamellar keratoplasty]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201201015]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To study the tear film stability after lamellar keratoplasty. 
METHODS: Five female and eight male patients with lamellar keratoconus, aged from 18 to 32, were involved. After lamellar keratoplasty, SchirmerⅠtest(SⅠt), tear break-up time(BUT) test, fluorescein staining test were used to judge the effect of the surgery at different time point. 
RESULTS: The SⅠt were greatly increased in 7 days post operation (11.86±2.28 -25.14±1.97, 19.86±1.61) (P<0.05), there is no significant difference between 2nd month, 3rd month post-operative and pre-operation (11.86±2.28 - 14.57±1.48, 8.14±0.86) (P>0.05). The mean break-up time decreased in 7 days post operation (5.00±1.31 - 2.71±0.18, 2.57±0.20, 2.71±0.36, 2.43±0.20)(P<0.05). The mean scores of fluorescence increased post-operatively (0.14±0.14 - 8.00±0.00, 8.00±0.00, 8.00±0.00, 7.57±0.20) (P <0.01).
CONCLUSION: Lamellar keratoplaty influence the tear film stability, artificial tears and improving corneal epithelium cured medicine should be used after surgery.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Wan-Rong Huang,Qiu-Lian Chen,Jin-Hong Cai and Yue Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Wan-Rong Huang,Qiu-Lian Chen,Jin-Hong Cai and Yue Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201201015]]></guid><cfi:id>1350</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical evaluation of two multifocal intraocular lens implantation patterns]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201201016]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the visual outcomes and patient satisfaction of two multifocal intraocular lens implantation patterns, with the decision between the two patterns being guided by the patients’ choice of visual zones that best suited their lifestyle, or lifestyle zones. 
METHODS: This is a prospective non-randomized comparative study. The lifestyle zones of 32 consecutive age-related cataract patients (64 eyes) were investigated individually to guide the surgical decision between two multifocal intraocular lens implantation patterns. The first group (MIX) received a combined implantation of a ReZoom NXG1 lens in the dominant eye and a Tecnis ZM900 lens in the other eye. The second group (MATCH) received bilateral ReZoom NXG1 lenses. One year postoperatively, the patients were assessed for binocular uncorrected visual acuity, reading visual acuity, reading speed and depth of focus under different luminance and were surveyed for visual disturbances, satisfaction and complete spectacle independence. 
RESULTS: According to the determination of lifestyle zones, 18 and 14 patients were included in the MIX and MATCH groups, respectively. One year postoperatively, each of the patients exhibited positive visual outcomes and lifestyle satisfaction, although there were still some differences between the two groups. Generally, patients in the MATCH group had better distance visual acuity than those in the MIX group. In contrast, patients in the MIX group had better near visual acuity, better reading acuity and better reading speed than those in the MATCH group. Between the two groups, there was no clear difference in intermediate visual acuity, and the depths of focus between the two groups were approximately equal. The results of the mean NEI-RQL-42 questionnaire score, overall satisfaction, and complete spectacle independence did not differ between the two groups. 
CONCLUSION: Different multifocal intraocular lenses implantation patterns can have differing advantages and disadvantages; however, the best results with respect to visual outcome and patient satisfaction can be achieved by taking individual lifestyle zones into account.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hao-Tian Lin,Wei-Rong Chen,Zhao-Feng Ding,Wan Chen and Chang-Rui Wu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hao-Tian Lin,Wei-Rong Chen,Zhao-Feng Ding,Wan Chen and Chang-Rui Wu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201201016]]></guid><cfi:id>1349</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Study on the surface properties of surface modified silicone intraocular lenses]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201201017]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To prepare a new-type soft intraocular lens (IOL) that silicone intraocular lenses (IOLs) were modified by surface modification technique to assess IOLs biocompatibility. 
METHODS: With the technique of ion beam combined with low temperature and low pressure plasma, the surface characteristics of the IOLs including physical and optical properties were determined by the instruments of IOLs resolution, UV/VIS scanning spectrophotometer, contact angle measurement system, electron spectroscopy for chemical analysis (ESCA) and scanning electron microscope (SEM).
RESULTS: The color of titanium (Ti) modified IOLs was light yellow and that of titanium nitride (TiN) modified IOLs was light brown. The absorptive degree of ultraviolet rays and the hydrophilicity of the surfaces of modified IOLs were increased, and appeared suitable chemical compositions. The resolution of unmodified and modified IOLs reached normal standard. The surfaces of unmodified and Ti-modified IOLs appeared uniform. The surfaces of TiN-modified IOLs presented fine porcelain structure.
CONCLUSION: The optical properties of all IOLs and the surface morphology of the modified IOLs were not affected by modification processes. The surface properties of the modified IOLs were improved.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Gui-Qin Wang,Han-Qing Gu and Xiu-Jun Peng]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Gui-Qin Wang,Han-Qing Gu and Xiu-Jun Peng</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201201017]]></guid><cfi:id>1348</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical observation of removal of the necrotic corneal tissue combined with conjunctival flap covering surgery under the guidance of the AS-OCT in treatment of fungal keratitis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201201018]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To study the clinical observation of removal of the necrotic corneal tissue combined with conjunctival flap covering surgery under the guidance of the AS-OCT in treatment of fungal keratitis.
METHODS：A retrospective study was done to 10 patients (10 eyes) who had accepted removal of the necrotic corneal tissue combined with conjunctival flap covering surgery for fungal keratitis,the diagnosis by corneal scraping and smear examination or confocal microscopy check hyphae.Local and systemic antifungal therapy more than one week for all patients, corneal ulcer enlarge or no shrink.Slit lamp microscope examination the diameter of corneal ulcer about 2mm-4mm.Anterior segment optical coherence tomography（AS-OCT）examine the depth of corneal ulcer between 1/3-1/2,infiltrate corneal stroma about 20um-80um,the diameter of corneal ulcer about 3mm-6mm.Type-B ultrasonic exclusion endophthalmitis. Complete removal lesions until transparent of stroma, make conjunctival flap equal or greater than ulcer 1mm nearby conjunctiva. Continued antifungal therapy. The vision, fungal recurrence, conjunctival flap rollback or desquamate were analysed.
RESULTS：Ten patients had success done this surgery, the corneal ulcer was not enlarge and healing afteroperation.7 cases were bridging conjunctival flap and 3cases were single conjunctival flap. Preoperation vision above 0.1 had 8 cases,7 cases had vision above 0.1 one week after surgery, while 1 cases vision droped from 0.3 to 0.05.There was not recurrent for fungal,2 cases conjunctival flap rollback:1 case was bridging and 1case was single flap, no conjunctival flap desquamate.
CONCLUSION：It is safe and effective to perform removal of the necrotic corneal tissue combined with conjunctival flap covering surgery under the guidance of the AS-OCT in treatment of fungal keratitis which werenot sensitive or aggravate for antifungal drugs.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Guang-Hua Sun,Su-Xia Li,Hua Gao,Wen-Bo Zhang,Mei-Ai Zhang and Wei-Yun Shi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Guang-Hua Sun,Su-Xia Li,Hua Gao,Wen-Bo Zhang,Mei-Ai Zhang and Wei-Yun Shi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201201018]]></guid><cfi:id>1347</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Risk factors related to chronic rhegmatogenous retinal detachment]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201201019]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the clinical factors related to chronic rhegmatogenous retinal detachment (RRD). 
METHODS: A retrospective case-control study. A total of 103 consecutive patients (103 eyes) with primary RRD were studied to evaluate the clinical factors related to chronic RRD. 
RESULTS: Chi-square test was used to sift out the following associated factors with chronic RRD: younger patients (P=0.0028), better preoperative best corrected visual acuity (BCVA, P=0.0316), atrophic retinal break (P<0.0001), inferior retinal break (P<0.0001), smaller break (P=0.0005); then the independent risk factors related to chronic RRD was determined by stepwise logistic regression analysis as following: atrophic retinal break (odds ratio (OR)=7.997, P=0.007), inferior retinal break (OR=14.127, P<0.0001) and better preoperative BCVA (OR=1.636 P<0.0722) . 
CONCLUSION: Atrophic retinal break, inferior retinal break and better preoperative BCVA are the independent risk factors related to chronic RRD.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yu-Min Li,Wei Fang,Xiao-Hong Jin,Jiu-Ke Li,Jing Zhai and Li-Guo Feng]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yu-Min Li,Wei Fang,Xiao-Hong Jin,Jiu-Ke Li,Jing Zhai and Li-Guo Feng</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201201019]]></guid><cfi:id>1346</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Analysis of changes in crystalline lens thickness and its refractive power after laser in situ keratomileusis ]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201201020]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate changes in the anterior chamber depth (ACD), crystalline lens thickness (LT) and its refractive power after laser in situ keratomileusis (LASIK).
METHODS: In all cases, the preoperative and postoperative central ACD which were measured with Pentacam, Orbscan, IOL-Master and A-scan ultrasonography, central corneal true net power which was measured with the Pentacam, Orbscan and IOL-Master, axial length (AL) which was measured with IOL-Master and LT which was measured with the A-scan ultrasonography were compared using the paired sample t test. Ocular refractive errors and lens refractive power at corneal plane were calculated and their correlations were also evaluated before and after LASIK.
RESULTS: At 1 week after LASIK, LT and crystalline lens refractive power at corneal plane (Dlens) which were associated with the IOL-Master and Pentacam increased significantly (P≤0.005), ACD decreased significantly (P≤0.001), but no significant increase was observed in the Dlens which was associated with the Orbscan (P=0.261). Significant correlations between the changes in the ocular refractive errors and Dlens which were associated with the Pentacam were observed at 1 week and 6 months after LASIK (P=0.028; P=0.001).
CONCLUSION: LT increased significantly after LASIK, and this might partially lead to ACD decrease, Dlens increase and a small quantity of myopic regression. 
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Liang Wang,Hai-Ke Guo,Jing Zeng and Hai-Ying Jin]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Liang Wang,Hai-Ke Guo,Jing Zeng and Hai-Ying Jin</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201201020]]></guid><cfi:id>1345</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Assessment of intraocular pressure measured by Reichert Ocular Response Analyzer, Goldmann Applanation Tonometry, and Dynamic Contour Tonometry in healthy individuals]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201201021]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the accuracy of intraocular pressure (IOP) as measured by a Reichert Ocular Response Analyzer (ORA), as well as the relationship between central corneal thickness (CCT) and IOP as measured by ORA, Goldmann applanation tonometry (GAT), and dynamic contour tonometry (DCT).
METHODS: A total of 158 healthy individuals (296 eyes) were chosen randomly for measurement of IOP. After CCT was measured using A-ultrasound (A-US), IOP was measured by ORA, GAT, and DCT devices in a randomized order. The IOP values acquired using each of the three tonometries were compared, and the relationship between CCT and IOP values were analyzed separately. Two IOP values, Goldmann-correlated IOP value (IOPg) and corneal-compensated intraocular pressure (IOPcc), were got using ORA. Three groups were defined according to CCT: 1) thin cornea (CCT<520μm); 2) normal-thickness cornea (CCT: 520–580μm); and 3) thick cornea (CCT>580μm) groups.
RESULTS: In normal subjects, IOP measurements were 14.95±2.99mmHg with ORA (IOPg), 15.21±2.77mmHg with ORA (IOPcc), 15.22±2.77mmHg with GAT, and 15.49±2.56mmHg with DCT. Mean differences were 0.01±2.29mmHg between IOPcc and GAT (P>0.05) and 0.28±2.20mmHg between IOPcc and DCT (P>0.05). There was a greater correlation between IOPcc and DCT (r=0.946, P=0.000) than that between IOPcc and GAT (r=0.845, P=0.000). DCT had a significant correlation with GAT (r=0.854, P=0.000). GAT was moderately correlated with CCT (r=0.296, P<0.001), while IOPcc showed a weak but significant correlation with CCT (r=?0.155, P=0.007). There was a strong negative correlation between CCT and the difference between IOPcc and GAT(r=-0.803，P=0.000), with every 10μm increase in CCT resulting in an increase in this difference of 0.35mmHg. The thick cornea group (CCT>580μm) showed the least significant correlation between IOPcc and GAT (r=0.859, P=0.000); while the thin cornea group (CCT＜520μm) had the most significant correlation between IOPcc and GAT (r=0.926, P=0.000). The correlated differences between IOPcc and DCT were not significant in any of the three groups (P>0.05).
CONCLUSION: Measurement of IOP by ORA has high repeatability and is largely consistent with GAT measurements. Moreover, the ORA measurements are affected only to a small extent by CCT, and are likely to be much closer to the real IOP value than GAT.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ping-Bo Ouyang,Cong-Yi Li,Xiao-Hua Zhu and Xuan-Chu Duan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ping-Bo Ouyang,Cong-Yi Li,Xiao-Hua Zhu and Xuan-Chu Duan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201201021]]></guid><cfi:id>1344</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Long-term success of ahmed glaucoma valve  in refractory glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201201022]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the long-term results and complications of ahmed glaucoma valve (AGV) implantation in refractory glaucoma.
METHODS: A retrospective review of 13 patients (13 eyes) with refractory glaucoma who underwent AGV implantation and had a minimum follow-up of 18 months was performed. All patients underwent a complete ophthalmologic examination and intraocular pressure (IOP) measurement before surgery and at 1 month, 3 months, 6 months, 1 year after surgery and yearly afterwards. Complications and the number of antiglaucoma medications needed were recorded. 
RESULTS: Mean age was 27.3±16.0 years.  All eyes (100%) had at least one prior incisional surgery. Mean follow-up was 61.3±30.8 months. IOP was reduced from a mean of 35.0 ±7.0mmHg to 18.2±7.9mmHg at 12 months and to 17.0±4.1mmHg at 96 months (P<0.05) with a lower number of medications from baseline, 76.9% patients required additional procedures to achieve the success criteria set by previously published series. The most common complications were encapculated cyst formation in eight eyes (61.5 %) and tube exposure in four eyes (30.8%). 
CONCLUSION: Encapsulated cyst formation was the most common complication which hindered succesful IOP control after AGV implant insertion for refractory glaucoma. Despite cyst excision with anti-fibrotic agents, successful IOP reduction was not achieved in 76.9%  of the patients without antiglaucoma medication.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mahmut Kaya, Zeynep Ozbek, Ayl&#305;n Yaman and Ismet Durak]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mahmut Kaya, Zeynep Ozbek, Ayl&#305;n Yaman and Ismet Durak</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201201022]]></guid><cfi:id>1343</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Ocular alignment and results of strabismus surgery in neurologically impaired children]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201201023]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate ocular alignment and surgical results of strabismus surgery in neurologically impaired children.
METHODS: Files of 33 neurologically impaired squint children were evaluated. Twelve patients had cerebral palsy(CP), 4 had CP with mental retardation, therest had mental-motor retardation of unknown cause. Cycloplegic refractions, type and angle of strabismus, surgeries performed were  recorded.  
RESULTS: Mean follow-up was 34.0±16.5 months. Twenty-three patients had esodeviation, the remaining had exodeviation. In 19 patients, angle of deviations measured at different visits were highly variable. Twelve patients with stable angle of deviations or with unstable but high angle deviations had horizontal muscle surgery. Mean horizontal deviation decreased from 43.75±10,69 D to 12.83±8.38 D with surgery.
CONCLUSION: In neurologically impaired strabismic children, surgery is effective in patients with stable deviations or unstable but high angle deviations. Decision for surgery should be made after a long follow up period.
]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[&#199;i&#287;dem ülkü Can, Sibel Polat, Meryem Ya&#351;ar, Bayaz&#305;t &#304;lhan and Ay&#351;e Gül Ko&#231;ak Alt&#305;nta&#351;]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>&#199;i&#287;dem ülkü Can, Sibel Polat, Meryem Ya&#351;ar, Bayaz&#305;t &#304;lhan and Ay&#351;e Gül Ko&#231;ak Alt&#305;nta&#351;</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/201201023]]></guid><cfi:id>1342</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical outcomes after intrastromal corneal ring segments reoperation in keratoconus patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130610]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM</b>:To evaluate the clinical outcomes after Ferrara intrastromal corneal ring segments (ICRS) reoperation in patients with keratoconus.<b>RESULTS:</b> The mean follow-up time after the reoperation was 30.5±9.7 months. The mean UCVA improved from 20/300 to 20/80 (<i>P</i>=0.005); the mean BCVA improved from 20/160 to 20/50 (<i>P</i>=0.0002), the mean keratometry reduced from 49.33±4.19D to 46.16±3.90D (<i>P</i>=0.0001), the mean pachymetry at the thinnest point increased from 450±42.9mm to 469±40.8mm (<i>P</i>=0.0001). The asphericity increased from -0.84±0.74 to -0.35±0.81 (<i>P</i>=0.15) and the spherical equivalent reduced from -4.64±4.87D to -3.04±3.45D (<i>P</i>=0.137). The changes in the asphericity and spherical equivalent were not statistically significant.<b>CONCLUSION:</b> Ferrara ICRS implantation showed to be a reversible and readjustable surgical procedure for keratoconus treatment. Good outcomes can be obtained even after removal, addition, reposition or exchange of ICRS.]]></description>
<pubDate>2013/12/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Leonardo Torquetti,Guilherme Ferrara,Franklin Almeida,Leandro Cunha,Paulo Ferrara and Jesús Merayo-Lloves]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Leonardo Torquetti,Guilherme Ferrara,Franklin Almeida,Leandro Cunha,Paulo Ferrara and Jesús Merayo-Lloves</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130610]]></guid><cfi:id>1341</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparative study measuring the dilatory effect of a mydriatic device (Mydriasert</b><sup><b>?</b></sup><b>) versus topical drops]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130611]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To compare the mydriatic efficacy of an ophthalmic insert (Mydriasert, MY) versus phenylephrine and tropicamide (PT) eye drops.<b>METHODS:</b>Two controlled, prospective, randomized, single-blind studies were performed. In the first study, a total of 80 eyes from 40 outpatient-clinic patients were analyzed. PT drops were applied to the right eye, and a MY device was inserted in the left eye for 30min. Time until maximal pupil dilation for each eye was then assessed. In the second study, 80 eyes from 80 patients undergoing cataract surgery were analyzed. Pupil dilation was achieved using either PT drops three-times for one hour prior to surgery (40 patients), or a MY device was inserted one hour prior to surgery (40 patients).<b>RESULTS:</b> In the first study, MY achieved superior mydriasis compared to PT eye drops at 90min (9.04±1.33mm <i>vs</i> 8.78±1.37mm, <i>P</i>=0.012). However MY took longer than PT drops to achieve maximal dilation, and mydriasis was inferior in eyes with MY compared to PT drops at 30min (7.21±1.73mm <i>vs</i> 8.22±1.43mm, <i>P</i>&lt;0.001), the two groups only becoming similar by 60min (8.85±1.44mm <i>vs</i> 8.71±1.27mm, <i>P</i>=0.236). In the second study, both MY and PT achieved similar levels of mydriasis at the beginning of surgery (8.75±0.76mm with MY <i>vs</i> 8.77±0.63mm with PT), and also at the end of surgery (7.96±1.06mm with MY <i>vs</i> 8.32±0.72mm with PT), with no significant difference between groups (<i>P</i>=0.08). MY was well tolerated and cardiovascular effects were not influenced by dilation method.<b>CONLUSION:</b> MY could be a safe and efficacious alternative for mydriasis. The mydriatic effect of MY is as good as conventional PT eye drops after 60min, and is superior after 90min. MY also maintains good pupil dilation during cataract surgery.]]></description>
<pubDate>2013/12/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Manuel Saenz-de-Viteri,Patricia Fernández-Robredo,Elisa de Nova,Elvira Bonet-Farriol,Alfonso L. Sabater,Javier Zarranz-Ventura,Josemaria Caire,Luis M. Sádaba,Angel Salinas-Alamán and Alfredo García-Layana]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Manuel Saenz-de-Viteri,Patricia Fernández-Robredo,Elisa de Nova,Elvira Bonet-Farriol,Alfonso L. Sabater,Javier Zarranz-Ventura,Josemaria Caire,Luis M. Sádaba,Angel Salinas-Alamán and Alfredo García-Layana</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130611]]></guid><cfi:id>1340</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Relationship between dietary macronutrient intake and the risk of age-related cataract in middle-aged and elderly patients in northeast China]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130612]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To examine the association between dietary macronutrient intake and the risk of age-related cataract (ARC) in middle-aged and elderly men.<b>METHODS:</b>A hospital-based case-control study was conducted from December 2009 to November 2011. Cases (<i>n</i>=360) were patients with cataract aged 45-85 years old, and controls (<i>n</i>=360) were patients who had been admitted to the same hospital for diseases not related with cataract. All subjects were interviewed using a structured interviewer-administrated questionnaire that included information on socio-demographic characteristics, lifestyle habits and detailed medical history, simultaneously, the dietary intakes of nutrients were collected <i>via</i> a valid semi-quantitative food frequency questionnaire (FFQ). The odds ratios (OR) and corresponding 95% confidence intervals (CI) of three types of ARC were estimated using multiple logistic regression models.<b>RESULTS:</b> After adjusting for multiple potential confounders, total dietary intake of carbohydrate was positively associated with cortical cataract, compared to controls in the lowest quartile, and the OR for cases in the highest quartile of intake was 2.471 (95%CI:1.348-6.043, <i>P</i>=0.027). Higher dietary intakes of protein were protective for posterior subcapsular cataract (PSC) (OR=0.528, 95%CI:0.148-0.869, <i>P</i>=0.023). Dietary fat intake was not associated with any type of cataract, however, participants in the highest quartile of polyunsaturated fatty acids intake had 2.7 times the risk of nuclear cataract as did those in the lowest quartile (OR=2.742, 95%CI:1.790-4.200, <i>P</i>=0.033).<b>CONCLUSION:</b> A high intake of carbohydrate and polyunsaturated fatty acid may increase the odds of cortical and nuclear cataract, respectively, whereas high intake of protein, especially animal protein, may protect against PSC cataract. It is possible that dietary changes of target population may reduce the risk of ARC.]]></description>
<pubDate>2013/12/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Zhi-Quan Lu,Jia Yan,Wen-Hui Sun,Teng-Xuan Jiang,Shu-Na Zhai,Yan Li and Guang-Dong Gao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zhi-Quan Lu,Jia Yan,Wen-Hui Sun,Teng-Xuan Jiang,Shu-Na Zhai,Yan Li and Guang-Dong Gao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130612]]></guid><cfi:id>1339</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A randomized controlled trial of omega-3 fatty acids in dry eye syndrome]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130613]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To evaluate the role of dietary supplementation of omega-3 fatty acids in dry eye syndrome.<b>METHODS:</b> A prospective, interventional, placebo controlled, double blind randomized trial was done at two referral eye centers. Two hundred and sixty-four eyes of patients with dry eye were randomized to receive one capsule (500mg) two times a day containing 325mg EPA and 175mg DHA for 3 months (omega-3 group). The omega-3 group was compared to a group of patients (<i>n</i>=254) who received a placebo (placebo group). There were 4 patient visits (at baseline, 1 month, 2 months and 3 months). On each visit, recording of corrected distance visual acuity (CDVA), slit lamp examination and questionnaire based symptom evaluation and scoring was done. A symptomatic score of 0-6 was mild, 6.1-12 moderate and 12.1-18 severe dry eye. Response to intervention was monitored by routine tear function tests like Schirmer I test, tear film break-up time (TBUT), Rose Bengal staining and most notably, conjunctival impression cytology.<b>RESULTS:</b> Sixty-five percent of patients in the omega-3 group and 33% of patients in placebo group had significant improvement in symptoms at 3 months (<i>P</i>=0.005). There was a significant change in both Schirmer’s test value and TBUT values in the omega-3 group (<i>P</i>&lt;0.001), both comparisons. However, there was a larger drift in TBUT values in omega-3 than the placebo group, in comparison to Schirmer’s test values. The mean TBUT score was 2.54±2.34 in the omega-3 group and 0.13±0.16 in placebo group, respectively. The mean reduction in symptom score in omega-3 group was 2.02±0.96 as compared to 0.48±0.22 in placebo group (<i>P</i>&lt;0.001). Despite a slight increase mean score, the Schirmer scores did not correlate well with symptomatic improvement.<b>CONCLUSION:</b> Omega-3 fatty acids have a definite role for dry eye syndrome. The benefit seems to be more marked in conditions such as blepharitis and meibomian gland disease. The role of omega fatty acids in tear production and secretion needs further evaluation.]]></description>
<pubDate>2013/12/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Rahul Bhargava,Prachi Kumar,Manjushrii Kumar,Namrata Mehra and Anurag Mishra]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Rahul Bhargava,Prachi Kumar,Manjushrii Kumar,Namrata Mehra and Anurag Mishra</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130613]]></guid><cfi:id>1338</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Pathological, immunohistochemical and microbiologicalal analysis of lacrimal sac biopsies in patients with chronic dacrocystitis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130614]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To analyze cases of obstruction of the nasolacrimal duct which creates a fertile environment for secondary bacterial infection and can result in dacryocystitis,which is a constant threat to cornea and orbital soft tissue and a potential source of endophthalmitis following intraocular surgery. The majority of obstructions of the lacrimal excretory outflow system are acquired ones occurring in adulthood and involving the distal parts of the system. Acquired obstruction may be primary/idiopathic or secondary to a wide variety of infectious, inflammatory, traumatic, mechanical, toxic or neoplastic causes mimicking idiopathic inflammation. These cases are treated by dacryocystorhinostomy (DCR).<b>METHODS:</b>The present study was conducted to determine the histopathologic, immunohistochemical and current microbiologic characteristics of lacrimal sac specimens in patients undergoing external dacryocystorhinostomy.<b>RESULTS:</b>Non-specific lacrimal sac pathology was present in all 33 cases and 81.8% of the cases showed moderate chronic inflammation with a chronic inflammatory score (CIS) ranging between 4 and 6, whereas 12.12% showed severe inflammatory changes with a CIS of 7. Mild degree of inflammation was seen in 6.06% with a CIS of 3. The total prevalence of gram-positive, gram-negative, and culture-negative samples were 59.4%, 37.5%, and 3% respectively.<b>CONCLUSION:</b>Non-specific chronic inflammation with fibrosis is indeed the most commonly reported histopathological finding in lacrimal sac wall biopsy specimens.]]></description>
<pubDate>2013/12/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Rowayda Mahmoud Amin,Faten Aly Hussein,Hisham Farouk Idriss,Nesrine Fathy Hanafy and Dina Mohamed Abdallah]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Rowayda Mahmoud Amin,Faten Aly Hussein,Hisham Farouk Idriss,Nesrine Fathy Hanafy and Dina Mohamed Abdallah</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130614]]></guid><cfi:id>1337</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Apoptosis in the iris and trabecular meshwork of medically treated and untreated primary open angle glaucoma patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130615]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To compare the trabecular meshwork (TM) and iris apoptosis of treated and untreated primary open angle glaucoma (POAG) patients.<b>METHODS:</b> Eight treatment-naive, newly diagnosed (group 1) and 11 medicaly treated (group 2) patients with POAG were included in the study. Each patient underwent a limbus-based trabeculectomy. The TM and peripheral iris specimens were dissected out and were snap-frozen in liquid nitrogen and stored at –80℃ until they were assayed. Apoptosis in each group was assesed by TUNEL method.<b>RESULTS:</b>The mean patient age was 60.6±5.8 years (53-68 years)<i> vs</i> 58.9±8.9 years (47-70 years) in group 1 and group 2 (<i>P</i>=0.859). The mean treatment time in group 2 was 22.2±7.3 months (12-34 months). Apoptotic indexes in TM and iris were significantly higher in POAG patients using medication (group 2) compared to treatment-naive POAG patients (group 1) (<i>P</i>=0.004, 0.015; respectively).<b>CONCLUSION:</b> Long term administration of topical antiglaucoma medications causes additional toxic effects on TM.]]></description>
<pubDate>2013/12/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Zeynep Aktas,Emine Esra Karaca,Ipek Işik Gonul,Murat Hasanreisoglu and Merih Onol]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zeynep Aktas,Emine Esra Karaca,Ipek Işik Gonul,Murat Hasanreisoglu and Merih Onol</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130615]]></guid><cfi:id>1336</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Posterior chamber phakic intraocular lens implantation for high myopia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130616]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To evaluate the efficacy, safety and stability of posterior chamber phakic intraocular lens implantation for the correction of high myopia.<b>METHODS:</b> Retrospective case review of 82 eyes (43 patients) undergoing implantable Collamer lens (ICL) placement by a single surgeon (Xiao-Wei Gao) to correct preoperative mean spherical equivalents between -9.00 diopter (D) and -23.00D. Main outcome measures included uncorrected visual acuity (UCVA), refraction, best spectacle-corrected visual acuity (BSCVA), endothelial cell density (ECD), intraocular pressure (IOP), lens transparency, postoperative uveitis. Visante anterior segment optical coherence tomography (AS-OCT) was used to measure anterior chamber depth (ACD) and the position of ICL.<b>RESULTS:</b>Mean follow-up was 6.54±3.26 months (range 3-12 months). Predictability of the manifest spherical equivalent (SE) refraction to within ±1.00D was achieved in 88% of eyes and ±0.50D in 72.5% of eyes. The mean postoperative manifest SE refraction was -1.85±0.72D, with 96.34% of eyes maintaining or gaining ≥1 line(s) of BSCVA. The mean 3-month postoperative ECD decreased but had no statistically difference compared with the preoperative ECD. Of the 7 eyes (8.54%) with a mild transient increase in intraocular pressure (up to 30mmHg), none required a second surgical procedure or prolonged topical medication. There was no loss of lens transparency. Pigmented precipitates were observed in 5 eyes (6.09%). The mean preoperative ACD measured with AS-OCT was 3.28±0.14mm, three months after surgery, the mean ACD was 2.45±0.22mm. Anterior chamber depth showed a statistically significant reduction. One eye (1.22%) had ICL spontaneous rotation, 81 eyes (98.78%) of the lens remained correctly centered.<b>CONCLUSION:</b> The implantation of ICL is an effective surgical option for the management of high myopia. But its long time effect and safety still need more time to prove.]]></description>
<pubDate>2013/12/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yan Ju,Xiao-Wei Gao and Bing Ren]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yan Ju,Xiao-Wei Gao and Bing Ren</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130616]]></guid><cfi:id>1335</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Importance of 3-D image reconstruction of spectral-domain OCT on outcome of grid laser photocoagulation for diffuse diabetic macular edema]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130617]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To present the outcome of modified grid laser photocoagulation (GLP) in diffuse diabetic macular edema (DDME) in eyes without extrafoveal and/or vitreofoveal traction.
    
    <b>METHODS:</b>Inclusion criteria for the retrospective study were DDME eyes of patients with type II diabetes mellitus that had ≥4 months of follow-up following GLP. Only one eye per patient was analyzed. Using 3-D spectral-domain optical coherence tomography (3-D SD-OCT), eyes that had either extrafoveal or vitreofoveal traction, or had been previously treated by an intravitreal medication(s) were excluded. Treated DDME eyes were divided into 4 groups:A) “Classic” DDME that involved the central macula; B) edema did not involve the macular center; C) eyes associated with central epiretinal membrane (ERM); D) DDME that was associated with macular capillary dropout ≥2 disc-diameter (DD). 
    
    <b>RESULTS:</b>GLP outcome in 35 DDME eyes after 4-24 (mean, 13.1±6.9) months was as follows:Group A) 18 eyes with “classic” DDME. Following one or 2 (mean, 1.2) GLP treatments, best-corrected visual acuity (BCVA) improved by 1-2 Snellen lines in 44.4% (8/18) of eyes, and worsened by 1 line in 11.1% (2/18). Central macular thickness (CMT) improved by 7%-49% (mean, 26.6%) in 77.8% (14/18) of eyes. Causes of CMT worsening (<i>n</i>=4) were commonly explainable, predominantly (<i>n</i>=3) associated with emergence of extrafoveal traction, 5-9 months post-GLP. Group B) GLP(s) in DDME that did not involve the macular center (<i>n</i>=6) resulted in improved BCVA by 1-2 lines in 2 eyes. However, the central macula became involved in the edema process after the GLP in 3 (50%) eyes, associated with an emergence of extrafoveal traction in one of these eyes 4 months following the GLP. Group C) GLP failed in all 5 eyes associated with central ERM. Group D) GLP was of partial benefit in 2 of 6 treated eyes with macular capillary dropout ≥2DD.                                                                                                                               
    <b>CONCLUSION:</b>Eyes with DDME that involved the macular center were found to achieve favourable outcomes after GLP(s) during mid-term follow-up, unless complicated pre-GLP or post-GLP by vitreoretinal interface abnormalities, often extrafoveal traction or ERM, or by capillary dropout ≥2DD. Prospective studies with larger cohorts are required.]]></description>
<pubDate>2013/12/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Avinoam Ophir,Rana Hanna and Michael R. Martinez]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Avinoam Ophir,Rana Hanna and Michael R. Martinez</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130617]]></guid><cfi:id>1334</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A new specialized visual acuity chart for amblyopic children aged 3-5 years old:development and its clinical applications]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130618]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To introduce a new specialized visual acuity chart for amblyopic children aged 3-5 years old and its clinical applications.<b>METHODS:</b>The new visual acuity chart and notations were designed based on Weber-Fechner law. The optotypes were red against a white background and were specially shaped four basic geometric symbols:circle, square, triangle，and cross. A regular geometric progression of the optotype sizes and distribution was employed to arrange in 14 lines. The progression rate of the optotype size between two lines was 1.2589 and the testing distance was 3m. Visual acuity score could be recorded as logMAR notation or decimal notation. Age-stratified diagnostic criteria for amblyopia established by consensus statement on diagnosis of amblyopia (2011) among members of the Strabismus and Pediatric Ophthalmology Group, Ophthalmology Society, Chinese Medical Association (SPOGOSCMA) were illustrated in the new visual acuity chart.<b>RESULTS:</b> When assessing visual acuity in children aged 3-5 years old, this new visual acuity chart that consists of four symmetrical shapes (triangle, square, cross, and circle) overcame an inability to recognize the letters of the alphabet and difficulties in designating the direction of black abstract symbols such as the tumbling ‘E’ or Landolt ‘C’, which the subjects were prone to lose interest in. The visual acuity score may be recorded in different notations:decimal acuity and logMAR. These two notations can be easily converted each other in the new eye chart. The measurements of this new chart not only showed a significant correlation and a good consistency with the international standard logarithmic visual acuity chart (<i>r</i>=0.932, <i>P</i>&lt;0.01), but also indicated a high test-retest reliability (89% of retest scores were within 0.1logMAR units of the initial test score).<b>CONCLUSION:</b> The results of this study support the validity and reliability of distance visual acuity measurements using the new eye chart in children aged 3 to 5 years over a wide range of visual acuities, and the new eye chart is great for early detection of amblyopia. It can be applied in various clinical settings.]]></description>
<pubDate>2013/12/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yang-Qing Huang,He Huang and Rong-Zhi Huang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yang-Qing Huang,He Huang and Rong-Zhi Huang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130618]]></guid><cfi:id>1333</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of 1% brinzolamide and 0.5% timolol fixed combination on intraocular pressure after cataract surgery with phacoemulsification]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130619]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To evaluate the effect of brinzolamide-timolol fixed combination on intraocular pressure (IOP) after cataract surgery.<b>METHODS:</b>The study included 92 eyes of 87 patients who underwent cataract surgery and intraocular lens implantation. Patients scheduled for phacoemulsification were assigned to 1 of 2 groups. The treatment group received 1 drop of brinzolamide-timolol fixed combination immediately after surgery, and the control group received no treatment. The IOP was measured preoperatively and at 2h and 24h postoperatively.<b>RESULTS:</b> The mean IOP change was lower in the treatment group than in the control group at 2h postoperatively. The difference between the mean IOP values of the two groups at 2h postoperatively was found to be statistically significant. Twenty-four hours after the surgery, the mean IOP change was still higher in the control group when compared to the treatment group.<b>CONCLUSION:</b> The fixed combination brinzolamide-timolol can effectively reduce IOP after cataract surgery.]]></description>
<pubDate>2013/12/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Kemal Örnek,Nesrin Büyüktortop,Nurgül Örnek,Reyhan Oğurel,İnci Elif Erbahçeci and Zafer Onaran]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Kemal Örnek,Nesrin Büyüktortop,Nurgül Örnek,Reyhan Oğurel,İnci Elif Erbahçeci and Zafer Onaran</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130619]]></guid><cfi:id>1332</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Epidemiological and clinical features of paediatric open globe injuries in southwestern Turkey]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130620]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To evaluate the epidemiologic, anatomic, and clinical features of open globe injuries in children.<b>METHODS:</b> The medical files of patients under the age of 16 who had been operated for an open globe injury at Akdeniz University Hospital’s Department of Ophthalmology were retrospectively evaluated.<b>RESULTS:</b> A total of 90 patients were evaluated in this study. Among these patients, 26 (28.9%) were female and 64 (71.1%) were male. The mean age of the patients was 7.7±4.2 years. The male/female ratio was observed to increase with increasing age (<i>P</i>=0.006, <i>r</i>=7.48). Injuries were most likely to occur in spring and autumn (<i>P</i>=0.028). The time interval between the injury and the surgical repair was 9.36±27.4h. Forty (44.4%) of the injuries occurred in the home, 27 (30%) occurred in the yard, and 21 (23.3%) happened while playing in the street. The most common causes of injury were sharp metal objects (<i>P</i>&lt;0.001). Injury to the cornea occurred in 47 (52.2%) of the patients (<i>P</i>&lt;0.001). The most common complication to occur was cataract formation. Additional operations were necessary for 37 (41.1%) of the patients. The final visual acuity was correlated with both the initial visual acuity of the wounded eye prior to surgery and the length of the wound (<i>P</i>&lt;0.001, <i>r</i>=0.502 and <i>P</i>&lt;0.001, <i>r</i>=-0.442, respectively).<b>CONCLUSION:</b>Open globe injuries that are suffered in childhood generally occur either at home, in the yard, or on the street, with sharp metal objects being the most common cause of injury. The initial visual acuity and the length of the wound are the most important determinants of the final visual acuity.]]></description>
<pubDate>2013/12/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hatice Deniz Ilhan,Ahmet Burak Bilgin,Aslı Çetinkaya,Mustafa Unal and Iclal Yucel]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hatice Deniz Ilhan,Ahmet Burak Bilgin,Aslı Çetinkaya,Mustafa Unal and Iclal Yucel</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130620]]></guid><cfi:id>1331</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Temporal pattern of resolution/recurrence of choroidal neovascularization during bevacizumab therapy for wet age-related macular degeneration]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130510]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To characterize temporal pattern of resolution and recurrence of naive choroidal neovascularization (CNV) secondary to wet age-related macular degeneration (AMD) treated with intravitreal bevacizumab on as needed regimen, and to analyze baseline risk factors for CNV resolution or recurrence.<b>METHODS</b>:Ninety-one eyes of 80 patients with newly diagnosed wet AMD were retrospectively studied. All eyes were treated with a round of three monthly intravitreal bevacizumab injections, followed by one additional ‘bonus’ injection after resolution of CNV activity. During follow-up, eyes were monitored with fluorescein angiography, optical coherence tomography, and best-corrected visual acuity (BCVA). In case of recurrences of CNV activity, eyes were retreated with other rounds of bevacizumab injections following the same treatment protocol.<b>RESULTS</b>:Over a median follow-up of 532d, the median resolution time of CNV activity in the first, second, and third treatment round was 98d, 126d, and 111d, respectively. The median recurrence time for the three rounds was 154d, 126d, and 151d, respectively. No significant difference in resolution time (<i>P</i>=0.09) or in recurrence time (<i>P</i>=0.11) was detected among treatment rounds. Age (<i>P</i>=0.0082) and lens status (<i>P</i>=0.035) were found to be associated with CNV resolution; for every 1-year increase in age there was 4% greater chance of CNV resolution; Phakic eyes demonstrated a 33% better chance to experience CNV resolution than pseudophakic eyes. For CNV recurrence, lens status (<i>P</i>=0.0009) and gender (<i>P</i>=0.0446) were found to be predictive; pseudophakic eyes had a 3.69-fold greater risk to experience recurrence of CNV activity compared to phakic eyes; males had a 2.19-fold greater risk to experience recurrence of CNV activity than females. No significant BCVA changes among three treatment rounds were noted (<i>P</i>=0.56).<b>CONCLUSION</b>:Resolution time and recurrence time of CNV activity were not significantly different among treatment rounds, suggesting absence of tachyphylaxis to bevacizumab. A cautious decision should be made upon discontinuing treatment in wet AMD eyes of younger or pseudophakic patients, which showed slower response to bevacizumab. In addition, wet AMD eyes of male or pseudophakic patients should be evaluated more carefully after stopping the treatment, because they may have early reactivation of the CNV. BCVA was preserved by bevacizumab treatment despite multiple recurrences.]]></description>
<pubDate>2013/10/21 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Haiyan Wang,Giulio Barteselli,William R. Freeman,Su Na Lee,Jay Chhablani,Sharif El-Emam and Lingyun Cheng]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Haiyan Wang,Giulio Barteselli,William R. Freeman,Su Na Lee,Jay Chhablani,Sharif El-Emam and Lingyun Cheng</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130510]]></guid><cfi:id>1330</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Anisometropia magnitude and visual deficits in previously untreated anisometropic amblyopia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130511]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To assess the quantitative association between anisometropia magnitude and the losses of resolution and contrast sensitivity; and to exemplify how the function of fusion and stereopsis vary with anisometropia magnitude (AM) in previously untreated anisometropic amblyopes.<b>METHODS:</b>A total of 57 patients with previously untreated anisometropic amblyopia without strabismus (range:8-35 years), were measured refractive error, best corrected visual acuity (BCVA), fusion and stereopsis, and 48 patients have completed contrast sensitivity function test. AM was determined by dioptric vector addition model, and the amblyopia depth was determined by the difference of BCVA in logMAR units between the amblyopic and fellow eyes.<b>RESULTS:</b> AM was significantly correlated with both amblyopia depth (Pearson R=0.728, <i>P</i>&lt;0.001) and the inter-ocular difference of the area under the log contrast sensitivity function (AULCSF) (R=0.505, <i>P</i>&lt;0.001). Depth of amblyopia and the inter-ocular difference of AULCSF was also significantly correlated (R=0.761, <i>P</i>&lt;0.001). The more severity of amblyopia, the poorer levels of contrast sensitivity. Most pure anisometropes with AM was less than 3.0D retain fusion and some stereopsis, but when AM were more than 3.0D, especially for the anisometropes whose AM was more than 6.0D, fusion and stereopsis function were seriously impaired.<b>CONCLUSION:</b> In the patients with previously untreated anisometropia amblyopia, higher degree of anisometropia is significantly associated with deeper amblyopia, worse contrast sensitivity, fusion and stereopsis functions.]]></description>
<pubDate>2013/10/21 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Bin-Bin Chen,Feng-Wei Song,Zhao-Hui Sun and Yi Yang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Bin-Bin Chen,Feng-Wei Song,Zhao-Hui Sun and Yi Yang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130511]]></guid><cfi:id>1329</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of Ziemer FEMTO LDV “Classic” and “Crystal Line” femtosecond laser flap quality by Fourier-domain optical coherence tomography]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130512]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To compare the regularity and accuracy of laser <i>in situ</i> keratomileusis (LASIK) flaps created by the Ziemer FEMTO LDV “Classic” (Ziemer “Classic”) and Ziemer FEMTO LDV Crystal Line femtosecond laser (Ziemer Crystal Line).<b>METHODS:</b>Fourier-domain optical coherence tomography (RTVue OCT) was used tomeasure the morphology of 200 LASIK flaps of 100 consecutive patients created with the Ziemer Classic (100 flaps) or the Ziemer Crystal Line (100 flaps) at one week postoperatively. Flap thickness was evaluated at 36 specified measurement points on each flap. For all procedures with both lasers, the nominal flap thickness was 110μm.<b>RESULTS:</b>The mean flap thickness of the Ziemer Crystal Line group(102.49±2.68μm) was thinner than that of the Ziemer Classic group (107.65±5.09μm) (<i>P</i>&lt;0.01). Average thickness of all flaps was uniform within 4μm at all measurement points. The flaps in the Ziemer Crystal Line group were more regular than those in the Ziemer Classic group when measured from the center to the periphery. The maximum deviation from the nominal 110μm of 36 measurements was 8μm in the Ziemer Classic group, while in the Ziemer Crystal Line group it was 9μm. Within the 3 600 measurements on the 100 eyes, differences greater than 20μm were observed 0.14% in the Ziemer Classic group, and 0.04% in the Ziemer Crystal Line group.<b>CONCLUSION:</b>The flaps created with the Ziemer FEMTO LDV Crystal Linefemtosecond laser are more uniform and thinner than those created by the Ziemer FEMTO LDV Classic femtosecond laser.]]></description>
<pubDate>2013/10/21 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jing Zhang,Yue-Hua Zhou,Lei Tian and Chang-Bin Zhai]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jing Zhang,Yue-Hua Zhou,Lei Tian and Chang-Bin Zhai</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130512]]></guid><cfi:id>1328</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Non-cycloplegic spherical equivalent refraction in adults:comparison of the double-pass system, retinoscopy, subjective refraction and a table-mounted autorefractor]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130513]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To evaluate the accuracy of spherical equivalent (SE) estimates of a double-pass system and to compare it with retinoscopy, subjective refraction and a table-mounted autorefractor.<b>METHODS:</b> Non-cycloplegic refraction was performed on 125 eyes of 65 healthy adults (age 23.5±3.0 years) from October 2010 to January 2011 using retinoscopy, subjective refraction, autorefraction (Auto kerato-refractometerTOPCON KR-8100, Japan) and a double-pass system (Optical Quality Analysis System, OQAS, Visiometrics S.L., Spain). Nine consecutive measurements with the double-pass system were performed on a subgroup of 22 eyes to assess repeatability. To evaluate the trueness of the OQAS instrument, the SE laboratory bias between the double-pass system and the other techniques was calculated.<b>RESULTS:</b>The SE mean coefficient of repeatability obtained was 0.22D. Significant correlations could be established between the OQAS and the SE obtained with retinoscopy (<i>r</i>=0.956, <i>P</i>&lt;0.001), subjective refraction (<i>r</i>=0.955, <i>P</i>&lt;0.001) and autorefraction (<i>r</i>=0.957, <i>P</i>&lt;0.001). The differences in SE between the double-pass system and the other techniques were significant (<i>P</i>&lt;0.001), but lacked clinical relevance except for retinoscopy; Retinoscopy gave more hyperopic values than the double-pass system -0.51±0.50D as well as the subjective refraction -0.23±0.50D; More myopic values were achieved by means of autorefraction 0.24±0.49D.<b>CONCLUSION:</b> The double-pass system provides accurate and reliable estimates of the SE that can be used for clinical studies. This technique can determine the correct focus position to assess the ocular optical quality. However, it has a relatively small measuring range in comparison with autorefractors (-8.00 to +5.00D), and requires prior information on the refractive state of the patient.]]></description>
<pubDate>2013/10/21 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Meritxell Vilaseca,Montserrat Arjona,Jaume Pujol,Elvira Peris and Vanessa Martínez]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Meritxell Vilaseca,Montserrat Arjona,Jaume Pujol,Elvira Peris and Vanessa Martínez</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130513]]></guid><cfi:id>1327</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Peripapillary retinal nerve fiber layer thickness distribution in Chinese with myopia measured by 3D-optical coherence tomography]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130514]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To assess the effect of myopia on the thickness of retinal nerve fiber layer (RNFL) measured by 3D optical coherence tomography (3D-OCT) in a group of nonglaucomatous Chinese subjects.<b>METHODS:</b>Two hundred and fifty-eight eyes of 258 healthy Chinese myopic individuals were recruited and four groups were classified according to their spherical equivalent (SE):low myopia (<i>n</i>=42, -0.5D&lt;SE&lt;-3.0D), moderate myopia (<i>n</i>=120, -3.0D≤SE&lt;-6.0D), high myopia (<i>n</i>=58, -6.0D≤SE&lt;-8.0D) and extreme high myopia (<i>n</i>=38, SE≥-8.0D). The RNFL thickness profile including superior, nasal, inferior and temporal quadrant and each of the 12 clock-hour thicknesses were measured by 3D-OCT. The RNFL thicknesses among four sample groups were performed by one-way analysis of variance (one-way ANOVA) and least significant difference test (LSD test). Correlations between RNFL thickness and axial length/spherical equivalent were performed by linear regression analysis.<b>RESULTS:</b> The overall RNFL parameters shown significant differences between groups excluding 7, 9, 10, 11 o’clock hour thickness. The RNFL thickness of superior, nasal, inferior, average and 1, 2, 3, 4, 5, 6, 12 o’clock sectors were decreased with the increasing axial length and higher degree of myopia. In contrast, as axial length and the degree of myopia increased, the temporal and 8, 9 o’clock sectors thicknesses were increased. A considerable proportion of myopic eyes were classified as outside the normal limits. Six o’clock was the most notable of the total, which 43.4% were outside the normal limits.<b>CONCLUSION:</b>On the measurement of RNFL, the characteristics of RNFL with the change of the degree of myopia were observed. As the degree of myopia increases, the RNFL thickness measured by 3D-OCT including the average and superior, nasal, inferior sectors decreases. And due to the change of RNFL thickness, it should be considered when using OCT to access for the damage of glaucoma especially people with myopia.]]></description>
<pubDate>2013/10/21 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jing-Jing Zhao,Wen-Juan Zhuang,Xue-Qiu Yang,Shan-Shan Li and Wei Xiang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jing-Jing Zhao,Wen-Juan Zhuang,Xue-Qiu Yang,Shan-Shan Li and Wei Xiang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130514]]></guid><cfi:id>1326</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Bacterial flora of conjunctiva after death]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130515]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To evaluate the frequency of bacterial flora of conjunctiva after death (cadaver eyes) which will give information about the bacterial contamination of donor eyes, and the <i>in-vitro</i> sensitivity of isolated bacteria to the commonly used antibiotics in ophthalmic practice.<b>METHODS:</b> Conjunctival swabs were taken from the cadavers (motor vehicle accident deaths and patients who died in the hospital), within 6h after death, and sent for culture and sensitivity test. Conjunctival swabs, taken from the healthy conjunctiva of patients admitted for cataract surgery, were sent for culture and sensitivity as controls (eyes in those of living status). The bacterial isolates were tested against the commonly used antibiotics (chloramphenicol, gentamicin, ciprofloxacin) in ophthalmology practice.<b>RESULTS:</b> Bacteria were isolated in 41 out of 100 conjunctival swabs (41%), taken from 50 cadavers (study group). Coagulase negative <i>staphylococcus</i> was the most common bacteria isolated (15%), followed by <i>pseudomonas aeruginosa</i> (5%). Gentamicin was effective against majority of the bacterial isolates (82%). Bacteria were isolated from 7 out of 100 conjunctival swabs taken as control group (eyes in living state). Coagulase negative <i>staphylococcus</i> was the most common organism (5%) isolated in control group; the others were <i>staphylococcus aureus</i> (1%) and beta hemolyticus <i>streptococci</i> (1%).<b>CONCLUSION:</b> Bacteria were isolated from 41% of the cadaver eyes. High percentage sensitivity of the bacterial isolates to gentamicin (82%) supports the practice of thorough irrigation of the eyes with gentamicin solution before starting the procedure of enucleation followed by immersion of the enucleated eyeballs in gentamycin solution, to prevent the bacterial contamination.]]></description>
<pubDate>2013/10/21 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Sagili Chandrasekhara Reddy and George Paul]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Sagili Chandrasekhara Reddy and George Paul</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130515]]></guid><cfi:id>1325</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of IOPen rebound tonometer with Goldmann applanation tonometer at different IOP levels]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130516]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To compare the accuracy of IOPen rebound tonometer with Goldmann applanation tonometer (GAT) in individuals with low, normal and high intraocular pressure (IOP) and to evaluate the effect of central corneal thickness (CCT) on IOP measurements.<b>METHODS:</b>This cross-sectional study consisted of 159 participants. IOP of one eye of each subject was measured consecutively with IOPen and GAT. Then CCT was measured using an ultrasonic pachymeter. Based on GAT IOP readings, participants were divided into low, normal and high IOP groups. Correlation between tonometers and CCT was calculated by spearman’s correlation coefficient. Agreement between tonometers was evaluated using Bland-Altman method.<b>RESULTS:</b> Non-significant underestimation of IOP by IOPen was observed in low IOP group (Mean difference:0.20mmHg; <i>P</i>=0.454) and also in normal IOP group (Mean difference:0.56mmHg; <i>P</i>=0.065). However, IOPen significantly overestimated IOP in high IOP group (Mean difference:1.06mmHg; <i>P</i>=0.038). The 95% limits of agreement (LoA) width between IOPen and GAT IOPs were 7.84, 8.57 and 14.27mmHg in low, normal and high IOP groups, respectively. Low IOP group had thinner corneas compared to high IOP group (<i>P</i>=0.034). IOP measurements taken by IOPen were not influenced by CCT (<i>P</i>=0.099) while poor correlation between CCT and GAT was found (R=0.17, <i>P</i>=0.032). Using receiver operating characteristic (ROC) curve, cutoff value of 18.75mmHg was determined for IOPen with sensitivity of 98.1 and specificity of 97.2%.<b>CONCLUSION:</b>Accuracy of IOPen is comparable to GAT in patients with low or normal IOP but IOPen overestimates IOP at high IOP levels. CCT does not affect IOP readings with IOPen.]]></description>
<pubDate>2013/10/21 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[FereydounFarrahi,Farideh Sharifipour,Mohammad Malekahmadi and Bahman Cheraghian]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>FereydounFarrahi,Farideh Sharifipour,Mohammad Malekahmadi and Bahman Cheraghian</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130516]]></guid><cfi:id>1324</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparative study of visual acuity and aberrations after intralase femtosecond LASIK:small corneal flap versus big corneal flap]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130517]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To study the effect of different flap sizes on visual acuity, refractive outcomes, and aberrations after femtosecond laser for laser <i>in situ</i> keratomileusis (LASIK).<b>METHODS:</b> In each of the forty patients enrolled, 1 eye was randomly assigned to receive treatment with a 8.1mm diameter corneal flap, defined as the small flap, while the other eye was treated with a 8.6mm diameter corneal flap, defined as the big flap. Refractive errors, visual acuity, and higher-order aberrations were compared between the two groups at week 1, month 1 and 3 postoperatively.<b>RESULTS:</b> The postoperative refractive errors and visual acuity all conformed to the intended goal. Postoperative higher-order aberrations were increased, especially in spherical aberration (Z12) and vertical coma (Z7). There were no statistically significant differences between the two groups in terms of postoperative refractive errors, visual acuity, root mean square of total HOAs (HO-RMS), trefoil 30° (Z6), vertical coma (Z7), horizontal coma (Z8), trefoil 0° (Z9), and spherical aberration (Z12) at any point during the postoperative follow-up.<b>CONCLUSION:</b> Both the small and big flaps are safe and effective procedures to correct myopia, provided the exposure stroma meets the excimer laser ablations. The personalized size corneal flap is feasible, as we can design the size of corneal flap based on the principle that the corneal flap diameter should be equal to or greater than the sum of the maximum ablation diameter and apparatus error.]]></description>
<pubDate>2013/10/21 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ya-Li Zhang,Lei Liu,Chang-Xia Cui,Ming Hu,Zhao-Na Li,Li-Jun Cao,Xiu-Hua,Jing and Guo-Ying Mu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ya-Li Zhang,Lei Liu,Chang-Xia Cui,Ming Hu,Zhao-Na Li,Li-Jun Cao,Xiu-Hua,Jing and Guo-Ying Mu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130517]]></guid><cfi:id>1323</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparative study of modified and conventional secondary hydroxyapatite orbital implantations]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130518]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To compare the clinical effects of the modified and conventional secondary hydroxyapatite orbital implantations.<b>METHODS:</b>A total of 40 patients who had received eye enucleation were equally randomized into the modified and conventional groups. Twenty patients were treated by conventional method. The four rectus muscles were separated, and then an orbital implant wrapped with xenogenous sclera was implanted. Twenty patients were treated by modified method. An implant unwrapped with xenogenous sclera was directly implanted into the muscle pyramid. The operating time, costs, clinical effects, and complications of the two groups were compared.<b>RESULTS:</b>The average operating time of the modified group was 20.5±5.6min, whereas that of the conventional group was 56.8±14.6min (<i>P</i>&lt;0.01). The average cost of the modified group was 7 800±340RMB (1 274±55.6USD), whereas that of the conventional group was 9 800±660RMB (1 601±107.8USD) (<i>P</i>&lt;0.01). The two groups did not show significant difference in orbital implant mobility or postoperative complications.<b>CONCLUSION:</b>The modified secondary hydroxyapatite orbital implantation has advantages in operating time, surgery cost, and complication reducing. It is worthy for wide clinical application and further study.]]></description>
<pubDate>2013/10/21 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yong Zhao,Mao-Nian Zhang,Yun-Xian Gao,Xiao-Wei Gao and Bing Ren]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yong Zhao,Mao-Nian Zhang,Yun-Xian Gao,Xiao-Wei Gao and Bing Ren</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130518]]></guid><cfi:id>1322</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Long-term results of clear lens extraction combined with piggyback intraocular lens implantation to correct high hyperopia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130519]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To assess the refractive outcome of clear lensectomy combined with piggyback intraocular lens implantation in highly hyperopic patients.<b>METHODS:</b> This case review included 19 eyes of 10 patients with high hyperopia and axial length less than 21mm. Intraocular lens power was calculated for emmetropia using the Holladay II formula in 17 eyes, and SRK/T formula in 2 eyes following clear lens extraction and piggyback intraocular lens implantation. Patients were examined periodically over 24 months for visual acuity and spherical equivalent (SE).<b>RESULTS:</b> The mean postoperative SE at 24 months was 0.20±1.39D (range, -3.00 to 2.50D), better than preoperative 9.81±2.62D (range, +6.00 to +14.50D) (<i>P</i>&lt;0.001). Five eyes had SE within ±0.5D of emmetropia and 11 eyes within ±1.00D at postoperative 24 months. The mean postoperative uncorrected visual acuity (UCVA) at 24 months was 0.60±0.36, significantly improved compared to preoperative 1.39±0.33 (<i>P</i>&lt;0.001). The mean best-corrected visual acuity (BCVA) at 24 months was 0.49±0.35, not statistically different compared to preoperative 0.38±0.30 (<i>P</i>=0.34). Twelve eyes maintained and 1 gained 1 or more Snellen line of BCVA, 4 eyes lost 1 line, and 2 eyes lost 2 lines at 24 postoperative months. Twelve eyes best-corrected near visual acuity (BCNVA) achieved J1 at postoperative 24 months compared to preoperative 7 eyes and the other 7 eyes better than J3.<b>CONCLUSION:</b> Clear lens extraction combined piggyback intraocular lens implantation appears to be an effective procedure to correct high hyperopia but mild overcorrection and intralenticular opacification may require secondary procedure.]]></description>
<pubDate>2013/10/21 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xia Hua,Xiao-Yong Yuan,Hui Song and Xin Tang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xia Hua,Xiao-Yong Yuan,Hui Song and Xin Tang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130519]]></guid><cfi:id>1321</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[One-stitch anastomosis through the skin with bicanalicular intubation:a modified approach for repair of bicanalicular laceration]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130520]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To evaluate the efficacy and safety of one-stitch anastomosis through the skin with bicanalicular silicone tube intubation in repairing of bicanalicular laceration.<b>METHODS:</b>The clinical data of 15 consecutive patients with both superior and inferior canalicular laceration in one eye who underwent surgical repair using one-stitch anastomosis through the skin and bicanalicular stent were retrospective studied. All the operations were performed under surgical microscope, 5-0 silk sutures were used and were with bicanalicular silicone tube (diameter was 8mm) intubation, for one lacerated canaliculi one-stitch anastomosis through the skin. The stents were left in place for 3 months postoperatively and then removed. The follow-up period was 3 - 36 months (average 14 months).<b>RESULTS:</b>In 15 patients, 13 patients were cured entirely, 1 patient was meliorated, 1 patient with no effects. All patients had got good recovery of eyelid laceration with no traumatic deformity in eyelid and canthus. Complication was seen in one case, for not followed the doctor’s guidance to come back to hospital to had the suture removed on the 7<sup>th</sup> day after operation, when he came at the 15<sup>th</sup> day, the inferior canalicular wall and eyelid skin were corroded by the suture caused 2mm wound, and the inside silicone tube was exposed, a promptly repair with 10-0 nylon suture was done, the wound healed in a week. There were no early tube protrusions and punctal slits in the patients.<b>CONCLUSION:</b>One-stitch anastomosis through the skin with bicanalicular silicone tube intubation is a good method in repair of bicanalicular laceration in one eye, the cut ends can be anastomosed directly, and with excellent cosmetic results, it is acceptable for the patients. For there is no suture remained in the wound permanently, so there is no suture-related granuloma which may cause obstruction or stenosis of canaliculi. It is simple, economical, effective and safe.]]></description>
<pubDate>2013/10/21 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hai Tao,Peng Wang,Cui Han,Jian Zhang,Fang Bai and Zhao-Yan He]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hai Tao,Peng Wang,Cui Han,Jian Zhang,Fang Bai and Zhao-Yan He</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130520]]></guid><cfi:id>1320</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Characteristics of pupillo-accommodative functions according to time of onset, gender and age in tonic pupil]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130521]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To evaluate the characteristics of pupillo-accommodative functions in patients with idiopathic tonic pupil according to the time of onset, gender, and age.<b>METHODS</b>:Totally, 15 males and 19 females were divided into 2 groups depending on the time of disease onset:group Ⅰ (onset &lt;2 months, <i>n</i>=20) and group Ⅱ (onset &gt;2 months, <i>n</i>=14). A supersensivity test was conducted by applying diluted pilocarpine 0.125% to the eye and accommodative functions were evaluated using the near-point of accommodation (NPA) as the cutoff point, at which the patient experienced blurred vision. Pupil size and the ratio of decrease in the affected pupilafter instillation of 0.125% pilocarpine were investigated.<b>RESULTS:</b>There was no significant difference between the 2 groups regarding the various pupillary reflex results, including data on the affected pupil size before and after 0.125% pilocarpine, anisocoria, and ratio of pupil decrease. No significant difference in NPA was found between the 2 groups. However, female patients were noted to have greater anisocoria and a faster constriction ratio than those of the male patients (<i>P</i>=0.02 and <i>P</i>=0.04). On subgroup analysis, female patients from group Ⅱ had larger affected-pupil sizes before 0.125% pilocarpine instillation and longer NPAs than those of the male patients.<b>CONCLUSION:</b> No relationship was found between time of onset and dysfunction of pupillo-accommodative functions. Pupillo-accommodative functions and age were not related, except for the NPA.]]></description>
<pubDate>2013/10/21 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Kyung-Min Koh and Ungsoo Samuel Kim]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Kyung-Min Koh and Ungsoo Samuel Kim</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130521]]></guid><cfi:id>1319</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Peripapillary retinal nerve fibre layer thickness measurement with SD-OCT in normal and glaucomatous eyes:distribution and correlation with age]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130522]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To determine peripapillary retinal fiber layer thickness (RNFL) measured with spectral domain optical coherence tomography (SD-OCT) in normal and glaucomatous eyes in a large sample of exclusively white population and compare results with other similarly constructed studies.<b>METHODS:</b>Average, maximum, minimum and per quadrant RNFL thickness were measured in normal and glaucomatous Greek patients with a scanning laser ophthalmoscope (SLO)/SD-OCT device. The effect of age in normal RNFL thickness was also determined.<b>RESULTS:</b> A total of 278 normal (278 patients) and 67 glaucomatous (67 patients) eyes were included in the study. Average RNFL thickness was 114.8±13.3μm in normal and 92.1±18.5μm in glaucomatous eyes (<i>P</i>&lt;0.001). In normal discs, superior quadrant was the thickest, followed by the inferior, nasal and temporal. Decline of normal RNFL thickness with age was statistically significant for average RNFL thickness (1.92μm per decade of life) and for the superior and inferior quadrants of the disc.<b>CONCLUSION:</b>SD-OCT peripapillary RNFL measurements can be used to distinguish between normal and glaucomatous eyes and establish normative databases, since normal disc measurements differ between different ethnic groups and between different SD-OCT devices.]]></description>
<pubDate>2013/10/21 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[George Kampougeris,Dimitrios Spyropoulos,Adrianna Mitropoulou,Aggeliki Zografou and Pericles Kosmides]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>George Kampougeris,Dimitrios Spyropoulos,Adrianna Mitropoulou,Aggeliki Zografou and Pericles Kosmides</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130522]]></guid><cfi:id>1318</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of the effects of first and second generation silicone hydrogel contact lens wear on tear film osmolarity Running title:Tear film osmolarity and silicone hydrogel contact lens wear]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130523]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To compare the effects of first and second generation silicone hydrogel (SiH) contact lens wear on tear film osmolarity.<b>METHODS:</b>The healthy subjects who have never used contact lenses before were enrolled in the study. Tear film osmolarity values of 16 eyes (group 1) who wore first generation SiH contact lenses were compared with those of 18 eyes (group 2) who wore second generation SiH contact lenses after three months follow-up.<b>RESULTS:</b> Before contact lens wear, tear film osmolarity of groups 1 and 2 were 305.02±49.08 milliosmole (mOsm) and 284.66±30.18mOsm, respectively. After three months of contact lens wear, osmolarity values were found 317.74±60.23mOsm in group 1 and 298.40±37.77mOsm in group 2. Although osmolarity values for both groups of SiH contact lens wear after three months periods were slightly higher than before the contact lens wear, the difference was not statistically significant.<b>CONCLUSION:</b> Contact lens wear may cause evaporation from the tear film and can increase tear film osmolarity leading to symptoms of dry eye disease. In the current study, there is a tendency to increase tear film osmolarity for both groups of SiH contact lens wear, but the difference is not statistically significant.]]></description>
<pubDate>2013/10/21 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Guzin Iskeleli,Yunus Karakoc,Ahmet Ozkok,Ceyhun Arici,Omer Ozcan and Osman Ipcioglu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Guzin Iskeleli,Yunus Karakoc,Ahmet Ozkok,Ceyhun Arici,Omer Ozcan and Osman Ipcioglu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130523]]></guid><cfi:id>1317</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[The outcomes of pars plana vitrectomy without endotamponade for tractional retinal detachment secondary to proliferative diabetic retinopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130524]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To evaluate the outcomes of pars plana vitrectomy (PPV) without the use of an ocular tamponade in patients having tractional retinal detachment (TRD) secondary to proliferative diabetic retinopathy (PDR).<b>METHODS:</b> It was an interventional study conducted at the Department of Ophthalmology, B.V. Hospital, Bahawalpur, Pakistan, from July 2011 to July 2012. A total of 75 patients (84 eyes) having TRD secondary to PDR were treated by PPV without using an ocular tamponade. All patients included in the study had a tractional retinal detachment secondary to proliferative diabetic retinopathy but didn’t have or develop retinal breaks before or during the study period. The surgical procedure included a PPV combined with the removal of the tractional retinal membranes and the application of endolaser photocoagulation to the retina. The mean follow-up period was 12 months.<b>RESULTS:</b>Successful retinal reattachement was observed in 78 of the operated eyes (92.8%). In these patients, the retina remained attached till the end of the one year follow-up period. Improvement in best corrected visual acuity (BCVA) was seen in 63 eyes (75%). The visual acuity remained unchanged in 9 eyes (10.7%). Mean improvement in BCVA was 2.00+1.24 at baseline to 1.24+1.22 (<i>P</i>&lt;0.05) at the end of the follow-up period.<b>CONCLUSION:</b> In the absence of the retinal breaks, a TRD secondary to PDR can be successfully treated by pars plana vitrectomy without the use of an ocular tamponade.]]></description>
<pubDate>2013/10/21 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Rao Muhammad Rashad Qamar,Muhammad Imran Saleem and Muhammad Farhan Saleem]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Rao Muhammad Rashad Qamar,Muhammad Imran Saleem and Muhammad Farhan Saleem</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130524]]></guid><cfi:id>1316</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Plasma coenzyme Q10 levels in type 2 diabetic patients with retinopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130525]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To determine the relationship between proliferative diabetic retinopathy (PDRP) and plasma coenzyme Q10(CoQ10) concentration.<b>METHODS:</b> Patients with type 2 diabetes and PDRP were determined to be the case group (<i>n</i>=50). The control group was consist of healthy individuals (<i>n</i>=50). Plasma CoQ10 and malondialdehyde (MDA) levels were measured in both groups.<b>RESULTS:</b> Ubiquinone-10 (Coenzyme Q10) levels in PDRP and control subjects are 3.81±1.19μmol/L and 1.91±0.62μmol/L, respectively. Plasma MDA levels in PDRP and control subjects were 8.16±2μmol/L and 3.44±2.08μmol/L, respectively. Ratio of Ubiquinol-10/ubiquinone-10 in PDRP and control subjects were 0.26±0.16 and 1.41±0.68, respectively.<b>CONCLUSION:</b>The ratio of ubiquinol-10/ubiquinone-10 is found lower in patients with PDRP. High levels of plasma ubiquinol-10/ubiquinone-10 ratio indicate the protective effect on diabetic retinopathy.]]></description>
<pubDate>2013/10/21 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Orhan Ates, Habip Bilen, Sadullah Keles, H. Hakan Alp, Mevlüt Sait Kele&#351;, Kenan Y&#305;ld&#305;r&#305;m, Osman &#214;nda&#351;, L. Can P&#305;nar, Mustafa Civelekler and Orhan Baykal]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Orhan Ates, Habip Bilen, Sadullah Keles, H. Hakan Alp, Mevlüt Sait Kele&#351;, Kenan Y&#305;ld&#305;r&#305;m, Osman &#214;nda&#351;, L. Can P&#305;nar, Mustafa Civelekler and Orhan Baykal</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130525]]></guid><cfi:id>1315</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Assessment of the anterior chamber parameters after laser iridotomy in primary angle close suspect using Pentacam and gonioscopy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130526]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To evaluate the changes in the anterior segment parameters of the subjects with primary angle closure suspect (PACS) before and after laser iridotomy (LI) using the Pentacam and gonioscopy.<b>METHODS:</b> Forty-eight eyes of 48 PACS were included. Anterior chamber angle (ACA), central anterior chamber depth (ACD), anterior chamber volume (ACV) and central corneal thickness (CCT) were recorded from the Pentacam before and one month after LI. ACA was graded according to Shaffer classification using the Goldmann gonioscopy.<b>RESULTS:</b> ACA increased significantly from 25.59±4.41 to 26.46±4.33 degrees (<i>P</i>=0.009) and ACV changed from 85.97±16.07mm<sup>3</sup> to 99.25±15.83mm<sup>3</sup> (<i>P</i>=0.000). The changes in ACD, CCT and intraocular pressure were non-significant (<i>P</i>&gt;0.05). Gonioscopy showed significant widening of the Shaffer angle in 4 quadrants (<i>P</i>&lt;0.001).<b>CONCLUSION:</b>Pentacam can serve as the objective instrument in assessing the efficacy of LI.]]></description>
<pubDate>2013/10/21 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Alireza Esmaeili,Behzad Barazandeh,Sina Ahmadi,Alireza Haghi,Seyed Mahdi Ahmadi Hosseini and Fereshteh Abolbashari]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Alireza Esmaeili,Behzad Barazandeh,Sina Ahmadi,Alireza Haghi,Seyed Mahdi Ahmadi Hosseini and Fereshteh Abolbashari</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130526]]></guid><cfi:id>1314</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Fundus autofluorescence imaging of patients with idiopathic macular hole]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130527]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To investigate the role of fundus autofluorescence (FAF) both in the diagnosis and the preoperative and postoperative evaluation of patients with idiopathic macular hole (MH).<b>METHODS:</b> Forty eyes of 40 patients diagnosed as idiopathic MH between May 2010 and May 2011 were included in this retrospective study. All patients underwent full ophthalmologic examinations and imagings including fluorescein angiography, fundus autofluorescence (FAF) and optical coherence tomography. Thirty of these patients underwent MH surgery. FAF findings were associated with duration of symptoms, visual acuity at presentation, stage of MH, and postoperative anatomical correction.<b>RESULTS:</b>The mean duration of patients’ symptoms was 3.8±2.0 (1-9) months. The MH was stage 2 in 4 (10%), stage 3 in 24 (60%) and stage 4 in 12 (30%) eyes. The median preoperative best corrected visual acuity was 20/200 (between 20/800 and 20/100). Twenty-eight of cases (70%) showed a stellate appearance with dark radiating striae. Having a visual acuity ≥20/200 was significantly more common in eyes with stellate appearance (<i>P</i>&lt;0.001). The mean duration of symptoms was significantly shorter in eyes with stellate appearance (2.75±0.8 <i>vs</i> 6.33±1.61 months) (<i>P</i>&lt;0.001). The frequency of stage 4 MH was significantly higher in eyes with non-stellate appearance (<i>P</i>&lt;0.001). Anatomical correction of MH was achieved in 91.3% (21/23) of eyes with stellate appearance and 71.4% (5/7) of eyes without this appearance (<i>P</i>=0.225).<b>CONCLUSION:</b> Stellate appearance in FAF is associated with earlier stages of macular hole, better visual acuity at presentation, shorter duration of symptoms, thus more favorable prognosis.]]></description>
<pubDate>2013/10/21 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mehmet Yasin Teke,Pinar Cakar-Ozdal,Emine Şen,Ufuk Elgin,Pinar Nalcacıoglu-Yuksekkaya and Faruk Ozturk]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mehmet Yasin Teke,Pinar Cakar-Ozdal,Emine Şen,Ufuk Elgin,Pinar Nalcacıoglu-Yuksekkaya and Faruk Ozturk</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130527]]></guid><cfi:id>1313</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinicopathologic features and prognostic factors of malignant eyelid tumors]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130406]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To investigate the clinical characteristics and prognosis of patients with malignant eyelid tumors.<b>METHODS:</b> This was a retrospective, non-randomized, clinical reviews. Between January, 2002 and December, 2011, 75 cases with histologically confirmed malignant eyelid tumors were evaluated. Patients’ charts were reviewed for clinical information, treatment procedure, and disease course. Survival analysis in terms of recurrence-free survival was performed using age, sex, location of tumor and histopathological type. The follow-up ranged from 1 to 78 months (mean=21 months).<b>RESULTS:</b> The 75 eyelid tumors included 35 basal cell carcinoma (BCC, 46.7%), 22 sebaceous gland carcinoma (SGC, 29.3%), 7 squamous cell carcinoma (SCC, 9.3%), 10 malignant melanoma (MM, 13.3%), and 1 Merkel cell carcinoma (MCC, 1.3%). Recurrence developed in 17 cases (22.7%). The recurrence rate of BCC (4/35, 11.4%) was significant lower than MM (6/10, 60.0%, <i>P</i>&lt;0.001). The mean interval of recurrence was 21 months (range 3-62) for all eyelid tumors. Tumor located at canthus had higher recurrence rate (50%) compared with those located at eyelid (19%, <i>P</i>&lt;0.05). Histological type was independent variable for recurrence by Cox regression analysis.<b>CONCLUSION:</b> It is important to achieve a negative tumor margin in canthus located malignant eyelid tumor. Clinicians should have a high level of suspicion for recurrence according to histological type when treating patients with eyelid tumor.]]></description>
<pubDate>2013/8/22 11:25:06</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Chang-Jun Wang,Hui-Na Zhang,Han Wu,Xin Shi,Jia-Jun Xie,Jin-Jing He,Koung-Hoon KooK,Sang-Yeul Lee and Juan Ye]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Chang-Jun Wang,Hui-Na Zhang,Han Wu,Xin Shi,Jia-Jun Xie,Jin-Jing He,Koung-Hoon KooK,Sang-Yeul Lee and Juan Ye</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130406]]></guid><cfi:id>1312</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of trabeculectomy and trabeculectomy with amniotic membrane transplantation in the same patient with bilateral glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130407]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To observe effects of trabeculectomy with amniotic membrane transplantation (AMT) in controlling postoperative intraocular pressure (IOP) in patients with medically uncontrolled glaucoma.<b>METHODS:</b>This study included adult patients with requiring bilateral glaucoma surgery. Each patient underwent trabeculectomy (Non-AMT group) in one eye and with AMT (AMT group) in the other eye according to randomized principle. Success was defined as intraocular pressure (IOP)&lt;21mmHg without any anti-glaucoma medications at 24 months follow-up. The two groups were compared in terms of IOP, complications and success rate.<b>RESULTS:</b> Thirty-four eyes of 17 patients were investigated in this study. There was no statistically signifcant difference in pre-operative IOP between the two groups. The mean IOP was lower in AMT group compared with Non-AMT group on follow up months 12, 18, and 24.Postoperative complications were more frequent in Non-AMT group (35.3%, 6/17) compared with AMT group (5.9%, 1/17). The success rate of surgery was 88.2% (15/17) in Non-AMT group and 100% (17/17) in AMT group.<b>CONCLUSION:</b> Trabeculectomy with AMT is an effective procedure to reduce IOP and complications, thereby improving surgical success rates.]]></description>
<pubDate>2013/8/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Qing-Shan Ji,Bing Qi,Lian Liu,Wei Lao,Zhi-Hao Yang,Gui-Fang Wang,Guo-Cheng Yu and Jing-Xiang Zhong]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Qing-Shan Ji,Bing Qi,Lian Liu,Wei Lao,Zhi-Hao Yang,Gui-Fang Wang,Guo-Cheng Yu and Jing-Xiang Zhong</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130407]]></guid><cfi:id>1311</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison on conjunctival sac bacterial flora of the seniors with dry eye in Ganzi autonomous prefecture]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130408]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To compare the bacterial flora in palpebral conjunctiva of xerophthalmia seniors of Tibetan, Yi and Han, and analyze the differences and similarities of the bacteria.<b>METHODS:</b>The test subjects were selected from 2 Tibetan, 2 Yi and 3 Han populated places, respectively. Total 222 seniors (444 eyes) with dry eye were examined. Secretion was collected from the palpebral conjunctiva of the subjects and then inoculated onto a blood agar plate. After 48h of incubation, the bacteria were examined for the differences and similarities between different ethnics.<b>RESULTS:</b> There was no significant difference (<i>P</i>&gt;0.05) of Gram stain characterization, dominant bacteria and number of the bacterial species present in oxrophthalmia patients among Tibetan, Yi and Han nationalities. The bacteria presented in all groups include <i>staphylococcus epidermidis</i>,<i> corynebacterium</i>,<i> micrococcus luteu</i>,<i> intracellular bacteria sphingomonas</i>,<i> pseudomonas aeruginosa</i>. The bacteria detected from the two of three ethnic groups were <i>staphylococcus aureus</i>,<i> staphylococcus haemolyticus</i>,<i> escherichia coli</i>,<i> kytococcus sedentarius</i>,<i> streptococcus angina</i>,<i> micrococcus lylae</i>,<i> and staphylococcus heads</i>. The incidence rate of bacteria-associated dry eye in Tibetan population was significantly lower than that of Han and Yi population.<b>CONCLUSION:</b>There is no significant difference in the bacteria flora of palpebral conjunctiva observed among dry eye elder populations of Tibetan, Yi and Han people. All of <i>staphylococcus epidermidis</i>,<i> corynebacterium, micrococcus luteu</i>,<i> intracellular bacteria sphingomonas</i>,<i> pseudomonas aeruginosa</i>,<i> staphylococcus aureus, staphylococcus haemolyticus</i>,<i> escherichia coli</i>,<i> kytococcus sedentarius</i>,<i> streptococcus angina</i>,<i> micrococcus lylae </i>and<i> staphylococcus heads </i>are common bacteria flora of the three nationalities inhibiting in this area.]]></description>
<pubDate>2013/8/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yue Zhang,Zhi-Rong Liu,Hui Chen,Ying-Chuan Fan,Ji Duo,Hong Zheng,Guang-Jin Wang,Yu-Chan Li,Dan-Ba Jiachu and Ge-Ma Zewang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yue Zhang,Zhi-Rong Liu,Hui Chen,Ying-Chuan Fan,Ji Duo,Hong Zheng,Guang-Jin Wang,Yu-Chan Li,Dan-Ba Jiachu and Ge-Ma Zewang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130408]]></guid><cfi:id>1310</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Chinese family with atypical granular corneal dystrophy type I caused by the typical R555W mutation in TGFBI]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130409]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To investigate the clinical features and genetic defects in four generations of a Chinese family affected with atypical granular corneal dystrophy type I (GCD type I).<b>METHODS:</b> Family history and clinical data were recorded. Genomic DNA samples were obtained from peripheral blood leukocytes of all participated. Exons of the transforming growth factor-β-induced(<i>TGFBI</i>) gene were directly sequenced after being amplified by polymerase chain reaction (PCR), and multi-point linkage analysis using microsatellite makers flanking the gene was applied to identify the disease-causing mutation.<b>RESULTS:</b> Clinical features were quite variable in patients, some patients only had opacities in the epithelium, and others revealed multiple bilateral circular, discrete, crumb-like opacities mainly in the epithelium, with several in different depths of corneal stroma, and the performance was different bilaterally, even in the same patient. Directly nucleotide sequencing revealed a heterozygous p.R555W mutation in the coding sequence of the <i>TGFBI</i> gene in all affected individuals of the family, but was not found in all unaffected. The maximum logarithm of odds (LOD) score obtained by multi-point analysis was detected at marker locus D5S393 (LOD=2.740; α=1.000).<b>CONCLUSION:</b> Our case presented with clinical futures and the pathogenic mutations in<i> TGFBI </i>gene, the phenotype of the pedigree was quite different from typical GCD type I, so we suggested that this phenotype was a variant of GCD type I. These findings expand the knowledge about GCD type I, and demonstrate that molecular genetic analysis is important to make an accurate diagnosis of patients with variable corneal dystrophies in clinic.]]></description>
<pubDate>2013/8/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Su-Juan Zhao,Ya-Nan Zhu,Xing-Chao Shentu and Qi Miao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Su-Juan Zhao,Ya-Nan Zhu,Xing-Chao Shentu and Qi Miao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130409]]></guid><cfi:id>1309</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Simple keratectomy and corneal tattooing for limbal dermoids:results of a 3-year study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130410]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To evaluate and report the efficacy of combined surgical excision and corneal tattooing in patients with limbal dermoids.<b>METHODS:</b> In a retrospective interventional case series, 9 eyes of 8 patients were treated with combined surgery of simple keratectomy and corneal tattooing for limbal dermoids. Medical records, including best-corrected visual acuity, anterior segment photography, demographic, clinical data, and follow-up information were reviewed.<b>RESULTS:</b> The mean follow up period in this study was 50±15(range 36-77) months. There was no evidence of infection or recurrent limbal dermoids in any of the eyes during the follow-up period. All patients achieved good cosmetic outcomes with no complications.<b>CONCLUSION:</b> Simple keratectomy and corneal tattooing of limbal dermoids could be an alternative option for surgery, especially when a donor cornea is not available.]]></description>
<pubDate>2013/8/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Dong Min Cha,Kyung-Hoon Shin,Keun Ho Kim and Ji-Won Kwon]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Dong Min Cha,Kyung-Hoon Shin,Keun Ho Kim and Ji-Won Kwon</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130410]]></guid><cfi:id>1308</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Corneal endothelial cell density and morphology in low and moderate myopic Chinese eyes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130411]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To describe and compare the corneal endothelial cell density and morphology in young, low and moderate myopic Chinese adults in Malaysian Chinese population.<b>METHODS:</b> Non-contact specular microscopy (Topcon SP3000P, Tokyo, Japan) was performed in low (<i>n</i>=78; 21.22±1.51 years) and moderate (<i>n</i>=78; 21.82±1.40 years) myopic subjects. The mean of three consecutive measurements of endothelial cell density (MCD), coefficient of variation (CV) in the cell size, and hexagonal appearance of the cell were obtained.<b>RESULTS:</b> In low myopic eyes the MCD was 3 063.0±176.2/mm<sup>2</sup>, the mean CV was 33.4±4.0% and the mean hexagonal appearance of the cell was 57.9±2.7%. In moderate myopic eyes the MCD was 2961.6±159.0/mm<sup>2</sup>, the mean CV was 33.9±3.6% and mean hexagonal appearance of the cell was 56.2±4.7%. There were statistically significant differences in MCD (<i>P</i>&lt;0.000) and hexagonal appearance of the cell (<i>P</i>&lt;0.005) between low and moderate myopic eyes.<b>CONCLUSION:</b>The corneal endothelial cell layer in more myopic eyes tends to have less MCD and cell hexagonality compared to lower myopic eyes. Nevertheless, there is no significant difference in CV between low and moderate myopic eyes.]]></description>
<pubDate>2013/8/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Samaneh Delshad and Jane Mei Chun]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Samaneh Delshad and Jane Mei Chun</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130411]]></guid><cfi:id>1307</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of topical 0.05% cyclosporine A on corneal endothelium in patients with dry eye disease]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130412]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To determine the effect of topical 0.05% cyclosporine A (CsA) on corneal endothelium in patients with dry eye disease.<b>METHODS:</b> Observational, prospective, case series study. Fifty-five eyes of 29 consecutive patients (9 males and 20 females; median age:66.8 years, interquartile range:61-73.2 years) with moderate-severe dry eye disease were evaluated. All patients were treated with topical 0.05% CsA ophthalmic emulsion twice a day in addition to lubricant eyedrops 5 times a day. The follow-up period was 12 months. Before treatment and at 3 and 12 months post-treatment central corneal specular microscopy was performed. The endothelial cell density (ECD), coefficient of variation of cell size (CoV), and percentage of hexagonal cells (Hex %) were analyzed.<b>RESULTS:</b> The median ECDs pre-treatment and at 3 and 12 months post-treatment were 2 352.5/mm<sup>2</sup> (interquartile range, 2 178-2 548.5), 2364/mm<sup>2</sup> (interquartile range, 2 174.25-2 657.5), and 2366 cells/mm<sup>2</sup> (interquartile range, 2 174.75-2 539.75), respectively (<i>P</i>=0.927, one way ANOVA). The median CoVs pre-treatment and at 3 and 12 months post-treatment were 34.5 (interquartile range, 30-37), 35 (interquartile range, 30-38), and 34 (interquartile range, 30.75-38.25), respectively (<i>P</i>=0.7193, one way ANOVA). The median Hex % values pre-treatment and at 3 and 12 months post-treatment were 53 (interquartile range, 47-58), 54 (interquartile range, 45.75-59), and 50.5 (interquartile range, 45.75-58), respectively (<i>P</i>=0.824, one way ANOVA).<b>CONCLUSION:</b> Treatment of patients with dry eye disease for 12 months with topical 0.05% CsA does not seem to cause substantial changes on corneal endothelium.]]></description>
<pubDate>2013/8/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Consuelo Pérez-Rico, Francisco Germain, María Castro-Rebollo, Agustín Moreno-Salgueiro and Miguel Angel Teus]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Consuelo Pérez-Rico, Francisco Germain, María Castro-Rebollo, Agustín Moreno-Salgueiro and Miguel Angel Teus</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130412]]></guid><cfi:id>1306</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Spontaneous regression of retinopathy of prematurity:incidence and predictive factors]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130413]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To evaluate the incidence of spontaneous regression of changes in the retina and vitreous in active stage of retinopathy of prematurity(ROP) and identify the possible relative factors during the regression.<b>METHODS:</b> This was a retrospective, hospital-based study. The study consisted of 39 premature infants with mild ROP showed spontaneous regression (Group A) and 17 with severe ROP who had been treated before naturally involuting (Group B) from August 2008 through May 2011. Data on gender, single or multiple pregnancy, gestational age, birth weight, weight gain from birth to the sixth week of life, use of oxygen in mechanical ventilation, total duration of oxygen inhalation, surfactant given or not, need for and times of blood transfusion, 1,5,10-min Apgar score, presence of bacterial or fungal or combined infection, hyaline membrane disease (HMD), patent ductus arteriosus (PDA), duration of stay in the neonatal intensive care unit (NICU) and duration of ROP were recorded.<b>RESULTS:</b> The incidence of spontaneous regression of ROP with stage 1 was 86.7%, and with stage 2, stage 3 was 57.1%, 5.9%, respectively. With changes in zone Ⅲ regression was detected 100%, in zoneⅡ 46.2% and in zoneⅠ 0%. The mean duration of ROP in spontaneous regression group was 5.65±3.14 weeks, lower than that of the treated ROP group (7.34±4.33 weeks), but this difference was not statistically significant (<i>P=</i>0.201). GA, 1min Apgar score, 5min Apgar score, duration of NICU stay, postnatal age of initial screening and oxygen therapy longer than 10 days were significant predictive factors for the spontaneous regression of ROP (<i>P</i>＜0.05). Retinal hemorrhage was the only independent predictive factor the spontaneous regression of ROP (OR 0.030, 95%CI 0.001-0.775, <i>P</i>=0.035).<b>CONCLUSION</b>:This study showed most stage 1 and 2 ROP and changes in zone Ⅲ can spontaneously regression in the end. Retinal hemorrhage is weakly inversely associated with the spontaneous regression.]]></description>
<pubDate>2013/8/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Rui-Hong Ju,Jia-Qing Zhang,Xiao-Yun Ke,Xiao-He Lu,Li-Fang Liang and Wu-Jun Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Rui-Hong Ju,Jia-Qing Zhang,Xiao-Yun Ke,Xiao-He Lu,Li-Fang Liang and Wu-Jun Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130413]]></guid><cfi:id>1305</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Extraocular retinoblastoma in Indian children:clinical, imaging and histopathological features]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130414]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To study eyes with extraocular dissemination (EORB), with the following aims:first to establish the mean lag period and to understand various reasons for delayed presentation, second to study their imaging profiles and third to analyze histopathological features of eyes enucleated after neoadjuvant chemotherapy.<b>METHODS:</b> Prospective study of clinical and imaging features of EORBs (stage Ⅲ and Ⅳ International Retinoblastoma Staging System) presenting to a tertiary eye care centre. Histopathological features of eyes enucleated after receiving neoadjuvant chemotherapy were analyzed. A pictorial illustration of the varied imaging profile of EORB was also presented.<b>RESULTS:</b> Over a period of one year, 97 eyes were diagnosed with retinoblastoma; 32 children (36 eyes) (37.1%) had EORB. Mean age 3.6±1.9 years, 71.9% males, 71.9% unilateral, 3.1% with positive family history and 40.6% with metastasis. On imaging, there was extrascleral involvement in 22.2%, involvement of orbital part of optic nerve in 33.3%, involvement of central nervous system in 27.8% and orbital wall involvement in 2.9% eyes. On histopathological analysis of eyes enucleated after neoadjuvant chemotherapy, 25.0% had no residual viable tumour tissue and rest all tumours were poorly differentiated.<b>CONCLUSION</b>:There are very few human malignancies where definitive treatment is started without any confirmed histopathological diagnosis and imaging plays an important role in diagnosis and appropriate staging of the disease. Chemotherapy has a variable effect on EORB, 75.0% of eyes with EORB had residual viable tumour tissue when enucleated after receiving neoadjuvant chemotherapy.]]></description>
<pubDate>2013/8/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Sumita Sethi,Neelam Pushker,Seema Kashyap,Sanjay Sharma,Mridula Mehta,Sameer Bakhshi,Saurbhi Khurana and Supriyo Ghose]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Sumita Sethi,Neelam Pushker,Seema Kashyap,Sanjay Sharma,Mridula Mehta,Sameer Bakhshi,Saurbhi Khurana and Supriyo Ghose</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130414]]></guid><cfi:id>1304</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Improvement of visual acuity in children with anisometropic amblyopia treated with rotated prisms combined with near activity]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130415]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To evaluate the efficacy of a new modality for improving visual acuity (VA) in pediatric patients with anisometropic amblyopia.<b>METHODS:</b> Retrospective and interventional case series. Medical records of 360 children with anisometropic amblyopia treated with a modality that included rotated prisms, lenses, and near activities from January 2008 to January 2012 were analyzed. Characteristics such as improvement of VA and contrast sensitivity in amblyopic eyes and resolution of amblyopia (VA≤0.1logMAR or a difference of ≤2 lines in logMAR between the eyes) were assessed.<b>RESULTS:</b> Among the patients, the mean VA of the amblyopic eyes improved from 0.48logMAR (SD=0.16) to 0.12logMAR (SD=0.16) and the mean VA improvement was 0.36logMAR (SD=0.10, <i>P</i>&lt;0.001). Resolution of amblyopia was achieved in 233 of 360 patients (64.72%). The mean time for resolution of amblyopia was 8.05 weeks (SD=4.83) or 14.14 sessions (SD=8.76). Among the study group, refraction error did not change significantly after treatment (<i>P</i>=0.437). We found that better baseline VA may be related to success and shorten the time to amblyopic resolution.<b>CONCLUSION:</b> VA and contrast sensitivity improved with rotated prisms, correcting lenses, and near activities in children with anisometropic amblyopia. The VA improvement by this modality was comparable to other methods. However, the time to resolution of amblyopia was shorter with this method than with other modalities. Rotated prisms combined with near acuity could provide an alternative treatment in children with anisometropic amblyopia who can’t tolerant traditional therapy method like patching.]]></description>
<pubDate>2013/8/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Chao-Chyun Lin and Po-Liang Chen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Chao-Chyun Lin and Po-Liang Chen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130415]]></guid><cfi:id>1303</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effectivity of intraoperative adjustable suture technique in horizontal strabismus]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130416]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To compare the long-term effectivity of intraoperative adjustable suture technique with traditional non-adjustable strabismus surgery.<b>METHODS:</b>Two hundred and thirty-three patients, who underwent strabismus surgery either with traditional procedures or one-stage intraoperative adjustable suture technique, were included in our long-term follow-up study. One hundred and eighteen patients were evaluated in traditional surgery group (TSG) and 115 who underwent adjustable suture were in the one-stage intraoperative adjustable surgery group (ASG). In this group 9 patients had paralytic strabismus and 16 had reoperations, 2 patients had restrictive strabismus related to thyroid eye disease. The mean follow up in the TSG was 26.2 months and it was 24.8 months in the ASG group.<b>RESULTS:</b>In patients with exotropia (XT) the mean correction of deviation for near fixation in ASG (32.4±13.2PD) and in TSG (26.4±8.2PD) were similar (<i>P</i>=0.112). The correction for distant fixation in ASG (33.2±11.4PD) and TSG (30.9±7.2PD) were not significantly different (<i>P</i>=0.321). In patients with esotropia (ET) even the mean correction of deviation for both near (31±12PD) and distant (30.6±12.8PD) fixations were higher in ASG than in TSG, for both near (28.27±14.2PD) and distant (28.9±12.9PD) fixations, the differences were not significant (<i>P</i>=0.346, 0.824 respectively). The overall success rate of XT patient was 78.9% in TSG and 78.78% in ASG, the difference was not significant (<i>P</i>=0.629). The success rates were 78.75% in TSG and 75.51% in ASG in ET patient, which was also not significantly different (<i>P</i>=0.821).<b>CONCLUSION:</b>Although patients in ASG had more complex deviation such as paralysis, reoperations and restrictive strabismus, success rates of this tecnique was as high as TSG which did not contain complicated deviation. One-stage intraoperative adjustable suture technique is a safe and effective method for cooperative patient who has complex deviation.]]></description>
<pubDate>2013/8/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ayse Gul Kocak Altintas,Hasan Basri Arifoglu,Inci Kocak Midillioglu,Elif Damar Gungor and Saban Simsek]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ayse Gul Kocak Altintas,Hasan Basri Arifoglu,Inci Kocak Midillioglu,Elif Damar Gungor and Saban Simsek</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130416]]></guid><cfi:id>1302</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Visual performance after conventional LASIK and wavefront-guided LASIK with iris-registration:results at 1 year]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130417]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To compare visual performance of wavefront-guided laser <i>in situ</i> keratomileusis (LASIK) with iris-registration (Wg-LASIK group) and conventional LASIK (LASIK group) one year after surgery and analyze the correlation between wavefront aberrations and visual performance.<b>METHODS:</b> Eight hundred and fifty-two myopic eyes of 430 patients were enrolled in this prospective study and divided into two groups:Wg-LASIK group (436 eyes) and LASIK group (416 eyes). A Wavescan Wavefront aberrometer was used to analyze Zernike coefficients and the root-mean-square (RMS) of higher order aberrations, and Optec 6500 visual function instrument was used to measure contrast sensitivity (CS) before and 3, 6, 12 months after surgery.<b>RESULTS:</b>The mean spherical equivalent (SE) in Wg-LASIK group was significantly better than those in LASIK group one year after surgery (<i>P</i>=0.024). Wg-LASIK eyes showed better CS values than LASIK eyes at all spatial frequencies with and without glare after surgery (<i>P </i>all&lt;0.01). Moreover, the increase of higher RMS (RMSh), coma, RMS3, RMS4, RMS5 in Wg-LASIK group were significantly lower than those in LASIK group 1 year after surgery (<i>P </i>all&lt;0.05). The increase of coma, spherical aberration (SA), RMS3 and RMS4 in Wg-LASIK and coma and RMS3 in LASIK group were negatively correlated with reduction of contrast sensitivity 1 year after surgery.]]></description>
<pubDate>2013/8/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jing Zhang,Yue-Hua Zhou,Rui Li and Lei Tian]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jing Zhang,Yue-Hua Zhou,Rui Li and Lei Tian</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130417]]></guid><cfi:id>1301</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Change in subfoveal choroidal thickness after argon laser panretinal photocoagulation]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130418]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To evaluate changes in subfoveal choroidal thickness (SFCT) and macular thickness as measured by enhanced depth imaging spectral-domain optical coherence tomography (EDI-OCT) after argon laser panretinal photocoagulation (PRP) in patients with severe diabetic retinopathy.<b>METHODS:</b>This prospective, comparative case series included 21 patients (28 eyes) with severe diabetic retinopathy. All patients underwent three sessions of PRP. The SFCT and macular thickness were measured using EDI-OCT at baseline and one week after completion of 3 sessions of PRP.<b>RESULTS:</b>SFCT before PRP was (318.1±96.5)μm and increased to (349.9±108.3)μm (<i>P</i>=0.001) after PRP. Macular thickness significantly increased at one week after PRP (from 273.1±23.9μm at baseline <i>vs</i> 295.8±25.3μm at one week; <i>P</i>&lt;0.001). No significant relationship between the changes in macular thickness and SFCT was observed (<i>r</i>=-0.13, <i>P</i>=0.52).<b>CONCLUSION:</b> PRP induced increases in both SFCT and macular thickness. Changes in SFCT did not correlate with changes in macular thickness.]]></description>
<pubDate>2013/8/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ga Eun Cho,Hee Yun Cho and Yun Taek Kim]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ga Eun Cho,Hee Yun Cho and Yun Taek Kim</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130418]]></guid><cfi:id>1300</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of anterior segment measurements using rotating Scheimpflug imaging and partial coherence interferometry]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130419]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>METHODS:</b>As part of the first phase of Shahroud Eye Cohort Study with 5 190 subjects of 40 to 64 years of age, CCT and ACD were measured using Scheimpflug imaging with the Pentacam (Oculus, Inc., Lynnwood, WA, USA) and partial coherence interferometry with the Allegro BioGraph (Wavelight, Erlangen, Germany).<b>RESULTS:</b>After applying exclusion criteria, we had data of 4 387 subjects with a mean age of 50.7±6.2 years. Mean CCT with Pentacam and BioGraph were 528.6±33.2μm and 525.6±32μm respectively; the difference was statistically significant (<i>P</i>&lt;0.001), but the correlation was high (R=0.920). Mean ACD measurements using Pentacam and BioGraph  were 2.68±0.35mm and 2.62±0.33mm respectively; the inter-device difference was significant (<i>P</i>&lt;0.001) with high correlation (R=0.944). The 95% limits of agreements between devices were -22.65μm to 28.61μm and -0.16mm to 0.29mm for CCT and ACD measurements, respectively.<b>CONCLUSION:</b>For both CCT and ACD, the BioGraph gave significantly lower values than the Pentacam (<i>P</i>&lt;0.05). Despite the high inter-device correlation, the 95% limits of agreements were wide, and this may limit their interchangeability in measuring the CCT and ACD.]]></description>
<pubDate>2013/8/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mohammad Soleimani,Hassan Hashemi,Shiva Mehravaran,Mehdi Khabazkhoob,Mohammad Hassan Emamian,Mohammad Shariati and Akbar Fotouhi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mohammad Soleimani,Hassan Hashemi,Shiva Mehravaran,Mehdi Khabazkhoob,Mohammad Hassan Emamian,Mohammad Shariati and Akbar Fotouhi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130419]]></guid><cfi:id>1299</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Ultrasound biomicroscopic evaluation of anterior segment cysts as a risk factor for ocular hypertension and closure angle glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130420]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM</b>:To investigate the relationship between the ultrasound biomicroscopic (UBM) features of anterior-segment cysts (ASCs) and increased intraocular pressure (IOP) as a risk factor for closed-angle glaucoma (CAG).<b>METHODS</b>:Totally 24 eyes with recently diagnosed ASCs were divided into two groups . First group with ASC and ocular normotension (<i>n</i>=13), second group with ASC and ocular hypertension (<i>n</i>=11). An ophthalmologic examination, including tonometry, slit-lamp biomicroscopy (SLBM), gonioscopy, fundoscopy, pentacam, and UBM, was performed. The features of the ASCs were compared with the IOP.<b>RESULTS</b>:ASCs were accurately diagnosed and delineated in 24 eyes using UBM. IOP was elevated in those ASCs with a secondary aetiology (<i>P</i>=0.027), iridociliary location (<i>P</i>=0.006), deformed shape (<i>P</i>=0.013), increased size (<i>P</i>=0.001) and elongated pupillary aperture (<i>P</i>=0.009). However, the count (<i>P</i>=0.343) of ASCs, anterior chamber depth (ACD; <i>P</i>=0.22) and axial lenght (AL; <i>P</i>=0.31) were not associated with ocular hypertension. Correlations were found between the IOP and ASC size (<i>r</i>=-0.712; <i>P</i>=0.003), anterior chamber angle (ACA; <i>r</i>=-0.985; <i>P</i>&lt;0.001), angle opening area (AOA; <i>r</i>=0.885; <i>P</i>&lt;0.001), angulation of iris (<i>r</i>=-0.776, <i>P</i>&lt;0.001), and affected iris quadrant (<i>r </i>=-0.655, <i>P</i>=0.002).<b>CONCLUSION</b>:Ocular hypertension in some eyes with ASC might be associated with various mechanisms, including secondary aetiology, iridociliary location, deformed shape, increased size and elongated pupill, which can be determined by UBM.]]></description>
<pubDate>2013/8/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Abdurrahim Dusak,Mehmet Baykara,Guven Ozkaya,Cuneyt Erdogan,Hikmet Ozcetin and Ercan Tuncel]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Abdurrahim Dusak,Mehmet Baykara,Guven Ozkaya,Cuneyt Erdogan,Hikmet Ozcetin and Ercan Tuncel</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130420]]></guid><cfi:id>1298</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Measurements of anterior segment parameters using three different non-contact optical devices in keratoconus patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130421]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To evaluate the measurements of anterior segment parameters using three different non-contact optical devices in keratoconus patients.<b>METHODS:</b>A hundred and one eyes of 55 keratoconus patients were enrolled in this study. The mean age was 26.2±8.9 years. The inclusion criteria were keratoconus stage I to III according to the Amsler-Krumeich keratoconus classification. All the measurements were done by the same operator, under the mesopic light condition and repeated with three different optical methods; Visante , Orbscan and Pentacam. The evaluated anterior segment parameters were anterior chamber depth (ACD), central and thinnest corneal thickness (CCT and TCT) and pupil diameter (PD).<b>RESULTS:</b> The mean CCT measured by Visante, Orbscan and Pentacam were as follows:462.0±48.1μm, 463.9±60.9μm, 476.5±45.3μm, respectively (<i>P</i>=0.873). The mean ACD values were 3.34±0.33mm, 3.26±0.33mm, 3.49±0.40mm, respectively (<i>P</i>=0.118). The mean PD measurements were 5.11±1.14mm, 4.80±0.85mm, 3.80±1.38mm, respectively (<i>P</i>&lt;0.001). The mean TCT measurements of Visante, Orbscan and Pentacam were 437.9±48.2μm, 447.6±60.6μm and 459.9±44.0μm, respectively (<i>P</i>=0.214). The Visante and Orbscan measured CCT similarly, while Pentacam measured CCT thicker than the other two. The Visante measured TCT thinner than the other two devices. In ACD measurements, Orbscan was the one giving the lowest values. PD was measured differently by the devices.<b>CONCLUSION:</b> Although TCT, CCT and ACD measurements acquired by Visante, Orbscan and Pentacam in keratoconus patients are similar, PD measurements show large differences among the devices.]]></description>
<pubDate>2013/8/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ahmet Taylan Yaz&#305;c&#305;, G&#246;khan Pekel, Ercüment Bozkurt, Yusuf Y&#305;ld&#305;r&#305;m, Evre Pekel, Ahmet Demirok and &#214;mer Faruk Y&#305;lmaz]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ahmet Taylan Yaz&#305;c&#305;, G&#246;khan Pekel, Ercüment Bozkurt, Yusuf Y&#305;ld&#305;r&#305;m, Evre Pekel, Ahmet Demirok and &#214;mer Faruk Y&#305;lmaz</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130421]]></guid><cfi:id>1297</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Vitreo</b>-<b>retinal interface changes on optical coherence tomography in the fellow eyes of patients with macular hole]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130422]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To study the vitreo-retinal interface and macular changes on optical coherence tomography (OCT) in the fellow eyes of patients with macular hole.<b>METHODS:</b> Patients with idiopathic macular hole in one or both eyes presented to our institute between January 2003 and December 2009 were evaluated retrospectively. Demographic details, best-corrected visual acuity and vitreo-retinal interface, and macular changes of the fellow eye on OCT were studied.<b>RESULTS:</b> Seventy patients underwent OCT of both eyes during the study period. The average age group was 61.96 years and 35 (50%) were females. Among the fellow eyes, normal foveal contour was noted in 36 (51.4%) eyes and 34 (48.6%) eyes were observed to have vitreo-retinal interface changes. Of them, 13 (18.6%) eyes had some stage of full thickness macular hole and 21 (30.0%) eyes had interface changes. There was no statistical correlation between involved eye lesions (<i>P</i>=0.64) or visual acuity (<i>P</i>=0.55) as predictors of development of either fellow eye lesions or poor visual acuity.<b>CONCLUSION:</b>There is a significant chance of having vitreo-retinal interface findings in the fellow eyes of patients presenting with macular hole. OCT should be considered in both eyes of patients with macular hole to detect early changes in the fellow eyes, which may require an early intervention.]]></description>
<pubDate>2013/8/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ajit Babu Majji,Jay Kumar Chhablani and Bupesh Bagga]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ajit Babu Majji,Jay Kumar Chhablani and Bupesh Bagga</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130422]]></guid><cfi:id>1296</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Changes of total antioxidant capacity and total oxidant status of aqueous humor in diabetes patients and correlations with diabetic retinopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130423]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To measure changes of total oxidant status (TOS) and total antioxidant capacity (TAC) of aqueous humor (AH) in diabetic retinopathy (DR) patients, and to determine if there were any differences in TOS and TAC of AH in diabetic patients without retinopathy compared with non-diabetic patients.
    
    <b>METHODS:</b>One hundred and three eyes of 103 patients who were enrolled for cataract surgery were included in this study. Patients were grouped according to presence of diabetes and stage of DR. Prior to cataract surgery, 0.1mL to 0.2mL of AH was aspirated and analyzed for TAC and TOS level using a colorimetric method.
    
    <b>RESULTS:</b>TOS levels were highest among proliferative diabetic retinopathy (PDR) patients and lowest in patients with only cataracts. Results were statistically significant between all groups (<i>P</i>&lt;0.05). Whereas result between diabetic without retinopathy patients and non-proliferative diabetic retinopathy (NPDR) patients was not statistically significant (<i>P</i>=0.757). TAC levels were highest in patients with only cataract and lowest among PDR patients and results were statistically significant between all groups (<i>P</i>&lt;0.05).
    
    <b>CONCLUSION:</b>Aqueous humor TAC levels are low in diabetic patients and reduced further in DR patients, TOS levels are increased in diabetic patients and this is exacerbated in DR patients.]]></description>
<pubDate>2013/8/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Emrullah Beyazy&#305;ld&#305;z, Ali Bülent &#199;ankaya, Esra Ergan, Mustafa Alparslan Anayol, Yasemin &#214;zdamar, Sevilay Sezer, Mehmet Hakan T&#305;rh&#305;&#351;, Pelin Y&#305;lmazba&#351; and Faruk &#214;ztürk]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Emrullah Beyazy&#305;ld&#305;z, Ali Bülent &#199;ankaya, Esra Ergan, Mustafa Alparslan Anayol, Yasemin &#214;zdamar, Sevilay Sezer, Mehmet Hakan T&#305;rh&#305;&#351;, Pelin Y&#305;lmazba&#351; and Faruk &#214;ztürk</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130423]]></guid><cfi:id>1295</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effects of phacoemulsification surgery on ocular hemodynamics]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130424]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To evaluate the possible effects of phacoemulsification cataract surgery on ocular hemodynamics.<b>METHODS:</b>In this prospective study, intraocular pressure (IOP), pulsatile ocular blood flow (POBF), and ocular pulse amplitude (OPA) were measured pre-operatively (baseline) and at 1 week and 3 weeks postoperation in 52 eyes of 26 patients (mean age 63.15±10.25 years) scheduled for unilateral phacoemulsification cataract surgery with intraocular lens implantation. In all of the eyes, a blood flow analyzer (Paradigm DICON; Paradigm Medical Industries Inc.; USA) was used to obtain measurements of IOP, POBF, and OPA. The data obtained from operated eyes were compared statistically to untreated fellow phakic eyes of the patients.<b>RESULTS:</b> For operated eyes, the mean baseline IOP, POBF, and OPA values were 15.9±4.64mmHg, 17.41±4.84μL/s, and 2.91±1.12mmHg, respectively. The IOP, POBF, and OPA values were 17.19±4.34mmHg, 17.56±6.46μL/s, and 3.12±1.1mmHg, respectively, in the nonoperated control eyes. Statistically significant differences from baseline measurements were not observed 1 week and 3 weeks postoperation for the operated or nonoperated eyes. There were also no statistically significant differences in any measurements between the operated and nonoperated eyes in all the examination periods (<i>P</i>&gt;0.05 for all).<b>CONCLUSION:</b> Uncomplicated phacoemulsification surgery does not affect ocular hemodynamics in normotensive eyes with cataracts.]]></description>
<pubDate>2013/8/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Adem Turk,Suleyman Mollamehmetoglu,Halil Ibrahim Imamoglu,Mehmet Kola,Hidayet Erdol and Nurettin Akyol]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Adem Turk,Suleyman Mollamehmetoglu,Halil Ibrahim Imamoglu,Mehmet Kola,Hidayet Erdol and Nurettin Akyol</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130424]]></guid><cfi:id>1294</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Ethambutol induced toxic optic neuropathy in HIV positive patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130425]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To determine whether HIV and the use of antiretroviral therapy is a risk factor for the development of ethambutol toxic optic neuropathy. To describe the clinical course of ethambutol toxic optic neuropathy in patients with HIV and to identify prognostic factors.<b>METHODS:</b> The case notes of 14 consecutive patients referred to the neuro-ophthalmology clinic were reviewed. Data regarding HIV status, antiretroviral therapy, visual function, ethambutol therapy dosage, and ethambutol therapy duration were collected and analysed.<b>RESULTS:</b> Eleven of the 14 patients were HIV positive. Ten of the HIV positive patients were receiving antiretroviral therapy. The mean dose of ethambutol was 17.25mg/kg/day. No statistically significant difference in mean dose, duration of therapy, age or CD4 count was found between those who showed visual improvement and those who did not. Delay in presentation of more than one month post symptom onset was correlated with poor visual outcome (<i>P</i>=0.001).<b>CONCLUSION:</b>HIV and, perhaps more importantly, the potential mitochondrial toxic effects of Nucleoside analogue reverse transcriptase inhibitors (NRTIs) may be a risk factor for the development of toxic optic neuropathy from ethambutol therapy via a multiple hit effect. Delay in presentation results in poor visual outcome. Regular monitoring is recommended for HIV positive patients receiving antiretrovirals and requiring ethambutol therapy in order to avoid permanent visual loss.]]></description>
<pubDate>2013/8/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hamzah Mustak,Graeme Rogers and Colin Cook]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hamzah Mustak,Graeme Rogers and Colin Cook</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130425]]></guid><cfi:id>1293</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Relationship between higher-order aberrations and myopia progression in schoolchildren:a retrospective study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130307]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM</b>:To investigate the relationship between higher-order aberration (HOA) and myopic progression in school children.<b>METHODS</b>:Between April 23, 2011 and August 29, 2011 in the children’s myopia outpatient clinic of the West China Hospital of Sichuan University, 148 eyes of 74 schoolchildren were reviewed. HOAs for a 6-mm pupil were measured with an aberrometer. Myopic progression rate was defined according to the change in spherical equivalent refraction (SER) divided by the time span (years). Subjects with myopic progression rate of ≥0.50 diopters (D) were classified as the ‘fast’ group and the subjects with myopic progression rate of &lt;0.50D were classified as the ‘slow’ group. A retrospective study was conducted to compare HOA between the two groups, using root mean square (RMS) values and Zernike coefficients.<b>RESULTS:</b> The RMS values of HOA (<i>t</i>=2.316, <i>P</i>=0.02), HOA without Z4<sup>0</sup> (<i>t</i>=2.224, <i>P</i>=0.03), third-order aberrations (<i>t’</i>=2.62, <i>P</i>=0.01), and coma (<i>t’</i>=2.49, <i>P</i>=0.01) were significantly higher in the fast group than those in the slow group. The individual Zernike coefficients of Z3<sup>-1 </sup>(<i>t</i>=-2.072, <i>P</i>=0.04) and Z5<sup>1</sup> (<i>Z</i> =-2.627, <i>P</i>=0.01) displayed statistically significant differences between the two groups. Significant correlations were found between the RMS values of HOA (<i>r</i>=0.193, <i>P</i>=0.019), RMS values of HOA without Z4<sup>0 </sup>(<i>r</i>=0.23, <i>P</i> =0.005), RMS values of coma (<i>r</i>=0.235, <i>P</i>=0.004), RMS values of third-order aberrations (<i>r</i>=0.243, <i>P</i> =0.003), and the progression rate.<b>CONCLUSION:</b>Our results provide evidence of a relationship between HOA and myopic progression. In a future prospective longitudinal study, we aim to verify whether HOA is a risk factor for myopic progression.]]></description>
<pubDate>2013/6/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ning Zhang,Xu-Bo Yang,Wen-Qiu Zhang,Long-Qian Liu,Guang-Jing Dong,Tao-Wen Chen,Meng Liao and Xuan Liao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ning Zhang,Xu-Bo Yang,Wen-Qiu Zhang,Long-Qian Liu,Guang-Jing Dong,Tao-Wen Chen,Meng Liao and Xuan Liao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130307]]></guid><cfi:id>1292</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Visual outcome and optical quality after bilateral implantation of aspheric diffractive multifocal, aspheric monofocal and spherical monofocal intraocular lenses:a prospective comparison]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130308]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To evaluate the visual function after bilateral implantation of aspheric diffractive multifocal Tecnis ZMA00, aspheric monofocal ZA9003 versus spherical monofocal Akreos Adapt intraocular lenses (IOLs).<b>METHODS:</b>Tecnis ZMA00, Tecnis ZA9003 or Akreos Adapt IOLs were bilaterally implanted in 180 eyes from 90 patients. The following parameters were assessed 3 months postoperatively:monocular and binocular uncorrected visual acuity (UCVA) and distance-corrected visual acuity (DCVA) for distance, intermediate and near, spherical aberration (SA), contrast and glare sensitivity, near point refractive power, uncorrected and best-corrected near stereoscopic acuity (NSA). Patient satisfaction was assessed by a questionnaire.<b>RESULTS:</b>Three months postoperatively, the monocular and binocular UCVA and DCVA at near of Tecnis ZMA00 were significantly better than other two groups. The mean SA for 5.0mm optical zone in Tecnis ZMA00 and Tecnis ZA9003 was significantly lower than that in Akreos Adapt. Mean contrast sensitivity and glare sensitivity were better for Tecnis ZA9003 group than for other two groups. Patients with Tecnis ZMA00 had higher monocular and binocular near point refractive power and uncorrected NSA than monofocal groups. The patients in Tecnis ZMA00 had higher mean values for halo compared with other two groups.<b>CONCLUSION:</b>Tecnis ZMA00 provided better near VA and uncorrected NSA and higher near point refractive power than monofocal IOLs and patients were spectacle independent. The IOLs with Tecnis aspheric design improved contrast and glare sensitivity. Patients with Tecnis ZMA00 reported more disturbances on visual phenomena of halo.]]></description>
<pubDate>2013/6/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Pan-Pan Ye,Xia Li and Ke Yao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Pan-Pan Ye,Xia Li and Ke Yao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130308]]></guid><cfi:id>1291</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Characteristics of ocular abnormalities in gout patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130309]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b><i></i>To characterize the clinical features of ocular surface in gout patients in coastal area of Shandong Province in China.<b>METHODS:</b>A total of 380 consecutive gout patients were examined from January 2011 to May 2011. According to the course of gout, patients were divided into group A (&lt;5 years), B (5-10 years) and C (&gt;10 years). Group D (control group) was consist of 50 healthy subjects. Eyelids, lateral canthus, medial canthus, palpebral conjunctiva, sclera and cornea, anterior chamber, lens, anterior vitreous were examined by slit lamp to find whether there were deposition of uric acid crystals, ocular vascular tortuosity, redness and subconjunctival hemorrhage. The ophthalmic exams of visual acuity, intraocular pressure, fundus were used to assess any gout-related eye disease.<b>RESULTS:</b>Uric acid crystals were found in 3 patients and the positions of the deposite were in corneal stroma, corneal epithelium and superficial stroma, and sclera respectively. The incidence was 0.79%. Dilatated and tortuous blood vessels in conjunctiva and sclera surface were found in 38 (23.8%), 40 (44.0%), 58 (45.0%), 9 (18.0%) patients in groups A, B, C and D, respectively.  The differences between group B and D, group C and D were statistically significant (<i>P</i>&lt;0.01, <i>P</i>&lt;0.01). Transparent vesicles with metal-like reflected light in subconjunctiva were seen in 26 (16.2 %), 29 (31.9%), 41 (31.8%), 2 (4.00%) patients in groups A, B, C and D, respectively. The differences between A and D, B and D, C and D were statistically significant (<i>P</i>&lt;0.05, <i>P</i>&lt;0.01, <i>P</i>&lt;0.01). Subconjunctival hemorrhage was found in all groups, the difference among the four groups showed no statistically significance.<b>CONCLUSION:</b>Gout can cause ocular surface abnormalities, such as tophi deposition, subconjunctival transparent vesicles and hemorrhage, and vascular changes. These features have important clinical significance in early detection of the gout and prevention of eye injury.]]></description>
<pubDate>2013/6/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jing Lin,Gui-Qiu Zhao,Cheng-Ye Che,Shan-Shan Yang,Qian Wang and Chang-Gui Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jing Lin,Gui-Qiu Zhao,Cheng-Ye Che,Shan-Shan Yang,Qian Wang and Chang-Gui Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130309]]></guid><cfi:id>1290</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of TGF-β1 in tears and corneal haze following Epi-LASIK with and without mitomycin C]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130310]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To compare transforming growth factor-β1 (TGF-β1) levels in tears and the degree of corneal haze formation following epithelial laser <i>in situ</i> keratomileusis (Epi-LASIK) with and without the use of mitomycin C (MMC) and to investigate the effect of MMC on corneal wound healing.<b>METHODS:</b>Thirty-two patients (64 eyes) with high myopia underwent Epi-LASIK surgery, and MMC was randomly used in one eye in each patient. The epithelialization process was observed, and the TGF-β1 level in tears was measured at 1 day, 3, and 7 days postoperatively for comparison with baseline. Corneal haze was graded at 1 month, 3, and 6 months after surgery.<b>RESULTS:</b>Mean preoperative spherical equivalent refraction was -8.24±2.18D (range -6.00 to -10.50D) in the MMC group and -7.82±1.55D (range -6.00 to -9.75D) in the non-MMC group. There was no significant difference between the two groups (<i>P</i>=0.38). Mean epithelialization time was (5.02±0.68) days in the MMC group and (4.86±0.57) days in the non-MMC group (<i>P</i>=0.31). Tear fluid TGF-β1 levels were similar before surgery (<i>P</i>=0.34), but were significantly higher in the non-MMC group at 1 day, 3, and 7 days postoperatively (<i>P</i>=0.004, 0.008, and 0.012, respectively). Corneal haze scores 1 month after surgery were significantly higher in the non-MMC group (<i>P</i>=0.03), and similar at 3 and 6 months after surgery (<i>P</i>=0.28 and 0.62, respectively).<b>CONCLUSION:</b>MMC did not delay epithelialization. In early postoperative period, lower TGF-β1 levels in tears and a lower grade of corneal haze were observed in the MMC group. Our findings suggest that the ability of MMC to inhibit Epi-LASIK-induced haze might be mediated through TGF-β1 suppression.]]></description>
<pubDate>2013/6/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jing Chen,Yi Chen and Su-Ning Han]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jing Chen,Yi Chen and Su-Ning Han</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130310]]></guid><cfi:id>1289</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Ahmed valve implantation for neovascular glaucoma after 23-gauge vitrectomy in eyes with proliferative diabetic retinopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130311]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To report on the outcome of Ahmed glaucoma valve (AGV) implantation for the management of neovascular glaucoma (NVG) after 23-gauge vitrectomy for proliferative diabetic retinopathy (PDR).<b>METHODS:</b> Twelve medically uncontrolled NVG with earlier 23-gauge vitrectomy for PDR underwent AGV implantation. The control of intraocular pressure (IOP), preoperative and postoperative best-corrected visual acuity,  the development of intraoperative and postoperative complications were evaluated during the follow-up.<b>RESULTS:</b> The mean follow-up was 15.4±4.3 months (9-23 months). Mean preoperative IOP was 49.4±5.1mmHg and mean postoperative IOP at the last visit was 17.5±1.6mmHg. The control of IOP was achieved at the final follow-up visits in all patients, however, 8 of 12 patients still needed anti-glaucoma medication (mean number of medications, 0.8±0.7). The visual acuity improved in nine eyes, and the visual acuity unchanged in three eyes at the final follow-up visits. The complications that occurred were minor hyphema in three eyes, choroid detachment in two eyes, and the minor hyphema and choroid detachments were reabsorbed without any surgical intervention.<b>CONCLUSION:</b> AGV implantation is a safe and effective procedure that enables successful IOP control and vision preservation in the NVG patients with the history of earlier 23-gauge vitrectomy for PDR.]]></description>
<pubDate>2013/6/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yu Cheng,Xiao-Hong Liu,Xi Shen and Yi-Sheng Zhong]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yu Cheng,Xiao-Hong Liu,Xi Shen and Yi-Sheng Zhong</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130311]]></guid><cfi:id>1288</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Unrecognized and unregistered blindness in people 70 or older in Jing’an district, Shanghai, China]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130312]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To evaluate the efficacy of a registration system for the blind people and to monitor the blindness due to uncorrected refractive error and cataract in Jing’an district, Shanghai, China.#$NL<b>METHODS:</b> Five hundred and ten blind people, based on visual acuity screening in a population aged 70 or older were enrolled into the study. Four hundred and forty subjects were interviewed. The following data were collected on each patient:demographic data, number of hospital visits for eye related problems, distance visual acuity, visual fields, ophthalmic diagnoses, education and registration status. If the eligible subject was not registered as blind, the reason for non-registration was recorded.#$NL<b>RESULTS:</b> Ten point nine one percent blindness was due to cataract, 27.5% due to uncorrected refractive error, and only 61.59% met the eligible blindness criteria (uncorrected refractive error and cataract are not considered as eligible blindness). The first four leading causes of eligible blindness were age related macular degeneration (25.09%), myopic macular degeneration (21.40%), glaucoma (18.82%) and corneal disease (8.12%). Only 68.27% eligible blind people were registered. The patients with macular degeneration and glaucoma tended not to register. Blind people with an above primary school education were 2.59 times more likely to be registered than those who were illiterate or had only a primary school education (OR=2.59, 95%CI:1.49-4.48, <i>P</i>&lt;0.01). Patients who had 4 or more visits to the hospital requesting eye care services in a year were 2.2 times more likely to be registered than those with less than 4 visits to the hospital (OR=2.54, 95%CI:1.47-4.38, <i>P</i>&lt;0.001). The first two leading reasons of misregistration were unknowing the registration system (48%) and unwilling to register (21%). #$NL<b>CONCLUSION:</b> Under-registration of the eligible blind people exists in the registry system. Education and the number of hospital visits for eye care services were factors associated with registration levels. Uncorrected refractive error and cataract are important causes of blindness.]]></description>
<pubDate>2013/6/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Liang-Cheng Wu,Xing-Huai Sun,Xing-Tao Zhou and Cheng-Hai Wen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Liang-Cheng Wu,Xing-Huai Sun,Xing-Tao Zhou and Cheng-Hai Wen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130312]]></guid><cfi:id>1287</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Factors affecting visual outcome of myopic choroidal neovascularization treated with verteporfin photodynamic therapy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130313]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To evaluate the visual outcomes of choroidal neovascularization (CNV) secondary to pathological myopia and the impact of novel risk factors affecting the final visual outcome.<b>METHODS:</b>Interventional case series of 18 consecutive patients with pathological myopia treated with photodynamic therapy (PDT). Inclusion criteria were spherical equivalent  -6D or worse or features of pathological myopia on retinal examination. The main outcome measure was final best-corrected visual acuity (BCVA).<b>RESULTS:</b>Of 18 eyes, 13 (72.2%) avoided moderate visual loss (≥3 lines of LogMAR BCVA) and 5 eyes (27.8%) improved by at least 1 line after 1 year. Patients with LogMAR BCVA ≤0.3 (Snellen equivalent 20/40) at one year were younger than those with BCVA &gt;0.3 (mean age 39.0 <i>vs</i> 61.6 years, <i>P</i>=0.001). A higher proportion of eyes with greatest linear dimension (GLD) of ≤1000μm avoided moderate visual loss (100% <i>vs</i> 50%, <i>P</i>=0.026). Among patients who were treated within 2 weeks of visual symptoms, 88.9% avoided the loss of 3 or more lines compared to 55.6% for those who presented later. The mean improvement in LogMAR BCVA of those with GLD ≤1000μm was +0.12 compared to a loss of 0.55 LogMAR units for those with GLD &gt;1000μm (<i>P</i>=0.02). Visual outcomes were not associated with gender or refractive error.<b>CONCLUSION:</b> Good visual outcome in myopic CNV is associated with younger age, smaller lesion size and earlier initiation of treatment. These factors are relevant for ophthalmologists considering treatment options for myopic CNV.]]></description>
<pubDate>2013/6/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Colin S. Tan,Milton C. Chew,Kai-Hung Lim and Tock-Han Lim]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Colin S. Tan,Milton C. Chew,Kai-Hung Lim and Tock-Han Lim</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130313]]></guid><cfi:id>1286</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Factors influencing stereoacuity levels after surgery to correct unilateral developmental cataracts in children]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130314]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>Toevaluate factors influencing stereoacuity after surgery to correct unilateral developmental pediatric cataracts.<b>METHODS:</b>We retrospectively surveyed110 patients who had undergone removal of unilateral acquired developmental cataracts and primary posterior chamber intraocular lens implantation between February 1992 and December 2009. In all patients, stereoacuity was assessed using the Titmus test at the last follow-up period of minimum 2 years after surgery. Patients were divided into two groups according to the extent of stereoacuity:group 1 (<i>n</i>=42) had stereoacuity values≤100sec/arc and group 2 (<i>n</i>=68) values &gt;100sec/arc. The values of ten parameters associated with stereoacuity were measured in each group:Cataract types, preoperative best corrected visual acuity (BCVA) of the affected eyes, preoperative inter-ocular difference of BCVA, age at cataract surgery, operative method, secondary cataract, postoperative strabismus, postoperative BCVA of the affected eyes, postoperative inter-ocular difference of BCVA, and anisometropia.<b>RESULTS:</b>The extent of stereoacuity was significantly associated with both operative method and secondary cataract (<i>P</i>=0.000 and <i>P</i>=0.016, respectively). All patients in whom the posterior capsule was preserved, had poor stereoacuity &gt;100sec/arc. Significant correlations with the extent of stereoacuity were found with postoperative strabismus (<i>P</i>=0.048), postoperative BCVA of the affected eyes (<i>P</i>=0.002), anisometropia (<i>P</i>=0.034).<b>CONCLUSION</b>:Postoperative stereoacuity was better in patients who underwent either optic capture or anterior vitrectomy after posterior continuous curvilinear capsulorhexis, and who didn’t develop secondary cataracts or strabismus postoperatively. Furthermore, postoperative BCVA of the affected eyes, and anisometropia influenced the stereoacuity of the patients surgically treated for unilateral developmental pediatric cataracts.]]></description>
<pubDate>2013/6/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Soo-Jung Lee and Wan-Soo Kim]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Soo-Jung Lee and Wan-Soo Kim</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130314]]></guid><cfi:id>1285</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Vitrectomy, lensectomy and silicone oil tamponade in the management of retinal detachment associated with choroidal detachment]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130315]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM</b>:To report the results of combined vitrectomy, lensectomy and silicone oil (SO) tamponade in treating primary rhegmatogenous retinal detachment (RRD) associated with choroidal detachment (CD).<b>METHODS</b>:A retrospective, consecutive and case series study of 21 subjects with concurrent RRD associated with CD was conducted. All subjects underwent a standard three-port 20G pars plana vitrectomy (PPV) with lensectomy and silicone oil tamponade. Mean follow-up time was 8 months (rang from 4 to 19 months). The primary and final anatomic success rate, visual acuity and final intraocular pressure(IOP) were recorded and analyzed.<b>RESULTS:</b>Of 21 subjects, 8 were women and 13 were men. Age at presentation ranged from 22 to 75 years (mean 57.4 years). The presenting vision ranged from light perception to 0.15. The initial IOP ranged from 3mmHg to 12mmHg (mean 6.2mmHg). All eyes were phakic except one pseudophakic. No intraocular lens was implanted during the primary surgical intervention. Fifteen of 21 (71.4%) eyes had retina reattached after one operation. Six eyes had recurrent inferior retinal detachment due to proliferation. Five of them were successfully reattached after one or more additional operations. Mean IOP at final follow-up was 15.2mmHg (range from 8mmHg to 20mmHg). One case declined for further operation. The final reattachment rate was 95.2%. Visual acuity improved in 19 (90.5%) eyes, was unchanged in 1 (4.8%) eye and decreased in 1 (4.8%) eye.<b>CONCLUSION</b>:Combination of vitrectomy, lensectomy and silicone tamponade is an effective method in treating RRD associated with CD, reducing the incidence of postoperative hypotony.]]></description>
<pubDate>2013/6/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jun-Min Gui,Li Jia,Lei Liu and Jian-Di Liu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jun-Min Gui,Li Jia,Lei Liu and Jian-Di Liu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130315]]></guid><cfi:id>1284</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Angiographic characteristics of central serous chorioretinopathy in an Egyptian population]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130316]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To describe and analyze the demographic characteristics and to determine the angiographic features of acute central serous chorioretinopathy(CSCR) in an Egyptian population.<b>METHODS:</b> A series of consecutive patients presenting with acute idiopathic CSCR to Mansoura Ophthalmology Center Mansoura University who underwent fluorescein angiography (FA) within a 3-year-period (between January 1, 2007 and December 31, 2009) was retrospectively studied. Patient demographics and angiographic features were studied. Results were compared to those of other Western and Asian populations.<b>RESULTS:</b>Fluorescein angiograms of 86 patients were analyzed. 91% were males. The age range of patients was 24 - 49 years, with a mean age of (38±6) years. The right eye was the presenting eye in 47% of patients. Eighty-seven percent of eyes showed delayed choroidal filling. Thirty-five percent of patients had more than one point of leakage. The macula was the most common site of fluorescein leakage seen in 79% of patients. Peripheral leakage was seen in 14% of patients while peripapillary leakage was seen in 12% of patients. The inkblot leakage pattern was found in 53% of patients. The presenting eye had RPE atrophic changes in 84% of cases. The other eye was assessed in 44 patients (51%). Fifty-five percent of them had signs of RPE atrophic changes.<b>CONCLUSION:</b>In the Egyptian population, CSCR is seen at younger age with higher male-to-female ratio and more frequent smokestack leaks than other populations. Despite younger age group, this series of patient showed higher frequency of bilateral and multifocal disease compared to other studies. Roles of psychological stress and choroidal ischemia in pathogenesis of CSCR need further evaluation.]]></description>
<pubDate>2013/6/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Maha M Shahin]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Maha M Shahin</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130316]]></guid><cfi:id>1283</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Association of serum lipid levels with diabetic retinopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130317]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To assess the association between serum lipids and diabetic retinopathy (DR).<b>METHODS</b>:Sixty-one diabetic patients without retinopathy(NDR), 55 diabetic patients with non-proliferative retinopathy(NPDR) and 75 diabetic patients with proliferative retinopathy (PDR) according to ETDRS grading scale were enrolled in this study. Total cholesterol, high density lipoprotein (HDL), low density lipoprotein (LDL), very low density lipoprotein (VLDL) and triglyceride values were compared between the groups.<b>RESULTS:</b> The groups were well-balanced in terms of age and gender (<i>P</i>=0.071, <i>P</i>=0.265 respectively). The mean HbA1c values were significantly lower in NDR group than the NPDR and PDR groups (<i>P</i>=0.004, <i>P</i>=0.009 respectively). Mean total cholesterol, triglyceride, LDL, HDL and VLDL levels were not significantly different between the groups (<i>P</i>=0.693, <i>P</i>=0.774, <i>P</i>=0.644, <i>P</i>=0.910 and <i>P</i>=0.967 respectively, one way ANOVA). Mean total cholesterol, triglyceride, LDL, HDL and VLDL levels were not significantly different between the patients with ME and patients without ME (<i>P</i>=0.622, <i>P</i>=0.113, <i>P</i>=0.955, <i>P</i>=0.735 and <i>P</i>=0.490 respectively, <i>t</i>-test). The mean blood glucose significantly correlated with total cholesterol (<i>r</i>=0.173, <i>P</i>=0.017) and LDL (<i>r</i>=0.190, <i>P</i>=0.008). The mean HbA1c significantly correlated with total cholesterol (<i>r</i>=0.158, <i>P</i>=0.030) and triglyceride (<i>r</i>=0.148, <i>P</i>=0.042).<b>CONCLUSION:</b> Serum lipid levels were not significantly associated with the severity of DR or existence of ME despite the significant correlation between the mean blood glucose, HbA1c and total cholesterol.]]></description>
<pubDate>2013/6/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ebru Nevin Cetin, Yunus Bulgu, Seyfullah Ozdemir, Senay Topsakal, Fulya Ak&#305;n, Hulya Aybek and Cem Y&#305;ld&#305;r&#305;m]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ebru Nevin Cetin, Yunus Bulgu, Seyfullah Ozdemir, Senay Topsakal, Fulya Ak&#305;n, Hulya Aybek and Cem Y&#305;ld&#305;r&#305;m</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130317]]></guid><cfi:id>1282</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of visual acuity, refractive results and complications of femtosecond laser with mechanical microkeratome in LASIK]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130318]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To compare the outcomes of laser <i>in situ </i>keratomileusis (LASIK) performed with a femtosecond laser (Femtec, Technolas Perfect Vision GmbH, Germany) versus a mechanical microkeratome (Hansatome, Bausch and Lomb, USA)  for the correction of myopia and astigmatism.<b>METHODS:</b> In this retrospective study, patients who had undergone LASIK using the 80-kHz Femtec femtosecond laser were compared to age- and refraction-matched patients in whom the Hansatome microkeratome was used. Refractive and visual results 1 month and 3 months postoperatively, and complication rates were compared between the two groups.<b>RESULTS:</b>A total of 280 eyes were analyzed (140 in each group).At 3 months postoperatively in the Femtec vs Hansatome group, spherical equivalent refraction was within ±1.00D of emmetropia in 140 <i>vs</i> 138 eyes (<i>P</i>=0.498), the cylinder was within ±0.50D in 137 <i>vs</i> 139 eyes (<i>P</i>=0.622), and the UDVA was 20/20 or better in 136 <i>vs</i> 137 eyes (<i>P</i>=0.724), respectively. There was no statistically significant difference in the complication rates between the two groups (<i>P</i>=0.099).<b>CONCLUSION:</b>LASIK performed both with Femtec femtosecond laser and Hansatome microkeratome achieved satisfactory refractive and visual results at 3 months postoperatively, without significant differences in efficacy, safety, and complication rates between the two procedures.]]></description>
<pubDate>2013/6/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Cemile Banu Cosar,Tansu Gonen,Murat Moray and Asim Bozkurt Sener]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Cemile Banu Cosar,Tansu Gonen,Murat Moray and Asim Bozkurt Sener</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130318]]></guid><cfi:id>1281</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Photorefractive keratectomy in the correction of astigmatism using Schwind Amaris 750s laser]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130319]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To evaluate the results of three photorefractive keratectomy<b> (</b>PRK) procedures in the treatment of astigmatism.<b>METHODS:</b>In thisretrospective comparative case series<b>, </b>89 eyes of 50 patients who underwent PRK treatment for astigmatism were enrolled. The patients were divided into 3 groups based on the PRK procedure:Group 1:PRK without mitomycin-C (MMC) application, Group 2:PRK with MMC application, and Group 3:Trans-Photorefractive Keratectomy(T-PRK). The efficacy, safety, predictability, and complications of treatment were assessed at 1, 3 and 6 months after the treatment.<b>RESULTS:</b> At postoperative 6 months, the percentage of postoperative uncorrected visual acuity (UCVA) of 20/20 or better was 55.6% (20 eyes) in group 1, 75% (15 eyes) in group 2, and 75.8% (25 eyes) in group 3 (<i>P</i>=0.144).The percentage of postoperative best corrected visual acuity (BCVA) of unchanged or gained ≥1 lines was 80.6% (29 eyes) in group 1, 70% (14 eyes) in group 2, and 90.9% (30 eyes) in group 3 (<i>P</i>=0.151). The percentage of postoperative BCVA of lost ≥2 lines was 11.1% (4 eyes) in group 1, 20% (4 eyes) in group 2, and 6.1% (2 eyes) in group 3. The mean manifest refractivespherical equivalent (MRSE) and mean cylindrical refraction were not significantly different among the each groups (<i>P</i>&gt;0.05). At postoperative 6 months, the percentage of MRSE of within ±0.50 D was 100% (36 eyes) in Group 1, 100% (20 eyes) in Group 2, and 93.9% (31 eyes) in Group 3. At the each follow-up period, there was no significant difference in number of eyes with haze and mean haze score(<i>P</i>&gt;0.05).<b>CONCLUSION:</b>The study showed that PRK without MMC, PRK with MMC and T-PRK appears to have similar effectiveness, safety and predictability in the treatment of astigmatism. The incidence of haze was also similar between the three groups.]]></description>
<pubDate>2013/6/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Okkes Baz,Necip Kara,Ercument Bozkurt,Engin Bilge Ozgurhan,Alper Agca,Kemal Yuksel,Yavuz Ozpinar and Ahmet Demirok]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Okkes Baz,Necip Kara,Ercument Bozkurt,Engin Bilge Ozgurhan,Alper Agca,Kemal Yuksel,Yavuz Ozpinar and Ahmet Demirok</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130319]]></guid><cfi:id>1280</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Laser </b><i><b>in situ </b></i><b>keratomileusis in adult patients with anisometropic amblyopia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130320]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM:To evaluate the increase in corrected distance visual acuity (CDVA) after laser <i>in situ</i> keratomileusis (LASIK) in adults with anisometropic amblyopia.METHODS:The medical records of consecutive patients diagnosed with anisometropic amblyopia at the time of refractive evaluation who underwent LASIK were retrospectively reviewed. Patients with at least a two-line difference of visual acuity (VA) between the eyes with a spherical refractive error difference of at least 3.00 diopters (D) or an astigmatic difference of at least 2.00D were included. Patients with any other possible reason for amblyopia other than anisometropia or those who had undergone previous amblyopia treatment were excluded. Amblyopic eyes with myopia or myopic astigmatism were considered as group 1, hypermetropia or hypermetropic astigmatism constituted group 2, and mixed astigmatism patients comprised group 3. Uncorrected distance visual acuity (UDVA), subjective manifest refraction, and CDVA were analyzed at 1 week and 1 month, 3, and 6 months.RESULTS:The study included 57 eyes of 57 patients. There were 33 eyes in group 1, 12 eyes in group 2, and 12 eyes in group 3. The preoperative mean values for spherical equivalent of subjective manifest refraction (SE) in groups 1, 2, and 3 were (-4.66±1.97)D, (4.40±1.00)D, and (0.15±1.05)D, respectively. Mean CDVA improved 0.1 log units (1 line LogMAR) at 6 months (<i>P</i>&lt;0.05). Sixteen eyes (28%) exhibited an improvement in CDVA in week 1. Fourteen eyes (25%) experienced two or more lines of CDVA improvement at month 6. There were no statistically significant differences among the groups in terms of CDVA (<i>P</i>&gt;0.05). Moreover, age, the amount of preoperative refractive error, and the levels of preoperative corrected and UDVA had no effect on postoperative CDVA improvement (<i>P</i>&gt;0.05).CONCLUSION:Correction of refractive errors with LASIK produced significant CDVA improvement in adult patients with anisometropic amblyopia and no previous amblyopia treatment.]]></description>
<pubDate>2013/6/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Alper Agca, Engin Bilge &#214;zgürhan, &#214;kke&#351; Baz, Ercüment Bozkurt, Abdullah Ozkaya, Dilek Ya&#351;a and Ahmet Demirok]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Alper Agca, Engin Bilge &#214;zgürhan, &#214;kke&#351; Baz, Ercüment Bozkurt, Abdullah Ozkaya, Dilek Ya&#351;a and Ahmet Demirok</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130320]]></guid><cfi:id>1279</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effects of vernal and allergic conjunctivitis on severity of keratoconus]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130321]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To demonstrate the effects of two different types of allergic conjunctivitis on severity of keratoconus (KC).<b>METHODS:</b> We retrospectively reviewed the medical records of 171 KC patients referred between June 2010 and June 2011. The KC patients were divided into 3 groups as KC (group A), KC with vernal keratoconjunctivitis (VKC) (group B) and KC with allergic conjunctivitis (AC) (group C). Main outcome measures were demographic and ocular clinical features including age at presentation, gender, spherical equivalent (SE), best spectacle corrected visual acuity (BCVA), mean keratometric measurement (Km), central corneal thickness (CCT), and intraocular pressure (IOP). Groups were compared in term of study variables.<b>RESULTS:</b>The median age at presentation was significantly lower in group B (<i>P</i>&lt;0.001). According to the median SE (<i>P</i>=0.003), BCVA (<i>P</i>=0.022), Km (<i>P</i>&lt;0.001), CCT (<i>P</i>=0.015) and Amsler–Krumeich classification (<i>P</i>&lt;0.001), KC was more severe in group B. There was no significant difference in terms of IOP and corrected IOP among the groups (<i>P</i>=0.44), however there were 4 patients who had increased corrected IOP developed after topical corticosteroid use in group B. The differences among the groups persisted even after controlling for age and gender.<b>CONCLUSION:</b> Our findings demonstrated a more severe KC in VKC patients despite their younger age which suggests evaluation of VKC patients as a separate group in keratoconus disease.]]></description>
<pubDate>2013/6/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Abdullah Kursat Cingu,Yasin Cinar,Fatih Mehmet Turkcu,Alparslan Sahin,Seyhmus Ari,Harun Yuksel,Muhammed Sahin and Ihsan Caca]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Abdullah Kursat Cingu,Yasin Cinar,Fatih Mehmet Turkcu,Alparslan Sahin,Seyhmus Ari,Harun Yuksel,Muhammed Sahin and Ihsan Caca</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130321]]></guid><cfi:id>1278</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Forty-five years of keratoprosthesis study and application at the Filatov Institute:a retrospective analysis of 1 060 cases]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130322]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To present results of the keratoprosthesis method used at The Filatov Institute of Eye Diseases and Tissue Therapy.<b>METHODS:</b>A retrospective case series analysis was used to describe the development of new types of keratoprostheses and methods of implantation as well as different ways of leukoma strengthening.<b>RESULTS:</b>Keratoprosthesis was performed in 1 060 eyes of 1 040 patients with leukomas of different etiology:burns, 725 eyes (68.4%); trauma, 120 eyes (11.3%); keratitis and ocular pemphigoid, 108 eyes (10.2%); and bullous keratopathy, 107 eyes (10.1%). Visual acuity before keratoprosthesis consisted of light perception in 962 eyes (92%), and 98 eyes (8%) had minimal visual acuity (1/200-1/50). Both eyes were blind (visual acuity less than 1/200) in 955 patients (91.8%). The period of blindness varied from 1 to 52 years. As a result of keratoprosthesis, visual acuity of ≥1/200 was restored in 1 023 of 1 060 eyes (96.5%). Visual acuity of 20/200-20/20 was achieved in 716 eyes (67.5%). At the last follow-up visit visual acuity of ≥1/200 was preserved in 806 eyes (76%), visual acuity of 20/200-20/20 was measured in 583 of 1 060 eyes (55%) and good keratoprosthesis fixation in the cornea was achieved in 986 of 1 060 eyes (93%). The minimal follow-up was 12 months (range, 12 months to 37 years, median 5 years).<b>CONCLUSION:</b> Our techniques of keratoprosthesis effectively restore vision in patients with leukomas that cannot be treated by optical corneal grafting.]]></description>
<pubDate>2013/6/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Stanislav Iakymenko]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Stanislav Iakymenko</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130322]]></guid><cfi:id>1277</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Prevalence of retinopathy of prematurity in Brunei Darussalam]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130323]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To identify the prevalence of retinopathy of prematurity (ROP) among preterm neonates admitted to Department of Neonatology, RIPAS hospital, Brunei Darussalam.<b>METHODS:</b>We studied 67 preterm infants fulfilling the eligibility criteria for ROP screening. All infants studied were admitted to the Department of Neonatology, RIPAS Hospital, within a period of one year. Birth weight (BW), gestational age (GA), corrected age at each review, initial and final diagnoses and number of reviews required was recorded for each infant. Infants were followed up two weekly until they reach a corrected age of 40 weeks or complete vascularization was noted. Prevalence of ROP was identified. Descriptive analysis, regression analysis and independent-sample <i>t</i>-test were used to statistically check for differences between ROP and non-ROP groups.<b>RESULTS:</b>A total number of 201 ROP screenings were carried out for 67 preterm infants.  Males outnumbered females (56.7%). The mean number of reviews per child was (3.19±1.1) times (range:1-6 times), the mean GA among the preterm babies examined was (29.5±2.6) weeks (range:23-36 weeks), and the mean BW was 1300±500g (range:660-3600g). The prevalence of ROP among the examined infants was 34.8%. Prevalence of threshold disease that required laser treatment was 25.4%. Prevalence of ROP among those with extremely low BW was 86.7% compared to 27.8% in those with very low BW. Respiratory distress and congenital heart diseases were significantly associated with higher incidence of ROP.<b>CONCLUSION:</b> Lower BW, lower GA and female gender are associated with higher risk of developing ROP among preterm infants in Brunei Darussalam.]]></description>
<pubDate>2013/6/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Nadir Ali Mohamed Ali,Joshua George,Nayan Joshi and Elizabeth Chong]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Nadir Ali Mohamed Ali,Joshua George,Nayan Joshi and Elizabeth Chong</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130323]]></guid><cfi:id>1276</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Graft survival and visual outcome after simultaneous penetrating keratoplasty and cataract extraction]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130324]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To evaluate the indications, complications, and visual and graft survival outcomes in eyes that had undergone simultaneous cataract extraction and penetrating keratoplasty (PKP).<b>METHODS:</b>We described a retrospective study of 101 patients who had undergone simultaneous cataract extraction and PKP at King Khaled Eye Specialist Hospital between January 1, 2001, and December 31, 2002. All patients were followed up postoperatively with maximum follow-up 68 months.<b>RESULTS:</b>The mean age of patients was 61 years. The mean overall follow-up was 27 months. The most common indications for surgery were corneal scarring (45.5%), previous failed graft (15.8%), corneal ulcer (12.9%), Fuchs endothelial dystrophy (8.9%), stromal dystrophy (2.9%), and other conditions (14.5%). Overall, 69 grafts (68.3%) remained clear at final follow-up. Previous glaucoma or postoperative glaucoma had no statistically significant effects on graft outcome (<i>P</i>&gt;0.05).The graft rejection rate (17.8%) was a significant risk factor for failure (<i>P</i>=0.00). Age, gender, indications for surgery, corneal graft diameter, and intraoperative vitreous loss had no statistically significant effects on the PKP outcome (<i>P&gt;</i>0.05). Postoperative visual acuity was significantly associated with preoperative visual acuity (<i>P</i>&lt;0.01).<b>CONCLUSION:</b> The present study provides evidence that performing a combined procedure results in more rapid visual rehabilitation and good graft clarity.]]></description>
<pubDate>2013/6/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mansour M. Al-Mohaimeed]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mansour M. Al-Mohaimeed</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130324]]></guid><cfi:id>1275</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effects of intensive control of blood glucose and blood pressure on microvascular complications in patients with type II diabetes mellitus]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130206]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To evaluate the effects of intensive control of blood glucose and blood pressure on microvascular complications in patients with type II diabetes by comparing the therapeutic effects of intensive and standard treatment in patients with type II diabetes.<b>METHODS:</b> A total of 107 patients with type II diabetes were randomly assigned into intensive and standard treatment groups. Patients in the intensive treatment group received preterax (perindopril/ indapamide) to control blood pressure, and gliclazide (diamicron) MR to control blood glucose. Patients in the standard treatment group received routine medications or placebo. Urinary microalbumin (UMA), urinary creatinine (UCR), the UMA/UCR ratio, and visual acuity were monitored according to the study design of the ADVANCE trial. Direct ophthalmoscopy and seven-field stereoscopic retinal photography were used to examine the fundi at baseline, and repeated after 5 years of treatment.<b>RESULTS:</b> The characteristics of patients in both groups were well balanced at baseline. After 5 years of treatment, visual acuity was found to be decreased in the standard group (<i>P</i>=0.04), but remained stable in the intensive group. The severity of diabetic retinopathy had not progressed in patients in the intensive group, but had deteriorated in the standard group (<i>P</i>=0.0006). The UMA/UCR ratio was not obviously changed in patients in the intensive group, whereas it was significantly increased in the standard group (<i>P</i>=0.00).<b>CONCLUSION:</b> Intensive control of blood glucose and blood pressure can decrease the incidence or slow the progression of microvascular complications in patients with type II diabetes, and maintain stable vision.]]></description>
<pubDate>2013/4/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Cai-Hong Zhu,Shi-Sheng Zhang,Yan Kong,Yu-Fang Bi,Ling Wang and Qiong Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Cai-Hong Zhu,Shi-Sheng Zhang,Yan Kong,Yu-Fang Bi,Ling Wang and Qiong Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130206]]></guid><cfi:id>1274</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[CT features of exophthalmos in Chinese subjects with thyroid-associated ophthalmopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130207]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM</b>:To investigate computed tomography (CT) features of exophthalmos in Chinese subjects with thyroid-associated ophthalmopathy (TAO).<b>METHODS:</b>A total of605 eyes of 325 patients with exophthalmos due to TAO were classified as grade I (mild exophthalmos) or II (severe exophthalmos) based on orbital CT imaging. The increased orbital volume features, such as changes from extraocular muscles, orbital fat, or both, were analyzed.<b>RESULTS:</b> A total of 605 eyes were analyzed, among them 62.98% presented grade I exophthalmos, while 36.02% showed grade II exophthalmos.#$TAB In grade I, 56.69% showed orbital fat change, and in grade II, 89.29% exhibited extraocular muscle enlargement.<b>CONCLUSION:</b> Orbital fat and extraocular muscle enlargement are likely to be observed on CTs of subjects with mild and severe exophthalmos, respectively. Our results suggest that CT findings may guide TAO clinical therapy recommendations and prognosis.]]></description>
<pubDate>2013/4/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Zhi-Jia Fang,Jenny Y. Zhang and Wei-Min He]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zhi-Jia Fang,Jenny Y. Zhang and Wei-Min He</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130207]]></guid><cfi:id>1273</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Optical biometry intraocular lens power calculation using different formulas in patients with different axial lengths]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130208]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM</b>:To investigate the predictability of intraocular lens (IOL) power calculation using the IOLMaster and different IOL power calculation formulas in eyes with various axial length (AL).<b>METHODS</b>:Patients were included who underwent uneventful phacoemulsification with IOL implantation in the Department of Ophthalmology, Far Eastern Memorial Hospital, Taipei, Taiwan, Chinafrom February 2007 to January 2009. Preoperative AL and keratometric values (Ks) were measured by IOLMaster optical biometry. Patients were divided into 3 groups based on AL less than 22mm (Group 1), 22–26mm (Group 2), and more than 26mm (Group 3). The power of the implanted IOL was used to calculate the predicted postoperative spherical equivalence (SE) by various formulas:the Haigis, Hoffer Q, Holladay 1, and SRK/T. The predictive accuracy of each formula was analyzed by comparing the difference between the actual and predicted postoperative SE (MedAE, median absolute error). All the patients had follow-up periods exceeding 3 months.<b>RESULTS</b>:Totally, there were 200 eyes (33 eyes in Group 1, 92 eyes in Group 2, 75 eyes in Group 3). In all patients, the Haigis had the significantly lower MedAE generated by the other formulas (<i>P</i>&lt;0.05). In Group 1 to 3, the MedAE calculated by the Haigis was either significantly lower or comparable to those calculated by the other formulas.<b>CONCLUSION</b>:Compared with other formulas using IOLMaster biometric data, the Haigis formula yields superior refractive results in eyes with various AL.]]></description>
<pubDate>2013/4/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jia-Kang Wang and Shu-Wen Chang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jia-Kang Wang and Shu-Wen Chang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130208]]></guid><cfi:id>1272</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Long-term cost and efficacy analysis of latanoprost versus timolol in glaucoma patients in Germany]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130209]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM<i>:</i> To evaluate 5-year effectiveness and cost between latanoprost or timolol monotherapy in a pilot trial.
METHODS<i>:</i> A retrospective, multi-center trial performed at 6 sites in Germany of patients who had a diagnosis of primary open-angle or pigmentary glaucoma, in at least one eye, initiated on monotherapy with latanoprost or timolol maleate. Qualified consecutive charts were reviewed in which 5-year efficacy, safety and cost data was abstracted. 
RESULTS<i>:</i> Seventy-seoen latanoprost and 49 timolol patients were included, at the final visit no difference existed between the two groups in disc parameters including:rim area, rim area/disc area ratio, cup volume or vertical cup/disc ratio (<i>P</i>&gt;0.05). There was no difference in intraocular pressure (IOP) between the initial latanoprost (17.4±2.6) and timolol (16.3±2.8mmHg) groups. There was less change in medicines over the follow-up period (0.1 <i>vs</i> 0.8) and fewer medications at the final visit (1.2 <i>vs</i> 1.8) with latanoprost compared to timolol. No patient treated with latanoprost discontinued therapy during follow-up, while 12% discontinued timolol mostly due to inadequate IOP control. Cost/year was less with initial timolol ($458±236) as compared to latanoprost ($552±202).CONCLUSION:Patients begun on latanoprost or timolol and followed over 5 years may have similar clinical outcomes. However, timolol patients may require more medicines and medicine changes to control IOP for long-term, but at a lower cost.]]></description>
<pubDate>2013/4/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ulrich Thelen, Dietmar Schnober, Sonja Sch&#246;lzel, Michael S. Kristoffersen, Lindsay A. Nelson, Jeanette A. Stewart and William C. Stewart]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ulrich Thelen, Dietmar Schnober, Sonja Sch&#246;lzel, Michael S. Kristoffersen, Lindsay A. Nelson, Jeanette A. Stewart and William C. Stewart</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130209]]></guid><cfi:id>1271</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Pediatric traumatic cataract and surgery outcomes in eastern China:a hospital-based study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130210]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To evaluate the etiologies, management, and outcomes of pediatric traumatic cataract in eastern China.<b>METHODS:</b>Pediatric traumatic cataract were reviewed for demographic information, type of injury, mode of injury, time of injury, interval between injury and first visiting doctors, hospital of first visiting, surgeries, complications and prognosis.<b>RESULTS:</b>A total of 117 eyes of 117 patients (96 boys and 21 girls) with unilateral injuries (66 right and 51 left eyes) were included in the study. The mean (SEM) age at diagnosis was (6.6±3.2) years (range, 1.3-13.8 years). Each cataract was categorized according to the type of trauma:closed-globe (<i>n</i>=26) or open-globe (<i>n</i>=91) injuries. The most common injuring objects were sharp metal objects (37.61%). The most common complication in open-globe injuries was corneal laceration, whereas traumatic mydriasis was most common in closed-globe injuries. Of 68 eyes in patients with open-globe injuries who received cataract extraction, intraocular lens (IOLs) were primarily implanted in 47 eyes (68.12%), whereas 18 eyes with closed-globe injuries received cataract extraction, and IOLs were primarily implanted in 17 eyes (94.4%). The surgical procedures included reconstruction of the anterior segment, synechiolysis, excision of the membrane, lensectomy, vitrectomy and related techniques. Postoperative vision was significantly improved compared with preoperative vision.<b>CONCLUSION:</b> Pediatric traumatic cataract should be treated in time to attenuate the complications, and education on pediatric traumatic cataract and improvements in pediatric health care are needed for the early detection of cataract in children.]]></description>
<pubDate>2013/4/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ying-Nan Xu,Yu-Sen Huang and Li-Xin Xie]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ying-Nan Xu,Yu-Sen Huang and Li-Xin Xie</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130210]]></guid><cfi:id>1270</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Episcleral macular buckling for posterior retinal detachment in silicone oil filled eyes associated with myopic macular hole]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130211]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To evaluate anatomical and visual outcomes of episcleral macular buckling (EMB) for posterior retinal detachment in silicone oil filled eyes associated with myopic macular hole.<b>METHODS:</b> Five cases of EMB for initial failure of retinal reattachment after internal limiting membrane (ILM) peeling and silicone oil tamponade caused by myopic macular hole were retrospectively reviewed. A silicone sponge sutured directly across the macular region was performed on the silicone oil filled eyes. Silicone oil was removed no sooner than 1 month post-EMB. The duration of follow-up time after removal of silicone oil was more than 3 months.<b>RESULTS:</b> Retinas of five eyes were all reattached at the last follow-up. The postoperative vision ranged from counting fingers to 0.08.<b>CONCLUSION:</b> Anatomical results improved after EBM for posterior retinal detachment in silicone oil filled eyes associated with myopic macular hole, which was not evident for visual outcome.]]></description>
<pubDate>2013/4/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jiao Tian,Luo-Sheng Tang,Xiao-Jian Guo and Yong-Heng Luo]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jiao Tian,Luo-Sheng Tang,Xiao-Jian Guo and Yong-Heng Luo</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130211]]></guid><cfi:id>1269</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Bevacizumab </b><i><b>vs</b></i><b> ranibizumab for neovascular age-related macular degeneration in Chinese patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130212]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To compare the clinical efficacy of intravitreal injections of bevacizumab and ranibizumab for treating Chinese patients with neovascular age-related macular degeneration (AMD).<b>METHODS:</b> Among 60 Chinese patients with exudative AMD (60 eyes), 28 received intravitreal bevacizumab injections (1.25mg) and 32 received intravitreal ranibizumab injections (0.5mg), once a month for 3 months and were followed for a total of 6 months. Monthly optical coherence tomography (OCT) was used to determine whether the patients received additional treatments during the follow-up. We compared the baseline and 6-month follow-up values of mean best-corrected visual acuity (BCVA) and central retinal thickness (CRT) in both groups of patients. We also compared the occurrence of adverse events.<b>RESULTS:</b>At the 6-month follow-up, the mean BCVA (logMAR) of the bevacizumab and ranibizumab treatment groups improved from the baseline measurements of 0.72±0.23 and 0.73±0.22 to 0.47±0.14 and 0.45±0.20, respectively (<i>P</i>&lt;0.05 for both groups). However, the change was not significantly different between the two groups. As evaluated by OCT, CRT decreased from 366.71±34.72μm and 352±36.9μm at baseline to 250.86±41.51μm and 243.22±41.38μm in the bevacizumab and ranibizumab groups, respectively (<i>P</i>&lt;0.05 for both groups). However, the change was not significantly different between the two groups. There were no severe local adverse reactions or systemic adverse events.<b>CONCLUSION:</b>Intravitreal bevacizumab and ranibizumab have equivalent effects on BCVA and CRT and appeare safe over the short-term.]]></description>
<pubDate>2013/4/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jun Li,Han Zhang,Peng Sun,Feng Gu and Zhe-Li Liu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jun Li,Han Zhang,Peng Sun,Feng Gu and Zhe-Li Liu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130212]]></guid><cfi:id>1268</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Endoscope-assisted goniosynechialysis combined with phacoemulsification and intraocular lens implantation to manage primary angle-closure glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130213]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM:To describe and evaluate a new ophthalmic endoscope surgical technique combined with phacoemulsification andintraocular lens (IOL) implantation to treat goniosynechialysis and manage primary angle-closure glaucoma (PACG).METHODS:Endoscope-assisted goniosynechialysis combined with phacoemulsification andIOL implantation was performed in 32 eyes of 29 patients with PACG. Regular follow-up was performed 1 week and 1 month, 3, and 6 months after surgery to assess complications, intraocular pressure (IOP), anterior chamber depth, visual acuity, and anterior chamber angle.RESULTS:Preoperative mean IOP was 24.88±7.22mmHg with pharmacological treatment, and was 13.70±4.02, 13.06±3.74, 14.29±4.70, and 14.33±5.01mmHg 1 week, 1 month, 3 months, and 6 months after surgery, respectively. The postoperative decrease in IOP was significant (<i>P&lt;</i>0.05). The rate for all eyes with IOP of 21mmHg or less was 93.8% (30 eyes) at the final visit without ocular hypotensive agents. The average preoperative anterior chamber depth was 1.60±0.64mm, and this value significantly increased to 2.72±0.62, 2.76±0.70, 2.73±0.68, and 2.74±0.71mm at 1 week, 1 month, 3 months, and 6 months, respectively. Visual acuity was improved in 28 eyes (87.5%) at 6 months postoperatively. The anterior chamber angle had increased in 25 eyes (78.1%) at the final visit; it was adhesive 90°-180° in 6 eyes, 180°-270° in only 1 eye. Two eyes exhibited minimal hyphema in the early postoperative period, but it could gradually be absorbed. Fibrinous reaction was observed in five eyes and spontaneously disappeared within 7 days. No shallow anterior chamber, iridodialysis, choroidal detachment, or malignant glaucoma was found in any eyes.CONCLUSION:Endoscope-assisted goniosynechialysis combined with phacoemulsification and IOL implantation to manage PACG has several advantages, including optimized visualization, greater accuracy, and improved safety. Our results suggest that it has certain curative effects and clinical application value.]]></description>
<pubDate>2013/4/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jing Chen and Yu-Ping Zou]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jing Chen and Yu-Ping Zou</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130213]]></guid><cfi:id>1267</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Aberration changes of the corneal anterior surface following discontinued use of rigid gas permeable contact lenses]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130214]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To record aberrations with a corneal topographic device on the anterior surface of the cornea at different time-points prior to wearing and following discontinued use of rigid gas permeable (RGP) contact lenses. The effect of wearing RGP on the anterior surface of the cornea was discussed to provide guidance for clinical refractive error correction.<b>METHODS:</b> The study objects were 24 eyes from 24 patients. All patients underwent identical examination procedures prior to lens use, as well as afterwards, including slit-lamp examination, non-contact tonometer measurement, computer optometry and corneal curvature measurement, subjective refraction test, and corneal topography analysis. The patients wore contact lenses everyday for 1 month and then discontinued. Corneal topographies were recorded at certain time points of 30 minutes, 1 day, 3, 7 and 14 days following use.<b>RESULTS:</b> Total corneal aberration at each time point following discontinued use of RGP contact lenses was less than the time point prior to use. Detailed results were as follows:root mean square (RMS) (pre)=(1.438±0.328)μm, RMS (30 minutes)=(1.076±0.355)μm, RMS (1 day)=(1.362±0.402)μm, RMS (3 days)=(1.373±0.398)μm, RMS (7 days)=(1.387±0.415)μm, and RMS (14 days)=(1.430±0.423)μm. Results showed that at 30 minutes after discontinued use of RGP contact lenses, almost all 2<sup>nd</sup>- and 3<sup>rd</sup>-order aberrations change. Quadrafoil Z10 and spherical Z12 of the 4<sup>th</sup>-order were also changed. Alterations to Z5, Z6, and Z12 at 1 day after discontinued use were significant differences compared with the time period prior to RGP use:Z5 and Z6 decreased, and Z12 increased slightly. Z5 and Z6 remained decreased at 3 days after discontinued use, but Z9 and Z10 continued to increase and Z12 returned to levels prior to RGP use. At 14 days after discontinued use, all aberrations were not significantly different from the values prior to use.<b>CONCLUSION:</b> The use RGP contact lenses greatly reduced total aberration of the anterior surface of the cornea. Changes to 2<sup>nd</sup>- and 3<sup>rd</sup>-order aberrations (including Z3, Z4, Z5, Z6, Z7, and Z8) were more significant. Following discontinued use of RGP contact lenses, the majority of lower order aberrations returned to original levels in a short period of time. During this process, a transient higher order aberration appeared, but all changes disappeared within 14 days after discontinued use of RGP contact lenses.]]></description>
<pubDate>2013/4/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Qing Yu,Jiang-Xiu Wu,He-Ning Zhang,Sheng Ye,Shi-Qi Dong and Chen-Hao Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Qing Yu,Jiang-Xiu Wu,He-Ning Zhang,Sheng Ye,Shi-Qi Dong and Chen-Hao Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130214]]></guid><cfi:id>1266</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Black diaphragm intraocular lens implantation and penetrating keratoplasty in aphakic eyes with traumatic aniridia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130215]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To evaluate the long-term outcome of implantation of black diaphragm intraocular (BDI) lens combined with penetrating keratoplasty (PKP) for managing aphakic eyes with traumatic aniridia and corneal damage.<b>METHODS:</b> Six aphakic eyes of six patients with traumatic aniridia and corneal damage had BDI lens implantation at Qingdao Eye Hospital, Shandong Eye Institute from June 2008 to November 2011. Medical records of the patients were reviewed. Three patients received PKP and after 12-18months were implanted with BDI lens. The other three patients completed PKP and BDI lens implantation at the same time. The corrected visual acuity, intraocular pressure and number of corneal endothelial cells were monitored.<b>RESULTS:</b> The patients were followed up for an average of 24.3±12.1months (range 14-48 months). All BDI lenses were located well. The best corrected visual acuity got improved in 5 patients (0.1-1.0) and decreased in 1 patient from 0.4 to 0.2. Three patients had normal intraocular pressure (IOP) after implantation. Two patients required antiglaucoma medications to control IOP within the normal range and 1 patient implanted Ahmed glaucoma valve to control IOP. The corneal grafts kept transparent in all eyes and the corneal endothelial counting &gt;1 000/mm<sup>2</sup>, although two patients experienced acute graft rejection and loss more than 30% corneal endothelial cells.<b>CONCLUSION:</b> Implantation of BDI lens combined with PKP is an effective option for managing aphakic eyes with traumatic aniridia and corneal damage. Although the results in our study are encouraging, additional studies of the long-term safety and efficacy are required. A larger study population and longer follow-up may be beneficial.]]></description>
<pubDate>2013/4/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jun Li and Xiao-Guang Dong]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jun Li and Xiao-Guang Dong</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130215]]></guid><cfi:id>1265</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Cyclopexy versus vitrectomy combined with intraocular tamponade for treatment of cyclodialysis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130216]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To compare the effects and complications of direct cyclopexy (DC) versus vitrectomy, endophotocoagulation, and gas/silicone oil endotamponade (VEE) treatment in patients with cyclodialysis and persistent hypotony.<b>METHODS:</b> This is a prospective, comparative, nonrandomized clinical trial which includes 52 patients with cyclodialysis and persisting hypotony. Fifty-two patients suffering from cyclodialysis and persistent hypotony in one eye were divided into 2 groups (groups DC and VEE) and treated, respectively, with direct cyclopexy or vitrectomy, endophotocoagulation, and gas/silicone oil endotamponade. The patients were followed up for 12 months. Assessments included best corrected visual acuity (BCVA), intraocular pressure (IOP), anterior chamber depth (ACD), anterior chamber volume (ACV) and subjective rating of the pain caused by the treatments.<b>RESULTS:</b>After a follow-up of 12 months, significant improvement was seen in postoperative mean BCVA, IOP, ACD and ACV in both treatment groups (which were not significantly different from each other). The success rates for the treatments were not significantly different (DC:50.0% <i>vs</i> VEE:62.5%, <i>P</i>=0.383). Postoperative morbidity of cataract and subjective pain rating were significantly higher in the VEE group <i>vs</i> the DC group (<i>P</i>= 0.003 and <i>P</i>&lt;0.001 respectively).<b>CONCLUSION:</b> DC and VEE were effective surgical procedures in treating patients with cyclodialysis and persistent hypotony. Patients had better tolerance to DC treatment and VEE was more likely lead to cataract complications. Taking into consideration the ease of the operation, success rate, and patient comfort, DC treatment seems preferable to VEE treatment in patients with simple cyclodialysis. While VEE has the advantage of treating patients with cyclodialysis combined with vitreous hemorrhage.]]></description>
<pubDate>2013/4/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Wei-Wei Xu,Yi-Fei Huang,Li-Qiang Wang and Mao-Nian Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Wei-Wei Xu,Yi-Fei Huang,Li-Qiang Wang and Mao-Nian Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130216]]></guid><cfi:id>1264</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Treatment of intractable orbital implant exposure with a large conjunctival defect by secondary insertion of the implant after preceding dermis fat graft]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130217]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM:To report a procedure and results of a two-stage operation to manage intractable extensive orbital implant exposure with a large conjunctival defect which was difficult to treat with dermis fat grafts due to repeated graft necrosis.METHODS:A retrospective chart review of four patients who had extensive orbital implant exposures with large conjunctival defects and had past histories of repeated autologous or preserved dermis graft failures was done. As a first-stage operation, the problematic pre-existing orbital implants were removed and autologous dermis fat grafts alone were performed on the defect area. Four months later, new orbital implants were secondarily inserted after confirmation of graft survival. The size of the conjunctival defects and state of the extraocular muscles were checked preoperatively. Success of the operations and complications were investigated.RESULTS:The mean size of the conjuctival defects was 17.3mm×16.0mm, and the mean time from the initial diagnosis of orbital implant exposure to implant removal and autologous dermis fat graft was 20.8 months. After implant removal and autologous dermis fat graft, no graft necrosis was observed in any patients. Also, implant exposure or fornix shortening was not observed in any patients after new orbital implant insertion.CONCLUSION:The secondary insertion of a new orbital implant after pre-existing implant removal and preceding dermis fat graft is thought to be an another selective management of intractable orbital implant exposure in which dermis fat grafts persistently fail.]]></description>
<pubDate>2013/4/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hyun Kyung Kim and Tae Yoon La]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hyun Kyung Kim and Tae Yoon La</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130217]]></guid><cfi:id>1263</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Vitrectomy combined with silicone oil tamponade in the treatment of severely traumatized eyes with the visual acuity of no light perception]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130218]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To evaluate the efficacy of surgical treatment of vitrectomy combined with silicone oil tamponade in the treatment of severely traumatized eyes with the visual acuity of no light perception (NLP).<b>METHODS:</b> This was a retrospective uncontrolled interventional case-series of 19 patients of severely traumatized eyes with NLP who underwent vitrectomy surgery at the Affiliated Hospital of Medical College, Qingdao University (Qingdao, China) during a 3-year period. We recorded perioperative factors with the potential to influence functional outcome including duration from the injury to intervention; causes for ocular trauma; open globe or closed globe injury; grade of vitreous hemorrhage; grade of endophthalmitis; grade of retinal detachment; size and location of intraocular foreign body (IOFB); extent and position of retinal defect; grade of proliferative vitreoretinopathy (PVR); type of surgery; perioperative complications and tamponade agent. The follow-up time was from 3 to 18 months, and the mean time was 12 months.<b>RESULTS:</b> After a mean follow-up period of 12 months (3-18 months) 10.53% (2/19) of eyes had visual acuity of between 20/60 and 20/400, 52.63% (10/19) had visual acuity less than 20/400 but more than NLP, and 36.84% (7/19) remained NLP. Visual acuity was improved from NLP to light perception (LP) or better in 63.16% (12/19) of eyes and the rate of complete retinal reattachment was 73.68% (14/19). Good visual acuity all resulted from those patients of blunt trauma with intact eyewall (closed globe injury). The perioperative factors of poor visual acuity prognosis included delayed intervention; open globe injury; endophthalmitis; severe retinal detachment; large IOFB; macular defect; a wide range of retinal defects and severe PVR.<b>CONCLUSION:</b>The main reasons of NLP after ocular trauma are severe vitreous hemorrhage opacity; refractive media opacity; retinal detachment; retinal and uveal damages and defects, especially defects of the macula; PVR and endophthalmitis. NLP after ocular trauma in some cases does not mean permanent vision loss. Early intervention of vitrectomy combined with silicone oil tamponade and achieving retinal reattachment of the remaining retina, may make the severely traumatized eyes regain the VA of LP or better.]]></description>
<pubDate>2013/4/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Shan-Shan Yang and Tao Jiang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Shan-Shan Yang and Tao Jiang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130218]]></guid><cfi:id>1262</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Ocular disorders in children with spastic subtype of cerebral palsy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130219]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To document common ocular abnormalities in children with spastic subtype of cerebral palsy (CP) and to find out whether any correlation exists between their occurance and etiologic factors.<b>METHODS:</b> Totally 194 patients with the diagnosis of spastic type CP were enrolled in this retrospective study. Detailed ophthalmic examinations were performed. Demographic data and neuroradiological findings were documented. Kruskal-Wallis, Mann Whitney U, Pearson Chi-square tests and Student’s <i>t</i> tests were used in the statistical analysis.<b>RESULTS:</b> The mean age was 64.7±44.2 months on the first ophthalmic examination. Prevalences of diplegia (47.4%) and tetraplegia (36.1%) were found to be higher than the frequency of hemiplegia (16.5%) in our study population. Etiologic factor was asphyxia in 60.8% of the patients. Abnormal ocular findings were present in 78.9% of the patients. Statistically significant poor vision was detected in tetraplegia group among all the spastic ubtypes of CP (<i>P</i>=0.000). Anisometropia and significant refractive error were found in 14.4% and 70.1% of the patients, respectively. Thirty-six children (18.6%) had nystagmus and 107 children (55.2%) had strabismus.  Lower gestational age and birth weight were statistically higher in patients with esotropia than exotropia (<i>P</i>=0.009 and <i>P</i>=0.024, respectively). Abnormal morphology of the optic disc was present in 152 eyes (39.2%). Severe periventricular leukomalacia (PVL) was found in 48 patients and statistically significant poor vision was detected in the presence of PVL (<i>P</i>=0.000).<b>CONCLUSION:</b> Spastic diplegic or tetraplegic CP patients with positive neuroradiological symptoms, younger gestational age and lower birth weight ought to have detailed ophthalmic examinations as early as possible to provide best visual rehabilitation.]]></description>
<pubDate>2013/4/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[A.Taylan Ozturk,A.Tulin Berk and Aylin Yaman]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>A.Taylan Ozturk,A.Tulin Berk and Aylin Yaman</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130219]]></guid><cfi:id>1261</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effects of multiple intravitreal anti-VEGF injections on retinal nerve fiber layer and intraocular pressure:a comparative clinical study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130220]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To determine the effect of multiple injections of ranibizumab or bevacizumab on retinal nerve fiber layer (RNFL) and intraocular pressure (IOP) in patients with age-related macular degeneration (AMD).<b>METHODS:</b>This retrospective study includes 35 eyes of 35 patients treated with intravitreal bevacizumab (IVB, 1.25mg/0.05mL) and 30 eyes of 30 patients with intravitreal ranibizumab (IVR, 0.5mg/0.05mL) who had  Fast RNFL analysis (Stratus?); IOP measurements were taken 30 minutes and 24 hours after each injection.<b>RESULTS:</b>The mean ages were 68.0±7.5 and 69.1±7.7 years in the IVR and IVB groups, respectively (<i>P</i>=0.55). They underwent (6.3±1.9) and (5.1±1.3) injections (<i>P</i>=0.07) over (13.6±2.1) and (14.05±2.6) months (<i>P</i>=0.45) in the IVR and IVB groups, respectively. Changes in overall and temporal RNFL thickness in IVR-treated eyes (105.3±6.9μm and 74.4±11.2μm) were not different from those in untreated eyes in the IVR group (104.6± 8.4μm and 75.1±12.6μm) (<i>P</i>=0.57 and <i>P</i>=0.41, respectively). Similarly, overall and temporal RNFL thickness in IVB-treated eyes (105.8±8.1μm and 74.5±11.8μm) were not different from those in untreated eyes in the IVB group (104.6±8μm and 74.8±12.9μm) (<i>P</i>=0.42 and <i>P</i>=0.80, respectively). The frequencies of IOP rise (<i>P</i>=0.60) and changes in RNFL thickness from baseline (<i>P</i>=0.16) were comparable between groups.<b>CONCLUSION:</b>Repeated intravitreal injection of ranibizumab or bevacizumab does not seem have adverse effects on RNFL thickness or IOP in wet AMD patients.]]></description>
<pubDate>2013/4/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Güng&#246;r Sobac&#305;, R&#305;za Güng&#246;r and G&#246;khan &#214;zge]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Güng&#246;r Sobac&#305;, R&#305;za Güng&#246;r and G&#246;khan &#214;zge</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130220]]></guid><cfi:id>1260</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Secondary glaucoma after pediatric cataract surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130221]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To determine the incidence and risk factors of secondary glaucoma after pediatric cataract surgery.<b>METHODS:</b> Two hundred and forty nine eyes of 148 patients underwent cataract surgery without intraocular lens (IOL) implantation (group 1), and 220 eyes of 129 patients underwent cataract surgery with IOL implantation (group 2) retrospectively, were evaluated between 2000 and 2011.The outcome measure was the presence or absence of post-cataract surgery glaucoma, defined as an intraocular pressure (IOP) ≥26mmHg, as measured on at least two occasions along with corneal or optic nerve changes.<b>RESULTS:</b> The mean follow-up periods of group 1 and 2 were (60.86±30.95) months (12-123 months) and (62.11±31.29) months (14-115 months) respectively. In group 1, 12 eyes of 8 patients (4.8%) developed glaucoma. None of the patients developed glaucoma after surgery in group 2. The mean age of the patients at the cataract surgery was (2.58±0.90) months (1 month-4 months) and the average period for glaucoma development after surgery was (9.50±4.33) months (4-16 months) in group 1. Three of the 12 glaucomatous eyes were controlled with antiglaucomatous medication and 9 eyes underwent trabeculectomy+mitomycin C surgery. One patient underwent a second trabeculectomy + mitomycin C operation for both of his eyes.<b>CONCLUSION:</b> The incidence of glaucoma after pediatric cataract surgery is very low in patients in whom IOL is implanted. The aphakic eyes after pediatric cataract surgery are at an increased risk for glaucoma development particularly if they underwent surgery before 4 months of age.]]></description>
<pubDate>2013/4/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Alparslan &#350;ahin, Ihsan &#199;a&#231;a, Abdullah Kür&#351;at Cingü, Fatih Mehmet Türkcü, Harun Yüksel, Muhammed &#350;ahin, Yasin &#199;inar and &#350;eyhmus Ari]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Alparslan &#350;ahin, Ihsan &#199;a&#231;a, Abdullah Kür&#351;at Cingü, Fatih Mehmet Türkcü, Harun Yüksel, Muhammed &#350;ahin, Yasin &#199;inar and &#350;eyhmus Ari</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130221]]></guid><cfi:id>1259</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Predictors of visual outcome in eyes with choroidal neovascularization secondary to age related macular degeneration treated with intravitreal bevacizumab monotherapy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130113]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM: </b>To evaluate the predictors of visual improvement in eyes with naive choroidal neovascularization secondary to age-related macular degeneration (CNV -AMD) treated with intravitreal bevacizumab (IVB) monotherapy.<b>METHODS: </b>Fifty eyes with naive CNV- AMD with pretreatment best-corrected visual acuity (BCVA) better than 20/200 and treated with IVB monotherapy were evaluated. Several variables including age, sex, pre-treatment BCVA, CNV type and lesion size on fluorescein angiogram as well as SD-OCT parameters including pre-treatment central macular thickness (CMT), inner-segment/outer-segment (IS/OS) junction integrity, and external limiting membrane (ELM) integrity were analyzed to predict visual outcome.<b>RESULTS:</b>On univariate regression, pretreatment ELM damage was associated with less visual improvement after treatment (<i>P</i>=0.0145). However, ELM damage predicted only 10% of the visual outcome. On multivariate regression, pretreatment BCVA, IS/OS junction, and ELM integrity on SD-OCT were the significant predictors for the treatment effect and together predicted 37% of visual improvement.<b>CONCLUSION:</b> Pretreatment BCVA, ELM and IS/OS junction integrity on SD-OCT are of significant value in predicting the visual improvement in naive wet AMD patients treated with IVB monotherapy.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jay Chhablani,Jae Suk Kim,William R Freeman,Igor Kozak,Hai-Yan Wang and Lingyun Cheng]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jay Chhablani,Jae Suk Kim,William R Freeman,Igor Kozak,Hai-Yan Wang and Lingyun Cheng</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130113]]></guid><cfi:id>1258</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Prospective case series on trabecular-iris angle status after an acute episode of phacomorphic angle closure]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130114]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To investigate the trabecular-iris angle with ultrasound biomicroscopy (UBM) post cataract extraction after an acute attack of phacomorphic angle closure.<b>METHODS:</b> This prospective study involved 10 cases of phacomorphic angle closure that underwent cataract extraction and intraocular lens insertion after intraocular pressure (IOP) lowering. Apart from visual acuity and IOP, the trabecular-iris angle was measured by gonioscopy and UBM at 3 months post attack.<b>RESULTS:</b> In 10 consecutive cases of acute phacomorphic angle closure from December 2009 to December 2010, gonioscopic findings showed peripheral anterior synechiae (PAS) ≤ 90° in 30% of phacomorphic patients and a mean Shaffer grading of (3.1±1.0). UBM showed a mean angle of (37.1°±4.5°) in the phacomorphic eye with the temporal quadrant being the most opened and (37.1°±8.0°) in the contralateral uninvolved eye. The mean time from consultation to cataract extraction was (1.4±0.7) days and the mean total duration of phacomorphic angle closure was (3.6±2.8) days but there was no correlation to the degree of angle closure on UBM (Spearman correlation <i>P</i>=0.7). The presenting mean IOP was (50.5±7.4) mmHg and the mean IOP at 3 months was (10.5±3.4) mmHg but there were no correlations with the degree of angle closure (Spearman correlations <i>P</i>=0.9).<b>CONCLUSION:</b>An open trabecular-iris angle and normal IOP can be achieved after an acute attack of phacomorphic angle closure if cataract extraction is performed within 1 day - 2 days after IOP control. Gonioscopic findings were in agreement with UBM, which provided a more specific and object angle measurement. The superior angle is relatively more narrowed compared to the other quadrants. All contralateral eyes in this series had open angles.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jacky Lee,Jimmy Lai,Doris Yick and Can Yuen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jacky Lee,Jimmy Lai,Doris Yick and Can Yuen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130114]]></guid><cfi:id>1257</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Quality of life and emotionalchange for middle-aged and elderly patients with diabetic retinopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130115]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM:To evaluate the SF-36, Diabetes Specificity Quality of Life Scale (DSQL) and anxiety and depression symptoms and investigate its changes in proliferative diabetic retinopathy (PDR) by vitrectomy interventions.METHODS:The present study included 108 diabetic retinopathy (DR) patients:54 with PDR and 54 with non-proliferative diabetic retinopathy (NPDR). Each healthy control group (<i>n</i>=54) sociodemographically matched to DR groups was established respectively. The quality of life, anxiety and depression symptoms were evaluated and analyzed on preoperative and postoperative month 1 using SF-36, DSQL and Hospital Anxiety and Depression Scale (HADS).RESULTS:DR patients described impaired HRQL (Health Related Quality of life, SF-36) in 6 out of 8 subscales, including ‘Body Health’, ‘Body Role Function’, ‘General Health’, ‘Society Function’, ‘Emotion Role Function’ and‘ Mental Health’. Compared with controls, DR patients (NPDR and PDR) suffered from statistically significantly impaired HRQL (SF-36 Summary score) (<i>P</i>&lt;0.05). By surgical intervention, the anxiety and depression score were significantly reduced, while the health and quality of life (SF-36 Summary scores and DSQL scores) was improved in patients with PDR (<i>P</i>&lt;0.05).CONCLUSION:DR patients were affected in mentation and quality of life. Surgery interventions can improve SF-36, DSQL, anxiety and depression in PDR patients.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yao Yu,Lie Feng,Yi Shao,Ping Tu,He-Ping Wu,Xun Ding and Wei-Hua Xiao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yao Yu,Lie Feng,Yi Shao,Ping Tu,He-Ping Wu,Xun Ding and Wei-Hua Xiao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130115]]></guid><cfi:id>1256</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Green-light fundus autofluorescence in diabetic macular edema]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130116]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To evaluate the role of central green-light fundus autofluorescence (FAF) in diabetic macular edema (DME).<b>METHODS:</b> A consecutive series of 92 study eyes with diabetic retinopathy were included. Out of those, 51 diabetic eyes had DME and were compared to 41 diabetic eyes without DME. In all subjects, green-light FAF images were obtained, quantified and classified into various FAF patterns. Cross-sectional optical coherence tomography (OCT) scans were obtained for evaluation of Inner/Outer segment (IS/OS) layer integrity, measurements of central RPE-IS/OS layer thickness as well as classification of DME into various subtypes.<b>RESULTS:</b>Mean central green-light FAF intensity of eyes with DME (1.289±0.140)log did not significantly differ from diabetic patients without DME (1.317±0.137)log. Most classifiable FAF patterns were seen in patients with cystoid DME. Mean central retinal thickness (CRT) of all study eyes with DME was (501.9±112.4)µm compared to (328.2±27.0)µm in diabetic patients without DME. Patients with DME had significantly more disrupted photoreceptor IS/OS layers than diabetic patients without DME (28/51 <i>vs</i> 5/41, <i>P</i>&lt;0.001). Mean RPE-IS/OS thickness of patients with DME (60.7±14.1)µm was significantly (<i>P</i>&lt;0.001) lower than in diabetic eyes without DME (73.5±9.4)µm. Correlation analys1s revealed non-significant correlations of green-light FAF intensity and OCT parameters in all subtypes of DME.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Lukas Reznicek,Simeon Dabov,Christos Haritoglou,Anselm Kampik,Marcus Kernt and Aljoscha S Neubauer]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Lukas Reznicek,Simeon Dabov,Christos Haritoglou,Anselm Kampik,Marcus Kernt and Aljoscha S Neubauer</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130116]]></guid><cfi:id>1255</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of Densiron 68 and 1 000 cSt silicone oil in the management of rhegmatogenous retinal detachment with inferior breaks]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130117]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To compare success rates and complications of Densiron 68 and 1000cSt silicone oil (SO) in the management of rhegmatogenous retinal detachment (RRD) with inferior breaks (IBs).<b>METHODS:</b>Totally 61 eyes of 61 consecutive patients with RRD with IBs were assigned to pars plana vitrectomy (PPV) with Densiron (<i>n</i>=31) or PPV with SO (<i>n</i>=30) in order of presentation. SO and Densiron removal was performed 3 months after initial surgery. Follow up visits were terminated 6 months after SO removal.<b>RESULTS:</b>With a single operation, the Densiron group showed 84% and SO 74% reattachment. With further surgery, both groups showed 90% re-attachment. Complications such as cataract, raised intraocular pressure (IOP), inflammatory reaction, macular epiretinal membranes, and emulsification of SO were seen in both groups.<b>CONCLUSION:</b>Densiron and SO are found to have similar success rates and complications.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ibrahim Kocak and Haci Koc]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ibrahim Kocak and Haci Koc</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130117]]></guid><cfi:id>1254</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Macular and peripapillary retinal nerve fiber layer thickness in children with hyperopic anisometropic amblyopia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130118]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To compare the retinal nerve fiber layer (RNFL) thickness and macular thickness in the amblyopic eye with that in the sound eye of children with hyperopic anisometropic amblyopia using optical coherence tomography (OCT).<b>METHODS:</b> A prospective, nonrandom, intraindividual comparative cohort study includes 72 children with hyperopic anisometropic amblyopia in a single center. Macular thickness, macular foveola thickness, and peripapillary RNFL thickness were compared between the amblyopia eyes and the contralateral sound eyes.<b>RESULTS:</b>There were 38 male and 34 female patients, with a mean age as 9.7±1.9 years (range, 5–16 years). Hyperopic was +3.62±1.16D (range +2.00D to +6.50D) in the amblyopic eyes, which was significantly higher in the control eyes with +0.76±0.90D (range 0D to +2.00D) (<i>P </i>&lt; 0.01). The mean peripapillary RNFL thickness was 113.9±7.2µm and 109.2±6.9µm in the amblyopic eye and the normal eye, respectively, reaching statistical significance (<i>P</i> = 0.02). The mean macular foveola thickness was significantly thicker in the amblyopic eyes than the contralateral sound eyes (181.4±14.2µm <i>vs</i> 175.2±13.3µm, <i>P</i> &lt; 0.01), but the 1mm, 3mm or 6mm macular thickness central macular thickness was not significantly different. Degree of anisometropia in the contralateral eyes was not significantly correlated with differences of peripapillary RNFL, macular foveola thickness or central macular thickness.<b>CONCLUSION:</b>Eyes with hyperopic anisometropic amblyopia are found thicker macular foveola and peripapillary RNFL than the contralateral eyes in children.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Shuang-Qing Wu,Li-Wei Zhu,Qi-Bin Xu,Jun-Li Xu and Yu Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Shuang-Qing Wu,Li-Wei Zhu,Qi-Bin Xu,Jun-Li Xu and Yu Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130118]]></guid><cfi:id>1253</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Evaluation of peripapillary retinal nerve fiber layer, macula and ganglion cell thickness in amblyopia using spectral optical coherence tomography]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130119]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To investigate peripapillary retinal nerve fiber layer (RNFL), macula and ganglion cell layer thicknesses (GCC) in amblyopic eyes with spectral domain optical coherence tomography (SD-OCT).<b>METHODS:</b>Thirty six patients with a history of unilateral amblyopia and thirty two children who had emmetropia without amblyopia were included in this study.In this institutional study, 36 eyes of 36 patients with amblyopia (AE), 36 fellow eyes without amblyopia (FE), and 32 eyes of 32 normal subjects (NE) were included. RNFL, GCC and macular thickness measurements were performed with RS-3000 OCT Retina Scan (Nidek Inc CA. USA).<b>RESULTS:</b>The mean global thicknesses of the RNFL were 113.22±21.47, 111.57±18.25, 109.96±11.31μm in the AE, FE, and NE, respectively. There was no statistically significant difference for mean global RNFL thickness among the eyes (<i>P</i>=0.13). The mean thicknesses of the macula were 258.25±18.31, 258.75±19.54, 248.62±10.57μm in the AE, FE and NE, respectively. There was no statistically significant difference for thickness of macula among the eyes (<i>P</i>=0.06). The GCC was investigated into two parts:superior and inferior. The mean thicknesses of superior GCC were 102.57±13.32, 103.32±10.64, 100.52±5.88μm in the AE, FE, and NE, respectively. The mean thicknesses of inferior GCC were 103.82±12.60, 107.82±12.33, 105.86±10.79μm in the AE, FE and NE, respectively. There was no statistically significant difference for thickness of superior and inferior GCC between the eyes (<i>P</i>=0.63, <i>P</i>=0.46).<b>CONCLUSION:</b>The macular thicknesses of AE and FEwere greater than the NE, although it was not statistically significant. Amblyopia does not seem to have a profound effect on the RNFL, macula and GCC.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Penpe Gul Firat,Ercan Ozsoy,Soner Demirel,Tongabay Cumurcu and Abuzer Gunduz]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Penpe Gul Firat,Ercan Ozsoy,Soner Demirel,Tongabay Cumurcu and Abuzer Gunduz</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130119]]></guid><cfi:id>1252</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[The East London glaucoma prediction score:web-based validation of glaucoma risk screening tool]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130120]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>It is difficult for Optometrists and General Practitioners to know which patients are at risk. The East London glaucoma prediction score (ELGPS) is a web based risk calculator that has been developed to determine Glaucoma risk at the time of screening. Multiple risk factors that are available in a low tech environment are assessed to provide a risk assessment. This is extremely useful in settings where access to specialist care is difficult. Use of the calculator is educational. It is a free web based service. Data capture is user specific.<b>METHOD:</b>The scoring system is a web based questionnaire that captures and subsequently calculates the relative risk for the presence of Glaucoma at the time of screening. Three categories of patient are described:Unlikely to have Glaucoma; Glaucoma Suspect and Glaucoma. A case review methodology of patients with known diagnosis is employed to validate the calculator risk assessment.<b>RESULTS:</b>Data from the patient records of 400 patients with an established diagnosis has been captured and used to validate the screening tool. The website reports that the calculated diagnosis correlates with the actual diagnosis 82% of the time. Biostatistics analysis showed:Sensitivity = 88%; Positive predictive value = 97%; Specificity = 75%.<b>CONCLUSION:</b>Analysis of the first 400 patients validates the web based screening tool as being a good method of screening for the at risk population. The validation is ongoing. The web based format will allow a more widespread recruitment for different geographic, population and personnel variables.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Cook Stephen and Longo-Mbenza Benjamin]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Cook Stephen and Longo-Mbenza Benjamin</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130120]]></guid><cfi:id>1251</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Anterior vitrectomy and partial capsulectomy via anterior approach to treat chronic postoperative endophthalmitis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130121]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM:To describe the results of vitrectomy and partial capsulectomy <i>via</i> anterior approach surgical technique in treatment of chronic postoperative endophthalmitis (CPE).METHODS:Clinical records of 9 patients treated for CPE between 2006 and 2010 were reviewed retrospectively. All of these patients were treated with vitrectomy and partial capsulectomy <i>via</i> anterior approach.RESULTS:Six of 9 patients were male. The average patients’ age was (60±8.1) years. The average period between cataract extraction and onset of signs and symptoms was (3.6±1.3) weeks. The average presenting visual acuity was 0.3±0.1 and the average final post operative visual acuity was 0.7±0.2. The mean follow-up period was (28.1±8.9) weeks. In all patients, the inflammation subsided after surgery.CONCLUSION:Our results suggest that anterior vitrectomy and partial capsulectomy <i>via</i> anterior approach may be considered as potentially useful and relatively less invasive technique to treat CPE.]]></description>
<pubDate></pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mete Güler and Turgut Y&#305;lmaz]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mete Güler and Turgut Y&#305;lmaz</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20130121]]></guid><cfi:id>1250</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Corneal injury and its protection using hydro-gel patch during general anesthesia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140609]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To evaluate corneal injury during general anesthesia and analyze the protective effect of medical hydro-gel eye patch in clinics.<b>METHODS:</b> Seventy-six patients with 152 eyes undergoing general anesthesia were included. None had positive corneal fluorescein staining before surgery. Both eyes of each patient were analyzed, with one randomly allocated to receive medical hydro-gel eye patch, and the other to receive common adhesive tape as a control. Corneal injuries were evaluated by scoring fluorescein staining under a hand-held slit lamp immediately after surgery in postanesthesia care unit and 24h thereafter. Patients’ discomforts were also evaluated.<b>RESULTS:</b>Twelve eyes (15.8%) in the hydro-gel patch group and 30 eyes (39.5%) in the adhesive tape group showed corneal injury immediately after surgery. The eyes protected with hydro-gel patch showed statistically less corneal fluorescein staining than the control group. Four eyes in hydro-gel patch group and 6 eyes in adhesive tape group suffered discomfort immediately after surgery without intergroup difference and all discomforts disappeared after 24h (<i>P</i>=0.257). No side effect was observed in hydro-gel patch group, while 5 eyes had brow avulsion and 2 got skin itching in adhesive tape group.<b>CONCLUSION:</b>Corneal injury complication was more frequent than we thought following general anesthesia. The medical hydro-gel eye patch can protect the occurrence of corneal injury following general anesthesia.]]></description>
<pubDate>2014/12/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ting Wan,Yan Wang and Xiu-Ming Jin]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ting Wan,Yan Wang and Xiu-Ming Jin</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140609]]></guid><cfi:id>1249</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Elevation of serum apelin-13 associated with proliferative diabetic retinopathy in type 2 diabetic patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140610]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To compare apelin-13, a ligand of G-protein-coupled receptor which has been shown to be involved in retinal angiogenesis, and vascular endothelial growth factor (VEGF) serum levels in type 2 diabetes mellitus (T2DM) with or without retinopathy, and to investigate the relationship between the serum concentration of apelin-13 and diabetes retinopathy.<b>METHODS:</b> Sixty-nine patients with T2DM were enrolled. Of the 69 patients, 16 had proliferative diabetic retinopathy (PDR group), 23 had non-PDR (NPDR group) and 30 had no retinopathy (T2DM group). Subjects’ information, including demographics, medical history, and use of medications were recorded. Their serum samples were collected for measuring the levels of C-reactive protein (CRP), serum lipid and glycosylated hemoglobin. Apelin-13 and VEGF serum levels were measured by enzyme-linked immunosorbent assay. Kruskal-Wallis test and one-way ANOVA were used to compare the differences among these groups. Chi-square test was used to assess categorical variables. Correlations between variables were investigated by Spearman rho correlation test and stepwise regression analysis. All statistical analyses were performed through SPSS 17.0 software.<b>RESULTS:</b>Sex, age, body mass index (BMI), blood pressure, CRP, hemoglobin A1c (HbA1c) have no significantly difference in the three groups. Serum level of apelin-13 was significantly elevated in PDR group as compared with T2DM group (<i>P=</i>0.041). Differences of VEGF serum concentration in the three groups were statistically significant (<i>P=</i>0.007, <i>P=</i>0.007 and <i>P&lt;</i>0.001, respectively). Spearman rho correlation test showed that serum apelin-13 was positively correlated with BMI, serum triglycerides, VEGF, but not with age, duration of diabetes, blood pressure, CRP, HbA1c and total-cholesterol. Stepwise regression analysis showed that BMI also significantly associated with serum apelin-13 (<i>P=</i>0.002), while VEGF and serum triglycerides were irrelevant.<b>CONCLUSION:</b> This study elucidated a positive association of apelin-13 serum level with PDR, but not with VEGF. Apelin-13 may influence the promotion of PDR but unrelated with VEGF.]]></description>
<pubDate>2014/12/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jun-Hui Du,Xia Li,Rong Li,Lin Xu,Ran-Ran Ma,Song-Fang Liu,Zhong Zhang and Hong-Zhi Sun]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jun-Hui Du,Xia Li,Rong Li,Lin Xu,Ran-Ran Ma,Song-Fang Liu,Zhong Zhang and Hong-Zhi Sun</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140610]]></guid><cfi:id>1248</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Visual acuity and endothelial cell density with respect to the graft thickness in Descemet''s stripping automated endothelial keratoplasty:one year results]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140611]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To evaluate the visual acuity and endothelial cell density according to thethickness in Descemet''s stripping automated endothelial keratoplasty (DSAEK) one year after surgery.<b>METHODS:</b> DSAEK patients'' data were reviewed. Thirty-seven eyes of 37 patients who underwent DSAEK for pseudophakic bullous keratopathy (PBK) were included in this study. Graft thickness was measured with optical coherence tomography (OCT) 12mo after DSAEK. Eyes were divided into 3 groups based on the graft thickness:thick (&gt;200 μm), medium-thick (150-200 μm) and thin (&lt;150 μm). Best corrected visual acuity (BCVA), endothelial cells density (ECD) and complications were assessed and comparisons were done between groups.<b>RESULTS:</b>There was no significant difference in age, sex, preoperative BCVA, or follow-up period between DSAEK groups. At postoperative 12mo, mean BCVA was 0.28±0.10 in thick graft group, 0.52±0.08 in medium-thick graft group, and 0.72±0.06 in thin graft group. Thin grafts showed better postoperative BCVA as compared with the medium-thick and thick grafts (<i>P</i>=0.001). Thick graft group had 1637.44±88.19-mm<sup>2</sup>, medium thick graft had 1764.50±34.28-mm<sup>2</sup> and thin graft group had 1845.30±65.62-mm<sup>2 </sup>ECD at 12mo after the surgery. Thin graft group had better ECD at 12mo after surgery (<i>P</i>=0.001).<b>CONCLUSION:</b> Thin grafts after DSAEK ensure better visual rehabilitation. Eyes with thin grafts had significantly lesser loss of ECD compared to eyes with medium-thick and thick grafts one year after surgery.]]></description>
<pubDate>2014/12/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Banu Torun Acar¹,Mehmet Orcun Akdemir² and Suphi Acar¹]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Banu Torun Acar¹,Mehmet Orcun Akdemir² and Suphi Acar¹</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140611]]></guid><cfi:id>1247</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Curative effect assessment of bandage contact lens in neurogenic keratitis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140612]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To observe the curative effect of bandage contact lens in neurogenic keratitis.<b>METHODS:</b>Twenty cases of neurogenic keratitis were studied attheDepartment of Ophthalmology, the first Affiliated Hospital of China Medical University, between October 2012 and June 2013. These included 13 males and 7 females, aged from 35 to 88y. Patients were voluntarily divided into an experimental group (lens wearing group, <i>n</i>=10) and control group (drug therapy, <i>n</i>=10). In experimental group patients wore silicone hydrogel bandage soft contact lens. Both groups used the following eyedrops:0.5% levofloxacin TID; 0.5% Sodium carboxymethyl cellulose QID; fibroblast growth factor BID; ganciclovir BID [cases complicated with herpes simplex virus (HSV)]; compound tropicamide BID (cases concurrent hypopyon). The healing time of corneal ulcer and complication rates were observed in the two groups.<b>RESULTS:</b> The healing time of corneal ulcer in the experimental group was 10.80±4.44d versus 46.70±13.88d in the control group (<i>P</i>＜0.05). No complications occurred in the experimental group, except for the lens falling off twice in one case, the patient recovered eight days after rewearing the lens. While in the control group, all cases vascularized, 2 cases were complicated with descemetocele that recovered with amniotic membrane transplantation and 1 case was complicated with corneal perforation that recovered by autologous conjunctival flap covering.<b>CONCLUSION:</b> Bandage contact lens is a safe and effective method of treating neurogenic keratitis and significantly shortened the healing time of corneal ulcer.]]></description>
<pubDate>2014/12/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yu-Zhao Sun,Lei Guo and Fu-Sheng Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yu-Zhao Sun,Lei Guo and Fu-Sheng Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140612]]></guid><cfi:id>1246</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Influence factors for successful corneal donation among Chinese adults:data from Nanjing between 2001 and 2012]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140613]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To investigate the factors that may influence the successful corneal donation among adults in China.<b>METHODS:</b>This retrospective study was conducted in 2012. The eligible participants were all the adults registered in Nanjing Red Cross Eye Bank to donate their corneas after death during the period of 2001 and 2012. Multivariate logistic regression models were applied to investigate the influence factors for successful donation, the outcome events.<b>RESULTS:</b>Totally, 210 of 328 (64.0%) registered potential donors successfully donated their corneas after death. The mean (SD) age at registration was 64.7 (12.5) for all participants, with 65.5 (10.1) and 63.2 (15.8) for successful and unsuccessful donors, respectively. With multivariate logistic regression analysis, five factors, the willingness of donation, age, education level, residence area, and cause of death were identified to be associated with successful corneal donation.<b>CONCLUSION:</b>The willingness of donation and some socio-demographic factors might substantially affect their successful donation after death for people who registered to donate corneas.]]></description>
<pubDate>2014/12/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Li-Xun Chen and Qing-Huai Liu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Li-Xun Chen and Qing-Huai Liu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140613]]></guid><cfi:id>1245</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Quantification of corneal neovascularization after ex vivo limbal epithelial stem cell therapy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140614]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To assess cultured limbal epithelial stem cell transplantation in patients with limbal stem cell deficiency by analyzing and quantifying corneal neovascularization.<b>METHODS:</b> This retrospective, interventional case series included eight eyes with total limbal stem cell deficiency. <i>Ex vivo</i> limbal epithelial stem cells were cultured on human amniotic membrane using an animal-free culture method. The clinical parameters of limbal stem cell deficiency, impression cytology, and quantification of corneal neovascularization were evaluated before and after cultured limbal stem cell transplantation. The area of corneal neovascularization, vessel caliber (VC), and invasive area (IA) were analyzed before and after stem cell transplantation by image analysis software. Best-corrected visual acuity (BCVA), epithelial transparency, and impression cytology were also measured.<b>RESULTS:</b> One year after surgery, successful cases showed a reduction (improvement) of all three parameters of corneal neovascularization [neovascular area (NA), VC, IA], while failed cases did not. NA decreased a mean of 32.31% (<i>P=</i>0.035), invasion area 29.37% (<i>P=</i>0.018) and VC 14.29% (<i>P=</i>0.072). BCVA improved in all eyes (mean follow-up, 76±21mo). Epithelial transparency improved significantly from 2.00±0.93 to 0.88±1.25 (<i>P=</i>0.014). Impression cytology showed that three cases failed after limbal epithelial stem cell therapy before 1y of follow-up.<b>CONCLUSION:</b> This method of analyzing and monitoring surface vessels is useful for evaluating the epithelial status during follow-up, as successful cases showed a bigger reduction in corneal neovascularization parameters than failed cases. Using this method, successful cases could be differentiated from failed cases.]]></description>
<pubDate>2014/12/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Adriano Guarnieri,Javier Moreno-Montañés,Belén Alfonso-Bartolozzi,Alfonso L. Sabater,María García-Guzmán,Enrique J. Andreu and Felipe Prosper]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Adriano Guarnieri,Javier Moreno-Montañés,Belén Alfonso-Bartolozzi,Alfonso L. Sabater,María García-Guzmán,Enrique J. Andreu and Felipe Prosper</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140614]]></guid><cfi:id>1244</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Amniotic membrane welded to contact lens by 1470-nm diode laser:a novel method for sutureless amniotic membrane transplantation]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140615]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To avoid the side effects of the suture usage by welding amniotic membrane (AM) to contact lens (CL) with laser.<b>METHODS:</b>AM was taken from pregnant women and cleaned from blood clots with sterile phosphate-buffered physiological saline solution which included antibiotics. Stromal side of the AM was spread inside of the CL and it was welded to CL by 1470 nm diode laser. 600 μm diameter fiber tip of the laser was contacted with the epithelial side of the AM from 4 separate points. After welding excess amniotic membrane around the CL was cut with a scalpel.<b>RESULTS:</b>Stromal side of the AM was spread inside of the CL and then with laser fiber, different power levels and exposure times were applied on the epithelium of AM and 340 mW for seven seconds was found optimal. CL and AM attached with the spot welding effect in 4 points by touching fiber tip. CL-AM welded complex did not separated from each other while holding AM that extend beyond the CL with the help of two forceps.<b>CONCLUSION:</b>As a conclusion, it was aimed in this study to achieve the success of the conventional amniotic membrane transplantation (AMT)with the easiness of applying a CL and to avoid risks and side effects of corneal or conjunctival suturing. The results showed that the application of the CL–AM complex will be as easy as the application of a CL and lasts shortly.]]></description>
<pubDate>2014/12/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Rifat Rasier and Murat Gulsoy]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Rifat Rasier and Murat Gulsoy</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140615]]></guid><cfi:id>1243</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of surgically induced astigmatism in various incisions in manual small incision cataract surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140616]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To determine the surgically induced astigmatism (SIA) in Straight, Frown and Inverted V shape (Chevron) incisions in manual small incision cataract surgery (SICS).<b>METHODS:</b>A prospective cross sectional study was done on a total of 75 patients aged 40y and above with senile cataract. The patients were randomly divided into three groups (25 each). Each group received a particular type of incision (Straight, Frown or Inverted V shape incisions). Manual SICS with intraocular lens (IOL) implantation was performed. The patients were compared 4wk post operatively for uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA) and SIA. All calculations were performed using the SIA calculator version 2.1, a free software program. The study was analyzed using SPSS version 15.0 statistical analysis software.<b>RESULTS:</b>The study found that 89.5% of patients in Straight incision group, 94.2% in Frown incision group and 95.7% in Inverted V group attained BCVA post-operatively in the range of 6/6 to 6/18. Mean SIA was minimum (-0.88±0.61D×90 degrees) with Inverted V incision which was statistically significant.<b>CONCLUSION:</b>Inverted V (Chevron) incision gives minimal SIA.]]></description>
<pubDate>2014/12/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Nidhi Jauhari,Deepak Chopra,Rajan Kumar Chaurasia and Ashutosh Agarwal]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Nidhi Jauhari,Deepak Chopra,Rajan Kumar Chaurasia and Ashutosh Agarwal</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140616]]></guid><cfi:id>1242</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Spontaneous resolution of macular edema after silicone oil removal]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140617]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To investigate the macular changes in eyes filled with silicone oil (SO) and course of these changes after SO removal.<b>METHODS:</b>A retrospective optical coherence tomography scan review was conducted for twenty-four patients who underwent uncomplicated pars plana vitrectomy with SO tamponade for complex retinal detachments were detected with optical coherence tomography before, and one week, one month and three months after SO removal.<b>RESULTS:</b>Mean duration of SO tamponade was 3.6±1.0mo (range:3-7mo). Cystoid macular edema (CME) was detected in 3 eyes before SO removal. Submacular fluid was represented in 1 eye before silicone SO removal. Resolution of CME and submacular fluid was achieved 1mo after SO removal in all eyes. Mean best corrected visual acuity (BCVA) was 1.15±0.65 (range, hand movement to 0.2) before SO removal in the eyes without macular changes. After SO removal, the mean BCVA values at 1wk and 1 and 3mo, and 0.82±0.23, 0.76±0.21, and 0.70±0.19, all of which were significantly better than baseline (<i>P=</i>0.030, 0.017, 0.006 respectively). In the eyes with macular CME and subretinal fluid the mean BCVA was significantly improved at 3mo after SO removal compared with baseline (<i>P=</i>0.037).<b>CONCLUSION:</b>Decreased visual acuity in eyes filled with SO could be caused by macular complications due to SO. CME and subretinal fluid may resolve without any additional macular surgery after SO removal.]]></description>
<pubDate>2014/12/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Eyyup Karahan,Ibrahim Tuncer,Mehmet Ozgur Zengin,Cem Kucukerdonmez and Suleyman Kaynak]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Eyyup Karahan,Ibrahim Tuncer,Mehmet Ozgur Zengin,Cem Kucukerdonmez and Suleyman Kaynak</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140617]]></guid><cfi:id>1241</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Uveitis associated with multiple sclerosis:complications and visual prognosis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140618]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To determine the frequency, subtype, complications, treatment and visual prognosis of uveitis in patients with multiple sclerosis (MS).<b>METHODS:</b>A total of 1702 MS patients’ medical records were reviewed for a history of uveitis both with a neurologist and an ophthalmologist.<b>RESULTS:</b>Nine patients (0.52%) with uveitis were detected. Eight of them were female, one was male. The mean age was 42.0±14.1y (range 22-66). Seven patients were relapsing remitting MS, two were secondary progressive MS. The mean duration of MS was 10.8±10.3y, and the mean duration of uveitis 10.3±9.9y. The onset of uveitis preceded that of MS (four patients) by a mean of 5.0±4.3y (range 1-11). MS diagnosed prior to the onset of uveitis (five patients) by an interval of 0.75-16y (mean 4.95±6.24y). There were 16 affected eyes of nine patients. The most common types of uveitis were panuveitis and intermediate uveitis. Uveitis was bilateral in most patients. The most common complications were cataract and glaucoma, and patients with such complications were surgically treated. The range of visual acuity of affected eyes was 20/800 to 20/22, with only six of 16 affected eyes better than 20/40. After treatment, the visual acuity of the affected eyes was better than 20/40 in 11 of 16 eyes.<b>CONCLUSION:</b>Uveitis should be considered when assessing an MS patient with visual loss, as surgical interventions other than medical treatments may be needed to improve visual function. Complications could be seen more often when posterior segment is involved.]]></description>
<pubDate>2014/12/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Derya Kaya,Mahmut Kaya,Serkan Özakbaş and Egemen İdiman]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Derya Kaya,Mahmut Kaya,Serkan Özakbaş and Egemen İdiman</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140618]]></guid><cfi:id>1240</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Relationship between pinguecula formation and exposure to tandoor ovens in a hospital-based study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140619]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To investigate the relationship between pinguecula and the use of tandoor ovens.<b>METHODS:</b>A total of 539 women, ranging in age from 20 to 86y who attended an outpatient clinic were enrolled. All the patients were asked whether they used tandoor ovens. Women exposed to tandoor ovens (<i>n</i>=286) were accepted as participants in the study group and they were compared with participants in the control group (<i>n</i>=253). The age, presence of pinguecula, duration of exposure to tandoor ovens as years and occupations were recorded for all the subjects.<b>RESULTS:</b>Mean duration for exposure to tandoor was 20.26y (range 1-62y) in the study group. The rate of pinguecula in the study group was 82.2% (235/286), and the rate in the control group was 37.5% (95/253); this difference was statistically significant (<i>P&lt;</i>0.05). Pinguecula was seen in 61.2% (330/539) of all the participants.<b>CONCLUSION:</b><i></i>Pinguecula is strongly associated with exposure to tandoor ovens.]]></description>
<pubDate>2014/12/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Adem Gul,Hasan Goker,Senol Sabanci,Ali Kurt and Kemal Turkyilmaz]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Adem Gul,Hasan Goker,Senol Sabanci,Ali Kurt and Kemal Turkyilmaz</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140619]]></guid><cfi:id>1239</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Bilateral same-session intravitreal injections of anti-vascular endothelial growth factors]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140620]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To document the indications, safety and possible complications of bilateral same-session intravitreal anti-vascular endothelial growth factor (VEGF) injections performed in the ophthalmic operating room.<b>METHODS</b>:A retrospective case series study. Consecutive records of seventy four patients receiving simultaneous bilateral intravitreal injections of either ranibizumab or bevacizumab, between September 2010 and September 2013, were reviewed and the outcomes were assessed. Data collected included number of injections, indications for injections, pre-injection and post-injection visual acuity (VA), pre-injection and post-injection intraocular pressure and ocular and systemic complications/complaints after each injection.<b>RESULTS:</b> A total of 342 injections were administered to 74 patients, with a mean of 4.62 injections per patient. Seventy-three patients received bevacizumab (Avastin; Genentech Inc., South San Francisco, California, USA) alone, and only one patient received both bevacizumab and ranibizumab (Lucentis; Genentech Inc.) distributed between the injections. Pre- and post-injection VA follow-up measurements were available for 65 patients. Mean follow up period was 22mo. The indications for initiating therapy were choroidal neovascular membrane from age-related macular degeneration (3 patients) and diabetic macular edema (71 patients). The mean Snellen VA before each injection was 6/22. The next post-injection follow-up mean Snellen VA was 6/20. One patient had a painful, culture-positive endophthalmitis in one eye 3d after bilateral bevacizumab. Another patient had a painless subconjunctival hemorrhage in one eye. No other ocular or systemic adverse side effects/complaints have been registered in this study group.<b>CONCLUSION:</b>Bilateral same-session intravitreal injections using a separate povidone-iodine preparation, speculum, needle, and syringe for each eye are well-tolerated. None of the subjects in this study requested to switch to alternating unilateral injections. Proper patient counseling as to the risk of complications with this procedure is necessary.]]></description>
<pubDate>2014/12/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Nakhleh E. Abu-Yaghi,Ahmed N Shokry and Rami H Abu-Sbeit]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Nakhleh E. Abu-Yaghi,Ahmed N Shokry and Rami H Abu-Sbeit</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140620]]></guid><cfi:id>1238</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Spectral domain optical coherence tomography cross-sectional image of optic nerve head during intraocular pressure elevation]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140621]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To analyze changes of the optic nerve head (ONH) and peripapillary region during intraocular pressure (IOP) elevation in patients using spectral domain optical coherence tomography (SD-OCT).<b>METHODS:</b> Both an optic disc 200×200 cube scan and a high-definition 5-line raster scan were obtained from open angle glaucoma patients presented with monocular elevation of IOP (≥30 mm Hg) using SD-OCT. Additional baseline characteristics included age, gender, diagnosis, best-corrected visual acuity, refractive error, findings of slit lamp biomicroscopy, findings of dilated stereoscopic examination of the ONH and fundus, IOP, pachymetry findings, and the results of visual field.<b>RESULTS:</b> The 24 patients were selected and divided into two groups:group 1 patients had no history of IOP elevation or glaucoma (<i>n=</i>14), and group 2 patients did have history of IOP elevation or glaucoma (<i>n=</i>10). In each patient, the study eye with elevated IOP was classified into group H (high), and the fellow eye was classified into group L (low). The mean deviation (MD) differed significantly between groups H and L when all eyes were considered (<i>P=</i>0.047) and in group 2 (<i>P=</i>0.042), not in group 1 (<i>P=</i>0.893). Retinal nerve fiber layer (RNFL) average thickness (<i>P=</i>0.050), rim area (<i>P=</i>0.015), vertical cup/disc ratio (<i>P=</i>0.011), cup volume (<i>P=</i>0.028), inferior quadrant RNFL thickness (<i>P=</i>0.017), and clock-hour (1, 5, and 6) RNFL thicknesses (<i>P=</i>0.050, 0.012, and 0.018, respectively), cup depth (<i>P=</i>0.008), central prelaminar layer thickness (<i>P=</i>0.023), mid-inferior prelaminar layer thickness (<i>P=</i>0.023), and nasal retinal slope (<i>P=</i>0.034) were significantly different between the eyes with groups H and L.<b>CONCLUSION:</b>RNFL average thickness, rim area, vertical cup/disc ratio, cup volume, inferior quadrant RNFL thickness, and clock-hour (1, 5, and 6) RNFL thicknesses significantly changed during acute IOP elevation.]]></description>
<pubDate>2014/12/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ji Young Lee,You Kyung Lee,Jung Il Moon and Myoung Hee Park]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ji Young Lee,You Kyung Lee,Jung Il Moon and Myoung Hee Park</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140621]]></guid><cfi:id>1237</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Evaluation of choroidal thickness using spectral-domain optical coherence tomography in patients with severe obstructive sleep apnea syndrome:a comparative study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140622]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To assess choroidal thickness in patients with severe obstructive sleep apnea syndrome (OSAS) and compare them with healthy controls, using spectral domain optical coherence tomography (OCT).<b>METHODS:</b> In this observational, cross-sectional study, choroidal thicknesses of 23 newly severe OSAS patients and 23 body mass index- age- and sex-matched healthy subjects were measured using a high-speed, high-resolution frequency domain-OCT device (λ=840 nm, 26000 A-scans/s, 5 μm axial resolution). All patients underwent a complete ophthalmic examination before the measurements. OCT measurements were taken at the same time of day (9:00 a.m.), in order to minimize the effects of diurnal variation.<b>CONCLUSION:</b> The decreased choroidal thickness of patients with severe OSAS might be related to the the autonomic disregulation associated with this disease. Further studies are needed to evaluate the etiopathologic relationship between choroidal thickness and OSAS.]]></description>
<pubDate>2014/12/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Aylin Karalezli,Fatma Corak Eroglu,Tulay Kivanc and Rusina Dogan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Aylin Karalezli,Fatma Corak Eroglu,Tulay Kivanc and Rusina Dogan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140622]]></guid><cfi:id>1236</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Surgical results of the slipped medial rectus muscle after hang back recession surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140623]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To analyze the surgical results of a slipped medial rectus muscle (MRM) after hang back recession surgery for esotropia.<b>METHODS:</b>Twenty-one patients who underwent re-exploration for diagnosed slipped muscle after hang back recession surgery were included in this retrospective study. Dynamic magnetic resonance imaging was performed to identify the location of the slipped muscle. Ocular motility was evaluated with assessment with prism and cover test in gaze at cardinal positions. The operations were performed by the same consultant. Intraoperative forced duction test was performed under general anesthesia. The empty sheath of the slipped MRM was resected and the muscle was advanced to the original insertion site in all patients.<b>RESULTS:</b>The average age of 21 patients who hadconsecutive exotropia with a slipped MRM at the time of presentation was 17.4±5.4y (5-50y). The average duration between the first operation and the diagnosis of the slipped muscle was 25mo (12 to 36mo). The mean follow up after the corrective surgery was 28mo. The mean preoperative adduction limitation in the field of action of the slipped muscle was -2.26 (ranging from -1 to -4). All patients had full adduction postoperatively.<b>CONCLUSION:</b>The diagnosis of the slipped muscle should be confirmed during the strabismus surgery. The slipped muscle may be caused due to insufficient suture and excessive rubbing of the eye. When divergent strabismus is observed after the recession of the MRM, a slipped muscle should be considered in the differential diagnosis.]]></description>
<pubDate>2014/12/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yasar Duranoglu,Hatice Deniz Ilhan and Meryem Guler Alis]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yasar Duranoglu,Hatice Deniz Ilhan and Meryem Guler Alis</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140623]]></guid><cfi:id>1235</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A comparison between monocanalicular and pushed monocanalicular silicone intubation in the treatment of congenital nasolacrimal duct obstruction]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140624]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To compare the success rate of monocanalicular versus pushed monocanalicular silicone intubation (PMCI) of the nasolacrimal duct for congenital nasolacrimal duct obstruction (CNLDO).<b>METHODS:</b> In a prospective randomized clinical trial 53 eyes of 49 patients with CNLDO underwent either monocanalicular silicone intubation (MCI) (<i>n</i>=28 eyes) or PMCI (<i>n</i>=25 eyes). All procedures were performed by 1 oculoplastic surgeon. Treatment success was defined as the complete resolution of epiphora at 3mo after tube removal.<b>Results:</b> The surgical outcome was assessed in 20 eyes with MCI and 20 eyes with PMCI. The mean age of treatment was 26.25±10.08mo (range, 13-49mo) for MCI and 26.85±12.25mo (range, 16-68mo) for PMCI. Treatment success was achieved in 18 of 20 eyes (90.0%) in the MCI group compared with 10 of 20 eyes (50%) in the PMCI group (<i>P</i>=0.01). In the PMCI group, the tube loss (30%) was greater than the MCI group (5%), however the differences between the 2 groups proved to be not significant (<i>P</i>=0.91).<b>CONCLUSION:</b> Our results indicate that MCI has higher success rate in CNLDO treatment compared with PMCI in this small series of patients.]]></description>
<pubDate>2014/12/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Dima Andalib and Hossein Mansoori]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Dima Andalib and Hossein Mansoori</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140624]]></guid><cfi:id>1234</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Long-term postoperative outcomes of bilateral lateral rectus recession vs unilateral recession-resection for intermittent exotropia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140625]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To discuss the long-term postoperative results of bilateral lateral rectus recession (BLR) and unilateral lateral rectus recession-medial rectus resection (RR) in therapy of intermittent exotropia.<b>METHODS:</b> We retrospectively analyzed 213 cases of intermittent exotropia who underwent surgery between 2008 and 2010. The patients were grouped into BLR group and RR group. Motor outcomes were divided into three groups on the basis of the angle of deviation after surgery:overcorrection (esotropia/phoria ＞5<sup>△</sup>), orthophoria (esotropia/phoria ≤5<sup>△</sup>to exotropia/phoria ≤10<sup>△</sup>), and undercorrection/recurrence (exotropia/phoria＞10<sup>△</sup>). Titmus test was used to evaluate stereoacuity, the stereoacuity ＜800s of arc meaned the patients had stereopsis. Surgical outcome including motor criteria and sensory status were compared at postoperative 6, 12, 24mo and at 36mo examination between groups.<b>RESULTS:</b>At 12, 24mo after surgery, the motor outcomes had no difference (<i>P</i>＞0.05) between groups. However, the motor outcomes at 6, 36mo were signally different in each group, indicating the success rate in RR group at 6mo was higher than that in BLR group (83.02% <i>vs</i> 82.24%, <i>P</i>＜0.05) but the result was contrary at the 3y examination (60.75% <i>vs</i> 43.40%, <i>P</i>＜0.05). No statistical significance were found in the sensory outcomes between the groups at mean of 3.7y follow-up.<b>CONCLUSION:</b>Themotor outcomes in RR group were better than in BLR group at 6mo after surgery, while the 3y outcomes were better in BLR group. This may be due to the recurrence rate of the BLR was lower than the RR group’s.]]></description>
<pubDate>2014/12/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xian Yang,Teng-Teng Man,Qiao-Xia Tian,Gui-Qiu Zhao,Qing-Lan Kong,Yan Meng,Yan Gao and Mei-Zhen Ning]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xian Yang,Teng-Teng Man,Qiao-Xia Tian,Gui-Qiu Zhao,Qing-Lan Kong,Yan Meng,Yan Gao and Mei-Zhen Ning</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140625]]></guid><cfi:id>1233</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Amniotic membrane covering promotes healing of cornea epithelium and improves visual acuity afterdebridement for fungal keratitis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140508]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To investigate the effect of amniotic membrane covering (AMC) on the healing of cornea epithelium and visual acuity for fungal keratitis after debridement.<b>METHODS:</b>Twenty fungal keratitis patients were divided into two groups randomly, the AMC group and the control group, ten patients each group. Both debridement of the infected cornea tissue and standard anti-fungus drugs treatments were given to every patients, monolayer amniotic membrane were sutured to the surface of the entire cornea and bulbar conjunctiva with 10-0 nylon suture for patients in the AMC group. The diameter of the ulcer was determined with slit lamp microscope and the depth of the infiltration was determined with anterior segment optical coherence tomography. Uncorrected visual acuity (UCVA) was tested before surgery and three month after healing of the epithelial layer. The healing time of the cornea epithelium, visual acuity (VA) was compared between the two groups using <i>t-</i>test.<b>RESULTS:</b>There was no statistical difference of the diameter of the ulcer, depth of the infiltration, height of the hypopyon and VA between the two groups before surgery (<i>P</i>＞0.05). The average healing time of the AMC group was 6.89±2.98d, which was statistically shorter than that of the control group (10.23±2.78d) (<i>P</i>＜0.05). The average UCVA of the AMC group was 0.138±0.083, which was statistically better than that of the control group (0.053±0.068) (<i>P</i>＜0.05).<b>CONCLUSION:</b>AMC surgery could promote healing of cornea epithelium after debridement for fungal keratitis and lead to better VA outcome.]]></description>
<pubDate>2014/10/20 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Bo Zeng,Ping Wang,Ling-Juan Xu,Xin-Yu Li,Hong Zhang and Gui-Gang Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Bo Zeng,Ping Wang,Ling-Juan Xu,Xin-Yu Li,Hong Zhang and Gui-Gang Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140508]]></guid><cfi:id>1232</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Application of Prussian blue staining in the diagnosis of ocular siderosis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140509]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To explore the value of Prussian blue staining in the diagnosis of ocular siderosis.<b>METHODS:</b> Between January 2012 and January 2013, the Prussian blue stain used in anterior lens capsule and vitreous liquid after centrifugation from patients with definitive diagnosis and suspicious diagnosed of ocular siderosis. At the same time, give a negative control.<b>RESULTS:</b> Anterior lens capsule membrane and liquid of vitreous cavity from patients with definitive diagnosis and suspicious diagnosed of ocular siderosis revealed ferric ions that stained positively with Prussian blue. In the control group, there is no positive reaction.<b>CONCLUSION:</b> Prussian blue staining in the diagnosis of ocular siderosis has a very significant worth, suspected cases can be definitive diagnosed.]]></description>
<pubDate>2014/10/20 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Zhen Yang,Xiao-Li Yang,Li-Shuai Xu,Le Dai and Mei-Chao Yi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zhen Yang,Xiao-Li Yang,Li-Shuai Xu,Le Dai and Mei-Chao Yi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140509]]></guid><cfi:id>1231</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Safety of prophylactic intracameral moxifloxacin ophthalmic solution after cataract surgery in patients with penetrating keratoplasty]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140510]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To determine the safety of prophylactic intracameral moxifloxacin after cataract surgery in patients with penetrating keratoplasty (PKP).<b>METHODS:</b>In this retrospective study of consecutive patients who had phacoemulsification cataract surgery after PKP, were treated with intracameral moxifloxacin 0.5% ophthalmic solution (0.5 mg/0.1 mL). The main outcome measures were anterior chamber reaction, best corrected visual acuity (BCVA), corneal endothelial cell count (ECC), and central corneal thickness (CCT).<b>RESULTS:</b>Fifty-five patients were recruited (26 males, 29 females). The mean age was 54.36±4.97y (range 45-64y). All eyes had improved postoperative BCVA. The mean BCVA was 0.25 preoperatively and 0.57 postoperatively, which was statistically significant (<i>P&lt;</i>0.001). One eye had 3+, 7 eyes had 2+, 12 eyes had 1+ and 8 eyes had trace amount of aqueous cells on the first day after surgery. All eyes had no anterior chamber cells at subsequent follow up examinations. Effective phacoemulsification time was 4.33±1.01s. The mean ECC was 2340.20 cells/mm<sup>2</sup> preoperatively and 1948.75 cells/mm<sup>2</sup> 1mo postoperatively (<i>P&lt;</i>0.001). The increase of 21.09 μm in postoperative pachymetry 1mo after surgery was statistically significant (<i>P&lt;</i>0.001).<b>CONCLUSION:</b> No untoward effects were observed after intracameral injection of moxifloxacin (0.5 mg/0.1 mL) in terms of anterior chamber reaction, CCT, ECC, and visual rehabilitation at the conclusion of cataract surgery in patients with PKP.]]></description>
<pubDate>2014/10/20 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Osman Sevki Arslan,Ceyhun Arici,Mustafa Unal,Erdogan Cicik,Mehmet Serhat Mangan and Eray Atalay]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Osman Sevki Arslan,Ceyhun Arici,Mustafa Unal,Erdogan Cicik,Mehmet Serhat Mangan and Eray Atalay</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140510]]></guid><cfi:id>1230</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Visual rehabilitation in low-moderate keratoconus:intracorneal ring segment implantation followed by same-day topography-guided photorefractive keratectomy and collagen cross linking</b>]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140511]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To present the results of same-day topography-guided photorefractive keratectomy (TG-PRK) and corneal collagen crosslinking (CXL) after previous intrastromal corneal ring segment (ISCR) implantation for keratoconus.<b>METHODS:</b>An experimental clinical study on twenty-one eyes of 19 patients aged 27.1±6.6y (range 19-43y), with low to moderate keratoconus who were selected to undergo customized TG-PRK immediately followed by same-day CXL, 9mo after ISCR implantation in a university ophthalmology clinic. Refraction, uncorrected distance visual acuities (UDVA) and corrected distance visual acuities (CDVA), keratometry (K) values, central corneal thickness (CCT) and coma were assessed 3mo after TG-PRK and CXL.<b>RESULTS:</b>After TG-PRK/CXL:the mean UDVA (logMAR) improved significantly from 0.66±0.41 to 0.20±0.25 (<i>P&lt;</i>0.05); Kflat value decreased from:48.44±3.66 D to 43.71±1.95 D; Ksteep value decreased from 45.61±2.40 D to 41.56±2.05 D; Kaverage also decreased from 47.00±2.66 D to 42.42±2.07 D (<i>P&lt;</i>0.05 for all). The mean sphere and cylinder decreased significantly post-surgery from, -3.10±2.99 D to -0.11±0.93 D and from -3.68±1.53 to -1.11±0.75 D respectively, while the CDVA, CCT and coma showed no significant changes. Compared to post-ISCR, significant reductions (<i>P&lt;</i>0.05 or all) in all K values, sphere and cylinder were observed after TG-PRK/CXL.<b>CONCLUSION:</b>Same-day combined topography-guided PRK and corneal crosslinking following placement of ISCR is a safe and potentially effective option in treating low-moderate keratoconus. It significantly improves all visual acuity, reduced keratometry, sphere and astigmatism, but causes no change in central corneal thickness and coma.]]></description>
<pubDate>2014/10/20 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ferial M. Zeraid,Asma A Jawkhab,Waleed S Al-Tuwairqi and Uchechukwu L. Osuagwu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ferial M. Zeraid,Asma A Jawkhab,Waleed S Al-Tuwairqi and Uchechukwu L. Osuagwu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140511]]></guid><cfi:id>1229</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Umbilical cord blood serum therapy for the management of persistent corneal epithelial defects]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140512]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To evaluate the role of umbilical cord blood serum (CBS) therapy in cases with persistent corneal epithelial defects (PED).<b>METHODS:</b>Sixteen eyes of 14 patients with PED who were resistant to conventional treatment were treated with 20% umbilical cord serum eye drops. Patients were followed-up weekly until epithelization was complete. The collected data included the grade of corneal lesion (Grade I:epithelial defect+superficial vascularization, Grade II:epithelial defect+stromal edema, Grade III:corneal ulcer+stromal melting), the size of epithelial defect (pretreatment, 7<sup>th</sup>, 14<sup>th</sup> and 21<sup>st</sup> days of treatment), and follow-up time was evaluated retrospectively.<b>RESULTS:</b>The mean size of epithelial defect on two perpendicular axes was 5.2×4.6-mm<sup>2</sup> (range:2.5-8×2.2-9 mm<sup>2</sup>). Mean duration of treatment was 8.3±5wk. CBS therapy was effective in 12 eyes (75%) and ineffective in 4 eyes (25%). The epithelial defects in 4 ineffective eyes were healed with amniotic membrane transplantation and tarsorrhaphy. The rate of complete healing was 12.5% by 7d, 25% by 14d, and 75% by 21d. The healing time was prolonged in Grade III eyes in comparison to eyes in Grade I or Grade II.<b>CONCLUSION:</b>The results of the current study indicated the safety effectiveness of CBS drops in the management of PED. The grade of disease seems have a role on the healing time.]]></description>
<pubDate>2014/10/20 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Elif Erdem,Meltem Yagmur,Inan Harbiyeli,Hande Taylan-Sekeroglu and Reha Ersoz]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Elif Erdem,Meltem Yagmur,Inan Harbiyeli,Hande Taylan-Sekeroglu and Reha Ersoz</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140512]]></guid><cfi:id>1228</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Short-term effects of intravitreal triamcinolone acetonide injection on ocular blood flow evaluated with color Doppler ultrasonography]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140513]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To evaluate the changes in ocular blood flow with color Doppler ultrasonography (CDU) after intravitreal triamcinolone acetonide (IVTA) injection.<b>METHODS:</b> A total of 46 patients who underwent IVTA (4 mg/0.1 mL) injection for diabetic macular edema (DME) (<i>n</i>=22), central retinal vein occlusion (CRVO) (<i>n</i>=12) and choroidal neovascular membrane (CNVM) (<i>n</i>=12) were included in the study. Peak systolic velocity (PSV), end diastolic velocity (EDV) and resistivity index (RI) were measured from the ophthalmic artery (OA), the central retinal artery (CRA) and the posterior ciliary artery (PCA) of each patient with CDU before, at the end of the first week and at the end of the first month following IVTA injection.<b>RESULTS:</b>In the DME group, PSV of OA at the first of the first month (mean±SD) (37.48±10.87 cm/s) increased compared to pre-injection value (31.39±10.84 cm/s) (<i>P</i>=0.048). There was a statistically significant decrease (<i>P</i>=0.049) in PSV of CRA at the end of the first month (7.97±2.67 cm/s) compared to the pre-injection (9.47±3.37 cm/s). There was not any statistically significant difference on the other parameters in the DME group. Also, there was not any statistically significant difference on the ocular blood flow values in the CRVO and CNVM groups.<b>CONCLUSION:</b> We observed that 4 mg/0.1 mL IVTA increased PSV of OA and decreased PSV of CRA in DME patients and did not have any effect on ocular blood flow values of CRVO and CNVM patients.]]></description>
<pubDate>2014/10/20 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mustafa Alpaslan Anayol,Yasin Toklu,Elif Asik Kamberoglu,Sabri Raza,Hasan Basri Arifoglu,Huseyin Simavli,Ayse Gul Kocak Altintas and Saban Simsek]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mustafa Alpaslan Anayol,Yasin Toklu,Elif Asik Kamberoglu,Sabri Raza,Hasan Basri Arifoglu,Huseyin Simavli,Ayse Gul Kocak Altintas and Saban Simsek</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140513]]></guid><cfi:id>1227</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical study of customized aspherical intraocular lens implants]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140514]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To compare if there is an improvement in visual functions with age-related cataracts between patients receiving a aspherical intraocular lens (IOL) based on corneal wavefront aberration and patients randomly assigned lenses.<b>METHODS:</b>A total of 124 eyes of 124 patients with age-related cataracts were placed in experimental group and a group receiving randomly assigned (RA) lenses. The experimental group was undergone Pentacam corneal spherical aberration measurement before surgery; the targeted range for residual total spherical aberration after surgery was set to 0-0.3 μm. Patients with a corneal spherical aberration ＜0.3 μm were implanted with a zero-spherical aberration advanced optics (AO) aspherical IOL and patients with an aberration ≥0.3 μm received a Tecnis Z9003 aspherical lens in experimental group. RA patients were randomly implanted with an AO lens or a Tecnis Z9003 lens. Three months after surgery total spherical aberration, photopic/mesopic contrast sensitivities, photopic/mesopic with glare contrast sensitivities, and logMAR vision were measured.<b>RESULTS:</b>Statistical analysis on logMAR vision showed no significant difference between two groups (<i>P</i>=0.413). The post-surgical total spherical aberration was 0.126±0.097 μm and 0.152±0.151 μm in the experimental and RA groups, respectively (<i>P</i>=0.12). The mesopic contrast sensitivities at spatial frequencies of 6, 12 and 18 c/d in the experimental group were significantly higher than of the RA group (<i>P</i>=0.00; <i>P</i>=0.04; <i>P</i>=0.02). The mesopic with glare contrast sensitivity in the experimental group at a spatial frequency of 18 c/d was also significantly higher <i>vs</i> the RA group (<i>P</i>=0.01).<b>CONCLUSION:</b>Pre-surgical corneal spherical aberration measurement in cataract patients followed by customized selection of aspherical IOL implants improved mesopic contrast sensitivities at high spatial frequencies, and thus is a superior strategy compared to the random selection of aspherical IOL implants.]]></description>
<pubDate>2014/10/20 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Lie-Xi Jia and Zhao-Hui Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Lie-Xi Jia and Zhao-Hui Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140514]]></guid><cfi:id>1226</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of corneal endothelial changes following phacoemulsification with transversal and torsional phacoemulsification machines]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140515]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To compare if there is an improvement in visual functions with age-related cataracts between patients receiving a aspherical intraocular lens (IOL) based on corneal wavefront aberration and patients randomly assigned lenses.<b>METHODS:</b>A total of 124 eyes of 124 patients with age-related cataracts were placed in experimental group and a group receiving randomly assigned (RA) lenses. The experimental group was undergone Pentacam corneal spherical aberration measurement before surgery; the targeted range for residual total spherical aberration after surgery was set to 0-0.3 μm. Patients with a corneal spherical aberration ＜0.3 μm were implanted with a zero-spherical aberration advanced optics (AO) aspherical IOL and patients with an aberration ≥0.3 μm received a Tecnis Z9003 aspherical lens in experimental group. RA patients were randomly implanted with an AO lens or a Tecnis Z9003 lens. Three months after surgery total spherical aberration, photopic/mesopic contrast sensitivities, photopic/mesopic with glare contrast sensitivities, and logMAR vision were measured.<b>RESULTS:</b>Statistical analysis on logMAR vision showed no significant difference between two groups (<i>P</i>=0.413). The post-surgical total spherical aberration was 0.126±0.097 μm and 0.152±0.151 μm in the experimental and RA groups, respectively (<i>P</i>=0.12). The mesopic contrast sensitivities at spatial frequencies of 6, 12 and 18 c/d in the experimental group were significantly higher than of the RA group (<i>P</i>=0.00; <i>P</i>=0.04; <i>P</i>=0.02). The mesopic with glare contrast sensitivity in the experimental group at a spatial frequency of 18 c/d was also significantly higher <i>vs</i> the RA group (<i>P</i>=0.01).<b>CONCLUSION:</b>Pre-surgical corneal spherical aberration measurement in cataract patients followed by customized selection of aspherical IOL implants improved mesopic contrast sensitivities at high spatial frequencies, and thus is a superior strategy compared to the random selection of aspherical IOL implants.]]></description>
<pubDate>2014/10/20 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mustafa Ata&#351;, Süleyman Demircan, Arzu Seyhan Karatepe Ha&#351;ha&#351;, Ahmet Gülhan and G&#246;kmen Zarars&#305;z]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mustafa Ata&#351;, Süleyman Demircan, Arzu Seyhan Karatepe Ha&#351;ha&#351;, Ahmet Gülhan and G&#246;kmen Zarars&#305;z</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140515]]></guid><cfi:id>1225</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Evaluation of early results of quick-chop phacoemulsification in the patients with high myopic cataract]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140516]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To assess the early surgical outcomes ofquick-chop phacoemulsification technique in patients with high myopia.<b>METHODS:</b> The data of patients with high myopia who underwent quick-chop phacoemulsification were reviewed retrospectively. There were 42 eyes of 31 patients. The axial length was more than 26 mm in all eyes. All eyes underwent quick-chop phacoemulsification surgery with the placement of an intraocular lens (IOL) in the capsular bag. Postoperative visits were performed at 1, 3d; 2wk, 1mo. Early postoperative best corrected visual acuity (BCVA), preoperative and postoperative corneal endothelial cell density (ECD), central corneal thickness (CCT) and postoperative complications were assessed. Paired sample <i>t</i>-test or Wilcoxon tests were used to compare data between preoperative and postoperative data.<b>RESULTS:</b>There was no statistically significant difference between preoperative and postoperative ECD and CCT. Retinal detachment was developed in one eye at postoperative first day. There was an iris prolapsus from side port insicion.<b>CONCLUSION:</b> Quick-chop phacoemulsification technique is a safe surgical technique. However we can encounter some complications in high myopic eyes due to histopathological differences. Both side port and clear corneal tunnel insicion size is crucial for preventing postoperative complications. If any persistent leakage is noticed, suture should be placed.]]></description>
<pubDate>2014/10/20 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ali Akal,Tugba Goncu,Sevin Soker Cakmak,Isa Yuvaci,Mustafa Atas,Süleyman Demircan and Omer Faruk Yilmaz]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ali Akal,Tugba Goncu,Sevin Soker Cakmak,Isa Yuvaci,Mustafa Atas,Süleyman Demircan and Omer Faruk Yilmaz</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140516]]></guid><cfi:id>1224</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Intraocular pressure-lowering effects of commonly used fixed combination drugs with timolol in the management of primary open angle glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140517]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To evaluate intraocular pressure (IOP)-lowering effect and ocular tolerability of brimonidine/timolol, dorzolamide/timolol and latanoprost/timolol fixed combination therapies in the management of primary open angle glaucoma.<b>METHODS:</b>Each drug was administered for two months, after which a circadian tonometric curve was recorded using a Goldmann applanation tonometer. Ocular discomfort (conjunctival hyperemia, burning or stinging, foreign body sensation, itching, ocular pain) of each eye was assessed by the subject on a standardized ocular discomfort scale.<b>RESULTS:</b>Among the three study groups, there were no significant differences in the mean baseline IOP measurements, mean 2<sup>nd</sup> mo IOP measurements, and mean (%) change of IOPs from baseline. Among the three study groups, there were no significant differences in the mean IOP measurements obtained at circadian tonometric curves at baseline and at two months controls. In sum brimonidine/timolol, dorzolamide/timolol and latanoprost/timolol fixed combination therapies showed similar effects on IOP levels.<b>CONCLUSION:</b>Brimonidine/timolol, dorzolamide/timolol and latanoprost/timolol fixed combination therapies showed similar lowering efficaties on IOP levels whereas there was no any difference between each other.]]></description>
<pubDate>2014/10/20 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Murat Atabey Ozer,Mutlu Acar and Cem Yildirim]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Murat Atabey Ozer,Mutlu Acar and Cem Yildirim</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140517]]></guid><cfi:id>1223</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Intravitreal bevacizumab and Ahmed glaucoma valve implantation in patients with neovascular glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140518]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To explore the efficacy of preoperative intravitreal bevacizumab (IVB) injection combined with Ahmed glaucoma valve (AGV) implantation in the treatment of neovascular glaucoma (NVG).<b>METHODS:</b> This retrospective study included 35 eyes from 35 patients who underwent preoperative IVB and AGV implantation for treatment of NVG. Findings such as intraocular pressure (IOP) number of anti-glaucoma medications, visual acuity (VA), surgical success rates, and complications were recorded.<b>RESULTS:</b> After AGV implantation, IOP was 18.2±4.0 mm Hg, 15.5±3.3 mm Hg and 9.8±2.6 mm Hg at 6, 12 and 36mo, significantly decreased compared with pre-IOP (<i>P&lt;</i>0.01). The number of anti-glaucoma medications was 0.9±0.5, 0.8±0.9 and 0.8±0.6 at 6, 12 and 36mo, significantly decreased compared to pre-treatment (<i>P&lt;</i>0.01). At last visit, there were 19 eyes with stable VA, 4 with VA improvement, 12 with diminished VA and 3 with complete loss light perception. There were 7 cases that failed during 3-year fellow up period. Cumulative probabilities of valve survival by Kaplan-Meier analysis were 82.9%, 74.1% and 71.0% at 12, 24 and 36mo, respectively. Cox stepwise regression analysis found that the survival time was significant associated with the pre-visual acuity &lt;2/400 (<i>P&lt;</i>0.05). Post-operative complications occurred in 8 eyes, of which hyphema presented in 2 eyes, choroidal effusion in 2 eyes.<b>CONCLUSION:</b> The procedure of preoperative IVB and AGV implantation should be one of treatments for NVG because of its safety and effectiveness.]]></description>
<pubDate>2014/10/20 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hai-Tao Zhang,Yu-Xin Yang,Ying-Ying Xu,Rui-Min Yang,Bao-Jun Wang and Jun-Xi Hu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hai-Tao Zhang,Yu-Xin Yang,Ying-Ying Xu,Rui-Min Yang,Bao-Jun Wang and Jun-Xi Hu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140518]]></guid><cfi:id>1222</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Risk factors for posterior synechiae of the iris after 23-gauge phacovitrectomy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140519]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To identify risk factors for the development of posterior synechiae of the iris (PSI) after 23-gauge phacovitrectomy.<b>METHODS:</b>A retrospective chart review was performed in consecutive Asian patients treated with 23-gauge phacovitrectomy with a 3-piece intraocular lens (IOL) or a single-piece 4 haptics IOL.<b>RESULTS:</b>A total of 263 eyes from 242 patients were included in the study. Postoperative PSI was identified in 16 (6.1%) eyes. In multivariate analysis, C3F8 gas tamponade, oil tamponade, and long operation time were significantly associated with PSI formation. There was no difference in the incidence of PSI between the groups using two different types of IOL (<i>P</i>=0.779).
<b>CONLUSION:</b>C3F8 gas or oil tamponade and long operation time increased the incidence of PSI after 23-gauge phacovitrectomy. The single-piece 4 haptics IOL, in lieu of a 3-piece IOL, may be inserted into the capsular bag with a comparable incidence of PSI.]]></description>
<pubDate>2014/10/20 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jong-Hyun Oh,Jaehoon Na,Seong-Woo Kim,Jaeryung Oh and Kuhl Huh]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jong-Hyun Oh,Jaehoon Na,Seong-Woo Kim,Jaeryung Oh and Kuhl Huh</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140519]]></guid><cfi:id>1221</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Rhegmatogenous retinal detachment associated with massive spontaneous suprachoroidal hemorrhage and prognosis of pars plana vitrectomy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140520]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To describe the clinical characters of rhegmatogenous retinal detachment (RRD) associated with massive spontaneous suprachoroidal hemorrhage (SSCH). To evaluate optimal timing and prognosis of pars plana vitrectomy.<b>METHODS:</b> A retrospective review of 6 cases (6 eyes) of RRD and massive SSCH among 3772 cases of RRD was conducted. All of 6 patients were treated with twenty-gauge vitrectomy, suprachoroidal blood drainage, phacoemulsification (PHACO) or lensectomy and silicon oil tamponade. The clinical characters, intraoperative findings and treatment outcomes were reported.<b>RESULTS:</b> In the 6 affected eyes of 6 patients (3 men and 3 women; mean age, 53.83y; range 34-61y), preoperative visual acuity ranged from faint light perception (LP) to counting finger (CF). The average interventional duration from visual decreased to surgery was 12.8 d (range 9-15d). All eyes were associated with high myopia and the mean ocular length was 30.32 mm (range 28.14-32.32 mm). Choroidal hemorrhage were successfully drained in the operation of all 6 eyes. Intraoperative findings showed there were multiple retinal breaks in all 6 eyes and in 4 eyes breaks were along supratemporal and/or infratemporal retinal vascular arcade, especially in the edge of chorioretinal atrophy areas. These patients were followed up from 6 to 34mo (Mean, 23.5mo). The best-corrected visual acuity after surgery varied from CF to 20/100, with improvement in 5 eyes (83.33%) and no change in 1 eye (16.67%). Ocular hypertension ocurred in 1 eye (16.67%), which was successfully treated by silicon oil removal combined with trabeculectomy. In 4 eyes, tractional retinal detachment caused by proliferative vitreoretinopathy (PVR) appeared and a secondary surgery of pre-retinal membrane peeling and silicon oil retained were performed. In 4 eyes, silicon oil cannot be removed. The initial and final reattachment rates were 33.33% and 66.67%, respectively.<b>CONCLUSION:</b> RRD associated with massive SSCH is an extremely rare event. The most common risk factor is long axial length. Vitrectomy and choroidal blood drainage can effectively remove suprachoroidal hemorrhage and promote retinal reattachment in these eyes. However, silicon oil could not be removed in most eyes and final visual acuities are generally poor.]]></description>
<pubDate>2014/10/20 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jie Zhang,Xiao-Hua Zhu and Luo-Sheng Tang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jie Zhang,Xiao-Hua Zhu and Luo-Sheng Tang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140520]]></guid><cfi:id>1220</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effects of moxifloxacin exposure on the conjunctival flora and antibiotic resistance profile following repeated intravitreal injections]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140521]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To evaluate the effects of moxifloxacin exposure on the conjunctival flora and antibiotic resistance profile following repeated intravitreal injections.<b>METHODS:</b>Seventy-two eyes of 36 patients <b>[36 eyes in control group, 36 eyes in intravitreal injection (IVI) group] were enrolled in the study. All the eyes had at least one IVI and had diabetic macular edema (DME) or age-related macular degeneration (ARMD). Moxifloxacin was prescribed to all the patients four times a day for five days following injection. Conjunctival cultures were obtained from the lower fornix </b><i><b>via</b></i><b> standardized technique with every possible effort made to minimize contamination from the lids, lashes, or skin. Before the application of any ophthalmic medication, conjunctival cultures were obtained from both eyes using sterile cotton culture. An automated microbiology system was used to identify the growing bacteria and determine antibiotic sensitivity. <b>RESULTS:</b>The bacterial cultures were isolated from 72 eyes of 36 patients, sixteen of whom patients (44.4%) were male and twenty (55.6%) were female. Average age was 68.4±9.0 (range 50-86). The average number of injections before taking cultures was 3.1+1.0. Forty-eight (66.7%) of 72 eyes had at least one significant organism. There was no bacterial growth in 8 (20.5%) of IVI eyes and in 16 (44.4%) of control eyes (</b><i><b>P=</b></i><b>0.03). Of the bacteria isolated from culture, 53.8% of coagulase negative staphylococci (CoNS) in IVI eyes and 47.2% CoNS in control eyes. This difference between IVI eyes and control eyes about bacteria isolated from culture was not statistically significant (</b><i><b>P=</b></i><b>0.2). Eleven of 25 bacteria (44.0%) isolated from IVI eyes and 11 (57.9%) of 19 bacteria isolated from control eyes were resistant to oxacillin. The difference in frequency of moxifloxacine resistance between two groups was not statistically significant (12.0% in IVI eyes and 21.1% in control eyes) (</b><i><b>P=</b></i><b>0.44). There were no cases of resistance to vancomycin, teicoplanin and linezolid.<b>CONCLUSION:</b>There was no difference in species of bacteria isolated from cultures, or in the frequency of resistance to antibiotics between eyes that had recurrent IVI followed by moxifloxacin exposure compared with control eyes. However, the number of eyes that had bacterial growth was higher in IVI group than in the control group.</b>]]></description>
<pubDate>2014/10/20 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mustafa Ataş,Burhan Başkan,Ayşe Özköse,Fatma Mutlu Sarıgüzel,Süleyman Demircan and Emine Pangal]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mustafa Ataş,Burhan Başkan,Ayşe Özköse,Fatma Mutlu Sarıgüzel,Süleyman Demircan and Emine Pangal</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140521]]></guid><cfi:id>1219</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Visual impact of sub-Tenon anesthesia during combined phacoemulsification and vitrectomy surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140522]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To investigate the visual impact of sub-Tenon anesthesia during combined phacoemulsification and vitrectomy surgery.<b>METHODS</b>:In this prospective case series, consecutive patients who underwent combined phacoemulsification and pars plana vitrectomy (PPV) under sub-Tenon anesthesia between October 2008 and September 2009 were enrolled. The patients were asked whether they could see the light of the operating microscope or not between various surgical steps with their contralateral eye being covered.<b>RESULTS</b>:A total of 163 eyes of 163 patients were enrolled in this study. After their contralateral eyes were covered, 152 (93.3%) patients said that they could not see any light at least during one of the surgical steps. All eyes recovered to at least light perception on the first postoperative day. The incidence of no light perception during the surgery was not related to demographic factors, including age, gender, or type of ocular diseases.<b>CONCLUSION</b>:The incidence of no light perception during combined phacoemulsification and vitrectomy under sub-Tenon anesthesia was high in our study. Patients should be duly informed about this temporary but potential intraoperative event.]]></description>
<pubDate>2014/10/20 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Wei-Qi Chen,Vishal Jhanji,Hao-Yu Chen,Gui-Hua Zhang and Ping Hou]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Wei-Qi Chen,Vishal Jhanji,Hao-Yu Chen,Gui-Hua Zhang and Ping Hou</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140522]]></guid><cfi:id>1218</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Microbiologic spectrum of acute and chronic dacryocystitis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140523]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To report the microbiological spectrum of acute and chronic dacrocystitis.<b>METHODS:</b> Retrospective study on 100 patients who presented to the ophthalmic plastic clinic of a tertiary eye care center from May 2011 and April 2013 with acute and chronic dacryocystitis was reviewed for demographic and microbiological profile. The culture results and organisms isolated were recorded.<b>RESULTS</b>:Sixty patients had acute onset and the remaining 40 patients had chronic onset dacryocystitis. The female to male ratio was 1.78. The mean age of patients was 44y.Gram-positive organisms were the most commonly isolated accounting for 54%, and the commonest species isolated was <i>S. aureus</i> in 26%. Percentage of gram positive cultures was higher in chronic dacryocystitis than acute ones (82% <i>vs</i> 48% of positive cultures; <i>P</i>=0.003). Also in culture positive acute dacryocystitis, gram negative species were found in 52% of eyes but only in 18% of chronic dacryocystitis.<b>CONCLUSION</b>:Gram negative bacteria, culture negative samples, unusual and more virulent organisms are more common in acute dacryocystitis than chronic ones. The results of this study have significant bearing on the treatment of patients with dacrocystitis.]]></description>
<pubDate>2014/10/20 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Bahram Eshraghi,Parisa Abdi,Mohammadreza Akbari and Masoud Aghsaei Fard]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Bahram Eshraghi,Parisa Abdi,Mohammadreza Akbari and Masoud Aghsaei Fard</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140523]]></guid><cfi:id>1217</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effects of medication methods after simple and effective probing of lacrimal passage]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140524]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To evaluate the effect of reducing the use of antibiotics in the treatment of infant bacterial dacryocystitis after probing of the lacrimal duct.<b>METHODS:</b> A total of 542 cases of children under one year old and accepting nasolacrimal duct probing treatment were divided into two groups, which were treated with topical and oral antibiotics, respectively. Conjunctival sac secretions were used as a control index of bacterial infection, whereas the disappearance of epiphora symptoms and lacrimal passage patency were used as cure indexes. The <i>χ</i><sup>2</sup> test was used to compare enumeration and measurement data, and a statistical significance was set at <i>P&lt;</i>0.05. The therapeutic effect on the two groups of postoperative patients was investigated.<b>RESULTS:</b>In the two study groups, no significant differences in gender, age and postoperative control of lacrimal sac infection were observed. The cure rates after three probing operations also showed no significant difference.<b>CONCLUSION:</b>After probing of the lacrimal passage, results of this study confirmed that postoperative medication without oral antibiotics but an ophthalmic dosage of antibiotics was a simple and effective treatment method.]]></description>
<pubDate>2014/10/20 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Bin Lu,Hua-Ying Xie,Cai-Ping Shi,Chun-Si Xu and Mei-Hong Gu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Bin Lu,Hua-Ying Xie,Cai-Ping Shi,Chun-Si Xu and Mei-Hong Gu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140524]]></guid><cfi:id>1216</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Evaluation of immersion 20 MHz B-scan ultrasonography in observing lens in the alkali burn eyes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140408]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To evaluate the accuracy of 20 MHz immersion B-scan ultrasonography in observing lens and to investigate the value of this noninvasive preoperative diagnosis method in alkali burn eyes.<b>METHODS:</b> It was a comparative study. Fifty-six cases (56 eyes) of alkali burn eyes were examined by ultrasound biomicroscopy (UBM) and immersion 20 MHz B-scan ultrasonography from June 2011 to April 2013, the images were analyzed, and the ultrasonographic diagnosis compared with the operation results.<b>RESULTS:</b> In 56 alkali burn eyes examined by UBM, the lens were not detected in 16 eyes; the IOL could be detected in 2 eyes; the anterior lens capsule surface or/and the front lens could be detected in 18 eyes, and lens opacification in 3 eyes of them; suspected abnormal lens were detected in the other 20 eyes. In all the same eyes examined by immersion 20 MHz B-scan ultrasonography, the lens were not detected in 16 eyes; the IOL could be detected in 2 eyes; 24 abnormal lens (opacity, lens expansion, shrinkage) and 14 normal lens were found. Compared with the intraoperative findings, the diagnostic accordance rate of the immersion 20 MHz B-scan appearance of lens was 100% (56/56), which was significantly higher than examined by UBM 57.14% (32/56) (χ<sup>2</sup>=30.55, <i>P</i>=0.0000).<b>CONCLUSION:</b>Immersion 20 MHz B-scan ultrasonography can observe the lens accurately in alkali burn eyes. It has important clinical value to combine with UBM in eyes of alkali burn.]]></description>
<pubDate>2014/8/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Qing-Hua Yang,Bing Chen,Li-Qiang Wang,Guang-Hua Peng,Zhao-Hui Li and Yi-Fei Huang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Qing-Hua Yang,Bing Chen,Li-Qiang Wang,Guang-Hua Peng,Zhao-Hui Li and Yi-Fei Huang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140408]]></guid><cfi:id>1215</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Femtosecond laser-assisted deep anterior lamellar keratoplasty for keratoconus and keratectasia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140409]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To describe the initial outcomes and safety of femtosecond laser-assisted deep anterior lamellar keratoplasty (DALK) for keratoconus and post-LASIKkeratectasia.<b>METHODS</b>:In this non-comparative case series, 10 eyes of 9 patients underwent DALK procedures with a femtosecond laser (Carl Zeiss Meditec AG, Jena, Germany). Of the 9 patients, 7 had keratoconus and 2 had post-LASIK keratectasia. A 500 kHz VisuMax femtosecond laser was used to perform corneal cuts on both donor and recipient corneas.The outcome measures were the uncorrected visual acuity (UCVA), best-corrected visual acuity (BCVA), corneal thickness, astigmatism, endothelial density count (EDC), and corneal power.<b>RESULTS:</b> All eyes were successfully treated. Early postoperative evaluation showed a clear graft in all cases. Intraoperative complications included one case of a small Descemet’s membrane perforation. Postoperatively, there was one case of stromal rejection, one of loosened sutures, and one of wound dehiscence. A normal corneal pattern topography and transparency were restored, UCVA and BCVA improved significantly, and astigmatism improved slightly. There was no statistically significant decrease in EDC.<b>CONCLUSION:</b> Our early results indicate that femtosecond laser-assisted deep anterior lamellar keratoplasty could improve UCVA and BCVA in patients with anterior corneal pathology. This approach shows promise as a safe and effective surgical choice in the treatment of keratoconus and post-LASIK keratectasia.]]></description>
<pubDate>2014/8/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yan Lu,Yu-Hua Shi,Li-Ping Yang,Yi-Rui Ge,Xiang-Fei Chen,Yan Wu and Zhen-Ping Huang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yan Lu,Yu-Hua Shi,Li-Ping Yang,Yi-Rui Ge,Xiang-Fei Chen,Yan Wu and Zhen-Ping Huang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140409]]></guid><cfi:id>1214</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Presence of thyroid-associated ophthalmopathy in Hashimoto’s thyroiditis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140410]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM</b>:To determine the prevalence of ophthalmopathy in Hashimoto’s patients and to make a comparison in subgroups of patients<b>METHODS:</b>The study involved 110 Hashimoto’s thyroiditis patients and 50 control subjects attending to the endocrinology department of the hospital. Subgroup classification of patientswas made as euthyroid, subclinic and clinic in Hashimato’s thyroiditis. All patients were evaluated by a single experienced ophthalmologist for the prevalence and characteristics of eye signs.<b>RESULTS:</b> The overall prevalences of eye changes were 22.7% (25 patients) in patients and 4% (2 persons) in control subjects respectively (<i>P=</i>0.002). In patients the most common symptom was retrobulbar eye pain with or without any eye movement. Thirteen patients had significant upper eyelid retraction (11.8%). Six patients had eye muscle dysfunction as reduced eye movements in up gaze. In control patients one person had proptosis and another had lid retraction. The clinical activity score and classification of the ophthalmopathy did not show any significant differences among subgroups.<b>CONCLUSION:</b>The eye signs were mostly mild (22.7%) and the most common eye sign was the presence of upper eyelid retraction (11.8%). Additionally six patients had eye muscle dysfunction as reduced eye movements in up gaze. Therefore we recommend to make a routine ophthalmic examination in Hashimoto’s thyroiditis patients in order not to omit the associated ophthalmopathy.]]></description>
<pubDate>2014/8/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Emrah Kan,Elif Kilic Kan,Gülcin Ecemis and Ramis Colak]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Emrah Kan,Elif Kilic Kan,Gülcin Ecemis and Ramis Colak</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140410]]></guid><cfi:id>1213</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effects of laser photocoagulation on serum angiopoietin-1, angiopoietin-2, angiopoietin-1/angiopoietin-2 ratio, and soluble angiopoietin receptor Tie-2 levels in type 2 diabetic patients with proliferative diabetic retinopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140411]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To determine the effects of laser photocoagulation on serum levels of angiopoietin-1 (Ang-1), angiopoietin-2 (Ang-2), soluble angiopoietin receptor Tie-2 (Tie-2), Ang-1/Ang-2 ratio and vascular endothelial growth factor (VEGF) in patients with type 2 diabetes mellitus (T2DM) and proliferative diabetic retinopathy (PDR). We also explored the role of the Ang/Tie system in PDR.<b>METHODS:</b> 160 patients with T2DM, including 50 patients with non-diabetic retinopathy (NDR), 58 patients with non-proliferative diabetic retinopathy (NPDR), and 52 patients with PDR were enrolled in this study. Serum Ang-1, Ang-2, Tie-2 receptor and VEGF levels were measured using enzyme-linked immunosorbent assays for all patients and were repeated in 26 patients who underwent laser photocoagulation two months after the procedure.<b>RESULTS:</b> The median levels of Ang-2 and VEGF in serum were significantly higher in the NPDR group (4.23 ng/mL and 303.2 pg/mL, respectively) compared to the NDR group (2.67 ng/mL and 159.8 pg/mL, respectively, <i>P</i>&lt;0.01), with the highest level in the PDR group (6.26 ng/mL and 531.2 pg/mL, respectively, <i>P</i>&lt;0.01). The median level of Ang-1 was significantly higher in the NPDR group (10.77 ng/mL) compared to the NDR group (9.31 ng/mL) and the PDR groups (9.54 ng/mL) (<i>P</i>&lt;0.05), while no difference was observed between the PDR and NDR groups. Ang-1/Ang-2 ratio of PDR group was lowest in three groups (1.49 <i>vs</i> 2.69 and 2.90, both <i>P</i>&lt;0.01). The median level of Tie-2 was not significantly different among three groups (<i>P</i>&gt;0.05). Ang-2 was positively correlated with VEGF and Tie-2 in the PDR and NPDR groups (both <i>P</i>&lt;0.05). Among the 26 patients who underwent laser photocoagulation, serum Ang-2 and VEGF levels significantly decreased (both <i>P</i>&lt;0.05), whereas serum Ang-1 level and Ang-1/Ang-2 ratio were weakly increased (<i>P</i>&gt;0.05). The median levels of Ang-2 and VEGF in serum were highest in PDR group, however, Ang-1/Ang-2 ratio of PDR group was lowest in three groups.<b>CONCLUSION:</b> Laser photocoagulation can reduce serum Ang-2 and VEGF levels. The Ang/Tie system and VEGF play an important role in the development and progression of T2DM patients with PDR.]]></description>
<pubDate>2014/8/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Qiao-Ying You,Fu-Yuan Zhuge,Qi-Qian Zhu and Xu-Wei Si]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Qiao-Ying You,Fu-Yuan Zhuge,Qi-Qian Zhu and Xu-Wei Si</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140411]]></guid><cfi:id>1212</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Analysis of peripapilary retinal nerve fiber layer thickness of healthy Chinese from northwestern Shanghai using Cirrus HD-OCT]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140412]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To investigate peripapillary retinal nerve fiber layer (RNFL) thickness of healthy Chinese individuals from northwestern Shanghai using Cirrus HD-OCT (Carl Zeiss Meditec, Inc. Dublin, CA, USA).<b>METHODS:</b>The peripapillary RNFL thickness of 720 eyes from 360 healthy Chinese participants were measured using the Optic Disc Cube 200×200 protocol. Each eye was scanned 3 times. Global and each quadrant’s RNFL thickness around the optic nerve were compared between genders, and interocular differences were analyzed. The correlation between global RNFL thickness and age were also assessed in this study.<b>RESULTS:</b>The mean global, superior, nasal, inferior and temporal RNFL thickness of all the eyes were 96.04±7.40 μm, 118.36±13.52 μm, 67.63±8.60 μm, 125.17±13.48 μm, 72.49±10.70 μm, respectively. When analyzing between genders, the mean nasal RNFL thickness of male and female were 68.29±8.44 μm and 66.97±8.70 μm, with statistically significant difference (<i>P</i>=0.038), while the data of global, superior, inferior and temporal quadrant showed no significant difference (all <i>P</i>&gt;0.05). When analyzing interocular differences, the mean RNFL thickness of all the right eyes and all the left eyes were 116.46±13.17 μm and 120.27±13.61 μm in superior quadrant (<i>P</i>&lt;0.001); 68.74±8.80 μm and 66.52±8.25 μm in nasal quadrant (<i>P</i>&lt;0.001); 73.16±10.95 and 71.83±10.41 in temporal quadrant (<i>P</i>&lt;0.001), all having statistically significant differences. There were no statistically significant interocular differences of global and inferior RNFL thickness (both <i>P</i>&gt;0.05). There was a significantly negative correlation (<i>r</i>=-0.618<i>, P</i>&lt;0.001) between the mean global RNFL thickness and the age.<b>CONCLUSION:</b>In healthy Chinese from northwestern Shanghai, there were no significant differences detected interocular difference and between genders in the mean global RNFL thickness. Nevertheless, significant difference existed in the nasal quadrant between genders, and interocular differences existed in the superior, nasal and temporal quadrants. The RNFL thickness appeared to gradually decrease with age.]]></description>
<pubDate>2014/8/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Shen Qu,Xiao-Ting Sun,Wei Xu and Ao Rong]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Shen Qu,Xiao-Ting Sun,Wei Xu and Ao Rong</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140412]]></guid><cfi:id>1211</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Diagnosis of lacrimal canalicular diseases using ultrasound biomicroscopy:a preliminary study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140413]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To evaluate the application of ultrasound biomicroscopy (UBM) in the examination of lacrimal canalicular diseases, and to investigate UBM image characteristics of lacrimal canaliculi in disease states.<b>METHODS:</b>Sixty cases (63 eyes, 69 canaliculi) of lacrimal canalicular diseases were enrolled that included 32 patients (32 eyes, 32 canaliculi) with chronic lacrimal canaliculitis, 18 patients (18 eyes, 18 canaliculi) with previous lacrimal canalicular laceration, 9 patients (12 eyes, 18 canaliculi) with congenital absence of lacrimal puncta and canaliculi, and 1 case (1 eye, 1 canaliculus) of canalicular mass. The patients were examined using UBM, and disease-specific features of the UBM images were noted.<b>RESULTS:</b>UBM imaging of lacrimal canaliculi in chronic canaliculitis patients showed obvious ectasia of the lacrimal canalicular lumen. Dot-like moderate echoic signals were detected on some ectatic lumina of the lacrimal canaliculus. Some lumen-like structures of the lower lacrimal canaliculus were observed in 2 (2 eyes, 2 canaliculi) of the 9 patients (12 eyes, 18 canaliculi) with congenital absence of the lacrimal canaliculus. Of the 18 patients (18 eyes, 18 canaliculi) with previous lacrimal canalicular laceration, the lacerated end on the nasal side of the lacrimal canaliculus was detected only in 14 patients (14 eyes, 14 canaliculi).<b>CONCLUSION:</b>UBM can be used to evaluate lacrimal canalicular diseases and can provide an imaging basis for the diagnosis of lacrimal canalicular diseases.]]></description>
<pubDate>2014/8/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hai Tao,Li-Ping Xu,Cui Han,Peng Wang and Fang Bai]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hai Tao,Li-Ping Xu,Cui Han,Peng Wang and Fang Bai</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140413]]></guid><cfi:id>1210</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Birth weight and gestational age on retinopathy of prematurity in discordant twins in China]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140414]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM</b>:To assess the relative effect of birth weight and gestational age on retinopathy of prematurity (ROP) using preterm twin pairs discordant for birth weigh in a tertiary neonatal intensive care unit in China.<b>METHODS:</b> Fifty-six discordant twin pairs of 112 preterm infants were retrospectively analyzed. The twin pairs were divided into two subgroups based on birth weight in each pair. The occurrence of ROP and severe ROP requiring treatment were compared between the lower birth weight infants and their co-twins with the higher birth weight. Some neonatal morbidities related to prematurity and neonatal characteristics were also compared between the twin pairs.<b>RESULTS:</b> Based on the univariate analysis, gestational age and birth weight were significantly associated with the occurrence and progression of ROP. But no significant differences in ROP between larger and smaller infants were observed in the twin-paired analysis. The incidence of neonatal morbidities regarding respiratory distress syndrome (RDS), patent ductus arteriosus (PDA), intraventricular hemorrhage (IVH), sepsis and neonatal characteristics regarding gender distribution, one- and five-minute Apgar score, postnatal steroid treatment, blood transfusion, supplemental oxygen therapy, and mechanical ventilation were not different between the twins. However, gestational age of ≤28wk was significantly associated with significantly higher rates of ROP and severe ROP.<b>CONCLUSION:</b> Gestational age is a better predictor of ROP than birth weight in the twin-paired study.]]></description>
<pubDate>2014/8/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Zong-Hua Wang,Yao-Yu Li and Zhi-Min Liu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zong-Hua Wang,Yao-Yu Li and Zhi-Min Liu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140414]]></guid><cfi:id>1209</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Anatomical characterization of central, apical and minimal corneal thickness]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140415]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To anatomically locate the points of minimum corneal thickness and central corneal thickness (pupil center) in relation to the corneal apex.<b>METHODS:</b> Observational, cross-sectional study, 299 healthy volunteers. Thickness at the corneal apex (AT), minimum corneal thickness (MT) and corneal thickness at the pupil center (PT) were determined using the pentacam. Distances from the corneal apex to MT (MD) and PT (PD) were calculated and their quadrant position (taking the corneal apex as the reference) determined:point of minimum thickness (MC) and point of central thickness (PC) depending on the quadrant position. Two multivariate linear regression models were constructed to examine the influence of age, gender, power of the flattest and steepest corneal axes, position of the flattest axis, corneal volume (determined using the Pentacam) and PT on MD and PD. The effects of these variables on MC and PC were also determined in two multinomial regression models.<b>RESULTS:</b> MT was located at a mean distance of 0.909 mm from the apex (79.4% in the inferior-temporal quadrant). PT was located at a mean distance of 0.156 mm from the apex. The linear regression model for MD indicated it was significantly influenced by corneal volume (B=-0.024; 95%CI:-0.043 to -0.004). No significant relations were identified in the linear regression model for PD or the multinomial logistic regressions for MC and PC.<b>CONCLUSION:</b> MT was typically located at the inferior-temporal quadrant of the cornea and its distance to the corneal apex tended to decrease with the increment of corneal volume.]]></description>
<pubDate>2014/8/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Federico Saenz-Frances,Martha Cecilia Bermúdez-Vallecilla,Lara Borrego-Sanz,Luis Jañez,José María Martinez-de-la-Casa,Laura Morales-Fernandez,Enrique Santos-Bueso,Julián Garcia-Sanchez and Julián Garcia-Feijoo]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Federico Saenz-Frances,Martha Cecilia Bermúdez-Vallecilla,Lara Borrego-Sanz,Luis Jañez,José María Martinez-de-la-Casa,Laura Morales-Fernandez,Enrique Santos-Bueso,Julián Garcia-Sanchez and Julián Garcia-Feijoo</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140415]]></guid><cfi:id>1208</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Multicolor pattern scan laser for diabetic retinopathy with cataract]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140416]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To evaluate the ability of various laser wavelengths in delivering sufficient burns to the retina in eyes with cataract using a new multicolor pattern scan laser with green (532 nm), yellow (577 nm), and red (647 nm) lasers.<b>METHODS:</b>The relationship between the Emery-Little (EL) degree of cataract severity and the laser wavelength required to deliver adequate burns was investigated in 102 diabetic eyes. Treatment time, total number of laser shots, and intra-operative pain were assessed as well.<b>RESULTS:</b>All EL-1 grade eyes and 50% of EL-2 eyes were successfully treated with the green laser, while 50% of EL-2 eyes, 96% of EL-3 eyes, and 50% of EL-4 eyes required the yellow laser. The red laser was effective in the remaining 4% of EL-3 and 50% of EL-4 eyes.<b>CONCLUSION:</b> Longer wavelength lasers are more effective in delivering laser burns through cataract when we use a multicolor pattern scan laser system.]]></description>
<pubDate>2014/8/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Takao Hirano,Yasuhiro Iesato and Toshinori Murata]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Takao Hirano,Yasuhiro Iesato and Toshinori Murata</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140416]]></guid><cfi:id>1207</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Enucleation and evisceration:indications, complications and clinicopathological correlations]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140417]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM</b>:To assess main indications, postoperative complications and clinicopathological correlation of ocular enucleation-evisceration.<b>METHODS:</b> A total of 107 subjects who underwent enucleation and/or evisceration and received hydroxyapatite implants (Scleral wrap or mesh) were assessed. For each patient clinicopathological data was collected which included demographic information, clinical history, primary clinical diagnosis, main cause of ophthalmic surgery (traumatic, non-traumatic), type of surgical procedure (enucleation, evisceration) and pathological report. Patients’ postoperative clinical visits were checked for procedure-related complications during first year after surgery.<b>RESULTS:</b>One hundred and seven patients (male:65.4%; mean age:26y) underwent enucleation (<i>n=</i>100) or evisceration (<i>n=</i>7) due to traumatic (<i>n</i>=41) and non-traumatic (<i>n</i>=66) causes. Disfiguring painful blind eye was the most common indication of surgery (66.4%), followed by leukocoria (19.6%) and endophthalmitis (4.7%). The main types of injury included ?recracker, traf?c and work accidents, and sharp object perforating injury. In 53 (80.3%) subjects in non-traumatic group the initial clinical diagnosis matched the histopathological results. Malignant tumors (retinoblastoma:47.5%, malignant melanoma:27.3%) were the most common pathological diagnoses followed by phthisis bulbi (25.8%). The most common procedure-related complications were major eye discharge (39.6%), and implant exposure and discharge (20.8%).<b>CONCLUSION:</b> Trauma and malignant tumors are the leading causes of enucleation-evisceration. Despite developing new techniques and materials, enucleation is still associated with considerable postoperative complications.]]></description>
<pubDate>2014/8/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ali Kord Valeshabad,Masood Naseripour,Rajab Asghari,Seyed Hamid Parhizgar,Seyed Ehsan Parhizgar,Mohammad Taghvaei and Shahin Miri]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ali Kord Valeshabad,Masood Naseripour,Rajab Asghari,Seyed Hamid Parhizgar,Seyed Ehsan Parhizgar,Mohammad Taghvaei and Shahin Miri</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140417]]></guid><cfi:id>1206</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Spontaneous or secondary to intravitreal injections of anti-angiogenic agents retinal pigment epithelial tears in age-related macular degeneration]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140418]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To evaluate the visual function evolution of retinal pigment epithelial (RPE) tears in patients with age-related macular degeneration (AMD) according to type of occurrence [spontaneous or secondary to anti-vascular endothelial growth factor (anti-VEGF) injection] and the topographic location of the tear after a two-year follow-up period.<b>METHODS:</b>A total of 15 eyes of 14 patients with RPE tears in exudative AMD were analyzed retrospectively at the University Eye Clinic of Trieste. Inclusion criteria were:patient age of 50 or older with AMD and RPE tears both spontaneous occurring or post anti-VEGF treatment. Screening included:careful medical history, complete ophthalmological examination, fluorescein angiography (FA), indocyanine green angiography (ICG), autofluorescence and infrared imaging and optical coherence tomography (OCT). Patients were evaluated every month for visual acuity (VA), fundus examination and OCT. Other data reported were:presence of PED, number of injections before the tear, location of the lesion.<b>RESULTS:</b> Mean follow-up was 24wk (SD±4wk). A total of 15 eyes were studied for RPE tear. In 6 cases (40%), the RPE tears occurred within two years of anti-VEGF injections the others occurred spontaneously. In 13 cases (86.6%), the RPE tear was associated with pigment epithelial detachment (PED). In 7 cases (46.6%), the RPE tear occurred in the central area of the retina and involved the fovea. Two lesions were found in the parafoveal region, six in the extra-macular area. In all cases visual acuity decreased at the end of the follow-up period (<i>P&lt;</i>0.01) independently of the type or the topographical location of the lesion.<b>CONCLUSION:</b>RPE tear occurs in exudative AMD as a spontaneous complication or in relation to anti-VEGF injections. Visual acuity decreased significantly and gradually in the follow-up period in all cases. No correlation was found between visual loss and the type of onset or the topographic location of the tears.]]></description>
<pubDate>2014/8/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Pia E. Leon,Sandro Saviano,Andrea Zanei,Marco R. Pastore,Elvira Guaglione,Alessandro Mangogna and Daniele Tognetto]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Pia E. Leon,Sandro Saviano,Andrea Zanei,Marco R. Pastore,Elvira Guaglione,Alessandro Mangogna and Daniele Tognetto</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140418]]></guid><cfi:id>1205</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Evaluation of bacterial contamination rate of the anterior chamber during phacoemulsification surgery using an automated microbial detection system]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140419]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To assess the incidence of anterior chamber bacterial contamination during phacoemulsification surgery using an automated microbial detection system (BacT/Alert).<b>METHODS:</b>Sixty-nine eyes of 60 patients who had uneventful phacoemulsification surgery, enrolled in this prospective study. No prophylactic topical or systemic antibiotics were used before surgery. After antisepsis with povidone-iodine, two intraoperative anterior chamber aqueous samples were obtained, the first whilst entering anterior chamber, and the second at the end of surgery. BacT/Alert culture system was used to detect bacterial contamination in the aqueous samples.<b>RESULTS:</b> Neither aqueous samples obtained at the beginning nor conclusion of the surgery was positive for microorganisms on BacT/Alert culture system. The rate of bacterial contamination during surgery was 0%. None of the eyes developed acute-onset endophthalmitis after surgery.<b>CONCLUSION:</b>In this study, no bacterial contamination of anterior chamber was observed during cataract surgery. This result shows that meticulous surgical preparation and technique can prevent anterior chamber contamination during phacoemulsification cataract surgery.]]></description>
<pubDate>2014/8/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ibrahim Kocak,Funda Kocak,Bahri Teker,Ali Aydin,Faruk Kaya and Hakan Baybora]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ibrahim Kocak,Funda Kocak,Bahri Teker,Ali Aydin,Faruk Kaya and Hakan Baybora</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140419]]></guid><cfi:id>1204</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Endoscopic vs external dacryocystorhinostomy-comparison from the patients’ aspect]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140420]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To compare the success and complication rates, duration of surgeries and clinical comfort after endoscopic dacryocystorhinostomy (END-DCR) or external dacryocystorhinostomy (EXT-DCR).<b>METHODS:</b> Fifty patients who underwent EXT- or END-DCR between January 2010-2012 were involved in the study. A questionnaire was applied to patients preoperatively, and postoperatively. Subjective success was defined by absence of epiphora, objective success by a normal nasolacrimal lavage and a positive functional endoscopic dye test (FEDT). Postoperative pain and cosmetic result of surgery were interpreted by the patients, who were also asked whether they would offer this surgery to a friend or would prefer this surgery once more if necessary.<b>RESULTS:</b>Twenty-five patients underwent END-DCR and 25 underwent EXT-DCR. Mean duration of surgeries were 35min both for EXT-DCR (30-50) and END-DCR (35-50) (<i>P=</i>0.778). Intraoperative bleeding were documented in 48% of EXT-DCR and 4% of END-DCR cases (<i>P&lt;</i>0.001). In total 96% of EXT-DCR and 100% of END-DCR patients had subjective success. Objective success was 100% in each group. There was no significant difference between the epiphora scorings and FDDT results in postoperative visits among the groups.END-DCR group reported less pain in first week and month (<i>P&lt;</i>0.05, <i>P&lt;</i>0.05). More patients in END-DCR group were happy with the cosmetic result in first week and month (<i>P&lt;</i>0.001, <i>P&lt;</i>0.001). More patients in END-DCR group offered this surgery to a friend (<i>P&lt;</i>0.001). All patients in END-DCR group preferred this surgery once more if necessary, only 48% in EXT-DCR preferred the same method (<i>P&lt;</i>0.001).<b>CONCLUSION:</b> Although both END- and EXT-DCRs provide satisfactory outcomes with similar objective and subjective success rates, we demonstrated that the endonasal approach caused significantly less pain in early postoperative period than the external approach. Clinical comfort defined by the patients was quite higher in END-DCR group, in which patients mainly were pleased to encounter a sutureless surgical area.]]></description>
<pubDate>2014/8/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Serdar Ozer and Pinar A. Ozer]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Serdar Ozer and Pinar A. Ozer</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140420]]></guid><cfi:id>1203</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Role of wide-field autofluorescence imaging and scanning laser ophthalmoscopy in differentiation of choroidal pigmented lesions]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140421]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To evaluate the diagnostic properties of wide-field fundus autofluorescence (FAF) scanning laser ophthalmoscope (SLO) imaging for differentiating choroidal pigmented lesions.<b>METHODS:</b>A consecutive series of 139 patients were included, 101 had established choroidal melanoma with 13 untreated lesions and 98 treated with radiotherapy. Thirty-eight had choroidal nevi. All patients underwent a full ophthalmological examination, undilated wide-field imaging, FAF and standardized US examination. FAF images and imaging characteristics from SLO were correlated with the structural findings in the two patient groups.<b>RESULTS:</b>Mean FAF intensity of melanomas was significantly lower than the FAF of choroidal nevi. Only 1 out of 38 included eyes with nevi touched the optic disc compared to 31 out of 101 eyes with melanomas. In 18 out of 101 melanomas subretinal fluid was seen at the pigmented lesion compared to none seen in eyes with confirmed choroidal nevi. In “green laser separation”, a trend towards more mixed FAF appearance of melanomas compared to nevi was observed. The mean maximal and minimal transverse and longitudinal diameters of melanomas were significantly higher than those of nevi.<b>CONCLUSION:</b>Wide-field SLO and FAF imaging may be an appropriate non-invasive diagnostic screening tool to differentiate benign from malign pigmented choroidal lesions.]]></description>
<pubDate>2014/8/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Lukas Reznicek,Carmen Stumpf,Florian Seidensticker,Anselm Kampik,Aljoscha S Neubauer and Marcus Kernt]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Lukas Reznicek,Carmen Stumpf,Florian Seidensticker,Anselm Kampik,Aljoscha S Neubauer and Marcus Kernt</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140421]]></guid><cfi:id>1202</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Retinal nerve fiber layer thickness changes in obstructive sleep apnea syndrome:one year follow-up results]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140422]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To investigate the retinal nerve fiber layer (RNFL) thickness changes in patients with obstructive sleep apnea syndrome (OSAS) for one year follow-up. To discuss the possibility of detecting tendency of glaucoma in this population by using spectral domain optical coherence tomography (3D-OCT-2000 Spectral domain).<b>METHODS:</b>After polysomnographic study, all subjects (64 OSAS patients and 40 controls) underwent detailed ophthalmological examination. After these examinations, patients with glaucoma and patients who had ophthalmological and/or systemic disease were excluded from the study. Totally, 20 patients in OSAS group and five patients in controls were excluded from the study in the first examination and follow-up period. The RNFL thickness was assessed with OCT. Forty-four OSAS patients and 35 control subjects were followed up 12mo. RNFL thickness change and OSAS patients were evaluated for severity of disease by Apnea-Hypopnea Index (AHI).<b>RESULTS:</b>Forty-four OSAS patients and 35 controls were enrolled in the study. Statistically significance was found between OSAS patients and controls at the 12<sup>th</sup> mo. Average RNFL thickness was found to be significantly lower in last measurements in OSAS patients when compared with first measurements and control subjects (<i>P&lt;</i>0.001, 0.002, respectively). There was a statistically significant correlation among AHI, and RNFL thickness (<i>P&lt;</i>0.05).<b>CONCLUSION:</b>The results suggest that the patients with OSAS were related with a proportional decrease in the RNFL thickness. These patients should be followed up regularly for glaucomatous changes. Detecting more RNFL thinning in severe OSAS was important.]]></description>
<pubDate>2014/8/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mehmet Ozgur Zengin,Ibrahim Tuncer and Eyyup Karahan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mehmet Ozgur Zengin,Ibrahim Tuncer and Eyyup Karahan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140422]]></guid><cfi:id>1201</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of surgically induced astigmatism in patients with horizontal rectus muscle recession]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140423]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To compare surgically induced astigmatism (SIA) following horizontal rectus muscle recession surgery between suspension recession with both the “hang-back" technique and conventional recession technique.<b>METHODS:</b>Totally, 48 eyes of 24 patients who had undergone horizontal rectus muscle recession surgery were reviewed retrospectively. The patients were divided into two groups. Twelve patients were operated on by the hang-back technique (Group 1), and 12 by the conventional recession technique (Group 2). SIA was calculated on the 1<sup>st</sup> wk, 1<sup>st</sup> and in the 3<sup>rd</sup> mo after surgery using the SIA calculator.<b>RESULTS:</b> SIA was statistically higher in the Group 1 all postoperative follow-up. SIA was the highest in the 1<sup>st</sup> wk, and decreased gradually in both groups.<b>CONCLUSION:</b> The suspension recession technique induced much more SIA than the conventional recession technique. This difference also continued in the following visits. Therefore, the refractive power should be checked postoperatively in order to avoid refractive amblyopia. Conventional recession surgery should be the preferred method so as to minimize the postoperative refractive changes in patients with amblyopia.]]></description>
<pubDate>2014/8/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Harun Çakmak,Tolga Kocatürk and Sema Oruç Dündar]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Harun Çakmak,Tolga Kocatürk and Sema Oruç Dündar</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140423]]></guid><cfi:id>1200</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Topographic characteristics of keratoconus among a sample of Jordanian patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140424]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To identify topographic characteristics of keratoconus in a Jordanian sample.<b>METHODS</b>:This study characterized 210 corneas affected with keratoconus presenting to Jordan University Hospital. Patients were diagnosed based on clinical examinations and Pentacam imaging. Eyes of males (<i>n=</i>101) were of a similar proportion to females (<i>n=</i>109). All of the 111 patients were affected bilaterally. Ages ranged between 13 and 44y with a mean age of 25.2y.<b>RESULTS</b>:Results revealed significant differences between males and females at the level of the flat curvature power, basement membrane thickness and size of the anterior chamber. Eyes were arranged in three groups based on severity levels:mild, moderate and severe determined by the mean curvature power (Km). Results show that the flat (K1) and steep (K2) curvature powers, corneal asphericity coefficient (QV), thinnest point, pachy apex and basement membrane thickness are significantly different among the three groups, but not the corneal and anterior chamber volumes. Morphological analyses, based on sagittal maps, show no differences in keratometric values between eyes with different sagittal patterns except for the vertical location of the pachy apex relative to the pupil center and the thinnest point. Eyes with the island front elevation map are significantly more affected than eyes with the U shape and the ridge pattern.<b>CONCLUSION</b>:All keratometric values measured except for corneal and anterior chamber volumes vary significantly with disease severity. The vertical pachy apex location correlates well with severity levels while the horizontal location seems to have no effect. Our study also indicates that front elevation maps may be a better predictor of the severity of keratoconus than sagittal maps.]]></description>
<pubDate>2014/8/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mohammed Ali Abu Ameerh,Nathalie Bussières,Ghada Ismail Hamad and Muawyah Dawoud Al Bdour]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mohammed Ali Abu Ameerh,Nathalie Bussières,Ghada Ismail Hamad and Muawyah Dawoud Al Bdour</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140424]]></guid><cfi:id>1199</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Accuracy of axial length measurements from immersion B-scan ultrasonography in highly myopic eyes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140310]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To evaluate the accuracy of axial length (AL) measurements obtained from immersion B-scan ultrasonography (immersion B-scan) for intraocular lens (IOL) power calculation in patients with high myopia and cataracts.<b>METHODS:</b>Immersion B-scan, contact A-scan ultrasonography (contact A-scan), and the IOLMaster were used to preoperatively measure the AL in 102 eyes from 102 patients who underwent phacoemulsification and IOL implantation. Patients were divided into two groups according to the AL:one containing patients with 22 mm≤AL&lt;26 mm(group A) and the other containing patients with AL≥26 mm (group B). The mean error (ME) was calculated from the difference between the AL measurement methods predicted refractive error and the actual postoperative refractive error.<b>RESULTS:</b>In group A, ALs measured by immersion B-scan (23.48±1.15) didn’t differ significantly from those measured by the IOLMaster (23.52±1.17) or from those by contact A-scan (23.38±1.20). In the same group, the standard deviation (SD) of the mean error (ME) of immersion B-scan (-0.090±0.397 D) didn’t differ significantly from those of IOLMaster (-0.095±0.411 D) and contact A-scan (-0.099±0.425 D). In group B, ALs measured by immersion B-scan (27.97±2.21 mm) didn’t differ significantly from those of the IOLMaster (27.86±2.18 mm), but longer than those measured by Contact A-scan (27.75±2.23 mm, <i>P=</i>0.009). In the same group, the standard deviation (SD) of the mean error (ME) of immersion B-scan (-0.635±0.157 D) didn’t differ significantly from those of the IOLMaster (-0.679±0.359 D), but differed significantly from those of contact A-scan (-0.953±1.713 D, <i>P=</i>0.028).<b>CONCLUSION:</b>Immersion B-scan exhibits measurement accuracy comparable to that of the IOLMaster, and is thus a good alternative in measuring AL in eyes with high myopia when the IOLMaster can’t be used, and it is more accurate than the contact A-scan.]]></description>
<pubDate>2014/6/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Qing-Hua Yang,Bing Chen,Guang-Hua Peng,Zhao-Hui Li and Yi-Fei Huang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Qing-Hua Yang,Bing Chen,Guang-Hua Peng,Zhao-Hui Li and Yi-Fei Huang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140310]]></guid><cfi:id>1198</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Analysis of glistenings in hydrophobic acrylic intraocular lenses on visual performance]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140311]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To assess patients’ visual performance with glistenings in one piece soft hydrophobic acrylic intraocular lenses (IOLs) (Alcon) 2 years postoperatively.<b>METHODS:</b>This cross section trial included 120 eyes with one piece IOL at 2 years postoperatively. Glistening was classified in 4 groups, ranging from 0 (none) to 3 (most evident) according to their severity in IOLs optics observed under a slit lamp. All eyes underwent a uncorrected and best-corrected visual acuity evaluation (UCVA and BCVA, LogMAR scale), a complete clinical examination, a contrast sensitivity (CS) evaluation by F.A.C.T chart, and a visual field test by Humphrey Field AnalyzerⅡ(HFA). One-way ANOVA was used for quantitative data, while Pearson <i>χ</i><sup>2</sup> test was used for qualitative data to analyze the visual function of 4 glistening groups.<b>RESULTS:</b> Totally 120 eyes were enrolled with 30 eyes in each glistening group. There was no statistical correlation between glistening grades and patients’ age, IOLs power, postoperative UCVA and BCVA (<i>P</i>&gt;0.05). Quantificationally, CS values among each group were not statistically different. However, qualitative analysis showed there were more eyes in grade 3 group than in grade 0 group having abnormally declined CS at high spatial frequency (10% <i>vs</i> 36.7% at 18 cpd, <i>P=</i>0.029; 6.7% <i>vs</i> 26.7% at 12 cpd, <i>P</i>=0.013). Mean deviation (MD) of the visual field test was -2.14±2.31, -1.97±2.23, -3.02±3.17, -4.12±3.38 in group 0 to 3 respectively. There was a significant decrease in the most serious glistenings group (<i>P</i> =0.018).<b>CONCLUSION:</b>Glistenings may potentially have an impact on contrast sensitivity at high spatial frequencyand MD in visual field test.]]></description>
<pubDate>2014/6/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Lei Xi,Yi Liu,Feng Zhao,Chuan Chen and Bing Cheng]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Lei Xi,Yi Liu,Feng Zhao,Chuan Chen and Bing Cheng</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140311]]></guid><cfi:id>1197</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Using LaserSight Astrapro Planner 2.2 Z software in corneal topography-guidedlaser in situ keratomileusis for myopia with asymmetric corneal shape]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140312]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To determine the clinical outcomes of laser <i>in situ</i> keratomileusis (LASIK) treatments using LaserSight AstraPro Planner 2.2 Z software for myopia with asymmetric corneal shape.<b>METHODS:</b>Four hundred and eighty-five eyes <b>[243 patients; spherical equivalent (SE), -5.93±1.88 diopters (D)] were treated with asymmetric ablations using LaserSight SLX laser (version 5.3, 300Hz) were retrospectively analyzed and LaserSight AstraPro Planner 2.2 Z software. Preoperative and postoperative uncorrected visual acuities (UCVA), spherical equivalent (SE) refraction, pachymetry, and corneal asphericity (Q value) and decentration were evaluated. </b><b>RESULTS:</b>At 12mo postoperatively, the decimal UCVA was 1.0 or better in 449 (92.6%) eyes. Two eyes (0.4%) lost 1 line of the decimal best spectacle-corrected visual acuity (BCVA), 316 (65.2%) did not change, 149 (30.7%) gained 1 line, and 18 (3.7%) gained 2 lines or more after surgery. Three hundred and thirty-two eyes (68.5%) were within 0.5 D in SE. The mean tissue saving ablation depth was 4.28±2.86 (0-16) μm (median, 4 μm). The mean attempted remaining central corneal thickness was 435.79±29.56 μm, the mean postoperative pachymetry was 444.94±28.93 μm. The mean preoperative Q value was -0.19±0.18, the postoperative was 0.30±0.48 (</b><i><b>P=</b></i><b>0.000). The mean postoperative decentration was 0.39±0.19 mm. <b>CONCLUSION:</b>Topography-guided LASIK with AstraPro Planner 2.2 Z custom ablation planning software in an asymmetric ablation mode was an effective, safe, predictable, and stable refractive procedure for the myopia with asymmetric corneal topography.]]></description>
<pubDate>2014/6/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Bing Liu,Wei Chen,De-Wang Shao,Hua Wang,Hai-Xia Ru,Min Zhang,Ying Wang and Chun-Yan Yang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Bing Liu,Wei Chen,De-Wang Shao,Hua Wang,Hai-Xia Ru,Min Zhang,Ying Wang and Chun-Yan Yang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140312]]></guid><cfi:id>1196</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A near-vision chart for children aged 3-5 years old:new designs and clinical applications]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140313]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To introduce a new near-vision chart for children aged 3-5 years old and its clinical applications.<b>METHODS:</b>The new near-vision chart which combined the Bailey-Lovie layout with a newly devised set of symmetry symbols was designed based on Weber-Fechner law. It consists of 15 rows of symmetry symbols, corresponding to a visual acuity range from 1.3 to 0.1 logMAR. The optotypes were red against a white background and were specially shaped four basic geometric symbols:circle, square, triangle，and cross, which matched the preschool children''s cognitive level. A regular geometric progression of the optotype sizes and distribution was employed to arrange in 15 lines. The progression rate of the optotype size between two lines was 1.2589 and two smaller groups of optotypes ranging from 0.7 to -0.1 logMAR were included for repetitive testing. A near visual acuity was recorded in logMAR or decimal, and the testing distance was 25 cm.<b>RESULTS:</b>This new near-vision chart with pediatric acuity test optotypes which consists of 4 different symbols (triangle, square, cross, and circle) met the national and international eye chart design guidelines. When performing the near visual acuity assessment in preschoolers (3-5 years old). It overcame an inability to recognize the letters of the alphabet and difficulties in designating the direction of black abstract symbols such as the tumbling ''E'' or Landolt ''C'', which the subjects were prone to lose interest in. Near vision may be recorded in different notations:decimal acuity and logMAR. These two notations can be easily converted each other in the new near-vision chart. The measurements of this new chart not only showed a significant correlation and a good consistency with the Chinese national standard logarithmic near-vision chart (<i>r</i>=0.932, <i>P&lt;</i>0.01), but also indicated good test-retest reliability (89% of retest scores were within 0.1 logMAR units of the initial test score) and a high response rate.<b>CONCLUSION:</b>The results of this study support the validity and reliability of near visual acuity measurements using the new near-vision chart in children aged 3-5y over a wide range of visual acuities, and the new eye chart was especially suitable for the detection of amblyopia risk factors and low vision examination in children (3-5y of age). It can be applied in routine clinical practice.]]></description>
<pubDate>2014/6/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yang-Qing Huang,He Huang and Rong-Zhi Huang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yang-Qing Huang,He Huang and Rong-Zhi Huang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140313]]></guid><cfi:id>1195</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Relationship between modified homeostasis model assessment/correlative serum factors and diabetic retinopathy among type 2 diabetics with insulin therapy in Guangzhou, China]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140314]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To explore the related risk factors for diabetic retinopathy (DR) in type 2 diabetes with insulin therapy.<b>METHODS:</b> We studied the relationships among blood glucose, serum C-peptide, plasma insulin, beta-cell function and the development of DR. Beta-cell function was assessed by a modified homeostasis model assessment (modified HOMA) which was gained by using C-peptide to replace insulin in the homeostasis model assessment (HOMA) of beta-cell function. We also studied the relationships between modified HOMA index and serum C-peptide response to 100g tasteless steamed bread to determine the accuracy of modified HOMA.<b>RESULTS:</b>Our study group consisted of 170 type 2 diabetic inpatients with DR (age:58.35±13.87y, mean±SD) and 205 type 2 diabetic inpatients with no DR (NDR) (age:65.52±11.59y). DR patients had higher age, longer diabetic duration, higher hypertension grade, higher postprandial plasma glucose, higher fluctuation level of plasma glucose, lower body mass index (BMI), lower postprandial serum insulin and C-peptide, lower fluctuation level of serum insulin and C-peptide (<i>P</i>＜0.05). In our logistic regression model, duration of diabetes, hypertension grade, fasting plasma insulin and glycosylated hemoglobin (HbA1C) were significantly associated with the presence of DR after adjustment for confounding factors (<i>P</i>＜0.05).<b>CONCLUSION:</b>Our results suggested although modified HOMA showed significant correlation to the occurrence of DR on Spearman’s rank-correlation analysis, logistic regression showed no significant association between these two variables after adjustment for relevant confounding factors (such as age, sex, duration of diabetes, BMI, hypertension grade, HbA1C, plasma insulin). Duration of diabetes, hypertension grade, fasting plasma insulin and HbA1C were independently associated with the development of DR in Chinese type 2 diabetics.]]></description>
<pubDate>2014/6/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Li Hu and Dong-Hao Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Li Hu and Dong-Hao Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140314]]></guid><cfi:id>1194</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Anatomical and functional outcomes after Densiron 68 heavy silicone oil tamponade for complicated retinal detachment in Chinese eyes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140315]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To evaluate the safety and efficacy of Densiron 68 heavy silicone oil (HSO) tamponade for complicated retinal detachment (RD) in Chinese eyes.<b>METHODS:</b> Twenty-one eyes of 21 patients with complicated RD were included in this retrospective study. All patients underwent pars plana vitrectomy with an internal tamponade using Densiron 68 HSO. Anatomical and functional results and complications were evaluated, including retinal status, visual acuity (VA), intraocular pressure (IOP), intraocular inflammation, lens opacity, and HSO emulsification.<b>RESULTS:</b>All the patients were followed up for 3mo to 1y (5.8±1.16mo). Retinal reattachment was achieved in 19 of 21 patients (90.5%). VA improved in 18 of 21 patients (85.7%), from 1.93 logMAR (±0.48) to 1.52 logMAR (±0.45) (<i>P</i>=0.001). Postoperative complications included early dispersion of HSO in 7 eyes (38.8%), cataract in 10 of 18 phakic eyes (55.5%), moderate postoperative inflammation reaction in 10 eyes (47.6%), and elevated IOP in 5 eyes (23.8%), all of which were controlled by medication or by surgery.<b>CONCLUSION:</b> High anatomical and functional success rates can be achieved with primary vitrectomy for complicated RD by using Densiron 68 HSO; however, it should not be ignored that Densiron 68 HSO can cause some complications in the eye.]]></description>
<pubDate>2014/6/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Fang Liu,Hui Li,Le Feng and Fang Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Fang Liu,Hui Li,Le Feng and Fang Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140315]]></guid><cfi:id>1193</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Agreement in identification of glaucomatous progression between the optic disc photography and Heidelberg retina tomography in young glaucomatous patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140316]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To evaluate concordance between the clinical assessment of glaucomatous progression of the optic disc photography and progression identified by Heidelberg Retina Tomograph (HRT) in patients with suspected primary juvenile open angle glaucoma (JOAG).<b>METHODS:</b>Optic disc photographs and corresponding HRT Ⅱ series were reviewed. Optic disc changes between first and final photographs were noted as well as progression identified by HRT topographic change analysis (TCA) and rim area regression line (RARL) Agreement between progression indentified by photography and HRT methods was assessed. Progression, determined from optic disc photographs by consensus assessment was used as the reference standard.<b>RESULTS:</b> A total of 31 patients (59 eyes) with suspected JOAG were studied. Agreement for progression/no progression between TCA and photography was obtained in 4 progressing eyes and 38 stable eyes (71.19%, <i>k</i>=0.11). Agreement for progression/no progression between RARL and photography was detected in 5 progressing eyes and in 34 stable eyes (66.10%, <i>k</i>=0.15). The number of HRT per patient was statistically higher in the progressing group (<i>P=</i>0.034).<b>CONCLUSION:</b>Agreement for detection of longitudinal changes between photography and HRT analysis was poor. One way to improve the chance of discovery of the progression could be increasing the number of HRT examinations.]]></description>
<pubDate>2014/6/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Paraskeva Hentova-Sencanic,Ivan Sencanic,Goran Trajković,Marija Bozic and Nevena Bjelovic]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Paraskeva Hentova-Sencanic,Ivan Sencanic,Goran Trajković,Marija Bozic and Nevena Bjelovic</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140316]]></guid><cfi:id>1192</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of the efficacies of patching and penalization therapies for the treatment of amblyopia patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140317]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> Tocompare the efficacies of patching and penalization therapies for the treatment of amblyopia patients.<b>METHODS:</b>The records of 64 eyes of 50 patients 7 to 16y of age who had presented to our clinics with a diagnosis of amblyopia, were evaluated retrospectively. Forty eyes of 26 patients who had received patching therapy and 24 eyes of 24 patients who had received penalization therapy included in this study. The latencies and amplitudes of visual evoked potential (VEP) records and best corrected visual acuities (BCVA) of these two groups were compared before and six months after the treatment.<b>RESULTS:</b>In both patching and the penalization groups, the visual acuities increased significantly following the treatments (<i>P</i>&lt;0.05). The latency measurements of the P100 wave obtained at 1.0°, 15 arc min. Patterns of both groups significantly decreased following the 6-months-treatment. However, the amplitude measurements increased (<i>P</i>&lt;0.05).<b>CONCLUSION:</b> The patching and the penalization methods, which are the main methods used in the treatment of amblyopia, were also effective over the age of 7y, which has been accepted as the critical age for the treatment of amblyopia.]]></description>
<pubDate>2014/6/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Cemalettin Cabi,Isil Bahar Sayman Muslubas,Ayse Yesim Aydin Oral and Metin Dastan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Cemalettin Cabi,Isil Bahar Sayman Muslubas,Ayse Yesim Aydin Oral and Metin Dastan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140317]]></guid><cfi:id>1191</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Open globe injury in Hospital Universiti Sains Malaysia - A 10-year review]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140318]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To identify the aetiology of open globe injuries at Hospital Universiti Sains Malaysia over a period of 10y and the prognostic factors for visual outcome.<b>METHODS:</b>Retrospective review of medical records of open globe injury cases that presented from January 2000 to December 2009. Classification of open globe injury was based on the Birmingham Eye Trauma Terminology (BETT). Records were obtained with hospital permission <i>via</i> the in-house electronic patient management system, and the case notes of all patients with a diagnosis of open globe injury were scrutinised. Patients with prior ocular trauma, pre-existing ocular conditions affecting the visual acuity, contrast sensitivity, central vision or corneal thickness, as well as those with a history of previous intraocular or refractive surgery were excluded. Analysis of data was with SPSS version 20.0. Ordinal logistic regression analysis was used to examine the association between prognostic factors and visual outcome.<b>RESULTS:</b> This study involved 220 patients (<i>n</i>=222 eyes). The most common place of injury was the home (51.8%), followed by the workplace (23.4%). Among children aged less than 16y of age, domestic-related injury was the predominant cause (54.6%), while in those aged 16y and above, occupational injuries were the most common cause (40.0%). Most eyes (76.5%) had an initial visual acuity worse than 3/60, and in half of these, the visual acuity improved. The visual outcome was found to be significantly associated with the initial visual acuity (<i>P</i>&lt;0.005), posterior extent of wound (<i>P</i>&lt;0.001), length of wound (<i>P</i>&lt;0.001), presence of hyphaema (<i>P</i>&lt;0.001) and presence of vitreous prolapse ((<i>P</i>&lt;0.005).<b>CONCLUSION:</b>The most common causes of open globe injury are domestic accidents and occupational injuries. Significant prognostic factors for final visual outcome in patients with open globe injury are initial visual acuity, posterior extent and length of wound, presence of hyphaema and presence of vitreous prolapse. Awareness of the factors predicting a poor visual outcome may be helpful during counselling of patients with open globe injuries.]]></description>
<pubDate>2014/6/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Madhusudhan A/L Paramananda,Evelyn-Tai Li Min,Zamri Noordin,Adil Hussein and Wan-Hazabbah Wan Hitam]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Madhusudhan A/L Paramananda,Evelyn-Tai Li Min,Zamri Noordin,Adil Hussein and Wan-Hazabbah Wan Hitam</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140318]]></guid><cfi:id>1190</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of the Retinomax hand-held autorefractor versus table-top autorefractor and retinoscopy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140319]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To compare noncycloplegic and cycloplegic results of Retinomax measurements  with findings  achieved after cycloplegia using table-top autorefractor and retinoscopy.<b>METHODS:</b> The study included 127 patients (mean age 96.7mo, range 21 to 221). Retinomax (Rmax) (Nikon Inc., Japan)  was used to obtain noncycloplegic refraction. Under cycloplegia, refraction was measured with Rmax, table-top autorefractor (TTR) (Nikon NRK 8000, Inc., Japan) and retinoscopy. The values of sphere, spherical equivalent, cylinder and axis of cylinder were recorded for Rmax, TTR and retinoscopy in each eye. All results were analyzed statistically.<b>RESULTS:</b> The mean spheric values (SV), spherical equivalent values (SEV) and cylindrical values (CV) of the noncycloplegic Rmax (SV:0.64 D, SEV:0.65 D and CV:0.03 D, respectively) were found to be significantly lower than cycloplegic TTR (1.43 D, 1.38 D and 0.3 D; <i>P=</i>0.012, <i>P=</i>0.011 and <i>P=</i>0.04, respectively) and retinoscopy (1.34 D, 1.45 D and 0.23 D; <i>P=</i>0.04, <i>P=</i>0.002 and <i>P=</i>0.045, respectively). Mean cycloplegic SV, SEV, CV were not significantly different between Rmax and TTR, Rmax and retinoscopy, TTR and retinoscopy. Cycloplegic or noncycloplegic axis values were not different between any method.<b>CONCLUSION:</b> Rmax may be used successfully as a screening tool but may not be accurate enough for actual spectacle prescription. Cycloplegic Rmax measurements may be able to identify refractive error in children because of approximate results to retinoscopy.]]></description>
<pubDate>2014/6/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ibrahim Tuncer,Mehmet Ozgur Zengin and Eyyup Karahan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ibrahim Tuncer,Mehmet Ozgur Zengin and Eyyup Karahan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140319]]></guid><cfi:id>1189</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Central corneal thickness measurements in premature infants]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140320]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To evaluate the central corneal thickness (CCT) measurements of premature infants<b>METHODS:</b> The premature infants who were born between 25-34wk of gestational age (GA) were retrieved for the study. All CCT measurements were performed within the first 2d of their life under topical anesthesia by using an ultrasonic pachymeter.<b>RESULTS:</b> The mean CCT of 200 eyes was 647.79±63.94 μm. The mean CCT of the right and left eyes were similar (647.30±64.72 μm and 648.29±63.47 μm consecutively). The mean CCT of the girls was 642.08±54.89 μm and the boys was 653.07±71.14 μm, with no statistically significant difference (<i>P&gt;</i>0.05). But there was a negative correlation of the CCT with GA and birth weight (BW) (<i>P&lt;</i>0.01).<b>CONCLUSION:</b>The CCT values of premature babies were negatively correlated with GA and BW.]]></description>
<pubDate>2014/6/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Murat Gunay,Gokhan Celik,Betul Onal Gunay,Mahmut Dogru,Tugba Gursoy and Husnu Fahri Ovali]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Murat Gunay,Gokhan Celik,Betul Onal Gunay,Mahmut Dogru,Tugba Gursoy and Husnu Fahri Ovali</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140320]]></guid><cfi:id>1188</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Aqueous levels of erythropoietin in acute retinal vein occlusion with macular edema]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140321]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To investigate the aqueous erythropoietin (EPO) levels and associated factors in patients with acute retinal vein occlusion (RVO).<b>METHODS:</b>The aqueous EPO level was measured in patients with macular edema (ME) secondary to acute branched retinal vein occlusion (BRVO) or central retinal vein occlusion (CRVO). Aqueous fluid from cataract patients served as the control. We also evaluated whether aqueous level of EPO was associated with factors such as serum EPO level, non-perfusion area, central macular thickness (CMT), and arterio-venous (AV) transit time<b>RESULTS:</b>Twenty-seven RVO patients (16 BRVO, 11 CRVO) and 9 control subjects were enrolled in the study. The aqueous EPO level (mU/mL) was higher in RVO (68.2±54.3) than that in the control subjects (12.9±5.9). More specifically, the aqueous EPO level was higher in CRVO (118.9±52.1) than that in BRVO (33.3±10.8). However, no differences were found in serum EPO levels among three groups. CMT in RVO patients had a positive correlation with the aqueous EPO level (<i>r</i>=0.66). Also, in terms of non-perfusion area, the aqueous EPO levels were more elevated in the ischemic subgroup than in the non-ischemic subgroup in both BRVO and CRVO.<b>CONCLUSION:</b>Aqueous EPO levels are elevated in patients with macular edema secondary to recent onset RVO. Patients with CRVO have higher EPO levels than those with BRVO. The aqueous EPO level in RVO has a positive correlation with CMT and is associated with non-perfusion area. These results suggest that the aqueous EPO level could be associated with retinal ischemia and may be involved in the pathogenesis of macular edema secondary to RVO.]]></description>
<pubDate>2014/6/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hyun Jin Shin,Hyung Chan Kim and Jun Woong Moon]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hyun Jin Shin,Hyung Chan Kim and Jun Woong Moon</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140321]]></guid><cfi:id>1187</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Total lower lid reconstruction:clinical outcomes of utilizing three-layer flap and graft in one session]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140322]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To report the clinical outcomes of utilizing a three-layer flap and graft in reconstruction of the lower lid in one session.
<b>METHODS:</b> Seventeen patients with total or near total lower eyelid defect were included. The defects were reconstructed in three layers. Posterior lamella was reconstructed by using tarsoconjunctival free graft from the ipsilateral upper lid and periosteal flap from lateral orbital rim. Mobilization of residual orbicularis muscle provided a rich blood supply; and the anterior lamella was reconstructed by skin flap prepared from upper lid blepharoplasty as a one-pedicular or bipedicular bucket handle flap.<b>RESULTS:</b> The cause of lower eyelid defect was basal cell carcinoma in 15 patients and trauma in two of them. No intraoperative and postoperative complication occurred. Patients were followed from 10 to 15mo postoperatively. Cosmetic results were favorable in all patients and we had acceptable functional results. Thickness of the reconstructed tissue was a concern in early postoperative period.<b>CONCLUSION:</b>Three-layer lower lid reconstruction in one session is an effective technique for total lower lid reconstruction with minimal complications and acceptable functional and aesthetic outcomes and can be considered as a safe alternative for the preexisting techniques.]]></description>
<pubDate>2014/6/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mohammad Tahe rRajabi,Fatemeh Bazvand,Seyedeh Simindokht Hosseini,Ali Makateb,Mohammad Bagher Rajabi,Syed ZiaeddinTabatabaie and Yalda Abrishami]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mohammad Tahe rRajabi,Fatemeh Bazvand,Seyedeh Simindokht Hosseini,Ali Makateb,Mohammad Bagher Rajabi,Syed ZiaeddinTabatabaie and Yalda Abrishami</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140322]]></guid><cfi:id>1186</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Does topical bevacizumab prevent postoperative recurrence after pterygium surgery with conjunctival autografting?]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140323]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To assess the effect of topical bevacizumab use on postoperative pterygium recurrence in eyes who underwent pterygium excision with limbal-conjunctival autograft transplantation (LCAT).<b>METHODS:</b>Eighty-eight eyes of 88 patients with primary pterygium were included. Pterygia were graded preoperatively from type 1 to type 3 (type 1 atrophic, type 3 inflamed) according to the inflammatory status. The eyes were preoperatively randomized to receive topical steroid and antibiotic treatment (group 1, 46 eyes) and additional topical bevacizumab (5 mg/mL; group 2, 42 eyes) in the postoperative period. All eyes underwent pterygium excision and LCAT. Medications were tapered and discontinued at one month. Postoperative complications and recurrence rates were recorded.<b>RESULTS:</b> The mean follow-up duration was 29.3±4.2mo (24-52mo) and 28.5±3.4 (24-48mo) in group 1 and 2, respectively (<i>P</i>＞0.05). There were no statistically significant differences regarding the age or gender between groups (<i>P</i>＞0.05). Also, the difference between groups with respect to pterygium type was not significant. During the follow-up period, recurrence developed in 2 eyes (4.3%) in group 1, whereas in one eye (2.4%) in group 2. No statistically significant difference between groups was found in recurrence rates (<i>P</i>＞0.05). No re-operation for recurrence was necessary during the follow-up period in both groups.
<b>CONCLUSION:</b> Topical bevacizumab seems to have no additonal effect on pterygium recurrence after LCAT.
]]></description>
<pubDate>2014/6/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Aylin Karalezli,Cem Kucukerdonmez,Yonca A. Akova and Bengu Ekinci Koktekir]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Aylin Karalezli,Cem Kucukerdonmez,Yonca A. Akova and Bengu Ekinci Koktekir</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140323]]></guid><cfi:id>1185</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Long-term outcomes of penetrating keratoplasty in keratoconus:analysis of the factors associated with final visual acuities]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140324]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To investigate the long-term results of penetrating keratoplasty (PK) in patients with keratoconus (KC) and to evaluate factors that might influence the final visual outcome.<b>METHODS:</b>We retrospectively reviewed the data of all patients with clinical KC who had undergone PK by a single corneal surgeon in a single center from May 1980 to December 2005. The age of the patients, preoperative best-corrected visual acuity (BCVA), corneal thickness, death to preservation time, and preservation to transplantation time were recorded. Additionally, postoperative complications such as graft rejection, development of glaucoma and specular microscopy were checked during the follow-up.<b>RESULTS:</b>Sixty-nine eyes from 69 patients were finally included. The follow-up period was 8.64±6.13y. Graft rejection occurred in 4 eyes of 69 cases (5.8%), and the time to graft rejection was 2.1±1.3y. A Kaplan–Meier survival analysis showed that the estimated cumulative probability of graft rejection at 6, 13, and 17y after PK were 95.6%, 90.0%, and 78.8%, respectively. When we evaluated factors that might influence final BCVA in eyes, no disparity donor-host trephine size (same graft size) as well as higher spherical equivalent, and average <i>K</i>-value were associated with higher final BCVA. (<i>P</i>=0.006, 0.051, 0.092, and 0.021 in eyes with follow-up &lt;8y; <i>P</i>=0.068, 0.065, and 0.030 in eyes with follow-up ≥8y, respectively).<b>CONCLUSION:</b> The long-term results of PK in patients with KC were favorable with a high percentage of good BCVA. Less myopic change and low average K-reading, as well as a surgical technique using the same size donor-recipient button may provide better visual outcomes particularly in patients with KC.]]></description>
<pubDate>2014/6/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jin A Choi,Min A Lee and Man-Soo Kim]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jin A Choi,Min A Lee and Man-Soo Kim</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140324]]></guid><cfi:id>1184</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Factors associated with strabismus after cataract extraction and primary intraocular lens implantation in congenital cataracts]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140325]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To evaluate factors associated with the development of strabismus after cataract extraction and primary intraocular lens implantation.<b>METHODS:</b> The medical records of 122 patients, aged 1.5mo to 9y, who had undergone cataract extraction with primary intraocular lens implantation between January 1993 and August 2011 were reviewed. Fourteen patients (17 eyes) with strabismus before cataract surgery were excluded. Patients were divided into those with congenital bilateral cataracts (64 patients, 128 eyes) and those with unilateral cataracts (44 patients, 44 eyes). The associations between the development of strabismus and age at cataract surgery, pre- and post-cataract extraction corrected distance visual acuity (CDVA), interocular CDVA difference, nystagmus, surgical method, and secondary cataract were evaluated.<b>RESULTS:</b> Factors significantly associated with the development of strabismus included age at cataract surgery (≤1y), preoperative mean CDVA ≤20/100, presence of nystagmus in the bilateral cataract group and postoperative interocular CDVA difference ＞20/70 in the unilateral group. Postoperative CDVA ≤20/100 and preservation of posterior capsule, and presence of secondary cataract were significant factors in both groups.<b>CONCLUSION:</b> Children with congenital cataracts should be monitored carefully after cataract surgery for the development of strabismus, especially when they underwent surgery at age ≤1y, and they have nystagmus, large postoperative interocular CDVA difference, poor preoperative and postoperative CDVA, preservation of the posterior capsule, or secondary cataract.]]></description>
<pubDate>2014/6/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Soo Jung Lee and Wan-Soo Kim]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Soo Jung Lee and Wan-Soo Kim</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140325]]></guid><cfi:id>1183</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Survival analysis following early surgical success in intermittent exotropia surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140326]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM</b>:To assess the consecutive recurrence following early success of intermittent exotropia surgery and to determine the clinical factors that affect the survival.<b>METHODS</b>:One hundred and thirty-five patients who underwent intermittent exotropia surgery and experienced early surgical success [<i>≤</i>5 prism diopters (PD) esophoria (E) to <i>≤</i>10 PD exophoria (X) on the postoperative sixth month] were enrolled in this study. Their consecutive survival on the postoperative first year, second year and third year and at the last visit of fourth year or more, and the factors that might affect their survival, were analyzed. The final surgical outcomes after the postoperative fourth year were also investigated by dividing the patients into the success group (<i>≤</i>5 PD E to <i>≤</i>10 PD X) and the failure group (&gt;5 PD esodeviation or &gt;10 PD exodeviation)<b>RESULTS</b>:The survival rates from the Kaplan-Meier analysis were 97.78%, 92.89%, 83.70% and 50.49% on the postoperative first, second and third years and fourth year or more, respectively. None of the clinical factors was determined to have affected the survival. The amount of the exodrift was largest (2.29 PD) between the first year and the second year, and smallest (1.47 PD) between the fourth year and the last visit. Sixty-three patients had their final visit after the postoperative fourth year, and 29 of them were in the failure group. Twenty-five patients in the failure group had an intermittent exotropia (IXT) of &lt;20 PD with good to fair distant fusion; two had an IXT of &lt;20 PD with poor distant fusion; one had an IXT of <i>≥</i>20 PD with fair distant fusion; and another had delayed-onset consecutive esotropia. The exodeviation on the postoperative sixth month was smaller in the success group than in the failure group (2.81 PD <i>vs</i> 5.86 PD, <i>P</i>=0.012). The reoperation rate for recurrent IXT was 3.7%.<b>CONCLUSION</b>:The survival rate steadily decreases with the exodrift, but the amount of the exodrift decreases with long-term follow-up. The final outcomes demonstrate favorable results via surgical success or small-angle IXT with good fusion in most of the patients. A smaller deviation on the postoperative sixth month is associated with long-term survival.]]></description>
<pubDate>2014/6/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Joo Yeon Lee,Sung Ju Ko and Sung Uk Baek]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Joo Yeon Lee,Sung Ju Ko and Sung Uk Baek</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140326]]></guid><cfi:id>1182</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of scanning electron microscopy findings regarding biofilm colonization with microbiological results in nasolacrimal stents for external, endoscopic and transcanalicular dacryocystorhinostomy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140327]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To compare bacterial biofilm colonization in lacrimal stents following external dacryocystorhinostomy (EX-DCR), endoscopic dacryocystorhinostomy (EN-DCR), and transcanalicular dacryocystorhinostomy (TC-DCR) with multidiode laser.<b>METHODS:</b> This prospective study included 30 consecutive patients with nasolacrimal duct obstruction who underwent EXT-, EN-, or TC-DCR. Thirty removed lacrimal stent fragments and conjunctival samples were cultured. The lacrimal stent biofilms were examined by scanning electron microscopy (SEM).<b>RESULTS:</b>Eleven (36.7%) of the 30 lacrimal stent cultures were positive for aerobic bacteria (most commonly S<i>taphylococcus epidermidis</i> and P<i>seudomonas aeruginosa</i>). However anaerobic bacteria and fungi were not identified in the lacrimal stent cultures. Twenty-seven (90%) patients had biofilm-positive lacrimal stents. The conjunctival culture positivity after the DCR, biofilm positivity on stents, the grade of biofilm colonization, and the presence of mucus and coccoid and rod-shaped organisms did not significantly differ between any of the groups (<i>P</i>＞0.05). However, a significant difference was found when the SEM results were compared to the results of the lacrimal stent and conjunctival cultures (<i>P</i>＜0.001).<b>CONCLUSION:</b> Type of dacryocystorhinostomy (DCR) surgery did not affect the biofilm colonization of the lacrimal stents. SEM also appears to be more precise than microbiological culture for evaluating the presence of biofilms on lacrimal stents.]]></description>
<pubDate>2014/6/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Melike Balikoglu-Yilmaz,Tolga Yilmaz,Sule Cetinel,Umit Taskin,Ayse Banu Esen,Muhittin Taskapili and Timur Kose]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Melike Balikoglu-Yilmaz,Tolga Yilmaz,Sule Cetinel,Umit Taskin,Ayse Banu Esen,Muhittin Taskapili and Timur Kose</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140327]]></guid><cfi:id>1181</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Improvement of visual acuity based on optical coherence tomography patterns following intravitreal bevacizumab treatment in patients with diabetic macular edema]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140211]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To report the visual outcome based on various patterns of optical coherence tomography (OCT) morphology in diabetic macular edema (DME), following treatment with anti-VEGF intravitreal bevacizumab (IVB) injection.<b>METHODS:</b>Sixty-seven consecutive subjects with centre involving DME underwent intravitreal injection of Bevacizumab (1.25 mg/0.05 mL) in this retrospective, comparative, non randomized study. The DME was classified into one of four categories:focal, diffuse, focal cystoid and neurosensory detachment based on OCT. Best corrected visual acuity (BCVA), macular appearance, and OCT findings were used to decide whether the subject should have a repeat injection of intravitreal bevacizumab. Outcome measures were a change in mean BCVA (Snellen converted to logMAR) and central macular thickness (CMT) in each group during the six month follow-up period.<b>RESULTS:</b>The mean BCVA improved to logMAR 0.23 at final follow-up from a baseline of 0.32 logMAR (<i>P=</i>0.040) in the focal group, logMAR 0.80 at final follow-up from a baseline of 0.82 logMAR (<i>P=</i>0.838) in the diffuse group, worsened to logMAR 0.53 at final follow-up from a baseline of 0.43 logMAR (<i>P=</i>0.276) in the focal cystoid group, and improved to logMAR 0.79 at final follow-up from a baseline of 0.93 logMAR (<i>P=</i>0.490) in the neurosensory detachment group. The mean CMT before treatment were 298.8±25.03 μm in the focal group, 310.8±40.6 μm in the diffuse group, 397.15±31.05 μm in the focal cystoid group and 401.03±75.1 μm in the neurosensory detachment group. A mean of 2.05 (range:1-5) injections in the focal group, 1.32 (range:1-2) in the diffuse group, 2.6 (range:1-6) in the focal cystoid group and 2.6 (range:1-6) in the neurosensory detachment group were performed during the six month follow-up period. Following intravitreal bevacizumab treatment, vision improved, remained unchanged or worsened in 11, 7 and 2 subjects in focal group; 11, 9 and 8 in diffuse group; 0, 2 and 4 in focal cystoid group and 5, 5 and 3 subjects respectively in neurosensory detachment group.<b>CONCLUSION:</b>OCT morpholgy patterns in DME may predict the effects of intravitreal bevacizumab treatment, and patients with focal DME are most likely to benefit from the improvent of visual acuity from this treatment.]]></description>
<pubDate>2014/4/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Haider R. Cheema,Ahmed Al Habash and Essam Al-Askar]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Haider R. Cheema,Ahmed Al Habash and Essam Al-Askar</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140211]]></guid><cfi:id>1180</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparative proteomic analysis of plasma proteins in patients with age-related macular degeneration]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140212]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To find the significant altered proteins in age-related macular degeneration (AMD) patients as potential biomarkers of AMD.<b>METHODS:</b> A comparative analysis of the protein pattern of AMD patients versus healthy controls was performed by means of proteomic analysis using two-dimensional gel electrophoresis followed by protein identification with MALDI TOF/TOF mass spectrometry.<b>RESULTS:</b> We identified 28 proteins that were significantly altered with clinical relevance in AMD patients. These proteins were involved in a wide range of biological functions including immune responses, growth cytokines, cell fate determination, wound healing, metabolism, and anti-oxidance.<b>CONCLUSION:</b> These results demonstrate the capacity of proteomic analysis of AMD patient plasma. In addition to the utility of this approach for biomarker discovery, identification of alterations in endogenous proteins in the plasma of AMD patient could improve our understanding of the disease pathogenesis.]]></description>
<pubDate>2014/4/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xin-Rong Xu,Lu Zhong,Bing-Lin Huang,Yuan-Hua Wei,Xin Zhou,Ling Wang and Fu-Qiang Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xin-Rong Xu,Lu Zhong,Bing-Lin Huang,Yuan-Hua Wei,Xin Zhou,Ling Wang and Fu-Qiang Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140212]]></guid><cfi:id>1179</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Multiple methods of surgical treatment combined with primary IOL implantation on traumatic lens subluxation/dislocation in patients with secondary glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140213]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To describe clinical findings and complications from cases of traumatic lens subluxation/dislocation in patients with secondary glaucoma, and discuss the multiple treating methods of operation combined with primary intraocular lens (IOL) implantation.
<b>METHODS:</b>Non-comparative retrospective observational case series. Participants:30 cases (30 eyes) of lens subluxation/dislocation in patients with secondary glaucoma were investigated which accepted the surgical treatment by author in the Ophthalmology of Xi''an No.4 Hospital from 2007 to 2011. According to the different situations of lens subluxation/dislocation, various surgical procedures were performed such as crystalline lens phacoemulsification, crystalline lens phacoemulsification combined anterior vitrectomy, intracapsular cataract extraction combined anterior vitrectomy, lensectomy combined anterior vitrectomy though peripheral transparent cornea incision, pars plana lensectomy combined pars plana vitrectomy, and intravitreal cavity crystalline lens phacofragmentation combined pars plana vitrectomy. And whether to implement trabeculectomy depended on the different situations of secondary glaucoma. The posterior chamber intraocular lenses (PC-IOLs) were implanted in the capsular-bag or trassclerally sutured in the sulus decided by whether the capsular were present. Main outcome measures:visual acuity, intraocular pressure, the situation of intraocular lens and complications after the operations.<b>RESULTS:</b> The follow-up time was 11-36mo (21.4±7.13). Postoperative visual acuity of all eyes were improved; 28 cases maintained IOP below 21 mm Hg; 2 cases had slightly IOL subluxation, 4 cases had slightly tilted lens optical area; 1 case had postoperative choroidal detachment; 4 cases had postoperative corneal edema more than 1wk, but eventually recovered transparent; 2 cases had mild postoperative vitreous hemorrhage, and absorbed 4wk later. There was no postoperative retinal detachment, IOL dislocation, and endophthalmitis.<b>CONCLUSION:</b>To take early treatment of traumatic lens subluxation/dislocation in patients with secondary glaucoma by individual surgical plan based on the different eye conditions would be safe and effective, which can effectively control the intraocular pressure and restore some vision.]]></description>
<pubDate>2014/4/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Rui Wang,Chun-Chao Bi,Chun-Ling Lei,Wen-Tao Sun,Shan-Shan Wang and Xiao-Juan Dong]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Rui Wang,Chun-Chao Bi,Chun-Ling Lei,Wen-Tao Sun,Shan-Shan Wang and Xiao-Juan Dong</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140213]]></guid><cfi:id>1178</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of corneal flap thickness using a FS200 femtosecond laser and a moria SBK microkeratome]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140214]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To evaluate differences in flap thickness resulting from use of an Alcon Wavelight FS200 femtosecond laser and a MORIA SBK microkeratome when making a 110-μm-thick corneal flap and to identify the potential factors that affect corneal flap thickness.<b>METHODS:</b> A prospective case study was performed on 120 eyes of 60 patients who were divided into two groups for LASIK, each group consisting of 60 eyes (30 patients). The corneal flaps were created using an Alcon Wavelight FS200 femtosecond laser or a MORIA SBK microkeratome. The central corneal flap thickness was calculated by subtraction pachymetry. Age, central corneal thickness (CCT), spherical equivalent refraction, mean keratometry, and corneal diameter were recorded preoperatively for analysis.<b>RESULTS:</b> Cutting of all flaps was easily performed without intraoperative complications. In the Alcon Wavelight FS200 femtosecond lasergroup, the mean right and left corneal flap thicknesses were 114.0±6.6 μm (range:98-126) and 111.4±7.6 μm (range:98-122), respectively. The difference (2.6±9.1 μm) in the corneal flap thickness between the right and left eyes was not significant (<i>t</i>=1.59, <i>P</i>=0.12). Stepwise regression analysis indicated that the resulting corneal flap thickness was unrelated to the patient’s age, preoperative CCT, spherical equivalent refraction, mean keratometry, or corneal diameter. In the MORIA SBK microkeratome group, the mean right and left corneal flap thicknesses were 110.6±7.4 μm (range:97-125 μm) and 108.2±6.1 μm (range:78-123 μm), respectively. The difference in the corneal flap thickness between the right and left eyes (2.4±6.5μm) was not significant (<i>t</i>=2.039, <i>P</i>=0.0506). The corneal flap thickness was positively correlated with the preoperative CCT through stepwise regression analysis (<i>r</i>=0.297,<i> P</i>=0.021). The corneal flap thickness was not related to age, spherical equivalent refraction, mean keratometry, or corneal diameter. The corneal flap thickness was estimated using the following equation:Tflap=67.77+0.076 CCT (<i>F</i>=5.63, <i>P</i>=0.021).<b>CONCLUSION:</b>Both the Alcon Wavelight FS200 femtosecond laser and the MORIA SBK microkeratome produced 110-μm-thick corneal flaps. The central corneal flap thickness was positively correlated with the preoperative CCT in MORIA SBK microkeratome surgery.]]></description>
<pubDate>2014/4/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jing Zhang,Shi-Sheng Zhang,Qing Yu,Jiang-Xiu Wu and Jing-Cai Lian]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jing Zhang,Shi-Sheng Zhang,Qing Yu,Jiang-Xiu Wu and Jing-Cai Lian</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140214]]></guid><cfi:id>1177</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[General anesthesia versus local anesthesia for penetrating keratoplasty:a prospective study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140215]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To examine which anesthesia general or local is more effective for penetrating keratoplasty (PKP).<b>METHODS:</b> Patients with indications for PKP (<i>n</i>=141) were enrolled in a prospective study and randomly divided into general anesthesia group (group A, 70 eyes) and local anesthesia group (group B, 71 eyes). Patients received optical PKP (group A1, 30 eyes; group B1, 30 eyes) or therapeutic PKP (group A2, 40 eyes; group B2, 41 eyes). Measurement of anterior chamber treatment time (T) for PKP patients and the ratio (R) of the area of the pupils to that of recipient graft region. T and R values, as well as perioperative and postoperative complications, were compared between groups A and B using <i>t</i>-test or<i> χ</i><sup>2</sup> test.<b>RESULTS:</b> Patients were followed for 2wk after PKP. T was (13.45±8.64)min for group A and (7.36±5.24)min for group B, a statistically significant difference (<i>P</i>&lt;0.001). The R value for group A was stable during the operation, while for PKP patients in group B the value initially increased then gradually decreased to normal after suturing. In group B, extrusion of intraocular contents occurred in 5 eyes, and iridal prolapse occured in 11 cases; no perioperative complications occurred in group A. Relapse rate for fungal keratitis was 13.04% in group B and 0% in group A.<b>CONCLUSION:</b> Under general anesthesia, pupils remaine stable during PKP and perioperative complications are averted. General anesthesia gives more time to treat pathological changes in the anterior chamber and treatment success rate is higher.]]></description>
<pubDate>2014/4/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xu Wang,Guang-Fu Dang,Ying-Mei Li,Wei-Fan Li and Xin-Yi Wu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xu Wang,Guang-Fu Dang,Ying-Mei Li,Wei-Fan Li and Xin-Yi Wu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140215]]></guid><cfi:id>1176</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of Artisan iris-claw intraocular lens implantation and posterior chamber intraocular lens sulcus fixation for aphakic eyes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140216]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To compare the efficacy and complications of Artisan iris-claw intraocular lens (IOL) implantation and posterior chamber IOL sulcus fixation for the treatment of aphakic eyes without capsular support after vitrectomy.<b>METHODS</b>:A prospective study of 45 cases was conducted. Forty-five eyes without sufficient lens capsule support following pars plana vitrectomy (PPV) combined lens extraction were divided into two groups. Group A:25 eyes received Artisan iris-claw IOL implantation. Group B:20 eyes received posterior chamber IOL sulcus fixation. The corrected distance visual acuity (CDVA) and intraocular pressure (IOP), corneal endothelial cell loss rate, surgical time and complications were compared between the two groups. Pigment changes of trabecular meshwork and anterior chamber depths were measured at each time point in Artisan group.<b>RESULTS:</b>The mean surgical time of Artisan group was significantly shorter (<i>P</i>&lt;0.05). No statistically significant difference in endothelial cell loss rate was noted between two groups at any time point (<i>P</i>&gt;0.05). CDVA of Artian group was better than that of the sulcus fixation group 1d after surgery (<i>P</i>&lt;0.05) and there was no statistically significant difference 1 and 3mo after surgery (<i>P</i>&gt;0.05). Mean IOP showed no significant differences between groups before and after surgery. The postoperative complications of Artisan group were anterior uveitis, iris depigmentation, pupillary distortion and spontaneous lens dislocation. The complications of sulcus fixation group include choroidal detachment, intraocular haemorrhage, tilt of IOL optic part and retinal detachment.<b>CONCLUSION:</b>Secondary Artisan IOL implantation can be performed less invasively and in a shorter surgical time period with earlier visual recovery after surgery compared to transscleral suturing fixation of an IOL. This technique is an effective and safe procedure. It is a promising option for the treatment of aphakic eyes without capsular support after vitrectomy.]]></description>
<pubDate>2014/4/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[He Teng and Hong Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>He Teng and Hong Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140216]]></guid><cfi:id>1175</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A self-made disposable iris retractor in small pupil phacoemulsification]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140217]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To explore a simple and low-cost self-made disposable flexible iris retractor and study its clinical efficacy and safety in small pupil phacoemulsification.
<b>METHODS:</b> Polyproplyene suture and scalp acupuncture were used to make iris retractor. A prospective study were carried on 50 patients (50 eyes) with a maximally dilated pupil size of 2.5-4.0 mm which underwent phacoemulsification using this self-made iris retractor. Another 50 cases of phacoemulsification with normal pupil size sever as control group. The mean operation time, ultrasound time and ultrasonic power, volume of irrigation fluid were documented intraoperatively. The visual acuity, pupil size and complication were observed on 1d, 1wk, 1mo and 1y after operation. Corneal endothelial cell was measured at 1mo postoperatively.
<b>RESULT:</b> Pupils could be expanded to approximately 4.5-5.5 mm with our self-made iris retractor in operation. No serious postoperative complication was found. Most (88%) of the pupils returned round or oval shape, light reflex restored to varying degrees at the first day after surgery. Best corrected visual acuity stabilized in 37 eyes (74%) at one day, in 43 eyes (86%) at one week, in 44 eyes (88%) at one month and 46 eyes (92%) at one year. Compared with the control, more time was needed to complete the operation in the small pupil group. There was no significant difference of the mean ultrasound time, ultrasonic power, volume of irrigation fluid required and corneal endothelial cell loss in 1mo follow up between the two groups.
<b>CONCLUSION:</b> Our self-made disposable flexible iris retractor could be easy obtained preoperatively or intraoperatively. It performed both safety and efficacy in our clinical trials. This simple self-made device has shown economic and practical values, especially in primary care hospital of the less developed districts.
]]></description>
<pubDate>2014/4/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jie Li,Fei Liu,Wei-Wei Zhang and Jun-Jun Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jie Li,Fei Liu,Wei-Wei Zhang and Jun-Jun Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140217]]></guid><cfi:id>1174</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Retinopathy in non diabetics, diabetic retinopathy and oxidative stress:a new phenotype in Central Africa?]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140218]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To evaluate the rates of retinopathy without diabetes and diabetic retinopathy (DR), associated with some markers of oxidative stress, antioxidants and cardiometabolic risk factors.<b>METHODS:</b> We determined the prevalence of DR in 150 type 2 diabetes mellitus (T2DM) patients, that of retinopathy in 50 non diabetics, the levels of body mass index (BMI), waist circumference (WC), blood pressure, lipids, 8-isoprostane, 8-hydroxydeoxyguanosine (8-OHdG), gamma-glutamyl transferase GT (GGT), oxidized low-density lipoprotein (OxLDL), thiobarbituric acid reacting substances (TBARS), reduced glutathione (GSH), superoxide dismutase (SOD), uric acid, creatinine, albumin, total antioxidant status (TAOS), zinc, selenium, magnesium, vitamin C, vitamin D, vitamin E, glucose, apolipoprotein B (ApoB).<b>RESULTS:</b> The prevalences of DR at 53y and Rtp at 62y were 44% (<i>n=</i>66) and 10% (<i>n=</i>5), respectively. The highest levels of 8-isoprostane, 8-OHdG, TBARS, SOD, and OxLDL were in DR. The lowest levels of vitamin D, vitamin C, TAOS, and vitamin E were in DR. In the case-control study discriminant analysis, the levels of vitamin C, vitamin D, ApoB, 8-OHdG, creatinine, Zn, vitamin E, and WC distinguished significantly non-diabetics without DR (controls), T2DM patients without DR and T2DM patients with DR.<b>CONCLUSION:</b> Anticipation of DR onset is significantly associated with the exageration of oxidative stress biomarkers or decrease of antioxidants in African type 2 diabetics. Prevention of oxidative stress and abdominal obesity is needed. Supplementation in vitamin C, D, and E should be recommended as complement therapies of T2DM.]]></description>
<pubDate>2014/4/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Benjamin Longo-Mbenza,Moise Mvitu Muaka,Wayiza Masamba,Lucien Muizila Kini,Igor Longo Phemba,Dalida Kibokela Ndembe and Doris Tulomba Mona]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Benjamin Longo-Mbenza,Moise Mvitu Muaka,Wayiza Masamba,Lucien Muizila Kini,Igor Longo Phemba,Dalida Kibokela Ndembe and Doris Tulomba Mona</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140218]]></guid><cfi:id>1173</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of central corneal thickness measurements with three new optical devices and a standard ultrasonic pachymeter.]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140219]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To compare the RTVue spectral optical coherence tomography (SD-OCT), Sirius Scheimpflug-Placido topographer, Lenstar optical low coherence reflectometry (OLCR) and ultrasound pachymetry (USP) devices in terms of their agreement and repeatability of measuring central corneal thickness (CCT).<b>METHODS:</b> In this prospective study, 50 eyes of 50 patients were included. Three repeated measures were obtained using SD-OCT, Scheimpflug-Placido topographer and USP and five measurements were determined with the OLCR. Bland-Altman plots were used to assess agreement among the instruments, and 95% limits of agreement (LoA) for each comparison were calculated. Intra-examiner repeatability was assessed using intraclass correlation coefficients (ICCs).<b>RESULTS:</b> The mean CCT by SD-OCT, Scheimpflug-Placido topographer, OLCR, and USP were 525.90±34.08 μm, 525.92±34.10 μm, 530.30±35.62 μm, and 543.50±37.11 μm respectively. All 4 modalities of CCT measurements correlated closely with each other, with Pearson correlation coefficients ranging from 0.977 to 0.995. The mean differences (and upper/lower LoA) for CCT measurements were -0.05±6.77 μm (13.3/-13.3) between SD-OCT and Scheimpflug-Placido topographer, 4.38±3.79 μm (11.8/-3.1) between OLCR and SD-OCT, 4.38±6.03 μm (16.2/-7.5) between OLCR and Scheimpflug-Placido topographer, 13.20±6.46 μm (25.9/0.5) between USP and OLCR, 17.59±6.76 μm (30.8/4.3) between USP and SD-OCT<b>,</b> and 17.58±8.13 μm (33.5/1.6) between USP and Scheimpflug-Placido topographer. Intra-examiner repeatability was excellent for all devices with ICCs&gt;0.98.<b>CONCLUSION:</b> For most practical purposes, CCT measurements with the RTVue, Sirius and Lenstar can be used interchangeably. Although highly correlated, CCT measurement differences between USP and these 3 optical instruments can be significant depending on the clinical situation.]]></description>
<pubDate>2014/4/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hasan Ali Bayhan,Seray Aslan Bayhan and İzzet Can]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hasan Ali Bayhan,Seray Aslan Bayhan and İzzet Can</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140219]]></guid><cfi:id>1172</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[White-to-white corneal diameter:normal values in healthy Iranian population obtained with the Orbscan II]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140220]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM</b>:To determine the normative values of white-to-white corneal diameter with Orbscan II Topography System and to compare right and left eyes data in the normal young population.<b>Methods</b>:A total of 1001 healthy participants aged 18-45y participated in this observational cross-sectional study. The study population consisted of 616 female and 385 male subjects. The corneal diameter was measured with the Orbscan II. The differences between genders, between right and left eyes and age-related changes were evaluated. Statistical analyses were performed using Student’s <i>t</i>-test.<b>RESULTS</b>:The average white-to-white distance in our study population was recorded as 11.65±0.36 mm (median:11.60 mm, mode:11.70 mm, minimum:10.50 mm and maximum:13.60 mm). The white-to-white distance was 11.60±0.35 mm in males and 11.71±0.36 mm in females which was statistically different between genders (<i>P</i>&lt;0.01). However, white-to-white distance was not statistically different between right and left eyes. In addition, this parameter decreased with increasing age. Considering 95% confidence interval, corneal diameter less than 10.93 mm and greater than 12.34 mm would be considered as microcornea and megalocornea, respectively based on this study population, using the Orbscan II topography.<b>CONCLUSION</b>:Detailed description and analysis of corneal diameter with Orbscan demonstrate that the obtained average value of horizontal white-to-white is higher in male than female and decreases slightly with increasing age. Our data also suggests the cut off values for definition of microcornea and megalocornea, which can be employed with this population.]]></description>
<pubDate>2014/4/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hamid Gharaee,Mojtaba Abrishami,Masoud Shafiee and Asieh Ehsaei]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hamid Gharaee,Mojtaba Abrishami,Masoud Shafiee and Asieh Ehsaei</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140220]]></guid><cfi:id>1171</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Scheimpflug imaged corneal changes on anterior and posterior surfaces after collagen cross-linking]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140221]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To compare the anterior and posterior corneal parameters before and after collagen cross-linking therapy for keratoconus.<b>METHODS:</b> Collagen cross-linking was performed in 31 eyes of 31 keratoconus patients (mean age 30.6±8.9y). Prior to treatment and an average 7mo after therapy, Scheimpflug analysis was performed using Pentacam HR. In addition to corneal thickness assessments, corneal radius, elevation, and aberrometric measurements were performed both on anterior and posterior corneal surfaces. Data obtained before and after surgery were statistically analyzed.<b>RESULTS:</b> In terms of horizontal and vertical corneal radius, and central corneal thickness no deviations were observed an average 7mo after operation. Corneal higher order aberration showed no difference neither on anterior nor on posterior corneal surfaces. During follow-up period, no significant deviation was detected regarding elevation values obtained by measurement in mm units between the 3.0-8.0 mm-zones.<b>CONCLUSION:</b> Corneal stabilization could be observed in terms of anterior and posterior corneal surfaces, elevation and higher order aberration values 7mo after collagen cross-linking therapy for keratoconus.]]></description>
<pubDate>2014/4/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ziad Hassan,Laszlo Modis,Eszter Szalai,Andras Berta and Gabor Nemeth]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ziad Hassan,Laszlo Modis,Eszter Szalai,Andras Berta and Gabor Nemeth</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140221]]></guid><cfi:id>1170</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Corneal properties in children with congenital isolated growth hormone deficiency]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140222]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To compare the corneal parameters of children with congenital isolated growth hormone deficiency and healthy subjects.<b>METHODS:</b> In this cross-sectional, prospective study, 50 cases with growth hormone (GH) deficiency treated with recombinant GH and 71 healthy children underwent a complete ophthalmic examination. The corneal hysteresis (CH), corneal resistance factor (CRF), Goldmann-correlated intraocular pressure (IOPg) and corneal-compensated intraocular pressure (IOPcc) were measured with the Ocular Response Analyzer (ORA). Central corneal thickness (CCT) was measured by a ultrasonic pachymeter.<b>RESULTS:</b> The mean age was 13.0±3.0 years in the GH deficiency group consisting of 21 females and 29 males and 13.4±2.4 years in the healthy children group consisting of 41 females and 30 males. There was no statistically significant difference between the groups for gender or age (Chi-square test, <i>P</i>=0.09; independent <i>t</i>-test, <i>P</i>=0.28, respectively). The mean duration of recombinant GH therapy was 3.8±2.4y in the study group. The mean CH, CRF, IOPg and IOPcc values were 11.0±2.0, 10.9±1.9, 15.1±3.3, and 15.1±3.2 mm Hg respectively in the study group. The same values were 10.7±1.7, 10.5±1.7, 15.2±3.3, and 15.3±3.4 mm Hg respectively in the control group. The mean CCT values were 555.7±40.6, 545.1±32.5 μm in the study and control groups respectively. There was no statistically significant difference between the two groups for CH, CRF, IOPg, IOPcc measurements or CCT values (independent <i>t</i>-test, <i>P</i>=0.315, 0.286, 0.145, 0.747, 0.13 respectively).<b>CONCLUSION:</b> Our study suggests that GH deficiency does not have an effect on the corneal parameters and CCT values. This observation could be because of the duration between the beginning of disease and the diagnosis and beginning of GH therapy.]]></description>
<pubDate>2014/4/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Pinar Nalcacioglu-Yuksekkaya,Emine Sen,Ufuk Elgin,Mumin Hocaoglu,Faruk Ozturk,Sebahat Agladıoglu Yilmaz,Havva Nur Kendirci,Semra Çetinkaya and Zehra Aycan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Pinar Nalcacioglu-Yuksekkaya,Emine Sen,Ufuk Elgin,Mumin Hocaoglu,Faruk Ozturk,Sebahat Agladıoglu Yilmaz,Havva Nur Kendirci,Semra Çetinkaya and Zehra Aycan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140222]]></guid><cfi:id>1169</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Conjunctival impression cytology in non-proliferative and proliferative diabetic retinopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140223]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To examine the integrity of the ocular surfaces of subjects with and without diabetes with no conjunctival and dry eye signs and symptoms and compare conjunctival impression cytology findings in diabetics with non-proliferative and proliferative diabetic retinopathy.<b>METHODS:</b> Conjunctival impression cytology was performed on 43 eyes of 43 subjects with non-proliferative diabetic retinopathy (NPDR), 42 eyes of 42 subjects with proliferative diabetic retinopathy (PDR), and 30 eyes of 30 control subjects. Impression cytology specimens of each group were graded and scored in the range 0-3 according to Nelson’s method.<b>RESULTS:</b> There were 45 (52.9%) women and 40 (47.1%) men. The mean age of the patients was 59.6±9.3y (range, 43-76y) in NPDR group and 58.0±8.8y (range, 41-85y) in PDR group. Cases with NPDR and PDR showed statistically significant higher impression cytology scores than control group (<i>P</i>&lt;0.05). There was no difference between the NPDR and PDR patients for impression cytology grading scores.<b>CONCLUSION:</b> It is determined that impression cytology grades are altered in patients with NPDR and PDR. Consequently, we suggest that there might be an association between the impression cytology grading scores and the severity of diabetic retinopathy]]></description>
<pubDate>2014/4/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mehmet Citirik,Nilufer Berker,Hulya Haksever,Ufuk Elgin and Huseyin Ustun]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mehmet Citirik,Nilufer Berker,Hulya Haksever,Ufuk Elgin and Huseyin Ustun</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140223]]></guid><cfi:id>1168</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Correlation of pattern reversal visual evoked potential parameters with the pattern standard deviation in primary open angle glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140224]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To evaluate whether glaucomatous visual field defect particularly the pattern standard deviation (PSD) of Humphrey visual field could be associated with visual evoked potential (VEP) parameters of patients having primary open angle glaucoma (POAG).<b>METHODS:</b>Visual field by Humphrey perimetry and simultaneous recordings of pattern reversal visual evoked potential (PRVEP) were assessed in 100 patients with POAG. The stimulus configuration for VEP recordings consisted of the transient pattern reversal method in which a black and white checker board pattern was generated (full field) and displayed on VEP monitor (colour 14”) by an electronic pattern regenerator inbuilt in an evoked potential recorder (RMS EMG EP MARK II).<b>RESULTS:</b>The results of our study indicate that there is a highly significant (<i>P</i>&lt;0.001) negative correlation of P100 amplitude and a statistically significant (<i>P</i>&lt;0.05) positive correlation of N70 latency, P100 latency and N155 latency with the PSD of Humphrey visual field in the subjects of POAG in various age groups as evaluated by Student’s <i>t</i>-test.<b>CONCLUSION:</b>Prolongation of VEP latencies were mirrored by a corresponding increase of PSD values. Conversely, as PSD increases the magnitude of VEP excursions were found to be diminished.]]></description>
<pubDate>2014/4/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ruchi Kothari,Pradeep Bokariya,Ramji Singh,Smita Singh and Purvasha Narang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ruchi Kothari,Pradeep Bokariya,Ramji Singh,Smita Singh and Purvasha Narang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140224]]></guid><cfi:id>1167</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A 4-year retrospective study of add-on therapy to the fixed combination of dorzolamide/timolol for the treatment of POAG]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140225]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To evaluate the long-term response to the fixed combination of dorzolamide/timolol in patients with primary open angle glaucoma (POAG) and the addition of other intraocular pressure (IOP) lowering medications such as prostaglandin analogs and brimonidine.<b>METHODS:</b> A retrospective, non-randomized, and descriptive clinical study was performed with 182 eyes diagnosed with POAG. Patients were divided into three groups:a group with fixed combination of dorzolamide/timolol only, a second group with prostaglandin analogs plus fixed combination of dorzolamide/timolol, and a third group with the addition of brimonidine to the same fixed combination. IOP data were gathered retrospectively and the differences between groups were calculated.<b>RESULTS:</b> IOP was reduced satisfactorily in all three groups; however, a progressive IOP reduction was noted in the group with the fixed combination plus prostaglandin analogs. In this group, a progressive, significant and more homogeneous response of the reduction was noted in comparison with the other groups.<b>CONCLUSION:</b> IOP reduction was efficacious in all three groups. The addition of prostaglandin analogs showed progressive IOP reduction, progressive response and absence of long-term drift. Brimonidine did not show a significant additive effect.]]></description>
<pubDate>2014/4/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Curt Hartleben-Matkin,Diddier Prada and Rafael Mancilla-Vences]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Curt Hartleben-Matkin,Diddier Prada and Rafael Mancilla-Vences</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140225]]></guid><cfi:id>1166</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Combined therapy with bevacizumab and photodynamic therapy for myopic choroidal neovascularization:A one-year follow-up controlled study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140226]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To evaluate the efficacy and safety of a combined treatment for myopic choroidal neovascularization (CNV) using photodynamic therapy (PDT) and intravitreal bevacizumab and to compare it with intravitreal bevacizumab monotherapy.<b>METHODS:</b> Thirty-four eyes with angiographic evidence of myopic CNV were randomly divided into two groups:17 were treated with one intravitreal bevacizumab injection (1.25 mg) and low-fluence-rate PDT within seven days of the injection (Group A). The other 17 received monotherapy with bevacizumab injections (Group B). Clinical evidence of complications, best corrected visual acuity (BCVA) and fluorescein leakage were evaluated. BCVA and optical coherence tomography (OCT) were evaluated monthly. The timepoints follow-up was established at 6 and 12mo. All patients were retreated following a PRN protocol.<b>RESULTS:</b>A total of 34 eyes of 34 patients (26 women and 8 men) with a mean age of 62.35 years were included. In Group A (17 eyes) the mean BCVA increased from 0.55±0.13 logMAR before the treatment to 0.40±0.09 logMAR at the 12mo follow-up (<i>P&lt;</i>0.01). In Group B (17 eyes) the mean BCVA increased from 0.60±0.11 logMAR before the treatment to 0.55±0.12 logMAR at the 12mo follow-up (<i>P&lt;</i>0.01). There was no statistically significant difference between the two groups in terms of LogMar visual acuity. In Group A the mean number of combined treatments was 1.8±0.11 per patient; in Group B the mean number of intravitreal bevacizumab injections was 3.1±0.08 per patient. The number of treatments was significantly fewer in Group A (<i>P&lt;</i>0.01). No local or systemic side effects occurred among any of the patients treated in this study.<b>CONCLUSION:</b>The combination of anti-angiogenic injections and PDT appears to be a safe and effective option for myopic CNV treatment and allows for a significant reduction of intravitreal injections.]]></description>
<pubDate>2014/4/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Sandro Saviano,Rita Piermarocchi,Pia E. Leon,Alessandro Mangogna,Andrea Zanei,Fabiano Cavarzeran Sc and Daniele Tognetto]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Sandro Saviano,Rita Piermarocchi,Pia E. Leon,Alessandro Mangogna,Andrea Zanei,Fabiano Cavarzeran Sc and Daniele Tognetto</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140226]]></guid><cfi:id>1165</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical and impression cytology findings of amniotic membrane and oral mucosal membrane transplantation for the management of socket contracture]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140227]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To investigate and compare the cytopathological and clinical effects of amniotic membrane transplantation (AMT) and oral mucosal membrane transplantation (OMMT) in socket contraction.
    
    <b>METHODS:</b>Twelve patients who could not be fitted with ocular prosthesis due to socket contracture were included in this study. Seven patients underwent AMT and 5 patients underwent OMMT. Thirteen patients who had healthy sockets were included as control group. Depth of inferior fornix, degree of inflammation, extent of the socket contracture and socket volume were measured in the preoperative period and at sixth and twelfth weeks postoperatively. Impression cytology of conjunctival fornices and tear transforming growth factor beta-1 (TGFβ1) levels were determined.
    
    <b>RESULTS:</b>In the AMT group,socket volume and lower fornix depth values were significantly higher (<i>P</i>=0.030 and <i>P</i>=0.004 respectively) and inflammation levels and impression cytology stages (<i>P</i>=0.037 and <i>P</i>=0.022 respectively) were significantly lower in postoperative period compared to preoperative period. In the OMMT group, no statistical differences were found in terms of clinical parameters, inflammation levels and impression cytology stages of preoperative versus postoperative values. Preoperative tear TGFβ1 levels were higher in AMT and OMMT groups compared to the control group (25.5 ng/mL, 26.3 ng/mL and 21.7 ng/mL respectively). Decreased tear TGFβ1 levels were observed in both the AMT and OMMT groups postoperatively (median decrease value=2.1 ng/mL and 2.7 ng/mL respectively).
    
    <b>CONCLUSION:</b> AMT is associated with postoperative improvement in inferior fornix depth, socket volume, inflammation and impression cytology levels and may be a more proper alternative method than OMMT in the management of socket contracture.]]></description>
<pubDate>2014/4/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Bengi Ece Kurtul,Ugur Erdener,Mehmet Cem Mocan,Murat Irkec and Mehmet Orhan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Bengi Ece Kurtul,Ugur Erdener,Mehmet Cem Mocan,Murat Irkec and Mehmet Orhan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140227]]></guid><cfi:id>1164</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A new technique for Nd:YAG laser posterior capsulotomy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140228]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To investigate the effects of a new opening pattern in neodymium:yttrium-aluminum-garnet (Nd:YAG) laser posterior capsulotomy on visual function.<b>METHODS:</b> This technique was conducted along a circular pattern. The energy ranged between 0.8 and 1.2 mJ/pulse was consumed and mean total energy levels were 74±21 mJ (mean±standard deviation:SD, from 40 to 167) and laser shots aimed at 150 μm away behind a datum point and went along an imaginary line which extends 0.5 mm inside from optic margin and into the circular en bloc pattern. Vitreous stands were attached with fragment and then they were cut off by the laser after circular application. The circular fragment was completely separated from vitreous, and then this fragment was quickly sunk in intravitreal space.<b>RESULTS:</b> The follow-up period ranges from at least a week to 40mo, making 15.8mo on average. The procedural outcome showed 96% (74 eyes out of the 77 eyes) enhancement in patients’ visual acuity. Cystoid macular edema or retinal detachment was not observed in any of the patients during follow-up periods.<b>CONCLUSION:</b> This new technique is expected to improve the weaknesses that the conventional procedures have by adding the process to cut off vitreous stands attached with the fragment by the laser to the circular application.]]></description>
<pubDate>2014/4/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jung Kee Min,Jae Hwan An and Jin Ho Yim]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jung Kee Min,Jae Hwan An and Jin Ho Yim</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140228]]></guid><cfi:id>1163</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of autofluorescence and optical coherence tomography findings in acute and chronic central serous chorioretinopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140229]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To discuss and compare the fundus autofluorescence (FAF) and optical coherence tomography (OCT) in acute or chronic central serous chorioretinopathy (CSCR).<b>METHODS:</b> Medical records of 100 cases of CSCR were reviewed. Acute and chronic cases were evaluated according to the duration of decreased visual acuity, serous retinal detachment (RD) and focal leakage on fluorescein angiography (FA). Chi-square test was used for statistical analysis.<b>RESULTS:</b>Forty cases had acute and 60 cases had chronic CSCR. FAF showed focal hypo-autofluorescence in 34 (85%) and iso-autofluorescence in 6 (15%) of acute cases and hypo-autofluorescence in 51 (85%), hyper-autofluorescence in 6 (10%) and iso-autofluorescence in 3 (5%) of chronic cases. OCT showed serous RD with distinct borders correlated with FAF findings (hypo-autofluorescence) in all acute CSCR cases. In chronic CSCR group, OCT showed serous RD with indistinct borders correlated with FAF findings. The differences between the OCT and FAF findings of the two groups were significant (<i>P</i>=0.000).<b>CONCLUSION:</b> OCT and FAF findings can support the clinical observations in differential diagnosis of acute and chronic CSCR and help clinicians to evaluate retinal pigment epithelium, outer segments of photoreceptors and the components of serous RD.]]></description>
<pubDate>2014/4/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mehmet Yasin Teke,Ufuk Elgin,Pinar Nalcacioglu-Yuksekkaya,Emine Sen,Pinar Ozdal and Faruk Ozturk]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mehmet Yasin Teke,Ufuk Elgin,Pinar Nalcacioglu-Yuksekkaya,Emine Sen,Pinar Ozdal and Faruk Ozturk</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140229]]></guid><cfi:id>1162</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Fibrin glue</b>-<b>assisted for the treatment of corneal perforationsusing glycerin-cryopreserved corneal tissue]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140111]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To evaluate the outcomes and safety of lamellar keratoplasty (LK) assisted by fibrin glue in corneal perforations.<b>METHODS:</b> Six eyes of 6 patients affected by different corneal pathologies (2 posttraumatic corneal scar and 3 bacterial keratitis) underwent LK procedures by using fibrin glue. The mean corneal perforation diameter was 1.35±0.64mm (range, 0.7-2.5mm), and the greatest diameter of the ulcerative stromal defect was 2.47±0.77mm in average (range, 1.5-3.5mm). The donor corneal lamella diameters were 0.20-mm larger and thicker than the recipient to restore a physiologic corneal thickness and shape:mean donor diameter was 8.34±0.28mm (range, 8.2-8.7mm) and mean thickness was 352±40.27mm (range, 220-400mm). Mean follow-up was 7.33±1.97 months (range, 6-11 months). Postoperatively, the graft status, graft clarity, anterior chamber response, the visual prognosis, intraocular pressures, and postoperative complications were recorded.<b>RESULTS:</b> All the corneal perforations were successfully healed after the procedure. The best-corrected visual acuity (BCVA) ranged from 20/1 000 to 20/50 in their initial presentation, and from 20/100 to 20/20 in their last visit, showed increase in all the patients. No major complications such as graft dislocation and graft failure were noted. Neovascularization developed in the superficial stroma of donor graft in 1 case. High intraocular pressure developed on day 2 after surgery, while was remained in normal range after application of anti-glaucomatous eyedrops for 1 week in 1 case.<b>CONCLUSION:</b> Fibrin glue-assisted sutureless LK is valuable for maintaining the ocular integrity in the treatment of corneal perforations.]]></description>
<pubDate>2014/2/20 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Nuo Dong,Cheng Li,Wen-Sheng Chen,Wen-Juan Qin,Yu-Hua Xue and Hu-Ping Wu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Nuo Dong,Cheng Li,Wen-Sheng Chen,Wen-Juan Qin,Yu-Hua Xue and Hu-Ping Wu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140111]]></guid><cfi:id>1161</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of outcomes between overlapping-spot and single-spot photodynamic therapy for circumscribed choroidal hemangioma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140112]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To compare the efficacy and safety of photodynamic therapy (PDT) with overlapping multiple spots and single spot for treating circumscribed choroidal hemangioma.<b>METHODS:</b>Twenty-two patients (22 eyes) with symptomatic circumscribed choroidal hemangioma received PDT treatment. Fourteen patients received overlapping spots (two to three spots) PDT, whereas eight patients received single-spot PDT. Laser was used at 50J/cm<sup>2</sup> for 83s in the overlapping-spot group and 50J/cm<sup>2</sup> for 166s in the single-spot group. Clinical examination, funduscopy, fluorescein angiography, and ultrasonography were performed at baseline and after treatment.<b>RESULTS:</b>The mean follow-up time was 28.5±8.0 months in the overlapping-spot group and 27.0±5.0 months in the single-spot group. Nine patients (64.2%) had their vision improved over two lines on the Snellen chart, and five patients showed stable visual acuity in the overlapping-spot group. The mean thickness of tumor decreased from 2.7±0.8mm to 1.2±0.9mm, and the mean greatest tumor linear dimension decreased from 7.4±1.5mm to 4.5±3.5mm after treatment. In the single-spot group, two patients (25%) had their vision improved over two lines on the Snellen chart, and six patients had unchanged stable vision. The mean tumor thickness in this group decreased from 2.5±0.7mm to 1.4±1.0mm, and the mean greatest tumor linear dimension decreased from 7.2±1.3mm to 4.7±3.6mm. No significant differences in visual improvement and tumor regression were found between the two groups.<b>CONCLUSION:</b> Overlapping-spot PDT under appropriate treatment parameters and strategies is as effective and safe as single-spot PDT for treating symptomatic circumscribed choroidal hemangioma. Improved or stabilized visual acuity was achieved as a result of tumor regression.]]></description>
<pubDate>2014/2/20 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Zhao-An Su,Xia-Jing Tang,Li-Xia Zhang and Xiao-Hong Su]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zhao-An Su,Xia-Jing Tang,Li-Xia Zhang and Xiao-Hong Su</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140112]]></guid><cfi:id>1160</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Evaluation of regional bulbar redness using an image-based objective method]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140113]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To develop an image-based objective method to precisely evaluate regional ocular bulbar injection.<b>METHODS:</b>Six healthy adult volunteers were photographed in four orientations (superior, inferior, nasal and temporal sides) with and without stimulating eye drops. Six line segments (covering 30°) were drawn 4mm away from the limbus on each image using ImageJ software. The graph peaks, which were derived from the areas under the line segments and corresponded to the cross-sectional grey-level of the vessels, were analyzed to obtain peak area, peak height/width (PH/PW), and peak numbers. Different-sized areas were selected to calculate the pixels based on the edge-detection algorithm. Also, conjunctival and superficial scleral vessels were analyzed separately. <b>RESULTS:</b>This method had a smaller coefficient of variation, especially for PH/PW, in all four orientations. Hyperaemia parameters changed the least after challenging in the superior region. Moreover, 95% of the PH/PW ratios were greater than 0.87 in conjunctival vessels and less than 1.00 in superficial scleral vessels. PH/PW significantly increased in conjunctival vessels and changed less in superficial scleral vessels.<b>CONCLUSION:</b>A new method of objectively assessing bulbar injection based on ocular surface images was developed. This method can be used to quantify ocular regional injection and to distinguish the superficial scleral and conjunctival vessels.]]></description>
<pubDate>2014/2/20 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Wen-Juan Zhao,Fang Duan,Zhong-Ting Li,Hua-Jun Yang,Qiang Huang and Kai-Li Wu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Wen-Juan Zhao,Fang Duan,Zhong-Ting Li,Hua-Jun Yang,Qiang Huang and Kai-Li Wu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140113]]></guid><cfi:id>1159</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[An enhanced functional ability questionnaire (faVIQ) to measure the impact of rehabilitation services on the visually impaired]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140114]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To develop a short, enhanced functional ability Quality of Vision (faVIQ) instrument based on previous questionnaires employing comprehensive modern statistical techniques to ensure the use of an appropriate response scale, items and scoring of the visual related difficulties experienced by patients with visual impairment.<b>METHODS:</b>Items in current quality-of-life questionnaires for the visually impaired were refined by a multi-professional group and visually impaired focus groups. The resulting 76 items were completed by 293 visually impaired patients with stable vision on two occasions separated by a month. The faVIQ scores of 75 patients with no ocular pathology were compared to 75 age and gender matched patients with visual impairment.<b>RESULTS:</b>Rasch analysis reduced the faVIQ items to 27. Correlation to standard visual metrics was moderate (<i>r</i>=0.32-0.46) and to the NEI-VFQ was 0.48. The faVIQ was able to clearly discriminate between age and gender matched populations with no ocular pathology and visual impairment with an index of 0.983 and 95% sensitivity and 95% specificity using a cut off of 29.<b>CONCLUSION:</b>The faVIQ allows sensitive assessment of quality-of-life in the visually impaired and should support studies which evaluate the effectiveness of low vision rehabilitation services.]]></description>
<pubDate>2014/2/20 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[James Stuart Wolffsohn,Jonathan Jackson,Olivia Anne Hunt,Charles Cottriall,Jennifer Lindsay,Richard Gilmour,Anne Sinclair and Robert Harper]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>James Stuart Wolffsohn,Jonathan Jackson,Olivia Anne Hunt,Charles Cottriall,Jennifer Lindsay,Richard Gilmour,Anne Sinclair and Robert Harper</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140114]]></guid><cfi:id>1158</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of intravitreal ranibizumab and bevacizumab for the treatment of macular edema secondary to retinal vein occlusion]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140115]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To compare the efficacy of ranibizumab and bevacizumab for macular edema due to retinal vein occlusion (RVO).<b>METHODS:</b>A retrospective study was conducted at a single academic institution. Eighty-one patients na?ve to anti-VEGF therapy with RVO and macular edema were identified. Twenty-six eyes were treated with ranibizumab, 33 eyes with bevacizumab, and 22 eyes with bevacizumab then switched to ranibizumab (crossover)<i>. </i>The main outcome was change in visual acuity at 3 months, 6 months, and final visit.<b>RESULTS:</b>The mean visual acuity improved from 20/80 to 20/40 in the ranibizumab (R) group and from 20/125 to 20/60 in the bevacizumab (B) group (<i>P=</i>0.66). The mean change in central subfield thickness (CST) was -186 and -212μm, respectively (<i>P=</i>0.69). Mean time between injections was 94±21.1d in the R group and 103.8±10.5d in the B group (<i>P=</i>0.78). In the crossover group, mean initial visual acuity was 20/125, reached 20/60 at crossover, and remained 20/60 at conclusion (<i>P=</i>0.91).<b>CONCLUSION:</b>Both ranibizumab and bevacizumab are effective for the treatment of RVO and appear to have similar visual and anatomic outcomes<i>. </i>Changing treatments from bevacizumab to ranibizumab did not result in further gains in visual acuity<i>. </i>]]></description>
<pubDate>2014/2/20 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Alex Yuan,Baseer U. Ahmad,David Xu,Rishi P. Singh,Peter K. Kaiser,Daniel F. Martin,Jonathan E. Sears,Andrew P. Schachat and Justis P. Ehlers]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Alex Yuan,Baseer U. Ahmad,David Xu,Rishi P. Singh,Peter K. Kaiser,Daniel F. Martin,Jonathan E. Sears,Andrew P. Schachat and Justis P. Ehlers</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140115]]></guid><cfi:id>1157</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Tono-pen measurement of intraocular pressure under topical anaesthesia in full term normal newborns ]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140116]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> Tono-pen measurement of intraocular pressure (IOP) under topical anaesthesia in full term normal newborns.<b>METHODS:</b> The IOP measurements were taken using Tono-pen XL tonometer under topical anaesthesia in 150 newborns (300 eyes) within 24h after birth, over a period of three months, in a university hospital. Gender, gestation period, mode of delivery and birth weight of newborns were noted from medical records.<b>RESULTS:</b>There were 70 males and 80 females. All babies were Malays. The IOP measurements were taken between 12 and 24h after birth. The gestation period of babies ranged between 37 and 41 weeks; 118 babies were delivered by spontaneous vaginal delivery and 32 by caesarian section.  The birth weight of babies ranged between 2.1 and 4.3kg. The mean IOP of 300 eyes was 15.99±2.79mmHg (range 8-22). There was no statistically significant difference of mean IOP and gender, laterality of eye, type of delivery, gestation age, or birth weight of newborns.<b>CONCLUSION:</b> The IOP in full term normal newborns was 16mmHg. Tono-Pen appears to be ideal instrument for taking IOP in newborns because of its small size and easy handling.]]></description>
<pubDate>2014/2/20 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Sagili Chandrasekhara Reddy and Rosnita Alias]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Sagili Chandrasekhara Reddy and Rosnita Alias</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140116]]></guid><cfi:id>1156</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A new measure of nystagmus acuity]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140117]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To construct a new visual acuity measuring function for congenital nystagmus (CN) patients by studying the relationships between acuity, velocities and positions of the eye.<b>METHODS:</b> After assessing the relationship between acuity, movement velocities and positions of the eye separately, a new function, which we call the automated nystagmus acuity function (ANAF), was constructed to measure the visual acuity of CN patients. Using a high-speed digital video system working at 500 frames per second, each eye was calibrated during monocular fixation. Twenty-six recorded nystagmus data were selected randomly. Using nystagmus waveforms, the best vision position (foveation period) and visual acuity were analyzed in three groups of subjects, and then all outputs were compared with the well-known expanded nystagmus acuity function (NAFX) and ANAF. Standard descriptive statistics were used to summarize the outputs of the two programs.<b>RESULTS:</b>Foveation periods were brief intervals in the CN waveform when the image was on or near the fovea and eye velocity was relatively slow. Results showed good visual acuity happened during the period when velocity was low and the eye position was near the zero position, which fitted the foveation periods. The data analyzed with NAFX and ANAF had a correlation coefficient of 0.934276, with an average error of -0.00973.<b>CONCLUSION:</b> The results from ANAF and NAFX analyses showed no significant difference. The NAFX manually identifies foveation eye positions and produces accurate measurements. The ANAF, however, can be calculated simply using the factors eye position and velocity, and it automatically calculates the ANAF without the need to manually identify foveation eye positions.]]></description>
<pubDate>2014/2/20 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jun-Ping Yao,Zheng Tai and Zheng-Qin Yin]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jun-Ping Yao,Zheng Tai and Zheng-Qin Yin</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140117]]></guid><cfi:id>1155</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Contrast visual acuity after multifocal intraocular lens implantation:aspheric versus spherical design]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140118]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To evaluate contrast visual acuity (CVA) after implantation of an aspheric apodized diffractive intraocular lens (IOL) or a spherical apodized diffractive IOL in cataract surgery.
<b>METHOD:</b> This prospective randomized controlled study with a 12-month follow-up compared the results of cataract surgery with implantation of an aspheric AcrySof ReSTOR SN6AD3 IOL (30 eyes) and a spherical AcrySof ReSTOR SN60D3 IOL (30 eyes). CVA with best distance correction was measured at 4 contrast levels (100%, 25%, 10% and 5%) under 3 levels of chart luminance <b>[250, 85 and 25 candelas per square meter (cd/m</b><sup><b>2</b></sup><b>)] using a multi-functional visual acuity tester (MFVA-100)．
<b>RESULTS:</b>At 12 months after surgery, there were no statistically significant differences in 100% CVA and 25% CVA under 250cd/m</b><sup><b>2</b></sup><b> (</b><i><b>P</b></i><b>100%=0.875 and </b><i><b>P</b></i><b>25%=0.057) and 85cd/m</b><sup><b>2</b></sup><b> (</b><i><b>P</b></i><b>100%=0.198 and </b><i><b>P</b></i><b>25%=0.193) between the aspheric group and the spherical group. However, the 10% CVA and 5% CVA were significant better in aspheric group than spherical group under 250cd/m</b><sup><b>2</b></sup><b> (</b><i><b>P</b></i><b>10%=0.042 and </b><i><b>P</b></i><b>5%=0.007) and 85cd/m</b><sup><b>2</b></sup><b> (</b><i><b>P</b></i><b>10%=0.002 and </b><i><b>P</b></i><b>5%=0.039). Under the luminance level of 25cd/m</b><sup><b>2</b></sup><b>, no significant differences was found in the 100% CVA between the 2 group (</b><i><b>P</b></i><b>100%=0.245), while aspheric group had better visual acuity in the remaining 3 contracts (</b><i><b>P</b></i><b>25%=0.023, </b><i><b>P</b></i><b>10%=0.026 and </b><i><b>P</b></i><b>5%=0.002, respectively).
<b>CONCULSION:</b>The aspheric AcrySof ReSTOR SN6AD3 IOL provided patients with better low-contrast visual acuity than the spherical AcrySof ReSTOR SN60D3 IOL.]]></description>
<pubDate>2014/2/20 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jun-Hua Li,Yi-Fan Feng,Yun-E Zhao,Yin-Ying Zhao and Lei Lin]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jun-Hua Li,Yi-Fan Feng,Yun-E Zhao,Yin-Ying Zhao and Lei Lin</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140118]]></guid><cfi:id>1154</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Trabeculectomy with large area mitomycin-C application as a first-line treatment in advanced glaucoma:retrospective review]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140119]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To evaluate the outcomes of trabeculectomy with large area mitomycin-C (MMC) application as a first line treatment in advanced glaucoma.<b>METHODS:</b>The records of 55 patients with severe visual field defects undergoing trabeculectomy were retrospectively reviewed. The patients were classified as first-line therapy to either early trabeculectomy (initial trabeculectomy-Group 1) or long term medical therapy followed by trabeculectomy (primary trabeculectomy-Group 2). Trabeculectomy was performed with large-area MMC application. Intraocular pressure (IOP) values, visual acuities, mean deviations, morphology and function of the blebs, necessity for anti-glaucomatous medications and surgical complications were reported.<b>RESULTS:</b>There were 20 eyes of 18 patients in Group 1 and 37 eyes of 37 patients in Group 2<b>.</b> The mean preoperative IOPs in Groups 1 and 2 were 40.2±10.0mmHg (27-68mmHg) and 29.0±4.4mmHg (21-41mmHg), respectively (<i>P</i>=0.001). Average preoperative mean deviations (MD) in Groups 1 and 2 were 17.4±2.8dB (13.3-23dB) and 17.9±2.4 dB (13.7-23.2dB), respectively (<i>P</i>=0.441). Postoperative IOPs significantly decreased and were comparable in both Groups. The mean number of medications was significantly higher in Group 2 (<i>P</i>=0.005)<i><b>.</b></i> No cystic bleb formation was observed in Group 1, whereas 4 patients from Group 2 (10.8 %) developed cystic bleb (<i>P</i>=0.040). No visually devastating complication has occurred in both Groups.<b>CONCLUSION:</b>Initial trabeculectomy with large area MMC application might be applied in patients with advanced glaucoma with low complication rates. Long-term topically applied anti-glaucomatous medications seem to increase the risk of cystic bleb formation.]]></description>
<pubDate>2014/2/20 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Zeynep Aktas,Safak Korkmaz,Murat Hasanreisoglu,Merih Onol and Berati Hasanreisoglu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zeynep Aktas,Safak Korkmaz,Murat Hasanreisoglu,Merih Onol and Berati Hasanreisoglu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140119]]></guid><cfi:id>1153</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Peribulbar anesthesia in 750 patients treated with oral anticoagulants]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140120]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To check the safety of continuation of oral anticoagulants in ophthalmic procedures requiring a peribulbar anesthesia.
<b>METHOD:</b>A prospective case control study included 750 patients with oral anticoagulants in group A and 750 patients who had never been treated with oral anticoagulant in group B. Hemorrhages were graded as follows:1) spot ecchymosis of eyelid and or subconjunctival hemorrhage; 2) eyelid ecchymosis involving half of the lid surface area; 3) eyelid ecchymosis all around the eye, no increase in intraocular pressure; 4) retrobulbar hemorrhage with increased intraocular pressure.<b>RESULTS:</b> In group A, grade 1 was observed in 13 patients (1.74%) and grade 2 in 2 patients (0.26%). In group B, grade 1 was observed in 12 patients (1.6%) and grade 2 was absent. No 3 or 4 hemorrhage grade was encountered in both groups. There was not significant difference in grade 1 hemorrhage between both groups (<i>P</i>=0.21).<b>CONCLUSION:</b>Oral anticoagulants were not associated with a significant increase in potentially sight-threatening local anesthetic complications.]]></description>
<pubDate>2014/2/20 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Emile Calenda,Olivier Genevois,Annie Cardon and Marc Muraine]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Emile Calenda,Olivier Genevois,Annie Cardon and Marc Muraine</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140120]]></guid><cfi:id>1152</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Spectrum of fungal keratitis:clinicopathologic study of 44 cases]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140121]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To determine the causative agents of fungal keratitis and study the predisposing factors over a period of ten years in a single tertiary care hospital.<b>METHODS:</b>A retrospective analysis of fungal corneal ulcers was done from 2003-2012. Patients’ clinical data were noted from the file records. Correlation of histopathological diagnosis was done with the report on fungal culture.<b>RESULTS:</b> Mycotic keratitis was established in 44 cases by a positive fungal culture. Direct microscopic examination of potassium hydroxide (KOH) mounts revealed fungal elements in 39 cases while 40 cases showed fungus on Gram stained smears. Males (54.55%) were more commonly affected than the females (45.45%). The age ranged from 18 to 82 years. Most common age group to be involved was 41-60 years. Predisposing risk factors were seen in 34 (77.27%) cases. Most common findings on clinical examination were anterior chamber reaction and conjunctival injection seen in all the cases. Other common findings were stromal infiltration and hypopyon seen in 20 (45.45%) and 18 (40.91%) cases respectively. On histopathological examination the fungus was typed, as aspergillus in 34 cases while no definite typing was possible in 10 cases. The predominant isolate was aspergillus flavus (59.09%) followed by fusarium (15.91%). Mixed fungal and bacterial infection was seen in 3 (6.82%) cases.<b>CONCLUSION:</b>Although culture is the gold standard for definitive diagnosis of fungal keratitis, direct microscopic examination of corneal scrapings or histomorphological evaluation of biopsies allow a rapid preliminary diagnosis. Early administration of antifungal treatment helps in preventing dreadful complications.]]></description>
<pubDate>2014/2/20 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Rajpal Singh Punia,Reetu Kundu,Jagdish Chander,Sudesh Kumar Arya,Uma Handa and Harsh Mohan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Rajpal Singh Punia,Reetu Kundu,Jagdish Chander,Sudesh Kumar Arya,Uma Handa and Harsh Mohan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140121]]></guid><cfi:id>1151</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Ocular findings in children with thalassemia major in Eastern Mediterranean]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140122]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To investigate ophthalmologic findings in children with thalassemia major (TM) and compare the findings with healthy controls.

<b>METHODS:</b> In a cross-sectional study, 43 children with thalassemia major from pediatric hematology outpatient clinics from two university hospitals and age/sex matched 47 healthy children were included in the study. After a complete ophthalmic examination, tear function tests including the Schirmer test, fluorescein tear break-up time (BUT), ultrasound pachymetry, and axial length measurement were performed. Obtained data was recorded for statistical analysis and the values of right eyes were compared between groups. 

<b>RESULTS:</b> The mean best corrected visual acuity was 1.34±0.75 in TM and 1.08±0.28 in controls. It was found lower than 0.1 logMAR unit in 10 (23.2%) children with TM and 2 (4.2%) in controls, and the difference was statistically significant (P＜0.05). The mean central corneal thickness was 540±26.95 in children with TM and 536.98±20.45μm in controls (P＞0.05). The mean axial length was 22.53±0.50 in TM and 22.57±0.43mm in the control group. The mean Schirmer test score was 19.94±6.91 in TM and 24.22±3.95mm in the control group (P＜0.01). The mean BUT score was 9.62±1.28 in TM and 9.73±0.6s in the control group (P＞0.05).

<b>CONCLUSION:</b> In TM, while corneal thickness, axial length, and BUT are close to controls, the Schirmer scores are less than normal. The study revealed that TM may be affected by the tear function and visual acuity.

]]></description>
<pubDate>2014/2/20 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Adnan Aksoy, Murat Aslankurt, Lokman Aslan, &#214;zlem Gül, Mesut Garipard&#305;&#231;, O&#287;uz &#199;elik, Seydi Okumu&#351;, Murat &#214;zdemir and G&#246;khan &#214;zdemir]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Adnan Aksoy, Murat Aslankurt, Lokman Aslan, &#214;zlem Gül, Mesut Garipard&#305;&#231;, O&#287;uz &#199;elik, Seydi Okumu&#351;, Murat &#214;zdemir and G&#246;khan &#214;zdemir</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140122]]></guid><cfi:id>1150</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Measurement of retinal thickness in macular region of high myopic eyes using spectral domain OCT]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140123]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b><i></i>To investigate the changes of retinal thickness in macula of high myopic eyes using spectral domain optical coherence tomography (OCT).<b>METHODS:</b> Middle-aged and young myopic patients were divided into three groups according to their refractive error/axial length:low and medium myopia group (LMMG), high myopia group (HMG) and super high myopia group (SHMG). Cirrus HD-OCT was used to evaluate total average macular thickness, central subfield thickness, inner/outer macular thickness and macular volume. The differences among experimental groups were analyzed by one-factor analysis of variance. Associations between macular thickness and refractive error/axial length were analyzed by Pearson correlation analysis.<b>RESULTS:</b> There was no significant difference in age among the three groups (<i>P</i>=0.2789). The mean refraction error in the LMMG, HMG, and SHMG groups was -2.49±1.38D, -8.53±1.95D and -13.88±1.76D, respectively (<i>P</i>＜0.001). The central subfield thickness of three groups was 244.56±12.19μm, 254.33±11.61μm and 261.75±11.83μm, respectively, and there were statistically significance between random two groups. The total average macular thickness, inner/outer macular thickness, and macular volume decreased with increased myopia/axial length. Average foveal thickness had negative correlations with refractive error (<i>P</i>＜0.001), and positive correlations with axial length. The inferior and temporal inner macular thickness, all the quadrants of outer ring, total average macular thickness and macular volume featured positive correlations with refractive error, and negative correlations with axial length. Average foveal thickness, superior and temporal inner macular thicknesses, and temporal outer macular thickness was lower in females compared to males.<b>CONCLUSION:</b><i></i>With an increase in myopia degree/axial length, the average foveal thickness increased and the inner/outer macular thickness decreased. Females featured thicker average foveal thickness, and thinner macular thickness compared to males.]]></description>
<pubDate>2014/2/20 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ai-Ping Song,Xin-Yi Wu,Jian-Rong Wang,Wei Liu,Yan Sun and Tao Yu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ai-Ping Song,Xin-Yi Wu,Jian-Rong Wang,Wei Liu,Yan Sun and Tao Yu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140123]]></guid><cfi:id>1149</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Study of long term structural and functional changes in medically controlled glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140124]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>Prospectively analyze the long term structural and functional changes in patients of primary open angle glaucoma (POAG) receiving medical therapy (beta blockers and non beta blockers). In this study an attempt has been made to evaluate whether medical reduction of IOP prevents or delays the progression of glaucomatous visual field loss and/or optic nerve damage in patients with open angle glaucoma.<b>METHODS:</b>Study conducted over a period of 27 months, at a tertiary eye care hospital including both eyes of 40 patients with POAG. Group 1 (20 patients, 40 eyes) received beta-blockers, and Group 2 (20 patients, 40 eyes) received non-beta-blockers. Each patient underwent intraocular pressure measurement, best corrected visual acuity, slit-lamp, fundus examination, gonioscopy, central corneal thickness, visual field assessment by Humphrey automated perimetry and  retinal nerve fibre layer thickness by Stratus optical coherence tomography at baseline and at two subsequent visits. The average time interval between each visit was 10-11 months. The statistical analysis was done using one-way analysis of variance (ANOVA). Post-hoc test, using tukey’ method were adopted. Probablity (<i>P</i>) value of 0.05 or less was considered to be statistically significant.<b>RESULTS:</b>A total of 80 eyes of 40 patients of POAG were enrolled, 24 males, 16 females, age group 50-80 years. In both beta and non beta blocker group, reduction (improvement) in mean IOP from initial levels to the levels achieved at the 2nd and 3rd visits was statistically significant. One way ANOVA (df=2), fisher <i>f</i> value=11.64, <i>P</i>=0.000, one way ANOVA (df=3), fisher <i>f</i> value=35.61, <i>P=</i>0.000. Both mean deviation (MD) and pattern standard deviation (PSD) in both beta and non beta blockers at different visits were not statistically significant. Retinal nerve fibre layer thickness (RNFL) -only mean inferior retinal nerve fibre layer, the difference between the mean value in beta and non beta blocker groupwere statistically significant. [unpaired <i>t</i> test value (df=78) =2.27, <i>P=</i>0.03]. Side effects with beta blocker were conjunctival hyperemia (10%), burning (5%), and conjunctival hyperemia (5%) in non beta blockers.<b>CONCLUSION:</b> Non-beta-blockers are as effective as beta-blockers in bringing about a significant lowering of intraocular pressure to the normal range, and in preventing progressive damage to the visual fields and retinal nerve fibre layer. The absence of systemic side effects and superior IOP lowering efficacy has made non beta-blockers attractive for first line therapy for the treatment of glaucoma worldwide.]]></description>
<pubDate>2014/2/20 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Achyut N Pandey and S Sujata]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Achyut N Pandey and S Sujata</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20140124]]></guid><cfi:id>1148</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of effectiveness of silicone hydrogel contact lens and hydrogel contact lens in patients after LASEK]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150609]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To conduct a comparative study of effectiveness of silicone hydrogel contact lens and hydrogel contact lens, which are used in patients after laser-assisted subepithelial keratomileusis (LASEK).
METHODS: Sixty-three patients (121 eyes) with a spherical equivalent ≤-5.0 D were chosen after undergoing LASEK in 2012 at Guangdong General Hospital. They were randomly divided into 2 groups. The silicone hydrogel group included 32 cases (61 eyes) that wore silicone hydrogel contact lenses for 4-6d after the operation, while the hydrogel group included 31 cases (60 eyes) who wore hydrogel contact lenses for 4-6d after the operation. Patients’ self-reported postoperative symptoms (including pain, photophobia, tears, and foreign body sensation) were evaluated. The healing time of the corneal epithelium, the visual acuity of patients without contact lens after epithelial healing, and the incidence of delayed corneal epithelial shedding were also assessed. The follow-up time was 1mo.
RESULTS: Postoperative symptoms were milder in the silicone hydrogel group than in the hydrogel group. There were significant differences in pain, foreign body sensation, and photophobia between the 2 groups (P<0.05), although there was no significant difference in postoperative tearing (P>0.05). The healing time of the corneal epithelium in the silicone hydrogel lens group was markedly shorter than that in the hydrogel group (4.07±0.25 vs 4.33±0.82d, t=2.43, P=0.02). Visual acuity without contact lenses after healing of the corneal epithelium was better in the silicone hydrogel group compared with the hydrogel group (χ2=7.76, P=0.02). There was no significant difference in the occurrence of delayed corneal epithelial shedding between the 2 groups (P>0.05).
CONCLUSION: Patients with LASEK using silicon hydrogel contact lenses had less discomfort and shorter corneal epithelial healing time compared with those using hydrogel contact lenses, suggesting that silicon hydrogel contact lenses may be considered to be a better choice of bandage contact lens after LASEK.]]></description>
<pubDate>2015/11/12 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Wen-Juan Xie,Jin Zeng,Ying Cui,Juan Li,Zhong-Ming Li,Wei-Xiong Liao and Xiao-Hong Yang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Wen-Juan Xie,Jin Zeng,Ying Cui,Juan Li,Zhong-Ming Li,Wei-Xiong Liao and Xiao-Hong Yang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150609]]></guid><cfi:id>1147</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Correlation of basic indicators with stages of keratoconus assessed by Pentacam tomography]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150610]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the diagnostic efficiency of basic indicators and find characteristic indicators for keratoconus (KC) at adjacent stages, and to assess the progression pattern of KC.
METHODS: One hundred and eight (41 subclinical, 40 moderate, and 27 severe) keratoconic patients (108 eyes) and 105 myopic patients (105 eyes) as controls were recruited in this prospective, comparative case series study. Pentacam topography was performed. Receiver-operating-characteristic curves were used to get the characteristic indicators.
RESULTS: The most efficient distinguishing index between the subclinical KC and the controls was posterior elevation value (PEV, AUC=0.882), with the highest specificity being 93.8%. Corneal thickness (AUC=0.852) and posterior inferior-superior value (I-S) ranked second and third (AUC=0.776). When KC became moderate, PEV remained to be of the highest diagnostic efficiency (AUC=0.988), followed by the anterior elevation value (AUC=0.986) and other parameters of anterior surface. The diagnostic value increased significantly in the anterior curvature indices (all AUC>0.900) and appeared in the anterior best fitting sphere radius (AUC=0.919) when KC developed into the severe stage.
CONCLUSION: In the subclinical stage of KC, PEV, thickness, and posterior I-S had important diagnostic values, and elevation values remained most efficient when KC developed to the moderate stage. The anterior curvature indices were most characteristic when KC became severe. KC first appeared in the inferior cornea of posterior surface, but the feature of protrusion formed at the moderate stage.]]></description>
<pubDate>2015/11/12 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xian-Li Du,Min Chen and Li-Xin Xie]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xian-Li Du,Min Chen and Li-Xin Xie</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150610]]></guid><cfi:id>1146</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[In-vivo corneal biomechanical analysis of unilateral keratoconus]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150611]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate and compare corneal biomechanical findings measured by ocular response analyzer, topographic and pachymetric findings in patients with unilateral keratoconus patients and healthy controls.
METHODS: This is an observational, case-control study. Patients with keratoconus in one eye and forme fruste keratoconus in the fellow eye were compared with sex and age matched with controls healthy subjects. All subjects were evaluated with rotating scheimpflug imaging system. The receiver-operating-characteristic curves were analyzed to evaluate the sensitivity and specificity of the parameters.
RESULTS: Twenty-seven patients with keratoconus in one eye and forme fruste keratoconus in the fellow eye were compared with 40 eyes of 40 normal subjects. Corneal hysteresis (CH) was 8.0±1.7 mm Hg in keratoconus group, 8.3±1.6 mm Hg in forme fruste keratoconus group, and 9.8±1.6 mm Hg in control groups (P=0.54 between keratoconus and forme fruste keratoconus groups, P<0.01 between control group and other groups). Corneal resistance factor (CRF) was 7.1±2.2 mm Hg in keratoconus group, 7.8±1.2 mm Hg in forme fruste keratoconus group and 9.9±1.5 mm Hg in control group (P<0.001 between control group and other groups). Using receiver-operating-characteristic analysis, the area under curve values of the parameters to distinguish forme fruste keratoconus from control subjects were: CH (0.768), CRF (0.866). Best cut-off points were 9.3 mm Hg and 8.8 mm Hg for CH and CRF respectively.
CONCLUSION: Ocular response analyzer parameters (CH and CRF) are found to be significantly lower in forme fruste keratoconus patients compared to normal control subjects.]]></description>
<pubDate>2015/11/12 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Orhan Ayar,Mehmet Cuneyt Ozmen,Orkun Muftuoglu,Mehmet Orcun Akdemir,Mustafa Koc and Kemal Ozulken]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Orhan Ayar,Mehmet Cuneyt Ozmen,Orkun Muftuoglu,Mehmet Orcun Akdemir,Mustafa Koc and Kemal Ozulken</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150611]]></guid><cfi:id>1145</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of pseudophakic retinal straylight in spherical/aspherical and hydrophobic/hydrophilic intraocular lens]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150612]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To study the potential reasons of increased straylight in pseudophakic eyes.
METHODS: Cross-sectional study. Seventy patients diagnosed as bilateral age-related cataract and implanted with Tecnis ZA9003, Sensar AR40e, SA60AT, XLSTABI ZO or Akeros AO intraocular lens (IOL) were enrolled in this research. Straylight was measured by a C-Quant straylight meter three to four weeks postoperatively. Five different modalities of IOL, including spherical/aspherical optics and hydrophobic/hydrophilic material were tested in this study. Normal as well as dilated pupils were used. The main outcome variable for straylight measurement was the logarithmic straylight parameter, log(s). 
RESULTS: The straylight parameter increased significantly after pupil dilation (P<0.05). Straylight of aspherical IOL was significantly higher after pupil dilation (P<0.05) compared to spherical IOL. In normal pupil, straylight of hydrophobic IOL was significant higher when compared with hydrophilic IOL (P<0.05).
CONCLUSION: Straylight and visual acuity stand for the different aspects of visual function. Several factors including pupil diameter, optic material, aspherical design of IOL influence intraocular light scattering in pseudophakic eyes. Further investigation was needed to study the impact of optic material and optic surface design on pseudophakic straylight.]]></description>
<pubDate>2015/11/12 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yong Tang,Hui Song,Jing Chen and Xin Tang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yong Tang,Hui Song,Jing Chen and Xin Tang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150612]]></guid><cfi:id>1144</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Lens thickness assessment: anterior segment optical coherence tomography versus A-scan ultrasonography]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150613]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess lens thickness measurements with anterior segment-optical coherence tomography (AS-OCT) in comparison with A-scan ultrasonography (A-scan US).
METHODS: There were 218 adult subjects (218 eyes) aged 59.2±9.2y enrolled in this prospective cross-sectional study. Forty-three eyes had open angles and 175 eyes had narrow angles. Routine ophthalmic exam was performed and nuclear opacity was graded using the Lens Opacities Classification System III (LOCS III). Lens thickness was measured by AS-OCT (Visante OCT, Carl Zeiss Meditec, Dublin, CA, USA). The highest quality image was selected for each eye and lens thickness was calculated using ImageJ software. Lens thickness was also measured by A-scan US.
RESULTS: Interclass correlations showed a value of 99.7% for intra-visit measurements and 95.3% for inter-visit measurements. The mean lens thickness measured by AS-OCT was not significantly different from that of A-scan US (4.861±0.404 vs 4.866±0.351 mm, P=0.74). Lens thickness values obtained from the two instruments were highly correlated overall (Pearson correlation coefficient=0.81, P<0.001), and in all LOCS III specific subgroups except in grade 5 of nuclear opacity. Bland-Altman analysis revealed a 95% limit of agreement from -0.45 to 0.46 mm. Lens thickness difference between the two instruments became smaller as the lens thickness increased and AS-OCT yielded smaller values than A-scan US in thicker lens (β=-0.29, P<0.001)
CONCLUSION: AS-OCT-derived lens thickness measurement is valid and comparable to the results obtained by A-scan US. It can be used as a reliable noncontact method for measuring lens thickness in adults with or without significant cataract.]]></description>
<pubDate>2015/11/12 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Nikoo Hamzeh,Sasan Moghimi,Golshan Latifi,Massood Mohammadi,Nassim Khatibi and Shan C. Lin]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Nikoo Hamzeh,Sasan Moghimi,Golshan Latifi,Massood Mohammadi,Nassim Khatibi and Shan C. Lin</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150613]]></guid><cfi:id>1143</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Correlations between corneal and optic nerve head variables in healthy subjects and patients with primary open angle glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150614]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To correlate corneal variables (determined using the Pentacam) with optic nerve head (ONH) variables determined using the Heidelberg retina tomograph (HRT) in healthy subjects and patients diagnosed with primary open angle glaucoma (POAG).
METHODS: Measurements were made in 75 healthy eyes and 73 eyes with POAG and correlations examined through Pearson correlation coefficients between the two sets of variables in the two subject groups. The corneal variables determined were corneal volume (CVol), central corneal thickness (CCT), overall corneal thickness (OvCT), the mean thickness of a circular zone centered at the corneal apex of 1 mm radius (zone I) and the mean thickness of several concentric rings, also centered at the apex until the limbus, each of 1 mm width (zones II to VI respectively). The ONH variables were determined using the HRT.
RESULTS: The following pairs of variables were correlated in the control group: CCT-disc area (DAr) (-0.48; P<0.0001), Zone I-DAr (-0.503; P<0.0001) and Zone II-DAr (-0.443; P<0.0001); and in the POAG group: CCT-cup-to-disc area ratio (CDRa) (-0.402; P<0.0001), Zone I-CDRa (-0.418; P<0.0001), Zone II-CDRa (-0.405; P=0.006), Zone I-cup shape measure (CSM) (-0.415; P=0.002), Zone II-CSM (-0.405; P=0.001), Zone IV-height variation contour (HVC) (0.378; P=0.002); Zone V-HVC (0.388, P<0.0001).CONCLUSION: AS-OCT-derived lens thickness measurement is valid and comparable to the results obtained by A-scan US. It can be used as a reliable noncontact method for measuring lens thickness in adults with or without significant cataract.]]></description>
<pubDate>2015/11/12 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Federico Saenz-Frances, Luis Ja&#241;ez, Lara Borrego-Sanz, Clara Berrozpe-Villabona, Jose Maria Martinez-de-la-Casa, Laura Morales-Fernandez, Julian Garcia-Sanchez, Enrique Santos-Bueso and Julian Garcia-Feijoo]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Federico Saenz-Frances, Luis Ja&#241;ez, Lara Borrego-Sanz, Clara Berrozpe-Villabona, Jose Maria Martinez-de-la-Casa, Laura Morales-Fernandez, Julian Garcia-Sanchez, Enrique Santos-Bueso and Julian Garcia-Feijoo</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150614]]></guid><cfi:id>1142</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Long-term results of viscocanalostomy and phacoviscocanalostomy: a twelve-year follow-up study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150615]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the long-term efficacy and safety results of viscocanalostomy and phacoviscocanalostomy.
METHODS: The charts of 49 glaucoma patients who underwent viscocanalostomy or phacoviscocanalostomy surgery between February 1999 and August 2004 were reviewed retrospectively. Thirty-one eyes of 21 glaucoma patients who underwent filtering procedure with a postoperative follow-up of at least 5y were included in the study. Results of complete ophthalmologic examinations were recorded and statistically analyzed. Long-term surgical outcome was defined as an overall success when intraocular pressure (IOP) was found as ≤20 mm Hg with or without antiglaucomatous medication at the last follow-up visit, while it was defined as a complete success when IOP was measured ≤20 mm Hg without antiglaucomatous medication.
RESULTS: Mean age was 68.1±9.6y (range: 32-81y). Mean follow-up time was 101.5±27.3mo (range: 60-144mo). Viscocanalostomy was performed in 8 eyes (25.8%) and phacoviscocanalostomy was performed in 23 eyes (74.2%). The mean preoperative IOP was 23.1±7.6 mm Hg with 2.1±1.0 medications, while mean IOP was 16.8±3.8 mm Hg with 0.9±1.1 medication at the last follow-up visit. Both the IOP decrease and the reduction in the antiglaucomatous medication were statistically significant (P<0.001 and P<0.001). No case required further glaucoma surgery. Overall success and complete success were found as 87.1% and 51.6%, respectively. Complete success rate was statistically higher in phacoviscocanalostomy group compared with the viscocanalostomy group (P=0.031), however there was no significant difference in overall success rate between two groups (P=0.072).
CONCLUSION: Both viscocanalostomy and phacoviscocanalostomy provide good IOP reduction in the long-term period.]]></description>
<pubDate>2015/11/12 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Uzeyir Gunenc,Taylan Ozturk,Gul Arikan and Nilufer Kocak]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Uzeyir Gunenc,Taylan Ozturk,Gul Arikan and Nilufer Kocak</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150615]]></guid><cfi:id>1141</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of 45-degree Kelman and 45-degree balanced phaco tip designs in torsional microcoaxial phacoemulsification]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150616]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the intraoperative performance and postoperative outcome after microcoaxial torsional phacoemulsification using either a Kelman or balanced phaco tip.
METHODS: Cataracts were treated using 2.2 mm microcoaxial torsional phacoemulsification using either a 45-degree mini-flared Kelman&#174; or a 45-degree Intrepid&#174; Balanced phaco tip. Intraoperative measurements included total ultrasound (US) time, cumulative dissipated energy (CDE), torsional US time, and balanced salt solution (BSS) use. The central endothelial cell density (ECD) and central corneal thickness (CCT) were evaluated preoperatively and postoperatively 1, 7, and 30d after surgery using noncontact specular microscopy.
RESULTS: The 116 enrolled eyes (116 patients) were divided equally between the Kelman and balanced tip groups. Intraoperative measurements showed significantly less total US time, torsional US time, CDE, and BSS use in the balanced group than in Kelman group (P<0.05). The total US time, torsional US time, CDE, and BSS use were 17.45±14.53s, 16.63±13.97s, 6.38±5.26, and 48.21±17.21 mL in the Kelman group and 11.39 ± 9.60s, 10.90 ± 9.25s, 4.04 ± 3.42, and 41.36 ± 12.70 mL in the balanced group, respectively.
CONCLUSION: Torsional phacoemulsification performed with a balanced tip provided more effective lens removal with less total US time, torsional time, CDE, and BSS use, as well as similar changes in ECD with a Kelman tip in all cataract grades. This special designed phaco tip for torsional phacoemulsification provides an alternative phaco tip for many surgeons' preference with straight phaco tip.]]></description>
<pubDate>2015/11/12 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Süleyman Demircan, Mustafa Ata&#351;, Emre G&#246;kta&#351; and Burhan Ba&#351;kan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Süleyman Demircan, Mustafa Ata&#351;, Emre G&#246;kta&#351; and Burhan Ba&#351;kan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150616]]></guid><cfi:id>1140</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A comparison of visual outcomes in three different types of monofocal intraocular lenses]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150617]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the visual outcomes (distance and near) in patients opting for three different types of monofocal intraocular lens (IOL) (Matrix Aurium, AcrySof single piece, and AcrySof IQ lens).
METHODS: The present study is a cross-sectional analysis of secondary clinical data collected from 153 eyes (52 eyes in Matrix Aurium, 48 in AcrySof single piece, and 53 in AcrySof IQ group) undergoing cataract surgery (2011-2012). We compared near vision, distance vision, distance corrected near vision in these three types of lenses on day 15 (±3) post-surgery.
RESULTS: About 69% of the eyes in the Matrix Aurium group had good uncorrected distance vision post-surgery; the proportion was 48% and 57% in the AcrySof single piece and AcrySof IQ group (P=0.09). The proportion of eyes with good distance corrected near vision were 38%, 33%, and 15% in the Matrix Aurium, AcrySof single piece, and AcrySof IQ groups respectively (P=0.02). Similarly, The proportion with good “both near and distance vision” were 38%, 33%, and 15% in the Matrix Aurium, AcrySof single piece, and AcrySof IQ groups respectively (P=0.02). It was only the Matrix Aurium group which had significantly better both “distance and near vision” compared with the AcrySof IQ group (odds ratio: 5.87, 95% confidence intervals: 1.68 to 20.56).
CONCLUSION: Matrix Aurium monofocal lenses may be a good option for those patients who desire to have a good near as well as distance vision post-surgery.]]></description>
<pubDate>2015/11/12 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Vijay Shetty,Suhas S Haldipurkar,Rujuta Gore,Rita Dhamankar,Anirban Paik and Maninder Singh Setia]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Vijay Shetty,Suhas S Haldipurkar,Rujuta Gore,Rita Dhamankar,Anirban Paik and Maninder Singh Setia</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150617]]></guid><cfi:id>1139</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of 25-gauge sutureless vitrectomy and 20-gauge vitrectomy in the treatment of posterior capsule opacification in pseudophakic children]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150618]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the effectiveness and safety of pars plana capsulotomy and vitrectomy using 25-gauge tansconjunctival sutureless vitrectomy system and 20-gauge vitrectomy system for posterior capsule opacification (PCO) in pseudophakic children.
METHODS: Retrospectively study. Pars plana capsulotomy and vitrectomy using 25-gauge sutureless vitrectomy system was performed for PCO in the study group (32 eyes). Patients in the control group (34 eyes) underwent capsulotomy and vitrectomy using standard 20-gauge vitrectomy system, providing a comparison between 2 groups with regard to preoperative and postoperative best corrected visual acuity (BCVA), intraocular pressure (IOP), and intraoperative and postoperative complications. The two groups were performed consequentially. The patients ages ranged from 2 to 13y (means: 6.61±2.73y). Surgical technique, intraoperative and postoperative complications, visual acuity, IOP, and recurrent PCO were recorded.
RESULTS: The surgical procedure was performed uneventfully in all patients. Visual acuity improved significantly in both groups. BCVA improved in 22 eyes (81.5%) in the study group and in 28 eyes (87.5%) in the control group. There was no statistical difference of visual acuity that were attainable in two groups (H=0.115, P=0.909). Mean postoperative IOP showed no significant difference between the groups at 1wk. All sort of PCO were accomplished by 20-gauge system, while 25-gauge system was effective for pearls style and 2 grade of fibrous PCO, and was insufficient to grade 3 of PCO. In the study group two cases were not accomplished by 25-gauge system while 20-gauge system conquered them. Compared with the control group, mean operative time for opening and closing the sclerotomy in the study group was considerably reduced. The mean follow-up was 38.2mo (range: 8-79mo). During the follow-up period, no incision leakage, corneal edema, vitreous loss, IOL damage, retinal detachment, recurrent PCO, or other complications were noted.
CONCLUSION: Pars plana capsulotomy and vitrectomy using 25-gauge transconjunctival sutureless vitrectomy appeared to be a safe and effective approach for PCO in pseudophakic children. Combined sutureless surgery needed shorter setup time for sclerotomy and caused less surgical trauma than combined surgery with 20-gauge vitrectomy. Therefore, this type of procedure would be a good option for selected cases with PCO in pseudophakic children.]]></description>
<pubDate>2015/11/12 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xiao-Ming Wu and Li-Xin Xie]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiao-Ming Wu and Li-Xin Xie</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150618]]></guid><cfi:id>1138</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Risk factors for endophthalmitis following cataract surgery-our experience at a tertiary eye care centre in India]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150619]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the risk factors for acute endophthalmitis after cataract extraction in a tertiary care centre in India.
METHODS: We performed a nested case control study within a retrospective cohort. The surgical records of all patients with clinically diagnosed endophthalmitis within one month after cataract surgery, performed between January 2006 and December 2009, were reviewed. These were compared with randomly selected age and gender-matched controls, from patients having routine cataract surgery within ±1wk of the endophthalmitis case. Univariable and multivariable analysis were performed to identify risk factors for endophthalmitis.
RESULTS: Of the total 33 856 cataract surgeries performed during this period, there were 57 cases of postoperative acute endophthalmitis that met our study criteria. Thus, the overall incidence of endophthalmitis in our cohort was 1.6 per 1000 cataract extractions performed. Mean age of cases was 55.9y (SD: 10.9y) and for controls was 55.6y (SD: 9.8y). Thirty-five cases (61.4%) and 133 controls (59.6%) were males. Median time of onset of endophthalmitis was 4d (IQR 2-9d; range: 1-30d). Thirty-nine cases (68.4%) presented within 7d and 27 cases (47.4%) were culture positive. Two hundred and twenty-three age and gender matched controls were selected. In multivariate analysis, endophthalmitis was associated with posterior capsular rupture (PCR) during surgery (OR 6.98, 95%CI: 2.22-21.98), phacoemulsification via scleral incision with a foldable intraocular lens (IOL) implantation (OR 3.02, 95%CI: 1.13-8.04) and ocular co-morbidity (OR 2.32, 95%CI: 1.11-4.87).
CONCLUSION: PCR, presence of ocular co-morbidity, and phacoemulsification via scleral incision with foldable-IOL were found to be independent risk factors for acute endophthalmitis.]]></description>
<pubDate>2015/11/12 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Rohit C. Khanna,Vanita Pathak Ray,Madhavi Latha,Sandra D Cassard,Annie Mathai and Garudadri C Sekhar]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Rohit C. Khanna,Vanita Pathak Ray,Madhavi Latha,Sandra D Cassard,Annie Mathai and Garudadri C Sekhar</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150619]]></guid><cfi:id>1137</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Measurement of macular pigment optical density among healthy Chinese people and patients with early-stage age-related macular degeneration]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150620]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To measure the macular pigment optical density (MPOD) in healthy Chinese people and patients with early age-related macular degeneration (AMD).
METHODS: Cross-sectional population based study. Demographic and lifestyle characteristics were ascertained by questionnaire. A food frequency questionnaire was completed for all participants. Participants underwent general physical and ophthalmic examinations and MPOD was measured by heterochromatic flicker photometry. Foveal architecture was measured by optical coherence tomography.
RESULTS: MPOD of 225 participants (122 healthy and 103 early AMD) was 0.48±0.18. Patients with early AMD (0.52±0.19) tended to have higher MPOD levels than healthy people (0.47±0.17), but the difference was not statistically significant (P=0.06). Participants with carrot or corn oil intake every week tended to have higher levels of MPOD (P=0.002 and 0.008 respectively) while those with corn intake had relatively lower level of MPOD (P=0.01). MPOD increased with the center foveal thickness (P=0.01).
CONCLUSION: Our findings show that there is no statistically significant association between MPOD and early AMD in the studied population. MPOD is related to center foveal thickness and diets would influence MPOD levels.]]></description>
<pubDate>2015/11/12 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xue-Tao Ren,Hong Gu,Xu Han,Jun-Yan Zhang,Xue Li,Xiu-Fen Yang,Jun Xu,Torkel Snellingen,Xi-Pu Liu,Ning-Li Wang and Ning-Pu Liu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xue-Tao Ren,Hong Gu,Xu Han,Jun-Yan Zhang,Xue Li,Xiu-Fen Yang,Jun Xu,Torkel Snellingen,Xi-Pu Liu,Ning-Li Wang and Ning-Pu Liu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150620]]></guid><cfi:id>1136</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison and interchangeability of macular thickness measured with Cirrus OCT and Stratus OCT in myopic eyes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150621]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the difference of macular thickness measurements between stratus optical coherence tomography (OCT) and Cirrus OCT (Carl Zeiss Meditec, Dublin, CA, USA) in the same myopic patient and to develop a conversion equation to interchange macular thickness obtained with these two OCT devices.
METHODS: Eighty-nine healthy Chinese adults with spherical equivalent (SE) ranging from -1.13 D to -9.63 D were recruited. The macular thickness was measured by Cirrus OCT and Stratus OCT. The correlation between macular thickness and axial length and the agreement between two OCT measurements were evaluated. A formula was generated to interchange macular thickness obtained with two OCT devices.
RESULTS: Average macular thickness measured with Stratus OCT (r=-0.280, P=0.008) and Cirrus OCT (r=-0.224, P=0.034) were found to be negatively correlated with axial length. No statistically significant correlation was found between axial length and central subfield macular thickness (CMT) measured with Stratus OCT (r=0.191, P=0.073) and Cirrus OCT (r=0.169, P=0.113). The mean CMT measured with Cirrus OCT was 53.63±7.94 μm thicker than with Stratus OCT. The formula CMTCirrus OCT=78.328+0.874×CMTStratus OCT was generated to interchange macular thickness obtained with two OCT devices.
CONCLUSION: Macular thickness measured with Cirrus OCT were thicker than with Stratus OCT in myopic eyes. A formula can be used to interchange macular thickness measured with two OCT devices in myopic eyes. Studies with different OCT devices and larger samples are warranted to enable the comparison of macular values measured with different OCT devices.]]></description>
<pubDate>2015/11/12 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Geng Wang,Kun-Liang Qiu,Xue-Hui Lu and Ming-Zhi Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Geng Wang,Kun-Liang Qiu,Xue-Hui Lu and Ming-Zhi Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150621]]></guid><cfi:id>1135</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Changes in vitreous VEGF, bFGF and fibrosis in proliferative diabetic retinopathy after intravitreal bevacizumab]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150622]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the relationship between intravitreal bevacizumab (IVB) treatment and the levels of vitreous vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) and vitreous-retina surface fibrosis in patients with proliferative diabetic retinopathy (PDR).
METHODS: This study was a prospective, open-label, controlled, randomized clinical trial. Sixty-eight eyes of PDR patients (n=53) and macular hole patients (n=15) were enrolled in this study. Thirty-four eyes of the PDR patients received IVB before vitrectomy. Twenty-three of the 34 PDR patients received IVB treatment 5d before vitrectomy (subgroup a), and 11 of the 34 PDR patients received IVB treatment greater than 2wk prior to vitrectomy (subgroup b). Nineteen of the PDR patients did not receive IVB treatment at any time prior to vitrectomy. The levels of bFGF and VEGF in vitreous samples were measured using enzyme-linked immunosorbent assay (ELISA) and the degree of vitreoretinal fibrosis was characterized using clinical data and data obtained intra-operatively.
RESULTS: In PDR patients, VEGF and bFGF levels were significantly increased compared to non-PDR (control) subject’s eyes (P<0.01). In PDR patients, vitreous VEGF levels were significantly decreased following IVB treatment compared to PDR patients that did not receive IVB treatment (P<0.01). The degree of vitreoretinal fibrosis was significantly increased in subgroup b compared to subgroup a(P<0.05) and to patients that did not receive IVB (P<0.05). Vitreous bFGF levels were significantly greater in subgroup b than subgroup a (P<0.01) or in patients who did not receive IVB treatment (P<0.05). A Spearman’s rank correlation test indicated that higher levels of vitreous bFGF, but not VEGF, correlated with the degree of vitreoretinal fibrosis.
CONCLUSION: We found that bFGF levels increase in PDR patient’s vitreous after IVB treatment longer than two weeks prior to vitrectomy and correlated with the degree of fibrosis after IVB treatment. These findings suggest vitreous fibrosis is increased in PDR patients after IVB treatment may be due to increased levels of bFGF.]]></description>
<pubDate>2015/11/12 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jiu-Ke Li,Fang Wei,Xiao-Hong Jin,Yuan-Min Dai,Hu-Shan Cui and Yu-Min Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jiu-Ke Li,Fang Wei,Xiao-Hong Jin,Yuan-Min Dai,Hu-Shan Cui and Yu-Min Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150622]]></guid><cfi:id>1134</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Postnatal weight gain in very low birth weight infants in Beijing and the risk of retinopathy of prematurity]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150623]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyze the low weight gain (WG) from birth to 4 and 6wk of life to predict the development of retinopathy of prematurity (ROP) among very low birth weight (VLBW) preterm babies.
METHODS: Three hundred and three newborns with VLBW were analyzed. Body weight measurements were recorded weekly. In all patients, the proportion of the WG was defined as the preterm weight measured at the 4th and 6th weeks of life minus the birth weight (BW) divided by the BW. Other risk factors for ROP were also analyzed.
RESULTS: Mean gestational age and mean BW of the whole cohort were 29.56±1.44wk and 1270.58±176.18g respectively. WG proportion at 4wk postnatal age (18.89%±13.58%) were significantly lower in infants with ROP (P=0.003). WG proportion at 6wk was not different between ROP and no ROP group (42.48%±20.36% vs 46.43%±15.65% P=0.118). When all the other risk factors signi?cant for ROP were included in the logistic regression poor WG did not arise as an independent risk factor. Area under the ROC curve was 0.591 (95%CI: 0.515-0.666; P=0.016). For ROP, the best discriminative cutoff of 18.06% of the proportional WG at the 4th week over the BW, sensitivity and specificity values were 67.3% and 50.0% respectively.
CONCLUSION: Low WG proportion in the first 4wk of life is maybe an additional predictor of ROP in very low BW infants. Preterm babies with low BW and low WG proportion should be followed closely for ROP.]]></description>
<pubDate>2015/11/12 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Zong-Hua Wang,Peng-Fen Gao,Hua Bai and Yao-Yu Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zong-Hua Wang,Peng-Fen Gao,Hua Bai and Yao-Yu Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150623]]></guid><cfi:id>1133</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A study of retinal parameters measured by optical coherence tomography in patients with multiple sclerosis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150624]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the difference of retinal nerve fiber layer (RNFL) thickness and macular fovea thickness/volume between multiple sclerosis (MS) patients and healthy normal individuals using optical coherence tomography (OCT) and assess its association with visual field parameters.
METHODS: Thirty consecutive MS patients and 28 healthy controls were recruited in this prospective study. Comprehensive standardized ophthalmic examinations included visual acuity, cycloplegic refraction, intraocular pressure, gonioscopy, visual field, and RNFL thickness and macular fovea thickness/volume detection using Humphrey OCT. Mean values for the thickness of the peripapillary RNFL and macular volume were calculated. Associations between visual field parameters and RNFL thickness/macular volume were analyzed by Pearson correlation analysis.
RESULTS: The RNFL thicknesses in each quadrant, the average macular thickness, and the average macular volume in MS patients were all less than those in healthy controls, with statistically significant differences. The RNFL thickness and macular fovea thickness/volume were greater in eyes without optic neuritis than in eyes with optic neuritis. The average visual field parameters had positive correlations with the RNFL thickness and negative correlations with macular parameters in MS patients.
CONCLUSION: OCT measurements can effectively identify the nerve changes of MS patients, which provide more data for the diagnosis of MS.]]></description>
<pubDate>2015/11/12 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Sai-Jing Hu,Yi-An You and Yi Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Sai-Jing Hu,Yi-An You and Yi Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150624]]></guid><cfi:id>1132</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical features and visual outcomes of scleritis patients presented to tertiary care eye centers in Saudi Arabia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150625]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To describe the clinical features, systemic associations, treatment and visual outcomes in Saudi patients with scleritis.
METHODS: A retrospective chart review was performed for patients with scleritis presenting to two tertiary care eye hospitals in Riyadh, Saudi Arabia, from 2001 to 2011. Data were collected on the clinical features of scleritis, subtypes of scleritis, associated systemic disease, history of previous ocular surgery and medical therapy, including the use of immunosuppressants. Treatment outcomes were evaluated based on best-corrected visual acuity (BCVA) and response to treatment.
RESULTS: Of the 52 patients included in the study, non-necrotizing anterior scleritis was the most common type of scleritis in 22 patients (42.3%), followed by posterior scleritis in 14 patients (26.9%). The majority of cases, 31 patients (59.6%), were idiopathic in nature. Systemic associations were present in 12 patients (23.1%). Infectious scleritis was confirmed in 6 patients (11.5%): 3 with bacterial scleritis after pterygium excision, 2 patients with scleritis related to tuberculosis and 1 patient with scleritis resulting from herpes simplex infection. For the various subtypes of scleritis, BCVA values after treatment and time to remission significantly differed (P<0.05, all cases). Systemic immunosuppressive therapies in addition to steroids were administered to 46.2% of all patients. The T-sign was present on B-scan ultrasonography in 9 (64.3%) of the 14 posterior scleritis patients.
CONCLUSION: Non-necrotizing anterior scleritis was the most common subtype of scleritis. Final visual outcome and time to remission differed among the various scleritis subtypes.]]></description>
<pubDate>2015/11/12 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mohammad Al Barqi,Ashley Behrens and Abdullah M. Alfawaz]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mohammad Al Barqi,Ashley Behrens and Abdullah M. Alfawaz</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150625]]></guid><cfi:id>1131</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparative clinical study of conjunctival toxicities of newer generation fluoroquinolones without the influence of preservatives]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150626]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the conjunctival epithelial toxicities of three newer-generation fluoroquinolones without preservatives.
METHODS: In a prospective, randomized, double blind comparative study, 47 eyes of 47 patients with a primary pterygium were enrolled, and divided randomly into three groups (levofloxacin 0.5%, gatifloxacin 0.3%, and moxifloxacin 0.5%). After pterygium surgery with the same conjunctival autograft technique, each patient maintained a regimen with a randomly assigned fluoroquinolone eye drop. Patients were examined every other day after surgery until the epithelium had completely healed. Photos were taken and used to measure the area of residual epithelial defects. Conjunctival healing time and speed (initial defect area/healing time (mm2/d) compared in each group using Kruskal-Wallis tests.
RESULTS: There were no significant differences in mean age, gender, and conjunctival defect size of the donor site between these groups. However, the mean of conjunctival healing time and speed were statistically different in each group. The mean of conjunctival epithelial healing time was 8.93±2.69d (levofloxacin group), 10.31±2.96d (gatifloxacin group), and 13.50±4.10d (moxifloxacin group), P=0.006. The mean conjuctival epithelial healing speed was 6.18±1.39 mm2/d (levofloxacin group), 5.52±1.68 mm2/d (gatifloxacin group), and 4.40±1.30 mm2/d (moxifloxacin group), P=0 .003.
CONCLUSION: Without the influence of preservatives, levofloxacin and gatifloxacin might be less toxic to the regeneration of conjunctival epithelial cells and cause a faster conjunctival wound healing relative to moxifloxacin.]]></description>
<pubDate>2015/11/12 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Han Sang Park,Jun Hun Lee and Hong Kyun Kim]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Han Sang Park,Jun Hun Lee and Hong Kyun Kim</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150626]]></guid><cfi:id>1130</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Factors influencing improvement of visual field after trans-sphenoidal resection of pituitary macroadenomas: a retrospective cohort study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150627]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the influencing factors of visual field improvement after trans-sphenoidal resection of pituitary macroadenomas.
METHODS: This retrospective cohort study included 201 patients (366 eyes) with visual field defect induced by pituitary macroadenomas. All of them were treated with trans-sphenoidal surgery. Ophthalmologic evaluation, best-corrected visual acuity (BCVA), and visual field examination were performed before and 3mo after surgery. BCVA, visual field defect index mean deviation (MD), duration of symptoms, age, sex, and volume of tumors were compared. Expression of vascular endothelial growth factor (VEGF) and Ki-67 of tumor tissue were detected by immunohistochemical technique.
RESULTS: The mean age of patients was 44.23±1.29y. Ninety-three patients were female and 108 were male. The mean tumor volume was 14.36±6.23 cm3. The mean duration of preoperative symptoms was 11.50±0.88mo. Mean preoperative MD was -17.50±0.82 dB. Mean Preoperative visual acuity was 0.64±0.04. Postoperative visual field improved in 270 (73.77%) eyes, unchanged in 96 (26.23%) eyes. Multivariate logistic regression displayed that the factors independently influencing visual field improvement were young age (OR=1.71, 95%CI: 1.325-2.387, P=0.013), low preoperative MD absolute value (OR=1.277, 95%CI: 1.205-1.355, P<0.001), small volume of tumor (OR=1.458, 95%CI: 1.060-4.289, P<0.001), low expression of VEGF in tumor tissue (OR=1.554, 95%CI: 1.089-2.457, P=0.022), and low expression of Ki-67 in tumor tissue (OR=1.552, 95%CI: 1.161-2.847, P=0.026).
CONCLUSION: After pituitary macroadenomas trans-sphenoidal resection, the independent influencing factors of the visual fields recovery were low preoperative MD absolute value, young age, small volume of tumor, and expression levels of VEGF/ Ki-67.]]></description>
<pubDate>2015/11/12 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Fen-Fen Yu,Li-Li Chen,Yi-Hua Su,Li-Hun Huo,Xian-Xuan Lin and Rui-Duan Liao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Fen-Fen Yu,Li-Li Chen,Yi-Hua Su,Li-Hun Huo,Xian-Xuan Lin and Rui-Duan Liao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150627]]></guid><cfi:id>1129</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Visual outcomes in patients with open globe injuries compared to predicted outcomes using the Ocular Trauma Scoring system]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150628]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the visual outcomes in adult patients who sustained open globe injuries and to determine whether the visual prognosis following an eye injury in an African setting differs from the predicted outcomes according to the Ocular Trauma Score (OTS) study. A secondary aim was to establish the evisceration rate for these injuries and assess how this form of intervention affected outcomes in comparison to the OTS.
METHODS: A prospective case series of all patients admitted with open globe injuries over a two-year (July 2009 to June 2011) period. Injuries were scored using the OTS and the surgical intervention was recorded. The best corrected visual acuity at three months was regarded as visual outcome.
RESULTS: There were 249 open globe injuries, of which 169 patients (169 eyes) completed the 3-month follow-up. All patients underwent primary surgery, 175 (70.3%) repairs, 61 (24.5%) eviscerations and 13 (5.2%) other procedures. Globe eviscerations were mainly done on OTS Category 1 cases, but outcomes in this category were not found to be different from OTS outcomes. Outcomes were significantly worse in Category 2, but when the entire distribution was tested, the differences were not statistically significant. The overall association between OTS outcomes and the final visual outcomes in this study was found to be a strong (P<0.005).
CONCLUSION: Reliable information regarding the expected outcomes of eye injuries will influence management decisions and patient expectations. The OTS is a valuable tool, the use of which has been validated in many parts of the world-it may also be a valid predictor in an African setting.]]></description>
<pubDate>2015/11/12 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Nagib du Toit,Hamza Mustak and Colin Cook]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Nagib du Toit,Hamza Mustak and Colin Cook</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150628]]></guid><cfi:id>1128</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Combined pars plana vitrectomy and Baerveldt glaucoma implant placement for refractory glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150511]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To evaluate outcomes of combined pars plana vitrectomy and Baerveldt glaucoma implant (PPV-BGI) placement for refractory glaucoma.<b>METHODS:</b> The medical records of 92 eyes (89 patients) that underwent PPV-BGI were retrospectively reviewed, including 43 eyes with neovascular glaucoma (NVG) and 49 eyes with other types of glaucoma (non-NVG).<b>RESULTS:</b> Outcome measures were visual acuity (VA), intraocular pressure (IOP), glaucoma medical therapy, complications, and success [VA&gt;hand motions (HM), IOP≥6 mm Hg and ≤21 mm Hg, no subsequent glaucoma surgery]. Cumulative success rates for the non-NVG group and NVG group were 79% and 40% at 1y, respectively (<i>P</i>=0.038). No difference in the rates of surgical success were found between pars plana and anterior chamber tube placement. Preoperative IOP (mean±SD) was 30.3±11.7 mm Hg in the Non-NVG group and 40.0±10.6 mm Hg in the NVG group, and IOP was reduced to 15±9.5 mm Hg in the non-NVG group and 15±10.5 mm Hg in the NVG at 1y. Number of glaucoma medications (mean±SD) decreased from 2.7±1.3 in the non-NVG group and 2.8±1.3 in the NVG group preoperatively to 0.76±1.18 in the non-NVG group and 0.51±1.00 in the NVG group at 1y. Improvement in VA of ≥2 Snellen lines was observed in 25 (27%) eyes, although only 33% of non-NVG eyes and 2.3% of NVG eyes maintained VA better than 20/200 at 1y. Nonclearing vitreous hemorrhage was the most common postoperative complication occurring in 16 (17%) eyes, and postoperative suprachoroidal hemorrhages developed in 5 (5.4%) eyes.#$NL<b>CONCLUSION:</b> PPV-BGI is a viable surgical option for eyes with refractory glaucoma, but visual outcomes are frequently poor because of ocular comorbidities, especially in eyes with NVG. The location of tube placement does not influence surgical outcome and should be left to the discretion of the surgeon.]]></description>
<pubDate>2015/10/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Thalmon R. Campagnoli,Sung Soo Kim,William E. Smiddy,Steve J. Gedde,Donald L. Budenz,Richard K. Parrish II,Paul F. Palmberg,William Feuer and Wei Shi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Thalmon R. Campagnoli,Sung Soo Kim,William E. Smiddy,Steve J. Gedde,Donald L. Budenz,Richard K. Parrish II,Paul F. Palmberg,William Feuer and Wei Shi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150511]]></guid><cfi:id>1127</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Presence of Fleischer ring and prominent corneal nerves in keratoconus relatives and normal controls]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150512]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To examine the occurrence of commonly known clinical signs of keratoconus (KC), <i>i.e.</i> Fleischer ring, prominent corneal nerves and thinning, among unaffected family members of KC patients and healthy control individuals.<b>METHODS:</b> Data of both eyes of 117 relatives of KC patients having no manifest disease based on videokeratography indices (KC relatives), and 142 controls were used for Pearson correlation and <i>t</i>-test statistics. Correlation of Fleischer ring, prominent corneal nerves and central pachymetry data were tested with each other and with videokeratography indices (KSI, KISA, 3 and 6 mm Fourier asymmetry, and I-S)<i>. </i><b>RESULTS:</b> A moderate correlation was found between Fleischer ring and all examined topographical indices. Most important correlation was present with 6 mm Fourier asymmetry, and corneal pachymetry (<i>r</i>=0.272, <i>P</i>&lt;0.001; <i>r</i>=-0.234, <i>P</i>=0.027, respectively). Similar correlations were found with prominent corneal nerves (<i>r</i>=0.234, <i>P</i>&lt;0.001 for 6 mm Fourier asymmetry and <i>r</i>=-0.235, <i>P</i>=0.0265 for pachymetry). KC family members who exhibited Fleischer ring or prominent nerves had thinner and more asymmetric corneas than those without Fleischer ring or prominent corneal nerves (<i>P</i>&lt;0.05 for pachymetry and topographic indices with <i>t</i>-test and Mann-Whitney rank sum test). Though rarely, Fleischer ring and prominent corneal nerves occurred among normal controls, indicating the existence of forme fruste cases in the normal population. Control subjects, who had corneal Fleischer ring or prominent nerves had corneas more similar to KC than other controls (<i>t</i>-test:increased KSI and KISA, <i>P</i>=0.048 and 0.012, respectively).<b>CONCLUSION:</b> In KC family members and healthy individuals, Fleischer ring and prominent corneal nerves are associated with features of KC and may suggest a possibility of forme fruste KC. Searching for the possible presence of Fleischer ring or prominent nerves on the cornea may help in the decision whether or not to diagnose subclinical KC in a borderline case.]]></description>
<pubDate>2015/10/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[gnes Kriszt, Gergely Losonczy, András Berta and Lili Takács]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>gnes Kriszt, Gergely Losonczy, András Berta and Lili Takács</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150512]]></guid><cfi:id>1126</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A new multiple noncontinuous puncture (pointage) technique for corneal tattooing]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150513]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To assess the safety and cosmetic efficacy of a new multiple noncontinuous transepithelial puncture technique for tattooing a decompensated cornea.<b>METHODS:</b>It was anon-comparative clinical case series study.The study examines 33 eyes in 33 patients with total corneal opacity due to corneal decompensation, which developed following intraocular surgery.Corneal tattooing was performed using the multiple noncontinuous transepithelial puncture technique (<i>i.e.</i> pointage). The safety of this new surgical strategy was assessed by occurrence of adverse events for the follow-up period. The cosmetic efficacy was determined by the patient’s cosmetic satisfaction and independent observer’s opinion about patient appearance.<b>RESULTS:</b>Seven women and 26 men were included in the study. The mean age was 46.4±17.5y (range:7-67). In total, 30 of 33 patients (91%) reported cosmetic satisfaction within the follow-up period. Only 3 patients (9%) required additional tattooing due to cosmetic unsatisfaction. Cosmetic outcomes were analyzed and classified as excellent or good in 13 (39%) and 17 (52%) patients, respectively. No serious adverse events developed, except delayed epithelial healing in 3 cases.<b>CONCLUSION:</b>The cosmetic outcomes of the multiple noncontinuous transepithelial puncture technique for corneal tattooing were good. The safety of this method is higher than conventional procedures. This new procedure also provides improved cost-effectiveness and safety over current corneal tattooing techniques.]]></description>
<pubDate>2015/10/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jin Hyoung Park,Taewoong Um,Myoung Joon Kim,Hungwon Tchah and Jae Yong Kim]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jin Hyoung Park,Taewoong Um,Myoung Joon Kim,Hungwon Tchah and Jae Yong Kim</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150513]]></guid><cfi:id>1125</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Risk factors of regression and undercorrection in photorefractive keratectomy:a case-control study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150514]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To determine risk factors of regression and undercorrection following photorefractive keratectomy (PRK) in myopia or myopic astigmatism.<b>METHODS:</b> A case-control study was designed in which eyes with an indication for re-treatment (RT) were defined as cases; primary criteria for RT indication, as assessed at least 9mo postoperatively, included an uncorrected distance visual acuity (UDVA) of 20/30 or worse and a stable refraction for more than 3mo. Additional considerations included optical quality symptoms and significant higher order aberrations (HOAs). Controls were chosen from the same cohort of operated eyes which had complete post-operative follow up data beyond 9mo and did not need RT. The cohort included patients who had undergone PRK by the Tissue-Saving (TS) ablation profile of Technolas 217z100 excimer laser (Bausch & Lomb, Rochester, NY, USA). Mitomycin C had been used in all of the primary procedures.<b>RESULTS:</b>We had 70 case eyes and 158 control eyes, and they were comparable in terms of age, sex and follow-up time (<i>P</i> values:0.58, 1.00 and 0.89, respectively). Pre-operative spherical equivalent of more than -5.00 diopter (D), intended optical zone (OZ) diameter of less than 6.00 mm and ocular fixation instability during laser ablation were associated with RT indications (all <i>P</i> values &lt;0.001). These factors maintained their significance in the multiple logistic regression model with odd ratios of 6.12, 6.71 and 7.89, respectively.<b>CONCLUSION:</b>Higher refractive correction (&gt;-5.00 D), smaller OZ (&lt;6.00 mm) and unstable fixation during laser ablation of PRK for myopia and myopic astigmatism were found to be strong predictors of undercorrection and regression.]]></description>
<pubDate>2015/10/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Seyed-Farzad Mohammadi,Payam Nabovati,Ali Mirzajani,Elham Ashrafi and Banafsheh Vakilian]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Seyed-Farzad Mohammadi,Payam Nabovati,Ali Mirzajani,Elham Ashrafi and Banafsheh Vakilian</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150514]]></guid><cfi:id>1124</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Toxic keratopathy associated with abuse of topical anesthetics and amniotic membrane transplantation for treatment]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150515]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To evaluate the clinical findings of toxic keratopathy associated with abuse of topical anesthetics and the treatment efficacy of amniotic membrane transplantation (AMT).<b>METHODS:</b> Fifteen eyes of 10 patients with abuse of topical anesthetics were included in this study. The data collected included patients’ demographic information, initial best corrected visual acuity (BCVA), clinical findings, time to AMT, duration of epithelization, additional treatments, posttreatment BCVA, and the results of psychiatric examination.<b>RESULTS:</b>All patients were male, with the mean age of 37.9±5.4y. The patients had received 0.5% proparacaine hydrochloride due to pain resulting from foreign bodies, such as welding flash burns and car battery explosions, for a mean of 18.2±12.4d. The mean initial BCVA of the patients was 0.069±0.100. All patients had persistent epithelial defects, stromal infiltration, ring ulcer, and corneal edema. Initially, medical treatment was attempted in all cases. Because of severe pain, persistent epithelial defects and progressing stromal thinning did not improve with medical treatment, thus, the patients underwent AMT. The mean posttreatment BCVA of the patients was 0.33±0.27. All of them, except for two patients, showed improved visual acuity. One patient underwent evisceration for corneal melting and endophthalmitis in another center, and one patient underwent evisceration for severe pain of unknown origin. All 5 patients who consented to a psychiatric examination had depression, had personality disorder, and used tobacco.<b>CONCLUSION</b>:AMT appears to be an effective method for pain relief, rapid epithelial and stromal healing; however, visual prognosis is still poor despite medical and surgical interventions.]]></description>
<pubDate>2015/10/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ozlem Yalcin Tok,Levent Tok,Inci Meltem Atay,Tugba Cakmak Argun,Nazire Demirci and Alime Gunes]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ozlem Yalcin Tok,Levent Tok,Inci Meltem Atay,Tugba Cakmak Argun,Nazire Demirci and Alime Gunes</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150515]]></guid><cfi:id>1123</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of brimonidine-timolol and dorzolamide-timolol in the management of intraocular pressure increase after phacoemulsification]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150516]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To compare the effectiveness of brimonidine/timolol fixed combination (BTFC) and dorzolamide/timolol fixed combination (DTFC) in the management of short-term intraocular pressure (IOP) increase after phacoemulsi?cation surgery.<b>METHODS:</b> Eighty eyes of 80 patients undergoing phacoemulsi?cation and intraocular lens (IOL) implantation were randomly assigned into three groups. Group 1 consisted of 28 eyes and represented the control group. Group 2 consisted of 25 eyes undergoing phacoemulsi?cation surgery and BTFC was instilled at the end of surgery. Group 3 consisted of 27 eyes undergoing phacoemulsi?cation surgery and DTFC was instilled at the end of surgery. IOP was measured preoperatively and 6, 24h and 1wk postoperatively.<b>RESULTS:</b> There was no statistically signi?cant difference in preoperative baseline IOP among the three groups (<i>P</i>=0.84). However, IOP was significantly lower in groups 2 and 3 compared to the control group (<i>P</i>&lt;0.05 for all comparisons) at all postoperative visits. There was no significant difference between groups 2 and 3 at any visit. Eight eyes (28.6%) in the control group, two (8%) in Group 2 and one (3.7%) in Group 3 had IOP &gt;25 mm Hg at 6h after surgery (<i>P</i>=0.008). However, IOP decreased and was &gt;25 mm Hg in only one eye in each group at 24h after surgery.<b>CONCLUSION:</b> BTFC and DTFC have similar effects in reducing increases in IOP after phacoemulsification surgery and can both be recommended for preventing IOP spikes after such surgery.]]></description>
<pubDate>2015/10/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Adem Turk,Osman Melih Ceylan,Gokcen Gokce,Mehmet Borazan and Mehmet Kola]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Adem Turk,Osman Melih Ceylan,Gokcen Gokce,Mehmet Borazan and Mehmet Kola</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150516]]></guid><cfi:id>1122</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Management of hypotony and flat anterior chamber associated with glaucoma filtration surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150517]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To determine the effectiveness of pharmacological and interventional treatment of hypotony and flat anterior chamber (FAC) resulting from glaucoma filtration surgery.
<b>METHODS:</b>We retrospectively examined the medical records of fifty-two trabeculectomy patients (52 eyes) who developed postoperative hypotony and FAC. The management and associated complications of hypotony, changing intraocular pressure (IOP) and best corrected visual acuity (BCVA) were evaluated.
<b>RESULTS:</b>Of the 52 patients with hypotony, 29 (56%) had a grade 1 FAC, 21 (40%) had a grade 2 FAC, and only 2 had a grade 3 FAC. There was no significant difference between the mean preoperative IOP and the mean IOP at three and six months after surgery. Thirteen eyes (25%) required antiglaucomatous medication three months after surgery. The mean BCVA at 6mo after surgery was significantly reduced as compared with the mean preoperative BCVA.
<b>CONCLUSION:</b>Hypotonia and FAC following trabeculectomy are associated with troublesome complications that require pharmacological and/or surgical treatment. Thus, close follow-up is essential for affected patients.]]></description>
<pubDate>2015/10/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yavuz Tun, Mehmet Tetikoglu, Necip Kara, Haci Murat Sagdk, Selahattin zarpaci and Mustafa Nuri Eliolu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yavuz Tun, Mehmet Tetikoglu, Necip Kara, Haci Murat Sagdk, Selahattin zarpaci and Mustafa Nuri Eliolu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150517]]></guid><cfi:id>1121</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effects of primary selective laser trabeculoplasty on anterior segment parameters]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150518]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b><i></i>To investigate the effects of selective laser trabeculoplasty (SLT) on the main numerical parameters of anterior segment with Pentacam rotating Scheimpflug camera in patients with ocular hypertension (OHT) and primary open angle glaucoma (POAG).<b>METHODS:</b> Pentacam measurements of 45 eyes of 25 (15 females and 10 males) patients (12 with OHT, 13 with POAG) before and after SLT were obtained. Measurements were taken before and 1 and 3mo after SLT. Pentacam parameters were compared between OHT and POAG patients, and age groups (60y and older, and younger than 60y).<b>RESULTS:</b> The mean age of the patients was 57.8±13.9 (range 20-77y). Twelve patients (48%) were younger than 60y, while 13 patients (52%) were 60y and older. Measurements of pre-SLT and post-SLT 1mo were significantly different for the parameters of central corneal thickness (CCT) and anterior chamber volume (ACV) (<i>P</i>&lt;0.05). These parameters returned back to pre-SLT values at post-SLT 3mo. Decrease of ACV at post-SLT 1mo was significantly higher in younger than 60y group than 60y and older group. There was no statistically significant difference in Pentacam parameters between OHT and POAG patients at pre- and post-treatment measurements (<i>P</i>&gt;0.05).<b>CONCLUSION:</b>SLT leads to significant increase in CCT and decrease in ACV at the 1<sup>st</sup> month of the procedure. Effects of SLT on these anterior segment parameters, especially for CCT that interferes IOP measurement, should be considered to ensure accurate clinical interpretation.]]></description>
<pubDate>2015/10/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Suzan Guven Yilmaz,Melis Palamar,Emil Yusifov,Halil Ates,Sait Egrilmez and Ayse Yagci]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Suzan Guven Yilmaz,Melis Palamar,Emil Yusifov,Halil Ates,Sait Egrilmez and Ayse Yagci</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150518]]></guid><cfi:id>1120</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Long-term outcomes in patients initially responsive to selective laser trabeculoplasty]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150519]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To determine the long-term effects of selective laser trabeculoplasty (SLT) on intraocular pressure (IOP) and the number of medications used up to 5y following treatment in glaucoma patients receiving maximally tolerated medical therapy (MTMT).<b>METHODS:</b>The Wills Eye Hospital Glaucoma Research Center retrospectively reviewed the charts of glaucoma patients who underwent SLT after receiving MTMT. Eyes that did not achieve their target pressure within 3mo following SLT were excluded from the study. Changes in mean IOP and number of glaucoma medications used were analyzed at 1, 3, and 5y following SLT.<b>RESULTS:</b>Seventy-five eyes of 67 patients were included in the study. Fifteen eyes that received SLT failed to achieve their target pressure within 3mo and were excluded from the study. The average follow-up time was 37.4mo (±14.4). Mean IOP was significantly reduced 1y after treatment (<i>P=</i>0.005). It was also reduced 3, 5y after treatment without reaching statistical significance (<i>P</i>=0.20 and <i>P</i>=0.072, respectively). There was a significant decrease in mean number of medications used 1, 3, 5y after treatment (<i>P</i>&lt;0.001, <i>P</i>&lt;0.001, and <i>P</i>=0.039, respectively). In the span of 5y, 2 eyes (2.7%) underwent repeat SLT, 7 eyes (9.3%) underwent glaucoma surgery and an additional 3 eyes (4.0%) underwent both.<b>CONCLUSION:</b>SLT significantly reduced the number of glaucoma medications used 5y following treatment in glaucoma patients receiving MTMT. SLT may delay operating-room surgery.]]></description>
<pubDate>2015/10/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Varun Patel,Eman El Hawy,Michael Waisbourd,Camila Zangalli,Daniel M. Shapiro,Lalita Gupta,Michael Hsieh,Abigail Kasprenski,L. Jay Katz and George L. Spaeth]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Varun Patel,Eman El Hawy,Michael Waisbourd,Camila Zangalli,Daniel M. Shapiro,Lalita Gupta,Michael Hsieh,Abigail Kasprenski,L. Jay Katz and George L. Spaeth</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150519]]></guid><cfi:id>1119</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Phacoemulsification versus small incision cataract surgery in patients with uveitis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150520]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To compare the safety and efficacy of phacoemulsification and small incision cataract surgery (SICS) in patients with uveitic cataract.<b>METHODS:</b>In aprospective, randomized multi-centric study, consecutive patients with uveitic cataract were randomized to receive phacoemulsification or manual SICS by either of two surgeons well versed with both the techniques. A minimum inflammation free period of 3mo (defined as less than 5 cells per high power field in anterior chamber) was a pre-requisite for eligibility for surgery. Superior scleral tunnel incisions were used for both techniques. Improvement in visual acuity post-operatively was the primary outcome measure and the rate of post-operative complications and surgical time were secondary outcome measures, respectively. Means of groups were compared using <i>t</i>-tests. One way analysis of variance (ANOVA) was used when there were more than two groups. Chi-square tests were used for proportions. Kaplan Meyer survival analysis was done and means for survival time was estimated at 95% confidence interval (CI). A <i>P</i> value of &lt;0.05 was considered statistically significant.<b>RESULTS:</b>One hundred and twenty-six of 139 patients (90.6%) completed the 6-month follow-up. Seven patients were lost in follow up and another six excluded due to either follow-up less than six months (<i>n</i>=1) or inability implant an intraocular lens (IOL) because of insufficient capsular support following posterior capsule rupture (<i>n</i>=5). There was significant improvement in vision after both the procedures (paired <i>t</i>-test; <i>P</i>&lt;0.001). On first postoperative day, uncorrected distance visual acuity (UDVA) was 20/63 or better in 31 (47%) patients in Phaco group and 26 (43.3%) patients in SICS group (<i>P</i>=0.384). The mean surgically induced astigmatism (SIA) was 0.86±0.34 dioptres (D) in the phacoemulsification group and 1.16±0.28 D in SICS group. The difference between the groups was significant (<i>t</i>-test, <i>P</i>=0.002). At 6mo, corrected distance visual acuity (CDVA) was 20/60 or better in 60 (90.9%) patients in Phaco group and 53 (88.3%) in the manual SICS group (<i>P</i>=0.478). The mean surgical time was significantly shorter in the manual SICS group (10.8±2.9 versus 13.2±2.6min) (<i>P</i>&lt;0.001). Oral prednisolone, 1 mg/kg body weight was given 7d prior to surgery, continued post-operatively and tapered according to the inflammatory response over 4-6wk in patients with previously documented macular edema, recurrent uveitis, chronic anterior uveitis and intermediate uveitis. Rate of complications like macular edema (Chi-square, <i>P</i>=0.459), persistent uveitis (Chi-square, <i>P</i>=0.289) and posterior capsule opacification (Chi-square, <i>P</i>=0.474) were comparable between both the groups.<b>CONCLUSION:</b>ManualSICS and phacoemulsification do not differ significantly in complication rates and final CDVA outcomes. However, manual SICS is significantly faster. It may be the preferred technique in settings where surgical volume is high and access to phacoemulsification is limited, such as in eye camps. It may also be the appropriate technique for uveitic cataract under such circumstances.]]></description>
<pubDate>2015/10/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Rahul Bhargava,Prachi Kumar,Shiv Kumar Sharma,Manoj Kumar and Avinash Kaur]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Rahul Bhargava,Prachi Kumar,Shiv Kumar Sharma,Manoj Kumar and Avinash Kaur</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150520]]></guid><cfi:id>1118</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Results of cataract surgery in renal transplantation and hemodialysis patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150521]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To compare the effect of cataract surgery in renal transplantation and hemodialysis patients.<b>METHODS:</b> We evaluated 51 eyes of 31 renal transplantation patients, 41 eyes of 29 hemodialysis patients and 45 eyes of 32 normal control patients who received phacoemulsification and intraocular lens (IOL) implantation from January, 2000 to August, 2014 in the Beijing Friendship Hospital. Each individual underwent a blood routine and a kidney function examination. Routine ophthalmologic examination included best-corrected visual acuity (BCVA), a slit-lamp examination to detect cataract type, determination of intraocular pressure, a corneal endothelial count, and fundus examination. All patients received phacoemulsification and an IOL implantation.<b>CONCLUSION:</b> This study showed that the PSC was more in the renal transplantation patients. BCVA was better and fundus lesions were less frequent in the renal transplantation group than in the hemodialysis group after cataract surgery. The multiple linear regression was showed that the Hb was positively correlated with postoperative BCVA, while Cr was negatively correlated with postoperative BCVA. These results may act as indicators in predicting visual acuity for the renal transplantation and hemodialysis patients.]]></description>
<pubDate>2015/10/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Li-Hua Luo,Shi-Hong Xiong and Yan-Ling Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Li-Hua Luo,Shi-Hong Xiong and Yan-Ling Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150521]]></guid><cfi:id>1117</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Diffusion tensor imaging of optic nerve and optic radiation in primary chronic angle-closure glaucoma using 3T magnetic resonance imaging]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150522]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To evaluate the value of quantitative diffusion tensor imaging (DTI) in assessing the axonal and myelin damage of the optic nerves and optic radiations in patients with chronic primary angle-closure glaucoma (PACG) by using high-field magnetic resonance (MR) imaging (3T).<b>METHODS:</b>Twenty patients with bilateral chronic PACG and twenty age- and sex matched disease-free control subjects were enrolled. Conventional MRI and DTI were performed on all subjects using 3T MR scanner. Mean diffusivity (MD), fractional anisotropy (FA), axial diffusivities (AD) and radial diffusivities (RD) of each optic nerve and each optic radiation were measured by using post-processing software of DTI studio 2.3, and then compared between left eyes and right eyes and between patients group and control group. The paired-sample <i>t</i>- test were used．<b>RESULTS:</b> There was no abnormality in the shape and signal intensity of the optic nerves and optic radiations in patients group and control group on the conventional MRI. No significant differences were observed in the FA, MD, AD and RD between the right and left optic nerves and optic radiations within patients group and control group (<i>P</i>＞0.05). The optic nerves and optic radiations of patients with chronic PACG, as compared with control subjects, had significantly higher MD, AD, RD and significantly lower FA (<i>P</i>&lt;0.05).<b>CONCLUSION:</b>The diffusivity of optic nerves and optic radiations in chronic PACG group showed abnormal and diffusivity parameters could be used markers of axonal and myelin injury in glaucoma.]]></description>
<pubDate>2015/10/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Qiu-Juan Zhang,Dong Wang,Zhi-Lan Bai,Bai-Chao Ren and Xiao-Hui Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Qiu-Juan Zhang,Dong Wang,Zhi-Lan Bai,Bai-Chao Ren and Xiao-Hui Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150522]]></guid><cfi:id>1116</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Anterior segment changes after pharmacologic mydriasis using Pentacam and optical coherence tomography in angle closure suspects]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150523]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To compare the dynamic changes of anterior segment parameters especially iris morphology induced by pharmacologic mydriasis between angle closure suspects and normal controls.<b>METHODS:</b>The study group comprised 19 eyes of 19 angle closure suspects and 19 eyes of 19 age- and sex-matched normal open-angle eyes. Pentacam and optical coherence tomography measurements before and 30min after instillation of compound tropicamide eye drop were performed and compared. Biometric evaluations of iris tomography and anterior chamber angle were estimated by a customized image-processing software.<b>RESULTS:</b>Baseline axial length, iris cross sectional area and volume did not differ significantly between angle closure suspects and normal controls. Angle closure suspects had smaller pupil size, narrower anterior segment dimension and axial length, thinner iris with greater curve in comparison with normal controls. Pharmacologic mydriasis led to significant increments in iris thickness at 750 μm, anterior chamber depth and volume, whereas significant decrements in iris curve, cross sectional area and volume in both groups. Angle opening distance at 500 μm was increased significantly in normal controls (from 0.465±0.115 mm to 0.539±0.167 mm, <i>P</i>=0.009), but not in angle closure suspects (from 0.125±0.100 mm to 0.145±0.131 mm, <i>P</i>=0.326). Iris volume change per millimeter of pupil dilation (△IV/△PD) decreased significantly less in angle closure suspects than normal controls (-2.47±1.33 mm<sup>2</sup> <i>vs</i> -3.63±1.58 mm<sup>2</sup>, <i>P</i>=0.019). Linear regression analysis showed that the change of angle opening distance at 500 μm was associated most with the change of central anterior chamber depth (<i>β</i>=0.841, <i>P</i>=0.002) and △IV/△PD (<i>β</i>=0.028, <i>P</i>=0.002), followed by gender (<i>β</i>=0.062, <i>P</i>=0.032).<b>CONCLUSION:</b>Smaller iris volume decrement per millimeter of pupil dilation is related significantly with the less anterior angle opening in angle closure suspects after pharmacologic mydriasis. Dynamic iris change may be as a prospective indicator of iris compressibility and angle closure glaucoma.]]></description>
<pubDate>2015/10/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jing-Min Guo,Mu Li,Xiao-Lan Xu,Hong Zhang and Jun-Ming Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jing-Min Guo,Mu Li,Xiao-Lan Xu,Hong Zhang and Jun-Ming Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150523]]></guid><cfi:id>1115</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Total oxidative stress, paraoxonase and arylesterase levels at patients with pseudoexfoliation syndrome and pseudoexfoliative glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150524]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To investigate the oxidative stress status of the aqueous humor and serum of patients with pseudoexfoliation (PEX) syndrome and pseudoexfoliative glaucoma (PEG) and to measure paraoxonase (PON) and arylesterase (ARE) levels.<b>METHODS:</b> A total of 78 patients were enrolled in the study, with 26 patients in each separate group. The patients were divided into three groups:the first group entailed PEX syndrome patients, while the second group consisted of patients with PEG and the third group involved patients with no additional systemic diseases, other than the diagnosis of cataract as control. Total oxidative stress (TOS), total antioxidant capacity (TAC), PON, and ARE levels in aqueous humor and serum were measured.<b>RESULTS:</b> TAC, PON and arylesterase levels in aqueous humor and serum of the PEX syndrome and PEG patients were significantly decreased compared with control group (<i>P</i>&lt;0.05). TOS values were higher in patients with PEX syndrome and PEG than controls (<i>P</i>&lt;0.05). TAC, PON and ARE levels of aqueous humor did not differ significantly between the PEX syndrome and PEG groups<b>CONCLUSION:</b> These findings are potentially of significance and add to the growing body of evidence for oxidative stress in PEX syndrome and PEG. Decreased antioxidant defense and increased oxidative stress system may play an important role in the pathogenesis of PEX syndrome and PEG.]]></description>
<pubDate>2015/10/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Feyza Dursun,Ayse Vural Ozec,Huseyin Aydin,Aysen Topalkara,Ayhan Dursun,Mustafa Ilker Toker,Haydar Erdogan and Mustafa Kemal Arici]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Feyza Dursun,Ayse Vural Ozec,Huseyin Aydin,Aysen Topalkara,Ayhan Dursun,Mustafa Ilker Toker,Haydar Erdogan and Mustafa Kemal Arici</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150524]]></guid><cfi:id>1114</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Brain-derived neurotrophic factor in patients with advanced age-related macular degeneration]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150525]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To investigate the serum level of the brain-derived neurotrophic factor (BDNF) in age-related macular degeneration (AMD) and healthy control subjects. The disruption in the tight balance of neuroinflammatory and neuroprotective processes in an immune-privileged site like retina is proposed to contribute to the pathogenesis of AMD. One of the main neuroprotective mediators in the central nervous system is BDNF with its serum level notably affected in several neurodegenerative disorders.<b>METHODS</b>:Thirty-six patients with AMD and 36 age-matched controls were enrolled in this study. The serum level of BDNF was measured using the enzyme-linked immunosorbent assay method. Results were analyzed to compare case and control values. Comparisons were also made between the BDNF level of wet- <i>vs</i> dry-AMD, and male <i>vs</i> female patients and controls. Analysis of variance (ANOVA) and Student’s<i> t</i>-test were employed to analyze the data.<b>RESULTS:</b> The mean BDNF levels in AMD group were significantly higher than the control group. Furthermore, our analysis revealed greater BDNF values in all AMD subgroups compared to controls (<i>P</i>=0.004, 0.005, 0.001 and 0.02 for male wet-AMD, male dry-AMD, female wet-AMD and female dry-AMD <i>vs</i> controls, respectively). The BDNF level however did not vary between wet- and dry-AMD patients (<i>P</i>=0.74). While within-group comparisons in males and females of AMD and control groups did not show any difference in BDNF (<i>P</i>=0.16, 0.64 and 0.85 for wet-AMD, dry-AMD and control groups, respectively), between-group data showed a higher mean BDNF in both male and female AMD subjects than their peer controls.<b>CONCLUSION:</b> This study demonstrated that the serum BDNF level is different in patients with AMD as compared to subjects without AMD. Future attempts should be done to unravel beneficial or deleterious effect of this neurotrophin in the pathogenesis of AMD.]]></description>
<pubDate>2015/10/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mehrdad Afarid,Mohammad Torabi-Nami,Alijan Nemati,Amir Khosravi and Mahyar Malekzadeh]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mehrdad Afarid,Mohammad Torabi-Nami,Alijan Nemati,Amir Khosravi and Mahyar Malekzadeh</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150525]]></guid><cfi:id>1113</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Characterization of human retinal vessel arborisation in normal and amblyopic eyes using multifractal analysis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150526]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To characterize the human retinal vessel arborisation in normal and amblyopic eyes using multifractal geometry and lacunarity parameters.<b>METHODS:</b>Multifractal analysis using a box counting algorithm was carried out for a set of 12 segmented and skeletonized human retinal images, corresponding to both normal (6 images) and amblyopia states of the retina (6 images).<b>RESULTS:</b>It was found that the microvascular geometry of the human retina network represents geometrical multifractals, characterized through subsets of regions having different scaling properties that are not evident in the fractal analysis. Multifractal analysis of the amblyopia images (segmented and skeletonized versions) show a higher average of the generalized dimensions (<i>Dq</i>) for <i>q</i>=0, 1, 2 indicating a higher degree of the tree-dimensional complexity associated with the human retinal microvasculature network whereas images of healthy subjects show a lower value of generalized dimensions indicating normal complexity of biostructure. On the other hand, the lacunarity analysis of the amblyopia images (segmented and skeletonized versions) show a lower average of the lacunarity parameter <i>Λ</i> than the corresponding values for normal images (segmented and skeletonized versions).<b>CONCLUSION:</b>The multifractal and lacunarity analysis may be used as a non-invasive predictive complementary tool to distinguish amblyopic subjects from healthy subjects and hence this technique could be used for an early diagnosis of patients with amblyopia.]]></description>
<pubDate>2015/10/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Stefan Tlu, Cristina Vlduiu and Carmen A. Lupacu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Stefan Tlu, Cristina Vlduiu and Carmen A. Lupacu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150526]]></guid><cfi:id>1112</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Fundus autofluorescence in central serous chorioretinopathy:association with spectral-domain optical coherence tomography and fluorescein angiography]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150527]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To evaluate the correlation among changes in fundus autofluorescence (AF) measured using infrared fundus AF (IR-AF) and short-wave length fundus AF (SW-AF) with changes in spectral-domain optical coherence tomography (SD-OCT) and fluorescein angiography (FA) in central serous chorioretinopathy (CSC).<b>METHODS:</b>Two hundred and twenty consecutive patients with CSC were included. In addition to AF, patients were assessed by means of SD-OCT and FA. Abnormalities in images of IR-AF, SW-AF, FA were analyzed and correlated with the corresponding outer retinal alterations in SD-OCT findings.<b>RESULTS:</b>Eyes with abnormalities on either IR-AF or SW-AF were found in 256 eyes (58.18%), among them 256 eyes (100%) showed abnormal IR-AF, but SW-AF abnormalities were present only in 213 eyes (83.20%). The hypo-IR-AF corresponded to accumulation of sub-retinal liquid, collapse of retinal pigment epithelium (RPE) or detachment of RPE with or without RPE leakage point in the corresponding area. The hyper-IR-AF corresponded to the area with loss of the ellipsoid portion of the inner segments and sub-sensory retinal deposits or focal melanogenesis under sensory retina. The hypo-SW-AF corresponded to accumulation of sub-retinal liquid or atrophy of RPE. The hyper-SW-AF associated with sub-sensory retinal deposits, detachment of RPE and focal melanogenesis.<b>CONCLUSION:</b>IR-AF was more sensitive than SW-AF and FA for identifying pathological abnormalities in CSC. The characteristics of IR-AF in CSC were attributable to the modification of melanin in the RPE. IR-AF should be used as a common diagnostic tool for identifying pathological lesion in CSC.K<b>EYWORDS:</b>central serous chorioretinopathy; fluorescein angiography; fundus autofluorescence; optical coherence tomography]]></description>
<pubDate>2015/10/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Peng Zhang,Hai-Yan Wang,Zi-Feng Zhang,Dong-Jie Sun,Jin-Ting Zhu,Juan Li and Yu-Sheng Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Peng Zhang,Hai-Yan Wang,Zi-Feng Zhang,Dong-Jie Sun,Jin-Ting Zhu,Juan Li and Yu-Sheng Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150527]]></guid><cfi:id>1111</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Helvacioglu reproducibility index:a new algorithm to evaluate the effects of misalignments on the measurements of retinal nerve fiber layer by spectral-domain OCT]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150528]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To evaluate the effect of misalignment on the measurements of retinal nerve fiber layer (RNFL) by spectral-domain optical coherence tomography (OCT).<b>METHODS:</b>A total of 42 eyes from 21 healthy young subjects underwent RNFL measurements with RTVue spectral-domain OCT (Optovue Inc., Fremont, California, USA). Two baseline measurements with perfectly aligned central circle to the borders of the optic nerve and four misaligned measurements which were misaligned towards to four quadrants were taken. The differences in RNFL between the baseline and misaligned measurements were analyzed with a new algorithm called Helvacioglu reproducibility index (HRI) which is designed to measure the reproducibility of the scans by evaluating the RNFL changes in the four main quadrants.<b>RESULTS:</b>The average RNFL scores of the first two baseline measurements have good correlation (c=0.930) and good reproducibility scores (0.15±0.07). Superior misaligned measurements had significantly lower superior quadrant score and higher inferior quadrant score, similar nasal and little higher temporal scores (<i>P</i>1, <i>P</i>2&lt;0.001, <i>P</i>3=0.553, <i>P</i>4=0.001). Inferior misaligned measurements had significantly higher superior quadrant score and lower inferior quadrant score with similar temporal and little lower nasal scores (<i>P</i>1, <i>P</i>2&lt;0.001, <i>P</i>3=0.315, <i>P</i>4=0.016). Nasal misaligned measurements had significantly higher temporal quadrant score and lower nasal quadrant score with little lower superior and inferior scores (<i>P</i>1, <i>P</i>2, <i>P</i>4&lt;0.001, <i>P</i>3=0.005). Temporal misaligned measurements had significantly higher nasal quadrant score and lower temporal quadrant score with similar superior and little higher inferior scores (<i>P</i>1,<i> P</i>2&lt;0.001, <i>P</i>3=0.943, <i>P</i>4=0.001).<b>CONCLUSION:</b>Good alignment of the central circle to the borders of optic nerve is crucial to have correct and repeatable RNFL measurements. Misalignment to a quadrant resulted in falsely low readings at that quadrant and falsely high readings at the opposite quadrant.]]></description>
<pubDate>2015/10/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Firat Helvacioglu,Osman Murat Uyar,Sadik Sencan,Zeki Tunc and Ziya Kapran]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Firat Helvacioglu,Osman Murat Uyar,Sadik Sencan,Zeki Tunc and Ziya Kapran</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150528]]></guid><cfi:id>1110</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Relationship between short-wavelength automatic perimetry and Heidelberg retina tomograph parameters in eyes with ocular hypertension]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150529]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To compare and correlate optic nerve head parameters obtained byHeidelberg retina tomograph (HRT) with short-wavelength automatic perimetry (SWAP) indices in eyes with ocular hypertension (OHT).<b>METHODS:</b> One hundred and forty-six patients with OHT included in the present study. All subjects had reliable SWAP and HRT measurements performed within a 2wk period. The eyes were classified as normal/abnormal according to visual field criteria and Moorfields regression analysis (MRA). Correlations between visual field indices and HRT parameters were analyzed using Pearson correlation coefficient (<i>r</i>).<b>RESULTS:</b>Twenty-nine eyes (19.9%) had SWAP defects. Twenty-nine eyes (19.9%) were classified as abnormal according to global MRA. Six eyes (4.1%) had abnormal global MRA and SWAP defects. The <i>k</i> statistic is 0.116 (<i>P</i>=0.12) indicating a very poor agreement between the methods. No statistical significant correlation between HRT and SWAP parameters was detected.<b>CONCLUSION:</b><i></i>SWAP defects may coexist with abnormalities of optic disc detected by HRT in eyes with OHT. In most eyes, however, the two methods detect different glaucoma properties.]]></description>
<pubDate>2015/10/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Christos Pitsas,Dimitrios Papaconstantinou,Ilias Georgalas and Ioannis Halkiadakis]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Christos Pitsas,Dimitrios Papaconstantinou,Ilias Georgalas and Ioannis Halkiadakis</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150529]]></guid><cfi:id>1109</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Orbital metastases in Italy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150530]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To describe a series of Italian patients with orbital metastasis focusing on the outcomes in relation to the different primary site of malignancy.<b>METHODS</b>:Retrospective chart review of 93 patients with orbital metastasis collected in a tertiary referral centre in a period of 38y and review of literature.<b>RESULTS</b>:Out of 93 patients, 52 were females and 41 were males. Median age at diagnosis was 51y (range 1 to 88y). The patients have been divided into four groups on the basis of the year of diagnosis. The frequency of recorded cases had decreased significantly (<i>P</i>&lt;0.05) during the last 9.5y. Primary tumor site was breast in 36 cases (39%), kidney in 10 (11%), lung in 8 (9%), skin in 6 (6%); other sites were less frequent. In 16 case (17%) the primary tumor remained unknown. The most frequent clinical findings were proptosis (73%), limited ocular motility (55%), blepharoptosis (46%) and blurred vision (43%). The diagnosis were established by history, ocular and systemic evaluation, orbital imaging studies and open biopsy or fine needle aspiration biopsy (FNAB). Treatment included surgical excision, irradiation, chemotherapy, hormone therapy, or observation. Ninety-one percent of patients died of metastasis with an overall mean survival time (OMST) after the orbital diagnosis of 13.5mo.<b>CONCLUSION</b>:Breast, kidney and lung are the most frequent primary sites of cancer leading to an orbital metastasis. When the primary site is unknown, gastrointestinal tract should be carefully investigated. In the last decade a decrease in the frequency of orbital metastasis has been observed. Surgery provides a local palliation. Prognosis remains poor with a OMST of 13.5mo ranging from the 3mo in the lung cancer to 24mo in the kidney tumor.]]></description>
<pubDate>2015/10/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Patrizio Magliozzi,Diego Strianese,Paola Bonavolontà,Mariantonia Ferrara,Pasquale Ruggiero,Raffaella Carandente,Giulio Bonavolontà and Fausto Tranfa]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Patrizio Magliozzi,Diego Strianese,Paola Bonavolontà,Mariantonia Ferrara,Pasquale Ruggiero,Raffaella Carandente,Giulio Bonavolontà and Fausto Tranfa</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150530]]></guid><cfi:id>1108</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Removal of the eye in a tertiary care center of China:a retrospective study on 573 cases in 20 years]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150531]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To investigate the original protopathy, direct indications, clinical characteristics, complications of orbit plants and visual conditions of eye enucleation/evisceration.<b>METHODS:</b> A retrospective study of 573 eyes removed (573 inpatients) at Ophthalmology Department in a tertiary care center of China from January 1993 to December 2012 was completed.<b>RESULTS</b>:Cases underwent removal of the eye accounted for 2.15% of total ophthalmology inpatients, whose annual frequency declined from 3.80% to 0.52%. There were 167 eyes (29.14%) being enucleated and 406 (70.86%) eviscerated. Annual proportion of evisceration rose from 16.67% in 1993 to 90.48% in later years. Trauma was the top one (65.62%) in original protopathies followed by neoplasm (13.44%) and ocular infections (5.76%). Phthisis bulbi (45.20%) was the most common direct indication, succeeded by malignant tumor (12.57%), loss/unreconstructed of intraocular tissues due to trauma (11.00%), untreatable inflammation (9.60%), intractable glaucoma (8.55%) and sclerocorneal staphyloma (5.24%). Exenteration was underwent in 20 (25.97%) cases (40% for recurrent carcinoma). Following evisceration, secondary prosthesis implantation was more and earlier, implant exposure occurred in less but earlier and infection and extraction/exchange of implants were more than those following enucleation. Male, phthisis bulbi, evisceration and secondary implantation meant lower risk of implant exposure; eyes removed within 24h following trauma was an independent risk factor. There were 14.37% of eyes with vision of light perception at least as been removed. In the residual contralateral eyes, low vision accounted 5.58% and blindness 3.14%.<b>CONCLUSION</b>:Ocular trauma, tumor and infections were great threats to eyeball preservation. Early and effective controlling of any original protopathies was vital. Generally evisceration presented more superior and safe outcomes than enucleation did. Visual conditions of the sufferers should be focused on.]]></description>
<pubDate>2015/10/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ying Zhang,Mao-Nian Zhang,Xin Wang and Xiao-Fei Chen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ying Zhang,Mao-Nian Zhang,Xin Wang and Xiao-Fei Chen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150531]]></guid><cfi:id>1107</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Evaluation of patient visual comfort and repeatability of refractive values in non-presbyopic healthy eyes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150532]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To evaluate the intra-operator repeatability in healthy subjects using the WAM-5500 auto-kerato/refractometer and the iTrace aberrometer, to compare the refractive values and the subjective refraction obtained with both devices and to determine which of these three spherocylindrical corrections allows the subject to achieve the best visual comfort.
<b>METHODS:</b> Forty-two non-presbyopic healthy eyes of 42 subjects were enrolled in this prospective study. Refractive values were compared, evaluating the repeatability, the relationship between the methods and the best visual comfort obtained.
<b>RESULTS:</b> Sphere, cylinder and axis results showed good intraclass correlation coefficients (ICC); the highest ICC was obtained using the spherical refraction with the autorefractometer and the aberrometer, achieving levels of 0.999 and 0.998, respectively. The power vector (PV) was calculated for each refraction method, and the results indicated that there were no statistically significant differences between them (P>0.05). Direct comparison of PV measurements using the three methods showed that aberrometer refraction gave the highest values, followed by the subjective values; the autorefractometer gave the lowest values. The subjective method correction was most frequently chosen as the first selection. Equal values were found for the autorefractometer and the aberrometer as the second selection.
<b>CONCLUSION:</b> The iTrace aberrometer and the WAM-5500 auto-kerato/refractometer showed high levels of repeatability in healthy eyes. Refractive corrections with the aberrometer, the autorefractometer and subjective methods presented similar results, but spherocylindrical subjective correction was the most frequently selected option. These technologies can be used as complements in refractive evaluation, but they should not replace subjective refraction.
]]></description>
<pubDate>2015/10/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Francisco Segura,Ana Sanchez-Cano,Carmen Lopez de la Fuente,Lorena Fuentes-Broto and Isabel Pinilla]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Francisco Segura,Ana Sanchez-Cano,Carmen Lopez de la Fuente,Lorena Fuentes-Broto and Isabel Pinilla</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150532]]></guid><cfi:id>1106</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Oxygen permeability of soft contact lenses in different pH, osmolality and buffering solution]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150533]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To determine the effect of pH, osmolality, and buffering system on the oxygen permeability (Dk) of soft contact lenses.<b>METHODS:</b> Two hydrogel lenses (nelfilcon A and etafilcon A) and 2 silicone hydrogel lenses (lotrafilcon A and balafilcon A) were used in the study. These lenses were incubated in phosphate-buffered saline (PBS) and borate-buffered saline (BBS) solutions adjusted by 0.8 pH increments to a pH in the range of 5.8-9.0 or in hypotonic (280 mOsmol/kg), isotonic (310 mOsmol/kg) and hypertonic (380 mOsmol/kg) PBS solutions. Polarographic method was used for measuring the Dk and lenses were stacked as 4 layers to correct the boundary effect.<b>RESULTS:</b> Dk values of all contact lenses measured in BBS solutions were more stable than those in PBS solutions. Especially the etafilcon A lens showed a relative big change compared with other types of contact lenses at the same conditions. When the osmolality of PBS solution increased from hypotonic to hypertonic, Dk of all contact lenses decreased. Variations in Dk existed depending on lens materials, etafilcon A lens was the most affected and nelfilcon A was the least affected by osmolality.<b>CONCLUSION</b>:From the result obtained, it is revealed that Dk of contact lenses is changed by the pH, osmolality, and buffering condition of tear. Thus, Dk of contact lens can be varied by the lens wearers'' physiological and/or pathological conditions.]]></description>
<pubDate>2015/10/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Se Eun Lee,So Ra Kim and Mijung Park]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Se Eun Lee,So Ra Kim and Mijung Park</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150533]]></guid><cfi:id>1105</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Reproducibility of optical quality parameters measured at objective and subjective best focuses in a double-pass system]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150534]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To evaluate intra-session repeatability and reproducibility of optical quality parameters measured at objective and subjective best focuses in a double-pass system.<b>METHODS:</b> Thirty Chinese healthy adults (19 to 40 years old) meeting our inclusion criterion were enrolled in the study. After a basic eye examination, two methods of optical quality measurement, based on subjective and objective best focuses were performed using the Optical Quality Analysis System (OQAS) with an artificial pupil diameter of 4.0 mm.<b>RESULTS:</b> With each method, three consecutive measurements of the following parameters:the modulation transfer function cutoff frequency (MTFcutoff), the Strehl<sup>2D</sup> ratio, the OQAS values (OVs) at contrasts of 100%, 20%, 9% and the objective scatter index (OSI) were performed by an experienced examiner. The repeatability of each method was evaluated by the repeatability limit (RL) and the coefficient of repeatability (COR). Reproducibility of the two methods was evaluated by intra-class correlation coefficient (ICC) and the 95% limits of agreement (Bland and Altman analysis). Thirty subjects, seven females and twenty three males, of whom 15 right eyes and 15 left eyes were selected randomly for recruitment in the study. The RLs (percentage) for the six parameters measured at objective focus and subjective focus ranged from 8.44% to 15.13% and 10.85% to 16.26%, respectively. The CORs for the two measurement methods ranged from 8.27% to 14.83% and 10.63% to 15.93%, respectively. With regard to reproducibility, the ICCs for the six parameters of OQAS ranged from 0.024 to 0.276. The 95% limits of agreement obtained for the six parameters (in comparison of the two methods) ranged from -0.57 to 42.18 (MTFcutoff), -0.01 to 0.23 (Strehl<sup>2D</sup> ratio), -0.02 to 1.40 (OV100%), -0.10 to 1.75 (OV20%), -0.14 to 1.80 (OV9%) and -1.46 to 0.18 (OSI).<b>CONCLUSION:</b>Measurements provided by OQAS with either method showed a good repeatability. However, the results obtained from the two different measurement methods showed a poor reproducibility. These findings suggest that it might be best to evaluate patients’ optical quality by OQAS using the best focus as chosen automatically by the instrument.]]></description>
<pubDate>2015/10/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ai-Lian Hu,Li-Ya Qiao,Ye Zhang,Xiao-Gu Cai,Lei Li and Xiu-Hua Wan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ai-Lian Hu,Li-Ya Qiao,Ye Zhang,Xiao-Gu Cai,Lei Li and Xiu-Hua Wan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150534]]></guid><cfi:id>1104</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Application of traditional indexes and adverse events in the ophthalmologic perioperative medical quality evaluation during 2010-2012]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150535]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To evaluate the medical quality of ophthalmologic perioperative period during 2010-2012 in our hospital.<b>METHODS:</b>The relevant data of perioperative period were collected in our hospital during 2010-2012, and the medical quality of perioperative period was evaluated by using the traditional evaluation indexes and adverse events. Whereby, the traditional indicators include vision changes, improving of intraocular pressure, diagnostic accordance rate before and after operation, cure improvement rate, successful rescue rate, and incidence of surgical complications, <i>etc</i>. Adverse events are associated with ophthalmologic perioperative events including pressure sores, postoperative wound infection, drug adverse events, and equipment related adverse events.<b>RESULTS:</b>There were 1483, 1662 and 1931 ophthalmic operations in our hospital in the year 2010, 2011 and 2012, respectively. From traditional index analysis, the proportions of vision improvement for each year were 96.43%, 96.76% and 97.32%, respectively; the rates of intraocular pressure improvement were 87.50%, 85.72% and 90.17%, respectively (<i>P</i> &lt;0.05); the diagnostic accordance rates before and after operation were 99.86%, 99.94% and 99.90%, respectively; cure improvement rates were 99.73%, 99.93% and 99.84%, respectively; the successful rescue rates were 82.98%, 81.46% and 76.66%, respectively; the complications incidence rates were 18.44%, 17.52% and 17.97%, respectively. The negative factor analysis results showed that:among all the patients of ophthalmic surgeries in our hospital during 2010 and 2012, only one case of postoperative wound infection was found in 2011, and also only one case of tumbling in 2010. The adverse drug events for each year were 1 case (0.07%), 2 cases (0.12%), and 4 cases (0.21%), respectively; the medical device adverse events for each year were 3 cases (0.20%), 5 cases (0.30%), and 6 cases (0.31%), respectively. Noticeably, only one case with postoperative infection of endophthalmitis was found in 2011. Moreover, no pulmonary infection or pulmonary embolism occurred during the three years. The perioperative adverse event rates for each year were 0.34% (5/1483), 0.48% (8/1662) and 0.52% (10/1931), respectively. Though incidence was rising during the three years period, no statistical significance was observed (<i>P</i>&gt;0.05). It is the same case with drugs and medical devices adverse events (<i>P</i> &gt;0.05).<b>CONCLUSION:</b>Traditional indicators reflect an excellent operation of the perioperative ophthalmologic quality, whereas adverse events analysis indicates some underlying problems. Compared with the traditional indexes for medical quality evaluation, the index of adverse events is more reasonable and easier to make an objective evaluation for medical quality of ophthalmologic perioperation, facilitating further refine analysis. Reasonable application of the adverse events indicators helps hospital to make the detailed quality control measures.]]></description>
<pubDate>2015/10/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yong-Na Bian,Jian Shi,Jun-Jun She,Jie Wu and Jian-Min Gao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yong-Na Bian,Jian Shi,Jun-Jun She,Jie Wu and Jian-Min Gao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150535]]></guid><cfi:id>1103</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Investigation of the efficiency of intrastromal ring segments with cross-linking using different sequence and timing for keratoconus]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150411]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To evaluate and compare the efficacy and stability of intrastromal corneal ring segment (ICRs) implantation with cross-linking (CXL) using different sequence and timing.<b>METHODS</b>:In this single retrospective study, 86 keratoconic eyes subjected the ICRs implantation. We analyzed only 41 eyes that had complete follow-ups. They were divided into three groups:ICRs implantation was applied only (group normal), ICRs first followed by CXL immediately (group CXL-S), CXL first followed by ICRs long after (group CXL-B). The visual acuity, refractive results, keratometry were compared preoperatively and 1y postoperatively. Their differences among the three groups were also analyzed.<b>RESULTS:</b>Group normal comprised 25 eyes, group CXL-S 8 eyes, and group CXL-B 8 eyes. There were improvements in the mean uncorrected distance visual acuity (UDVA) and the mean corrected distance visual acuity (CDVA) compared preoperatively and 1y postoperatively {UDVA:0.31 (<i>P</i>=0.030) logarithmic minimum angle of resolution [logMAR] group normal, 0.4<i> (P</i>=0.020) group CXL-S, 0.45 (<i>P</i>=0.001) group CXL-B; CDVA:0.21 logMAR (<i>P</i>=0.013) group normal, 0.30 (<i>P</i>=0.036) group CXL-S; 0.26 (<i>P</i>=0.000) group CXL-B}. The refractive and topographic outcomes also showed improvements. In terms of comparisons among the three groups, all the<i> P</i> values were above 0.05, showing no significant difference. But only group CXL-B had improvement in UDVA and CDVA for all the patients.<b>CONCLUSION:</b>With safety and good visual outcomes, ICRs implantation is a viable alternative for keratoconus. No significant difference was found among these three groups.]]></description>
<pubDate>2015/7/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xuan-Li Liu,Ping-Hua Li,Pierre Fournie and François Malecaze]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xuan-Li Liu,Ping-Hua Li,Pierre Fournie and François Malecaze</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150411]]></guid><cfi:id>1102</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Nd:Yag laser iridotomy in Shaffer-Etienne grade 1 and 2:angle widening in our case studies]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150412]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To obtain widening of a potentially occludable angle, in according to Kanski’s indications, through preventive Nd:Yag laser iridotomy. The observational study was performed by using gonioscopy for the selection and follow-up of 1165 treated eyes and exploiting Shaffer-Etienne gonioscopic classification as a quality/quantity test of the angle recession.<b>METHODS</b>:Between September 2000 and July 2012, 586 patients were selected at the Outpatients’ Ophthalmological Clinic of the Policlinico Umberto I of Rome in order to undergo Nd:Yag laser iridotomy. A Goldmann type contact lens, Q-switched mode, 2-3 defocus, and 7-9 mJ intensity with 2-3 impulse discharges were used for surgery.<b>RESULTS</b>:From as early as the first week, a whole 360° angle widening were evident in the patients, thus showing the success of Nd:Yag laser iridotomy in solving relative pupil block. The angle remained narrow by 270° in 14 eyes only, despite repetitions of further treatment with laser iridotomy in a different part of the iris, twice in 10 eyes and three times in 4 eyes.<b>CONCLUSION</b>:Nd:Yag laser iridotomy revealed itself as being a safe and effective treatment in widening those critical Shaffer-Etienne grade 1 and 2 potentially occludable angles.]]></description>
<pubDate>2015/7/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Sandra Cinzia Carlesimo,Luigi Di Santo,Pietro Bruni,Aloisa Librando,Antonietta Pompea Falace and Andrea Barbato]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Sandra Cinzia Carlesimo,Luigi Di Santo,Pietro Bruni,Aloisa Librando,Antonietta Pompea Falace and Andrea Barbato</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150412]]></guid><cfi:id>1101</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Autologous sclera-muscle flaps technique in evisceration with hydroxyapatite implantation]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150413]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To provide superior cosmetic results and reduce complications, unlike traditional evisceration coupled with implant insertion technique and its modifications, we have developed a novel and simple technique for anophthalmic patients.<b>METHODS:</b> All patients who underwent the scleral-muscle flaps procedure in evisceration with the placement of hydroxyapatite implant were included in the study. Main outcome measures were complications such as exposure, infection, chemosis, conjunctival inclusion cysts, granulomas. Meanwhile, implant motility was indirectly measured and the results were collected and analyzed.<b>RESULTS:</b> A total of twenty-eight patients were enrolled in the study. Eighteen were men (64.29%) and ten were women (35.71%). Ages ranged from 18 to 65y (mean age, 32 years old). Mean follow-up was 12.32mo (range, 9-16mo). All patients received a hydroxyapatite implant. The average diameter of the implant was 19.29±1.36 mm (range, 18-22 mm). Minor complications occurred in 3 patients, and a major complication was observed in 1 patient. Mean motility were 11.04±1.45 mm horizontally (range, 7-14 mm) and 8.57±1.50 mm vertically (range, 5-12 mm).<b>CONCLUSION:</b> The sclera-muscle flaps technique in evisceration with hydroxyapatite implantation is simple and practical that eases the surgical procedure, enables a proper size hydroxyapatite implantation, distinctively reduces complications and provides superior surgery results, especially the motility of the implant.]]></description>
<pubDate>2015/7/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ying Zhu,Hong Zhang,Yin-Wei Song,Jing-Min Guo,Xiao-Lan Xu and Jun-Ming Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ying Zhu,Hong Zhang,Yin-Wei Song,Jing-Min Guo,Xiao-Lan Xu and Jun-Ming Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150413]]></guid><cfi:id>1100</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Correction of low corneal astigmatism in cataract surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150414]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To evaluate and compare aspheric toric intraocular lens (IOL) implantation and aspheric monofocal IOL implantation with limbal relaxing incisions (LRI) to manage low corneal astigmatism (1.0-2.0 D) in cataract surgery.<b>METHODS:</b>A prospective randomized comparative clinical study was performed<b>. </b>There were randomly recruited 102 eyes (102 patients) with cataracts associated with corneal astigmatism and divided into two groups. The first group received toric IOL implantation and the second one monofocal IOL implantation with peripheral corneal relaxing incisions. Outcomes considered were:visual acuity, postoperative residual astigmatism, endothelial cell count, the need for spectacles, and patient satisfaction. To determine the postoperative toric axis, all patients who underwent the toric IOL implantation were further evaluated using an OPD Scan III (Nidek Co, Japan). Follow-up lasted 6mo.<b>RESULTS:</b> The mean uncorrected distance visual acuity (UCVA) and the best corrected visual acuity (BCVA) demonstrated statistically significant improvement after surgery in both groups. At the end of the follow-up the UCVA was statistically better in the patients with toric IOL implants compared to those patients who underwent implantation of monofocal IOL plus LRI. The mean residual refractive astigmatism was of 0.4 D for the toric IOL group and 1.1 D for the LRI group (<i>P</i>&lt;0.01). No difference was observed in the postoperative endothelial cell count between the two groups.<b>CONCLUSION:</b> The two surgical procedures demonstrated a significant decrease in refractive astigmatism. Toric IOL implantation was more effective and predictable compared to the limbal relaxing incision.]]></description>
<pubDate>2015/7/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Pia Leon,Marco Rocco Pastore,Andrea Zanei,Ingrid Umari,Meriem Messai,Corrado Negro and Daniele Tognetto]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Pia Leon,Marco Rocco Pastore,Andrea Zanei,Ingrid Umari,Meriem Messai,Corrado Negro and Daniele Tognetto</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150414]]></guid><cfi:id>1099</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of posterior capsule opacification at 360-degree square edge hydrophilic and sharp edge hydrophobic acrylic intraocular lens in diabetic patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150415]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To compare posterior capsule opacification (PCO) degree and visual functions after phacoemulsification in eyes implanted with 360-degree square edge hydrophilic acrylic intraocular lens (IOL) (570C C-flex, Rayner) and sharp edge hydrophobic acrylic IOL (Sensar AR40e, AMO) in diabetic patients.<b>METHODS:</b>Sixty diabetic patients underwent uneventful phacoemulsification and randomly implanted one of the two IOLs. The PCO value was measured by retroillumination photographs and Evaluation of Posterior Capsule Opacification (EPCO) 2000 image-analysis software at 1, 6, 12, and 24mo after surgery. Visual acuity, and contrast sensitivity in photopic and mesopic conditions were also examined at each follow up time point. The incidence of eye that required Nd:YAG laser posterior capsulotomy were also compared.<b>RESULTS:</b>There was not any statistically significant difference in PCO scores between Rayner C-flex 570C group and Sensar AR40e group at each follow up time point. Visual acuity, Nd:YAG capsulotomy incidence and contrast sensitivity also had no significant difference during the 24mo follow-up.<b>CONCLUSION:</b> For diabetic patients, Rayner 570C C-flex and Sensar AR40e IOLs are same effective for prevent PCO. The 360-degree square edge design maybe is a good alternative technique to improve PCO prevention.]]></description>
<pubDate>2015/7/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ling Bai,Jin Zhang,Ling Chen,Ting Ma and Hou-Cheng Liang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ling Bai,Jin Zhang,Ling Chen,Ting Ma and Hou-Cheng Liang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150415]]></guid><cfi:id>1098</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Optical performance of toric intraocular lenses in the presence of decentration]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150416]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To evaluate the optical performance of toric intraocular lenses (IOLs) after decentration and with different pupil diameters, but with the IOL astigmatic axis aligned.<b>METHODS:</b> Optical performances of toric T5 and SN60AT spherical IOLs after decentration were tested on a theoretical pseudophakic model eye based on the Hwey-Lan Liou schematic eye using the Zemax ray-tracing program. Changes in optical performance were analyzed in model eyes with 3-mm, 4-mm, and 5-mm pupil diameters and decentered from 0.25 mm to 0.75 mm with an interval of 5° at the meridian direction from 0° to 90°. The ratio of the modulation transfer function (MTF) between a decentered and a centered IOL (MTFDecentration/MTFCentration) was calculated to analyze the decrease in optical performance.<b>RESULTS:</b>Optical performance of the toric IOL remained unchanged when IOLs were decentered in any meridian direction. The MTFs of the two IOLs decreased, whereas optical performance remained equivalent after decentration. The MTFDecentration/MTFCentration ratios of the IOLs at a decentration from 0.25 mm to 0.75 mm were comparable in the toric and SN60AT IOLs. After decentration, MTF decreased further, with the MTF of the toric IOL being slightly lower than that of the SN60AT IOL. Imaging qualities of the two IOLs decreased when the pupil diameter and the degree of decentration increased, but the decrease was similar in the toric and spherical IOLs.
<b>CONCLUSIONS:</b> Toric IOLs were comparable to spherical IOLs in terms of tolerance to decentration at the correct axial position.]]></description>
<pubDate>2015/7/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Bin Zhang,Jin-Xue Ma,Dan-Yan Liu,Ying-Hua Du,Cong-Rong Guo and Yue-Xian Cui]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Bin Zhang,Jin-Xue Ma,Dan-Yan Liu,Ying-Hua Du,Cong-Rong Guo and Yue-Xian Cui</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150416]]></guid><cfi:id>1097</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[High order aberration and straylight evaluation after cataract surgery with implantation of an aspheric, aberration correcting monofocal intraocular lens]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150417]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To evaluate the quality of vision in respect to high order aberrations and straylight perception after implantation of an aspheric, aberration correcting, monofocal intraocular lens (IOL).<b>METHODS:</b>Twenty-one patients (34 eyes) aged 50 to 83y underwent cataract surgery with implantation of an aspheric, aberration correcting IOL (Tecnis ZCB00, Abbott Medical Optics). Three months after surgery they were examined for uncorrected (UDVA) and corrected distance visual acuity (CDVA), contrast sensitivity (CS) under photopic and mesopic conditions with and without glare source, ocular high order aberrations (HOA, Zywave II) and retinal straylight (C-Quant).<b>RESULTS:</b>Postoperatively, patients achieved a postoperative CDVA of 0.0 logMAR or better in 97.1% of eyes. Mean values of high order abberations were +0.02±0.27 (primary coma components) and -0.04±0.16 (spherical aberration term). Straylight values of the C-Quant were 1.35±0.44 log which is within normal range of age matched phakic patients. The CS measurements under mesopic and photopic conditions in combination with and without glare did not show any statistical significance in the patient group observed (<i>P</i>≥0.28).<b>CONCLUSION:</b>The implantation of an aspherical aberration correcting monofocal IOL after cataract surgery resulted in very low residual higher order aberration (HOA) and normal straylight.]]></description>
<pubDate>2015/7/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Florian T A Kretz,Tamer Tandogan,Ramin Khoramnia and Gerd U Auffarth]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Florian T A Kretz,Tamer Tandogan,Ramin Khoramnia and Gerd U Auffarth</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150417]]></guid><cfi:id>1096</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Angle parameter changes of phacoemulsification and combined phacotrabeculectomy for acute primary angle closure]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150418]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To evaluate the difference in angle parameters and clinical outcome following phacoemulsification and combined phacotrabeculectomy in patients with acute primary angle closure (APAC) using ultrasound biomicroscopy (UBM).<b>METHODS:</b> Patients (<i>n=</i>23, 31 eyes) were randomized to receive phacoemulsification or combined phacotrabeculectomy (<i>n=</i>24, 31 eyes). Best-corrected visual acuity (BCVA), intraocular pressure (IOP), the main complications following surgery, and indentation gonioscopy and angle parameters measured using UBM were documented preoperatively and postoperatively.<b>RESULTS:</b>The improvement in BCVA in the phacoemulsification group was significantly greater than in the combined group (<i>P</i>&lt;0.05). IOP in the phacoemulsification group was slightly higher than in the combined group following 1wk of follow-up (<i>P&lt;</i>0.05), whereas there was no significant difference between the two groups at the latter follow-up (<i>P</i>&gt;0.05). Phacoemulsification alone resulted in a slight increase in the trabecular ciliary processes distance compared with the combined surgery (<i>P&lt;</i>0.05), whereas the other angle parameters showed no significant difference between the groups. Complications in combined group were greater than phacoemulsification only group.<b>CONCLUSION:</b>Both surgeries effectively opened the drainage angle and deepened the anterior chamber, and IOP was well controlled postoperatively. However, phacoemulsification showed better efficacy in improving visual function and showed reduced complications following surgery.]]></description>
<pubDate>2015/7/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Shi-Wei Li,Yan Chen,Qiang Wu,Bin Lu,Wen-Qing Wang and Jian Fang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Shi-Wei Li,Yan Chen,Qiang Wu,Bin Lu,Wen-Qing Wang and Jian Fang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150418]]></guid><cfi:id>1095</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Bleb needling outcomes for failed trabeculectomy blebs in Asian eyes:a 2-year follow up]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150419]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To describe the outcomes of bleb needling in primary glaucoma in an Asian tertiary eye centre over a 2y period. To compare the success rates between primary angle-closure glaucoma (PACG) and primary open angle glaucoma (POAG). Lastly, to identify factors associated with success of bleb needling.<b>METHODS:</b>This was a retrospective review of 227 patients who underwent bleb needling between June 2009 and June 2011 in Singapore National Eye Centre. The 5-fluorouracil (5-FU) augmented bleb needling was performed either at the slit lamp or in the operating theatre. Repeat bleb needlings were performed as necessary. Complete success was defined as maintenance of intraocular pressure (IOP) ≥6 mm Hg and ≤21 mm Hg, in the absence of further surgery or use of antiglaucoma medication. Qualified success met the above criteria with or without use of antiglaucoma medications.<b>RESULTS:</b>One hundred and seventy-five eyes completed the two-year follow up. Sixty-nine percent of participants had POAG and 31% had PACG. The mean interval between filtering surgery and bleb needling was 299.9±616.4d for POAG and 167.1±272.2d for PACG. Mean needling attempts were 1.9±1.4 and 2±1.6 for POAG and PACG respectively. In general, there was a statistically significant reduction of IOP ranging from 21.9% to 26.8% from month 1 through to month 24. The complete success rates at month 6 were 70.0% for POAG and 65.7% for PACG. At month 12, this decreased to 62.2% for POAG and PACG and at month 24, 57.9% for POAG and 63.0% for PACG respectively. The qualified success rates at month 6 for POAG and PACG were 23.8% and 29.9% respectively, 32.2% and 29.2% at month 12, and 34.7% and 29.6% at month 24. The success rates between POAG and PACG were not significantly different (<i>P</i>&gt;0.05 for complete and qualified success at months 6, 12 and 24). An increased number of needlings and higher pre-needling IOP were associated with failure.<b>CONCLUSION:</b>The5-FU augmented bleb needling within one year of trabeculectomy in Asian eyes can provide clinically significant IOP lowering of more than 20% for 2y. POAG and PACG had similar complete success rates (58% and 63% respectively). Factors associated with greater risk of procedure failure included increased number of needlings and higher pre-needling IOP. Asian eyes have a greater propensity for scarring but bleb needling, if performed in a timely manner can rescue bleb function.]]></description>
<pubDate>2015/7/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Andrew S. H. Tsai,Pui Yi Boey,Hla M Htoon and Tina T Wong]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Andrew S. H. Tsai,Pui Yi Boey,Hla M Htoon and Tina T Wong</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150419]]></guid><cfi:id>1094</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Ultrasound biomicroscopy in patients with unilateral pseudoexfoliation]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150420]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To compare the anterior segment morphology evaluated using ultrasound biomicroscopy (UBM) in patients with clinical pseudoexfoliation syndrome (XFS) in one eye and no clinical XFS in the fellow eye.<b>METHODS:</b> Thirty patients with unilateral XFS were included in the study. All patients underwent evaluation of their anterior segment using UBM with and without dilatation with 1% cyclopentolate. The anterior chamber depth (ACD), lens thickness (LT), anterior chamber angle (ACA), ciliary body thickness (CBT), scleral thickness (ST), trabeculae -ciliary processes distance (T-CPD), and iris-ciliary processes distance (I-CPD) were measured using UBM scans. All results between the eyes with clinical XFS and their fellow eyes without clinical XFS were then compared.<b>RESULTS:</b> Before dilatation the eyes with XFS (4.350±0.531 mm) were found to have a significantly thicker lens (<i>P</i>=0.002) than the eyes without XFS (4.238±0.540 mm). In addition after dilatation, the eyes with XFS (4.310±0.500 mm) were found to have a significantly thicker lens than the eyes without XFS (4.160±0.480 mm) (<i>P</i>=0.019). The average ACD, for the group with XFS, comparing pre-dilatation (2.616±0.349 mm) and post-dilatation measurements (2.714±0.413) was found to be statistically increased (<i>P</i>=0.014). The average ACD, comparing pre-dilatation to post-dilatation measurements in patients without XFS (2.680±0.360), (2.720±0.500) was found to be statistically unchanged (<i>P</i>=0.450).
<b>DISCUSSION:</b> Crystalline lenses tended to be thicker in the eyes with clinical pseudoexfoliation than their fellow eyes without pseudoexfoliation.]]></description>
<pubDate>2015/7/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Erkan Ünsal,Kadir Eltutar,Ilkay Muftuoglu,Tulay Alpar Akcetin and Yıldız Acar]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Erkan Ünsal,Kadir Eltutar,Ilkay Muftuoglu,Tulay Alpar Akcetin and Yıldız Acar</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150420]]></guid><cfi:id>1093</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical characteristics of intermediate uveitis in adult Turkish patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150421]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To describe the clinical characteristics of Turkish patients with intermediate uveitis (IU) and to investigate the effect of clinical findings and complications on final visual acuity (VA).<b>METHODS:</b>We retrospectively analyzed the medical records of patients with IU who had at least 6mo of follow-up and were older than 16y<i>.</i><b>RESULTS:</b>A total of 78 eyes of 45 patients were included in the study and the mean follow-up period was 19.4mo. The mean age at the time of presentation was 42.9s. Systemic disease associations were found in 17.7% of cases; sarcoidosis (8.8%) and multiple sclerosis (6.6%) were the most common diseases. Recurrence rate (odds ratio=45.53; 95%CI:2.181-950.58), vitritis equals to or more than 3+ cells (odds ratio =57.456; 95%CI:4.154-794.79) and presenting with VA less than 20/40 (odds ratio =43.81; 95%CI:2.184-878.71) were also found as high risk factors for poor final VA. At the last follow-up examination, 67.9% of eyes had VA of 20/40 or better.<b>CONCLUSION:</b> IU is frequently seen at the beginning of the fourth decade of life. The disease is most commonly idiopathic in adult Turkish patients. Patients with severe vitritis at presentation and patients with frequent recurrences are at high risk for poor visual outcome.]]></description>
<pubDate>2015/7/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Esra Kardes,Betül Ilkay Sezgin Akcay,Kansu Bozkurt,Cihan Unlu,Gurkan Erdogan and Gulunay Akcali]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Esra Kardes,Betül Ilkay Sezgin Akcay,Kansu Bozkurt,Cihan Unlu,Gurkan Erdogan and Gulunay Akcali</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150421]]></guid><cfi:id>1092</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Visual function and vision-related quality of life after vitrectomy for idiopathic macular hole:a 12mo follow-up study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150422]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To investigate the visual function and the relationship with vision-related quality of life (VRQOL) after macular hole repair surgery．<b>METHODS:</b> Prospective case series. Thirty-six consecutive eyes in 36 patients who underwent pars plana vitrectomy (PPV) and internal limiting membrane (ILM) peeling were included. The 25-item National Eye Institute Visual Function Questionnaire (VFQ-25) was answered by the participants before and 3 and 12mo after operation. Follow-up visits examinations included best-corrected visual acuity (BCVA), clinical examination, and central macular thickness (CMT) measured by optical coherence tomography (OCT).<b>RESULTS:</b> Macular-hole closure was achieved in 35 of 36 eyes (97.2%). At baseline and months 3 and 12, the logMAR BCVAs (mean±SD) were 1.15±0.47, 0.68±0.53 (<i>P</i>&lt;0.0001 versus baseline), and 0.55±0.49 (<i>P</i>&lt;0.001 versus baseline, <i>P</i> =0.273 versus month 3), respectively; the CMTs (μm) were 330±81, 244±62 (<i>P</i>&lt;0.001 versus baseline), and 225±58 (<i>P</i>&lt;0.001 versus baseline, <i>P</i>=0.222 versus month 3), respectively; the median preoperative VFQ-25 composite score of 73.50 (63.92-81.13) increased postoperatively to 85.50 (80.04-89.63) at 3mo (<i>P</i>&lt;0.001) and 86.73(82.50-89.63) at 12mo (<i>P</i>&lt;0.001) respectively. The improved BCVA was correlated with improvements in five subscales (<i>r</i>=-0.605 to -0.336, <i>P</i>&lt;0.001 to <i>P</i>=0.046) at 12mo.<b>CONCLUSION:</b> PPV with ILM peeling improved anatomic outcome, visual function, and VRQOL. The improved BCVA was an important factor related to the improved VRQOL.]]></description>
<pubDate>2015/7/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hong-Tao Duan,Song Chen,Yue-Xin Wang,Jia-Hui Kong and Meng Dong]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hong-Tao Duan,Song Chen,Yue-Xin Wang,Jia-Hui Kong and Meng Dong</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150422]]></guid><cfi:id>1091</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Characterisation of human non-proliferativediabetic retinopathy using the fractal analysis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150423]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate and quantify changes in the branching patterns of the retina vascular network in diabetes using the fractal analysis method.
METHODS: This was a clinic-based prospective study of 172 participants managed at the Ophthalmological Clinic of Cluj-Napoca, Romania, between January 2012 and December 2013. A set of 172 segmented and skeletonized human retinal images, corresponding to both normal (24 images) and pathological (148 images) states of the retina were examined. An automatic unsupervised method for retinal vessel segmentation was applied before fractal analysis. The fractal analyses of the retinal digital images were performed using the fractal analysis software ImageJ. Statistical analyses were performed for these groups using Microsoft Office Excel 2003 and GraphPad InStat software.
RESULTS: It was found that subtle changes in the vascular network geometry of the human retina are influenced by diabetic retinopathy (DR) and can be estimated using the fractal geometry. The average of fractal dimensions D for the normal images (segmented and skeletonized versions) is slightly lower than the corresponding values of mild non-proliferative DR (NPDR) images (segmented and skeletonized versions). The average of fractal dimensions D for the normal images (segmented and skeletonized versions) is higher than the corresponding values of moderate NPDR images (segmented and skeletonized versions). The lowest values were found for the corresponding values of severe NPDR images (segmented and skeletonized versions).
CONCLUSION: The fractal analysis of fundus photographs may be used for a more complete undeTrstanding of the early and basic pathophysiological mechanisms of diabetes. The architecture of the retinal microvasculature in diabetes can be quantitative quantified by means of the fractal dimension. Microvascular abnormalities on retinal imaging may elucidate early mechanistic pathways for microvascular complications and distinguish patients with DR from healthy individuals.
]]></description>
<pubDate>2015/7/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[&#350;tefan &#354;&#259;lu, Dan Mihai C&#259;lug&#259;ru and Carmen Alina Lupa&#351;cu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>&#350;tefan &#354;&#259;lu, Dan Mihai C&#259;lug&#259;ru and Carmen Alina Lupa&#351;cu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150423]]></guid><cfi:id>1090</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of suction on macular thickness and retinal nerve fiber layer thickness during LASIK used femtosecond laser and Moria M2 microkeratome]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150424]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To compare the effect of suction on the macular thickness and retinal nerve fiber layer (RNFL) thickness during laser <i>in situ</i> keratomileusis (LASIK) used Ziemer FEMTO LDV femtosecond laser (Ziemer group) and Moria M2 automated microkeratome (Moria group) for flap creation.<b>METHODS:</b> Fourier-domain optical coherence tomography (FD-OCT) was used to measure macular thickness, ganglion cell complex thickness and (RNFL) thickness of 204 eyes of 102 patients with the Ziemer femtosecond laser (102 eyes) and the Moria M2 microkeratome (102 eyes) before surgery and 30min; 1, 3d; 1wk; 1, 3mo; 1y after surgery.<b>RESULTS:</b>The average foveal thickness and parafoveal retinal thickness 30min after the surgery were statistically more than that before surgery (Ziemer <i>P</i>&lt;0.001, <i>P</i>=0.003 and Moria <i>P</i>=0.001, <i>P</i>=0.006) and the effect was less in the Ziemer group than that in the Moria group (<i>P</i> all&lt;0.05). The ganglion cell complex thickness was not significantly changed in both groups (<i>P</i> all&gt;0.05). The RNFL thickness was statistically less 30min after surgery in both groups (<i>P</i>=0.014, <i>P</i>&lt;0.001), but the influence was less in Ziemer group than that in Moria group (<i>P</i>=0.038). However, the RNFL thickness had recovered to the preoperative level only 1d after surgery.<b>CONCLUSION:</b>The suction offemtosecond laser and mechanical microkeratome led to the increase in macular central fovea thickness and the decrease in RNFL thickness values at the early stage after LASIK. The effect of suction on macular and the RNFL thicknesses in Ziemer group is smaller than that in Moria group.]]></description>
<pubDate>2015/7/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jing Zhang and Yue-Hua Zhou]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jing Zhang and Yue-Hua Zhou</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150424]]></guid><cfi:id>1089</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of the femtosecond laser and mechanical microkeratome for flap cutting in LASIK]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150425]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To compare refractive results, higher-order aberrations (HOAs), contrast sensitivity and dry eye after laser <i>in situ</i> keratomileusis (LASIK) performed with a femtosecond laser versus a mechanical microkeratome for myopia and astigmatism.<b>METHODS:</b> In this prospective, non-randomized study, 120 eyes with myopia received a LASIK surgery with the VisuMax femtosecond laser for flap cutting, and 120 eyes received a conventional LASIK surgery with a mechanical microkeratome. Flap thickness, visual acuity, manifest refraction, contrast sensitivity function (CSF) curves, HOAs and dry-eye were measured at 1wk; 1, 3, 6mo after surgery.<b>RESULTS:</b>At 6mo postoperatively, the mean central flap thickness in femtosecond laser procedure was 113.05±5.89 μm (attempted thickness 110 μm), and 148.36±21.24 μm (attempted thickness 140 μm) in mechanical microkeratome procedure. An uncorrected distance visual acuity (UDVA) of 4.9 or better was obtained in more than 98% of eyes treated by both methods, a gain in logMAR lines of corrected distance visual acuity (CDVA) occurred in more than 70% of eyes treated by both methods, and no eye lost ≥1 lines of CDVA in both groups. The difference of the mean UDVA and CDVA between two groups at any time post-surgery were not statistically significant (<i>P</i>＞0.05). The postoperative changes of spherical equivalent occurred markedly during the first month in both groups. The total root mean square values of HOAs and spherical aberrations in the femtosecond treated eyes were markedly less than those in the microkeratome treated eyes during 6mo visit after surgery (<i>P</i>＜0.01). The CSF values of the femtosecond treated eyes were also higher than those of the microkeratome treated eyes at all space frequency (<i>P</i>＜0.01). The mean ocular surface disease index scores in both groups were increased at 1wk, and recovered to preoperative level at 1mo after surgery. The mean tear breakup time (TBUT) of the femtosecond treated eyes were markedly longer than those of the microkeratome treated eyes at postoperative 1, 3mo (<i>P</i>＜0.01).<b>CONCLUSION:</b>Both the femtosecond laser and the mechanical microkeratome for LASIK flap cutting are safe and effective to correct myopia, with no statistically significant difference in the UDVA, CDVA during 6mo follow-up. Refractive results remained stable after 1mo post-operation for both groups. The femtosecond laser may have advantages over the microkeratome in the flap thickness predictability, fewer induced HOAs, better CSF, and longer TBUT.]]></description>
<pubDate>2015/7/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Li-Kun Xia,Jie Yu,Guang-Rui Chai,Dang Wang and Yang Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Li-Kun Xia,Jie Yu,Guang-Rui Chai,Dang Wang and Yang Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150425]]></guid><cfi:id>1088</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of the extrusion rate of Crawford tubes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150426]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To compare the outcomes of dacryocystorhinostomy (DCR) using traditional Crawford tubes (TCT) and Crawford tubes with suture (CTS) in the lumen.<b>METHODS:</b>Retrospective case series consisting of patients who underwent DCR between 2008 and 2013.<b>RESULTS:</b>A total of 61 DCRs were performed on 50 patients. Patients who underwent DCR using CTS had higher rates of prolapse compared to the TCT group (50% <i>vs</i> 9.4%; <i>P</i>=0.003). Stent removal occurred earlier in patients who received CTS (3.3mo <i>vs</i> 5.1mo; <i>P</i>=0.004). Success rates were equivalent between the two groups (75% <i>vs</i> 81.1%; <i>P</i>=0.684).<b>CONCLUSION:</b>CTS in the lumen increases the risk of prolapse, prompting earlier tube removal in patients following DCR for nasolacrimal duct obstruction (NLDO). Earlier removal of tubes does not appear to significantly decrease success rates.]]></description>
<pubDate>2015/7/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Kira L. Segal,Sarah H. Van Tassel,Charles Kim,Nicole Hsu,Ashutosh Kacker and Gary J. Lelli Jr]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Kira L. Segal,Sarah H. Van Tassel,Charles Kim,Nicole Hsu,Ashutosh Kacker and Gary J. Lelli Jr</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150426]]></guid><cfi:id>1087</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Extensive full-thickness eyelid reconstruction with rotation flaps through “subcutaneous tunnel” and palatal mucosal grafts]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150427]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To reconstruct the extensive full-thickness defects of eyelids is a challenge for the plastic surgeon because of their complex anatomy and special functions. This article presents and discusses an improved surgical technique in which the orbicularis oculi myocutaneous flap is rotated through a “subcutaneous tunnel” in conjunction with a palatal mucosal graft employed for lining.<b>METHODS:</b> Data from 22 eyes with extensive full-thickness eyelid defects from various causes between 2009 and 2013 were analyzed in this study. After the different layers of eyelid were separated completely, a temporally based orbicularis oculi myocutaneous flap was designed following fishtail lines and was mobilized, leaving the base of the pedicle intact with a submuscular tissue attachment. The flap was then rotated through a “subcutaneous tunnel” to the defect, and the donor site was closed primarily. Posterior lamellar reconstruction was performed with a mucosal graft harvested from the hard palate.<b>RESULTS:</b>All the flaps were survived without any healing problems. There was no corneal irritation, flap contraction, or significant donor-site morbidity in the follow-up period. The incision scars were almost invisible. The defects were repaired completely, and the evaluations showed satisfactory function and appearance.<b>CONCLUSION:</b> This technique is an improved single-stage operation and can be applied to repair large, full-thickness eyelid defects from various causes. With our method, the functional and aesthetic results can be obtained in either the upper or lower eyelids.]]></description>
<pubDate>2015/7/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jian-Xia Cheng,Lan Zuo,Xin-Yu Huang,Ji-Zhe Cui,Shuai Wu and Yuan-Yuan Du]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jian-Xia Cheng,Lan Zuo,Xin-Yu Huang,Ji-Zhe Cui,Shuai Wu and Yuan-Yuan Du</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150427]]></guid><cfi:id>1086</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Visual findings as primary manifestations in patients with intracranial tumors]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150428]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To evaluate the visual findings as primary manifestations in patients with intracranial tumors.<b>METHODS:</b>The medical charts of the patients with intracranial tumors who initially admitted to the Neuro-ophthalmology and Strabismus Department with ocular complaints between August 1999 and December 2012 were reviewed retrospectively. The detailed clinical history and the findings of neuro-ophthalmologic examination were recorded. Ocular symptoms and signs, the types and locations of intracranial tumors, and the duration of symptoms before the diagnosis were evaluated.<b>RESULTS:</b>The mean age of 11 women (61.1%) and 7 men (38.9%) was 42.2±11.0 (range 20-66y) at the time of intracranial tumor diagnosis. Initial symptoms were transient visual obscurations, visual loss or visual field defect in 16 cases (88.9%), and diplopia in 2 cases (11.1%). Neuro-ophthalmologic examination revealed normal optic discs in both eyes of 6 patients (33.3%), paleness, atrophy or edema of optic disc in 12 patients (66.7%), and sixth cranial nerve palsy in 2 patients (11.1%). Visual acuity ranged between normal vision and loss of light perception. Cranial imaging demonstrated craniopharyngioma (<i>n</i>=1), plasmacytoma (<i>n</i>=1), meningioma (<i>n</i>=6; olfactory groove and tuberculum sellae, pontocerebellar angle, anterior cranial fossa, frontal vertex, suprasellar region), and pituitary macroadenoma (<i>n</i>=10). The mean duration between the onset of visual disturbances and the diagnosis of intracranial tumor was 9.8±18mo (range 3d-6y).<b>CONCLUSION:</b>The ophthalmologist is frequently the first physician to encounter a patient with clinical manifestations of intracranial tumors that may cause neurological and ocular complications. Neuro-ophthalmologic findings should be carefully evaluated to avoid a delay in the diagnosis of intracranial tumors.]]></description>
<pubDate>2015/7/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Nazife Sefi-Yurdakul]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Nazife Sefi-Yurdakul</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150428]]></guid><cfi:id>1085</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Association of n3 and n6 polyunsaturated fatty acids in red blood cell membrane and plasma with severity of normal tension glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150308]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To determine whether red blood cell (RBC) membrane and plasma lipids, particularly long-chain polyunsaturated fatty acids such as eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), arachidonic acid (AA) are significantly correlated with severity of normal tension glaucoma (NTG).<b>METHODS:</b>This study included 35 patients with NTG and 12 healthy normal control subjects, matched for age and sex with the study group. The stage of glaucoma was determined according to the Hodapp-Parrish-Anderson classification. Lipids were extracted from RBC membranes and plasma, and fatty acid methyl esters prepared and analyzed by gas chromatography-mass spectrometry (GC-MS).<b>RESULTS:</b>When RBC lipids were analyzed, the levels of EPA, the levels of DHA and the ratio of n3 to n6 were positively associated with the Humphrey Perimetry mean deviation (MD) score (<i>r</i>=0.617, <i>P</i>&lt;0.001; <i>r</i>=0.727, <i>P</i>&lt;0.001 and <i>r</i>=0.720, <i>P</i>&lt;0.001, respectively), while the level of AA was negatively associated with the MD score (<i>r</i>=-0.427, <i>P</i>=0.001). When plasma lipids were analyzed, there was a significant positive relationship between the levels of EPA and the MD score (<i>r</i>=0.648, <i>P</i>&lt;0.001), and the levels of AA were inversely correlated with the MD score (<i>r</i>=-0.638, <i>P</i>&lt;0.001).<b>CONCLUSION:</b>The levels of n3 and n6 polyunsaturated fatty acids in RBC membrane and plasma lipids were associated with severity of NTG.]]></description>
<pubDate>2015/6/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Man Yu,Bo Chen,Bo Gong,Ping Shuai,Zheng-Zheng Wu and Wei Lin]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Man Yu,Bo Chen,Bo Gong,Ping Shuai,Zheng-Zheng Wu and Wei Lin</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150308]]></guid><cfi:id>1084</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Standardization of choroidal thickness measurements using enhanced depth imaging optical coherence tomography]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150309]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To describe and evaluate a standardized protocol for measuring the choroidal thickness (ChT) using enhanced depth imaging optical coherence tomography (EDI OCT).<b>METHODS:</b>Single 9 mm EDI OCT line scans across the fovea were used for this study. The protocol used in this study classified the EDI OCT images into four groups based on the appearance of the choroidal-scleral interface and suprachoroidal space. Two evaluation iterations of experiments were performed:first, the protocol was validated in a pilot study of 12 healthy eyes. Afterwards, the applicability of the protocol was tested in 82 eyes of patients with diabetes. Inter-observer and intra-observer agreements on image classifications were performed using Cohen’s kappa coefficient (k). Intraclass correlation coefficient (ICC) and Bland-Altman’s methodology were used for the measurement of the ChT.<b>RESULTS:</b>There was a moderate (k=0.42) and perfect (k=1) inter- and intra-observer agreements on image classifications from healthy eyes images and substantial (k=0.66) and almost perfect (k=0.86) agreements from diabetic eyes images. The proposed protocol showed excellent inter- and intra-observer agreements for the ChT measurements on both, healthy eyes and diabetic eyes (ICC&gt;0.90 in all image categories). The Bland-Altman plot showed a relatively large ChT measurement agreement in the scans that contained less visible choroidal outer boundary.<b>CONCLUSIONS:</b>A protocol to standardize ChT measurements in EDI OCT images has been developed; the results obtained using this protocol show that the technique is accurate and reliable for routine clinical practice and research.]]></description>
<pubDate>2015/6/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Nattapon Boonarpha,Yalin Zheng,Alexandros N. Stangos,Huiqi Lu,Ankur Raj,Gabriela Czanner,Simon P. Harding and Jayashree Nair-Sahni]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Nattapon Boonarpha,Yalin Zheng,Alexandros N. Stangos,Huiqi Lu,Ankur Raj,Gabriela Czanner,Simon P. Harding and Jayashree Nair-Sahni</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150309]]></guid><cfi:id>1083</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Imaging of filtering blebs after implantation of the Ex-PRESS shunt with the use of the Visante optical coherence tomography]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150310]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To analyze the features of the filtering blebs following implantation of the Ex-PRESS glaucoma device (model P-50) with the aid of the Visante anterior segment optical coherence tomography (AS-OCT)<b>METHODS:</b> Five patients with open angle glaucomas were included in the study. They all underwent implantation of the Ex-PRESS device under a scleral flap. The surgical procedure was augmented with the use of mitomycin C subconjunctivally. The filtering blebs were analyzed with the Visante AS-OCT with the scans taken along the axis of the implantation of the glaucoma device.<b>RESULTS:</b> All filtering blebs were graded as diffuse functioning. The morphological characteristics of the blebs were similar to those of the trabeculectomy. However the use of the Ex-PRESS implant tend to form a characteristic episcleral lake at the site of the plate of the implant.<b>CONCLUSION:</b> The use of the Ex-PRESS implant produces filtering blebs similar to those of the trabeculectomy with the formation of a characteristic episcleral lake at the site of the plate of the implant.]]></description>
<pubDate>2015/6/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Aristeidis Konstantinidis,Georgios D Panos,Magdalini Triantafylla,Georgios Labiris,Efthimia Tsaragli,Zisis Gatzioufas and Vassilios Kozobolis]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Aristeidis Konstantinidis,Georgios D Panos,Magdalini Triantafylla,Georgios Labiris,Efthimia Tsaragli,Zisis Gatzioufas and Vassilios Kozobolis</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150310]]></guid><cfi:id>1082</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of dorzolamide-timolol fixed combination prophylaxis on intraocular pressure spikes after intravitreal bevacizumab injection]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150311]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To evaluate the effect of topical dorzolamide-timolol fixed combination prophylaxis on short term intraocular pressure (IOP) changes in patients who had intravitreal bevacizumab injection.<b>METHODS:</b> One hundred and fifty one eyes of 151 patients which were followed up in retina clinic in Ulucanlar Eye Training and Research Hospital were evaluated in this study. Patients were divided into two groups. Group 1 consists of 75 patients who had topical dorzolamid-timolol medication two hours before injection; while Group 2 consists of 76 patients without prophylaxis. Demographic data, IOP measurements prior to the injection and one, thirty and sixty minutes and twenty-four hours after the injection were recorded. The data were analyzed using SPSS software version 15.0 (SPSS Inc., Chicago, IL, USA).<b>RESULTS:</b>There were no significant difference between two groups in age, gender distrubition and indications for injections. The mean IOPs in Groups 1 and 2 prior to the injection (T0) were 17.84±0.43 and 18.15±0.43 mm Hg, one minute after the injection (T1) were 29.75±1.6 and 34.44±1.59 mm Hg, 30min after the injection (T30) were 20.06±0.6 and 21.71±0.59 mm Hg respectively. The mean IOPs were 18.26±0.56 mm Hg in Group 1 and 19.78±0.56 mm Hg in Group 2 sixty minutes after the injection (T60). All IOP values after the injection were compared between two groups, there was a significant difference between two groups only on T1; one minute after the injection (<i>P</i>=0.04). There were a statiscially significant difference between the baseline values and other recorded values; except on T60, in Groups 1 and 2 (<i>P</i>&lt;0.05).<b>CONCLUSION:</b> After intravitreal bevacizumab injection; we observe a transient IOP elevation which normalizes about one hour after intravitreal injection. In patients who had topical dorzolamid-timolol combination prophylaxis before injections, a significant decrease is seen in IOP spikes due to this injection. The appropiate approach will monitor IOP after intravitreal injection and evaluate the using prophylactic antiglaucomatous drugs before the injection in patients with ganglion nerve cell damage.]]></description>
<pubDate>2015/6/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Sehnaz Ozcaliskan,Faruk Ozturk,Pelin Yilmazbas and Ozlem Beyazyildiz]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Sehnaz Ozcaliskan,Faruk Ozturk,Pelin Yilmazbas and Ozlem Beyazyildiz</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150311]]></guid><cfi:id>1081</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Error induced by the estimation of the corneal power and the effective lens position with a rotationally asymmetric refractive multifocal intraocular lens]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150312]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To evaluate the prediction error in intraocular lens (IOL) power calculation for a rotationally asymmetric refractive multifocal IOL and the impact on this error of the optimization of the keratometric estimation of the corneal power and the prediction of the effective lens position (ELP).<b>METHODS</b>:Retrospective study including a total of 25 eyes of 13 patients (age, 50 to 83y) with previous cataract surgery with implantation of the Lentis Mplus LS-312 IOL (Oculentis GmbH, Germany). In all cases, an adjusted IOL power (PIOLadj) was calculated based on Gaussian optics using a variable keratometric index value (nkadj) for the estimation of the corneal power (Pkadj) and on a new value for ELP (ELPadj) obtained by multiple regression analysis. This PIOLadj was compared with the IOL power implanted (PIOLReal) and the value proposed by three conventional formulas (Haigis, Hoffer Q and Holladay Ⅰ).<b>RESULTS</b>:PIOLReal was not significantly different than PIOLadj and Holladay IOL power (<i>P</i>&gt;0.05). In the Bland and Altman analysis, PIOLadj showed lower mean difference (-0.07 D) and limits of agreement (of 1.47 and -1.61 D) when compared to PIOLReal than the IOL power value obtained with the Holladay formula. Furthermore, ELPadj was significantly lower than ELP calculated with other conventional formulas (<i>P</i>&lt;0.01) and was found to be dependent on axial length, anterior chamber depth and Pkadj.<b>CONCLUSION</b>:Refractive outcomes after cataract surgery with implantation of the multifocal IOL Lentis Mplus LS-312 can be optimized by minimizing the keratometric error and by estimating ELP using a mathematical expression dependent on anatomical factors.]]></description>
<pubDate>2015/6/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[David P. Pi&#241;ero, Vicente J. Camps, María L. Ramón, Verónica Mateo and Rafael J. Pérez-Cambrodí]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>David P. Pi&#241;ero, Vicente J. Camps, María L. Ramón, Verónica Mateo and Rafael J. Pérez-Cambrodí</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150312]]></guid><cfi:id>1080</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[CD18 expression in granulocytes infiltrating the vitreous fluid in patients with diabetic retinopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150313]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To assess the levels of CD18 on the surface of granulocytes infiltrating the vitreous fluid in patients with diabetic retinopathy (DR).<b>METHODS:</b>Vitreous samples from twelve patients with non-proliferative DR with significant macula edema (group A), 33 patients with proliferative DR (grade 3 as group B, <i>n</i>=14, and, grade 4 as group C, <i>n</i>=19) were obtained during pars plana vitrectomy. Vitreous samples from 12 patients with macular hole as controls (group D) were analyzed together. The infiltrating of granulocytes and its surface level of CD18 were measured by flow cytometry. The level of CD18 was presented as the mean channel fluorescence (MCF) on a logarithmic scale.<b>RESULTS:</b> Granulocytes were detected in 6 of 12 vitreous samples from group A, 9 of 14 from group B, 15 of 19 from group C, and none of 12 from group D. MCF of CD18 on granulocytes from groups A, B, and C were 2.978±1.446, 3.201±0.692, and 4.072±0.837, respectively. The difference was significant (<i>F</i>=4.354, <i>P</i>=0.021). Subjects with more severe DR were more likely to have a higher level of CD18 MCF (trend test, <i>c</i><sup>2</sup>=7.351, <i>P</i>=0.007). CD18 MCF was significantly associated with the development of DR (<i>r</i>=0.46, <i>P</i>=0.005 and β=0.147, <i>P</i>=0.035).<b>CONCLUSION</b>:Our results confirm the presence of granulocytes and the elevated levels of CD18 on the surface of them in the vitreous fluid from DR patients. These results may provide indirect evidence shown that granulocytes activation also has occurred in the retinal local compared to non-DR control.]]></description>
<pubDate>2015/6/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Qi Zhu and Hu-Ping Song]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Qi Zhu and Hu-Ping Song</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150313]]></guid><cfi:id>1079</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Focal choroidal excavation:a preliminary interpretation based on clinic and review]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150314]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To describe the clinical and imaging characteristics associated with focal choroidal excavation (FCE), analyze the possible complication, and interpret its probable etiopathogenesis.<b>METHODS:</b>Retrospective descriptive case series of 37 eyes of 32 patients with FCE. Findings of spectral-domain optical coherence tomography (SD-OCT), fluorescein angiography, indocyanine green angiography, and clinical features were analyzed.<b>RESULTS: </b>All patients were Chinese. Five patients (15.6%) were bilaterally involved. Patients’ ages ranged from 7 to 66y. Refractive error ranged between +2.0 D and ?11.0 D. Mean best-corrected visual acuity was 0.6 (range, 0.1 to 1.2). Fundus examinations exhibited mild-moderate localized pigmentary disturbances in the corresponding area of 17 eyes. Fluorescein angiography performed in 18 patients showed varying degrees of hyperfluorescence and hypofluorescence related to a range of retinal pigment epithelium (RPE) alterations. Indocyanine green angiography performed in 7 patients showed hypofluorescence at the excavation. SD-OCT demonstrated choroidal excavation in all 37 eyes. Twenty-nine eyes showed a single lesion of FCE, and three eyes showed 2-3 separated lesions. Fifteen eyes showed separation between the photoreceptor tips and RPE consistent with nonconforming FCE. Central serous chorioretinopathy (CSC, <i>n</i>=1) and choroidal neovascularization (CNV, <i>n</i>=1) developed during follow-up.<b>CONCLUSION:</b>FCE could be interpreted as congenital focal choroidal dysplasia involving the RPE, choriocapillaris, and photoreceptor associated with the faulty anatomy. The abnormal anatomy of FCE was similar to anatomy at risk of CSC and CNV.]]></description>
<pubDate>2015/6/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Guang-Hui Liu,Bing Lin,Xin-Quan Sun,Zi-Fang He,Ji-Rong Li,Rong Zhou and Xiao-Ling Liu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Guang-Hui Liu,Bing Lin,Xin-Quan Sun,Zi-Fang He,Ji-Rong Li,Rong Zhou and Xiao-Ling Liu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150314]]></guid><cfi:id>1078</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical analysis of risk factors contributing to recurrence of pterygium after excision and graft surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150315]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To find the risk factors related to the reproliferation of the pterygial tissue after excision and graft surgery.<b>METHODS:</b>Charts of 130 eyes of 130 patients who had pterygial excision from March 2006 to April 2011 were reviewed. Preoperative pterygium morphology, surgical methods, and adjunctive treatments were statistically analyzed for their relationship with recurrence.<b>RESULTS:</b> During the follow-up period, recurrence was observed in 20 eyes (15.4%). None of the preoperative morphologic features were affected the rate of the recurrence. However, an age &lt; 40y [<i>P </i>=0.085, odds ratio (OR) 3.609, 95% confidence interval (CI) 0.838-15.540] and amniotic membrane graft instead of conjunctival autograft (<i>P</i> =0.002, OR 9.093, 95% CI 2.316-35.698) were statistically significant risk factors for recurrence. Multivariate analysis revealed that intraoperative mitomycin C (MMC) (<i>P</i>=0.072, OR 0.298, 95% CI 0.080-1.115) decreased the rate of recurrence.<b>CONCLUSION:</b>Younger age is a risk factor for reproliferation of pterygial tissue after excision and amniotic membrane transplantation (AMT) are less effective in preventing recurrence of pterygium after excision based on the comparison between conjunctival autograft and AMT. Intraoperative MMC application and conjunctival autograft reduce recurrence.]]></description>
<pubDate>2015/6/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Sang Won Ha,Joon Ho Park,Im Hee Shin and Hong Kyun Kim]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Sang Won Ha,Joon Ho Park,Im Hee Shin and Hong Kyun Kim</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150315]]></guid><cfi:id>1077</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Surgical induced astigmatism correlated with corneal pachymetry and intraocular pressure:transconjunctival sutureless 23-gauge versus 20-gauge sutured vitrectomy in diabetes mellitus]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150316]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To determine the difference of surgical induced astigmatism between conventional 20-gauge sutured vitrectomy and 23-gauge transconjunctival sutureless vitrectomy, and the influence of corneal pachymetry and intraocular pressure (IOP) on surgical induced astigmatism in diabetic patients.<b>METHODS:</b>This retrospective, consecutive case series consisted of 40 eyes of 38 diabetic subjects who underwent either 20-gauge or 23-gauge vitrectomy. The corneal curvature and thickness were measured with Scheimpflug imaging before surgery and 1wk; 1, 3mo after surgery. We compared the surgical induced astigmatism (SIA) on the true net power in 23-gauge group with that in 20-gauge group. We determined the correlation between corneal thickness change ratio, IOP and SIA measured by Pentacam.<b>RESULTS:</b> The mean SIAs were 1.082±0.085 D (mean±SEM), 0.689±0.070 D and 0.459±0.063 D at postoperative 1wk; 1, 3mo respectively in diabetic subjects. The vitrectomy induced astigmatisms were declined significantly with time (<i>F</i>2,36=33.629,<i> P</i>=0.000) postoperatively. The 23-gauge surgery group induced significantly less astigmatism than 20-gauge surgery group (<i>F</i>1,37=11.046, <i>P</i>=0.020). Corneal thickness in diabetes elevated after surgery (<i>F</i>3,78=10.532, <i>P</i>=0.000). The linear regression analysis at postoperatively 1wk went as:SIA=-4.519+4.931 change ratio (Port3) +0.026 IOP (R<sup>2</sup>=0.46,<i> P</i>=0.000), whereas the rate of corneal thickness change and IOP showed no correlation with the change of astigmatism at postoperatively 1 and 3mo.<b>CONCLUSION:</b> There are significant serial changes in both 20-gauge and 23-gauge group in diabetic subjects. 23-gauge induce less astigmatism than 20-gauge and become stable more rapidly than 20-gauge. The elevation of corneal thickness and IOP was associated with increased astigmatim at the early postoperative stage both in 23-gauge and 20-gauge surgery group.]]></description>
<pubDate>2015/6/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yan Shao,Li-Jie Dong,Yan Zhang,Hui Liu,Bo-Jie Hu,Ju-Ping Liu and Xiao-Rong Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yan Shao,Li-Jie Dong,Yan Zhang,Hui Liu,Bo-Jie Hu,Ju-Ping Liu and Xiao-Rong Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150316]]></guid><cfi:id>1076</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[In vivo corneal confocal microscopic analysis in patients with keratoconus]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150317]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To quantify corneal ultrastructure using laser scanning <i>in vivo</i> confocal microscopy (IVCM) in patients with keratoconus and control subjects.<b>METHODS:</b> Unscarred corneas of 78 keratoconic subjects without a history of contact lens use and 36 age-matched control subjects were evaluated with slit-lamp examination (SLE), corneal topography and laser scanning IVCM. One eye was randomly chosen for analysis. Anterior and posterior stromal keratocyte, endothelial cell and basal epithelial cell densities and sub-basal nerve structure were evaluated.<b>RESULTS:</b> IVCM qualitatively demonstrated enlarged basal epithelial cells, structural changes in sub-basal and stromal nerve fibers, abnormal stromal keratocytes and keratocyte nuclei, and pleomorphism and enlargement of endothelial cells. Compared with control subjects, significant reductions in basal epithelial cell density (5817±306 cells/mm<sup>2</sup> <i>vs</i> 4802±508 cells/mm<sup>2</sup>, <i>P</i>&lt;0.001), anterior stromal keratocyte density (800±111 cells/mm<sup>2</sup> <i>vs</i> 555±115 cells/mm<sup>2</sup>, <i>P</i>&lt;0.001), posterior stromal keratocyte density (333±34 cells/mm<sup>2</sup> <i>vs</i> 270±47 cells/mm<sup>2</sup>, <i>P</i>&lt;0.001), endothelial cell density (2875±223 cells/mm<sup>2</sup> <i>vs</i> 2686±265 cells/mm<sup>2</sup>, <i>P</i>&lt;0.001), sub-basal nerve fiber density (31.2±8.4 nerves/mm<sup>2</sup> <i>vs</i> 18.1±9.2 nerves/mm<sup>2</sup>, <i>P</i>&lt;0.001), sub-basal nerve fiber length (21.4±3.4 mm/mm<sup>2</sup> <i>vs</i> 16.1±5.1 mm/mm<sup>2</sup>, <i>P</i>&lt;0.001), and sub-basal nerve branch density (median 50.0 (first quartile 31.2 - third quartile 68.7) nerve branches/mm<sup>2</sup> <i>vs</i> median 25.0 (first quartile 6.2 - third quartile 45.3) nerve branches/mm<sup>2</sup>, <i>P</i>&lt;0.001) were observed in patients with keratoconus.<b>CONCLUSION:</b> Significant microstructural abnormalities were identified in all corneal layers in the eyes of subjects with keratoconus using IVCM. This non-invasive <i>in vivo</i> technique provides an important means to define and follow progress of microstructural changes in patients with keratoconus.]]></description>
<pubDate>2015/6/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Gulfidan Bitirgen,Ahmet Ozkagnici,Banu Bozkurt and Rayaz A Malik]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Gulfidan Bitirgen,Ahmet Ozkagnici,Banu Bozkurt and Rayaz A Malik</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150317]]></guid><cfi:id>1075</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Intraocular pressure measurement over soft contact lens by rebound tonometer:a comparative study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150318]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To evaluate the intraocular pressure (IOP) measurements by Icare rebound tonometer over a contact lens in comparison with Goldmann applanation tonometry (GAT).<b>METHODS:</b> Fifty patients using contact lens were included in this study. One of the eyes of the patients was selected randomly and their IOP were measured by rebound tonometer with and without contact lens (RTCL, RT respectively) and by GAT, as well as their central corneal thickness (CCT) by optical pachymeter. The results of both methods were compared by correlation analysis, general linear method repeated measure and Bland-Altman analysis.<b>RESULTS:</b> Mean IOP values measured by RTCL, RT and GAT were 15.68±3.7, 14.50±3.4 and 14.16±2.8 (<i>P</i>&lt;0.001), respectively. Mean IOP by RTCL was significantly higher than the measurements implemented by RT and GAT (<i>P</i>&lt;0.001), while there was no difference between the measurements by GAT and RT (<i>P</i>=0.629). There was a good level of positive correlation between GAT and RTCL as well as RT (<i>r</i>=0.786 <i>P</i>&lt;0.001, <i>r</i>=0.833 <i>P</i>&lt;0.001, respectively). We have observed that CCT increase did not show any correlation with the differences of the measurements between RTCL and RT (<i>P</i>=0.329), RTCL and GAT (<i>P</i>=0.07) as well as RT and GAT (<i>P</i>=0.189) in linear regression model.<b>CONCLUSION:</b> The average of the measurements over contact lens by rebound tonometer was found to be higher than what was measured by GAT. Although this difference is statistically significant, it may be clinically negligible in the normal population.]]></description>
<pubDate>2015/6/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Senay Asik Nacaroglu,Emine Seker Un,Mehmet Giray Ersoz and Yelda Tasci]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Senay Asik Nacaroglu,Emine Seker Un,Mehmet Giray Ersoz and Yelda Tasci</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150318]]></guid><cfi:id>1074</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Treatment of ocular rosacea:comparative study of topical cyclosporine and oral doxycycline]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150319]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To compare the effectiveness of topical cyclosporine A emulsion with that of oral doxycycline for rosacea associated ocular changes and dry eye complaints.<b>METHODS:</b>One hundred and ten patients with rosacea were screened. Thirty-eight patients having rosacea associated eyelid and ocular surface changes and dry eye complaints were included in the study. Patients were randomly divided into two groups:nineteen patients were given topical cyclosporine twice daily and nineteen patients were given oral doxycycline 100 mg twice daily for the first month and once daily for the following two months. Symptom and sign scores, ocular surface disease index questionnarie and tear function tests were evaluated at baseline and monthly for 3mo. Three months after results were compared with that of baseline.<b>RESULTS:</b>Mean values of symptom, eyelid sign and corneal/conjunctival sign scores of each treatment group at baseline and 3mo after treatments were compared and both drugs were found to be effective on rosacea associated ocular changes (<i>P</i>&lt;0.001). Cyclosporine was more effective in symptomatic relief and in the treatment of eyelid signs (<i>P</i>=0.01). There was statistically significant increase in the mean Schirmer score with anesthesia and tear break up time scores in the cyclosporine treatment group compared to the doxycycline treatment group (<i>P</i>&lt;0.05).<b>CONCLUSION</b>:Cyclosporine as a topical drug can be used in the treatment of rosacea associated ocular complications because it is more effective than doxycycline. In addition ocular rosacea as a chronic disease requires long term treatment and doxycycline has various side effects limiting its long term usage.]]></description>
<pubDate>2015/6/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Aysegul Arman,Duriye Deniz Demirseren and Tamer Takmaz]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Aysegul Arman,Duriye Deniz Demirseren and Tamer Takmaz</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150319]]></guid><cfi:id>1073</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of intravitreal bevacizumab and triamcinolone acetonide theraphies for diffuse diabetic macular edema]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150320]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To compare therapeutic effects of intravitreal triamcinolone acetonide (IVTA) versus intravitreal bevacizumab (IVB) injections for bilateral diffuse diabetic macular edema (DDME).<b>METHODS:</b> Forty eyes of 20 patients with bilateral DDME participated in this study. For each patient, 4 mg/0.1 mL IVTA was injected to one eye and 2.5 mg/0.1 mL IVB was injected to the other eye. The effects of injection for diabetic macular edema (DME) were evaluated using best-corrected visual acuity (BCVA), central macular thickness (CMT) by optical coherence tomography (OCT) and intraocular pressure (IOP) by applanation tonometer. Patients underwent eye examinations, including BCVA, CMT, and IOP at pre-injection, 1, 4, 8, 12 and 24wk after injection. During the follow-up, second injections were performed to eyes which have CMT greater than 400 μm at 12wk for salvage therapy.<b>RESULTS:</b> BCVA (logarithm of the minimum angle of resolution) at pre-injection, 1, 4, 8, 12 and 24wk after injection was 0.71±0.19, 0.62±0.23, 0.63±0.12, 0.63±0.13, 0.63±0.14 and 0.61±0.24 in the IVTA group and 0.68±0.25, 0.61±0.22, 0.60±0.24, 0.62±0.25, 0.65±0.26 and 0.59±0.25 in the IVB group, respectively. CMT (μm) at pre-injection, 1, 4, 8, 12 and 24wk after injection was 544±125, 383±96, 335±87, 323±87, 333±92, 335±61 in the IVTA group and 514±100, 431±86, 428±107, 442±106, 478±112, 430±88 in the IVB group respectively. Reduction ratios of mean CMT were 29% at 1wk, 38% at 4wk, 40% at 8wk, 38% at 12wk, and 38% at 24wk in the IVTA group. Second IVTA injections were performed to the 6 eyes (30%) at 12wk. Reduction ratios of mean CMT were 16% at 1wk, 17% at 4wk, 14% at 8wk, 7% at 12wk, and 16% at 24wk in the IVB group. Second IVB injections were performed to the 15 eyes (75%) at 12wk.<b>CONCLUSION:</b>This study showed earlier and more frequent macular edema recurrences in the eyes treated with bevacizumab compared with the ones treated with triamcinolone acetonide. Triamcinolone acetonide was found to provide more efficient and long-standing effect in terms of reducing CMT compared with the bevacizumab.]]></description>
<pubDate>2015/6/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Sibel Aksoy,Gursel Yilmaz,Imren Akkoyun and Ayse Canan Yazici]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Sibel Aksoy,Gursel Yilmaz,Imren Akkoyun and Ayse Canan Yazici</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150320]]></guid><cfi:id>1072</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Matrix γ-carboxyglutamate protein and Fetuin-A, in wet type age-related macular degeneration]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150321]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To evaluate the high sensitivity C-reactive protein (hsCRP), Fetuin-A and matrix γ-carboxyglutamate protein (MGP) as the main factors for vascular calcification and inflammation in serum of patients with advanced age-related macular degeneration (ARMD) in comparison to healthy controls.<b>METHODS:</b> The subjects were 40 patients with choroidal neovascularization (CNV) having a mean age of 70.9±9.1y and a matched group of 49 apparently healthy control subjects. The ARMD was diagnosed using a slit-lamp with superfield lens, fundus photography and fluorescein angiography. Measurement of hsCRP was done by nephelometry method. Levels of Fetuin-A and MGP were measured by enzyme-linked immunosorbent assay (ELISA) technique.<b>RESULTS:</b>hsCRP [0.45(0.07-2.63) mg/L <i>vs</i> 0.25(0.03-1.2) mg/L, <i>P</i>=0.02)] and Fetuin-A levels (50.27±5.04 <i>vs</i> 44.99±10.28 ng/mL, <i>P</i>=0.009) were higher in the patients than in the control groups. We could not find significant difference in MGP level between two groups (<i>P</i>=0.08). There was not a significant correlation between MGP with Fetuin-A and hsCRP among the patients (<i>P</i>=0.7, <i>P</i>=0.9 respectively). A significant negative correlation of hsCRP with Fetuin-A was observed in both case and control groups (<i>P=</i>0.004, <i>r=</i>-0.33 and <i>P=</i>0.001, <i>r</i>=-0.54, respectively).<b>CONCLUSION:</b> Although our study shows that serum hsCRP and Fetuin-A is increased in CNV patients as well as negatively correlated with both study groups, their direct role on pathogenesis of ARMD required future studies.]]></description>
<pubDate>2015/6/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Alireza Javadzadeh,Amir Ghorbanihaghjo,Ebadolah Heidari,Nader Baharivand,Karim Sadeghi,Rana Sorkhabi and Mohammad Hossein Ahoor]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Alireza Javadzadeh,Amir Ghorbanihaghjo,Ebadolah Heidari,Nader Baharivand,Karim Sadeghi,Rana Sorkhabi and Mohammad Hossein Ahoor</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150321]]></guid><cfi:id>1071</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Outcomes of Ahmed valve surgery for refractory glaucoma in Dhahran, Saudi Arabia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150322]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To evaluate the outcomes of Ahmed glaucoma valve (AGV) implantation surgery for refractory glaucoma.<b>METHODS:</b>This one-armed historical cohort study was conducted in 2011. Refractory glaucoma was defined as eyes with an intraocular pressure (IOP) greater than 21 mm Hg with maximally tolerated glaucoma medications, failed surgeries, or both. For all eyes with refractory glaucoma that underwent AGV implantation, data were collected on IOP, the best corrected visual acuity (BCVA) and glaucoma medications preoperatively and 4, 6, 12, 24 and 56wk postoperatively. Logarithm values of IOP were calculated and compared.<b>RESULTS:</b> The study group was comprised of 30 patients (30 eyes, 16 males and 14 females) with refractory glaucoma. Mean preoperative IOP was 39.3±13.8 mm Hg. Postoperative mean IOP was 15.7±7.1 mm Hg, 19.6±12.8 mm Hg and 13.9±14.2 mm Hg at 12, 24 and 56wk respectively. BCVA was ≥ 6/60 in 11 eyes preoperatively, and five eyes had BCVA≥6/60 at 56wk postoperatively. Preoperatively, more than four medications were used to treat glaucoma in 21 eyes. At 12wk postoperatively, no medications were required to control IOP in 20 eyes. At 56wk postoperatively, at least one medication was required to control IOP in 10 eyes. Over the entire follow up period, four eyes were treated with yttrium aluminium garnet (YAG) laser and 14 eyes required a second surgery. The AGV was removed in four eyes.<b>CONCLUSION:</b> AGV implantation reduced IOP and the number of medications required to control refractory glaucoma. However, there was a higher risk of decreased vision. Long-term follow up and prompt intervention are recommended.]]></description>
<pubDate>2015/6/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Tariq Alasbali,Abdullah Ali Alghamdi and Rajiv Khandekar]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Tariq Alasbali,Abdullah Ali Alghamdi and Rajiv Khandekar</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150322]]></guid><cfi:id>1070</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Higher order aberration comparison between two aspherical intraocular lenses:MC6125AS and Akreos advanced optics]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150323]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To compare higher order aberrations in two aspherical intraocular lenses (IOLs):Akreos advanced optics (AO) and Dr. Schmidt Microcrystalline 6125 aspheric anterior surface (MC6125AS) with each other.<b>METHODS:</b> Forty eyes of 39 patients underwent phacoemulsification and Akreos AO and MC6125AS were implanted in their eyes in a random manner. Three months post-operatively, higher order aberrations including spherical aberration, coma aberration, and total aberrations were measured and compared.<b>RESULTS:</b> The total aberration was 0.24±0.17 in eyes with Dr. Schmidt and 0.20±0.01 in eyes with Akreos AO (<i>P</i>=0.361). The mean of coma aberration was 0.17±0.21 and 0.09±0.86 in Dr. Schmidt and Akreos lenses, respectively (<i>P</i>=0.825). Total spherical aberration was almost the same in both groups (Mean:0.05, <i>P</i>=0.933). Best corrected visual acuity in Akreos AO (0.10±0.68) and Dr. Schmidt (0.09±0.67) did not differ significantly (<i>P</i>=0.700).<b>CONCLUSION:</b> There is no statistically significant difference in the higher order aberrations between these two aspherical lenses.]]></description>
<pubDate>2015/6/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mohammad Taher Rajabi,Sara Korouji,Mahgol Farjadnia,Mohammad Naderan,Mohammad Bagher Rajabi,Bahram Khosravi and Seyed Mehdi Tabatabaie]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mohammad Taher Rajabi,Sara Korouji,Mahgol Farjadnia,Mohammad Naderan,Mohammad Bagher Rajabi,Bahram Khosravi and Seyed Mehdi Tabatabaie</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150323]]></guid><cfi:id>1069</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Inferior oblique weakening surgery on ocular torsion in congenital superior oblique palsy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150324]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To investigate changes in fundus excyclotorsion after inferior oblique myectomy or myotomy.<b>METHODS:</b>The records of 21 patients undergoing strabismus surgery by a single surgeon between 2009 and 2012 were examined. Only patients who had undergone an inferior oblique myectomy or myotomy, with or without horizontal rectus muscle surgery, were evaluated. Digital fundus photographs were obtained, and the angle formed by a horizontal line passing through the optic disc center and a reference line connecting the foveola and optic disc center was measured. Associated clinical factors examined include age at the time of surgery, presence or absence of a head tilt, degree of preoperative vertical deviation, torsional angle, inferior oblique muscle overaction/superior oblique muscle underaction, and surgery laterality. Whether the procedure was performed alone or in combination with a horizontal rectus muscle surgery was also examined.<b>RESULTS:</b>Mean preoperative torsional angle was 12.0±6.4°, which decreased to 6.9±5.7° after surgery (<i>P</i>&lt;0.001, paired <i>t</i>-test). Torsional angle also decreased from 15.1±7.0° to 6.2±4.3° in the myectomy group (<i>P</i>&lt;0.001, paired <i>t</i>-test) but there were no significant changes in the myotomy group (<i>P</i>=0.093, Wilcoxon signed rank test). Multivariable linear regression analysis showed that preoperative torsional angle, degree of inferior oblique overaction, and age at surgery independently and significantly affected postoperative torsional angle.<b>CONCLUSION:</b>Mean torsional angle decreased after inferior oblique myectomy. Degree of preoperative torsional angle, inferior oblique overaction, and age at surgery influence postoperative torsional angle.]]></description>
<pubDate>2015/6/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jinho Lee,Soh-Youn Suh,Ho-Kyung Choung and Seong-Joon Kim]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jinho Lee,Soh-Youn Suh,Ho-Kyung Choung and Seong-Joon Kim</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150324]]></guid><cfi:id>1068</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Long term results of no-alcohol laser epithelial keratomileusis and photorefractive keratectomy for myopia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150325]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>RESULTS:</b> Twenty-one eyes and 22 eyes completed follow-up of 60mo in LASEK and PRK group respectively. Manifest refraction at 60mo follow-up was -0.01 and 0.26 in LASEK and PRK group respectively. In the LASEK group mean UDVA and mean CDVA after 60mo were 20/22 and 20/20 respectively (<i>P</i>&gt;0.01). In the PRK group mean UDVA and mean CDVA at 60mo follow-up were 20/20 and 20/20 after 60mo (<i>P</i>&gt;0.01). The efficacy indexes were 0.87 and 0.95, and the safety indexes were 1.25 and 1.4 respectively for LASEK group and PRK group.<b>CONCLUSION:</b>Both standard PRK and no-alcohol LASEK offer safe and effective correction of low-moderate myopia in the long term without any statistically significant difference between the two groups.]]></description>
<pubDate>2015/6/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Leopoldo Spadea,Francesca Verboschi,Vittoria De Rosa,Mariella Salomone and Enzo Maria Vingolo]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Leopoldo Spadea,Francesca Verboschi,Vittoria De Rosa,Mariella Salomone and Enzo Maria Vingolo</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150325]]></guid><cfi:id>1067</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Evaluation of the efficacy of laser peripheral iridoplasty in reversing the darkroom provocative test result in Chinese patients with primary angle closure status post laser iridotomy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150326]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To investigate the efficacy and safety of krypton laser peripheral iridoplasty (LPIP) for Chinese patients with primary angle closure (PAC) or primary angle-closure glaucoma (PACG) status post laser iridotomy in reversing the positive results of the dark room provocative test (DRPT).<b>METHODS</b>:This study was prospective, noncomparative, interventional case series. Thirty-three patients (thirty-eight eyes) with PAC or PACG status post patent laser iridotomy and maintained normal intraocular pressure (IOP) but with positive DRPT results were enrolled. All the subjects were treated with krypton LPIP. DRPT was repeated after krypton LPIP. Results of DRPT were recorded. The visual acuity, IOP and gonioscopy were analyzed before and after krypton LPIP. A minimum time limit for follow-up was 6mo.<b>RESULTS</b>:Thirty-three patients (thirty-eight eyes) were followed for 17.7±8.37mo (range 7-41mo) after LPIP. Positive results of DRPT decreased from 38 eyes to 9 eyes (23.7%) after LPIP. Peripheral anterior synechiae of angle in 34 of 38 eyes (89.5%) remained unchanged at dynamic gonioscopy throughout the follow-up period after LPIP.<b>CONCLUSION</b>:LPIP decreased positive rates of the DRPT significantly. The mechanism may be that LPIP minimized contact between the peripheral iris and trabecular meshwork, which is a key factor for developing peripheral anterior synechiae.]]></description>
<pubDate>2015/6/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ping Huang and Ling-Ling Wu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ping Huang and Ling-Ling Wu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150326]]></guid><cfi:id>1066</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Retinal circulation and its role in macular disorders in patients without systemic disease]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150327]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To determine whether retinal circulatory changes play a role in the pathogenesis of macular disorders in patients who are otherwise healthy.<b>METHODS:</b>Patients with macular disorders that required angiographic imaging were included in this prospective case series. After a complete ocular exam, fluorescein angiography was performed using a standardized technique on the HRA-II (Heidelberg Engineering, Heidelberg, Germany) with special focus on the posterior pole. Only patients with good quality images were included in the analysis. Circulatory parameters recorded included the arm-choroid time, choroid-retinal artery, and finally the retinal artery-vein time. Zonal asymmetry (between the upper and lower zones divided by a line passing through the centre of the fovea) in transit times, if any was also noted. Appropriate statistical analysis was done. Circulation times were compared with age matched historical controls. Changes in retinal dye transit times relative to historical age matched controls, if any, were noted and compared between various disorders.<b>RESULTS:</b>A total of 156 eyes of 156 patients (120 males) were included in the study. Mean age:49.14±14.93y. Macular disorders studied were age related degeneration, polypoidal vasculopathy, central serous chorioretinopathy (CSCR) and parafoveal telangiectasia. Delayed circulation time was noted in CSCR patients only.<b>CONCLUSION:</b>CSCR patients appear to have delayed arterial filling, retinal circulatory disturbances do not seem to contribute to the pathogenesis of other macular disorders.]]></description>
<pubDate>2015/6/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Priyangshu Chandra,Aditya Sudhalkar,Souvik Mandal and Jay Chhablani]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Priyangshu Chandra,Aditya Sudhalkar,Souvik Mandal and Jay Chhablani</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150327]]></guid><cfi:id>1065</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A randomized controlled trial of peeling and aspiration of Elschnig pearls and neodymium:yttrium-aluminium-garnet laser capsulotomy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150328]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b>To compare surgical peeling and aspiration and neodymium yttrium garnet laser capsulotomy for pearl form of posterior capsule opacification (PCO).<b>METHODS</b>:A prospective, randomized, double blind, study was done at Rotary Eye Hospital, Maranda, Palampur, India, Santosh Medical College Hospital, Ghaziabad, India and Laser Eye Clinic, Noida India. Consecutive patients with pearl form of PCO following surgery, phacoemulsification, manual small incision cataract surgery and conventional extracapsular cataract extraction (ECCE) for age related cataract, were randomized to have peeling and aspiration or neodymium yttrium garnet laser capsulotomy. Corrected distance visual acuity (CDVA), intra-operative and post-operative complications were compared.<b>RESULTS</b>:A total of 634 patients participated in the study, and 314 (49.5%) patients were randomized to surgical peeling and aspiration group and 320 (50.5%) to the Nd:YAG laser group. The mean pre-procedural logMAR CDVA in peeling and neodymium:yttrium-aluminium-garnet (Nd:YAG) laser group was 0.80±0.25 and 0.86±0.22, respectively. The mean final CDVA in peeling group (0.22±0.23) was comparable to Nd:YAG group (0.24±0.28; <i>t</i> test, <i>P</i>=0.240). There was a significant improvement in vision after both the procedures (<i>P&lt;</i>0.001). A slightly higher percentage of patients in Nd:YAG laser group (283/88.3%) than in peeling group (262/83.4%) had a CDVA of 0.5 (20/63) or better at 9mo (<i>P&lt;</i>0.001). On the contrary, patients having CDVA worse than 1.00 (20/200) was also significantly higher in Nd:YAG laser group as compared to peeling group (25/7.7% <i>vs</i> 15/4.7%, respectively). On application of ANCOVA, there was less than 0.001% risk that PCO thickness and total laser energy had no effect on rate of complications in Nd:YAG laser group and less than 0.001 % risk that PCO thickness had no effect on complications in peeling group respectively. Sum of square analysis suggests that in the Nd:YAG laser group, thick PCO had a stronger impact on complications (Fischer test probability, <i>P</i>r&lt;0.0001) than thin PCO and total laser energy (Fischer test probability, <i>P</i>r&lt;0.002), respectively; similarly, in peeling group, thick PCO and preoperative vision had a stronger effect on complications than thin PCO, respectively (Fischer test probability, <i>P</i>r&lt;0.001).The rate of complications like uveitis (<i>P=</i>0.527) and cystoid macular edema (<i>P=</i>0.068), did not differ significantly between both the groups. However, intraocular pressure spikes (<i>P</i>=0.046) and retinal detachment (<i>P</i>&lt;0.001) were significantly higher in Nd:YAG laser group as compared to peeling group. Retinal detachment was more common in patients having degenerative myopia (7/87.5%, <i>P&lt;</i>0.001). Recurrence of pearls was the most common cause of reduction of vision in the peeling group (24/7.6%, <i>P&lt;</i>0.001).<b>CONCLUSION</b>:There is no alternative to Nd:YAG laser capsulotomy for fibrous subtype of PCO. For pearl form of PCO, both techniques are comparable with regard to visual outcomes. Nd:YAG laser capsulotomy has a higher incidence of IOP spikes and retinal detachment whereas recurrence of pearls may occur after successful peeling and aspiration. When posterior capsulotomy is needed in patients with retinal degenerations, retinopathies and pre-existing retinal breaks, the clinician should be cautious about increased risks of possible complications of Nd:YAG laser capsulotomy.]]></description>
<pubDate>2015/6/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Rahul Bhargava,Prachi Kumar,Shiv Kumar Sharma and Avinash Kaur]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Rahul Bhargava,Prachi Kumar,Shiv Kumar Sharma and Avinash Kaur</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150328]]></guid><cfi:id>1064</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of corneal measurements in keratoconic eyes using rotating Scheimpflug camera and scanning-slit topography]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150211]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the anterior segment measurements obtained by rotating Scheimpflug camera (Pentacam) and Scanning-slit topography (Orbscan IIz) in keratoconic eyes.
METHODS: A total of 121 patients, 71 males (58.7%) and 50 females (41.3%) (214 eyes) with the diagnosis of keratoconus (KC) were enrolled in this study. Following diagnosis of KC by slit-lamp biomicroscopic examination, central corneal thickness (CCT), thinnest corneal thickness (TCT), anterior chamber depth (ACD), and pupil diameter (PD) were measured by a single examiner using successive instrumentation by Pentacam and Orbscan.
RESULTS: There was no significant difference between the two instruments for the measurement of CCT and TCT. In contrast, scanning-slit topography measured ACD (3.46±0.40 mm vs. 3.38±0.33 mm, P=0.019) and PD (4.97±1.26 mm vs 4.08±1.19 mm, P<0.001) significantly larger than rotating Scheimpflug camera. The two devices made similar measurements for CCT (95% CI: -2.94 to 5.06, P=0.602). However, the mean difference for TCT was -6.28 (95% CI: -10.51 to -2.06, P=0.004) showing a thinner measurement by Orbscan than by Pentacam. In terms of the ACD, the mean difference was 0.08 mm (95% CI: 0.04 to 0.12, P<0.001) with Orbscan giving a slightly larger value than Pentacam. Similarly, Orbscan measurement for PD was longer than Pentacam (95% CI: 0.68 to 1.08, P<0.001).
CONCLUSION: A good agreement was found between Pentacam and Orbscan concerning CCT measurement while comparing scanning-slit topography and rotating Scheimpflug camera there was an underestimation for TCT and overestimation for ACD and PD.]]></description>
<pubDate>2015/4/16 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mohammad Naderan, Saeed Shoar, Morteza Naderan, Mohammad Amin Kamaleddin and Mohammad Taher Rajabi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mohammad Naderan, Saeed Shoar, Morteza Naderan, Mohammad Amin Kamaleddin and Mohammad Taher Rajabi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150211]]></guid><cfi:id>1063</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of torsional mode phacoemulsification on cornea in eyes with/without pseudoexfoliation]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150212]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the effect of torsional mode phacoemulsification on central corneal thickness, corneal endothelial cell density, and morphology in eyes with/without pseudoexfoliation (PEX) syndrome.
METHODS: Fourty-two consecutive patients with and 42 patients without PEX as a control group scheduled for cataract surgery was studied. Phacoemulsification, using OZiL IP system, was performed with quick chop technique. Using noncontact specular microscopy, the central endothelial cell density (ECD), coefficient of variation, percentage of hexagonal cells, and the central corneal thickness (CCT) were evaluated preoperatively and postoperatively at 1, 7 and 30d. 
RESULTS: The ECD in PEX syndrome was statistically significantly lower than that in the control group preoperatively and postoperatively (P≤0.001). Percentage change in ECD was statistically significantly higher in PEX than that in control group after surgery follow up (P≤0.04). There was no statistically significant difference between both groups comparing percentage of hexagonal cells and coefficient of variation in the cell size before and after the surgery. At 1 and 7d after surgery, percentage change in CCT was statistically significantly higher in PEX group than that in the control group (P≤0.041). 
CONCLUSION: Although torsional mode phacoemulsification and intraocular lens (IOL) implantation provided a safe and favorable surgical outcome in patients with/without PEX, torsional phacoemulsification led to significantly higher ECD loss in the PEX group than that in the control group during the whole follow up period. In addition, more corneal swelling in the PEX group than that in the control group during the early postoperative period has indicated that the corneal endothelium, in presence of PEX endotheliopathy, seems to be more susceptible to the effects of phacoemulsification surgery in eyes with PEX. The increased risk of anterior chamber manipulations in patients with PEX should be taken into account for an increased risk of bullous keratopathy.]]></description>
<pubDate>2015/4/16 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Süleyman Demircan,Mustafa Atas and Yusufcan Yurtsever]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Süleyman Demircan,Mustafa Atas and Yusufcan Yurtsever</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150212]]></guid><cfi:id>1062</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of laser iridotomy using short duration 532-nm Nd: YAG laser (PASCAL) vs conventional laser in dark irides]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150213]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the outcome of laser iridotomy using 532-nm Nd: YAG laser (PASCAL) with short pulse duration and Nd: YAG laser compared to conventional combined laser iridotomy. 
METHODS: Retrospective, nonrandomized, comparative case series. Forty-five eyes of 34 patients underwent laser iridotomy. Twenty-two eyes underwent iridotomy using short duration PASCAL and Nd: YAG laser, and 23 eyes underwent iridotomy using conventional combined laser method. The average settings of PASCAL were 60 μm and 700-900 mW with a short duration of 0.01s to reduce the total applied energy. The conventional laser was 50 μm and 700-900 mW for 0.1s. After photocoagulation with these laser, the Nd: YAG laser was added in each group. Endothelial cell counts of pre-iridotomy and 2mo after iridotomy were measured and compared. 
RESULTS: All eyes completed iridotomy successfully. The total energy used in the PASCAL group was 1.85±1.17 J. Compared to conventional laser 13.25±1.67 J, the energy used was very small due to the short exposure time of PASCAL. Endothelial cell counts were reduced by 0.88% in the PASCAL group and 6.72% in the conventional laser group (P=0.044). The change in corneal endothelial cell counts before and after iridotomy was significant in conventional combined laser iridotomy group (P=0.004). 
CONCLUSION: Combined PASCAL and Nd:YAG laser iridotomy is an effective and safe technique in the dark brown irides of Asians. Furthermore, the short duration of exposure in PASCAL offers the advantages of reducing the total energy used and minimizing the corneal damage.]]></description>
<pubDate>2015/4/16 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hye Jin Chung,Hae-Young Park and Su-Young Kim]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hye Jin Chung,Hae-Young Park and Su-Young Kim</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150213]]></guid><cfi:id>1061</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Assessment of visual outcomes of cataract surgery in Tujia nationality in Xianfeng County, China]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150214]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the visual outcome and factors influencing visual outcome of manual small incision cataract surgery (MSICS) in the rural area in the Xianfeng County. 
METHODS: Eighty-two eyes of 82 patients who underwent cataract surgery performed by using MSICS technique were identified. Data collected included each patient’s age, gender, the level of education. Uncorrected and corrected distance visual acuity (UDVA and CDVA) at presentation and at 1, 6, 8wk postoperatively, pre-existing eye disease, operative findings and complications, the risk factors were evaluated. 
RESULTS: In 82 patients, the average age was 69.6±0.6y, illiterate were 52 (63.4%). Of 82 eyes, pseudophakia was present in 77 eyes (93.9%). At 1wk postoperatively, 47 eyes (57.3%) had the UDVA of ≥6/18, and 52 eyes (63.4%) had the CDVA of ≥6/18. At 6 to 8wk postoperatively, 50 eyes (61.0%) had UDVA of ≥6/18, and 57 eyes (69.5%) had the CDVA of ≥6/18. Postoperative visual status was significantly related to the co-morbidities, such as corneal pathology, glaucoma (P<0.001). Operative complications, such as posterior capsule opacity and cystoid macular edema were main operative cause for the poor visual outcome.
CONCLUSION: MSICS provides a good visual recovery in our study but the vision outcome did not fulfill the standards proposed by WHO, which highlights the need for an improvement in local socioeconomic understanding, population education and surgery quality.]]></description>
<pubDate>2015/4/16 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jing Yuan,Xia Wang,Li-Qin Yang,Yi-Qiao Xing and Yan-Ning Yang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jing Yuan,Xia Wang,Li-Qin Yang,Yi-Qiao Xing and Yan-Ning Yang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150214]]></guid><cfi:id>1060</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of Goldmann applanation tonometry, rebound tonometry and dynamic contour tonometry in normal and glaucomatous eyes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150215]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the intraocular pressure (IOP) measurements obtained with the rebound tonometry (RT), dynamic contour tonometry (DCT) and Goldmann applanation tonometry (GAT) in normal and glaucomatous eyes and investigate the effects of central corneal thickness (CCT) and corneal curvature (CC) on IOP measurements.
METHODS: One hundred and twenty-four eyes of 124 subjects were enrolled in this cross-sectional study. Fifty-six of participants were healthy individuals and 68 of them were glaucomatous patients. IOP was measured on each subject always in the same order, ICare  RT-Pascal DCT-GAT, after a minimum interval of 10min between measurements. CCT and CC were measured using a rotating Scheimpflug camera before the IOP measurements in all subjects. One way repeated measures ANOVA, Pearson correlation coefficient and regression analysis, and Bland-Altman analysis was used for the statistical assessment.
RESULTS: Mean IOP for all enrolled eyes was 16.00±3.80 mm Hg for GAT, 16.99±4.91 mm Hg for RT, and 20.40±4.44 mm Hg for DCT. Mean differences between GAT and RT was -1.75±3.41 mm Hg in normal (P<0.001) and -0.37±3.00 mm Hg in glaucomatous eyes (P=0.563). Mean differences between GAT and DCT was -4.06±3.42 mm Hg in normal (P<0.001) and -4.67±3.12 mm Hg in glaucomatous eyes (P<0.001). GAT and RT were significantly positive correlated with CCT in normal (r=0.317, P=0.017 and r=0.576, P<0.001, respectively) and glaucomatous eyes (r=0.290, P=0.016 and r=0.351, P=0.003, respectively). DCT was also significantly positive correlated with CCT in normal eyes (r=0.424, P=0.001) but not in glaucomatous eyes (r=0.170, P=0.165). All tonometers were unaffected by CC.
CONCLUSION: IOP measurements by RT and DCT were significantly higher than GAT. DCT has highest IOP measurements among these tonometers. RT was most influenced tonometer from CCT although all tonometers were significantly positive correlated with CCT except DCT in glaucomatous eyes. CC did not influence IOP measurements.]]></description>
<pubDate>2015/4/16 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Fatih &#214;zcura, Nilgün Yildirim, Afsun &#350;ahin and Ertu&#287;rul &#199;olak]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Fatih &#214;zcura, Nilgün Yildirim, Afsun &#350;ahin and Ertu&#287;rul &#199;olak</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150215]]></guid><cfi:id>1059</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Central retinal artery resistive index and optical coherence tomography in assessment of glaucoma progression]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150216]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the relation between central retinal artery (CRA) resistive index (RI) and retinal nerve fiber thickness measured by optical coherence tomography (OCT) in assessment of disease progress in cases of open angle glaucoma. 
METHODS: Twenty-three patients with diagnosed open angle glaucoma were included in this study. They were examined by colored duplex ultrasonography of CRA with estimation of RI of CRA and ophthalmic artery (OA) with estimation of CRA/OA RI ratio as well as OCT measurement of the average retinal nerve fiber layer (RNFL) thickness in order to assess the disease progress. 
RESULTS: There was strong inverse relation between the increased RI in CRA as well as the increased CRA/OA RI ratio and the decrease in average RNFL thickness in cases of open angle glaucoma. 
CONCLUSION: Assessment of CRA RI can indirectly assess the vascular changes associated with glaucoma and can assess the degree of retinal atrophy helping in evaluating prognosis thus guiding the choice of treatment.]]></description>
<pubDate>2015/4/16 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ahmed F. Abdel Ghany,Samer M. Botros and Tamer M. El-Raggal]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ahmed F. Abdel Ghany,Samer M. Botros and Tamer M. El-Raggal</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150216]]></guid><cfi:id>1058</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Oral eplerenone for the management of chronic central serous chorioretinopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150217]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To examine eplerenone (Inspra, Pfizer), a mineralocorticoid receptor antagonist, as a treatment option for chronic central serous chorioretinopathy  (CSCR).
METHODS: A retrospective consecutive case series was conducted for patients receiving oral eplerenone for chronic CSCR. At baseline and each follow-up visit, spectral domain optical coherence tomography (SD-OCT) imaging was performed, including manual measurements of the height and diameter size of subretinal fluid. The primary outcome measure was the reduction in subretinal fluid following initiation of therapy. 
RESULTS: A total of 17 eyes of 13 patients treated with 25 and 50 mg of oral eplerenone per day were identified. Subretinal fluid (SRF) decreased over time following eplerenone therapy (P= 0.007 and P = 0.002, diameter and height respectively). Maximum SRF height decreased from a mean of 131.5 μm at baseline to 15.3 μm at day 181+. SRF diameter decreased from an average of 2174.4 μm at baseline to 46.9 μm at day 181+. LogMAR visual acuity improved from 0.42 (Snellen equivalent: 20/53) at baseline to 0.29 (Snellen equivalent: 20/39) at day 181+ (P = 0.024). Central subfield thickness (CST) decreased from 339.5 μm at baseline to 270.3 μm at day 181+ (P = 0.029). 
CONCLUSION: Eplerenone therapy resulted in significant anatomic and visual improvements in eyes with chronic CSCR.]]></description>
<pubDate>2015/4/16 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Rishi P Singh,Jonathan E Sears,Rumneek Bedi,Andrew P Schachat,Justis P Ehlers and Peter K Kaiser]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Rishi P Singh,Jonathan E Sears,Rumneek Bedi,Andrew P Schachat,Justis P Ehlers and Peter K Kaiser</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150217]]></guid><cfi:id>1057</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effects of three consecutive monthly intravitreal injection of ranibizumab for polypoidal choroidal vasculopathy in Korea]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150218]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the efficacy and safety of three consecutive monthly injections of intravitreal ranibizumab for the treatment of polypoidal choroidal vasculopathy (PCV) in Korea.
METHODS: A retrospective chart review of 25 patients (27 eyes) with PCV was conducted. Patients received three initial monthly intravitreal injections (0.5 mg) of ranibizumab and were monitored monthly for 12mo between January 2010 and October 2011. Reinjection of ranibizumab after three initial monthly loading was administered on an as-needed basis, guided by the optical coherence tomography (OCT), fluorescein angiography (FA) and indocyanine green angiography (ICGA). The main outcomes were the changes of the mean best corrected Snellen visual acuity (VA), central macular thickness (CMT) by OCT, the changes of polyps and branching vascular network by FA and ICGA, and total number of injections received by patients during the 12mo.
RESULTS: The mean best corrected Snellen visual acuities at baseline, 1, 3, 6 and 12mo after primary injection were 0.77±0.59, 0.76±0.53, 0.70±0.47, 0.63±0.43, 0.61±0.43, 0.62±0.42 logMAR, respectively, and showed significant improvement at 3, 6, 12mo (P=0.003, P=0.002, P=0.018, Wilcoxon signed-rank test). The mean CMT at baseline, 1, 2, 3, 6, and 12mo was 312.41±66.38 μm, 244.59±71.47 μm, 232.32±69.41 μm, 226.69±69.03 μm, 228.62±37.07 μm, 227.59±51.01 μm respectively, and showed significant reduction (all P<0.001, Wilcoxon signed-rank test). Polypoidal lesions resolved on ICGA in 3 eyes (11.1%) and a branching vascular network remained in all 24 eyes (88.9%). A total of 106 injections were given in the 12-month period, which equaled to a mean of 3.92 (range, 3-6) times. Sixteen of the 27 treated eyes had additional 1.56±0.91 injections. The others (11 eyes) had just 3 consecutive injections.
CONCLUSION: An initial loading dose of three monthly ranibizumab injections is a safe and effective method in treating PCV, with visual and anatomical improvement over one year follow-up.]]></description>
<pubDate>2015/4/16 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Young Gun Park,Seungbum Kang and Young Jung Roh]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Young Gun Park,Seungbum Kang and Young Jung Roh</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150218]]></guid><cfi:id>1056</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Measurement of choroidal thickness and macular thickness during and after pregnancy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150219]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the effect of pregnancy on subfoveal choroidal thickness (SFCT) and macular thickness in both pregnant and not pregnant healthy women.
METHODS: Twenty-nine healthy pregnant women in their third trimester and 36 age-matched healthy women were enrolled in a prospective, cross-sectional study. Foveal and parafoveal thickness in the four quadrants and SFCT were measured by optical coherence tomography (OCT) in the healthy pregnant women (i.e. study group) and healthy women (i.e. control group). OCT measurements were again measured 3mo after delivery in the study group.
RESULTS: Mean SFCT measurements in the control group, pregnant women of the study group, and after delivery of the study group were 320.86±59.18 μm, 387.97±59.91 μm, and 332.40±26.03 μm, respectively. There was a statistically significant difference in the mean SFCT values between pregnant women of the study group and the control group (P=0.000). Foveal and parafoveal thickness values were not statistically significant in either the study or control group.
CONCLUSION: SFCT increases during pregnancy and returns to normal range in the three months after delivery. Macular thickness does not show any change during pregnancy.]]></description>
<pubDate>2015/4/16 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[D&#246;ndü Melek Ulusoy, Necati Duru, Mustafa Ata&#351;, Hasan Alt&#305;nkaynak, Zeynep Duru and G&#246;khan A&#231;maz]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>D&#246;ndü Melek Ulusoy, Necati Duru, Mustafa Ata&#351;, Hasan Alt&#305;nkaynak, Zeynep Duru and G&#246;khan A&#231;maz</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150219]]></guid><cfi:id>1055</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Is there any correlation between vitamin D insufficiency and diabetic retinopathy?]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150220]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine a relation between vitamin D level, which is an inhibitor of angiogenesis, and diabetic retinopathy and its risk factors
METHODS: In a clinic-based cross sectional study two hundred and thirty-five type 2 diabetic patients older than 20y were selected. Patients were classified according to ophthalmologic examination as following: no diabetic retinopathy (NDR) (n=153), non-proliferative diabetic retinopathy (NPDR) (n=64) and proliferative diabetic retinopathy (PDR) (n=18). Study subjects were tested for fasting blood glucose, glycated hemoglobin A1C  (HbA1C), lipid profile, microalbuminuria, HsCRP, IGF1, insulin (in patients without history of insulin taking) and 25 hydroxy vitamin D [25 (OH) D] levels. Vitamin D insufficiency was defined according to 25 (OH) D level less than 30 ng/mL. The relationship between diabetic retinopathy and serum 25 (OH) D insufficiency was evaluated.
RESULTS: The prevalence of diabetic retinopathy was 34.8% in our patients. Long duration of diabetes, hypertension, poor glycemic control, diabetic nephropathy, hyperinsulinemia and insulin resistance were risk factors for diabetic retinopathy but 25 (OH) D level was not significant different between NDR, NPDR and PDR groups. Correlation between 25 (OH) D level and other known risk factors of diabetic retinopathy was not significant.
CONCLUSION: This study did not find any association between diabetic retinopathy and its severity and vitamin D insufficiency. Vitamin D insufficiency is not related to risk factors of diabetic retinopathy.
]]></description>
<pubDate>2015/4/16 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Shokoufeh Bonakdaran and Nasser Shoeibi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Shokoufeh Bonakdaran and Nasser Shoeibi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150220]]></guid><cfi:id>1054</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Retinal vessel diameters and their correlation with retinal nerve fiber layer thickness in patients with pseudoexfoliation syndrome]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150221]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare retinal artery-vein diameters (RAVDs) of patients with pseudoexfoliation (PSX) syndrome with healthy controls and investigate the correlations between retinal nerve fiber layer (RNFL) thickness parameters and RAVDs.
METHODS: Seventeen eyes with PSX and 17 eyes of age-matched controls were included in the study. All participants underwent routine ophthalmological examination, Humphrey visual field and RNFL examination by using Stratus OCT. Retinal images were obtained by using a retinal camera (Topcon 501X). RAVDs were measured from inferior nasal, inferior temporal, superior nasal and superior temporal arcuates by using IMAGEnet software. Superior, inferior, nasal, temporal and average RNFL thicknesses were recorded. RAVDs and RNFL parameters in groups and correlations were analyzed by Mann-Whitney U and Spearmann correlation tests. 
RESULTS: Only inferior quadrant and average RNFL thickness were detected thinner in the PSX group compared with control group (P=0.009, P=0.038, respectively). No statistically significant difference regarding RAVDs was found between two groups.
CONCLUSION: RAVDs seems to be comparable in the PSX and control group. RNFL is thinner in the inferior quadrant in the PSX group. RNFL thickness and RAVDs show significant correlations in both groups. This correlation doesn’t seem to be specific to PSX.]]></description>
<pubDate>2015/4/16 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mehmet Cuneyt Ozmen,Zeynep Aktas,Burcin Kepez Yildiz,Murat Hasanreisoglu and Berati Hasanreisoglu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mehmet Cuneyt Ozmen,Zeynep Aktas,Burcin Kepez Yildiz,Murat Hasanreisoglu and Berati Hasanreisoglu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150221]]></guid><cfi:id>1053</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical patterns and characteristics of uveitis in a secondary hospital in southern China]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150222]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the characteristics of uveitis in a secondary hospital in southern China.
METHODS: We reviewed all records of patients with uveitis at Hengli Hospital from January 2008 to December 2011. Demographic data, past history, ophthalmic examinations and other laboratory tests were analyzed.
RESULTS: One hundred and ninety-nine uveitis patients were enrolled in this study, including 134 (67.3%) males and 65 females (32.7%) with an average age of 41.0±15.1y. The anatomical distribution included 103 (51.8%) cases of anterior uveitis, followed by panuveitis (65, 32.7%), posterior uveitis (29, 14.6%) and intermediate uveitis (2, 1.0%). Of the 98 (49.2%) non-idiopathic cases, there were 10.1% Behcet’s disease, 9.5% Vogt-Koyanagi-Harada (VKH) syndrome, 7.5%infectious uveitis, 7.5% traumatic uveitis and 3.5% postoperative uveitis.
CONCLUSION: Idiopathic anterior and posterior uveitis, Behcet’s disease, VKH syndrome, infectious uveitis and traumatic uveitis are the most common uveitis entities in a secondary hospital in southern China. Additional measures should be taken to prevent infectious and traumatic uveitis.]]></description>
<pubDate>2015/4/16 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yang Zheng,Li-Xin Zhang,Qian-Li Meng,Min Zhang,Ying Cui,Qing-Yang Liu,Zhong-Ling Luo and Li-Ping Du]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yang Zheng,Li-Xin Zhang,Qian-Li Meng,Min Zhang,Ying Cui,Qing-Yang Liu,Zhong-Ling Luo and Li-Ping Du</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150222]]></guid><cfi:id>1052</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Agreement of angle closure assessments between gonioscopy, anterior segment optical coherence tomography and spectral domain optical coherence tomography]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150223]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine angle closure agreements between gonioscopy and anterior segment optical coherence tomography (AS-OCT), as well as gonioscopy and spectral domain OCT (SD-OCT). A secondary objective was to quantify inter-observer agreements of AS-OCT and SD-OCT assessments.
METHODS: Seventeen consecutive subjects (33 eyes) were recruited from the study hospital’s Glaucoma clinic. Gonioscopy was performed by a glaucomatologist masked to OCT results. OCT images were read independently by 2 other glaucomatologists masked to gonioscopy findings as well as each other’s analyses of OCT images.
RESULTS: Totally 84.8% and 45.5% of scleral spurs were visualized in AS-OCT and SD-OCT images respectively (P<0.01). The agreement for angle closure between AS-OCT and gonioscopy was fair at k=0.31 (95% confidence interval, CI: 0.03-0.59) and k=0.35 (95% CI: 0.07-0.63) for reader 1 and 2 respectively. The agreement for angle closure between SD-OCT and gonioscopy was fair at k=0.21 (95% CI: 0.07-0.49) and slight at k=0.17 (95% CI: 0.08-0.42) for reader 1 and 2 respectively. The inter-reader agreement for angle closure in AS-OCT images was moderate at 0.51 (95% CI: 0.13-0.88). The inter-reader agreement for angle closure in SD-OCT images was slight at 0.18 (95% CI: 0.08-0.45).
CONCLUSION: Significant proportion of scleral spurs were not visualised with SD-OCT imaging resulting in weaker inter-reader agreements. Identifying other angle landmarks in SD-OCT images will allow more consistent angle closure assessments. Gonioscopy and OCT imaging do not always agree in angle closure assessments but have their own advantages, and should be used together and not exclusively.]]></description>
<pubDate>2015/4/16 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Elton Lik Tong Tay,Vernon Khet Yau Yong,Boon Ang Lim,Stelson Sia,Elizabeth Poh Ying Wong and Leonard Wei Leon Yip]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Elton Lik Tong Tay,Vernon Khet Yau Yong,Boon Ang Lim,Stelson Sia,Elizabeth Poh Ying Wong and Leonard Wei Leon Yip</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150223]]></guid><cfi:id>1051</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Efficacy and safety of active silicone oil removal through a 23-gauge transconjunctival cannula using an external vacuum pump]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150224]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the efficacy and safety of active removal of silicone oil with low and high viscosity through a 23-gauge transconjunctival cannula using an external vacuum pump.
METHODS: This study was conducted as a prospective, interventional case series. A total of 22 eyes of 21 patients [1000 centistokes (cSt): 17 eyes, 5700 cSt: 5 eyes] were included in this study. All patients underwent active silicone oil removal via the entire lumen of a 23-gauge microcannula with suction pressure of a 650-700 mm Hg vacuum using an external vacuum pump. A tubing adaptor from the Total Plus Pak? (Alcon, Fort Worth, USA) was used to join the microcannula and silicone vacuum tube connected to an external vacuum pump. Main outcome measures were mean removal time, changes of intraocular pressure (IOP) and visual acuity, and intraoperative and postoperative complications.
RESULTS: Mean removal time (min) was 1.49±0.43 for 1000 cSt and 7.12±1.27 for 5700 cSt. The IOP was 18.57±7.48 mm Hg at baseline, 11.68±4.55 mm Hg at day 1 postoperatively (P<0.001), and 15.95±4.92, 16.82±3.81, 17.41±3.50, and 17.09±3.01 mm Hg after one week, one month, three months, and six months, respectively. All patients showed improved or stabilized visual acuity. There was no occurrence of intraoperative or postoperative complications during the follow up period.
CONCLUSION: This technique for active removal of silicone oil through a 23-gauge cannula using an external vacuum pump is fast, effective, and safe as well as economical for silicone oil with both low and high viscosity in all eyes with pseudophakia, aphakia, or phakia.]]></description>
<pubDate>2015/4/16 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hyun Ju Oh,Woohyok Chang and Min Sagong]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hyun Ju Oh,Woohyok Chang and Min Sagong</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150224]]></guid><cfi:id>1050</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Outcome comparison between transcanalicular and external dacryocystorhinostomy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150225]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the outcomes achieved with external dacryocystorhinostomy (EX-DCR) and transcanalicular dacryocystorhinostomy (TC-DCR) using a multidiode laser in patients with bilateral nasolacrimal duct obstruction (NLDO).
METHODS: This prospective study was conducted on 38 eyes of 19 patients with bilateral NLDO. Simultaneous bilateral surgery was performed on all patients. TC-DCR (Group 1) with a diode laser was used in the right eye, and EX-DCR (Group 2) was used in the left eye. All patients were placed under general anesthesia. Routine follow-ups were scheduled at 1wk; 1, 3, 6 and 12mo postoperative intervals. Objective (lacrimal system irrigation) and subjective [tearing, irritation, pain, discharge and visual analogue scale (VAS) score] outcomes were evaluated. 
RESULTS: The overall objective success rate at 12mo was 73.7% (14/19) in Group 1 and 89.5 % (17/19) in Group 2. This difference was statistically significant. There were no significant between-group differences in the subjective results, such as tearing, pain and irritation. Only the discharge scores were found to be significantly higher in Group 1 compared to Group 2 at the 1y follow-up. The average VAS score was 6.8 in Group 1 and 8.7 in Group 2, with no statistically significant differences.
CONCLUSION: Although TC-DCR allows surgeons to perform a minimally invasive and safe procedure, EX-DCR offers better objective and subjective outcomes than TC-DCR.]]></description>
<pubDate>2015/4/16 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Gunay Uludag,Baris Yeniad,Erdinc Ceylan,Ayse Yildiz-Tas and Lale Kozer-Bilgin]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Gunay Uludag,Baris Yeniad,Erdinc Ceylan,Ayse Yildiz-Tas and Lale Kozer-Bilgin</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150225]]></guid><cfi:id>1049</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Ocular surface changes in type II diabetic patients with proliferative diabetic retinopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150226]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To detect and analyze the changes on ocular surface and tear function in type II diabetic patients with proliferative diabetic retinopathy (PDR), an advanced stage of diabetic retinopathy (DR), using conventional ophthalmic tests and the high-resolution laser scanning confocal microscopy. 
METHODS: Fifty-eight patients with type II diabetes were selected. Based on the diagnostic criteria and stage classification of DR, the patients were divided into the non-DR (NDR) group and the PDR group. Thirty-six patients with cataract but no other ocular and systemic disease were included as non-diabetic controls. All the patients were subjected to the conventional clinical tests of corneal sensitivity, Schirmer I Test, and corneal fluorescein staining. The non-invasive tear film break-up time (NIBUT) and tear interferometry were conducted by a Tearscope Plus. The morphology of corneal epithelia and nerve fibers was examined using the high-resolution confocal microscopy.  
RESULTS: The NDR group exhibited significantly declined corneal sensitivity and Schirmer I test value, as compared to the non-diabetic controls (P< 0.001). The PDR group showed significantly reduced corneal sensitivity, Schirmer I test value, and NIBUT in comparison to the non-diabetic controls (P < 0.001). Corneal fluorescein staining revealed the progressively injured corneal epithelia in the PDR patients. Moreover, significant decrease in the corneal epithelial density and morphological abnormalities in the corneal epithelia and nerve fibers were also observed in the PDR patients. 
CONCLUSION: Ocular surface changes, including blunted corneal sensitivity, reduced tear secretion, tear film dysfunction, progressive loss of corneal epithelia and degeneration of nerve fibers, are common in type II diabetic patients, particularly in the diabetic patients with PDR. The corneal sensitivity, fluorescein staining scores, and the density of corneal epithelial cells and nerve fibers in the diabetic patients correlate with the duration of diabetes. Therefore, ocular surface of the patients with PDR should be examined regularly by conventional approaches and confocal microscopy to facilitate early diagnosis and treatment of keratopathy.]]></description>
<pubDate>2015/4/16 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yan Gao,Yan Zhang,Yu-Sha Ru,Xiao-Wu Wang,Ji-Zhong Yang,Chun-Hui Li,Hong-Xing Wang,Xiao-Rong Li and Bing Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yan Gao,Yan Zhang,Yu-Sha Ru,Xiao-Wu Wang,Ji-Zhong Yang,Chun-Hui Li,Hong-Xing Wang,Xiao-Rong Li and Bing Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150226]]></guid><cfi:id>1048</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of pathological myopia on biomechanical properties: a study by ocular response analyzer]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150227]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the ocular response analyzer (ORA) measurements of patients with pathological myopia in comparison with those of emmetropic control subjects, and to investigate the correlation between these ORA measurements and spherical equivalent (SE).
METHODS: Measurements of 53 eyes of 53 subjects with pathological myopia (SE>-6.00 D) were compared with those of 60 eyes of 60 emmetropic controls. Corneal hysteresis (CH), corneal resistance factor (CRF), noncontact tonometer intraocular pressure (IOPg), and corneal-compensated IOP (IOPcc) were obtained for each subject. The refractive error value was determined as SE via a cycloplegic refraction test.
RESULTS: The mean age was 54.1±18.9y (ranging from 5 to 88) in the pathological myopic group and 56.2±19.0y (ranging from 6 to 89) in the control group. There were no significant differences between the groups concerning age and sex. CH and CRF were significantly lower in the pathological myopic group than in the control group (P<0.001, P=0.005, respectively). IOPcc and IOPg were significantly higher in the pathological myopic group than in the control group (P<0.001, P=0.009, respectively). There were significantly positive correlations between CH and SE (r=0.565, P<0.001) and between CRF and SE (r=0.364, P=0.007). There were significantly negative correlations between IOPcc and SE (r=-0.432, P=0.001) and between IOPg and SE (r=-0.401, P=0.003). 
CONCLUSION: The present study displayed that pathological myopia affected biomechanical properties measured by ORA. The results of corneal biomechanical properties measured by ORA may need to be appreciated by taking refraction into account. Further, pathological myopia might be related with the increased IOP.]]></description>
<pubDate>2015/4/16 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Veysi &#214;ner, Mehmet Ta&#351;, Erdal &#214;zkaya and Yavuz Oru&#231;]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Veysi &#214;ner, Mehmet Ta&#351;, Erdal &#214;zkaya and Yavuz Oru&#231;</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150227]]></guid><cfi:id>1047</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Refractive errors in high myopic eyes after phacovitrectomy for macular hole]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150228]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To examine the refractive prediction error in high myopic eyes after phacovitrectomy.
METHODS: This retrospective comparative case series included 91 eyes (18 high myopic eyes and 73 non-high myopic eyes) of 91 patients who underwent successful phacovitrectomy (phacoemulsification, intraocular lens implantation, and pars plana vitrectomy). The high myopic eyes were defined as the eye with more than 26.0 mm of axial length. The postoperative prediction error of mean error and mean absolute error were evaluated at 4mo postoperatively. Axial length and keratometry measurement were performed preoperatively and 4mo postoperatively using the IOL Master.
RESULTS: The refractive outcome after phacovitrectomy showed significantly greater myopic shift in the high myopic eyes [-1.08±0.87 diopters (D)] than that in the non-high myopic eyes (-0.43±0.63 D, P=0.004). Axial length and keratometric value in the high myopic eyes were significantly increased (P=0.043, 0.037 respectively), whereas those in the non-high myopic group were not significantly increased (P=0.135, 0.347 respectively). The change of the axial length in the myopic eye (0.46±0.28 mm) was greater than that in the non-high myopic eye (0.11 ± 0.34 mm; P<0.001).
CONCLUSION: High myopic eyes showed more myopic shift than non-high myopic eyes after phacovitrectomy. The cause of myopic shift in high myopic eyes seems to be attributed to actual elongation of the axial length in high myopia.]]></description>
<pubDate>2015/4/16 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Donghyun Jee,Yi-Ryeung Park,Kyoung In Jung,Eunchul Kim and Tae Yoon La]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Donghyun Jee,Yi-Ryeung Park,Kyoung In Jung,Eunchul Kim and Tae Yoon La</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150228]]></guid><cfi:id>1046</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Intraexaminer repeatability and agreement in stereoacuity measurements made in young adults]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150229]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the repeatability and agreement of stereoacuity measurements made using some of the most widely used clinical tests: Frisby, TNO, Randot and Titmus. 
METHODS: Stereoacuity was measured in two different sessions separated by a time interval of at least 24h but no longer than 1wk in 74 subjects of mean age 20.6y using the four methods. The study participants were divided into two groups: subjects with normal binocular vision and subjects with abnormal binocular vision. 
RESULTS: Best repeatability was shown by the Frisby and Titmus [coefficient of repeatability (COR): ±13 and ±12s arc respectively] in the subjects with normal binocular vision though a clear ceiling effect was noted. In the subjects with abnormal binocular vision, best repeatability was shown by the Frisby (COR: ±69s arc) and Randot (COR: ±72s arc). In both groups, the TNO test showed poorest agreement with the other tests. 
CONCLUSION: The repeatability of stereoacuity measures was low in subjects with poor binocular vision yet fairly good in subjects with normal binocular vision with the exception of the TNO test. The reduced agreement detected between the tests indicates they cannot be used interchangeably.]]></description>
<pubDate>2015/4/16 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Beatriz Antona,Ana Barrio,Isabel Sanchez,Enrique Gonzalez and Guadalupe Gonzalez]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Beatriz Antona,Ana Barrio,Isabel Sanchez,Enrique Gonzalez and Guadalupe Gonzalez</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150229]]></guid><cfi:id>1045</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Visual pathways involvement in clinically isolated syndrome in children]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150230]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate extent and nature of visual pathways involvement in children with clinically isolated syndrome (CIS). 
METHODS: Forty-seven patients (age 11-17y) with CIS, which later proved to be multiple sclerosis (MS) onset, and 30 controls underwent visual evoked potentials (VEP) investigation within 12d from the appearance of the first signs of disease. Latency and amplitude of P100 peak were compared with normative data and between groups. 
RESULTS: In 58% patients, including those without signs of retrobulbar neuritis, significant slowing of conduction along the central visual pathways (P100 latency lengthening) is seen. P100 amplitudes drop (signs of axonal damage) are registered less frequently (29% cases). 
CONCLUSION: The results indicate that visual pathways are often affected in the MS onset; mostly demyelination signs are seen. Despite MRI significance for MS diagnostic, VEPs proved to be still effective in early diagnosis of MS in children.]]></description>
<pubDate>2015/4/16 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Vladislav Voitenkov,Natalia Skripchenko and Andrey Klimkin]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Vladislav Voitenkov,Natalia Skripchenko and Andrey Klimkin</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150230]]></guid><cfi:id>1044</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[QT interval dispersion in the patients with central serous chorioretinopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150111]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate QT dispersion (QTD) in patients with central serous chorioretinopathy (CSC).
METHODS: This clinical, comperative, case-control study included 30 patients with CSC at acute phase (Group 1) and 30 age- and sex-matched healthy subjects (Group 2, the control group). From all subjects, a 12-lead surface electrocardiography was obtained. The heart rate (HR), QT maximum (QTmax), QT minimum (QTmin), QT corrected (QTc), QTD and Tmean were manually measured and analyzed. Student’s t-test and Pearson’s method of correlation were used for statistical analysis. 
RESULTS: The patient and control groups were matched for age, smoking status (rate and duration) and gender. There were no significant differences with regard to these among the groups (P>0.05). The participants included 19 men (63.3%) and 11 women (36.7%) in Group 1, 20 men (66.7%) and 10 women (33.3%) in Group 2. 
QTmax, QTD and QTc were significantly higher than those of healthy controls (P<0.001 for QTmax, P=0.01 for QTD and P=0.001 for QTc). QTmin, Tmean and HR did not differ significantly between the study groups (P=0.28 for QTmin, P=0.56 for Tmean and P>0.05 for HR). No significant correlation was found between duration of the disorder and QTD values (r=0.13, P>0.05). 
CONCLUSION: These findings suggest that CSC may be associated with an increase in QTD and that the patients might be at risk for ventricular arrhythmia.
]]></description>
<pubDate>2015/2/13 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Necati Dagli, Burak Turgut, Rumeysa Tanyildizi, Sabiha Kobat, Mehmet Ali Kobat and Orhan Dogdu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Necati Dagli, Burak Turgut, Rumeysa Tanyildizi, Sabiha Kobat, Mehmet Ali Kobat and Orhan Dogdu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150111]]></guid><cfi:id>1043</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Optical quality of toric intraocular lens implantation in cataract surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150112]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To analyze the optical quality after implantation of toric intraocular lens with optical quality analysis system.
<b>METHODS:</b> Fifty-two eyes of forty-four patients with regular corneal astigmatism of at least 1.00 D underwent implantation of AcrySof toric intraocular lens, including T3 group 19 eyes, T4 group 18 eyes, T5 group 10 eyes, T6 group 5 eyes. Main outcomes evaluated at 3mo of follow-up, included uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), residual refractive cylinder and intraocular lens (IOL) axis rotation. Objective optical quality were measured using optical quality analysis system (OQAS Ⅱ?, Visiometrics, Spain), included the cutoff frequency of modulation transfer function (MTFcutoff), objective scattering index (OSI), Strehl ratio, optical quality analysis system value (OV) 100%, OV 20% and OV 9% [the optical quality analysis system (OQAS) values at contrasts of 100%, 20%, and 9%].
<b>RESULTS:</b> At 3mo postoperative, the mean UDVA and CDVA was 0.18±0.11 and 0.07±0.08 logMAR; the mean residual refractive cylinder was 0.50±0.29 D; the mean toric IOL axis rotation was 3.62±1.76 degrees, the mean MTFcutoff, OSI, Strehl ratio, OV 100%, OV 20% and OV 9% were 22.862±5.584, 1.80±0.84, 0.155±0.038, 0.76±0.18, 0.77±0.19 and 0.78±0.21. The values of UDVA, CDVA, IOL axis rotation, MTFcutoff, OSI, Strehl ratio, OV100%, OV20% and OV9% depending on the power of the cylinder of the implantation were not significantly different (P>0.05), except the residual refractive cylinder (P<0.05).    
<b>CONCLUSION:</b> The optical quality analysis system was useful for characterizing the optical quality of AcrySof toric IOL implantation. Implantation of an AcrySof toric IOL is an effective and safe method to correct corneal astigmatism during cataract surgery.]]></description>
<pubDate>2015/2/13 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xian-Wen Xiao,Jing Hao,Hong Zhang and Fang Tian]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xian-Wen Xiao,Jing Hao,Hong Zhang and Fang Tian</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150112]]></guid><cfi:id>1042</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of refractive error on temperament and character properties]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150113]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To determine the effect of refractive error on temperament and character properties using Cloninger’s psychobiological model of personality. 
<b>METHODS:</b> Using the Temperament and Character Inventory (TCI), the temperament and character profiles of 41 participants with refractive errors (17 with myopia, 12 with hyperopia, and 12 with myopic astigmatism) were compared to those of 30 healthy control participants. Here, temperament comprised the traits of novelty seeking, harm-avoidance, and reward dependence, while character comprised traits of self-directedness, cooperativeness, and self-transcendence.
<b>RESULTS:</b> Participants with refractive error showed significantly lower scores on purposefulness, cooperativeness, empathy, helpfulness, and compassion (P<0.05, P<0.01, P<0.05, P<0.05, and P<0.01, respectively).
<b>CONCLUSION:</b> Refractive error might have a negative influence on some character traits, and different types of refractive error might have different temperament and character properties. These personality traits may be implicated in the onset and/or perpetuation of refractive errors and may be a productive focus for psychotherapy.]]></description>
<pubDate>2015/2/13 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Emine Kalkan Akcay,Fatih Canan,Huseyin Simavli,Derya Dal,Hacer Yalniz,Nagihan Ugurlu,Omer Gecici and Nurullah Cagil]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Emine Kalkan Akcay,Fatih Canan,Huseyin Simavli,Derya Dal,Hacer Yalniz,Nagihan Ugurlu,Omer Gecici and Nurullah Cagil</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150113]]></guid><cfi:id>1041</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effects of chronic smoking on color vision in young subjects]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150114]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To evaluate the effects of chronic smoking on color vision in young subjects.
<b>METHODS:</b> This study included 91 smokers and 88 non-smokers (a total of 179 volunteers) without any ophthalmologic and systemical disorders. The subjects were between 18-40 years of age with a best corrected visual acuity (BCVA) of 20/20, normal anterior and posterior segment examinations and normal intraocular pressure. The color vision of the subjects were evaluated with Farnsworth-Munsell 100 Hue test (FMHT). The total error scores and axis calculation were performed for each subject and the results correlated.
<b>RESULTS:</b> Mean age and the standard deviation was 28±5y in the smokers group, and 26.7±5.5y in the control group (P=0.101). Sex distribution was similar in the two groups (P=0.365). There was no significant correlation between age and FMHT total error scores (P=0.069). Median of FMHT total error scores of smokers and non-smokers were 65 and 50.50, respectively. FMHT total error scores was found significantly higher in smokers than non-smokers (P=0.004). There was no statisticaly significant difference between smoker and non-smoker groups with respect to axis ratio calculation (P=0.611). There was no significant correlation with FMHT total error scores with neither smoking duration nor number of cigarettes smoked per day (P=0.405, P=0.454, respectively).
<b>CONCLUSION:</b> This study suggested that chronic smoking affects the color vision of young smokers but this  may not be sector selective.]]></description>
<pubDate>2015/2/13 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hatice Arda,G Ertugrul Mirza,Osman A Polat,Sarper Karakucuk,Ayse Oner and Koray Gumus]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hatice Arda,G Ertugrul Mirza,Osman A Polat,Sarper Karakucuk,Ayse Oner and Koray Gumus</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150114]]></guid><cfi:id>1040</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Eye rubbing-induced changes in intraocular pressure and corneal thickness measured at five locations, in subjects with ocular allergy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150115]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To assess the effects of eye rubbing on corneal thickness (CT) and intraocular pressure (IOP) measurements obtained 0-30min after habitual eye rubbing in symptomatic patients.
<b>METHODS:</b> Measurements of IOP and CT were obtained at five locations (central, temporal, superior, nasal and inferior) before, and every 5min for 30min interval after 30s of eye rubbing, for 25 randomly selected eyes of 14 subjects with ocular allergy and 11 age-matched normals. Differences in measurements were calculated in each group [Baseline measurements minus measurements recorded at each time interval after eye rubbing (for IOP), and for each corneal location (for CT)] and comparison were then made between groups (allergic versus control) for differences in any observed effects. 
<b>RESULTS:</b> Within groups, baseline mean IOPs in the allergic patient-group (14.2±3.0 mm Hg) and in the control group (13.1±1.9 mm Hg) were similar at all times, after eye rubbing (P >0.05, for all). The maximum reduction in IOP was 0.8 mm Hg in the control subjects and the maximum increase was also 0.8 mm Hg in the allergic subjects. Between groups (allergic versus control), the changes in IOP remained under 1 mm Hg at all times (P=0.2) after 30min of eye rubbing. Between 0 and 30min of CT measurements after eye rubbing, the mean central CT (CCT), inferior CT (ICT), superior CT (SCT), temporal CT (TCT) and nasal CT (NCT) did not vary significantly from baseline values in the control and allergic-subject groups (P>0.05, for both). Between both groups, changes in CT were similar at all locations (P>0.05) except for the TC which was minimally thinner by about 4.4 μm (P=0.001) in the allergic subjects than in the control subjects, 30min following 30s of eye rubbing. 
<b>CONCLUSION:</b> IOP measured in allergic subjects after 30s of habitual eye rubbing was comparable with that obtained in normal subjects at all times between 0 and 30min. Although, CT in the allergic subjects were similar to those of the control subjects at all times, it varied between +10 and -7.5 μm following eye rubbing, with the temporal cornea showing consistent reductions in thickness in the subjects with allergy. However, this reduction was minimal and was considered to not be clinically relevant.]]></description>
<pubDate>2015/2/13 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Uchechukwu L. Osuagwu and Saud A. Alanazi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Uchechukwu L. Osuagwu and Saud A. Alanazi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150115]]></guid><cfi:id>1039</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Concurrent removal of intravitreal lens fragments after phacoemulsification with pars plana vitrectomy prevents development of retinal detachment]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150116]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To evaluate the outcomes of ‘‘concurrent vitrectomy’’ to retrieve dislocated lens fragment during phacoemulsification. 
<b>METHODS:</b> In a retrospective, observational case series, data of patients who underwent ‘‘concurrent’’ pars plana vitrectomy (PPV) for dislocated lens fragments between the period 2000 and 2008 were reviewed. Data collected included patient demographics, pre-operative visual acuity, intra-operative occurrence of retinal breaks, duration of follow up, post-operative intraocular pressure, final best-corrected visual acuity (BCVA), presence of cystoid macular edema (CME) and occurrence of rhegmatogenous retinal detachment (RRD).
<b>RESULTS:</b> A total of 58 eyes of 58 patients were included in the study. At 12mo the mean postoperative BCVA was logMAR 0.17 (20/30) with a range of logMAR 0 to 0.69 (20/20 to 20/100), with 96.6% (56/58) of patients showing post-operative improvement in visual acuity (P=0.005). None of the patients developed postoperative retinal detachment, endophthalmitis or non-resolving uveitis at 12mo. 
<b>CONCLUSION:</b> Our study results suggest concurrent PPV for retained lens fragments after cataract surgery is beneficial and may decrease the risk of glaucoma and prevent development of RRD.]]></description>
<pubDate>2015/2/13 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Kakarla V Chalam,Ravi K Murthy,Joshua C Priluck,Vijay Khetpal and Shailesh K Gupta]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Kakarla V Chalam,Ravi K Murthy,Joshua C Priluck,Vijay Khetpal and Shailesh K Gupta</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150116]]></guid><cfi:id>1038</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A short-term study of corneal collagen cross-linking with hypo-osmolar riboflavin solution in keratoconic corneas]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150117]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To report the 3mo outcomes of collagen cross-linking (CXL) with a hypo-osmolar riboflavin in thin corneas with the thinnest thickness less than 400 μm without epithelium.
<b>METHODS:</b> Eight eyes in 6 patients with age 26.2±4.8y were included in the study. All patients underwent CXL using a hypo-osmolar riboflavin solution after its de-epithelization. Best corrected visual acuity, manifest refraction, the thinnest corneal thickness, and endothelial cell density were evaluated before and 3mo after the procedure. 
<b>RESULTS:</b> The mean thinnest thickness of the cornea was 408.5±29.0 μm before treatment and reduced to 369.8±24.8 μm after the removal of epithelium. With the application of the hypo-osmolar riboflavin solution, the thickness increased to 445.0±26.5 μm before CXL and recover to 412.5±22.7 μm at 3mo after treatment, P=0.659). Before surgery, the mean K-value of the apex of the keratoconus corneas was 57.6±4.0 diopters, and slightly decreased (54.7±4.9 diopters) after surgery (P=0.085). Mean best-corrected visual acuity was 0.55±0.23 logarithm of the minimal angle of resolution, and increased to 0.53±0.26 logarithm after surgery (P=0.879). The endothelial cell density was 2706.4±201.6 cells/mm2 before treatment, and slightly decreased (2641.2±218.2 cells/mm2) at last fellow up (P=0.002). 
<b>CONCLUSION:</b> Corneal collagen cross-linking with a hypo-osmolar riboflavin in thin corneas seems to be a promising treatment. Further study should be done to evaluate the safety and efficiency of CXL in thin corneas for the long-term.]]></description>
<pubDate>2015/2/13 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Shao-Feng Gu,Zhao-Shan Fan,Li-Hua Wang,Xiang-Chen Tao,Yong Zhang,Chun-Qin Wang,Ya Wang and Guo-Ying Mu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Shao-Feng Gu,Zhao-Shan Fan,Li-Hua Wang,Xiang-Chen Tao,Yong Zhang,Chun-Qin Wang,Ya Wang and Guo-Ying Mu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150117]]></guid><cfi:id>1037</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of retinal nerve fiber layer and macular thickness measurements with Stratus OCT and OPKO/OTI OCT devices in healthy subjects]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150118]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To compare retinal nerve fiber layer (RNFL) and macular thickness measurements obtained with the Stratus optical coherence tomography (OCT) and OPKO/OTI OCT devices.
<b>METHODS:</b> Included in the study were 59 eyes of 30 participants. All measurements for each eye were done on the same day with both devices. Student’s paired t-tests were used to compare the central macular thickness and RNFL measurements of the Stratus OCT and OPKO/OTI OCT. Pearson correlation was used to assess the relationship between the devices. Coefficient of variation (COV) was calculated to assess intersession repeatability.
<b>RESULTS:</b> Using both the Stratus OCT and OPKO/OTI OCT, respectively, the measured mean average RNFL thicknesses were 98.9±11.1 μm and 115.1±9.6 μm (P=0.001), and the measured mean central retinal thicknesses (CRT) were 196.2±18.8 μm and 204.5±21.1 μm (P<0.001). Measured by the two devices, the RNFL thickness values were correlated in all quadrants, as were the retinal thickness values except the inferior outer sector. COV for average RNFL and CRT thickness were 2.9% and 4.6% for Stratus OCT, and 2.1% and 4.2% for OPKO/OTI OCT, respectively.
<b>CONCLUSION:</b> We found good reproducibility of RNFL and retina thickness measurements for both Stratus OCT and OPKO/OTI OCT devices. However, even though the two OCT systems provided statistically correlated results, the values for both RNFL and macular thickness were statistically different. RNFL and macular thickness measurements with the OPKO/OTI OCT were higher than that of the Stratus OCT; therefore, the two OCT systems cannot be used interchangeably for the measurements of RNFL and macular thickness.]]></description>
<pubDate>2015/2/13 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ahmet Ozkok,Julide Canan Umurhan Akkan,Nevbahar Tamcelik,Mehmet Erdogan,Didar Ucar Comlekoglu and Rengin Yildirim]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ahmet Ozkok,Julide Canan Umurhan Akkan,Nevbahar Tamcelik,Mehmet Erdogan,Didar Ucar Comlekoglu and Rengin Yildirim</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150118]]></guid><cfi:id>1036</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A knotless, one-haptic fixation of posterior chamber intraocular lenses:one-year results]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150119]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM: </b>To assess the results of a modified technique for scleral fixation of a posterior chamber intraocular lens (IOL) in eyes which had deficient of posterior capsular support.
<b>METHODS:</b> This retrospective study was comprised of ten patients with deficient posterior capsular support who underwent one-haptic fixation of posterior chamber IOLs, between February 2010 and October 2011. IOL as implanted with one haptic supported on the capsular remnant and the other haptic drawn into the sulcus by anchoring suture without a knot. All patients were evaluated for pre- and postoperative visual acuity, lens centration, intra-and postoperative complications.
<b>RESULTS:</b> A knotless, one-haptic fixation of posterior chamber IOLs has successfully been performed on ten eyes. All cases had inadequate capsular support (i.e. a capsular tear ranged from 5 to 7 clock hours). The average age was 74.25±8.87y (SD). The average postoperative uncorrected visual acuity was 0.51 logMAR. Complications included hyphema in one eye, a mild inflammatory reaction in the anterior chamber in two eyes, and a transient rise in IOP in one eye. Neither IOL tilt nor dislocation was observed and there were no later complications.
<b>CONCLUSION:</b> In the presence of insufficient capsular support, a knotless, one-haptic fixation of posterior chamber IOLs is a safe and viable option which reduces the operation time, and minimizes postoperative suture-related complications.]]></description>
<pubDate>2015/2/13 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Pipat Kongsap]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Pipat Kongsap</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150119]]></guid><cfi:id>1035</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Surgical outcomes for unilateral superior oblique palsy in Chinese population:a retrospective study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150120]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To evaluate the outcome after surgery for unilateral superior oblique (SO) palsy in Chinese.
<b>METHODS:</b> The medical records of 39 patients that underwent surgery for unilateral SO palsy between January 2003 and December 2012 at Caritas Medical Centre, Hong Kong, were retrospectively reviewed. All surgeries were performed by a single surgeon. Pre-operative assessments for vertical deviation, cyclo-deviation, and Knapp’s classification were obtained to determine the nature and degree of surgical correction. Vertical deviation was measured at 1wk; 1, 6mo and on last follow-up day post-operatively. Cyclo-deviation was measured on last follow-up day post-operatively. 
<b>RESULTS:</b> During the 10y period, 39 subjects were recruited. The most common etiology was congenital (94.9%). Knapp’s Type III (66.7%) and Type I (12.8%) classifications were the most common subtypes. To treat SO palsy, the most common surgical procedures were: isolated inferior oblique (IO) anteriorization (41.0%), isolated IO myectomy (10.3%), and isolated IO recession (10.3%). At 3.5±2.1y post-operatively, the vertical deviation was significantly reduced (15.1±6.2 PD versus 0.5±1.4 PD, P<0.0001) without significant improvement in cyclo-deviation (P=0.5). Initial vertical deviation was correlated with cyclo-torsion (r=0.4, P=0.007). Those with over-correction had greater initial vertical deviation (19.4±7.2 PD versus 13.2±4.3 PD, P=0.003). After a single operation, 84.6% of subjects achieved a vertical deviation within ±3 PD.
<b>CONCLUSION:</b> The majority of subjects achieved corrected vertical deviation after a single surgery although there was no improvement in cyclo-deviation. Those with over-correction of primary position deviation had greater preoperative vertical deviation and it may be related to simultaneous multiple muscle surgery.]]></description>
<pubDate>2015/2/13 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Gordon Shing kin Yau,Victor Tak Yau Tam,Jacky Wai Yip Lee,Theo Tak Kwong Chan and Can Yin Fun Yuen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Gordon Shing kin Yau,Victor Tak Yau Tam,Jacky Wai Yip Lee,Theo Tak Kwong Chan and Can Yin Fun Yuen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150120]]></guid><cfi:id>1034</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Reproducibility of peripapillary retinal nerve fiber layer thickness measurements with cirrus HD-OCT in glaucomatous eyes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150121]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM: </b>To assess the reproducibility of Cirrus high-definition optical coherence tomography (HD-OCT; Carl Zeiss Meditec, Dublin, CA, USA) for analysis of peripapillary retinal nerve fiber layer (RNFL) thickness in glaucomatous eyes
<b>METHODS:</b> Forty-five eyes (one eye from each glaucomatous patient) were imaged with Cirrus HD-OCT. Each eye was imaged three times by two separate operators. Intraclass correlation coefficient (ICC), coefficient of variation (CV), and test-retest variability were evaluated for both intraobserver and interobsever measurements
<b>RESULTS:</b> In intraobserver measurements, the average RNFL thickness ICC was 0.983. CV and test-retest variability were 2.3% and 4.4 μm respectively. In quadrants ICC ranged from 0.886 to 0.956, the lowest associated with nasal quadrant and CV ranged from 3.6% to 7.7%. In interobsever measurements, the average RNFL thickness ICC was 0.979. CV and test-retest variability were 2.4% and 4.5 μm respectively. In quadrants ICC ranged from 0.886 to 0.957, the lowest associated with nasal quadrant and CV ranged from 3.8% to 8.6%.
<b>CONCLUSION:</b> The reproducibility of Cirrus OCT for RNFL thickness is sufficiently good to be useful clinically as a measure of glaucoma progression.]]></description>
<pubDate>2015/2/13 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Reza Soltani-Moghadam,Yousef Alizadeh,Ehsan Kazemnezhad Leili and Mohamadreza Absari Haghighi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Reza Soltani-Moghadam,Yousef Alizadeh,Ehsan Kazemnezhad Leili and Mohamadreza Absari Haghighi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150121]]></guid><cfi:id>1033</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of four different intraocular lenses on posterior capsule opacification]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150122]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To evaluate the impact of 4 different intraocular lenses (IOLs) on posterior capsule opacification (PCO) by comparing the neodymium: yttrium-aluminum-garnet (Nd:YAG) laser capsulotomy rates.
<b>METHODS:</b> This retrospective study included 4970 eyes of 4013 cataract patients who underwent phacoemulsification and IOL implantation between January 2000 and January 2008 by the same surgeon at one clinic. Four different IOLs were assessed. The outcome parameter was the incidence of Nd:YAG laser posterior capsulotomies.
<b>RESULTS:</b> An Nd:YAG laser posterior capsulotomy was performed in 153 (3.07%) of the 4970 eyes. The mean follow-up time was 84mo for all of the IOL groups. The percentage of eyes developing PCO was significantly greater for the acrylic hydrophilic IOLs than for the hydrophobic IOLs, although eyes with acrylic hydrophilic IOLs did not require Nd:YAG laser capsulotomy as soon as eyes with acrylic hydrophobic IOLs. There was no difference between the long-term PCO rates when 1- and 3-piece acrylic hydrophobic IOLs were compared or when IOLs made of the same material but with different haptic angles were compared.
<b>CONCLUSION:</b> In this study, eyes with acrylic hydrophilic IOLs were more likely to develop PCO than those with acrylic hydrophobic IOLs. The lens design (1-piece versus 3-piece and varying haptic angles) did not affect the PCO rate.]]></description>
<pubDate>2015/2/13 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Rahmi Duman, Fatih Karel, Pelin &#214;zyol and Can Ate&#351;]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Rahmi Duman, Fatih Karel, Pelin &#214;zyol and Can Ate&#351;</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150122]]></guid><cfi:id>1032</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Combined 23-gauge sutureless vitrectomy and clear corneal phacoemulsification for rhegmatogenous retinal detachment repair]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150123]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To assess the outcomes of combined 23-gauge sutureless vitrectomy and clear corneal phacoemulsification with intraocular lens implantation for rhegmatogenous retinal detachment (RRD) repair.
<b>METHODS:</b> This was a retrospective, consecutive, non-comparative, interventional case series of 30 eyes of 30 patients who underwent combined sutureless vitrectomy and clear corneal cataract surgery for the repair of RRD. The principal outcome measures were primary anatomical success rate, reasons for redetachment, final visual acuity, and surgical complications.
<b>RESULTS:</b> Primary reattachment was achieved in 27 eyes (90.0%). The reasons for redetachment (3 eyes, 10%) were incomplete laser retinopexy, persistent chronic subretinal fluid, and proliferative vitreoretinopathy, respectively. The logarithm of the minimum angle of resolution visual acuity (mean±SD) improved from 0.76±0.74 preoperatively to 0.21±0.37 6 months’ postoperatively (P<0.0001). Postoperative hypotony was not detected, but 1 eye (3.3%) had increased intraocular pressure (30mmHg) with spontaneous resolution. No endophthalmitis developed during follow-up. Macular pucker was detected in 3 eyes (10.0%).
<b>CONCLUSION:</b> Combined 23-gauge sutureless vitrectomy and clear corneal phacoemulsification with intraocular lens implantation for RRD repair was proven safe and effective. It may provide not only the known advantages of conventional combined surgery, but also additional advantages such as less conjunctival fibrosis and the maintenance of stable intraocular pressure with low risks of postoperative hypotony and intraocular pressure elevation.]]></description>
<pubDate>2015/2/13 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hoseok Moon,Hee Jin Sohn,Dea Yeong Lee,Jong Yeon Lee and Dong Heun Nam]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hoseok Moon,Hee Jin Sohn,Dea Yeong Lee,Jong Yeon Lee and Dong Heun Nam</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150123]]></guid><cfi:id>1031</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of non-cycloplegic photorefraction, cycloplegic photorefraction and cycloplegic retinoscopy in children]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150124]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To compare the results of noncycloplegic photorefraction, cycloplegic photorefraction and cycloplegic refraction in preschool and non-verbal children.
<b>METHODS:</b> One hundred and ninety-six eyes of 98 children (50 females, 48 males) were included in the study. Firstly, non-cycloplegic photorefraction was achieved with Plusoptix A09; secondly, cycloplegic photorefraction was carried out with Plusoptix A09 after 10 min cyclopentolate. Finally, 30min after instillation of twice cyclopentolate, cycloplegic refraction was obtained with autorefraction and/or standard retinoscopy. Spheric equivalent, spheric power, cylindric power and cylindrical axis measurements were statistically compared. 
<b>RESULTS:</b> The mean age was 28.8±18.5mo (range 12-72mo). The differences in spherical equivalent, spheric power and cylindrical power measured by the three methods were found statistically significant (P<0.05). The spherical equivalent and spheric power measured by cycloplegic photorefraction were statistically higher than the measurements of the other methods (P<0.05). The cylindrical power measured by cycloplegic refraction was statistically lower than the measurements of the photorefraction methods (P<0.05). There was no significant difference in cylindrical axis measurements between three methods (P>0.05). 
<b>CONCLUSION:</b> For the determination of refractive errors in children, the Plusoptix A09 measurements give incorrect results after instillation of cyclopentolate. Additionally, the cylindrical power measured by Plusoptix A09 with or without cycloplegia is higher. However, the non-cycloplegic Plusoptix A09 measures spheric equivalent and spheric power similar to cycloplegic refraction measurements in preschool and non-verbal children.]]></description>
<pubDate>2015/2/13 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ozdemir Ozdemir, Zuhal &#214;zen Tunay, Ikbal Seza Petri&#231;li, Damla Ergintürk Acar and Muhammet Kaz&#305;m Erol]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ozdemir Ozdemir, Zuhal &#214;zen Tunay, Ikbal Seza Petri&#231;li, Damla Ergintürk Acar and Muhammet Kaz&#305;m Erol</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150124]]></guid><cfi:id>1030</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Using Markov Chains to predict the natural progression of diabetic retinopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150125]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>AIM:</b> To study the natural progression of diabetic retinopathy in patients with type 2 diabetes. 
<b>METHODS:</b> This was an observational study of 153 cases with type 2 diabetes from 2010 to 2013. The state of patient was noted at end of each year and transition matrices were developed to model movement between years. Patients who progressed to severe non-proliferative diabetic retinopathy (NPDR) were treated. Markov Chains and Chi-square test were used for statistical analysis. 
<b>RESULTS:</b> We modelled the transition of 153 patients from NPDR to blindness on an annual basis. At the end of year 3, we compared results from the Markov model versus actual data. The results from Chi-square test confirmed that there was statistically no significant difference (P=0.70) which provided assurance that the model was robust to estimate mean sojourn times. The key finding was that a patient entering the system in mild NPDR state is expected to stay in that state for 5y followed by 1.07y in moderate NPDR, be in the severe NPDR state for 1.33y before moving into PDR for roughly 8y. It is therefore expected that such a patient entering the model in a state of mild NPDR will enter blindness after 15.29y.  
<b>CONCLUSION:</b> Patients stay for long time periods in mild NPDR before transitioning into moderate NPDR. However, they move rapidly from moderate NPDR to proliferative diabetic retinopathy (PDR) and stay in that state for long periods before transitioning into blindness.]]></description>
<pubDate>2015/2/13 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Priyanka Srikanth]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Priyanka Srikanth</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20150125]]></guid><cfi:id>1029</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effects of posterior corneal astigmatism on the accuracy of AcrySof toric intraocular lens astigmatism correction]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160907]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the effects of posterior corneal surface measurements on the accuracy of total estimated corneal astigmatism.
METHODS: Fifty-seven patients with toric intraocular lens (IOL) implantation and posterior corneal astigmatism exceeding 0.5 diopter were enrolled in this retrospective study. The keratometric astigmatism (KA) and total corneal astigmatism (TA) were measured using a Pentacam rotating Scheimpflug camera to assess the outcomes of AcrySof IOL implantation. Toric IOLs were evaluated in 26 eyes using KA measurements and in 31 eyes using TA measurements. Preoperative corneal astigmatism and postoperative refractive astigmatism were recorded for statistical analysis. The cylindrical power of toric IOLs was estimated in all eyes.
RESULTS: In all cases, the difference of toric IOL astigmatism magnitude between KA and TA measurements for the estimation of preoperative corneal astigmatism was statistically significant. Of a total of 57 cases, the 50.88% decreased from Tn to Tn-1, and 10.53% decreased from Tn to Tn-2. In all cases, 5.26% increased from Tn to Tn+1. The mean postoperative astigmatism within the TA group was significantly lower than that in the KA group.
CONCLUSION: The accuracy of total corneal astigmatism calculations and the efficacy of toric IOL correction can be enhanced by measuring both the anterior and posterior corneal surfaces using a Pentacam rotating Scheimpflug camera.]]></description>
<pubDate>2016/9/12 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Bin Zhang, Jing-Xue Ma, Dan-Yan Liu, Cong-Rong Guo, Ying-Hua Du, Xiu-Jin Guo and Yue-Xian Cui]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Bin Zhang, Jing-Xue Ma, Dan-Yan Liu, Cong-Rong Guo, Ying-Hua Du, Xiu-Jin Guo and Yue-Xian Cui</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160907]]></guid><cfi:id>1028</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Evaluation of anterior and posterior surfaces of the cornea using a dual Scheimpflug analyzer in keratoconus patients implanted with intrastromal corneal ring segments]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160908]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate corneal parameters measured with a dual Scheimpflug analyzer in keratoconus patients implanted with intrastromal corneal ring segments (ICRS).
METHODS: Fifty eyes of 40 keratoconus patients had Ferrara ICRS implantation from November 2010 to April 2014. Uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), refraction, keratometry, asphericity, elevation, pachymetry, root mean square (RMS), spherical aberration and coma were studied. All patients were evaluated using a dual Scheimpflug system.
RESULTS: The mean follow-up time after the procedure was 12.7mo. The mean UCVA improved from 0.82 to 0.31 (P<0.001); the mean BCVA improved from 0.42 to 0.05 (P<0.0001), the mean spherical refraction changed from -3.06±3.80 D to -0.80±2.5 D (P<0.0001) and the mean refraction astigmatism reduced from -4.51±2.08 D to -2.26±1.18 D (P<0.0001). The changes from preoperative to postoperative, in parameters of the anterior and posterior surface of the cornea, were statistically significant except the elevation posterior at the apex of the cornea and posterior asphericity.
CONCLUSION: The implantation of Ferrara ICRS induces changes in both anterior and posterior surfaces of the cornea.]]></description>
<pubDate>2016/9/12 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Leonardo Torquetti, Carlos Arce, Jesús Merayo-Lloves, Guilherme Ferrara, Paulo Ferrara, Brenno Signorelli and Armando Signorelli]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Leonardo Torquetti, Carlos Arce, Jesús Merayo-Lloves, Guilherme Ferrara, Paulo Ferrara, Brenno Signorelli and Armando Signorelli</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160908]]></guid><cfi:id>1027</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Toric markers-assisted implantation of the scleral-fixated intraocular lens]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160909]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the efficacy of toric intraocular lens markers-assisted implantation of the scleral-fixated intraocular lens (SFIOL).
METHODS: From October 2010 to December 2013, all patients who had undergone secondary SFIOL implantation were assigned to group 1 and 2, in group 1 SFIOL was performed with the assist of radial keratotomy (RK)-marker, and in group 2 SFIOL was performed with the assisted of toric intraocular lens markers (T-and axis markers). Patients’ demographic data and information on baseline preoperative visual acuity, indication for surgery and latest postoperative visual acuity were collected and analyzed. The haptic and optic positions were determined by ultrasound biomicroscopy. The optic tilt angle and decentration distance were measured.
RESULTS: The study evaluated 43 eyes of 43 patients ranging in age from 3 to 66y. Group 1 comprised 24 eyes (24 patients) and group 2, 19 eyes (19 patients). Uncorrected reoperative acuity was improved on all the eyes postoperatively. The improved postoperative acuity was significantly more in group 2 than that in group 1 (1.11±0.38 vs 0.82±0.45 logMAR; F=4.85, P=0.03). Ultrasonic biomicrograph examination showed that the rate of haptic asymmetry was significantly higher in group 1 (42%, 10/24) than that in group 2 (11%; 2/19) (Chi square=3.68, P=0.04). The mean tilted degree in group 1 was significantly higher than that in group 2 (P=0.04). Mean decentration distance in group 1 was greater than that in group 2 (P=0.03).
CONCLUSION: During SFIOL the toric markers help the surgeon identify the placement of fixation more precisely than that with the use of RK marker.]]></description>
<pubDate>2016/9/12 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hu-Ping Song, Bing-Yu Tian and Jing Peng]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hu-Ping Song, Bing-Yu Tian and Jing Peng</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160909]]></guid><cfi:id>1026</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A modified approach to actively remove high viscosity silicone oil through 23-gauge cannula]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160910]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report a simple approach to actively remove high viscosity silicone oil through a 23-gauge cannula via pars plana.
METHODS: Forty-eight eyes of 48 patients underwent silicone oil (5700 centistokes) removal (SOR) were enrolled. A section of blood transfusion set was prepared to connect a standard 23-gauge cannula and vitrectomy machine. Silicone oil was removed with suction of 500-mm Hg vacuum through the cannula. Main outcome measures were SOR duration, number of sutured sites, intraocular pressure (IOP), best-corrected visual acuity (BCVA), and complications.
RESULTS: Silicone oil was successfully removed in all cases. The mean SOR time was 5.70±0.85min. Nine eyes (18.75%) needed suture partial sclerotomies. No intraoperative complications were noted. Transient hypotony (≤8 mm Hg) was seen in 3 eyes (6.25%) on postoperative day 1, but all resolved within 1wk. Retinal reattachment was achieved in all cases and no other postoperative complications were noted during 3-month following-up. BCVA at the final visit improved or stabilized in all patients comparing to the preoperative level.
CONCLUSION: Active removal of high viscosity silicone oil through a 23-gauge instrument cannula jointed with blood transfusion set is a practical and reliable technique when considering two sides of efficacy and safety.]]></description>
<pubDate>2016/9/12 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Zong-Ming Song, Xu-Ting Hu, Lei Wang, Zhi-Xiang Hu, Pei-Quan Zhao and Ding Chen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zong-Ming Song, Xu-Ting Hu, Lei Wang, Zhi-Xiang Hu, Pei-Quan Zhao and Ding Chen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160910]]></guid><cfi:id>1025</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Ultra-wide field imaging system and traditional retinal examinations for screening fundus changes after cataract surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160911]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the results of non-mydriatic ultra-wide field imaging system, mydriatic slit-lamp lens (Volk +90 D) and mydriatic Goldmann three-mirror contact lens examinations in screening fundus lesions among patients after cataract surgery.
METHODS: Non-mydriatic images were obtained with an Optomap panoramic 200Tx (Optomap 200Tx) 3d after surgery and graded by a blinded ophthalmologist. A mydriatic slit-lamp lens examination was performed by another blinded retinal specialist on the same day. A third blinded retinal specialist examined patients two weeks after surgery using a Goldmann three-mirror contact lens.
RESULTS: In total, 160 patients (184 eyes) were examined, and 66, 69, and 75 cases of retinal lesion(s) were identified using the Optomap 200Tx, slit-lamp lens, and Goldmann three-mirror contact lens, respectively. In 13 cases, fundus changes were sight-threatening. The results obtained by Optomap 200Tx examination and by mydriatic slit-lamp lens examination have good consistency (P=0.375, Kappa=0.942). The mydriatic Goldmann three-mirror lens examination revealed more fundus lesions but are consistent with Optomap 200Tx (P=0.004, Kappa=0.897) and mydriatic slit-lamp lens examination (P=0.031, Kappa=0.932).
CONCLUSION: Early post-operative fundus screening in cataract patients is extremely important and necessary to prevent further vision loss. Wide-field imaging is a feasible and convenient tool for fundus examination that can be used as a primary screening method among patients after cataract surgery.]]></description>
<pubDate>2016/9/12 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jie Peng, Qi Zhang, Hai-Ying Jin, Wu-Yi Lu and Pei-Quan Zhao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jie Peng, Qi Zhang, Hai-Ying Jin, Wu-Yi Lu and Pei-Quan Zhao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160911]]></guid><cfi:id>1024</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Influence of CFH, HTRA1 and ARMS2 polymorphisms in the response to intravitreal ranibizumab treatment for wet age-related macular degeneration in a Spanish population]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160912]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine whether gene polymorphisms of the major genetic risk loci for age-related macular degeneration (AMD): ARMS2 (rs10490923), the complement factor H (CFH) (rs1410996) and HTRA1 (rs11200638) influence the response to a treatment regimen with ranibizumab for exudative AMD.
METHODS: This study included 100 patients (100 eyes) with exudative AMD. Patients underwent a treatment with ranibizumab injections monthly during three months. Reinjections were made when the best corrected visual acuity (BCVA) decrease five letters (ETDRS) or central subfield retinal thickness gained 100 μm in optical coherence tomography image. Genotypes (rs10490923, rs1410996 and rs11200638) were analyzed using TaqMan probes or polymerase chain reaction-restricted fragment length polymorphisms analysis.
RESULTS: There were no statistically significant differences in allelic distribution of CFH (rs1410996), ARMS2 (rs10490923) and HTRA1 (rs11200638) polymorphisms regarding to response to ranibizumab treatment.
CONCLUSION: Ranibizumab treatment response is not related to CFH (rs1410996), ARMS2 (rs10490923) and HTRA1 (rs11200638) poymorphisms.]]></description>
<pubDate>2016/9/12 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Fernando Cruz-Gonzalez, Lucia Cabrillo-Estevez, Vanesa Rivero-Gutierrez, Ana Sanchez-Jara, Lourdes De Juan-Marcos and Rogelio Gonzalez-Sarmiento]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Fernando Cruz-Gonzalez, Lucia Cabrillo-Estevez, Vanesa Rivero-Gutierrez, Ana Sanchez-Jara, Lourdes De Juan-Marcos and Rogelio Gonzalez-Sarmiento</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160912]]></guid><cfi:id>1023</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of scleral buckling using wide-angle viewing systems and indirect ophthalmoscope for rhegmatogenous retinal detachment]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160913]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the effects of scleral buckling using wide-angle viewing systems (WAVS) with that using indirect ophthalmoscope for the treatment of rhegmatogenous retinal detachment.
METHODS: The study was a retrospective analyses of the medical records of 94 eyes (94 patients) with rhegmatogenous retinal detachment. Among them, 47 eyes underwent scleral buckling using WAVS with endoilluminator (Group W), and 47 eyes underwent scleral buckling using indirect ophthalmoscope (Group I). Surgical durations, primary success rate, best-corrected visual acuities (BCVA), delayed subretinal fluid absorptions and surgical complications were compared between the two groups.
RESULTS: At baseline, there were no statistical differences between the two groups in patient's age (P=0.997), gender (P=0.853), symptom duration (P=0.216), BCVA (P=0.389), refractive error (P=0.167), intraocular pressure (P=0.595), the number of retinal breaks (P=0.832), the extent of retinal detachment (P=0.246), subretinal demarcation line (P=0.801), and macular detachment (P=0.811). The follow-up period was 12mo. The surgical durations in Group W (with or without encircling buckling) were significant shorter than those in Group I (P?<0.001 respectively). The primary success rate was 94.27% in Group W, which was similar to that in Group I (92.38%, P?=?0.931). The BCVA in Group W was better than that in Group I (P<0.001) at 1-month follow-up visit. However, there were no significant differences between the two groups at 3-month (P=0.221), 6-month (P=0.674), and 12-month (P=0.363) follow-up visits respectively. Delayed subretinal fluid absorptions were more common in Group I than in Group W at 1-month (P=0.045) follow-up visit, but there were no significant differences between the two groups at 3-month (P=0.111), 6-month (P=1.000) and 12-month follow-up visits respectively.
CONCLUSION: Scleral buckling using WAVS can be an alternative choose for rhegmatogenous retinal detachment.]]></description>
<pubDate>2016/9/12 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xiu-Juan Li, Xiao-Peng Yang and Xiao-Bei Lyu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiu-Juan Li, Xiao-Peng Yang and Xiao-Bei Lyu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160913]]></guid><cfi:id>1022</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Analyses on the misdiagnoses of 25 patients with unilateral optic nerve sheath meningioma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160914]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate clinical features of optic nerve sheath meningioma (ONSM) that was misdiagnosed, and to find methods to reduce the misdiagnoses.
METHODS: Retrospective series study. Twenty-five misdisgnosed patients with unilateral ONSM were collected from Jan. 2008 to Jan. 2015 and the clinical records reviewed.
RESULTS: Patients were misdiagnosed with acute papillitis most frequently (n=17), immediately followed by optic atrophy (n=8), ischemic optic neuropathy (n=5), acute retrobulbar optic neuritis (n=5), optic disc vasculitis (n=3). For each patient, the minimum frequency of misdiagnoses was once and the maximum was 4 times. As for the lasting time of being misdiagnosed, the shortest was 1.5mo and the longest was 45mo. Twenty-one cases (84%) were once treated with glucocorticoids, and its side effects was found in seventeen patients. Twenty patients (80%) complained with varying degree of vision loss. When a definite diagnosis was made, sixteen cases (64%) showed slight exophthalmos and eighteen cases (72%) had the tubular ONSM.
CONCLUSION: ONSM without loss obvious exophthalmos is easily misdiagnosed in clinic, and for most of these ONSMs are tubular.]]></description>
<pubDate>2016/9/12 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jun-Feng Mao, Xiao-Bo Xia, Xiang-Bo Tang, Xue-Yong Zhang and Dan Wen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jun-Feng Mao, Xiao-Bo Xia, Xiang-Bo Tang, Xue-Yong Zhang and Dan Wen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160914]]></guid><cfi:id>1021</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effects of upper lid blepharoplasty on visual quality in patients with lash ptosis and dermatochalasis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160915]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the effects of upper lid blepharoplasty on visual quality.
METHODS: Seventy-three eyelids of 39 patients were subjected to upper lid blepharoplasty. Pre- and post-operative contrast sensitivity, visual acuity, vertical palpebral aperture and the degree of lash ptosis were measured.
RESULTS: The mean log contrast sensitivities under photopic (P=0.017) and scotopic conditions (P=0.009) were improved after surgery, and these differences were significant. The degree of lash ptosis was also decreased after blepharoplasty (P<0.001).
CONCLUSION: In our study, a significant increase in contrast sensitivity was found after surgery. These results suggest that upper lid blepharoplasty can be helpful for improving visual quality.]]></description>
<pubDate>2016/9/12 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Seoung Hyun An, Sang Wook Jin, Yoon Hyung Kwon, Won Yeol Ryu, Woo Jin Jeong and Hee Bae Ahn]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Seoung Hyun An, Sang Wook Jin, Yoon Hyung Kwon, Won Yeol Ryu, Woo Jin Jeong and Hee Bae Ahn</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160915]]></guid><cfi:id>1020</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Retinal vessels caliber changes after strabismus surgery: results of 6mo follow-up]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160916]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the effect of strabismus surgery on retinal vessels calibers with digital color fundus photographs.
METHODS: Two hundred consecutive strabismus patients underwent surgery, and 118 patients (female/male, 55/63) who finished 6-month follow-up were finally included in this study. Optic disc-centered digital color fundus photographs of both eyes of all patients were taken prior to surgery and 6mo post surgery. The retinal vascular caliber of 116 operated eyes were measured using the computer program IVAN. The operated eyes were divided into 3 groups according to the surgical methods, recession of one muscle, one muscle recession and one muscle folding, one muscle resection and one muscle recession. The effect of number of altered muscles on retinal vessels was analyzed using statistic software SPSS 16.0.
RESULTS: The mean age was 12.4±8.6y. Averaged central retinal artery equivalent (CRAE) of all patients was 120.31±23.02 μm preoperatively, and 122.87±15.93 μm six months after surgery. Averaged central retinal vein equivalent (CRVE) was 171.11±31.73 μm preoperatively and 175.02±21.00 μm postoperatively. There was no significant difference of averaged CRAE (P=0.22) or CRVE (P=0.19) before and after operation. Averaged arteriole to venule ratio (AVR) was 0.71±0.07 before surgery and 0.70±0.07 after surgery. Comparison of preoperative and postoperative retinal vessels calibers among different surgical groups did not show significant differences. Also, there was no advantage of rectus muscle folding to muscle resection.
CONCLUSION: Up to 6mo after strabismus surgery, the retinal vascular calibers were not altered. No more than two muscles in one surgery are safe for retinal perfusion.]]></description>
<pubDate>2016/9/12 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ji-Peng Li, Jing Fu, Jin-Qiong Zhou, Xiao-Zhen Wang, Wen-Ying Wang and Ning-Pu Liu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ji-Peng Li, Jing Fu, Jin-Qiong Zhou, Xiao-Zhen Wang, Wen-Ying Wang and Ning-Pu Liu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160916]]></guid><cfi:id>1019</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Correlation between visual function and refractive, topographic, pachymetric and aberrometric data in eyes with keratoconus]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160807]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyze the relationship between two visual functions and refractive, topographic, pachymetric and aberrometric indicators in eyes with keratoconus.METHODS: Corrected distance visual acuity (CDVA), and letter contrast sensitivity (CS) were correlated with refraction, corneal topography, pachymetry, and total corneal wavefront data prospectively in 71 eyes with keratoconus. The topographic indices assessed were simulated keratometry for the flattest and steepest meridians (SimK1 and SimK2), posterior steeper K (Ks), elevation value in best-fit sphere (BFS) maps, squared eccentricity (Є2), aspheric asymmetric index (AAI), pachymetry, thickness progression index (TPI), the amount of pachymetric decentralization (APD), and GalileiTM-keratoconus indices.RESULTS: The mean CDVA (expressed as logMAR) were 0.25±0.21. The mean CS was 1.25±0.46. The spherical refraction correlated well with CDVA (r=-0.526, P<0.001). From topographic indices, SRI correlated with CS (r=-0.695), and IAI with CS (r=-0.672) (P<0.001 for all). Root mean square (RMS) was 4.3±1.81 µm, spherical aberration (SA) was -0.4±0.67 µm, vertical and horizontal coma were -2.1±1.47 and -0.4±0.72 µm. All wavefront data (except horizontal coma), AAI, Є2 and maximum BFS correlated significantly with the visual function (P≤0.001 for all).CONCLUSION: In this study, CS is more affected than CDVA as a visual function. The quantity and quality of vision is significantly correlated with well-known and new topographic indices. There is not a significant correlation between visual function and pachymetric parameters. The significantly correlated indices can be used in staging keratoconus and to follow the outcome of a treatment.]]></description>
<pubDate>2016/8/15 15:51:38</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Neslihan Bayraktar Bilen, Ibrahim F. Hepsen and Carlos G. Arce]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Neslihan Bayraktar Bilen, Ibrahim F. Hepsen and Carlos G. Arce</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160807]]></guid><cfi:id>1018</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Optic disc area in different types of glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160808]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the possible relationship of optic disc area with retina nerve fiber layer in different glaucoma subtypes.
METHODS: One eye each was chosen from 45 patients with ocular hypertension, 45 patients with primary open angle glaucoma, 45 patients with pseudoexfoliation glaucoma and 45 healthy controls followed in our hospital. The records of the patients were reviewed retrospectively. Optic disc area and circumpapillary retina nerve fiber layer measurements were obtained using optical coherence tomography. Central corneal thickness was measured by ultrasound pachymetry.
RESULTS: The median disc area in the patients with primary open angle glaucoma was significantly higher than the patients with ocular hypertension (2.19 vs 1.90 mm2, P=0.030). The median retina nerve fiber layer was thinner in the patients with primary open angle glaucoma and pseudoexfoliation glaucoma than the patients with ocular hypertension for superior, inferior and temporal quadrants. After adjustment for age, no difference in central corneal thickness was found between the groups. Greater disc area was associated with thicker retinal nerve fiber layer for superior, inferior and nasal quadrants in the patients with primary open angle glaucoma. There was no correlation between disc area and central corneal thickness measurements of the groups.
CONCLUSION: Disc size affects the retinal nerve fiber layer thickness in eyes with primary open angle glaucoma and is a possible risk factor for glaucomatous optic nerve damage.]]></description>
<pubDate>2016/8/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Oya Tekeli, Esra Savku and Ahmed Abdullayev]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Oya Tekeli, Esra Savku and Ahmed Abdullayev</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160808]]></guid><cfi:id>1017</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Nitric oxide and tumour necrosis factor alpha in the process of pseudoexfoliation glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160809]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To establish the role of nitric oxide (NO), ascorbic acid and tumour necrosis factor-α (TNF-α) in the pathogenesis of pseudoexfoliation glaucoma (XFG).
METHODS: Our study included 120 patients who were referred for cataract surgery. All patients were divided into four groups according to clinical findings: XFG, early and late pseudoexfoliation syndrome (XFS), and cataract (without pseudoexfoliation). Serum and aqueous humour levels of the ascorbic acid, NO and TNF-α were measured. The concentrations of the ascorbic acid and NO were measured by an appropriate spectrophotometric method. Enzyme-linked immunosorbent assay (ELISA) was used to determine TNF-α level.
RESULTS: Aqueous humour concentration of ascorbic acid was significantly lower in patients with late XFS (0.61±0.11 mmol/L) and XFG (0.48±0.15 mmol/L) compared to patients with early XFS (0.9±0.15 mmol/L) and cataract (1.16±0.22 mmol/L), while there was no difference in serum concentration in all examined groups. Aqueous humour concentration of NO was significantly higher in patients with XFG (77.7±11.4 μmol/L) compared to patients with early XFS (50.27±9.34 μmol/L) and cataract (49.77±7.1 μmol/L), while serum concentration was increased in the early stage of XFS (73.26±8.29 μmol/L). Aqueous humour level of proinflammatory cytokine TNF-α was increased in patients with XFS (early 460.04±18.32 pg/mL; late 502.42±53.23 pg/mL) and XFG (510.34±43.07 pg/mL), while there was no difference in serum level in all examined groups of patients.
CONCLUSION: Reduced ascorbic acid and elevated NO and inflammation related cytokine TNF-α level in aqueous humour of the patients with developed XFG suggest that oxidative stress induces local inflammation.]]></description>
<pubDate>2016/8/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Tatjana S. Sarenac Vulovic, Sladjana M. Pavlovic, Vladimir LJ. Jakovljevic, Katarina B. Janicijevic and Nemanja S. Zdravkovic]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Tatjana S. Sarenac Vulovic, Sladjana M. Pavlovic, Vladimir LJ. Jakovljevic, Katarina B. Janicijevic and Nemanja S. Zdravkovic</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160809]]></guid><cfi:id>1016</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Association between choroidal thickness and anterior chamber segment in eyes with narrow or open-angle]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160810]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the relationship between choroidal thickness and anterior chamber segment in subjects with eyes with narrow or open-angle.
METHODS: The subfoveal choroidal thickness was measured with enhanced depth-imaging optical coherence tomography and anterior chamber parameters were measured with ultrasound biomicroscopy in one eye of 23 subjects with open-angle eyes and 38 subjects with narrow-angle eyes. The mean age was 59.52±7.04y for narrow-angle subjects and 60.76±7.23y for open-angle subjects (P=0.514). Multivariate linear regression analysis was performed to assess the association between choroidal thickness and narrow-angle parameters.
RESULTS: There were no differences in subfoveal choroidal thickness between open- and narrow-angle subjects (P=0.231). Anterior chamber parameters, including central anterior chamber depth, trabecular iris angle, iris thickness 500 &micro;m from the scleral spur (IT500), and ciliary body thickness at 1 mm and 2 mm from the scleral spur (CBT1, CBT2) showed significant differences between the two groups (P<0.05). Subfoveal choroidal thickness showed negative correlation (β=-0.496, P=0.016) only with anterior chamber depth in the open-angle group and with age (β=-0.442, P=0.003) and IT500 (β=-0.399, P=0.008) in the narrow-angle group. However, subfoveal choroidal thickness was not correlated with trabecular iris angle, anterior chamber depth, ciliary body thickness, or central corneal thickness in the narrow-angle group.
CONCLUSION: Choroidal thickness does not differ in the two groups and has not correlated with anterior chamber parameters in narrow-angle subjects, suggesting a lack of relationship between choroidal thickness and primary angle-closure glaucoma.]]></description>
<pubDate>2016/8/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Song- Feng Li, Ge-Wei Wu, Chang-Xi Chen, Ling Shen, Zhi-Bao Zhang, Fei Gao and Ning-Li Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Song- Feng Li, Ge-Wei Wu, Chang-Xi Chen, Ling Shen, Zhi-Bao Zhang, Fei Gao and Ning-Li Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160810]]></guid><cfi:id>1015</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Systemic changes and adverse effects induced by retinopathy of prematurity screening]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160811]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To estimate the potential systemic events during and after retinopathy of prematurity (ROP) screening.
METHODS: A prospective and descriptive designed study was conducted to detect the physiologic and pathological changes 24h before, during, and 72h after ROP screening. Control blood pressure (BP), saturation, pulse rate, and body temperature were routinely taken at various time internals before and after screening. Adverse effects pertain to cardiovascular system, respiratory system, gastric system, urinary system and nervous system were retrospect 0-72h after ROP screening at a 24-hour interval.
RESULTS: Totally 1254 prematurity babies receiving ROP screening during Jan. 1st 2013 to Dec. 31th 2013 were enrolled in our survey. Compared to control vital sign data taken before the examination, there was a fluctuation in the diastolic BP with the increased 3.03 mm Hg (P=0.04) after 3 doses of mydriatic drops. Immediately after the examination, there was a further 12.64 mm Hg (P<0.01) increase in systolic BP and a 7.24 mm Hg (P<0.01) in diastolic BP. The mean pulse rate during examination was 22.4 bpm (P<0.01) higher than the 133.3±9.0 bpm control level. The oxygen saturation shared an average drop of 5% (P<0.01) during screening. In prematurity with postconceptional age less than 31wk, the incidence of apnea (23.5%), necrotizing enterocolitis (NEC) (8.7%), gastric residual (25.4%) and upper digestive tract hemorrhage (6.4%) also demonstrated a significant rise (P<0.01).
CONCLUSION: In our study sample, ROP screening was associated with NEC, gastric residual and upper digestive tract hemorrhage. These gastrointestinal side effects, along with breath activity pattern change and vital signs indicators fluctuation, may be results of additional stress responses.]]></description>
<pubDate>2016/8/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jing-Bo Jiang, Zhi-Wei Zhang, Jia-Wen Zhang, Yan-Li Wang, Chuan Nie and Xian-Qiong Luo]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jing-Bo Jiang, Zhi-Wei Zhang, Jia-Wen Zhang, Yan-Li Wang, Chuan Nie and Xian-Qiong Luo</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160811]]></guid><cfi:id>1014</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Fixed bimonthly aflibercept in na&iuml;ve and switched neovascular age-related macular degeneration patients: one year outcomes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160812]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine real life clinical outcomes in poorly responsive and treatment-na&iuml;ve neovascular age related macular degeneration (nvAMD) patients using bimonthly fixed dosing aflibercept regimen.
METHODS: This was a retrospective study of 165 eyes with nvAMD started on aflibercept at Southampton Eye Unit between June 2013 and June 2014. Patients were either switched from pro re nata (PRN) ranibizumab/bevacizumab due to poor response (107 eyes), or treatment-na&iuml;ve (58 eyes). Patients initially received 3-monthly intravitreal aflibercept injections followed by 2-monthly fixed doses. Clinic visits were scheduled at month 0, 4, 10 and 12. Mean change in best-corrected visual acuity (BCVA) and central retinal thickness (CRT) from baseline were assessed using the Wilcoxon signed-rank test. The proportion of patients maintaining BCVA (<15 letters loss) at 12mo was also evaluated.
RESULTS: Mean BCVA change at month 12 was +3.29 and +4.67 letters in the switched and na&iuml;ve aflibercept groups respectively (P<0.01). BCVA was maintained in 95.3% of switched and 96.6% of na&iuml;ve patients. CRT at month 12 showed a decrease of -6.16 &micro;m in the switched group and -35.36 &micro;m in the na&iuml;ve group (P<0.01). Patients previously treated with ranibizumab/bevacizumab had on average received 7.4 ranibizumab/bevacizumab injections over 12.6mo, attending 10 clinic visits. The fixed dosing aflibercept regimen required an average of 7.1 injections (na&iuml;ve group), 7.5 injections (switched group) and 4 clinic visits per year.
CONCLUSION: Fixed bimonthly aflibercept is effective in both treatment-na&iuml;ve and poorly responsive nvAMD patients. Adopting a fixed dosing regimen can reduce patient burden without compromising on outcomes.]]></description>
<pubDate>2016/8/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Alasdair N Warwick, Hannah H Leaver, Andrew J Lotery and Srini V Goverdhan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Alasdair N Warwick, Hannah H Leaver, Andrew J Lotery and Srini V Goverdhan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160812]]></guid><cfi:id>1013</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical outcomes of 25-gauge vitrectomy surgery for vitreoretinal diseases: comparison of vitrectomy alone and phaco-vitrectomy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160813]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the clinical outcomes of combined 25-gauge pars plana vitrectomy (PPV) and phacoemulsification/posterior chamber intraocular lens (PC-IOL) implantation with vitrectomy alone surgery in patients with various vitreoretinal diseases.
METHODS: A total of 306 eyes (145 with PPV alone and 161 with phaco-vitrectomy) were enrolled in this retrospective analysis. The surgical approach was 25-gauge PPV combined with phacoemulsification and PC-IOL implantation at the same time in eyes in phaco-vitrectomy group and only PPV in eyes in vitrectomy alone surgery group. The main outcome measures were postoperative clinical outcomes included anterior chamber inflammation, changes in intraocular pressure (IOP) and best corrected visual acuity (BCVA).
RESULTS: The most common postoperative complication was anterior chamber reaction which has higher incidence in phaco-vitrectomy group (P<0.001). The mean postoperative 1st day IOP of vitrectomy alone group was significantly lower than that of phaco-vitrectomy group (16.3±5.8 mm Hg vs 17.8±8.1 mm Hg, respectively, P=0.02). Hypotony (IOP(8 mm Hg) was not different between groups in the postoperative 1st day (P>0.05). The mean preoperative visual acuity was not different between groups (1.6±0.9 logMAR vs 1.8±0.9 logMAR, respectively, P>0.05). However, the mean visual acuity was decreased in vitrectomy alone group at the final visit compared to phaco-vitrectomy group (1.2±0.8 logMAR, 0.9±0.7 logMAR, respectively P<0.05).
CONCLUSION: Twenty-five gauge PPV combined with phacoemulsification surgery is a safe and efficient procedure, which can be preferred in phacic patients with a variety of vitreoretinal diseases compared to vitrectomy alone. Despite improved outcomes, this approach is not free of limitations as anterior chamber complications especially with combined surgery.]]></description>
<pubDate>2016/8/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mucella Arikan Yorgun, Yasin Toklu, Melek Mutlu and Umut Ozen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mucella Arikan Yorgun, Yasin Toklu, Melek Mutlu and Umut Ozen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160813]]></guid><cfi:id>1012</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of head tilt on repeatability of optic nerve head parameters using cirrus spectral-domain optical coherence tomography]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160814]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the repeatability of measuring optic nerve head (ONH) parameters using the Cirrus optical coherence tomography (OCT), as well as to assess the effect of head tilt on these measurements.
METHODS: Thirty healthy participants with no evidence of glaucoma were recruited for the study. Visual acuity, intraocular pressure, standard automated perimetry and ocular examination were performed for each participant. One eye was then randomly selected and scanned undilated with the Cirrus OCT in 3 positions (neutral, 30° right tilt and 30° left tilt).
RESULTS: Data collected from 29 eyes were used for analysis. One patient was omitted due to poor scan quality. The repeatability of the ONH parameters was analyzed using analysis of variance, coefficient of variation (COV) and intraclass correlation coefficient (ICC). Analysis of variance showed no statistically significant difference between 3 scans in a single position. There was good agreement between measurements (ICC 0.919-0.996, COV 1.94%-5.48%). Even with the presence of head tilt, repeated scans in the 3 positions showed good agreement as well (ICC 0.888-0.996, COV 2.04%-5.39%).
CONCLUSION: Serial measurements of ONH parameters using the Cirrus OCT are found to have good repeatability. The ONH parameters with Cirrus OCT also maintain good repeatability despite head tilt.]]></description>
<pubDate>2016/8/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Lilian Hui Li Koh, Muhammad Amir Ismail, Sae Cheong Yap, Elizabeth Poh Ying Wong and Leonard Wei Leon Yip]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Lilian Hui Li Koh, Muhammad Amir Ismail, Sae Cheong Yap, Elizabeth Poh Ying Wong and Leonard Wei Leon Yip</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160814]]></guid><cfi:id>1011</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Study of the prevalence and association of ocular chlamydial conjunctivitis in women with genital infection by Chlamydia trachomatis, Mycoplasma genitalium and Candida albicans attending outpatient clinic]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160815]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the association between chlamydial conjunctivitis and genital infection by Chlamydia trachomatis, Mycoplasma genitalium and Candida albicans, in addition to the possible relationship between cultured bacterial pathogens and oculogenital chlamydial infection.
METHODS: This study was performed on 100 (50 symptomatic and 50 asymptomatic) women attending the Gynecological and Obstetric outpatient clinic of Alzahra hospital, Alazhar University. Simultaneously a conjunctival swab was taken from these patients. Polymerase chain reaction (PCR) was done on DNA extracted from both vaginal and conjunctival swab samples. Culture for both vaginal and conjunctival swabs was also done.
RESULTS: Candida albicans was the predominant organism isolated by culture in 20% and 40% of conjunctival and vaginal swabs respectively. By the PCR method, ocular Chlamydia trachomatis was present in 60% of symptomatic women, while genital Chlamydia trachomatis infection was present in 30% of symptomatic women. The results of this method also indicated that 25/50 (50%) vaginal swabs were positive with PCR for Candida albicans versus 15/50 (30%) were PCR positive in conjunctival swab. Mycoplasma genitalium was present in only 10% of vaginal swabs. Concomitant oculogenital PCR positive results for Chlamydia trachomatis and Candida albicans were 30% and 28% respectively.
CONCLUSION: Ocular Chlamydia trachomatis was associated with genital Chlamydia trachomatis in a high percentage of women followed by Candida albicans. Cultured bacterial organisms do not play a role in enhancement of Chlamydia trachomatis infection.]]></description>
<pubDate>2016/8/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Rania Abdelmonem Khattab and Maha Mohssen Abdelfattah]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Rania Abdelmonem Khattab and Maha Mohssen Abdelfattah</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160815]]></guid><cfi:id>1010</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of corneal biomechanical properties in normal tension glaucoma patients with different visual field progression speed]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160706]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the corneal biomechanical properties difference by ocular response analyzer (ORA) in normal tension glaucoma (NTG) patients with different visual field (VF) progression speed.
METHODS: NTG patients with well-controlled Goldmann applanation tonometer (GAT) who routinely consulted Kitasato University Hospital Glaucoma Department between January 2010 and February 2014 were enrolled. GAT and ORA parameters including corneal compensated intraocular pressure (IOPcc), Goldmann estimated intraocular pressure (IOPg), corneal hysteresis (CH), corneal resistance factor (CRF) were recorded. VF was tested by Swedish interactive threshold algorithm (SITA)-standard 30-2 fields. All patients underwent VF measurement regularly and GAT did not exceed 15 mm Hg at any time during the 3y follow up. Patients were divided into four groups according to VF change over 3y, and ORA findings were compared between the upper 25th percentile group (slow progression group) and the lower 25th percentile group (rapid progression group).
RESULTS: Eighty-two eyes of 56 patients were studied. There were 21 eyes (21 patients) each in rapid and slow progression groups respectively. GAT, IOPcc, IOPg, CH, CRF were 12.1±1.4 mm Hg, 15.8±1.8 mm Hg, 12.8±2.0 mm Hg, 8.4±1.1 mm Hg, 7.9±1.3 mm Hg respectively in rapid progression group and 11.5±1.3 mm Hg, 13.5±2.1 mm Hg, 11.2±1.6 mm Hg, 9.3±1.1 mm Hg, 8.2±0.9 mm Hg respectively in slow progression group (P=0.214, <0.001, 0.007, 0.017, 0.413, respectively). In bivariate correlation analysis, IOPcc, IOPcc-GAT and CH were significant correlated with m△MD (r=-0.292, -0.312, 0.228 respectively, P=0.008, 0.004, 0.039 respectively).
CONCLUSION: Relatively rapid VF progression occurred in NTG patients whose IOPcc are rather high, CH are rather low and the difference between IOPcc and GAT are relatively large. Higher IOPcc and lower CH are associated with VF progression in NTG patients. This study suggests that GAT measures might underestimate the IOP in such patients.]]></description>
<pubDate>2016/7/12 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ying Hong, Nobuyuki Shoji, Tetsuya Morita, Kazunori Hirasawa, Kazuhiro Matsumura, Masayuki Kasahara and Kimiya Shimizu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ying Hong, Nobuyuki Shoji, Tetsuya Morita, Kazunori Hirasawa, Kazuhiro Matsumura, Masayuki Kasahara and Kimiya Shimizu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160706]]></guid><cfi:id>1009</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Diurnal changes in retinal nerve fiber layer thickness with obstructive sleep apnea/hypopnea syndrome]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160707]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the retinal nerve fiber layer (RNFL) thickness in the morning and evening in Thai patients with varying degrees of obstructive sleep apnea/hypopnea syndrome (OSAHS).
METHODS: In this cross-sectional study, potential OSAHS patients at Siriraj Hospital underwent polysomnography to determine the severity of OSAHS and an eye examination (including best corrected visual acuity, slit-lamp examination, and Goldmann applanation tonometry). RNFL thickness was recorded once in the morning and once in the evening, using spectral domain optical coherence tomography. Thickness was expressed as an average and given for each quadrant. Patients with ocular or systemic diseases that might affect RNFL thickness were excluded.
RESULTS: Forty-one eyes of 41 patients were classified into 4 OSAHS groups. The average and mean RNFL thickness in most of the four quadrants of the severe OSAHS group trended toward being less than those in the comparable quadrants of the other groups in both the morning and evening. In the moderate OSAHS group, the average RNFL thickness and temporal and superior quadrant thickness in the morning were significantly higher than in the evening (P=0.01, P=0.01, and P=0.03, respectively). In the severe OSAHS group, the inferior quadrant thickness in the morning was significantly higher than in the evening (P=0.03).
CONCLUSION: The RNFL thickness in the morning was higher than in the evening in moderate OSAHS.]]></description>
<pubDate>2016/7/12 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Niphon Chirapapaisan, Techawit Likitgorn, Mintra Pleumchitchom, Darin Sakiyalak, Wish Banhiran, Manatsawin Saiman and Wanicha Chuenkongkaew]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Niphon Chirapapaisan, Techawit Likitgorn, Mintra Pleumchitchom, Darin Sakiyalak, Wish Banhiran, Manatsawin Saiman and Wanicha Chuenkongkaew</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160707]]></guid><cfi:id>1008</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Epidemiology and risk factors of retinoblastoma in Chongqing area]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160708]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the risk factors of retinoblastoma in Chongqing and offer the bases for scientific measures.
METHODS: One hundred and thirty-three retinoblastoma patients were taken as case group, and 133 children were taken as control group in 1:1 ratio. The relevant factors were collected from a questionnaire survey which was made by our research group. First, Chi-square and t-test were used to discuss the various factors, and then the logistic regression analysis was made by statistics software SPSS17.0 based on the result of 266 people.
RESULTS: Single factor analysis results showed the differences between the two groups were statistically significant (P<0.05) in 17 factors which were education level of their parents, occupation of their parents, exposure to harmful chemicals of their parents 6mo before pregnancy, the history of pelvic inflammatory disease of mother before pregnancy, childbearing history of their parents, pregnant age of their parents, the medication history of father 6 mo before pregnancy, living place of their parents, the pollution living place of mother, hobbies of their parents. Multivariate analysis showed that the living place of parents, mother who feed pets before pregnancy, and exposure to harmful chemicals of father before pregnancy were the independent risk factors of retinoblastoma (P<0.05).
CONCLUSION: The living place of parents, mother who feed pets before pregnancy, exposure to harmful chemicals of father before pregnancy were the risk factors of retinoblastoma which affects the occurrence of retinoblastoma in a certain extent.]]></description>
<pubDate>2016/7/12 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yu-Qiong Yang, Jia Li and Hong-Feng Yuan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yu-Qiong Yang, Jia Li and Hong-Feng Yuan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160708]]></guid><cfi:id>1007</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Risk factors of rhegmatogenous retinal detachment associated with choroidal detachment in Chinese patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160709]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To comprehensively analyze the risk factors of rhegmatogenous retinal detachment (RRD) associated with choroidal detachment (CD).
METHODS: A total of 265 eyes of 265 consecutive cases of RRD were retrospectively analyzed. All patients had systemic and ophthalmologic examination. CD was diagnosed by indirect ophthalmoscopy, B-scan ultrasonography, and ultrasound biomicroscope (UBM). Each parameter was compared between patients of RRD and rhegmatogenous retinal detachment associated with choroidal detachment (RRDCD). Logistic regression analysis was used to determine the independent risk factors of CD.
RESULTS: There were 52 eyes (19.62%) with CD. Pseudophakia was more commonly seen in RRDCD (21.15% vs 6.10%, P=0.002). Intraocular pressure (IOP) was lower (8.60±3.62 vs 12.96±3.55, P<0.001), best-corrected visual acuity was worse [3.00 (2.00 to 3.00) vs 1.92 (1.22 to 3.00), P=0.001], and refractive error was more myopic [-4 (-9 to -2) vs -2 (-6 to 0), P=0.007] in RRDCD. Eyes with RRDCD had larger extent of retinal detachment (P=0.007). In RRDCD, 34.62% of eyes presented with multiple holes (P=0.044) and 25.00% with macular holes (P=0.012), compared with 20.66% and 14.08% in RRD. High myopia (P=0.039), low IOP (P=0.017), and larger extent of retinal detachment (P<0.001) were significant and independent risk factors for developing CD.
CONCLUSION: For CD in RRD, related factors include BCVA, IOP, lens status, refractive error, extent of retinal detachment, number of holes, and macular hole. Larger extent of retinal detachment, high myopia, and low IOP are significant and independent risk factors.]]></description>
<pubDate>2016/7/12 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yong-Hao Gu, Gen-Jie Ke, Lin Wang, Qi-Hong Gu, En-Liang Zhou, Hong-Biao Pan and Shi-Ying Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yong-Hao Gu, Gen-Jie Ke, Lin Wang, Qi-Hong Gu, En-Liang Zhou, Hong-Biao Pan and Shi-Ying Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160709]]></guid><cfi:id>1006</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Predictive factors for postoperative visual function of primary chronic rhegmatogenous retinal detachment after scleral buckling]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160710]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate predictive factors for postoperative visual function of primary chronic rhegmatgenous retinal detachment (RRD) after sclera buckling (SB).
METHODS: Totally 48 patients (51 eyes) with primary chronic RRD were included in this prospective interventional clinical cases study, which underwent SB alone from June 2008 to December 2014. Age, sex, symptoms duration, detached extension, retinal hole position, size, type, fovea on/off, proliferative vitreoretinopathy (PVR), posterior vitreous detachment (PVD), baseline best corrected visual acuity (BCVA), operative duration, follow up duration, final BCVA were measured. Pearson correlation analysis, Spearman correlation analysis and multivariate linear stepwise regression were used to confirm predictive factors for better final visual acuity. Student’s t-test, Wilcoxon two-sample test, Chi-square test and logistic stepwise regression were used to confirm predictive factors for better vision improvement.
RESULTS: Baseline BCVA was 0.8313±0.6911 logMAR and final BCVA was 0.4761±0.4956 logMAR. Primary surgical success rate was 92.16% (47/51). Correlation analyses revealed shorter symptoms duration (r=0.3850, P=0.0053), less detached area (r=0.5489, P<0.0001), fovea (r=0.4605, P=0.0007), no PVR (r=0.3138, P=0.0250), better baseline BCVA (r=0.7291, P<0.0001), shorter operative duration (r=0.3233, P=0.0207) and longer follow up (r=-0.3358, P=0.0160) were related with better final BCVA, while independent predictive factors were better baseline BCVA [partial R-square (PR2)=0.5316, P<0.0001], shorter symptoms duration (PR2=0.0609, P=0.0101), longer follow up duration (PR2=0.0278, P=0.0477) and shorter operative duration (PR2=0.0338, P=0.0350). Patients with vision improvement took up 49.02% (25/51). Univariate and multivariate analyses both revealed predictive factors for better vision improvement were better baseline vision [odds ratio (OR) =50.369, P=0.0041] and longer follow up duration (OR=1.144, P=0.0067).
CONCLUSION: Independent predictive factors for better visual outcome of primary chronic RRD after SB are better baseline BCVA, shorter symptoms duration, shorter operative duration and longer follow up duration, while independent predictive factors for better vision improvement after operation are better baseline vision and longer follow up duration.]]></description>
<pubDate>2016/7/12 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Wei Fang, Jiu-Ke Li, Xiao-Hong Jin, Yuan-Min Dai and Yu-Min Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Wei Fang, Jiu-Ke Li, Xiao-Hong Jin, Yuan-Min Dai and Yu-Min Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160710]]></guid><cfi:id>1005</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effects of two different doses of intravitreal bevacizumab on subfoveal choroidal thickness and retinal vessel diameter in branch retinal vein occlusion]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160711]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the effects of two different doses of intravitreal bevacizumab on subfoveal choroidal thickness (SFChT) and retinal vessel diameter in patients with branch retinal vein occlusion.
METHODS: An interventional, restrospective study of 41 eyes of 41 patients who had completed 12mo of follow-up, divided into group 1 (1.25 mg of bevacizumab, 21 eyes of 21 patients) and group 2 (2.5 mg of bevacizumab, 20 eyes of 21 patients). Complete ophthalmic examination, fluorescein angiography, enhanced depth imaging optical coherence tomography and measurement of retinal vessel diameter with IVAN software were performed at baseline and follow-up.
RESULTS: The SFChT changed from 279.1 (165-431) &micro;m at baseline to 277.0 (149-413) &micro;m at 12mo in group 1 (P=0.086), and from 301.4 (212-483) &micro;m to 300.3 (199-514) &micro;m in group 2 (P=0.076). The central retinal arteriolar equivalent (CRAE) changed from 128.8±11.2 μm at baseline to 134.5±8.4 μm at 12mo in group 1, and from 134.6±9.0 μm to 131.4±12.7 μm in group 2 (P=0.767). The central retinal venular equivalent (CRVE) changed from 204.1±24.4 μm at baseline to 196.3±28.2 μm at 12mo in group 1, and from 205.8±16.3 μm to 194.8±18.2 μm in group 2 (P=0.019). The mean central macular thickness (P<0.05) and average best-corrected visual acuity (BCVA; P<0.05) improved in both groups
CONCLUSION: Changes in the SFChT are not statistically significant and not different according to the doses of bevacizumab. The CRAE did not show significant change, however, the CRVE showed significant decrease regardless of the dose.]]></description>
<pubDate>2016/7/12 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jongyeop Park, Seungwoo Lee and Yengwoo Son]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jongyeop Park, Seungwoo Lee and Yengwoo Son</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160711]]></guid><cfi:id>1004</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of corneal flaps created by Wavelight FS200 and Intralase FS60 femtosecond lasers]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160712]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess and compare the morphology of corneal flaps created by the Wavelight FS200 and Intralase FS60 femtosecond lasers in laser in situ keratomileusis (LASIK).
METHODS: Four hundred eyes of 200 patients were enrolled in this study and divided into Wavelight FS200 groups (200 eyes) and Intralase FS60 groups (200 eyes). Fourier-domain optical coherence tomography (RTVue OCT) was used to measure the corneal flap thickness of 36 specified measurements on each flap one week after surgery. Results were used to analyze the regularity, uniformity and accuracy of the two types of LASIK flaps.
RESULTS: The mean thickness of corneal flap and central flap was 105.71±4.72 μm and 105.39±4.50 μm in Wavelight FS200 group and 109.78±11.42 μm and 109.15 ±11.59 μm in Intralase FS60 group, respectively. The flaps made with the Wavelight FS200 femtosecond laser were thinner than those created by the Intralase FS60 femtosecond laser (P=0.000). Corneal flaps in the 2 groups were uniform and regular, showing an almost planar configuration. But the Wavelight FS200 group has more predictability and uniformity of flap creation. The mean deviation between achieved and attempted flap thickness was smaller in the Wavelight FS200 group than that in the Intralase FS60 group, which were 5.18±3.71 μm and 8.68±7.42 μm respectively. The deviation of more than 20 &micro;m was 0.2% measurements in Wavelight FS200 group and 8.29% measurements in Intralase FS60 group.
CONCLUSION: The morphologies of flaps created by Wavelight FS200 are more uniform and thinner than those created by Intralase FS60.]]></description>
<pubDate>2016/7/12 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Qian Liu, Yue-Hua Zhou, Jing Zhang, Yan Zheng, Chang-Bin Zhai and Jing Liu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Qian Liu, Yue-Hua Zhou, Jing Zhang, Yan Zheng, Chang-Bin Zhai and Jing Liu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160712]]></guid><cfi:id>1003</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Post-operative strabismus control and motor alignment for basic intermittent exotropia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160713]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess strabismus control and motor ocular alignment for basic exotropia surgery at 5y follow-up.
METHODS: The medical records of 80 consecutive patients aged less than 17 years of age, who underwent surgery for basic exotropia by a single surgeon between years 2000 to 2009 and completed a minimum of 5y follow-up post-operatively were reviewed. Pre- and post-operative characteristics were documented at 1wk, 6mo, 1, 3 and 5y follow-up. Subjects at 5-year follow-up were assigned to the success group if they had a post-operative angle of deviation within 10 prism diopters of exotropia or within 5 prism diopters of esotropia for distance on prism cover test, and had moderate to good strabismus control. The remaining subjects were assigned to the failure group.
RESULTS: Post-operative surgical success at one week was 75%, which decreased to 41% at 5y follow-up. The success group was noted to have more patching pre-operatively (P=0.003). The duration of patching a day (P=0.020) and total duration of patching pre-operatively (P=0.030) was higher in the success group. Surgical success at 1y (P=0.004) and 3y (P=0.002) were associated with higher surgical success at 5y follow-up.
CONCLUSION: Post-operative motor alignment and strabismus control for basic exotropia surgery at 1y and beyond is associated with higher exotropia surgery success at 5-year follow-up. There is an association between pre-operative patching and 5-year surgical success of basic intermittent exotropia surgery.]]></description>
<pubDate>2016/7/12 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Fiona Chew Lee Min, Bhambi Uellyn Gesite-de Leon and Boon Long Quah]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Fiona Chew Lee Min, Bhambi Uellyn Gesite-de Leon and Boon Long Quah</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160713]]></guid><cfi:id>1002</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of therapeutic effects of topical azithromycin solution and systemic doxycycline on posterior blepharitis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160714]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the effect of azithromycin drop and doxycycline capsule on treatment of posterior blepharitis.
METHODS: Fifty patients (100 eyes) with moderate posterior blepharitis, randomly divided into two therapeutic groups; all the patients got warm eyelid compress and massage three times a day for 3wk. In addition the first group got azithromycin 1% drop, twice daily for 1wk and then one drop daily for 2wk. The second group got oral doxycycline 100 mg daily for 3wk. At the end of the research, patients’ signs and symptoms were compared together. ANOVA, Chi-square and Mann-Whitney tests were used for statistical analysis.
RESULTS: Topical therapy with azithromycin and oral therapy with doxycycline relieved signs and symptoms after 3wk. There were no significant differences between symptoms healing rate and foreign body sensation healing in these two groups (P>0.05). However, azithromycin drop was more effective in reduction of eye redness and doxycycline was more effective in meibomian glands plugging healing and reducing the corneal staining.
CONCLUSION: Topical azithromycin could have similar effects as oral doxycycline on posterior blepharitis in improving subjective symptoms. However, doxycycline can reduce objective signs such as ocular surface staining and meibomian gland plugging more than azithromycin.]]></description>
<pubDate>2016/7/12 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mehdi Zandian, Neda Rahimian and Sanaz Soheilifar]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mehdi Zandian, Neda Rahimian and Sanaz Soheilifar</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160714]]></guid><cfi:id>1001</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Long-term outcomes of wedge resection at the limbus for high irregular corneal astigmatism after repaired corneal laceration]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160609]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the clinical value of wedge resection at corneal limbus in patients with traumatic corneal scarring and high irregular astigmatism.
METHODS: Patients with traumatic corneal astigmatism received wedge resection at least 6mo after suture removal from corneal wound. The uncorrected distance visual acuities (UCVA) and best corrected distance visual acuities (BCVA), pre- and post-operation astigmatism, spherical equivalent (SE), safety and complications were evaluated.
RESULTS: Ten eyes (10 patients) were enrolled in this study. Mean follow-up time after wedge resection was 37.8±15.4mo (range, 20-61mo). The mean UCVA improved from +1.07±0.55 logMAR to +0.43±0.22 logMAR (P=0.000) and the mean BCVA from +0.50±0.30 logMAR to +0.15±0.17 logMAR (P=0.000). The mean astigmatism power measured by retinoscopy was -2.03±2.27 D postoperatively and -2.83±4.52 D preoperatively  (P=0.310). The mean SE was -0.74±1.61 D postoperatively and -0.64±1.89 D preoperatively (P=0.601). Two cases developed mild pannus near the sutures. No corneal perforation, infectious keratitis or wound gape occurred.
CONCLUSION: Corneal-scleral limbal wedge resection with compression suture is a safe, effective treatment for poor patients with high irregular corneal astigmatism after corneal-scleral penetrating injury. Retinoscopy can prove particularly useful for high irregular corneal astigmatism when other measurements are not amenable.]]></description>
<pubDate>2016/6/16 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jun Du, Guang-Ying Zheng, Cheng-Lin Wen, Xiao-Fang Zhang and Yu Zhu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jun Du, Guang-Ying Zheng, Cheng-Lin Wen, Xiao-Fang Zhang and Yu Zhu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160609]]></guid><cfi:id>1000</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Surgical management of fungal endophthalmitis resulting from fungal keratitis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160610]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report the fungal organisms, clinical features, surgical treatment strategies, and outcomes of patients with culture-proven exogenous fungal endophthalmitis (EFE) secondary to keratitis, and evaluate the role of surgery in the treatment.
METHODS: The clinical records of 27 patients (27 eyes) with culture-proven EFE resulting from fungal keratitis treated at Shandong Eye Institute from January 2007 to January 2015 were retrospectively reviewed. Information about fungal culture results, clinical features, surgical procedures, and final visual acuity was obtained.
RESULTS: There were 39 positive culture results from samples of cornea, hypopyon, vitreous and lens capsule, accounting for 56%, 26%, 15% and 2.5%, respectively. Fusarium was identified in 44% (12/27) of the eyes, followed by Aspergillus in 22% (6/27). Posterior segment infection was involved in 78% (21/27) of the patients. The corneal infection was larger than 3 mm ×3 mm in 89% (24/27) of the patients, and 22% (6/27) of them had the entire cornea, and even the sclera involved. Three eyes had silicone oil tamponade, and two eyes had retinal detachment. Twenty-two eyes (81.5%) underwent penetrating keratoplasty (PKP), and over half of them (54.5%) were operated within 3d from the onset of antifungal therapy. Fourteen eyes (52%) underwent intracameral antifungal drug injection, and three of them required repeated injections. Fifteen eyes (55.6%) underwent pars plana vitrectomy (PPV). The rate of the eyes undergoing PPV as the initial surgical procedure was 60% (9/15), lower than 77% in PKP. Intravitreal injection was given in 59% of the eyes (16/27), and 75% of them required repeated injections. The final visual acuity was 20/100 or better in 37% of the eyes, and better than counting fingers in 55.6% of the eyes. Five eyes (18.5%) were eviscerated. In the two eyes with concurrent retinal detachment, one achieved retinal reattachment, and the other was eviscerated. In the three eyes with silicone oil tamponade, two eyes received silicone oil removal, and the other one was eviscerated.
CONCLUSION: Fusarium and Aspergillus are the dominant pathogens in EFE resulting from keratitis.  Aggressive antifungal surgeries including multiple intravitreal injections, PKP and core vitrectomy (especially in the initial surgery) are helpful procedures to improve prognosis of severe EFE secondary to keratitis.]]></description>
<pubDate>2016/6/16 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yan Gao, Nan Chen, Xiao-Guang Dong, Gong-Qiang Yuan, Bin Yu and Li-Xin Xie]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yan Gao, Nan Chen, Xiao-Guang Dong, Gong-Qiang Yuan, Bin Yu and Li-Xin Xie</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160610]]></guid><cfi:id>999</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of biometric characteristics on biomechanical properties of the cornea in cataract patient]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160611]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the impact of biometric characteristics on the biomechanical properties of the human cornea using the ocular response analyzer (ORA) and standard comprehensive ophthalmic examinations before and after standard phacoemulsification.
METHODS: This study comprised 54 eyes with cataract with significant lens opacification in stages I or II that underwent phacoemulsification (2.8 mm incision). Corneal hysteresis (CH), corneal resistance factor (CRF), Goldmann-correlated intraocular pressure (IOPg), and corneal-compensated intraocular pressure (IOPcc) were measured by ORA preoperatively and at 1mo postoperatively. Biometric characteristics were derived from corneal topography [TMS-5, anterior equivalent (EQTMS) and cylindric (CYLTMS) power], corneal tomography [Casia, anterior and posterior equivalent (EQaCASIC, EQpCASIA) and cylindric (CYLaCASIA, CYLpCASIA) power], keratometry [IOLMaster, anterior equivalent (EQIOL) and cylindric (CYLIOL) power] and autorefractor [anterior equivalent (EQAR)]. Results from ORA were analyzed and correlated with those from all other examinations taken at the same time point.
RESULTS: Preoperatively, CH correlated with EQpCASIA and CYLpCASIA only (P=0.001, P=0.002). Postoperatively, IOPg and IOPcc correlated with all equivalent powers (EQTMS, EQIOL, EQAR, EQaCASIA and EQpCASIA) (P=0.001, P=0.007, P=0.001, P=0.015, P=0.03 for IOPg and P<0.001, P=0.003, P<0.001, P=0.009, P=0.014 for IOPcc). CH correlated postoperatively with EQaCASIA and EQpCASIC only (P=0.021, P=0.022).
CONCLUSION: Biometric characteristics may significantly affect biomechanical properties of the cornea in terms of CH, IOPcc and IOPg before, but even more after cataract surgery.]]></description>
<pubDate>2016/6/16 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xue-Fei Song, Achim Langenbucher, Zisis Gatzioufas, Berthold Seitz and Moatasem El-Husseiny]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xue-Fei Song, Achim Langenbucher, Zisis Gatzioufas, Berthold Seitz and Moatasem El-Husseiny</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160611]]></guid><cfi:id>998</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Peripheral retinal non-perfusion and treatment response in branch retinal vein occlusion]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160612]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the association between the size of peripheral retinal non-perfusion and the number of intravitreal ranibizumab injections in patients with treatment-naive branch retinal vein occlusion (BRVO) and macular edema.
METHODS: A total of 53 patients with treatment-naive BRVO and macular edema were included. Each patient underwent a full ophthalmologic examination including optical coherence tomography (OCT) imaging and ultra wide-field fluorescein angiography (UWFA). Monthly intravitreal ranibizumab injections were applied according to the recommendations of the German Ophthalmological Society. Two independent, masked graders quantified the areas of peripheral retinal non-perfusion.
RESULTS: Intravitreal injections improved best-corrected visual acuity (BCVA) significantly from 22.23±16.33 Early Treatment of Diabetic Retinopathy Study (ETDRS) letters to 36.23±15.19 letters (P<0.001), and mean central subfield thickness significantly reduced from 387±115 &micro;m to 321±115 &micro;m (P=0.01). Mean number of intravitreal ranibizumab injections was 3.61±1.56. The size of retinal non-perfusion correlated significantly with the number of intravitreal ranibizumab injections (R=0.724, P<0.001).
CONCLUSION: Peripheral retinal non-perfusion in patients with BRVO associates significantly with intravitreal ranibizumab injections in patients with BRVO and macular edema.]]></description>
<pubDate>2016/6/16 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Kaveh Abri Aghdam, Lukas Reznicek, Mostafa Soltan Sanjari, Carsten Framme, Anna Bajor, Annemarie Klingenstein, Marcus Kernt and Florian Seidensticker]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Kaveh Abri Aghdam, Lukas Reznicek, Mostafa Soltan Sanjari, Carsten Framme, Anna Bajor, Annemarie Klingenstein, Marcus Kernt and Florian Seidensticker</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160612]]></guid><cfi:id>997</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[High frequency of latent Chlamydia trachomatis infection in patients with rhegmatogenous retinal detachment]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160613]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the frequency of detection of ocular and extraocular Chlamydia trachomatis (CT) infection in non-high myopes with rhegmatogenous retinal detachment (RRD).
METHODS: This was a single-center, nonrandomized, prospective, case-control study. One hundred and four patients were divided into a study group with RRD (n=63) and a control group with traumatic retinal detachment (n=41). Samples of subretinal fluid (SFR), conjunctival, urethral/cervical swabs, and blood were collected. The frequency of detection of CT infection in SRF samples was determined by polymerase chain reaction (PCR), direct fluorescence assay (DFA) and cell culture, whereas that in conjunctival swabs was determined by PCR and DFA, and those in urethral/cervical swabs and blood were determined by DFA. Yates Chi-square test (with Bonferroni correction) and two-tailed Student’s t-test were used for statistical analysis.
RESULTS: SRF CT infection was detected more frequently in the study group (50.8%-71.4%) than in the control group (9.8%-12.2%) by all the methods used (P<0.01). The frequency of detection of conjunctival CT infection by DFA was higher in the RRD patients compared with the controls (81.0% vs 24.4%, P=0.004). The PCR detected conjunctival CT infection more often in the study group than in the controls (46.0% vs 9.8%, P=0.007). The DFA detected CT in blood specimens almost as frequently as in urogenital specimens, for the RRD patients (61.2% vs 63.5%) and the controls (7.3% vs 9.8%).
CONCLUSION: CT infection is detected with high frequency in non-high myopes with RRD.]]></description>
<pubDate>2016/6/16 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ernest V. Boiko, Alexei L. Pozniak, Dmitrii S. Maltsev, Alexei A. Suetov and Irina V. Nuralova]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ernest V. Boiko, Alexei L. Pozniak, Dmitrii S. Maltsev, Alexei A. Suetov and Irina V. Nuralova</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160613]]></guid><cfi:id>996</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Orbital decompression surgery and horse chestnut seed extract improved superior orbital vein blood flow in patients with thyroid-associated ophthalmopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160614]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the efficacy and safety of orbital decomposition (OD) surgery in combination with horse chestnut seed extract (HCSE), as compared to OD alone, in patients with thyroid-associated ophthalmopathy (TAO).
METHODS: Sixty-two orbits from 62 TAO patients were randomly assigned to OD or OD+HCSE at 1:1 ratio (31 received OD alone, 31 received OD+HCSE). Forty-two orbits from 21 healthy subjects were used as controls. Complete ophthalmic examination and color Doppler flow imaging (CDFI) were performed before surgery and 3mo post-surgery on all 62 orbits from the TAO patients. CDFI were also performed on the 42 control orbits. The effect of OD+HCSE and OD alone on TAO orbits was compared on several endpoints, including superior ophthalmic vein blood flow (SOVBF) parameters, subjective assessment, soft tissue involvement, lid retraction, diplopia, eye movement restriction, degree of exophthalmos, and intraocular pressure. The control orbits were used as reference for the SOVBF parameters.
RESULTS: OD surgery with or without HCSE improved SOVBF, symptoms and soft tissue involvement, decreased degree of exophthalmos and intraocular pressure in orbits of TAO patients. The OD+HCSE combination led to significantly better improvement of SOVBF than OD alone. The differences between the reductions of SOVBF in the two groups are 1.26 cm/s in max-volecity and 0.52 cm/s in min-volecity (P<0.0001).
CONCLUSION: SOVBF is significantly reduced in the orbits affected with TAO, indicating that congestion may be an important factor contributing to TAO pathogenesis. OD surgery improves the SOVBF, and combination of HCSE medication and OD surgery further improved venous return than OD surgery alone.]]></description>
<pubDate>2016/6/16 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yu-Jie Wu, Xin Wei, Man-Yi Xiao and Wei Xiong]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yu-Jie Wu, Xin Wei, Man-Yi Xiao and Wei Xiong</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160614]]></guid><cfi:id>995</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison axial length measurements from three biometric instruments in high myopia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160615]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the axial lengths (ALs) measured with Lenstar, IOLMaster and A-scan contact ultrasound (Ultrasound) in normal and high myopia (HM).
METHODS: Eighty-four normal eyes and 49 HM eyes were included. Three consecutive measurements were performed on each eye in the following order: Lenstar, IOLMaster, and Ultrasound. The repeatabilities of the AL measurements for each instrument were assessed by calculating the pooled coefficients of variation (CVs) of 18 eyes in each group. Comparisons between the HM and normal groups were made with independent sample t-tests. The inter-device agreements were evaluated with Bland-Altman analyses and paired two-tailed t-tests.
RESULTS: For normal group, the CVs of the AL measurements taken with the Lenstar, IOLMaster and Ultrasound were 0.001%, 0.01% and 0.14%, respectively. The corresponding CVs for the HM group were 0.005%, 0.02% and 0.15%, respectively. There was significant difference between the Lenstar and the IOLMaster in normal group (P=0.031) but not in HM group (P=0.100). In the two groups, the Lenstar and the IOLMaster produced higher values than did the Ultrasound (all P<0.001). All three instruments exhibited good agreement in terms of AL values. For the intraocular lens (IOL) power calculation using SRK II formula, the Lenstar and the IOLMaster showed 0.5 D higher than Ultrasound in both groups (all P<0.001). No significant difference existed between the Lenstar and the IOLMaster for the IOL power calculation in both normal (P=0.474) and HM group (P=0.103).
CONCLUSION: The three devices exhibited excellent intra-visit repeatabilities in the AL measurements. The AL and IOL power difference between partial coherence interferometry and ultrasound instruments should be noticed.]]></description>
<pubDate>2016/6/16 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xiao-Gang Wang, Jing Dong, Yu-Lan Pu, Hui-Jun Liu and Qiang Wu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiao-Gang Wang, Jing Dong, Yu-Lan Pu, Hui-Jun Liu and Qiang Wu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160615]]></guid><cfi:id>994</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Visual and ocular effects from the use of flat-panel displays]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160616]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the prevalence of eye symptoms in a non-presbyopic population of video display unit (VDU) users with flat-panel displays.
METHODS: One hundred and sixteen VDU users with flat-panel display from an urban population participated in the study; their ages ranging from 20 to 34y. There were 60 females and 56 males. An eye examination to rule out the presence of significant uncorrected refractive errors, general binocular dysfunctions and eye conditions was carried out. In order to determine and quantify the type and nature of eye symptoms, participants were asked to answer written questionnaire and the results were grouped by gender, age and number of hours a day spent using a VDU.
RESULTS: Seventy-two percent of participants reported eye symptoms related to VDU use. Eye symptoms from moderate-to-severe were found in 23% of participants. The main symptom was moderate-to-severe tired eyes (14%); followed by sensitivity to bright lights (12%), blurred vision at far distances (10%), eyestrain or dry eye or irritated or burning eyes (9%), difficulty in refocusing from one distance to another or headache (8%) and blurred vision at near or intermediate distances (<4%). Eye symptoms were greater among females (P=0.005) and increased with VDU use, markedly above 6h spent using a VDU in a typical day (P=0.01).
CONCLUSION: Significant eye symptoms relate to VDU use often occur and should not be underestimated. The increasing use of electronic devices with flat-panel display should prompt users to take appropriate measures to prevent or to relieve the eye symptoms arising from their use.]]></description>
<pubDate>2016/6/16 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Esteban Porcar, Alvaro M. Pons and Amalia Lorente]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Esteban Porcar, Alvaro M. Pons and Amalia Lorente</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160616]]></guid><cfi:id>993</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical risk factors for the development of consecutive exotropia: a comparative clinical study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160617]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare a group of patients with consecutive exotropia with patients who had ≤10 prism diopters (PD) esotropia or no deviation postoperatively in terms of probable clinical risk factors for the development of consecutive exotropia. 
METHODS: The study recruited fourteen patients who developed consecutive exodeviation during follow-up period after the correction of esotropia who were categorized as group 1 and thirty-one patients who had still ≤10 PD esotropia or no deviation at the final visit that were considered as group 2. Clinical risk factors leading the development of consecutive deviation were analyzed as the main outcome measures. 
RESULTS: The mean age of patients was 4.57±3.11y in group 1 and 5.10±3.52y in group 2 (P=0.634). There was no significant difference of preoperative near and distant deviations among two groups (P=0.835, 0.928 respectively). The mean amount of medial rectus recession and lateral rectus resection was similar in both groups (P=0.412, 0.648 respectively). Convergence insufficiency and neurological diseases were more frequent in group 1 (P=0.007, 0.045). Accompanying neurological disease was found to be as a significant factor increasing the risk of the development of consecutive exotropia significantly [odds ratios (OR): 5.75 (1.04-31.93)]. 
CONCLUSION: Accompanying neurological disease appears to be a significant clinical risk factor for the development of consecutive exodeviation during postoperative follow-up after the correction of esotropia. However, larger studies are needed in order to interpret the results to the clinical practice and to ascertain other concurrent risk factors.
KEYWORDS: consecutive exotropia; esotropia; medial rectus recession; neurological disorder; lateral rectus resection
]]></description>
<pubDate>2016/6/16 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hande Taylan Sekeroglu, Kadriye Erkan Turan, Jale Karakaya, Emin Cumhur Sener and Ali Sefik Sanac]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hande Taylan Sekeroglu, Kadriye Erkan Turan, Jale Karakaya, Emin Cumhur Sener and Ali Sefik Sanac</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160617]]></guid><cfi:id>992</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Real-time polymerase chain reaction for the diagnosis of necrotizing herpes stromal keratitis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160507]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To design, optimize and validate a rapid, internally controlled real-time polymerase chain reaction (RT-PCR) test for herpes simplex virus (HSV) in the diagnosis of necrotizing herpes stromal keratitis.
METHODS: Tears alone or together with corneal epithelium scrapings from 30 patients (30 eyes) suspected of necrotizing herpes stromal keratitis were tested for HSV DNA by RT-PCR. The samples were collected during the first visit and then on the subsequent 7, 14, 28, 42, and 56d. The symptoms of the patients were scored before treatment to determine the correlation between HSV concentration in the corneal epithelium scrapings and clinical scores.
RESULTS: The positive rate (46.4%) in the corneal epithelium group before the therapy was significantly higher than that (13.3%) in the tears group (P=0.006). There were 13 positive HSV patients before the therapy, the concentration of HSV DNA in corneal epithelium scrapings group was significantly higher than that in the tears group (paired t-test, P=0.0397). Multilevel mixed-effects model analysis showed that the difference between the corneal epithelium scrapings group and the tears group was statistically significant (P=0.0049). The Spearman rank correlation analysis indicated a positive correlation between the HSV concentration in the corneal epithelium scrapings and clinical scores before the treatment (r=0.844, P<0.0001).
CONCLUSION: RT-PCR appears to be a powerful molecular tool for the diagnosis of necrotizing herpes stromal keratitis.]]></description>
<pubDate>2016/5/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jun-Xin Ma,Lin-Nong Wang,Ru-Xia Zhou,Yang Yu and Tong-Xin Du]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jun-Xin Ma,Lin-Nong Wang,Ru-Xia Zhou,Yang Yu and Tong-Xin Du</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160507]]></guid><cfi:id>991</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of phacotrabeculectomy and sequential surgery in the treatment of chronic angle-closure glaucoma coexisted with cataract]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160508]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the safety and effectiveness of phacotrabeculectomy versus sequential surgery in chronic angle-closure glaucoma (CACG) with coexisting cataract.METHODS: One hundred and sixty-two CACG patients (162 eyes) were retrospectively analyzed. Of them, 87 patients (87 eyes) in group A had underwent phacotrabeculectomy with intraocular lens (IOL) implantation, and 75 patients (75 eyes) in group B had underwent sequential surgery with IOL implanted. Best-corrected visual acuity (BCVA), intraocular pressure (IOP), complications and anterior chamber angle (ACA) were measured.RESULTS: Demographic characteristics of the two groups were similar. A mean follow-up period was 15±6mo (range 13 to 24mo), a mean IOP of 16.61±6.43 mm Hg in group A and 15.80±5.35 mm Hg in group B (P=0.84) at the last follow up. The Kaplan-Meier analysis revealed that the cumulative probability of success in both groups was similar (P=0.61). Anterior uveitis and hypotony were the most common complications in group A, whereas group B experienced shallow anterior chamber with trabeculectomy. With the exception of anterior uveitis, no complications occurred to 11 trabeculectomized eyes. All postoperative measurements of anterior chamber showed statistically significant differences in each group according to the preoperative data (P<0.05). However, fewer changes occurred in group B than in group A.CONCLUSION: Phacotrabeculectomy and sequential surgery exhibit similar IOP reduction, visual recovery, and complications when treating CACG patients with cataract. However, for a wider ACA, phacotrabeculectomy has demonstrated higher effectiveness than sequential surgery.]]></description>
<pubDate>2016/5/23 11:36:15</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hai-Jun Li,Jie Xuan,Xiao-Min Zhu and Lin Xie]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hai-Jun Li,Jie Xuan,Xiao-Min Zhu and Lin Xie</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160508]]></guid><cfi:id>990</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Efficacy of combined cataract extraction and endoscopic cyclophotocoagulation for the reduction of intraocular pressure and medication burden]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160509]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report on the efficacy of combined endoscopic cyclophotocoagulation (ECP) and phacoemulsification cataract extraction (PCE) with intraocular lens placement for reduction of intraocular pressure (IOP) and medication burden in glaucoma.
METHODS: A retrospective case review of 91 eyes (73 patients) with glaucoma and cataract that underwent combined PCE/ECP surgery was performed. Baseline demographic and ocular characteristics were recorded, as well as intraocular pressure, number of glaucoma medications, and visual acuity postoperatively with 12-month follow-up. Treatment failure was defined as less than 20% reduction in IOP from baseline on two consecutive visits (at 1, 3, 6, or 12mo postoperatively), IOP ≥21 mm Hg or ≤5 mm Hg on two consecutive visits, or additional glaucoma surgery performed within 12mo after PCE/ECP.
RESULTS: Overall, mean medicated IOP was reduced from 16.65 mm Hg at baseline to 13.38 mm Hg at 12mo (P<0.0001). Mean number of glaucoma medications was reduced from 1.88 medications at baseline to 1.48 medications at 12mo (P=0.0003). At 3mo postoperatively, the success rate was 73.6% (95%CI: 63.3, 81.5), 57.1% at 6mo (95% CI: 46.3, 66.6), and 49.7% at 12mo (95%CI: 38.9, 59.6). Patient demographic characteristics were not associated with treatment success.  The only ocular characteristic associated with treatment success was a higher baseline IOP.
CONCLUSION: Combined PCE/ECP surgery is an effective surgical option for the reduction of IOP and medication burden in glaucoma patients. Patients with higher baseline IOP levels are most likely to benefit from this procedure.]]></description>
<pubDate>2016/5/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Sammie J. Roberts,Matthew Mulvahill,Jeffrey R. SooHoo,Mina B. Pantcheva,Malik Y. Kahook and Leonard K. Seibold]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Sammie J. Roberts,Matthew Mulvahill,Jeffrey R. SooHoo,Mina B. Pantcheva,Malik Y. Kahook and Leonard K. Seibold</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160509]]></guid><cfi:id>989</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[The refractive outcome of Toric Lentis Mplus implant in cataract surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160510]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the refractive outcome of Toric Lentis Mplus intraocular lens (IOL) implant.
METHODS: This is a retrospective case series. Consecutive patients with corneal astigmatism of at least 1.5 D had Toric Lentis Mplus IOL implant during cataract surgery. The exclusion criteria included irregular astigmatism on corneal topography, large scotopic pupil diameter (>6 mm), poor visual potential and significant ocular comorbidity. Postoperative manifest refraction, uncorrected distance visual acuity (UDVA), best-corrected distance visual acuity (BCVA), uncorrected intermediate visual acuity (UIVA) at 3/4 m and uncorrected near visual acuity (UNVA) were obtained.
RESULTS: There were 70 eyes from 49 patients in this study. Patients were refracted at a median of 8.9wk (range 4.0 to 15.5) from the operation date. Sixty-five percent of eyes had 6/7.5 (0.10 logMAR) or better, and 99% 6/12 (0.30 logMAR) or better postoperative UDVA. Eighty-nine percent could read Jaeger (J) 3 (0.28 logMAR) and 95% J5 (0.37 logMAR) at 40 cm. The median magnitude of astigmatism decreased from 1.91 D to 0.49 D (Wilcoxon, P<0.001) after the operation. The range of the cylindrical error was reduced from 1.5-3.95 D (keratometric) preoperatively to 0.00-1.46 D (subjective refraction transposed to corneal plane) postoperatively.
CONCLUSION: Toric Lentis Mplus IOL has good predictability in reducing preexisting corneal astigmatism.]]></description>
<pubDate>2016/5/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Patrick J Chiam and Say A Quah]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Patrick J Chiam and Say A Quah</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160510]]></guid><cfi:id>988</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of two different methods of preoperative marking for toric intraocular lens implantation: bubble marker versus pendulum marker]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160511]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the accuracy of two different methods of preoperative marking for toric intraocular lens (IOL) implantation, bubble marker versus pendulum marker, as a means of establishing the reference point for the final alignment of the toric IOL to achieve an outcome as close as possible to emmetropia.
METHODS: Toric IOLs were implanted in 180 eyes of 110 patients. One group (55 patients) had preoperative marking of both eyes done with bubble marker (ASICO AE-2791TBL) and the other group (55 patients) with pendulum marker (Rumex(3-193). Reference marks were placed at 3-, 6-, and 9-o'clock positions on the limbus. Slit-lamp photographs were analyzed using Adobe Photoshop (version 7.0). Amount of alignment error (in degrees) induced in each group was measured.
RESULTS: Mean absolute rotation error in the preoperative marking in the horizontal axis was 2.42±1.71 in the bubble marker group and 2.83±2.31in the pendulum marker group (P=0.501). Sixty percent of the pendulum group and 70% of the bubble group had rotation error ≤3 (P=0.589), and 90% eyes of the pendulum group and 96.7% of the bubble group had rotation error ≤5 (P=0.612).
CONCLUSION: Both preoperative marking techniques result in approximately 3 of alignment error. Both marking techniques are simple, predictable, reproducible and easy to perform.]]></description>
<pubDate>2016/5/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Javed Hussain Farooqui,Archana Koul,Ranjan Dutta and Noshir Minoo Shroff]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Javed Hussain Farooqui,Archana Koul,Ranjan Dutta and Noshir Minoo Shroff</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160511]]></guid><cfi:id>987</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[The association analysis polymorphism of CDKAL1 and diabetic retinopathy in Chinese Han population]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160512]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To identify the contribution of CDKAL1 to the development of diabetic retinopathy (DR) in Chinese population.
METHODS: A case-control study was performed to investigate the genetic association between DR and polymorphic variants of CDKAL1 in Chinese Han population with type 2 diabetes mellitus (T2DM). A well-defined population with T2DM, consisting of 475 controls and 105 DR patients, was recruited. All subjects were genotyped for the genetic variant (rs10946398) of CDKAL1. Genotyping was performed by iPLEX technology. The association between rs10946398 and T2DM was assessed by univariate and multivariate logistic regression (MLR) analysis.
RESULTS: There were significant differences in C allele frequencies of rs10946398 (CDKAL1) between control and DR groups (45.06% versus 55.00%, P<0.05). The rs10946398 of CDKAL1 was found to be associated with the increased risk of DR among patients with diabetes.
CONCLUSION: Our findings suggest that rs10946398 of CDKAL1 is independently associated with DR in a Chinese Han population.]]></description>
<pubDate>2016/5/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Nai-Jia Liu,Qian Xiong,Hui-Hui Wu,Yan-Liang Li,Zhen Yang,Xiao-Ming Tao,Yan-Ping Du,Bin Lu,Ren-Ming Hu,Xuan-Chun Wang and Jie Wen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Nai-Jia Liu,Qian Xiong,Hui-Hui Wu,Yan-Liang Li,Zhen Yang,Xiao-Ming Tao,Yan-Ping Du,Bin Lu,Ren-Ming Hu,Xuan-Chun Wang and Jie Wen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160512]]></guid><cfi:id>986</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Infrared autofluorescence, short-wave autofluorescence and spectral-domain optical coherence tomography of optic disk melanocytomas]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160513]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the findings of infrared fundus autofluorescence (IR-AF) and spectral-domain optical coherence tomography (SD-OCT) in eyes with optic disc melanocytoma (ODM).
METHODS: IR-AF findings and those of other ophthalmologic imaging examinations, including short-wave autofluorescence (SW-AF), fluorescein angiography (FA), fundus color photography, and SD-OCT of 8 eyes of 8 consecutive cases with ODM were assessed.
RESULTS: The ODMs in all cases (100%) presented similar IR-AF, SW-AF, and FA findings. On IR-AF images, ODMs showed outstanding hyper-AF with well-defined outline. On SW-AF images, the area of ODMs presented as hypo-AF. FA images revealed the leaking retinal telangiectasia on the surface of the ODMs. On SD-OCT images in 8 cases (100%), the ODMs were sloped with highly reflective surface, which were disorganized retina and optic nerve layers. In 7 cases (87.5%), peripapillary choroids were involved. The melanocytomas of 8 cases (100%) presented as optically empty spaces. Vitreous seeds were found in one case (12.5%).
CONCLUSION: IR-AF imaging may provide a new modality to evaluate the pathologic features of ODMs, and together with SW-AF imaging, offers a new tool to study biological characteristics associated with ODMs. SD-OCT is a valuable tool in delimitating the tumor extension and providing morphological information about the adjacent retinal tissue.]]></description>
<pubDate>2016/5/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Peng Zhang,Yan-Nian Hui,Wen-Qin Xu,Zi-Feng Zhang,Hai-Yan Wang,Dong-Jie Sun and Yu-Sheng Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Peng Zhang,Yan-Nian Hui,Wen-Qin Xu,Zi-Feng Zhang,Hai-Yan Wang,Dong-Jie Sun and Yu-Sheng Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160513]]></guid><cfi:id>985</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Axial length in unilateral idiopathic central serous chorioretinopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160514]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the axial length (AXL) in unilateral idiopathic central serous chorioretinopathy (CSC).
METHODS: This retrospective case-control study was comprised of a consecutive case series of 35 patients with acute unilateral idiopathic CSC, and age- and sex-matched 50 control eyes. AXL of both eyes of unilateral CSC patients and the control eyes were investigated. AXL was measured by ultrasonic biometry, and the adjusted AXL was calculated for CSC eyes as measured AXL plus differences of foveal thickness between CSC and normal fellow eyes in millimeters. The main outcome measures were comparison of AXL between CSC, fellow and control eyes.
RESULTS: The mean age of 35 CSC patients was 45.5y, and 31 males were included. The adjusted AXL of CSC eyes was 23.52 mm, and the AXL of fellow eyes was 23.46 mm, and of control eyes 23.94 mm. The AXL of both CSC and fellow eyes were significantly shorter than control eyes (CSC vs control, P=0.044; fellow vs control, P=0.026). There was no statistically significant difference in AXL between CSC and fellow eyes.
CONCLUSION: In unilateral idiopathic CSC, the AXL of CSC and fellow eyes are shorter than that of control eyes. Short AXL may be related with choroidal circulation abnormality in CSC.]]></description>
<pubDate>2016/5/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hoseok Moon,Dae Yeong Lee and Dong Heun Nam]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hoseok Moon,Dae Yeong Lee and Dong Heun Nam</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160514]]></guid><cfi:id>984</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Increased melatonin levels in aqueous humor of patients with proliferative retinopathy in type 2 diabetes mellitus]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160515]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report the association between melatonin levels in aqueous humor and serum, and diabetic retinopathy (DR) grade in type 2 diabetic patients.
METHODS: Aqueous humor and plasma samples from 26 patients with DR (in nonproliferative and proliferative stages) and 14 control subjects were collected during cataract surgery after 6 p.m. Melatonin concentrations were determined using an enzyme-linked immunosorbent assay (ELISA).
RESULTS: Melatonin levels were significantly higher in the aqueous humor of patients with proliferative diabetic retinopathy (PDR) [18.57±2.67 pg/mL (range 15.20-23.06) vs 13.63±2.71 pg/mL (range 10.20-20.20), P=0.0001], but not in those with nonproliferative retinopathy (NPDR) [13.79±2.56 pg/mL (range 9.80-20.10) vs 13.63±2.71 pg/mL (range 10.20-20.20), P=0.961] compared to controls. There was decrement in the plasma melatonin level of patients with PDR, but no significant differences between the plasma melatonin levels of the study groups [5.37±1.74 pg/mL (range 2.85-8.65) vs 6.11±1.90 pg/mL (range 3.13-9.41), P=0.293], or between control and DR groups [NPDR 6.11±1.90 pg/mL (range 3.13-9.41) vs control 6.15±1.91 pg/mL (range 2.18-9.86); PDR (5.37±1.74 pg/mL (range 2.85-8.65) vs control 6.15±1.91 pg/mL (range 2.18-9.86), P=0.808, P=0.264].
CONCLUSION: Elevated melatonin levels in aqueous humor in PDR may indicate the level to be associated with DR severity.]]></description>
<pubDate>2016/5/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Erdinc Aydin and Semsettin Sahin]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Erdinc Aydin and Semsettin Sahin</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160515]]></guid><cfi:id>983</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Choroidal thickness measurements with optical coherence tomography in branch retinal vein occlusion]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160516]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate central macular thickness (CMT) and mean choroidal thickness (MCT) in eyes with branch retinal vein occlusion (BRVO), before and after ranibizumab treatment using spectral domain-optical coherence tomography (SD-OCT).
METHODS: Forty-two patients with unilateral BRVO and macular edema were included in this study. There were 25 men and 17 women. Using SD-OCT, choroidal thickness was measured at 500 &micro;m intervals up to 1500 &micro;m temporal and nasal to the fovea. MCT was calculated based on the average of the 7 locations. All the eyes with BRVO were treated with intravitreal ranibizumab (0.5 mg/0.05 mL). Comparisons between the BRVO and fellow eyes were analyzed using Mann-Whitney U test. Pre-injection and post-injection measurements were analyzed using Wilcoxon test and repeated measure analysis.
RESULTS: At baseline, there was a significant difference between the BRVO and fellow eyes in MCT [BRVO eyes 245 (165-330) &micro;m, fellow eyes 229 (157-327) &micro;m] and CMT [BRVO eyes 463 (266-899) &micro;m, fellow eyes 235 (148-378) &micro;m (P=0.041, 0.0001, respectively)]. Following treatment, CMT [295 (141-558) &micro;m] and MCT [229 (157-329) &micro;m] decreased significantly compared to the baseline measurements (P=0.001, 0.006, respectively). Also BCVA (logMAR) improved significantly (P=0.0001) in the BRVO eyes following treatment. After treatment CMT [BRVO eyes 295 (141-558) &micro;m, fellow eyes 234 (157-351) &micro;m] and MCT [BRVO eyes 229 (157-329) &micro;m, fellow eyes 233 (162-286) &micro;m] values did not reveal any significant difference in BRVO eyes and fellow eyes (P=0.051, 0.824, respectively).
CONCLUSION: In eyes with BRVO, CMT and MCT values are greater than the fellow eyes, and decrease significantly following ranibizumab injection.]]></description>
<pubDate>2016/5/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Muge Coban-Karatas,Rana Altan-Yaycioglu,Burak Ulas,Selcuk Sizmaz,Handan Canan and Cagla Sariturk]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Muge Coban-Karatas,Rana Altan-Yaycioglu,Burak Ulas,Selcuk Sizmaz,Handan Canan and Cagla Sariturk</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160516]]></guid><cfi:id>982</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical features and in vivo confocal microscopy assessment in 12 patients with ocular cicatricial pemphigoid]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160517]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To describe the clinical features and microstructural characteristics assessed by in vivo confocal microscopy (IVCM) in patients with ocular cicatricial pemphigoid (OCP).
METHODS: A descriptive, uncontrolled case series study. Patients diagnosed with OCP were examined by clinical history, slit-lamp biomicroscopy features and IVCM images. The results of direct immunofluorescence (DIF) biopsies and indirect immunofluorescence (IIF) were also recorded. Local and systemic immunosuppressive therapy were administered and adjusted according to response.
RESULTS: A total of 12 consecutive OCP patients (7 male, 5 female; mean age 60.42±10.39y) were recruited. All patients exhibited bilateral&nbsp;progressive conjunctival scarring and recurrent chronic conjunctivitis was the most frequent clinical pattern. The mean duration of symptoms prior to diagnosis of OCP was 2.95±2.85y (range: 5mo to 10y). The Foster classification varied from stage I to IV and 20 eyes (83%) were within or greater than Foster stage Ⅲ on presentation. Two of the 12 patients (17%) demonstrated positive DIF; 3 of the 12 (25%) patients reported positive IIF. The mean duration of the follow-up period was 20.17±11.88mo (range: 6 to 48mo). IVCM showed variable degrees of abnormality in the conjuctiva-cornea and conjuctival scarring was detected in all the involved eyes. Corneal stromal cell activation and dendritic cell infiltration presented as ocular surface inflammation, ocular surface keratinization along with the destroyed Vogt palisades was noted in eyes with potential limbal stem cell deficiency. After treatment, remission of ocular surface inflammation was achieved in all the patients, 18 eyes (75%) remained stable, 6 eyes (25%) had recurrent conjunctivitis and cicatrization in 2 eyes (8%) was progressing.&nbsp;
CONCLUSION: As an autoimmune disease, OCP manifests as variable degrees of clinical and laboratory abnormalities with both local and systemic immunosuppressive treatment playing important roles in disease therapy. IVCM can be as a valuable non-invasive technique to assess ocular surface changes in a cellular level with a potential value for providing diagnostic evidence and monitoring therapeutic effects during follow-up.]]></description>
<pubDate>2016/5/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Qin Long,Ya-Gang Zuo,Xue Yang,Ting-Ting Gao,Jie Liu and Ying Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Qin Long,Ya-Gang Zuo,Xue Yang,Ting-Ting Gao,Jie Liu and Ying Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160517]]></guid><cfi:id>981</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Ocular trauma treated with pars plana vitrectomy: early outcome report]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160518]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate demographic variables and visual outcomes, among patients with ocular injuries involving the posterior segment, managed with pars plana vitrectomy.
METHODS: The records of patients were studied retrospectively from March to September 2010, to determine the age, gender, place of occurrence of trauma, visual acuity, anatomical site, nature of injury, wound length, the presence of an afferent pupillary defect, and the timing of vitrectomy.  The Ocular Trauma Score was measured. The minimum follow-up from presentation was 6mo.
RESULTS: Ninety patients (77 males, 13 females), with a mean age of 32.7±15.8y were included over the 6-month period.  The majority of cases occurred in the workplace (47 patients), followed by home (14 patients). The mean visual acuity (logMAR) of patients significantly improved from 2.36±0.72 preoperatively to 1.50±1.14 postoperatively. Twenty-three patients had preoperative vision better than 2.0 logMAR, the postoperative visual acuity was significantly better among these patients than patients with worse than 2.0 logMAR (P<0.001). Visual improvement between groups with early vitrectomy (<7d) and delayed vitrectomy (>7d) was not significantly different (P=0.66). Postoperative visual acuity was not significantly different between patients with injury in Zone I and II (P=0.64), but patients with injury in Zone III had significantly poorer visual acuity (P=0.02). Patients with relative afferent pupillary defect had significantly poorer postoperative visual acuity (P=0.02). Preoperative visual acuity, the difference of preoperative and postoperative visual acuity, and postoperative visual acuity were significantly different between groups with different ocular trauma scores (P<0.001).
CONCLUSION: Trauma is more likely to occur in men under 40y of age and in the workplace. The favorable final visual outcome is associated with the absence of afferent pupillary defect, ocular trauma score and presenting visual acuity as well as the zone of injury, and not associated with the timing of vitrectomy.]]></description>
<pubDate>2016/5/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mohammad Reza Mansouri,Seyed Ali Tabatabaei,Mohammad Soleimani,Mohammad Yaser Kiarudi,Saber Molaei,Mehdi Rouzbahani,Meysam Mireshghi,Mohsen Zaeferani and Mehrbod Ghasempour]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mohammad Reza Mansouri,Seyed Ali Tabatabaei,Mohammad Soleimani,Mohammad Yaser Kiarudi,Saber Molaei,Mehdi Rouzbahani,Meysam Mireshghi,Mohsen Zaeferani and Mehrbod Ghasempour</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160518]]></guid><cfi:id>980</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[An overlooked effect of systemic anticholinergics: alteration on accommodation amplitude]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160519]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the effect of oral solifenacin succinate, tolterodine-L-tartarate and oxybutinin hydrochloride (HCl) on accommodation amplitude.
METHODS: Female overactive bladder syndrome (OAB) patients who were planned to use oral anticholinergics, patients that uses solifenacin succinate 5 mg (Group I, n=25), tolterodine-L-tartarate 4 mg (Group II, n=25), and oxybutinin HCl 5 mg b.i.d (Group III, n=25) and age matched healthy female subjects (Group IV, n=25) were recruited and complete ophthalmological examination and accommodation amplitude assessment were done at baseline and 4wk after initiation of treatment.
RESULTS: The mean age of 100 consecutive female subjects was 51.6±5.7 (40-60)y and there were no statistically significant difference with regard to the mean age (P=0.107) and baseline accommodation amplitude (P=0.148) between study groups. All treatment groups showed a significant decrease in accommodation amplitude following a 4-week course of anticholinergic treatment (P=0.008 in Group I, P=0.002 in Group II, P=0.001 in Group III), but there was no statistically significant difference in Group IV (P=0.065).
CONCLUSION: A 4-week course of oral anticholinergic treatment have statistically significant effect on accommodation amplitude. Clinicians should avoid both overestimating this result, as this would unnecessarily restrict therapeutic possibilities, and also underestimating it which may lead to drug intolerance.]]></description>
<pubDate>2016/5/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mehmet Ali Sekeroglu,Emre Hekimoglu,Mustafa Alpaslan Anayol,Yasemin Tasci and Ismail Dolen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mehmet Ali Sekeroglu,Emre Hekimoglu,Mustafa Alpaslan Anayol,Yasemin Tasci and Ismail Dolen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160519]]></guid><cfi:id>979</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Binocular vision and abnormal head posture in children when watching television]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160520]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the association between the binocular vision and an abnormal head posture (AHP) when watching television (TV) in children 7-14y of age.
METHODS: Fifty normal children in the normal group and 52 children with an AHP when watching TV in the AHP group were tested for spherical equivalents, far and near fusional convergence (FC) and fusional divergence (FD) amplitudes, near point of convergence, far and near heterophoria, accommodative convergence/ accommodation ratio and stereoacuity. The values of these tests were compared between the two groups. The independent t test was applied at a confidence level of 95%.
RESULTS: The far and near FC amplitudes and far FD amplitudes were lower in the AHP group (the far FC amplitudes: break point 13.6±5.4△, recovery point 8.7±5.4△. The near FC amplitudes: break point 14.5±7.3△, recovery point 10.3±5.1△. The far FD amplitudes: break point 3.9±2.7△, recovery point 2.6±2.3△) compared with those in the normal group (the far FC amplitudes: break point 19.1±6.2△, recovery point 12.4±4.5△. The near FC amplitudes: break point 22.3±8.0△, recovery point 16.1±5.7△. The far FD amplitudes: break point 7.0±2.1△, recovery point 4.6±1.9△). Other tests presented no statistically significant differences.
CONCLUSION: An association between the reduced FC and FD amplitudes and the AHP in children when watching TV is proposed in the study. This kind of AHP is considered to be an anomalous manifestation which appears in a part of puerile patients of fusional vergence dysfunction.]]></description>
<pubDate>2016/5/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Di Zhang,Wei-Hong Zhang,Shu-Zhen Dai,Hai-Ying Peng and Li-Ya Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Di Zhang,Wei-Hong Zhang,Shu-Zhen Dai,Hai-Ying Peng and Li-Ya Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160520]]></guid><cfi:id>978</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Short term effects of small incision lenticule extraction surgery on corneal endothelium]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160409]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the effects of small incision lenticule extraction (SMILE) surgery on the corneal endothelium at 1d to 1mo postoperatively.
METHODS: A retrospective, observational study was conducted on 47 patients (47 eyes) who received SMILE surgery. Patients were grouped according to contact lens wear condition. The corneal endothelium was examined preoperatively and at 1d, 1wk and 1mo postoperatively. The corneal endothelium was analyzed for endothelial cell density (ECD), percentage of hexagonal cells, and coefficient of variation (CV) of cell size.
RESULTS: There were no significant decrease in the ECD, percentage of hexagonal cells or increase in CV at 1d, 1wk and 1mo postoperatively (P>0.05). However, there was a small increase of ECD by 2.88% in contact lens wearers (78.26±113.62 cell/mm2, P<0.05).
CONCLUSION: SMILE has no significant adverse effects on the corneal ECD and morphology during 1mo follow-up time.]]></description>
<pubDate>2016/4/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Dan-Yang Wang,Man-Li Liu,Yi-Le Chen,Xiao-Ying Zhang,Yang-Tao Xu,Jian-Chao Wang,Chi-Ho To,Jian-Guo Wang and Quan Liu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Dan-Yang Wang,Man-Li Liu,Yi-Le Chen,Xiao-Ying Zhang,Yang-Tao Xu,Jian-Chao Wang,Chi-Ho To,Jian-Guo Wang and Quan Liu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160409]]></guid><cfi:id>977</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Optimal incision sites to reduce corneal aberration variations after small incision phacoemulsification cataract surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160410]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyze the effect of steep meridian small incision phacoemulsification cataract surgery on anterior, posterior and total corneal wavefront aberration.
METHODS: Steep meridian small incision phacoemulsification cataract surgery was performed in age-related cataract patients which were divided into three groups according to the incision site: 12 o’clock, 9 o’clock and between 9 and 12 o’clock (BENT) incision groups. The preoperative and 3-month postoperative root mean square (RMS) values of anterior, posterior and total corneal wavefront aberration including coma, spherical aberration, and total higher-order aberrations (HOAs), were measured by Pentacam scheimpflug imaging. The mean preoperative and postoperative corneal wavefront aberrations were documented.
RESULTS: Total corneal aberration and total lower-order aberrations decreased significantly in three groups after operation. RMS value of total HOAs decreased significantly postoperatively in the 12 o’clock incision group (P<0.001). Corneal spherical aberration was statistically significantly lower after steep meridian small incision phacoemulsification cataract surgery in BENT incision group (P<0.05) and Pearson correlation analysis indicated that spherical aberration changes had no significant relationship with total astigmatism changes in all three corneal incision location.
CONCLUSION: Corneal incision of phacoemulsification cataract surgery can affect corneal wavefront aberration. The 12 o’clock corneal incision eliminated more HOAs and the spherical aberrations decreased in BENT incision group obviously when we selected steep meridian small incision. Cataract lens replacement using wavefront-corrected intraocular lens combined with optimized corneal incision site would improve ocular aberration results.]]></description>
<pubDate>2016/4/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ling Chu,Jiang-Yue Zhao,Jin-Song Zhang,Jie Meng,Ming-Wu Wang,Ya-Jing Yang and Jia-Ming Yu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ling Chu,Jiang-Yue Zhao,Jin-Song Zhang,Jie Meng,Ming-Wu Wang,Ya-Jing Yang and Jia-Ming Yu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160410]]></guid><cfi:id>976</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Evaluation of the Ex-PRESS&reg; P-50 implant under scleral flap in combined cataract and glaucoma surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160411]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the efficacy and safety of glaucoma drainage device Ex-PRESS&reg; P-50 for combined cataract surgery and glaucoma.
METHODS: Patients having cataract and open angle glaucoma or patients with open advanced glaucoma which needed two or more antiglaucoma medications were included. Combined cataract surgery and glaucoma with Ex-PRESS&reg; P-50 model placed under scleral flap was performed.
RESULTS:&nbsp; Out of 40 eyes of 40 patients (55% male and 45% female) completed the study during one-year follow-up. The mean of age was 76.6±11.02y. The intraocular pressure (IOP) decreased significantly during the 12-month follow-up from 23.5 mm Hg to 16.8 mm Hg (Wilcoxon signed ranks test, P<0.001). A 59.5% of patients did not need any topical treatment, 10.8% of them needed one active principle, 27% needed two active principles, and 2.7% of them needed three active principles for successful IOP control (<21 mm Hg).
CONCLUSION: Combined surgery of phacoemulsification with ExPRESS&reg; P-50 lowers IOP from the preoperative baseline and reduces significantly the number of antiglaucoma active principles for IOP control after the operation.]]></description>
<pubDate>2016/4/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Valentín Huerva,Jordi Soldevila,Francisco J. Ascaso,Laura Lavilla,M. Jesús Muniesa and M. Carmen Sánchez]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Valentín Huerva,Jordi Soldevila,Francisco J. Ascaso,Laura Lavilla,M. Jesús Muniesa and M. Carmen Sánchez</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160411]]></guid><cfi:id>975</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[6-weekly bevacizumab versus 4-weekly ranibizumab for neovascular age-related macular degeneration: a 2-year outcome]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160412]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare visual acuity and central macular thickness (CMT) changes in neovascular age related macular degeneration patients treated with either 6 weekly bevacizumab regimen or 4 weekly ranibizumab on an as required basis.
METHODS: Patients made an informed choice between bevacizumab 1.25 mg or ranibizumab 0.5 mg. The selected treatment was administered in the first 3 visits. Bevacizumab patients were followed-up 6 weekly and ranibizumab 4 weekly. Retreatment criteria was based on the reduction of >5 letters in the best-corrected visual acuity (BCVA), the presence of retinal fluid on optical coherence tomography (OCT) or new retinal haemorrhage.
RESULTS: Visual acuity at 2y bevacizumab patients gained 7.0 letters and ranibizumab 9.2 (P=0.31, 95% CI -6.4 to 2.0). At 2y 86% of bevacizumab and 94% ranibizumab patients had not lost 15 letters or more (P=0.13). Mean CMT decreased at 2y bevacizumab by 146 &micro;m, ranibizumab 160 &micro;m (P=0.72). Mean number of injections was at 2y bevacizumzb 11.9, ranibizumab 10.3 (P=0.023).
CONCLUSION: Bevacizumab 6 weekly on an as required basis was not demonstrably non-inferior to ranibizumab 4 weekly pro re nata (prn) in terms of BCVA and change in CMT. In the bevacizumab group, one more injection was required in the second year compared to the ranibizumab group.]]></description>
<pubDate>2016/4/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Patrick J Chiam,Vivian W Ho,Nicholas M Hickley and Venkat Kotamarthi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Patrick J Chiam,Vivian W Ho,Nicholas M Hickley and Venkat Kotamarthi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160412]]></guid><cfi:id>974</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Serum vascular endothelial growth factor receptor-2 and adropin levels in age-related macular degeneration]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160413]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the serum levels of vascular endothelial growth factor receptor-2 (VEGFR-2) and adropin in age-related macular degeneration (AMD) patients.
METHODS: Ninety-eight AMD patients were included in the study. Seventy-eight age- and sex-matched healthy volunteers were recruited as the control group. Fundus florescein angiography and optical coherence tomography were performed to assess the posterior segment details. Serum VEGFR-2 and adropin levels were measured using enzyme-linked immunosorbent assays and compared between the study groups.
RESULTS: AMD group had significantly increased foveal retinal thickness, serum LDL and HDL levels and significantly decreased subfoveal choroidal thickness (P =0.01, 0.047, 0.025 and <0.001, respectively). Serum VEGFR-2 level revealed a significant decrease in AMD patients compared to controls (26.48±6.44 vs 30.42±7.92 ng/mL, P<0.001). There was an insignificant increase in serum adropin level in AMD patients (6.17±3.19 vs 5.79±2.71 ng/mL, P=0.4) . Serum level of VEGFR-2 in AMD patients had a significant negative correlation with foveal retinal thickness (r=-0.226, P=0.025) and a significant positive correlation with subfoveal choroidal thickness (r=0.2, P=0.048).
CONCLUSION: The current study demonstrated that the decreased serum VEGFR-2 level may be considered in the development of AMD. Adropin does not seem to play a role in the pathogenesis of AMD.]]></description>
<pubDate>2016/4/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Nurgül &Ouml;rnek, Kemal &Ouml;rnek, Süleyman Aydin, Musa Yilmaz and Ya&#351;ar &Ouml;lmez]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Nurgül &Ouml;rnek, Kemal &Ouml;rnek, Süleyman Aydin, Musa Yilmaz and Ya&#351;ar &Ouml;lmez</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160413]]></guid><cfi:id>973</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[The diurnal variation pattern of choroidal thickness in macular region of young healthy female individuals using spectral domain optical coherence tomography]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160414]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the pattern of diurnal variations of choroidal thickness of macular region of healthyindividuals.
METHODS: A prospective study of 32 healthy female subjects was conducted. Each subject underwent 1) a questionnaire on daily schedule, 2) the Pittsburgh Sleep Quality Index questionnaire (PSQI), and 3) ocular examinations including an eye dominance test, fundus photography, and sequential optical coherence tomography (OCT) imaging, on two separate days at five fixed 3h time intervals. Choroidal thickness was measured by two masked graders.
RESULTS: A significant diurnal variation of choriodal thickness at fovea (P<0.001), at 500 μm nasal (P<0.001), temporal to fovea (P=0.01) or 1500 μm nasal to fovea (P=0.001) was observed. The median choroidal thickness peaked at 11:00 at fovea (P=0.01), at 500 μm nasal (P=0.009) and temporal (P=0.03) to fovea. The median amplitude of foveal choroidal thickness was 20.5 μm (13, 31) and 20.0 μm (12.5, 28.2) for the first and second series of measurements, respectively. The greater amplitude of foveal choroidal thickness was associated with thickner initial foveal choroidal thickness [0.05 (0.03, 0.08), P=0.01], dominant eye [10.51 (4.02, 14.60), P=0.04] in the multivariate linear regression.
CONCLUSION: Our data show a significant diurnal variation of the choroidal thickness at fovea, at 500 μm nasal and temporal to fovea and 1500 μm nasal to fovea. Thicker initial foveal choroidal thickness and being dominant eye may influence the amplitude of foveal choroidal thickness.]]></description>
<pubDate>2016/4/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Meng Zhao,Xiu-Fen Yang,Xuan Jiao,Apiradee Lim,Xue-Tao Ren,Torkel Snellingen and Ning-Pu Liu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Meng Zhao,Xiu-Fen Yang,Xuan Jiao,Apiradee Lim,Xue-Tao Ren,Torkel Snellingen and Ning-Pu Liu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160414]]></guid><cfi:id>972</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Late clinical characteristics of infants with retinopathy of prematurity and treated with cryotherapy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160415]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To describe the clinical characteristics and late results of patients with retinopathy of prematurity (ROP) treated with “6h cryotherapy”.
METHODS: Out of 1252 infants screened for ROP, 52 patients were treated with temporal 6h cryotherapy from 1997 to 2005 were recalled to our clinic. Among these 23 patients were available and 46 eyes of 23 infants were included to evaluate for visual acuity, refractive error, ocular alignment, nystagmus, retinal examination (abnormal branching of retinal vessels, retinal thinning, latis degenerations, tortuosity of vessels, straightening of temporal vessels, narrowing of the angle of vessel in the juxtapapillary entrance, pigment changes, macular heterotopia), optic atrophy and optic disc cupping, axial length at birth and axial length at 1y.
RESULTS: The median age at examination was 7 (5-18)y. In 32.6% of patients, the visual acuity was ≤20/200 and the mean best corrected visual acuity was 20/35 as measured with a Snellen chart. Mean spherical refractive error was -1.76±2.69 D. The degree of myopia at the last examination was found to be correlated with the elongation of the eye in the first year of life. Exotropia was present in 17.4% (n=8) of infants and esotropia in 13% (n=6). The most common retinal abnormality was abnormal branching of retinal vessels (82.6%) followed by retinal thinning (52.2%).
CONCLUSION: The late clinical outcomes of infants with ROP treated in our clinic with cryotherapy seems to comparable with results of laser treatment.]]></description>
<pubDate>2016/4/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Eren Cerman,Deniz Ozarslan Ozcan,Hande Celiker,Muhsin Eraslan,Ozlem Sahin and Haluk Kazokoglu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Eren Cerman,Deniz Ozarslan Ozcan,Hande Celiker,Muhsin Eraslan,Ozlem Sahin and Haluk Kazokoglu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160415]]></guid><cfi:id>971</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effects of scleral encircling surgery on vitreous cavity length and diopter]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160416]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To observe the changes of vitreous cavity length and diopter after scleral encircling (SE) produce.
METHODS: This prospective study included 68 eyes of 68 non-consecutive patients with macula-off retinal detachment who were operated by SE surgery. The corneal refractive power, ocular axial length and diopter were measured by keratometer, A-mode ultrasonic meter and computed dioptometer.
RESULTS: There was no significant difference in corneal refractive power among preoperative and postoperative 1, 3 and 6 mo (0.57±0.54 D at pre-surgery;0.72±0.26 D at 1mo; 0.71±0.34 D at 3mo; 0.69±0.31 D at 6mo; all P>0.05 ). Axial lengths were obviously lengthened, especially in vitreous cavity length (17.87±3.09 mm, 19.69±3.12 mm, 18.97±3.56 mm, 18.76±3.47 mm, 18.68±3.42 mm at pre-surgery, 1wk, 1, 3 and 6mo postoperatively, P <0.05) and diopter also increased at beginning and then recovered gradually. After 1 and 3 mo, axial length (vitreous cavity length) and myopia were more and in higher degree than before surgery.
CONCLUSION: The change of postoperative vitreous cavity length is the main factor that results in the changes of axial length and then makes the change of diopter.]]></description>
<pubDate>2016/4/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Zi-Cheng Zhu,Gen-Jie Ke,Yue-Chun Wen and Zhang-You Wu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zi-Cheng Zhu,Gen-Jie Ke,Yue-Chun Wen and Zhang-You Wu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160416]]></guid><cfi:id>970</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Early changes to dry eye and ocular surface after small-incision lenticule extraction for myopia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160417]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the early changes in dry eye symptoms, tear function and ocular surface following small-incision lenticule extraction (SMILE) for myopia.
METHODS: Ninety-seven consecutive patients (193 eyes) who underwent SMILE for myopia were observed in this longitudinal and retrospective study. Parameters evaluated included: subjective dry eye symptoms (dryness, foreign body sensation and photophobia), tear film breakup time (TBUT), Schirmer Ⅰ test (SⅠT) without anesthesia, tear meniscus height (TMH) and corneal fluorescein staining. Each parameter was evaluated before, and subsequently at 1d, 1wk, 1 and 3mo after surgery.
RESULTS: Compared with preoperative data, dryness was noted to be significantly increased at 1wk and 1mo postoperatively (P<0.01). Symptoms of photophobia and foreign body sensation demonstrated significant differences at 1d and 1wk as compared with preoperative scores respectively (P<0.01). These values were decreased at 1 and 3mo post-surgery (P>0.05). Conversely the corneal staining scores were higher than the preoperative data at 1d, 1wk and 1mo (P<0.01), but were close to the preoperative level at 3mo postoperatively. There was a significant decrease in TMH at 1wk and 1mo (P<0.01), but the value was close to the preoperative level at 3mo postoperatively (P=0.16). The examination outcomes of SⅠT were significantly increased at 1d then reduced at 1wk after surgery (P<0.01). Each value subsequently returned to the baseline value at 1 and 3mo (P>0.05). TBUT was significantly decreased at all postoperative time points (P<0.01).
CONCLUSION: SMILE resulted in mild dry eye symptoms, tear film instability and ocular surface damages; however, these complications can recover in a short period of time.]]></description>
<pubDate>2016/4/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Pei-Jin Qiu and Ya-Bo Yang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Pei-Jin Qiu and Ya-Bo Yang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160417]]></guid><cfi:id>969</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Posterior scleral reinforcement for the treatment of pathological myopia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160418]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the effects of posterior scleral reinforcement (PSR) in the treatment of pathological myopia.
METHODS: The study included 52 eyes in 43 patients with pathological myopia who underwent PSR (PSR group), and 52 eyes in 36 age- and myopia-matched patients who did not undergo such treatment as control group. Axial length, refraction error, best corrected visual acuity (BCVA), and macular scans by optical coherence tomography (OCT) were recorded at baseline, 6mo, 1, 3 and 5y after the surgery, and the complications were noted.
RESULTS: There were no statistical differences in axial length, refractive error, or BCVA between the PSR group and the control group at baseline. At the end of the follow-up, the mean axial length was 29.79±1.26 mm in the PSR group, which was significantly shorter than that in the control group (30.78±1.30 mm) (P＜0.01), and the mean refractive error was -16.86±2.53 D in the PSR group, which was significantly lower than that in the control group (-19.18±2.12 D) (P＜0.01). A statistically significant difference in BCVA was found between the PSR group (0.51?±0.25 logMAR) and the control group (0.62?±0.26 logMAR) at the postoperative 5-year follow-up (P＜0.01). There were no serious complications during the 5-year follow-up period.
CONCLUSION: PSR can prevent axial elongation and myopia progression in eyes with pathological myopia.]]></description>
<pubDate>2016/4/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xiu-Juan Li,Xiao-Peng Yang,Qiu-Ming Li,Yu-Ying Wang,Yuan Wang,Xiao-Bei Lyu and Heng Jia]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiu-Juan Li,Xiao-Peng Yang,Qiu-Ming Li,Yu-Ying Wang,Yuan Wang,Xiao-Bei Lyu and Heng Jia</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160418]]></guid><cfi:id>968</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Kappa angles in different positions in patients with myopia during LASIK]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160419]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the difference in kappa angle between sitting and supine positions during laser-assisted in situ keratomileusis (LASIK).
METHODS: A retrospective study was performed on 395 eyes from 215 patients with myopia that received LASIK. Low, moderate, and high myopia groups were assigned according to diopters. The horizontal and vertical components of kappa angle in sitting position were measured before the operation, and in supine position during the operation. The data from the two positions were compared and the relationship between kappa angle and diopters were analyzed.
RESULTS: Two hundred and twenty-three eyes (56.5%) in sitting position and 343 eyes (86.8%) in supine position had positive kappa angles. There were no significant differences in horizontal and vertical components of kappa angle in the sitting position or horizontal components of kappa angle in the supine position between the three groups (P>0.05). A significant difference in the vertical components of kappa angle in the supine position was seen in the three groups (P<0.01). Differences in both horizontal and vertical components of kappa angles were significant between the sitting and supine positions. Positive correlations in both horizontal and vertical components of kappa angles (P<0.05) were found and vertical components of kappa angle in sitting and supine positions were negatively correlated with the degree of myopia (sitting position: r=-0.109; supine position: r=-0.172; P<0.05).
CONCLUSION: There is a correlation in horizontal and vertical components of kappa angle in sitting and supine positions. Positive correlations in both horizontal and vertical components of kappa angle in sitting and supine positions till the end of the results. This result still needs further observation. Clinicians should take into account different postures when excimer laser surgery needs to be performed.]]></description>
<pubDate>2016/4/15 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hui Qi,Jing-Jing Jiang,Yan-Ming Jiang,Li-Qiang Wang and Yi-Fei Huang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hui Qi,Jing-Jing Jiang,Yan-Ming Jiang,Li-Qiang Wang and Yi-Fei Huang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160419]]></guid><cfi:id>967</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Indications for and techniques of keratoplasty at Vietnam National Institute of Ophthalmology]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160309]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report the indications for and techniques of corneal transplantation at Vietnam National Institute of Ophthalmology (VNIO) over a period of 12y (2002-2013).
METHODS: Records of patients who had undergone corneal transplantation at VNIO from January 1, 2002 to January 1, 2014 were reviewed to determine the indication for and type of corneal transplant performed. Patient age, gender, indication for corneal transplantation and surgical technique were recorded and analyzed.
RESULTS: Corneal transplantation were underwent in 1390 eyes of 1278 patients with a mean age of 44.9±18.1y during the period under review. The most common indication was infectious corneal ulcer (n=670; 48.2%), followed by corneal scar (n=333, 24.0%), corneal dystrophy (n=138, 9.9%) and failed graft (n=112, 8.1%). Nearly all procedures performed were penetrating keratoplasty (n=1300, 93.5%), with a few lamellar keratoplasty procedures performed: lamellar keratoplasty (n=52, 3.7%), Descemet’s stripping automated endothelial keratoplasty (n=27, 1.9%) and deep anterior lamellar keratoplasty (n=11, 0.8%).
CONCLUSION: While the most common indication for keratoplasty was infectious keratitis, nearly all indications for corneal transplantation were managed with penetrating keratoplasty. However, lamellar keratoplasty techniques, including deep anterior lamellar keratoplasty and Descemet’s stripping automated endothelial keratoplasty, are being performed with increasing frequency for isolated stromal and endothelial disorders, respectively.]]></description>
<pubDate>2016/3/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Pham Ngoc Dong,Truong Nhu Han,Anthony J. Aldave and Hoang Thi Minh Chau]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Pham Ngoc Dong,Truong Nhu Han,Anthony J. Aldave and Hoang Thi Minh Chau</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160309]]></guid><cfi:id>966</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Bacterial spectrum and resistance patterns in corneal infections at a Tertiary Eye Care Center in South China]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160310]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the spectrum and antibiotic susceptibility of bacteria isolated from patients with suspected corneal infections in Zhongshan Ophthalmic Center in South China over the past four years retrospectively.
METHODS: Totally 1943 corneal scrapes from patients with corneal infections from 2010 to 2013 were cultured and processed using standard microbiological procedures to identify bacterial isolates. Simultaneously, the bacterial isolates were tested for antibiotic susceptibility to 8 antibiotics (ceftazidime, cefuroxim, cefazolin, levofloxacin, ofloxacin, neomycin, tobramycin, chloramphenicol) using the Kirby-Bauer disc diffusion technique.
RESULTS: Of the total 1943 scrapes, 397 (20.43%) were culture-positive, of which 294 (74.06%) were gram-positive (GP) and 103 (25.94%) were gram-negative (GN) bacteria. Of the GP organisms, the most prevalent genera were Staphylococcus spp. (56.17%, n=223), Kocuria spp. (5.29%, n=21) and Micrococcus spp. (1.26%, n=5). On the other hand, the most prevalent genera were Pseudomonas spp. (12.85%, n=51), Burkholderia spp. (2.02%, n=8) and Acinetobacter spp. (1.51%, n=6) for the GN organisms. Among five antibiotics that have eye drop products, the resistant to neomycin of GP (7.82%, 95% CI: 4.72%-10.92%) and GN isolates (9.71%, 95% CI: 4.01%-15.41%) was lowest, while the resistant to chloramphenicol was highest (GP: 34.35%, 95% CI: 28.92%-39.78%; GN: 60.19%, 95% CI: 50.74%-69.64%).
CONCLUSION: Staphylococcus spp. was the most common bacterial pathogens isolated from patients with corneal infections in this setting. High percentages of GP and GN bacteria were mostly susceptible to neomycin and highly resistant to chloramphenicol.]]></description>
<pubDate>2016/3/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Nan Wang,Qiang Huang,Yi-Wei Tan,Li-Ping Lin and Kai-Li Wu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Nan Wang,Qiang Huang,Yi-Wei Tan,Li-Ping Lin and Kai-Li Wu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160310]]></guid><cfi:id>965</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Descemet-membrane endothelial keratoplasty in patients with retinal comorbidity-a prospective cohort study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160311]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate indications, surgical challenges, and outcome of Descemet-membrane endothelial keratoplasty (DMEK) in patients with retinal comorbidities (RC).
METHODS: In a prospective cohort study, 8 eyes of 8 DMEK-patients with known RC were compared to 38 eyes of 38 DMEK-patients without RC. The duration of surgery, the degree of difficulty graded by the surgeon, and the complications through DMEK-surgery were analyzed for each patient. The best-corrected visual acuity (BCVA), the endothelial cell count, the intraocular pressure, and the subjective satisfaction was evaluated after a 6-month follow-up. Data were compared applying the non-parametric Wilcoxon-, Chi-square- and Fisher&acute;s-exact-test with P≤0. 05 as level of significance.
RESULTS: RC-patients had dry age-related macular degeneration (n=4) or history of pars-plana vitrectomy (n=4). The main indication for DMEK was pain due to bullous keratopathy for the RC-patients (n=7, 88%) and visual impairment due to Fuchs endothelial keratoplasty for the non-RC-patients (n=33, 87%). The BCVA increased for both groups (P=0.01, P<0.001) and all corneas cleared. For the RC-patients, the subjective satisfaction improved significantly (P=0.02). Oil-filling and missing support of the vitreous body complicated surgery in vitrectomized eyes.
CONCLUSION: DMEK is a favorable technique to treat endothelial disorders even if patients suffer from a retinal comorbidity. By enhancing the corneal clarity, it enables retinal examination or intraocular surgery and increases the patients&acute; satisfaction. However, in vitrectomized or silicone-oil filled eyes, the duration of surgery and degree of complexity are increased. An experienced surgeon should perform DMEK in these patients. Clinical trial registration number: DRKS00007566.]]></description>
<pubDate>2016/3/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Kristina Spaniol, Christoph Holtmann, Jan-Hendrik Schwinde, Sophia Deffaa, Rainer Guthoff and Gerd Geerling]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Kristina Spaniol, Christoph Holtmann, Jan-Hendrik Schwinde, Sophia Deffaa, Rainer Guthoff and Gerd Geerling</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160311]]></guid><cfi:id>964</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of Diaton transpalpebral tonometer with applanation tonometry in keratoconus]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160312]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the added value of using a Diaton transpalpebral tonometer (DT) to measure IOP in keratoconus. Most type of tonometers use corneal applanation or biomechanical resistance to measure intraocular pressure (IOP); however, these factors can be altered by keratoconus. Specifically, we examined whether DT can detect false-negative low Goldmann applanation tonometry (AT) measurements.
METHODS: Patients with keratoconus were recruited from our tertiary academic treatment center. Measurements included AT and DT (in random order) and Scheimpflug imaging. An age- and gender-matched group of control subjects with no history of corneal disease or glaucoma was also recruited.
RESULTS: In total, 130 eyes from 66 participants were assessed. In the keratoconus group, mean AT was 11.0 ± 2.6, mean DT 11.2±5.5 (P=0.729), and the two measures were correlated significantly (P=0.006, R=0.323). However, a Bland-Altman plot revealed a wide distribution and poor agreement between both measurements. Previous corneal crosslinking, corneal pachymetry, and Krumeich classification had no effect on measured IOP.
CONCLUSION: Measurements obtained using a Diaton tonometer are not affected by corneal biomechanics; however, its poor agreement with Goldmann AT values calls into question the added value of using a Diaton tonometer to measure IOP in keratoconus.]]></description>
<pubDate>2016/3/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Robert PL Wisse,Natalie Peeters,Saskia M Imhof and Allegonda van der Lelij]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Robert PL Wisse,Natalie Peeters,Saskia M Imhof and Allegonda van der Lelij</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160312]]></guid><cfi:id>963</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A comparable study of clinical and optical outcomes after 1.8, 2.0 mm microcoaxial and 3.0 mm coaxial cataract surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160313]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the clinical and optical outcomes after clear corneal incision cataract surgery (CICS) with three different incision sizes (1.8, 2.0 and 3.0 mm).
METHODS: Eyes of 150 patients with age-related cataract scheduled for coaxial cataract surgery were randomized to three groups: 1.8, 2.0, or 3.0 mm CICS. Intraoperative data and postoperative outcomes including surgically induced astigmatism (SIA), the corneal incision thickness, wavefront aberrations and modulation transfer function (MTF) of cornea were obtained.
RESULTS: There were no significant differences among the three groups in demographic characteristics and intraoperative outcome. The 1.8 and 2.0 mm microincisions showed more satisfactory clinical outcomes than the 3.0 mm incision. The 1.8 mm incision showed significantly less SIA than the 2.0 mm incision until postoperative 1mo (P<0.05), but the difference was only 0.14-0.18 D. Combined with less increased incision thickness only at postoperative 1d (P=0.013), the 1.8 mm incision presented better uncorrected distance visual acuity (UCDVA) than the 2.0 mm incision only at 1d postoperatively (P=0.008). For higher-order aberrations and other Zernike coefficients, there were no significant differences between the 1.8 mm group and 2.0 mm group (P>0.05).
CONCLUSION: Converting from 3.0 mm CICS to 1.8 or 2.0 mm CICS result in better clinical and optical outcomes. However, when incision is 1.8 mm, the benefits from further reduction in size compared with 2.0 mm are limited. The necessity to reduce the incision size is to be deliberated.]]></description>
<pubDate>2016/3/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yi-Bo Yu,Ya-Nan Zhu,Wei Wang,Yi-Dong Zhang,Yin-Hui Yu and Ke Yao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yi-Bo Yu,Ya-Nan Zhu,Wei Wang,Yi-Dong Zhang,Yin-Hui Yu and Ke Yao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160313]]></guid><cfi:id>962</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Selective laser trabeculoplasty in patients with pseudoexfoliative glaucoma vs primary open angle glaucoma: a one-year comparative study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160314]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the efficacy of single-session 360-degree selective laser trabeculoplasty (SLT) for reduction of intraocular pressure (IOP) in patients with pseudoexfoliative glaucoma (PXFG) and primary open angle glaucoma (POAG).
METHODS: This is a single-center, prospective, nonrandomized comparative study. Patients older than 18 years of age with uncontrolled PXFG or POAG eyes requiring additional therapy while on maximally tolerated IOP-lowering medications were included. The primary outcome measure changed in IOP from baseline. Success was defined as IOP reduction ≥20% from baseline without any additional IOP-lowering medication. All patients were examined at 1d, 1wk, 1, 3, 6, 9, 12mo after SLT.
RESULTS:  Nineteen patients (20 eyes) with PXFG and 27 patients (28 eyes) with POAG were included in the study. In the visual fields mean deviation was -2.88 (±1.67) in the POAG and -3.1 (±1.69) in the PXFG groups (P=0.3). The mean (±SD) IOP was 22.9 (±3.7) mm Hg in the POAG group and 25.7 (±4.4)?mm Hg in the PXFG group at baseline and decreased to 18.4 (±3.2) and 18.0 (±3.9) mm Hg in the POAG group (P<0.001 and P=0.02), and to 17.9 (±4.0) and 21.0 (±6.6) mm Hg in the PXFG group (P<0.001 and P=0.47) at 6 and 12mo, respectively. The number of medications was 2.6 (±0.8) in the POAG group and 2.5 (±0.8) in the PXFG group at baseline, and did not change at all follow-up visits in both groups (P=0.16 in POAG and 0.57 in PXFG). Based on Kaplan-Meier survival analysis, the success rate was 75% in the POAG group compared to 94.1% in the PXFG group (P=0.08; log rank test) at 6mo, and 29.1% and 25.0% at 12mo, respectively (P=0.9; log rank).
CONCLUSION: The 360-degree SLT is an effective and well-tolerated therapeutic modality in patients with POAG and PXFG by reducing IOP without any change in number of medications. The response was more pronounced early in the postoperative period in patients with PXFG whereas there was no statistically significant difference at 12-month follow-up.]]></description>
<pubDate>2016/3/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Arezoo Miraftabi,Naveed Nilforushan,Nariman Nassiri and Kouros Nouri-Mahdavi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Arezoo Miraftabi,Naveed Nilforushan,Nariman Nassiri and Kouros Nouri-Mahdavi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160314]]></guid><cfi:id>961</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Elevated urine formaldehyde in elderly patients with primary open angle glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160315]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the risk factor of primary open angle glaucoma (POAG), which is the leading cause of irreversible blindness worldwide. An abnormally high level of endogenous formaldehyde (FA) has recently been found correlated with cell death and neurodegenerative disease, raising the possibility of a putative correlation of abnormal endogenous FA with POAG.
METHODS: Thirty-four elderly patients with POAG and sixteen healthy controls were enrolled. Glaucomatous visual defects were present at both the functional (visual field) and structural [retinal nerve fiber layer (RNFL) thickness] levels. Morning urine samples were obtained and were analyzed by high-performance liquid chromatography (HPLC) to detect the endogenous FA level in a double blind manner.
RESULTS: Patients with POAG (P<0.05) had significantly higher urine FA levels. The urine FA level of patients with severe visual field defects [mean deviation (MD)≥12 dB] was significantly (P<0.001) greater than that of patients with mild to moderate defects (MD<12 dB). By optical coherence tomography (OCT), the superior and inferior RNFL thickness of POAG group was significantly (P<0.001) thinner than in controls. Furthermore, the superior and inferior thinning of the RNFL was correlated with the elevation of urine FA concentration.
CONCLUSION: Endogenous FA level is positively correlated with the neuronal defects of POAG.]]></description>
<pubDate>2016/3/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ying Cui,Tao Su,Shao-Dan Zhang,Ping Huang,Ying-Ge He,Ying Liu,Chun Zhang,Robert Ritch and Rong-Qiao He]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ying Cui,Tao Su,Shao-Dan Zhang,Ping Huang,Ying-Ge He,Ying Liu,Chun Zhang,Robert Ritch and Rong-Qiao He</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160315]]></guid><cfi:id>960</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of ultrasound biomicroscopy and spectral-domain anterior segment optical coherence tomography in evaluation of anterior segment after laser peripheral iridotomy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160316]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To quantitatively assess narrow anterior chamber angle using spectral-domain anterior segment optical coherence tomography (SD-AS-OCT) and ultrasound biomicroscopy (UBM), and to evaluate the correlations and consistency between SD-AS-OCT and UBM.METHODS: Fifty-five eyes from 40 patients were examined. Patients were diagnosed with primary angle-closure glaucoma (PACG) remission (11 eyes from 8 patients), primary angle closure (PAC, 20 eyes from 20 patients) and PAC suspect (24 eyes from 12 patients). Each eye was examined by SD-AS-OCT and UBM after laser peripheral iridotomy (LPI). The measurements of SD-AS-OCT were angle open distance (AOD), anterior chamber angle (ACA), trabecular iris angle (TIA), and trabecular iris space area (TISA). UBM measurements were AOD and TIA. Correlations of AOD500 and TIA500 between UBM and AS-OCT were assessed. All parameters were analysed by SPSS 16.0 and MedCalc.RESULTS: ACA, TIA and AOD measured by SD-AS-OCT reached a maximum at the temporal quadrant and minimum at the nasal quadrant. TISA reached the maximum at the inferior and minimum at the superior quadrant. Group parameters of AOD500 and AOD750 showed a linear positive correlation, and AOD750 had less variability. UBM outcomes of AOD500 and TIA500 were significantly smaller than those of SD-AS-OCT. The results of the two techniques were correlated at the superior, nasal and inferior quadrants.CONCLUSION: Both UBM and SD-AS-OCT are efficient tools for follow-up during the course of PACG. We recommended using parameters at 750 µm anterior to the sclera spur for the screening and follow-up of PACG and PAC. The two methods might be alternatives to each other.]]></description>
<pubDate>2016/3/11 9:55:50</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xiao-Yun Ma, Dan Zhu, Jun Zou, Wen-Jie Zhang and Yi-Lin Cao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiao-Yun Ma, Dan Zhu, Jun Zou, Wen-Jie Zhang and Yi-Lin Cao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160316]]></guid><cfi:id>959</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Bevacizumab for neovascular age-related macular degeneration in Chinese patients in a clinical setting]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160317]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the outcome of non-investigational treatment with intravitreal bevacizumab (IVB) in neovascular age-related macular degeneration (AMD) patients.
METHODS: Retrospective chart review of 81 eyes with neovascular AMD followed-up for at least 12mo and received 3-monthly loading IVB injections. Re-treat was based upon the individual clinician’s judgment. Best-corrected visual acuity (BCVA) and optical coherence tomography measurements of central foveal thickness outcomes were evaluated at 12, 24mo.
RESULTS: Eighty-one eyes (of 75 patients) completed 12mo of follow-up and 44 eyes (of 41 patients) completed 24mo of follow-up. The mean baseline logMAR BCVA significantly improved from 0.94±0.69 to 0.85±0.68 at 12mo (P<0.001) and from 0.91±0.65 to 0.85±0.60 (P=0.004) at 24mo. The proportion of eyes that lost <15 logMAR letters at 12mo was 90.1% and at 24mo was 81.8%. IVB was effective in improving visual acuity in both treatment na&iuml;ve and previous photodynamic therapy (PDT)-treated subgroups. Treatment naive patients required significantly fewer injections than patients with prior PDT. Multiple regression analysis identified that poorer baseline visual acuity was associated with greater improvement in visual acuity (P=0.015).
CONCLUSION: Fewer injections in clinical practice may result in suboptimal visual outcomes compared with clinical trials of IVB in neovascular AMD patients. Poor baseline visual acuity and prior PDT treatment may also improve vision after IVB. The safety and durability of effect was maintained at 24mo.]]></description>
<pubDate>2016/3/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Danny Siu-Chun Ng,Alvin Kwan-Ho Kwok,Justin Man-Kit Tong,Clement Wai-Nang Chan and Walton Wai-Tat Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Danny Siu-Chun Ng,Alvin Kwan-Ho Kwok,Justin Man-Kit Tong,Clement Wai-Nang Chan and Walton Wai-Tat Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160317]]></guid><cfi:id>958</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of anti-vascular endothelial growth factors, laser treatments and a combination of the both for treatment of central retinal vein occlusion]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160318]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare changes in visual acuity and macular edema in patients with central retinal vein occlusion (CRVO) treated with intravitreal injections of bevacizumab, macular grid photocoagulation combined with pan retinal photocoagulation (PRP), or both (bevacizumab+grid+PRP).
METHODS: Our study is a retrospective cohort clinical study that examined patients that suffered from ischemic CRVO with macular edema. Study inclusion criteria were ischemic CRVO with macula edema and the availability of complete medical records for at least 12mo after treatment. Excluded were patients with diabetes or any other retinal disease. We reviewed the medical records of patients treated in one ophthalmology department-comparing changes in visual acuity and macular edema in patients treated with intravitreal injections of bevacizumab vs those that were treated with macular grid photocoagulation and PRP or both. The main outcome measures were the differences in best corrected visual acuity (BCVA) and in macular thickness, as assessed by optical coherence tomography, between the enrollment and the final follow up visits.
RESULTS: Sixty-five patients met inclusion criteria. There were no statistically significant differences among the three groups in the mean changes in macular thickness as measured by ocular coherence tomography (131.5±41.2, 108.6±29.2, and 121.1±121.1, P=0.110), or in visual acuity (0.128±0.077, 0.088±0.057, and 0.095±0.065), for intravitreal injections, macular grid photocoagulation+PRP and a combination of the treatments, respectively, P=0.111. The proportions of patients with macular edema after treatment were: 26.1%, 28.6%, and 14.3%, respectively, P=0.499.
CONCLUSION: Similar benefit was observed for intravitreal injections, laser photocoagulation, or a combined regimen in the treatment of CRVO. A non-statistically significant trend for reduction in macular edema was observed following combined treatment.]]></description>
<pubDate>2016/3/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yoav Y. Pikkel,Adi Sharabi-Nov,Itzchak Beiran and Joseph Pikkel]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yoav Y. Pikkel,Adi Sharabi-Nov,Itzchak Beiran and Joseph Pikkel</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160318]]></guid><cfi:id>957</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in children with obesity]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160319]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate retinal nerve fiber layer (RNFL) thickness analysis of peripapillary optic nerve head (PONH) and macula as well as ganglion cell-inner plexiform layer (GCIPL) thickness in obese children.
METHODS: Eighty-five children with obesity and 30 controls were included in the study. The thicknesses of the PONH and macula of each subject’s right eye were measured by high-resolution spectral-domain optic coherence tomography (OCT).
RESULTS: The RNFL thicknesses of central macular and PONH were similar between the groups (all P>0.05). The GCIPL thickness was also similar between the groups. However, the RNFL thickness of temporal outer macula were 261.7±13.7 and 268.9±14.3 &micro;m for the obesity and the control group, respectively (P=0.034).
CONCLUSION: Obesity may cause a reduction in temporal outer macular RNFL thickness.]]></description>
<pubDate>2016/3/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Selim Demir, Samet &Ouml;zer, Sait Alim, Alper Güne&#351;, Hüseyin Ortak and Resul Y&#305;lmaz]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Selim Demir, Samet &Ouml;zer, Sait Alim, Alper Güne&#351;, Hüseyin Ortak and Resul Y&#305;lmaz</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160319]]></guid><cfi:id>956</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Corneal biomechanical changes and intraocular pressure in patients with thyroid orbitopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160320]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the relevance of the objective parameters addressing the altered biomechanical properties of cornea for glaucoma monitoring in patients with mild or moderate thyroid associated orbitopathy (TAO), and in healthy individuals.
METHODS: Twenty-five patients with TAO (group 1) and 25 healthy adults (group 2) were included to the study. Both groups were of a similar age and the ratio women:man. For each patient, the following parameters of both eyes were measured with ocular response analyzer (ORA): corneal hysteresis (CH), corneal resistance factor (CRF), Goldmann correlated intraocular pressure (IOPg) and corneal compensated intraocular pressure (IOPcc). In both groups participating in our study, all measurements were performed within minutes to reduce the diurnal effects.
RESULTS: The mean age in group 1 was 56±11y and 76% were women, 24% were men. The mean age in group 2 was 64±11y and 68% were women, 32% were men. CH correlated negatively with IOPg in group 1 (r2=0.10, P<0.05). IOPg strongly correlated with IOPcc in both groups (group 1: r2=0.79, P<0.0001; group 2: r2=0.85, P<0.0001). There was positive correlation between CRF and IOPg in group 1 (r2=0.12, P<0.05) and in group 2 (r2=0.31, P<0.0001). Statistical analysis revealed no significant correlation between CRF and IOPcc in group 1 (r2=0.009, P>0.05) and also no significant correlation in group 2 (r2=0.04, P>0.05). CRF mean value in group 2 (11.51±1.72 mm Hg) was higher than in group 1 (10.85±1.45 mm Hg) (P<0.05). IOPg strongly correlated with IOPcc in both groups (group 1: r2=0.79, P<0.0001; group 2: r2=0.85, P<0.0001). There was also strong correlation between CRF and CH in both populations: group 1: (r2=0.58, P<0.0001), group 2: (r2=0.41, P<0.0001).
CONCLUSION: Biomechanical parameters of cornea, as quantified by CH and CRF, and measured together with IOPcc, precisely reveal glaucoma staging in TAO and thus are reliable for diagnosing and follow-up in clinical practice.]]></description>
<pubDate>2016/3/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Zofia Pniakowska,Anna Klysik,Roman Gos and Piotr Jurowski]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zofia Pniakowska,Anna Klysik,Roman Gos and Piotr Jurowski</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160320]]></guid><cfi:id>955</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Relationship between dacryoadenitis subtype of idiopathic orbital inflammatory pseudotumor and paranasal sinusitis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160321]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the clinical features of the dacryoadenitis subtype of idiopathic orbital inflammatory pseudotumor and its relationship with paranasal sinusitis.
METHODS: A retrospective analysis of 46 patients who received surgical treatment at the Department of Ophthalmology, Beijing Tongren Hospital, Capital Medical University for the dacryoadenitis subtype of idiopathic orbital inflammatory pseudotumor from October 2010 to December 2012. Each patient underwent magnetic resonance imaging (MRI) of the orbits and the 4 paranasal sinuses. Disease status and the level of serum immunoglobulin G4 (IgG4) was measured before and 6mo after surgery.
RESULTS: The initial clinical feature of the idiopathic dacryoadenitis type of orbital inflammatory pseudotumor was redness or swelling of the eyelids. Masses were palpated in the area of the lacrimal gland in some patients. Of the 46 patients, 16 also suffered from sinusitis (34.8%), with 14 cases of ethmoid sinusitis, 8 cases of maxillary sinusitis, 9 cases of sphenoid sinusitis, and 8 cases of frontal sinusitis. Of the 16 patients with sinusitis, 4 patients had a medical history of rhinitis (range: 10mo to 15y previously), 10 patients had occasional nasal congestion, and 2 patients had no nasal congestion. Thirteen of the 46 patients had elevated serum IgG4 levels. Nine of these 13 patients had MRI signs of sinusitis. All patients (n=46) received oral glucocorticoid treatment for approximately 3mo after surgery. No sign of recurrence was found in the orbital MRI 6mo after surgery. Of the 16 patients with sinusitis, 9 cases of elevated serum IgG4 levels improved after treatment with decreased serum IgG4 level and 7 cases of normal serum IgG4 levels remained unchanged.
CONCLUSION: Some patients with the dacryoadenitis subtype of idiopathic orbital inflammatory pseudotumor may also suffer from paranasal sinusitis. The incidence of paranasal sinusitis was much higher in patients with IgG4-elevated dacryoadenitis subtype orbital inflammatory pseudotumor than in those with normal IgG4 levels. Dacryoadenitis subtype orbital inflammatory pseudotumor and paranasal sinusitis may both the clinical manifestations of IgG4-related disease involved in different locations.]]></description>
<pubDate>2016/3/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jing Li,Xin Ge and Jian-Min Ma]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jing Li,Xin Ge and Jian-Min Ma</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160321]]></guid><cfi:id>954</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of visual acuity of the patients on the first day after sub-Bowman keratomileusis or laser in situ keratomileusis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160322]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare recovery of the visual acuity in patients one day after sub-Bowman keratomileusis (SBK) or laser in situ keratomileusis (LASIK).
METHODS: Data from 5923 eyes in 2968 patients that received LASIK (2755 eyes) or SBK (3168 eyes) were retrospectively analyzed. The eyes were divided into 4 groups according to preoperative spherical equivalent: between -12.00 to -9.00 D, extremely high myopia (n=396, including 192 and 204 in SBK and LASIK groups, respectively); -9.00 to -6.00 D, high myopia (n=1822, including 991 and 831 in SBK and LASIK groups, respectively), -6.00 to -3.00 D, moderate myopia (n=3071, including 1658 and 1413 in SBK and LASIK groups, respectively), and -3.00 to 0.00 D, low myopia (n=634, including 327 and 307 in SBK and LASIK groups, respectively). Uncorrected logMAR visual acuity values of patients were assessed under standard natural light. Analysis of variance was used for comparisons among different groups.
RESULTS: Uncorrected visual acuity values were 0.0115±0.1051 and 0.0466±0.1477 at day 1 after operation for patients receiving SBK and LASIK, respectively (P<0.01); visual acuity values of 0.1854±0.1842, 0.0615±0.1326, -0.0033±0.0978, and -0.0164±0.0972 were obtained for patients in the extremely high, high, moderate, and low myopia groups, respectively (P<0.01). In addition, significant differences in visual acuity at day 1 after operation were found between patients receiving SBK and LASIK in each myopia subgroup.
CONCLUSION: Compared with LASIK, SBK is safer and more effective, with faster recovery. Therefore, SBK is more likely to be accepted by patients than LASIK for better uncorrected visual acuity the day following operation.]]></description>
<pubDate>2016/3/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Wei Zhao,Ting Wu,Ze-Hong Dong,Jie Feng,Yu-Feng Ren and Yu-Sheng Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Wei Zhao,Ting Wu,Ze-Hong Dong,Jie Feng,Yu-Feng Ren and Yu-Sheng Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160322]]></guid><cfi:id>953</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Argon laser photocoagulation versus intrastromal voriconazole injection in treatment of mycotic keratitis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160207]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare argon laser photocoagulation and intrastromal injection of voriconazole as adjunctive treatment modalities in cases of resistant mycotic corneal ulcers.
METHODS: Two groups each of them included 20 cases of resistant mycotic corneal ulcers. Both groups treated with local and systemic specific antimicrobial drugs guided with culture and sensitivity results. In one group argon laser photocoagulation was used as an adjunctive therapy to the specific antifungal drugs and in the other group, intrastromal injection of voriconazole was done besides the specific antifungal drugs. The 40 cases included in the study were proven according to culture and sensitivity to be 28 cases with pure fungal results and 12 cases with mixed (fungal and bacterial). In argon laser group, argon laser irradiation of the corneal ulcer was performed using argon laser 532 nm wavelength (Carl Zeiss LSL 532s AG; Meditec, Inc.) after fluorescein staining. In the other group, voriconazole solution (500 μg/mL) was prepared and injected in the corneal stroma. All cases were followed up for 3mo after healing was achieved.
RESULTS: Complete healing of the epithelial defect and resolution of stromal infiltration with no adverse effects were achieved in argon laser group in duration ranged from 2-4wk in 90% of cases. In voriconazole group 4 cases needed amniotic membrane graft due to thinning and 16 cases healed in duration ranged from 2-6wk (80% of cases).
CONCLUSION: Argon laser photocoagulation is superior to intrastromal voriconazole injection in treatment of resistant fungal corneal ulcers.]]></description>
<pubDate>2016/2/4 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mohammad M. Khater,Mohammad S. El-Shorbagy and Adel A. Selima]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mohammad M. Khater,Mohammad S. El-Shorbagy and Adel A. Selima</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160207]]></guid><cfi:id>952</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Corneal biomechanical properties changes after coaxial 2.2-mm microincision and standard 3.0-mm phacoemulsification]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160208]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the changes in corneal biomechanics measured by ocular response analyzer (ORA) after 2.2-mm microincision cataract surgery and 3.0-mm standard coaxial phacoemulsification.
METHODS: The prospective nonrandomized study comprised eyes with cataract that had 2.2-mm coaxial microincision or 3.0-mm standard incision phacoemulsification. The corneal hysteresis (CH), corneal resistance factor (CRF), corneal-compensated intraocular pressure (IOPcc) and Goldmann-correlated intraocular pressure (IOPg) were measured by ORA preoperatively and at 1d, 1-, 2-, 3- and 4-week postoperatively. Results were analyzed and compared between groups.
RESULTS: In both groups, CH decreased in the immediate postoperative period (P<0.05), returned to the preoperative level at one week (P=0.249) in the 2.2-mm group, and at two weeks in the 3.0-mm group (P=0.264); there was no significant change in CRF values. In 2.2-mm group, mean IOPcc and IOPg increased at 1d postoperatively (both P<0.05), and returned to preoperative level at one week (P=0.491 and P=0.923, respectively). In 3.0-mm group, mean IOPcc and IOPg increased at 1d and 1wk postoperatively (P=0.005 and P=0.029, respectively), and returned to preoperative level at 2wk (P=0.347 and P=0.887, respectively).
CONCLUSION: Significant differences between preoperative and postoperative corneal biomechanical values were found for CH, IOPcc and IOPg. But the recovery time courses were different between the two groups. The 2.2-mm coaxial microincision cataract surgery group seemed recovery faster compared to the 3.0-mm standard coaxial phacoemulsification group.]]></description>
<pubDate>2016/2/4 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Zhe Zhang,Hua Yu,Hui Dong,Li Wang,Ya-Ding Jia and Su-Hua Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zhe Zhang,Hua Yu,Hui Dong,Li Wang,Ya-Ding Jia and Su-Hua Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160208]]></guid><cfi:id>951</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Ocular biomechanical measurements on post-keratoplasty corneas using a Scheimpflug-based noncontact device]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160209]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyse ocular biomechanical properties, central corneal thickness (CCT) and intraocular pressure (IOP) in post-keratoplasty eyes, as compared to normal subjects, with a new Scheimpflug-based technology. Moreover, biomechanical data were correlated with the size and age of the donor and recipient corneas.
METHODS: Measurements were conducted on 46 eyes of 46 healthy patients without any corneal pathology (age: 53.83±20.8y) and 30 eyes of 28 patients after penetrating keratoplasty (age: 49.43±21.34y). Ten biomechanical parameters, the CCT and IOP were recorded by corneal visualization scheimpflug technology (CorVis ST) using high-speed Scheimpflug imaging. Keratometry values were also recorded using Pentacam HR system. Scheimpflug measurements were performed after 43.41±40.17mo (range: 11-128mo) after the keratoplasty and after 7.64±2.34mo (range: 5-14mo) of suture removal.
RESULTS: Regarding the device-specific biomechanical parameters, the highest concavity time and radius values showed a significant decrease between these two groups (P=0.01 and P<0.001). None of other biomechanical parameters disclosed a significant difference. The CCT showed a significant difference between post-keratoplasty eyes as compared to normal subjects (P=0.003) using the CorVis ST device. The IOP was within the normal range in both groups (P=0.84). There were no significant relationships between the keratometric data, the size of the donor and recipient, age of the donor and recipient and biomechanical properties obtained by CorVis ST.
CONCLUSION: The ocular biomechanics remain stable after penetrating keratoplasty according to the CorVis ST measurements. Only two from the ten device-specific parameters have importance in the follow-up period after penetrating keratoplasty.]]></description>
<pubDate>2016/2/4 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Laszlo Modis Jr.,Ziad Hassan,Eszter Szalai,Zsuzsanna Flaskó,Andras Berta and Gabor Nemeth]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Laszlo Modis Jr.,Ziad Hassan,Eszter Szalai,Zsuzsanna Flaskó,Andras Berta and Gabor Nemeth</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160209]]></guid><cfi:id>950</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of 2% fluorescein on Scheimpflug central corneal thickness measurements]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160210]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess central corneal thickness (CCT) changes measured with Scheimpflug device following instillation of 2% fluorescein in normal subjects.
METHODS: This was a prospective randomized study of 60 hospital volunteers. After baseline CCT measurements of both eyes of 40 subjects were obtained using Scheimpflug system, a drop of preservative-free 2% fluorescein, was instilled in one eye and in other eye, one drop of normal saline (control). Measurements were repeated after 1, 2, 5, 10, 20, 30, 40, 50 and 60min (continuous assessment group). Twenty subjects had baseline CCT taken, then fluorescein was instilled in one eye and measurements were taken at 1min. Ten eyes had saline rinse after 1min and 10 other eyes did not, measurements were repeated at 2min (eye rinse group).
RESULTS: The mean baseline CCT for continuous assessment group was 546.2 ±32.1 μm (range, 489.0-606.0), control eyes was 546.6±30.7 μm (range, 489.0-602.0). At 1min after fluorescein instillation, CCT significantly increased by 37.0±34.0 μm (P<0.001), then decreased gradually, reaching baseline at 60min. CCT variations were not significant in control group (P>0.05). For eye rinse group, CCT  mean differences between baseline and 2min were 18.2 μm (95 % CI: -54.7 to 18.3) with rinse  and 26.5 μm (95% CI: -62.9 to 9.9) without rinse; paired sample tests were not significant (P>0.05).
CONCLUSION: The presence of fluorescein increased CCT value to a clinically relevant level of 6.8%. Eye rinse did not significantly reduce the effect at 2min post fluorescein timepoint.]]></description>
<pubDate>2016/2/4 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Stella Briggs and Marwa Bin Moammar]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Stella Briggs and Marwa Bin Moammar</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160210]]></guid><cfi:id>949</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Therapeutic effect analysis on the treatment of congenital glaucoma through modified combined trabeculotomy-trabeculectomy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160211]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the therapeutic effect and the safety of the treatment of congenital glaucoma through modified combined trabeculotomy-trabeculectomy.
METHODS: The clinical data of 27 cases (altogether 42 eyes), which included 7 cases of infants (10 eyes) and 20 cases of teenagers (32 eyes), of congenital glaucoma undertook modified combined trabeculotomy-trabeculectomy were analyzed retrospectively. The parameters evaluated included the post operation visual acuity, the anterior chamber, the filtering bleb, the intraocular pressure, the C/D ratio, visual field, the retinal nerve fiber layer changes and the complications.
RESULTS: The follow-up period was 1 to 29mo, averaging 13.3±7.7mo. Upon the last visit after the operation, functional filtering blebs developed in all the involved eyes. The intraocular pressure was controlled under 21 mm Hg, which was decreased by 60% when compared with that before the operation, without using any medication. There were no significant changes in the post operation visual acuity and the retinal nerve fiber layer thickness before and after the operation in teenager group (P＞0.05), and both the post operation C/D ratio and the visual field mean defect (MD) were reduced compared with those before the operation (P<0.05). There were no severe complications in any of the patients.
CONCLUSION: The modified combined trabeculotomy-trabeculectomy can effectively reduce the intraocular pressure and control the development of glaucoma in cases of congenital glaucoma. It is a safe and effective operative method for the treatment of congenital glaucoma.]]></description>
<pubDate>2016/2/4 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Zhen-Kai Wu,Jing Wu,Qian Tan,Jian Jiang,Wei-Tao Song and Xiao-Bo Xia]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zhen-Kai Wu,Jing Wu,Qian Tan,Jian Jiang,Wei-Tao Song and Xiao-Bo Xia</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160211]]></guid><cfi:id>948</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Oxidant/antioxidant balance in the aqueous humor of patients with glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160212]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate total antioxidant status (TAS), total oxidant status (TOS), and the oxidative stress index (OSI) of the aqueous humor (AH) in patients with glaucoma.
METHODS: The prospective study was composed of a study group (n=31) and a control group (n=31). Fifteen patients in the study group were diagnosed with primary open angle glaucoma (POAG), and 16 patients were diagnosed with pseudoexfoliation glaucoma (PEG). The control group was composed of non-glaucomatous patients with cataracts. AH samples were collected and analyzed for TAS, TOS, and OSI levels.
RESULTS: Mean AH TAS level was significantly higher in patients with glaucoma than that in the control group (P<0.01). Mean TOS and OSI levels tended to increase in patients with glaucoma. No significant differences in TAS, TOS, or OSI levels were observed between patients with POAG and PEG.
CONCLUSION: High levels of TAS were observed in patients with glaucoma, which was likely a response to the increased oxidative stress observed in these patients.]]></description>
<pubDate>2016/2/4 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Esra Ergan,Faruk Ozturk,Emrullah Beyazyildiz,Ufuk Elgin,Emine Sen,Ali Bulent Cankaya and Tugrul Celik]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Esra Ergan,Faruk Ozturk,Emrullah Beyazyildiz,Ufuk Elgin,Emine Sen,Ali Bulent Cankaya and Tugrul Celik</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160212]]></guid><cfi:id>947</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Predicting anatomical results of surgical treatment of idiopathic macular hole]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160213]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the parameters most informative in predicting the anatomical results of surgical treatment of idiopathic full-thickness macular hole (IMH).
METHODS: One hundred and sixty-two consecutive patients (170 eyes) after primary operation for IMH were enrolled. Outcomes were classified as anatomical success when both IMH closure and restoration of the outer retinal structure were achieved. “Prospective” group included 108 patients (115 eyes) followed with optical coherence tomography (OCT) and microperimetry for 1y after surgery. Potential prognostic criteria, except microperimetry data, were tested in “retrospective” group (54 patients, 55 eyes). Prognostic value of each parameter was determined using receiver operating characteristic (ROC) analysis. Combined predictive power of the best prognostic parameters was tested with the use of linear discriminant analysis.
RESULTS: IMH closure was achieved in 106 eyes (92%) in the prospective group and 49 eyes (89%) in the retrospective group. Despite anatomical closure, the outer retinal structure was not restored in two eyes in the first group and in one eye in the second group. Preoperative central subfield retinal thickness demonstrated the best discriminatory capability between eyes with anatomical success and failure: area under the ROC-curve (AUC) 0.938 (95% CI: 0.881-0.995), sensitivity 64% at fixed specificity 95% (cut-off value 300 &micro;m) in the prospective group; sensitivity 57% and specificity 90% in the retrospective group. Other continuous parameters except tractional hole index (AUC: 0.796, 95% CI: 0.591-1.000) had significantly lower AUCs (P<0.05). The best combination of the parameters, established by discriminant analysis in the prospective group, could not confirm its predictive value in the retrospective group.
CONCLUSION: Preoperative central subfield retinal thickness is a strong and probably the best predictor of anatomical results of IMH surgical treatment.]]></description>
<pubDate>2016/2/4 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Alexander A. Shpak,Dmitry O. Shkvorchenko,Ilias Kh. Sharafetdinov and Olga A. Yukhanova]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Alexander A. Shpak,Dmitry O. Shkvorchenko,Ilias Kh. Sharafetdinov and Olga A. Yukhanova</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160213]]></guid><cfi:id>946</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Posterior scleral reinforcement combined with vitrectomy for myopic foveoschisis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160214]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the effects of posterior scleral reinforcement (PSR) combined with vitrectomy for myopic foveoschisis. 
METHODS: Thirty-nine highly myopic eyes of 39 patients with myopic foveoschisis underwent PSR combined with vitrectomy. Best corrected visual acuity (BCVA), refraction error, and the foveal thickness by optical coherence tomography (OCT) were recorded before and after the surgery, and complications were noted.
RESULTS: The follow-up period was 12mo, and the main focus was on the results of the 12-month follow-up visit. The mean preoperative BCVA was 0.96±0.43 logMAR. At the final follow-up visit, the mean BCVA was 0.46±0.28 logMAR, which significantly improved compared with the preoperative one (P=0.003). The BCVA improved in 33 eyes (84.62%), and unchanged in 6 eyes (15.38%). At the end of follow-up, the mean refractive error was -15.13±2.55 D, and the improvement was significantly compared with the preoperative one (-17.53±4.51 D) (P=0.002). Twelve months after surgery, OCT showed complete resolution of the myopic foveoschisis and a reat&not;tachment of the fovea in 37 eyes (94.87%) and partial resolution in the remained two eyes (5.13%). The foveal thickness was obviously reduced at 12-month follow-up visit (196.45±36.35 μm) compared with the preoperative one (389.32±75.56 μm) (P=0.002). There were no serious complications during the 12mo follow-up period. 
CONCLUSION: PSR combined with vitrectomy is a safe and effective procedure for myopic foveoschisis with both visual and anatomic improvement.]]></description>
<pubDate>2016/2/4 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xiu-Juan Li,Xiao-Peng Yang,Qiu-Ming Li,Yu-Ying Wang,Jing Wang,Xiao-Bei Lyu and Heng Jia]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiu-Juan Li,Xiao-Peng Yang,Qiu-Ming Li,Yu-Ying Wang,Jing Wang,Xiao-Bei Lyu and Heng Jia</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160214]]></guid><cfi:id>945</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Screening for retinopathy of prematurity: a report from upper Egypt]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160215]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To detect the incidence of retinopathy of prematurity (ROP) in a tertiary referral neonatal intensive care unit in upper Egypt and to describe the obstacles faced during implementing the screening protocol for the first time.
METHODS: Consecutive infants were enrolled at birth and screened for ROP. We used the UK ROP guideline (May 2008) for infant selection, follow up and treatment. Repeat examinations were performed until retinal vascularisation was complete.
RESULTS: Fifty-two infants were enrolled: 24 males and 28 females. Mean gestational age was 31.3wk (±2.8 SD) and mean birth weight was 1234.6 g (±221.1 SD). Incidence of ROP was 36.5% (stages 1, 2, 3 and 4a were 9.6%, 9.6%, 15.4% and 1.9% respectively), no stages 4b or 5 were found in this series. Six infants (11.5%) died during screening without ROP, 25 infants (48.1%) were discharged from screening with retinal vascularisation reaching zone III, 5 infants (9.6%) were treated with indirect diode with or without additional cryotherapy and 16 infants (30.8%) were lost to follow up. In this series gestational age rather than birth weight was found significantly correlated and predictive (P<0.05) with ROP stages.
CONCLUSION: ROP in a single site in Upper Egypt appears to have comparable incidence to other areas worldwide. The main screening obstacle was missing cases due to the absence of a national ROP screening protocol.]]></description>
<pubDate>2016/2/4 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mahmoud M. Nassar]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mahmoud M. Nassar</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160215]]></guid><cfi:id>944</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Is myopia a protective factor against central serous chorioretinopathy?]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160216]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate if any association exists between central serous chorioretinopathy (CSCR) and the refractive status of the eye.
METHODS: This retrospective, institutional, case control study included 499 patients, wherein 262 patients diagnosed as acute CSCR, were compared with an age and gender matched control group of 237 patients. All patients were evaluated with a detailed systemic and ocular history, objective and subjective refractions for both eyes and complete ocular examination by a retina specialist, at all visits. Optical coherence tomography confirmed the diagnosis of CSCR.
RESULTS: The mean age was found to be 40±7y in the study group (Group 1) compared to 38±10y in the control group (Group 2). Most common refractive status in the study group, was emmetropia seen in 191 patients (72.9%), followed by hypermetropia seen in 47 patients (17.9%) and astigmatism seen in 21 patients (8.0%). Only 3 subjects (1.1%) had myopia, which was less than or equal to 1.0 D, compared to 70 subjects (29.5%) in the control group, suggesting a statistically significant lower incidence of CSCR among the myopic patients (P< 0.0001). With respect to the systemic factors, 26 (9.9%) patients were using systemic steroids in the study group (Group 1) compared to none in the control group (Group 2) suggesting a statistically significant association of CSCR with systemic steroid use (P<0.05). No other significant systemic risk factors were noted.
CONCLUSION: Though CSCR is a multifactorial disease, myopia serves as a protective factor for CSCR. Thus, myopic eyes are less likely to develop CSCR. Since both retinal pigment epithelium (RPE) and choriocapillaris are postulated in the pathogenesis of CSCR, chorio-retinal thinning and atrophy seen in myopic eyes are less likely to cause CSCR.]]></description>
<pubDate>2016/2/4 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[George J. Manayath,Saurabh Arora,Hardik Parikh,Parag K. Shah,Sarvesh Tiwari and Venkatapathy Narendran]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>George J. Manayath,Saurabh Arora,Hardik Parikh,Parag K. Shah,Sarvesh Tiwari and Venkatapathy Narendran</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160216]]></guid><cfi:id>943</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Optical coherence tomography characteristics of responses to intravitreal bevacizumab in idiopathic choroidal neovascularization]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160217]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate factors associated with responses to intravitreal bevacizumab (IVB) in naive idiopathic choroidal neovascularization (iCNV) by high domain optical coherence tomography (OCT).
METHODS: We retrospectively reviewed clinical data of 40 eyes of iCNV patients who received a single or multiple IVB on an as-needed basis (1.25 mg/0.05 mL). One month after the first injection, subretinal fluid (SRF) volume was evaluated and the eyes were divided into 3 groups based on responses to IVB. Good, moderate, and poor responses were defined as 61%-99%, 30%-60%, and <30% resolution of SRF on OCT after IVB in iCNV, respectively. OCT findings were analyzed to find factors associated with difference in response levels. Comparisons were made using Wilcoxon’s matched-pairs signed-rank test, the Mann-Whitney U test for means with continuous data and Fisher’s exact test for categorical data.
RESULTS: The mean number of IVB was 1.28±1.50 and mean follow up time was 3.60±1.20mo. At postoperative 1mo, there were 8 (20%) eyes in good response, 20 (50%) in moderate response and 12 (30%) eyes in poor response group and at last visit there were 28 good responders (70%), 8 (20%) moderate responders and 4 (10%) poor responders. Statistically significant difference was detected between good responders and non good responders in choroidal neovessels thickness (P=0.029), SRF height (P=0.049) and SRF volume (P=0.031) at post treatment 1mo.
CONCLUSION: OCT is a valuable diagnostic tool. Decrease in choroidal neovessels thickness, SRF height and volume predicts favorable response of iCNV to IVB therapy.]]></description>
<pubDate>2016/2/4 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Syed Nasir Ali Shah,Qian-Yan Kang,Xiao-Juan Fan and Yue-Ming Sun]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Syed Nasir Ali Shah,Qian-Yan Kang,Xiao-Juan Fan and Yue-Ming Sun</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160217]]></guid><cfi:id>942</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Role of IgG4 serology in identifying common orbital lymphoproliferative disorders]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160218]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To explore the role of IgG4 serology in identifying common orbital lymphoproliferative disorders. METHODS: Eighty-one patients with orbital lymphoproliferative diseases were treated in the Department of Ocular Oncology, Beijing Tongren Hospital, Capital Medical University between September 2010 and December 2012. Serum IgG4 levels were measured in 46 cases of idiopathic orbital inflammatory pseudotumor (IOIP), 17 benign lymphoepithelial lesion (BLEL), 12 cases of orbital mucosa-associated lymphoid tissue (MALT), and 6 cases of diffuse large B-cell lymphoma (DLBL) using immuno-scatter turbidmetry (ISTM).

RESULTS: The frequency of elevated IgG4 levels in patients with IOIP, BLEL, MALT, and DLBL was 30.43% (14/46), 76.47% (13/17), 8.33% (1/12), and 0.00 (0/6), respectively. Among the patients with elevated serum IgG4 levels, all IgG-IOIP patients were male, and 92.31% of the IgG4-BLEL patients were female (12/13). The mean serum IgG4 level of IgG4-IOIP patients was lower than that of individuals with IgG4-BLEL, but the variation in serum IgG4 levels was larger in IgG4-IOIP than IgG4-BLEL patients. Only one case of IgG4-MALT with elevated serum IgG4 levels had a medical history >10y, which was significantly longer than the MALT patients with normal serum IgG4 levels. There was no significant elevation of serum IgG4 levels in patients with DLBL.
CONCLUSION: Detecting serum IgG4 levels plays an important role in the differential diagnosis of orbital lymphoproliferative diseases.]]></description>
<pubDate>2016/2/4 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jing Li,Jian-Min Ma and Xin Ge]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jing Li,Jian-Min Ma and Xin Ge</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160218]]></guid><cfi:id>941</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Epidemiological aspects of ocular superglue injuries]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160219]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report the frequency, associated risk factors and characteristics of cases referred to Farabi Eye Hospital with ocular superglue injuries.
METHODS: In a descriptive cross-sectional study conducted between December 2012 and February 2013, patients with ocular superglue injuries were evaluated. Age, sex, educational level, location, time, mechanism, type, site and time of eye injury were gathered through interview using a customized questionnaire. All participants had given consent to undergo thorough eye examination.
RESULTS: Over the course of three months, 105 patients with ocular superglue injuries enrolled in the study, including 56(53.3%) men and 49(46.7%) women with the mean age of 24.7±11.6 (range, 2 to 53)y. The right eye, left eye and both eyes were involved in 52%, 42% and 6% of the patients, respectively. Most of injuries had occurred at home (72.4%) and at night (55%). More than half of patients (52.4%) did not take any primary aids following the ocular injury. Patient carelessness (78.1%), childhood curiosity and lack of parental supervision (11.4%), storing superglue in inappropriate places and inadvertently using superglue as eye drops due to poor vision (2.9%), inadequate awareness of superglue applications [used to stick on artificial nails (3.8%), artificial eyelashes (1.9%) and broken tooth (1%)] and being assaulted with glue (1%) were common risk factors.
CONCLUSION: The frequency of ocular superglue injuries in patients referred to Farabi Eye Hospital is relatively high. This finding underlines the importance of public education and awareness about superglue injuries to the eye and taking protective measures and safety strategies in order to prevent these injures.]]></description>
<pubDate>2016/2/4 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Seyed Ali Tabatabaei,Shokoufeh Modanloo,Arezoo Mohammadkhani Ghiyasvand,Abolghasem Pouryani,Mohammad Soleimani,Seyed Mehdi Tabatabaei,Ahmad Reza Pakrah and Hamideh Masarat]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Seyed Ali Tabatabaei,Shokoufeh Modanloo,Arezoo Mohammadkhani Ghiyasvand,Abolghasem Pouryani,Mohammad Soleimani,Seyed Mehdi Tabatabaei,Ahmad Reza Pakrah and Hamideh Masarat</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160219]]></guid><cfi:id>940</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Use of the Crawford tube for symptomatic epiphora without nasolacrimal obstruction]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160220]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the effectiveness of the Crawford tube in treating symptomatic epiphora without nasolacrimal obstruction.
METHODS: A protocol was adopted for the management of symptomatic epiphora without nasolacrimal obstruction. Patients who suffered symptomatic epiphora without nasolacrimal obstruction in both eyes were included in the study. One eye was treated with Crawford tube intubation and the other eye was treated with medication therapy. Degree of watering, patient satisfaction, and symptomatic improvement were carefully evaluated by one of the authors at the end of the follow-up period, after Crawford tube removal, to ascertain functional results.
RESULTS: Thirty-seven adult patients (37 eyes) underwent Crawford tube intubation for functional epiphora. The mean follow-up time after removal of the tube was 14.8±4.8mo. The procedure was an overall success in 28 eyes (75.7%), with symptoms improving significantly. Two eyes (5.4%) were relieved of indoor epiphora, two (5.4%) had minimal epiphora outdoors, but only with wind or cold, and five (13.5%) continued to experience tearing both indoors and outdoors. Thirty of the patients (81%) expressed satisfaction with the procedure.
CONCLUSION: Crawford tube insertion is an effective, safe, simple, and relatively noninvasive treatment strategy for functional lacrimal system obstruction.]]></description>
<pubDate>2016/2/4 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Nyu-Xia Tong,Ying-Ying Zhao and Xiu-Ming Jin]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Nyu-Xia Tong,Ying-Ying Zhao and Xiu-Ming Jin</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160220]]></guid><cfi:id>939</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Multifocal electroretinogram in non-pathological myopic subjects: correlation with optical coherence tomography]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160221]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the changes of retinal function in non-pathological myopic subjects using multifocal electroretinography (mfERG) and to correlate the data with the central macular thickness obtained using optical coherence tomography (OCT).
METHODS: One hundred and thirteen subjects (113 eyes) with age range from 18 to 35y were enrolled in the study. The subjects were divided into four groups according to spherical equivalent (SE) and axial length (AL): emmetropia group (EG, n=31; SE: +0.75 to -0.50 D; AL: 22 to 24 mm), low and medium myopia group (LMMG, n=26; SE: ＞-0.50 to -6.00 D; AL: ＞24 to 26 mm), high myopia group (HMG, n=34; SE: ＞-6.00 to -10.00 D; AL: ＞26 to 28 mm) and super high myopia group (SHMG, n=22; SE: ＞-10.00 D; AL:＞28 mm). The P1 amplitude density, P1 amplitude, and P1 implicit time of the first-order kernel mfERG responses were obtained and grouped into five rings. The central subfield macular thickness (CST) was obtained using macular cube 512×218 scan of Cirrus HD-OCT.
RESULTS:  With the increasing of eccentricity, the first positive peak (P1) amplitude density (P=0.0000, 0.0001, 0.0021 in ring 1-3 respectively) and P1 amplitude (all P=0.0000 in ring 1-5) of each group decreased. With the increasing of myopia, P1 implicit time gradually extended (all P=0.0000 in ring 1-3). The average CST in four diagnostic groups was 241.56±12.72 μm, 244.56±12.19 μm, 254.33±11.61 μm, 261.75±11.83 μm respectively. With the increasing of myopia, CST increased (P<0.001). There was negative relationship between CST and P1 amplitude, P1 amplitude density (r=-0.402, P<0.001; r=-0.261, P=0.003). There was positive relationship between CST and P1 implicit time (r=0.34, P<0.001).
CONCLUSION: With the increasing of myopia, P1 amplitude density and P1 amplitude of the first-order reaction gradually reduced. This showed potential decline in retinal function in myopia. To some extent it may reflect the functional disorder or depression of the visual cells. The exact mechanism needs further study.]]></description>
<pubDate>2016/2/4 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ai-Ping Song,Tao Yu,Jian-Rong Wang,Wei Liu,Yan Sun and Su-Xiang Ma]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ai-Ping Song,Tao Yu,Jian-Rong Wang,Wei Liu,Yan Sun and Su-Xiang Ma</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160221]]></guid><cfi:id>938</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of two types of visual quality analyzer for the measurement of high order aberrations]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160222]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the difference and agreement of KR-1W and iTrace for measurement of high order aberrations.
METHODS: KR-1W and iTrace were respectively used in a group of healthy people (40 volunteers, 32 eyes) to measure the high order aberration (HOA) of corneal, internal and total ocular. The clinical difference and agreement of two instruments were respectively evaluated by paired-samples t-test and Bland-Altman analysis.
RESULTS: The paired-samples t-test showed that the corneal HOA measured by the two instruments had no statistical differences (P＞0.05); but the internal and total ocular HOA had significant statistical differences (P＜0.05), and the mean results measured by iTrace were higher than that of KR-1W. However, Bland-Altman analysis revealed that the HOA of corneal and internal were all in 95% limits of agreement; and just one point of total ocular HOA was beyond the 95% limits of agreement.
CONCLUSION:  KR-1W and iTrace were consistent well in the measurement of corneal, internal and total ocular HOA, especially for the cornea.]]></description>
<pubDate>2016/2/4 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jing Hao,Lin Li,Fang Tian and Hong Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jing Hao,Lin Li,Fang Tian and Hong Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160222]]></guid><cfi:id>937</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Changing trends in corneal graft surgery: a ten-year review]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160108]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To review indications and corneal tissue use for penetrating and lamellar surgery between 2002 and 2011.
METHODS: The surgical reports of corneal grafts performed during 2002-2011, using tissues supplied by the Eye Bank of Piedmont (Italy), were reviewed retrospectively. Patient demographic data, date of intervention, indication for surgery, and surgical technique used were recorded. Surgical techniques included penetrating keratoplasty (PK), deep anterior lamellar keratoplasty (DALK) and endothelial keratoplasty (EK). The χ2 test was used to compare the distribution of indications and types of surgical technique used, for corneal grafts done during 2002-2006 versus those done during 2007-2011.
RESULTS: The number of corneal grafts increased by 30.7% from 2002-2006 to 2007-2011 (from 1567 to 2048). Comparing the two periods, both main indications and surgical techniques changed significantly. In 2007-2011, the proportion of interventions for aphakic/pseudophakic bullous keratopathy (from 16.8% to 21.3%), graft failure (from 16.4% to 19.1%) and Fuchs endothelial dystrophy (from 12.8% to 16.7%) all increased significantly (P<0.05), while those for keratoconus decreased significantly (from 35.6% to 27.3%; P<0.001). In 2007-2011, the proportion of PK decreased significantly (from 92.4% to 57.2%; P<0.001) while that of EK and DALK went from 0.4% to 30.2% (P<0.001) and from 7.2% to 12.6% (P<0.001) respectively.
CONCLUSION: During 2002-2011 the number of interventions increased significantly for corneal endothelial diseases and graft failure. The growing demand for interventions for these diseases corresponded to the widespread adoption of EK techniques. The use of DALK also increased, but more moderately than EK procedures.]]></description>
<pubDate>2015/12/29 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ugo de Sanctis,Camilla Alovisi,Luigi Bauchiero,Guido Caramello,Gianfranco Girotto,Claudio Panico,Luisa Vinai,Federico Genzano,Antonio Amoroso and Federico Grignolo]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ugo de Sanctis,Camilla Alovisi,Luigi Bauchiero,Guido Caramello,Gianfranco Girotto,Claudio Panico,Luisa Vinai,Federico Genzano,Antonio Amoroso and Federico Grignolo</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160108]]></guid><cfi:id>936</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Corneal infection in Shandong peninsula of China: a 10-year retrospective study on 578 cases]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160109]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the epidemiological characteristics, clinical signs, laboratory findings, and outcomes in patients with corneal infection in Shandong peninsula of China.
METHODS: The medical records of 578 inpatients (578 eyes) with corneal infection were reviewed retrospectively for demographic characteristics, risk factors, seasonal variation, clinical signs, laboratory findings, and treatment strategy. Patient history, ocular examination findings using slit-lamp biomicroscopy, laboratory findings resulted from microbiological cultures, and treatment.
RESULTS: Fungal keratitis constituted 58.48% of cases of infectious keratitis among the inpatients, followed by herpes simplex keratitis (20.76%), bacterial keratitis (19.03%) and acanthamoeba keratitis (1.73%). The most common risk factor was corneal trauma (71.80%). The direct microscopic examination (338 cases) using potassium hydroxide (KOH) wet mounts was positive in 296 cases (87.57%). Among the 298 fungal culture-positive cases, Fusarium species were the most common isolates (70.47%). A total of 517 cases (89.45%) received surgical intervention, including 255 (44.12%) cases of penetrating keratoplasty, 74 (12.80%) cases of lamellar keratoplasty which has become increasingly popular, and 77 cases (13.32%) of evisceration or enucleation.
CONCLUSION: At present, infectious keratitis is a primary corneal disease causing blindness in China. With Fusarium species being the most commonly identified pathogens, fungal keratitis is the leading cause of severe infectious corneal ulcers in Shandong peninsula of China.]]></description>
<pubDate>2015/12/29 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xiao-Jing Pan,Tao Jiang,Hai Zhu,Peng-Peng Liu,Zhan-Yu Zhou and Alexander J. Mao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiao-Jing Pan,Tao Jiang,Hai Zhu,Peng-Peng Liu,Zhan-Yu Zhou and Alexander J. Mao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160109]]></guid><cfi:id>935</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of anterior section parameters using anterior segment optical coherence tomography and ultrasound biomicroscopy in myopic patients after ICL implantation]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160110]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the agreement of anterior chamber depth (ACD) and central vault measurements obtained by anterior segment optical coherence tomography (AS-OCT) and ultrasound biomicroscopy (UBM) of post surgical high myopic eyes with posterior chamber phakic intraocular lens (Visian ICL; STAAR Surgical) implantation.
METHODS: Fifty-two phakic eyes of 28 high myopic patients who underwent implantable Collamer lens (ICL) surgery for the correction of high myopia were studied. The postoperative ACD, the distance between the corneal endothelium and the anterior surface of ICL (cornea-ICL) and the central vault were measured with the AS-OCT system and the UBM system. Intraclass correlation coefficient (ICC) and the Bland-Altman plot were used to evaluate the repeatability and agreement of two devices.
RESULTS: The mean ACD, cornea-ICL and central vault in the 52 phakic eyes after ICL surgery was 3.19±0.28 mm, 2.47±0.28 mm, 0.50±0.19 mm by AS-OCT and 3.13±0.25 mm, 2.49±0.25 mm, 0.44±0.19 mm by UBM, respectively. Pairwise comparison of ACD and central vault measurements showed significant differences between AS-OCT and UBM (P<0.05). However, no statistically significant difference was found between these imaging techniques in cornea-ICL (P>0.05). The Pearson correlation coefficient (r) between AS-OCT and UBM measurements for ACD, cornea-ICL and vault was 0.88, 0.80 and 0.89, respectively (P<0.001). The ICC was   0.89-0.94 for the measurements of AS-OCT and UBM. Bland-Altman analysis showed the 95% limits of agreement of ACD, cornea-ICL, central vault measurements between these two devices were -0.20 to 0.32 mm, -0.36 to 0.32 mm and -0.12 to 0.24 mm, respectively.
CONCLUSION: Central ACD and vault measurements using AS-OCT demonstrated a slight significantly higher value than using UBM in phakic eyes after ICL surgery. These two devices should not be used interchangeably for measurements of central ACD and vault in patients after phakic intraocular lens implantation.]]></description>
<pubDate>2015/12/29 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jing Zhang,Hui-Hui Luo,Jing Zhuang and Ke-Ming Yu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jing Zhang,Hui-Hui Luo,Jing Zhuang and Ke-Ming Yu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160110]]></guid><cfi:id>934</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Management strategies in malignant glaucoma secondary to antiglaucoma surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160111]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the outcomes of various interventions for malignant glaucoma (MG).
METHODS: A retrospective, comparative analysis of case series were performed on 38 eyes of 35 MG patients treated in Aier Eye Hospital of Wuhan between Jan. 2009 and Dec. 2012. Numerous treatments were administered including medical therapy, neodymium: yttrium- aluminium-garnet (Nd:YAG) laser posterior capsulotomy and hyaloidotomy as well as 3 surgical options. The characteristic, treatment option and outcome of MG in every individual patient were reviewed and analyzed among all patients who were followed up for an average of 27.1±9.1mo.
RESULTS: Four eyes of 3 patients achieved complete resolution with medical therapy. Nd:YAG laser posterior capsulotomy and hyaloidotomy were performed on 2 eyes, both of which achieved resolution after initial intervention. Thirty-two eyes were given surgical treatments with anterior vitrectomy- reformation of anterior chamber in 13 eyes, phacoemulsification- intraocular lens implantation in 10 eyes and phacoemulsification- intraocular lens implantation- anterior vitrectomy in 9 eyes. Resolution of MG was seen in almost all patients. The mean intraocular pressure decreased from 41.87±9.44 mm Hg at presentation to 15.84±3.73 mm Hg at the last visit. The mean anterior chamber depth improved from 0.28±0.27 mm to 2.28±0.19 mm. Twenty eyes with preoperative visual acuity better than counting figure/ 50 cm had various visual improvements. Complications occurred in 3 eyes of 3 patients including bleeding at the entry site of vitrectomy into vitreous cavity, corneal endothelial decompensation and allergic to atropine respectively.
CONCLUSION: MG occurs as a result of multiple mechanisms involved simultaneously or sequentially.Medical therapy is advocated as the initial treatment, laser therapy is beneficial in pseudophakic eyes, and different surgical regimen is recommended based on different pathogenesis of MG when non-response occurs to nonsurgical management. MG can be managed successfully by appropriate and timely interventions with good visual outcome.]]></description>
<pubDate>2015/12/29 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Zuo-Hong Wu,Yu-Hong Wang and Ying Liu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zuo-Hong Wu,Yu-Hong Wang and Ying Liu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160111]]></guid><cfi:id>933</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Bimatoprost/timolol fixed combination (BTFC) in patients with primary open angle glaucoma or ocular hypertension in Greece]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160112]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the efficacy and tolerability of the fixed combination of bimatoprost 0.03% and timolol 0.5% (BTFC) in patients in Greece with primary open angle glaucoma (POAG) or ocular hypertension (OHT) whose previous therapy provided insufficient lowering of intraocular pressure (IOP).
METHODS: A multicenter, prospective, open-label, non-interventional, observational study of the use of BTFC in clinical practice was conducted at 41 sites in Greece. The primary endpoint was the reduction in IOP from baseline at study end, approximately 12wk after initiation of BTFC therapy.
RESULTS: A total of 785 eligible patients were enrolled in the study and 97.6% completed the study. The mean±SD IOP reduction from baseline at 12wk after initiation of BTFC was 6.3±2.8 mm Hg (n=764; P<0.001). In patients (n=680) who replaced their previous IOP-lowering monotherapy (a single drug, or a fixed combination of 2 drugs in a single ophthalmic drop) with once-daily BTFC, the mean±SD IOP reduction from baseline at 12wk was 6.2±2.8 mm Hg (P<0.001). IOP was reduced from baseline in 99.2% of patients, and 58.0% of patients reached or exceeded their target IOP. Substantial mean IOP reductions were observed regardless of the previous therapy. BTFC was well tolerated, with 96.0% of patients who completed the study rating the tolerability of BTFC as “good” or “very good.” Adverse events were reported in 8.3% of patients; only 0.6% of patients discontinued the study due to adverse events.
CONCLUSION: In clinical practice in Greece, BTFC is well tolerated and effectively lower the IOP in patients with POAG or OHT who requires additional IOP lowering on their previous therapy.]]></description>
<pubDate>2015/12/29 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Tryfon G. Rotsos,Vasso G. Kliafa,Kevin J. Asher and Dimitrios Papaconstantinou]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Tryfon G. Rotsos,Vasso G. Kliafa,Kevin J. Asher and Dimitrios Papaconstantinou</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160112]]></guid><cfi:id>932</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of intraocular pressure measurements with different contact tonometers in young healthy persons]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160113]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyze the correlation of Goldmann applanation tonometer (GAT), I-Care tonometer and Tono-Pen tonometer results in young healthy persons, and to investigate the influence of central corneal thickness (CCT) on intraocular pressure (IOP) measurements recorded with these tonometers.
METHODS: We conducted a pilot clinical study in 78 eyes of 78 subjects aged 22-28 years old (44 women and 34 men; mean age 23.8±1.19y). IOP was measured using GAT, I-Care and Tono-Pen tonometers, followed by measurements of CCT. Statistical analysis was performed using SPSS 20.0.
RESULTS: The mean IOPs and standard deviation (±SD) for GAT, I-Care and Tono-Pen were 15.62±2.281 mm Hg, 16.29±2.726 mm Hg and 16.32±2.393 mm Hg, respectively. The mean CCT was 555.15±29.648 μm. Clear positive correlations between GAT and I-Care, GAT and Tono-Pen, and I-Care and Tono-Pen tonometers were found (r=0.867, P<0.001; r=0.861, P<0.001; r=0.915, P<0.001, respectively). In comparison between devices, Bland–Altman analysis showed a significant mean difference (MD) in the measurements by GAT and I-Care of ?0.679 mm Hg and by GAT and Tono-Pen of ?0.705 mm Hg ( P<0.001), but there was no significant difference between I-Care and Tono-Pen ( P>0.05). Both non-gold standard tonometers were affected by CCT; that is, both I-Care and Tono-Pen tonometer values were significantly higher with higher CCT means (>555 μm; MD=?1.282, P<0.001; MD=?0.949, P<0.001, respectively) compared with GAT.
CONCLUSION: Both I-Care and Tono-Pen tonometers overestimated IOP compared with the GAT values. Either the I-Care or Tono-Pen tonometer could be used instead of GAT because there was no significant difference between their results. Higher CCT values (>555 μm) were associated with overestimated IOP values.]]></description>
<pubDate>2015/12/29 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Saulius Galgauskas,Rasa Strupaite,Ernesta Strelkauskaite and Rimvydas Asoklis]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Saulius Galgauskas,Rasa Strupaite,Ernesta Strelkauskaite and Rimvydas Asoklis</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160113]]></guid><cfi:id>931</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Macular edema after cataract surgery in diabetic eyes evaluated by optical coherence tomography]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160114]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess quantitative changes of the macula in diabetic eyes after cataract surgery using optical coherence tomography (OCT) and to estimate the incidence of development or worsening of macular edema (ME) in diabetic eyes with or without pre-existing ME.
METHODS: In this prospective, observational study, 92 eyes of 60 diabetic patients who underwent cataract surgery were evaluated before surgery and 1, 3mo after surgery using OCT. Macular thickness was measured with OCT at nine macular subfields defined by the 9 zones early treatment of diabetic retinopathy study (ETDRS), as well as total macular volume obtained by OCT at 1, 3mo after surgery were compared with baseline features obtained before surgery. In addition, the incidence of development or worsening of ME was analyzed in diabetic eyes with or without pre-existing ME.
RESULTS: The central subfield mean thickness increased 21.0 μm and 25.5 μm at 1, 3mo follow-up, respectively (P<0.01). The average thickness of inner ring and outer ring increased 14.2 μm and 9.5 μm at 1mo, 18.2 μm and 12.9 μm at 3mo. Central-involved ME developed in 12 eyes at 3mo, including 4 eyes with pre-existing central-involved and 8 eyes with pre-existing non-central involved ME. Pre-existing diabetic macular edema (DME) was significantly associated with central-involved ME development (P<0.001).
CONCLUSION: A statistically significant increase could be detected in the central subfield as well as perifoveal and parafoveal sectors though the increase was mild. And eyes with pre-operative DME prior to cataract surgery are at higher risk for developing central-involved ME.]]></description>
<pubDate>2015/12/29 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xiao-Yong Chen,Wen-Jun Song,Hong-Yuan Cai and Lin Zhao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiao-Yong Chen,Wen-Jun Song,Hong-Yuan Cai and Lin Zhao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160114]]></guid><cfi:id>930</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Predictors of short-term outcomes related to central subfield foveal thickness after intravitreal bevacizumab for macular edema due to central retinal vein occlusion]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160115]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the predictive factors for short-term effects of intravitreal bevacizumab injections on central subfield foveal thickness (CSFT) in patients with macular edema (ME) secondary to central retinal vein occlusion (CRVO).
METHODS: This was a retrospective study in 60 eyes treated with intravitreal bevacizumab injections for ME due to CRVO. Follow-up was three months. The Early Treatment Diabetic Retinopathy Study (ETDRS) score and CSFT measured by spectral-domain optical coherence tomography (SD-OCT) were used to observe the changes in best-corrected visual acuity (BCVA). Baseline BCVA, CSFT, age, CRVO duration and the presence of cystoid macular edema (CME) or subretinal fluid (SRF) were analyzed as potential predictive factors of the effects of intravitreal bevacizumab injections.
RESULTS: BCVA improved from 0.9 logMAR at baseline to 0.6 logMAR at 3mo, which was associated with a significant reduction in CSFT from 721 &micro;m to 392 μm 3mo after injection. About 50% of CME cases and more than 90% of SRF cases responded to treatment with a complete resolution at 3mo. Age (P=0.036) and low baseline CSFT (P=0.037) were associated with a good 3-month prognosis. Patients >60 years old achieved better CME resolution (P=0.031) and lower CSFT at 3mo (305 μm vs 474 μm, P=0.003).
CONCLUSION: Intravitreal bevacizumab significantly improved visual acuity and CSFT in patients with CRVO after 3mo. Older age and lower baseline CSFT were good predictors of short-term CSFT outcomes. The retinal thickness response to bevacizumab might depend on the resolution of CME rather than SRF.]]></description>
<pubDate>2015/12/29 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mei-Zi Wang,Kang Feng,Yao Lu,Fang Qian,Xin-Rong Lu,Si-Wen Zang and Lin Zhao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mei-Zi Wang,Kang Feng,Yao Lu,Fang Qian,Xin-Rong Lu,Si-Wen Zang and Lin Zhao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160115]]></guid><cfi:id>929</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Reflectivity and thickness analysis of epiretinal membranes using spectral-domain optical coherence tomography]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160116]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare thickness and reflectivity spectral domain optical coherence tomography (SD-OCT) findings in patients with idiopathic epiretinal membranes (ERMs), before and after ERM peeling surgery, with normal controls. METHODS: A retrospective study analyzed SD-OCTs of eyes with ERMs undergoing ERM peeling surgery by one surgeon from 2008 to 2010 and normal control eyes. SD-OCTs were analyzed using a customized algorithm to measure reflectivity and thickness. The relationship between the SD-OCT findings and best corrected visual acuity (BCVA) outcomes was also studied.

RESULTS: Thirty-four ERM eyes and 12 normal eyes were identified. Preoperative eyes had high reflectivity and thickness of the group of layers from the internal limiting membrane (ILM) to the retinal pigment epithelium (RPE) and the group of layers from the ILM to the external limiting membrane (ELM). The values of reflectivity of these two groups of layers decreased postoperatively, but were still higher than normal eyes. In contrast, preoperative eyes had lower reflectivity of two 10×15 pixel regions of interest (ROIs) incorporating: 1) ELM + outer nuclear layer (ONL) and 2) photoreceptor layer (PRL) + RPE, compared to controls. The values of reflectivity of these ROIs increased postoperatively, but were still lower than normal controls. A larger improvement in BCVA postoperatively was correlated with a greater degree of abnormal preoperative reflectivity and thickness findings.
CONCLUSION: Quantitative differences in reflectivity and thickness between preoperative, postoperative, and normal SD-OCTs allow assessment of changes in the retina secondary to ERM. Our study identified hyperreflective inner retina changes and hyporeflective outer retina changes in patients with ERMs. SD-OCT quantitative measures of reflectivity and/or thickness of specific groups of retinal layers and/or ROIs correlate with improvement in BCVA.]]></description>
<pubDate>2015/12/29 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ajay E. Kuriyan,Delia Cabrera DeBuc and William E. Smiddy]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ajay E. Kuriyan,Delia Cabrera DeBuc and William E. Smiddy</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160116]]></guid><cfi:id>928</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Study of retinal vessel oxygen saturation in ischemic and non-ischemic branch retinal vein occlusion]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160117]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To explore how oxygen saturation in retinal blood vessels is altered in ischemic and non-ischemic branch retinal vein occlusion (BRVO).
METHODS: Fifty BRVO eyes were divided into ischemic (n=26) and non-ischemic (n=24) groups, based on fundus fluorescein angiography. Healthy individuals (n=52 and n=48, respectively) were also recruited as controls for the two groups. The mean oxygen saturations of the occluded vessels and central vessels were measured by oximetry in the BRVO and control groups.
RESULTS: In the ischemic BRVO group, the occluded arterioles oxygen saturation (SaO2-A, 106.0%±14.3%), instead of the occluded venule oxygen saturation (SaO2-V, 60.8%±9.4%), showed increases when compared with those in the same quadrant vessels (SaO2-A, 86.1%±16.5%) in the contralateral eyes (P<0.05). The oxygen saturations of the central vessels showed similar trends with those of the occluded vessels. In the non-ischemic BRVO group, the occluded and central SaO2-V and SaO2-A showed no significant changes. In both the ischemic and non-ischemic BRVOs, the central SaO2-A was significantly increased when compared to healthy individuals.
CONCLUSION: Obvious changes in the occluded and central SaO2-A were found in the ischemic BRVO group, indicating that disorders of oxygen metabolism in the arterioles may participate in the pathogenesis of ischemic BRVO.]]></description>
<pubDate>2015/12/29 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Lei-Lei Lin,Yan-Min Dong,Yao Zong,Qi-Shan Zheng,Yue Fu,Yong-Guang Yuan,Xia Huang,Garrett Qian and Qian-Ying Gao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Lei-Lei Lin,Yan-Min Dong,Yao Zong,Qi-Shan Zheng,Yue Fu,Yong-Guang Yuan,Xia Huang,Garrett Qian and Qian-Ying Gao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160117]]></guid><cfi:id>927</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Visual outcome after removal of silicone oil in patients undergoing retinectomy for complex retinal detachment]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160118]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the functional outcome after removal of silicone oil (ROSO) in patients undergoing retinectomy for complex retinal detachment.
METHODS: We performed a retrospective case note review of patients who underwent ROSO after retinectomy for complex retinal detachment. Patients with less than 6mo follow up and recurrent retinal detachment following ROSO were excluded.
RESULTS: Thirty-six patients were included. The mean best corrected visual acuity (BCVA) pre-ROSO was 1.13 logMAR (SD 0.5). The mean BCVA 3mo following ROSO was 1.16 logMAR (SD 0.53), 6mo following ROSO 1.13 (SD 0.63), and 12mo following ROSO 1.18 (SD 0.69). At 12mo after ROSO, the BCVA improved in 38.9% of patients, remained unchanged in 25%, and deteriorated in 36.1%, although there was no statistical significant difference in BCVA after ROSO at 3, 6 and 12mo (P=0.93). The size of retinectomy ranged from 15° to 270° (SD 53) and did not influence the visual outcome (P=0.11).
CONCLUSION: There was no statistically significanT difference in BCVA between pre- and post- ROSO following retinectomy for complex retinal detachment. There was no statistical difference in visual outcome related to the size of the retinectomy.]]></description>
<pubDate>2015/12/29 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Roger Wong,Marco De Luca,Manoharan Shunmugam,Tom Williamson,Alistair Laidlaw and Valeria Vaccaro]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Roger Wong,Marco De Luca,Manoharan Shunmugam,Tom Williamson,Alistair Laidlaw and Valeria Vaccaro</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160118]]></guid><cfi:id>926</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[C-reactive protein and diabetic retinopathy in Chinese patients with type 2 diabetes mellitus]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160119]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the relationship between C-reactive protein (CRP) and diabetic retinopathy (DR) in a cohort of Chinese patients with type 2 diabetes mellitus (T2DM).
METHODS: Community-based observational cohort study. There were 1131 participants recruited from November 2009 to September 2011 in Desheng community in urban Beijing. Patients diagnosed T2DM were recruited and underwent a standardized evaluation consisting of a questionnaire, ocular and anthropometric examinations and laboratory investigation. The presence and severity of DR were assessed by seven fields 30° color fundus photographs. Subjects were then classified into groups with no DR, any DR, or vision-threatening DR. CRP was analyzed from serum of study subjects.
RESULTS: A total of 1007 patients with T2DM were included for analysis, including 408 (40.5%) men and 599 (59.5%) women. The median CRP level was 1.5 mg/L for women and 1.1 mg/L for men (P=0.004, OR 0.37, 95% CI 0.18-0.74). After adjusting for possible covariates, higher levels of CRP were associated with lower prevalence of any DR (P=0.02, OR 0.55, 95% CI 0.35-0.89), but not associated with vision-threatening DR (P=0.62, OR 0.78, 95% CI 0.28-2.14). After stratification by sex, the inverse association between CRP and DR was found to be statistically significant in men (P=0.006, OR 0.35, 95% CI 0.16-0.73), but not in women (P=0.58, OR 0.88, 95% CI 0.29-1.16).
CONCLUSION: The data drawn from a Chinese population with T2DM suggest that increasing CRP levels may be inversely associated with development of DR.]]></description>
<pubDate>2015/12/29 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xiu-Fen Yang,Yu Deng,Hong Gu,Apiradee Lim,Torkel Snellingen,Xi-Pu Liu,Ning-Li Wang,Amitha Domalpally,Ronald Danis and Ning-Pu Liu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiu-Fen Yang,Yu Deng,Hong Gu,Apiradee Lim,Torkel Snellingen,Xi-Pu Liu,Ning-Li Wang,Amitha Domalpally,Ronald Danis and Ning-Pu Liu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160119]]></guid><cfi:id>925</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of Snellen and Early Treatment Diabetic Retinopathy Study charts using a computer simulation]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160120]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare accuracy, reproducibility and test duration for the Snellen and the Early Treatment Diabetic Retinopathy Study (ETDRS) charts, two main tools used to measure visual acuity (VA).
METHODS: A computer simulation was programmed to run multiple virtual patients, each with a unique set of assigned parameters, including VA, false-positive and false-negative error values. For each virtual patient, assigned VA was randomly chosen along a continuous scale spanning the range between 1.0 to 0.0 logMAR units (equivalent to 20/200 to 20/20). Each of 30 000 virtual patients were run ten times on each of the two VA charts.
RESULTS: Average test duration (expressed as the total number of characters presented during the test ±SD) was 12.6±11.1 and 31.2±14.7 characters, for the Snellen and ETDRS, respectively.  Accuracy, defined as the absolute difference (± SD) between the assigned VA and the measured VA, expressed in logMAR units, was superior in the ETDRS charts: 0.12±0.14 and 0.08±0.08, for the Snellen and ETDRS charts, respectively.  Reproducibility, expressed as test-retest variability, was superior in the ETDRS charts: 0.23±0.17 and 0.11±0.09 logMAR units, for the Snellen and ETDRS charts, respectively.
CONCLUSION: A comparison of true (assigned) VA to measured VA, demonstrated, on average, better accuracy and reproducibility of the ETDRS chart, but at the penalty of significantly longer test duration. These differences were most pronounced in the low VA range. The reproducibility using a simulation approach is in line with reproducibility values found in several clinical studies.]]></description>
<pubDate>2015/12/29 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Reuben R. Shamir,Yael Friedman,Leo Joskowicz,Michael Mimouni and Eytan Z. Blumenthal]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Reuben R. Shamir,Yael Friedman,Leo Joskowicz,Michael Mimouni and Eytan Z. Blumenthal</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20160120]]></guid><cfi:id>924</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Changes of meibomian glands in patients with type 2 diabetes mellitus]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161206]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the morphological changes of meibomian glands in patients with type 2 diabetes mellitus (DM).
METHODS: Of 118 eyes (118 patients) with type 2 DM (DM group) and 100 eyes of 100 control subjects (control group) were enrolled. After completing an ocular surface disease index (OSDI) questionnaire, the non-invasive tear film break-up time (NI-BUT) and the structure of the meibomian glands (MGs, meibography) were assessed by the Keratograph 5M system. Partial or complete loss of MG was scored for each eyelid from grade 0 (no loss) to grade 3 (lost area was >2/3 of the total MG area), which were also examined by laser scanning confocal microscopy (LSCM). The primary outcomes were meibomian gland acinar unit density (MGAUD), meibomian gland acinar longest diameter (MGALD) and meibomian gland acinar shortest diameter (MGASD).
RESULTS: Compared with control group, the OSDI was significantly higher in DM group (Z=-5.916; P<0.001), while the NI-BUT was significantly lower (Z=-7.765; P<0.001). Keratograph showed that there were more MGs dropout in DM group than that in control group. The meiboscore was significantly higher in DM group compared with control group (Z=-3.937; P<0.001). LSCM revealed that there were cytological alterations of MGs in DM group compared with control group, which included enlargement of MG acinar units and decreased in density of MG acinar units. Specifically, there were lower MGAUD, larger MGALD and MGASD in DM group than control group (Z=-10.120, -9.4442, -7.771; P<0.001).
CONCLUSION: Compared with the normal control participants, the patients with type 2 DM had more unstable tear films and severe symptoms of dry eye. Using Keratograph 5M system and LSCM, we found that the patients with type 2 DM had more significant morphological and cytological changes and dysfunction in MGs.]]></description>
<pubDate>2016/12/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Tao Yu, Wei-Yun Shi, Ai-Ping Song, Yang Gao, Guang-Fu Dang and Gang Ding]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Tao Yu, Wei-Yun Shi, Ai-Ping Song, Yang Gao, Guang-Fu Dang and Gang Ding</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161206]]></guid><cfi:id>923</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Cosmetic evaluation of surgical scars after external dacryocystorhinostomy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161207]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the surgical scars of external dacryocystorhinostomy (DCR) cosmetically.
METHODS: Totally 50 consecutive cases of primary acquired nasolacrimal duct obstruction (PANDO) were included in the study. Surgical scars were assessed by the patients and two independent observers at 2, 6 and 12wk postoperatively on the basis of visibility of the scars and still photographs respectively and were graded from 0-3. Kappa test was utilised to check the agreement of scar grading between the two observers. Wilcoxan signed ranks test was used to analyse the improvement of scar grading.
RESULTS: Thirty-four (68%) patients graded their incision site as very visible (grade 3) at 2wk. At 6 and 12wk, incision site was observed as grade 3 by 7 (14%) and 1 (2%) patients respectively. Photographic evaluation of patients by 2 observers showed an average score of 2.75, 1.94 and 0.94 at 2, 6 and 12wk respectively. Change in scar grading from grade 3 to grade 0 in consecutive follow-up (2, 6 and 12wk) was found to be highly significant both for the patient as well for the observers (P<0.0001).
CONCLUSION: The external DCR is a highly effective and safe procedure and in view of low percentage of cases who complained of marked scarring in the present study, thus scarring should not be the main ground for deciding the approach to DCR surgery, even in young cosmetically conscious patients.]]></description>
<pubDate>2016/12/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Syed Ali Raza Rizvi, Mohammad Saquib, Rakesh Maheshwari1, Yogesh Gupta, Zafar Iqbal and Puneet Maheshwari]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Syed Ali Raza Rizvi, Mohammad Saquib, Rakesh Maheshwari1, Yogesh Gupta, Zafar Iqbal and Puneet Maheshwari</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161207]]></guid><cfi:id>922</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Etiology, diagnosis, management and outcomes of epiphora referrals to an oculoplastic practice]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161208]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the etiology, diagnosis, management and outcome of epiphora referrals to an oculoplastic practice.
METHODS: Retrospective chart review of patients referred for epiphora to an oculoplastic clinic between 2005 and 2009. Patient demographics, past history, ophthalmic examination, treatment and outcome were analyzed.
RESULTS: There were 237 subjects with a primary complaint of epiphora. They included 130 (55%) females and 107 (45%) males with an average age of 55.9±25.9y. The most common cause of epiphora was lacrimal obstruction (46%); followed by multifactorial epiphora (22%), reflex tearing (22%) and eyelid malposition (11%). Differences in prevalence of etiology were noted in terms of age and gender distribution. Of the 182 (77%) patients who returned for follow up, 41 (23%) reported a complete resolution and 102 (56%) reported a significant improvement in their symptoms.
CONCLUSION: Epiphora is a common condition with many causes. A thorough history and examination are required to provide the appropriate treatment tailored to the underlying cause.]]></description>
<pubDate>2016/12/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Guang-Lin Shen, John D. Ng and Xiao-Ping Ma]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Guang-Lin Shen, John D. Ng and Xiao-Ping Ma</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161208]]></guid><cfi:id>921</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Preoperative evaluation and outcome of corneal transplantation for limbal dermoids: a ten-year follow-up study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161209]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To summarize preoperative evaluation and outcome of corneal transplantation for limbal dermoids for ten years.
METHODS: Eighty-five patients diagnosed with limbal dermoids and treated with corneal transplantation were analyzed retrospectively. All patients were further divided into two groups according to absence or presence of neovascularization surrounding the dermoids in the corneal stroma. Eighty-two eyes were treated with tumor excision combined with partial lamellar sclerokeratoplasty, and the other three eyes were performed by penetrating keratoplasty. The size and location of the tumor, the associated ocular and systemic anomalies, the depth of the corneal penetration of tumor tissues, the preoperative and postoperative best-corrected visual acuity (BCVA), graft survival and cosmetic outcome, and surgical complications were recorded respectively.
RESULTS: The average age at surgery was 5.3y (range, 3mo-36y). The mean size of dermoids was 6.1±1.6 mm. The 43.5% of eyes (37/85) were present with hair at the surface of the dermoid and 72.9% of dermoids were located inferotemporal of the eye. Amplyopia was present in 34.1% of patients (29/85) and 9.4% of patients (8/85) had lipodermoids. Eighteen patients suffered from Goldenhar’s syndrome with an accessory ear. The 75% of patients in group 1 had involvement of the corneal deep stroma down to Descemet’s membrane without involving it, but 71.4% of patients had Descemet’s membrane involvement in group 2. Preoperative BCVA ranged from counting fingers to 20/20. Postoperatively 81.1% had a BCVA of 20/800 or better. There was no significant difference between the post-surgical BCVA of the two groups (t=1.584, P>0.05). The grafts of 70.5% patients were present as 1+ opacity, 21.1% as 2+ opacity, 8.2% as 3+ opacity and none as 4+ opacity. Surgical complications included graft rejection, microperforation, prolonged reepithelialization, steroid glaucoma, interface neovascularization, and interface hemorrhage.
CONCLUSION: The dermoids with neovascularization surrounding them in the corneal stroma invaded deeper tissues in the cornea than those with no neovascularization surrounding them in the corneal stroma. Therefore, surgeons should take care to avoid corneal perforation during the corneal transplantation operation. The majority of patients markedly improved their cosmetic appearance after surgery.]]></description>
<pubDate>2016/12/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Meng Xin, Yue-Rong Gong, Shan-Hao Jiang, Chun-Hua Dai, Su-Xia Li and Wei-Yun Shi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Meng Xin, Yue-Rong Gong, Shan-Hao Jiang, Chun-Hua Dai, Su-Xia Li and Wei-Yun Shi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161209]]></guid><cfi:id>920</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Application of optical coherence tomography angiography in assessment of posterior scleral reinforcement for pathologic myopia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161210]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the effect of posterior scleral reinforcement (PSR) on circulation of pathologic myopia eyes with posterior staphyloma by optical coherence tomography angiography (OCTA).
METHODS: The study included 30 pathologic myopia eyes with posterior staphyloma which underwent PSR (PSR group) for 6 to 18mo ago, and 30 age and myopia matched eyes without PSR surgery as control group. Macular, choriocapillaris and radial peripapillary capillary (RPC) flow density were measured by OCTA, and the measurements were compared between groups.
RESULTS: OCTA found no significant differences in macular flow density between PSR and control groups. For the superficial flow, whole enface flow density (WED), fovea density (FD), and parafoveal density (PD) were 46.55%±5.19% vs 47.29%±4.12% (P=0.542), 31.45%±6.35% vs 31.17%±4.48% (P=0.841), and 48.82%±5.66% vs 49.21%±4.15% (P=0.756) in PSR and control groups, respectively. For the deep flow, WED, FD, and PD were 52.07%±5.78% vs 53.95%±4.62% (P=0.168), 29.62%±6.55% vs 29.50%±6.38% (P=0.940), and 56.93%±6.17% vs 58.15%±5.13% (P=0.407) in PSR and control groups, respectively. The choriocapillary flow density was 61.18±3.25% in PSR group vs 60.88%±2.56% in control group (P=0.692). Also, OCTA found no significant differences in RPCs flow density between PSR and control groups. The optic disc WED, inside disc flow density and peripapillary flow density were 48.47%±4.77% vs 48.11%±4.57% (P=0.813), 45.47%±11.44% vs 46.68%±9.02% (P=0.709), 54.32%±5.29% vs 52.47%±6.62% (P=0.349) in PSR and control groups, respectively.
CONCLUSION: OCTA provides a non-invasive and quantitative approach for monitoring macular and papillary blood flow in pathologic myopia. PSR can not improve but may maintain the circulation of pathologic myopia eyes with posterior staphyloma.]]></description>
<pubDate>2016/12/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jing Mo, An-Li Duan, Szy-Yann Chan, Xue-Fei Wang and Wen-Bin Wei]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jing Mo, An-Li Duan, Szy-Yann Chan, Xue-Fei Wang and Wen-Bin Wei</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161210]]></guid><cfi:id>919</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Combination of Toric and multifocal intraocular lens implantation in bilateral cataract patients with unilateral astigmatism]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161211]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the binocular visual function in bilateral cataract patients with unilateral astigmatism after combined implantations of Toric with multifocal intraocular lens (IOL), and to compare with that of Toric and monofocal IOL implantation.
METHODS: All the 30 patients with unilateral astigmatism suffered bilateral cataract were randomly divided into two groups: Toric plus multifocal IOL group and Toric plus monofocal IOL group. Uncorrected and corrected visual acuity at distance (5.0 m), intermediate distance (0.6 m), and near (0.33 m), contrast sensitivity, and stereopsis were assessed 6mo after surgery. Patients were also surveyed for visual disturbances and spectacle dependence.
RESULTS: Binocular uncorrected visual acuity (LogMAR) of Toric/multifocal IOL eyes at distance, intermediate, near were 0.05±0.05, 0.24±0.10, and 0.14±0.06 respectively. The values of Toric plus monofocal IOL eyes were 0.06±0.07, 0.26±0.08, and 0.37±0.10 respectively. These values did not indicate significant differences between two groups with exception of near visual acuity. In the photopic condition (with or without glare), the contrast sensitivity of multifocal IOL eyes was significant lower than the monofocal IOL eyes in 18 cpd. In the mesopic condition, the contrast sensitivity of multifocal group was significant lower than monofocal group in 12 cpd, and in mesopic glare condition, this significant difference was found both in 6 cpd and 12 cpd. The stereopsis of Toric/multifocal IOL eyes decreased slightly (100±80 seconds of arc, t=2.222, P=0.136). Mean near vision for patient satisfaction was statistically significantly higher in Toric/multifocal IOL group patients versus than that in Toric/monofocal IOL group (80% vs 25.5%, P=0.000). Visual disturbance was not noticed in either group.
CONCLUSION: Although the combination of Toric and multifocal IOL implantation results in compromising stereoacuity, it can still provide patients with high levels of spectacle freedom and good overall binocular visual acuity.]]></description>
<pubDate>2016/12/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jing-Li Liang, Fang Tian, Hong Zhang and He Teng]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jing-Li Liang, Fang Tian, Hong Zhang and He Teng</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161211]]></guid><cfi:id>918</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Panretinal photocoagulation versus panretinal photocoagulation plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161212]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the effects of panretinal photocoagulation (PRP) compared with PRP plus intravitreal bevacizumab (IVB) in patients with high-risk proliferative diabetic retinopathy (PDR) according to the Early Treatment Diabetic Retinopathy Study criteria.
METHODS: The data were collected retrospectively from the eyes of high-risk PDR patients, which were divided into two groups. After treated with standard PRP, the eyes were randomly assigned to receive only PRP (PRP group) or PRP plus intravitreal injection of 1.25 mg of bevacizumab (PRP-Plus group). Patients underwent complete ophthalmic evaluation, including best corrected visual acuity (BCVA), intraocular pressure (IOP), and new vessel size in fluorescein angiography (FA) and optical coherence tomography for the assessment of central subfield macular thickness (CSMT) at baseline and at weeks 12 (±2), 16 (±2), 24 (±2) and 48 (±2). Main outcome measures also included vitreous clear-up time and neovascularization on the disc (NVD) regression time. Adverse events associated with intravitreal injection were investigated.
RESULTS: Thirty consecutive patients (n=36 eyes) completed the 48-week follow-up. There was no significant difference between the PRP and PRP-Plus groups with respect to age, gender, type or duration of diabetes, area of fluorescein leakage from active neovascularizations (NVs), BCVA or CSMT at baseline. The mean vitreous clear-up time was 12.1±3.4wk after PRP and 8.4±3.5wk after PRP combined with IVB. The mean time interval from treatment to complete NVD regression on FA examination was 15.2±3.5wk in PRP group and 12.5±3.1wk in PRP-Plus group. No significant difference in CSMT was observed between the groups throughout the study period. However, the total area of actively leaking NVs was significantly reduced in the PRP-Plus group compared with the PRP group (P<0.05). Patients received an average of 1.3 injections (range: 1-2). Ten eyes (27.8%) underwent 2 injections. Two eyes had ocular complication of PDR progression to dense vitreous hemorrhage (VH). No major adverse events were identified.
CONCLUSION: The adjunctive use of IVB with PRP is associated with a greater reduction in the area of active leaking NVs than PRP alone in patients with high-risk PDR. Short-term results suggest combined IVB and PRP achieved rapid clearance of VH and regression of retinal NV in the treatment of high-risk PDR. Further studies are needed to determine the effect of repeated intravitreal bevacizumab injections and the proper number of bevacizumab injections as an adjuvant.]]></description>
<pubDate>2016/12/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ai-Yi Zhou, Chen-Jing Zhou, Jing Yao, Yan-Long Quan, Bai-Chao Ren and Jian-Ming Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ai-Yi Zhou, Chen-Jing Zhou, Jing Yao, Yan-Long Quan, Bai-Chao Ren and Jian-Ming Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161212]]></guid><cfi:id>917</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Evaluation of fundus autofluorescence patterns in age-related macular degeneration]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161213]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To study the various morphological patterns of fundus autofluorescence (FAF) images in patients with age-related macular degeneration (AMD) in Indian population.
METHODS: Totally 179 eyes of 104 patients with clinical diagnosis of AMD were recruited into the study. Autofluorescence images were captured using confocal scanning laser ophthalmoscope and the patterns of FAF were classified.
RESULTS: Of 179 eyes, 27 (15.08%) were early AMD, 58 (32.41%) were intermediate AMD, 94 eyes (52.51%) were late AMD. Of 94 eyes with late AMD, 79 (84.04%) were neovascular AMD and 15 (15.96%) were central geographic atrophy. In eyes with early and intermediate AMD, 9 patterns of FAF were noted. Six patterns (normal, minimal change, focal increased, patchy increased, linear, reticular) were similar to that in the published classification. Two patterns (lacelike and speckled) described in the published classification were not found. Three new patterns (focal hypo-fluorescence, patchy hypo-fluorescence, mixed focal hypo-fluorescence and hyper-fluorescence) were detected. In eyes with neovascular AMD, 6 morphological patterns of FAF were noted. Two patterns (mixed hypo-fluorescence and hyper-fluorescence, central hypo-fluorescence with hyper-fluorescent rim) were similar to that in published classification. Two patterns (normal, near normal or normal background fluorescence in the centre of hypo-fluorescent area) described in the published classification were not found. Four new patterns (minimal change, hypo-fluorescent patch, central hypo-fluorescence with surrounding reticular, bull’s eye) were recognized. In eye with central geographic atrophy 5 morphological patterns were noted and these were similar to that in published classification.
CONCLUSION: Phenotypic differences in the pattern of FAF exist in the study population compared to existing classification systems.]]></description>
<pubDate>2016/12/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Pradeep Venkatesh, Pradeep Sagar, Rohan Chawla, Varun Gogia, Rajpal Vohra and Yog Raj Sharma]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Pradeep Venkatesh, Pradeep Sagar, Rohan Chawla, Varun Gogia, Rajpal Vohra and Yog Raj Sharma</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161213]]></guid><cfi:id>916</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of incision types for Artisan phakic intraocular lens implantation on ocular higher order aberrations]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161214]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the effect of incision types for Artisan phakic intraocular lens (PIOL) implantation on ocular higher-order aberrations (HOAs).
METHODS: A retrospective review was conducted of the patients who had undergone Artisan PIOL implantation for the correction of myopia and followed up for at least 6mo. Patients are classified into 2 groups considering the incision type: cornea group with patients undergone clear corneal incision; sclera group with patients undergone sclera tunnel incision. All patients with postoperative astigmatism of under 1 diopter (D) were included to minimize the effect of residual astigmatism on postoperative HOAs. Visual acuity, special equivalents, astigmatism, predictability (±1 D from target refraction), HOAs (coma, trefoil, spherical aberration), and corneal endothelial counts were analyzed preoperatively and 6mo postoperatively.
RESULTS: At the postoperative 6mo, all patients of both groups achieved uncorrected visual acuity of 16/20 or better, and significantly decreased the spherical equivalents compared with preoperative values. The predictability of refractive correction was 96% in the former, and 94% in the latter. Unlike the sclera group, preoperative astigmatism decreased significantly in cornea group at postoperative 6mo. The HOAs increased significantly at postoperative 6mo compared to the preoperative values in both groups, and the root mean square (RMS) total and trefoil wavefront aberration of cornea group were significantly higher than those of sclera group.
CONCLUSION: Although corneal incision significantly reduces preexisting astigmatism, the postoperative 6mo of total RMS and trefoil aberration change may deteriorate the visual quality after Artisan PIOL implantation.]]></description>
<pubDate>2016/12/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Young Min Park, Bong Joon Choi and Jong Soo Lee]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Young Min Park, Bong Joon Choi and Jong Soo Lee</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161214]]></guid><cfi:id>915</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Phakic posterior chamber intraocular lens for unilateral high myopic amblyopia in Chinese pediatric patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161215]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the outcomes of posterior chamber implantable collamer lens (ICL) implantation in Chinese pediatric patients with unilateral high myopic amblyopia.
METHODS: Eleven eyes of 11 amblyopic patients aged 11.02±3.34y underwent ICL (model V4, Staar Surgical Inc.) implantation to treat unilateral anisometropia were studied. Visual acuity, cycloplegic refraction, contrast sensitivity, stereopsis, intraocular pressure (IOP), vaulting, corneal endothelial cell count and complications were evaluated. Patients completed follow-up at 3d, 1, 3mo and the last follow-up time (mean 8.18±2.82mo) after surgery.
RESULTS: The mean myopic anisometropia was -13.70±3.25 D preoperatively and +0.69±2.63 D at 8mo postoperatively. The logMAR corrected distance visual acuity (CDVA) of the amblyopic eye was 1.51±0.72 preoperatively and 0.75±0.40 at 8mo postoperatively. The logMAR CDVA at 3d, 1, 3 and 8mo postoperatively improved by a mean of 0.64, 1.55, 1.82 and 2.64 lines and gained more than 2 lines accounted for 18%, 45%, 45%, 64%, respectively. The contrast sensitivity of 0.5, 1 and 2 cpd in amblyopic eyes was significantly increased after surgery. No patient had near stereopsis recovery. The vaulting at 3 and 8mo was significantly lower than that at 1mo postoperatively. No other intraoperative or postoperative complications were observed, except an acute pupillary block glaucoma happened in a patient at two weeks postoperatively.
CONCLUSION: This short-term results indicate that ICL implantation can be a promising alternative therapy for high myopic anisometropic amblyopia in pediatric patients who have failed with conventional treatments and not suitable to corneal refraction surgery.]]></description>
<pubDate>2016/12/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jing Zhang, Jin-Rong Li, Zi-Dong Chen, Min-Bin Yu and Ke-Ming Yu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jing Zhang, Jin-Rong Li, Zi-Dong Chen, Min-Bin Yu and Ke-Ming Yu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161215]]></guid><cfi:id>914</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Assessment of contrast sensitivity loss after intrastromal femtosecond laser and LASIK procedure]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161216]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the loss of contrast sensitivity (CS) function for INTRACOR or intrastromal femtosecond laser presbyopia procedure to conventional LASIK procedures.
METHODS: Patients were recruited from a refractive surgery center for either INTRACOR or conventional LASIK. INTRACOR was performed on 8 eyes and LASIK was performed for 40 eyes in an overlapping period. Pre-operative evaluation and post-operative follow up for up to three months was done. Drops of CS in 4 spatial frequency (3 cpd, 6 cpd, 12 cpd and 18 cpd) right before and 3mo after the surgery were compared by Wilcoxon signed ranks test.
RESULTS: For INTRACOR, CS threshold showed significant drop at both glare and non-glare condition, the drop was seen in all 4 spatial frequency. The averaged loss over the 4 spatial frequencies 3mo after surgery was 1.18 for non-glare and 0.71 for glare. For LASIK the CS threshold drop was most significant in 12 cpd for glare.
CONCLUSION: INTRACOR procedure produces a gain of near vision for presbyopia patients but also introduces a high lost of contrast sensitivity plus worsen of vision quality. Pre-surgical patient selection and advise should be given with specific regards to night driving and glare conditions.]]></description>
<pubDate>2016/12/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Elsa L.C. Mai, Ie-Bin Lian and David C. K. Chang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Elsa L.C. Mai, Ie-Bin Lian and David C. K. Chang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161216]]></guid><cfi:id>913</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Essential infantile esotropia with inferior oblique hyperfunction: long term follow-up of 6 muscles approach]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161217]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate long term follow-up (10y) of 6 muscle surgical approach in essential infantile esotropia (EIE).
METHODS: A 6 muscle approach to EIE was retrospectively evaluated in patients with inferior oblique (IO) hyperfunction and lateral rectus (LR) pseudoparalysis, who underwent surgery at different ages. Different clinical characters were analyzed pre- and postoperatively, in patients who underwent a 6 muscles approach ≤4 years of age. All patients underwent a multiple muscles approach: bilateral medial recti (MR) recession (4-5 mm), bilateral LR resection (lower than 7 mm) and bilateral IO recession and anteroposition. Of 108 children with preoperative angle ≥+30 prism diopters (PD) and IO hyperfunction were selected from larger cohort of patients (n=213, 103 females and 110 males) after excluding patients with: angle variability, who underwent reoperation and with incomplete follow up. Preoperative assessment and complete orthoptic examination were performed. Follow-up was performed 3mo, 2, 5 and 10y after surgery. Statistical analysis was performes using SAS statistical software package (version 9.1, SAS Institute Inc., Cary, NC, USA).
RESULTS: Ten years follow up data analysis showed the following percentage of orthotropic patients: (0 PD): 3mo, 22.2%; 2y, 16.7%; 5y, 25.0% and 10y, 27.8%. A slight, significant (P<0.01), increase of 2y follow up residual deviation was found when compared to 3mo one. Stationary surgical results is reported during time, with a trend of mean residual deviation reduction (P=0.04).
CONCLUSION: Our results confirm the reliability of multiple muscles surgical approach in the treatment of patients affected by EIE with OI hyperfunction.]]></description>
<pubDate>2016/12/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Adriano Magli, Roberta Carelli, Elisabetta Chiariello Vecchio, Francesca Esposito, Luca Rombetto and Paolo Esposito Veneruso]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Adriano Magli, Roberta Carelli, Elisabetta Chiariello Vecchio, Francesca Esposito, Luca Rombetto and Paolo Esposito Veneruso</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161217]]></guid><cfi:id>912</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Incidence of orbital, conjunctival and lacrimal gland malignant tumors in USA from Surveillance, Epidemiology and End Results, 1973-2009]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161218]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the types and incidence of tumors affecting the orbit, conjunctiva and lacrimal glands and to study the trend line of these tumors in the United States from 1973 to 2009.
METHODS: We used the publicly available Surveillance, Epidemiology and End Results (SEER) database registries to determine the incidence rates. Age was adjusted to the 2000 US Standard Population. Patients were stratified according to age group, gender, race and histological grouping of tumor lesions. Three age groups were defined: 0-19, 20-49 and ≥50y. Annual percentage changes were calculated to examine trends.
RESULTS: The overall age adjusted incidence rate was 3.39 (95%CI: 3.27-3.52) per million person-years. The tumors were more prevalent in age group ≥50 counting 9.51 (95%CI: 9.11-9.92) per million person-years. Most of the soft tissue sarcomas occurred in the young age with incidence rate of 0.35 (95%CI: 0.28-0.42) per million person-years. Lymphomas were the dominant subtype in the adult population with incidence rate of 5.74 (95%CI: 5.43-6.06) per million person-years. Incidence rates were higher in males than females with an overall rate ratio of 1.31 (95%CI: 1.21-1.41) mainly caused by the increase in carcinoma subtypes. White race had a higher tumor incidence with a rate ratio of 1.47(95%CI: 1.25-1.73) driven by the higher incidence of most histological subtypes. Orbital tumors showed a higher incidence rate followed by conjunctival and lacrimal gland tumors with incidence rates of 1.59, 1.37 and 0.43 per million person-years respectively. The trend line of overall incidence of tumors showed a significant increase (APC=3.11, 95%CI: 2.61-3.61) mainly due to increase of lymphomas. This increase was higher than the increase of lymphomas at other sites.
CONCLUSION: Orbital, conjunctival and lacrimal gland malignant tumors differ among children and adults. Over the years there has been a noticeable increase in incidence rates of orbital and lacrimal gland tumors mainly caused by an increase in lymphomas and an apparent increase due to advances in diagnostic techniques. ICD-O-3 topographical coding should be improved to consider the different orbital bones and ocular structures.]]></description>
<pubDate>2016/12/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Waleed M. Hassan, Mohamed S. Bakry, Housam M. Hassan and Ahmad S. Alfaar]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Waleed M. Hassan, Mohamed S. Bakry, Housam M. Hassan and Ahmad S. Alfaar</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161218]]></guid><cfi:id>911</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Corneal sensitivity, ocular surface health and tear film stability after punctal plug therapy of aqueous deficient dry eye]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161110]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the effect of punctal occlusion using thermosensitive (smart plug) versus silicone plug for management of aqueous deficient dry eye on corneal sensitivity, ocular surface health and tear film stability.
METHODS: A comparative prospective interventional case study included 45 patients with bilateral severe form of aqueous deficient dry eye. In each patient, the smart plug was inserted in the lower punctum of the right eye which was considered as study group 1 and silicone plug was inserted in the lower punctum of the left eye of the same patient which was considered as study group 2. All patients were subjected to careful history taking and questionnaire for subjective assessment of severity of symptoms. Corneal sensitivity, corneal fluorescein, rose bengal staining, Schirmer’s I test, tear film break up time and conjunctival impression cytology were performed pre and 1, 3 and 6mo post plug insertion.
RESULTS: A statistically significant improvement in subjective and objective manifestations occurred following treatment with both types of plugs (P<0.01). The thermosensitive plug caused significant overall improvement, decrease in frequency of application of tear substitutes and improvement of conjunctival impression cytology parameters in the inserted side (P<0.01). Canaliculitis was reported in two eyes (4.4%) following punctal occlusion using thermosensitive plug (study group 1). Spontaneous plug loss occurred in 21 eyes (46.6%) in the silicone plug group (study group 2).
CONCLUSION: Improvement of subjective and objective manifestations of aqueous deficient dry eye occurs following punctal plug occlusion. Thermosensitive plug has good patient's compliance with fewer complications and lower rates of loss compared to the silicone plug.]]></description>
<pubDate>2016/11/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Azza Mohamed Ahmed Said, Mona Elsayed Farag, Tarek Mohamed Abdulla, Othman Ali Othman Ziko and Wesam Mohamed Osman]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Azza Mohamed Ahmed Said, Mona Elsayed Farag, Tarek Mohamed Abdulla, Othman Ali Othman Ziko and Wesam Mohamed Osman</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161110]]></guid><cfi:id>910</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of iris-fixated foldable lens and scleral-fixated foldable lens implantation in eyes with insufficient capsular support]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161111]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the outcomes of vision using two different intraocular lens (IOL) replacement techniques, iris-fixated foldable intraocular lens (IF-IOL) and scleral-fixated foldable intraocular lens (SF-IOL) in patients with insufficient capsular support.
METHODS: Total 63 eyes (62 patients) with insufficient posterior capsule support underwent replacement of IF-IOL or SF-IOL between January 2008 and August 2011. Outcome measures included changes in visual acuity, slit lamp examination, refractive indices and corneal curvatures.
RESULTS: The mean improvement of uncorrected visual acuity (UCVA) was greater in IF-IOL group compared to the SF-IOL group (0.43 D±0.19 D vs 0.35 D±0.18 D, P<0.05). Moreover, 12 (38.71%) eyes in IF-IOL group and 4 (12.50%) in SF-IOL group had a higher postoperative UCVA than preoperative best corrected visual acuity (BCVA) while 9 (29.03%) eyes in IF-IOL group and 18 (56.25%) in SF-IOL group had a lower postoperative UCVA than preoperative BCVA. The myopic mean manifest sphere and mean cylinder magnitude were lower in the IF-IOL group than that in the SF-IOL group (-0.47 D±0.58 D vs 0.50 D±0.43 D, P<0.01; 0.84 D±0.53 D vs 1.23 D±0.70 D, P<0.05). No difference of corneal astigmatism and surgically induced astigmatism was found between the two groups. In addition, fewer complications were observed in IF-IOL eyes.
CONCLUSION: IF-IOL implantation can give a significant improvement in vision with fewer complications than SF-IOL in patients with insufficient capsular support.]]></description>
<pubDate>2016/11/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Han Zhang, Jun Zhao, Li-Jun Zhang, Jing Liu, Yuan Liu, Wei Song, Qing-Fen Tian, Qi Wang and David-Rex Hamilton]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Han Zhang, Jun Zhao, Li-Jun Zhang, Jing Liu, Yuan Liu, Wei Song, Qing-Fen Tian, Qi Wang and David-Rex Hamilton</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161111]]></guid><cfi:id>909</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Blood pressure change during phacoemulsification and femtosecond laser-assisted cataract surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161112]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate blood pressure (BP) changes during phacoemulsification (PC) and femtosecond laser (FSL)-assisted cataract surgery.
METHODS: A retrospective chart review was performed for all patients who received traditional phacoemulsification surgery (PC group) and FSL-assisted cataract surgery (FS group) from July 2013 to December 2014. Totally 206 eyes from 133 patients receiving the two types of procedures were included. Patient characteristics (age, gender, and hypertension history), pre- and post-operative BPs were collected. RESULTS: The pro-operative systolic and diastolic BPs (mm Hg) were 124.89±20.48 vs 126.98±16.85, and 71.88±9.81 vs 73.56±10.03, in PC and FS groups, respectively. While the post-operative systolic and diastolic BPs (mm Hg) were 130.13±22.59 vs 134.77±17.52, and 73.41±11.62 vs 78.89±12.2, in PC and FS groups, respectively. Paired-sample t-tests showed obvious systolic and diastolic BP elevations in FS group after surgery (P=0.001 and 0.007) and no reliability in PC group (P=0.094 and 0.359). A linear regression model revealed systolic and diastolic BP elevations, which were related to longer surgical times for FS group (P=0.008 and 0.021). Age, gender, and hypertension history were not correlated with blood pressure elevation in either group.

CONCLUSION: BP increases but at a limited level after FSL-assisted cataract surgery compared to traditional phacoemulsificationKEYWORDS: cataract surgery; blood pressure; femtosecond-assisted cataract surgery; phacoemulsification]]></description>
<pubDate>2016/11/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hung-Yuan Lin, Ching-Jen Tung, Guo-Xing Xu, Chun-Chi Wang, Hsin-Yang Chen, Ya-Jung Chuang, Wen-Fu Li and Pi-Jung Lin]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hung-Yuan Lin, Ching-Jen Tung, Guo-Xing Xu, Chun-Chi Wang, Hsin-Yang Chen, Ya-Jung Chuang, Wen-Fu Li and Pi-Jung Lin</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161112]]></guid><cfi:id>908</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of the anti-inflammatory effects of fluorometholone 0.1% combined with levofloxacin 0.5% and tobramycin/dexamethasone eye drops after cataract surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161113]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the combination of fluorometholone 0.1% and levofloxacin 0.5% to tobramycin/dexamethasone eye drops in controlling inflammation and preventing infection after phacoemulsification with an intraocular lens implantation.
METHODS: Sixty eyes from 60 patients undergoing cataract phacoemulsification were randomized into two groups; half of the patients were treated with fluorometholone (6 times/d) combined with levofloxacin (4 times/d), while the other half were treated with tobramycin/dexamethasone (4 times/d) eye drops for one week. Preoperative and postoperative intraocular pressure, aqueous flare, corneal thickness, and signs and symptoms were recorded before the operation and 1wk following treatments.
RESULTS: There were no statistically significant differences between the two groups in corneal thickness (P≥0.629), aqueous flare (P≥0.398), and signs and symptoms scores (P≥0.350) at each time point. Ocular hypertension was only observed in two eyes in the tobramycin/dexamethasone group.
CONCLUSION: Fluorometholone combined with levofloxacin treatment shows comparable efficacy but without the tendency to increase intraocular pressure; thus, it might be a better regimen for postoperative use.]]></description>
<pubDate>2016/11/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Pei-Qing Chen, Xue-Mei Han, Ya-Nan Zhu and Jia Xu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Pei-Qing Chen, Xue-Mei Han, Ya-Nan Zhu and Jia Xu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161113]]></guid><cfi:id>907</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of ICare and IOPen vs Goldmann applanation tonometry according to international standards 8612 in glaucoma patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161114]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare IOPen and ICare rebound tonometry to Goldmann applanation tonometry (GAT) according to International Standards Organization (ISO) 8612 criteria.
METHODS: Totally 191 eyes (n=107 individuals) were included. Criteria of ISO 8612 were fulfilled: 3 clusters of IOP, measured by GAT, were formed. The GAT results were given as mean±standard deviation.
RESULTS: GAT (19.7±0.5 mm Hg) showed a significant correlation to ICare (19.8±0.5 mm Hg) (r=0.547, P<0.001) and IOPen (19.5±0.5 mm Hg) (r=0.526, P<0.001). According to ISO 8612 criteria in all 3 IOP groups the number of outliers (of the 95% limits of agreement) exceeded 5% for ICare and IOPen vs GAT: No.1 (n=68) 29.4% and 22.1%, No.2 (n=62) 35.5% and 37.1%, No.3 (n=61) 26.2% and 42.6%, respectively.
CONCLUSION: The strict requirements of the ISO 8612 are not fulfilled in a glaucoma collective by ICare and IOPen at present. As long as the Goldmann tonometry is applicable it should be used first of all for reproducible IOP readings. ICare and IOPen tonometry should be considered as an alternative tool, if application of Goldmann tonometry is not possible.]]></description>
<pubDate>2016/11/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Milena Pahlitzsch, Jeanette Brünner, Johannes Gonnermann, Anna-Karina B. Maier, Necip Torun, Eckart Bertelmann and Matthias KJ. Klamann]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Milena Pahlitzsch, Jeanette Brünner, Johannes Gonnermann, Anna-Karina B. Maier, Necip Torun, Eckart Bertelmann and Matthias KJ. Klamann</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161114]]></guid><cfi:id>906</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Missed retinal breaks in rhegmatogenous retinal detachment]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161115]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the causes and associations of missed retinal breaks (MRBs) and posterior vitreous detachment (PVD) in patients with rhegmatogenous retinal detachment (RRD).
METHODS: Case sheets of patients undergoing vitreo retinal surgery for RRD at a tertiary eye care centre were evaluated retrospectively. Out of the 378 records screened, 253 were included for analysis of MRBs and 191 patients were included for analysis of PVD, depending on the inclusion criteria. Features of RRD and retinal breaks noted on examination were compared to the status of MRBs and PVD detected during surgery for possible associations.
RESULTS: Overall, 27% patients had MRBs. Retinal holes were commonly missed in patients with lattice degeneration while missed retinal tears were associated with presence of complete PVD. Patients operated for cataract surgery were significantly associated with MRBs (P=0.033) with the odds of missing a retinal break being 1.91 as compared to patients with natural lens. Advanced proliferative vitreo retinopathy (PVR) and retinal bullae were the most common reasons for missing a retinal break during examination. PVD was present in 52% of the cases and was wrongly assessed in 16%. Retinal bullae, pseudophakia/aphakia, myopia, and horse shoe retinal tears were strongly associated with presence of PVD. Traumatic RRDs were rarely associated with PVD.
CONCLUSION: Pseudophakic patients, and patients with retinal bullae or advanced PVR should be carefully screened for MRBs. Though Weiss ring is a good indicator of PVD, it may still be over diagnosed in some cases. PVD is associated with retinal bullae and pseudophakia, and inversely with traumatic RRD.]]></description>
<pubDate>2016/11/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Brijesh Takkar, Shorya Azad, Adarsh Shashni, Amar Pujari, Indrish Bhatia and Rajvardhan Azad]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Brijesh Takkar, Shorya Azad, Adarsh Shashni, Amar Pujari, Indrish Bhatia and Rajvardhan Azad</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161115]]></guid><cfi:id>905</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Evaluation of retinal nerve fiber layer thickness profile in thyroid ophthalmopathy without optic nerve dysfunction]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161116]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate retinal nerve fiber layer (RNFL) thickness profile in patients of thyroid ophthalmopathy with no clinical signs of optic nerve dysfunction.
METHODS: A prospective, case-control, observational study conducted at a tertiary care centre. Inclusion criteria consisted of patients with eyelid retraction in association with any one of: biochemical thyroid dysfunction, exophthalmos, or extraocular muscle involvement; or thyroid dysfunction in association with either exophthalmos or extra-ocular muscle involvement; or a clinical activity score (CAS)>3/7. Two measurements of RNFL thickness were done for each eye, by Cirrus HD-optical coherence tomography 6mo apart.
RESULTS: Mean age of the sample was 38.75y (range 13-70y) with 18 males and 22 females. Average RNFL thickness at first visit was 92.06±12.44 &micro;m, significantly lower than control group (101.28±6.64 &micro;m) (P=0.0001). Thickness of inferior quadrant decreased from 118.2±21.27 &micro;m to 115.0±22.27 &micro;m after 6mo (P=0.02). There was no correlation between the change in CAS and RNFL thickness.
CONCLUSION: Decreased RNFL thickness is an important feature of thyroid orbitopathy, which is an inherent outcome of compressive optic neuropathy of any etiology. Subclinical RNFL damage continues in the absence of clinical activity of the disease. RNFL evaluation is essential in Grave’s disease and active intervention may be warranted in the presence of significant damage.]]></description>
<pubDate>2016/11/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Kumari Mugdha, Apjit Kaur, Neha Sinha and Sandeep Saxena]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Kumari Mugdha, Apjit Kaur, Neha Sinha and Sandeep Saxena</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161116]]></guid><cfi:id>904</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Macular changes of neuromyelitis optica through spectral-domain optical coherence tomography]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161117]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the thickness of the retinal layers in the macula using spectral-domain optical coherence tomography (SD-OCT) in patients with neuromyelitis optica (NMO).
METHODS: Spectralis SD-OCT, utilizing automated macular layer segmentation, was performed in 26 NMO patients and 26 healthy controls. Visual function including visual field tests and pattern visual evoked potential were recorded in study subjects.
RESULTS: Forty-one eyes from 26 NMO patients and 52 eyes from 26 age- and sex-matched healthy controls were included. Besides total macular volume, peri-paipillary retinal nerve fiber layer (RNFL) thickness, the thickness of macular RNFL, ganglion cell layer (GCL) and inner plexiform layer (IPL) were also significantly reduced in NMO patients compared to those inhealthy controls (P<0.000). No differences were found in the thickness of macular inner nuclear layer (INL), outer plexiform layer (OPL), and outer nuclear layer (ONL) between the two groups. Reversely, the outer retinal layer (ORL) was shown to be thicker in NMO than controls (P<0.05). Compared with the peri-papillary RNFL thickness, the GCL thickness was demonstrated to correlate with visual function better.
CONCLUSION: The study provides in vivo evidence of retinal neural loss in NMO patients and demonstrates a better structure-function correlation between retinal ganglion cell and visual function than peri-papillary RNFL does. In addition, no evidence of primary neural damage is found. Besides, the photoreceptor cells and retinal pigments epithelial (RPE) cells presumably proliferated in compensation in NMO after retinal neural loss.]]></description>
<pubDate>2016/11/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Lu Cheng, Jing Wang, Xu He, Xun Xu and Zhen-Fen Ling]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Lu Cheng, Jing Wang, Xu He, Xun Xu and Zhen-Fen Ling</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161117]]></guid><cfi:id>903</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Adult reference values of the computerized diplopia test]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161118]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To estimate the adult reference values for measured deviations by a computerized diplopia test and testify the validity.
METHODS: Totally 391 participants were recruited and taken the computerized diplopia test. The plots and amplitude of deviations were recorded. The differences in different gender, age and visual acuity groups were analyzed respectively. Of 30 subjects were enrolled to testify the interobserver reliability. Another 46 subjects (including 26 normal subjects and 20 patients) were taken the test and theirs deviations were recorded to testify the validity of the reference value.
RESULTS: The max horizontal and vertical deviations were 2.55° and 0.76° with normal corrected visual acuity while 3.88° and 1.46° for subjects with poor corrected vision. The differences between age groups was insignificant (Z=3.615, 4.758; P=0.461, 0.313 for horizontal and vertical respectively). The max horizontal deviation of female was smaller than male (Z=-2.177; P=0.029)，but the difference in max vertical deviation was insignificant (Z=-1.296; P=0.195). The mean difference between observers were both -0.1°, with 95% confidence limits (CI) of -1.4° and 1.6° in max horizontal deviations while -2.1° and 1.8° in max vertical deviation. The mean deviation of 26 normal subjects was 1.02°±0.84° for horizontal and 0.47°±0.30° for vertical which both within the range of reference values. The mean deviation of 20 patients was 13.51°±11.69° for horizontal and 8.34°±8.58° for vertical which both beyond the reference range.
CONCLUSION: The max amplitude of horizontal and vertical deviation is pointed as the numerical parameters of computerized diplopia test. The reference values are different between normal corrected visual acuity and poor corrected vision. These values may useful for evaluating patients with diplopia in veriety conditions during clinical practice.]]></description>
<pubDate>2016/11/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ling-Yun Zhou, Tie-Juan Liu and Xue-Mei Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ling-Yun Zhou, Tie-Juan Liu and Xue-Mei Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161118]]></guid><cfi:id>902</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of femtosecond and microkeratome flaps creation on the cornea biomechanics during laser in situ keratomileusis: one year follow-up]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161007]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the corneal biomechanical outcomes at one year after laser in situ keratomileusis (LASIK) with the flaps created by Ziemer and Moria M2 microkeratome with 110 head and -20 blade.
METHODS: Totally 100 eyes of 50 consecutive patients were enrolled in this prospective study and divided into two groups for corneal flaps created by ZiemerFemto LDV and Moria M2 microkeratome with 110 head and -20 blade. Corneal biomechanical properties including cornea resistance factor (CRF) and cornea hysteresis (CH) were measured before and 1, 3, 6, 12mo after surgery by ocular response analyzer. Central cornea thickness and corneal flap thickness were measured by optical coherence tomography.
RESULTS: The ablation depth (P=0.693), residual corneal thickness (P=0.453), and postoperative corneal curvature (P=0.264) were not significant different between Ziemer group and Moria 110-20 group after surgery. The residual stromal bed thickness, corneal flap thickness, CH and CRF at 12mo after surgery were significant different between Ziemer group and Moria 110-20 group (P<0.01);Ziemer group gained better corneal biomechanical results. The CRF and CH increased gradually from 1 to 12mo after surgery in Ziemer group, increased from 1 to 6mo but decreased from 6 to 12mo in Moria 110-20 group. Both CRF and CH at one year after surgery increased with the increasing of residual cornea thickness; pre-LASIK CRF, CRF also increased with residual stromal bed thickness, while CH decreased with the increasing of pre-LASIK intraocular pressure and cornea flap thickness (P<0.01).
CONCLUSION: In one year follow-up, femtosecond laser can provide better cornea flaps with stable cornea biomechanics than mechanical microkeratome.]]></description>
<pubDate>2016/10/13 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Qian Sun, Zheng-Zheng Deng, Yue-Hua Zhou, Jing Zhang and Xiao-Yan Peng]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Qian Sun, Zheng-Zheng Deng, Yue-Hua Zhou, Jing Zhang and Xiao-Yan Peng</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161007]]></guid><cfi:id>901</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Trabeculectomy with Ex-PRESS implant versus Ahmed glaucoma valve implantation-a comparative study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161008]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the surgical outcomes of trabeculectomy with Ex-PRESS implant and Ahmed glaucoma valve (AGV) implantation.
METHODS: Patients who underwent trabeculectomy with Ex-PRESS implants or AGV implantation separately were included in this retrospective chart review. Main outcome measures were surgical failure and complications. Failure was defined as intraocular pressure (IOP) >21 mm Hg or <5 mm Hg on two consecutive visits after 3mo, reoperation for glaucoma, or loss of light perception. Eyes that had not failed were considered as complete success if they did not required supplemental medical therapy.
RESULTS: A total of 64 eyes from 57 patients were included: 31 eyes in the Ex-PRESS group and 33 eyes in the AGV group. The mean follow-up time was 2.6±1.1y and 3.3±1.6y, respectively. Patients in the AGV group had significantly higher baseline mean IOP (P=0.005), lower baseline mean visual acuity (VA) (P=0.02), and higher proportion of patients with history of previous trabeculectomy (P<0.0001). Crude failure rates were 16.1%, n=5/31 in the Ex-PRESS group and 24.2%, n=8/33 in the AGV group. The cumulative proportion of failure was similar between the groups, P=0.696. The proportion of eyes that experienced postoperative complications was 32.3% in the Ex-PRESS group and 60.1% in the AGV group (P=0.0229).
CONCLUSION: Trabeculectomy with Ex-PRESS implant and AGV implantation had comparable failure rates. The AGV group had more post-operative complications, but also included more complex cases with higher baseline mean IOP, worse baseline mean VA, and more previous glaucoma surgeries. Therefore, the results are limited to the cohort included in this study.]]></description>
<pubDate>2016/10/13 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Michael Waisbourd, Naomi Fischer, Hadas Shalev, Oriel Spierer, Elad Ben Artsi, Rony Rachmiel, Gabi Shemesh and Shimon Kurtz]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Michael Waisbourd, Naomi Fischer, Hadas Shalev, Oriel Spierer, Elad Ben Artsi, Rony Rachmiel, Gabi Shemesh and Shimon Kurtz</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161008]]></guid><cfi:id>900</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Implantable collamer lens for residual refractive error after corneal refractive surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161009]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the safety, efficacy, predictability and stability of implantable collamer lens (ICL) for residual refractive error after corneal refractive surgery.
METHODS: This study evaluated 19 eyes of 12 patients who underwent ICL implantation after corneal refractive surgeries. They were followed up for 1y to 5y of uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), manifest refractive error, flat and steep K value, axial length, intraocular pressure, corneal endothelial cell density, adverse events after ICL surgery.
RESULTS: The mean follow-up period was 39.05±19.22 mo (range, 1-5y). Spherical equivalent refractive error changed from -7.45±3.02 D preoperatively to -0.85±1.10 D 1wk to 1mo after ICL implantation, with the safety and efficacy indices being 1.12 and 1.15, respectively. A total of 52.63% of eyes were within ±0.5 D of the predicted spherical equivalents, 73.68% were within ±1.0 D. A trend of mild regression towards myopia with axial elongation after 5y was observed. One eye with mild anterior capsule opacity and retinal detachment 1y after surgery were observed.
CONCLUSION: ICL implantation is safe and effective for the correction of residual refractive error after corneal refractive surgeries, especially in moderate to high residual myopia.]]></description>
<pubDate>2016/10/13 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xun Chen, Xiao-Ying Wang, Xi Zhang, Zhi Chen and Xing-Tao Zhou]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xun Chen, Xiao-Ying Wang, Xi Zhang, Zhi Chen and Xing-Tao Zhou</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161009]]></guid><cfi:id>899</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[An eighteen-month follow-up study on the effects of Intravitreal Dexamethasone Implant in diabetic macular edema refractory to anti-VEGF therapy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161010]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the long-term efficacy and safety of dexamethasone implants in subjects affected by diabetic macular edema (DME) resistant to anti-vascular endothelial growth factor (VEGF) therapy.
METHODS: Thirty-two DME patients were enrolled. A 700 microgram slow release Intravitreal Dexamethasone Implant (Ozurdex&reg;) was placed in the vitreous cavity. All patients were followed for 18mo. Best-corrected visual acuity (BCVA) measured with Early Treatment Diabetic Retinopathy Study (ETDRS) and central macular thickness (CMT) exams were carried out at baseline (T0) and after 1 (T1), 3 (T3), 4 (T4), 6 (T6), 9 (T9), 12 (T12), 15 (T15), and 18mo (T18) post injection.
RESULTS: Repeated measures ANOVA showed an effect of treatment on ETDRS (P<0.0001). Post hoc analyses revealed that ETDRS values were significantly increased at T1, T3, T4, T9, and T15 (P<0.001) as compared to baseline value (T0). At T6, T12, and T18, ETDRS values were still statistically higher than baseline (P<0.001 vs T0). However, at these time points, we observed a trend to return to baseline conditions. ANOVA also showed an effect of treatment (P<0.0001). CMT decreased significantly at T1, T3, T4, T9, and T15 (P<0.001). At T6 (P<0.01), T12 and T18 (P<0.001) CMT was also significantly lower than T0 although a trend to return to the baseline conditions was also observed.
CONCLUSION: Our findings demonstrate that Intravitreal Dexamethasone Implant is a good option to improve BCVA and CMT in DME patients resistant to anti-VEGF therapy. Our data also show that the use of drugs administered directly into the vitreous allows achieving appropriate and long-lasting concentration at the site of disease without systemic side effects.]]></description>
<pubDate>2016/10/13 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Fernanda Pacella, Maria Rosaria Romano, Paolo Turchetti, Giovanna Tarquini, Anna Carnovale, Antonella Mollicone, Alessandra Mastromatteo and Elena Pacella]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Fernanda Pacella, Maria Rosaria Romano, Paolo Turchetti, Giovanna Tarquini, Anna Carnovale, Antonella Mollicone, Alessandra Mastromatteo and Elena Pacella</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161010]]></guid><cfi:id>898</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Association of macular pigment optical density with early stage of non-proliferative diabetic retinopathy in Chinese patients with type 2 diabetes mellitus]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161011]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To detect the association between macular pigment optical density (MPOD), which reflects the antioxidant ability of retina, and diabetic retinopathy (DR) and to investigate the correlated factors of MPOD.
METHODS: Totally 435 subjects of urban Chinese were recruited to the study and divided into 3 groups: non-diabetes mellitus controls (NDM), diabetic patients without retinopathy (DWR), and patients with early stage of non-proliferative diabetic retinopathy (DR). Demographic and lifestyle characteristics were ascertained by questionnaire. A food-frequency questionnaire, general physical and ophthalmic examinations were completed for all participants. MPOD was measured by heterochromatic flicker photometry. Foveal thickness was measured by optical coherence tomography. The difference of MPOD among 3 groups was analyzed by analysis of covariance. The correlation analyses of MPOD with the candidate influence factors were assessed using the generalized estimating equations (GEE) model.
RESULTS: Of the 435 participants, 34 could not perform the MPOD measurements. Final analysis included 401 subjects, including 48 were in DR group, 134 in DWR group, and 219 in NDM group. MPOD was not significantly different among DR (0.49±0.21), DWR (0.45±0.21), and NDM (0.49±0.17) groups (P=0.24) after adjustment for fasting plasma glycemia, central foveal thickness, green vegetables, Chinese wolfberry, carotene and vitamin E. For all the 401 participants included, MPOD was positively associated with central foveal thickness (E=0.0007, P=0.001), Chinese wolfberry (E=0.0345, P=0.01), and green vegetables (E=0.0596, P<0.001) intake.
CONCLUSION: The data suggest that MPOD level is not statistically significantly influenced by the onset of diabetes or early stage of DR in the studied population. MPOD level is positively associated with thicker central foveal thickness and higher intake of foods containing carotenoids.]]></description>
<pubDate>2016/10/13 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Chong-Yang She, Hong Gu, Jun Xu, Xiu-Fen Yang, Xue-Tao Ren and Ning-Pu Liu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Chong-Yang She, Hong Gu, Jun Xu, Xiu-Fen Yang, Xue-Tao Ren and Ning-Pu Liu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161011]]></guid><cfi:id>897</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of focal laser photocoagulation in eyes with mild to moderate non-proliferative diabetic retinopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161012]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report the effect of focal laser photocoagulation on both the severity of hard exudates (HEs) and the rate of disease progression in eyes with mild to moderate non-proliferative diabetic retinopathy (NPDR).
METHODS: We retrospectively reviewed the medical records of 33 patients (60 eyes) who had been diagnosed with mild to moderate NPDR between January 2006 and December 2012. The patients were divided into 2 groups: Group A (38 eyes in 20 patients treated using focal laser photocoagulation) and Group B (treated without laser photocoagulation). We also reviewed the best corrected visual acuity measurements, and the fundus photographs taken at both baseline and follow-up visits.
RESULTS: In Group A, HE severity grade had decreased significantly from baseline to the final visit (P<0.05), but this was not the case in Group B (P=0.662). The cumulative probabilities of retinopathy progression at 5y were 26% in Group A and 30% in Group B. Kaplan-Meier survival curves showed no significant difference between the groups with regard to retinopathy progression (P=0.805).
CONCLUSION: Focal laser photocoagulation reduced the levels of HEs in eyes with mild to moderate NPDR. However, the treatment was not able to decelerate the progression of DR.]]></description>
<pubDate>2016/10/13 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Seong Hun Jeong, Jung Il Han, Sung Won Cho, Dong Won Lee, Chul Gu Kim, Tae Gon Lee and Jong Woo Kim]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Seong Hun Jeong, Jung Il Han, Sung Won Cho, Dong Won Lee, Chul Gu Kim, Tae Gon Lee and Jong Woo Kim</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161012]]></guid><cfi:id>896</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical research of fenofibrate and spironolactone for acute central serous chorioretinopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161013]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the effectiveness of combined fenofibrate and spironolactone with fenofibrate alone for treatment of central serous chorioretinopathy (CSCR).
METHODS: Totally 60 patients (60 eyes) with a history of acute CSCR were randomed into two groups: group A with combination of fenofibrate (200 mg) and spironolactone (100 mg), and group B with only fenofibrate (200 mg). They were taken half an hour before meals and once per day for 8wk. The changes of the visual acuity, subjective symptom, ocular surface disease index (OSDI), the tear film and optical coherence tomography were observed at 2, 4, 6, and 8wk before and after treatment.
RESULTS: The best corrected visual acuity (BCVA, logMAR) was improved to 0.22 and 0.27 after treatment from baseline of 0.35 and 0.36 in groups A and B (P<0.05), respectively. After 8wk treatment, the central subfield thickness (CST), and subretinal fluid volumn (SFV) decreased significantly to 49.5% and 78.8% in group A and 37.0% and 57.2% in group B. There were significant differences of CST and SFV in both groups (all P<0.05).
CONCLUSION: Fenofibrate combined with spironolactone may have more clinical efficacy in the treatment of CSCR than fenofibrate only.]]></description>
<pubDate>2016/10/13 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yong Chai, Rong-Qiang Liu, Jing-Lin Yi, Ling-Hong Ye, Jing Zou, Nan Jiang and Yi Shao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yong Chai, Rong-Qiang Liu, Jing-Lin Yi, Ling-Hong Ye, Jing Zou, Nan Jiang and Yi Shao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161013]]></guid><cfi:id>895</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Peripapillary choroidal thickness in Chinese children using enhanced depth imaging optical coherence tomography]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161014]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the peripapillary choroidal thickness (PPCT) in Chinese children, and to analyze the influencing factors.
METHODS: PPCT was measured with enhanced depth imaging optical coherence tomography (EDI-OCT) in 70 children (53 myopes and 17 non-myopes) aged 7 to 18y, with spherical equivalent refractive errors between 0.50 and -5.87 diopters (D). Peripapillary choroidal imaging was performed using circular scans of a diameter of 3.4 mm around the optic disc. PPCT was measured by EDI-OCT in six sectors: nasal (N), superonasal (SN), superotemporal (ST), temporal (T), inferotemporal (IT) and inferonasal (IN), as well as global RNFL thickness (G).
RESULTS: The mean global PPCT was 165.49±33.76 &micro;m. The temporal, inferonasal, inferotemporal PPCT were significantly thinner than the nasal, superonasal, superotemporal segments PPCT were significantly thinner in the myopic group at temporal, superotemporal and inferotemporal segments. The axial length was significantly associated with the average global (β= -0.419, P=0.014), superonasal (β= -2.009, P=0.049) and inferonasal (β= -2.000, P=0.049) PPCT. The other factors (gender, age, SE) were not significantly associated with PPCT.
CONCLUSION: PPCT was thinner in the myopic group at temporal, superotemporal and inferotemporal segments. The axial length was found to be negatively correlated to PPCT. We need more further studies about the relationship between PPCT and myopia.]]></description>
<pubDate>2016/10/13 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xi-Shi Wu, Li-Jun Shen, Ru-Ru Chen and Zhe Lyu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xi-Shi Wu, Li-Jun Shen, Ru-Ru Chen and Zhe Lyu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161014]]></guid><cfi:id>894</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Evaluation of patients with dry eye disease for conjunctival Chlamydia trachomatis and Ureaplasma urealyticum]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161015]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the possibility of the development of dry eye disease (DED) as a result of persistent infection with Chlamydia trachomatis and Ureaplasma urealyticum in the conjunctiva of patients.
METHODS: This study was conducted on 58 patients of age range 20-50y, diagnosed with DED confirmed by Schirmer I test and tear breakup time. The non-dry eye control group included 27 subjects of the same age. Ocular specimens were collected as conjunctival scrapings and swabs divided into three groups: the first used for bacterial culture, the second and third taken to detect Chlamydia trachomatis and Ureaplasma urealyticum by direct fluorescent antibody (DFA) assay and polymerase chain reaction (PCR) method.
RESULTS: Chlamydia trachomatis was detected in 65.5% and 76% of DED patients by DFA and PCR methods respectively. Ureaplasma urealyticum was found in 44.8% of DED infected patients using the PCR method. Both organisms were identified in only 37.9% of DED patients found to be infected. Control subjects had a 22% detection rate of Chlamydia trachomatis by DFA assay versus a 7% detection rate by PCR; while Ureaplasma urealyticum was detected in 3.7% of the controls by PCR method. The conjunctival culture revealed that gram positive microorganisms represented 75% of isolates with coagulase negative Staphylococci the most common (50%) followed by Staphylococcus aureus (20%), whereas gram negative microorganisms occurred in 25% of cases, isolating Moraxella spp. as the most frequent organism.
CONCLUSION: Our results tend to point out that Chlamydia trachomatis and Ureaplasma urealyticum were detected in a moderate percentage of patients with DED, and could be a fair possibility for its development. PCR is more reliable in detecting Chlamydia trachomatis than DFA technique. The presence of isolated conjunctival bacterial microflora can be of some potential value.]]></description>
<pubDate>2016/10/13 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Maha Mohssen Abdelfattah, Rania Abdelmonem Khattab, Magda H. Mahran and Ebrahim S. Elborgy]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Maha Mohssen Abdelfattah, Rania Abdelmonem Khattab, Magda H. Mahran and Ebrahim S. Elborgy</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161015]]></guid><cfi:id>893</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Bicanalicular versus monocanalicular intubation after failed probing in congenital nasolacrimal duct obstruction]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161016]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the clinical outcomes of different intubation techniques in the cases of failed primary probing.
METHODS: This retrospective study was performed on 338 patients with the diagnosis of congenital nasolacrimal duct obstruction with age 1-4y that had failed primary probing. Intubation was performed under light sedation in operating room and the stent was left 3mo in place. Clinical outcome was investigated 3mo after tube removal.
RESULTS: Bicanalicular intubation method had higher complete and relative success rates compared to monocanalicular intubation (P=0.00). In addition, Monoka intubation had better outcomes compared to Masterka technique (P=0.046). No difference was found between genders but the higher the age, the better the outcomes with bicanalicular technique rather than monocanalicular.
CONCLUSION: Overall success rate of bicanalicular intubation is superior to monocanalicular technique especially in older ages. Also, based upon our clinical outcomes, Masterka intubation is not recommended in cases of failed probing.]]></description>
<pubDate>2016/10/13 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mohammad Taher Rajabi, Najmeh Zavarzadeh, Alireza Mahmoudi, Mohammad Karim Johari, Seyedeh Simindokht Hosseini, Yalda Abrishami and Mohammad Bagher Rajabi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mohammad Taher Rajabi, Najmeh Zavarzadeh, Alireza Mahmoudi, Mohammad Karim Johari, Seyedeh Simindokht Hosseini, Yalda Abrishami and Mohammad Bagher Rajabi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161016]]></guid><cfi:id>892</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Outcomes of endoscopic endonasal dacryocystorhinostomy for intractable lacrimal dacryostenosis and associated factors]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161017]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To examine the effects of patient age, canalicular obstruction, mode of anesthesia, and duration of nasolacrimal intubation on the outcomes of endoscopic endonasal dacryocystorhinostomy (DCR).
METHODS: Totally 56 eyes of 46 patients with prolonged epiphora underwent minimally invasive endoscopic endonasal DCR. A successful surgical outcome was defined as a significant improvement in symptoms, adequate water passage from the puncta to the nasal cavity, and patency of the DCR ostium. All outcomes were assessed at least 6mo after extubation. Fisher’s exact test was used to discuss the factors, and then the logistic regression analysis was made by SAS 9.4 software.
RESULTS: The overall success rate was 75.0%, and complete resolution was observed in 27 eyes. The success rate was higher for patients with ≥6mo intubation than for those with <6mo intubation. However, there were no significant differences in outcomes between groups stratified by age (<65 or ≥65y), presence or absence of canalicular obstruction, mode of anesthesia (local or general), and use or nonuse of a radiowave unit. One patient developed subcutaneous emphysema around the eye and nose and one developed subcutaneous hemorrhage after surgery.
CONCLUSION: Endoscopic endonasal DCR can be considered safe and minimally invasive with reasonable success rates, particularly when the duration of nasolacrimal intubation is ≥6mo.]]></description>
<pubDate>2016/10/13 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Tohru Tanigawa, Hirokazu Sasaki, Hiroshi Nonoyama, Yuichiro Horibe, Kunihiro Nishimura, Tetsuro Hoshino, Tetsuya Ogawa, Kenta Murotani, Hiromi Ueda and Masahiro Kaneda]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Tohru Tanigawa, Hirokazu Sasaki, Hiroshi Nonoyama, Yuichiro Horibe, Kunihiro Nishimura, Tetsuro Hoshino, Tetsuya Ogawa, Kenta Murotani, Hiromi Ueda and Masahiro Kaneda</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161017]]></guid><cfi:id>891</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Prevalence and characteristics of ophthalmological extra-intestinal manifestations in Chinese patients with inflammatory bowel disease]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161018]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the prevalence of ophthalmological extra-intestinal manifestations (O-EIMs) in Chinese patients with inflammatory bowel disease (IBD) and to identify risk factors for the development of O-EIMs.
METHODS: The study population consisted of Chinese patients with a definite diagnosis of Crohn’s disease (CD) or ulcerative colitis (UC) in a large teaching hospital between January 1995 and December 2014. Demographic and clinical characteristics of patients were extracted retrospectively.
RESULTS: In this twenty-year cohort, 645 IBD patients (517 with UC, 128 with CD) were registered. Among them 122 (18.9%) exhibited at least one EIM. Of 13 patients (2.0%) developed O-EIMs, 7 of CD (5.5%) and 6 of UC (1.2%). Clinical ophthalmological manifestations included redness (76.9%), burning (61.5%), pain (38.5%), itching (15.4%) of eyes and vision change (7.7%). O-EIMs included episcleritis (7), uveitis (5) and dry eye (1). O-EIMs were more prevalent in female (odds ratio for male 0.61, 95% confidence interval 0.52-0.73, P<0.0001), and patients who had IBD diagnosis at young age (odds ratio for patients aged >30 years 0.76, 95% confidence interval 0.65-0.88, P<0.0001).
CONCLUSION: The frequency of O-EIMs in Chinese patients with IBD is lower than the rates reported in the studies of European and American countries. Episcleritis and uveitis are the most common O-EIMs. O-EIMs are more frequent in patients with CD and more prevalent in female and patients who have IBD diagnosis at young age.]]></description>
<pubDate>2016/10/13 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ying-Chao Li, Wei-Zhi Li, Chang-Rui Wu, Yun Feng, Li Ren, Chen Mi and Yang Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ying-Chao Li, Wei-Zhi Li, Chang-Rui Wu, Yun Feng, Li Ren, Chen Mi and Yang Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20161018]]></guid><cfi:id>890</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of phacoemulsification on intraocular pressure in patients with primary open angle glaucoma and pseudoexfoliation glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170907]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the effect of phacoemulsification on intraocular pressure (IOP) in patients with primary open angle glaucoma (POAG) and pseudoexfoliation glaucoma (PXG).
METHODS: A retrospective comparative case series conducted at the Glaucoma Department at the Association to Prevent Blindness in Mexico. The study enrolled consecutive patients having phacoemulsification with intraocular lens (IOL) implantation and a diagnosis of POAG or PXG. Data about IOP values and number of glaucoma medications used was collected at baseline, 1, 3, 6 and 12mo postoperatively.
RESULTS: The study enrolled 88 patients (88 eyes). After phacoemulsification, there was a statistically significant reduction in IOP values and glaucoma medications use compared to baseline in both POAG and PXG patients (P<0.001). In the POAG group, a 20% decrease in IOP values was evidenced, and a 56.5% reduction in the number of medications used at the one-year follow-up. The PXG group showed a 20.39%, and a 34.46% decrease in IOP and number of medications used, respectively. A significant difference in the mean ΔIOP (postoperative changes in IOP) was evidenced between groups (P=0.005). The reduction of the postsurgical IOP mean values in both groups, the POAG group showed a greater reduction in IOP values compared to the PXG group.
CONCLUSION: In both types of glaucoma, phacoemulsification cataract surgery can result in a significant IOP reduction (20%) over a 12mo follow-up period. The number of medications used is also significantly reduced up to 12mo after surgery, especially in the PXG group.]]></description>
<pubDate>2017/9/5 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jesus Jimenez-Roman, Gabriel Lazcano-Gomez, Karina Martínez-Baez, Mauricio Turati, Rosario Gulías-Ca&ntilde;izo, Luis F. Hernández-Zimbrón, Lenin Ochoa-De la Paz, Rubén Zamora and Roberto Gonzalez-Salinas]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jesus Jimenez-Roman, Gabriel Lazcano-Gomez, Karina Martínez-Baez, Mauricio Turati, Rosario Gulías-Ca&ntilde;izo, Luis F. Hernández-Zimbrón, Lenin Ochoa-De la Paz, Rubén Zamora and Roberto Gonzalez-Salinas</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170907]]></guid><cfi:id>889</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Long-term efficacy and safety of ExPress implantation for treatment of open angle glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170908]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the long-term efficacy and safety of ExPress implantation and standard trabeculectomy in patients with primary open angle glaucoma (POAG).
METHODS: In this retrospective study, we compared 17 eyes treated by ExPress implantation with 23 eyes treated by trabeculectomy. Efficacy was assessed according to the relevant intraocular pressure (IOP) values and success rates during the first year of follow-up. Postoperative corneal endothelial cell loss was also compared.
RESULTS: The number of antiglaucoma medications and the IOP reduction were similar between the 2 groups during the follow-up period. Although the mean IOP was similar, the IOP-fluctuation rate during the early postoperative period was significantly lower in the ExPress group than in the trabeculectomy group (P=0.038). A Kaplan-Meier survival curve analysis showed no significant success-rate difference between the groups (P=0.810). The corneal endothelial cell loss rate, moreover, was significantly lower in the ExPress group (P=0.05).
CONCLUSION: ExPress implantation compared with trabeculectomy showed similar IOP-reduction and success rates along with lower IOP fluctuation and endothelial cell loss rates. For this reason, it can be considered to be the treatment of choice for patients with advanced glaucoma or low corneal endothelial cell density.]]></description>
<pubDate>2017/9/5 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Geun Young Lee, Chong Eun Lee, Kyoo Won Lee and Sam Seo]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Geun Young Lee, Chong Eun Lee, Kyoo Won Lee and Sam Seo</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170908]]></guid><cfi:id>888</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Influence of corneal power on circumpapillary retinal nerve fiber layer and optic nerve head measurements by spectral-domain optical coherence tomography]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170909]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the influence of corneal power on circumpapillary retinal nerve fiber layer (cpRNFL) and optic nerve head (ONH) measurements by spectral-domain optical coherence tomography (SD-OCT).
METHODS: Twenty-five eyes of 25 healthy participants (mean age 23.6±3.6y) were imaged by SD-OCT using horizontal raster scans. Disposable soft contact lenses of different powers (from ?11 to +5 diopters including 0 diopter) were worn to induce 2-diopter changes in corneal power. Differences in the cpRNFL and ONH measurements per diopter of change in corneal power were analyzed.
RESULTS: As corneal power increased by 1 diopter, total and quadrant cpRNFL thicknesses, except for the nasal sector, decreased by ?0.19 to ?0.32 μm (P<0.01). Furthermore, the disc, cup, and rim areas decreased by ?0.017, ?0.007, and ?0.015 mm2, respectively (P<0.001); the cup and rim volumes decreased by ?0.0013 and ?0.006 mm3, respectively (P<0.01); and the vertical and horizontal disc diameters decreased by ?0.006 and ?0.007 mm, respectively (P<0.001).
CONCLUSION: For more precise OCT imaging, the ocular magnification should be corrected by considering both the axial length and corneal power. However, the effect of corneal power changes on cpRNFL thickness and ONH topography are small when compare with those of the axial length.]]></description>
<pubDate>2017/9/5 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Kazunori Hirasawa and Nobuyuki Shoji]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Kazunori Hirasawa and Nobuyuki Shoji</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170909]]></guid><cfi:id>887</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Long-term outcome of highly myopic foveoschisis treated by vitrectomy with or without gas tamponade]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170910]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the long-term safety and efficacy of vitrectomy and internal limiting membrane (ILM) peeling with or without gas tamponade for highly myopic foveoschisis.
METHODS: We performed an open-label, observer-blinded clinical trial of 85 patients with myopic foveoschisis between 2000 and 2012. Patients were randomly allocated to one of two groups, those who received vitrectomy and ILM peeling without gas tamponade (no-gas group) or those who with gas tamponade (gas group) and follow up at least 5y.
RESULTS: Visual acuity of gas group improved from 0.82±0.33 to 0.79±0.73 in 6mo, improved to 0.71±0.67 in 1y and within this range in the following 4y. Visual acuity of no-gas group improved from 0.81±0.46 to 0.78±0.66 in 6mo, improved to 0.70±0.65 in 1y. The finial visual acuity of two groups were significantly increased compared with the baseline (P<0.05). The visual acuity was improved in 35 of 40 eyes (87.5%) in gas group and 29 of 33 eyes (87.9%) in no-gas group, while there were no significant differences between gas group and no-gas group in the visual acuity. The foveoschisis on optical coherence tomography (OCT) completely resolved in 5 of 40 eyes in 1mo, 14 eyes in 6mo and 40 eyes in 1y in the gas group. While the foveoschisis completely resolved in 4 of 33 eyes in 1mo, 10 eyes in 6mo and 33 eyes in 1y in the no-gas group.
CONCLUSION: Vitrectomy and ILM peeling without gas tamponade appears to be as effective in the treatment of myopic foveoschisis as vitrectomy and ILM with gas tamponade. However, eyes treated with no-gas tamponade showed more rapid resolution of myopic foveoschisis.]]></description>
<pubDate>2017/9/5 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Li-Na Yun and Yi-Qiao Xing]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Li-Na Yun and Yi-Qiao Xing</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170910]]></guid><cfi:id>886</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparative analysis of cytomegalovirus retinitis and microvascular retinopathy in patients with acquired immunodeficiency syndrome]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170911]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the clinical manifestation of cytomegalovirus (CMV) retinitis and microvascular retinopathy (MVR) in patients with acquired immunodeficiency syndrome (AIDS) in China.
METHODS: A total of 93 consecutive patients with AIDS, including 41 cases of CMV retinitis and 52 cases of MVR were retrospectively reviewed. Highly active antiretroviral therapy (HAART) status was recorded. HIV and CMV immunoassay were also tested. CD4+ T-lymphocyte count and blood CMV-DNA test were performed in all patients. Aqueous humor CMV-DNA test was completed in 39 patients. Ophthalmological examinations including best corrected visual acuity (BCVA, by International Standard Vision Chart), intraocular pressure (IOP), slit-lamp biomicroscopy, indirect ophthalmoscopy were performed.
RESULTS: In MVR group, the anterior segment examination was normal in all patients with a mean BCVA of 0.93±0.13. Blood CMV-DNA was 0 (0, 269 000) and 42 patients (80.77%) did not receive HAART. In CMV retinitis group, 13 patients (31.71%) had anterior segment abnormality. The mean BCVA was 0.64±0.35 and blood CMV-DNA was 3470 (0, 1 450 000). Nineteen patients (46.34%) had not received HAART. MVR group and CMV retinitis group the positive rates of aqueous CMV-DNA were 0 and 50%, respectively. Two patients with MVR progressed to CMV retinitis during the follow-up period.
CONCLUSION: In comparison of CMV, patients with MVR have relatively mild visual function impairment. Careful ophthalmological examination and close follow-up are mandatory, especially for patients who have systemic complications, positive CMV-DNA test and without received HAART.]]></description>
<pubDate>2017/9/5 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Chao Chen, Chun-Gang Guo, Li Meng, Jing Yu, Lian-Yong Xie, Hong-Wei Dong and Wen-Bin Wei]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Chao Chen, Chun-Gang Guo, Li Meng, Jing Yu, Lian-Yong Xie, Hong-Wei Dong and Wen-Bin Wei</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170911]]></guid><cfi:id>885</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Optical coherence tomography angiography of optic disc perfusion in non-arteritic anterior ischemic optic neuropathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170912]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the optic disc blood flow of non-arteritic ischemic optic neuropathy (NAION) eyes with normal eyes.
METHODS: The optic disc blood flow densities of diagnosed non-acute phase NAION eyes (21 eyes, 14 individuals) and normal eyes (19 eyes, 12 individuals) were detected via Optovue optical coherence tomography angiography (OCTA). The optic disc blood flow was measured via Image J software. Correlations between optic disc perfusion and visual function variables were assessed by linear regression analysis.
RESULTS: The average percentage of the optic disc non-perfusion areas in the non-acute phase NAION patients (17.84%±6.18%) was increased, when compared to the normal control eyes (8.61%±1.65%), and the difference was statistically significant (P<0.01). Moreover, there was a proportional correlation between the visual field mean defect (MD) and the optic disc non-perfusion area percentage, and the relationship was statistically significant (t=3.65, P<0.01, R2=0.4118). In addition, the critical correlation between the best corrected visual acuity (BCVA) and the optic disc non-perfusion area percentage was statistically significant (t=4.32, P<0.01, R2=0.4957).
CONCLUSION: The optic disc non-perfusion area percentages detected via OCTA in NAION eyes were significantly increased when compared with the normal eyes. Both the BCVA and MD were correlated with the optic disc flow detected, revealing that OCTA may be valuable in the diagnosis and estimation of NAION.]]></description>
<pubDate>2017/9/5 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jia-Wen Ling, Xue Yin, Qian-Yi Lu, Yi-Yi Chen and Pei-Rong Lu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jia-Wen Ling, Xue Yin, Qian-Yi Lu, Yi-Yi Chen and Pei-Rong Lu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170912]]></guid><cfi:id>884</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effects of higher-order aberrations on contrast sensitivity in normal eyes of a large myopic population]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170913]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To study the relation between higher-order aberrations (HOAs) and contrast sensitivity (CS) in normal eyes among a population of laser in situ keratomileusis (LASIK) candidates. 
METHODS: In 6629 eyes of 3315 LASIK candidates, CS were measured under dark environment at the spatial frequencies of 1.5, 3, 6, 12 and 18 cycles per degree (c/d), respectively, using an Optec 6500 visual function tester. Meanwhile, ocular HOAs were measured for a 6.0 mm pupil with a Hartmann-Shack wavefront analyzer.  
RESULTS: In the study, the subjects with an average spherical equivalent of -4.86±2.07 D were included. HOAs decreased from the third to the sixth order aberrations with predominant aberrations of third-order coma, trefoil and fourth-order spherical aberration. At low and moderate spatial frequencies, CS was negatively correlated with the third-order coma and trefoil aberrations, and decreased with increasing Z31, but increased with increasing Z3-3 and Z5-1. At high spatial frequencies, CS decreased with increasing Z3-3 and increased with increasing Z5-1. 
CONCLUSION: At a large pupil size of 6.0 mm, the third-order aberrations, but not the total aberrations, are the main factors affecting CS. Vertical coma is negatively correlated with CS.]]></description>
<pubDate>2017/9/5 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Peng-Fei Zhao, Shi-Ming Li, Jing Lu, Hong-Min Song, Jing Zhang, Yue-Hua Zhou and Ning-Li Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Peng-Fei Zhao, Shi-Ming Li, Jing Lu, Hong-Min Song, Jing Zhang, Yue-Hua Zhou and Ning-Li Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170913]]></guid><cfi:id>883</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Validity of autorefractor based screening method for irregular astigmatism compared to the corneal topography- a cross sectional study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170914]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To present a method of screening for irregular astigmatism with an autorefractor and its determinants compared to corneal topography.
METHODS: This cross-sectional validity study was conducted in 2013 at an eye hospital in Spain. A tabletop autorefractor (test 1) was used to measure the refractive status of the anterior surface of the cornea at two corneal meridians of each eye. Then corneal topography (test 2) and Bogan’s classification was used to group eyes into those with regular or no astigmatism (GRI) and irregular astigmatism (GRII). Test 1 provided a single absolute value for the greatest cylinder difference (Vr). The receiver operating characteristic (ROC) were plotted for the Vr values measured by test 1 for GRI and GRII eyes. On the basis a Vr value of 1.25 D as cut off, sensitivity, specificity were also calculated.
RESULTS: The study sample was comprised of 260 eyes (135 patients). The prevalence of irregular astigmatism was 42% [95% confidence interval (CI): 36, 48]. Based on test 2, there were 151 eyes in GRI and 109 eyes in GRII. The median Vr was 0.75 D (25% quartile, 0.5 D) for GRI and 1.75 D (25% quartile, 1.25 D) for GRII. The area under curve was 0.171 for GRI and 0.83 for GRII. The sensitivity of test I was 78.1% and the specificity was 76.1%.
CONCLUSION: A conventional autorefractor can be effective as a first level screening method to detect irregular corneal astigmatism in places where corneal topography facilities are not available.]]></description>
<pubDate>2017/9/5 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Alicia Galindo-Ferreiro, Julita De Miguel-Gutierrez, Manuel González-Sagrado, Alberto Galvez-Ruiz, Rajiv Khandekar, Silvana Schellini and Julio Galindo-Alonso]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Alicia Galindo-Ferreiro, Julita De Miguel-Gutierrez, Manuel González-Sagrado, Alberto Galvez-Ruiz, Rajiv Khandekar, Silvana Schellini and Julio Galindo-Alonso</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170914]]></guid><cfi:id>882</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Old canalicular laceration repair: a retrospective study of the curative effects and prognostic factors]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170611]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the epidemiology and surgical outcomes of old canalicular laceration and analyze the variables impacting on the prognosis of reparation.
METHODS: A retrospective review of all old canalicular laceration repairs from Jan. 1, 2008 to Dec. 30, 2015 was performed. Analyzed data included demographics, mechanisms of injury, the time from injury to repair, causes for delayed repair, old associated injuries, the types of surgery, and the effects of repair using canaliculus anastomosis combined with bicanalicular stent intubation.
RESULTS: Totally 148 patients with old canalicular laceration received surgical repair and were enrolled. The mean age at presentation was 32.52 years old (ranged from 3 to 63 years old). The 110 patients (74.32%) were male and 127 patients (85.81%) were adults (≥18 years old). The old upper, lower, and bicanalicular lacerations were found in 5 (3.38%), 39 (26.35%), and 104 patients (70.27%), respectively. The mechanism of old injury was primarily due to motor vehicle accidents (n=53, 35.81%). The mean time from injury to repair was 43.61mo (ranged from 1 to 360mo). Associated old ocular and orbit injuries were found in 65 patients (43.92%), and chronic dacryocystitis in 18 patients (12.16%). The main cause of delayed repair was that doctors or patients didn’t pay attention to the canalicular laceration because of the concurrent severe injuries (n=71, 47.97%). Totally 136 patients (91.89%) with old canalicular laceration underwent canaliculus anastomosis combined with bicanalicular stent intubation. In all of them, 20 patients (13.51%) were combined with dacryocystorhinostomy. In these cases, 132 patients (97.06%) attained anatomic success, 121 patients (88.97%) reported no epiphora (functional success), 11 patients (8.09%) reported significant epiphora anesis (functional improvement), and 4 (2.94%) reported no significant anesis (functional failure). Rates of anatomic success and functional success were significantly correlated with different canaliculus involved. However, rates of anatomic success and functional success were not significantly affected by the time from injury to repair.
CONCLUSION: The canalicular anastomosis combined with bicanalicular stent intubation could act as an effective therapeutics for old canalicular laceration.]]></description>
<pubDate>2017/6/14 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Fang Bai,Hai Tao,Yan Zhang,Peng Wang,Cui Han,Yi-Fei Huang and Ye Tao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Fang Bai,Hai Tao,Yan Zhang,Peng Wang,Cui Han,Yi-Fei Huang and Ye Tao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170611]]></guid><cfi:id>881</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of human autologous serum and fetal bovine serum on human corneal epithelial cell viability, migration and proliferation in vitro]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170612]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyze the concentration-dependent effects of autologous serum (AS) and fetal bovine serum (FBS) on human corneal epithelial cell (HCEC) viability, migration and proliferation.
METHODS: AS was prepared from 13 patients with non-healing epithelial defects Dulbecco's modified eagle medium/Ham’s F12 (DMEM/F12) with 5% FBS, 0.5% dimethyl sulphoxide (DMSO), 10 ng/mL human epidermal growth factor, 1% insulin-transferrin-selenium, then were incubated in serum media: DMEM/F12 supplemented by 5%, 10%, 15% or 30% AS or FBS. HCEC viability was analyzed using cell proliferation kit XTT, migration using a wound healing assay, proliferation by the cell proliferation enzyme-linked immunosorbent assay (ELISA) BrdU kit. Statistical analysis was performed using the generalized linear model, the values at 30% AS or 30% FBS were used as the baselines.
RESULTS: HCEC viability was the highest at 30% AS or 15% FBS and the lowest at 10% AS or 30% FBS application. HCEC migration was the quickest through 30% AS or 30% FBS and the slowest through 5% AS or 5% FBS concentrations. Proliferation was the most increased through 15% AS or 5% FBS and the least increased through 30% AS or 30% FBS concentrations. HCEC viability at 10% and 15% AS was significantly worse (P=0.001, P=0.023) compared to baseline and significantly better at 15% FBS (P=0.003) concentrations. HCEC migration was significantly worse (P≤0.007) and HCEC proliferation significantly better (P<0.001) in all concentration groups compared to baseline.
CONCLUSION: For the best viability of HCEC 30% AS or 15% FBS, for HCEC migration 30% AS or 30% FBS, for proliferation 15% AS or 5% FBS should be used. Therefore, we suggest the use of 30% AS in clinical practice.]]></description>
<pubDate>2017/6/14 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ming-Feng Wu,Tanja Stachon,Berthold Seitz,Achim Langenbucher and Nóra Szentmáry]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ming-Feng Wu,Tanja Stachon,Berthold Seitz,Achim Langenbucher and Nóra Szentmáry</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170612]]></guid><cfi:id>880</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Evaluation of visual quality of spherical and aspherical intraocular lenses by Optical Quality Analysis System]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170613]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the impact of spherical and aspherical intraocular lenses on the postoperative visual quality of age-related cataract patients using Optical Quality Analysis System (OQAS).
METHODS: Seventy-four eyes with age-related cataracts were randomly divided into spherical and aspherical lens implantation groups. Best-corrected visual acuity (BCVA) was measured preoperatively, one day, one week, two weeks, one month and two months after surgery. A biometric systems analysis using the OQAS objective scattering index (OSI) was performed.
RESULTS: There were no significant differences in visual acuity (P>0.05) before and after spherical and aspheric lens implantation. There was a negative linear correction between the OSI value and BCVA (r=-0.634, P=0.000), and positive corrections between the OSI value and the lens LOCUS III value of nucleus color (NC), nucleus opacity (NO), cortex (C) and posterior lens capsular (P) (r=0.704, P=0.000; r=0.514, P=0.000; r=0.276, P=0.020; r=0.417, P=0.000, respectively). OSI values of spherical vs aspherical lenses were 11.5±3.6 vs 11.8±3.4, 4.1±0.9 vs 3.3±0.8, 3.5±0.9 vs 2.7±0.7, 3.3±0.8 vs 2.6±0.7, 3.2±0.7 vs 2.5±0.8, and 3.2±0.8 vs 2.5±0.8 before and 1d, 1, 2wk, 1 and 2mo after surgery, respectively. All time points varied significantly (P<0.01) between the two groups.
CONCLUSION: Aspherical IOLs does not significantly affect visual acuity compared with spherical IOLs. The OSI value, was significantly lower in the aspherical lens group compared with the spherical lens. This study shows that objective visual quality of aspheric IOLs is better than that of the spherical lens by means of OQAS biological measurement method.]]></description>
<pubDate>2017/6/14 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yan Chen,Xue Wang,Chuan-Di Zhou and Qiang Wu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yan Chen,Xue Wang,Chuan-Di Zhou and Qiang Wu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170613]]></guid><cfi:id>879</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Viscocanalostomy combined with trabeculotomy and mitomycin C in the treatment of primary congenital glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170614]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the long-term outcome of viscocanalostomy combined with trabeculotomy and mitomycin C in the treatment of primary congenital glaucoma.
METHODS: This is a retrospective study. Forty-two eyes of 26 patients with primary congenital glaucoma were enrolled. Intraocular pressure (IOP), corneal diameter (mm) and cup/disc (C/D) were measured before and after the surgery respectively. Follow-up period was 30mo.
RESULTS: The mean preoperative IOP was 30.6±7.35 mm Hg. Of the 42 eyes, 2 eyes were required conversion to trabeculectomy for the absence of Schlemm’s canal. Of remained 40 eyes, 38 eyes (95%) achieved successful IOP control. The average postoperative IOP was 11.69±4.18 mm Hg at 12mo. The mean reduction was 18.91 mm Hg (P<0.0001). Eighteen (75%) eyes presented a reduction in corneal diameter, and 25 (62.5%) eyes presented a C/D ratio reversal after the surgery. There was no serious complication in any patients over the follow-up period.
CONCLUSION: Viscocanalostomy combined with trabeculotomy and mitomycin C is useful in the management of primary congenital glaucoma.]]></description>
<pubDate>2017/6/14 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Chao-Xu Qian,Yuan Zong,Qin Chen and Zhi-Lan Yuan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Chao-Xu Qian,Yuan Zong,Qin Chen and Zhi-Lan Yuan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170614]]></guid><cfi:id>878</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Analyzing cytokines as biomarkers to evaluate severity of glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170615]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyze cytokines as biomarkers for evaluation of severity of glaucoma.
METHODS: This was a prospective case-control study including 29 eyes with glaucoma. Besides, 28 eyes with senile cataract were used as control. Patients were classified into four groups: acute angle closure glaucoma (AACG), chronic angle closure glaucoma (CACG), primary open angle glaucoma (POAG) and senile cataract. Undiluted vitreous samples were collected, then vitreous concentrations of 9 types of cytokines were determined by cytometric bead assay system: γ-interferon (IFNg), interleukin (IL)-10, IL-2, IL-4, IL-5, interferon-γ-inducible protein (IP)-10, monocyte chemoattractant protein (MCP)-1, tumor necrosis factor (TNF) -α, and vascular endothelial growth factor (VEGF). We also recorded the intraocular pressure (IOP) of patients in each group and Pearson correlated analysis was performed to analysis the correlation between each type of cytokine with IOP.
RESULTS: Vitreous levels of IL-2, IL-5, MCP-1, TNF-α and IP-10 were significantly higher (P<0.05) in AACG group. Patients with AACG, CACG and POAG have higher IOP than senile cataract, but we didn’t find any significant correlation between IOP with any type of the cytokines.
CONCLUSION: Inflammation and immune reaction have a strong link with the pathology of glaucoma especially AACG. Some cytokines may act as biomarkers to evaluate the severity of glaucoma. Anti-inflammatory treatments and controlling of IOP are necessary for the therapy of glaucoma.]]></description>
<pubDate>2017/6/14 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yao Tong,Ya-Li Zhou,Yan Zheng,Manas Biswal,Pei-Quan Zhao and Zhao-Yang Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yao Tong,Ya-Li Zhou,Yan Zheng,Manas Biswal,Pei-Quan Zhao and Zhao-Yang Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170615]]></guid><cfi:id>877</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Ocular surface evaluation in eyes with chronic glaucoma on long term topical antiglaucoma therapy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170616]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate ocular surface changes and its correlation with the central corneal subbasal nerve fibre layer in chronic glaucoma patients.
METHODS: A prospective comparative study of ocular surface evaluation was performed in 50 eyes of 25 patients using two or more antiglaucoma medications for at least 6mo and 50 eyes of 25 normal subjects without any ocular problems as controls. The study parameters evaluated included visual acuity, intraocular pressure, ocular surface evaluation parameters [fluorescein break-up time (FTBUT), Schirmer’s I test, ocular surface staining scores and ocular surface disease index score (OSDI)], central corneal sensation (Cochet Bonnett aesthesiometer), central subbasal nerve fiber layer density (SBNFLD) by confocal microscopy.
RESULTS: The mean values in the glaucoma cases and control groups respectively were as follows: OSDI score (35.89±16.07/6.02±3.84; P=0.001), Schirmer’s I test score (7.63±2.64 mm/12.86±1.93 mm; P=0.001), FTBUT (9.44±2.76s/11.8±1.88s; P=0.001), corneal (5.7±2.33/ 1.1±0.58; P=0.001) and conjunctival staining score (5.06±1.94/0.84±0.46; P=0.001), corneal sensitivity (4.68±0.44/5.07±0.37; P=0.076), mean subbasal nerve fiber number (3.58±0.99/5.40±1.70; P=0.001), SBNFL length (1101.44±287.56 μm/1963.70±562.56 μm; P=0.001) and density (6883.94±1798.03 μm/mm2/12 273.15±3516.04 μm/mm2; P=0.001). Dry eye severity of level 2 and 3 was seen in 66% of glaucoma group. Corneal (R2=0.86) and conjunctival staining (R2=0.71) and OSDI score (R2=0.67) showed statistically significant negative correlation with central corneal SBNFLD while FTBUT (R2=0.84), corneal sensitivity (R2=0.52) showed positive correlation to central corneal SBNFLD in the long term topical antiglaucoma medication group.
CONCLUSION: Ocular surface changes and antiglaucoma therapy induced dry eye is found to be associated with decreased SBNFLD in eyes on long term topical antiglaucoma medications.]]></description>
<pubDate>2017/6/14 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Manu Saini,Murugesan Vanathi,Tanuj Dada,Tushar Agarwal,Rebika Dhiman and Sudarshan Khokhar]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Manu Saini,Murugesan Vanathi,Tanuj Dada,Tushar Agarwal,Rebika Dhiman and Sudarshan Khokhar</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170616]]></guid><cfi:id>876</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Peptidome profiling of human serum of uveal melanoma patients based on magnetic bead fractionation and mass spectrometry]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170617]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To find new biomarkers for uveal melanoma (UM) by analyzing the serum peptidome profile.
METHODS: Proteomic spectra in patients with UM before and after operation were analyzed and compared with those of healthy controls. Magnetic affinity beads were used to capture serum peptides and matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometer were used to compile serum peptide profiles.
RESULTS: A panel of 49 peptides were differentially expressed between UM patients and controls, of which 33 peptides were of higher intensities in patient group and 16 peptides were of higher intensities in control group. Based on combined use of these potential markers, peptides with mean molecular masses of 1467 and 9289.0 Da provide high sensitivity (83.3%), specificity (100%) and accuracy rate (93.0%) together to differentiate melanoma patients from healthy controls. At the time point of 6mo postoperatively, the levels of many peptides differentially expressed before surgery showed no more statistical difference between the patients and the control group. Fibrinogen α-chain precursors were identified as potential UM markers.
CONCLUSION: We have shown that a convenient and fast proteomic technique, affinity bead separation and MALDI-TOF analysis combined with bioinformatic software, facilitates the identification of novel biomarkers for UM.]]></description>
<pubDate>2017/6/14 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xiang-Yu Shi,Qing Li,Wen-Bin Wei and Li-Ming Tao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiang-Yu Shi,Qing Li,Wen-Bin Wei and Li-Ming Tao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170617]]></guid><cfi:id>875</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Frequency of diabetic retinopathy and associated risk factors in Khartoum, Sudan: population based study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170618]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the frequency and associated risk factors of diabetic retinopathy among Sudanese individuals with diabetes attending Makka Eye complex in Khartoum, Sudan.
METHODS: The cross sectional hospital based study recruited 316 individuals with diabetes from Makkah Eye Complex Retina Clinic. Standard questionnaire was used to collect demographic data, medical history and life style characteristics. Blood samples were taken to measure HbA1c and lipid profile. Fundus and slit lamp examination were performed for screening of diabetic retinopathy.
RESULTS: Among 316 participants, 187 (59.2%) were males and 129 (40.8%) were females. The mean age of participants was 58.7±10.5y. The overall frequency of retinopathy was 261 (82.6%). The percentages of the total participants with proliferative diabetic retinopathy (PDR) were 126 (39.9%) and non-proliferative diabetic retinopathy (NPDR) were 135 (42.7%). Importantly, duration of diabetes mellitus (DM) (72.2% of more than 10y), being on oral hypoglycaemic drugs (versus insulin), and hypertension were all significant risk factors for diabetic retinopathy (P=0.00, 0.01 and 0.00 respectively). Complications of diabetes like diabetic foot (17.7%), history of amputation (6.7%) and clinically significant macular edema (CSME) (47.4%) of the eyes were all significant risk factors (P<0.05). Logistic regression analysis showed that duration of diabetes, hypertension and CSME were found to be absolute risk factors (P=0.007, 0.003 and 0.000 respectively). Duration of DM of more than 10y have more than double risk (OR=2.8), while having hypertension triples the risk of retinopathy (OR=3.1).
CONCLUSION: High rates of diabetic retinopathy are noted among individuals with diabetes attending Makkah Eye hospital in capital Khartoum. Urgent strategies are needed to monitor and treat hypertension and optimize diabetes control in individuals with diabetes. More investment in diabetes services is urgently needed.]]></description>
<pubDate>2017/6/14 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Einas S Elwali,Ahmed O Almobarak,Mona A Hassan,Amir A Mahmooud,Heitham Awadalla and Mohamed H Ahmed]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Einas S Elwali,Ahmed O Almobarak,Mona A Hassan,Amir A Mahmooud,Heitham Awadalla and Mohamed H Ahmed</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170618]]></guid><cfi:id>874</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of even and odd-order aberrations on the accommodation response]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170619]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the potential effect that odd and even-order monochromatic aberrations may have on the accommodation response of the human eye.
METHODS: Eight healthy subjects with astigmatism below 1 D, best corrected visual acuity 20/20 or better and normal findings in an ophthalmic examination were enrolled. An adaptive optics system was used in order to measure the accommodation response of the subjects’ eyes under different conditions: with the natural aberrations being present, and with the odd and even-order aberrations being corrected. Three measurements of accommodation response were monocularly acquired at accommodation demands ranging from 0 to 4 D (0.5 D step).
RESULTS: The accommodative lag was greater for the accommodative demands of 1.5, 3, 3.5 and 4 D for the condition in which the even-order aberrations were corrected, in comparison to that obtained for the natural aberrations and corrected odd-order aberrations for the same accommodation demands. No statistically significant differences were found between the accommodation responses under the three conditions.
CONCLUSION: The odd and even-order aberrations are not helping the visual system to accommodate, because their partial correction do not affect the accommodation performance.]]></description>
<pubDate>2017/6/14 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Aikaterini I. Moulakaki, Antonio J. Del &Aacute;guila-Carrasco, José J. Esteve-Taboada and Robert Montés-Micó]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Aikaterini I. Moulakaki, Antonio J. Del &Aacute;guila-Carrasco, José J. Esteve-Taboada and Robert Montés-Micó</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170619]]></guid><cfi:id>873</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of corneal biomechanics in Sj&ouml;gren’s syndrome and non-Sj&ouml;gren’s syndrome dry eyes by Scheimpflug based device]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170508]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the corneal biomechanics of Sj&ouml;gren’s syndrome (SS) and non-SS dry eyes with Corneal Visualization Scheimpflug Technology (CorVis ST).
METHODS: Corneal biomechanics and tear film parameters, namely the Schirmer I test value, tear film break-up time (TBUT) and corneal staining score (CSS) were detected in 34 eyes of 34 dry eye patients with SS (SSDE group) and 34 dry eye subjects without SS (NSSDE group) using CorVis ST. The differences of the above parameters between the two groups were examined, and the relationship between corneal biomechanics and tear film parameters were observed.
RESULTS: The differences in age, sex, intraocular pressure (IOP) and central corneal thickness (CCT) were not significant between the two groups (P>0.05). The tear film parameters had significant differences between the SSDE group and NSSDE group (all P<0.05). Patients in the SSDE group had significantly lower A1-time and HC-time, but higher DA (P=0.01, 0.02, and 0.02, respectively) compared with the NSSDE group. In the SSDE group, DA was negatively correlated with TBUT (rho=-0.38, P=0.03); HC-time was negatively correlated with CSS (rho=-0.43, P=0.02). In the NSSDE group, HC-time was again negatively correlated with CSS (rho=-0.39, P=0.02).
CONCLUSION: There are differences in corneal biomechanical properties between SSDE and NSSDE. The cornea of SSDE tends to show less “stiffness”, as seen by a significantly shorter A1-time and HC-time, but larger DA, compared with the cornea of NSSDE. Biomechanical parameters can be influenced by different tear film parameters in both groups.]]></description>
<pubDate>2017/5/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Qin Long,Jing-Yi Wang,Dong Xu and Ying Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Qin Long,Jing-Yi Wang,Dong Xu and Ying Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170508]]></guid><cfi:id>872</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Iontophoresis-assisted corneal crosslinking using 0.1% riboflavin for progressive keratoconus]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170509]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report the clinical results of iontophoresis-assisted epithelium-on corneal crosslinking (I-CXL) using 0.1% riboflavin in distilled water for progressive keratoconus.
METHODS: In this prospective clinical study, we examined 94 eyes of 75 patients with progressive keratoconus who were treated with I-CXL using 0.1% riboflavin in distilled water. Best correct visual acuity (BCVA), Scheimpflug tomography, corneal topography, anterior segment optical coherence tomography, intraocular pressure, and endothelial cell density were evaluated at baseline and 1, 3, 6, 12, and 24mo after I-CXL.
RESULTS: After 24mo I-CXL, compared to the level at baseline, BCVA significantly improved 0.14±0.07 (P=0.010); mean keratometry signifi&shy;cantly decreased 0.72±1.97 (P=0.021); maximum keratometry significantly reduced 2.30±5.01 (P=0.014); central keratoconus index significantly reduced 0.04±0.08 (P=0.007). The demarcation line was visible in 83.1% of eyes at 1mo after treatment, with a depth of 298.95±51.97 μm, and gradually indistinguishable. One eye had repeat treatment. Intraocular pressure and endothelial cell density did not change significantly.
CONCLUSION: I-CXL using 0.1% riboflavin halts keratoconus progression within 24mo, resulting in a significant improvement in visual and topographic parameters. Moreover, the depth of the demarcation line is similar to that previously reported in standard epithelium-off CXL procedures.]]></description>
<pubDate>2017/5/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hong-Zhen Jia,Xu Pang,Zheng-Jun Fan,Na Li,Gang Li and Xiu-Jun Peng]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hong-Zhen Jia,Xu Pang,Zheng-Jun Fan,Na Li,Gang Li and Xiu-Jun Peng</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170509]]></guid><cfi:id>871</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Safety of hydroimplantation in cataract surgery in patients with pseudoexfoliation syndrome]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170510]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the safety of hydroimplantation in cataract surgery in patients with pseudoexfoliation syndrome.
METHODS: This prospective randomized study comprised 100 eyes of 100 consecutive patients who underwent cataract surgery and implantation of foldable intraocular lens (IOL). Each eye was assigned to group 1 or group 2. Hydroimplantation without using viscoelastic agent as group 1 (n=50), and hydroxypropylmethylcellulose (Eyevisc, Biotech, India) was used in group 2 (n=50).
RESULTS: There were no statistically significant differences in central corneal thickness (CCT) and corneal endothelial cell count (ECC) between both groups at each visit and percentage change in CCT and ECC (P>0.05). The mean intraocular pressure (IOP) at postoperative 5h increased statistically significantly in group 2 (P<0.001). There was no statistically significant difference in IOP between two groups, before and after surgery excluding the 24h postoperative IOP, but patients in group 2 had higher IOP than that in the group 1 at 24h after surgery (P=0.035). No case in either group experienced posterior capsular rupture, or zonular dialysis. Fixation of the globe during IOL implantation was better in group 1 than that in group 2.
CONCLUSION: Hydroimplantation has advantages in terms of IOP changes and duration of the surgery and seems to be safe in patients with pseudoexfoliation syndrome.]]></description>
<pubDate>2017/5/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Tevfik O&#287;urel, Reyhan O&#287;urel, Zafer Onaran and Kemal &Ouml;rnek]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Tevfik O&#287;urel, Reyhan O&#287;urel, Zafer Onaran and Kemal &Ouml;rnek</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170510]]></guid><cfi:id>870</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Modified deep sclerectomy combined with Ex-PRESS filtration device versus trabeculectomy for primary open angle glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170511]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the efficacy of modified deep sclerectomy combined with Ex-PRESS shunt versus trabeculectomy in primary open angle glaucoma.
METHODS: This is a prospective cohort comparative single-center study. Forty-nine eyes of 49 patients were enrolled in the study. Patients were randomly divided into two groups. Group A (22 patients) underwent classic trabeculectomy and group B (27 patients) underwent modified deep sclerectomy combined with insertion of Ex-PRESS model P50 drainage device.
RESULTS: Mean age was 69±7y in group A and 64±8y in group B (P=0.03). The mean reduction was 11.1±5.7 mm Hg in group A compared to 15.8±5.7 mm Hg in group B at 6mo (P=0.006), and 9.8±4.9 mm Hg and 15.4±4.7 mm Hg respectively at 1y (P=0.0001). Regarding the postoperative glaucoma medication, significant difference was observed between the two groups (in favour of group B) only at 6mo (P=0.017). At the end of the follow-up period complete success rate in group A was 68.2% compared to 92.6% in group B (χ2 test, P=0.07) and qualified success rate was 100% in both groups.
CONCLUSION: Modified deep sclerectomy combined with Ex-PRESS shunt may provide comparable IOP reduction with fewer complications in management of primary open angle glaucoma.]]></description>
<pubDate>2017/5/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Vassilios Kozobolis,Georgios D. Panos,Aristeidis Konstantinidis,Miguel Teus and Georgios Labiris]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Vassilios Kozobolis,Georgios D. Panos,Aristeidis Konstantinidis,Miguel Teus and Georgios Labiris</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170511]]></guid><cfi:id>869</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Aqueous proinflammatory cytokines in acute primary angle-closure eyes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170512]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate changes of proinflammatory cytokines in aqueous humor of patients with acute primary angle-closure (APAC) and age-related cataracts.
METHODS: Twenty eyes of 20 APAC patients and 15 eyes of 15 age-related cataract patients were included in this cross-sectional study. Aqueous humor samples were collected prospectively. The levels of 20 proinflammatory cytokines were evaluated in the aqueous humor of the APAC and cataract patients using the multiplex bead immunoassay technique. Clinical data were collected for correlation analysis.
RESULTS: Seven of the 20 proinflammatory cytokines included in the magnetic bead panel were detectable in both APAC eyes and cataract eyes: interleukin (IL)-10, IL-12, IL-15, IL-21, IL-6, chemokine (C-C motif) ligand 20, and tumor necrosis factor alpha (TNF-α). IL-27 was only detectable in APAC eyes. Compared with the cataract eyes, the APAC eyes had significantly elevated concentrations of IL-12 (P=0.036), IL-15 (P=0.001), IL-6 (P=0.012), and IL-27 (only detectable in APAC eyes). Age was positively correlated with IL-12 (P=0.022) and IL-6 (P=0.037), and time elapsed between APAC onset and aqueous humor samples collection was positively correlated with IL-15 (P=0.037), IL-27 (P=0.040), and TNF-α (P=0.042).
CONCLUSION: Several proinflammatory cytokines including IL-12，IL-15, IL-6 and IL-27, were elevated in the APAC eyes and may be implicated in its pathologic mechanism.]]></description>
<pubDate>2017/5/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yao-Ming Liu,Shi-Da Chen,Xing-Yi Li,Wen-Bin Huang,Fei Li,Jia-Wei Wang,Ying-Qi Li and Xiu-Lan Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yao-Ming Liu,Shi-Da Chen,Xing-Yi Li,Wen-Bin Huang,Fei Li,Jia-Wei Wang,Ying-Qi Li and Xiu-Lan Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170512]]></guid><cfi:id>868</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Implantation of trabecular micro-bypass stent using a novel “landing strip” technique]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170513]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To describe a novel technique of creating a landing strip within the trabecular meshwork to guide trabecular micro-bypass stent (iStent) implantation in patients who underwent phacoemulsification.
METHODS: Thirty-four eyes from 30 patients who underwent iStent implantation after phacoemulsification from May 2014 to February 2015 were included in our retrospective study. All iStents were implanted via the “landing strip” technique. A 25-gauge microvitreoretinal blade was used to bisect the trabecular meshwork to less than 1 clock-hour, effectively creating a landing strip. The iStent applicator was pressed along the landing strip and then the stent was released into the trabecular meshwork.
RESULTS: Of the 34 eyes with iStent implantation, 27 (79.4%) eyes had primary open-angle glaucoma, 6 (17.6%) eyes had pseudoexfoliation glaucoma, and 1 (2.9%) eye had ocular hypertension. At 6-month follow-up (n=17), the mean number of hypotensive medications decreased from 2.2±1.2 at baseline to 0.8±1.3 (P=0.05) and mean intraocular pressure decreased from 19.7±4.1 mm Hg at baseline to 16.7±2.1 mm Hg (P=0.58). Two eyes (5.9%) required subsequent trabeculectomy.
CONCLUSION: The “landing strip” technique appears to be an effective way to assist with iStent implantation.]]></description>
<pubDate>2017/5/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Cindy X. Zheng,Marlene R. Moster,Priyanka Gogte,Yang Dai,Remy S. Manzi and Michael Waisbourd]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Cindy X. Zheng,Marlene R. Moster,Priyanka Gogte,Yang Dai,Remy S. Manzi and Michael Waisbourd</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170513]]></guid><cfi:id>867</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Quality of life in glaucoma patients after selective laser trabeculoplasty]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170514]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare quality of life and treatment satisfaction between patients who had selective laser trabeculoplasty (SLT) and those on medication.
METHODS: A prospective clinical trial on 143 glaucoma patients that received SLT and a control group that continued using anti glaucoma medication was conducted. Tear break-up time (BUT), punctuate keratitis, need for help, use of artificial tears and the treatment satisfaction survey of intraocular pressure (IOP) were measured at baseline, 6 and 12mo.
RESULTS: SLT was able to reduce the mean number of medications needed from 1.56±0.81 to 0.42±0.66 at six months and to 0.33±0.69 at one year. Punctuate keratitis was observed significantly less often (12.24%) after SLT than before (35.94%; P=0.03). Use of artificial tears and BUT did not change significantly after SLT (P>0.05). At baseline, patients in the SLT group were significantly less convinced of medication effectiveness (P=0.006) and complained more about side effects (P=0.003). After SLT, these patients had significantly more confidence in their therapy (P<0.001), showed less side effects (P=0.006), complained less about changes in appearance of the eyes (P=0.003) and were less inconvenienced by the use of eye drops (P<0.001).
CONCLUSION: SLT is able to improve treatment-related quality of life in glaucoma patients.]]></description>
<pubDate>2017/5/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Myrjam De Keyser,Maya De Belder and Veva De Groot]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Myrjam De Keyser,Maya De Belder and Veva De Groot</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170514]]></guid><cfi:id>866</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Removal of intraocular foreign body in anterior chamber angle with prism contact lens and 23-gauge foreign body forceps]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170515]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To introduce a novel approach in removal of anterior chamber angle foreign body (ACFB) using a prism contact lens and 23-gauge foreign body forceps.
METHODS: Data of 42 eyes of 42 patients who had undergone removal of ACFB using a prism contact lens and 23-gauge foreign body forceps from January 2008 to October 2013 were collected and analyzed. Twenty eyes in group A received the conventional approach by using toothed forceps through corneal limbus incision, and 22 eyes in group B underwent the novel method through the opposite corneal limbus incision.
RESULTS: The success rate of ACFB once removal was 75% (15/20) in group A, and 100% (22/22) in group B. The average operation time of group A was significantly longer compared with group B (34.9±9.88min vs 22.13±8.85min; P<0.05). The average size of corneal limbus incision in group A was significantly larger than that of group B (4.85±1.89 mm vs 3.95±1.17 mm; P<0.05). The corneal limbus incision suturing were conducted in all eyes in group A, and only 5 eyes in group B.
CONCLUSION: Removal of ACFB using a prism contact lens and 23-gauge foreign body forceps is a safer, more effective, and convenient technique compared with the conventional approach.]]></description>
<pubDate>2017/5/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yan-Ming Huang,Hua Yan,Jin-Hong Cai and Hai-Bo Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yan-Ming Huang,Hua Yan,Jin-Hong Cai and Hai-Bo Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170515]]></guid><cfi:id>865</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Correlation of neutrophil/lymphocyte and platelet/lymphocyte ratio with visual acuity and macular thickness in age-related macular degeneration]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170516]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the place of neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in the diagnosis of and prognosis for neovascular age-related macular degeneration (AMD).
METHODS: One hundred AMD patients and 100 healthy controls were included in the study. Blood samples were obtained from the venous blood, which is used for routine analysis, and these samples were subjected to complete blood count. NLR was defined as the neutrophil count divided by the number of lymphocytes, and PLR was defined as the platelet count divided by the number of lymphocytes.
RESULTS: No statistically significant difference was observed between the two groups under consideration in terms of demographic features (P>0.05). The average NLR in the patient group was found to be significantly higher than that in the healthy control group (P<0.05). The average PLR was significantly higher in the patient group as compared to the control group (P<0.05). As best corrected visual acuity (BCVA) increased, both NLR and PLR decreased (significant negative correlations at 49.8% and 63.0%, respectively), whereas as central macular thickness (CMT) increased, both NLR and PLR increased (significant positive correlations at 59.3% and 70.0%, respectively).
CONCLUSION: NLR and PLR levels are higher among neovascular AMD patients as compared to healthy control group. NLR and PLR levels were found to be inversely proportional to BCVA and directly proportional to CMT.]]></description>
<pubDate>2017/5/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Elvan Alper Sengul,Ozgur Artunay,Alev Kockar,Ceyda Afacan,Rifat Rasier,Palmet Gun,Nazli Gul Yalcin and Erdal Yuzbasioglu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Elvan Alper Sengul,Ozgur Artunay,Alev Kockar,Ceyda Afacan,Rifat Rasier,Palmet Gun,Nazli Gul Yalcin and Erdal Yuzbasioglu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170516]]></guid><cfi:id>864</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Foveal thickness reduction after anti-vascular endothelial growth factor treatment in chronic diabetic macular edema]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170517]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report foveal thickness reduction in eyes with resolution of macular edema and recovery of a foveal depression after one-year of anti-vascular endothelial growth factor (anti-VEGF) therapy for center-involving diabetic macular edema (DME).
METHODS: Foveal thickness was assessed with optical coherence tomography to determine the central subfield foveal thickness (CSFT) and macular volume in 42 eyes with DME (CSFT>275 &micro;m). Evaluations also included measurement of best-corrected visual acuity (BCVA), and were performed at baseline, and upon foveal depression recovery achieved after 12 monthly intravitreal injections of either 1.5 mg/0.06 mL bevacizumab (n=21) or 0.5 mg/0.05 mL ranibizumab (n=21). Data was compared to 42 eyes of normally sighted, non-diabetic, healthy individuals with similar age, gender and race distributions.
RESULTS: Mean baseline BCVA was 0.59±0.04 and 0.32± 0.03 logMAR (P<0.001) after treatment and resolution of DME, with all, but 3 eyes, showing BCVA improvement. Mean CSFT before treatment was 422.0±20.0 &micro;m, and after treatment, decreased to 241.6±4.6 &micro;m (P<0.001), which is significantly thinner than CSFT found in control subjects (272.0±3.4 &micro;m; P<0.001). Moreover, in 33/42 DM eyes (79%), CSTF was thinner than the matched control eye. Macular volume showed comparable results, but with lower differences between groups (control: 8.5±0.4 mm3; DME: 8.2±1.0 mm3; P=0.0267).
CONCLUSION: DME eyes show significantly lower foveal thickness than matched controls after DME resolution achieved with one-year anti-VEGF therapy. Further investigation into the reasonsfor this presumable retinal atrophy using fluorescein angiography and functional parameters as well as establishing possible predictors is warranted. This finding should be considered during the treatment of DME.]]></description>
<pubDate>2017/5/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Gabriel Willmann,Antonio Brunno Nepomuceno,Katharina Messias,Leticia Barroso,Ingrid U. Scott,André Messias and Rodrigo Jorge]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Gabriel Willmann,Antonio Brunno Nepomuceno,Katharina Messias,Leticia Barroso,Ingrid U. Scott,André Messias and Rodrigo Jorge</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170517]]></guid><cfi:id>863</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Prognostic factors of short-term outcomes of intravitreal ranibizumab in diabetic macular edema]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170518]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the prognostic factors for short-term visual and anatomical improvement of intravitreal ranibizumab (IVR) for diabetic macular edema (DME).
METHODS: Fifty-one eyes from 35 patients that received three consecutive monthly IVR for DME with moderate visual loss were retrospectively recruited; all cases had their baseline best-corrected visual acuity (BCVA) between 20/400 and 20/40. BCVA and central subfield thickness (CST) at baseline and month 3 were collected. Linear mixed models were used to evaluate the prognostic factors for visual and anatomical improvement at month 3.
RESULTS: Younger age, poorer baseline BCVA and proliferative diabetic retinopathy (PDR) were correlated with better visual improvement at month 3 (P=0.002, 0.0001 and 0.007, respectively). Thicker CST and the presence of subretinal fluid at baseline were correlated with a greater reduction in CST (P<0.0001 and P=0.018, respectively). The presence of epiretinal membrane or previous posterior subtenon injection of triamcinolone acetonide (PSTA) were associated with a smaller reduction in CST (P=0.029 and 0.018, respectively), but had no significant effects in visual improvement at month 3 (P>0.05 for both).
CONCLUSION: For eyes with DME and moderate visual loss, those with younger age, poorer baseline BCVA or PDR tend to have better visual improvement after three consecutive monthly IVR. Epiretinal membrane or previous PSTA result in less resolution of CST, but do not significantly affect visual improvement.]]></description>
<pubDate>2017/5/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[I-An Lai,Wei-Cherng Hsu,Chung-May Yang and Yi-Ting Hsieh]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>I-An Lai,Wei-Cherng Hsu,Chung-May Yang and Yi-Ting Hsieh</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170518]]></guid><cfi:id>862</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical characteristics of sibling patients with comitant strabismus]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170519]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the clinical characteristics of sibling patients with comitant strabismus.
METHODS: Sibling patients who were diagnosed with comitant strabismus from January 2005 to December 2014 were retrospectively reviewed. Factors including age, sex, types of strabismus, refractive errors, angle of deviation, and coexistence of other strabismus were analyzed.
RESULTS: A total of 62 patients (31 pairs of siblings) were included. Of these, 26 pairs had intermittent exotropia, 3 had accommodative esotropia, and 2 had infantile esotropia. There were no pairs with different subtypes of strabismus. The age at first visit was 3.7±2.6y and the mean follow-up period was 30.5±24.1mo. In siblings with intermittent exotropia, there was no difference in age of onset, age at operation, or refractive errors between the first and second-born children. The 20 (77%) pairs of siblings with exotropia showed more than 80% concordance of maximum angle of deviation during follow-up. In the 9 pairs in which both siblings had an operation, the final angle of deviation after the operation was 8.2±8.1 prism diopters (PD) in first-born children and 8.6±6.5 PD in second-born children.
CONCLUSION: The subtypes of strabismus are the same in all pairs of siblings and clinical characteristics of strabismus are similar between the first and second-born children. This similarity could be an indicator for the diagnosis of second-born children. Further prospective study including a larger number of sibling patients is needed.]]></description>
<pubDate>2017/5/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Haeng Jin Lee,Seong-Joon Kim and Young Suk Yu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Haeng Jin Lee,Seong-Joon Kim and Young Suk Yu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170519]]></guid><cfi:id>861</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Ocular manifestation and their associated factors among HIV/AIDS patients receiving highly active antiretroviral therapy in Southern Ethiopia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170520]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the pattern of ocular manifestation and associated factors among human immunodeficiency virus (HIV) /acquired immunodeficiency syndrome (AIDS) patients on highly active antiretroviral therapy (HAART) at Hawassa University Referral Hospital, Southern Ethiopia.
METHODS: A cross sectional study was conducted from January 2014 to April 2015. After obtaining informed written consent, 240 adult HIV/AIDS patients on HAART were randomly selected regardless of their ophthalmic symptoms, WHO status or CD4 count. Data were collected using structured questionnaires and ophthalmologic clinical examination. Data were entered and analyzed using SPSS version 20.0 software.
RESULTS: The mean duration of HAART was 62.5mo. The prevalence of HIV related ocular manifestation was 14.2%. Seborrheic blepharitis (5%) was the most common ocular manifestation, followed by squamoid conjunctival growth (3.8%). The rate of ocular manifestation was significantly higher among study participants who had CD4+ count <200 cells/μL (AOR=3.83; 95%CI: 1.315-11.153), low duration of HAART (AOR=3.0; 95%CI: 1.305-6.891) and who had primary school education [odds ratio (OR) =2.8; 95%CI: 1.105-7.099]. Prevalence of visual impairment and blindness was 10.9% and 5.8%, respectively.
CONCLUSION: HAART may be the reason for the decline in the prevalence of ocular manifestation in HIV/AIDS patients in the study area. Ophthalmologic screening of HIV/AIDS patients, especially those with CD4 counts of <200/μL cells and in the first five years of HAART follow-up is recommended to reduce visual impairment and/or blindness.]]></description>
<pubDate>2017/5/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Anteneh Amsalu,Kindie Desta,Demiss Nigussie and Demoze Delelegne]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Anteneh Amsalu,Kindie Desta,Demiss Nigussie and Demoze Delelegne</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170520]]></guid><cfi:id>860</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Suitability of open-field autorefractors as pupillometers and instrument design effects]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170411]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the agreement and repeatability of the pupil measurement obtained with VIP-200 (Neuroptics), PowerRef II (Plusoptix), WAM-5500 (Grand Seiko) and study the effects of instrument design on pupillometry.METHODS: Forty patients were measured twice in low, mid and high mesopic. Repeatability was analyzed with the within-subject standard deviation (Sw) and paired t-tests. Agreement was studied with Bland-Altman plots and repeated measures ANOVA. Instrument design analysis consisted on measuring pupil size with PowerRef II simulating monocular and binocular conditions as well as with proximity cues and without proximity cues.RESULTS: The mean difference (±standard deviation) between test-retest for low, mid and high mesopic conditions were, respectively: -0.09 (±0.16), -0.05 (±0.18) and -0.08 (±0.23) mm for Neuroptics, -0.05 (±0.17), -0.12 (±0.23) and -0.17 (±0.34) mm for WAM-5500, -0.04 (±0.27), -0.13 (±0.37) and -0.11 (±0.28) mm for PowerRef II. Regarding agreement with Neuroptics, the mean difference for low, mid and high mesopic conditions were, respectively: -0.48 (±0.35), -0.83 (±0.52) and -0.38 (±0.56) mm for WAM-5500, -0.28 (±0.56), -0.70 (±0.55) and -0.61 (±0.54) mm for PowerRef II. The mean difference of binocular minus monocular pupil measurements was: -0.83 (±0.87) mm; and with proximity cues minus without proximity cues was: -0.30 (±0.77) mm.CONCLUSION: All the instruments show similar repeat-ability. In all illumination conditions, agreement of Neuroptics with WAM-5500 and PowerRef II is not good enough, which can be partially induced due to their open field design.]]></description>
<pubDate>2017/4/14 11:24:40</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Carles Otero,Mikel Aldaba,Oriol Ferrer,Andrea Gascón,Juan C Ondategui-Parra and Jaume Pujol]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Carles Otero,Mikel Aldaba,Oriol Ferrer,Andrea Gascón,Juan C Ondategui-Parra and Jaume Pujol</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170411]]></guid><cfi:id>859</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Long-term rotational stability and visual outcomes of a single-piece hydrophilic acrylic toric IOL: a 1.5-year follow-up]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170412]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the rotational stability and visual outcomes of a single-piece hydrophilic acrylic toric intraocular lenses (IOL) over a 1.5-year follow-up period. Data from the 6-month follow-up study have been previously reported.
METHODS: Forty eyes of 26 cataract patients (mean age: 72.8±7.9y) with pre-existing corneal astigmatism of 1.0 to 2.6 D were enrolled in the study. Mean axial length was 23.17±0.88 mm. Main outcome measures after implantation of the Torica-aA IOL (HumanOptics) were IOL rotational stability, subjective refraction, astigmatism correction, uncorrected and corrected distance visual acuity (UDVA, CDVA).
RESULTS: There was no significant change in the parameters evaluated between the 6-month and 1.5-year follow-ups. At last visit, mean absolute IOL rotation (objective method) was 1.81°±1.87° (range 0.00° to 7.20°) with 78.6% of eyes having IOL rotation <3°, 92.9% of eyes <5° and 100% of eyes <8°. No patient required secondary IOL repositioning during the course of the study. Mean residual refractive cylinder was -0.60±0.40 D. There was a significant reduction in the magnitude of the J0 vector postoperatively (P<0.0001) with a mean absolute change of 0.76±0.40 D. The mean J45 vector was close to zero preoperatively and postoperatively and didn’t change significantly (P=0.28). Mean monocular UDVA and CDVA was 0.09±0.12 logMAR and -0.01±0.12 logMAR, respectively. No treatment with Nd:YAG laser was required.
CONCLUSION: The Torica-aA IOL shows good and stable visual performance and rotational stability over a 1.5-year follow-up period.]]></description>
<pubDate>2017/4/14 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Balázs Gy&ouml;ngy&ouml;ssy, Paul Jirak and Ulrich Sch&ouml;nherr]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Balázs Gy&ouml;ngy&ouml;ssy, Paul Jirak and Ulrich Sch&ouml;nherr</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170412]]></guid><cfi:id>858</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A pilot study of intraocular lens explantation in 69 eyes in Chinese patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170413]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To study the effects of intraocular lens (IOL) explantation and demographic characteristics.
METHODS: Retrospective non-comparative case series. Clinical data recorded from patient charts included the following: demographic, preoperative and postoperative characteristics; complications; surgical methods, and changes in visual acuity.
RESULTS: A total of 69 eyes in 67 Chinese patients who received IOL explants were studied. The patients’ mean age at the time of explantation was 46.1 years old [SD 22.5 (6-85)], and 37 patients were female (55.2%). Regarding employment, 47.8% were farmers, 23.9% were retired, 16.4% were students, 4.5% were unemployed, 3% were workers, and 4.5% were other (including staff members, teachers and officers). The main reasons for explantation were dislocation/decentration in 41 cases (59.4%) and retinal detachment in 10 cases (14.5%). The third most prevalent cause was incorrect lens power in 7 eyes (10.1%). The remaining reasons were endophthalmitis in 6 cases (8.7%), posterior capsular opacity in 3 eyes (4.3%), and impacting retinal surgery operation in 2 cases (2.9%). The main comorbidities were high myopia in 18 eyes (26.1%), trauma in 8 eyes (11.6%), retinal detachment in 6 eyes(8.7%), congenital cataracts in 8 eyes (11.6%), and Marfan’s syndrome in 2 eyes (2.9%). The mean time from implantation to explantation was 4.0y [SD 4.2 (0.005-15)]. Treatment after explantation included posterior chamber IOL implantation in 44 eyes (63.8%) and aphakia in 25 eyes (36.2%). After surgery, the best corrected visual ability (BCVA) was improved in 50 cases (72.5%), including 28 patients (40.6%) in whom visual ability was improved by more than two lines.
CONCLUSION: Dislocation/decentration is the main cause for explantation, and high myopia is a main risk factor. Posterior chamber IOL implantation remains the most elected treatment after explantation.]]></description>
<pubDate>2017/4/14 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Fang Chai,Bo Ma,Xin-Guang Yang,Juan Li and Mei-Fang Chu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Fang Chai,Bo Ma,Xin-Guang Yang,Juan Li and Mei-Fang Chu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170413]]></guid><cfi:id>857</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Nutrient patterns and risk of cataract: a case-control study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170414]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the relation between nutrient patterns and cataract risk.
METHODS: This is a hospital-based case-control study with 97 cataract patients and 198 matched controls. Dietary consumption was collected through a valid food frequency questionnaire (FFQ). Nutrient patterns were detected by applying factor analysis. Unconditional logistic regression models were used to estimate odds ratio (ORs) and 95%CIs.
RESULTS: We extracted 5 main nutrient patterns. Factor 1 included niacin, thiamin, carbohydrates, protein, zinc, vitamin B6 and sodium (sodium pattern). Factor 2 was characterized by oleic acid, monounsaturated fats, polyunsaturated fats, linoleic acid, trans fatty acid, linolenic acid, vitamin E and saturated fats (fatty acid pattern). The third factor represented high intake of vitamin B12, vitamin D, cholesterol and calcium (mixed pattern). The 4th pattern was high in intake of beta and alpha carotene, vitamin A and vitamin C (antioxidant pattern). Finally, the 5th pattern loaded heavily on docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) (omega-3 pattern). In crude and multivariate analysis, the sodium pattern was associated with increased risk of cataract (OR=1.97, 95%CI: 1.09-3.96). The fatty acid pattern elevated the risk of cataract (OR=1.94, 95%CI: 1.1-3.86). Antioxidant pattern was associated with a significant 79% reduced risk (2nd category compared with the 1st). Omega-3 pattern was significantly negatively associated with risk of cataract (P=0.04).
CONCLUSION: These findings imply that nutrient patterns reflecting a combined consumption of nutrients might be important in the etiology of cataract. Additional studies with more efficient designs are warranted to confirm our findings.]]></description>
<pubDate>2017/4/14 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Fatemeh Sedaghat,Matin Ghanavati,Parisa Nezhad Hajian,Sara Hajishirazi,Mehdi Ehteshami and Bahram Rashidkhani]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Fatemeh Sedaghat,Matin Ghanavati,Parisa Nezhad Hajian,Sara Hajishirazi,Mehdi Ehteshami and Bahram Rashidkhani</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170414]]></guid><cfi:id>856</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Selective laser trabeculoplasty in pseudophakic and phakic eyes: a prospective study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170415]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the efficacy of selective laser trabeculoplasty (SLT) in replacing medical therapy in pseudophakic and phakic eyes.
METHODS: Subgroup of a prospective randomized clinical trial including patients with primary open angle glaucoma or ocular hypertension controlled with medication. Of 38 pseudophakic eyes were matched with 38 phakic eyes. SLT was offered as a way to decrease medication while maintaining the same low eye pressure. SLT was performed over 360°, at 3ns, spotsize 400 &micro;m, 100 spots. Data [intraocular pressure (IOP), number of medications needed] were measured at 1h, 1wk, 1, 3, 6 and 12mo. An independent-samples t-test was performed to compare baseline characteristics of the phakic and the pseudophakic group and differences in evolution of mean IOP and number of used medications. Chi-squared analysis was performed to investigate proportions of fast, slow and non-responders.
RESULTS: The mean IOP measurement was 13.00± 2.88 mm Hg in the phakic group (38 eyes) and 13.51±
CONCLUSION: IOP lowering effect of SLT is comparable between phakic and pseudophakic eyes.]]></description>
<pubDate>2017/4/14 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Myrjam De Keyser,Maya De Belder and Veva De Groot]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Myrjam De Keyser,Maya De Belder and Veva De Groot</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170415]]></guid><cfi:id>855</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of isolated-check visual evoked potential and standard automated perimetry in early glaucoma and high-risk ocular hypertension]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170416]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the diagnostic performance of isolated-check visual evoked potential (icVEP) and standard automated perimetry (SAP), for evaluating the application values of icVEP in the detection of early glaucoma.
METHODS: Totally 144 subjects (288 eyes) were enrolled in this study. icVEP testing was performed with the Neucodia visual electrophysiological diagnostic system. A 15% positive-contrast (bright) condition pattern was used in this device to differentiate between glaucoma patients and healthy control subjects. Signal-to-noise ratios (SNR) were derived based on a multivariate statistic. The eyes were judged as abnormal if the test yielded an SNR≤1. SAP testing was performed with the Humphrey Field Analyzer II. The visual fields were deemed as abnormality if the glaucoma hemifield test results outside normal limits; or the pattern standard deviation with P<0.05; or the cluster of three or more non-edge points on the pattern deviation plot in a single hemifield with P<0.05, one of which must have a P<0.01. Disc photographs were graded as either glaucomatous optic neuropathy or normal by two experts who were masked to all other patient information. Moorfields regression analysis (MRA) used as a separate diagnostic classification was performed by Heidelberg retina tomograph (HRT).
RESULTS: When the disc photograph grader was used as diagnostic standard, the sensitivity for SAP and icVEP was 32.3% and 38.5% respectively and specificity was 82.3% and 77.8% respectively. When the MRA Classifier was used as the diagnostic standard, the sensitivity for SAP and icVEP was 48.6% and 51.4% respectively and specificity was 84.1% and 78.0% respectively. When the combined structural assessment was used as the diagnostic standard, the sensitivity for SAP and icVEP was 59.2% and 53.1% respectively and specificity was 84.2% and 84.6% respectivlely. There was no statistical significance between the sensitivity or specificity of SAP and icVEP, regardless of which diagnostic standard was based on.
CONCLUSION: The diagnostic performance of icVEP is not better than that of SAP in the detection of early glaucoma.]]></description>
<pubDate>2017/4/14 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xiang-Wu Chen and Ying-Xi Zhao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiang-Wu Chen and Ying-Xi Zhao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170416]]></guid><cfi:id>854</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Evaluation of hyperreflective foci as a prognostic factor of visual outcome in retinal vein occlusion]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170417]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the potential role of hyperreflective foci (HF) as a prognostic indicator of visual outcome in patients with macular edema (ME) due to retinal vein occlusion (RVO).
METHODS: We retrospectively reviewed 50 eyes of 50 patients with ME due to ischemic central retinal vein occlusion (CRVO), non-ischemic CRVO and branch retinal vein occlusion (BRVO) who were treated with anti-vascular endothelial growth factor (anti-VEGF) at Beijing Tongren Eye Center from January 2013 to July 2016. All patients underwent best-corrected visual acuity (BCVA), spectral domain optical coherence tomography (SD-OCT) at baseline and follow-up. Such factors were evaluated and compared among three groups as baseline and final BCVA, central retinal thickness (CRT), external limiting membrane (ELM) status and the numbers of HF in different position. Multiple linear regression analysis was employed to analyze the relationship between baseline HF and final BCVA. Changes of HF before and after treatment were evaluated too.
RESULTS: Among three groups, HF could be located in each retinal layers, as well as in vitreous cavity. The mean HF in outer retinal layer (ORL) at baseline was 5.29±8.48 in ischemic CRVO with intact ELM, 1.93±2.76 in non-ischemic CRVO, and 1.75±2.05 in BRVO. With disrupted ELM, the mean HF in ORL increased. There was statistically difference of HF in ORL between intact and disrupted ELM. The numbers of HF in ORL were associated with poor visual outcome among three groups. However, HF in inner retinal layer (IRL) and vitreous cavity were not associated with poor visual outcome. Meanwhile, the baseline HF in ORL and vitreous cavity reduced significantly in non-ischemic CRVO and BRVO after anti-VEGF treatment.
CONCLUSION: The numbers of HF in ORL are prognostic factors associated with the final BCVA in patients with ME due to RVO after anti-VEGF treatment.]]></description>
<pubDate>2017/4/14 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Bin Mo,Hai-Ying Zhou,Xuan Jiao and Feng Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Bin Mo,Hai-Ying Zhou,Xuan Jiao and Feng Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170417]]></guid><cfi:id>853</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Association of choroidal thickness with early stages of diabetic retinopathy in type 2 diabetes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170418]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the correlation between choroidal thickness (CT) and the early stages of diabetic retinopathy (DR) in type 2 diabetic patients.
METHODS: We divided 83 diabetic patients (51-80 years of age; 50 females) into non diabetic retinopathy group (NDR) and mild/moderate nonproliferative diabetic retinopathy (NPDR) group, and compared them with 26 non-diabetic control subjects (51-78 years of age; 16 females). Subfoveal choroidal thickness (SFCT) and parafoveal choroidal thickness (PFCT) were measured using enhanced depth imaging spectral-domain optical coherence tomography (EDI-OCT). Ocular health status, disease duration, body mass index, and hemoglobin A1c (HbA1c) were recorded.
RESULTS: The mean ages of the NDR, NPDR, and control groups were 68.0±6.9y, 67.8±6.4y, and 65.1±6.3y, respectively (P=0.17). Pearson correlation of the right and left eyes for the control subjects was 0.95 and for the NDR subjects was 0.93. SFCT for the right eyes of the controls was 252.77±           41.10 μm, which was significantly thicker than that of the right eyes in NDR group (221.51±46.56 μm) and the worse eyes of the NPDR group (207.18±61.87 μm; ANOVA, P<0.01). In the diabetic patients pooled together, age was the only variable significantly associated with SFCT (multiple linear regression analysis, P=0.01).
CONCLUSION: CT decreased significantly in the NDR and mild/moderate NPDR eyes compared with the control eyes. Age is significantly associated with SFCT in the diabetic patients. Diabetic choroidopathy may be present before clinical retinopathy.]]></description>
<pubDate>2017/4/14 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Zhi-Jun Shen,Xiu-Fen Yang,Jun Xu,Chong-Yang She,Wen-Wen Wei,Wan-Lu Zhu and Ning-Pu Liu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zhi-Jun Shen,Xiu-Fen Yang,Jun Xu,Chong-Yang She,Wen-Wen Wei,Wan-Lu Zhu and Ning-Pu Liu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170418]]></guid><cfi:id>852</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of postoperative optical quality according to the degree of decentering of V4c implantable collamer lens]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170419]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the clinical outcomes of V4c implantable collamer lens (Hole ICL) implantation with regard to the optical quality assessed according to different degrees of decentering.
METHODS: This included 49 eyes that received conventional ICL and 94 eyes that received Hole ICL. The eyes that received Hole ICL were divided into three groups according to the degree of decentering: group 1, central hole within 1 hole diameter (HD) from the pupil center; group 2, central hole within 1 HD to 2 HD; and group 3, central hole within 2 HD to 3 HD. Visual acuity (VA), intraocular pressure (IOP), and spherical equivalent (SE) values were assessed at 1wk, 1 and 3mo after surgery. The ocular modulation transfer function, Strehl ratio, objective scattering index, and higher order aberrations (HOAs) were measured for 4-mm pupils at 3mo after surgery.
RESULTS: There were no significant differences in VA, IOP, and SE among the conventional and Hole ICL groups. With regard to HOAs, values for coma and spherical aberrations showed no differences. The total HOA and trefoil values were significantly higher in group 2 than in group 1 (P=0.02, 0.03, respectively). There were no significant differences among groups with regard to other optical quality parameter at 3mo after surgery.
CONCLUSION: Our results suggest that Hole ICL implantation provides satisfactory visual quality that is equivalent to that provided by conventional ICL, regardless of the presence of central hole and degree of decentering.]]></description>
<pubDate>2017/4/14 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Min Ji Park,Hye Min Jeon,Kyoung Heon Lee and Sang Youp Han]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Min Ji Park,Hye Min Jeon,Kyoung Heon Lee and Sang Youp Han</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170419]]></guid><cfi:id>851</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of visual effects of FS-LASIK for myopia centered on the coaxially sighted corneal light reflex or the line of sight]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170420]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare visual quality after femtosecond laser in situ keratomileusis (FS-LASIK), between the coaxially sighted corneal light reflex (CSCLR) group and conventional ablation line of sight (LOS) group.
METHODS: In total, 243 eyes (122 patients) were treated with centration on the CSCLR (visual axis) and 238 eyes (119 patients) treated with centration on the pupil center (LOS). Postoperative outcomes [uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity (BSCVA)], safety index, efficacy index, refractive outcome, ablation center distance from the visual axis, corneal high-order aberrations, subjective discomfort glare and shadowing incidence rate, and contrast sensitivity at 1, 3, and 6mo were measured and compared.
RESULTS: The mean age was 27.77±7.1y in the CSCLR group and 26.03±7.70y in the LOS group. Preoperatively, the manifest refraction spherical equivalent (MRSE) was -6.68±2.60 D in the CSCLR group and -6.65±2.68 D in the LOS group. The postoperative UCVA, BSCVA, MRSE (-0.03±0.263 D in the CSCLR group, -0.05±0.265 D in the LOS group), efficacy index (1.04, 1.03), and safety index (1.09, 1.08) were not significantly different between the groups (all P>0.05). In total, 3% lost one line and more of BSCVA in the CSCLR group, as 9% in the LOS group postoperatively (P<0.05). The ablation center deviation was 0.20±0.15 mm from the visual axis (Pentacam system default setting; range, 0-0.75 mm) in the CSCLR group, and 0.43±0.22 mm (range, 0-1.32 mm) in the LOS group (P<0.0001). Statistically significant greater augmentation of total corneal higher-order aberrations (0.15±0.10 &micro;m and 0.20±0.12 &micro;m respectively, P=0.03) and vertical and horizontal coma (P<0.0001) were noted in the LOS group. Subjective discomfort glare and shadowing incidence rates were 8.59% and 17.5% in the CSCLR and LOS groups, respectively (P<0.05). The 1-month postoperative contrast sensitivity visual acuity in the CSCLR group was significantly higher than that in the LOS group on contrast (100%, 25%, 10%) with a dark background, but there was no significant difference between the groups at 3 or 6m.
CONCLUSION: Myopic LASIK centered on the CSCLR achieves significantly lower induction of loss of BSCVA, corneal high-order aberrations, and lower risk of subjective discomfort glare and shadowing, and lower decline in early contrast sensitivity by comparison with centration on the LOS, giving advantages in visual quality postoperatively.]]></description>
<pubDate>2017/4/14 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jing Zhang,Shi-Sheng Zhang,Qin Yu and Jing-Cai Lian,]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jing Zhang,Shi-Sheng Zhang,Qin Yu and Jing-Cai Lian,</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170420]]></guid><cfi:id>850</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Weighing of risk factors for penetrating keratoplasty graft failure: application of Risk Score System]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170308]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyze the relationship between the score obtained in the Risk Score System (RSS) proposed by Hicks et al with penetrating keratoplasty (PKP) graft failure at 1y postoperatively and among each factor in the RSS with the risk of PKP graft failure using univariate and multivariate analysis.
METHODS: The retrospective cohort study had 152 PKPs from 152 patients. Eighteen cases were excluded from our study due to primary failure (10 cases), incomplete medical notes (5 cases) and follow-up less than 1y (3 cases). We included 134 PKPs from 134 patients stratified by preoperative risk score. Spearman coefficient was calculated for the relationship between the score obtained and risk of failure at 1y. Univariate and multivariate analysis were calculated for the impact of every single risk factor included in the RSS over graft failure at 1y.
RESULTS: Spearman coefficient showed statistically significant correlation between the score in the RSS and graft failure (P<0.05). Multivariate logistic regression analysis showed no statistically significant relationship (P>0.05) between diagnosis and lens status with graft failure. The relationship between the other risk factors studied and graft failure was significant (P<0.05), although the results for previous grafts and graft failure was unreliable. None of our patients had previous blood transfusion, thus, it had no impact.
CONCLUSION: After the application of multivariate analysis techniques, some risk factors do not show the expected impact over graft failure at 1y.]]></description>
<pubDate>2017/3/14 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Abdo Karim Tourkmani,Valeria Sánchez-Huerta,Guillermo De Wit,Jaime D. Martínez,David Mingo,Ignacio Mahillo-Fernández and Ignacio Jiménez-Alfaro]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Abdo Karim Tourkmani,Valeria Sánchez-Huerta,Guillermo De Wit,Jaime D. Martínez,David Mingo,Ignacio Mahillo-Fernández and Ignacio Jiménez-Alfaro</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170308]]></guid><cfi:id>849</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Analysis of corneal morphologic and pathologic changes in early-stage congenital aniridic keratopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170309]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine typical corneal changes of congenital aniridic keratopathy (CAK) using corneal topography and confocal systems, and to identify characteristics that might assist in early diagnosis.
METHODS: Patients with CAK and healthy control subjects underwent detailed ophthalmic examinations including axial length, corneal thickness, tear film condition, corneal topography, and laser-scanning in vivo confocal microscopy (IVCM).
RESULTS: In early stage aniridic keratopathy, Schirmer I test (SIT), break-up time (BUT), mean keratometry (mean K) and simulated keratometry (sim K) were reduced relative to controls (P<0.05), while simulation of corneal astigmatism (sim A) and corneal thickness were increased (P<0.05). In addition, significantly more eyes exhibited flat cornea compared with the control group. Inflammatory dendritic cells were present in the aniridic epithelium, with significantly increased density relative to controls (P<0.05). Palisade ridge-like features and abnormal cell morphology were observed in six out of sixteen CAK cases. In central cornea area, the aniridic corneas had the increased subbasal nerve density.
CONCLUSION: These changes in corneal morphology in borderline situations can be useful to confirm the diagnosis of CAK.]]></description>
<pubDate>2017/3/14 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Juan Du,Rong-Qiang Liu,Lei Ye,Zhi-Hui Li,Feng-Tu Zhao,Nan Jiang,Lin-Hong Ye and Yi Shao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Juan Du,Rong-Qiang Liu,Lei Ye,Zhi-Hui Li,Feng-Tu Zhao,Nan Jiang,Lin-Hong Ye and Yi Shao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170309]]></guid><cfi:id>848</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of visual and topographic outcomes of deep-anterior lamellar keratoplasty and penetrating keratoplasty in keratoconus]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170310]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare visual, surgical and topographic outcomes of deep anterior lamellar keratoplasty (DALK) and penetrating keratoplasty (PK) for keratoconus (KC).
METHODS: In this multicenter, prospective, randomized clinical trial 76 eyes of 71 KC patients operated between January 2011 and July 2014 in 2 tertiary referral hospitals were included. Consecutive patients were alternately selected to receive one of the two surgical methods. Thirty eight eyes underwent DALK with the big-bubble technique and 38 eyes underwent PK.
RESULTS: Mean best spectacle corrected visual acuity (BSCVA) at the first postoperative week (P=0.012) and the first postoperative month (P＜0.001) was statistically significantly higher in DALK group. The mean BSCVA at 12mo was not significantly different for DALK (0.30±1.99 logMAR) versus PK (0.40±0.33 logMAR) (P=0.104). The 76.3% of the eyes had a BSCVA over 0.5 in DALK and 47.4% in PK group (P=0.009). The 7.9% of the eyes had a BSCVA of 1.0 in DALK and 5.3% in PK group (P=0.644). Mean spherical equivalent was -2.94 D in DALK and -3.09 D in PK group. Mean topographic astigmatism was 4.62 D and 4.18 D respectively. Regular topographic patterns were observed in 31 (81.6%) of DALK and 29 (76.3%) of PK (P=0.574). The most frequent topographic pattern was oblate asymmetric bow tie, seen in 39.5% in DALK and 23.7% in PK.
CONCLUSION: Big bubble DALK provides an earlier visual improvement compare to PK. However, visual and topographic outcomes are similar to those in PK at 1y. Postoperative complications including rejection and intraocular pressure elevation are more frequent in PK. DALK is a safer alternative to PK for KC. However, intraoperative perforation of the Descemet’s membrane is a significant complication.]]></description>
<pubDate>2017/3/14 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Bora Yüksel, Baran Kandemir, Umut Duygu Uzunel, Ozan &Ccedil;elik, Sezgin Ceylan and Tuncay Küsbeci]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Bora Yüksel, Baran Kandemir, Umut Duygu Uzunel, Ozan &Ccedil;elik, Sezgin Ceylan and Tuncay Küsbeci</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170310]]></guid><cfi:id>847</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Surgical treatment and visual outcomes of cataract with persistent hyperplastic primary vitreous]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170311]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the surgical treatment and visual outcomes of eyes with cataract and persistent hyperplastic primary vitreous (PHPV).
METHODS: This retrospective study included patients with cataract and PHPV treated with various strategies. Anterior PHPV was treated using phacoemulsification with underwater electric coagulation on posterior capsule neovascularization, posterior capsulotomy, anterior vitrectomy, and intraocular lens (IOL) implantation. Posterior PHPV was treated with lensectomy, posterior vitrectomy, retinal photocoagulation, and IOL implantation or silicone oil tamponade. Visual acuity (VA), pattern visual evoked potential (P-VEP), anatomic recovery, postoperative complications, and amblyopia outcome were examined. Subjects were followed-up for 3-48mo after surgery.
RESULTS: Of the 30 patients (33 eyes) with congenital cataract and PHPV included (average age, 39.30±35.47mo), 9 eyes had anterior PHPV and 24 had posterior PHPV. Thirty-two eyes were surgically treated. Eyes with anterior PHPV received an IOL during one-stage (6 eyes) and two-stage (3 eyes) implantation. Postoperative complications included retinal detachment (1 eye) and recurrent anterior chamber hemorrhage (1 eye). In eyes with posterior PHPV, 6 and 11 eyes received IOLs in one- and two-stage procedures, respectively. Silicone oil was retained in 2 eyes, and IOLs were not implanted in 4 eyes. VA significantly improved in 25 eyes following operations and 3-48mo of amblyopia treatment. P-VEP P100 was improved following surgery in both PHPV types.
CONCLUSION: Our surgical strategies are appropriate and effective for anterior and posterior PHPV. Early surgical intervention and amblyopia therapy result in positive treatment outcomes.]]></description>
<pubDate>2017/3/14 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Li Li,Da-Bei Fan,Ya-Ting Zhao,Yun Li,Fang-Fei Cai and Guang-Ying Zheng]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Li Li,Da-Bei Fan,Ya-Ting Zhao,Yun Li,Fang-Fei Cai and Guang-Ying Zheng</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170311]]></guid><cfi:id>846</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Efficacy and safety of intravitreal ranibizumab with panretinal photocoagulation followed by trabeculectomy compared with Ahmed glaucoma valve implantation in neovascular glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170312]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the efficacy and safety of intravitreal ranibizumab (IVR) with panretinal photocoagulation (PRP) followed by trabeculectomy compared with Ahmed glaucoma valve (AGV) implantation in neovascular glaucoma (NVG).
METHODS: This was a retrospective comparative study. We reviewed the cases of a total of 45 eyes from 45 NVG patients among which 23 eyes underwent AGV implantation and the other 22 underwent trabeculectomy. The causes of neovascular glaucoma included: diabetic retinopathy (25 eyes), and retinal vein occlusion (20 eyes). All patients received preoperative IVR combined with postoperative PRP. The mean best-corrected visual acuities (BCVA) were converted to the logarithms of the minimum angle of resolution (logMAR) for the statisitical analyses. Intraocular pressure (IOP), the logMAR BCVA and surgical complications were evaluated before and after surgery. The follow-up period was 12mo.
RESULTS: A total of 39 cases showed complete regression of iris neovascularization at 7d after injection, and 6 cases showed a small amount of residual iris neovascularization. The success rates were 81.8% and 82.6% at 12mo after trabeculectomy and AGV implantation, respectively. In the trabeculectomy group, the logMAR BCVA improved at the last follow-up in 14 eyes, remained stable in 6 eyes and decreased in 2 eyes. In 4 cases, slight hyphemas developed after trabeculectomy. A shallow anterior chamber developed in 2 cases and 2 vitreous hemorrhages. In the AGV group, the logMAR BCVA improved in 14 eyes, remained stable in 5 eyes and decreased in 4 eyes. Slight hyphemas developed in 3 cases, and a shallow anterior chamber in 3 cases. The mean postoperative IOP was significantly lower in both groups after surgery (F=545.468, P<0.05), and the mean postoperative logMAR BCVA was also significantly improved (F=10.964, P<0.05) with no significant difference between two groups.
CONCLUSION: It is safe and effective to treat NVG with this combined procedure, and we found similar results after IVR+AGV implantation+PRP and IVR+trabeculectomy+PRP in eyes with NVG.]]></description>
<pubDate>2017/3/14 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jin-Tao Sun,Hai-Jing Liang,Meng An and Da-Bo Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jin-Tao Sun,Hai-Jing Liang,Meng An and Da-Bo Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170312]]></guid><cfi:id>845</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Uveal effusion following acute primary angle-closure: a retrospective case series]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170313]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the morphological changes in anterior segment in Chinese patients with uveal effusion (UE) after the attack of acute primary angle-closure (APAC) using ultrasound biomicroscopy (UBM), and to assess the clinical course and prognosis of the disease.
METHODS: In a retrospective case series, 26 eyes in 26 consecutive patients diagnosed with UE after the treatment of intraocular pressure (IOP)-lowering medication for the attack of APAC were enrolled. The unaffected fellow eyes served as controls. The morphological changes were observed by ultrasonography, slit lamp microscopy and gonioscopy. UBM was used to assess the degree and extent of effusion based on the analysis of parameters associated with UE.
RESULTS: The mean IOP was 9.2 (SD 2.1) mm Hg at the diagnosis of UE after IOP-lowering medication, while 14.1 (SD, 2.6) mm Hg in the fellow eyes (P=0.000). The anterior chamber depth (ACD) (P=0.000), angle opening distance at 500 μm (AOD500) (P<0.01) and anterior chamber angle (ACA) (P<0.05) were decreased significantly, while ciliary body thickness (CBT) (P<0.05) increased significantly in UE eyes. UE grade analysis showed 7 eyes in grade 1, 9 eyes in grade 2, and 10 eyes in grade 3. Quadrant scores were performed of 4 eyes in 1 quadrant, 3 eyes in 3 quadrants, and 19 eyes in 4 quadrants. There was the positive correlation between grade and quadrant score (r=0.644, P=0.000). The effusion on all eyes were recovered after medication, which mean IOP was 13.9 (SD, 2.8) mm Hg.
CONCLUSION: UE is a frequent complication in Chinese patients after the attack of APAC, partially associated with hypotony. The severity of UE is correlation with height of effusion, extent of detachment, and shallower ACD.]]></description>
<pubDate>2017/3/14 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jian-Gang Yang,Jian-Jun Li,Hua Tian,Yan-Hong Li,Yu-Jing Gong,An-Le Su and Na He]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jian-Gang Yang,Jian-Jun Li,Hua Tian,Yan-Hong Li,Yu-Jing Gong,An-Le Su and Na He</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170313]]></guid><cfi:id>844</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Combined photodynamic therapy and ranibizumab for polypoidal choroidal vasculopathy: a 2-year result and systematic review]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170314]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report a cohort of patients with polypoidal choroidal vasculopathy (PCV) treated with photodynamic therapy (PDT) followed by intravitreal ranibizumab injection 24-48h later, and to compare the results between eyes with PCV treated by PDT followed by intravitreal anti-vascular endothelial growth factor (VEGF) injection and intravitreal anti-VEGF injection followed by PDT by Meta-analysis.
METHODS: Retrospective study and systematic literature review. Medical records of patients with PCV who were initially treated using PDT followed by intravitreal ranibizumab injection 24-48h after PDT and had completed at least 2y follow-up were reviewed and analyzed. Clinical data, including age, sex, best-corrected visual acuity (BCVA), fundus photograph, fluorescein angiography, indocyanine green angiography and optical coherence tomography were investigated. A systematic literature review was also conducted, and a visual outcome of studies over 1y was compared using Meta-analysis.
RESULTS: A total of 52 patients were included in the study. Mean BCVA at baseline and follow-up at 1 or 2y were 0.71±0.61, 0.51±0.36 and 0.68±0.51 logMAR, respectively. The cumulative hazard rate for recurrence at 1 and 2y follow-up was 15.4% and 30.3% respectively. The percentage of eyes with polyps regression at 3, 12 and 24mo follow-up was 88.5%, 84.6% and 67.3% respectively. A Meta-analysis based on 22 independent studies showed the overall vision improvements at 1, 2 and 3y follow-up were 0.13±0.04 (P<0.001), 0.12±0.03 (P<0.001), 0.16±0.06 (P<0.001), respectively. The proportion of polyps regression at 1y follow-up was 64.6% (95%CI: 51.5%, 77.7%, P<0.001) in 434 eyes treated by intravitreal anti-VEGF agents before PDT and 76.0% (95%CI: 64.8%, 87.3%, P=0.001) in 199 eyes treated by intravitreal anti-VEGF agents after PDT.
CONCLUSION: Intravitreal ranibizumab injection 24-48h following PDT effectively stabilizes visual acuity in the eye with PCV. PDT followed by intravitreal anti-VEGF agents may contribute to a relatively higher proportion of polyps’ regression as compared to that of intravitreal anti-VEGF before PDT.]]></description>
<pubDate>2017/3/14 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Meng Zhao,Hai-Ying Zhou,Jun Xu,Feng Zhang,Wen-Bin Wei and Ning-Pu Liu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Meng Zhao,Hai-Ying Zhou,Jun Xu,Feng Zhang,Wen-Bin Wei and Ning-Pu Liu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170314]]></guid><cfi:id>843</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Intravitreal aflibercept in neovascular age-related macular degeneration previously treated with ranibizumab]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170315]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report the change in visual acuity and central macular thickness (CMT) following treatment with intravitreal aflibercept injections in patients with neovascular age-related macular degeneration (nAMD) with suboptimum response to ranibizumab.
METHODS: This was a retrospective study. The inclusion criteria were patients with nAMD who responded poorly to ranibizumab. Patients then received either 3 consecutive aflibercept injections followed by PRN treatment or PRN alone. Primary endpoints were mean change in best-corrected visual acuity (BCVA) and CMT at 12mo. Secondary endpoints were number of injections and adverse events.
RESULTS: Forty-nine eyes from 49 patients met the inclusion criteria and completed 12-month follow up on aflibercept. Thirty-eight eyes received 3 consecutive aflibercept injections followed by PRN treatment and 11 eyes received pro re nata (PRN) injections alone. At 12mo, mean BCVA improved by one letters (logMAR 0.56±0.31 to 0.54±0.34) and mean CMT decreased from 303.9±82.1 to 259.2±108.3 &micro;m. Four percent of eyes gained 15 letters or more, 6% lost more than 15 letters and the remaining 90% had stable BCVA. The mean number of aflibercept injections was 6. There was one case of infectious endophthalmitis.
CONCLUSION: Intravitreal aflibercept in patients with nAMD with a previous suboptimal response to ranibizumab resulted in an anatomical improvement in macular appearance at 12mo without a corresponding improvement in visual acuity.]]></description>
<pubDate>2017/3/14 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Rachel Hui Fen Lim,Bhaskar Gupta and Peter Simcock]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Rachel Hui Fen Lim,Bhaskar Gupta and Peter Simcock</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170315]]></guid><cfi:id>842</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Retinal ganglion cell complex changes using spectral domain optical coherence tomography in diabetic patients without retinopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170316]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the ganglion cell complex (GCC) thickness in diabetic eyes without retinopathy.
METHODS: Two groups included 45 diabetic eyes without retinopathy and 21 non diabetic eyes. All subjects underwent full medical and ophthalmological history, full ophthalmological examination, measuring GCC thickness and central foveal thickness (CFT) using the RTVue&reg; spectral domain-optical coherence tomography (SD-OCT), and HbA1C level.
RESULTS: GCC focal loss volume (FLV%) was significantly more in diabetic eyes (22.2% below normal) than normal eyes (P=0.024). No statistically significant difference was found between the diabetic group and the control group regarding GCC global loss volume (GLV%) (P=0.160). CFT was positively correlated to the average, superior and inferior GCC (P=0.001, 0.000 and 0.001 respectively) and negatively correlated to GLV% and FLV% (P=0.002 and 0.031 respectively) in diabetic eyes. C/D ratio in diabetic eyes was negatively correlated to average, superior and inferior GCC (P=0.015, 0.007 and 0.017 respectively). The FLV% was negatively correlated to the refraction and level of HbA1c (P=0.019 and 0.013 respectively) and positively correlated to the best corrected visual acuity (BCVA) in logMAR in diabetic group (P=0.004).
CONCLUSION: Significant GCC thinning in diabetes predates retinal vasculopathy, which is mainly focal rather than diffuse. It has no preference to either the superior or inferior halves of the macula. Increase of myopic error is significantly accompanied with increased focal GCC loss. GCC loss is accompanied with increased C/D ratio in diabetic eyes.]]></description>
<pubDate>2017/3/14 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ahmed I. Hegazy,Rasha H. Zedan,Tamer A. Macky and Soheir M. Esmat]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ahmed I. Hegazy,Rasha H. Zedan,Tamer A. Macky and Soheir M. Esmat</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170316]]></guid><cfi:id>841</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Analysis of normal human retinal vascular network architecture using multifractal geometry]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170317]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To apply the multifractal analysis method as a quantitative approach to a comprehensive description of the microvascular network architecture of the normal human retina.
METHODS: Fifty volunteers were enrolled in this study in the Ophthalmological Clinic of Cluj-Napoca, Romania, between January 2012 and January 2014. A set of 100 segmented and skeletonised human retinal images, corresponding to normal states of the retina were studied. An automatic unsupervised method for retinal vessel segmentation was applied before multifractal analysis. The multifractal analysis of digital retinal images was made with computer algorithms, applying the standard box-counting method. Statistical analyses were performed using the GraphPad InStat software.
RESULTS: The architecture of normal human retinal microvascular network was able to be described using the multifractal geometry. The average of generalized dimensions (Dq) for q=0, 1, 2, the width of the multifractal spectrum (Δα=αmax - αmin) and the spectrum arms’ heights difference (│Δf│) of the normal images were expressed as mean±standard deviation (SD): for segmented versions, D0=1.7014±0.0057; D1=1.6507±0.0058; D2=1.5772±0.0059; Δα=0.92441±0.0085; │Δf│= 0.1453±0.0051; for skeletonised versions, D0=1.6303±0.0051; D1=1.6012±0.0059; D2=1.5531±0.0058; Δα=0.65032±0.0162; │Δf│= 0.0238±0.0161. The average of generalized dimensions (Dq) for q=0, 1, 2, the width of the multifractal spectrum (Δα) and the spectrum arms’ heights difference (│Δf│) of the segmented versions was slightly greater than the skeletonised versions.
CONCLUSION: The multifractal analysis of fundus photographs may be used as a quantitative parameter for the evaluation of the complex three-dimensional structure of the retinal microvasculature as a potential marker for early detection of topological changes associated with retinal diseases.]]></description>
<pubDate>2017/3/14 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[&#350;tefan &#354;&#259;lu, Sebastian Stach, Dan Mihai C&#259;lug&#259;ru, Carmen Alina Lupa&#351;cu and Simona Delia Nicoar&#259;]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>&#350;tefan &#354;&#259;lu, Sebastian Stach, Dan Mihai C&#259;lug&#259;ru, Carmen Alina Lupa&#351;cu and Simona Delia Nicoar&#259;</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170317]]></guid><cfi:id>840</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Changes in retinal vessel diameters in migraine patients during attack-free period]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170318]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the retinal vessel diameters in patients with migraine by optical coherence tomography (OCT).
METHODS: In this cross-sectional study, 124 eyes of 62 patients with a diagnosis of unilateral migraine during attack-free period and 42 age- and sex-matched control subjects were included. Migraine patients were divided into the ≤2 migraine attacks per month group and the ≥5 migraine attacks per month group. All subjects underwent complete ophthalmological and neurological examinations before measurements. Retinal vessel diameters and choroidal thickness were examined with the Spectralis OCT.
RESULTS: The mean diameters of the arteries in the eyes on the headache side of control group, ≥5 migraine attacks per month and ≤2 migraine attacks per month group at 480 &micro;m from the optic disk (Raster 3) were 119.54±46.69, 136.68±25.93 and 119.34±31.75 &micro;m respectively with a steady decline to 105.57±32.15, 118.18±31.87 and 108.05±38.77 &micro;m at 1440 &micro;m (Raster 7), the last measurement point, respectively. The retinal artery diameter measurements were significantly increased in ≥5 migraine attacks per month patients at four out of five measured points compared to control group (P<0.05). There were no statistical differences at any of the points of vein measurements. The choroidal thickness measurements were significantly decreased in ≥5 migraine attacks per month patients at all measured points compared to control group (P<0.05).
CONCLUSION: The retinal artery diameter is found to increase significantly and the choroidal thickness is found to decrease in the eyes on the headache side in ≥5 migraine attacks per month patients compared to control group.]]></description>
<pubDate>2017/3/14 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Metin Unlu,Duygu Gulmez Sevim,Murat Gultekin,Recep Baydemir,Cagatay Karaca and Ayse Oner]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Metin Unlu,Duygu Gulmez Sevim,Murat Gultekin,Recep Baydemir,Cagatay Karaca and Ayse Oner</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170318]]></guid><cfi:id>839</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Single-step transepithelial photorefractive keratectomy in high myopia: qualitative and quantitative visual functions]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170319]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate quantitative and qualitative optical outcomes of single-step transepithelial photorefractive keratectomy (TransPRK) in high myopia.
METHODS: In a prospective interventional case-series, 30 eyes with high myopia (-6.00 to -8.75 D) with (up to -3.00 D) or without astigmatism were enrolled from Bina Eye Hospital, Tehran, Iran. One-step TransPRK was performed with aberration-free aspherical optimized profile and SCHWIND AMARIS 500 laser. One-year follow-up results for refraction, visual acuities, vector analysis, ocular wave-front (OWF) and corneal wave-front (CWF) higher order aberrations (HOA), contrast sensitivity (CS), and post-operative haze were assessed.
RESULTS: After the surgery, both photopic and mesopic CSs significantly improved (both P<0.001). We detected significant induction of OWF coma and trefoil (P<0.001 for both) HOAs; CWF coma (P=0.002), spherical (P<0.001), and tetrafoil (P=0.003) HOAs in 6 mm analysis diameter; and CWF trefoil (P=0.04) HOA in 4 mm analysis diameter. The range of mean induction observed for various HOAs was 0.005-0.11 &micro;m. The 86.7% of eyes reached an uncorrected distance visual acuity of 20/20 or better; 96.7% of eyes were within ±0.5 D of targeted spherical refraction. In vector analysis, mean correction index value was 1.03 and mean index of success was 0.22. By 12mo after the operation, no eye lost any number of corrected distance visual acuity lines. We detected no corneal haze greater than 1+ throughout the follow-up.
CONCLUSION: Our findings show promising effects of single-step TransPRK on quality of vision in high myopic eyes. It also improves refraction and visual acuity.]]></description>
<pubDate>2017/3/14 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Soheil Adib-Moghaddam,Saeed Soleyman-Jahi,Fatemeh Adili-Aghdam,Samuel Arba Mosquera,Niloofar Hoorshad and Salar Tofighi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Soheil Adib-Moghaddam,Saeed Soleyman-Jahi,Fatemeh Adili-Aghdam,Samuel Arba Mosquera,Niloofar Hoorshad and Salar Tofighi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170319]]></guid><cfi:id>838</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Placido disk-based topography versus high-resolution rotating Scheimpflug camera for corneal power measurements in keratoconic and post-LASIK eyes: reliability and agreement]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170320]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the repeatability/reproducibility of measurement by high-resolution Placido disk-based topography with that of a high-resolution rotating Scheimpflug camera and assess the agreement between the two instruments in measuring corneal power in eyes with keratoconus and post-laser in situ keratomileusis (LASIK).
METHODS: One eye each of 36 keratoconic patients and 20 subjects who had undergone LASIK was included in this prospective observational study. Two independent examiners worked in a random order to take three measurements of each eye with both instruments. Four parameters were measured on the anterior cornea: steep keratometry (Ks), flat keratometry (Kf), mean keratometry (Km), and astigmatism (Ks-Kf). Intra-examiner repeatability and inter-examiner reproducibility were evaluated by calculating the within-subject standard deviation (Sw) the coefficient of repeatability (R), the coefficient of variation (CoV), and the intraclass correlation coefficient (ICC). Agreement between instruments was tested with the Bland-Altman method by calculating the 95% limits of agreement (95% LoA).
RESULTS: In keratoconic eyes, the intra-examiner and inter-examiner ICC were >0.95. As compared with measurement by high-resolution Placido disk-based topography, the intra-examiner R of the high-resolution rotating Scheimpflug camera was lower for Kf (0.32 vs 0.88), Ks (0.61 vs 0.88), and Km (0.32 vs 0.84) but higher for Ks-Kf (0.70 vs 0.57). Inter-examiner R values were lower for all parameters measured using the high-resolution rotating Scheimpflug camera. The 95% LoA were -1.28 to +0.55 for Kf, -1.36 to +0.99 for Ks, -1.08 to +0.50 for Km, and -1.11 to +1.48 for Ks-Kf. In the post-LASIK eyes, the intra-examiner and inter-examiner ICC were >0.87 for all parameters. The intra-examiner and inter-examiner R were lower for all parameters measured using the high-resolution rotating Scheimpflug camera. The intra-examiner R was 0.17 vs 0.88 for Kf, 0.21 vs 0.88 for Ks, 0.17 vs 0.86 for Km, and 0.28 vs 0.33 for Ks-Kf. The inter-examiner R was 0.09 vs 0.64 for Kf, 0.15 vs 0.56 for Ks, 0.09 vs 0.59 for Km, and 0.18 vs 0.23 for Ks-Kf. The 95% LoA were -0.54 to +0.58 for Kf, -0.51 to +0.53 for Ks and Km, and -0.28 to +0.27 for Ks-Kf.
CONCLUSION: As compared with Placido disk-based topography, the high-resolution rotating Scheimpflug camera provides more repeatable and reproducible measurements of Ks, Kf and Ks in keratoconic and post-LASIK eyes. Agreement between instruments is fair in keratoconus and very good in post-LASIK eyes.]]></description>
<pubDate>2017/3/14 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Rachele R. Penna,Ugo de Sanctis,Martina Catalano,Luca Brusasco and Federico M. Grignolo]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Rachele R. Penna,Ugo de Sanctis,Martina Catalano,Luca Brusasco and Federico M. Grignolo</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170320]]></guid><cfi:id>837</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Corneal biomechanical data and biometric parameters measured with Scheimpflug-based devices on normal corneas]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170206]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyze the correlations between ocular biomechanical and biometric data of the eye, measured by Scheimpflug-based devices on healthy subjects.
METHODS: Three consecutive measurements were carried out using the corneal visualization Scheimpflug technology (CorVis ST) device on healthy eyes and the 10 device-specific parameters were recorded. Pentacam HR-derived parameters (corneal curvature radii on the anterior and posterior surfaces; apical pachymetry; corneal volume; corneal aberration data; depth, volume and angle of the anterior chamber) and axial length (AL) from IOLMaster were correlated with the 10 specific CorVis ST parameters.
RESULTS: Measurements were conducted in 43 eyes of 43 volunteers (age 61.24±15.72y). The 10 specific CorVis ST data showed significant relationships with corneal curvature radii both on the anterior and posterior surface, pachymetric data, root mean square (RMS) data of lower-order aberrations, and posterior RMS of higher-order aberrations and spherical aberration of the posterior cornea. Anterior chamber depth showed a significant relationship, but there were no significant correlations between corneal volume, anterior chamber volume, mean chamber angle or AL and the 10 specific CorVis ST parameters.]]></description>
<pubDate>2017/2/10 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Gabor Nemeth, Eszter Szalai, Ziad Hassan, Agnes Lipecz, Zsuzsa Flasko and Laszlo Modis]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Gabor Nemeth, Eszter Szalai, Ziad Hassan, Agnes Lipecz, Zsuzsa Flasko and Laszlo Modis</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170206]]></guid><cfi:id>836</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical results of non-Descemet stripping endothelial keratoplasty]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170207]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the impact of non-Descemet stripping endothelial keratoplasty (non-DSEK) on graft rejection rate, and its overall procedural effectiveness in patients.
METHODS: Non-DSEK was performed on 65 eyes of 64 patients, and the procedural outcomes, including rejection episodes, failure and dislocation of the grafts, best corrected visual acuity (BCVA), endothelial cell density (ECD), and other complications, were analyzed retrospectively.
RESULTS: Of the 65 eyes, 63 recovered from bullous keratopathy with a clear cornea. The mean follow-up time was 26.4mo (range, 6-84mo). The mean BCVA improved from 1.70 logMAR preoperatively to 0.54 logMAR at 3mo, 0.46 logMAR at 6mo, and 0.37 logMAR at 1y after surgery. The postoperative donor ECD of the 25 patients who successfully underwent specular microscopic examination was 1918±534 cells/mm2 (range, 637 to 3056 cells/mm2), and the mean endothelial cell loss was 41.9% at 24mo postoperatively. One eye developed secondary glaucoma and required regrafting via penetrating keratoplasty (PKP). Another eye had postoperative graft failure due to rejection at 26mo. Postoperative graft dislocation occurred in eight eyes. All of the eight dislocated grafts were reattached using air reinjection.
CONCLUSION: Immunological graft rejection of the donor graft rarely occurs in non-DSEK. Therefore, non-DSEK is a safe, concise, and effective alternative to restore corneal decompensation when the Descemet membrane is disease-free.]]></description>
<pubDate>2017/2/10 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Tao Zhang, Shao-Wei Li, Tie-Hong Chen, Jing-Liang He, Yan-Wei Kang, Fang-Qi Lyu, Jian-Hua Ning and Chang Liu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Tao Zhang, Shao-Wei Li, Tie-Hong Chen, Jing-Liang He, Yan-Wei Kang, Fang-Qi Lyu, Jian-Hua Ning and Chang Liu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170207]]></guid><cfi:id>835</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effects of contact lens wearing on keratoconus: a confocal microscopy observation]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170208]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the corneal cell morphology of new keratoconus patients wearing two different types of rigid gas-permeable (RGP) contact lenses for 1y.
METHODS: Thirty nine eyes of 39 new keratoconus patients were selected and randomly fitted with two types of RGP contact lenses. Group 1 had 21 eyes with regular rigid gas-permeable (RRGP) contact lens and rest 18 eyes were in group 2 with specially designed rigid gas-permeable (SRGP) contact lens. Corneal cell morphology was evaluated using a slit scanning confocal microscope at no-lens wear and after 1y of contact lens wearing.
RESULTS: After 1y of contact lens wearing in group 1, the mean anterior and posterior stromal keratocyte density were significantly less (P=0.006 and P=0.001, respectively) compared to no-lens wear. The mean cell area of anterior and posterior stromal keratocyte were also significantly different (P=0.005 and P=0.001) from no-lens wear. The anterior and posterior stromal haze increased by 18.74% and 23.81%, respectively after 1y of contact lens wearing. Whereas in group 2, statistically significant changes were observed only in cell density & area of anterior stroma (P=0.001 and P=0.001, respectively) after 1y. While, level of anterior and posterior stromal haze increased by 16.67% and 11.11% after 1y of contact lens wearing. Polymegathism and pleomorphism also increased after 1y of contact lens wearing in both the contact lens groups.
CONCLUSION: Confocal microscopy observation shows the significant alterations in corneal cell morphology of keratoconic corneas wearing contact lenses especially in group 1. The type of contact lens must be carefully selected to minimize changes in corneal cell morphology.]]></description>
<pubDate>2017/2/10 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Somnath Ghosh, Haliza A Mutalib, Sharanjeet Kaur, Rituparna Ghoshal and Shamala Retnasabapathy]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Somnath Ghosh, Haliza A Mutalib, Sharanjeet Kaur, Rituparna Ghoshal and Shamala Retnasabapathy</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170208]]></guid><cfi:id>834</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Visual performance with accommodating and multifocal intraocular lenses]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170209]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the visual functional outcomes with accommodating and multifocal intraocular lenses (IOLs).
METHODS: Our retrospective comparative study included 51 patients (60 eyes) received implantation of an accommodating IOL (Tetraflex; 16 patients, 20 eyes), a refractive multifocal IOL (ReZoom; 18 patients, 20 eyes), or a diffractive multifocal IOL (ZMA00; 17 patients, 20 eyes). Subjective refraction, visual acuity, contrast sensitivity (CS), intraocular aberration, and subjective photic phenomena were detected at 3mo after surgery.
RESULTS: The spherical equivalent in the three groups was -0.38±0.54 D, 0.14±0.56 D, and 0.35±0.41 D, respectively. No statistically significant differences were found in uncorrected and corrected distance visual acuity  and uncorrected intermediate visual acuity among the groups (P=0.39). The ReZoom group had significantly better distance-corrected intermediate visual acuity than the ZMA00 group (P=0.003). The ZMA00 group had significantly better near visual acuity than the other groups (P＜0.05). Better contrast sensitivity values were observed in the Tetraflex group under most of the spatial frequencies conditions (P=0.025). The total aberration was lowest in the ZMA00 group (P=0.000), and the spherical aberration was highest in the Tetraflex group (P=0.000). The three groups had similar frequency of ghosting and glare, and the Tetraflex group had a low rate of halos (P=0.01).
CONCLUSION: Both accommodating and multifocal IOLs can successfully restore distance and uncorrected intermediate visual acuities. Tetraflex accommodating IOLs perform better in CS and with less halos of photic phenomena. ReZoom refractive multifocal IOLs have better performance in distance-corrected intermediate visual acuity than ZMA00 diffractive multifocal IOLs, and the latter achieved better near visual acuity and efficiently decreased the optical aberration.]]></description>
<pubDate>2017/2/10 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jie Lan, Yu-Sen Huang, Yun-Hai Dai, Xiao-Ming Wu, Jia-Jun Sun and Li-Xin Xie]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jie Lan, Yu-Sen Huang, Yun-Hai Dai, Xiao-Ming Wu, Jia-Jun Sun and Li-Xin Xie</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170209]]></guid><cfi:id>833</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Predictive factors for photic phenomena after refractive, rotationally asymmetric, multifocal intraocular lens implantation]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170210]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the independent factors associated with photic phenomena in patients implanted with refractive, rotationally asymmetric, multifocal intraocular lenses (MIOLs).
METHODS: Thirty-four eyes of 34 patients who underwent unilateral cataract surgery, followed by implantation of rotationally asymmetric MIOLs were included. Distance and near visual acuity outcomes, intraocular aberrations, preferred reading distances, preoperative and postoperative refractive errors, mesopic and photopic pupil diameters, and the mesopic and photopic kappa angles were assessed. Patients were also administered a satisfaction survey. Photic phenomena were graded by questionnaire. Independent-related factors were identified by correlation and bivariate logistic regression analyses.
RESULTS: The distance from the photopic to the mesopic pupil center (pupil center shift) was significantly associated with glare/halo symptoms [odds ratio (OR)=2.065, 95% confidence interval (CI)=0.916-4.679, P=0.006] and night vision problems (OR=1.832, 95% CI=0.721-2.158, P=0.007). The preoperative photopic angle kappa was significantly associated with glare/halo symptoms (OR=2.155, 95% CI=1.065-4.362, P=0.041). The photopic angle kappa was also significantly associated with glare/halo symptoms (OR=2.155, 95% CI=1.065-4.362, P=0.041) and with night vision problems (OR=1.832, 95% CI=0.721-2.158, P=0.007) in patients implanted with rotationally asymmetric MIOLs.
CONCLUSION: A large pupil center shift and misalignment between the visual and pupillary axis (angle kappa) may play a role in the occurrence of photic phenomena after implantation of rotationally asymmetric MIOLs.]]></description>
<pubDate>2017/2/10 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hungwon Tchah, Kiyeun Nam and Aeri Yoo]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hungwon Tchah, Kiyeun Nam and Aeri Yoo</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170210]]></guid><cfi:id>832</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[The vitreomacular interface in different types of age-related macular degeneration]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170211]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the vitreomacular interface in cases with wet age-related macular degeneration (AMD) and to compare them to eyes with dry AMD and normal eyes.
METHODS: This was a cross-sectional comparative study that included 87 eyes with wet AMD, 42 eyes with dry AMD and 40 eyes without AMD as a control group. Optical coherence tomography (OCT) examination was performed for all patients to assess the vitreomacular interface.
RESULTS: In the wet AMD group, 34.5% of cases had vitreomacular adhesion (VMA). Only 14.3% of dry AMD cases and 10% of control cases had VMA. There was a significant difference between the control group and the wet AMD group (P=0.004) as well as the dry and wet AMD group (P=0.017). There was also a significant difference between the incidence of VMA in patients with subretinal choroidal neovascularization (CNV, type 1) and intraretinal CNV (type 2 or type 3) (P=0.020).
CONCLUSION: There is an association between posterior vitreous attachment and AMD. There is also an increased incidence of VMA with intra-retinal CNV.]]></description>
<pubDate>2017/2/10 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mohamed Abd ElMonaem El-Hifnawy, Hisham Ali Ibrahim, Amir Ramadan Gomaa and Mohamed A Elmasry]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mohamed Abd ElMonaem El-Hifnawy, Hisham Ali Ibrahim, Amir Ramadan Gomaa and Mohamed A Elmasry</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170211]]></guid><cfi:id>831</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Short-duration transient visual evoked potentials and color reflectivity discretization analysis in glaucoma patients and suspects]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170212]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the use of short-duration transient visual evoked potentials (VEP) and color reflectivity discretization analysis (CORDA) in glaucomatous eyes, eyes suspected of having glaucoma, and healthy eyes.
METHODS: The study included 136 eyes from 136 subjects: 49 eyes with glaucoma, 45 glaucoma suspect eyes, and 42 healthy eyes. Subjects underwent Humphrey visual field (VF) testing, VEP testing, as well as peripapillary retinal nerve fiber layer optical coherence tomography imaging studies with post-acquisition CORDA applied. Statistical analysis was performed using means and ranges, ANOVA, post-hoc comparisons using Turkey’s adjustment, Fisher’s Exact test, area under the curve, and Spearman correlation coefficients.
RESULTS: Parameters from VEP and CORDA correlated significantly with VF mean deviation (MD) (P<0.05). In distinguishing glaucomatous eyes from controls, VEP demonstrated area under the curve (AUC) values of 0.64-0.75 for amplitude and 0.67-0.81 for latency. The CORDA HR1 parameter was highly discriminative for glaucomatous eyes vs controls (AUC=0.94).
CONCLUSION: Significant correlations are found between MD and parameters of short-duration transient VEP and CORDA, diagnostic modalities which warrant further consideration in identifying glaucoma characteristics.]]></description>
<pubDate>2017/2/10 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Michael Waisbourd, Rebekah H. Gensure, Ardalan Aminlari, Sonya B. Shah, Nitasha Khanna, Neil Sood, Jeanne Molineaux, Alberto Gonzalez, JonathanS.Myers and L. Jay Katz]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Michael Waisbourd, Rebekah H. Gensure, Ardalan Aminlari, Sonya B. Shah, Nitasha Khanna, Neil Sood, Jeanne Molineaux, Alberto Gonzalez, JonathanS.Myers and L. Jay Katz</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170212]]></guid><cfi:id>830</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Novel biomarkers for patients with idiopathic acute anterior uveitis: neutrophil to lymphocyte ratio and platelet to lymphocyte ratio]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170213]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the levels of the neutrophil to lymphocyte ratio (N/L) and the platelet to lymphocyte ratio (P/L) in patients with idiopathic acute anterior uveitis (AAU) and to compare with healthy controls.
METHODS: Thirty-six male patients with idiopathic AAU and 36 male healthy subjects were enrolled in this retrospective study. Complete ophthalmological examination and complete blood count measurements results of all subjects were evaluated.
RESULTS: There was a significant difference in N/L and P/L between idiopathic AAU and control groups (P=0.006, P=0.022). Also, correlation analysis revealed a significant correlation between C-reactive protein (CRP) and N/L (P=0.002; r=0.461).
CONCLUSION: Our study for the first time provides evidence of N/L and P/L may be useful biomarkers in patients with idiopathic AAU. N/L is correlated with CRP, so it can be a useful biomarker to predict the prognosis in idiopathic AAU.]]></description>
<pubDate>2017/2/10 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Cem Ozgonul, Erdim Sertoglu, Onder Ayyildiz, Tarkan Mumcuoglu, Murat Kucukevcilioglu, Gokcen Gokce and Ali Hakan Durukan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Cem Ozgonul, Erdim Sertoglu, Onder Ayyildiz, Tarkan Mumcuoglu, Murat Kucukevcilioglu, Gokcen Gokce and Ali Hakan Durukan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170213]]></guid><cfi:id>829</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Retinal vessel oxygen saturation in healthy subjects and early branch retinal vein occlusion]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170214]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To measure the retinal oxygen saturation in healthy subjects and early branch retinal vein occlusion (BRVO) in Chinese population.
METHODS: The retinal vessel oxygen saturation of the healthy subjects and BRVO patients were measured by a noninvasive retinal oximeter (Oxymap ehf., Reykjavik, Iceland).
RESULTS: The study included 22 patients with unilateral BRVO (mean age: 55.1±8.8y) in the study group and 91 healthy participants (mean age: 37.5±14.0y) in the control group. In the healthy individuals, mean arterial and venous oxygen saturation were significantly (P<0.001) higher in the superior nasal quadrant (98.5%±10.1% and 57.3%±8.7%, respectively) than in the inferior nasal quadrant (94.2%±9.0% and 54.1%±9.6%, respectively), followed by the superior temporal quadrant (89.1%±10.1% and 51.9%±8.9%, respectively) and the inferior temporal quadrant (86.4%±9.4% and 46.6%±9.6%, respectively). In patients with ischemic BRVO, arterial oxymetric values were significantly higher and venous measurements significantly lower for the affected vessel (107.5%±9.7% and 46.4%±14.2%, respectively) than the unaffected vessel in the same eye (99.2%±12.2% and 55.5%±7.9%, respectively) and as compared to the vessel in the unaffected fellow eye (93.1%±6.9% and 55.7%±6.8%) (P=0.005 and P=0.02, respectively). In the patients with non-ischemic BRVO, mean venous oxygen saturation was lower in the affected vein (39.8%±12.2%) than in the unaffected vessels of the same eye (50.8%±10.5%) and in the fellow eye (58.21%±5.7%) (P=0.03). Mean arterial oxygen saturation did not differ significantly (P=0.42) between all three groups.
CONCLUSION: In patients with BRVO, the venous oxygen saturation in the affected vessels is decreased potentially due to decreased blood velocity and flow. Interestingly, the arterial oxygen saturation in eyes with ischemic BRVO is increased in the affected arteries.]]></description>
<pubDate>2017/2/10 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jing-Yan Yang, Bing You, Qian Wang, Szy Yann Chan, Jost B. Jonas and Wen-Bin Wei]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jing-Yan Yang, Bing You, Qian Wang, Szy Yann Chan, Jost B. Jonas and Wen-Bin Wei</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170214]]></guid><cfi:id>828</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Characteristics of retinal vein occlusion with final vision better than 78 letters after sequential therapy with ranibizumab and triamcinolone acetate]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170215]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyze the reasons that may lead to the different vision result by combining the ranibizumab and triamcinolone acetate (TA) in sequence to treat macular edema in retinal vein occlusion (RVO).
METHODS: Ranibizumab and TA were combined in sequence to treat 43 patients with macular edema secondary to RVO. Six months after the treatment, patients with central fovea thickness (CFT) less than 300 μm in optical coherence tomography (OCT) were collected into GroupsⅠand Ⅱ, based on vision acuity (VA) better than 78 letters or less than 60 letters. The age, baseline VA, duration from onset to treatment, CFT at the baseline, sub-retinal fluid (SRF), sub-foveal exudates and injection times of TA and ranibizumab were taken into comparison.
RESULTS: The mean age of the subjects was 46.4y in Group Ⅰbut 57.5y in Group Ⅱ. The difference of age was significant between groups (P<0.01). The mean baseline VA was 51.4 letters in Group Ⅰand 43.9 letters in Group Ⅱ (P<0.05). The baseline CFT were 670.9 μm in Group Ⅰwith SRF in 54.3% patients and 678.1 μm in Group Ⅱ with SRF in 52.9% (P>0.05). The mean number of injections of TA was 0.9 and the mean number of injections of ranibizumab was 2.3 in Group Ⅰbut 1.7 and 2.9 respectively in Group Ⅱ. The treatment times of ranibizumab had no difference between the 2 groups (P>0.05) but the difference of TA injection times was significant, P<0.05. Subfoveal exudates at final stage happened in no subjects in Group Ⅰ but in 45.83% subjects in Group Ⅱ.
CONCLUSION: This combined treatment is safer than TA injection and cheaper than ranibizumab injection alone. Younger patients and earlier treatment will help to get better vision outcome. Subfoveal exudates at the final stage have significant relationship with vision outcome. No relationship existed between the baseline CFT, SRF and the vision outcome.]]></description>
<pubDate>2017/2/10 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yao-Wu Qin, Jia Yu and Quan Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yao-Wu Qin, Jia Yu and Quan Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170215]]></guid><cfi:id>827</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Long-term follow-up of vitrectomy in patients with pathologic myopic foveoschisis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170216]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report the long-term surgical outcomes of pathologic myopic foveoschisis (MF) following vitrectomy. METHODS: We performed a retrospective case series analysis of 50 consecutive patients diagnosed with MF who experienced vision loss due to progression of foveoschisis. The 50 patients (67 eyes) were treated in our hospital with vitrectomy with internal limiting membrane (ILM) peeling from December 2004 to September 2010. Best corrected visual acuity (BCVA), refractive error, optical coherence tomography (OCT), and routine examination results were analysed. The changes of BCVA, foveal anatomical features on OCT scan, and complications were the main outcome measures.

RESULTS: The mean follow-up duration was 42±17mo (range 24 to 93mo). BCVA improved significantly postoperatively (0.76±0.65 logMAR) compared with preoperative baselines (1.31±0.78 logMAR, P<0.0001), and in 53 eyes (79%) including 3 lines gain in 44 eyes (66%) at the last follow-up visit. OCT scans showed that central retinal thickness decreased from 580.0±270.0 μm preoperatively (n=67) to 179.7±84.7 μm postoperatively (n=58, P<0.0001). Total resolution of foveoschisis occurred in 41 eyes (61%). Preoperative BCVA correlated well with postoperative BCVA, whereas other factors such as age, axial length, and refractive error were not correlated. The most common complications were cataract and full-thickness macular hole formation in 14 and 9 cases, respectively.
CONCLUSION: Patients with progressive vision loss due to MF who were treated with vitrectomy with ILM peeling show favourable outcomes. In most eyes, visual acuity and foveal structure remain stable during long-term observation.]]></description>
<pubDate>2017/2/10 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ting Zhang, Ying Zhu, Chun-Hui Jiang and Ge-Zhi Xu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ting Zhang, Ying Zhu, Chun-Hui Jiang and Ge-Zhi Xu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170216]]></guid><cfi:id>826</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparative analysis of the efficacy of astigmatic correction after wavefront-guided and wavefront-optimized LASIK in low and moderate myopic eyes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170217]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate and compare the efficacy of the astigmatic correction achieved with laser in situ keratomileusis (LASIK) in eyes with myopic astigmatism using wavefront-guided (WFG) and wavefront-optimized (WFO) ablation profiles.
METHODS: Prospective study included 221 eyes undergoing LASIK: 99 and 122 eyes with low and moderate myopic astigmatism (low and moderate myopia groups). Two subgroups were differentiated in each group according to the ablation profile: WFG subgroup, 109 eyes (45/64, low/moderate myopia groups) treated using the Advanced CustomVue platform (Abbott Medical Optics Inc.), and WFO subgroup, 112 eyes (54/58, low/moderate myopia groups) treated using the EX-500 platform (Alcon). Clinical outcomes were evaluated during a 6-month follow-up, including a vector analysis of astigmatic changes.
RESULTS: Significantly better postoperative uncorrected visual acuity and efficacy index was found in the WFG subgroups of each group (P≤0.041). Postoperative spherical equivalent and cylinder were significantly higher in WFO subgroups (P≤0.003). In moderate myopia group, a higher percentage of eyes with a postoperative cylinder ≤0.25 D was found in the WFG subgroup (90.6% vs 65.5%, P=0.002). In low and moderate myopia groups, the difference vector was significantly higher in the WFO subgroup compared to WFG (P<0.001). In moderate myopia group, the magnitude (P=0.008) and angle of error (P<0.001) were also significantly higher in the WFO subgroup. Significantly less induction of high order aberrations were found with WFG treatments in both low and moderate myopia groups (P≤0.006).
CONCLUSION: A more efficacious correction of myopic astigmatism providing a better visual outcome is achieved with WFG LASIK compared to WFO LASIK.]]></description>
<pubDate>2017/2/10 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mounir A. Khalifa, Mahmoud F. Alsahn, Mohamed Shafik Shaheen and David P. Pinero]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mounir A. Khalifa, Mahmoud F. Alsahn, Mohamed Shafik Shaheen and David P. Pinero</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170217]]></guid><cfi:id>825</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Ex-PRESS implantation with phacoemulsification in POAG versus CPACG]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170108]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the long-term outcomes of the Ex-PRESS miniature glaucoma device implanted under a scleral flap in combination of phacoemulsification with intraocular lens implantation in primary open angle glaucoma (POAG) and chronic primary angle-closure glaucoma (CPACG).
METHODS: Retrospective, comparative study. A total of 60 eyes (60 patients) receiving the Ex-PRESS miniature glaucoma device implantation combined with phacoemulsification were reviewed. Thirty eyes (30 patients) had the combined procedures for POAG, and the other 30 eyes (30 patients) for CPACG.
RESULTS: The follow-up was 39.37±7.09mo (range 3 to 49mo) in patients with POAG and 37.10±9.26mo (range 9 to 49mo) in patients with CPACG (P=0.29). The mean change in best corrected visual acuity was 0.41 logMAR for POAG and 0.38 logMAR for CPACG at the last follow-up (P=0.22). The postoperative intraocular pressure (IOP) of the POAG group was significantly lower than the CPACG group at 1, 3, 12, and 18mo after surgery (P=0.02, 0.00, 0.04, 0.01) with similar glaucoma medications after surgery (P＞0.16). At 3y after surgery, the cumulative complete and qualified success rates were 63.3% (POAG) and 53.3% (CPACG), 83.3% (POAG) and 73.3% (CPACG) (P=0.41, 0.49), respectively. The POAG group had more hypotony than the CPACG group (P=0.04).
CONCLUSION: The long-term outcomes show the Ex-PRESS implantation combined with phacoemulcification can effectively lower the IOP in both the POAG and CPACG groups. The POAG group seems to have lower postoperative IOP and a higher risk of hypotony.]]></description>
<pubDate>2017/1/4 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jie Lan, Da-Peng Sun, Jie Wu, Ya-Ni Wang and Li-Xin Xie]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jie Lan, Da-Peng Sun, Jie Wu, Ya-Ni Wang and Li-Xin Xie</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170108]]></guid><cfi:id>824</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Ex-PRESS implantation versus trabeculectomy in Chinese patients with POAG: fellow eye pilot study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170109]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the outcomes of Ex-PRESS implantation in one eye versus trabeculectomy with mitomycin C in the fellow eye in Chinese patients with primary open-angle glaucoma (POAG).
METHODS: This was a prospective, non-randomized comparative study. Forty-eight eyes of 24 patients with bilateral POAG necessitating surgery were included and underwent Ex-PRESS implantation under the scleral flap in one eye and trabeculectomy in the other eye according to patients’ choice. Primary outcome measures included mean intraocular pressure (IOP) and success rate. Secondary outcome measures were aqueous flare, postoperative medication use, visual acuity, and incidence of complications.
RESULTS: All 24 patients finished a 1-year follow-up. Both groups maintained significant reductions in IOP after surgery throughout the follow-up period. At any point in time, the IOP of the two groups did not differ significantly. The Kaplan-Meier survival curve analysis showed no significant differences in success between the two groups (P=0.289). The mean number of anti-glaucoma medicines and visual acuity in both groups were not significantly different. Eyes with Ex-PRESS implantation had lower aqueous flare values on days 1 and 3 (both P<0.05). Instances of early postoperative hypotony and choroidal effusion were significantly fewer in frequency after Ex-PRESS implantation under the scleral flap compared with those after trabeculectomy (P<0.001).
CONCLUSION: Ex-PRESS is comparable to trabeculectomy in terms of IOP, success rate, number of glaucoma medications used, and visual acuity. However, Ex-PRESS resulted in fewer cases of in?ammation and a lower rate of complications.]]></description>
<pubDate>2017/1/4 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Wei Wang, Min-Wen Zhou, Wen-Bin Huang, Xin-Bo Gao and Xiu-Lan Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Wei Wang, Min-Wen Zhou, Wen-Bin Huang, Xin-Bo Gao and Xiu-Lan Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170109]]></guid><cfi:id>823</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Epidemiological, clinical and laboratory findings of infectious keratitis at Mansoura Ophthalmic Center, Egypt]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170110]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyze the epidemiological, clinical and laboratory findings of infectious keratitis.
METHODS: A retrospective study on cases of infective keratitis, attended our institution from Mar. 2013 to Feb. 2015, was done at Mansoura Ophthalmic Center, Egypt. Corneal scrapings were performed and processed for direct microscopy and culture in appropriate media using standard laboratory protocols.
RESULTS: Out of 245 patients enrolled for study, 247 corneal scrapings were obtained. Ocular trauma was the most common predisposing factor (51.4%), followed by diabetes mellitus (15.1%). Cultures were positive in 110 scraping samples (44.5%): 45.5% samples had pure fungal infection, 40% had pure bacterial infections and 10% had mixed fungal and bacterial growths. Acanthamoeba was detected in 5 (4.5%) samples. The most common fungal pathogen was Aspergillus spp. (41%). The most common bacterial isolates were Staphylococcus aureus (38.2%) and Pseudomonas aeruginosa (21.8%).
CONCLUSION: Incidence of fungal keratitis is high in our region. Therapeutic approach can initially be based on clinical features and sensitivity/resistance patterns. Microbiological research should direct the antimicrobial treatment. Antibiotic resistance to fluoroquinolones and aminoglycosides is an important consideration.]]></description>
<pubDate>2017/1/4 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Amani E Badawi, Dalia Moemen and Nora L El-Tantawy]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Amani E Badawi, Dalia Moemen and Nora L El-Tantawy</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170110]]></guid><cfi:id>822</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical evaluation of surgery-induced astigmatism in cataract surgery using 2.2 mm or 1.8 mm clear corneal micro-incisions]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170111]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate corneal astigmatism after phacoemulsification using 2.2 mm or 1.8 mm clear corneal micro-incisions and its effects on visual function.
METHODS: Sixty cases (60 eyes) with cataract were randomly divided into groups A (n=30) and B (n=30) respectively underwent 2.2 mm and 1.8 mm clear corneal tunnel incision phacoemulsification combined with folding intraocular lens implantation from the time direction of 11:00. On day 1 and at 1, 4, and 6wk after operation, patients’ vision was measured and both the corneal curvature and corneal thickness (CT) were recorded using Pentacam.
RESULTS: The measured surgery-induced astigmatism (SIA) in both groups A and B peaked on day 1 after operation, and then gradually decreased and eventually stabilized in week 4. No statistically significant difference was found in corneal astigmatism between two groups (P>0.05). The measured corneal astigmatism at 4wk and 6wk postoperatively were 0.28±0.09 D and 0.27±0.10 D for groups A and 0.27±0.09 D and 0.25±0.10 D for groups B without statistically significant difference (P>0.05). In addition, no significant differences in visual acuity and CT were found between groups A and B before or after operation.
CONCLUSION: Both 2.2 mm and 1.8 mm micro-incision cataract surgeries result in relatively small SIA with no difference in visual function and corneal astigmatism between two surgery approaches. Thus, the two types of surgical systems are safe and efficient for cataract treatment, by which satisfactory uncorrected visual acuity can be regained early postoperatively.]]></description>
<pubDate>2017/1/4 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jun Yang, Xiu Wang, Hong Zhang, Yi Pang and Rui-Hua Wei]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jun Yang, Xiu Wang, Hong Zhang, Yi Pang and Rui-Hua Wei</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170111]]></guid><cfi:id>821</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Corneal topographic changes and surgically induced astigmatism following combined phacoemulsification and 25-gauge vitrectomy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170112]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate corneal topographic changes and surgically induced astigmatism (SIA) after combined phacoemulsification and 25-gauge transconjunctival sutureless vitrectomy (25-G TSV).
METHODS: A retrospective study on 96 eyes of 87 patients who underwent combined phacoemulsification and 25-G TSV. The different topographic parameters and SIA were analyzed pre- and postoperatively.
RESULTS: There was no significant changes in corneal topographic parameters at different follow up periods. Only surface regularity index changed significantly in the 2nd postoperative week and then returned to baseline values thereafter. Mean SIA gradually decreased to reach 0.12 D by the 6th postoperative month.
CONCLUSION: Corneal surface and astigmatic changes are insignificant in either early or late postoperative periods following combined phacoemulsification and 25-G TSV. The SIA was the minimum among previous reports on sutureless vitrectomy alone or combined with phacoemulsification. Improvement of SIA did not stop at the 3rd postoperative month but it continued till the 6th month postoperatively.]]></description>
<pubDate>2017/1/4 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Khulood Mohammed Sayed, Mahmoud M. Farouk, Takashi Katome, Toshihiko Nagasawa, Takeshi Naito and Yoshinori Mitamura]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Khulood Mohammed Sayed, Mahmoud M. Farouk, Takashi Katome, Toshihiko Nagasawa, Takeshi Naito and Yoshinori Mitamura</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170112]]></guid><cfi:id>820</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[High speed small gauge anterior vitrectomy cutter for scleral fixated intraocular lens implantation]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170113]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report the outcomes of anterior vitrectomy using high speed cutter for scleral fixated intraocular lens (SFIOL) implantation in patients with posterior capsular rupture .
METHODS: Medical records of 51 patients with posterior capsular rupture who received high speed cutter anterior vitrectomy via limbal incision with SFIOL implantation from June 2011 to December 2013 were reviewed retrospectively for visual outcomes and complications.
RESULTS: Totally 51 eyes of 51 patients were identified (23 males and 28 females). Mean age at surgery was 67.2±15y (range 27-91y), with mean follow-up of 23±8.2mo (range 12-40mo). The 49 (96.1%) eyes had improvement or unchanged of final postoperative visual acuity. The most common complication was vitreous haemorrhage (5.9%) and transient rise in intraocular pressure (5.9%) which all spontaneously resolved
CONCLUSION: High speed cutter anterior vitrectomy via limbal incision is a safe and effective method for those with posterior capsular rupture for SFIOL implantation.]]></description>
<pubDate>2017/1/4 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yuan Bo Liang, Yoly Y.Y. Fong, Lulu L. Cheng and Alvin L. Young]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yuan Bo Liang, Yoly Y.Y. Fong, Lulu L. Cheng and Alvin L. Young</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170113]]></guid><cfi:id>819</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Six-year outcomes in neovascular age-related macular degeneration with ranibizumab]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170114]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the outcomes of (6y ranibizumab therapy in neovascular age-related macular degeneration (AMD).
METHODS: HELIX was a retrospective, observational effectiveness study using medical records of patients treated in three clinics in Belgium. Patients had neovascular AMD and were initially treated with intravitreal ranibizumab (0.5 mg) between November 1, 2007 and October 31, 2008, had (6y of data available, and were treated on an ongoing, as-needed basis. Outcomes included best-corrected visual acuity (BCVA) and central retinal thickness (CRT).
RESULTS: The sample consisted of 88 eyes from 69 patients. Mean age was 76.4±6.5y, most patients were female (62.3%). Most eyes (62.5%) were treatment-naive, 33 previously treated eyes had received predominantly other anti-vascular endothelial growth factor agents and verteporfin. Mean baseline BCVA was 57.4±12.7 ETDRS letters and CRT was 291.5±86.1 (m. On average, patients received 20.6±11.9 ranibizumab injections over the (6y. Intervals between injections were on average 12.7±16.1wk. Mean change in BCVA from baseline to last observation for the sample was less than one letter (-0.9±17.3 letters), with an average loss of -3.2±15.6 letters in previously treated eyes versus a gain of 0.6±18.4 letters in treatment-na&iuml;ve eyes. When considering a loss of <15 letters over 6y as stabilization of disease, 75.9% of all eyes showed a positive (improvement or stabilization) outcome. Mean change in CRT from baseline to last observation for the sample was -26.9±148.4 (m with the greatest reduction observed in treatment-naive eyes.
CONCLUSION: This retrospective study of 69 neovascular AMD patients treated for (6y with ranibizumab demonstrates long-term visual stabilization. In light of the natural evolution of the disease, these data confirm that ranibizumab is effective long-term under real-world conditions of heterogeneity of patients, clinicians, and centers.]]></description>
<pubDate>2017/1/4 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Julie Jacob, Heidi Brié, Anita Leys, Laurent Levecq, Filip Mergaerts, Kris Denhaerynck, Stefaan Vancayzeele, Eline Van Craeyveld, Ivo Abraham and Karen MacDonald]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Julie Jacob, Heidi Brié, Anita Leys, Laurent Levecq, Filip Mergaerts, Kris Denhaerynck, Stefaan Vancayzeele, Eline Van Craeyveld, Ivo Abraham and Karen MacDonald</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170114]]></guid><cfi:id>818</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Efficacy and safety of ranibizumab for wet age-related macular degeneration in Chinese patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170115]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the clinical efficacy and safety of ranibizumab for wet age-related macular degeneration (wAMD) in Chinese patients and to determine the mean number of injections administered over one year of follow-up.
METHODS: This single centre, retrospective observational case series study included data from 121 patients with wAMD (121 eyes) who were diagnosed by indirect ophthalmoscopy, fluorescence fundus angiography (FFA), indocyanine green angiography, and optical coherence tomography. Ranibizumab was injected into the vitreous cavities once per month for 3mo and as needed afterwards. Changes in visual acuity and central foveal thickness (CFT) during the follow-up period were compared, and the mean number of injections over the year was calculated. Patients with one or more adverse events related to the drugs and injections were recorded for further adverse events analysis.
RESULTS: The study population included 70 males and 51 females aged between 50 and 87y (mean: 71.32±9.41y). The mean number of injections over the first year was 5±1 (range: 3-9). The mean best-corrected visual acuity by Early Treatment Diabetic Retinopathy Study increased from 43.2±19.3 (95%CI: 39.8-46.7) at baseline to 51.7±20.1 (95%CI: 48.1-55.3), and central foveal thickness (CFT) decreased from 526.5±277.0 μm (95%CI: 476.6-576.4) to 258.2±161.6 μm (95%CI: 229.2-287.3) at 12mo. The differences were statistically significant (P<0.001). Visual acuity significantly improved in 34.1% of the patients (38 eyes), stabilized in 66.1% of the patients (80 eyes), and significantly decreased in 2.5% of the patients (3 eyes). CFT at baseline was an independent risk factor of decreased CFT and increased visual acuity. None of the patients had severe adverse events during the follow-up period.
CONCLUSION: Ranibizumab can effectively control disease progression and improve visual acuity in patients with wAMD. The disease conditions of most patients stabilized after a one-year treatment with an average of 5 injections.]]></description>
<pubDate>2017/1/4 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hui-Jun Qi, Xiao-Xin Li, Jun-Yan Zhang and Ming-Wei Zhao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hui-Jun Qi, Xiao-Xin Li, Jun-Yan Zhang and Ming-Wei Zhao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170115]]></guid><cfi:id>817</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Spectrum and visual outcomes of Vogt-Koyanagi-Harada disease in Argentina]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170116]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To review all cases of Vogt-Koyanagi-Harada (VKH) disease in an Inflammatory Eye Disease Service in Argentina and to describe the clinical profile and outcomes of treatment.
METHODS: The records from patients with VKH disease between January 1980 and December 2008 were retrospectively analyzed for clinical profile, complications, and treatment. Patients were classified according to their initial treatment in group 1: high corticosteroid dose [≥1 mg/(kg·d)] within 2wk of illness onset; group 2: high corticosteroid dose, 2 to 4wk of onset and group 3: patients who received the high dose after 1mo of illness onset, patients who received lower oral doses than 1 mg/(kg·d) without regarding the time of beginning of the disease.
RESULTS: A total of 210 eyes of 105 patients were included. The mean age at presentation was 32.6±13y (range: 10-74y), and 86.7% were female. The mean duration of follow up was 144±96.6mo. Patients in the group 1 had significantly higher visual acuity than the other groups (P<0.0001), none had (loss of, or no) light perception at the end of follow up, whereas 24.7% patients in group 3 ended in light perception (P<0.004).
CONCLUSION: Patients with early high dose corticosteroid treatment have better visual acuity and fewer complications. Proper timing in referral and treatment is critical for better visual outcome in VKH disease.]]></description>
<pubDate>2017/1/4 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Verónica E. Giordano, Ariel Schlaen, Martín J. Guzmán-Sánchez and Cristobal Couto]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Verónica E. Giordano, Ariel Schlaen, Martín J. Guzmán-Sánchez and Cristobal Couto</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170116]]></guid><cfi:id>816</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Objective assessment of the effect of pupil size upon the power distribution of multifocal contact lenses]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170117]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analytically assess the effect of pupil size upon the refractive power distributions of different designs of multifocal contact lenses.
METHODS: Two multifocal contact lenses of center-near design and one multifocal contact lens of center-distance design were used in this study. Their power profiles were measured using the NIMO TR1504 device (LAMBDA-X, Belgium). Based on their power profiles, the power distribution was assessed as a function of pupil size. For the high addition lenses, the resulting refractive power as a function of viewing distance (far, intermediate, and near) and pupil size was also analyzed.
RESULTS: The power distribution of the lenses was affected by pupil size differently. One of the lenses showed a significant spread in refractive power distribution, from about ?3 D to 0 D. Generally, the power distribution of the lenses expanded as the pupil diameter became greater. The surface of the lens dedicated for each distance varied substantially with the design of the lens.
CONCLUSION: In an experimental basis, our results show how the lenses power distribution is affected by the pupil size and underlined the necessity of careful evaluation of the patient’s visual needs and the optical properties of a multifocal contact lens for achieving the optimal visual outcome.]]></description>
<pubDate>2017/1/4 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Eleni Papadatou, Antonio J. Del &Aacute;guila-Carrasco, José J. Esteve-Taboada, David Madrid-Costa and Alejandro Cervi&ntilde;o- Expósito]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Eleni Papadatou, Antonio J. Del &Aacute;guila-Carrasco, José J. Esteve-Taboada, David Madrid-Costa and Alejandro Cervi&ntilde;o- Expósito</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20170117]]></guid><cfi:id>815</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Anterior lamellar recession for management of upper eyelid cicatricial entropion and associated eyelid abnormalities]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171207]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the functional and aesthetic outcomes of upper eyelid cicatricial entropion (UCE) correction using anterior lamellar recession (ALR) with addressing the associated conditions including dermatochalasis, brow ptosis, blepharoptosis, and lid retraction.
METHODS: Chart review of patients with upper lid cicatricial entropion who had undergone ALR from 2013 to 2016 was reviewed. Success was defined as the lack of any lash in contact with the globe, no need for a second procedure, and acceptable cosmesis at the final follow up.
RESULTS: Sixty eight patients (97 eyelids) were operated by ALR with simultaneous correction of associated lid problems in each case when necessary. The mean follow-up time was 17.8mo (range, 6.0-24.0mo). Concomitantly, levator tucking was performed in 19 eyelids (19.6%), upper lid retractor recession in 18 eyelids (18.6%), and internal browpexy in 31 eyelids (32.0%). In 95.8% of patients (95%CI: 0.85-0.96), satisfactory functional and cosmetic outcome was achieved with a single surgical procedure.
CONCLUSION: Based on the principles of lamellar recession and concurrently addressing the associated lid problems, this approach is an effective and safe treatment of UCE.]]></description>
<pubDate>2017/12/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Tamer I.Gawdat, Mahmoud A. Kamal, Ahmed S.Saif and Mostafa M. Diab]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Tamer I.Gawdat, Mahmoud A. Kamal, Ahmed S.Saif and Mostafa M. Diab</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171207]]></guid><cfi:id>814</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Timing and approaches in congenital cataract surgery: a four-year, two-layer randomized controlled trial]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171208]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare visual prognoses and postoperative adverse events of congenital cataract surgery performed at different times and using different surgical approaches.
METHODS: In this prospective, randomized controlled trial, we recruited congenital cataract patients aged 3mo or younger before cataract surgery. Sixty-one eligible patients were randomly assigned to two groups according to surgical timing: a 3-month-old group and a 6-month-old group. Each eye underwent one of three randomly assigned surgical procedures, as follows: surgery A, lens aspiration (I/A); surgery B, lens aspiration with posterior continuous curvilinear capsulorhexis (I/A+PCCC); and surgery C, lens aspiration with posterior continuous curvilinear capsulorhexis and anterior vitrectomy (I/A+PCCC+A-Vit). The long-term best-corrected visual acuity (BCVA) and the incidence of complications in the different groups were compared and analyzed.
RESULTS: A total of 57 participants (114 eyes) with a mean follow-up period of 48.7mo were included in the final analysis. The overall logMAR BCVA in the 6-month-old group was better than that in the 3-month-old group (0.81±0.28 vs 0.96±0.30; P=0.02). The overall logMAR BCVA scores in the surgery B group were lower than the scores in the A and C groups (A: 0.80±0.29, B: 1.02±0.28, and C: 0.84±0.28; P=0.007). A multivariate linear regression revealed no significant relationships between the incidence of complications and long-term BCVA.
CONCLUSION: It might be safer and more beneficial for bilateral total congenital cataract patients to undergo surgery at 6mo of age than 3mo. Moreover, with rigorous follow-up and timely intervention, the postoperative complications in these patients are treatable and do not compromise visual outcomes.]]></description>
<pubDate>2017/12/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hao-Tian Lin, Er-Ping Long, Jing-Jing Chen, Zhen-Zhen Liu, Zhuo-Ling Lin, Qian-Zhong Cao, Xia-Yin Zhang, Xiao-Hang Wu, Qi-Wei Wang, Duo-Ru Lin, Xiao-Yan Li, Jin-Chao Liu, Li-Xia Luo, Bo Qu, Wei-Rong Chen and Yi-Zhi Liu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hao-Tian Lin, Er-Ping Long, Jing-Jing Chen, Zhen-Zhen Liu, Zhuo-Ling Lin, Qian-Zhong Cao, Xia-Yin Zhang, Xiao-Hang Wu, Qi-Wei Wang, Duo-Ru Lin, Xiao-Yan Li, Jin-Chao Liu, Li-Xia Luo, Bo Qu, Wei-Rong Chen and Yi-Zhi Liu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171208]]></guid><cfi:id>813</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical outcomes of a new diffractive multifocal intraocular lens]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171209]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate clinical outcomes after implantation of a new diffractive aspheric multifocal intraocular lens (IOL) with +3.00 addition power.
METHODS: This is a retrospective, consecutive case series of cataract patients who underwent bilateral implantation of the Optiflex MO/HF D012 (Moss Vision Inc. Ltd, London, UK) multifocal IOL. Patients followed for 6mo were included in the study. Data on distance, intermediate and near visual acuity, refractive error [manifest spherical equivalent (MSE)], contrast sensitivity, adverse events, subjective symptoms, spectacle independence and patient satisfaction [visual function questionnaire (VFQ)-25 questionnaire] were retrieved from electronic medical records and analyzed.
RESULTS: Forty eyes of 20 patients with a mean age of 66.7±8.5y (range: 53-82) were included in the study. Mean uncorrected distance, near and intermediate visual acuity remained stable through postoperative visits and was 0.19±0.19 logMAR, Jaeger 4 and Jaeger 3 respectively at the 6mo visit. At the end of postoperative 6mo, MSE was -0.14±0.42 diopters (D) and 98% of the eyes were within 1.00 D of target refraction. Postoperative low contrast (10%) visual acuity remained stable (P=0.54) through follow up visits with a mean of 0.35±0.17 logMAR at the 6mo visit. There were no reported adverse events. None of the patients reported subjective symptoms of halo or glare. Spectacle independence rate was 90%. Mean VFQ-25 questionnaire score was 93.5±6.12.
CONCLUSION: The Optiflex MO/HF-DO12 IOL was safely implanted and successfully restored distance, intermediate and near visual acuity without impairing contrast sensitivity. High levels of spectacle independence were achieved at all distances including intermediate distance.]]></description>
<pubDate>2017/12/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Baha Toygar, Ozge Yabas Kiziloglu, Okan Toygar and Ali Murat Hacimustafaoglu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Baha Toygar, Ozge Yabas Kiziloglu, Okan Toygar and Ali Murat Hacimustafaoglu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171209]]></guid><cfi:id>812</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Outcomes of small gauge pars plicata vitrectomy for patients with persistent fetal vasculature: a report of 105 cases]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171210]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the surgical outcomes in eyes with persistent fetal vasculatures (PFV) managed by small gauge pars plicata vitrectomy.
METHODS: Consecutive patients with PFV treated by small gauge pars plicata vitrectomy at Beijing Tongren Eye Center between January 2010 and January 2013 were retrospectively reviewed.
RESULTS: A total of 118 eyes of 105 patients with PFV were included and undergone small gauge pars plicata vitrectomy, of which 84 (71.2%) eyes had lensectomy and 16 (13.6%) eyes had lens aspiration and immediate intraocular lens implantation. The percentage of sutured scleral incision of 23 gauge vitrectomy (71.7%, 33/46) was higher than that of the 25 gauge vitrectomy (18.1%, 13/72). At last follow-up, visual acuity remained stable in 34 eyes (28.8%) and improved in 84 eyes (71.2%). Age at surgery (less than 2y), anterior type of PFV, and immediate IOL implantation were associated with postoperative improved visual acuity. Sixty five (55.1%) eyes had retinal detachment preoperatively, among which 33 (50.8%, 33/65) eyes had retinal reattachment or partial retinal reattachment.
CONCLUSION: The results suggest that cases with PFV have a potential for developing good visual acuity after small gauge pars plicata vitrectomy with favorable anatomic outcomes and acceptable rate of serious surgical complications.]]></description>
<pubDate>2017/12/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jing-Hua Liu, Hai Lu, Song-Feng Li, Yong-Hong Jiao, Nan Lin and Ning-Pu Liu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jing-Hua Liu, Hai Lu, Song-Feng Li, Yong-Hong Jiao, Nan Lin and Ning-Pu Liu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171210]]></guid><cfi:id>811</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A new strategy to interpret OCT posterior pole asymmetry analysis for glaucoma diagnosis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171211]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To detect early glaucoma by optical coherence tomography (OCT) posterior pole asymmetry analysis.
METHODS: Totally 39 eyes from 39 healthy subjects, 40 eyes from 40 mild glaucoma patients, 33 eyes from 33 moderate glaucoma patients and 41 eyes from severe glaucoma patients were included in this study. All subjects underwent posterior pole asymmetry analysis (PPAA) of OCT and the posterior pole area was divided into three zones. Means, standard deviations and 95% confidence intervals of each zone asymmetry in control group were assessed. Retina thickness asymmetry (RTA) of different stage of glaucoma were compared for each zone, and receiver operating characteristic (ROC) curves were made to test the efficacy of strategies using different zones to discriminate glaucomatous eyes from the healthy ones.
RESULTS: In a healthy population, RTA of the centre zone showed the minimal mean value (3.085 μm), standard deviation (1.756), and the narrowest 95% confidence interval (from 2.360 to 3.810 μm). It was only in the center zone that RTA exhibited significant difference between control and moderate glaucoma group (P<0.01), as well as control and severe glaucoma group (P<0.00001). The strategy utilized in the center zone had the strongest diagnostic capability (zone 3 AUROC=0.816, P=0.0016) in comparison to that of the periphery area (zone 1 AUROC=0.675, P=0.0016; zone 2 AUROC=0.623, P=0.0197), the whole posterior pole involved interpreting strategy showed inferior diagnostic power than the centre zone dependent strategy (z=2.851, P=0.0044).
CONCLUSION: Utilizing the posterior pole centre zone to interpret OCT PPAA results are more effective than making use of the whole posterior pole map.]]></description>
<pubDate>2017/12/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yi Zhang, Ni Li, Jun Chen, Hong Wei, Shan-Ming Jiang and Xiao-Min Chen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yi Zhang, Ni Li, Jun Chen, Hong Wei, Shan-Ming Jiang and Xiao-Min Chen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171211]]></guid><cfi:id>810</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Negative effects of transthyretin in high myopic vitreous on diabetic retinopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171212]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyze the relationship between vitreous transthyretin (TTR) levels, high myopia and diabetic retinopathy (DR).
METHODS: We selected 6722 individuals from the southern Jiangsu Province for diabetes and ophthalmic examinations. The TTR concentration in the vitreous of 50 patients with high myopia and diabetes, 50 patients with only DR, and 20 healthy controls were determined by ELISA. Key factors in Tie2 pathway in DR development including vascular endothecial growth factor (VEGF), Tie2, Angpt1, Angpt2, vascular endothelial growth factor receptor (VEGFR) 1 and VEGFR2 were also detected by ELISA.
RESULTS: The prevalence of DR in patients with diabetes and myopia [<6.00 diopter (D)], diabetes and high myopia (>6.00 D), and diabetes without myopia were 11.1%, 2.5%, and 60.0%, respectively. The vitreous TTR concentration of patients with diabetes and high myopia was approximately 6.5- and 4.2-times higher than those of patients with DR and healthy controls, respectively (P<0.05). Following the vitreous TTR concentration, the levels of VEGF, Tie2, Angpt1, Angpt2, VEGFR1 and VEGFR2 in vitreous of diabetes and high myopia patients, DR patients and healthy controls were detected as dramatically fluctuated.
CONCLUSION: The results suggest that TTR can affect the vitreous contents of key factors in Tie2 pathway for neovascularization, and there should be a protective association between abundant TTR levels in the vitreous of highly myopic patients and a decreased risk of DR.]]></description>
<pubDate>2017/12/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jun Shao and Yong Yao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jun Shao and Yong Yao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171212]]></guid><cfi:id>809</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Subfoveal choroidal thickness and volume in severe internal carotid artery stenosis patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171213]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To demonstrate the differences of retinal and choroidal structure changes in internal carotid artery (ICA) patients of China by enhanced-depth imaging optical coherence tomography (EDI-OCT).
METHODS: A retrospective review was conducted of 46 patients with a diagnosis of ICA stenosis greater than 65% on only one side (the opposite ICA Stenosis had less than 40% stenosis) from June 2015 through June 2016. All of the patients were combined with amaurosis fugax, but without any abnormality with other ocular examination. Thickness and volume of choroid and retina were manually measured by EDI-OCT. Differences were compared between ICA stenosis eyes and fellow eyes.
RESULTS: There were no significant differences in the retinal thickness, macular retinal nerve fiber layer (mRNFL) thickness, inner thickness, or outer retinal thickness between the ICA Stenosis group and the control group (P=0.834, 0.187, 0.552, and 0.903, respectively). The mean central choroidal thickness of the ICA Stenosis group was significantly lower than that of the control group (239.70±23.76 &micro;m vs 257.46±22.13 &micro;m, P<0.001). The percentage of ICA stenosis was significantly associated with the central choroidal thickness, central retinal thickness, foveal center choroidal volume, and foveal center retinal volume (r=0.854, 0.678, 0.729, and 0.785, respectively; P<0.001). There were no significant differences in the retinal and choroidal volume values in the 4 inner and 4 outer sectors between the two groups.
CONCLUSION: The choroidal thickness in severe ICA stenosis eyes is lower than in fellow eyes. The choroidal thinning may occur before the retinal changes in patients with ocular ischemic syndrome. Evaluations of choroidal thickness may be useful to choose the optimal therapeutic schedule for ICA patients.]]></description>
<pubDate>2017/12/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hui Wang, Yan-Ling Wang and Hong-Yang Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hui Wang, Yan-Ling Wang and Hong-Yang Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171213]]></guid><cfi:id>808</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[The impact of macular surgery in different grades of epiretinal membrane]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171214]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the impact of macular surgery on the functional and anatomic outcomes of the patients in different grades of epiretinal membrane (ERM).
METHODS: Seventy-one eyes of 71 patients who underwent 23-gauge transconjunctival sutureless pars plana vitrectomy for primary isolated ERM were evaluated in this study.
RESULTS: There were 38 females (53.5%) and 33 males (46.5%). The average age of the patients was 68.1y (range 42-89y). Mean follow up period was 14mo (range 6-26mo). The cases were divided into two subgroups of cellophane maculopathy (CM) and macular pucker (MP). An improvement was observed in the postoperative best-corrected visual acuity (BCVA), as well as a decrement in central foveal thickness (CFT) in both groups (both of these being statistically significant; P=0.001). In comparison between two groups, it was found that there was a significant improvement on BCVA and CFT in CM group than MP group (P=0.01). Furthermore, the postoperative fundus findings regarding RPE alterations and macular edema were significantly higher in MP group when compared to the CM group (P=0.01).
CONCLUSION: ERM and internal limiting membrane peeling surgery can lead to a significant reduction of CFT and visual improvements in idiopathic ERM. A long-term ERM persistence will cause unrecoverable retinal damage and visual loss.]]></description>
<pubDate>2017/12/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Cosar Batman and Mehmet Citirik]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Cosar Batman and Mehmet Citirik</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171214]]></guid><cfi:id>807</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Optic nerve compression: the role of the lamina cribrosa and translaminar pressure]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171215]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To describe the morphological changes of the lamina cribrosa (LC) in patients with optic nerve compression.
METHODS: Cross-sectional study. Twenty eyes with optic nerve compression, affected by Graves' ophthalmopathy (GO) were compared with 18 refractive error-matched healthy eyes. The following examinations were performed: best-corrected visual acuity (BCVA), intraocular pressure, optic nerve echography,&nbsp;visual field, SD-OCT including the retinal nerve fiber layer (RNFL), ganglion cell complex (GCC), and LC thickness and extent.
RESULTS: A-scan revealed significant differences in the subarachnoid space (SAS) between the affected and control groups. LC thickness and LC area were 233 &micro;m (SD 23) and 0.41 mm2 (SD 0.19), respectively.  Average GCC thickness (P=0.0005), LC thickness (P=0.001), MD (P=0.001) and PSD (P=0.001) differed significantly between the two groups; whereas LC area (P=0.2) and average RFNL (P=0.1) did not.
CONCLUSION: Optic nerve compression reduces the SAS thereby altering the morphology of LC thickness and causing GCC damage.]]></description>
<pubDate>2017/12/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mario R Romano, Gilda Cennamo, Maria Angelica Breve, Michela Piedepalumbo, Claudio Iovino, Nunzio Velotti and Giovanni Cennamo]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mario R Romano, Gilda Cennamo, Maria Angelica Breve, Michela Piedepalumbo, Claudio Iovino, Nunzio Velotti and Giovanni Cennamo</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171215]]></guid><cfi:id>806</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of mistletoe combined with carboxymethyl cellulose on dry eye in postmenopausal women]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171106]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the protective effect of mistletoe combined with carboxymethyl cellulose eye drops on dry eye in postmenopausal women.
METHODS: Sixty postmenopause female patients diagnosed of dry eye were assigned randomly to mistletoe combined with carboxymethyl cellulose eye drops treatment group (n=30) and control group treated with normal saline eye drops (n=30). The subjective symptoms of ocular surface, Ocular Surface Disease Index (OSDI), tear film function tests, tear protein and corneal morphology by confocal scanning microscopy were analyzed before treatment and at 1, 2, 4 and 8wk after treatment respectively. To ensure the safety of the trial, all patients were examined with systolic pressure, diastolic pressure, glutamic-pyruvic transaminase, glutamic oxaloacetic transaminase, urine creatinine, and blood urea nitrogen at 8wk after treatment.
RESULTS: There were no obvious differences between two groups before the treatment (P>0.05). In two months after the treatment, the symptoms of ocular surface, OSDI, tear protein, and tear film function were only slightly changed in normal saline eye drops group. However, all indices were improved after the treatment of mistletoe combined with carboxymethyl cellulose eye drops group (P<0.05). In addition, the average amount of corneal epithelium basal cells and inflammatory cells of mistletoe treated group were 3174±379 and 38±25 cells/mm2, significantly decreased as compared to the control group with 4309±612 and 158± 61 cells/mm2, respectively. In the control group, although nerves still maintained straight under corneal epithelium, the number of nerves were significantly decreased, as compared with normal female. In the mistletoe treated group, the number of nerves was only slightly reduced, compared with normal female.
CONCLUSION: Mistletoe combined with carboxymethyl cellulose eye drops can alleviate the symptoms and signs of dry eye symptoms.]]></description>
<pubDate>2017/11/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Nan Jiang, Lin-Hong Ye, Lei Ye, Jing Yu, Qi-Chen Yang, Qing Yuan, Pei-Wen Zhu and Yi Shao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Nan Jiang, Lin-Hong Ye, Lei Ye, Jing Yu, Qi-Chen Yang, Qing Yuan, Pei-Wen Zhu and Yi Shao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171106]]></guid><cfi:id>805</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Femtosecond laser corneal refractive surgery for the correction of high myopic anisometropic amblyopia in juveniles]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171107]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the effects of femtosecond laser-assisted in situ keratomileusis (FS-LASIK) and small-incision lenticule extraction (SMILE) to correct high myopic anisometropic amblyopia in juvenile patients.
METHODS: From November 2013 to January 2015, 33 amblyopic patients with high myopic anisometropic amblyopia were studied. FS-LASIK (30 eyes) or SMILE (3 eyes) was performed in the amblyopic eyes. Visual acuity, refraction, contrast sensitivity, stereoacuity and complications were evaluated. Patients completed follow-up examinations at 3d, 1mo, 3mo and the last follow-up time (mean 8.17±3.23mo) after surgery.
RESULTS: The mean age at surgery was 9.04±3.04y (range 6-16y). The mean spherical equivalent in the amblyopic eyes was significantly decreased from -10.00±2.39 D preoperatively to -0.06±1.06 D at 1mo, -0.19±1.33 D at 3mo and -0.60±1.43 D at approximately 8mo postoperatively (P<0.05 for all). The mean myopic anisometropia was significantly decreased from -9.45±2.33 D preoperatively to +0.37±1.48 D at 1mo, -0.46±1.47 D at 3mo and -0.09±1.83 D at approximately 8mo (P<0.05 for all). The logarithm of the minimum angle of resolution (logMAR) for uncorrected and corrected distance visual acuity (UDVA and CDVA, respectively) of the amblyopic eye improved from 1.74±0.35 and 0.98±0.63 preoperatively to 0.45±0.31 and 0.41±0.33 at approximately 8mo after surgery, respectively. The logMAR CDVA at 3d, 1, 3 and 8mo postoperatively improved by means of 1.42, 2.22, 2.96, and 4.39 lines, and a gain of more than two lines accounted for 45%, 50%, 74% and 86% of all patients, respectively. The contrast sensitivity of both amblyopic eyes and dominant eyes at 0.5, 2, 8 cycles per degree was significantly improved postoperatively (P<0.05 for all). Of the 33 pediatric patients, no patients had near stereopsis preoperatively and seven patients (21.2%) recovered near stereopsis (400″ to 60″) at approximately 8mo after surgery. No intraoperative or postoperative complications occurred in any patient.
CONCLUSION: FS-LASIK or SMILE can be promising alternative methods to correct high myopic anisometropic amblyopia in juvenile patients who have failed with traditional approaches.]]></description>
<pubDate>2017/11/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jing Zhang and Ke-Ming Yu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jing Zhang and Ke-Ming Yu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171107]]></guid><cfi:id>804</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Scanning-slit topography in patients with keratoconus]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171108]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the anterior and posterior corneal surfaces using scanning-slit topography and to determine the diagnostic ability of the measured corneal parameters in keratoconus.
METHODS: Orbscan II measurements were taken in 39 keratoconic corneas previously diagnosed by corneal topography and in 39 healthy eyes. The central minimum, maximum, and astigmatic simulated keratometry (K) and anterior axial power values were determined. Spherical and cylindrical mean power diopters were obtained at the central and at the steepest point of the cornea both on anterior and on posterior mean power maps. Pachymetry evaluations were taken at the center and paracentrally in the 3 mm zone from the center at a location of every 45 degrees. Receiver operating characteristic (ROC) analysis was used to determine the best cut-off values and to evaluate the utility of the measured parameters in identifying patients with keratoconus.
RESULTS: The minimum, maximum and astigmatic simulated K readings were 44.80±3.06 D, 47.17±3.67 D and 2.42±1.84 D respectively in keratoconus patients and these values differed significantly (P<0.0001 for all comparisons) from healthy subjects. For all pachymetry measurements and for anterior and posterior mean power values significant differences were found between the two groups. Moreover, anterior central cylindrical power had the best discrimination ability (area under the ROC curve=0.948).
CONCLUSION: The results suggest that scanning-slit topography and pachymetry are accurate methods both for keratoconus screening and for confirmation of the diagnosis.]]></description>
<pubDate>2017/11/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[László Módis Jr., Gábor Németh, Eszter Szalai, Zsuzsa Flaskó and Berthold Seitz]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>László Módis Jr., Gábor Németh, Eszter Szalai, Zsuzsa Flaskó and Berthold Seitz</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171108]]></guid><cfi:id>803</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Phacoemulsification combined with transpupillary removal of silicone oil and intracapsular intraocular lens implantation]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171109]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To estimate the effectiveness of phacoemulsification and foldable intraocular lens (IOL) implantation combined with transpupillary silicone oil removal.
METHODS: There were 168 eyes of 168 candidate patients with cataract and silicone oil-filled eyes recruited in our study. All of the patients received the intraocular silicone oil removal surgery by transpupillary drainage and cataract extraction by phacoemulsi?cation. Then the IOL implantation were also performed through corneal incision.
RESULTS: The surgery was successfully completed in all eyes. Best corrected visual acuity (BCVA) and postoperative complications were recorded in three months after surgery. There were 143 eyes with BCVA improved, otherwise 25 eyes remained stable at the last follow-up visit. The mean BCVA statistically improved from 20/400±0.02 to 20/100±0.15 (P<0.001) and mean postoperative IOP was 13.85±2.18 mm Hg (P=0.415). No intra-operative complications were reported.
CONCLUSION: Phacoemulsi?cation combined with transpupillary removal of silicone oil is a safe and simple effective method. In general, it enables quick recovery of visual acuity with less complication rate.]]></description>
<pubDate>2017/11/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yu-Cheng Zhu, Dong-Qing Yuan, Ping Xie, Xiao-Yi Liu, Song-Tao Yuan and Qing-Huai Liu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yu-Cheng Zhu, Dong-Qing Yuan, Ping Xie, Xiao-Yi Liu, Song-Tao Yuan and Qing-Huai Liu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171109]]></guid><cfi:id>802</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Prospective study of Centurion&#174; versus Infiniti&#174; phacoemulsification systems: surgical and visual outcomes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171110]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate surgical outcomes (SOs) and visual outcomes (VOs) in cataract surgery comparing the Centurion&#174; phacoemulsification system (CPS) with the Infiniti&#174; phacoemulsification system (IPS).
METHODS: Prospective, consecutive study in a single-site private practice. Totally 412 patients undergoing cataract surgery with either the CPS using the 30-degree balanced&#174; tip (n=207) or the IPS using the 30-degree Kelman&#174; tip (n=205). Intraoperative and postoperative outcomes were documented prospectively up to one month follow-up. Nuclear sclerosis (NS) grade, cumulated dissipated energy (CDE), preoperative corrected distance visual acuity (CDVA), and CDVA at one month were recorded.
RESULTS: CDE was 13.50% less in the whole CPS compared with the whole IPS subcohort. In eyes with NS grade III or greater, CDE was 28.87% less with CPS (n=70) compared with IPS (n=44) (P=0.010). Surgical complications were not statistically different between the two subcohorts (P=0.083), but in the one case of vitreous loss using the CPS, CDVA of 6/4 was achieved at one month. The mean CDVAs (VOs) at one month for NS grade III and above cataracts were -0.17 logMAR (6/4.5) in the CPS and -0.15 logMAR (6/4.5) in the IPS subcohort respectively (P=0.033).
CONCLUSION: CDE is 28.87% less, and VOs are significantly improved, in denser cataracts in the CPS compared with the IPS. The authors recommend the CPS for cases with denser nuclei.]]></description>
<pubDate>2017/11/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Lawrence J. Oh, Chu Luan Nguyen, Eugene Wong, Samuel S.Y. Wang and Ian C. Francis]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Lawrence J. Oh, Chu Luan Nguyen, Eugene Wong, Samuel S.Y. Wang and Ian C. Francis</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171110]]></guid><cfi:id>801</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Repeatability of Ophtha Top topography and comparison with IOL-Master and LenstarLS900 in cataract patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171111]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the repeatability of Ophtha Top topography and assess the consistency with intraocular lens (IOL)-Master and LenstarLS900 (Lenstar) in measuring corneal parameters among cataract patients.
METHODS: Totally 125 eyes were enrolled. Corneas were successively measured with Ophtha Top, IOL-Master and Lenstar at least three times. The flattest meridian power (Kf), the steepest meridian power (Ks), mean power (Km), J0 and J45 were recorded. Intra-class correlation coefficients (ICCs), the coefficient of variance (COV), within subject standard deviation (Sw), and test-retest repeatability (2.77Sw) were adopted to determine the repeatability. The 95% limit of agreement (95%LOA) and Bland-Altman plots were used to assess comparability.
RESULTS: Repeatability of Ophtha Top topography for measuring corneal parameters showed the ICCs were all above 0.93, 2.77Sw was lower than 0.31, and the COV of the Kf and Ks was lower than 0.25. The keratometric readings with Ophtha Top topography were flatter than with the IOL-Master and Lenstar devices, while the Pearson correlation coefficients were over 0.97. The J0 and J45 with Ophtha Top topography were smaller compared with Lenstar and IOL-Master, while was comparable between Lenstar and IOL-Master.
CONCLUSION: Ophtha Top topography shows excellent repeatability for measuring corneal parameters. However, differences between the Ophtha TOP topography and Lenstar, IOL-Master both in cornea curvature and the astigmatism should be noted clinically.]]></description>
<pubDate>2017/11/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Sha-Sha Yu, Hui Song and Xin Tang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Sha-Sha Yu, Hui Song and Xin Tang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171111]]></guid><cfi:id>800</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Bimanual microincision cataract surgery with implantation of the new Incise&#174; MJ14 intraocular lens through a 1.4 mm incision]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171112]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyze the visual outcomes and the posterior capsule opacification (PCO) with the new Incise&#174; MJ14 intraocular lens (IOL) implanted through a 1.4 mm clear corneal incision (CCI) in patients who underwent bimanual microincision cataract surgery (B-MICS).
METHODS: Eighty eyes which underwent cataract surgery using B-MICS technique performed by the same experienced surgeon were included in the study: 40 eyes were implanted with an Incise&#174; MJ14 IOL through a 1.4 mm CCI (group A) without enlargement of the main CCI, while 40 eyes were implanted with an Akreos&#174; MI60 IOL with enlargement of the main CCI to 1.8 mm (group B). Best corrected visual acuity (BCVA), astigmatism and endothelial cell loss were evaluated before and after surgery at 7, 30d and 6mo. Anterior segment-optical coherence tomography (AS-OCT) of CCI was performed at 1, 3, 7, 30d, 6 and 18mo. PCO incidence was evaluated at 18mo using EPCO 2000 Software.
RESULTS: Mean BCVA improvement and endothelial cell loss were statistically significant at 18mo in both groups with no difference between the two groups; no statistically significant difference in surgically induced astigmatism (SIA) was noticed in the two groups. At AS-OCT the only significant alterations in the CCI were endothelial gaping and local detachment of Descemet’s membrane at 1 and 7d after surgery; no statistically significant alterations were found at 1, 6 and 18mo. PCO score at 18mo was 0.03±0.07 for group A and 0.08±0.18 for group B (P=0.11) with no sign of central optic plate invasion in both groups.
CONCLUSION: The implant of the new Incise&#174; MJ14 IOL through a 1.4 mm CCI and B-MICS technique appeared to be a safe and effective procedure with rapid visual recovery. PCO rate resulted very low and the CCI presented few morphological alterations which were only detectable in the first days postoperatively and achieved fast corneal healing during the long-term follow-up.]]></description>
<pubDate>2017/11/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Gian Maria Cavallini, Tommaso Verdina, Michele De Maria, Elisa Fornasari, Giulio Torlai, Veronica Volante, Simone Donati and Carlo Cagini]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Gian Maria Cavallini, Tommaso Verdina, Michele De Maria, Elisa Fornasari, Giulio Torlai, Veronica Volante, Simone Donati and Carlo Cagini</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171112]]></guid><cfi:id>799</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[The prognostic value of lymphocyte-to-monocyte ratio in retinopathy of prematurity]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171113]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the associations between development of retinopathy of prematurity (ROP) and serum lymphocyte-to-monocyte ratio (LMR), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR).
METHODS: A retrospective cohort study was performed, involving infants who were screened for ROP from January 2015 to December 2015. Preterm newborns of ≤32 gestational weeks with ROP were enrolled as the observation group, and non-ROP infants were enrolled as the control group, whose complete blood cell were measured within the first 24h of life. The levels of NLR, LMR and PLR were determined in all groups. The data obtained were analyzed using univariate and multivariate logistic regression analysis.
RESULTS: In this study, 40 cases of ROP were enrolled and 40 cases of non-ROP as controls. The LMR levels were significantly higher (P<0.001) in ROP group (3.96±1.16) compared to non-ROP group (2.85±0.79). The NLR levels were significantly lower (P=0.035) in ROP group {median [interquartile range (IQR)], 0.88 (0.67-1.46)} compared to non-ROP group [median (IQR), 1.20 (0.85-1.89)]. The median PLR values were 61.99 (IQR, 50.23-75.98) in ROP group and 69.24 (IQR, 55.52-88.12) in non-ROP group (P=0.104). Logistic regression analysis suggested that LMR was an independent risk factor for ROP (OR: 0.275; 95% CI: 0.134-0.564; P=0.001).
CONCLUSION: The findings demonstrate that higher LMR is independently and significantly associated with the development of ROP, and the LMR may be invoked as a predictive tool for identifying risk for ROP.]]></description>
<pubDate>2017/11/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yu-Xiang Hu, Xiao-Xuan Xu, Yi Shao, Gao-Le Yuan, Feng Mei, Quan Zhou, Yi Cheng, Jun Wang and Xiao-Rong Wu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yu-Xiang Hu, Xiao-Xuan Xu, Yi Shao, Gao-Le Yuan, Feng Mei, Quan Zhou, Yi Cheng, Jun Wang and Xiao-Rong Wu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171113]]></guid><cfi:id>798</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A predictive score for retinopathy of prematurity by using clinical risk factors and serum insulin-like growth factor-1 levels]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171114]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To detect the impact of insulin-like growth factor-1 (IGF-1) and other risk factors for the early prediction of retinopathy of prematurity (ROP) and to establish a scoring system for ROP prediction by using clinical criteria and serum IGF-1 levels.
METHODS: The study was conducted with 127 preterm infants. IGF-1 levels in the 1st day of life, 1st, 2nd, 3rd and 4th week of life was analyzed. The score was established after logistic regression analysis, considering the impact of each variable on the occurrences of any stage ROP. A validation cohort containing 107 preterm infants was included in the study and the predictive ability of ROP score was calculated.
RESULTS: Birth weights (BW), gestational weeks (GW) and the prevalence of breast milk consumption were lower, respiratory distress syndrome (RDS), bronchopulmonary dysplasia (BPD) and necrotizing enterocolitis (NEC) were more frequent, the duration of mechanical ventilation and oxygen supplementation was longer in patients with ROP (P<0.05). Initial serum IGF-1 levels tended to be lower in newborns who developed ROP. Logistic regression analysis revealed that low BW (<1250 g), presence of intraventricular hemorrhage (IVH) and formula feeding increased the risk of ROP. Afterwards, the scoring system was validated on 107 infants. The negative predictive values of a score less than 4 were 84.3%, 74.7% and 79.8% while positive predictive values were 76.3%, 65.5% and 71.6% respectively.
CONCLUSION: In addition to BW <1250 g and IVH, formula consumption was detected as a risk factor for the development of ROP. Breastfeeding is important for prevention of ROP in preterm infants.]]></description>
<pubDate>2017/11/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ye&#351;im Co&#351;kun, Ceyhun Dalkan, &#214;zge Yaba&#351;, &#214;zlem ünay Demirel, Elif Samiye Bayar, Sibel Sakarya, Tuba Müftüo&#287;lu, Dilaver Er&#351;anl&#305;, Nerin Bah&#231;eciler and &#304;pek Akman]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ye&#351;im Co&#351;kun, Ceyhun Dalkan, &#214;zge Yaba&#351;, &#214;zlem ünay Demirel, Elif Samiye Bayar, Sibel Sakarya, Tuba Müftüo&#287;lu, Dilaver Er&#351;anl&#305;, Nerin Bah&#231;eciler and &#304;pek Akman</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171114]]></guid><cfi:id>797</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Validity of automated refraction after segmented refractive multifocal intraocular lens implantation]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171115]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the clinical utility of automated refraction (AR) and keratometry (KR) compared with subjective or manifest refraction (MR) after cataract or refractive lens exchange surgery with implantation of Lentis Mplus X (Oculentis GmbH) refractive multifocal intraocular lens (IOL).
METHODS: Eighty-six eyes implanted with the Lentis Mplus X multifocal IOL were included. MR was performed in all patients followed by three consecutive AR measurements using the Topcon KR-8000 autorefractor. Assessment of repeatability of consecutive AR before and after dilation with phenylephrine 10%, and comparison of the AR and KR with MR using vector analysis were performed at 3mo follow-up.
RESULTS: Analysis showed excellent repeatability of the AR measurements. Linear regression of AR versus MR showed good correlation for sphere and spherical equivalent, whereas the correlation for astigmatism was low. The mean difference AR-MR was -1.28±0.29 diopters (D) for sphere. Astigmatism showed better correlation between KR and MR.
CONCLUSION: We suggest AR sphere plus 1.25 D and the KR cylinder as the starting point for MR in eyes with a Lentis Mplus X multifocal IOL. If AR measurements are equal to MR, decentration of the IOL should be suspected.]]></description>
<pubDate>2017/11/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[César Albarrán-Diego, Gonzalo Mu&#241;oz, Stephanie Rohrweck, Santiago García-Lázaro and José Ricardo Albero]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>César Albarrán-Diego, Gonzalo Mu&#241;oz, Stephanie Rohrweck, Santiago García-Lázaro and José Ricardo Albero</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171115]]></guid><cfi:id>796</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Dependence of dynamic contour and Goldmann applanation tonometries on peripheral corneal thickness]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171007]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the effects of peripheral corneal thickness (PCT) on dynamic contour tonometry(DCT) and Goldmann applanation tonometry (GAT).
METHODS: A cross-sectional study. We created a software which calculates the corneal contour (CC) as a function of the radius from the corneal apex to each pixel of the contour. The software generates a central circumference with a radius of 1 mm and the remainder of the cornea is segmented in 5 rings concentric with corneal apex being its diameter not constant around the corneal circumference as a consequence of the irregular CC but keeping constant the diameter of each ring in each direction of the contour. PCT was determined as the mean thickness of the most eccentric ring. Locally weighted scatterplot smoothing (LOWESS) regression was used to determine the pattern of the relationship between PCT and both DCT and GAT respectively. Thereafter, two multivariable linear regression models were constructed. In each of them, the dependant variable was intraocular pressure (IOP) as determined using GAT and DCT respectively. In both of the models the predictive variable was PCT though LOWESS regression pattern was used to model the relationship between the dependant variables and the predictor one. Age and sex were also introduced control variables along with their first-degree interactions with PCT. Main outcome measures include amount of IOP variation explained through regression models (R2) and regression coefficients (B).
RESULTS: Subjects included 109 eyes of 109 healthy individuals. LOWESS regression suggested that a 2nd-degree polynomial would be suitable to model the relationship between both DCT and GAT with PCT. Hence PCT was introduced in both models as a linear and quadratic term. Neither age nor sex nor interactions were statistically significant in both models. For GAT model, R2 was 17.14% (F=9.02; P=0.0002), PCT linear term B was -1.163 (95% CI: -1.163, -0.617). PCT quadratic term B was 0.00081 (95% CI: 0.00043, 0.00118). For DCT model R2 was 14.28% (F=9.29; P=0.0002), PCT linear term B was -0.712 (95% CI: -1.052, -0.372), PCT quadratic term was B=0.0005 (95% CI: 0.0003, 0.0007).
CONCLUSION: DCT and GAT measurements are conditioned by PCT though this effect, rather than linear, follows a 2nd-degree polynomial pattern.]]></description>
<pubDate>2017/9/30 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Federico Saenz-Frances, Claudia Sanz-Pozo, Lara Borrego-Sanz, Luis Ja&#241;ez, Laura Morales-Fernandez, Jose Maria Martinez-de-la-Casa, Julian Garcia-Sanchez, Julian Garcia-Feijoo and Enrique Santos-Bueso]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Federico Saenz-Frances, Claudia Sanz-Pozo, Lara Borrego-Sanz, Luis Ja&#241;ez, Laura Morales-Fernandez, Jose Maria Martinez-de-la-Casa, Julian Garcia-Sanchez, Julian Garcia-Feijoo and Enrique Santos-Bueso</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171007]]></guid><cfi:id>795</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Postoperative visual performance with a bifocal and trifocal diffractive intraocular lens during a 1-year follow-up]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171008]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate and compare the clinical outcomes with a diffractive bifocal and trifocal intraocular lens (IOL) during a 12-month follow-up.
METHODS: Prospective comparative study including 75 eyes of 38 patients (44-70y) undergoing uneventful cataract surgery. Each patient was randomly assigned to one type of IOL, bifocal (35 eyes) or trifocal (40 eyes). Visual, refractive, and contrast sensitivity changes were evaluated in a 12-month follow-up. The binocular defocus curve was also measured at 12mo postoperatively.
RESULTS: No statistically significant differences between groups were found in postoperative uncorrected and corrected distance visual acuities (P≥0.276). Postoperative corrected near visual acuity (33 cm) was significantly better in the trifocal group during all follow-up (P≤0.004) as well as 6-month uncorrected near (P=0.008) and distance-corrected near visual acuities (P=0.016) (33/40 cm). Significantly better uncorrected intermediate and distance corrected-intermediate visual acuity were found during all follow-up in the trifocal group (P<0.001), which was consistent with differences among groups in binocular defocus curve. Differences among groups in contrast sensitivity were minimal, being only significant at 6 months for some low to medium spatial frequencies (P≤0.006).
CONCLUSION: Bifocal and trifocal diffractive IOLs are able to provide an effective visual restoration which is maintained during a 12-month follow-up, with a clear benefit of the trifocal IOL for the intermediate vision.]]></description>
<pubDate>2017/9/30 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Peter Mojzis, Lucia Kukuckova, Katarina Majerova, Peter Ziak and David P. Pi&#241;ero]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Peter Mojzis, Lucia Kukuckova, Katarina Majerova, Peter Ziak and David P. Pi&#241;ero</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171008]]></guid><cfi:id>794</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Structure-function relationship comparison between retinal nerve fibre layer and Bruch’s membrane opening-minimum rim width in glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171009]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate and compare structural optical coherence tomography (OCT)-based parameters, such as Bruch’s membrane opening-minimum rim width (BMO-MRW), and retinal nerve fiber layer (RNFL) thickness in glaucoma patients with visual field (VF) defects, and to correlate both to mean deviation (MD) values of obtained standard achromatic perimetry (SAP) examinations.
METHODS: Patients with glaucoma and glaucomatous VF defects were enrolled in this prospective study and compared to age-matched healthy individuals. All study participants underwent a full ophthalmic examination and VF testing with SAP. Peripapillary RNFL thickness and BMO-MRW were acquired with SD-OCT. Correlation analyses between obtained global functional and global as well as sectorial structural parameters were calculated.
RESULTS: A consecutive series of 30 glaucomatous right eyes of 30 patients were included and compared to 36 healthy right eyes of 36 individuals in the control group. Global MD of values correlated significantly with global RNFL (Pearson corr. coeff: 0.632, P=0.001) and global BMO-MRW (Pearson corr. coeff: 0.746, P<0.001) values in the glaucoma group. Global MD and sectorial RNFL or BMO-MRW values correlated less significantly. In the control group, MD values did not correlate with RNFL or BMO-MRW measurements. A subgroup analysis of myopic patients (>4 diopters) within the glaucoma group (n=6) revealed a tendency for higher correlations between MD and BMO-MRW than MD and RNFL measurements.
CONCLUSION: In a clinical setting, RNFL thickness and BMO-MRW correlate similarly with global VF sensitivity in glaucoma patients with BMO-MRW showing higher correlations in myopic glaucoma patients.]]></description>
<pubDate>2017/9/30 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Lukas Reznicek, Sophie Burzer, Andrea Laubichler, Ali Nasseri, Chris P Lohmann, Nikolaus Feucht, Michael Ulbig and Mathias Maier]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Lukas Reznicek, Sophie Burzer, Andrea Laubichler, Ali Nasseri, Chris P Lohmann, Nikolaus Feucht, Michael Ulbig and Mathias Maier</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171009]]></guid><cfi:id>793</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Optical coherence tomography with or without enhanced depth imaging for peripapillary retinal nerve fiber layer and choroidal thickness]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171010]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess peripapillary retinal nerve fiber layer (RNFL) and choroidal thickness obtained with enhanced depth imaging (EDI) mode compared with those obtained without EDI mode using Heidelberg Spectralis optical coherence tomography (OCT).
METHODS: Fifty eyes of 25 normal healthy subjects and 32 eyes of 20 patients with different eye diseases were included in the study. All subjects underwent 3.4 mm diameter peripapillary circular OCT scan centered on the optic disc using both the conventional and the EDI OCT protocols. The visualization of RNFL and choroidoscleral junction was assessed using an ordinal scoring scale. The paired t-test, intraclass correlation coefficient (ICC), 95% limits of agreement (LoA), and Bland and Altman plots were used to test the agreement of measurements.
RESULTS: The visibility score of RNFL obtained with and without EDI was of no significant difference (P=0.532), the visualization of choroidoscleral junction was better using EDI protocol than conventional protocol (P<0.001). Peripapillary RNFL thickness obtained with EDI was slightly thicker than that obtained without EDI (103.25±9.42 μm vs 101.87±8.78 μm, P=0.010). The ICC of the two protocols was excellent with the value of 0.867 to 0.924, the 95% LoA of global RNFL thickness was between -10.0 to 7.4 μm. Peripapillary choroidal thickness obtained with EDI was slightly thinner than that obtained without EDI (147.23±51.04 μm vs 150.90±51.84 μm, P<0.001). The ICC was also excellent with the value of 0.960 to 0.987, the 95% LoA of global choroidal thickness was between -12.5 to 19.8 μm.
CONCLUSION: Peripapillary circular OCT scan with or without EDI mode shows comparable results in the measurement of peripapillary RNFL and choroidal thickness.]]></description>
<pubDate>2017/9/30 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Meng-Ai Wu, Wei-Xin Xu, Zhe Lyu and Li-Jun Shen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Meng-Ai Wu, Wei-Xin Xu, Zhe Lyu and Li-Jun Shen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171010]]></guid><cfi:id>792</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Foveal avascular zone area and parafoveal vessel density measurements in different stages of diabetic retinopathy by optical coherence tomography angiography]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171011]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate foveal avascular zone (FAZ) and parafoveal vessel densities (PRVD) by means of optical coherence tomography angiography (OCTA) in diabetic patients with or without diabetic retinopathy (DR) and to assess the reproducibility of FAZ and PRVD measurements.
METHODS: Sixty diabetic patients (60 eyes) with different stage of DR (graded according to the International Clinical Severity Scale for DR) and 20 healthy subjects underwent FAZ area and PRVD measurements using OCTA by two experienced examiners. FAZ area in all patients was also assessed using fluorescein angiography (FA).
RESULTS: In subject with proliferative DR and with moderate-severe non proliferative DR, FAZ area was significantly increased compared to healthy controls (P=0.025 and P=0.050 respectively measured with OCTA and P=0.025 and P=0.048 respectively measured with FA). OCTA showed significantly less inter-observer variability compared to FA. Concordance correlation coefficient (CCC) for FAZ area measurements was 0.829 (95%CI: 0.736-0.891) P<0.001 with FA and 1.000 (95%CI: 0.999-1.000) P<0.001 with OCTA. CCC was 0.834 (95%CI: 0.746-0.893) P<0.001 and 0.890 (95%CI: 0.828-0.930) P<0.001 for parafoveal superficial and deep vessel density measurements, respectively.
CONCLUSION: OCTA shows progressive increase of FAZ area and reduction of PRVD in both superficial and deep plexus at increasing DR severity. FAZ area and PRVD measurements using OCTA are highly reproducible.]]></description>
<pubDate>2017/9/30 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Rodolfo Mastropasqua, Lisa Toto, Alessandra Mastropasqua, Raffaella Aloia, Chiara De Nicola, Peter A Mattei, Guido Di Marzio, Marta Di Nicola and Luca Di Antonio]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Rodolfo Mastropasqua, Lisa Toto, Alessandra Mastropasqua, Raffaella Aloia, Chiara De Nicola, Peter A Mattei, Guido Di Marzio, Marta Di Nicola and Luca Di Antonio</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171011]]></guid><cfi:id>791</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Evaluating role of bone marrow-derived stem cells in dry age-related macular degeneration using multifocal electroretinogram and fundus autofluorescence imaging]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171012]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the role of bone marrow-derived stem cells in the treatment of advanced dry age-related macular degeneration (AMD) using multifocal electroretinogram (mf-ERG) and fundus autofluorescence imaging.
METHODS: Thirty patients (60 eyes) with bilateral central geographic atrophy (GA) were recruited. Worse eye of each patient received autologous bone marrow-derived hematopoietic stem cells (BM-HSCs) (group 1) and the fellow eye with better visual acuity served as control (group 2). The effect of stem cell therapy was determined in terms of visual acuity, amplitude and implicit time in mf-ERG and size of GA on fundus autofluorescence imaging. These tests were performed at presentation and first, third and sixth month follow up. Adverse events (if any) were also monitored.
RESULTS: At 6mo follow-up there was no statistically significant improvement in median logMAR best corrected visual acuity (BCVA) in either group. Mf-ERG revealed significant improvement in amplitude and implicit time in the intervention group. A significant decrease was also noted in greatest linear dimension (GLD) of GA in the eyes receiving stem cells [6.78±2.60 mm at baseline to 6.56±2.59 mm at 6mo (P=0.021)]. However, no such improvement was noted in the control group.
CONCLUSION: Electrophysiological and anatomical improvement in the intervention group sheds light on the therapeutic role of BM-HSCs. Further studies are required to determine the stage of disease at which the maximal benefit can be achieved and to standardize the dose and frequency of stem cell injection.]]></description>
<pubDate>2017/9/30 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Atul Kumar, Neha Midha, Sujata Mohanty, Annu Chohan, Tulika Seth, Varun Gogia and Shikha Gupta]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Atul Kumar, Neha Midha, Sujata Mohanty, Annu Chohan, Tulika Seth, Varun Gogia and Shikha Gupta</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171012]]></guid><cfi:id>790</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Evaluation of refractive correction for standard automated perimetry in eyes wearing multifocal contact lenses]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171013]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the refractive correction for standard automated perimetry (SAP) in eyes with refractive multifocal contact lenses (CL) in healthy young participants.
METHODS: Twenty-nine eyes of 29 participants were included. Accommodation was paralyzed in all participants with 1% cyclopentolate hydrochloride. SAP was performed using the Humphrey SITA-standard 24-2 and 10-2 protocol under three refractive conditions: monofocal CL corrected for near distance (baseline); multifocal CL corrected for distance (mCL-D); and mCL-D corrected for near vision using a spectacle lens (mCL-N). Primary outcome measures were the foveal threshold, mean deviation (MD), and pattern standard deviation (PSD).
RESULTS: The foveal threshold of mCL-N with both the 24-2 and 10-2 protocols significantly decreased by 2.2-2.5 dB
CONCLUSION: Despite the induced mydriasis and the optical design of the multifocal lens used in this study, our results indicated that, when the dome-shaped visual field test is performed with eyes with large pupils and wearing refractive multifocal CLs, distance correction without additional near correction is to be recommended.]]></description>
<pubDate>2017/9/30 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Kazunori Hirasawa, Hikaru Ito, Yukari Ohori, Yui Takano and Nobuyuki Shoji]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Kazunori Hirasawa, Hikaru Ito, Yukari Ohori, Yui Takano and Nobuyuki Shoji</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171013]]></guid><cfi:id>789</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of visual performance recovery after thin-flap LASIK with 4 femtosecond lasers]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171014]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the speed of visual recovery following myopic thin-flap LASIK with four femtosecond lasers.
METHODS: Eighty-eight eyes of 46 patients who were consecutively scheduled for bilateral LASIK with the IntraLase FS60 (Group 1), Femto LDV Crystal Line (Group 2), Wavelight FS200 (Group 3) and VisuMax (Group 4) femtosecond lasers were enrolled in. Monocular uncorrected distance visual acuity (UDVA), best-corrected distant visual acuity (CDVA), refraction, contrast sensitivity and higher-order aberrations (HOAs) were evaluated at 1, 3d, 1wk and 1mo postoperatively.
RESULTS: Sixteen eyes (72.7%) achieved 20/16 and 8 eyes (36.4%) were 20/12.5 at 1d in Group 2, which was significantly more than other 3 groups. At 1wk, 20 eyes (90.9%) achieved 20/16 in Groups 2 and 4. At 1mo, 20 eyes (90.9%) achieved 20/16 in Group 2 and Group 4, which were significantly more than other two groups. While by 1 mo, the difference of the residual spherical equivalent (SE) was not statistically significant among 4 groups (P=0.121). The induction of spherical aberration (SA) were significantly less for Groups 2, 3, 4 than for Group 1 one day after surgery (P=0.015). The differences among 4 groups were not statistically significant before and after surgery on every time points (all P>0.05).
CONCLUSION: The thin-flap LASIK procedure using the Femto LDV Crystal Line and VisuMax femtosecond laser show faster visual performance recovery.]]></description>
<pubDate>2017/9/30 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jing Zhang, Yue-Hua Zhou, Yan Zheng and Qian Liu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jing Zhang, Yue-Hua Zhou, Yan Zheng and Qian Liu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20171014]]></guid><cfi:id>788</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[The inflammation influence on corneal surface after frontalis suspension surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180910]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To study the influence of frontalis muscle flap suspension on ocular surface by analyzing the clinical features and inflammatory cytokines.
METHODS: A prospective, observational case series. Thirty-one eyes of 25 patients with severe congenital blepharoptosis who underwent frontalis muscle flap suspension surgery with at least 6mo of follow-up were included in the study. The main outcome measures were margin reflex distance 1 (MRD1), degree of lagophthalmos, ocular surface disease index (OSDI), fluorescein staining (Fl), tear break-up time (BUT), Schirmer I test, and inflammatory cytokine assay.
RESULTS: The degrees of lagophthalmos significantly increased after surgery. The OSDI scores significantly increased 1wk postoperatively and then decreased 4wk after operation. The Fl scores reflected corneal epithelial defects in sixteen patients at early stage postoperatively. The BUT and Schirmer I test values remained stable and did not show change compared to those before surgery. The inflammatory cytokines in conjunctival epithelial cells (including IL-1β, IL-6, IL-8, TNF-α, and IL-17A) significantly increased 1wk after the surgery (P<0.001), then returned to the normal level at 24wk postoperatively. The levels of inflammatory cytokine IL-1β, IL-6, IL-8, TNF-α, and IL-17A elevated significantly and were positively correlated with OSDI and Fl scores.
CONCLUSION: Frontalis muscle flap suspension surgery results in lagophthalmos in early period of post-operation and relieved after months. The elevation of inflammatory cytokines level may participate in the occurrence of corneal epithelial defects at the early postoperative stage.]]></description>
<pubDate>2018/8/6 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Kang Li, Xin-Chun Zhang, Xian-Xian Cai, Ya-Dan Quan and Rong Lu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Kang Li, Xin-Chun Zhang, Xian-Xian Cai, Ya-Dan Quan and Rong Lu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180910]]></guid><cfi:id>787</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Lipid layer thickness and tear meniscus height measurements for the differential diagnosis of evaporative dry eye subtypes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180911]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To explore a new diagnostic index for differentiating the evaporative dry eye (EDE) subtypes by analysis of their respective clinical characteristics.
METHODS: A cross-sectional study of 139 patients (139 eyes) with EDE who were enrolled and classified as obstructive meibomian gland dysfunction (MGD) (n=81) and non-obstructive MGD (n=58) EDE. All patients completed a Standard Patient Evaluation of Eye Dryness (SPEED) questionnaire and were evaluated for average lipid layer thickness (LLT), tear meniscus height measurements (TMH), tear break-up time (TBUT), ocular surface staining score, Schirmer I test (SIT), lid margin abnormalities, and meibomian gland function and morphology.
RESULTS: Age, average LLT, TMH, scores of lid margin abnormalities, meibum quality, meibomian gland loss (MGL) (all P≤0.001), and TBUT (P=0.03) were all significantly different between obstructive MGD EDE patients and non-obstructive MGD EDE patients. Average LLT in obstructive MGD EDE was correlated with meibomian expressibility (r= -0.541, P≤0.001), lid margin abnormalities were marginally not significant (r=0.197, P=0.077), and TMH was correlated with MGL (total MGL: r=0.552, P≤0.001; upper MGL: r=0.438, P≤0.001; lower MGL: r=0.407, P≤0.001). Average LLT in non-obstructive MGD EDE, was correlated with meibomian expressibility and Oxford staining (r=-0.396, P=0.002; r=-0.461, P≤0.001). The efficiency of combining average LLT and TMH was optimal, with a sensitivity of 80.2% and a specificity of 74.1%. Obstructive MGD EDE patients had an average LLT≥69 nm and TMH≥0.25 mm, while non-obstructive MGD EDE patients had an average LLT<69 nm and TMH<0.25 mm.
CONCLUSION: Obstructive MGD EDE and non-obstructive MGD EDE have significantly different clinical characteristics. Combining average LLT and TMH measurements enhanced their reliability for differentiating these two subtypes and provided guidance for offering more precise treatments for EDE subtypes.]]></description>
<pubDate>2018/8/6 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xuan Sang, Yan Li, Liu Yang, Jia-Hui Liu, Xiao-Ran Wang, Chao-Yang Li, Ying Liu, Chen-Jie Wang, Xiong-Jun He, Shou-Bi Wang and Zhi-Chong Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xuan Sang, Yan Li, Liu Yang, Jia-Hui Liu, Xiao-Ran Wang, Chao-Yang Li, Ying Liu, Chen-Jie Wang, Xiong-Jun He, Shou-Bi Wang and Zhi-Chong Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180911]]></guid><cfi:id>786</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Eye reflux: an ocular extraesophageal manifestation of gastric reflux]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180912]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To suspect laryngopharyngeal reflux (LPR) in patients with ocular surface disease (OSD).METHODS: The present study evaluated a group of subjects with OSD assessing the Ocular Surface Disease Index (OSDI) and the Reflux Symptom Index (RSI) to detect patients with suspected LPR and define a possible relationship between tests.RESULTS: Two hundred and ninety subjects (175 females, mean age: 60.41±15.68y) were consecutively visited at ophthalmologist offices. One hundred and one (34%) patients had pathological RSI (>13) and consequently a suspected LPR.CONCLUSION: The current study shows that suspected LPR may be common (34%) in patients with OSD and a suspected LPR may be considered in OSD patients when RSI score is >13 and OSDI score is >42.]]></description>
<pubDate>2018/8/6 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Danilo Mazzacane, Valerio Damiani, Michela Silvestri, Giorgio Ciprandi and Pierfranco Marino]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Danilo Mazzacane, Valerio Damiani, Michela Silvestri, Giorgio Ciprandi and Pierfranco Marino</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180912]]></guid><cfi:id>785</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Investigation of possible risk factors in the development of seasonal allergic conjunctivitis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180913]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyze the possible risk factors in the development of seasonal allergic conjunctivitis (SAC) through an evaluation of skin allergy tests and data obtained from questionnaires.
METHODS: The study included a total of 75 SAC patients and 71 control subjects without SAC diagnosis who were admitted to the Abant Izzet Baysal University Medical Faculty Ophthalmology Clinic between March 2016 and December 2016. Skin prick tests were performed for all participants. Serum levels of total IgE and 25-OH vitamin D were also measured. In the tear, total IgE levels were measured. Moreover, possible risk factors for the onset of SAC (smoking, paracetamol exposure, vitamin D supplementation and environmental factors etc.) were examined for all patients by both prenatal and postnatal aspects.
RESULTS: The patients with SAC were found to have a history of maternal paracetamol exposure during the prenatal period. Likewise, in the same patient group, the duration of postnatal vitamin D supplementation was shorter (P<0.001). However, no significant correlation was found between SAC and maternal antibiotic exposure, maternal smoking, the mode of delivery and birth weight, as well as presence of pets. Moreover, patients with SAC were more likely to have asthma, allergic rhinitis and oral allergy syndrome. We have also found that SAC patients’ mothers and siblings were more likely to have allergic conjunctivitis. Likewise, their fathers were more likely to have allergic rhinitis.
CONCLUSION: Prenatal maternal paracetamol exposure and shorter duration of vitamin D supplementation in the postnatal period may play a role in development of SAC. Therefore prevention of unnecessary gestational paracetamol intake and vitamin D supplementation during infancy could potentially reduce the onset and development of SAC.]]></description>
<pubDate>2018/8/6 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[ümit Do&#287;an and Sümeyra A&#287;ca]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>ümit Do&#287;an and Sümeyra A&#287;ca</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180913]]></guid><cfi:id>784</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[GSTM1-null and GSTT1-active genotypes as risk determinants of primary open angle glaucoma among smokers]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180914]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate glutathione transferase theta 1 and mu 1 (GSTT1 and GSTM1) polymorphisms as determinants of primary open angle glaucoma (POAG) risk, independently or in combination with cigarette smoking, hypertension and diabetes mellitus.
METHODS: A case-control study with 102 POAG patients and 202 age and gender-matched controls was carried out. Multiplex-polymerase chain reaction method was used for the analysis of GSTM1 and GSTT1 polymorphisms. The differences between two groups were tested by the t-test or χ2 test. Logistic regression analysis was used for assessing the risk for disease development.
RESULTS: The presence of GSTM1-null genotype did not contribute independently towards the risk of POAG. However, individuals with GSTT1-active genotype were at almost two-fold increased risk to develop glaucoma (P=0.044) which increased up to 4.36 when combined with GSTM1-null carriers (P=0.024). When glutathione transferase (GST) genotypes were analyzed in association with cigarette smoking, hypertension and diabetes, only carriers of GSTT1-active genotype had significantly increased risk of POAG development in comparison with GSTT1-null genotype individuals with no history of smoking, hypertension and diabetes, respectively (OR=3.52, P=0.003; OR=10.02, P<0.001; OR=4.53, P=0.002).
CONCLUSION: The results obtained indicate that both GSTM1-null and GSTT1-active genotypes are associated with increased POAG risk among smokers, suggesting potential gene-environment interaction in glaucoma development.]]></description>
<pubDate>2018/8/6 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Miroslav Stamenkovic, Vesna Lukic, Sonja Suvakov, Tatjana Simic, Ivan Sencanic, Marija Pljesa-Ercegovac, Vesna Jaksic, Sinisa Babovic, Marija Matic, Aleksandra Radosavljevic, Ana Savic-Radojevic and Tatjana Djukic]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Miroslav Stamenkovic, Vesna Lukic, Sonja Suvakov, Tatjana Simic, Ivan Sencanic, Marija Pljesa-Ercegovac, Vesna Jaksic, Sinisa Babovic, Marija Matic, Aleksandra Radosavljevic, Ana Savic-Radojevic and Tatjana Djukic</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180914]]></guid><cfi:id>783</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Multimodal imaging in acute retinal ischemia: spectral domain OCT, OCT-angiography and fundus autofluorescence]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180915]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To describe retinal findings of various imaging modalities in acute retinal ischemia.METHODS: Fluorescein angiography (FA), spectral domain optical coherence tomography (SD-OCT), OCT-angiography (OCT-A) and fundus autofluorescence (FAF) images of 13 patients (mean age 64y, range 28-86y) with acute retinal ischemia were evaluated. Six suffered from branch arterial occlusion, 2 had a central retinal artery occlusion, 2 had a combined arteriovenous occlusions, 1 patient had a retrobulbar arterial compression by an orbital haemangioma and 2 patients showed an ocular ischemic syndrome.RESULTS: All patients showed increased reflectivity and thickening of the ischemic retinal tissue. In 10 out of 13 patients SD-OCT revealed an additional highly reflective band located within or above the outer plexiform layer. Morphological characteristics were a decreasing intensity with distance from the fovea, partially segmental occurrence and manifestation limited in time. OCT-A showed a loss of flow signal in the superficial and deep capillary plexus at the affected areas. Reduced flow signal was detected underneath the regions with retinal edema. FAF showed areas of altered signal intensity at the posterior pole. The regions of decreased FAF signal corresponded to peri-venous regions.CONCLUSION: Multimodal imaging modalities in retinal ischemia yield characteristic findings and valuable diagnostic information. Conventional OCT identifies hyperreflectivity and thickening and a mid-retinal hyperreflective band is frequently observed. OCT-A examination reveals demarcation of the ischemic retinal area on the vascular level. FAF shows decreased fluorescence signal in areas of retinal edema often corresponding to peri-venous regions.]]></description>
<pubDate>2018/8/6 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Nikolaus Feucht, Daniel Zapp, Lukas Reznicek, Chris P. Lohmann, Mathias Maier and Christian S. Mayer]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Nikolaus Feucht, Daniel Zapp, Lukas Reznicek, Chris P. Lohmann, Mathias Maier and Christian S. Mayer</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180915]]></guid><cfi:id>782</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Bimodal imaging of proliferative diabetic retinopathy vascular features using swept source optical coherence tomography angiography]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180916]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To categorize neovessels morphology and to detect response to anti-angiogenic therapy by using structural and angiographic modes of swept source optical coherence tomography (SS-OCT).
METHODS: Thirty-two eyes with neovessels at disc (NVD) and neovessels elsewhere (NVE) - as diagnosed by fluorescein angiography- were included. Cross sectional OCT images of disc and macular regions were registered to enface OCT angiography (OCTA), B-scan blood flow over lay and density maps. Three eyes received anti-angiogenic treatment.
RESULTS: Pin point registration of cross-sectional OCT and OCTA images differentiated active NVD with vascular elements from fibrous or equivalent fibrovascular elements. En face images delineated NVE as vascular tufts or area of filling while cross-sectional images differentiated NVE from microvascular intraretinal abnormality (IRMA). All cases were associated with enlargement of foveal avascular zone and or areas of capillary non perfusion. Regressed NVD appeared as ghost vessel or pruned vascular loops after injection.
CONCLUSION: Structural and angiographic modes of SS-OCT can detect, characterize and categorize the pattern of wide spectrum of neovessels based on blood flow data and density maps. It is potentially useful to detect ischemic changes in the vascular bed and regression of NVD after therapeutic regimens providing substitute for invasive techniques.]]></description>
<pubDate>2018/8/6 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Amal M Elbendary and Hossam Youssef Abouelkheir]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Amal M Elbendary and Hossam Youssef Abouelkheir</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180916]]></guid><cfi:id>781</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of one and three initial monthly intravitreal ranibizumab injection in patients with macular edema secondary to branch retinal vein occlusion]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180917]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare three initial monthly intravitreal ranibizumab (IVR) injections followed by pro re nata (PRN) dosing with one initial monthly IVR injections followed by PRN dosing for macular edema (ME) secondary to branch retinal vein occlusion (BRVO).METHODS: Forty-two eyes of 42 patients who had IVR injections for BRVO were retrospectively studied. Eighteen eyes received 1 initial IVR injection (1+PRN group) and 24 eyes received 3 monthly IVR injections (3+PRN). At 1, 3, 6 and 12mo; spectral-domain optical coherence tomography (SD-OCT) was performed. Central macular thickness (CMT), the integrity of the external limiting membrane (ELM), the presence of subretinal fluid, cyst size, the presence of inner segment/outer segment (IS/OS) defect were determined.RESULTS: At baseline the mean CMT was 521.3±153.2 µm in the 3+PRN group while it was 438.1±162.4 µm in 1+PRN group. At the final visit, mean CMT was 278.3±87.8 µm in the 3+PRN group and 285.2±74.2 µm in the 1+PRN group (P=0.079). The changes in CMT over the entire study period were also comparable in both groups (243±160 µm in the 3+PRN group, and 152.9±175.3 µm in the 1+PRN group; P=0.090). At baseline, best-corrected visual acuity (BCVA) was 0.92±0.60 logarithm of the minimal angle of resolution (logMAR) in the 3+PRN group, while it was 0.72±0.46 logMAR in the 1+PRN group. Final BCVA was 0.42±0.55 logMAR in the 3+PRN group and 0.38±0.50 logMAR in the 1+PRN group (P=0.979). Additionally, the BCVA changes from baseline to final visit were not significantly different (-0.50±0.45 logMAR in the 3+PRN group, and -0.33±0.39 logMAR in the 1+PRN group; P=0.255).CONCLUSION: No significant differences in the anatomical or functional results are found between 3+PRN and 1+PRN regimens in the patients receiving ranibizumab for ME secondary to BRVO. Intact IS/OS and baseline BCVA are good predictor of the visual gain, while baseline CMT is a good predictor of the anatomical gain.]]></description>
<pubDate>2018/8/6 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Alper Halil Bayat, Ak&inodot;n &Ccedil;ak&inodot;r, &Scedil;eyma G&uuml;lcenur &Ouml;zturan, Selim B&ouml;l&uuml;kba&scedil;&inodot;, Burak Erden and Mustafa Nuri El&ccedil;io&gbreve;lu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Alper Halil Bayat, Ak&inodot;n &Ccedil;ak&inodot;r, &Scedil;eyma G&uuml;lcenur &Ouml;zturan, Selim B&ouml;l&uuml;kba&scedil;&inodot;, Burak Erden and Mustafa Nuri El&ccedil;io&gbreve;lu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180917]]></guid><cfi:id>780</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A clinicopathological study on IgG4-related ophthalmic disease]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180918]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate clinicopathological features of immunoglobulin G4-related ophthalmic disease (IgG4-ROD), and analyze the recurrence rates following systemic corticosteroid administration.
METHODS: We retrospectively searched clinical features, laboratory and histological findings based on the medical records of 21 patients with IgG4-ROD. All the patients examined in this study underwent surgical resection in the ocular adnexal lesions and underwent histological evaluation. This study further investigated clinical and histopathological features of 15 patients who received systemic corticosteroid after the resection.
RESULTS: The mean age of the patients consisting of 7 males (33%) and 14 females (67%) was 61y. Fourteen patients were diagnosed as definitive, and 2 and 5 patients were probable and possible IgG4-ROD, respectively. Eyelid swelling was an initial symptom in 11 patients (52%) who did not show systemic involvements at a diagnosis. Fifteen patients received systemic corticosteroid administration, and all showed remission of inflammation. Among them, 10 patients did not recur, whereas 5 patients (33%) recurred during tapering. There were no significant difference between patients with or without recurrence in clinicopathological features.
CONCLUSION: In this study, female patients are more predominant in IgG4-ROD. While inflammation recurs in one-third of patients, this study do not identify factors associated with recurrence after systemic corticosteroid administration.]]></description>
<pubDate>2018/8/6 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yuka Suimon, Satoru Kase, Kan Ishijima, Hiromi Kanno-Okada and Susumu Ishida]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yuka Suimon, Satoru Kase, Kan Ishijima, Hiromi Kanno-Okada and Susumu Ishida</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180918]]></guid><cfi:id>779</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Long-term effect of triamcinolone acetonide in the treatment of upper lid retraction with thyroid associated ophthalmopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180807]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report the long-term outcomes of a large cohort of upper lid retraction patients treated with subconjunctival triamcinolone acetonide injections.
METHODS: This retrospective clinical study was conducted from 2009 to 2016. The documents of 97 patients (126 eyes) were reviewed. The patients were treated with subconjunctival triamcinolone acetonide injections monthly and evaluated pre- and post-treatment by taking measurements of the upper margin reflex distance (MRD1, the distance between the upper-lid margin and the pupil center), lid aperture, lagophthalmos and proptosis. The patients were divided into the cured group, the improved group and the ineffective group based on the final treatment effectiveness. The improved group and the ineffective group were combined into non-cured group.
RESULTS: The follow-up time was 23.45±14.86mo. Of the patients, 63 (64.9%) were assigned to the cured group, 22 (22.7%) in the improved group, 12 (12.4%) in the ineffective group. Injection times for cured group was 4.66±1.74, and for non-cured group was 5.17±2.08 (P≤0.05). The MRD1 was significantly reduced between baseline and 1mo after the initiation of treatment in the cured and improved groups (P<0.001). The values did not change significantly after 4mo for the improved group, while they continued to decrease in the cured group. In the ineffective group, the MRD1 did not significantly change after treatment. A statistically significant difference was observed between the baseline and post-treatment values of the mean muscle thickness (2.95±0.99 mm vs 2.04±0.63 mm, P<0.05) and surface area (27.27±10.5 mm2 vs 18.3±7.04 mm2, P<0.05) of the levator superioris with magnetic resonance imaging examination. Twelve patients (12.4%) relapsed after treatment and required additional subconjunctival injections. The main side effects included menstrual cycle disturbances (32%) and elevations of intra-ocular pressure (18.6%).
CONCLUSION: A repeated subconjunctival injection of triamcinolone is an effective and relatively safe treatment for upper lid retraction due to thyroid-associated ophthalmopathy. This is related to the anti-inflammation effect of the medicine and the levator thickness can become thinner. Patients must be monitored regularly for recurrences and side effects.]]></description>
<pubDate>2018/8/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Dong-Dong Xu, Yu Chen, Hai-Yan Xu, Hui Li, Zhu-Hua Zhang and Yu-Hua Liu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Dong-Dong Xu, Yu Chen, Hai-Yan Xu, Hui Li, Zhu-Hua Zhang and Yu-Hua Liu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180807]]></guid><cfi:id>778</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Lacrimal gland tumors in Turkey: types, frequency, and outcomes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180808]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the clinical, radiological, and treatment features of lacrimal gland tumors.
METHODS: Retrospective review of 99 eyes of 92 patients with lacrimal gland tumors diagnosed and managed in a single institution between January 1999 and March 2017. Clinical and radiological features, histopathology, treatment methods, and prognosis were evaluated.
RESULTS: The mean patient age was 40.3 (range: 7-80)y. The diagnosis was made histopathologically in 91 (91.9%) tumors and on a clinical and radiological basis in 8 (8.1%) tumors. Final diagnoses included idiopathic orbital inflammation (pseudotumor) in 46 (46.5%) lesions, pleomorphic adenoma in 14 (14.1%), adenoid cystic carcinoma in 12 (12.1%), granulomatous inflammation in 10 (10.1%), lymphoma in 5 (5.0%), benign reactive lymphoid hyperplasia in 3 (3.0%), dacryops in 3 (3.0%), carcinoma ex pleomorphic adenoma in 2 (2.0%), adenocarcinoma in 1 (1.0%), dermoid cyst in 1 (1.0%), cavernous hemangioma in 1 (1.0%), and leukemic infiltration in 1 (1.0%). Non-epithelial tumors comprised 64.6% (n=64) of all lacrimal gland tumors, epithelial tumors 32.3% (n=32), dermoid cyst 1% (n=1), cavernous hemangioma 1% (n=1), and leukemic infiltration 1% (n=1). There were in total 78 (78.8%) benign and 21 (21.2%) malignant tumors.
CONCLUSION: Overall, 65% of lacrimal gland tumors were of non-epithelial origin and 32% of epithelial origin. By histopathology and clinical evaluation, 79% of lacrimal gland tumors were benign. The most common lacrimal gland tumors include idiopathic orbital inflammation (46.5%), epithelial (32.3%), and lymphoproliferative (8.1%) lesions.]]></description>
<pubDate>2018/8/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ya&#287;mur Seda Ye&#351;ilta&#351;, Ahmet Kaan Gündüz, Esra Erden and Carol L. Shields]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ya&#287;mur Seda Ye&#351;ilta&#351;, Ahmet Kaan Gündüz, Esra Erden and Carol L. Shields</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180808]]></guid><cfi:id>777</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of intracorneal ring segment implantation on corneal asphericity]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180809]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the visual, refractive and corneal asphericity changes after intrastromal corneal ring segment (ICRS) implantation for visual rehabilitation of keratoconus.
METHODS: A total of 42 eyes of 32 patients were included. After creation of intrastromal tunnels of 5.01±0.03 mm inner diameter, 5.71±0.03 mm outer diameter and at 384.21±34.12 μm depth, 1 or 2 ICRS of 150-300 μm thickness and 90°-210° arc length were implanted. Changes in uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), refractive errors, mean simulated keratometry readings (SimKavg), anterior and posterior corneal asphericity values (Qant and Qpost, respectively) measured with Scheimpflug topography were evaluated retrospectively.
RESULTS: There was a significant improvement in UDVA and CDVA, along with a significant decrease in refractive spherical equivalent (SE), cylinder and SimKavg postoperatively (P<0.001 for all). Mean Qant increased from -1.06±0.48 to -0.57±0.58 postoperatively (P<0.001). Change in mean Qpost was insignificant (P=0.92). Postoperative changes in UDVA and CDVA were not correlated with the postoperative changes in SE and cylinder (P>0.05 for all); but were correlated with the preoperative SimKavg and Qant values (P<0.001 for all).
CONCLUSION: ICRS implantation seems to approximate the anterior corneal asphericity of “advanced prolate” shape to “optimal prolate” shape and an “ideal Q value” of -0.46; which may have a role in improved UDVA and CDVA postoperatively, besides decreased refractive cylinder values.]]></description>
<pubDate>2018/8/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Canan A. Utine, Ziya Ayhan and Ceren Durmaz Engin]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Canan A. Utine, Ziya Ayhan and Ceren Durmaz Engin</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180809]]></guid><cfi:id>776</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Differences in energy and corneal endothelium between femtosecond laser-assisted and conventional cataract surgeries: prospective, intraindividual, randomized controlled trial]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180810]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare intraoperative phacoemulsification parameters and its effect on the corneal endothelium of eyes undergoing femtosecond laser-assisted cataract surgery (FLACS) versus conventional phacoemulsification (CP) cataract surgery.
METHODS: Two hundred eyes from one hundred patients were included in a prospective, non-blinded, randomized, controlled, intraindividual clinical study. One hundred eyes underwent FLACS while their one hundred fellow eyes underwent CP. All surgeries were performed using the Victus&#174; femtosecond laser platform and Infinity&#174; Vision System phacoemulsification machine. Primary outcome measure was endothelial cell density 6mo after surgery. Secondary outcome measures included central corneal thickness (CCT), average cell area, standard deviation, coefficient of variation and hexagonality before surgery and 6mo after surgery and endothelial cell density loss during this period were also evaluated. Intraoperative efficiency parameters [cumulative dissipated energy (CDE), total intraocular surgery time, total ultrasound time, total phacoemulsification time, total torsional energy time, total aspiration time, ultrasound energy, torsional amplitude and fluid required during surgery] were also collated.
RESULTS: Data from these patients was not considered for analysis. Data from 92 patients were analysed. Postoperative endothelial cell density (cells/mm2) between groups (2211.88±392.49 CP; 2246.31±403.48 FLACS) was not statistically significant (P=0.869). Total ultrasound time, torsional energy time, CDE and fluid requirements were significantly lower the FLACS group (P<0.05). Other parameters did not show statistically significant difference between FLACS and CP.
CONCLUSION: FLACS displays significant improvements in phacoemulsification parameters in comparison to CP. There are no significant differences in corneal endothelium measures between FLACS and CP.]]></description>
<pubDate>2018/8/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Lucia Bascaran, Txomin Alberdi, Itziar Martinez-Soroa, Cristina Sarasqueta and Javier Mendicute]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Lucia Bascaran, Txomin Alberdi, Itziar Martinez-Soroa, Cristina Sarasqueta and Javier Mendicute</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180810]]></guid><cfi:id>775</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of diathermic high-frequency capsulorhexis and continuous curvilinear capsulorrhexis in white cataract surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180811]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the corneal endothelial cell counts pre- and post-operation, ultrastructure of anterior lens capsule and surgical completion after diathermic high-frequency capsulorhexis (DHC) and continuous curvilinear capsulorrhexis (CCC) applied in phacoemulsification (PHACO) of white cataract surgery.
METHODS: Sixty-six eyes of 66 patients (33 males and 33 females) with cataract aged between 60 and 80y (mean 72.5±5.5) were recruited and undergone the surgery from June 2014 to November 2016. Anterior lens capsule, derived from two kinds of capsulorhexis, were randomly divided into two groups according to random number table. The ultrastructure of the capsule edge and its closer tissue were observed by transmission electron microscopy (TEM) and optical microscopy respectively. The surgical completion conditions and corneal endothelial cell counts were analyzed pre- and post-operation after two capsulorhexis.
RESULTS: The capsule derived from CCC had smooth edge, well-organized cellular structure and the cells filling into the cutting edge under TEM and optical microscopy. The capsule derived from DHC had an approximate 60 banded area of cell degeneration and necrosis, with dentiform prominences at the edge of the capsule, and no cell structure was observed at this area. The corneal endothelial cell counts of both groups were slightly declined 1wk post-operation compared with that of pre-operation. There was no statistical difference between the two groups (t=1.63, P>0.05).
CONCLUSION: DHC shows good clinical value in white mature and hypermature cataract surgery.]]></description>
<pubDate>2018/8/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Li Wang, Peng Li and Xiong Guo]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Li Wang, Peng Li and Xiong Guo</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180811]]></guid><cfi:id>774</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Risk factors for flat anterior chamber after glaucoma filtration surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180812]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the incidence rate and risk factors for grade III flat anterior chamber (FAC) after glaucoma filtration surgery based on 5-year data.
METHODS: Patients who underwent glaucoma filtration surgery in Daping hospital from January 2009 to December 2013 were enrolled in this retrospective study. The incidence of grade III FAC following glaucoma filtration surgery was determined. Regression analysis was performed to investigate the influence of glaucoma type, surgical approach, age, and preoperative intraocular pressure (IOP) on the risk of postoperative FAC.
RESULTS: A total of 2179 eyes receiving anti-glaucoma surgery were included. Ninety-one eyes suffered from postoperative FAC, with an overall incidence rate of 4.18%. Of 471 eyes with primary open angle glaucoma (POAG), grade III FAC occurred in only 3 eyes (0.64%). Primary angle- closure glaucoma (PACG) was diagnosed in 1076 eyes, 39 (3.62%) of which developed grade III FAC, including 12 eyes (12/300, 4%) with acute PACG (aPACG) and 27 eyes (27/776, 3.48%) with chronic PACG (cPACG). Six of 259 eyes (2.32%) with secondary glaucoma, 28 of 186 eyes (15.05%) with neovasular glaucoma, 1 of 66 eyes (1.52%) with congenital glaucoma, and 14 of 115 eyes (12.17%) with remnant glaucoma suffered from grade III FAC. Of 6 eyes with mixed glaucoma, none developed grade III FAC after surgery. When stratified by surgical approach, 24 of 766 eyes (3.13%) undergoing trabeculectomy, 21 of 924 eyes (2.27%) treated by trabeculectomy plus mitomycin C (MMC), 18 of 109 eyes (16.51%) undergoing Ahmed glaucoma valve implantation, 23 of 201 eyes (11.44%) managed by Ahmed implantation plus MMC, and 5 of 133 eyes (3.76%) treated by Ahmed implantation plus lens extraction or vitrectomy developed grade III FAC. Logistic regression analysis revealed that factors including neovasular glaucoma, remnant glaucoma, glaucoma valve implantation, glaucoma valve implantation+MMC, glaucoma valve implantation+vitrectomy, age>60y, and IOP at admission >50 mm Hg were significantly associated with an increased risk for grade III FAC.
CONCLUSION: The overall incidence of grade III FAC after glaucoma filtration surgery is 4.18%. Patients with neovasular glaucoma and remnant glaucoma are at a higher risk of developing FAC. Ahmed glaucoma valve implantation is associated with a higher risk for grade III FAC compared with trabeculectomy. No significant correlation was observed between the use of MMC in glaucoma filtration surgery and the risk of postoperative FAC. Higher IOP at admission (>50 mm Hg) and old age (>60y) are risk factors for grade III FAC.]]></description>
<pubDate>2018/8/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xiang-Ji Li, Richard Filek, Xiang-Ge He, Wei Wang, Hong Liu, Lian He, Yu-Rong Tang and Lin Xie]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiang-Ji Li, Richard Filek, Xiang-Ge He, Wei Wang, Hong Liu, Lian He, Yu-Rong Tang and Lin Xie</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180812]]></guid><cfi:id>773</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison among Ocular Response Analyzer, Corvis ST and Goldmann applanation tonometry in healthy children]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180813]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To explore the relationship between different parameters of Ocular Response Analyzer (ORA) and Corvis ST (CST) in a sample of healthy Iranian school-aged children and the relationship between parameters of these 2 instruments against intraocular pressure (IOP), measured by the Goldmann applanation tonometer (GAT-IOP), age and gender, and find possible correlation between ORA and CST with GAT.
METHODS: This cross-sectional study included 90 healthy children. A general interview and complete eye examination were performed. Following successful GAT-IOP measurement, ORA and CST were conducted. The CST parameters were A 1/2 length (A1L, A2L), A 1/2 velocity (A1V, A2V), highest concavity deformation amplitude (HCDA), radius of curvature (RoC), peak distance (PD), central corneal thickness (CCT) and IOP. The ORA parameters were corneal hysteresis (CH), corneal resistance factor (CRF), Goldmann-correlated IOP (IOP-G) and corneal compensated IOP (IOP-CC). Extracted data was analyzed using the Statistical Package for Social Science software.
RESULTS: Totally 39 males with age of 9.08±1.60 (6-12)y and 51 females with age of 8.96±1.55 (6-13)y were included. Many CST parameters were significantly correlated with CH, CRF, IOP-G and IOP-CC. Some CST parameters had a significant correlation with GAT-IOP, including IOP-CST in both eyes and HCDA, A2L, PD, and RoC in the left eye, but none with age, except A2L in the right eye. The CRF measurement showed a significant correlation with GAT-IOP in both eyes and CH in the right eye, yet, none with age. Among all CST and ORA parameters, CCT-CST in both eyes and A1L in right eye had a significant correlation with gender, although this was a negligible negative correlation. Comparison of mean IOP values by different devices showed a significantly highest IOP overestimation by CST and lowest by IOP-CC compared with GAT. Also, IOP-G versus IOP-CST significantly had the lowest IOP overestimation among others. Overall, either low positive correlation or negligible correlation was found between IOP measurements by 3 instruments.
CONCLUSION: The study finds the highest IOP overestimation by CST and lowest by IOP-CC compared with GAT. Overall, either low positive correlation or negligible correlation is found between IOP measurements by the 3 instruments.]]></description>
<pubDate>2018/8/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ramin Salouti, Ali agha Alishiri, Reza Gharebaghi, Mostafa Naderi, Khosrow Jadidi, Ahmad Shojaei-Baghini, Mohammadreza Talebnejad, Zahra Nasiri, Seyedmorteza Hosseini and Fatemeh Heidary]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ramin Salouti, Ali agha Alishiri, Reza Gharebaghi, Mostafa Naderi, Khosrow Jadidi, Ahmad Shojaei-Baghini, Mohammadreza Talebnejad, Zahra Nasiri, Seyedmorteza Hosseini and Fatemeh Heidary</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180813]]></guid><cfi:id>772</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Melatonin concentrations in serum of primary glaucoma patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180814]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine whether glaucoma patients exhibit an abnormal melatonin concentration in serum and the effects of psychiatric disorders caused by glaucoma in melatonin secretion.
METHODS: A sample of 80 primary angle-closure glaucoma (PACG) patients, 120 primary open angle glaucoma (POAG) patients, and 120 normal controls were enrolled in this study. All the participants were asked to complete the following questionnaires: Pittsburgh sleep quality index (PSQI), self-rating anxiety scale (SAS), and self-rating depression scale (SDS). Variance analysis was used to compare the subscores between the groups. After that, we chose 58 patients with primary glaucoma and 20 non-glaucoma control patients to collect their serum samples at 7-10 a.m. Serum melatonin levels were measured using enzyme linked immunosorbent assay (ELISA).
RESULTS: Of all participants, the scores of PSQI, SAS, and SDS in PACG and POAG group were 9.38±0.40, 46.08±8.99, 51.11±10.72 and 7.43±0.35, 45.42±9.87, 49.04±12.24 respectively, significantly higher than those in control group (4.16±0.28, 35.49±9.18, 40.31±13.08). The serum melatonin levels in PACG (37.29±2.99 pg/mL) and POAG (35.97±3.64 pg/mL) were significantly higher than the controls (29.96±3.94 pg/mL) (P<0.001). But no difference was found between the PACG and POAG (P=0.216). Glaucoma patients with sleep disorders, anxiety and depression were more likely resulting in the increase of melatonin levels.
CONCLUSION: There is a significant increase in serum melatonin levels in glaucoma patients compared to the controls especially in glaucoma patients with psychiatric disorders such as sleep disorders, anxiety and depression.]]></description>
<pubDate>2018/8/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xiao-Ping Ma, Man-Yi Shen, Guang-Lin Shen, Qiao-Ran Qi and Xing-Huai Sun]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiao-Ping Ma, Man-Yi Shen, Guang-Lin Shen, Qiao-Ran Qi and Xing-Huai Sun</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180814]]></guid><cfi:id>771</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Intraocular retinal thickness asymmetry in early stage of primary open angle glaucoma and normal tension glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180815]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the intraocular retinal thickness asymmetry of peripapillary retinal nerve fiber layer (pRNFL) and macular layers measured by spectral-domain optical coherence tomography (SD-OCT) in patients with early stage of primary open angle glaucoma (POAG) and normal tension glaucoma (NTG).
METHODS: A total of 117 patients with early stage of glaucoma (54 patients with POAG and 63 patients with NTG) and 32 normal subjects were recruited for the study. The pRNFL thickness, total macular layer (TML) thickness, and isolated inner macular layer (IML) thickness were measured by SD-OCT. Hemisphere TML thickness asymmetry measured by the posterior pole asymmetry scan was evaluated. Thickness differences of pRNFL and IML between superior and inferior quadrants were calculated. Asymmetry indices (AIs) of the pRNFL, TML and isolated IML were also computed. Areas under the receiver-operating characteristic curves (AROCs) were generated to determine the diagnostic capabilities of different parameters.
RESULTS: Intraocular pRNFL thickness differences and AIs between the superior and inferior quadrants were significantly different between normal and NTG groups (P=0.009 and P<0.001, respectively). Intraocular pRNFL thickness differences and AIs between the temporal-superior and temporal-inferior sectors were also significantly different between normal and NTG groups (P=0.035 and P<0.001, respectively). The thickness differences and AIs of TML between superior and inferior hemispheres were significantly different between normal and NTG groups (P=0.001 and P=0.001, respectively) and between normal and POAG groups (P=0.032 and P=0.020, respectively). The thickness differences and AIs of macular ganglion cell layer (mGCL) between superior and inferior quadrants were significantly different between normal and NTG groups (P=0.013 and P=0.004, respectively), and between NTG and POAG groups (P=0.015 and P=0.012, respectively). The thickness difference of TML between superior and inferior hemispheres showed the highest diagnostic capability for early NTG eyes (AROC=0.832).
CONCLUSION: Intraocular retinal thickness asymmetry in pRNFL, TML and mGCL are found in early stage of NTG. Hemisphere TML thickness asymmetry is also found in POAG eyes. Asymmetry analysis of retinal thickness can be an adjunctive modality for early detection of glaucoma.]]></description>
<pubDate>2018/8/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Pei-Wen Lin, Hsueh-Wen Chang, Ing-Chou Lai, Jen-Chia Tsai and Yi-Chieh Poon]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Pei-Wen Lin, Hsueh-Wen Chang, Ing-Chou Lai, Jen-Chia Tsai and Yi-Chieh Poon</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180815]]></guid><cfi:id>770</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical features and surgical treatment of double elevator palsy in young children]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180816]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To describe the clinical features of congenital double elevator palsy (CDEP) and to evaluate various surgical outcomes between the standard Knapp and augmented Knapp procedures, based on improvements in primary eye position and ocular motility.
METHODS: Twenty-two patients with CDEP at Shanghai Children’s Hospital were enrolled from July 2014 to January 2018. The forced duction test (FDT) was negative in 21 patients, aged 8mo to 12y (mean 5.4y). Patients were divided into two treatment groups: 16 patients underwent the standard Knapp procedure (group A), with or without horizontal squint procedure; and 5 patients underwent the augmented Knapp procedure (Foster procedure; group B). One patient underwent inferior rectus recession in the affected eye and superior rectus recession in the sound eye because of a positive FDT. The pre- and postoperative vertical deviations in the primary position and ocular motility were compared in the two groups.
RESULTS: Twenty-one eyes of the 22 patients (95%) were aligned within 10 prism diopters (PD), and all patients (100%) reached ≥25% elevation improvement after surgery. The average corrected vertical deviation in group B was statistically better than that of group A. For group A, the vertical deviation in the primary position decreased from 24.75Δ±8.35Δ to 4.56Δ±8.07Δ after surgery, for an improvement of 23.06Δ±6.51Δ (P<0.05). In group B, the decrease was from 35.00Δ±5.00Δ (range 30Δ-40Δ) to 1.00Δ±2.24Δ, for an improvement of 34.00Δ±4.18Δ (P<0.05). There were significant differences between the pre- and postoperative elevation in each group (group A, P<0.05; group B, P<0.05). The average scale of improved elevation in group B (1.80±0.45) was not significantly better than that of group A (1.69±0.87; Z=-0.732, P=0.548). The average follow-up periods lasted 21mo in group A and 18mo in group B.
CONCLUSION: For vertical deviations <30Δ, the standard Knapp procedure can be chosen. For deviations greater than 30Δ-40Δ, the Foster procedure should be chosen. Because of our early interference, the inferior rectus (IR) muscle did not show mechanical restriction. Monocular elevation deficiency (MED) should be diagnosed early so that complications will be reduced and the procedure will be easier for the surgeon.]]></description>
<pubDate>2018/8/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Wen-Ting Luo, Tong Qiao, Hai-Yun Ye, Si-Hong Li and Quan-Li Chen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Wen-Ting Luo, Tong Qiao, Hai-Yun Ye, Si-Hong Li and Quan-Li Chen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180816]]></guid><cfi:id>769</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Relation between early postoperative deviation and long-term outcome after unilateral lateral rectus recession and medial rectus resection for adult exotropia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180817]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the relationship between early postoperative deviation and long-term outcome after unilateral recession and resection surgery for adult exotropia, and to evaluate exotropic shift after surgery.
METHODS: This was a retroprospective study involving adult patients with exotropia who underwent unilateral recession and resection surgery and were followed up for at least 2y. The results were evaluated at 2y and the final visit. Factors influencing a successful outcome were analyzed. Early postoperative deviation at 1wk was used to evaluate relationship with long-term outcome. The long-term outcome was classified into 3 groups: successful, acceptable, and poor. Successful outcome was defined as a distance deviation between esodeviation 8 prism diopters (PD) and exodeviation 10 PD.
RESULTS: Forty-two patients were enrolled. The mean age at surgery was 26y (range, 15-49y). The median follow-up period was 30mo (range, 24-108mo). Successful outcome was found in 81% of patients at 2y and in 71% at the final visit. Overcorrection at 1wk postoperatively was associated with a successful outcome at 2y. Initial postoperative alignment between orthotropia and esodeviation of 8 PD had the highest chance of a successful outcome (RR=2.2). The mean postoperative exotropic drift was 4.7 PD at the first month and 9.3 PD at 2y.
CONCLUSION: Initial postoperative deviation can predict long-term outcome after unilateral recession and resection surgery for adult exotropia. The most desirable outcome at 1wk post-operatively was orthotropia to small esodeviation. Most patients have exotropic drift at a subsequent follow-up, especially in the first month after surgery.]]></description>
<pubDate>2018/8/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ponnarun Kanjanawasee, Pokpong Praneeprachachon and Parnchat Pukrushpan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ponnarun Kanjanawasee, Pokpong Praneeprachachon and Parnchat Pukrushpan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180817]]></guid><cfi:id>768</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Orbital decompression surgery for the treatment of Graves' ophthalmopathy: comparison of different techniques and long-term results]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180818]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the long-term results of different orbital decompression techniques performed in patients with Graves' ophthalmopathy (GO).
METHODS: Totally 170 cases with GO underwent orbital decompression between 1994 and 2014. Patients were divided into 4 groups as medial-inferior, medial-lateral (balanced), medial-lateral-inferior, and lateral only according to the applied surgical technique. Surgical indications, regression degrees on Hertel exophthalmometer, new-onset diplopia in the primary gaze and new-onset gaze-evoked diplopia after surgery and visual acuity in cases with dysthyroid optic neuropathy (DON) were compared between different surgical techniques.
RESULTS: The study included 248 eyes of 149 patients. The mean age for surgery was 42.3±13.2y. DON was the surgical indication in 36.6% of cases, and three-wall decompression was the most preferred technique in these cases. All types of surgery significantly decrease the Hertel values (P<0.005). Balanced medial-lateral, and only lateral wall decompression caused the lowest rate of postoperative new-onset diplopia in primary gaze. The improvement of visual acuity in patients with DON did not significantly differ between the groups (P=0.181).
CONCLUSION: The study show that orbital decompression surgery has safe and effective long term results for functional and cosmetic rehabilitation of GO. It significantly reduces Hertel measurements in disfiguring proptosis and improves visual functions especially in DON cases.]]></description>
<pubDate>2018/8/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mehmet Ozgur Cubuk, Onur Konuk and Mehmet Unal]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mehmet Ozgur Cubuk, Onur Konuk and Mehmet Unal</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180818]]></guid><cfi:id>767</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Evaluation of traumatic retinopathy with ultra-wide field imaging under corneal scar or fixed small pupil]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180819]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the value of ultra-wide field (UWF) imaging in the management of traumatic retinopathy under the condition of corneal scar or fixed small pupil after complicated ocular trauma.
METHODS: Twenty-eight patients (28 eyes) with complicated ocular trauma were enrolled in the study from June 2016 to May 2017, including 19 males and 9 females with age ranged from 11 to 64 (43.42±12.62)y. All patients were treated with secondary vitrectomy after emergency operation for wound repair of open ocular trauma. Direct ophthalmoscopy and 45-degree fundus photography were taken at each time point of follow up for comparison of findings with UWF images. Routine eye examination including visual acuity, intraocular pressure, slit lamp examination were performed and analyzed as well.
RESULTS: Among the 28 traumatized eyes, the positive rate for identification of traumatic retinopathed was 32.1% (9 cases), 14.9% (5 cases), and 85.7% (24 cases) with direct ophthalmoscopy, 45-degree fundus photography, and UWF imaging, respectively. The detective rate of UWF imaging under the condition of corneal scar or fixed small pupil was statistically greater than that of 45-degree fundus photography and direct ophthalmoscopy (Bonferroni correction, P<0.001). UWF image was obtained in 19 eyes with opaque corneal scar, otherwise their fundus could not be seen by conventional methods. The additional findings of traumatic retinopathies by UWF imaging included periretinal membranes or pre-retinal proliferating strip, retinal holes, hemorrhage in the vitreous or sub-retinal space.
CONCLUSION: UWF imaging is superior to traditional fundus photography in the evaluation of traumatic retinopathies under the condition of corneal scar or fixed small pupil after complicated ocular trauma.]]></description>
<pubDate>2018/8/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Min Tang, Yan-Nian Hui, You-Yi Li, Yue He, Yang Cao, Xiao-Hong Xiang and Hong-Bin Lyu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Min Tang, Yan-Nian Hui, You-Yi Li, Yue He, Yang Cao, Xiao-Hong Xiang and Hong-Bin Lyu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180819]]></guid><cfi:id>766</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Alcohol delamination of the corneal epithelium for recurrent corneal erosion syndrome]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180709]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the outcomes of alcohol delamination (ALD) of the corneal epithelium for the treatment of recurrent corneal erosion syndrome (RCES) and to implement a standardized treatment protocol for this condition utilizing evidence based practice and the findings of an internal audit.
METHODS: A retrospective analysis of 42 eyes of 40 patients diagnosed with RCES who were treated with ALD between January 2006 and March 2016 was conducted. Patients had 20% alcohol applied to the cornea with the use of a well for 40s. Patients were reviewed one week later in the Outpatient Department. Outcome criteria were established based on standards from other studies in the medical literature. These included, a treatment success rate of at least 72% (defined as complete resolution of symptoms one month after treatment), a postoperative complication a rate of <5% (mainly infective keratitis, and subepithelial haze), and the absence of any detrimental effect on visual acuity in ≥95% of patients.
RESULTS: The mean age at the time of ALD was 41.17±13.44y. Patients were followed for an average of 12.8±15.65mo. The majority were female (52.5%, n=21) and the majority of eyes treated with ALD were left eyes (62.9%, n=26). Trauma was the primary aetiology in our study population. Treatment was successful in 73.8% (n=31) of eyes and in 75% (n=30) of patients. Recurrence occurred in 26.2% of eyes at a mean of 10.41±12.63mo post treatment.
CONCLUSION: ALD is an efficacious and cost-effective primary surgical intervention for RCES.]]></description>
<pubDate>2018/7/10 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[áine Ní Mhéalóid, Taylor Lukasik, William Power and Conor C. Murphy]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>áine Ní Mhéalóid, Taylor Lukasik, William Power and Conor C. Murphy</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180709]]></guid><cfi:id>765</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Characteristics, management, and outcome of squamous carcinoma of the conjunctiva in a single tertiary cancer center in Jordan]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180710]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the features and outcome of management of malignant conjunctival squamous tumors in King Hussein Cancer Center (a referral tertiary cancer center in the Middle East).
METHODS: Retrospective case series of 31 eyes for 31 patients with conjunctival squamous neoplasia. Main outcome measures included: age, gender, laterality, tumor location, pathological features, tumor stage, treatment modality, and outcome.
RESULTS: Twenty (65%) patients were males and median age was 58y. Twenty-two (71%) eyes had the tumor in the nasal quadrant. Tumor invasion to nearby structures was seen in 19 (61%) eyes, including the cornea, fornix, eyelid, and orbit in 17 (55%), 1 (3%), 2 (6%), and 3 (10%) eyes, respectively. Eye salvage was achieved by surgical excision with cryotherapy followed by topical chemotherapy in 28 (90%) eyes, and orbital exenteration was necessary in 3 (10%) eyes due to orbital tumor invasion. Tumor recurrence was seen in 7 (23%) eyes, and the significant predictive factors for recurrence were tumor extension onto the nearby structures (P=0.04), tumor invasiveness (P=0.038), and tumor TNM stage (P=0.031). No significant change in visual acuity was seen, and disease related mortality was 6% (2 patients, both had orbital invasion by invasive squamous carcinoma).
CONCLUSION: Conjunctival squamous carcinoma is more common in males. Advanced American Joint Committee on Cancer (AJCC) T-stage, tumor local invasion, more pathologically aggressive tumors, and surgical treatment alone (without adjuvant therapy) are associated with higher risk for recurrence, and orbital invasion is the most important poor prognostic factor for metastasis and death. Treatment strategies should be affected by tumor characteristics at presentation.]]></description>
<pubDate>2018/7/10 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ata Rajeh, Fareed Barakat, Samer Khurma, Khaleel AlRawashdeh, Osama H. Ababneh, Ibrahim AlNawaiseh, Mustafa Mehyar, Ghadeer Abdeen, Imad Jaradat, Mona Mohammad and Yacoub A. Yousef]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ata Rajeh, Fareed Barakat, Samer Khurma, Khaleel AlRawashdeh, Osama H. Ababneh, Ibrahim AlNawaiseh, Mustafa Mehyar, Ghadeer Abdeen, Imad Jaradat, Mona Mohammad and Yacoub A. Yousef</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180710]]></guid><cfi:id>764</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Repeatability of in-vitro optical quality measurements of intraocular lenses with a deflectometry technique effect of the toricity]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180711]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the repeatability of an optical device for measuring the Zernike coefficients of toric intraocular lenses (IOLs) and assess whether its toricity has any impact in its repeatability.
METHODS: An experienced technician used the NIMO TR1504 to measure the Zernike coefficients 30 times for an aperture of 4.50 mm for all lenses included. The IOLs included were divided into two group: toric and non-toric ones. The cylindrical powers of the toric lenses included in the present study were 1.00, 1.50, 2.25, 3.00 and 3.75 D. Finally, the repeatability of the NIMO TR1504 was described in terms of within subject standard deviation (Sw) and repeatability limit.
RESULTS: The Sw was smaller than 0.011 μm for both lens groups and all Zernike coefficients, and the difference between both groups was smaller than 0.004 μm for all Zernike coefficients. Regarding the repeatability limit, this value was smaller than 0.025 μm for the toric lens group, and smaller than 0.031 μm for the non-toric lens one for all Zernike coefficients. Furthermore, the maximum difference between both lens groups was 0.010 μm.
CONCLUSION: The repeatability of the NIMO TR1504 to measure the optical quality is high and independent of the lens toricity. These results reflect that this system is robust and could be used to measure the in-vitro optical quality of either toric or non-toric IOLs.]]></description>
<pubDate>2018/7/10 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Teresa Ferrer-Blasco, Alberto Domínguez-Vicent, Santiago García-Lázaro, María Amparo Díez-Ajenjo, José F. Alfonso and José J. Esteve-Taboada]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Teresa Ferrer-Blasco, Alberto Domínguez-Vicent, Santiago García-Lázaro, María Amparo Díez-Ajenjo, José F. Alfonso and José J. Esteve-Taboada</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180711]]></guid><cfi:id>763</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Induction of oxidative stress in human aqueous and vitreous humors by Nd:YAG laser posterior capsulotomy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180712]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate whether the Q-switched Nd:YAG laser treatment applied in routine capsulotomy elicits oxidative stress in aqueous and vitreous humors.
METHODS: Thirty-six patients who had to undergo a 25 gauge pars plana vitrectomy due to vitreoretinal disorders were enrolled, 15 of them underwent a Q-switched Nd:YAG laser capsulotomy 7d before vitrectomy due to posterior capsule opacification (PCO) (Nd:YAG laser group) while the remaining 21 patients were not laser treated before vitrectomy (no Nd:YAG laser group). Samples of the aqueous and vitreous humors were collected during vitrectomy from all patients for the assessment of oxidative parameters which were compared between the Nd:YAG laser group and no Nd:YAG laser group. Thiobarbituric acid reactive substances (TBARS), a product of membrane lipid peroxidation, nitrite levels, the antioxidative activities of SOD and catalase, the 4-HNE-protein conjugate formation, indicating structural modifications in proteins due to lipoperoxidation, were assessed in aqueous and vitreous samples.
RESULTS: In the human vitreous humor TBARS levels are significantly higher in the Nd:YAG laser group compared to the no Nd:YAG laser group and importantly, there is a significant correlation between the TBARS levels and the total energy of Nd:YAG laser used during capsulotomy. Moreover the anti-oxidative activities of SOD and catalase were significantly decreased by Nd:YAG laser treatment, both in aqueous and vitreous humors. In accordance with the TBARS data and anti-oxidative enzyme activities, significantly higher levels of proteins were conjugated with the lipoperoxidation product 4-HNE in the aqueous and vitreous humors in the Nd:YAG laser-treated group in comparison to no Nd:YAG laser group.
CONCLUSION: These data, clearly suggest that any change that Q-switched Nd:YAG photo disruption may cause in the aqueous and vitreous compartments, resulting in a higher level of oxidative damage might be of considerable clinical significance particularly by accelerating the aging of the anterior and posterior segments of the eye and by worsening the intraocular pressure, the uveal, the retinal (especially macular) pathologies.]]></description>
<pubDate>2018/7/10 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Loredana Bergandi, Oleksii A Skorokhod, Federica Franzone, Rosalba La Grotta, Evelin Schwarzer and Raffaele Nuzzi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Loredana Bergandi, Oleksii A Skorokhod, Federica Franzone, Rosalba La Grotta, Evelin Schwarzer and Raffaele Nuzzi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180712]]></guid><cfi:id>762</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of 25 MHz and 50 MHz ultrasound biomicroscopy for imaging of the lens and its related diseases]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180713]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the results of 25 MHz and 50 MHz ultrasound biomicroscopy (UBM) regarding the image characteristics of the lens and its related diseases and to discuss the application value of 25 MHz UBM in ophthalmology.
METHODS: A total of 302 patients (455 eyes) were included in this study from November 2014 to May 2015. Patient ages ranged from 5 to 89y (mean±SD: 61.0±17.7y). Different cross-sectional images of the lens were collected to compare and analyze the image characteristics and anterior segment parameters using 25 MHz and 50 MHz UBM in axial and longitudinal scanning modes, respectively. SPSS 19.0 for Windows, paired t-tests and B&A plot analysis were used for data analysis, and a value of P<0.05 was considered statistically significant.
RESULTS: The 25 MHz UBM images displayed the lens shape more clearly than 50 MHz UBM images. Particularly for cataracts, the whole opacity of the lens was shown by 25 MHz UBM, but 50 MHz UBM only showed part of the lens. The means of the anterior segment parameters obtained using 25 MHz and 50 MHz UBM were as follows: central corneal thickness: 0.55±0.03 and 0.51±0.04 mm, respectively; central anterior chamber depth: 2.48±0.54 and 2.56±0.56 mm, respectively; and central lens thickness: 4.26±0.62 and 4.15±0.56 mm, respectively. A statistically significant difference was found between the results obtained with 25 MHz UBM and those obtained with 50 MHz UBM. The two devices had a good agreement in measuring the anterior segment parameters.
CONCLUSION: The 25 MHz UBM had an obvious advantage in showing the lens shape. It can provide reliable imaging of the lens and its related diseases and has a high application value for ophthalmology.]]></description>
<pubDate>2018/7/10 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ming-Yu Shi, Xiao Han, Jin-Song Zhang and Qi-Chang Yan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ming-Yu Shi, Xiao Han, Jin-Song Zhang and Qi-Chang Yan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180713]]></guid><cfi:id>761</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of long-term topical latanoprost medication on conjunctival thickness in patients with glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180714]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the effect of long-term use of topically administered latanoprost on conjunctival thickness (CT) and conjunctival epithelium thickness (CET) in the patients with glaucoma.
METHODS: A series of 106 glaucomatous patients were included. Of the 106 eyes, 55 eyes were treated with latanoprost eye drops once a day (latanoprost group), while 51 eyes were treated with carteolol hydrochloride eye drops (carteolol group). All the included patients completed a 2-year follow-up. CT and CET were measured with optical coherence tomography (OCT) in all patients at presentation and at 2-year visit, respectively. Statistical analysis was then performed to compare the change in CT and CET.
RESULTS: At presentation, there was no difference in CET (t=0.400, P=0.689) or CT (t=1.14, P=0.259) between the two groups. No significant difference was found in CET (61.65±5.35 μm at baseline, 60.36±6.36 μm at 2-year follow-up, respectively; t=1.977, P=0.0531), while there was a significant decrease in CT from 201.45±14.99 μm at baseline to 167.81±14.57 μm at 2-year visit (t=14.1407, P<0.001) in the latanoprost group. At 2-year follow-up, no statistically difference was found in CET (62.24±5.27 μm; t=1.086, P=0.282) or CT (201.23±12.45 μm; t=1.44, P=0.154) compared to it at baseline (CET: 61.23±5.42 μm; CT: 198.76±13.68 μm, respectively) in the carteolol group.
CONCLUSION: A significant decrease in conjunctival thickness is found in glaucoma patients treated with long-term topical latanoprost; its potential effect on the outcome of filtration surgery should be considered.]]></description>
<pubDate>2018/7/10 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Qing-Song Li, Fang-Fang Bao, Zhen-Yong Zhang and Kai Ma]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Qing-Song Li, Fang-Fang Bao, Zhen-Yong Zhang and Kai Ma</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180714]]></guid><cfi:id>760</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Analysis of peripapillary retinal nerve fiber layer and inner macular layers by spectral-domain optical coherence tomography for detection of early glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180715]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyze the diagnostic capabilities of peripapillary retinal nerve fiber layer (pRNFL) thickness and segmented inner macular layer (IML) thickness measured by spectral-domain optical coherence tomography for detection of early glaucoma.
METHODS: Fifty-three patients with primary open angle glaucoma (POAG), 60 patients with normal tension glaucoma (NTG) and 32 normal control subjects were enrolled. Thicknesses of pRNFL, total macular layers (TML), and the IML, including macular RNFL (mRNFL) and macular ganglion cell layer (mGCL) were assessed. The areas under the receiver operating characteristic curves (AROC) were calculated to compare the diagnostic power of different parameters.
RESULTS: There were no differences in the parameters of pRNFL, TML, and IML between POAG and NTG groups. The thicknesses of superior and inferior mGCL showed significant correlation with mean deviation of visual field (R2=0.071, P=0.004; R2=0.08, P=0.002). The mGCL thickness significantly correlated with the pRNFL thickness in the superior and inferior quadrants (R2=0.156, P<0.001; R2=0.407, P<0.001). The thickness of the inferior-outer sector of macula had greater AROCs than those in the inferior-inner sector of macula. The AROCs for superior (0.894) and inferior (0.879) pRNFL thicknesses were similar with the AROCs for superior (0.839) and inferior mGCL (0.864) thicknesses. Sensitivities at 80% specificity for global pRNFL, inferior-outer mGCL and inferior-outer mRNFL thicknesses were 0.938, 0.867, and 0.725, respectively.
CONCLUSION: The diagnostic capability of the mGCL thickness is comparable to that of the pRNFL thickness in patients with early glaucoma. The inferior-outer sector of IML has a better diagnostic capability than the inferior-inner sector of IML for detection of early glaucoma.]]></description>
<pubDate>2018/7/10 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Pei-Wen Lin, Hsueh-Wen Chang, Jih-Pin Lin and Ing-Chou Lai]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Pei-Wen Lin, Hsueh-Wen Chang, Jih-Pin Lin and Ing-Chou Lai</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180715]]></guid><cfi:id>759</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Ocular hypertension in patients with central/hemicentral retinal vein occlusions: cumulative prevalence and management]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180716]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To prospectively evaluate the cumulative prevalence and the management of ocular hypertension (OH) in patients with unilateral acute central/hemicentral retinal vein occlusions (C/HCRVOs) over the course of 3y.
METHODS: The study included 57 patients with unilateral acute C/HCRVOs. All patients underwent a comprehensive ophthalmological examination of both eyes. OH associated with C/HCRVO in patients showing a score >5% for the risk of conversion to primary open angle glaucoma (POAG) was treated with OH medication. The treatment aimed for a decrease in intraocular pressure (IOP) to <21 mm Hg with a >22% reduction from the initial values. The cumulative prevalence of OH and the effectiveness of treatment assessed by the cumulative prevalence of conversion from OH to POAG, were estimated.
RESULTS: Fifteen patients had OH associated with C/HCRVOs, the cumulative prevalence of OH was 29.4% (95% confidence interval, 16.9-41.9). The mean value of the risk score of OH conversion to POAG for the 5 subsequent years was 11.7%±5.4%. The IOP significantly decreased from 25.67±2.16 mm Hg to 18.73±2.96 mm Hg. None of the OH patients converted to POAG during the follow-up period.
CONCLUSION: The increased cumulative prevalence of OH in C/HCRVO patients indicates that OH is a risk factor for the appearance of venous occlusion. Patients with OH associated with C/HCRVO must be considered to be at high risk for conversion to POAG. Treatment with OH medications prevented conversion to POAG during the 3-year follow-up.]]></description>
<pubDate>2018/7/10 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Dan C&#259;lug&#259;ru, Mihai C&#259;lug&#259;ru and &#350;tefan &#354;&#259;lu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Dan C&#259;lug&#259;ru, Mihai C&#259;lug&#259;ru and &#350;tefan &#354;&#259;lu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180716]]></guid><cfi:id>758</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Changes in choroidal thickness in healthy pediatric individuals: a longitudinal study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180717]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the changes in the choroidal thickness in healthy pediatric children in a longitudinal study, and to determine the ocular and systemic parameters that were significantly correlated with the changes in the choroidal thickness.
METHODS: This study included 64 eyes of 34 healthy Japanese children with a mean age (±SD) of 4.4 (±0.4)y (range, 3.6-5.8y) at baseline. Swept-source optical coherence tomography (SS-OCT) was used to record images of the retina and choroid at the baseline and after a mean follow-up period of about 1.5y. The 3D raster scan protocol was used to construct the choroidal thickness map. Mean choroidal thickness was calculated for each of the nine sectors of the Early Treatment Diabetic Retinopathy Study grid. Best-corrected visual acuity, axial length, body height, and weight were also measured. Changes in measurements were defined as the baseline values subtracted from the values at the final visit. A generalized estimating equation was used to eliminate the effect of within-subject intereye correlations.
RESULTS: The mean central choroidal thickness was significantly reduced during the follow-up period (baseline, 301.8±8.6 μm; final visit, 286.6±8.0 μm, P<0.001). The decrease in the choroidal thickness was greatest in the central sector, followed by the sectors of the inner and outer rings. The inner and outer rings had diameters of 1 to 3 mm and 3 to 6 mm, respectively. The changes in the choroidal thickness in the central, inner ring, and outer ring sectors were significantly and negatively correlated with the age, baseline body height, baseline body weight, and elongation of the axial length.
CONCLUSION: These results indicate that the choroidal thickness among preschool-aged Japanese children decreased significantly during the follow-up period. The choroidal thinning is significantly associated with the elongation of axial length. These characteristics should be considered in the evaluation of choroidal thickness in younger children with retinochoroidal disorders.]]></description>
<pubDate>2018/7/10 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Eiko Ohsugi, Yoshinori Mitamura, Kayo Shinomiya, Masanori Niki, Hiroki Sano, Toshihiko Nagasawa, Yukiko Shimizu, Daisuke Nagasato and Hitoshi Tabuchi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Eiko Ohsugi, Yoshinori Mitamura, Kayo Shinomiya, Masanori Niki, Hiroki Sano, Toshihiko Nagasawa, Yukiko Shimizu, Daisuke Nagasato and Hitoshi Tabuchi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180717]]></guid><cfi:id>757</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Macular integrity assessment to determine the association between macular microstructure and functional parameters in diabetic macular edema]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180718]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To respectively evaluate macular morphological features and functional parameters by using spectral-domain optical coherence tomography (SD-OCT) and macular integrity assessment (MAIA) in patients with diabetic macular edema (DME).
METHODS: This prospective, non-controlled, open study included 61 eyes of 38 consecutive patients with DME. All patients underwent best-corrected visual acuity (BCVA) measurement, MAIA microperimetry, and SD-OCT. DME morphology, including central retinal thickness (CRT) and central retinal volume (CRV); integrity of the external limiting membrane (ELM) and photoreceptor inner segment/outer segment (IS/OS) junction; and the deposition of hard macular exudates were assessed within a 1000-μm central subfield area. MAIA microperimetry parameters evaluated were average threshold (AT)-retinal sensitivity, macular integrity index (MI), fixation points within a circle of radius 1° (P1) and 2° (P2), and bivariate contour ellipse area considering 63% and 95% of the fixation points (A63 and A95, respectively).
RESULTS: MI was significantly higher in eyes with disrupted ELM or IS/OS, compared with eyes with intact ELM and IS/OS. Values of BCVA (logMAR), total AT, AT within 1000-μm diameter, P2, A63, A95, and CRT were significantly worse in eyes with disrupted IS/OS, compared with eyes with intact IS/OS. The values of BCVA (logMAR), AT within 1000-μm diameter, and CRT were significantly worse in eyes with disrupted ELM, compared with eyes with intact ELM. These parameters were not significantly different between eyes with or without hard macular exudate deposition. CRV was not significantly different in the presence or absence of the integrity of ELM, IS/OS, or deposition of hard macular exudates. At the center, nasal and temporal sectors of the fovea, significant negative correlations were observed between retinal thickness and AT of the corresponding area. At the inferior and superior sectors of the fovea, no correlations were observed between retinal thickness and AT of the corresponding area. In the intact IS/OS group, significant negative correlations were observed between CRT and central AT. There was no correlation between retinal sensitivity and thickness when the IS/OS layer was disrupted. Multiple linear regression analyses revealed that IS/OS integrity was an independent factor affecting MI.
CONCLUSION: Functional (BCVA and visual field) and morphological parameters (retinal thickness) were significantly associated with an intact IS/OS. Local photoreceptor integrity was a strong predictor of local visual function throughout the retina. MI revealed the functional status in DME, reflecting the IS/OS juction status in the macula.]]></description>
<pubDate>2018/7/10 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jian-Wei Wang, Chuan-Hong Jie, Yong-Jian Tao, Ning Meng, Yuan-Chun Hu, Zheng-Zheng Wu, Wen-Jing Cai and Xi-Mei Gong]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jian-Wei Wang, Chuan-Hong Jie, Yong-Jian Tao, Ning Meng, Yuan-Chun Hu, Zheng-Zheng Wu, Wen-Jing Cai and Xi-Mei Gong</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180718]]></guid><cfi:id>756</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[10-year fundus tessellation progression and retinal vein occlusion]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180719]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To access the 10-year fundus tessellation progression in patients with retinal vein occlusion.
METHODS: The Beijing Eye Study 2001/2011 is a population-based longitudinal study. The study participants underwent a detailed physical and ophthalmic examination. Degree of fundus tessellation was graded by using fundus photographs of the macula and optic disc. Progression of fundus tessellation was calculated by fundus tessellation degree of 2011 minus degree of 2001. Fundus photographs were used for assessment of retinal vein occlusion.
RESULTS: The Beijing Eye Study included 4403 subjects in 2001, 3468 subjects was repeated in 2011. Assessment of retinal vein obstruction and fundus tessellation progression were available for 2462 subjects (71.0%), with 66 subjects fulfilled the diagnosis of retinal vein occlusion. Of the 66 participants, 59 participants with unilateral branch retinal vein occlusion, 5 participants with unilateral central retinal vein occlusion, 1 participant with bilateral branch retinal vein occlusion, and 1 participant with branch retinal vein occlusion in one eye and central retinal vein occlusion in the other eye. Mean degree of peripapillary fundus tessellation progression were significantly higher in the whole retinal vein occlusion group (0.33±0.39, P<0.001), central retinal vein occlusion group (0.71±0.8, P=0.025) and branch retinal vein occlusion group (0.29±0.34, P=0.006) than the control group (0.20±0.26). After adjustment for age, prevalence of tilted disc, change of best corrected visual acuity, axial length, progression of peripapillary fundus tessellation was associated with the presence of retinal vein occlusion (P=0.004; regression coefficient B, 0.094; 95%CI, 0.029, 0.158; standardized coefficient B, 0.056). As a corollary, after adjusting for smoking duration, systolic blood pressure, anterior corneal curvature, prevalence of RVO was associated with more peripapillary fundus tessellation progression (P<0.001; regression coefficient B: 1.257; OR: 3.517; 95%CI: 1.777, 6.958).
CONCLUSION: Peripapillary fundus tessellation progresses faster in individuals with retinal vein occlusion. This may reflect the thinning and hypoperfusion of choroid in patients with retinal vein occlusion.]]></description>
<pubDate>2018/7/10 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yan-Ni Yan, Ya-Xing Wang, Yan Yang, Liang Xu, Jie Xu, Qian Wang, Jing-Yan Yang, Wen-Jia Zhou, Wen-Bin Wei and Jost B. Jonas]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yan-Ni Yan, Ya-Xing Wang, Yan Yang, Liang Xu, Jie Xu, Qian Wang, Jing-Yan Yang, Wen-Jia Zhou, Wen-Bin Wei and Jost B. Jonas</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180719]]></guid><cfi:id>755</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Air tamponade in retinal detachment surgery followed by ultra-widefield fundus imaging system]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180720]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report the surgical result of pars plana vitrectomy (PPV) with air tamponade for rhegmatogenous retinal detachment (RRD) by ultra-widefield fundus imaging system.
METHODS: Of 25 consecutive patients (25 eyes) with fresh primary RRD and causative retinal break and vitreous traction were presented. All the patients underwent PPV with air tamponade. Visual acuity (VA) was examined postoperatively and images were captured by ultra-widefield scanning laser ophthalmoscope system (Optos).
RESULTS: Initial reattachment was achieved in 25 cases (100%). The air volume was >60% on the postoperative day (POD) 1. The ultra-widefield images showed that the retina was reattached in all air-filled eyes postoperatively. The retinal break and laser burns in the superior were detected in 22 of 25 eyes (88%). A missed retinal hole was found under intravitreal air bubble in 1 case (4%). The air volume was range from 40% to 60% on POD 3. A double-layered image was seen in 25 of 25 eyes with intravitreal gas. Retinal breaks and laser burns around were seen in the intravitreal air. On POD 7, small bubble without effect was seen in 6 cases (24%) and bubble was completely disappeared in 4 cases (16%). Small oval bubble in the superior area was observed in 15 cases (60%). There were no missed and new retinal breaks and no retinal detachment in all cases on the POD 14 and 1mo and last follow-up. Air disappeared completely on a mean of 9.84d postoperatively. The mean final postoperative best-corrected visual acuity (BCVA) was 0.35 logMAR. Mean final postoperative BCVA improved significantly relative to mean preoperative (P<0.05). Final VA of 0.3 logMAR or better was seen in 13 eyes.
CONCLUSION: PPV with air tamponade is an effective management for fresh RRD with superior retinal breaks. The ultra-widefield fundus imaging can detect postoperative retinal breaks in air-filled eyes. It would be a useful facility for follow-up after PPV with air tamponade. Facedown position and acquired visual rehabilitation may be shorten.]]></description>
<pubDate>2018/7/10 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Qian-Yin Chen, Yun-Xia Tang, Yan-Qiong He, Hui-Min Lin, Ru-Long Gao, Meng-Yuan Li, Jin-Tong Hou, Hong-Jie Ma and Jing-Lin Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Qian-Yin Chen, Yun-Xia Tang, Yan-Qiong He, Hui-Min Lin, Ru-Long Gao, Meng-Yuan Li, Jin-Tong Hou, Hong-Jie Ma and Jing-Lin Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180720]]></guid><cfi:id>754</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Evaluation of systemic risk factors in different optical coherence tomographic patterns of diabetic macular edema]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180721]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To elucidate the relationship between systemic risk factors and different patterns of diabetic macular edema (DME) determined with optical coherence tomography (OCT).
METHODS: In this cross-sectional study, DME was classified by OCT as diffuse retinal thickness (DRT), cystoid macular edema (CME) and serous retinal detachment (SRD) and the relationship between the systemic risk factors and DME patterns was evaluated.
RESULTS: Of the 57 patients with DME, 21 (36.8%) had DRT, 24 (42.1%) had CME and 12 (21.0%) had SRD. Micro- or macro-albuminuria was significantly higher in the DRT pattern (61.9%) compared with the SRD (50.0%) and CME patterns (25.0%; P=0.040). Hemoglobin A1c (HbA1c) level was significantly higher and patients were younger in the DRT pattern group (P=0.034, P=0.032). Best corrected visual acuity was the worst and central macular thickness was the thickest in the CME pattern group.
CONCLUSION: Micro- or macro-albuminuria may be more frequent and HbA1c level may be higher in patients with DRT. These patients are also seen to be younger than patients with non-DRT.]]></description>
<pubDate>2018/7/10 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Durgul Acan, Eyyup Karahan, Nilufer Kocak and Suleyman Kaynak]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Durgul Acan, Eyyup Karahan, Nilufer Kocak and Suleyman Kaynak</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180721]]></guid><cfi:id>753</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparative study of the efficacy and safety of bromfenac, nepafenac and diclofenac sodium for the prevention of cystoid macular edema after phacoemulsification]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180722]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the efficacy, tolerability and safety of bromfenac 0.09%, nepafenac 0.1% or diclofenac 0.1% for the prophylaxis of the cystoid macular edema (CME) after phacoemulsification.
METHODS: Group sequential observational comparative study. After phacoemulsification, patients received two months for topical treatment of either diclofenac sodium, bromfenac or nepafenac. All patients received concomitant topical tobramycin 0.3% and topical prednisolone 1%. We measured CME using optical coherence tomography (OCT) central foveal thickness, macular thickness and total macular volume.
RESULTS: We enrolled 243 patients from January to June 2015, and 35% received diclofenac, 32.9% bromfenac and 32.1% nepafenac. When we compared pre-operative to three weeks to two months, bromfenac was more effective in reducing foveal volume (21.3 and 35.4 mm3, respectively), compared with the diclofenac (1.3 and 11.5 mm3, respectively), and the nepafenac group, became more edematous 6.4 and 5.3, respectively. Totally 133 patients completed the post-surgical satisfaction questionnaire. Patients complained of eye stickiness in 13.8% whom we gave nepafenac, versus 10.3% whom we gave diclofenac sodium, and in 0 whom we gave bromfenac.
CONCLUSION: Bromfenac is the best tolerated and is more effective than diclofenac and nepafenac in reducing CME after phacoemulsification.]]></description>
<pubDate>2018/7/10 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ana María Chinchurreta Capote, Mercedes Lorenzo Soto, Francisco Rivas Ruiz, Enrique Caso Peláez, Alicia García Vazquez, Group OftaCosta and Antonio Ramos Suárez]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ana María Chinchurreta Capote, Mercedes Lorenzo Soto, Francisco Rivas Ruiz, Enrique Caso Peláez, Alicia García Vazquez, Group OftaCosta and Antonio Ramos Suárez</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180722]]></guid><cfi:id>752</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of intravitreal conbercept treatment before vitrectomy in proliferative diabetic retinopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180723]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the safety and efficacy of intravitreal conbercept (IVC) injections as pretreatment for pars plana vitrectomy (PPV) in severe proliferative diabetic retinopathy (PDR).
METHODS: This was a retrospective chart review of all patients who underwent PPV for PDR from January 2014 to October 2016. Patients who underwent IVC injection before PPV were assigned to the IVC group; the others were assigned to the control group. The IVC was performed 3-7d before surgery in the IVC group. All the eyes in the two groups were operated by the same doctor to complete the vitrectomy. Intraoperative complications and the changes in best-corrected visual acuity (BCVA) before and after surgery were compared between the two groups.
RESULTS: A total of 68 eyes of 63 patients (22 eyes in the IVC group and 46 eyes in the control group) were examined. The risk of intraoperative bleeding was lower in the IVC group (2/22) than in the control group (25/46, P=0.000). Furthermore, the use of endodiathermy was significantly lower in the IVC group (1/22) than in the control group (12/46, P=0.047). The surgical time in the IVC group (112.64±34.52min) was significantly shorter than in the control group (132.85±40.04min, P<0.05). Compared to the BCVA before surgery, the mean BCVA was significantly improved after surgery for both groups (P<0.05).
CONCLUSION: PPV is an effective treatment and can improve vision in patients with PDR. Preoperative intravitreal injection of conbercept could reduce the chances of intraoperative bleeding and the use of endodiathermy and shorten the operative time, which are beneficial in the management of PDR.]]></description>
<pubDate>2018/7/10 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jian-Bo Mao, Han-Fei Wu, Yi-Qi Chen, Shi-Xin Zhao, Ji-Wei Tao, Yun Zhang, Bin Zheng, Lin Wang and Li-Jun Shen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jian-Bo Mao, Han-Fei Wu, Yi-Qi Chen, Shi-Xin Zhao, Ji-Wei Tao, Yun Zhang, Bin Zheng, Lin Wang and Li-Jun Shen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180723]]></guid><cfi:id>751</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Prognostic factors of trans-ethmosphenoid optic canal decompression for indirect traumatic optic neuropathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180724]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate a possible correlation between visual acuity (VA) prognosis and the presence at baseline of various orbital and ocular signs in patients affected by indirect traumatic optic neuropathy (ITON).
METHODS: From July 1st, 2012 to July 1st, 2015, 224 adults diagnosed with ITON who underwent endoscopic trans-ethmosphenoid optic canal decompression (ETOCD) were reviewed. Visual outcome before and after treatment were taken into comparison.
RESULTS: Accompanied older in age, longer time to medical treatment and existence of optic canal fracture (OCF) were the independent predictors for poor postoperative VA and lower improvement degree of visual acuity (IDVA), while worse preoperative VA was predictive factor for poor postoperative VA only. Mean value of IDVA in patients with OCF was 0.19±0.30. Mean value of IDVA in patients without OCF was 0.29±0.35. IDVA in cases without OCF was significant higher than those with OCF (t=2.272, P<0.05).
CONCLUSION: Patients suffered from ITON without OCF before ETOCD have better surgical outcome than those with OCF. Older in age, longer time to medical treatment and existence of OCF are independent factors for poor VA prognosis and lower IDVA. Preoperative VA is independent factor for VA prognosis only.]]></description>
<pubDate>2018/7/10 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ying-Jie Ma, Bo Yu, Yun-Hai Tu, Bang-Xun Mao, Xin-Yi Yu and Wen-Can Wu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ying-Jie Ma, Bo Yu, Yun-Hai Tu, Bang-Xun Mao, Xin-Yi Yu and Wen-Can Wu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180724]]></guid><cfi:id>750</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Long-term safety of laser in situ keratomileusis in eyes with thin corneas: 5-year follow-up]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180725]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the long term (≥5y) efficacy, predictability, and safety of laser in situ keratomileusis (LASIK) in eyes with thin corneas [central corneal thickness (CCT) <500 μm].
METHODS: A total of 339 patients met the criteria of this study. Finally, 175 eyes of 89 patients who had thin corneas and underwent LASIK≥5y ago returned to our clinic and included in this study. Preoperative parameters recorded included uncorrected visual acuity (UCVA), corrected distance visual acuity (CDVA), manifest refraction, CCT and corneal topography. At returning visits, in addition to visual acuity and manifest refraction, ultrasound CCT and corneal topography were performed. Optical coherence tomography was used to measure the CCT, LASIK flap thickness, and residual stromal bed thickness (RSBT). Safety index, efficacy index, percentage of eyes within ±0.5 D and ±1.0 D of refraction, percent tissue altered (PTA), and percentage stromal bed thickness (PSBT) were calculated.
RESULTS: The safety index was 1.09 and efficacy index was 0.99. The percentages of eyes within ±0.5 D and ±1.0 D were 71.2% and 87.7%, respectively. The mean PTA was 40%±6% (range 20% to 55%); 76 eyes (43.4%) had PTA <40% and 99 eyes (56.6%) had PTA≥40%. The mean RSBT was 303±27 μm (range 240 to 390 μm), and 2 eyes had RSBT<250 μm. The mean PSBT was 61%±9% (range 51% to 85%). No eyes developed ectasia.
CONCLUSION: In this cohort with the PSBT of 50% or more, LASIK is safe with follow-up for at least 5y.]]></description>
<pubDate>2018/7/10 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yao-Wen Song, Rui He, Jack X. Ma, Douglas D. Koch and Li Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yao-Wen Song, Rui He, Jack X. Ma, Douglas D. Koch and Li Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180725]]></guid><cfi:id>749</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Accommodation function comparison following use of contact lens for orthokeratology and spectacle use in myopic children: a prospective controlled trial]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180726]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To study effects of orthokeratology (Ortho-k) on accommodation function in myopic children.
METHODS: A prospective, non-randomized, case-control study was performed from September to October 2016. Eighty-three children with myopia were divided into two groups. One group was treated with the rigid contact lens for overnight Ortho-k, and the other was treated with single-vision spectacle lens (SVL). Accommodation function were assessed by accommodative amplitude (AA), accommodative sensitivity (AS), accommodative lag (Lag), negative relative accommodation (NRA), and positive relative accommodation (PRA) before and 1, 3, 6 and 12mo after treated.
RESULTS: Totally 72 myopic children were finished the follow-up: 37 in Ortho-k group and 35 in SVL group. Wearing time had a significant effect on AA, AS, Lag, and NRA of myopic children in two groups (all P<0.05). Meanwhile, there was an interaction effect between wearing time and wearing types (FAA=5.3, FAS=45.5, FLag=7.0, FNRA=3.7, all P<0.05). However, the between-group difference of AA (F=0.1), AS (F=3.2), Lag (F=1.1), NRA (F=0.3), and PRA (F=0.1) showed no significance. AA, AS, NRA, Lag and PRA were improved significantly in Ortho-k group within 1 to 6mo after wearing.
CONCLUSION: Wearing Ortho-k can improve the accommodation function of myopic children, which might be one of the mechanisms for myopia control.]]></description>
<pubDate>2018/7/10 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yang Yang, Li Wang, Peng Li and Jun Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yang Yang, Li Wang, Peng Li and Jun Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180726]]></guid><cfi:id>748</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Two-year outcomes of ab interno trabeculectomy with the Trabectome for Chinese primary open angle glaucoma: a retrospective multicenter study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180608]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the 2-year efficacy and safety of ab interno trabeculectomy with the Trabectome in Chinese primary open angle glaucoma (POAG) patients.
METHODS: This was a multicenter, retrospective, observational study and included POAG patients with or without visually-significant cataracts. The Chinese patients were enrolled from three glaucoma centers and a group of comparable Japanese POAG patients was analyzed from our international Trabectome database. The patients received Trabectome or a combined surgery with phacoemulsification and intraocular lens implantation. The primary outcome was intraocular pressure (IOP) reduction. Secondary outcomes included reduction of glaucoma medications, surgical complications, and success at 2y. Success was defined as: 1) IOP≤21 mm Hg and at least 20% IOP reduction from baseline after 3mo at any two consecutive visits; 2) no additional glaucoma surgery required.
RESULTS: A total of 42 Chinese POAG patients from three glaucoma centers were enrolled. Twelve patients underwent Trabectome surgery combined with phacoemulsification and intraocular lens implantation while the remainder underwent Trabectome surgery alone. Thirteen patients had a history of failed glaucoma surgery and were considered as complicated cases. In China data, the mean preoperative IOP was 21.4±1.23 mm Hg. The Trabectome lowered IOP to 17.9±1.8 mm Hg at 2y (P=0.05). The number of glaucoma medications also decreased significantly from a baseline of 2.0±0.9 to 1.1±0.8 at 2y post-surgery (P=0.04). The overall 2-year success rate was 78%, with patients undergoing combined surgery having a higher success rate compared with those undergoing Trabectome surgery alone (100% vs 76%). In Japan data, the mean preoperative IOP was 20.8±7.7 mm Hg. The Trabectome lowered IOP to 12.20±2.0 mm Hg at 2y. The number of glaucoma medications also decreased significantly from a baseline of 2.1±0.9 to 3.4±0.6 at 2y post-surgery. In all patients, no major complications were seen.
CONCLUSION: Surgery with the Trabectome appears to be an efficient and safe procedure in Chinese POAG patients in the long-term.]]></description>
<pubDate>2018/6/12 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ya-Long Dang, Xiao Wang, Wan-Wei Dai, Ping Huang, Nils A Loewen, Chun Zhang, China Trabectome Study Group and International Trabectome Study Group]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ya-Long Dang, Xiao Wang, Wan-Wei Dai, Ping Huang, Nils A Loewen, Chun Zhang, China Trabectome Study Group and International Trabectome Study Group</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180608]]></guid><cfi:id>747</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A new diagnostic model of primary open angle glaucoma based on FD-OCT parameters]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180609]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To build a clinical diagnostic model of primary open angle glaucoma (POAG) using the normal probability chart of frequency-domain optical coherence tomography (FD-OCT).
METHODS: This is a cross-sectional study. Total 133 eyes from 133 healthy subjects and 99 eyes from 99 early POAG patients were included in the study. The retinal nerve fibre layer (RNFL) thickness parameters of optic nerve head (ONH) and RNFL3.45 scan were measured in one randomly selected eye of each subject using RTVue-100 FD-OCT. Then, we used these parameters to establish the diagnostic models. Four different diagnostic models based on two different area partition strategies on ONH and RNFL3.45 parameters, including ONH traditional area partition model (ONH-T), ONH new area partition model (ONH-N), RNFL3.45 traditional area partition model (RNFL3.45-T) and RNFL3.45 new area partition model (RNFL3.45-N), were built and tested by cross-validation.
RESULTS: The new area partition models had higher area under the receiver operating characteristic (AROC; ONH-N: 0.990; RNFL3.45-N: 0.939) than corresponding traditional area partition models (ONH-T: 0.979; RNFL3.45-T: 0.881). There was no statistical difference among AROC of ONH-T, ONH-N, and RNFL3.45-N. Nevertheless, ONH-N was the simplest model.
CONCLUSION: The new area partition models had higher diagnostic accuracy than corresponding traditional area partition models, which can improve the diagnostic ability of early POAG. In particular, the simplest ONH-N diagnostic model may be convenient for clinical application.]]></description>
<pubDate>2018/6/12 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ya-Jie Zheng, Ying-Zi Pan, Xue-Ying Li, Yuan Fang, Mei Li, Rong-Hua Qiao and Yu Cai]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ya-Jie Zheng, Ying-Zi Pan, Xue-Ying Li, Yuan Fang, Mei Li, Rong-Hua Qiao and Yu Cai</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180609]]></guid><cfi:id>746</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of the posterior corneal surface on total corneal astigmatism in patients with age-related cataract]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180610]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To explore the effect of the posterior astigmatism on total corneal astigmatism and evaluate the error caused by substituting the corneal astigmatism of the simulated keratometriy (simulated K) for the total corneal astigmatism in age-related cataract patients.
METHODS: A total of 211 eyes with age-related cataract from 164 patients (mean age: 66.8±9.0y, range: 45-83y) were examined using a multi-colored spot reflection topographer, and the total corneal astigmatism was measured. The power vector components J0 and J45 were analyzed. Correlations between the magnitude difference of the simulated K and total cornea astigmatism (magnitude differenceSimK-Tca), anterior J0, and absolute meridian difference (AMD) between the anterior and posterior astigmatisms were calculated. To compare the astigmatism of the simulated K and total cornea both in magnitude and axial orientation, we drew double-angle plots and calculated the vector difference between the two measures using vector analysis. A corrective regression formula was used to adjust the magnitude of the simulated K astigmatism to approach that of the total cornea.
RESULTS: The magnitude differenceSimK-Tca was positively correlated with the anterior corneal J0 (Spearman’s rho= 0.539; P<0.001) and negatively correlated with the AMDR (Spearman’s rho=-0.875, P<0.001). When the anterior J0 value was larger than 1.3 D or smaller than -0.8 D, the errors caused by determining the total corneal astigmatism with the karatometric calculation tended to be greater than 0.25 D. An underestimation by 16% was observed for against the rule (ATR) astigmatism and an overestimation by 9% was observed for with the rule (WTR) astigmatism when ignoring the posterior measurements.
CONCLUSION: Posterior corneal astigmatism should be valued for more precise corneal astigmatism management, especially for higher ATR astigmatism of the anterior corneal surface. We suggest a 9% reduction in the magnitude of the simulated K in eyes with WTR astigmatism, and a 16% addition of the magnitude of the simulated K in eyes with ATR astigmatism.]]></description>
<pubDate>2018/6/12 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ying-Ying Jin, Zhen Zhou, Xiao-Yong Yuan, Hui Song and Xin Tang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ying-Ying Jin, Zhen Zhou, Xiao-Yong Yuan, Hui Song and Xin Tang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180610]]></guid><cfi:id>745</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of immersion ultrasound and low coherence reflectometry for ocular biometry in cataract patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180611]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the results of axial length (AL) biometry in cataract eyes by three methods: immersion B-ultrasound (IB) biometry, immersion A-ultrasound (IA) biometry and optical low coherence reflectometry.
METHODS: In this prospective observational study of eyes with cataract AL measurements were performed using immersion ultrasound and optical low coherence reflectometry device. The results were evaluated using Bland-Altman analyses. The differences between both methods were assessed using the paired t-test, and its correlation was evaluated by Pearson coefficient.
RESULTS: Eighty eyes of 80 patients (39 men and 41 women) for cataract surgery were included in the study. The values of AL could be got from all 80 eyes by IB and IA, the difference of AL measurements between IA and IB was of no statistical significance (P=0.97); the mean difference in AL measurements was -0.031 mm (P=0.26; 95%CI, -0.09 to 0.02); linear regression showed an excellent correlation (r=0.98, P<0.0001). Forty-five of eighty eyes with results of AL measurements, which can be obtained by three methods; the difference of AL measurements was of no statistical significance (IA vs IB, P=0.18; IA vs Lenstar, P=0.51; IB vs Lenstar, P=0.07); linear regression showed an excellent correlation (IA vs IB, r=0.99; IA vs Lenstar, r=0.96; IB vs Lenstar, r=0.96); Bland-Altman analysis also showed good agreement between the two methods [IA vs IB, 95% limits of agreement (LoA), -0.36 to 0.28 mm; IA vs Lenstar, 95% LoA, -0.65 to 0.69 mm; IB vs Lenstar, 95% LoA, -0.55 to 0.68 mm].
CONCLUSION: Measurements with the optical low coherence reflectometry correlated well with IB and IA. In the eyes with serious refractive medium opacity, the measurements of AL could not be achieved or existed deviations when using optical low coherence reflectometry device. Under such circumstances, we should choose IA or IB as the optimization method to obtain measurements, in order to get much more accurate results.]]></description>
<pubDate>2018/6/12 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yan Li, Hong-Xun Li, Yang-Chen Liu, Ya-Tu Guo, Jian-Min Gao, Bin Wu, Nan Zhang, Dong Liu and Xiao-Yong Yuan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yan Li, Hong-Xun Li, Yang-Chen Liu, Ya-Tu Guo, Jian-Min Gao, Bin Wu, Nan Zhang, Dong Liu and Xiao-Yong Yuan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180611]]></guid><cfi:id>744</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Macular pigment and serum zeaxanthin levels with Goji berry supplement in early age-related macular degeneration]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180612]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the efficacy of Goji berry supplementation on improving macular pigment, serum zeaxanthin levels and visual acuity in patients with early age-related macular degeneration (AMD).
METHODS: A total of 114 patients (aged from 51 to 92y, mean age 69.53±8.41y) with early AMD were enrolled in our prospective, randomized controlled study. The included patients were assigned randomly to the Goji group (n=57) with 25 g of Goji berries supplementation per day for 90d and the control group (n=57) with their normal diet for 90d. Macular pigment optical density (MPOD) was measured using heterochromatic flicker photometry (HFP). The levels of serum lutein (L)/zeaxanthin (Z) were analyzed using high-performance liquid chromatography (HPLC). MPOD, serum L/Z levels and best corrected visual acuity (BCVA) were recorded at baseline and 90d.
RESULTS: In the Goji group, there were no statistically significant differences in the serum L levels between the baseline (0.199±0.149 μmol/mL) and 90d (0.203±0.181 μmol/mL) (t=-0.186, P=0.850); however the serum Z levels were increased at 90d (0.101±0.087 μmol/mL) compared with those at the baseline (0.029±0.032 μmol/mL) (t=6.412, P<0.001). Patients treated with Goji berry for 90d showed an elevated MPOD (0.877±0.202 DU) from the baseline (0.731±0.205 DU) (t=-4.741, P=0.000). In contrast to the control group, the serum Z levels and MPOD were higher in the Goji group at 90d (both P<0.05). At 90d, patients with Goji berry supplementation had a relative decrease in BCVA (0.21±0.18 logMAR) compared with the baseline (0.27±0.20) (t=2.397, P=0.020).
CONCLUSION: Overall, daily supplementation with Goji berry for 90d improves MPOD by increasing serum Z levels rather than serum L levels in early AMD patients. Goji berry may be an effective therapeutic intervention for preventing the progression of early AMD.]]></description>
<pubDate>2018/6/12 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Shang Li, Na Liu, Li Lin, Er-Dan Sun, Jian-Da Li and Peng-Kun Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Shang Li, Na Liu, Li Lin, Er-Dan Sun, Jian-Da Li and Peng-Kun Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180612]]></guid><cfi:id>743</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[The role of intravitreal ranubizumab in the treatment of familial exudative vitreoretinopathy of stage 2 or greater]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180613]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the role of intravitreal ranubizumab (IVR) in the treatment of familial exudative vitreoretinopathy (FEVR) of stage 2 or greater either as primary or an ajunct to conventional treatments.
METHODS: Retrospective, non-controlled clinical study. Thirty patients (37 eyes) diagnosed with FEVR were enrolled. Twenty patients (66.67%) were male and 10 patients (33.33%) were female. Age ranged from 0.4 to 35 years old (median 3y). IVR was used either as primary or as a combined therapy according to the retinal neovasuclar activities. The follow up ranged from 1 to 57mo with mean 16.73±15.73 (median 11)mo. The treatment effect of retinal neovasuclar activites were recorded as well as the ocular and systemic side effects.
RESULTS: Among 30 patients (37 eyes), 10 eyes received single IVR, 1 eye received 2 injections. Three eyes were treated with IVR and simutanous laser photocoagulation. Laser indirect ophthalmoscopy (LIO) was applied in 5 eyes 1mo after the primary IVR. Seven eyes were treated surgically following the primary IVR due to persistent retinal neovasuclar activities and retinal traction. IVR was used as combined treatment with vitrectomy in 11 eyes. Retinal neovascular regression was notified 1mo following the primary IVR in all eyes. Neither systemic nor ocular complications were recorded.
CONCLUSION: IVR may be an effective modality in the treatment of FEVR either as primary or as an ajunct to the conventional therapies. The long term effect and safty of IVR still need further research.]]></description>
<pubDate>2018/6/12 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yue-Zhu Lu, Guang-Da Deng, Jing-Hua Liu and Hong Yan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yue-Zhu Lu, Guang-Da Deng, Jing-Hua Liu and Hong Yan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180613]]></guid><cfi:id>742</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Short-term outcomes after the loading phase of intravitreal bevacizumab and subthreshold macular laser in non-center involved diabetic macular edema]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180614]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the effectiveness of intravitreal bevacizumab and subthreshold macular photocoagulation (SMP), for the treatment of non-center involved diabetic macular edema (non-CI DME).
METHODS: Prospective, randomized, controlled clinical study included patients with type 2 diabetes, non-CI DME and best-corrected visual acuity (BCVA) of 0.30 logMAR or better. Each eye was randomized into three groups: group 1, monthly intravitreal bevacizumab; group 2, single SMP; group 3, single SMP and monthly bevacizumab. Main outcome measures were BCVA, and macular thickness measured with optical coherence tomography as macular central subfield thickness (CST), macular area of greater thickness (MAGT) and total macular volume (TMV). Results were analyzed after 3mo.
RESULTS: A total of 32 eyes were included. Group 3 improved in BCVA (0.19±0.16 to 0.12±0.14 logMAR; P=0.041) and in TMV (7.90±0.57 to 7.65±0.73 mm3; P=0.025). Group 1 improved in MAGT (325±26.26 to 298.20±44.85 μm; P=0.022) and TMV (7.79±0.57 to 7.50±0.56 mm3, P=0.047). Group 2 didn’t show significant improvement of any variable.
CONCLUSION: The loading phase of bevacizumab as monotherapy or combined with SMP is superior to SMP as monotherapy in providing short-term visual and anatomical improvement in non-CI DME.]]></description>
<pubDate>2018/6/12 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Edgar Cuervo-Lozano, Jesús Hernán González-Cortés, Abraham Olvera-Barrios, Ezequiel Trevi&#241;o-Cavazos, Josué Rodríguez-Pedraza, Karim Mohamed-Noriega and Jesús Mohamed-Hamsho]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Edgar Cuervo-Lozano, Jesús Hernán González-Cortés, Abraham Olvera-Barrios, Ezequiel Trevi&#241;o-Cavazos, Josué Rodríguez-Pedraza, Karim Mohamed-Noriega and Jesús Mohamed-Hamsho</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180614]]></guid><cfi:id>741</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical observations of vitreoretinal surgery for four different phenotypes of X-linked congenital retinoschisis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180615]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the outcomes of vitreoretinal surgery for four different phenotypes of X-linked retinoschisis (XLRS).
METHODS: This study included thirty-one eyes of 25 patients who developed XLRS with severe complications. Among the 31 eyes, there were 7 eyes with vitreous hemorrhage, 8 eyes with retinal detachment and vitreous hemorrhage, and 16 eyes with rhegmatogenous retinal detachment. All of the patients underwent standard three-port pars plana vitrectomy. All of the eyes were divided into 4 groups before surgery according to a modified classification scheme, with the first three groups as follows: group A, with foveal cystic schisis; group B with macular lamellar schisis; and group C with foveolamellar changes. Peripheral schisis was not present in these 3 groups; however, group D was a complex group with both macular and peripheral changes. One year after surgery, we analyzed the best corrected visual acuity and postoperative anatomical and functional outcomes of these 4 groups.
RESULTS: There were 7 eyes in group A (22.6%), 1 eye in group B (3.2%), 15 eyes in group C (48.4%) and 8 eyes in group D (25.8%). Postoperative anatomical and functional outcomes were satisfactory at the last visit, while the mean visual acuity was increased to 0.27±0.11, with a significant difference (t=-1.049, P=0.000) compared with the results before surgery (0.1±0.08). Visual acuity was improved in 23 eyes (74.2%). Complications were found in three eyes: two eyes with proliferative vitreoretinopathy and traction retinal detachment 10 and 12mo after surgery, respectively; and one eye with vitreous hemorrhage 15mo after surgery. These eyes were in groups C and D. The retinas remained attached in these 3 eyes after reoperation.
CONCLUSION: We should pay greater attention to XLRS with foveolamellar changes because it is the most changeable phenotype. Once complications occur, vitreoretinal surgery can significantly improve visual acuity and restore the anatomic structure of the retina.]]></description>
<pubDate>2018/6/12 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Chen Zhao, Qi Zhang, Hai-Ying Jin and Pei-Quan Zhao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Chen Zhao, Qi Zhang, Hai-Ying Jin and Pei-Quan Zhao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180615]]></guid><cfi:id>740</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Short term effect of choroid thickness in the horizontal meridian detected by spectral domain optical coherence tomography in myopic children after orthokeratology]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180616]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate choroidal thickness changes in the horizontal meridian after orthokeratology.
METHODS: This is a prospective cross-sectional observed study. Subjects (n=30; 11.3±1.7y) with low-to-moderate myopia (-1.0 to -6.0 diopters), wore orthokeratology (Ortho-K) lenses for 3mo. Before and after Ortho-K, OCT scans were made through the fovea in the horizontal meridian. Choroid thickness around the fovea was acquired by custom software. The analyzed regions along the horizontal meridian were divided into 7 equal zones. Ocular parameters were measured by Lenstar LS 900 non-contact biometry.
RESULTS: Only the right eye ocular parameters were analyzed in this study. Before Ortho-K, choroidal thickness along the horizontal meridian was 273.7±31.8 μm in the temporal zone, 253.1±38.6 μm in the macula zone, and 194.8±52.2 μm in the nasal zone. After Ortho-K, the choroid was thicker in each horizontal zone (P<0.05). The increased thickness was greatest in the temporal zone (13.5±22.5 μm) and least in the nasal zone (8.4±14.2 μm). The axial length (AL) increased 0.02 mm (P>0.05). The choroid thickness change in each horizontal zone was negatively correlated with AL (r, -0.3 to -0.4; P<0.05) except one of the nasal zones.
CONCLUSION: In myopic children, the thickness of the choroid is greatest in the temporal zone and thinnest in the nasal zone. After nightly Ortho-K for 3mo, the thickness increase along the horizontal meridian. The choroid thickness changes are negatively correlated with the change of AL.]]></description>
<pubDate>2018/6/12 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Wan-Qing Jin, Sheng-Hai Huang, Jun Jiang, Xin-Jie Mao, Mei-Xiao Shen and Yan Lian]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Wan-Qing Jin, Sheng-Hai Huang, Jun Jiang, Xin-Jie Mao, Mei-Xiao Shen and Yan Lian</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180616]]></guid><cfi:id>739</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Correlations between the optic nerve head morphology and ocular biometrics in highly myopic eyes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180617]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyze peripapillary atrophy β/γ zone (PPA-β/γ) and the optic disc ovality index, and to assess their associations with the axial length (AL), refractive error, best corrected visual acuity (BCVA), choroidal thickness (CT), and age in highly myopic eyes.
METHODS: This was a retrospective observational case series. The study included 667 patients consecutively examined for highly myopic eyes [spherical equivalent ≤-6.0 diopters (D) and AL≥26 mm] with or without myopic retinopathy. Each patient went through a comprehensive ophthalmological examination that included spectral domain optical coherence tomography (SD-OCT) of the macula, A-mode ultrasonography, and a cycloplegic refraction test. The ovality index and PPA-β/γ area were measured from optic disc photographs.
RESULTS: A significant association was seen between PPA-β/γ area and the ovality index (P=0.000, r=-0.232). The PPA-β/γ area increased significantly with a longer AL, older age, worse BCVA, higher refractive error, and thinner choroid (P<0.01). The oval disc was significantly correlated with a longer AL, older age, worse BCVA, higher refractive error, larger PPA-β/γ area, and thinner choroid (P<0.01).
CONCLUSION: The PPA-β/γ zone and ovality index in highly myopic eyes show distinct associations with the AL, refractive error, BCVA, age, and CT.]]></description>
<pubDate>2018/6/12 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xiu-Juan Zhao, Huai-Yan Jiang, Yong-Hao Li, Bing-Qian Liu, Hong-Xia Xu, Jie Zhou, Xiao-Hong Chen, Can-Can Lyu, Wei Ma, Jin Ma, Xiao-Ling Liang, Chen-Jin Jin, Xiao-Yan Ding and Lin Lu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiu-Juan Zhao, Huai-Yan Jiang, Yong-Hao Li, Bing-Qian Liu, Hong-Xia Xu, Jie Zhou, Xiao-Hong Chen, Can-Can Lyu, Wei Ma, Jin Ma, Xiao-Ling Liang, Chen-Jin Jin, Xiao-Yan Ding and Lin Lu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180617]]></guid><cfi:id>738</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Etiology and failure analysis of anterior lamellar keratoplasty]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180511]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyze indications and reasons for failure of anterior lamellar keratoplasty (ALK).
METHODS: The clinical records were retrospectively reviewed. Main outcome measures included indications for ALK and reasons for failure of ALK.
RESULTS: A total of 434 patients (462 eyes) were treated with ALK at Qingdao Eye Hospital, Shandong Eye Institute from June 1, 2009 to May 31, 2016. The main indications were infectious keratitis (33.3%), keratoconus (23.6%), corneal dystrophy and degeneration (9.8%), Mooren’s ulcer (8.4%), corneal neoplasm (7.8%), viral keratitis (6.5%) and regrafting (3.7%). Fungal keratitis accounted for 73.4% in the infectious keratitis cases. ALKs were failed in 36 patients, with the major causes being recurrence of primary diseases (63.9%). The leading causes of graft failure was Mooren’s ulcer (36.1%), followed by infectious keratitis (30.6%). Recurrence of fungal keratitis accounted for 81.8% in the failed cases after ALK for infectious keratitis cases.
CONCLUSION: Infectious keratitis and keratoconus are the main indications for ALK, of which fungal keratitis was the major cause of corneal infections. Recurrence of primary disease is the main reason of graft failure after ALK, in which the main primary diseases associated with graft failure are Mooren’s ulcer and fungal keratitis.]]></description>
<pubDate>2018/5/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Zhen Wang, Xiao-Jun Tan, Hua-Lei Zhai, Jun Cheng, Yan Gao and Li-Xin Xie]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zhen Wang, Xiao-Jun Tan, Hua-Lei Zhai, Jun Cheng, Yan Gao and Li-Xin Xie</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180511]]></guid><cfi:id>737</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Diagnostic ability of ganglion cell complex thickness to detect glaucoma in high myopia eyes by Fourier domain optical coherence tomography]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180512]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the ability of macular ganglion cell complex (GCC) thickness using Fourier domain optical coherence tomography (FD-OCT) to detect glaucoma in highly myopic eyes.
METHODS: Cross-sectional study. A total of 114 participants, consecutively were enrolled. Macular GCC thickness and peripapillary retinal nerve fiber layer (RNFL) thickness were obtained with RTVue FD-OCT. Receiver operating characteristics curves were constructed for each measurement parameter, and areas under the curves (AUCs) were compared.
RESULTS: Both the average GCC and average RNFL thickness showed negative correlations with axial length (rGCC=-0.404, P=0.001; rRNFL=-0.561, P<0.001). The largest AUCs from GCC, and RNFL parameters were 0.968 [global loss volume (GLV)], and 0.855 (average RNFL), respectively. GLV was significantly better for detecting high myopic glaucoma than average RNFL (P<0.001).
CONCLUSION: Macular GCC thickness has higher diagnostic power than peripapillary RNFL thickness to discriminate glaucoma patients from non-glaucoma subjects in high myopia.]]></description>
<pubDate>2018/5/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Wei-Wei Wang, Huai-Zhou Wang, Jian-Rong Liu, Xi-Fang Zhang, Meng Li, Yan-Jiao Huo and Xin-Guang Yang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Wei-Wei Wang, Huai-Zhou Wang, Jian-Rong Liu, Xi-Fang Zhang, Meng Li, Yan-Jiao Huo and Xin-Guang Yang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180512]]></guid><cfi:id>736</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of single subconjunctival injection of bevacizumab  on primary pterygium: clinical, histopathological and immunohistochemical study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180513]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the effect (clinically, histopathologically and immunohistochemically) and safety of a single intra-pterygium injection of bevacizumab.
METHODS: Prospective interventional study comprised 40 eyes of 40 patients with primary fleshy pterygia who attended the Outpatient Clinic of Department of Ophthalmology, Assiut University Hospitals, Egypt from May 2015 to May 2016. Patients were randomly classified into 2 groups: the first group received a single intralesional injection of bevacizumab (Avastin; Genentech, San Francisco, CA, USA); the second group comprised patients who did not receive subconjunctival bevacizumab. Excision of pterygium and conjunctival auto graft was done in both groups. The excised pterygium tissues were subjected to histopathological and immunohistochemical evaluation.
RESULTS: The study comprised 40 eyes of 40 patients (33 men, 7 women) of age range from 31-58y. The study group included 22 eyes. The control group included 18 eyes. A decrease in the vascularity of the pterygium was noted in all injected cases. The mean vessel count was higher in non-injected pterygia than that in injected pterygia and the difference was statistically significant (P=0.001). Also, the mean vessel count in both groups was significantly higher than normal conjunctive (P=0.005 and 0.001). A statistically significant difference in vascular endothelial growth factor (VEGF) expression between injected and non-injected cases was detected in the epithelial, stromal and endothelial cells (P=0.0001, 0.016, 0.014). No serious intraoperative complications occurred in both groups.
CONCLUSION: The use of single intra lesional injection of Avastin in pterygium decreased vascularity and decreased VEGF expression in injected pterygium after one month. Our study proved the effect of single intra lesional injection of Avastin on pterygium. Further studies may enable limiting the need for surgery and improve quality of life for patients with pterygia.]]></description>
<pubDate>2018/5/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Tarek A Mohamed, Wael Soliman, Ahmed M. Fathalla and Abeer El Refaie]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Tarek A Mohamed, Wael Soliman, Ahmed M. Fathalla and Abeer El Refaie</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180513]]></guid><cfi:id>735</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical outcomes after implantation of a new intrastromal corneal ring with 140-degree of arc in patients with corneal ectasia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180514]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the clinical and tomographic outcomes after implantation of a new intrastromal corneal ring segment (ICRS) with 140-degrees of arc in eyes with corneal ectasia.
METHODS: We evaluated patients with corneal ectasia implanted with Ferrara 140° ICRS from April 2010 to February 2015. Outcome measures included preoperative and postoperative corrected distance visual acuity (CDVA), keratometry simulated (K) reading, tomographic astigmatism and asphericity. All patients were evaluated using the Pentacam Scheimpflug system.
RESULTS: The study evaluated 58 eyes. The mean follow-up was 16.81±10.8mo. The CDVA (logMAR) improved from 0.5±0.20 (20/60) to 0.3±0.21 (20/40) (P<0.01). The average K reduced from 49.87±7.01 to 47.34±4.90 D (P<0.01). The asphericity changed from -0.60±0.86 to -0.23±0.67 D (P<0.01). The mean preoperative tomographic astigmatism decreased from -8.0±3.45 to -4.53±2.52 D (P<0.01).
CONCLUSION: The new ICRS model with 140-degrees of arc effectively improve the visual acuity and reduce the high astigmatism usually found in patients with corneal ectasia.]]></description>
<pubDate>2018/5/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jordana Sandes, Larissa R. S. Stival, Marcos Pereira de ávila, Paulo Ferrara, Guilherme Ferrara, Leopoldo Magacho, Luana P. N. Araújo and Leonardo Torquetti]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jordana Sandes, Larissa R. S. Stival, Marcos Pereira de ávila, Paulo Ferrara, Guilherme Ferrara, Leopoldo Magacho, Luana P. N. Araújo and Leonardo Torquetti</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180514]]></guid><cfi:id>734</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Femtosecond laser-assisted deep anterior lamellar keratoplasty in phototherapeutic keratectomy versus the big-bubble technique in keratoconus]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180515]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the functional and anatomic results of femtosecond laser (FSL)-assisted deep anterior lamellar keratoplasty (DALK) associated with phototherapeutic keratectomy (PTK) and FSL-assisted DALK performed using the big-bubble technique in keratoconus.
METHODS: During the first phase of the study, an electron microscopy histopathology pilot study was conducted that included four unsuitable donor corneas divided into two groups: in FSL group, FSL lamellar cuts were performed on two corneas and in FSL+PTK group, PTK was performed at the stromal beds of two corneas after FSL lamellar cuts were made. During the second phase of the study, a randomized clinical trial was conducted that included two treatment groups of patients with keratoconus: group 1 (n=14 eyes) underwent FSL-assisted DALK associated with PTK and group 2 (n=12 eyes) underwent FSL-assisted DALK associated with the big-bubble technique. The main outcome measures were the postoperative visual acuity (VA) and optical coherence tomography (OCT) measurements, confocal microscopic findings, and contrast sensitivity.
RESULTS: In the pilot study, histopathology showed a more regular stromal bed in the FSL+PTK group. In the clinical trial, group 1 had significantly worse best spectacle-corrected VA and contrast sensitivity (P<0.05 for both comparisons). The residual stromal bed measured by OCT was significantly (P<0.05) thicker in group 1. Confocal microscopy detected opacities only at the donor-receptor interface in group 1.
CONCLUSION: Patients with keratoconus treated with FSL-assisted DALK performed using the big-bubble technique fare better than treated with FSL-assisted DALK associated with PTK.]]></description>
<pubDate>2018/5/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jarbas Pereira de Macedo, Lauro Augusto de Oliveira, Flavio Hirai and Luciene Barbosa de Sousa]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jarbas Pereira de Macedo, Lauro Augusto de Oliveira, Flavio Hirai and Luciene Barbosa de Sousa</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180515]]></guid><cfi:id>733</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical features of strabismus and nystagmus in bilateral congenital cataracts]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180516]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the prevalence, clinical features, and the factors affecting onset of strabismus and nystagmus in patients with bilateral congenital cataracts.
METHODS: This study evaluated 116 eyes of 58 patients who underwent lens removal for the treatment of bilateral congenital cataracts between January 1999 and January 2011. The presence and type of strabismus and nystagmus were determined before and after surgery. Type of strabismus and final visual acuity were compared in patients with and without nystagmus. Patients were divided into three groups (orthotropia/orthotropia, orthotropia/strabismus, and strabismus/strabismus) according to their preoperative and postoperative ocular alignment. Age at cataract surgery and associations of nystagmus and primary intraocular lens (IOL) implantation with strabismus were analyzed.
RESULTS: Six patients (10.3%) had strabismus preoperatively and an additional 11 (19.0%) developed postoperative strabismus. Exotropia was more common than esotropia both preoperatively and postoperatively. Eighteen patients (31.0%) had postoperative nystagmus, with sensory nystagmus being the most common type. Of the 18 patients with nystagmus, 10 had strabismus, with exotropia being more common than esotropia.  Postoperative visual acuity was poor in patients with nystagmus. Age at cataract surgery and rate of primary IOL implantation were significantly lower, and postoperative nystagmus was more common, in the orthotropia/strabismus group than in the other two groups.
CONCLUSION: Exotropia and sensory nystagmus are common in patients with bilateral congenital cataracts. Age at cataract surgery and rate of IOL implantation are lower and nystagmus more common in patients with postoperative onset of strabismus. Nystagmus is associated with poor visual prognosis.]]></description>
<pubDate>2018/5/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Sung Soo Hwang, Wan Soo Kim and Soo Jung Lee]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Sung Soo Hwang, Wan Soo Kim and Soo Jung Lee</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180516]]></guid><cfi:id>732</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Treatment of refractory giant macular hole by vitrectomy with internal limiting membrane transplantation and autologous blood]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180517]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the effect of internal limiting membrane transplantation and autologous blood on treating refractory giant macular hole.
METHODS: Thirty-seven eyes with giant macular hole of the smallest hole diameter >700 μm, the maximum diameter of the substrate >1000 μm and hole formation factor <0.6 underwent surgical treatment. The patients were randomly divided into two groups. Nineteen eyes with surgical flip of the internal limiting membrane in group A, 18 eyes with internal limiting membrane transplantation in group B who underwent the tamponade of internal limiting membrane into the hole, autologous plasma was used to seal the hole. The patients were followed up for 3mo, optical coherence tomography and best corrected visual acuity (BCVA) were recorded before and after operation, and the results were statistically analyzed.
RESULTS: At 3mo after operation, BCVA of the two groups was significantly improved compared with that before operation (tA=4.192, tB=4.374, P<0.05). But there was no significant difference in visual acuity between the two groups (χ2=0.128, P>0.05). At 3mo after operation, the closure rate of group A was 68.4%, and 100% in group B. (χ2=5.628, P<0.05). The defect diameter of inner segment/outer segment at 3mo after the operation was significantly lower than that before operation (tA=12.287, tB=15.481, P<0.05), and the difference was statistically significant (t=2.552, P<0.05).
CONCLUSION: Internal limiting membrane transplantation combined with autologous whole blood can improve the postoperative closure rate of the refractory large aperture, and can effectively improve the postoperative visual acuity.]]></description>
<pubDate>2018/5/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Wen-Juan Lyu, Lei-Bing Ji, Yun Xiao, Yin-Bo Fan and Xue-Hong Cai]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Wen-Juan Lyu, Lei-Bing Ji, Yun Xiao, Yin-Bo Fan and Xue-Hong Cai</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180517]]></guid><cfi:id>731</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of total/active ghrelin levels in primary open angle glaucoma, pseudoexfoliation glaucoma and pseudoexfoliation syndrome]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180518]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the levels of ghrelin (Gh), acylated ghrelin (AGh) and AGh/Gh ratio in the humor aqueous (HA) of cases with pseudoexfoliation syndrome (PXS), pseudoexfoliation glaucoma (PXG), primary open angle glaucoma (POAG) and to compare these with control subjects.
METHODS: A prospective examination was made of the total Gh, and AGh levels in HA of 67 patients undergoing cataract surgery. Patients were divided into 4 groups. HA samples were aspirated at the beginning of the surgery, stored at -70oC. Gh and AGh quantification was performed with ELISA kits and the AGh/total-Gh ratios were calculated. ANOVA, Kruskal-Wallis, Chi-square and post-hoc tests were used for statistical analysis.
RESULTS: Total Gh levels in HA were 189.2±45.6 pg/mL in the control group, 199.2±32.9 pg/mL in PXS, 180.6±20.9 pg/mL in PXG and 176.8±21.4 pg/mL in POAG groups (P>0.05). AGh levels in HA were 23.09±5.01 pg/mL in the control group, 24.13±5.22 pg/mL in PXS, 22.29±1.55 pg/mL in PXG and 19.69±2.93 pg/mL in POAG groups (P>0.05). The ratio of AGh/Gh was 10.3%±2.34% in the control group, 13.03%±2.58% in PXS, 12.3%±1.54% in PXG and 11.79%±1.41% in POAG groups (P=0.044). The difference between the PXS and control groups was significant (P=0.03).
CONCLUSION: In spite of statistically insignificant results, the HA total Gh levels were lower than those of the control subjects but not parallel with the AGh levels in glaucoma patients. The relative increase in the AGh/Gh ratio in glaucoma cases supports the view that proportional increases of AGh might play a role in the pathogenesis of glaucoma.]]></description>
<pubDate>2018/5/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Numan Eraslan, Ufuk Elgin, Emine &#350;en, Aytul Kilic and Pelin Yilmazbas]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Numan Eraslan, Ufuk Elgin, Emine &#350;en, Aytul Kilic and Pelin Yilmazbas</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180518]]></guid><cfi:id>730</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Bruch’s membrane opening-minimum rim width and visual field loss in glaucoma: a broken stick analysis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180519]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the Bruch’s membrane opening-minimum rim width (BMO-MRW) tipping point where corresponding visual field (VF) damages become detectable.
METHODS: A total of 85 normal subjects and 83 glaucoma patients (one eye per participant) were recruited for the study. All of the patients had VF examinations and spectral-domain optical coherence tomography to measure the BMO-MRW. Total deviation values for 52 VF points were allocated to the corresponding sector according to the Garway-Heath distribution map. To evaluate the relationship between VF loss and BMO-MRW measurements, a “broken-stick” statistical model was used. The tipping point where the VF values started to sharply decrease as a function of BMO-MRW measurements was estimated and the slopes above and below this tipping point were compared.
RESULTS: A 25.9% global BMO-MRW loss from normative value was required for the VF loss to be detectable. Sectorally, substantial BMO-MRW thinning in inferotemporal sector (33.1%) and relatively less BMO-MRW thinning in the superotemporal sector (8.9%) were necessary for the detection of the VF loss. Beyond the tipping point, the slopes were close to zero throughout all of the sectors and the VF loss was unrelated to the BMO-MRW loss. The VF loss was related to the BMO-MRW loss below the tipping point. The difference between the two slopes was statistically significant (P≤0.002).
CONCLUSION: Substantial BMO-MRW loss appears to be necessary for VF loss to be detectable in patients with open angle glaucoma with standard achromatic perimetry.]]></description>
<pubDate>2018/5/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Keun-Heung Park, Ji-Woong Lee, Jin-Mi Kim, Kouros Nouri-Mahdavi and Joseph Caprioli]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Keun-Heung Park, Ji-Woong Lee, Jin-Mi Kim, Kouros Nouri-Mahdavi and Joseph Caprioli</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180519]]></guid><cfi:id>729</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Vessel density in OCT angiography permits differentiation between normal and glaucomatous optic nerve heads]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180520]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate whether optical coherence tomography angiography (OCTA) can detect altered vessel density (VD) at the optic nerve head (ONH) in glaucoma patients. Special attention is paid to the accuracy of the OCTA technique for distinguishing healthy from glaucomatous eyes.
METHODS: A total of 171 eyes were examined by the OCTA system AngioVue? (Optovue): 97 eyes diagnosed with glaucoma and 74 healthy control eyes. The papillary and peripapillary VD was measured. Furthermore, the VD was correlated with different structural and functional measurements. In order to test the accuracy of differentiation between eyes with and without glaucoma, we calculated the receiver operating characteristic curve (ROC) and the area under the curve (AUC).
RESULTS: The papillary and peripapillary VD in glaucomatous eyes was significantly lower than in healthy eyes (P<0.05). The VD of the nasal peripapillary sector was significantly lower than in the other sectors. The further the disease had progressed [measured by determining the thickness of the ganglion cell complex (GCC) and the retinal nerve fiber layer (RNFL)] the greater the VD reduction. The AUC discriminated well between glaucomatous and normal eyes (consensus classifier 94.2%).
CONCLUSION: OCTA allows non-invasive quantification of the peripapillary and papillary VD, which is significantly reduced in glaucomatous eyes and accurately distinguishes between healthy and diseased eyes. OCTA expands the spectrum of procedures for detecting and monitoring glaucoma.]]></description>
<pubDate>2018/5/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Claudia Lommatzsch, Kai Rothaus, Joerg Michael Koch, Carsten Heinz and Swaantje Grisanti]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Claudia Lommatzsch, Kai Rothaus, Joerg Michael Koch, Carsten Heinz and Swaantje Grisanti</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180520]]></guid><cfi:id>728</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Change in foveal position based on age and axial length in high myopic eyes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180521]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the influence of age and axial length (AL) on the position of the fovea in patients with high myopia (HM).
METHODS: In this prospective study, 96 patients (186 eyes) with HM were consecutively recruited from the Third Affiliated Hospital of Nanchang University. DRI-OCT Atlantis, fundus imaging, and IOL Master were used in this study. Three indices were measured: the distance between the fovea and the optic nerve head (ONH) center (DFO), the vertical distance between the fovea and the horizontal line pass of the ONH center (VDFO), and the horizontal distance between the fovea and the vertical line pass of the ONH center (HDFO). These measurements were used to analyze the effects of different age groups (A1, A2, A3 groups) and AL (AL1, AL2, AL3, AL4 groups) on these indices.
RESULTS: The results showed that there was no statistical significance in DFO among the age and AL groups (F=0.46, 0.37; P=0.62, 0.76, respectively). In HDFO, there was also no statistical significance among the age and AL groups (F=0.10, 0.48; P=0.90, 0.69, respectively). In VDFO, however, the difference in the age and AL groups was statistically significant (F=3.21, 3.12; P=0.04, 0.02, respectively). Thus, VDFO were correlated with age and AL (r=0.21, 0.23, all P<0.01), while HDFO and DFO were not correlated with age and AL (r=0.30, P>0.05).
CONCLUSION: In high myopia, the foveal position changes mainly in the vertical direction along with factors of age and AL.]]></description>
<pubDate>2018/5/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Qian Zhang, Kaddie Kwok Chen, Wei-Feng Liu and Guo-Fu Huang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Qian Zhang, Kaddie Kwok Chen, Wei-Feng Liu and Guo-Fu Huang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180521]]></guid><cfi:id>727</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[The association between demodex infestation and ocular surface manifestations in meibomian gland dysfunction]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180408]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the association between ocular demodex folliculorum infestation and ocular surface manifestations in meibomian gland dysfunction (MGD).
METHODS: Eight-six patients with MGD were enrolled. All enrolled subjects were tested in the following sequence: ocular surface disease index (OSDI), slit-lamp biomicroscope examination, corneal surface regularity index (SRI) and surface asymmetry index (SAI), tear fluid collection, fluorescein tear film break-up time (F-BUT), corneal fluorescein staining (CFS), Schirmer I test (SIT) and demodex folliculorum counting. Tear matrix metalloproteinase (MMP)-9 activity was assessed using MMP-9 activity assay kit.
RESULTS: Among 86 MGD patients, 40 were positive for demodex. The ocular demodex-positive group showed significantly increased scores of OSDI (25.96±13.74 vs 18.07±11.55, P=0.01), lid margin abnormality (2.38±0.87 vs 1.98±0.91, P=0.04) and CFS (1.28±2.00 vs 0.94±1.36, P=0.01) compared to the ocular demodex-free group. The tear MMP-9 activity was higher in the ocular demodex-positive group (102.9±32.4 ng/mL) than the ocular demodex-free group (46.2±19.2 ng/mL, P=0.03). There was no significant difference in meibum quality and expressibility, SRI, SAI, F-BUT and SIT between the two groups (P>0.05 for each). No significant correlation was noted between the number of demodex and ocular surface parameters in demodex-positive MGD group (P>0.05 for each).
CONCLUSION: Ocular demodex folliculorum infestation may be associated with ocular discomfort and ocular surface damage in MGD.]]></description>
<pubDate>2018/4/10 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xiao-Bo Zhang, Ying-Hui Ding and Wei He]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiao-Bo Zhang, Ying-Hui Ding and Wei He</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180408]]></guid><cfi:id>726</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical efficacy of combined topical 0.05% cyclosporine A and 0.1% sodium hyaluronate in the dry eyes with meibomian gland dysfunction]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180409]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the efficacy of combined topical 0.05% cyclosporine A (CsA; Restasis&#174;, Allergan pharmaceuticals, USA) and 0.1% sodium hyaluronate treatment in dry eyes with meibomian gland dysfunction (MGD).
METHODS: In a retrospective analysis, 53 patients (106 eyes) with MGD were enrolled and performed lid warm massage for 10min daily and be instilled preservative free sodium hyaluronate 0.1% eye drops 4 times daily. Patients were divided into subjects treated with topical 0.05% CsA and preservative free sodium hyaluronate vehicle (experimental group, n=74 eyes) and subjects treated with the preservative free sodium hyaluronate vehicle (control group, n=32 eyes). They were evaluated at baseline and 1, 2, and 3mo for subjective symptoms and objective signs including tear film break-up time (tBUT), Schirmer test, corneal staining (CS) score, lid margin telangiectasia (LMT), meibomian gland secretion (MGS), and conjunctival injection (CI).
RESULTS: In the short-term treatment, the experimental group showed a statistically significant improvement in the ocular surface disease index (OSDI; P<0.001), tBUT (P=0.004), Schirmer test score (P=0.008) and LMT (P=0.021) by repeated measure ANOVA. Additionally, mean changes from baseline in OSDI (P<0.001), tBUT (P=0.001), Schirmer test score (P=0.029), CS score (P=0.047), LMT (P=0.002), CI (P=0.030) were improved better in the experimental group than in the control group at 3mo. However, there was no significant difference between the two groups in MGS (P=0.67).
CONCLUSION: In dry eyes with MGD, 0.05% CsA improves the tear film stability as well as subjective ocular discomfort, and is effective in controlling lid margin inflammation.]]></description>
<pubDate>2018/4/10 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ho-Yun Kim, Ji-Eun Lee, Ha-Na Oh, Ju-Whan Song, Sang-Youp Han and Jong-Soo Lee]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ho-Yun Kim, Ji-Eun Lee, Ha-Na Oh, Ju-Whan Song, Sang-Youp Han and Jong-Soo Lee</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180409]]></guid><cfi:id>725</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Efficacy of autologous conjunctival flap on repairing the late-onset filtering bleb leakage]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180410]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the effectiveness of autologous conjunctival flap surgery for repairing the late-onset filtering bleb leakage after trabeculectomy.
METHODS: This study retrospectively reviewed 106 eyes from 106 patients with late-onset filtering bleb leakage after trabeculectomy who received autologous conjunctival flap surgery at the Zhongshan Ophthalmic Centre from 2005 to 2015. The basic information was recorded, and the interval time between trabeculectomy and autologous conjunctival flap surgery as well as related risk factors, intraocular pressure (IOP), anterior chamber depth (ACD) and best corrected visual acuity (BCVA) were analysed. Moreover, 41 patients who completed the 1-year follow up were analysed to determine the IOP and BCVA changes and long-term success rates.
RESULTS: The 50 male and 56 female subjects (average age 39.13±17.96y) included 47 (44.34%) and 33 (31.13%) cases of primary open angle and primary angle-closure glaucoma. The mean interval between trabeculectomy and repair surgery was 60.60±56.92 (3-264)mo. The mean mitomycin (MMC) concentration during trabeculectomy was 0.27±0.04 (0.12-0.4) mg/mL in the fornix-based conjunctival flap group (68 patients) and 0.28±0.04 (0.20-0.33) mg/mL in the limbal-based conjunctival flap group (11 patients). After bleb leakage, the patients' vision remained stable while the IOP decreased from 10.25±4.76 (3-20.86) to 9.44±4.33 (2-21) mm Hg (P<0.01). In the 41 analysed patients, the IOP was controlled at 15.68±5.11 (7-40) mm Hg in the 1st year after autologous conjunctival flap surgery and recurrence was not observed, for a long-term success rate of 100%.
CONCLUSION: Autologous conjunctival flap repairing surgery is an effective technique for sealing filtering bleb leakages and controlling IOP postoperatively.]]></description>
<pubDate>2018/4/10 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jian-Gang Xu, Jing Zhong, Yang-Fan Yang, Ming-Kai Lin, Xing Liu and Min-Bin Yu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jian-Gang Xu, Jing Zhong, Yang-Fan Yang, Ming-Kai Lin, Xing Liu and Min-Bin Yu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180410]]></guid><cfi:id>724</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Complications and outcomes of descemet stripping automated endothelial keratoplasty with artisan aphakia intraocular lens implantation]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180411]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the complications and outcomes of descemet stripping automated endothelial keratoplasty (DSAEK) combined with artisan aphakia intraocular lens (IOL) implantation in severely damaged eyes without capsular support.
METHODS: DSAEK combined with artisan iris claw IOL implantation was performed on 29 eyes. All eyes were of abnormal structure due to complications from prior intraocular surgeries and ocular trauma. Ocular complications observed included graft dislocations, high intraocular pressure (IOP), IOL dislocations, macular edema and hyphema. Best corrected visual acuity (BCVA), IOP and mean central endothelial cell density (ECD) were recorded.
RESULTS: Thirteen eyes had a history of ocular trauma, 10 eyes had an anterior chamber IOL, 16 eyes had prior vitrectomy. The iris was abnormal in 22 cases. Graft dislocation occurred in 5 (17.2%) of 29 eyes. IOL dislocation occurred in 2 eyes (6.9%). High IOP was found in 9 eyes and was controlled with treatment. The preoperative mean BCVA was 20/286. The 6mo postoperative mean BCVA was 20/42. The average center ECD was 1965.3 cells/mm2 at 6mo, and the rate of the donor cell loss was 34.7%.
CONCLUSION: DSAEK combined with artisan aphakia IOL implantation is an alternative option for resolving endothelial and lens disorders in aphakic eyes without capsular support. However, it should be performed cautiously for eyes with severe iris defects.]]></description>
<pubDate>2018/4/10 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Rong-Mei Peng, Yu-Xin Guo, Yuan Qiu, Yan-Sheng Hao and Jing Hong]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Rong-Mei Peng, Yu-Xin Guo, Yuan Qiu, Yan-Sheng Hao and Jing Hong</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180411]]></guid><cfi:id>723</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Photorefractive keratectomy after cataract surgery in uncommon cases: long-term results]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180412]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the efficacy and safety of the excimer laser correction of the residual refractive errors after cataract extraction with intraocular lens (IOL) implantation in uncommon cases.
METHODS: Totally 24 patients with high residual refractive error after cataract surgery with IOL implantation were examined. Twenty-two patients had a history of phacoemulsification and IOL implantation, and two had extra-capsular cataract extraction with IOL implantation. Detailed examination of preoperative medical records was done to explain the origin of the post-cataract refractive errors. All patients underwent photorefractire keratectomy (PRK) enhancement. The mean outcome measures were refraction, uncorretted visual acuity (UCVA), best corrected visual acuity (BCVA) and corneal transparency and follow up ranged from 1 to 8y.
RESULTS: The principal causes of residual ametropia was inexact IOL calculation in abnormal eyes with high myopia and congenital lens abnormalities, followed by corneal astigmatism both suture induced and preexisting. After cataract surgery and before the laser enhancement the mean spherical equivalent (SE) was -0.56±3 D ranging from -4.62 to +2.25 D in high myopic patients, instead it was -1±1.73 D ranging from -3.25 to +3.75 D in the astigmatic eyes, with a mean cylinder of -3.75±0 ranging from -3 to +5.50 D. After laser refractive surgery the mean SE was 0.1±0.73, ranging from -0.50 to +1.50 in the myopic group, and it was -0.50±0.57 ranging from -1.25 to +0.50 in astigmatic patients, with a mean cylinder of -0.25±0.75. In myopic patients the mean UCVA and BCVA were 0.038±0.072 logMAR and 0.018±0.04 respectively, both ranging from 0.10 to 0.0. In astigmatic patients, the mean UCVA and BCVA were 0.213±0.132 and 0.00±0.0 respectively, UCVA ranging from 0.50 to 0.22 and BCVA was 0.00. All patients presented normal corneal transparency. No ocular hypertension was detected and no corneal haze was observed. All registered values remained stable also at the end line evaluation.
CONCLUSION: The excimer laser treatment of residual refractive errors after cataract surgery with IOL implantation in abnormal eyes resulted in satisfactory and stable visual outcome with good safety and efficacy.]]></description>
<pubDate>2018/4/10 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Anna Maria Roszkowska, Mario Urso, Giuseppe Alberto Signorino, Leopoldo Spadea and Pasquale Aragona]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Anna Maria Roszkowska, Mario Urso, Giuseppe Alberto Signorino, Leopoldo Spadea and Pasquale Aragona</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180412]]></guid><cfi:id>722</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Impact of topical nonsteroidal anti-inflammatory drugs in prevention of macular edema following cataract surgery in diabetic patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180413]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the efficacy of prophylactic administration of topical non-steroidal anti-inflammatory drugs (NSAIDs) on macular edema following cataract surgery in diabetic patients, and to compare between types of NSAIDs (ketorolac tromethamine 0.4% and nepafenac 0.1%).
METHODS: Group 1 (control) received artificial tears substitute as a placebo group, group 2 (nepafenac) received topical nepafenac 0.1%, and group 3 (ketorolac) received topical ketorolac tromethamine 0.4%. Patients were examined postoperatively after completing one week, one month, two months and three months' intervals for evaluating cystoid macular edema (CME) development. The main study outcomes were achieving the best corrected visual acuity (BCVA) and change in the central macular thickness (CMT) measured with optical coherence topography (OCT).
RESULTS: Eighty eyes of 76 patients were included in this study. BCVA showed a statistically significant difference at the third month postoperative follow up between the control group and the NSAIDs groups (P=0.04). There was an increase in the CMT in all cases starting from postoperative first week until third month. CMT showed a statistically significant difference between control group and NSAIDs groups from postoperative first month until third month (P=0.008, 0.027, 0.004). There was no statistically significant difference between nepafenac and ketorolac groups in BCVA and OCT CMT.
CONCLUSION: Prophylactic preoperative and postoperative NSAIDs may have a role in reducing the frequency and severity of CME in diabetic eyes following cataract surgery.]]></description>
<pubDate>2018/4/10 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ahmed A. Alnagdy, Hossam Y. Abouelkheir, Sherief E. El-Khouly and Sahar M. Tarshouby]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ahmed A. Alnagdy, Hossam Y. Abouelkheir, Sherief E. El-Khouly and Sahar M. Tarshouby</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180413]]></guid><cfi:id>721</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Anterior and posterior capsule densitometry levels after femtosecond laser-assisted cataract surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180414]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyze and compare five different variables over one year follow-up (1wk, 1, 3, 6 and 12mo): anterior capsule (AC), and posterior capsule (PC) area densitometry values, AC and PC linear densitometry values, and AC opening area reduction ratio after femtosecond laser-assisted cataract surgery.
METHODS: This was a prospective comparative study. Seventy-one patients underwent femtosecond laser-assisted cataract surgery on single eye between June 2014 and December 2015. A 5.0 mm diameter laser assisted anterior capsulotomy was performed on all eyes. In every post-surgery evaluation, AC opacificaction (ACO) and PC opacification (PCO) density levels were provided by Oculus Pentacam&#174;HR using area and linear densitometry methods. Digital images were captured with a slit-lamp Topcon photographic camera and IMAGEnet&#174; 5 software. The AC opening area on the digital images was measured using the Sketchandcalc area calculator and converted to reduction ratio levels.
RESULTS: Using Pearson correlation coefficient (PCC), we found no correlation (r=-0.091, P=0.46) in the twelfth month assessment between the evolution of ACO area densitometry values and PCO area densitometry values considered as independent variables. We found no correlation, using PCC (r=-0.096, P=0.43) between the evolution of ACO linear densitometry values and PCO linear densitometry values, in the twelfth month visit, working both as independent variables. AC linear densitometry levels and AC area densitometry levels continued to grow strongly from sixth to twelfth months. Analysis of the values of AC opening area reduction ratio (1wk, 1, 3, 6, 12mo) revealed statistically significant differences between the values of successive examinations but the magnitude of the change decreased. In the final period of monitoring between six and twelve months the magnitude of change was low.
CONCLUSION: Our results show strong increases of Scheimpflug ACO densitometry values from the sixth to the twelfth month while capsulorhexis area reduction ratio levels displayed a considerable decrease. We found no correlation between ACO area and linear densitometry values and PCO area and linear densitometry values, in the twelfth month examination, working as independent variables.]]></description>
<pubDate>2018/4/10 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Txomin Alberdi, Javier Mendicute, Lucía Bascarán, Olatz Barandika and Javier Ruiz-Ederra]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Txomin Alberdi, Javier Mendicute, Lucía Bascarán, Olatz Barandika and Javier Ruiz-Ederra</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180414]]></guid><cfi:id>720</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Long-term outcomes of uveitic glaucoma treated with Ahmed valve implant in a series of Chinese patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180415]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report long-term outcomes of secondary glaucoma due to uveitis treated with Ahmed glaucoma valve (AGV) implantation in a series of Chinese patients.
METHODS: The retrospective study included 67 eyes from 56 patients with uveitic glaucoma who underwent AGV implantation. Success of the treatment was defined as patients achieving intraocular pressure (IOP) levels between 6 and 21 mm Hg with or without additional anti-glaucoma medications and/or a minimum of 20% reduction from baseline IOP. The main outcome measurements included IOP, the number of glaucoma medications at 1, 3, 6, 12, 24, 36, 48 and 60mo after surgery, surgical complications, final best-corrected vision acuity (BCVA), visual field (VF) and retinal nerve fiber layer (RNFL).
RESULTS: The mean follow-up was 53.3±8.5 (range 48 to 60)mo. The cumulative probability of success rate was 98.5%, 95.5%, 89.6%, 83.6%, 76.1%, 70.1%, 65.7% and 61.2% at 1, 3, 6, 12, 24, 36, 48 and 60mo, respectively. IOP was reduced from a baseline of 30.8±6.8 to 9.9±4.1, 10.1±4.2, 10.9±3.7, 12.9±4.6, 13.8±3.9, 13.2±4.6, 12.3±3.5 and 13.1±3.7 mm Hg at 1, 3, 6, 12, 24, 36, 48 and 60mo, respectively (P<0.01). The number of postoperative glaucoma medications was significantly decreased compared with baseline at all time points during the study period (P<0.05). There was no significant difference between preoperative and postoperative BCVA. Remarkable surgical complications were not found after surgery. The VF and RNFL of the patients were stable after the surgery.
CONCLUSION: AGV implantation is safe and effect in terms of reducing IOP, decreasing the number of glaucoma medications, and preserving vision for patients with uveitic glaucoma.]]></description>
<pubDate>2018/4/10 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ning Bao, Zheng-Xuan Jiang, Paul Coh and Li-Ming Tao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ning Bao, Zheng-Xuan Jiang, Paul Coh and Li-Ming Tao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180415]]></guid><cfi:id>719</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical outcomes of patterned laser trabeculoplasty as adjuvant therapy in open angle glaucoma and ocular hypertension]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180416]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the efficacy and safety of patterned laser trabeculoplasty (PLT) as an adjunctive treatment in open angle glaucoma (OAG) or ocular hypertension (OHT) patients who were under antiglaucoma medical treatment.
METHODS: This study was a retrospective review of primary or secondary OAG patients and OHT patients with medically uncontrolled (≥18 mm Hg) intraocular pressure (IOP) who underwent 360o PLT from June 2016 to August 2016. Follow-up visits at week 1, and 1, 3 and 6mo were performed. IOP, best corrected visual acuity (BCVA), complications and eye drop glaucoma medication were recorded at each follow-up visit. Success was defined as IOP reduction ≥20% from baseline.
RESULTS: Forty-one eyes of 25 patients were included in this study. Pre-treatment mean IOP was 20.2±1.6 mm Hg. After PLT, IOP was 19.3±5.2, 16.1±2.7, 17.1±3.7 and 16.3±3.5 mm Hg, at 1wk, 1, 3 and 6mo, respectively. IOP reduction from baseline was statistically significant from the first month, remaining stable at 6mo (P<0.001). PLT success at 6mo of follow-up was 48.78%. The number of glaucoma medication per eye (P=0.10) and the mean BCVA both remained constant (P=0.37). Complications included transient IOP spikes in 4 eyes (9.8%) and peripheral anterior synechiae in 7 eyes (17.1%).
CONCLUSION: PLT is an effective and safe method for the management of patients with OHT or OAG as an adjunctive therapy. Additional larger studies should be designed to verify the long-term stability of IOP reduction with this laser technology.]]></description>
<pubDate>2018/4/10 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Gustavo Espinoza, Leonardo Castellanos, Ignacio Rodriguez-Una, Paul Anthony Camacho and Juan Camilo Parra]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Gustavo Espinoza, Leonardo Castellanos, Ignacio Rodriguez-Una, Paul Anthony Camacho and Juan Camilo Parra</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180416]]></guid><cfi:id>718</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of anti-VEGF treatment on retinopathy of prematurity in Zone II Stage 3+]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180417]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the effect of intravitreal ranibizumab injection for retinopathy of prematurity (ROP) in Zone II Stage 3+.
METHODS: Data was collected for ROP patients with Zone II Stage 3+ who received intravitreal ranibizumab injections between October 2014 and Janu-ary 2017 at the Department of Ophthalmology in our hospital. No prior laser or other intravitreal treatment was done. Prior to the intervention and at each follow-up visit, fundus examination was performed. Gestational age at birth, sex, birth weight, ROP zone, ROP stage, post menstrual age (PMA) at treatment, and follow-up pe-riod were recorded. The final clinical status of the retina was evaluated for each patient. The primary outcome mea-sures included ROP recurrences requiring re-treatment, complete or incomplete peripheral vascularization.
RESULTS: Eighty-six eyes of 46 premature infants with Zone II Stage 3+ ROP were enrolled in the study. The mean gestational age at birth was 28.18±1.67 (range: 25 to 33)wk and the mean birth weight was 1070.57±226.85 (range: 720.00 to 1650.00) g. The mean PMA at treatment was 38.32±2.99 (range: 32.29 to 46.00)wk. Seventy-one eyes (82.56%) were treated success-fully with intravitreal ranibizumab as monotherapy. Fifteen eyes (17.44%) developed recurrent disease. The mean interval between the treatment and retreatment was 5.96±3.22 (range: 1.86 to 11.71)wk. All eyes vascularized into zone III at the end of the study and among them 62 eyes (72.09%) achieved complete vascu-larization.
CONCLUSION: Intravitreal ranibizumab injection is an effective treatment in Zone II Stage 3+ ROP patients. More patients with longer follow-up duration are necessary to confirm the safety and efficacy of this treatment.]]></description>
<pubDate>2018/4/10 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xiu-Mei Yang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiu-Mei Yang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180417]]></guid><cfi:id>717</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Assessment of the long-term visual and anatomical outcomes of ranibizumab to treat neovascular age-related macular degeneration]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180418]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the long-term visual and anatomical outcomes of patients who underwent intravitreal ranibizumab monotherapy to treat neovascular age-related macular degeneration (AMD) and followed-up for at least 2y.
METHODS: A total of 74 eyes of 74 patients who underwent ranibizumab monotherapy for neovascular AMD were included in this retrospective study.
RESULTS: The average patient age was 72.1±6.5 (range, 57-85)y, the average follow-up time 46.2±13.1 (range, 24-75)mo, and the average number of visits 24.1±9.5 (range, 8-48). The mean number of injections in year 1 was 4.5, 1.6 in year 2, 0.9 in year 3, 0.4 on year 4, and 0.1 in the following years. Within the entire follow-up period, the mean number of injections was 7.6±4.4 (range, 2-21). The mean visual acuity was 48.1±15 (range, 15-76) letters at baseline and 45.7±19 (range, 7-75) at year 5. The mean central macular thickness was 303±78 (range, 178-552) μm at baseline and 251±51 (range, 138-359) μm at year 5. Scars developed in 47 (63.5%) eyes at the end of the follow-up period, and atrophy was evident in 6 (8.1%) eyes.
CONCLUSION: Ranibizumab monotherapy can stabilize visual acuity for a mean period of 4y in patients with neovascular AMD.]]></description>
<pubDate>2018/4/10 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Bekir Kü&#231;ük, Sibel Kaday&#305;f&#231;&#305;lar and Bora Eldem]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Bekir Kü&#231;ük, Sibel Kaday&#305;f&#231;&#305;lar and Bora Eldem</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180418]]></guid><cfi:id>716</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of myopia control between toric and spherical periphery design orthokeratology in myopic children with moderate-to-high corneal astigmatism]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180419]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare clinical results between toric and spherical periphery design orthokeratology (ortho-k) in myopic children with moderate-to-high corneal astigmatism.
METHODS: This retrospective study enrolled 62 eyes of 62 subjects using toric ortho-k lenses. These subjects were assigned to the toric group. Based on the one-to-one match principle (same age, proximate spherical equivalence and corneal astigmatism), 62 eyes of 62 subjects were enrolled and included in the spherical group. At one-year follow-up visit, visual acuity, corneal astigmatism, treatment zone decentration, axial elongation and adverse reaction were compared between these two groups.
RESULTS: At the one-year visit, corneal astigmatism was significantly lower in the toric group (1.22±0.76 D) than in the spherical group (2.05±0.85 D) (P=0.012). The mean magnitude of the treatment zone decentration was 0.62±0.42 mm in the toric group and 1.07±0.40 mm in the spherical group (P=0.004). Axial elongation was significantly slower in the toric group (0.04±0.13 mm) than in the spherical group (0.09±0.13 mm) (P=0.001). The one-year axial elongation was significantly correlated with initial age (r=-0.487, P<0.001) and periphery design of ortho-k lens (r=0.315, P<0.001). The incidence of corneal staining was lower in the toric group (8.1%) than in the spherical group (19.4%) (P<0.001).
CONCLUSION: Toric periphery design ortho-k lenses may provide lower corneal astigmatism, better centration, slower axial elongation and lower incidence of corneal staining in myopic children with moderate-to-high corneal astigmatism.]]></description>
<pubDate>2018/4/10 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yu Zhang and Yue-Guo Chen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yu Zhang and Yue-Guo Chen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180419]]></guid><cfi:id>715</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of optical quality after implantable collamer lens implantation and wavefront-guided laser in situ keratomileusis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180420]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the optical quality after implantation of implantable collamer lens (ICL) and wavefront-guided laser in situ keratomileusis (WG-LASIK).
METHODS: The study included 40 eyes of 22 patients with myopia who accepted ICL implantation and 40 eyes of 20 patients with myopia who received WG-LASIK. Before surgery and three months after surgery, the objective scattering index (OSI), the values of modulation transfer function (MTF) cutoff frequency, Strehl ratio, and the Optical Quality Analysis System (OQAS) values (OVs) were accessed. The higher order aberrations (HOAs) data including coma, trefoil, spherical, 2nd astigmatism and tetrafoil were also obtained. For patients with pupil size <6 mm, HOAs data were analyzed for 4 mm-pupil diameter. For patients with pupil size ≥6 mm, HOAs data were calculated for 6 mm-pupil diameter. Visual acuity, refraction, pupil size and intraocular pressures were also recorded.
RESULTS: In both ICL and WG-LASIK group, significant improvements in visual acuities were found postoperatively, with a significant reduction in spherical equivalent (P< 0.001). After the ICL implantation, the OSI decreased slightly from 2.34±1.92 to 2.24±1.18 with no statistical significance (P=0.62). While in WG-LASIK group, the OSI significantly increased from 0.68±0.43 preoperatively to 0.91±0.53 postoperatively (Wilcoxon signed ranks test, P=0.000). None of the mean MTF cutoff frequency, Strehl ratio, OVs showed statistically significant changes in both ICL and WG-LASIK groups. In the ICL group, there were no statistical differences in the total HOAs for either 4 mm-pupil or 6 mm-pupil. In the WG-LASIK group, the HOA parameters increased significantly at 4 mm-pupil. The total ocular HOAs, coma, spherical and 2nd astigmatism were 0.12±0.06, 0.06±0.03, 0.00±0.03, 0.02±0.01, respectively. After the operation, these values were increased into 0.16±0.07, 0.08±0.05, -0.04±0.04, 0.03±0.01 respectively (Wilcoxon signed ranks test, all P<0.05). At 6 mm-pupil, the induction of total HOAs was not statistically significant in the WG-LASIK group.
CONCLUSION: ICL implantation has a less disturbance to optical quality than WG-LASIK. The OQAS is a valuable complementary measurement to the wavefront aberrometers in evaluating the optical quality.]]></description>
<pubDate>2018/4/10 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hong-Ting Liu, Zhou Zhou, Wu-Qiang Luo, Wen-Jing He, Owhofasa Agbedia, Jiang-Xia Wang, Jian-Zhong Huang, Xin Gao, Min Kong, Min Li and Li Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hong-Ting Liu, Zhou Zhou, Wu-Qiang Luo, Wen-Jing He, Owhofasa Agbedia, Jiang-Xia Wang, Jian-Zhong Huang, Xin Gao, Min Kong, Min Li and Li Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180420]]></guid><cfi:id>714</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Consistent comparison of angle Kappa adjustment between Oculyzer and Topolyzer Vario topography guided LASIK for myopia by EX500 excimer laser]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180421]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate and compare the uniformity of angle Kappa adjustment between Oculyzer and Topolyzer Vario topography guided ablation of laser in situ keratomileusis (LASIK) by EX500 excimer laser for myopia.
METHODS: Totally 145 cases (290 consecutive eyes )with myopia received LASIK with a target of emmetropia. The ablation for 86 cases (172 eyes) was guided manually based on Oculyzer topography (study group), while the ablation for 59 cases (118 eyes) was guided automatically by Topolyzer Vario topography (control group). Measurement of adjustment values included data respectively in horizontal and vertical direction of cornea.
RESULTS: Horizontally, synclastic adjustment between manually actual values (dxmanu) and Oculyzer topography guided data (dxocu) accounts 35.5% in study group, with mean dxmanu/dxocu of 0.78±0.48; while in control group, synclastic adjustment between automatically actual values (dxauto) and Oculyzer topography data (dxocu) accounts 54.2%, with mean dxauto/dxocu of 0.79±0.66. Vertically, synclastic adjustment between dymanu and dyocu accounts 55.2% in study group, with mean dymanu/dyocu of 0.61±0.42; while in control group, synclastic adjustment between dyauto and dyocu accounts 66.1%, with mean dyauto/dyocu of 0.66±0.65. There was no statistically significant difference in ratio of actual values/Oculyzer topography guided data in horizontal and vertical direction between two groups (P=0.951, 0.621).
CONCLUSION: There is high consistency in angle Kappa adjustment guided manually by Oculyzer and guided automatically by Topolyzer Vario topography during corneal refractive surgery by WaveLight EX500 excimer laser.]]></description>
<pubDate>2018/4/10 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ming-Shen Sun, Li Zhang, Ning Guo, Yan-Zheng Song and Feng-Ju Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ming-Shen Sun, Li Zhang, Ning Guo, Yan-Zheng Song and Feng-Ju Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180421]]></guid><cfi:id>713</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Altered intrinsic functional connectivity of the primary visual cortex in youth patients with comitant exotropia: a resting state fMRI study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180422]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the differences in the functional connectivity (FC) of the primary visual cortex (V1) between the youth comitant exotropia (CE) patients and health subjects using resting functional magnetic resonance imaging (fMRI) data.
METHODS: Totally, 32 CEs (25 males and 7 females) and 32 healthy control subjects (HCs) (25 males and 7 females) were enrolled in the study and underwent the MRI scanning. Two-sample t-test was used to examine differences in FC maps between the CE patients and HCs.
RESULTS: The CE patients showed significantly less FC between the left brodmann area (BA17) and left lingual gyrus/cerebellum posterior lobe, right middle occipital gyrus, left precentral gyrus/postcentral gyrus and right inferior parietal lobule/postcentral gyrus. Meanwhile, CE patients showed significantly less FC between right BA17 and right middle occipital gyrus (BA19, 37).
CONCLUSION: Our findings show that CE involves abnormal FC in primary visual cortex in many regions, which may underlie the pathologic mechanism of impaired fusion and stereoscopic vision in CEs.]]></description>
<pubDate>2018/4/10 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Pei-Wen Zhu, Xin Huang, Lei Ye, Nan Jiang, Yu-Lin Zhong, Qing Yuan, Fu-Qing Zhou and Yi Shao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Pei-Wen Zhu, Xin Huang, Lei Ye, Nan Jiang, Yu-Lin Zhong, Qing Yuan, Fu-Qing Zhou and Yi Shao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180422]]></guid><cfi:id>712</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Low concentration of sodium hyaluronate temporarily elevates the tear film lipid layer thickness in dry eye patients with lipid deficiency]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180307]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the effects of different concentrations of artificial tears on lipid layer thickness (LLT) and blink rate (BR) in dry eye patients.
METHODS: This study included 106 eyes of 58 patients with dry eye. The lipid deficiency type was defined as the LLT baseline <75 nm. The LLT and BR were measured at baseline and 1, 5 and 15min after the instillation of 0.1% or 0.3% sodium hyaluronate (SH) eye drops by using the LipiView ocular surface interferometer.
RESULTS: In the lipid deficiency group, the LLT increased from baseline at 1min post instillation. The LLT after the instillation of 0.1% SH was significantly higher than that after the instillation of 0.3% SH (P<0.001). The LLT returned to baseline at 15min post instillation of 0.1% SH and at 5min post instillation of 0.3% SH. In the non-lipid deficiency group, the LLT decreased from baseline at 1min and returned to baseline at 5min for both treatments. The BRs were not significantly different at different time points for both treatments.
CONCLUSION: SH eye drops induce a short-term increase in LLT of patients with lipid deficiency. A low concentration of artificial tears have a stronger effect than a high concentration of artificial tears on the increase in LLT. In comparison, SH eye drops induce a transient and slight decrease in LLT of patients without lipid deficiency. A low concentration of artificial tears might be better for patients with lipid deficiency.]]></description>
<pubDate>2018/3/13 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yan Li, Xuan Sang, Liu Yang, Xiao-Ran Wang, Jia-Hui Liu, Xiong-Jun He, Ying Liu, Xiao-He Lu and Zhi-Chong Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yan Li, Xuan Sang, Liu Yang, Xiao-Ran Wang, Jia-Hui Liu, Xiong-Jun He, Ying Liu, Xiao-He Lu and Zhi-Chong Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180307]]></guid><cfi:id>711</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical outcome of combined conjunctival autograft transplantation and amniotic membrane transplantation in pterygium surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180308]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare long-term outcome of primary and recurrent pterygium surgery with three different techniques: combined conjunctival autograft and overlay amniotic membrane transplantation (CAT with AMT), conjunctival autograft transplantation (CAT) alone and amniotic membrane transplantation (AMT) alone.
METHODS: In this retrospective study, 142 eyes of 142 pterygium patients (104 primary, 38 recurrent) who underwent CAT (group A), AMT (group B) or CAT with AMT (group C) respectively following surgical excision were reviewed and compared based on the recurrences and post-operative complications.
RESULTS: The number of recurrence post-surgery were 17 (9 from primary, 8 from recurrent; the same description below), 18 (10, 8) and 2 (1, 1) in groups A, B, and C respectively; dry eyes were 22 (16, 6), 27 (18, 9) and 7 (3, 4); conjunctival inflammations were 30 (17, 13), 27 (16, 11) and 11 (6, 5). Patients in group C (either primary or recurrent or both) mainly showed significantly better results than those in group A or B (P<0.05) regarding above-mentioned clinical effects.
CONCLUSION: Combined CAT and overly AMT have significantly lower rates of recurrence and postoperative complications for primary and recurrent pterygium surgery than CAT or AMT alone.]]></description>
<pubDate>2018/3/13 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Tejsu Malla, Jing Jiang and Kai Hu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Tejsu Malla, Jing Jiang and Kai Hu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180308]]></guid><cfi:id>710</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Human lens epithelial cell apoptosis and epithelial to mesenchymal transition in femtosecond laser-assisted cataract surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180309]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate human lens epithelium cell apoptosis and epithelial to mesenchymal transition (EMT) induced by femtosecond laser in femtosecond laser assisted cataract surgery (FLACS).
METHODS: Sixty cataract patients with N2 to N3 stage according to the LOCS III were enrolled in this study and divided into three groups randomly: FLACS1 group (cataract surgery by FLACS with LenSx), FLACS2 group (cataract surgery by FLACS with LensAR) and manual group (cataract surgery by phacoemulsification). Patients in two FLACS groups performed anterior capsulotomy by LenSx or LensAR laser system. Patients in the manual group were performed continuous curvilinear capsulorrhexis (CCC) manually. The anterior capsules were fixed right after moved out of eye. Hematoxylin-eosine staining, immunofluorescence staining and real-time PCR were performed in order to observe human lens epithelium cells changes after cataract surgery.
RESULTS: The capsule cutting edge was shown irregularity and roughness in two FLACS groups and smooth edge in manual capsulotomy by pathologic staining. Irregularities of the cell configuration with partly swollen and destroyed nuclei were observed in two FLACS groups. Femtosecond laser could induce a significantly higher cell apoptosis in human lens epithelium cell than manually performed CCC (P<0.05). Lens epithelium cells apoptosis were correlated with femtosecond laser duration according to Pearson correlation analysis. Decreased N-cadherin expression, alpha-SMA and FSP-1 level in two FLACS groups showed the inhibition of cell EMT.
CONCLUSION: Femtosecond laser may affect the apoptosis and EMT of lens epithelium cells which are under the peeled central lens capsule.]]></description>
<pubDate>2018/3/13 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Wei Sun, Jia Liu, Jing Li, Di Wu, Jing Wang, Ming-Wu Wang, Jin-Song Zhang and Jiang-Yue Zhao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Wei Sun, Jia Liu, Jing Li, Di Wu, Jing Wang, Ming-Wu Wang, Jin-Song Zhang and Jiang-Yue Zhao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180309]]></guid><cfi:id>709</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Outcomes of transconjunctival sutureless 27-gauge vitrectomy for vitreoretinal diseases]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180310]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the safety and efficacy profile of 27-gauge (27G) pars plana vitrectomy (PPV) for the treatment of various vitreoretinal diseases.
METHODS: The clinical outcomes of 61 eyes (58 patients) with various vitreoretinal diseases following 27G PPV were retrospectively reviewed.
RESULTS: Surgical indications included rhegmatogenous retinal detachment (n=24), full-thickness macular hole (n=12), diabetic retinopathy (n=11), vitreous hemorrhage (n=6), Eales disease (n=4), pathological myopia-related vitreous floater (n=2), and macular epiretinal membrane (n=2). The mean follow-up was 166.4±61.3d (range 98-339d). The mean logMAR best-corrected visual acuity (BCVA) improved from 1.7±1.1 [0.02 decimal visual acuity (VA) equivalent] preoperatively to 1.2±1.0 (0.06 decimal VA equivalent) at the last postoperative visit (P<0.001). The mean operative time was 49.9min. With the exception of complicated cataract in one eye, no intraoperative complications were encountered. No case required conversion to conventional 20-, 23- or 25G instrumentation in all surgical maneuvers except for silicone oil infusion, which required a 25G oil injection syringe. Postoperative complications included transient ocular hypertension, vitreous hemorrhage, persistent intraocular pressure elevation, subconjunctival oil leakage, and recurrent retinal detachment. No cases of hypotony, endophthalmitis, and sclerotomy-related tears were observed.
CONCLUSION: The current results suggest that 27G PPV system is a safe and effective treatment for various vitreoretinal diseases. When learning to perform 27G PPV, surgeons may encounter a learning curve and should gradually expand surgical indications from easy to pathologically complicated cases.]]></description>
<pubDate>2018/3/13 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jie Li, San-Mei Liu, Wen-Tao Dong, Fang Li, Cai-Hong Zhou, Xiao-Dan Xu and Jie Zhong]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jie Li, San-Mei Liu, Wen-Tao Dong, Fang Li, Cai-Hong Zhou, Xiao-Dan Xu and Jie Zhong</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180310]]></guid><cfi:id>708</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Long-term results of Ahmed glaucoma valve implantation in Egyptian population]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180311]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the long-term results and complications of Ahmed glaucoma valve (AGV) implantation in a cohort of Egyptian patients.
METHODS: A retrospective study of 124 eyes of 99 patients with refractory glaucoma who underwent AGV implantation and had a minimum follow-up of 5y was performed. All patients underwent complete ophthalmic examination and intraocular pressure (IOP) measurement before surgery and at 1d, weekly for the 1st month, 3, 6mo, and 1y after surgery and yearly afterward for 5y. IOP was measured by Goldmann applanation tonometry and/or Tono-Pen. Complications and the number of anti-glaucoma medications needed were recorded. Success was defined as IOP less than 21 mm Hg with or without anti-glaucoma medication and without additional glaucoma surgery.
RESULTS: Mean age was 23.1±19.9y. All eyes had at least one prior glaucoma surgery. IOP was reduced from a mean of 37.2±6.8 to 19.2±5.2 mm Hg after 5y follow-up with a reduced number of medications from 2.64±0.59 to 1.81±0.4. Complete and qualified success rates were 31.5% and 46.0% respectively at the end of follow-up. The most common complications were encapsulated cyst formation in 51 eyes (41.1%), complicated cataract in 9 eyes (7.25%), recessed tube in 8 eyes (6.45%), tube exposure in 6 eyes (4.8%) and corneal touch in 6 eyes (4.8%). Other complications included extruded AGV, endophthalmitis and persistent hypotony. Each of them was recorded in only 2 eyes (1.6%).
CONCLUSION: Although refractory glaucoma is a difficult problem to manage, AGV is effective and relatively safe procedure in treating refractory glaucoma in Egyptian patients with long-term follow-up. Encapsulated cyst formation was the most common complication, which limits successful IOP control after AGV implantation. However, effective complications management can improve the rate of success.]]></description>
<pubDate>2018/3/13 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Eman Elhefney, Tharwat Mokbel, Waleed Abou Samra, Hanem Kishk, Tarek Mohsen and Amr El-Kannishy]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Eman Elhefney, Tharwat Mokbel, Waleed Abou Samra, Hanem Kishk, Tarek Mohsen and Amr El-Kannishy</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180311]]></guid><cfi:id>707</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Automatic localization of macular area based on structure label transfer]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180312]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To explore feasibility and practicability of macula localization independent of macular morphological features.
METHODS: A novel method was proposed to identify macula in fundus images by using structure label transfer. Its main idea was to match a processed image with the candidate images with known structures, and then transfer the structure label representing the macular to the processed image as a result of macula localization. In this way, macula localization couldn’t be influenced by lesion or other interference any more.
RESULTS: The average success rate in four datasets was 98.18%. For accuracy, the average error distance in four datasets was 0.151 optic disc diameter (ODD). Even for severe lesion images, the proposed method can still maintain high success rate and high accuracy, e.g., 95.65% and 0.124 ODD in the case of STARE dataset, respectively, which indicated that the proposed method was highly robust and stable in the complicated situations.
CONCLUSION: The proposed method can avoid the interference of lesion to macular morphological features in macula localization, and can locate macula with high accuracy and robustness, verifying its feasibility.]]></description>
<pubDate>2018/3/13 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xiao-Xin Guo, Qun Li, Chao Sun and Yi-Nan Lu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiao-Xin Guo, Qun Li, Chao Sun and Yi-Nan Lu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180312]]></guid><cfi:id>706</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Intravitreal anti-VEGF agents, oral glucocorticoids, and laser photocoagulation combination therapy for macular edema secondary to retinal vein occlusion: preliminary report]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180313]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the efficacy and safety of combined anti-vascular endothelial growth factor (VEGF) agents, oral glucocorticoid, and laser photocoagulation therapy for macular edema (ME) secondary to retinal vein occlusion (RVO).
METHODS: This study included 16 eyes of 16 patients with RVO-associated ME. Patients were initially treated with oral prednisone and an intravitreal anti-VEGF agent. Two weeks later, patients underwent standard laser photocoagulation. Best-corrected visual acuity (BCVA), central retinal thickness (CRT), and retinal vessel oxygenation were examined over 12mo.
RESULTS: Patients received 1.43±0.81 anti-VEGF injections. Mean baseline and 12-month logMAR BCVA were 0.96±0.51 (20/178) and 0.31±0.88 (20/40), respectively, in eyes with central retinal vein occlusion (CRVO) (P<0.00), and 1.02±0.45 (20/209) and 0.60±0.49 (20/80), respectively, in eyes with branch retinal vein occlusion (BRVO) (P<0.00). At 12mo, CRT had significantly decreased in eyes with CRVO (P<0.00) and BRVO (P<0.00). Venous oxygen saturation had significantly increased in eyes with CRVO (P<0.00) and BRVO (P<0.00). No examined parameters were significantly different between the 2 RVO groups. No serious adverse effects occurred.
CONCLUSION: Anti-VEGF, glucocorticoid, and photocoagulation combination therapy improves visual outcome, prolongs therapeutic effect, and reduces the number of intravitreal injections in eyes with RVO-associated ME.]]></description>
<pubDate>2018/3/13 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xiao-Xiao Feng, Cheng Li, Wan-Wen Shao, Yong-Guang Yuan, Xiao-Bing Qian, Qi-Shan Zheng, Yu-Jie Li and Qian-Ying Gao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiao-Xiao Feng, Cheng Li, Wan-Wen Shao, Yong-Guang Yuan, Xiao-Bing Qian, Qi-Shan Zheng, Yu-Jie Li and Qian-Ying Gao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180313]]></guid><cfi:id>705</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[The optic nerve head perfusion and its correlation with the macular blood perfusion in unilateral idiopathic macular hole: an optical coherence tomography angiography study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180314]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the optic nerve head (ONH) perfusion in both eyes of unilateral idiopathic macular hole (IMH) with normal control group by using optical coherence tomography angiography (OCTA) and investigate its correlationship with the macular blood perfusion.
METHODS: We performed a prospective and cross-sectional study that included 19 patients with full-thickness unilateral IMH and 24 age- and sex-matched controls. All participants received OCTA test. The ONH perfusion was evaluated by the regions of peripapillary and whole en face (the sum of peripapillary and optic disc). The potential correlationship between ONH and parafovea were implied. All the data were performed using the nonparametric test.
RESULTS: The mean values of ONH presented that normal control >IMH >unaffected eyes. A statistical variation was found between three groups in the region of temporal (P=0.007). Vessel density notablely decreased on the layers of superficial, deep and choroid of parafovea region in IMH group. The correlative coefficients showed that respectively whole en face and deep retina: r=0.528, peripapillary and deep retina: r=0.525, whole en face and choriocapillaries: r=0.569, peripapillary and choriocapillaries: r=0.504.
CONCLUSION: Our study demonstrate a reduced ONH vessel density in both eyes of IMH patients and the vessel density of ONH in IMH eyes are positively correlated with both the retina capillary and choriocapillary in parafoveal. The reduction of vessel densities may indicate the hypoperfusion in IMH eyes.]]></description>
<pubDate>2018/3/13 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xin-Xin Liu, Yu-Fei Teng, Meng Gao, Xi-Da Liang, Yan-Ping Yu and Wu Liu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xin-Xin Liu, Yu-Fei Teng, Meng Gao, Xi-Da Liang, Yan-Ping Yu and Wu Liu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180314]]></guid><cfi:id>704</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Safety and efficacy of posterior sub-Tenon’s carboplatin injection versus intravitreal melphalan therapy in the management of retinoblastoma with secondary vitreous seeds]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180315]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the safety and efficacy of posterior sub-Tenon’s carboplatin injection compared to intravitreal melphalan injection in the management of retinoblastoma (RB) with secondary vitreous seeds. The outcome measures were vitreous seeds regression, need for other treatment modalities to achieve ocular salvage and treatment side effects.
METHODS: A prospective interventional comparative nonrandomized study included RB eyes developed secondary vitreous seeds during the period of follow up. They subdivided into two groups: study group I where posterior sub-Tenon’s carboplatin (20 mg/2 mL) was injected and study group II where intravitreal melphalan (20 μg /0.1 mL) was injected. The injections repeated every 2-4wk.
RESULTS: Thirty-three eyes were included in the study. Seventeen eyes (16 patients) in study group I and 16 eyes (16 patients) in study group II. Ten eyes (30.3%) were completely salvaged following local chemotherapies. Ocular salvage was 23.5% following posterior sub-Tenon’s carboplatin injection versus 37.5% following intravitreal melphalan raised to 47.1% and 75% with addition of external beam radiotherapy (EBR) with no statistically significant difference between the study groups (P=0.16). A statistically significant correlation was found between ocular salvage rate and type of vitreous seeds either dust, spheres and clouds (r=0.42, P=0.015) and eyes harbor new solid tumor growth (r=0.35, P=0.045). The mean and median follow up periods following local chemotherapy injections were 2.0y in the study group I and 2.37y in the study group II. Few complications were reported: periorbital edema in all eyes and ocular motility disturbances in 13 eyes (76.5%) following posterior sub-Tenon’s carboplatin injection. Vitreous hemorrhage developed in 2 eyes (12.5%) and localized retinopathy in 5 eyes (31.25%) following intravitreal melphalan.
CONCLUSION: Local chemotherapy for treatment of RB with secondary vitreous seeds is safe and can salvage 30.3% of eyes without EBR. There is a superiority of intravitreal melphalan in ocular salvage however, no statistically significant difference between both groups.]]></description>
<pubDate>2018/3/13 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Azza Mohamed Ahmed Said, Mohamed Gamil Aly, Hazem Omar Rashed and Anwaar Mahmoud Rady]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Azza Mohamed Ahmed Said, Mohamed Gamil Aly, Hazem Omar Rashed and Anwaar Mahmoud Rady</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180315]]></guid><cfi:id>703</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Cap morphology after small-incision lenticule extraction and its effects on intraocular scattering]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180316]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate cap morphology after small-incision lenticule extraction (SMILE) and its effects on intraocular scattering.
METHODS: Sixty-five eyes of 33 patients undergoing SMILE were enrolled. In addition to regular evaluation, Fourier-domain optical coherence tomography was used to investigate cap thickness at 1d, 1wk, 1 and 3mo postoperatively. The optical quality including modulation transfer function cutoff frequency, Strehl ratio, Optical Quality Analysis System (OQAS) values, and objective scattering index (OSI), were evaluated using OQASTM.
RESULTS: Cap thickness decreased from 1d to 1wk (P<0.001), but remained higher than intended thickness of  120 μm after 3mo (P<0.001). Cap thickness in central area was thinner than that of in the paracentral and peripheral areas (P<0.0001). Total number of microdistortions decreased from 1d to 3mo (P<0.0001). Pearson analysis revealed a weak correlation between OSI and standard deviation of cap thickness at 1d and 1mo, as well as between range of cap thickness and OSI at 1mo. No correlation was found between microdistortion and OSI, but a negative correlation existed between microdistortion and range at 1d and 1moafter surgery.
CONCLUSION: The corneal cap tends to be more accurate and regular with time lapse. Better cap morphology tends to contribute less intraocular scattering in the eyes undergoing SMILE.]]></description>
<pubDate>2018/3/13 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Dan Fu, Lin Wang, Xing-Tao Zhou and Zhi-Qiang Yu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Dan Fu, Lin Wang, Xing-Tao Zhou and Zhi-Qiang Yu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180316]]></guid><cfi:id>702</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Visual quality assessment after presbyopic laser in-situ keratomileusis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180317]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess visual quality after presbyopia correction using an aspheric ablation profile and a micro-monovision protocol.
METHODS: This is a retrospective interventional study. Fifty-four eyes of 27 patients (mean age, 50.2±7.5y) who underwent presbyopia correction with an aspheric micro-monovision protocol were enrolled. The values of modulation transfer function (MTF) cutoff frequency, Strehl ratio, objective scattering index (OSI) and accommodation range were quantitatively assessed using the HD analyzer. Preoperative and postoperative contrast sensitivity (CS) at far (2.5 m) and near (40 cm) distance and higher-order aberrations (HOAs) were analyzed. Subjective visual satisfaction was evaluated by self-reported questionnaire regarding optical visual symptoms.
RESULTS: One year after presbyopia correction, no significant differences were found in the MTF cutoff frequency, Strehl ratio and OSI, however, the HD analyzer accommodation range significantly differed postoperatively (P=0.004). Postoperative CS at 12 and 18 cpd at near showed statistically significant improvement (P=0.020 and 0.008, respectively). Visual performance by self-reported questionnaire revealed satisfactory results in terms of subjective visual quality improvement.
CONCLUSION: Objective optical quality parameters show good visual outcomes. Subjective visual quality assessed by self-reported questionnaire in the presbyopia correction group show satisfactory results.]]></description>
<pubDate>2018/3/13 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Dong Hui Lim, Eui-Sang Chung, Myoung Joon Kim and Tae-Young Chung]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Dong Hui Lim, Eui-Sang Chung, Myoung Joon Kim and Tae-Young Chung</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180317]]></guid><cfi:id>701</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Three-year results of small incision lenticule extraction and wavefront-guided femtosecond laser-assisted laser in situ keratomileusis for correction of high myopia and myopic astigmatism]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180318]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare and calculate the 3-year refractive results, higher-order aberrations (HOAs), contrast sensitivity (CS) and dry eye parameters after small incision lenticule extraction (SMILE) and wavefront-guided femtosecond laser-assisted laser in situ keratomileusis (FS-LASIK) for correction of high myopia and myopic astigmatism.
METHODS: In this prospective, non-randomized comparative study, 78 eyes with spherical equivalent (SE) of -8.11±1.09 diopters (D) received a SMILE surgery, and 65 eyes with SE of -8.05±1.12 D received a wavefront-guided FS-LASIK surgery with the VisuMax femtosecond laser (Carl Zeiss Meditec, Jena, Germany) for flap cutting. Visual acuity, manifest refraction, CS, HOAs, ocular surface disease index (OSDI) and tear break-up time (TBUT) were evaluated during a 3-year follow-up.
RESULTS: The difference of uncorrected distance visual acuity (UDVA) postoperatively was achieved at 1mo and at 3mo, whereas the difference of the mean UDVA between two groups at 3y were not statistically significant (t=-1.59, P=0.13). The postoperative change of SE was 0.89 D in the FS-LASIK group (t=5.76, P=0.00), and 0.14 D in the SMILE group (t=0.54, P=0.59) from 1mo to 3y after surgery. At 3-year postoperatively, both HOAs and spherical aberrations in the SMILE group were obviously less than those in the FS-LASIK group (P=0.00), but the coma root mean square (RMS) was higher in the SMILE group (0.59±0.26) than in the FS-LASIK group (0.29±0.14, P=0.00). The mesopic CS values between two groups were not statistically significant at 3y postoperatively. Compared with the FS-LASIK group, lower OSDI scores and longer TBUT values were found in the SMILE group at 1mo and 3mo postoperatively. With regard to safety, no eye lost any line of CDVA in both groups at 3y after surgery.
CONCLUSION: Both SMILE and wavefront-guided FS-LASIK procedures provide good visual outcomes. Both procedures are effective and safe, but SMILE surgery achieve more stable long-term refractive outcome and better control of early postoperative dry eye as compared to FS-LASIK.]]></description>
<pubDate>2018/3/13 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Li-Kun Xia, Jing Ma, He-Nan Liu, Ce Shi and Qing Huang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Li-Kun Xia, Jing Ma, He-Nan Liu, Ce Shi and Qing Huang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180318]]></guid><cfi:id>700</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[The relationship between abduction deficit and reoperation among patients with infantile esotropia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180319]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the relationship between abduction deficit and reoperation among patients with infantile esotropia (IET).
METHODS: The records of 216 patients (432 eyes) with IET who underwent surgery, from 2010 to 2015 were studied. Patients with IET whose deviation appeared before 6mo of age and had stable preoperative deviation in two examinations with at least 2wk apart and a minimum 3mo postoperative follow up were included. Cases with early onset accommodative esotropia, congenital cataract, retinopathy of prematurity (ROP), manifest nystagmus, fundus lesions, neurologic and ophthalmic anomalies, 6th nerve palsy and Duane’s syndrome were excluded. Preoperative abduction deficit was considered from -1 to -3 grading scale. Three months after surgery, children were classified into no-need reoperation [deviation≤15 prism diopters (PD)], and need-reoperation groups (deviation>15 PD).
RESULTS: In this retrospective study, 117 female and 99 male patients with the mean surgical age of 4.7±6.4y were included. Reoperation rate was 33.3% and 16.0% in IET patients with and without abduction deficit, respectively in patients who had a history of late surgery. Abduction deficit increased the odds of reoperation by 82% [OR=1.82, 95% confidence interval (CI) =1.05 to 3.19, P=0.003] in patients who had a history of late surgery (>2 years old, P=0.021). Abduction deficit was improved significantly after operation (P<0.001).
CONCLUSION: Based on our results, abduction deficit can be considered as a risk factor of reoperation in IET patients who are operated at the age of more than 2y.]]></description>
<pubDate>2018/3/13 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Zhale Rajavi, Hamideh Sabbaghi, Pooya Torkian, Narges Behradfar, Mehdi Yaseri, Mohadeseh Feizi, Mohammad Faghihi and Kourosh Sheibani]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zhale Rajavi, Hamideh Sabbaghi, Pooya Torkian, Narges Behradfar, Mehdi Yaseri, Mohadeseh Feizi, Mohammad Faghihi and Kourosh Sheibani</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180319]]></guid><cfi:id>699</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Modified ulcer debridement in the treatment of the superficial fungal infection of the cornea]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180207]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the efficacy of modified corneal ulcer debridement in superficial fungal keratitis unresponsive to medications.
METHODS: A total of 209 patients (209 eyes) with fungal keratitis, involving no more than 50% of the stromal depth and not responding to antifungal agents for 2wk, were recruited in this retrospective, noncomparative study. The patients were treated with modified corneal ulcer debridement. All visible corneal infiltrates were removed under an operating microscope to obtain a clean stromal bed and smooth incised edges. Antifungal drugs were used immediately after surgery. Healing time of the ulcers was recorded. Fungal recurrence, visual acuity, corneal thickness and risk factors for treatment failure were monitored.
RESULTS: The follow-up was 13.6±5.8mo. The corneal ulcers healed in 195 of 209 eyes (93.3%), with a mean healing time of 8.4±6.8d. The other 14 eyes were further treated by penetrating keratoplasty (PK) (1 eye), anterior lamellar keratoplasty (LK) (7 eyes), conjunctival flap covering (4 eyes) or amniotic membrane transplantation (2 eyes). The best corrected visual acuity (BCVA) was ≥20/70 in 80.3% of the eyes, ≥20/40 in 56.9% of the eyes, and ≥20/25 in 27.3% of the eyes. The corneas at the lesions became thinner, but all in the safe range. No fungal recurrence or corneal ectasis developed during the follow-up. The risk of treatment failure was higher in patients with preoperative hypopyon (P=0.036) and ever using steroid (P=0.025).
CONCLUSION: Modified surgical debridement is a simple and effective method for the treatment of superficial fungal infection of the cornea, with improved visual acuity and no recurrence. Such an intervention in time can rapidly control fungal infection and largely shorten corneal ulcer healing time.]]></description>
<pubDate>2018/2/6 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jun-Yi Wang, Dian-Qiang Wang, Xiao-Lin Qi, Jun Cheng and Li-Xin Xie]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jun-Yi Wang, Dian-Qiang Wang, Xiao-Lin Qi, Jun Cheng and Li-Xin Xie</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180207]]></guid><cfi:id>698</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Evaluation of the safety and efficacy of therapeutic bandage contact lenses on post-cataract surgery patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180208]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the safety of therapeutic bandage contact lens for post-cataract surgery patients and to illustrate its efficacy on post-operative comfort and tear-film stability.
METHODS: A total of 40 participants were recruited and randomly divided into two groups. Group one was instructed to wear bandage contact lenses for a week and use antibiotic eye drops for a month since the first day after surgery. Group two received sub-conjunctival injection of tobramycin and was asked to wear eye pads on the first day after surgery and then were instructed to use antibiotic eye drops as the first group did. Ocular surface disease index (OSDI) questionnaire, slit-lamp microscope examination of tear break-up time (TBUT), corneal fluorescein score (CFS), tear meniscus height (TMH) together with anterior segment optical coherence tomography (AS-OCT) and corneal topography were evaluated preoperatively and postoperatively.
RESULTS: The subjective feeling (P=0.004), TBUT (P<0.001) and TMH (P=0.02) post-surgery had improved in patients who used bandage contact lenses compared with those who did not at 1wk post-surgery. Until three month postoperatively, the comfort degree (P=0.004) and TMH (P=0.01) of group two were still worse than group one. Moreover, TBUT (P<0.001) and CFS (P=0.004) of the group with eye pads got worse than the results before, whereas the group with bandage contact lenses recovered to normal. None of these patients had infections or other complications.
CONCLUSION: Wearing therapeutic bandage contact lens after cataract surgery, compared with traditional eye-pads, is a safe method to improve tear-film stability and reduce post-operative discomfort without hindering corneal incision recovery.]]></description>
<pubDate>2018/2/6 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Dan-Na Shi, Hang Song, Tong Ding, Wei-Qiang Qiu and Wei Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Dan-Na Shi, Hang Song, Tong Ding, Wei-Qiang Qiu and Wei Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180208]]></guid><cfi:id>697</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of two Nd:YAG laser posterior capsulotomy: cruciate pattern vs circular pattern with vitreous strand cutting]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180209]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the effects and safety of neodymium: yttrium-aluminium-garnet (Nd:YAG) laser posterior capsulotomy with vitreous strand cutting
METHODS: A total of 40 eyes of 37 patients with symptomatic posterior capsular opacity (PCO) were included in this prospective randomized study and were randomly subjected to either cruciate pattern or round pattern Nd:YAG posterior capsulotomy with vitreous strand cutting (modified round pattern). The best corrected visual acuity (BCVA), intraocular pressure (IOP), refractive error, endothelial cell count (ECC), anterior segment parameters, including anterior chamber depth (ACD) and anterior chamber angle (ACA) were measured before and 1mo after the laser posterior capsulotomy.
RESULTS: In both groups, the BCVA improved significantly (P<0.001 for the modified round pattern group, P=0.001 for the cruciate pattern group); the IOP and ECC did not significantly change. The ACD significantly decreased (P<0.001 for both) and the ACA significantly increased (P=0.001 for the modified round pattern group and P=0.034 for the cruciate group). The extent of changes in these parameters was not significantly different between the groups.
CONCLUSION: Modified round pattern Nd:YAG laser posterior capsulotomy is an effective and safe method for the treatment of PCO. This method significantly changes the ACD and ACA, but the change in refraction is not significant. Modified round pattern Nd:YAG laser posterior capsulotomy can be considered a good alternative procedure in patients with symptomatic PCO.]]></description>
<pubDate>2018/2/6 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jin-Soo Kim, Jung Yeol Choi, Ji-Won Kwon, Won Ryang Wee and Young Keun Han]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jin-Soo Kim, Jung Yeol Choi, Ji-Won Kwon, Won Ryang Wee and Young Keun Han</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180209]]></guid><cfi:id>696</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Managing high risk glaucoma with the Ahmed valve implant: 20 years of experience]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180210]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To estimate the efficacy and safety of the Ahmed implant in patients with high risk for failure after glaucoma surgery.
METHODS: In 342 eyes of 342 patients with refractory glaucoma, even with application of medical treatment, the Ahmed valve was introduced for intraocular pressure (IOP) control, in the period of the last 20y. The nature of glaucoma was neovascular in 162 eyes, pseudophakic or aphakic in 49 eyes, inflammatory in 29 eyes and non working previous antiglaucomatic surgical interventions in 102 eyes.
RESULTS: Follow-up ranged from 18 to 120mo with a mean follow-up of 63.2mo. IOP before the operation decreased from 31.6±10.4 mm Hg to 18.3±5.4 mm Hg (no systemic treatment) at the end of follow up period. When we compared the IOP values before the operation using ANOVA showed statistically significant difference (P<0.001). The success rate was 85.2% during the first semester, 76.8% at 12mo and 50.3% at the end of follow up period (18 to 120mo after implantation). Success rate was 25.7% in neovascular glaucoma, 63.2% in aphakic glaucoma and 73.8% in non working previous antiglaucomatic surgical interventions. Complications due to the implant were: serous choroidal detachment in 14.8%, blockage of the tube in 2.8%, malposition of the tube in 4.9%, suprachoroidal hemorrhage in 2.1%, cataract progression in 39.6% (phakic eyes), shallow anterior chamber in 9.2%, hyphaema in 28.9%, exposure of valve in 2.6%, exposure of tube in 9.3%, hypotony in 4.9% and conjunctival fibrosis in 41.5%.
CONCLUSION: Despite the fact that Ahmed valve implant had suchlike results as other implants concerning the IOP control, complications rate due to hypotony or over filtration in the first days after the intervention are not that frequent as with other valve implants.]]></description>
<pubDate>2018/2/6 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Tryfon Rotsos, Anastasia Tsioga, Konstantinos Andreanos, Andreas Diagourtas, Petros Petrou, Ilias Georgalas and Dimitrios Papaconstantinou]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Tryfon Rotsos, Anastasia Tsioga, Konstantinos Andreanos, Andreas Diagourtas, Petros Petrou, Ilias Georgalas and Dimitrios Papaconstantinou</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180210]]></guid><cfi:id>695</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Functional evaluation of the filtering bleb by ultrasound biomicroscopy after trabeculectomy with mitomycin C]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180211]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To study the role of ultrasound biomicroscopy (UBM) in the assessment of the bleb function after trabeculectomy with mitomycin C (MMC).
METHODS: This was a cross-sectional study including all cases had undergone trabeculectomy with MMC 0.2 mg/mL for 3min. Participants were recruited from the follow-up cases at Department of Ophthalmology, Tanta University in the period from August 2015 to August 2016. Full history taking and ophthalmological examination were performed. Intraocular pressure (IOP) was measured using Goldmann applanation tonometry and the history of prescribed postoperative antiglaucoma medications was recorded. Accordingly, the trabeculectomy blebs were divided clinically into successful blebs when the IOP post-operative was ≤18 mm Hg without medications. Scanning examination of the filtering bleb using UBM examination was performed at the period from 2 to 36mo after trabeculectomy (13.6±9.7mo).
RESULTS: This study included 33 trabeculectomy filtering blebs of 25 patients (9 males and 16 females). The mean age of patients was 53.2±14.2y (range 25-71y). We had 20 eyes with complete success, 9 eyes with qualified success, and 4 eyes with failure after trabeculectomy with MMC. The blebs were classified into successful blebs (IOP ≤18 mm Hg without antiglaucoma medications), others were classified into qualified successful and failed blebs. There was a significant correlation between certain UBM findings (intra-bleb reflectivity, draining sub-scleral tract, bleb height, and intrableb fluid cysts) and cases with different grades of clinical functional success (P<0.01).
CONCLUSION: UBM is an objective tool in the functional assessment of the post-trabeculectomy filtering bleb through a significant correlation between certain UBM parameters and the different grades of clinical functional success.]]></description>
<pubDate>2018/2/6 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ali Abbas El Salhy, Rabab Mohamed Elseht, Ahmed Fekry Al Maria, Saied Mohamed Abd El-wahab Shalaby and Tarek Ragaee Hossein]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ali Abbas El Salhy, Rabab Mohamed Elseht, Ahmed Fekry Al Maria, Saied Mohamed Abd El-wahab Shalaby and Tarek Ragaee Hossein</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180211]]></guid><cfi:id>694</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Trabeculectomy with Ologen implant versus mitomycin C in congenital glaucoma secondary]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180212]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the efficacy and safety of collagen matrix implant [Ologen (OLO) implant] versus mitomycin C (MMC) with subscleral trabeculectomy (SST) for the surgical treatment of congenital glaucoma (CG) in Sturge- Weber Syndrome (SWS).
METHODS: A prospective comparative randomized study of 20 eyes of 16 patients with CG associated with SWS was divided into two groups. The first group (MMC Group) included 10 eyes that were subjected to SST with MMC. The second group (OLO Group) included 10 eyes that were subjected to trabeculectomy with a collagen matrix implant (OLO implant). Postoperative evaluation included intraocular pressure (IOP) level, bleb evaluation, complications, and the need for further medication or surgical intervention.
RESULTS: The mean preoperative IOP was 29±3.16 mm Hg in MMC and 29.8±3.08 mm Hg in OLO eyes. Mean 12-month percentage reduction in IOP was significant in both groups (57.9% and 56.3%). At the end of the 12 postoperative follow-up month, in the MMC Group, 80% of eyes achieved the complete success, 20% of eyes had qualified success with no failed surgery in comparison to OLO Group which 70% of eyes achieved the complete success, 20% of eyes had qualified success with 10% failed surgery. In terms of complications, the MMC Group had a higher rate of complications than the OLO Group in the form of thin polycystic bleb in 6 eyes (60%), blebitis in only one eye (10%) treated with topical antibiotics, shallow anterior chamber in two eyes (20%).
CONCLUSION: This study proves that the use of a collagen matrix implant yields equally effective results as MMC when combined with trabeculectomy for the treatment of CG in SWS. Furthermore, OLO implantation is safe and has low incidences of complications.]]></description>
<pubDate>2018/2/6 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Thanaa Helmy Mohamed, Abdelrahman Gaber Salman and Riham Fawzy Elshinawy]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Thanaa Helmy Mohamed, Abdelrahman Gaber Salman and Riham Fawzy Elshinawy</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180212]]></guid><cfi:id>693</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Correlation between macular ganglion cell-inner plexiform layer thickness and visual acuity after resolution of the macular edema secondary to central retinal vein occlusion]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180213]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To examine the thickness of the ganglion cell-inner plexiform layer (GCIPL) in eyes with resolved macular edema (ME) in non-ischemic central retinal vein occlusion (CRVO), applying spectral-domain optical coherence tomography (SD-OCT), and its relationship with visual acuity.
METHODS: The retrospective observational case-control study included 30 eyes of non-ischemic CRVO patients with resolved ME (ME eyes) after treatment, and 30 eyes of non-ischemic CRVO patients without ME (non-ME eyes). The macular GCIPL thickness, peripapillary retinal nerve fiber layer (pRNFL) thickness and central macular thickness (CMT) were measured on a SD-OCT scan. Linear regression analyses were performed to determine the correlation between the thickness of each and the visual acuity (VA).
RESULTS: No significant difference in average GCIPL thickness, mean pRNFL thickness and CMT were observed between ME group and non-ME group (P=0.296, 0.183, 0.846). But, minimum GCIPL thickness was reduced in ME eyes compared with non-ME eyes (P=0.022). Final VA significantly correlated with the minimum GCIPL thickness in ME eyes (r=-0.482, P=0.007), whereas no correlation was found with average GCIPL thickness, average pRNFL thickness and mean CMT.
CONCLUSION: Minimum GCIPL thickness is reduced in ME eyes compared with non-ME eyes, and correlated with the VA in non-ischemic CRVO. These results propose that inner retinal damage occurring in patients with ME secondary to non-ischemic CRVO may lead to permanent visual defect after treatment.]]></description>
<pubDate>2018/2/6 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hyun Ju Kim, Han Gyul Yoon and Seong Taeck Kim]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hyun Ju Kim, Han Gyul Yoon and Seong Taeck Kim</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180213]]></guid><cfi:id>692</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Paediatric retinal detachment: aetiology, characteristics and outcomes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180214]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To provide contemporary data on the aetiology, clinical features and outcomes of paediatric retinal detachment.
METHODS: A retrospective review of all those under 16y who underwent surgical repair for retinal detachment at a single centre between the years 2008 and 2015 inclusive was performed. In each case the cause of retinal detachment, the type of detachment, the presence or absence of macular involvement, the number and form of reparative surgeries undertaken, and the surgical outcome achieved was recorded.
RESULTS: Twenty-eight eyes of 24 patients, 15 (62.5%) of whom were male and 9 (37.5%) of whom were female, their mean age being 11.6y and range 2-16y developed retinal detachment over the eight year period studied. Trauma featured in the development of retinal detachment in 14 (50.0%) cases. Retinal detachment was associated with other ocular and/or systemic conditions in 11 (39.3%) cases. A mean of 3.0 procedures with a range of 1-9 procedures per patient were undertaken in the management of retinal detachment. Complex vitrectomy combined with scleral buckling or complex vitrectomy alone were those most frequently performed. Mean postoperative visual acuity was 1.2 logMAR with range 0.0-3.0 logMAR. In 22 of 26 (84.6%) cases which underwent surgical repair the retina was attached at last follow-up.
CONCLUSION: Aggressive management of paediatric retinal detachment including re-operation increases the likelihood of anatomical success. In cases where the retinal detachment can be repaired by an external approach alone there is a more favourable visual outcome.]]></description>
<pubDate>2018/2/6 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Elizabeth McElnea, Kirk Stephenson, Sarah Gilmore, Michael O’Keefe and David Keegan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Elizabeth McElnea, Kirk Stephenson, Sarah Gilmore, Michael O’Keefe and David Keegan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180214]]></guid><cfi:id>691</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Real-life experience of ranibizumab therapy for neovascular age-related macular degeneration from Turkey]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180215]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report the real-life experience and clinical results of intravitreal ranibizumab injections to neovascular age-related macular degeneration (nAMD) in a single institution in Turkey.
METHODS: A total of 101 eyes of 89 patients with nAMD treated with intravitreal ranibizumab injection, followed up for at least 24mo between 2009 and June 2014, which were evaluated retrospectively. A pro re nata (PRN) treatment protocol was performed after the patients had received three, monthly loading injections. Best corrected visual acuity (BCVA) and central macular thickness measurements were evaluated at baseline and 3, 6, 12, 18, and 24mo. Number of injections and visits were also recorded.
RESULTS: Of the 89 patients, 34 (38.2%) were male and 55 (61.8%) were female and the mean age was 74.0±9.5 (52-91)y. The mean follow-up period was 24.82±4.4 (24-29)mo. Mean number of visits was 8.4±1.12 (7-12) in the first year and 6.6±1.33 (4-12) in the second year. The mean number of injections was 5.8±1.6 (3-10) and 4.2±2.2 (0-9) in the first and second year, respectively. The mean BCVA was 59±15.8 letters at baseline by the Early Treatment Diabetic Retinopathy Study (ETDRS) chart. The mean BCVA at 3, 12, and 24mo was 70.3±15.9, 67.9±14.3 and 67.3±16.9 letters, respectively. Improvement in visual acuity for each of the visits from baseline was found to be statistically significant (P<0.01). Visual acuity in 9 eyes at month 3, 7 eyes at month 12, and 13 eyes at month 24 did not change. The mean central macular thickness (CMT) was 437.99±164.78 μm at baseline. The mean CMT was 348.05±138.47 μm, 349.27±139.79 μm, and 344.13±146.30 μm at months 3, 12, and 24, respectively. The decrease in CMT for each of the visits from baseline was found to be statistically significant (P<0.01).
CONCLUSION: Anatomical and functional achievement are obtained in our study, but the mean number of injections and visits are found to be lower than the findings reported in randomized controlled clinical trials in the literature. However, the mean number of injections and visits in our study are compatible with the findings reported in real-life experience studies in the literature.]]></description>
<pubDate>2018/2/6 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Zafer Cebeci, Yusuf Cem Yilmaz and Nur Kir]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zafer Cebeci, Yusuf Cem Yilmaz and Nur Kir</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180215]]></guid><cfi:id>690</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of peripapillary retinal nerve fiber layer thickness between myopia severity groups and controls]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180216]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the peripapillary retinal nerve fiber layer (RNFL) thickness measured via optical coherence tomography (OCT) between different groups of myopia severity and controls.
METHODS: This was a prospective cross-sectional study. All subjects underwent a full ophthalmic examination, refraction, visual field analysis and A-scan biometry. Myopic patients were classified as low myopia (LM) [spherical equivalent (SE) from greater than -0.5 D, up to -3.0 D], moderate myopia (MM; SE greater than -3.0 D, up to -6.0 D) and high myopia (HM; SE greater than -6.0 D). The control group consisted of emmetropic (EM) patients (SE from +0.5 D to -0.5 D). A Zeiss Cirrus HD-OCT machine was used to measure the peripapillary RNFL thickness of both eyes of each subject. The mean peripapillary RNFL thickness between groups was compared using both analysis of variance and analysis of covariance.
RESULTS: A total of 403 eyes of 403 subjects were included in this study. The mean age was 31.48±10.23y. There were 180 (44.7%) eyes with EM, 124 (30.8%) with LM, 73 (18.1%) with MM and 26 (6.5%) with HM. All groups of myopia severity had a thinner average RNFL than the EM group, but after controlling for gender, age, and axial eye length, only the HM group differed significantly from the EM group (P=0.017). Likewise, the superior, inferior and nasal RNFL was thinner in all myopia groups compared to controls, but after controlling for confounders, only the inferior quadrant RNFL was significantly thinner in the HM group, when compared to the EM group (P=0.017).
CONCLUSION: The average and inferior quadrant RNFL is thinner in highly myopic eyes compared to emmetropic eyes. Refractive status must be taken into consideration when interpreting the OCT of myopic patients, as RNFL thickness varies with the degree of myopia.]]></description>
<pubDate>2018/2/6 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Evelyn Li Min Tai, Jiunn Loong Ling, Eng Hui Gan, Hussein Adil and Wan-Hitam Wan-Hazabbah]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Evelyn Li Min Tai, Jiunn Loong Ling, Eng Hui Gan, Hussein Adil and Wan-Hitam Wan-Hazabbah</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180216]]></guid><cfi:id>689</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A comparative study of risk factors for corneal infection in diabetic and non-diabetic patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180108]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the clinical characteristics of infectious keratopathy in type 2 diabetes mellitus (T2DM) and non-diabetes mellitus (NDM) and to investigate risk factors for infectious keratopathy in T2DM patients.
METHODS: Totally 230 patients with T2DM and 168 with NDM diagnosed as infectious keratopathy were hospitalized at Qingdao Eye Hospital from 2001 to 2015. Data including sex, age, occupation, season, smoking and alcohol consumption habits, duration between onset and treatments, duration of hospitalization were collected. Initially identified indicators were analyzed with a multivariate logistic regression. Glycosylated hemoglobin A1c (HbA1c) in patients with T2DM was analyzed. The infectious keratopathies in the two groups were categorized and compared.
RESULTS: The diabetic group consisted of 146 (63.5%) males and 84 (36.5%) females. The NDM group consisted of 111 (66.1%) males and 57 (33.9%) females. There was no signigicantly difference in sex distribution between the two groups (P>0.05). There were significant differences in age, occupation of patients, season of the onset of diseases, duration between onset and treatment, and durations of hospitalization between the two groups (P<0.05). In most of the patients in the diabetic group, the duration between onset and treatment was ≤3mo, and most was ≥3mo in the NDM group. Multivariate logistic regression analysis revealed that age and season were related to the development of corneal infection in the T2DM group (OR=1.709, 1.706). In the T2DM group, HbA1c was 9.09%±2.12%. There were statistically significant differences in the incidences of bacterial keratitis and herpes simplex keratitis in the two groups (P<0.05), but no significant statistical difference was found between fungal keratitis and amoebic keratitis (P>0.05).
CONCLUSION: Advanced age and the summer and winter seasons are identified as risk factors for infectious keratopathy in T2DM patients, and T2DM patients are more prone to bacterial keratitis.]]></description>
<pubDate>2018/1/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Bin Wang, Shuo Yang, Hua-Lei Zhai, Yang-Yang Zhang, Chun-Xia Cui, Jun-Yi Wang and Li-Xin Xie]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Bin Wang, Shuo Yang, Hua-Lei Zhai, Yang-Yang Zhang, Chun-Xia Cui, Jun-Yi Wang and Li-Xin Xie</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180108]]></guid><cfi:id>688</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[5-year follow-up of combined non-topography guided photorefractive keratectomy and corneal collagen cross linking for keratoconus]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180109]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the visual outcomes of simultaneous non-topography guided photorefractive keratectomy (PRK) and corneal collagen cross-linking (CXL) in eyes with keratoconus 5y after the procedure.
METHODS: Prospective, interventional, non-randomized, and non-controlled case series design was used. Sixty eyes of 30 patients (16 males and 14 females; age: 21-41y) with mild, non-progressive (stages 1-2) keratoconus were enrolled. Refraction, uncorrected distance visual acuity (UDVA) and corrected distance visual acuity (CDVA) , flat and steep keratometry readings, and adverse events were evaluated preoperatively and postoperatively. Data were collected preoperatively and postoperatively at 3mo, 1, 2, 3, 4, and 5y follow-up visits after combined non-topography-guided PRK with CXL was performed. All patients had at least 5y of follow-up.
RESULTS: All study parameters showed a statistically significant improvement at 5y over baseline values. The mean follow-up time was 68.20±4.71mo (range: 60-106mo). Patients showed a significant improvement in UDVA from 1.24±0.79 logMAR prior to combined non-TG-PRK+CXL to 0.06±0.15 logMAR postoperatively at the time of their last follow-up visit. CDVA significantly increased from 0.06±0.19 logMAR preoperatively to 0.03±0.12 logMAR postoperatively. A significant decrease in the mean spherical equivalent (SE) refraction was observed from -2.28±1.8 to -0.79±0.93 diopters (D) (P<0.05), and the manifest sphere decreased from -1.62±1.23 to -0.27±0.21 D (P=0.001). The manifest cylinder significantly decreased from -1.73±0.86 to -0.29±0.34 D postoperatively (P=0.001). The mean steep keratometry was 45.13±1.32 vs 47.28±2.12 D preoperatively (P<0.05), and the preoperative mean steepest keratometry (Kmax) 48.6±3.1 was reduced significantly to 46.8±2.9 postoperatively (P<0.05).
CONCLUSION: Combined non-TG-PRK with 15min CXL is an effective and safe option for correcting mild refractive error and improving visual acuity in patients with mild stable keratoconus.]]></description>
<pubDate>2018/1/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Abdulrahman Mohammed Al-Amri]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Abdulrahman Mohammed Al-Amri</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180109]]></guid><cfi:id>687</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Descemet stripping automated endothelial keratoplasty in phakic eyes: incision modification reducing cataract formation]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180110]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the efficacy of a technical modification to reduce the incidence of traumatic cataract induced by Descemet stripping automated endothelial keratoplasty (DSAEK) performed in phakic eyes.
METHODS: A retrospective cohort study. The records of all patients with a clear crystalline lens and endothelial failure that underwent modified DSAEK at our insitution were reviewed. In this modification, in order to avoid inadvertent touch of the insertion forceps against the exposed crystalline lens while passing across the anterior chamber, the incision sites were shifted from the standard 9 and 3 o’clock positions, superiorly to the 10 and 2 o’clock position respectively. Formation of typically traumatic, anterior subcapsular cataract in these patients was compared to that observed in a cohort including all the patients with a clear crystalline lens and endothelial failure that underwent conventional DSAEK at our institution.
RESULTS: The study group included 49 eyes following modified DSAEK and the control group included 35 eyes following DSAEK with conventional incision sites. Anterior subcapsular cataract occurring 4mo or less postoperatively was identified in 2 of 49 (4%) eyes in the study group and 7 of 35 (20%) eyes in the control group. The rates of traumatic cataract were significantly higher in the control group in comparison to the study group (P=0.03, RR=4.9, 95%CI 1.08-22.1).
CONCLUSION: Traumatic cataract formation following phakic DSAEK may be avoided with a simple modification to the position of the incision sites.]]></description>
<pubDate>2018/1/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jacqueline Beltz, Silvana Madi, Yoav Nahum, Paolo Santorum and Massimo Busin]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jacqueline Beltz, Silvana Madi, Yoav Nahum, Paolo Santorum and Massimo Busin</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180110]]></guid><cfi:id>686</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of infusion pressure during cataract surgery on ganglion cells measured using isolated-check visual evoked potential]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180111]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To detect the relationship between infusion pressure and postoperative ganglion cells function.
METHODS: This prospective observational cohort study included sixty-one eyes that underwent uncomplicated cataract surgery. Patients were divided into two groups according to infusion time (IT) recorded using surgery equipment [Group A: IT>ITmean (27 eyes); Group B: IT<ITmean (34 eyes)]. Best-corrected visual acuity, isolated-check visual evoked potential (icVEP), microperimetry, and optical coherence tomography examinations were performed preoperatively and 1wk and 1mo postoperatively. The changes in test results were measured with independent- sample t-tests and paired t-tests. Correlation between IT and these changes were analyzed with Pearson’s correlation analysis and Spearman correlation analysis.
RESULTS: Neither group showed significant postoperative changes in macular ganglion cell-inner plexiform layer (mGC-IPL) thickness (1-week postoperative: Group A P= 0.185, Group B P=0.381; 1-month postoperative: Group A P=0.775, Group B P=0.652). Postoperative mGC-IPL thickness of Group A was not significantly thicker than that of Group B at both post surgery time point (1-week postoperative P=0.913; 1-month postoperative P=0.954). In Group A, the mGC-IPL thickness change 1wk postoperatively was positively correlated with IT (R2=0.156, P=0.0198). A suspected progressive deficit in the magnocellular pathway was also found in Group A 1-month postoperatively [individual observed F (IOF)=0.63±0.70]. Significant increases were observed in postoperative retinal sensitivity measured by microperimetry (1-week postoperative: Group A P=0.015, Group B P<0.001; 1-month postoperative: Group A P=0.005, Group B P<0.001). In Group B, IT was negatively correlated with the increase in macular sensitivity (1-week postoperative: R2=0.372, P<0.001; 1-month postoperative: R2=0.209, P=0.007).
CONCLUSION: Both mGC-IPL thickness and retinal sensitivity increased postoperatively. A suspected progressive deficit in the magnocellular pathway was found in the group with a long IT, which induced more prominent changes.]]></description>
<pubDate>2018/1/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Tong Ding, Dan-Na Shi, Xiang Fan, Mi-Yun Zheng, Wei Wang and Wei-Qiang Qiu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Tong Ding, Dan-Na Shi, Xiang Fan, Mi-Yun Zheng, Wei Wang and Wei-Qiang Qiu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180111]]></guid><cfi:id>685</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of long-term results of trabeculectomy to treat pseudoexfoliative glaucoma and primary open angle glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180112]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the long term outcome of trabeculectomy in patients with pseudoexfoliative glaucoma (PEG) and primary open angle glaucoma (POAG) in terms of surgical success.
METHODS: The success of the trabeculectomy was evaluated by three criteria. Criterion A: intraocular pressure (IOP) ≤21 mm Hg and decrease in IOP ≥20%; Criterion B: IOP ≤18 mm Hg and decrease in IOP ≥30%; Criterion C: IOP ≤15 mm Hg and decrease in IOP ≥50%. Patients that met these criteria without medical treatment were considered to be completely successful, while those that met these criteria with medical treatment were considered partially successful. Significance levels of differences between the POAG and PEG groups in the Kaplan-Meier survival curves were calculated with the log-rank test.
RESULTS: Sixty-four eyes from 64 patients with PEG and 51 eyes from 51 patients with POAG were evaluated. No significant differences were detected between the PEG and POAG groups according to full or partial success relative to each of the three criteria (A: P=0.73, 0.32; B: P=0.73, 0.31; C:P=0.90, 0.27).
CONCLUSION: There is no difference in the long-term success of trabeculectomy between PEG and POAG patients whose clinical characteristics are otherwise the same.]]></description>
<pubDate>2018/1/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Vuslat Pelitli Gürlü, Hande Gü&#231;lü, Altan &#214;zal, &#214;mer Benian and Levent Alimgil]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Vuslat Pelitli Gürlü, Hande Gü&#231;lü, Altan &#214;zal, &#214;mer Benian and Levent Alimgil</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180112]]></guid><cfi:id>684</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Efficacy of selective laser trabeculoplasty following incisional glaucoma surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180113]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the efficacy of selective laser trabeculoplasty (SLT) in glaucomatous eyes with previous incisional glaucoma surgery.
METHODS: A retrospective cohort of eyes that underwent SLT at a single institution from 2013-2015 were followed for 1y. Reduction in intraocular pressure (IOP) following SLT was evaluated in eyes with prior trabeculectomy with ExPress mini shunt (Alcon, Ft Worth, TX, USA), Ahmed valve (New World Medical, Cucamonga, CA, USA), or combined phacoemulsification-trabeculectomy. A control group was included with eyes without prior surgery that underwent SLT. Success was defined as >20% drop in IOP from pre-SLT baseline.
RESULTS: One-hundred and six eyes were included with 53 in both the prior glaucoma surgery (PGS) and no prior glaucoma surgery (NPGS) groups. Mean pre-SLT IOP was 19.2±4.3 and 20.6±6.0 mm Hg for PGS and NPGS groups, respectively (P=0.17). Both groups produced statistically significant IOP reductions at 1 and 6mo (P<0.04). At 6mo, mean IOP reduction reached 7.3% and 10.8% for the PGS and NPGS groups, respectively (P=0.42). Overall, 27.9% and 31.7% of eyes in PGS and NPGS groups met success criteria at 1y (P=0.70). In the PGS group, eyes with baseline IOP ≥21 mm Hg had IOP reductions of 18.1% (P<0.001), 16.7% (P<0.01), and 8.4% (P=0.31) compared to eyes with baseline IOP <21 mm Hg who had IOP reductions of 2.3% (P=0.39), 3.4% (P=0.19), and 1.1% (P=0.72) at 1, 6mo, and 1y, respectively.
CONCLUSION: SLT is efficacious in eyes with prior incisional glaucoma surgery and results in similar IOP reductions compared to eyes without PGS. A larger IOP reduction is observed following SLT in eyes with higher pre-SLT IOP.]]></description>
<pubDate>2018/1/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Robert Allan Sharpe, Leah L Kammerdiener, David B. Williams, Sudeep K. Das and Matthew J. Nutaitis]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Robert Allan Sharpe, Leah L Kammerdiener, David B. Williams, Sudeep K. Das and Matthew J. Nutaitis</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180113]]></guid><cfi:id>683</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Intravitreal dexamethasone implants for diabetic macular edema]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180114]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the safety and efficacy of a dexamethasone (DEX) intravitreal implant for diabetic macular edema (DME).
METHODS: Totally 113 eyes of 84 patients were divided in three subgroups: naive patients (n=11), pseudophakic patients (n=72) and phakic patients (n=30). Inclusive criterion comprised adult diabetic patients with central fovea thickening and impaired visual acuity resulting from DME for whom previous standard treatments showed no improvement in both central macular thickness (CMT) and best corrected visual acuity (BCVA) after at least 3mo of treatment. Outcome data were obtained from patient visits at baseline and at months 1, 3, 5, 9 and 12 after the first DEX implant injection. At each of these visits, patients underwent measurement of BCVA, a complete eye examination and measurement of CMT and macular volume (MV) carried out with optical coherence tomography (OCT) images.
RESULTS: Seventy-three eyes (64.5%) received a single implant, 30 (26.5%) received two implants and 10 (9%) received three implants. At baseline, average in BCVA, CMT and MV were 43.5±20.8, 462.8±145 and 12.6±2.5 respectively. These values improved significantly at 1mo (BCVA: 47.2±19.5, CMT: 339.6±120, MV: 11.11±1.4) and 3mo (BCVA: 53.2±18.1, CMT: 353.8±141, MV: 11.3±1.3) (P≤0.05). At 5mo (BCVA: 50.9±19.8, CMT: 425±150, MV: 12.27±2.3), 9mo (BCVA: 48.4±17.6, CMT: 445.5±170, MV: 12.5±2.3) and 12mo (BCVA: 47.7±18.8, CMT: 413.2±149, MV: 12.03±2.5), improvements in the three parameters were no longer statistically significant and decreased progressively but did not reach baseline values. There were no clinical differences between subgroups. Ocular complications were minimal.
CONCLUSION: Patients with DEX implants show maximum efficacy at 3mo which then declined progressively, but is still better than baseline values at the end of follow-up.]]></description>
<pubDate>2018/1/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Alicia Pareja-Ríos, Paloma Ruiz-de la Fuente-Rodríguez, Sergio Bonaque-González, Maribel López-Gálvez, Virginia Lozano-López and Pedro Romero-Aroca]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Alicia Pareja-Ríos, Paloma Ruiz-de la Fuente-Rodríguez, Sergio Bonaque-González, Maribel López-Gálvez, Virginia Lozano-López and Pedro Romero-Aroca</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180114]]></guid><cfi:id>682</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Final anatomic and visual outcomes appear independent of duration of silicone oil intraocular tamponade in complex retinal detachment surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180115]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report anatomic and visual outcomes following silicone oil removal in a cohort of patients with complex retinal detachment, to determine association between duration of tamponade and outcomes and to compare patients with oil removed and those with oil in situ in terms of demographic, surgical and visual factors.
METHODS: We reported a four years retrospective case series of 143 patients with complex retinal detachments who underwent intraocular silicone oil tamponade. Analysis between anatomic and visual outcomes, baseline demographics, duration of tamponade and number of surgical procedures were carried out using Fisher’s exact test and unpaired two-tailed t-test.
RESULTS: One hundred and six patients (76.2%) had undergone silicone oil removal at the time of review with 96 patients (90.6%) showing retinal reattachment following oil removal. Duration of tamponade was not associated with final reattachment rate or with a deterioration in best corrected visual acuity (BCVA). Patients with oil removed had a significantly better baseline and final BCVA compared to those under oil tamponade (P=0.0001, <0.0001 respectively).
CONCLUSION: Anatomic and visual outcomes in this cohort are in keeping with those reported in the literature. Favorable outcomes were seen with oil removal but duration of oil tamponade does not affect final attachment rate with modern surgical techniques and should be managed on a case by case basis.]]></description>
<pubDate>2018/1/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Maedbh Rhatigan, Elizabeth McElnea, Patrick Murtagh, Kirk Stephenson, Elaine Harris, Paul Connell and David Keegan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Maedbh Rhatigan, Elizabeth McElnea, Patrick Murtagh, Kirk Stephenson, Elaine Harris, Paul Connell and David Keegan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180115]]></guid><cfi:id>681</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Retinal ganglion cell-inner plexiform and nerve fiber layers in neuromyelitis optica]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180116]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the thickness of the retinal ganglion cell-inner plexiform layer (GCIPL) and the retinal nerve fiber layer (RNFL) in patients with neuromyelitis optica (NMO).
METHODS: We conducted a cross-sectional study that included 30 NMO patients with a total of 60 eyes. Based on the presence or absence of optic neuritis (ON), subjects were divided into either the NMO-ON group (30 eyes) or the NMO-ON contra group (10 eyes). A detailed ophthalmologic examination was performed for each group; subsequently, the GCIPL and the RNFL were measured using high-definition optical coherence tomography (OCT).
RESULTS: In the NMO-ON group, the mean GCIPL thickness was 69.28±21.12 μm, the minimum GCIPL thickness was 66.02±10.02 μm, and the RNFL thickness were 109.33±11.23, 110.47±3.10, 64.92±12.71 and 71.21±50.22 μm in the superior, inferior, temporal and nasal quadrants, respectively. In the NMO-ON contra group, the mean GCIPL thickness was 85.12±17.09 μm, the minimum GCIPL thickness was 25.39±25.1 μm, and the RNFL thicknesses were 148.33±23.22, 126.36±23.45, 82.21±22.30 and 83.36±31.28 μm in the superior, inferior, temporal and nasal quadrants, respectively. In the control group, the mean GCIPL thickness was 86.98±22.37 μm, the minimum GCIPL thickness was 85.28±10.75 μm, and the RNFL thicknesses were 150.22±22.73, 154.79±60.23, 82.33±7.01 and 85.62±13.81 μm in the superior, inferior, temporal and nasal quadrants, respectively. The GCIPL and RNFL were thinner in the NMO-ON contra group than in the control group (P<0.05); additionally, the RNFL was thinner in the inferior quadrant in the NMO-ON group than in the control group (P<0.05). Significant correlations were observed between the GCIPL and RNFL thickness measurements as well as between thickness measurements and the two visual field parameters of mean deviation (MD) and corrected pattern standard deviation (PSD) in the NMO-ON group (P<0.05).
CONCLUSION: The thickness of the GCIPL and RNFL, as measured using OCT, may indicate optic nerve damage in patients with NMO.]]></description>
<pubDate>2018/1/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Sai-Jing Hu and Pei-Rong Lu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Sai-Jing Hu and Pei-Rong Lu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20180116]]></guid><cfi:id>680</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Surgical outcome and patient satisfaction after Z-epicanthoplasty and blepharoplasty]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181207]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate surgical outcomes of modified Z-epicanthoplasty with blepharoplasty that we previously reported from the patient’s perspective using patient-reported outcome measures (PROMs) and patient satisfaction scores.
METHODS: A total of patients (n=180) who underwent the surgery between January 2013 and June 2016 were randomly selected. Standardized patient satisfaction forms (total score, 40) and validated PROMs questionnaires (total score, 12) were sent to patients for completion. PROMs assesses the severity of scarring, pain and asymmetry, as well as functional and appearance issues.
RESULTS: All patients were female, ranging from 18 to 35 years old (mean=24). The response rate was 73.3% (n=132). The majority of patients reported good or excellent outcomes based on PROM analysis. Patients reported minimum or non-visible scarring at both the double eyelid surgical scar (85.6%) and the inner canthus (80.3%). Issues concerning function and appearance were minimal as 80.3% reported satisfaction with both domains. Notably, the majority of patients reported either a high or very high satisfaction rate to yield a mean score of 104 out of 120 (P<0.05).
CONCLUSION: Integration of our modified Z-epicanthoplasty with blepharoplasty produces good outcomes based on PROM results, which shows a positive linear relationship with patient satisfaction scores.]]></description>
<pubDate>2018/12/5 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jing-Yi Zhao, Xiao-Shuang Guo, Guo-Dong Song, Xian-Lei Zong, Xiao-Nan Yang, Le Du, Chen-Zhi Lai, Zuo-Liang Qi and Xiao-Lei Jin]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jing-Yi Zhao, Xiao-Shuang Guo, Guo-Dong Song, Xian-Lei Zong, Xiao-Nan Yang, Le Du, Chen-Zhi Lai, Zuo-Liang Qi and Xiao-Lei Jin</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181207]]></guid><cfi:id>679</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Factors influencing subjective symptoms in dry eye disease]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181208]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To retrospectively investigate the association between dry eye symptoms and clinical or in vivo confocal microscopy parameters in patients with dry eye disease (DED), and to compare these parameters between eyes with DED and normal subjects.
METHODS: This retrospective, cross-sectional, controlled study comprised 25 consecutive patients with non-Sj&#246;gren dry eye disease and age- and sex-matched 25 healthy subjects. Each patient underwent a complete examination of the ocular surface in the following order: tear osmolarity measurements, InflammaDry test, tear break-up time, corneal fluorescein staining, Schirmer I test, subjective symptoms questionnaire using the dry eye-related quality-of-life score (DEQS), and in vivo confocal microscopy analysis of the central cornea. Beck depression inventory (BDI) as depressive scale and history of medications and smoking were also evaluated. Stepwise multiple regression analysis was used to assess the factors affecting the DEQS.
RESULTS: In univariate analysis, DEQS was associated with tear break-up time (ρ=-0.48, P=0.01), oral medications, such as hypotensive drug (ρ=0.56, P=0.004) and anti-depressant (ρ=0.57, P=0.003), and BDI (ρ=0.61, P=0.001) in patients with DED. In multiple regression analysis, explanatory variables relevant to the DEQS were the anti-depressant medications (P=0.04, partial regression coefficient B=21.04) and BDI (P=0.02, B=0.76, adjusted R2=0.54) in these patients.
CONCLUSION: Our study shows a significant association between depression and dry eye symptoms. It suggests that dry eye symptoms associate with higher depressive symptoms and its medications, although our patients were not followed longitudinally.]]></description>
<pubDate>2018/12/5 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hidenaga Kobashi, Kazutaka Kamiya, Takehiko Sambe and Ryutaro Nakagawa]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hidenaga Kobashi, Kazutaka Kamiya, Takehiko Sambe and Ryutaro Nakagawa</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181208]]></guid><cfi:id>678</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Intracameral lidocaine as supplement to classic topical anesthesia for relieving ocular pain in cataract surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181209]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate safety, efficacy, and patient adherence of intracameral lidocaine as supplement of classic topical anesthetic drops in cataract surgery.
METHODS: A prospective and controlled trial including a large cohort of 1650 individuals suffering with bilateral cataract not complicated, in program by phacoemulsification surgery, were randomly assigned to 2 different groups for the type of anesthesia received, 0.4% oxybuprocaine hydrochloride (INN) drops, and INN drops associated to intracameral 1% lidocaine hydrochloride monohydrate. At the end of surgery, tables were assigned to each patient indicating the degree of pain (0-3) felt during the operation.
RESULTS: Thirty-two percent of patients in group 1 declared to have not felt any pain against the 77% of patients in group 2. Fifty-nine percent of patients in group 1 complained about only a slight discomfort against 20% of group 2 patients. Only a small percentage of patients in group 1 (5%) admitted severe pain, while no patient in group 2 admitted severe pain. Four patients of group 2 reported an episode of transient amaurosis, lasting several hours after surgery.
CONCLUSION: Intracameral administration of lidocaine is a simple and secure method able to increase the analgesia during the cataract surgery, eliminating the discomfort and increasing also the cooperation of the patients during the steps of manipulation.]]></description>
<pubDate>2018/12/5 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Marcella Nebbioso, Maria Luisa Livani, Valentina Santamaria, Aloisa Librando and Massimiliano Sepe]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Marcella Nebbioso, Maria Luisa Livani, Valentina Santamaria, Aloisa Librando and Massimiliano Sepe</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181209]]></guid><cfi:id>677</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effectiveness of 0.1% topical salicylic acid on blepharoconjunctivitis affecting glaucoma patients treated with topical prostaglandin analogues: a prospective randomized trial]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181210]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the efficacy of 0.1% topical salicylic acid (TSA) to treat iatrogenic chronic blepharoconjunctivitis in patients with primary open angle glaucoma (POAG), treated with topical prostaglandin analogues (TPAs).
METHODS: Totally 60 patients were randomly distributed into 3 equal size groups, two of which treated with 0.1% TSA (OMKASA&#174;) and 0.1% topical clobetasone butyrate (TCB; VISUCLOBEN&#174;) respectively, and one consisting of untreated controls. The parameters taken into account at baseline (T0) and after 30d (T1) of therapy were: conjunctival hyperemia, lacrimal function tests [Schirmer I test and break up time (BUT)] and intraocular pressure (IOP).
RESULTS: Conjunctival hyperemia showed a substantial improvement in both treated groups (P<0.001) but not among controls. Similarly, lacrimal function tests displayed an improvement of Schirmer I test in both treated groups (P<0.05) and an extension of BUT only in the group treated with 0.1% TSA (P<0.05). The IOP increase was statistically significant only in those patients treated with 0.1% TCB (P<0.001).
CONCLUSION: The 0.1% TSA has proved to be an effective anti-inflammatory treatment of blepharoconjunctivitis affecting glaucoma patients on therapy with TPAs, leading to a sizeable decrease of inflammation as well as both quantitative and qualitative improvement of tear film. Furthermore, differently from 0.1% TCB, it does not induce any significant IOP increase.]]></description>
<pubDate>2018/12/5 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Aloisa Librando, Sandra Cinzia Carlesimo, Giorgio Albanese, Giuseppe Maria Albanese, Raffaele Migliorini and Elena Pacella]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Aloisa Librando, Sandra Cinzia Carlesimo, Giorgio Albanese, Giuseppe Maria Albanese, Raffaele Migliorini and Elena Pacella</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181210]]></guid><cfi:id>676</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[XEN&#174; implant and trabeculectomy medium-term quality of life assessment and comparison of results]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181211]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate and compare the quality of life of patients submitted to XEN&#174; implant or trabeculectomy and the relationship with potentially involved variables.
METHODS: A cross-sectional study of patients with advanced open-angle glaucoma who underwent implantation of XEN&#174; (group 1) and trabeculectomy (group 2) between October 2015 and February 2017. The studied variables were: age, gender, follow-up time, need of topical anti-hypertensive therapy, visual acuity and intraocular pressure (IOP). The quantification of the quality of life was attained through the Glaucoma Symptom Scale (GSS) questionnaire.
RESULTS: Totally 34 eyes (34 patients) were included, 17 in each group. The mean GSS scores for group 1 were 42.6±6.8 (median, 47; p25, 36.5; p75, 48.5) and for group 2 it was 41.6±7.0 (median, 43; p25, 36.5; p75, 47.0; P=0.34). There was a strong negative correlation between the need for topical anti-hypertensive drugs and the GSS result in both groups (r=-0.88, P<0.01, r=-0.59, P=0.01, respectively) and a moderate negative correlation with IOP in group 1 (r=-0.50, P=0.03).
CONCLUSION: The analysis demonstrates the non-inferiority of medium-term quality of life of one group in relation to the other (XEN&#174; implant and trabeculectomy). The number of topical anti-hypertensive drugs and IOP negatively influenced the quality of life.]]></description>
<pubDate>2018/12/5 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ana Luísa Basílio, Nuno Moura-Coelho, Inês Passos, Mariana Sá Cardoso, Isabel Domingues, Maria Reina, Rita Flores and Teresa Gomes]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ana Luísa Basílio, Nuno Moura-Coelho, Inês Passos, Mariana Sá Cardoso, Isabel Domingues, Maria Reina, Rita Flores and Teresa Gomes</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181211]]></guid><cfi:id>675</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Long term follow-up of a family with GUCY2D dominant cone dystrophy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181212]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To describe long term follow-up in a family with GUCY2D dominant cone dystrophy.METHODS: Optical coherence tomography scans and fundus autofluorescence images were obtained. Flash and pattern electroretinograms (ERGs) and occipital pattern reversal visual evoked potentials were recorded.RESULTS: Two members of the same family (father and son) were identified to have the heterozygous R838C mutation in the GUCY2D gene. The father presented at the age of 45 with bilateral bull’s eye maculopathy and temporal disc pallor. Over 13y of serial follow up visits, the bull’s eye maculopathy progressed gradually into macular atrophy. Electrophysiological tests were significantly degraded suggesting poor macular function. Spectral-domain optical coherence tomography (SD-OCT) scans showed progressive loss and disruption of the ellipsoid layer at the foveal level. His son presented at the age of 16 with bilateral granular retinal pigment epithelial changes in both maculae. Electrophysiological testing was initially borderline normal but has gradually deteriorated to show reduced cone ERGs and macula function. SD-OCT demonstrated gradual macular thinning and atrophy bilaterally. Unlike his father, there was no disruption of the ellipsoid layer.CONCLUSION: Both family members exhibited gradual changes in their fundi, electrophysiological testing and multimodal imaging. Changes were milder than those observed in other mutations of the same gene.]]></description>
<pubDate>2018/12/5 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Georgios Tsokolas, Hussein Almuhtaseb, Helen Griffiths, Fatima Shawkat, Reuben J. Pengelly, Sarah Ennis and Andrew Lotery]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Georgios Tsokolas, Hussein Almuhtaseb, Helen Griffiths, Fatima Shawkat, Reuben J. Pengelly, Sarah Ennis and Andrew Lotery</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181212]]></guid><cfi:id>674</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Treatment of refractory diabetic macular edema with a fluocinolone acetonide implant in vitrectomized and non-vitrectomized eyes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181213]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report real-life data on the use of an intravitreal fluocinolone acetonide implant in the treatment of refractory diabetic macular edema (DME) in pars plana vitrectomized (PPV) and non-PPV eyes.METHODS: This was a comparative retrospective observational study of 23 eyes with chronic DME. Best-corrected visual acuity (BCVA) and central macular thickness (CMT) were recorded at baseline, 1, 4 and 12mo. Descriptive statistics and non-parametric tests were performed to analyze and compare PPV and non-PPV eyes.RESULTS: Seven PPV and 16 non-PPV eyes were included in the study. Median BCVA in the non-PPV group varied from 0.65 logMAR [Interquartile range (IQR): 0.40] at baseline to 0.42 logMAR (IQR: 0.40) at 12mo. Median CMT varied from 430 µm (IQR: 131.3) at baseline to 317 µm (IQR: 107.5) at 12mo. Median BCVA in the PPV group varied from 0.60 logMAR (IQR: 0.62) at baseline to 0.74 logMAR (IQR: 0.34) at 12mo. Median CMT varied from 483 µm (IQR: 146) at baseline to 397 µm (IQR: 132) at 12mo. Of 0/7 eyes and 1/16 eyes in the PPV and non-PPV eyes respectively had a baseline visual acuity of 6/12 or better (0.3 logMAR). At last follow up, 1/7 and 5/16 eyes in the PPV and non-PPV group respectively achieved a visual acuity of 6/12 or better.CONCLUSION: Visual outcomes are modest following the use of the fluocinolone acetonide implant for chronic DME. The steroid implant is a useful treatment option in the management of refractory DME in vitrectomized and non-vitrectmized eyes.]]></description>
<pubDate>2018/12/5 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Alberto La Mantia, Alan Hawrami, Heidi Laviers, Sudeshna Patra and Hadi Zambarakji]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Alberto La Mantia, Alan Hawrami, Heidi Laviers, Sudeshna Patra and Hadi Zambarakji</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181213]]></guid><cfi:id>673</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[The thickness and volume of the choroid, outer retinal layers and retinal pigment epithelium layer changes in patients with diabetic retinopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181214]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the thickness and volume changes of the choroidal, outer retinal layers (ORL) and retinal pigment epithelium (RPE) in patients with diabetic retinopathy (DR) using optical coherence tomography (OCT) and correlate them with visual acuity.
METHODS: We carried out a retrospective observational case series. Consecutive DR patients were recruited for color fundus photography and OCT assessment. The RPE, ORL and choroidal thickness were measured. The correlation with the best-corrected visual acuity (BCVA) was also investigated.
RESULTS: The study included 128 eyes, comprising 45 eyes of 25 diabetic macular edema (DME) patients, 34 eyes of 20 DR without DME (non-DME) patients, and 49 eyes of 25 age-matched normal individuals. The choroidal thickness in DR patients were decreased statistically significantly compared with the control group (P<0.05). The mean macular ORL thickness in DME (73.02±15.34 μm) and non-DME groups (76.35±7.32 μm) were decreased statistically significantly compared with the control group (80.20±5.85 μm; P=0.006, P=0.013, respectively). In both the non-DME and DME groups, the RPE thickness were decreased compared with the control group (P<0.05), except in the macular and central ring. The BCVA were significant interactions with the total inner retinal volume and macular RPE thickness in the DME group (r=0.115, P<0.001, r=-0.013, P=0.017, respectively).
CONCLUSION: The choroid, ORL and RPE thickness are significantly decreased in DR patients compared with controls in different segments.]]></description>
<pubDate>2018/12/5 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xiang-Ning Wang, Shu-Ting Li, Wei Li, Yan-Jun Hua and Qiang Wu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiang-Ning Wang, Shu-Ting Li, Wei Li, Yan-Jun Hua and Qiang Wu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181214]]></guid><cfi:id>672</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Relation between preoperative hyperopia and surgical outcome in infantile esotropia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181215]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the relation between preoperative hyperopia and surgical outcomes of infantile esotropia in patients younger than 24 months of age.
METHODS: Medical records of patients who underwent bilateral medial rectus muscle recession for infantile esotropia between November 1, 2002 and December 1, 2011 were retrospectively reviewed. Patients were divided into two groups according to the degree of preoperative hyperopia. Group I had less than +3.0 diopter (D) of hyperopia and group II had between +3.0 and +5.0 D of hyperopia. Postoperative alignments were evaluated 1wk, 3, 6mo, and 1y after surgery. Following the 1-year postoperative visit, patients were monitored yearly. Relationships between preoperative factors including hyperopia and postoperative outcomes were evaluated.
RESULTS: Forty-six patients were included, with 33 patients in group I and 13 patients in group II. The preoperative mean refractive error was +0.88 D in group I and +3.45 D in group II. Surgical outcomes were not significantly different between groups at any postoperative time point examined. Cumulative probability of surgical success, prevalence of inferior oblique overaction, dissociated vertical deviation, and re-operation rate were not significantly different between groups.
CONCLUSION: Preoperative moderate hyperopia (less than +5.0 D) did not affect the surgical outcome of infantile esotropia. Therefore, the surgical correction of esotropia should be considered when the angle of esodeviation is unchanged following hyperopia correction, even in children with moderate hyperopia.]]></description>
<pubDate>2018/12/5 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Haeng Jin Lee, Jeong-Ah Kim, Seong-Joon Kim and Young Suk Yu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Haeng Jin Lee, Jeong-Ah Kim, Seong-Joon Kim and Young Suk Yu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181215]]></guid><cfi:id>671</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Two-stage procedure in the management of selected cases of keratoconus: clear lens extraction with aspherical IOL implantation followed by WFG-PRK]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181105]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the objective and subjective results of a two-stage procedure for management of keratoconus: clear lensectomy with aspherical intraocular lens (IOL) implantation followed by wave front-guided photorefractive keratotomy (WFG-PRK).METHODS: This prospective interventional non-randomized study included patients aged 35 years old or more with grade I and II stable keratoconus, a clear visual axis, minimal corneal thickness (MCT) 420 μm or more and average keratometric reading (K) less than 54 diopter (D). Refraction of all selected eyes should be -8.00 D sphere or more with less than -6.00 D cylinder and could be corrected two lines or more with spectacles or contact lenses. All studied eyes underwent a two-stage approach treatment: first refractive lens exchange and aspherical IOL implantation followed, after at least 3mo, by WFG-PRK. Pre and postoperative complete ophthalmological examination were performed. Topographical, visual and aberrometric results were recorded and evaluated during 6mo follow up period. Moreover, patient satisfaction and other subjective outcomes were also analyzed.RESULTS: The 13 eyes of 11 patients diagnosed with stable keratoconus and aged from 39 to 49y (42.4±6.2y) were enrolled in the study. At baseline, 8 eyes had grade I and 5 eyes had grade II keratoconus. The manifest sphere was -10.3±4.2 D (ranged from -8.0 to -14.0 D) and the manifest cylinder was -4.2±1.2 D (ranged from -1.75 to -5.50 D). After the two-stage procedure, sphere and cylinder reduced significantly to -0.43±0.22 D and -1.3±0.72 D respectively (P<0.001). There was also a highly significant improvement in the mean uncorrected distance visual acuity (UDVA) from logMAR 1.41±0.49 preoperatively to 0.51±0.16 postoperatively (P<0.001) and the mean corrected distance visual acuity (CDVA) from 0.76±0.24 preoperatively to 0.49±0.13 after the operation (P<0.001). All aberrometric and mesopic vision parameters and most of the topographical indices demonstrated highly significant improvement that remains stable until the end of follow up. All recorded subjective data revealed a high degree of patient satisfaction.CONCLUSION: Two-stage approach (clear lens exchange with monofocal IOL followed by WFG-PRK) in selected cases of keratoconus is a safe, effective and highly predictable procedure with satisfactory visual and refractive results.]]></description>
<pubDate>2018/11/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Waleed Abou Samra, Tharwat Mokbel, Mohammed Elwan, Sameh Saleh, Ahmed Elwehidy, Mohammed Iqbal and Adel Ellayeh]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Waleed Abou Samra, Tharwat Mokbel, Mohammed Elwan, Sameh Saleh, Ahmed Elwehidy, Mohammed Iqbal and Adel Ellayeh</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181105]]></guid><cfi:id>670</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Endothelial parameters in central and peripheral cornea in patients wearing contact lenses]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181106]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To measure the parameters of endothelium in the central and peripheral parts of the cornea and evaluate the influence of wearing the hard and soft contact lenses on the mentioned parameters.
METHODS: A specular microscope was used to measure the corneal endothelium parameters in both eyes of 139 Caucasians (a total of 278). All participants were divided into three groups: soft lens wearers, hard lens wearers and a control group. Factors, such as age, smoking, types of lens material, duration of lens wear and lens air permeability were assessed to determine their impact on the morphometric parameters of the endothelium.
RESULTS: A lower percentage of hexagon-like cells and higher cell variation than in other groups were determined in hard contact lens wearers. The difference in density of endotheliocytes between the groups was not observed. The measurements of the morphometric parameters in soft contact lens wearers did not depend neither on the duration of lens wear, nor on air permeability. The relation between the patients’ age and the variation of endothelium parameters was determined in the group of hard contact lens wearers.
CONCLUSION: Wearing hard contact lenses provokes pleomorphism and polymegethism of the corneal endothelium, while soft contact lenses do not impact any parameters of the endothelium, most likely due to higher air permeability.]]></description>
<pubDate>2018/11/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Saulius Galgauskas, Justina Ignataviciute, Zivile Vieversyte and Rimvydas Asoklis]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Saulius Galgauskas, Justina Ignataviciute, Zivile Vieversyte and Rimvydas Asoklis</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181106]]></guid><cfi:id>669</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Correlation between choroidal thickness and intraocular pressure after 23-gauge vitrectomy for idiopathic epiretinal membrane]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181107]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the relationship between the subfoveal choroidal thickness (CT) and intraocular pressure (IOP) following idiopathic epiretinal membrane (ERM) surgery.
METHODS: Retrospective observational case series of patients who had undergone 23-gauge vitrectomy for an ERM. The measurements of CT and IOP were done at the baseline and 1d, 1wk, 1, 3, 6, and 12mo after the surgery.
RESULTS: Forty-four eyes of 43 patients with a mean age of 69.8±9.5y were studied. The CT was 200.8±86.3 μm at the baseline, 210.1±83.5 μm at 1d, 213.2±85.4 μm at 1wk, 203.1±84.0 μm at 1mo, 197.5±85.5 μm at 3mo, 197.7±84.0 μm　at 6mo, and 191.2±86.8 μm at 12mo after surgery. The CT on day 1 and week 1 after the surgery was significantly thicker than that at the baseline CT (P=0.0023 and P<0.0001). The CT at 12mo after surgery was significantly thinner than the baseline (P=0.0062). The IOP on day 1 and week 1 were significantly lower than the baseline (P<0.0001 and P=0.0042). The IOP at 1, 3, 6, and 12mo after surgery were significantly higher than the baseline IOP (P=0.0087, P=0.0023, P<0.00051, and P<0.0001). The rates of changes in the CT between baseline and day 1 and week 1 were significantly and negatively correlated with the rates of change in the IOP (P<0.0001 and P=0.046). In the group with the IOP change rate of -30% or less at 1d postoperatively, the change rate of CT was -21.1% to 31.2% (9.8%±12.4%) and in the group of -29% or more, it was -8.9% to 28.0% (2.6%±8.9%). The change rate of CT in the group with the IOP change rate of -30% or less was significantly higher than the group of -29% or more (P=0.016).
CONCLUSION: CT increases soon after the ERM surgery which is probably due to the transient hypotony, showing that IOP may be a significant confounding factor for CT.]]></description>
<pubDate>2018/11/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Masahiro Ishida, Takashi Wakakuri and Yutaka Imamura]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Masahiro Ishida, Takashi Wakakuri and Yutaka Imamura</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181107]]></guid><cfi:id>668</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Air tamponade and without heavy liquid usage in pars plana vitrectomy for rhegmatogenous retinal detachment repair]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181108]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report the results of rhegmatogenous retinal detachment (RRD) repair after pars plana vitrectomy (PPV) without operative use of heavy liquid, and utilizing air tamponade in selected cases.
METHODS: RRD patients without severity of proliferative vitreoretinopathy C2 or more underwent PPV without operative use of heavy liquid, and utilizing air tamponade were consecutively enrolled. Alternative postoperative facedown position or lateral position was required for 3-5d.
RESULTS: Totally 36 eyes of 36 patients (24 males, 66.7%) aged 53.8±10.9y underwent this modified surgery. The mean number of retinal break was 2.1±1.3. Most of the eyes (29, 80.6%) had retinal detachment involving more than one quadrant. Twenty-two (61.1%) eyes with cataract had combined phacoemulsification and intraocular lens implantation. The mean follow up time was 4.6±1.8mo. Two eyes with retinal redetachment underwent a second retinal repair surgery with silicone oil tamponade, yielding the primary reattachment rate to 94.4% (34/36). Six (16.7%) eyes had intraocular pressure higher than 25 mm Hg. The visual acuity (logMAR) improved from 0.98±0.74 preoperatively to 0.52±0.31 postoperatively (P<0.001).
CONCLUSION: The success rate of this modified retinal repair surgery is comparable with traditional surgery. This technique can be considered for certain retinal detachment patients, since its apparent advantages included lower surgical complications, reduced surgery expenditure, shorter time for postoperative facedown position, and avoiding silicone oil removal surgery.]]></description>
<pubDate>2018/11/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Zhong Lin, Qi-Hua Liang, Ke Lin, Zhi-Xiang Hu, Tian-Yu Chen, Rong-Han Wu and Nived Moonasar]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zhong Lin, Qi-Hua Liang, Ke Lin, Zhi-Xiang Hu, Tian-Yu Chen, Rong-Han Wu and Nived Moonasar</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181108]]></guid><cfi:id>667</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A quantitative comparison of five optical coherence tomography angiography systems in clinical performance]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181109]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the clinical performance of 4 spectral-domain (SD) optical coherence tomography angiography (OCTA) systems: AngioVueTM, AngioPlexTM, Spectralis&#174; OCTA, AngioScan, and 1 swept-source (SS) OCTA SS OCT AngioTM.
METHODS: Twenty-seven undilated right eyes of 27 participants underwent OCTA examination using five different systems respectively for both 3×3 and 6×6 mm2 scan pattern (Spectralis OCTA for 3×3 mm2 scan only). Image quality, including vessel valid visibility and the number of motion artifacts, and acquisition time were evaluated. Repeated measures analysis of variance (ANOVA) with Bonferroni's post-test and Friedman test with Dunn's post-test were used to compare measurements.
RESULTS: The age of the subjects was 28.19±5.55y (range, 23-49y). The spherical equivalent refraction was -2.55±1.84 D (range, 0.00 to -5.25 D). Significant difference was observed in the evaluation of vessel valid visibility (AngioVue the highest: 0.111±0.031 for 3×3 mm2 scan and 0.128±0.020 for 6×6 mm2 scan), number of motion artifacts (AngioVue the fewest: 0.778±1.086 for 3×3 mm2 scan and 0.333±0.620 for 6×6 mm2 scan) and acquisition time (AngioPlex the shortest: 8.537±1.921s for 3×3 mm2 scan and 8.298±1.741s for 6×6 mm2 scan; all P<0.001).
CONCLUSION: There is poor agreement of measurements among systems. AngioVue provides images with the highest vessel valid visibility and the fewest motion artifacts. AngioPlex achieves the shortest acquisition.]]></description>
<pubDate>2018/11/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xin-Xin Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xin-Xin Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181109]]></guid><cfi:id>666</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of persistent submacular fluid in different preoperative macular status after vitrectomy for rhegmatogenous retinal detachment]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181110]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the incidence of persistent submacular fluid (SMF) and visual outcome after pars plana vitrectomy (PPV) for rhegmatogenous retinal detachment (RRD) in different preoperative macular status according to optical coherence tomography (OCT).
METHODS: A non-randomized, retrospective review was performed for patients who underwent successful PPV for RRD. OCT exams were taken preoperatively and 1mo after surgery, until SMF disappeared. According to the preoperative macular status on OCT, patients were divided into two groups: macula-off RRD (Group A) and macula-on RRD (Group B). In Group A, there were two subgroups: macula partly detached (Group A1) and macula totally detached (Group A2). The main outcome measures were the presence of SMF on OCT 1mo after surgery, and the preoperative and postoperative best corrected visual acuities (BCVA), among the different groups and depending on the presence or absence of persistent SMF.
RESULTS: A total of 139 eyes of 139 patients were included in the study. Persistent SMF at 1mo after surgery was 15.8% (22/139), all occurring in Group A (22/101); Group B had no SMF at 1mo after surgery (0/38, P=0.002). The incidence of persistent SMF at 1mo after surgery in Group A1 was 50% (14/28), and in Group A2 was 11.0% (8/73, P<0.001). Significant differences were shown between the presence and absence of persistent SMF on foveola-off RRD, the preoperative BCVA, the 1mo postoperative BCVA, and the degree of the BCVA improvement from 1mo postoperatively to the final follow-up (P<0.05). However, there were no significant differences in the final BCVA (P>0.05).
CONCLUSION: Persistent SMF after PPV for retinal detachment is associated with preoperative macular status. Macula-uninvolving RRD shows no persistent SMF after PPV. Macular partly detached RRD has a higher incidence of SMF than macula totally detached RRD after PPV. The persistence of SMF may be responsible for the delayed visual recovery, whereas there were no significant differences in the final visual acuity.]]></description>
<pubDate>2018/11/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jian-Bo Mao, Jing-Jing Lin, Xue-Ting Yu, Dan Cheng, Yi-Qi Chen, Ji-Wei Tao, Han-Fei Wu, Lu Jiang, Yun Zhang and Li-Jun Shen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jian-Bo Mao, Jing-Jing Lin, Xue-Ting Yu, Dan Cheng, Yi-Qi Chen, Ji-Wei Tao, Han-Fei Wu, Lu Jiang, Yun Zhang and Li-Jun Shen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181110]]></guid><cfi:id>665</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[One-year real-world outcomes of ranibizumab 0.5 mg treatment in Taiwanese patients with polypoidal choroidal vasculopathy: a subgroup analysis of the REAL study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181111]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the effectiveness and safety of ranibizumab 0.5 mg in Taiwanese patients with polypoidal choroidal vasculopathy (PCV) by performing a retrospective exploratory subgroup analysis of the REAL study.
METHODS: REAL was a 12-month, observational, prospective, non-interventional phase IV post-marketing surveillance study conducted at 9 centers in Taiwan. The study collected data as part of the routine patient visits from the medical records of patients with neovascular age-related macular degeneration treated with ranibizumab 0.5 mg according to local standard medical practice and local label and/or reimbursement guidelines. The presence of PCV at baseline was determined using indocyanine green angiography.
RESULTS: At baseline, PCV was diagnosed in 64 of the 303 enrolled patients (21.1%). Of these, 41 patients (64.1%) had received prior treatment; 15 (23.4%) patients had received ranibizumab. The intent-to-treat population included 58 patients; 47 (80%) who received ranibizumab and 11 (20%) who received ranibizumab plus photodynamic therapy (PDT; 9 patients received once, 2 patients received twice). Bevacizumab was used as a concomitant medication in a similar percentage of patients who received ranibizumab (43%, n=20) or ranibizumab plus PDT (45%, n=5). In patients who received ranibizumab, visual acuity (VA) at baseline was 50.1±12.9 Early Treatment Diabetic Retinopathy Study letters, and the gain at month 12 was 1.1±17.8 letters. In patients who received ranibizumab plus PDT, VA at baseline was 51.4±15.9 letters, and there was a marked gain in VA at month 12 (14.0±9.2 letters, P=0.0009). In the intent-to-treat population, the reduction in central retinal subfield thickness from baseline at month 12 was 69.6±122.6 μm (baseline: 310.8±109.8 μm, P=0.0004). The safety results were consistent with the well-characterized safety profile of ranibizumab.
CONCLUSION: In real-world settings, ranibizumab 0.5 mg treatment for 12mo results in maintenance of VA and reduction in central retinal subfield thickness in Taiwanese patients with PCV. Improvements in VA are observed in patients who received ranibizumab plus PDT. There are no new safety findings.]]></description>
<pubDate>2018/11/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[San-Ni Chen, Cheng-Kuo Cheng, Ling Yeung, Jiann-Torng Chen, Wei-Chun Chan, Jorn-Hon Liu, Shwu-Jiuan Sheu, Wen-Chuan Wu and Chi-Chun Lai]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>San-Ni Chen, Cheng-Kuo Cheng, Ling Yeung, Jiann-Torng Chen, Wei-Chun Chan, Jorn-Hon Liu, Shwu-Jiuan Sheu, Wen-Chuan Wu and Chi-Chun Lai</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181111]]></guid><cfi:id>664</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Preventing condensation of objective lens in noncontact wide-angle viewing systems during vitrectomy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181112]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the optimal conditions for preventing condensation of objective lens during vitrectomy with noncontact wide-angle viewing systems (WAVSs).
METHODS: We explored the effectiveness of the coating with ophthalmic viscoelastic device (OVDs) on the corneal surface and the soaking the objective lens in warm-saline for preventing condensation of objective lens. First, to find the optimal soaking time to keep the objective lens warm, we measured the temperature of objective lens every minute after soaking in warm saline. Second, to find optimal distance between cornea and objective lens, which provide as wide a view as possible and less condensation at the same time, we measured the condensation time with different distances. With the obtained optimal soaking time and distance, we explored the effect of coating cornea with OVDs and soaking objective lens in warm saline on condensation time.
RESULTS: One and 5min of soaking in warm saline was most effective for keeping the lens warm enough (45.1℃±2.1℃ for 1min and 46.4℃±1.0℃ for 5min, P=0.109). The mean condensation times for the control group at 1, 3, and 5 mm from corneal surface to objective lens were 1±0.4, 4±1.4, 190±26.1s, respectively, thus 5 mm was most optimal distance for vitrectomy with WAVSs. For the OVD coating group, the mean condensation times were 1.5±0.3, 13±1.4, and 200±23.9s at 1, 3, and 5 mm distance and borderline significant compared with control group (P=0.068, 0.051, and 0.063, respectively). With the 1-minute warm saline soaking group, the mean condensation time were extended to 188±34.4, 416±65.7, and 600±121.3s at 1, 3, and 5 mm distance and statistically significant compared with control (P=0.043, 0.041 and 0.043, respectively).
CONCLUSION: OVD coating on corneal surface shows no difference on condensation time with control group. However, soaking the objective lens in warm saline revealed statistically significant extension of condensation time compared to control group. Therefore, keeping the objective lens warm with soaking in warm saline is a simple but effective to prevent condensation of objective lens during vitrectomy. The thermodynamics between objective lens and cornea during vitrectomy warrants further investigation.]]></description>
<pubDate>2018/11/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jung Pil Lee, Jinsoo Kim, Inwon Park, Ho Ra and Soonil Kwon]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jung Pil Lee, Jinsoo Kim, Inwon Park, Ho Ra and Soonil Kwon</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181112]]></guid><cfi:id>663</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Abnormal resting-state functional network centrality in patients with high myopia: evidence from a voxel-wise degree centrality analysis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181113]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the functional networks underlying the brain-activity changes of patients with high myopia using the voxel-wise degree centrality (DC) method.
METHODS: In total, 38 patients with high myopia (HM) (17 males and 21 females), whose binocular refractive diopter were -6.00 to -7.00 D, and 38 healthy controls (17 males and 21 females), closely matched in age, sex, and education levels, participated in the study. Spontaneous brain activities were evaluated using the voxel-wise DC method. The receiver operating characteristic curve was measured to distinguish patients with HM from healthy controls. Correlation analysis was used to explore the relationship between the observed mean DC values of the different brain areas and the behavioral performance.
RESULTS: Compared with healthy controls, HM patients had significantly decreased DC values in the right inferior frontal gyrus/insula, right middle frontal gyrus, and right supramarginal/inferior parietal lobule (P<0.05). In contrast, HM patients had significantly increased DC values in the right cerebellum posterior lobe, left precentral gyrus/postcentral gyrus, and right middle cingulate gyrus (P<0.05). However, no relationship was found between the observed mean DC values of the different brain areas and the behavioral performance (P>0.05).
CONCLUSION: HM is associated with abnormalities in many brain regions, which may indicate the neural mechanisms of HM. The altered DC values may be used as a useful biomarker for the brain activity changes in HM patients.]]></description>
<pubDate>2018/11/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yu-Xiang Hu, Jun-Rong He, Bo Yang, Xin Huang, Yu-Ping Li, Fu-Qing Zhou, Xiao-Xuan Xu, Yu-Lin Zhong, Jun Wang and Xiao-Rong Wu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yu-Xiang Hu, Jun-Rong He, Bo Yang, Xin Huang, Yu-Ping Li, Fu-Qing Zhou, Xiao-Xuan Xu, Yu-Lin Zhong, Jun Wang and Xiao-Rong Wu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181113]]></guid><cfi:id>662</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Preliminary study on visual recognition under low visibility conditions caused by artificial dynamic smog]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181114]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To quantitatively evaluate the effect of a simulated smog environment on human visual function by psychophysical methods.
METHODS: The smog environment was simulated in a 40×40×60 cm3 glass chamber filled with a PM2.5 aerosol, and 14 subjects with normal visual function were examined by psychophysical methods with the foggy smog box placed in front of their eyes. The transmission of light through the smog box, an indication of the percentage concentration of smog, was determined with a luminance meter. Visual function under different smog concentrations was evaluated by the E-visual acuity, crowded E-visual acuity and contrast sensitivity.
RESULTS: E-visual acuity, crowded E-visual acuity and contrast sensitivity were all impaired with a decrease in the transmission rate (TR) according to power functions, with invariable exponents of -1.41, -1.62 and -0.7, respectively, and R2 values of 0.99 for E and crowded E-visual acuity, 0.96 for contrast sensitivity. Crowded E-visual acuity decreased faster than E-visual acuity. There was a good correlation between the TR, extinction coefficient and visibility under heavy-smog conditions.
CONCLUSION: Increases in smog concentration have a strong effect on visual function.]]></description>
<pubDate>2018/11/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xu-Hong Zhang, Zhe-Yi Chen, Bin-Bin Su, Karunanedi Soobraydoo, Hao-Ran Wu, Qin-Zhuan Ren, Lu Sun, Fan Lyu and Jun Jiang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xu-Hong Zhang, Zhe-Yi Chen, Bin-Bin Su, Karunanedi Soobraydoo, Hao-Ran Wu, Qin-Zhuan Ren, Lu Sun, Fan Lyu and Jun Jiang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181114]]></guid><cfi:id>661</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical features of posterior microphthalmic and nanophthalmic eyes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181115]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To clinically differentiate nanophthalmos (NO) and posterior microphthalmos (PM) and to explore the mechanisms related to papillomacular folds (PMF).
METHODS: Medical records of 34 unrelated patients with microphthalmos (54 eyes) from April 2009 to October 2017 were retrospectively reviewed.
RESULTS: Fourteen eyes of 7 unrelated patients with NO and PM were included in the study. The presenting age of the NO cohort was significantly higher compared with the PM cohort (NO: 27±16y; PM: 3.7±0.6y). PMF was more likely to occur in cases with PM than in NO (25% in NO, 100% in PM). The anatomic features of PMF from optical coherence tomography (OCT) included: ganglion cell layer, inner plexiform layer, inner nuclear layer, outer plexiform layer and outer nuclear layer. In eyes without an apparent PMF (these were all NO eyes), rudimentary fovea without a foveal pit was noted. Four eyes that were NO developed angle closure glaucoma. Three NO eyes developed exudative retinal detachment and were successfully treated with lamellar sclerectomy.
CONCLUSION: Posterior segment changes are pervasive both in PM and NO. Complications like angle closure glaucoma and exudative retinal detachment are likely to occur in eyes with NO but not with PM. Detailed OCT analysis found that PMF was partially a neural retinal issue, suggesting that redundancy of retinal issues involved only inner retinal layers.]]></description>
<pubDate>2018/11/7 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jing-Jing Liu, Yi-Ye Chen, Xiang Zhang and Pei-Quan Zhao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jing-Jing Liu, Yi-Ye Chen, Xiang Zhang and Pei-Quan Zhao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181115]]></guid><cfi:id>660</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Laser-assisted dacryocystorhinostomy in nasolacrimal duct obstruction: 5-year follow-up]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181007]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the long-term sucess rate of laser-assisted dacryocystorhinostomy (L-DCR) in patients with nasolacrimal duct obstruction (NDO).
METHODS: Forty-one eyes of forty patients aged between 21-85y (mean 56.7y) who underwent L-DCR for the treatment of NDO were included in this retrospective, non-randomized study. The follow-up time was 72mo. Functional sucess was defined as the disappearance of epiphora under normal conditions and the presence of a patent ostium on lacrimal irrigation. Anatomical success was defined as a patent lacrimal passage on syringing besides continuing epiphora. Surgical failure was defined as persistent epiphora and closed ostium.
RESULTS: Twenty-seven of 40 patients (67.5%) were female and 13 of 40 patients (32.5%) were male. The NDO was right-sided in 17 (42.5%) patients and left-sided in 22 (55%) patients whereas 1 (2.5%) patient had undergone bilateral surgery. In 11 (27.5%) patients there were additional nasal abnormalities requiring simultaneous surgical approach. The average time for L-DCR was 26.50±4.9min (16-39min) and the average total amount of laser energy used was 287±27.9 J (239-367 J). At the 5y follow-up, anatomical sucess rate was 75.0% (30 patients) and functional success rate was 65.0% (26 patients), whereas surgical failure was seen in 25% (10 patients). Revision of surgery was performed in 10 cases (25.0%); failure of revision surgery was seen in 2 cases (5.0%).
CONCLUSION: Transcanalicular L-DCR is a reliable and fast procedure in the treatment of NDO. It can be alternative to external DCR which is accepted as the gold standard currently. The functional and anatomical success rate is higher in the first months and years, but still satisfactory at fifth year.]]></description>
<pubDate>2018/9/4 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mustafa Do&#287;an, Anar Alizada, Güliz Fatma Yava&#351;, Orhan Kemal Kahveci and Osman Bakan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mustafa Do&#287;an, Anar Alizada, Güliz Fatma Yava&#351;, Orhan Kemal Kahveci and Osman Bakan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181007]]></guid><cfi:id>659</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Contralateral eye study of refractive, topographic and aberrometric outcomes after femtosecond assisted MyoRing implantation and DALK for management of keratoconus]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181008]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the efficacy of femtosecond laser assisted MyoRing intrastromal corneal implant and deep anterior lamellar keratoplasty (DALK) for management of moderate to advanced keratoconus regarding the degree of changes in visual acuity, refraction, corneal asphericity and aberrations.
METHODS: A prospective non comparative interventional case study was conducted in Ophthalmology Department, Ain Shams University Hospital in the period from January 2015 to February 2017. The study included 30 eyes of moderate to advanced keratoconus. MyoRing was implanted in one eye (Group I) and DALK operation was performed in the contralateral eye of the same patient (Group II). Preoperative and 6mo post-operative uncorrected visual acuity (UCVA), corrected distance visual acuity (CDVA), spherical equivalent (SE), corneal and refractive astigmatisms, keratometry and Q-value using topography images were acquired. Quality of vision was assessed in all eyes including total corneal, anterior corneal high order aberrations analysis at 5 mm pupil size and the Strehl ratio of point spread function (PSF) as an objective measure of glare.
RESULTS: Mean postoperative UCVA, CDVA, SE, refractive astigmatism, keratometry readings and asphericity were statistically improved compared to preoperative parameters in both groups (P<0.05). Significant reduction of all corneal aberrations following both techniques (P<0.05) was achieved except mean trefoil and mean PSF in Group I (P>0.05). Postoperative corneal aberrations were significantly lower in Group II compared to Group I. A statistically significant negative correlation was found in Group I between the mean change in CDVA (logMAR) and the mean preoperative and mean postoperative total corneal aberrations root mean square (RMS; r=-0.78, P=0.04). Also a statistically significant negative correlation was found between mean preoperative coma RMS and mean post PSF (r=-0.86, P=0.01). In Group II, there was a statistically significant positive correlation between mean change in CDVA (logMAR) and mean change in Kmax (r=0.87, P=0.01) and between mean change in refractive cylinder and mean postoperative PSF (r=0.76, P=0.05).
CONCLUSION: Femtosecond laser assisted MyoRing and DALK are effective in improving visual acuities, refraction, corneal asphericity and aberrations. MyoRing reduced spherical error more than the corneal cylinder. Post operative homogenous corneal surface and good image quality were achieved following both techniques compared to the preoperative state. However, DALK results in better image quality and lower corneal aberrations.]]></description>
<pubDate>2018/9/4 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mohamed Omar Yousif and Azza Mohamed Ahmed Said]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mohamed Omar Yousif and Azza Mohamed Ahmed Said</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181008]]></guid><cfi:id>658</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[The assessment of structural changes on optic nerve head and macula in primary open angle glaucoma and ocular hypertension]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181009]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess morphological changes in macula, retinal nerve fiber layer (RNFL) and optic nevre head (ONH) of cases with primary open angle glaucoma (POAG) and ocular hypertension (OH) with spectral domain optic coherence tomography (OCT).
METHODS: This study included 109 eyes from 62 POAG patients, 50 eyes from 30 OH patients, and 101 eyes from 53 healthy volunteers. Data gained by OCT were compared with perimetry indexes. ONH, RNFL and macula analysis were performed for all subjects. Rim area, disc area, average cup/disc (C/D) ratio, vertical C/D ratio, cup volume data were recorded during ONH analysis. Average RNFL thickness and the thickness of four quadrants (superior, inferior, nasal and temporal) was established in microns. In total, nine macular quadrants involving the foveal region mentioned in the Early Treatment Diabetic Treatment Study (ETDRS) template were measured, and average macular thickness and macular volume data were recorded during macula analysis. Differences between groups were evaluated with the one-way ANOVA test. Tukey’s multiple comparison test was performed to detect difference between groups. Receiver-operating characteristic (ROC) analysis was done for early stage POAG patients to establish sensitivity and specificity of chosen parameters in early stage POAG. Area under the receiver operating characteristic (AUROC) values were calculated to compare ROC areas.
RESULTS: Statistically significant differences were found in all ONH parameters, except optic disc area. Neuroretinal rim area was identified as the parameter with the highest difference between groups (F=21.72, P<0.05). The highest correlation between ONH parameters and perimetry was observed at neuroretinal rim region (r=0.487). Inferior RNFL thickness was established as the parameter with the highest difference between groups among RNFL parameters. In the mean of all glaucoma patients, the highest correlation between data handled with OCT and mean deviation was observed in RNFL thickness. Average macular thickness was detected as the parameter with the highest difference between groups among macular parameters. The highest correlation between macula parameters and perimetry indexes was observed between average macular thickness and perimetry indexes (r=0.514).
CONCLUSION: Although the assessment of ONH and the analysis of macular thickness are important in diagnosis and treatment, RNFL assessment is the most valuable parameter.]]></description>
<pubDate>2018/9/4 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Kenan Dagdelen and Emrah Dirican]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Kenan Dagdelen and Emrah Dirican</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181009]]></guid><cfi:id>657</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of intravitreal ganciclovir monotherapy and combination with foscarnet as initial therapy for cytomegalovirus retinitis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181010]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the effectiveness between multiple intravitreal injections of ganciclovir alone and combined with foscarnet as initial treatment for patients with newly-onset cytomegalovirus retinitis (CMVR).
METHODS: The retrospective study observed 37 patients (58 eyes) who suffered from CMVR onset between 2013 and 2015. Among them, 35 eyes underwent 4 weekly intravitreal injections of 3.0 mg ganciclovir, and 23 eyes underwent 4 weekly injections of 3.0 mg ganciclovir combined with 2.4 mg foscarnet. Visual acuity, intraocular pressure and viral load of cytomegalovirus (CMV) in aqueous humor measured by real-time polymerase chain reaction were compared before and after each injection.
RESULTS: CMV-DNA copies in aqueous humor decreased remarkably in both groups. The average of CMV-DNA copies in patients’ aqueous decreased from 38.3×104 copies/mL at baseline to 2.2×104 copies/mL after the 4th injection in patients who were treated with ganciclovir monotherapy, and decreased from 76.9×104 copies/mL to 11.3×104 copies/mL after 4 continuous injections of ganciclovir combined with foscarnet. No significant difference was found in reduction of viral load, change of visual acuities or intraocular pressures between monotherapy or combined therapy.
CONCLUSION: Results of this study show that the initial effectiveness of treating CMVR after 4 weekly intravitreal injections is not significantly different from ganciclovir alone or combined with foscarnet. Continuous injection of ganciclovir alone is sufficient in treating immunosuppressive patients with newly-onset CMVR.]]></description>
<pubDate>2018/9/4 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jing-Jing Fan, Yong Tao and De-Kuang Hwang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jing-Jing Fan, Yong Tao and De-Kuang Hwang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181010]]></guid><cfi:id>656</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Structural impairment patterns in peripapillary retinal fiber layer and retinal ganglion cell layer in mitochondrial optic neuropathies]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181011]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the structural injure patterns in peripapillary retinal fiber layer (pRNFL), retinal ganglion cell layer (RGCL) and their correlations to visual function in various mitochondrial optic neuropathies (MON) to offer help to their differential diagnosis.
METHODS: Totally 32 MON patients (60 eyes) were recruited within 6mo after clinical onsets, including 20 Leber hereditary optic neuropathy (LHON) patients (37 eyes), 12 ethambutol-induced optic neuropathy (EON) patients (23 eyes), and 41 age-gender matched healthy controls (HC, 82 eyes). All subjects had pRNFL and RGCL examinations with optic coherence tomography (OCT) and visual function tests.
RESULTS: In the early stages of MON, the temporal pRNFL thickness decreased (66.09±22.57 μm), but increased in other quadrants, compared to HC (76.95±14.81 μm). The other quadrants remaining stable for LHON and EON patients besides the second hour sector of pRNFL thickness reduced and the temporal pRNFL decreased (56.78±15.87 μm) for EON. Total macular thickness in MON reduced remarkably (279.25±18.90 μm; P=0.015), which mainly occurring in the inner circle (3 mm diameter of circle) and the nasal temporal sectors in the outer circle (5.5 mm diameter of circle), in contrast to those in HC. RGCL thickness reduced in each sector of the macula (61.90±8.73 μm; P≤0.001). It strongly showed the correlationship of best corrected visual acuity (R=0.50, P=0.0003) and visual field injury (R=0.54, P=0.0002) in MON patients.
CONCLUSION: OCT is a potential tool for detecting structural alterations in the optic nerves of various MON. Different types of MON may have different damage patterns.]]></description>
<pubDate>2018/9/4 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Da Teng, Chun-Xia Peng, Hai-Yan Qian, Li Li, Wei Wang, Jun-Qing Wang, Bing Chen, Huan-Fen Zhou and Shi-Hui Wei]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Da Teng, Chun-Xia Peng, Hai-Yan Qian, Li Li, Wei Wang, Jun-Qing Wang, Bing Chen, Huan-Fen Zhou and Shi-Hui Wei</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181011]]></guid><cfi:id>655</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Optical coherence tomography in central nervous system demyelinating diseases related optic neuritis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181012]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the thickness of the peripapillary retinal nerve fiber layer (RNFL) and ganglion cell-inner plexiform layer (GCIPL) among patients with various forms of optic neuritis (ON) and to identify whether any particular parameters or their thinning pattern can be used to distinguish the type of ON.
METHODS: This prospective study was conducted at the Department of Ophthalmology, Faculty of Medicine, Siriraj Hospital, Thailand, between January, 2015 and December, 2016. We enlisted patients over 18 years of age with history of ON and categorized patients into 4 groups: 1) aquaporin 4 antibodies (AQP4-IgG) positive; 2) multiple sclerosis (MS); 3) myelin oligodendrocyte glycoprotein antibodies (MOG-IgG) positive; 4) idiopathic-ON patients. Healthy controls were also included during the same study period. All patients underwent complete ophthalmological examination and spectral domain optical coherence tomography (OCT) imaging to analyze RNFL and GCIPL thickness after at least 3mo since the last episode of acute ON. The generalized estimating equation (GEE) models were used to compare the data amongst ON groups.
RESULTS: Among 87 previous ON eyes from 57 patients (43 AQP4-IgG+ON, 17 MS-ON, 8 MOG-IgG+ON, and 19 idiopathic-ON), mean logMAR visual acuity of AQP4-IgG+ON, MS-ON, MOG-IgG+ON, and idiopathic-ON groups was 0.76±0.88, 0.12±0.25, 0.39±0.31, and 0.75±1.08, respectively. Average, superior, and inferior RNFL were significantly reduced in AQP4-IgG+ON, MOG-IgG+ON and idiopathic-ON eyes, relative to those of MS-ON. Differences were not statistically significant for RNFL or GCIPL between the AQP4-IgG+ON and MOG-IgG+ON groups, whereas visual acuity in MOG-IgG+ON was slightly, but not significantly, better (0.39 vs 0.76). Although RNFL thickness in MOG-IgG+ON was significantly reduced as compared to MS-ON, mean visual acuity and GCIPL were not different.
CONCLUSION: Thinning of superior and inferior quadrants of RNFL are more commonly seen in MOG-IgG+ON and AQP4-IgG+ON. Long term visual acuity in MOG-IgG+ON is often better than AQP4-IgG+ON, whereas the structural change from OCT is comparable.]]></description>
<pubDate>2018/9/4 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Nattapong Mekhasingharak, Poramaet Laowanapiban, Sasitorn Siritho, Chanjira Satukijchai, Naraporn Prayoonwiwat, Jiraporn Jitprapaikulsan, Niphon Chirapapaisan and Siriraj Neuroimmunology Research Group]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Nattapong Mekhasingharak, Poramaet Laowanapiban, Sasitorn Siritho, Chanjira Satukijchai, Naraporn Prayoonwiwat, Jiraporn Jitprapaikulsan, Niphon Chirapapaisan and Siriraj Neuroimmunology Research Group</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181012]]></guid><cfi:id>654</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[The diluted atropine for inhibition of myopia progression in Korean children]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181013]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the efficacy and safety of three different concentrations of diluted atropine for the control of myopia in Korean children, and to assess the risk factors associated with rapid myopia progression.
METHODS: A total of 285 children, with refractive errors within the range of -6 diopters (D) between 5 and 14 years of age were included. After using 0.01%, or 0.025%, or 0.05% atropine, for about 1y, changes in refraction, axial lengths and frequency of adverse events were analyzed. Logistic regression analyses were performed to evaluate the risk factors associated with rapid myopia progression.
RESULTS: The changes in the mean spherical equivalent values were -0.134 D/mo in the before atropine group, -0.070 D/mo in the 0.01% atropine group, -0.047 D/mo in the 0.025% atropine group, and -0.019 D/mo in the 0.05% atropine group, with significant differences between the groups (P<0.001). The axial elongation was 0.046 mm/mo, 0.037 mm/mo, 0.025 mm/mo, and 0.019 mm/mo respectively, with significant differences between the groups (P=0.003). The incidence of photophobia and near vision difficulty was not different among the three atropine groups (P=0.425 and P=0.356, respectively). Multivariate logistic regression analyses showed that only highly myopic parents were a significant predictive factor of rapid myopia progression in Korean children (odds ratio, 8.155; 95% confidence interval, 3.626-18.342; P<0.001).
CONCLUSION: Treatment with 0.01%, 0.025% and 0.05% atropine solution inhibits myopia progression in Korean children in a dose-dependent manner. Children with highly myopic parents preferentially shows a rapid myopia progression rate.]]></description>
<pubDate>2018/9/4 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ji-Sun Moon and Sun Young Shin]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ji-Sun Moon and Sun Young Shin</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181013]]></guid><cfi:id>653</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Lamina cribrosa thickness in children with hyperopic anisometropic amblyopia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181014]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine lamina cribrosa thickness (LCT) in the optic nerve head region of the eyes in children with hyperopic anisometropic amblyopia and to compare this thickness with that of fellow eyes, hyperopic non-amblyopia, and age-matched controls.
METHODS: Thirty-two patients (12.0±1.8y, mean± standard deviation) with hyperopic anisometropic amblyopia, 31 subjects with age- and refractive error- matched hyperopic non-amblyopia (10.7±2.2y), and 32 age-matched controls (11.2±2.0y) were included in this prospective, cross-sectional study. LCT was measured using an enhanced depth-imaging program of a spectral domain optical coherence tomographic instrument in all participants, and the correlation between LCT and axial length was calculated.
RESULTS: The mean LCT was 180.9±29.4 μm in amblyopic eyes, 247.7±19.0 μm in fellow eyes, 251.6±27.3 μm in hyperopic non-amblyopic eyes, and 240.2±15.8 μm in control eyes. Lamina cribrosa in amblyopic eyes was significantly thinner than fellow, hyperopic non-amblyopic, and control eyes (P<0.05). There was no significant correlation in LCT and axial length between amblyopic (P=0.16) and control (P=0.31) group.
CONCLUSION: Lamina cribrosa of eyes with hyperopic anisometropic amblyopia is significantly thinner than that of fellow eyes, hyperopic non-amblyopia, and age-matched controls. The LCT profile in amblyopic eyes is different from that observed in fellow, hyperopic non-amblyopic, and control eyes.]]></description>
<pubDate>2018/9/4 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Serkan Akkaya]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Serkan Akkaya</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181014]]></guid><cfi:id>652</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A survey of incidental ocular trauma by pencil and pen]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181015]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine characteristic features of ocular trauma resulted from self-trauma by writing instruments among pediatric population.
METHODS: Thirty-six children who suffered from self-inflicted ocular trauma with a writing instrument were included in this prospective cross-sectional study.
RESULTS: The mean age was 5.6±2.7y with male: female ratio of 1.77. The right eye was involved two times more than the left eye. The superomedial (55.5%) and inferomedial (30.6%) quadrants were the most common sites of injury. The leading culprit was colored pencils (44.4%). During surgical exploration, no foreign body (FB) was found in 25 (69.4%) patients while an FB was found in 11 (30.5%) patients. Brain injury was present in two patients (5.6%) and only in superomedial quadrant injuries. Zone 1 was the most common site for ocular trauma associated with penetrating injury. The mean ocular trauma score (OTS) in penetrating injuries was 3.8±1.2. The best corrected visual acuity (BCVA) was 0.3±0.6 upon admittance and 0.08±0.21 after one year. The final BCVA was significantly correlated with the entrance site, better final BCVA was found in nasal entrance site (P<0.05).
CONCLUSION: The ophthalmologists should keep a high index of suspicion to rule out penetrating eye injuries related to writing instruments in a young uncooperative child. Brain injury is a life-threatening event that should be ruled out by appropriate imaging. Medial canthal area as the most common site needs an especial attention in writing instrument injuries.]]></description>
<pubDate>2018/9/4 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Seyed Ali Tabatabaei, Mohammad Soleimani, Morteza Naderan, Aliasghar Ahmadraji, Mohammad Bagher Rajabi, Hajar Jafari and Mona Safizade]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Seyed Ali Tabatabaei, Mohammad Soleimani, Morteza Naderan, Aliasghar Ahmadraji, Mohammad Bagher Rajabi, Hajar Jafari and Mona Safizade</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20181015]]></guid><cfi:id>651</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Does the scleral encircling band provide a protective effect against the progression of diabetic retinopathy?]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190906]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the effect of scleral encircling bands on the development and progression of diabetic retinopathy (DR) in diabetic patients.
METHODS: The medical records of diabetic patients who underwent unilateral retinal detachment (RD) surgery using scleral buckle and encircling band were reviewed retrospectively. Both eyes of patients were included in the study: one eye in each patient had a scleral buckle with encircling band (the operated eye) and the other one is the non-operated eye. The demographic characters, duration of diabetes and period between surgery and the last recall visit were retrieved from each patient. All the cases underwent fundus photo and fluorescein angiography (when indicated) to confirm the DR staging.
RESULTS: Totally 25 patients fulfilled the inclusion and the exclusion criteria were become eligible for the study. A total of 50 eyes of 25 patients were enrolled in this analysis. The mean period of time passed from surgery with encircling band and the last reassessment visit was 12.5±2y. Even though DR could develop in the operated eyes, it was at a less degree of severity compared to the non-operated eyes of same patients (P=0.027).
CONCLUSION: Scleral encircling bands have protective effects against the development and progression of DR.]]></description>
<pubDate>2019/8/2 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hossam Youssef Abouelkheir, Amani E Badawi, Amr M. Abdelkader, Amr El-Kanishy, Sameh Saleh, Waleed Ali Abou Samra, Manal Ali Kasem and Tharwat Mokbel]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hossam Youssef Abouelkheir, Amani E Badawi, Amr M. Abdelkader, Amr El-Kanishy, Sameh Saleh, Waleed Ali Abou Samra, Manal Ali Kasem and Tharwat Mokbel</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190906]]></guid><cfi:id>650</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Morphological and cytological changes of meibomian glands in patients with type 2 diabetes mellitus]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190907]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To observe the changes of microcellular structure of meibomian glands (MGs) in type 2 diabetes mellitus (DM), and to explore its correlation with the duration of diabetes.
METHODS: The study assessed 132 eyes of 132 patients with type 2 diabetes mellitus (DM group) and 100 eyes of 100 non-diabetic participants (NDM group). All patients underwent the examination of the Keratograph 5M system to obtain the meibography which were used to evaluate the structure dropout of the MGs. And then laser scanning confocal microscopy (LSCM) was performed for observing the acinar cells and ducts of the MGs to obtain the following parameters: the MG acinar unit density (MGAUD), MG acinar longest diameter (MGALD) and MG acinar shortest diameter (MGASD). The examination results of the right eye were selected for analysis.
RESULTS: Compared with that in NDM group, the meiboscore was significantly higher (Z=-4.057, P<0.001), and there were more MGs dropout in DM group. With the prolongation of the course of diabetes, the absence of MGs aggravated and the MGs dropout score increased (r=0.596; P<0.001). LSCM showed that there were various cytological alterations in acinar cells of MGs with the progress of diabetes duration, such as expansion, atrophy or fibrosis of MG acinar units, decreased density of MG acinar units, deposition of lipid substances, infiltration of inflammatory cells, proliferation of fibrous tissues, etc. And the opening of the glandular duct changed from smooth at the beginning to narrow, blocked, fibrotic and so on. Compared with that in NDM group, the MGAUD in DM group was significantly lower (Z=-9.713; P<0.001), the MGALD and MGASD were significantly larger (Z=-9.751, -6.416; P<0.001). With the duration of diabetes, the MGAUD reduced, the MGASD increased (r=0.860, 0.364, P<0.001); but the MGALD had no correlation with diabetic duration (r=0.133, P=0.151).
CONCLUSION: With the progress of diabetes, the meibomian glandular acinar cells of diabetic patients show various manifestations. Those changes may result in the dysfuction of the MGs, tear film instability and dry eye symptoms in patients with type 2 DM.]]></description>
<pubDate>2019/8/2 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Tao Yu, Xu-Guang Han, Yang Gao, Ai-Ping Song and Guang-Fu Dang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Tao Yu, Xu-Guang Han, Yang Gao, Ai-Ping Song and Guang-Fu Dang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190907]]></guid><cfi:id>649</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of diluted povidone iodine in adenoviral keratoconjunctivitis on the rate of subepithelial corneal infiltrates]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190908]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the clinical characteristics of adenoviral keratoconjunctivitis, the management modalities, as well as the incidence of subepithelial corneal infiltrates (SEI).
METHODS: Patients with characteristic clinical symptoms and signs, who presented to our clinic within the first week of symptoms and received the diagnosis of adenoviral keratoconjunctivitis between January 2013 and April 2016, were included in the study. A total of 211 patients were included in the study. Patients were evaluated for the incidence of clinical signs, late complications, management preferences, and the effect of diluted povidone-iodine (d-PVP-I) 2%.
RESULTS: Patients’ mean age was 33.03±14.76y. We observed an increase in the number of cases according to the years. At presentation and/or early follow-up, the clinical signs were conjunctival hyperemia (100%), conjunctival follicules (79.1%), edema of the eyelids (39.3%), chemosis (16.1%), pseudomembrane formation (16.6%), and corneal epitheliopathy (29.9%). During late follow-up 13.3% patients developed conjunctival subepithelial fibrosis, and 39.8% developed SEI. A significant decrease in the incidence of SEI development was observed in patients who used d-PVP-I 2% (P=0.032; 33.3% vs 45.9%, respectively in patients who received d-PVP-I 2% and who did not).
CONCLUSION: Adenoviral keratoconjunctivitis has a tremendous effect on patient’s comfort and abilities in short-term. Additionally, almost half of the patients develop visual problems related to SEI. According to our clinical experience, using d-PVP-I 2% in the first days of adenoviral keratoconjunctivitis might be helpful in reducing the risk of SEI as a complication.]]></description>
<pubDate>2019/8/2 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Rana Altan-Yaycioglu, Nedime Sahinoglu-Keskek, Handan Canan, Muge Coban-Karatas and Burak Ulas]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Rana Altan-Yaycioglu, Nedime Sahinoglu-Keskek, Handan Canan, Muge Coban-Karatas and Burak Ulas</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190908]]></guid><cfi:id>648</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Factors affecting recurrence after surgical treatment in cases with ocular surface squamous neoplasia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190909]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the risk factors leading to recurrence in patients with ocular surface squamous neoplasia (OSSN)
METHODS: The records of 112 patients with OSSN who underwent treatment and follow-up between February 1999 and August 2018 were reviewed retrospectively.
RESULTS: Totally 67 patients (59.8%) were male and 45 patients (40.2%) were female. The mean age at presentation was 63.7y (range 22-87y). Partial lamellar scleroconjunctivectomy (PLSC) was performed in 105 (93.7%) cases and enucleation was performed in 7 (6.3%) cases due to bulbus invasion as the first step treatment. Treatments used in addition to PLSC included cryotherapy in 78 eyes (74.3%), alcohol epitheliectomy in 57 eyes (54.3%) for presence of corneal involvement, and amniotic membrane transplantation in 17 eyes (16.2%) for ocular surface reconstruction. Topical mitomycin C was used in 10 patients (9.5%) and strontium-90 (Str-90) treatment in 4 (3.8%) patients because surgical margins were tumor positive at the histopathological examination. Postoperative histopathologic diagnoses were squamous cell carcinoma (52 cases), carcinoma in situ (44 cases), moderate conjunctival intraepithelial neoplasia (11 cases), and mild conjunctiva intraepithelial neoplasia (5 cases). At a mean follow-up of 20.1mo, tumor recurrence was observed in 21 (18.8%) cases. The rate of recurrence was found to be lower in cases that underwent supplemental cryotherapy compared to those that did not (P<0.001). There was no metastasis in any case.
CONCLUSION: In our series, the recurrence rate is 18.8% and overall globe salvage rate is 90.2% for OSSN at relatively short-term follow-up.]]></description>
<pubDate>2019/8/2 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ibadulla Mirzayev, Ahmet Kaan Gündüz, Funda Seher &#214;zalp Ate&#351;, G&#246;k&#231;en &#214;zcan and Mehmed U&#287;ur I&#351;&#305;k]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ibadulla Mirzayev, Ahmet Kaan Gündüz, Funda Seher &#214;zalp Ate&#351;, G&#246;k&#231;en &#214;zcan and Mehmed U&#287;ur I&#351;&#305;k</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190909]]></guid><cfi:id>647</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Efficacy of low-energy selective laser trabeculoplasty on the treatment of primary open angle glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190910]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the efficacy of low-energy selective laser trabeculoplasty (SLT) on the treatment of primary open angle glaucoma (POAG) patients.
METHODS: Outpatients with POAG who underwent 360-degree SLT using an initial energy of 0.3 mJ (total energy of 30-40 mJ) were reviewed retrospectively from September 2011 to January 2018.
RESULTS: Eight-six eyes of 44 POAG patients underwent 360-degree SLT using initial energy of 0.3 mJ and were followed up regularly. The total energy used was 32.5±2.5 mJ (23-40 mJ, 105±6 spots). The average pretreatment intraocular pressure (IOP) was 19.8±3.9 mm Hg. At 1, 3, 6mo, 1, and 2y, the post-SLT IOPs (mm Hg) were 16.9±3.3, 16.5±3.3, 17.1±3.4, 16.6±3.5, 16.5±2.8, which were significantly lower than that before treatment (P<0.001). The patients in the SLT success group were found to be younger than those in the SLT failure group. After SLT, 59 eyes that maintained pretreatment medications were defined as the drug retention group. The pre-SLT IOP was 20.1±3.7 mm Hg. At 1, 3, 6mo, 1, and 2y, the post-SLT IOPs (mm Hg) were 17.3±3.6, 16.6±3.5, 17.2±3.6, 16.9±3.8 and 16.5±2.9, respectively. Twenty-seven eyes that required reduced drugs were defined as the drug reduction group. The pre-SLT IOP was 19.2±4.4 mm Hg. At 1, 3, 6mo, 1, and 2y, the post-SLT IOPs (mm Hg) were 16.1±2.6, 16.5±3.1, 16.8±2.9, 16.0±2.6 and 16.3±2.4,  respectively. Compared with the pretreatment IOPs, the post-SLT IOPs were significantly lower in drug retention group and drug reduction group. The patients in the drug reduction group were found to be younger than those in the drug retention group.
CONCLUSION: Low-energy SLT is safe and effective for POAG patients during a 2-year follow-up. Younger POAG patients may obtain better results after low-energy SLT treatment.]]></description>
<pubDate>2019/8/2 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Li Xu, Ru-Jing Yu, Xu-Ming Ding, Mao Li, Yue Wu, Li Zhu, Di Chen, Cheng Peng, Chang-Juan Zeng and Wen-Yi Guo]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Li Xu, Ru-Jing Yu, Xu-Ming Ding, Mao Li, Yue Wu, Li Zhu, Di Chen, Cheng Peng, Chang-Juan Zeng and Wen-Yi Guo</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190910]]></guid><cfi:id>646</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Fundus manifestations and HIV viral loads of AIDS patients before and after HAART]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190911]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the fundus manifestations and human immunodeficiency virus (HIV) viral loads of acquired immune deficiency syndrome (AIDS) patients before and after highly active antiretroviral therapy (HAART).
METHODS: This retrospective study included 21 AIDS patients (42 eyes) who presented to the Department of Ophthalmology, Peking Union Medical College Hospital, from 2007 to 2011. Among the patients, 16 showed a good response to HAART, 3 presented drug resistance and 2 were pre-HAART. All patients underwent comprehensive ophthalmic examinations. The HIV viral loads and the CD4+ T-cell counts were also determined.
RESULTS: The best-corrected visual acuity (BCVA) of 38 eyes (19 patients) was improved, and cytomegalovirus retinitis (CMVR) in 5 eyes (3 patients) regressed after HAART. Furthermore, 16 patients treated with effective HAART had decreased plasma HIV viral loads (<78 copies/mL) and increased CD4+ T-cell counts (343±161 cells/μL, P<0.005), but the HIV viral load in tears was still detected at 2404 copies/mL. The CD4+ T-cell count was lower in the CMVR group than in the non-CMVR group (P=0.022), but the HIV viral load in the tears was not significantly different between the two groups (P=0.439).
CONCLUSION: Most patients with AIDS show a good viral response with a decreased HIV viral load and an increased CD4+ T-cell count in plasma after HAART. However, the HIV viral load remain quite high in the tear samples. Based on our results, we suggest that AIDS patients undergo long-term HAART that should not be interrupted.]]></description>
<pubDate>2019/8/2 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yu Di, Xin-Yu Zhao, Jun-Jie Ye, Bing Li and Nan Ma]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yu Di, Xin-Yu Zhao, Jun-Jie Ye, Bing Li and Nan Ma</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190911]]></guid><cfi:id>645</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Novel transscleral sutureless subretinal fluid drainage using a 25-gauge trocar-cannula with a self-closing valve in patients with advanced Coats disease]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190912]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess surgical outcomes of a novel method of transscleral drainage of subretinal fluid using a 25-gauge trocar-cannula with a self-closing valve (DTV) in patients with severe exudative retinal detachment (ERD) in Coats disease.
METHODS: Retrospective consecutive cases of 20 patients (20 eyes) of severe ERD due to Coats disease (stage 3B) in total 156 Coats patients between June 2015 and April 2019 were included in this study. The participants were aged 1 to 10y with a mean age of 3.50±1.79y. The mean follow-up time were 11.9mo. Subretinal fluid was drained transsclerally using a novel method of DTV. The height of the retinal detachment and the regression of abnormal vessels including telangiectasias and aneurysms were observed. Complications including vitreoretinal fibrosis, tractional retinal detachments (TRD), endophthalmitis, retinal holes, and hemorrhages were evaluated.
RESULTS: Following surgeries, the patients showed the replacement of ERD and regression of telangiectatic retinal vessels observed with binocular indirect ophthalmoscopy. Six patients received retinal cryotherapies and 12 patients received laser photocoagulations following first external subretinal fluid drainage using DTV. All patients underwent intravitreal anti-vascular endothelial growth factor therapies to induce residual subretinal fluid absorption. During follow-ups, 8 patients underwent a second drainage operation, 17 patients received retinal laser photocoagulations and 7 patients received cryotherapies. Vitreoretinal fibrosis was found in 7 patients and 6 patients underwent micro-invasive vitrectomies during the follow-up period. Severe TRD, iatrogenic retinal holes, and hemorrhages were not found.
CONCLUSION: The authors present a new therapeutic approach that successfully drains subretinal fluid in advanced stage 3B Coats disease with severe ERD. This is a simple, safe and less invasive approach when compared with traditional managements. However, it should be strictly selected for patients with high bullous ERD close to the central axis of the eye in order to avoid the complication of retinal holes.]]></description>
<pubDate>2019/8/2 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Liang Li, Song-Feng Li, Jing-Hua Liu, Guang-Da Deng, Yan Ma, Jing Ma and Hai Lu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Liang Li, Song-Feng Li, Jing-Hua Liu, Guang-Da Deng, Yan Ma, Jing Ma and Hai Lu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190912]]></guid><cfi:id>644</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Beneficial effects of vincamine with thioctic acid and lutein on retinal and optic nerve functions in an opaque media]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190913]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To detect whether the combination of vincamine, thioctic acid and lutein will improve the retina and optic nerve functions in cases of an opaque media with an optic nerve and/or a retinal defect or not.
METHODS: Totally 2000 patients (2000 eyes) of corneal opacities with defects in the optic nerve or/and the retinal functions were studied. Every patient received three types of drugs: thioctic acid with cyanocobalamine, vincamine, and lutein. The drugs were given daily for 3-12mo according to patient’s responses. Full field flash electroretinogram (ERG) and flash visual evoked potential (VEP) were done before treatment and at 1, 3, 6, and 12mo sequentially. Patients were followed up for 12mo.
RESULTS: In the 2000 eyes, 1000 eyes had both moderate optic nerve and retinal function defects; and 840 eyes out of the 1000 improved with the medical treatment. Another 500 eyes out of the 2000 eyes had extinguished retinal function with normal optic nerve function and only 125 eyes of them improved. The 290 out of the 2000 eyes had severe defects in optic nerve with normal retinal function and 130 of them improved. Another 210 eyes have mild optic nerve and retinal function defects and 194 improved.
CONCLUSION: The combination of vincamine, thioctic acid with cyanocobalamine, and lutein improved both retina and optic nerve functions mainly in mild and moderate defect than in severe cases.]]></description>
<pubDate>2019/8/2 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mona Abdelkader, Sameh Saleh, Tharwat Mokbel, Hossam Abouelkheir and Ayman Abd El Ghafar]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mona Abdelkader, Sameh Saleh, Tharwat Mokbel, Hossam Abouelkheir and Ayman Abd El Ghafar</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190913]]></guid><cfi:id>643</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effects of steep-axis incision on corneal curvature in one-handed phacoemulsification]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190807]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To examine the effects of one-handed phacoemulsification with steep-axis incision on corneal curvature and analyze surgically induced astigmatism (SIA) on the true net power, anterior and posterior corneal surfaces.
METHODS: Patients with cataracts underwent one-handed phacoemulsification with a 2.4-mm steep-axis of clear corneal incision (CCI) based on true net power. CCI was created under the guidance of Verion. Central corneal thickness (CCT), keratometry readings of the true net power and anterior and posterior corneal surface were obtained using Pentacam. Biometry, such as axial length, anterior chamber depth (ACD) and white-to-white (WTW) were performed using Lenstar pre- and 3mo post-operatively.
RESULTS: The study evaluated 68 eyes of 65 patients. The mean age was 65.93±9.40y; CCT was 529.21±37.40 μm; WTW was 11.59±0.35 mm. Regarding true net power, keratometric value at the flattest corneal meridian for the 3-mm central zone (Ks) was significantly decreased postoperatively (P=0.031). Keratometric value at the steepest corneal meridian for the 3-mm central zone (Kf) was increased postoperatively (P>0.05). Astigmatism of true net power was 1.21±0.56 D preoperatively and significantly decreased to 1.02±0.58 D postoperatively (P=0.021). On the anterior corneal surface, no significant difference in Ks and Kf was noted pre- versus postoperatively. Anterior corneal astigmatism was 1.08±0.51 D preoperatively and significantly decreased to 0.87±0.46 D postoperatively (P=0.002). On the posterior corneal surface, Ks and Kf were significantly increased postoperatively (all P<0.05), and posterior corneal astigmatism also increased (P=0.008). The SIA values of true net power and the anterior and posterior corneal surfaces at 3mo postoperatively were 1.26±0.63 D (range: 0.11 to 2.80 D), 1.05±0.54 D (range: 0.23 to 2.40 D), and 0.21±0.17 D (range: 0.01 to 0.07 D), respectively.
CONCLUSION: One-handed phacoemulsification with steep-axis incision can effectively decrease astigmatism of true net power and anterior corneal astigmatism. In the same surgery, the difference in personal SIA potentially originated from a difference in personal corneal thickness and diameter, both CCT and WTW distance should always be measured preoperatively when planning steep-axis phacoemulsification.]]></description>
<pubDate>2019/7/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Pan-Pan Li, Ye-Meng Huang, Qi Cai, Li-Li Huang, Yu Song and Huai-Jin Guan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Pan-Pan Li, Ye-Meng Huang, Qi Cai, Li-Li Huang, Yu Song and Huai-Jin Guan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190807]]></guid><cfi:id>642</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Evaluation of suturless scleral fixation with posterior chamber foldable intraocular lens implantation]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190808]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the sutureless scleral fixation technique for posterior chamber foldable intraocular lens (PCIOL) implantation in aphakic eyes with insufficient or no capsular support.
METHODS: A technique for sutureless intrascleral fixation of the haptics of a standard 3-piece PCIOL was used which ensures sutureless fixation by permanent incarceration of the haptics in a scleral tunnel parallel to the limbus. All patients were evaluated for preoperative status [visual acuity, refractive error, K readings, intraocular pressure (IOP) measurement, slit lamp examination, fundus examination and optical biometry], postoperative status and complications. Ultrasound biomicroscopy (UBM) was done for 10 cases to evaluate optic tilt.
RESULTS: The study evaluated 42 eyes of 42 patients. The follow-up period was 6mo. Improvement of best corrected visual acuity (BCVA) one line occurred in 10 cases (23.8%) and loss of one line in 3 cases (7.1%). Intraoperative complications included: haptic kink in 4 cases (9.5%), haptic breakage in 1 case (2.4%), haptic dislocation in 1 case (2.4%), haptic slippage in 3 cases (7.1%), IOL dislocation in 1 case (2.4%) and sclerotomy related bleeding in 1 case (2.4%). Postoperative complications included: transient mild vitreous hemorrhage in 3 cases (7.1%), choroidal detachment in 1 case (2.4%), cystoid macular edema (CME) in 1 case (2.4%), optic capture in 1 case (2.4%), subconjunctival haptic in 2 cases (4.8%), ocular hypotony in 4 cases (9.5%) and ocular hypertension in 1 case (2.4%). There were no cases of retinal detachment or endophthalmitis. UBM showed optic tilt in 3 cases (30%).
CONCLUSION: Fixation of three-piece foldable IOL haptics in scleral tunnel parallel to the limbus- provided axial stability and proper centration of the IOL with minimal or no tilt in most cases and a low complication rate during the follow up period which lasted 6mo.]]></description>
<pubDate>2019/7/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ahmed M. Bedda, Hesham F. ElGoweini, Ahmed M. Abdelhadi and Amr M. Elhady]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ahmed M. Bedda, Hesham F. ElGoweini, Ahmed M. Abdelhadi and Amr M. Elhady</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190808]]></guid><cfi:id>641</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Ex-PRESS implantation for different types of glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190809]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the clinical results, efficacy and safety of Ex-PRESS P200 glaucoma shunt implant in different types of medically uncontrolled glaucoma.
METHODS: The study included 31 eyes of 31 patients that were unresponsive to medical antiglaucomatous therapy in whom Ex-PRESS P200 glaucoma shunt implantation was performed. The demographic characteristics of the patients, type of glaucoma, complete ocular examination results, number of antiglaucomatous drugs before and after surgery, early and late complications of surgery, additional surgical and nonsurgical medical interventions, and success rates were investigated from the patients’ files, retrospectively.
RESULTS: The mean postoperative follow-up time was 16.4±7.5mo. The preoperative mean corrected intraocular pressure (IOP) was 28.7±10.3 mm Hg and postoperative mean corrected IOP was 15.3±5.2 mm Hg (P<0.05) at the last visit. The mean IOP reduction was 39.9% when the preoperative and postoperative values of the last visits were compared. The average number of antiglaucomatous drug use decreased from 3.9±0.3 to 1.7±1.7 postoperatively (P<0.05). The use of antiglaucomatous medications at the last visit was more than in other studies in the literature.  The most common complication was conjunctival leakage, which was seen in 7 patients. Other early complications were iris touch, intravitreal hemorrhage, hyphema, choroidal effusion, early transient hypotonia and corneal edema. One of the late complications was endophthalmitis which was seen in one case 6mo after the operation, and the other late complication was opacification of the cornea in one patient. Twelve additional surgical operations associated to Ex-PRESS surgery and 3 bleb needling have done. At the last visit, the complete success rate was 32.3% and the qualified success rate was 77.5% in all patients.
CONCLUSION: Ex-PRESS P200 glaucoma shunt implantation may be an effective procedure for medically uncontrolled glaucoma with significantly lower use of antiglaucomatous medications.]]></description>
<pubDate>2019/7/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Meltem Guzin Altinel, Ayse Yagmur Kanra, Remzi Karadag and Huseyin Bayramlar]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Meltem Guzin Altinel, Ayse Yagmur Kanra, Remzi Karadag and Huseyin Bayramlar</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190809]]></guid><cfi:id>640</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Posterior vitreous detachment rate following intravitreal dexamethasone injection]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190810]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine whether intravitreal dexamethasone (DEX) implant induces posterior vitreous detachment or not.
METHODS: We retrospectively reviewed 810 eyes of 405 patients who underwent intravitreal DEX implantation due to macular edema caused by diabetic and retinal venous occlusion in our clinic. The eyes having no injection were determined as the control group. The examination findings of the patients before the injection and 3mo after the injection and optical coherence tomography (OCT) images were scanned. The pre-injection OCT findings and OCT findings of the patients having no posterior vitreous detachment (PVD) and determined to have partial PVD were compared.
RESULTS: The separation in vitreoretinal adhesion and total PVD development of DEX-injected 56/208 (26.9%) eyes were statistically greater in comparison with the 12/129 (9.3%) eyes that had not been injected (P=0.001). PVD development was observed more in the patients that were younger, had larger macula thickness and lower visual acuity.
CONCLUSION: It can be stated that intravitreal DEX implant induces PVD development. Prospective, controlled studies are required in order to determine prognosis of vitreoretinal disease in PVD-developed patients and in non-PVD-developed patients.]]></description>
<pubDate>2019/7/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Atilla Alpay]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Atilla Alpay</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190810]]></guid><cfi:id>639</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Assessment of optic nerve and optic tract alterations in patients with orbital space-occupying lesions using probabilistic diffusion tractography]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190811]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the diffusion changes in both the optic nerve and optic tract in orbital space-occupying lesion patients with decreased visual acuity, and its clinical significance using probabilistic diffusion tractography (PDT).
METHODS: Twenty patients with orbital space-occupying lesions and 25 age- and gender-matched healthy persons were included. All patients and controls underwent routine orbital magnetic resonance imaging and diffusion tensor imaging (DTI), using a 3.0T magnetic resonance scanner (Trio Tim Siemens). After the image data were preprocessed, each DTI parameters of the optic nerve and optic tract was obtained by PDT, including fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (AD) and radial diffusivity (RD). The asymmetry index (AI) of each parameter was calculated. Compared the parameters of the affected side optic nerve and ipsilateral optic tract with the contralateral side by paired sample t-test; compared AI of parameters of optic nerve and optic tract between the patient group and the control group by independent sample t-test. Patients were divided into three subgroups according to the low vision grade standard of WHO, compared the FA and AI of FA between the three subgroups by single factor variance analysis.
RESULTS: The affected side optic nerve presented significantly decreased FA, increased MD, AD, and RD values compared to the unaffected side (P<0.05). The AI of FA, MD, AD, and RD of optic nerve in the patients was significantly higher than that of the controls (P<0.05). The comparison results of the optic tract showed that there was no significant difference between the patient group and control group in terms of the bilateral optic tracts in patients (P>0.05). The AIs of the FA value of the optic nerve in the eyesight <0.1 subgroup was significantly higher than that in the other groups (P<0.05).
CONCLUSION: FA, MD, AD, and RD of the affected side optic nerve of the orbital space-occupying lesions have significantly changed, the FA value is the most sensitive. The PDT could be a useful tool to provide valid quantitative markers of optic nerve injuries and evaluate the severity of orbital diseases, which other examinations cannot be acquired.]]></description>
<pubDate>2019/7/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Chun-Nan Wu, Shao-Feng Duan, Xue-Tao Mu, Yi Wang, Peng-Yu Lan, Xiao-Lu Wang and Kun-Cheng Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Chun-Nan Wu, Shao-Feng Duan, Xue-Tao Mu, Yi Wang, Peng-Yu Lan, Xiao-Lu Wang and Kun-Cheng Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190811]]></guid><cfi:id>638</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of corneal curvature parameters obtained from two different instruments—Pentacam and VX120]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190812]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To explore whether the same corneal curvature parameters and anterior chamber depth measured by Pentacam and VX120 have a good consistency and can replace each other.
METHODS: This study enrolled 140 eyes of 70 patients ranging in age from 19 to 53y. All eyes underwent a comprehensive ophthalmologic examination including an anterior segment analysis with the VX120 system (Visionix-Luneau Technologies, Chartres, France) and Pentacam (Oculus Optikgerate GmbH) respectively. The comparison on corneal curvature parameters was done between Pentacam and VX120 using clustered signed rank test; the interclass correlation coefficients (ICC) with 95% confidence intervals (CI) was calculated for each parameter between Pentacam and VX120; the Bland-Altman plot of each parameter was supplemented.
RESULTS: The anterior corneal curvature measured by VX120 was Ks: 44.00±1.78 D, KsAt: 89.45±22.18, Kf: 42.84±1.58 D, KfAt: 93.91±79.34; which measured by Pentacam was Ks: 43.80±1.82 D, KsAt: 91.17±21.40, Kf: 42.61±1.64 D, KfAt: 91.16±78.69. There was statistical difference between Pentacam and VX120 for anterior corneal curvature parameter (P<0.001). The posterior corneal curvature measured by VX120 was Ks: -6.42±1.23 D, KsAt: 91.00±23.45, Kf: -5.85±1.24 D, KfAt: 95.93±79.11; which measured by Pentacam was Ks: -6.44±0.32 D, KsAt: 92.24±11.75, Kf: -6.01±1.05 D, KfAt: 74.43±80.64. There was statistical difference between Pentacam and VX120 for posterior corneal curvature parameters (P<0.001). Anterior chamber depth (ACD) measured by Pentacam and VX120 was statistically different. Pentacam and VX120 achieved high consistency only on corneal anterior surface, including Ks and Kf. The ICCs were 0.96 (95%CI: 0.95, 0.97) and 0.95 (95%CI: 0.94, 0.97) respectively. For other corneal surface curvature parameters, all ICCs of between Pentacam and VX120 were below 0.87. Bland-Altman plots indicated of low consistency of corneal surface curvature parameters measured by Pentacam and VX120.
CONCLUSION: The corneal curvature parameters and anterior chamber depth measured by Pentacam and VX120 were statistically different. Data measured by Pentacam and VX120 is not suggested to replace each other, mixing data measured by Pentacam and VX120 together is not suggested either.]]></description>
<pubDate>2019/7/9 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Qing-Wei Zhang, Chang-Bin Zhai and Dong-Li Ma]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Qing-Wei Zhang, Chang-Bin Zhai and Dong-Li Ma</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190812]]></guid><cfi:id>637</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Astigmatic correction with implantation of a light adjustable vs monofocal lens: a single site analysis of a randomized controlled trial]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190708]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the light adjustable lens (LAL) vs a standard monofocal lens in achieving target astigmatic refraction and improving postoperative uncorrected distance visual acuity (UDVA).
METHODS: This randomized controlled clinical trial included 40 patients with pre-existing astigmatism and visually significant cataract. Twenty-eight patients received the LAL and 12 control patients received a monofocal intraocular lens (IOL) after cataract extraction at a single institution. The patients with the LAL underwent adjustment by ultraviolet (UV) light postoperatively plus subsequent lock-in procedures and all patients returned to clinic for follow up of study parameters at 6, 9, and 12mo. Manifest refraction, distance visual acuity, and adverse events were recorded at each visit.
RESULTS: The mean cylinder before adjustment in eyes with the LAL was -0.89±0.58 D (-2.00 to 0.00 D) and -0.34±0.34 D (-1.25 to 0.00 D) after lock-in (P=1.68x10-8). The mean cylinder in patients with the monofocal lens was -1.00±0.32 D (-1.50 to -0.50 D) at 17-21d postoperatively, which was statistically different from the LAL cylinder post lock-in (P=1.43x10-6). UDVA in the LAL group was 20/20 or better in 79% of patients post lock-in with good stability over 12mo compared with 33% of the control patients with UDVA of 20/20 or better.
CONCLUSION: These results demonstrate that the LAL is more effective in achieving target refractions and improving postoperative UDVA in patients with pre-existing corneal astigmatism than a standard monofocal lens.]]></description>
<pubDate>2019/6/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Majid Moshirfar, William D. Wagner, Steven H. Linn, David F. Skanchy, Tanner W. Brown, Aaron T. Gomez, Jackson L. Goldberg, Yasmyne C. Ronquillo and Phillip C. Hoopes Jr.]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Majid Moshirfar, William D. Wagner, Steven H. Linn, David F. Skanchy, Tanner W. Brown, Aaron T. Gomez, Jackson L. Goldberg, Yasmyne C. Ronquillo and Phillip C. Hoopes Jr.</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190708]]></guid><cfi:id>636</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Imaging characteristics and surgical management of orbital neurilemmomas]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190709]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To review imaging characteristics and surgical outcomes of orbital neurilemmoma.
METHODS: Retrospective review of 21 patients with orbital neurilemmoma managed at the Zhongshan Ophthalmic Center of Sun Yat-sen University from June 2005 to December 2016. All patients underwent surgical excision following preoperative imaging including ultrasonography, computed tomography (CT) and magnetic resonance imaging (MRI).
RESULTS: Among these patients, 11 were male and 10 were female, with age ranging from 12 to 75y (average, 40.3y). Ultrasound of the orbit showed a roundish well-demarcated orbital mass with low or middle internal reflectivity in each case. Dark inner liquid fields were detected in 28.6% of these cases. Doppler ultrasound demonstrated blood flow signals in these masses. CT showed that the tumors were either homogeneous or heterogeneous. MRI of T1WI revealed isointense or hypointense tumors, while the T2WI indicated heterogeneous hyperintense lesions. Gd contrast MRI demonstrated heterogenous or homogeneous enhancement initiating from the wide area of the lesion. Six patients underwent lateral orbitotomy and 15 anterior orbitotomy. All tumors were completely removed. After a mean follow-up of 1.8y, 3 patients experienced reduced vision while the remaining 10 patients showed improved vision after surgery. One patient experienced a mild limitation of upward motility. No recurrence occurred.
CONCLUSION: Orbital neurilemmoma is a relatively rare, benign orbital tumor. Effective diagnosis requires a combination of ultrasonography, CT and/or MRI. These imaging techniques are also vital to differentiate neurilemmomas from other orbital masses like that of cavernous hemangiomas and meningiomas. Successful treatment requires complete resection of the neurilemmomas as performed either by lateral or anterior orbitotomy. Recurrence is rare after complete removal.]]></description>
<pubDate>2019/6/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ming-Hao Chen and Jian-Hua Yan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ming-Hao Chen and Jian-Hua Yan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190709]]></guid><cfi:id>635</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Radiofrequency ablation micro-dissecting of eyelid nevus with XL-RFA device under operating microscope]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190710]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To study the effect of an innovative micro-dissection procedure by radiofrequency ablation (MRA) in removing eyelid nevus.
METHODS: Fifty-six consecutive outpatients with eyelid nevus were treated with MRA using a monopolar device. The effect of MRA was determined after following-up for 6mo to 5y.
RESULTS: Fifty-two cases (52 eyes, 92.9%) were cured once, and 4 cases (4 eyes, 7.1%) received second treatment for small residual. All cases healed well after surgery, with no pigmentation, no scars, no loss of eyelashes, no deformation of eyelid margin. There was no visual impairment after healing.
CONCLUSION: MRA of eyelid nevus using the XL-RFA device is highly efficient without significant complications.]]></description>
<pubDate>2019/6/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jing-Xin Wang, Yi-Lan Li, Yue-Ming Gao, Li-Ning Zhang, Li-Ping Huang, Qing-Hua He, Hui-Min Xie, Tian-Yu Jiang, Zi-Shan Jia and Xing-Lin Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jing-Xin Wang, Yi-Lan Li, Yue-Ming Gao, Li-Ning Zhang, Li-Ping Huang, Qing-Hua He, Hui-Min Xie, Tian-Yu Jiang, Zi-Shan Jia and Xing-Lin Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190710]]></guid><cfi:id>634</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Changes in ocular surface status and dry eye symptoms following femtosecond laser-assisted cataract surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190711]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To observe the changes in ocular surface and the dry eye symptoms following femtosecond laser-assisted cataract surgery (FLACS).
METHODS: Patients with no eye signs or symptoms in Guangzhou Aier Eye Hospital between October 2017 and September 2018, who underwent FLACS and intraocular lens (IOL) implantation for age-related cataract were enrolled. Tear film stability assessed with OCULUS Keratograph 5M, Schirmer’s I test (SIT), and corneal fluorescein staining (CFS) were evaluated before and after surgery at 1d, 1wk, 1, and 3mo in order. Ocular Surface Disease Index scores (OSDI) and Subjective Symptom Questionnaires (SSQs) were recorded at the same time point.
RESULTS: Thirty-eight eyes of 38 patients were enrolled. The noninvasive tear film break-up time (first break-up time and average break-up time) decreased in a peak at the 1wk visit, and then increased to basic levels at 1mo. The tear meniscus height (TMH) increased transiently at 1d, and declined in the following 3mo visits. The SIT had a transient increase at 1d (P=0.357) and a decrease at 1wk and 1mo (both P<0.05) but returned to the preoperative levels at 3mo after surgery (P=0.062). CFS scores were significantly improved compared with those before surgery, and had a statistical difference (P<0.05). OSDI scores and SSQs after surgery were obviously higher, and had a statistical difference (P<0.001) but didn’t return to the basic level by 3mo.
CONCLUSION: Dry eye signs and symptoms can occur immediately following FLACS and have a peak severity on day 7 postoperatively. Most signs of dry eye can return to preoperative basic levels within 3mo postoperatively. However, all cases can not recover from CFS and dry eye symptoms at 3mo postoperatively.]]></description>
<pubDate>2019/6/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Rui-Hong Ju, Yun Chen, Hai-Song Chen, Wei-Jian Zhou, Wei Yang, Zhen-De Lin and Zhe-Ming Wu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Rui-Hong Ju, Yun Chen, Hai-Song Chen, Wei-Jian Zhou, Wei Yang, Zhen-De Lin and Zhe-Ming Wu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190711]]></guid><cfi:id>633</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Association between the levels of prostaglandin E2 in tears and severity of dry eye]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190712]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the relationship between the levels of prostaglandin E2 (PGE2) in tears and dry eye disease severity based on both clinical symptoms and signs.
METHODS: Tear samples were collected from 36 non-Sj&#246;gren syndrome dry eye patients (10 males and 26 females, mean age 50.11±11.17y). All participants completed the Ocular Surface Disease Index (OSDI) questionnaire and underwent a detailed ophthalmic examination including, tear film breakup time (TBUT), ocular surface fluorescein staining, Schirmer I test, and meibomian gland assessment. The level of PGE2 in tears was measured using enzyme-linked immunosorbent assay (ELISA). The independent associations between tear PGE2 levels and other variables including demographics, OSDI scores, TBUT, Schirmer scores, ocular surface staining scores, and stage of meibomian gland dysfunction (MGD) were evaluated using linear regression analysis.
RESULTS: The mean PGE2 level in tears of dry eye patients was 537.85±234.02 pg/mL. The tear PGE2 levels significantly positively correlated with OSDI scores (R=0.608, P<0.001), however, they did not significantly associate with TBUT (R=0.153, P=0.373), Schirmer scores (R=-0.098, P=0.570), ocular surface staining scores (R=0.282, P=0.095), and stage of MGD (R=-0.107, P=0.535). Male sex was significantly negatively correlated with tear PGE2 levels.
CONCLUSION: The levels of PGE2 in tears are positively correlated with dry eye symptoms. However, no significant association was found between tear PGE2 levels and the results of other common dry eye diagnostic tests.]]></description>
<pubDate>2019/6/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Kaevalin Lekhanont, Kanchalika Sathianvichitr, Punyanuch Pisitpayat, Thunyarat Anothaisintawee, Kitipong Soontrapa and Umaporn Udomsubpayakul]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Kaevalin Lekhanont, Kanchalika Sathianvichitr, Punyanuch Pisitpayat, Thunyarat Anothaisintawee, Kitipong Soontrapa and Umaporn Udomsubpayakul</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190712]]></guid><cfi:id>632</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Mode of delivery, birth weight and the incidence of congenital nasolacrimal duct obstruction]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190713]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To study any possible association of congenital nasolacrimal duct obstruction (CNLDO) with mode of delivery, birth weight and gestational age.
METHODS: We retrospectively reviewed charts of all patients (n=2591) under the age of 3y who were born between April 2015 and May 2017 and were examined at the Ophthalmology Clinic of Emsey Hospital Istanbul, Turkey. We identified patients (n=105) who were diagnosed as CNLDO. The mode of delivery, birth weight and gestational age along with any adverse event during or after delivery or any other health history were determined. Birth statistical data were obtained from the hospital’s medical records database.
RESULTS: Gestational age of babies who were born via cesarean section (CS) was lower than gestational age of babies who were born via normal spontaneous vaginal delivery (NSVD; P=0.002). Babies who were born via CS were found to have 3.75 times higher risk of developing NLDO when compared to babies who were born via NSVD (OR=3.754).
CONCLUSION: There is a possible association between CS and CNLDO.]]></description>
<pubDate>2019/6/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ayse Dolar Bilge]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ayse Dolar Bilge</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190713]]></guid><cfi:id>631</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Relationship between early structural changes at cornea incision sites and surgical outcomes after phacoemulsification]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190714]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the early structural changes at clear corneal cataract incision sites and surgical outcomes using anterior segment optical coherence tomography (AS-OCT).
METHODS: We evaluated 80 eyes of 59 patients who underwent phacoemulsification with a clear corneal incision. All incisions were evaluated 1wk, 1, and 3mo postoperatively using AS-OCT and analyzed regarding angle, length of the incision, maximal corneal thickness at the incision, and if present, corneal endothelial gap length and incision gap area. The patients were divided into two groups according to whether or not an endothelial gap was present at 1wk postoperatively (endothelial gap, group 1; no endothelial gap, group 2). We analyzed the difference in patient and surgical factors between the two groups, and compared the surgical outcome and the refractive outcome.
RESULTS: An endothelial gap was observed in 56 (70.0%) of 80 eyes at 1wk postoperatively but not at 3mo postoperatively. The mean patient age was significantly higher in group 1 than in group 2. The longer the length of the corneal incision and the steeper the incision angle, the greater the length and area of the endothelial gap. In group 1, the mean change in mean keratometry of the anterior cornea was significantly greater than in group 2, and the spherical equivalent (SE) and mean numerical error indicated significant myopic changes at 1wk postoperatively.
CONCLUSION: The risk of an endothelial gap increases with patient age and a long corneal incision and steep incision angle. The presence of an endothelial gap after surgery may affect the early postoperative corneal curvature and SE.]]></description>
<pubDate>2019/6/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Kyung Hyun Jin and Tae Gi Kim]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Kyung Hyun Jin and Tae Gi Kim</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190714]]></guid><cfi:id>630</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[The process of retinal vascularization in retinopathy of prematurity after ranibizumab treatment in China]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190715]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To explore the process of retinal vascularization and risk factors for retinopathy of prematurity (ROP) treated with intravitreal ranibizumab (IVR) as monotherapy.
METHODS: Infants with type 1 ROP who received IVR as primary treatment from August 2014 to October 2016 at Peking University People’s Hospital’s Ophthalmology Department were included in the study. All eyes received 0.25 mg ranibizumab at initial treatment. Retinal vascularization was evaluated clinically. Potential risk factors were also recorded and examined.
RESULTS: Retinal vascularization was completed in 126 eyes (62.7%), and retinal vascularization terminated in zone II and zone III with 16 eyes (7.9%) and 44 eyes (21.9%), respectively, after more than 1-year follow-up. In multivariate regression analysis, lower birth weight (BW), severity of ROP and repeated injections were found to be risk factors for peripheral avascular area (P<0.05).
CONCLUSION: In our retrospective study, 29.8% of the ROP eyes treated with ranibizumab have peripheral avascular area at the last follow-up. Lighter BW and the severity of ROP are risk factors. Furthermore, repeated injections also increase the risk of retinal peripheral avascular area remaining in ROP patients.]]></description>
<pubDate>2019/6/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Qing-Yu Meng, Yong Cheng, Ming-Wei Zhao and Jian-Hong Liang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Qing-Yu Meng, Yong Cheng, Ming-Wei Zhao and Jian-Hong Liang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190715]]></guid><cfi:id>629</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[The clinical features of posterior scleritis with serous retinal detachment: a retrospective clinical analysis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190716]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To summarize the clinical features, systemic associations, risk factors and choroidal thickness (CT) changing in posterior scleritis (PS) with serous retinal detachment.
METHODS: This retrospective study included 23 patients diagnosed PS with retinal detachment from August 2012 to July 2017. All patients’ medical history and clinical features were recorded. The examinations included best corrected visual acuity (BCVA), intraocular pressure (IOP), fundus examination, and routine eye examinations. Posterior coats thickness (PCT) was determined by B-scan ultrasound, the CT was measured by enhanced depth imaging spectral-domain optical coherence tomography (EDI-OCT) and clinical data were compiled and analyzed.
RESULTS: After application of extensive exclusion criteria, 23 patients with PS remained (13 females, 10 males). The average age at presentation was 29.5±9.24 years old. Ocular pain and blurred vision were the two most common complained symptoms by patients. Anterior scleritis occurred in 12 patients, which was confirmed by ultrasound biomicroscopy (UBM) examination. Despite all patients displaying serous retinal detachment in their macula, no fluorescein leakage was observed in the macular area. Optic disc swelling was documented in 10 of the 23 eyes. From B-scan ultrasound examination, the PCT increased with fluid in Tenon’s capsule demonstrated as a typical T-sign. The average PCT was 2.51±0.81 mm in the PS-affected eyes and only 1.09±0.29 mm in the unaffected eye (P<0.0001). The subfoveal CT was 442.61±55.61 μm, which correlated with axis length (r=-0.65, P=0.001) and PCT (r=0.783, P<0.001). The BCVA and IOP did not correlate with either CT or PCT.
CONCLUSION: PS with serous retinal detachment presented a variety of symptoms, such as pain, visual loss, and physical indicators. Typical T-sign detected by B-scan ultrasound is a useful confirmatory sign for PS diagnosis. Pathological increases in CT might be a potential predictive factor for inflammation.]]></description>
<pubDate>2019/6/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Zhi-Zhang Dong, Yi-Feng Gan, Yi-Nan Zhang, Yu Zhang, Juan Li and Hai-Hua Zheng]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zhi-Zhang Dong, Yi-Feng Gan, Yi-Nan Zhang, Yu Zhang, Juan Li and Hai-Hua Zheng</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190716]]></guid><cfi:id>628</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Artificial intelligence on diabetic retinopathy diagnosis: an automatic classification method based on grey level co-occurrence matrix and naive Bayesian model]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190717]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To develop an automatic tool on screening diabetic retinopathy (DR) from diabetic patients.
METHODS: We extracted textures from eye fundus images of each diabetes subject using grey level co-occurrence matrix method and trained a Bayesian model based on these textures. The receiver operating characteristic (ROC) curve was used to estimate the sensitivity and specificity of the Bayesian model.
RESULTS: A total of 1000 eyes fundus images from diabetic patients in which 298 eyes were diagnosed as DR by two ophthalmologists. The Bayesian model was trained using four extracted textures including contrast, entropy, angular second moment and correlation using a training dataset. The Bayesian model achieved a sensitivity of 0.949 and a specificity of 0.928 in the validation dataset. The area under the ROC curve was 0.938, and the 10-fold cross validation method showed that the average accuracy rate is 93.5%.
CONCLUSION: Textures extracted by grey level co-occurrence can be useful information for DR diagnosis, and a trained Bayesian model based on these textures can be an effective tool for DR screening among diabetic patients.]]></description>
<pubDate>2019/6/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Kai Cao, Jie Xu and Wei-Qi Zhao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Kai Cao, Jie Xu and Wei-Qi Zhao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190717]]></guid><cfi:id>627</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of lens constants optimization on the accuracy of intraocular lens power calculation formulas for highly myopic eyes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190610]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the effect of different lens constant optimization methods on the accuracy of intraocular lens (IOL) power calculation formulas for highly myopic eyes.
METHODS: This study comprised 108 eyes of 94 consecutive patients with axial length (AL) over 26 mm undergoing phacoemulsification and implantation of a Rayner (Hove, UK) 920H IOL. Formulas were evaluated using the following lens constants: manufacturer’s lens constant, User Group for Laser Interference Biometry (ULIB) constant, and optimized constant for long eyes. Results were compared with Barrett Universal II formula, original Wang-Koch AL adjustment method, and modified Wang-Koch AL adjustment method. The outcomes assessed were mean absolute error (MAE) and percentage of eyes with IOL prediction errors within ±0.25, ±0.50, and ±1.0 diopter (D). The nonparametric method, Friedman test, was used to compare MAE performance among constants.
RESULTS: Optimized constants could significantly reduce the MAE of SRK/T, Hoffer Q, and Holladay 1 formulas compared with manufacturer’s lens constant, whereas the percentage of eyes with IOL prediction errors within ±0.25, ±0.50, and ±1.0 D had no statistically significant differences. Optimized lens constant for long eyes alone showed non-significant refractive advantages over the ULIB constant. Barrett Universal II formula and formulas with AL adjustment showed significantly higher accuracy in highly myopic eyes (P<0.001).
CONCLUSION: Lens constant optimization for the subset of long eyes reduces the refractive error only to a limited extent for highly myopic eyes.]]></description>
<pubDate>2019/5/6 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jia-Qing Zhang, Xu-Yuan Zou, Dan-Ying Zheng, Wei-Rong Chen, Ao Sun and Li-Xia Luo]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jia-Qing Zhang, Xu-Yuan Zou, Dan-Ying Zheng, Wei-Rong Chen, Ao Sun and Li-Xia Luo</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190610]]></guid><cfi:id>626</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Impact of ultrasound and optical biometry on refractive outcomes of cataract surgery after penetrating keratoplasty in keratoconus]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190611]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyse the impact of ultrasound and optical intraocular lens (IOL) calculation methods on refractive outcomes of cataract phacoemulsification performed after penetrating keratoplasty (PK) in keratoconus.
METHODS: Phacoemulsification cataract surgery was performed on 42 eyes of 34 patients with keratoconus who had previously undergone PK. The IOL power was determined by using both standard and corneal topography-derived keratometry using the SRK/T formula. We used two independent methods-ultrasound biometry (UB) and interferometry [optical biometry (OB)] for IOL calculation. The analysed data from medical records included demographics, medical history, best corrected visual acuity (BCVA) on Snellen charts, technique of IOL calculation and calculation formula and its impact on final refractive result.
RESULTS: BCVA ranged from 0.01 to 0.4 (mean 0.09±0.19) before surgery and ranged from 0.2 to 0.7 (mean 0.38±0.14) at 1mo and from 0.2 to 1.0 (mean 0.56±0.16) (P<0.05) at 3mo, postoperatively. The refractive aim differed significantly from the refractive outcome in both the UB and OB groups (P<0.05). There was no statistically significant difference in the accuracy of the two biometry methods.
CONCLUSION: The refractive aim in keratoconus eyes post-PK is not achieved with either ultrasound or OB.]]></description>
<pubDate>2019/5/6 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Katarzyna Krysik, Anita Lyssek-Boron, Dominika Janiszewska-Bil, Edward Wylegala and Dariusz Dobrowolski]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Katarzyna Krysik, Anita Lyssek-Boron, Dominika Janiszewska-Bil, Edward Wylegala and Dariusz Dobrowolski</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190611]]></guid><cfi:id>625</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Late in-the-bag spontaneous IOL dislocation: risk factors and surgical outcomes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190612]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the possible predisposing risk factors for late in-the-bag spontaneous IOL dislocations and to study the early surgical and visual outcomes of repositioning and exchange surgeries.METHODS: Medical and surgical records of 39 eyes of 39 patients who underwent IOL repositioning or exchange surgery for dislocation between 2010 and 2018 were reviewed. Possible predisposing risk factors and some characteristics of late in-the-bag spontaneous IOL dislocations; outcomes of IOL repositioning and exchange surgeries, including visual acuity, refractive status before and after surgery and postoperative complications were evaluated.RESULTS: The predisposing factors for late in-the-bag spontaneous IOL dislocations were pseudoexfoliation [PEX; 12/39 (30.8%)], previous vitreoretinal surgery [7/39 (17.9%)], axial myopia [3/39 (7.7%)], both PEX and axial myopia [1/39 (2.6%)], both previous vitreoretinal surgery and axial myopia [2/39 (5.1%)] and uveitis [1/39 (2.6%)]. The mean interval between cataract and dislocation surgery was 7.23y, greater in PEX positive group (8.63y). The mean best corrected visual acuity (BCVA) improved significantly after dislocation surgery (P<0.001) and also improved significantly after exchange surgery (P=0.001). The mean value of spherical equivalant decreased significantly after dislocation surgery (P=0.011), whereas corneal astigmatism increased but this difference was not significant after dislocation surgery and exchange surgery (P=0.191, P=0.074, respectively).CONCLUSION: The most prevelant risk factors for late in-the-bag spontaneous IOL dislocations are PEX, previous vitreoretinal surgery and axial myopia. In the management of IOL dislocations, exchange surgery with small corneal incision seemed effective with improved BCVA and safety with low postoperative complications.]]></description>
<pubDate>2019/5/6 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Sevgi Subasi, Nursen Yuksel, V. Levent Karabas and Busra Yilmaz Tugan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Sevgi Subasi, Nursen Yuksel, V. Levent Karabas and Busra Yilmaz Tugan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190612]]></guid><cfi:id>624</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of femtosecond laser-assisted lens surgery on the optic nerve head and the macula]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190613]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the effect of femtosecond laser-assisted lens surgery (FLALS; cataract surgery or refractive lens exchange) on the structure of the optic nerve head and the macula.METHODS: This prospective longitudinal study included healthy eyes undergoing FLALS. Eyes with glaucoma or any other ocular disease that could alter optical coherence tomography results were excluded. Retinal nerve fiber layer (RNFL), Bruch’s membrane opening-minimum rim width (BMO-MRW) and macular thickness (MT) were measured preoperatively, 1 and 6mo after surgery using spectral-domain optical coherence tomography (SD-OCT). Changes between preoperative and postoperative values were evaluated.RESULTS: A total of 87 eyes of 46 patients were included in this study. Preoperative RNFL, BMO-MRW and MT in microns (µm) were 100.77±10.39, 330.31±49.99 and 276.30±33.39, respectively. Postoperative RNFL, BMO-MRW and MT were 104.74±11.55, 348.32±54.05 and 279.83±22.65 1mo after surgery and 102.93±11.17, 343.11±53.4 and 278.90±22.19 6mo after surgery, respectively; which equals an increase of 3.93%, 5.45% and 1.27%, respectively, 1mo after surgery, and 2.14%, 3.87% and 0.94% 6mo after surgery. The differences between the preoperative and the postoperative RNFL and BMO-MRW values were statistically significant (P<0.001). Regarding MT values, there were not statistically significant differences (P=0.26).CONCLUSION: Our study suggests that FLALS does not have a negative impact on the structural status of the optic nerve head in healthy eyes, assessed by SD-OCT. There is a slight increase in the values of RNFL, BMO-MRW and MT 1mo and 6mo after surgery.]]></description>
<pubDate>2019/5/6 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Josefina Re&ntilde;ones de Abajo, Beatriz Est&eacute;vez Jorge, Jes&uacute;s Mar&iacute;a Gonz&aacute;lez Mart&iacute;n, Humberto Carreras D&iacute;az, Juan Francisco Loro Ferrer and Alfonso Ant&oacute;n L&oacute;pez]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Josefina Re&ntilde;ones de Abajo, Beatriz Est&eacute;vez Jorge, Jes&uacute;s Mar&iacute;a Gonz&aacute;lez Mart&iacute;n, Humberto Carreras D&iacute;az, Juan Francisco Loro Ferrer and Alfonso Ant&oacute;n L&oacute;pez</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190613]]></guid><cfi:id>623</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Changes in intraocular pressure after intraocular eye surgery—the influence of measuring technique]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190614]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the changes in intraocular pressure (IOP) before and after intraocular surgery measured with Goldmann applanation tonometry (GAT) and pascal dynamic contour tonometry (PDCT), and assessed their agreement.METHODS: Patients who underwent trans pars plana vitrectomy (TPPV) with or without cataract extraction (CE) were included. The IOP was measured in both eyes with GAT and PDCT pre- and postoperatively, where the non-operated eyes functioned as control.RESULTS: Preoperatively, mean IOP measurements were 16.3±6.0 mm Hg for GAT and 12.0±2.8 mm Hg for PDCT for the operated eyes. Postoperatively, the mean IOP dropped to 14.3±5.6 mm Hg for GAT (P=0.011) and rose up to 12.7±2.6 mm Hg for PDCT (P=0.257). Bland-Altman analysis showed a poor agreement between GAT and PDCT with a mean difference of 2.9 mm Hg preoperatively and 95% limits of agreement ranging from -3.2 to 9.0 mm Hg. Postoperatively, the mean difference was 1.2 mm Hg with 95% limits of agreement ranging from -8.3 to 10.7 mm Hg. There were no significant differences between the TPPV and TPPV+CE group, except when measured with PDCT postoperatively (P=0.012).CONCLUSION: The IOP is reduced after surgery when measured with GAT and remained stable when measured with PDCT. However, the agreement between GAT and PDCT is poor. Although PDCT may be a more accurate predictor of the true IOP, it seems less suitable for daily use in the clinical practice.]]></description>
<pubDate>2019/5/6 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hrvoje Kovacic, Roger C.W. Wolfs, Emine K&inodot;l&inodot;&ccedil; and Wishal D. Ramdas]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hrvoje Kovacic, Roger C.W. Wolfs, Emine K&inodot;l&inodot;&ccedil; and Wishal D. Ramdas</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190614]]></guid><cfi:id>622</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Combined treatment of phacoemulsification and single-port limited pars plana vitrectomy in acute angle-closure glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190615]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the efficacy of combined treatment of phacoemulsification (PE) and micro-incisional single-port transconjunctival limited pars plana vitrectomy (PPV) in acute angle-closure glaucoma (AACG).
METHODS: A retrospective study included 26 patients who underwent PE diagnosed with AACG. Among them, 16 patients (16 eyes) underwent PE alone, 10 patients (10 eyes) underwent combined limited vitrectomy and PE. Then we compared intraocular pressure (IOP), anterior chamber angle, anterior chamber depth, central corneal thickness and corneal endothelial cell count before and after surgery, and effective PE time during cataract surgery.
RESULTS: Effective PE time was shorter in the combined surgery group than in the single surgery group (P=0.040). There was no statistically significant difference in IOP and best-corrected visual acuity between the two groups postoperatively. At 6mo postoperatively, there was no difference in the anterior chamber angle, anterior chamber depth, and central corneal thickness between two groups, but corneal endothelial cell count was higher in the combined surgery group than in the single surgery group (P=0.046). No complication such as vitreoretinal disease, endophthalmitis, bullous keratopathy was noted.
CONCLUSION: Combined micro-incisional single-port transconjunctival limited PPV and PE are more effective and safer than PE alone because of less operation time and fewer complications for management of AACG.]]></description>
<pubDate>2019/5/6 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ha Jeong Noh and Seong Taeck Kim]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ha Jeong Noh and Seong Taeck Kim</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190615]]></guid><cfi:id>621</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Focal choroidal excavation complicated with choroidal neovascularization in young and middle aged patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190616]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the clinical and optical coherence tomography (OCT) features of focal choroidal excavation (FCE) complicated with choroidal neovascularization (CNV) in young and middle aged patients.
METHODS: We performed a retrospective review of 26 patients with FCE accompanied by CNV. All patients underwent a complete ophthalmic examination. We analyzed the clinical characteristics of patients, focusing on the spectral-domain OCT features. All patients received intravitreal injection of anti-vascular endothelial growth factor (anti-VEGF) agents. And we assessed the changes of central retinal thickness and best-corrected visual acuity (BCVA) after anti-VEGF therapy.
RESULTS: The mean age of 26 patients was 35.5±7.3y (range, 21-48y). Of the 26 FCE lesions, 11 were located subfoveal, 6 were parafoveal, and 9 were extrafoveal. The mean FCE depth was 129.8±50.3 μm, and the mean width was 901.3±306.0 μm. The FCE depth was correlated positively with the width, but not correlated with age or refractive error. CNV was located within the excavation (19 eyes) or adjacent to the excavation (7 eyes). After anti-VEGF therapy, the central retinal thickness was significantly reduced and the BCVA was significantly improved. In the absorption process of subretinal fluid, we found that the fluid in the excavations needed to be absorbed at the last. A small amount of residual fluid could still be seen in a few deep excavations even after a long-term follow-up.
CONCLUSION: FCE may be an important reason to cause CNV. Especially in young patients with idiopathic CNV, we should pay attention to the use of OCT to check the presence of FCE. Anti-VEGF therapy is generally effective for CNV associated with FCE.]]></description>
<pubDate>2019/5/6 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Wen-Yi Tang, Ting Zhang, Qin-Meng Shu, Chun-Hui Jiang, Qing Chang, Hong Zhuang and Ge-Zhi Xu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Wen-Yi Tang, Ting Zhang, Qin-Meng Shu, Chun-Hui Jiang, Qing Chang, Hong Zhuang and Ge-Zhi Xu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190616]]></guid><cfi:id>620</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Renal function and choroidal thickness using swept-source optical coherence tomography in diabetic patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190617]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the relationship between choroidal thickness and renal function in diabetic patients.
METHODS: Cross-sectional retrospective clinical study of 42 eyes of 21 ocular treatment-na&#239;ve diabetic patients. Demographic data included: age, sex, type and course of diabetes. Ocular data included: severity of diabetic retinopathy; retinal thickness at the central macular region, as well as choroidal thickness at the central and paracentral quadrants, using automatically generated maps by swept-source optical coherence tomography; presence of cystic macular edema; and ocular axial length (AXL). Lab-test parameters included: glycated hemoglobin (HbA1c), albuminuria, albumin/creatinine ratio in urine, and glomerular filtration rate.
RESULTS: A significant negative correlation was mainly observed between several choroidal thicknesses, age (P<0.020) and ocular AXL (P<0.030). On the contrary, a significant positive correlation was found between all choroidal thicknesses, HbA1c (P<0.035) and albuminuria (P<0.040).
CONCLUSION: Choroidal thickness can represent an additional tool to help clinicians predicting the renal status in ocular treatment-na&#239;ve diabetic patients.]]></description>
<pubDate>2019/5/6 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Antonio Manuel Garrido-Hermosilla, Mariola Méndez-Muros, Estanislao Gutiérrez-Sánchez, Cristóbal Morales-Portillo, María Jesús Díaz-Granda, Eduardo Esteban-González, Isabel Relimpio-López, María Asunción Martínez-Brocca and Enrique Rodríguez-de-la-Rúa-Franch]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Antonio Manuel Garrido-Hermosilla, Mariola Méndez-Muros, Estanislao Gutiérrez-Sánchez, Cristóbal Morales-Portillo, María Jesús Díaz-Granda, Eduardo Esteban-González, Isabel Relimpio-López, María Asunción Martínez-Brocca and Enrique Rodríguez-de-la-Rúa-Franch</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190617]]></guid><cfi:id>619</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Disorganization of the retinal inner layers as a prognostic factor in eyes with central retinal artery occlusion]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190618]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate baseline foveal disorganisation of retinal inner layers (DRIL) as a prognostic factor in eyes with central retinal artery occlusion (CRAO).METHODS: Twenty-eight CRAO patients who were followed-up between 2010 and 2016 were retrospectively investigated. Demographic characteristics and detailed ophthalmological examination findings of all patients were recorded. Macular thicknesses (MTs) from 5 separate spots and DRIL were measured with spectral-domain optic coherence tomography (SD-OCT). Correlations between DRIL score and logMAR converted visual acuity (VA), change in VA, patient reference time (RT), number of hyperbaric oxygen therapy (HBOT) sessions, MT and MT change were investigated.RESULTS: There was a positive correlation between the DRIL score and the final VA (r=0.787) and a negative correlation with the change in VA (r=-0.763). The RT and MT were closely related to the DRIL score. A negative correlation was found between the number of HBOT sessions and the DRIL score (r=-0.341).CONCLUSION: The DRIL score is a parameter assessed by SD-OCT, which can provide us reliable information regarding the prognosis of visual functions and response to the treatment for CRAO patients at acute phase.]]></description>
<pubDate>2019/5/6 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hayati Yilmaz and Ali H. Durukan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hayati Yilmaz and Ali H. Durukan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190618]]></guid><cfi:id>618</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[International multi-center study of iatrogenic retinal tears in pars plana vitrectomy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190619]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To study and compare the effect of different surgical settings on the development of iatrogenic retinal tears (IRT) in conventional (20-gauge) and microincisional vitrectomy.METHODS: An international retrospective comparative study of 394 patients who had simple vitrectomy at three tertiary centers. Surgeries were performed by four retina surgeons using different viewing systems. Two groups of eyes were compared: microincisional vitrectomy (327 eyes) and conventional (67 eyes) vitrectomy. An iatrogenic tear was defined as the occurrence of one or more peripheral retinal tears during surgery or at any visit in the first 6wk postoperatively.RESULTS: Mean age was 67±12y and 55% were female. Iatrogenic tears occurred in 11/394 (2.8%) of eyes. The rate of tears was similar among different surgeons and viewing systems (P=0.93 and P=0.76, respectively). Surgical indication, preexisting pseudophakia/aphakia, induction of posterior vitreous detachment (PVD) during surgery, and the use triamcinolone acetonide didn’t significantly affect the rate of tears (P>0.1 for all factors). A higher rate of tears was found in the conventional group compared to the microincisional group (respectively, 7.5%, 1.8%, P=0.02).CONCLUSION: The rate of IRT in vitrectomy is not significantly affected by surgical indication, preexisting PVD or pseudophakia, or use of triamcinolone or different viewing systems but is significantly higher in conventional vitrectomy. Microincisional platforms improve the safety of vitrectomy regardless of the viewing system used.]]></description>
<pubDate>2019/5/6 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Omar A. Saleh, Rami A. Al-Dwairi, Hasan Mohidat, Denis Jusufbegovic, Brooke Nesmith, Yoreh Barak, Michael Mimouni and Shlomit Schaal]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Omar A. Saleh, Rami A. Al-Dwairi, Hasan Mohidat, Denis Jusufbegovic, Brooke Nesmith, Yoreh Barak, Michael Mimouni and Shlomit Schaal</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190619]]></guid><cfi:id>617</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[B-scan ultrasound and cytology of the vitreous in primary central nervous system lymphoma with vitreoretinal involvement]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190620]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the diagnostic value of B-scan ultrasound and explore the cytological characteristics of patients with vitreoretinal lymphoma (VRL) and primary central nervous system lymphoma (PCNSL).
METHODS: The clinical data and pathologic specimens from patients with VRL diagnosed at the North Huashan Hospital from 2016 to 2017 were retrospectively reviewed. The patients were diagnosed by slit lamp ophthalmoscopy, B-scan ultrasound, cytology of the vitreous, which was obtained by vitrectomy, and cytokine measurements of interleukin (IL)-10 and IL-6.
RESULTS: Twenty-six eyes (19.4%) out of 134 eyes of 67 patients (47 men and 20 women) with PCNSL were diagnosed with VRL by B-scan ultrasound, and 14 eyes (10.4%) were diagnosed by slit lamp ophthalmoscopy. Twenty-four eyes (17.9%) of 17 patients were confirmed as having VRL with cytology. No difference in the association between intracranial lesion location and ocular involvement was found. VRL patients had higher levels of vitreous IL-10 and IL-10/IL-6 when compared with macular hole cases, but the difference was not statistically significant.
CONCLUSION: A total of 25.4% of the PCNSL patients had VRL, B-scan ultrasound examination had characteristic features and is recommended over slit lamp ophthalmoscopy for the screening diagnosis of PCNSL with intraocular involvement. Moreover, the cytological and immunohistochemical analyses performed after 25-gauge diagnostic vitrectomy were accurate diagnostic techniques.]]></description>
<pubDate>2019/5/6 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jie Lai, Kun Chen, Hui-Min Shi, Lin Zhuang, Xian Zhou, Jian-Jiang Xiao, Yi Li, Bo-Bin Chen and Qing-Ping Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jie Lai, Kun Chen, Hui-Min Shi, Lin Zhuang, Xian Zhou, Jian-Jiang Xiao, Yi Li, Bo-Bin Chen and Qing-Ping Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190620]]></guid><cfi:id>616</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Conjunctival flora in anophthalmic patients: microbiological spectrum and antibiotic sensitivity]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190510]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To identify the spectrum and susceptibility pattern of isolated microorganisms from conjunctival flora of anophthalmic patients.METHODS: A cross-sectional clinical study including 60 patients with unilateral anophthalmia. Patients with use of antibiotic drops in their socket during the last month were also included. From each patient, three microbiological samples were taken from the lower conjunctival sac (healthy eye, pre-prosthesis, and retro-prosthesis space of socket). The 180 samples obtained were cultured. Isolates were identified and their antibiotic sensitivities were determined.RESULTS: A total of 251 isolates were recovered (62 isolates from healthy eye, 93 from pre-prosthesis, and 96 from retro-prosthesis space). The most common organism was Staphylococcus epidermidis, in both healthy eyes (64.5%) and sockets (45.5%). Altogether, coagulase-positive Staphylococci, Streptococci, and Gram-negative bacteria accounted for less than 15% of isolates in healthy eyes and more than 35% in sockets. Regarding the antibiotic sensitivities, there were no significant differences between isolates from sockets and healthy eyes. Nine patients recognized the use of self-prescribed antibiotic drops in their socket. In the healthy eyes of these subjects, Gram-positive microorganisms showed significantly greater resistance to aminoglycosides and tetracycline.CONCLUSION: Sockets of anophthalmic patients show a greater number of pathogens compared to healthy eyes. The use of antibiotic drops in the socket promotes a resistant flora not only in the socket but also in the healthy eye. Quinolones and macrolides may be better therapeutic options than aminoglycosides for treating conjunctivitis of anophthalmic sockets, since these antibiotics are less active against Staphylococcus epidermidis.]]></description>
<pubDate>2019/3/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Alvaro Toribio, Teresa Marrodán, Isabel Fernández-Natal, Honorina Martínez-Blanco, Leandro Rodríguez-Aparicio and Miguel &Aacute;. Ferrero]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Alvaro Toribio, Teresa Marrodán, Isabel Fernández-Natal, Honorina Martínez-Blanco, Leandro Rodríguez-Aparicio and Miguel &Aacute;. Ferrero</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190510]]></guid><cfi:id>615</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Safety & efficacy of single subconjunctival triamcinolone 5 mg depot vs topical loteprednol post cataract surgery: less drop cataract surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190511]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To do a randomized prospective interventional study for comparing the effects of a single subconjunctival triamcinolone acetonide (SCTA) injection to tapering topical loteprednol in patients undergoing phacoemulsification surgery under topical anesthesia.
METHODS: A total of 400 patients were randomized into 2 groups; Group A (200 patients) received 5 mg SCTA at the end of surgery and topical ketorolac tromethamine (0.5%) with ofloxacin (0.3%) combination for 3wk. Group B (200 patients) received tapering topical loteprednol etabonate (0.5%) along with ofloxacin (0.3%) and ketorolac tromethamine (0.5%) for 3wk. Outcomes evaluated were intraocular pressure (IOP), anterior chamber cells/flare and macular oedema postoperatively at 1, 6 and 12wk.
RESULTS: Baseline parameters were almost similar in both the groups. No statistical difference was seen between the preoperative and postoperative IOP values for Group A (P=0.82) and Group B (P=0.61) and postoperative IOP values in between both groups (P=0.14) at 1wk. Incidence of cells/flare postoperative was statistically not significant (P=0.82) in both groups at all follow up visits. Postoperative macular oedema was not observed at any follow up visit.
CONCLUSION: SCTA appears to be an effective alternative to prolong postoperative topical steroid use.]]></description>
<pubDate>2019/3/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jagadeesh Kumar Reddy, Vivek Chaitanya, Neeraj Shah, Venkata Prabhakar Guduru, Shadab Khan and Siddharthan Kuttupalayam]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jagadeesh Kumar Reddy, Vivek Chaitanya, Neeraj Shah, Venkata Prabhakar Guduru, Shadab Khan and Siddharthan Kuttupalayam</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190511]]></guid><cfi:id>614</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Pediatric Nd:YAG laser capsulotomy in the operating room: review of 87 cases]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190512]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report a large series of children having Nd:YAG laser capsulotomy in the operating room using the lateral decubitus position.
METHODS: Medical records of children who underwent Nd:YAG laser capsulotomy in the operating room at Ann & Robert H. Lurie Children’s Hospital of Chicago between September 2008 and April 2017 were reviewed. Induction of general anesthesia and intubation was performed in the supine position after which the patient was placed in lateral decubitus position. The Nd:YAG laser capsulotomy was performed using a standard protocol. At the completion of the procedure, the patient was turned back into the supine position and extubated.
RESULTS: This study included 87 eyes of 60 patients. Patient’s age ranged from 1 to 18y (mean 6.4±4.1y). In most cases (84/87, 97%), the procedure was performed under general anesthesia. In all cases, good focus on the membrane was achieved, and the procedure was performed successfully. There were no intraoperative ocular or anesthesia-related complications.
CONCLUSION: When performing Nd:YAG laser capsulotomy in the operating room, the lateral decubitus position allows an easy and safe approach without the risk of potentially devastating complications that have been associated with the previously described sitting and prone positions.]]></description>
<pubDate>2019/3/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Michael Kinori, Narasimhan Jagannathan, Anne M Langguth, Marjorie A Sasso, Marilyn B Mets, Bahram Rahmani, Hawke Yoon, Rebecca Mets-Halgrimson, Sudhi P Kurup and Janice L Zeid]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Michael Kinori, Narasimhan Jagannathan, Anne M Langguth, Marjorie A Sasso, Marilyn B Mets, Bahram Rahmani, Hawke Yoon, Rebecca Mets-Halgrimson, Sudhi P Kurup and Janice L Zeid</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190512]]></guid><cfi:id>613</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Efficacy and safety of micropulse laser trabeculoplasty for primary open angle glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190513]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the efficiency and safety of micropulse laser trabeculoplasty (MLT) for primary open angle glaucoma (POAG) patients.METHODS: Retrospective study. POAG patients undergoing MLT in Peking University Third Hospital from June 2016 to November 2017. Seventy-two eyes of 72 POAG patients were enrolled. Only one eye of each patient was treated by MLT. The intraocular pressure (IOP) before MLT and at 1d, 1, 4, 12 and 24wk and glaucoma medication before and after treatment were compared.RESULTS: The IOP was 20.6±5.9 mm Hg before MLT and 20.8±6.8 mm Hg at 2h after MTL. The IOP at 1d, 1, 4, 12 and 24wk was 17.9±4.4, 18.0±4.3, 17.5±3.4, 17.0±2.7, and 16.5±2.9 mm Hg, respectively. The IOP before and after MLT demonstrated a statistically significant difference by ANOVA analyses (F=5.797, P<0.001). Least significant difference t-tests showed there was no statistically significant difference between pre-MLT IOP within 2h after MLT (P=0.207). The statistically significant difference was confirmed between the pre-MLT IOP at 1d, 1, 4, 12 and 24wk after MLT (P=0.006, 0.009, 0.001, <0.001, <0.001, respectively). The number of glaucoma medications before MLT was 1.7±1.4 and 1.5±1.4 24wk after MLT with a significantly statistical difference (t=2.219, P=0.031)CONCLUSION: MLT is effective and safe for POAG patients. No patient experienced IOP spikes after MLT. The IOP 6mo after treatment decreased significantly with less glaucoma medication.]]></description>
<pubDate>2019/3/27 16:22:57</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ying Hong, Si-Jia Song, Bo Liu, Kiana Hassanpour, Chun Zhang and Nils Loewen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ying Hong, Si-Jia Song, Bo Liu, Kiana Hassanpour, Chun Zhang and Nils Loewen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190513]]></guid><cfi:id>612</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Retinal nerve fiber layer changes based on historic CD4 nadir among HIV positive patients undergoing glaucoma evaluation]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190514]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine relationships between retinal nerve fiber layer (RNFL) thickness and nadir CD4 cell count in human immunodeficiency virus (HIV) positive patients evaluated for glaucoma suspicion.METHODS: Data were reviewed for 329 HIV positive patients evaluated for glaucoma suspicion. High-definition optical coherence tomography (OCT) RNFL measurements were obtained at least 6mo apart. Analyses were performed to identify relationships between nadir CD4 count and RNFL thickness.RESULTS: Totally 110 eyes of 55 patients met inclusion criteria, of which 46 eyes were from subjects with nadir CD4<200 cells/mm3 and 64 had nadir CD4≥200 cells/mm3. Patients with nadir CD4<200 cells/mm3 had significantly thicker superior (119.7±18.6 µm) and temporal (63.8±11.7 µm) quadrants at time of initial OCT compared to the superior (112.8±16.8 µm, P=0.048) and temporal (57.1±11.9 µm, P=0.004) quadrants of patients with higher nadir CD4. This trend toward thicker RNFL among subjects with lower nadir CD4 cell counts persisted at the time of follow up OCT where participants with nadir CD4<200 cells/mm3 showed average RNFL thickness in the superior and temporal quadrants of 117.9±18.3 µm and 63.8±12.8 µm, respectively, compared to a superior thickness of 110.5±16.9 µm (P=0.034) and temporal thickness of 57.3±11.6 µm (P=0.007) among those with higher nadir CD4.CONCLUSION: Patients with lower nadir CD4 cell counts have thicker RNFL in the superior and temporal quadrants compared to those with higher nadir CD4 counts. RNFL thickness in HIV positive patients may be affected by historic HIV disease control and should be considered when evaluating HIV positive patients for glaucoma.]]></description>
<pubDate>2019/3/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Sarah H. Van Tassel, Paul Petrakos, Elizabeth Marlow, Elizabeth Mauer, Harjot K. Singh and Anna M. Demetriades]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Sarah H. Van Tassel, Paul Petrakos, Elizabeth Marlow, Elizabeth Mauer, Harjot K. Singh and Anna M. Demetriades</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190514]]></guid><cfi:id>611</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Inflammatory model in patients with primary open angle glaucoma and diabetes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190515]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the inflammatory cytokines expression in aqueous humor in diabetic primary open angle glaucoma (POAG) patients.
METHODS: A cross-sectional study on 87 eyes, distributed as following: 26 eyes from diabetic patients, 16 eyes with POAG and 21 eyes from diabetic POAG patients; healthy controls (24 eyes) were recruited from patients undergoing conventional cataract surgery. A volume of 100 μL of aqueous humor (AH) was collected during phacoemulsification and 21 inflammatory markers were quantified using a Luminex&#174; cytometric bead assay: IL-1Ra, IL-1α, IL-1β, IL-5, IL-6, IL-10, IL-17, GM-CSF, IFNγ, CCL2, CCL3, CCL4, CXCL5, CXCL8, bFGF, VEGF, TNFα. Main changes in cytokine profile were analyzed and compared between groups. Data on demographics, duration of glaucoma, intraocular pressure (IOP), number of anti-glaucoma substances were recorded for correlation analysis and prediction models.
RESULTS: Significant differences in cytokine expression between groups were detected for CXCL5 (P<0.001), CXCL8 (P=0.004), IL-1α (P<0.001), IL-2 (P<0.001), CCL4 (P=0.003), CCL5 (P<0.001) and TNFα (P=0.05). Post-hoc analysis identified IL-2 (P=0.009) and CXCL5 (P<0.001) as “separation markers” between POAG and diabetic POAG eyes. In POAG patients, the “separation markers” could highly predict the TNFα levels F(1, 16)=14.639, P<0.001, whereas in diabetic patients F(1, 24)=4.844, P=0.006 and diabetic POAG patients F(1, 19)=2.358, P=0.05 the level of prediction was inferior.
CONCLUSION: Our results reveal an inflammatory model based on increased TNFα levels in POAG eyes. Simultaneous co-stimulatory molecules and additional inflammatory pathways need to be further explored in diabetic POAG cases, since the prediction model could only partially explain the increased TNFα level in this category of patients.]]></description>
<pubDate>2019/3/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Anca Pantalon, Otilia Obad&#259;, Daniela Constantinescu, Crengu&#539;a Feraru and Dorin Chiseli&#539;&#259;]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Anca Pantalon, Otilia Obad&#259;, Daniela Constantinescu, Crengu&#539;a Feraru and Dorin Chiseli&#539;&#259;</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190515]]></guid><cfi:id>610</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Microvascular changes after conbercept therapy in central retinal vein occlusion analyzed by optical coherence tomography angiography]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190516]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate microvascular changes in eyes with central retinal vein occlusion (CRVO) complicated by macular edema before and after intravitreal conbercept injection and evaluate correlations between these changes and best-corrected visual acuity (BCVA) and retinal thickness.
METHODS: Twenty-eight eyes of 28 patients with macular edema caused by CRVO were included in this retrospective study. All patients received a single intravitreal conbercept injection to treat macular edema. BCVA and the results of optical coherence tomography angiography (OCTA) automatic measurements of the vessel density in the superficial (SCP) and deep retinal capillary plexus (DCP), the foveal avascular zone (FAZ) area, the FAZ perimeter (PERIM), the vessel density within a 300-μm wide ring surrounding the FAZ (FD-300), the acircularity index (AI), the choriocapillaris flow area, and retinal thickness were recorded before and at one month after treatment and compared with the results observed in age- and sex- matched healthy subjects.
RESULTS: The vessel density in the SCP and DCP, the FD-300, and the flow area of the choriocapillaris were all significantly lower in CRVO eyes than in healthy eyes, while the AI and retinal thickness were significantly higher (all P<0.05). After treatment, retinal thickness was significantly decreased, and the mean BCVA had markedly improved from 20/167 to 20/65 (P=0.0092). The flow area of the choriocapillaris was also significantly improved, which may result from the reduction of shadowing effect caused by the attenuation of macular edema. However, there were no significant changes in SCP and DCP vessel density after treatment. The flow area of the choriocapillaris at baseline was negatively correlated with retinal thickness.
CONCLUSION: OCTA enables the non-invasive, layer-specific and quantitative assessment of microvascular changes both before and after treatment, and can therefore be used as a valuable imaging tool for the evaluation of the follow-up in CRVO patients.]]></description>
<pubDate>2019/3/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yang Deng, Qi-Wen Zhong, Ai-Qi Zhang, Xiao-Juan Cai, Ming-Zhi Lu, Shao-Chong Zhang, Li-Shi Su, Hui Chen, Ying Lin, Li-Mei Sun, Guan-Di Chen, Li-Ting Zhong, Chen-Jin Jin and Wei Chi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yang Deng, Qi-Wen Zhong, Ai-Qi Zhang, Xiao-Juan Cai, Ming-Zhi Lu, Shao-Chong Zhang, Li-Shi Su, Hui Chen, Ying Lin, Li-Mei Sun, Guan-Di Chen, Li-Ting Zhong, Chen-Jin Jin and Wei Chi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190516]]></guid><cfi:id>609</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Validation and reproducibility of the Heidelberg Edge Perimeter in the detection of glaucomatous visual field defects]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190408]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To validate the ability of the Heidelberg Edge Perimeter (HEP) in detecting glaucomatous visual field (VF) defects compared to the Octopus Visual Field (OVF) Analyzer and to determine the test-retest repeatability of both modalities.METHODS: This prospective, cross-sectional study was conducted at Wills Eye Hospital, Philadelphia, PA. Glaucoma subjects and unaffected controls underwent VF testing using HEP standard automated perimetry (SAP) III 30-2 Adaptive Staircase Thresholding Algorithm (ASTA) FAST protocol and OVF G-TOP white-on-white strategy. Testing order was randomized. Pearson’s correlation coefficient was calculated for both mean deviation (MD) and pattern standard deviation/square root of loss of variance (PSD/sLV). Receiver operating characteristic (ROC) curves were used to determine the diagnostic abilities of both modalities. Glaucoma subjects returned for repeat testing and intraclass correlation coefficients (ICCs) were calculated to assess test-retest repeatability.RESULTS: Seventy-nine subjects with glaucoma and 36 unaffected controls were enrolled. HEP and OVF were significantly correlated for both MD (r=-0.84; P<0.01) and PSD/sLV (r=0.79; P<0.01). Areas under the ROC curves (AUCs) were also comparable between HEP and OVF for both MD (0.74 and 0.79, respectively; P=0.26) and PSD/sLV (0.74 and 0.82; P=0.08). ICC was high for both HEP (0.96 for MD, 0.95 for PSD/sLV) and OVF (0.82 and 0.88, respectively). Mean test duration (min) was significantly shorter for OVF (2.63) compared to HEP (5.15; P<0.01).CONCLUSION: HEP and OVF show strong correlation for both MD and PSD/sLV, and have similar validity for detecting glaucoma. The test-retest repeatability is high for both HEP and OVF, however the average testing duration of HEP is significantly longer than that of OVF.]]></description>
<pubDate>2019/3/6 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Qi N. Cui, Priyanka Gogt, Jonathan M. Lam, Safa Siraj, Lisa A. Hark, Jonathan S. Myers, L. Jay Katz and Michael Waisbourd]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Qi N. Cui, Priyanka Gogt, Jonathan M. Lam, Safa Siraj, Lisa A. Hark, Jonathan S. Myers, L. Jay Katz and Michael Waisbourd</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190408]]></guid><cfi:id>608</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of clinical outcomes of deep anterior lamellar keratoplasty and excimer laser assisted anterior lamellar keratoplasty in keratoconus]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190409]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare and evaluate the clinical outcomes of deep anterior lamellar keratoplasty (DALK) and excimer laser assisted anterior lamellar keratoplasty (ELLK) in eyes with keratoconus.
METHODS: In this study, 57 eyes of 56 patients operated between 2013 to 2017 were included. Thirty-one eyes underwent big-bubble DALK and twenty-six eyes underwent ELLK. Preoperative and at control visits complete ophthalmic examination was performed.
RESULTS: The mean patient age at the time of DALK surgery was 27y and mean follow-up period was 21±5.4mo. The mean patient age at the time of ELLK surgery was 27y and mean follow-up period was 40±18mo. Mean best spectacle corrected visual acuity (BSCVA) at postoperative period was significantly higher for DALK group (0.66±0.11) versus ELLK group (0.4±0.2) (P<0.05). Descemet’s membrane microperforation was occurred in 7 patients in DALK group versus in 1 patient in ELLK group. In 4 eyes, interface irregularity was developed in ELLK group. None of the patients in follow-up had graft rejection in both groups.
CONCLUSION: In ELLK group, complication rate is lower, the surgical technique is simpler, faster and safer and also ELLK requires less experience with respect to DALK. Further, DALK can be performed unless satisfactory visual acuity is achieved after ELLK.]]></description>
<pubDate>2019/3/6 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Kübra Serbest Ceylanoglu, Bahri Aydin and Mehmet Cuneyt Ozmen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Kübra Serbest Ceylanoglu, Bahri Aydin and Mehmet Cuneyt Ozmen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190409]]></guid><cfi:id>607</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Influence of preoperative astigmatism on corneal biomechanics and accurate intraocular pressure measurement after micro-incision phacoemulsification]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190410]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To define the corneal hysteresis (CH), corneal resistance factor (CRF), Goldmann-correlated intraocular pressure (IOPg) and corneal compensated intraocular pressure (IOPcc) prior to and following coaxial micro-incision phacoemulsification in patients with corneal astigmatism.
METHODS: Of 97 patients with cataracts were enrolled in the study. Group 1 included patients with corneal astigmatism (K1-K2) values of K1-K2<+1.0 D, and group 2 with values of K1-K2 ≥+1.0 D and ≤+2.25 D. Coaxial micro-incision phacoemulsification of a corneal incision of 2.0 mm with intraocular lens (IOL) implantation was performed. CH, CRF, IOPg, IOPcc, waveform score (WS) were measured preoperatively and one week, one month postoperatively using an Ocular Response Analyzer. Axial length (AXL) was calculated by Tomey Optical Biometer OA 2000.
RESULTS: Group 1 consisted of 51 patients with mean corneal astigmatism value of +0.49±0.25 D. Group 2 included 46 patients with astigmatism of +1.43±0.43 D. In group 1, CRF (t=2.68, P<0.05), CH (t=2.64, P<0.05) and WS (t=3.51, P<0.05) were significantly lower one week postoperatively, when compared to the preoperative values. CRF significantly decreased (t=3.61, P<0.05) when measured one month following the surgery. In group 2 CH (t=5.92, P<0.05), and WS (t=3.96, P<0.05) were significantly lowered one week after cataract surgery. Moreover, we observed a significant decrease in IOPg (t=2.24, P<0.05), CRF (t=5.05, P<0.05) and CH (t=2.31, P<0.05) one month after phacoemulsification. There was no statistically significant (t=-0.83, P=0.41) difference in AXL between study groups.
CONCLUSION: CRF, CH and IOPg are reduced in patients with preoperative corneal astigmatism equal or higher than +1.0 D and lower than +2.25 D. Hence, bias of IOPg measurement in these patients may cause underestimation of the real IOP both before and after cataract surgery. The measurement of IOPcc allows the precise assessment of IOP pre- and postoperatively, independently on corneal astigmatism, CH and CRF values.]]></description>
<pubDate>2019/3/6 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Zofia Pniakowska and Piotr Jurowski]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zofia Pniakowska and Piotr Jurowski</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190410]]></guid><cfi:id>606</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Outcomes of secondary sulcus intraocular lens implantation in unilateral anterior persistent fetal vasculature]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190411]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the surgical results of sulcus intraocular lens (IOL) implantation in children with unilateral anterior persistent fetal vasculature (PFV) underwent primary vitrectomy combined with lensectomy and preservation of the peripheral anterior capsule.
METHODS: Twenty-two eyes of 22 children with unilateral anterior PFV who underwent sulcus secondary IOL implantation were analyzed. Main outcome measures were preoperative and postoperative visual acuity, and complications both intraoperatively and postoperatively.
RESULTS: Review of 22 consecutive patients identified best-corrected visual acuity (BCVA) improvement from 1.37±0.84 to 0.73±0.57 logarithm of the minimal angle of resolution (logMAR) after IOL implantation (P<0.001) with a mean follow-up was 16.55±5.86mo. Average age at secondary IOL implantation was 41.05±15.41mo. Three eyes (13.64%) achieved BCVA of 0.3 logMAR at the final visit. Transient intraocular pressure rise (4 eyes; 18.18%), postoperative increased inflammation (3 eyes; 13.64%) and postoperative hypotony (2 eyes; 9.09%) were common complications.
CONCLUSION: Properly preservation of the anterior lens capsule during the primary surgery facilitated secondary sulcus IOL implantation in pediatric patients with anterior PFV, with favorable postoperative visual outcomes and compatible percentage of complications.]]></description>
<pubDate>2019/3/6 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jing-Hua Liu, Song-Feng Li, Guang-Da Deng, Yong-Hong Jiao and Hai Lu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jing-Hua Liu, Song-Feng Li, Guang-Da Deng, Yong-Hong Jiao and Hai Lu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190411]]></guid><cfi:id>605</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Safety and efficacy of ultrasound ciliary plasty as a primary intervention in glaucoma patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190412]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the safety and the efficacy of the ultrasound ciliary plasty (UCP) on the intraocular pressure (IOP) control in glaucomatous eyes without previous glaucoma surgery.METHODS: A retrospective study included patients with primary and secondary glaucoma who underwent UCP in Dar AlShifa Hospital, Kuwait between January 2017 to June 2018. High-intensity focused ultrasound procedures were performed under peribulbar anesthesia using the 2nd generation probe with 8s duration of each of the 6 shots. Complete ophthalmologic examinations were scheduled pre-treatment, and at 1d, 1wk, 1, 3, 6 and 12mo post-treatment. Primary outcomes were the IOP reduction and success rates at 12mo, while the secondary outcomes were the occurrence of vision threatening complications and visual acuity.RESULTS: The records of 62 eyes of 62 patients were analyzed with mean age of 63.8y (67.7% males). There was statistically significant reduction in the mean IOP from 35.2±8.3 mm Hg before treatment to 20.6±8.7 mm Hg at 12th month (P<0.0005) with a mean percentage IOP reduction of 42.3% with significant reduction in the mean number of antiglaucomatous drugs from 3.2±0.4 before treatment to 2.1±1.02 at 12mo (P<0.0005). Qualified success was achieved in 77.4% of eyes at 12mo. No major intra- or post-treatment complications were reported.CONCLUSION: Second-generation UCP prove to be effective in reducing IOP in naive glaucoma patients with lower success rates in cases of neovascular and uveitic glaucomas.]]></description>
<pubDate>2019/3/6 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Magda A. Torky, Yousif A Al Zafiri, Sherein M. Hagras, Abeer M. Khattab, Rania M. Bassiouny and Tharwat H. Mokbel]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Magda A. Torky, Yousif A Al Zafiri, Sherein M. Hagras, Abeer M. Khattab, Rania M. Bassiouny and Tharwat H. Mokbel</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190412]]></guid><cfi:id>604</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of peripapillary and macular choroidal thickness and ganglion cell complex thickness in glaucomatous and healthy eyes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190413]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess choroidal thickness (CT) and its association with ganglion cell-inner plexiform layer thickness (GCIPLT) and retinal nerve fiber layer thickness (RNFLT) in open angle glaucoma (OAG) comparing with preperimetric glaucoma (PPG) and normal eyes.
METHODS: Totally 55 eyes of OAG, 40 eyes of PPG, and 40 eyes of age-matched normal eyes were studied. Peripapillary CT (PCT), macular CT (MCT), RNFLT, and GCIPLT were evaluated. Relationship between the CT with RNFLT and GCIPLT were studied. The correlation between CT and confounding variables as gender, age, intraocular pressure, and visual field mean deviation were analyzed.
RESULTS: Mean PCT were 113.6±39.1 μm in OAG, 116.3±42.7 μm in PPG, and 148.9±41.7 μm in normal eyes. PCT and MCT was thinner in OAG compared to healthy eyes. There was a significant correlation for PCT and mean RNFLT in 1, 2, 6, and 7 clock hours of OAG eyes. The difference in PCT remained after adjusting for axial length, age, and disc area (P=0.003). No significant correlation was shown between MCT and mean GCIPLT in all eyes.
CONCLUSION: PCT is thinner in OAG and PPG compared with healthy eyes. The correlation of RNFLT and PCT found in OAG and PPG is not revealed in normal eyes.]]></description>
<pubDate>2019/3/6 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yuli Park, Hong Kyu Kim and Kyong Jin Cho]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yuli Park, Hong Kyu Kim and Kyong Jin Cho</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190413]]></guid><cfi:id>603</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Novel CYP1B1 mutations and a possible prognostic use for surgical management of congenital glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190414]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To identify CYP1B1 gene mutations and evaluate their possible role as a prognostic factor for success rates in the surgical management of Egyptian congenital glaucoma patients.METHODS: Totally 42 eyes of 29 primary congenital glaucoma patients were operated on with combined trabeculotomy/trabeculectomy with mitomycin-C and followed up at 1d, 1wk, 1, 6 and 12mo postoperatively. Genomic DNA was extracted from peripheral blood leukocytes. Coding regions of CYP1B1 gene were amplified using 13 pairs of primers, screened for mutations using single-strand conformation polymorphism followed by sequencing of both strands. Efficacy of the operation was graded as either a success [maintaining intraocular pressure (IOP) less than 21 mm Hg with or without anti-glaucoma medication], or a failure (IOP more than 21 mm Hg with topical antiglaucoma medications).RESULTS: Seven novel mutations out of a total of 15 different mutations were found in the CYP1B1 genes of 14 patients (48.2%). The presence of CYP1B1 gene mutations did not correlate with the failure of the surgery (P=0.156, odds ratio=3.611, 95%CI, 0.56 to 22.89); while the positive consanguinity strongly correlated with failure of the initial procedure (P=0.016, odds ratio=11.25, 95%CI, 1.57 to 80.30). However, the Kaplan-Meier survival analysis revealed a significantly lower time of IOP control in the subgroup with mutations in CYP1B1 versus the congenital primary glaucoma group without mutations (log rank test, P=0.015).CONCLUSION: Seven new CYP1B1 mutations are identified in Egyptian patients. Patients harboring confirmed mutations suffered from early failure of the initial surgery. CYP1B1 mutations could be considered as a prognostic factor for surgery in primary congenital glaucoma.]]></description>
<pubDate>2019/3/6 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mohamed M. Khafagy, Nadia El-Guendy, Marwa A Tantawy, Mohamed A. Eldaly, Hala M. Elhilali and Abdel Hady A. Abdel Wahab]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mohamed M. Khafagy, Nadia El-Guendy, Marwa A Tantawy, Mohamed A. Eldaly, Hala M. Elhilali and Abdel Hady A. Abdel Wahab</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190414]]></guid><cfi:id>602</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Densiron 68 heavy silicone oil in the management of inferior retinal detachment recurrence: analysis on functional and anatomical outcomes and complications]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190415]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the efficacy and safety of a heavy silicone oil (Densiron 68) in the management of inferior retinal detachment recurrence.
METHODS: A retrospective non-comparative consecutive case series study. Forty-nine cases of complex inferior retinal detachment were treated using Densiron 68 heavy silicone oil (HSO) as the endotamponade. Our main purpose was anatomic reattachment following Densiron 68 removal. Functional outcomes, rate of recurrences, the presence of inflammatory complications and intraocular pressure alterations were evaluated.
RESULTS: Forty-nine patients affected by complex retinal re-detachment were recruited. The mean follow-up was 7.6 (±1.5) mo. The mean best corrected visual acuity after Densiron 68 removal was 0.95 logMAR, standard error (SE: 0.068). Retinal reattachment was 61.2% after first surgery and 81.6% after second surgery. Nineteen cases (38.8%) had recurrences when intraocular heavy silicon oil was in situ, 26.3% (5 cases) of which involved the inferior retina.
CONCLUSION: Densiron 68 ef?ciently fills the inferior retinal periphery and might lower the risk of inferior proliferative vitreoretinopathy development, in particular after a standard silicon oil tamponade that reduces the proliferative process in the upper quadrants of the retina.]]></description>
<pubDate>2019/3/6 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Tomaso Caporossi, Fabrizio Franco, Lucia Finocchio, Francesco Barca, Fabrizio Giansanti, Ruggero Tartaro, Gianni Virgili and Stanislao Rizzo]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Tomaso Caporossi, Fabrizio Franco, Lucia Finocchio, Francesco Barca, Fabrizio Giansanti, Ruggero Tartaro, Gianni Virgili and Stanislao Rizzo</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190415]]></guid><cfi:id>601</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Analysis of the clinical characteristics and refraction state in premature infants: a 10-year retrospective analysis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190416]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report the visual outcomes and refractive status in premature infants with and without retinopathy of prematurity (ROP) who were or not treated.
METHODS: The clinical records of all premature infants with or without ROP and with or without treatment between 2007 and 2017 were retrospectively reviewed. Basic demographic data, serial changes in ROP incidence, treatment and outcomes, and the refractive states were analyzed. Correlations among myopia and astigmatism progression, birth weight, gestational age, and treatment methods were also analyzed.
RESULTS: A total of 562 screened premature infants (all Chinese, 1124 eyes), were recruited with a 378:184 male-to-female ratio. Birth weight did not directly influence ROP incidence. The overall ROP incidence was 16.55% (93/562 cases). The incidences in boys and girls were 16.14% (33/378 cases) and 17.39% (32/184 cases), respectively, and this difference was not significant. However, all infants with serious ROP (stage IV and V) were male. Myopia combined with astigmatism was common in premature infants with and without ROP (30.99%, 172/555 cases), and myopic refraction (including myopia and myopia combined with astigmatism) was more common in premature infants with ROP (48.84%, 42/86 cases). In the >8.00 diopter group, there were significantly more ROP infants than without ROP. Myopic refraction (including myopia and myopia combined with astigmatism) was most common in infants with ROP after treatment (63.63%, 7/11 cases).
CONCLUSION: The refractive state is different between premature infants and mature infants. Those treated for ROP had a higher chance of developing myopia, astigmatism, and higher diopter.]]></description>
<pubDate>2019/3/6 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yan Deng, Chun-Hong Yu, Yun-Tao Ma, Yang Yang, Xiao-Wei Peng, Yu-Jun Liao, Wei-Wei Xiong, Jin-Song Wu, Huan-Wen Mao and Xiao-Long Yin]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yan Deng, Chun-Hong Yu, Yun-Tao Ma, Yang Yang, Xiao-Wei Peng, Yu-Jun Liao, Wei-Wei Xiong, Jin-Song Wu, Huan-Wen Mao and Xiao-Long Yin</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190416]]></guid><cfi:id>600</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Chandelier-assisted scleral buckling using wide angle viewing contact lens for pseudophakic retinal detachment repair]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190417]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate a modified technique for scleral buckling (SB) in pseudophakic retinal detachment (RD).
METHODS: A retrospective non-comparative study included 21 consecutive eyes with uncomplicated pseudophakic RD that was repaired by chandelier assisted SB using wide angle viewing (WAV) contact lens. Segmental tire alone was used in 5 eyes (23.81%), and combined with encircling band in 7 eyes (33.33%). Radial sponge alone was used in 3 eyes (14.29%) and combined with encircling band in 6 eyes (28.57%).
RESULTS: Primary success rate was (90.48%). External drainage of subretinal fluid was performed in 8 eyes (38.1%). Intraoperative complications included vitreous prolapse at chandelier sclerotomy site in 4 eyes (19.05%) and localized subretinal hemorrhage at drainage site in one eye (4.76%). No case of intraocular lens (IOL) displacement, retinal incarceration or iatrogenic retinal tear was detected. Postoperative complications included choroidal detachment in one eye (4.76%), elevated intraocular pressure in 2 eyes (9.52%), epiretinal membrane formation in one eye (4.76%) and proliferative vitreoretinopathy in 3 eyes (14.29%). Mean postoperative corrected distance visual acuity was 0.7±0.3 logMAR units.
CONCLUSION: Chandelier-assisted SB using WAV contact lens is a reliable technique for repairing selected cases of simple pseudophakic RD.]]></description>
<pubDate>2019/3/6 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ashraf Ahmed Nossair, Wael Ahmed Ewais and Sherif Ahmed Eissa]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ashraf Ahmed Nossair, Wael Ahmed Ewais and Sherif Ahmed Eissa</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190417]]></guid><cfi:id>599</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Abnormalities of interhemispheric functional connectivity in individuals with acute eye pain: a resting-state fMRI study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190418]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To study the changes of the resting state functional connectivity (rsFC) between acute eye pain (EP) subjects and healthy controls (HCs) in the two hemispheres by using voxel-mirrored homotopic connectivity (VMHC) method.
METHODS: Totally 20 patients with EP and 20 HCs were enrolled, sex, age, and education were matched, and all subjects were examined by functional magnetic resonance imaging (fMRI) scans at resting-state. The changes of rsFC between the hemispheres were evaluated by the VMHC method according to Gaussian random field (GRF) theory. In order to identify the VMHC, as biomarkers for distinguishing EP and from HC, the receiver operating characteristic curves (ROC) had been analyzed. The relationships were evaluated with Pearson correlation analysis between the mean VMHC signal values and clinical features in these patients.
RESULTS: By comparing with health subjects, the significant decreased VMHC values was observed in lingual/calcarine (Brodmann area, BA 30), precentral/postcentral gyrus (PreCG/PosCG; BA 4) and medial frontal gyrus (MFG; BA 8) (false discovery rate corrected <0.01) in the acute EP individuals. The accuracy of area under curve was excellent indicated by the ROC curve analysis of each brain regions.
CONCLUSION: Our study demonstrates preliminary evidence of disrupted interhemispheric rsFC in acute EP in sensorimotor and limbic system and somatosensory cortex, which might give some useful information for understanding the neurological mechanisms in acute EP individuals.]]></description>
<pubDate>2019/3/6 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Zhi-Zhang Dong, Fei-Yin Zhu, Wen-Qing Shi, Yong-Qiang Shu, Lin-Long Chen, Qing Yuan, Qi Lin, Pei-Wen Zhu, Kang-Cheng Liu, You-Lan Min, Lei Ye and Yi Shao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zhi-Zhang Dong, Fei-Yin Zhu, Wen-Qing Shi, Yong-Qiang Shu, Lin-Long Chen, Qing Yuan, Qi Lin, Pei-Wen Zhu, Kang-Cheng Liu, You-Lan Min, Lei Ye and Yi Shao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190418]]></guid><cfi:id>598</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of the impact of nesofilcon A hydrogel contact lens on the ocular surface and the comfort of presbyopic and non-presbyopic wearers]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190419]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess and compare the impact of a daily disposable contact lens (CL) with high water content on the ocular surface and comfort of the presbyopic and non-presbyopic population after one day of use.
METHODS: Totally 20 presbyopes and 30 non-presbyopes non-contact wearers were fitted with nesofilcon A CLs. CL thickness was measured to assess material stability during daily wear, and ocular surface parameters were also assessed. Optical quality was analyzed for all cases. In addition, CL comfort was rated.
RESULTS: No significant differences were found in CL thickness, tear film osmolarity, average tear break-up time, bulbar redness, central corneal thickness, corneal volume, root-mean-square of higher-order aberrations (RMS of HOAs) and vertical and horizontal coma, either as a function of the group or time of use. A significant decrease in tear meniscus height and first break-up of the tear film was found in the presbyopic group (P=0.038; P=0.007 respectively). A decrease in spherical aberration coefficient was found after CL insertion (P=0.031 monofocal CL; P=0.023 low addition multifocal CL; P=0.016 high addition multifocal CL). Multifocal CL were thicker than monofocal CL (P=0.045). Comparison between groups showed more discomfort in presbyopes than non-presbyopes (P=0.003).
CONCLUSION: This study evidence that the behavior of the daily disposable CL with high water content seems to be stable during the day of use. Ocular parameters measured during wear show that CL behavior is the same for presbyopes and non-presbyopes, being more uncomfortable for presbyopes.]]></description>
<pubDate>2019/3/6 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Amalia Lorente-Velázquez, María García-Montero, Francisco Javier Gómez-Sanz, Laura Rico del Viejo, José Luis Hernández-Verdejo and David Madrid-Costa]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Amalia Lorente-Velázquez, María García-Montero, Francisco Javier Gómez-Sanz, Laura Rico del Viejo, José Luis Hernández-Verdejo and David Madrid-Costa</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190419]]></guid><cfi:id>597</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[The role of clinical diagnosis criteria on the frequency of accommodative insufficiency]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190420]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To estimate and compare the frequency of accommodative insufficiency (AI) within the same clinical population sample depending on the type of clinical criteria used for diagnosis. Comparing the frequency within the same population would help to minimize bias due to sampling or methodological variability.
METHODS: Retrospective study of 205 medical records of symptomatic subjects free of any organic cause and symptoms persisting despite optical compensation evaluated. Based on the most commonly clinical diagnostics criteria found in the literature, four diagnostics criteria were established for AI (I, II, III and IV) based on subjective accommodative tests: monocular accommodative amplitude two or more diopters below Hofstetter’s minimum value [15-(0.25×age)] (I, II, III, IV); failing monocular accommodative facility with minus lens, establishing the cut-off in 0 cycles per minute (cpm) (I) and in 6 cpm (II, III); failing binocular accommodative facility with minus lens, establishing the cut-off in 0 cpm (I) and in 3 cpm (II).
RESULTS: The proportion of AI (95%CI) for criteria I, II, III and IV were 1.95% (0.04%-3.86%), 2.93% (0.31%-4.57%), 6.34% (1.90%-7.85%) and 41.95% (35.14%-48.76%) respectively, with a statistically significant difference shown between these values (χ2=226.7, P<0.001). A pairwise multiple comparison revealed that the proportion of AI detected for criterion IV was significantly greater than the proportion for the rest of the criteria (P-adjusted<0.05 in all cases).
CONCLUSION: The prevalence of cases of AI within the same clinical population varies with the clinical diagnostic criteria selected. The variation is statistically significant when considering the monocular accommodative amplitude as the only clinical diagnostic sign.]]></description>
<pubDate>2019/3/6 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[María García-Montero, Beatriz Antona, Ana Rosa Barrio, Carmen Nieto-Zayas, Irene Martínez-Alberquilla and José Luis Hernández-Verdejo]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>María García-Montero, Beatriz Antona, Ana Rosa Barrio, Carmen Nieto-Zayas, Irene Martínez-Alberquilla and José Luis Hernández-Verdejo</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190420]]></guid><cfi:id>596</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Paired eye-control study of unilateral opaque bubble layer in femtosecond laser assisted laser in situ keratomileusis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190421]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the predictive factors of the opaque bubble layer (OBL) compared to the fellow eye of same patients in FS200 femtosecond laser assisted laser in situ keratomileusis (FS-LASIK).
METHODS: This study consisted of 60 consecutive patients (120 eyes) with unilateral OBL during FS-LASIK. Eyes were divided into OBL (the OBL eyes) and OBL-free groups (the fellow eyes) based on the occurrence of OBL. The preoperative demographic data, refraction, keratometry, corneal astigmatism, pachymetry, intraocular pressure and intraoperative data including the outlet location of gas diffusing canal were collected. Conditional logistic regression analysis was performed to find the associated factors with OBL in the two groups by determining odds ratios (OR) and 95%CI.
RESULTS: The preoperative demographic data, mean spherical errors, mean K value, suction time, intraocular pressure and central cornea thickness were not significantly different between the two groups. The outlet location of gas diffusing canal (P<0.01, OR 7.16, 95%CI 2.53-20.32) and the corneal astigmatism (P=0.013, OR 0.13, 95%CI 0.03-0.65) were significantly associated with the incidence of OBL by multivariate logistic regression analysis. Visual acuity, efficacy, and safety were comparable between the two groups two months after surgery except for a slightly lower predictability value for the hard OBL eyes.
CONCLUSION: The reduction of the incidence of OBL is obvious when the outlet of gas diffusing canal located at the posterior border of the corneoscleral limbus. This is probably consequent to more effectiveness of gas diffusing canal. Corneal astigmatism is also an independent protective factor for OBL formation.]]></description>
<pubDate>2019/3/6 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Cheng-Hua Wei, Qiao-Yun Dai, Li-Xin Mei, Yao Ge, Peng-Fei Zhang and E Song]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Cheng-Hua Wei, Qiao-Yun Dai, Li-Xin Mei, Yao Ge, Peng-Fei Zhang and E Song</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190421]]></guid><cfi:id>595</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Functional and anatomical evaluation of the effect of nepafenac in prevention of macular edema after phacoemulsification in diabetic patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190306]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the effect of prophylactic administration of nepafenac in prevention of macular edema occurring in diabetic patients after phacoemulsification and to investigate the correlation between optical coherence tomography (OCT) foveal thickness and multifocal electroretinogram (MF-ERG) parameters.
METHODS: The study included two groups. Group 1 included 50 diabetic patients with senile cataract (50 eyes, 30 females, 20 males, aged 55±7y) received nepafenac 0.1% eye drop. Group 2 included another 50 diabetic patients with senile cataract (50 eyes, 22 female, 28 males, aged 53.8±8y) did not receive nepafenac. All patients were followed up for 3mo postoperatively. OCT and MF-ERG were done preoperative and at 1wk, 1, 2 and 3mo.
RESULTS: The mean foveal thickness was statistically significantly lower in Group 1. Five eyes in Group 2 developed clinical cystoid macular oedema (CMO) (10%), and no patients in Group 1 developed central macular thickening more than 50 μm. There were insignificant differences in MF-ERG amplitudes and latencies between the two groups except in the five eyes that developed CMO, there statistically significant reduction of MF-ERG amplitude with increase in foveal thickness.
CONCLUSION: Perioperative nepafenac reduces the incidence of CMO following uncomplicated phacoemulsification significantly. Nepafenac has no side effects.]]></description>
<pubDate>2019/2/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Tharwat Mokbel, Sameh Saleh, Mona Abdelkader, Sherief E. El-khouly, Waleed Abou Samra and Mohamed Mamdouh]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Tharwat Mokbel, Sameh Saleh, Mona Abdelkader, Sherief E. El-khouly, Waleed Abou Samra and Mohamed Mamdouh</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190306]]></guid><cfi:id>594</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of the meibomian gland dysfunction in patients with chronic ocular graft-versus-host disease and Sj&#246;gren’s syndrome]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190307]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the abnormalities in the meibomian gland in patients with dry eye disease (DED) associated with chronic ocular graft-versus-host disease (coGVHD) in comparison with Sj&#246;gren’s syndrome (SS), a major form of aqueous deficient DED and meibomian gland dysfunction (MGD), a common cause of evaporative DED.
METHODS: A total 135 eyes of 135 subjects included in this study: patients with DED associated with coGVHD (n=30), patients with SS (n=35), patients with MGD (n=35), and normal controls (n=35). All participants completed the Ocular Surface Disease Index (OSDI) questionnaire, ocular surface examination [Schirmer test, tear film breakup time (TFBUT), and ocular surface staining], and meibomian gland assessment [meiboscore (gland dropout detected on meibography using infrared camera of the Keratograph 5M), meibum expressibility score (MES), meibum quality score (MQS), lid margin abnormality]. In addition, correlations of meibomian gland characteristics with ocular surface parameters as well as disease severity score were investigated in coGVHD group.
RESULTS: The coGVHD group showed significantly higher meiboscore, MES, and MQS than the other 3 groups (all P<0.05). In the coGVHD group, parameters of meibomian gland showed a significant correlation each other and those of ocular surface. The correlation between meibomian gland parameters and severity score of coGVHD was also established (meiboscore, r=0.62; MES, r=0.47; MQS, r=0.47; lid margin abnormality score, r=0.55; all P<0.05).
CONCLUSION: Patients with DED associated with coGVHD show poorer gland morphology and worse gland function than other types of DED. In addition, meibomian gland damage is not only associated with ocular surface damage but also disease severity of coGVHD.]]></description>
<pubDate>2019/2/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Won Choi, Jun Young Ha, Ying Li, Jung Han Choi, Yong Sok Ji and Kyung Chul Yoon]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Won Choi, Jun Young Ha, Ying Li, Jung Han Choi, Yong Sok Ji and Kyung Chul Yoon</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190307]]></guid><cfi:id>593</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[How reliable is the lacrimal scintigraphy report? An inter-observer agreement and reliability study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190308]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the inter-observer agreement and reliability as well as intra-observer repeatability for lacrimal scintigraphy (LS) reports with and without considering the irrigation test results.
METHODS: A prospective, observational, cross sectional study. Two masked clinicians (lacrimal surgeon and nuclear medicine specialist) independently reported 100 LS images (50 patients of >6 years of age with unilateral anophthalmic socket) in a university hospital. The lacrimal surgeon performed a diagnostic irrigation test and repeated the report of the same LS images 2y after the first report (intra-observer agreement). A weighted Kappa analysis was performed to determine inter-observer agreement and reliability as well as intra-observer repeatability for the type (normal, partial and complete obstruction) and location (presac, preduct, and intraduct) of the obstruction. Subgroup analysis was also performed with consideration of irrigation test results.
RESULTS: A significantly moderate agreement was found between lacrimal surgeon and nuclear medicine specialist for both the type (Kappa=0.55) and location (Kappa=0.48) of obstruction. Agreement values were higher for the type (Kappa=0.61 vs 0.41) and location (Kappa=0.56 vs 0.31) of obstruction in cases with normal than abnormal irrigation test. Strong and significant intra-observer (lacrimal surgeon) repeatability was found for both the type (Kappa=0.66) and location (Kappa=0.69) of obstruction. LS showed no to slight reliability based on irrigation test.
CONCLUSION: A moderate agreement is found between lacrimal surgeon and nuclear medicine specialist regarding the interpretation of LS suggesting the importance of consensus groups among nuclear medicine specialists and lacrimal surgeons to create a common language for interpretation of LS. Intra-observer repeatability is strong for the lacrimal surgeon.]]></description>
<pubDate>2019/2/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mohsen Bahmani Kashkouli, Navid Abolfathzadeh, Parya Abdolalizadeh, Nasser Karimi, Raheleh Hedayati, Samira Jafari and Amirpooya Alemzadeh]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mohsen Bahmani Kashkouli, Navid Abolfathzadeh, Parya Abdolalizadeh, Nasser Karimi, Raheleh Hedayati, Samira Jafari and Amirpooya Alemzadeh</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190308]]></guid><cfi:id>592</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Corneal esthesiometry and sub-basal nerves morphological changes in herpes simplex virus keratitis/uveitis patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190309]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To describe and compare corneal sensation and morphological changes of sub-basal corneal nerves by in vivo laser scanning confocal microscopy (LSCM) in herpes simplex virus (HSV) keratitis/uveitis and contralateral, clinically unaffected eyes.
METHODS: A prospective clinical study included 30 HSV eyes and 30 contralateral eyes of 30 patients, diagnosed with unilateral HSV keratitis/uveitis. Both eyes underwent a complete ophthalmological examination, Cochet-Bonnet aesthesiometry and LSCM of the central cornea, using the Heidelberg Retina Tomograph III Rostock Cornea Module. After 6mo, the same examination of the HSV affected and contralateral, clinically unaffected eyes was performed.
RESULTS: HSV eyes, as compared to contralateral eyes, demonstrated a significant decrease in mean corneal sensation (3.1±1.6 vs 5.3±0.8 cm), total nerve fibres number (5.7±4.4 vs 15.1±5.4), nerve branches (3.4±3.0 vs 8.4±4.7), main nerve trunks (2.3±1.6 vs 5.8±2.2), and nerve fibres density (7.5±5.6 vs 18.1±5.3 mm/mm2, P<0.05). There was no significant difference between keratitis and uveitis eyes in mean corneal sensation and nerve fibres parameters. After 6mo, corneal sensation and sub-basal nerve fibres parameters were increased significantly, but did not reach the parameters of contralateral, clinically unaffected eyes.
CONCLUSION: Corneal aesthesiometry and LSCM in HSV affected eyes reveals a significant decrease of corneal sensation and sub-basal nerve fibres which recovers at 6mo but does not reach the normal level.]]></description>
<pubDate>2019/2/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Reda Zemaitiene, Modesta Rakauskiene, Viliija Danileviciene, Violeta Use, Loresa Kriauciuniene and Dalia Zaliuniene]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Reda Zemaitiene, Modesta Rakauskiene, Viliija Danileviciene, Violeta Use, Loresa Kriauciuniene and Dalia Zaliuniene</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190309]]></guid><cfi:id>591</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Interchangeability of corneal curvature and asphericity measurements provided by three different devices]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190310]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the interchangeability of keratometric and asphericity measurements provided by three measurement systems based on different optical principles.
METHODS: A total of 40 eyes of 40 patients with a mean age of 34.1y were included. In all cases, a corneal curvature analysis was performed with IOL-Master  (IOLM), iDesign 2 (ID2), and Sirius systems (SIR). Differences between instruments for flattest (K1) and steepest (K2) keratometric readings, as well as for magnitude and axis of corneal astigmatism were analyzed. Likewise, differences in asphericity (Q) between SIR and ID2 were also evaluated.
RESULTS: Mean differences between devices for K1 were 0.20±0.21 (P<0.001), -0.12±0.36 (P=0.046) and -0.32±0.36 D (P<0.001) for the comparisons IOLM-SIR, IOLM-ID2 and SIR-ID2, respectively. The ranges of agreement for these comparisons between instruments were 0.41, 0.70, and 0.70 D. For K2, mean differences were 0.31±0.33 (P<0.001), -0.08±0.43 (P=0.265) and -0.39±0.38 D (P<0.001), with ranges of agreement of 0.65, 0.84, and 0.74 D. Concerning magnitude of astigmatism, ranges of agreement were in the limit of clinical relevance (0.49 D, P=0.011; 0.55 D, P=0.386; 0.43 D, P=0.05). In contrast, ranges of agreement were clinically relevant for astigmatic axis (26.68o, 33.83o and 18.37o, P≥0.121) and for Q between SIR and ID2 (0.16, P<0.001).
CONCLUSION: The keratometric corneal power, astigmatic axis and asphericity measurements provide by the three systems evaluated cannot be considered as interchangeable, whereas measurements of corneal astigmatism obtained with SIR and ID2 can be considered as interchangeable for clinical purposes.]]></description>
<pubDate>2019/2/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[David P. Pi&#241;ero, Roberto Soto-Negro, Pedro Ruiz-Fortes, Rafael J Pérez-Cambrodí and Hideki Fukumitsu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>David P. Pi&#241;ero, Roberto Soto-Negro, Pedro Ruiz-Fortes, Rafael J Pérez-Cambrodí and Hideki Fukumitsu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190310]]></guid><cfi:id>590</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Risk factors for endophthalmitis after cataract surgery in diabetic patients: a case control study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190311]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To identify risk factors associated with post-cataract surgery endophthalmitis (PCE) in type 2 diabetic patients.
METHODS: A hospital-based retrospective case-control study was conducted on 194 type 2 diabetic patients undergoing cataract surgery in Rajavithi Hospital from January 2007 to December 2015. Fifteen patients with PCE were included as the case group and 179 patients without PCE were included as the control group. Potential factors associated with PCE among both groups including demographics, pre-operative characteristics, surgical settings and complications, were statistically analyzed using Chi-square testing and a logistic regression model.
RESULTS: Within the case group, 53% were females and the median age was 68y. Univariate analysis of pre-operative characteristics, surgical settings and complications revealed that recent pre-operative fasting plasma glucose, insulin therapy, presence of diabetic retinopathy, and severe non-proliferative or proliferative diabetic retinopathy were significantly associated with PCE. In a multivariate analysis adjusting for blood glucose level, insulin treatment was the only significant factor associated with an increased risk of PCE (OR 3.9, 95%CI 1.0-15.0, P=0.04) compared to patients without insulin treatment. The most common causative organisms were gram-positive bacteria (89%). Staphylococcus species represented the most common group (67%). Median best corrected visual acuity at 1-month and 3-month follow-up was equal at 0.7 logMAR (20/100).
CONCLUSION: The authors identify insulin treatment as the only risk factor associated with endophthalmitis after cataract surgery in type 2 diabetic patients. Further studies with serum levels of pre-operative glycated hemoglobin (HbA1c) and post-operative fasting plasma glucose level are essential to truly demonstrate the role of peri-operative glycemic markers as a risk factor for PCE.]]></description>
<pubDate>2019/2/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Sukhum Silpa-archa, Apichaya Papirachnart, Panisa Singhanetr and Janine M Preble]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Sukhum Silpa-archa, Apichaya Papirachnart, Panisa Singhanetr and Janine M Preble</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190311]]></guid><cfi:id>589</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of visual quality in cataract patients with low astigmatism after ART2 or ReSTOR intraocular lens implantation]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190312]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare visual quality in cataract patients with low corneal astigmatism who underwent intraocular lens (IOL) implantation, and evaluate effects of low levels of astigmatism on visual outcomes in multifocal pseudophakic eyes.
METHODS: This retrospective review of clinical records comprised patients with preoperative regular corneal astigmatism of 0.75-1.0 diopters (D) with-the-rule or 0.5-0.75 D against-the-rule who had uneventful cataract surgery and AcrySof IQ ReSTOR Toric-2 IOL (ART2) or AcrySof IQ ReSTOR IOL (ReSTOR) implantation. Retrospective data collection included postoperative ART2 axis rotation, uncorrected astigmatism, uncorrected entire visual acuities, distance corrected entire visual acuities, average modulation transfer function (aMTF), Strehl ratio (SR), spectacle independence, and patient satisfaction between groups.
RESULTS: Mean ART2 axis rotation was 3.12°±0.70°. No secondary surgery was required to realign IOL axis. Residual astigmatism values were -0.18±0.07 D and -0.91±0.25 D in groups ART2 and ReSTOR (P<0.05). Three months postoperatively, the mean uncorrected distant, intermediate, and near visual acuities of group A were 0.01±0.05, 0.05±0.07, 0.02±0.07 logMAR, respectively; these were better than those of group R, which were 0.08±0.06, 0.15±0.12, and 0.09±0.08 logMAR, respectively (P<0.05). aMTF, SR, and spectacle independence rates were not significantly different. All patients were satisfied with postoperative results.
CONCLUSION: ART2 is more suitable than ReSTOR for cataract patients with regular corneal astigmatism 0.75-1.0 D with-the-rule or 0.5-0.75 D against-the-rule.]]></description>
<pubDate>2019/2/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jing Hao, Liang-Zhang Tan, Lin Li, Shao-Chong Bu, Xin-Jun Ren, Fang Tian and Hong Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jing Hao, Liang-Zhang Tan, Lin Li, Shao-Chong Bu, Xin-Jun Ren, Fang Tian and Hong Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190312]]></guid><cfi:id>588</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Modified viscocanalostomy in the Chinese population with open angle glaucoma: a 10-year follow-up results]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190313]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To study the long-term efficacy and safety of modified viscocanalostomy in Chinese people with open angle glaucoma (OAG).
METHODS: This retrospective study included a total of 100 eyes from 100 Chinese patients with medically uncontrolled OAG. All the patients underwent modified viscocanalostomy with injection of viscoelastic material in the surgically created ostia of Schlemm’s canal (SC). The modifications included peeling of the inner wall of SC and the juxtacanalicular meshwork, use of mitomycin C, and loosely suturing the superficial scleral flap. Intraocular pressure (IOP), visual acuity, number of medications, laser goniopuncture data and complications were recorded. The definition of complete (qualified) success was an IOP equal to or lower than 21, 18, 16 mm Hg without (with or without) anti-glaucoma medications.
RESULTS: The mean IOP was 33.5±9.9 mm Hg before surgery, 15.2±3.6 mm Hg (mean IOP reduction of 51%) at 5y after surgery, and 15.6±2.8 mm Hg (mean IOP reduction of 49.9%) at 10y after surgery (P<0.001). The number of anti-glaucoma medications dropped from 2.39±0.5 preoperatively to 0.47±0.8 at 5y and 0.67±0.8 at 10y postoperatively (P<0.001). The follow-up period was 104.5±37.0mo. The qualified success rate for an IOP of 21, 18 or 16 mm Hg or less was 84% [95% confidence interval (CI): 0.80-0.88], 73% (95%CI: 0.68-0.78), and 59% (95%CI: 0.52-0.66) after 5y, and 80% (95%CI: 0.76-0.84), 69% (95%CI: 0.64-0.74), 51% (95%CI: 0.44-0.58) after 10y, respectively. There was a relationship between age, preoperative IOP and success rate (P<0.01, P<0.05). A total of 31 eyes (31.3%) in 31 patients underwent laser goniopuncture, decreasing the IOP from 22.9±4.3 mm Hg to 16.3±2.5 mm Hg (P<0.01). Neither blebitis nor endophthalmitis occurred.
CONCLUSION: Modified viscocanalostomy could be performed to lower IOP, decrease multiple anti-glaucoma drops use as well. It’s a safe procedure with less complications over 10y in Chinese individuals with OAG.]]></description>
<pubDate>2019/2/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ya Liang, Hong Sun, Jie Shuai, Kai Xu, Fang-Fang Ji, Sucijanti and Zhi-Lan Yuan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ya Liang, Hong Sun, Jie Shuai, Kai Xu, Fang-Fang Ji, Sucijanti and Zhi-Lan Yuan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190313]]></guid><cfi:id>587</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Management of the open angle glaucoma in patients with central/hemicentral retinal vein occlusions]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190314]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To prospectively assess the cumulative prevalence and management of open angle glaucoma (OAG), including primary open angle glaucoma (POAG) with high and normal-pressure, as well as pseudoexfoliative glaucoma (PEXG), in patients with central/hemicentral retinal vein occlusions (RVOs) over a 3-year follow-up period.
METHODS: The study encompassed 57 patients with unilateral acute central/hemicentral RVOs. A complete ophthalmic examination of both eyes was undertaken for all patients. Patients with OAGs associated with central/hemicentral RVOs were treated with the current ocular hypotensive medications used worldwide and/or surgery and aimed to reduce the intraocular pressure (IOP) by 30% from baseline values for the 3 OAG forms existing in our series. The cumulative prevalence of OAG and the efficacy of treatment were evaluated.
RESULTS: OAG was observed in 3 clinical forms, namely, POAG with increased IOP in 4 patients, POAG with normal IOP in 3 patients, and PEXG in 3 patients. The cumulative prevalence of OAG was 19.6% (95%CI: 8.7-30.5). Using available ocular hypotensive medications (8 patients) and trabeculectomy (2 patients), the IOP decreased significantly from 24.3±4.36 mm Hg to 16.55±2.85 mm Hg, a reduction of 31.89% compared with baseline values. Glaucoma progression was not detected in any of the cases.
CONCLUSION: The high value of the cumulative prevalence of OAG is a risk factor for the development of venous occlusion. The treatment of glaucoma prevented its progression over a follow-up period of 3y.]]></description>
<pubDate>2019/2/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Dan C&#259;lug&#259;ru and Mihai C&#259;lug&#259;ru]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Dan C&#259;lug&#259;ru and Mihai C&#259;lug&#259;ru</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190314]]></guid><cfi:id>586</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Evaluation of outer retinal tubulations in diabetic macular edema underwent anti-VEGF treatment]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190315]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the incidence and subsequent changes of outer retinal tubulations (ORTs) in diabetic macular edema (DME) underwent anti-vascular endothelial growth factor (VEGF) therapy, and to assess the possibility of ORT as a biomarker of DME severity or response to anti-VEGF therapy.
METHODS: This retrospective and descriptive study included a total of 228 patients (435 eyes) with DME and treated with intravitreal anti-VEGF agents between March 2016 and January 2018. Patients were divided into 2 groups according to the presence of ORTs. High-resolution spectral-domain optical coherence tomography (SD-OCT) images acquired by vertical and horizontal scans and over consecutive visits were analyzed. The evolution of ORT over time, type of fluid and subfoveal photoreceptor integrity on OCT imaging was also assessed.
RESULTS: ORTs were identified in 108 eyes of 435 eyes with an overall incidence rate of 24.83% at baseline. ORTs were prone to locate adjacent to the lesions of exudation and/or cystoid edema and possibly situated in outer nuclear layer (ONL), outer plexiform layer (OPL) and/or inner nuclear layer (INL) in eyes with DME. The formation process of ORT led to focal downward displacement of OPL and INL toward RPE near the lesion. During the follow up, 45 eyes had steady ORTs and 63 eyes had dynamic variants in ORTs, including disappearance, reappearance, collapse, diminution, and enlargement. There were higher proportion of closed ORTs and fewer proportion of forming ORTs in eyes with steady ORTs, which showed a statistically significance when compared with eyes with variant ORTs (P=0.006, P=0.017, respectively). The eyes without ORTs had significantly better final best corrected visual acuity (BCVA) and more BCVA change than those eyes with ORTs in DME patients after anti-VEGF therapy (P=0.023, P=0.009, respectively). The disruption of subfoveal photoreceptor integrity in eyes with ORTs was more serious than that in eyes without ORTs (P=0.013). The proportion of stable vision in eyes with ORTs was significantly higher than that in eyes without ORTs, showing statistical significance (P=0.016). ORTs were associated with worse visual prognosis due to damage of the subfoveal photoreceptor integrity.
CONCLUSION: ORTs have a high incidence and changes over time in DME with anti-VEGF treatment and may be located at various retinal layers. Persistent ORT can be as a negative biomarker of outcome of DME.]]></description>
<pubDate>2019/2/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xiao-Li Huang, Yan-Ping Song, Qin Ding, Xiao Chen and Ling Hong]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiao-Li Huang, Yan-Ping Song, Qin Ding, Xiao Chen and Ling Hong</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190315]]></guid><cfi:id>585</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Characteristics of central visual field defect after macular hole surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190316]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the characteristics of postoperative central visual field defect (cVFD) in patients with macular hole (MH).
METHODS: Eighteen eyes from 18 MH patients were involved in this retrospective study which reviewed square root of loss variance (sLV) and mean defect (MD) of the visual field test in all subjects. The relationship between cVFD and MH stage, as well as the postoperative ellipsoid zone disruption were evaluated using Spearman’s correlation test.
RESULTS: Our analysis determined Spearman coefficient is 0.705 for the correlation between sLV and MH stage (P<0.01), 0.877 for the correlation between sLV and postoperative ellipsoid zone disruption (P<0.01) and 0.721 for the correlation between MD and postoperative ellipsoid zone disruption (P<0.01). A significant relationship was also detected between postoperative ellipsoid zone disruption and MH stage (r=0.470, P<0.05). Univariate regression analysis indicated that sLV and MD were associated with postoperative ellipsoid zone disruption (P<0.01, P<0.01, respectively).
CONCLUSION: Postoperative cVFD is highly correlated with MH stage and postoperative ellipsoid zone disruption in patients with MH.]]></description>
<pubDate>2019/2/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jia-Nan Li, Jia-Xing Wang, Xin-Lei Zhu and Hua Yan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jia-Nan Li, Jia-Xing Wang, Xin-Lei Zhu and Hua Yan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190316]]></guid><cfi:id>584</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Increased serum levels of soluble CD146 and vascular endothelial growth factor receptor 2 in patients with exudative age-related macular degeneration]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190317]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate serum levels of soluble CD146 (sCD146) and vascular endothelial growth factor receptor 2 (VEGFR2) in patients with age-related macular degeneration (AMD).
METHODS: Eighty-eight patients with exudative AMD and 45 sex- and age-matched healthy controls were enrolled in this study conducted in China. Serum samples was obtained from the patients with exudative AMD and from the controls. Serum sCD146 and VEGFR2 protein levels were measured using an enzyme-linked immunosorbent assay.
RESULTS: We found that serum sCD146 and VEGFR2 protein levels were significantly higher in the patients with exudative AMD group than in the controls (t=3.859, P<0.001 and t=3.829, P<0.001, respectively). Serum sCD146 levels were significantly higher in patients with classic choroidal neovascularization (CNV) than in those with occult CNV (t=9.899, P<0.001). There was a significant difference in the trend for exudative AMD in the highest versus lowest quartile of circulating sCD146 levels (χ2=10.29, P=0.001). The receiver operating characteristic curve analysis showed that the area under the curve was 0.696 for sCD146 (95%CI: 0.601-0.791) with an optimum diagnostic cut-off value of 157.16 ng/mL, a sensitivity of 55.7%, and a specificity of 82.2%.
CONCLUSION: The serum sCD146 level increases and may be a biomarker for exudative AMD.]]></description>
<pubDate>2019/2/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yan-Yao Liu, Yue Bin, Xing Wang and Hui Peng]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yan-Yao Liu, Yue Bin, Xing Wang and Hui Peng</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190317]]></guid><cfi:id>583</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Discriminating performance of macular ganglion cell-inner plexiform layer thicknesses at different stages of glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190318]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the discriminating performance of the macular ganglion cell-inner plexiform layer (GC-IPL) parameters between all the consecutive stages of glaucoma (from healthy to moderate-to-severe glaucoma), and to compare it with the discriminating performances of the peripapillary retinal nerve fiber layer (RNFL) parameters and optic nerve head (ONH) parameters.
METHODS: Totally 147 eyes (40 healthy, 40 glaucoma suspects, 40 early glaucoma, and 27 moderate-to-severe glaucoma) of 133 subjects were included. Optical coherence tomography (OCT) was obtained using Cirrus HD-OCT 5000. The diagnostic performances of GC-IPL, RNFL, and ONH parameters were evaluated by determining the area under the curve (AUC) of the receiver operating characteristics.
RESULTS: All GC-IPL parameters discriminated glaucoma suspect patients from subjects with healthy eyes and moderate-to-severe glaucoma from early glaucoma patients (P<0.017, for all). Also, minimum, inferotemporal and inferonasal GC-IPL parameters discriminated early glaucoma patients from glaucoma suspects, whereas no RNFL or ONH parameter could discriminate between the two. The best parameters to discriminate glaucoma suspects from subjects with healthy eyes were superonasal GC-IPL, superior RNFL and average c/d ratio (AUC=0.746, 0.810 and 0.746, respectively). Discriminating performances of all the parameters for early glaucoma vs glaucoma suspect comparison were lower than that of the other consecutive group comparisons, with the best GC-IPL parameters being minimum and inferotemporal (AUC=0.669 and 0.662, respectively). Moreover, minimum GC-IPL, average RNFL, and rim area (AUC=0.900, 0.858, 0.768, respectively) were the best parameters for discriminating moderate-to-severe glaucoma patients from early glaucoma patients.
CONCLUSION: GC-IPL parameters can discriminate glaucoma suspect patients from subjects with healthy eyes, and also all the consecutive stages of glaucoma from each other (from glaucoma suspect to moderate-to-severe glaucoma). Further, the discriminating performance of GC-IPL thicknesses is comparable to that.]]></description>
<pubDate>2019/2/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Melih Ustaoglu, Nilgun Solmaz and Feyza Onder]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Melih Ustaoglu, Nilgun Solmaz and Feyza Onder</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190318]]></guid><cfi:id>582</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Sectoral changes of the peripapillary choroidal thickness in patients with unilateral branch retinal vein occlusion]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190319]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate sectoral changes in the mean peripapillary choroidal thickness (PCT) in patients with unilateral branch retinal vein occlusion (BRVO).
METHODS: This retrospective, interventional study included 41 patients with acute, unilateral BRVO without macular edema. All patients completed at least a 6-month follow-up period. The PCT was measured at eight locations (temporal, superotemporal, superior, superonasal, nasal, inferonasal, inferior, and inferotemporal). In addition to calculating the average of all locations, the peripapillary choroidal area was divided into four sectors: superior (average of superotemporal PCT, superior PCT, and superonasal PCT), temporal, inferior (average of inferotemporal PCT, inferior PCT, and inferonasal PCT), and nasal.
RESULTS: In the BRVO-affected eyes, the mean PCT was 177.7±69.8 μm (range, 70.1-396.0 μm) at baseline and 127.8±54.8 μm (range, 56.4-312.1 μm) at 6mo (P<0.001). In the non-affected contralateral eyes, the mean PCT was 192.5±60.6 μm (range, 61.4-365.0 μm) at baseline and 165.9±61.1 μm (range, 56.8-326.8 μm) at 6mo (P<0.001). In sectoral analysis, the mean PCT in each sector was significantly reduced in over 6mo in the BRVO-affected eyes (all P<0.001). In the non-affected contralateral eyes, the mean PCT was not significantly changed in any sector over the 6-month follow-up period (superior sector, P=0.143; temporal sector, P=0.825; inferior sector, P=0.192; and nasal sector, P=0.599).
CONCLUSION: Sectoral analysis shows that the mean PCTs in all sectors are reduced significantly over 6mo in the BRVO-affected eyes, but not in the non-affected contralateral eyes.]]></description>
<pubDate>2019/2/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Na Eun Lee, Hae Min Kang, Jeong Hoon Choi, Hyoung Jun Koh and Sung Chul Lee]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Na Eun Lee, Hae Min Kang, Jeong Hoon Choi, Hyoung Jun Koh and Sung Chul Lee</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190319]]></guid><cfi:id>581</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Abrupt visual loss during anti-vascular endothelial growth factor treatment for type 3 neovascularization]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190320]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the incidence of abrupt visual loss and its associated factors, during anti-vascular endothelial growth factor (VEGF) treatment for type 3 neovascularization.
METHODS: This retrospective study included 137 eyes that were newly diagnosed with type 3 neovascularization. All eyes were treated with anti-VEGF therapy. Abrupt visual loss was defined as loss of 5 or more lines in best-corrected visual acuity (BCVA) in comparison to the previous visit. The incidence and timing of abrupt visual loss as well as the factors associated with it, were determined. In addition, the BCVA at the final follow-up was compared between the eyes with and those without abrupt visual loss.
RESULTS: The mean follow-up period was 42.4±18.9mo after diagnosis, and abrupt visual loss was noted in 22 eyes (16.1%) at a mean of 19.6±13.9mo. Abrupt visual loss was found to be associated with subretinal hemorrhage in 11 eyes (50.0%), development of or increase in the height of pigment epithelial detachment with fluid in 8 eyes (36.4%), and tears in the retinal pigment epithelium in 3 eyes (13.6%). The logarithm of minimum angle of resolution (logMAR) mean BCVA at the final follow-up was 2.07±0.67 (Snellen equivalents: 20/2349) and 1.00±0.55 (20/200) in eyes with and without abrupt visual loss, respectively. BCVA was significantly worse in the eyes with abrupt visual loss (P<0.001).
CONCLUSION: Abrupt visual loss is noted in 16.1% of patients with type 3 neovascularization and is associated with poor visual outcome. Additional studies are needed to determine how abrupt visual loss can be prevented.]]></description>
<pubDate>2019/2/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jae Hui Kim, Young Suk Chang, Jong Woo Kim, Chul Gu Kim and Dong Won Lee]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jae Hui Kim, Young Suk Chang, Jong Woo Kim, Chul Gu Kim and Dong Won Lee</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190320]]></guid><cfi:id>580</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of age on visual and refractive results after LASIK: mechanical microkeratome versus femtosecond laser]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190321]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the effect of age on visual and refractive results after laser in situ keratomileusis (LASIK) obtained with a mechanical microkeratome or a femtosecond laser.
METHODS: Retrospective, nonrandomized, cohort study. A total of 3826 eyes were included in the study (1725 eyes treated with mechanical LASIK and 2101 eyes treated with femtosecond LASIK). The relationship between patient age and the 3-month postoperative visual and refractive results of both procedures were analyzed by linear regression analysis.
RESULTS: Three months postoperatively, we found a significant correlation between age and the postoperative spherical equivalent (SE; r2=0.004, P=0.006), efficacy (r2=0.006, P=0.001), and safety indexes (r2=0.05, P=0.0001) in the mechanical LASIK group. On the other hand, we found a significant correlation between age and the postoperative SE (r2=0.02, P=0.0001) and the efficacy index (r2=0.01, P=0.0001) but not the safety index in the femtosecond laser group. Mechanical LASIK provided slightly but significantly better efficacy and predictability in patients 18 to 40 years of age and femtosecond LASIK did so in patients older than 40 years of age. The femtosecond laser provided better safety results than the mechanical microkeratome in both age groups.
CONCLUSION: A tendency toward undercorrection and less predictability is found with aging after myopic LASIK regardless of whether the flap was created with a mechanical microkeratome or a femtosecond laser. However, femtosecond laser provides significantly better outcomes in terms of efficacy, safety and predictability compared to mechanical microkeratome for the correction of myopia in patients over 40y.]]></description>
<pubDate>2019/2/11 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Montserrat Garcia-Gonzalez, Juan Gros-Otero, Isabel Rodriguez-Perez, Alberto Rodero and Miguel A. Teus]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Montserrat Garcia-Gonzalez, Juan Gros-Otero, Isabel Rodriguez-Perez, Alberto Rodero and Miguel A. Teus</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190321]]></guid><cfi:id>579</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical and microstructural changes with different iontophoresis-assisted corneal cross-linking methods for keratoconus]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190206]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the clinical and microstructural changes induced by different transepithelial iontophoresis-assisted corneal cross-linking (I-CXL) methods for keratoconus.
METHODS: A total of 42 eyes of 42 patients with progressive keratoconus were divided into two groups. Group A received I-CXL for 5min, while group B received I-CXL for 10min. Visual acuity, optical coherence tomography (OCT), specular microscopy and confocal microscopy were evaluated preoperatively and at 1, 3, 6, and 12mo postoperatively.
RESULTS: Twelve months after the operation, uncorrected visual acuity (UCVA) and corrected distance visual acuity (CDVA) were improved in both groups, with a better outcome in the I-CXL 10min group (P=0.025, 0.021, respectively). Kmax values decreased by 0.94±3.00 D in the I-CXL 10min group (P=0.033) but increased by 1.87±3.29 D in the I-CXL 5min group (P=0.012). OCT scans showed that the demarcation line was most visible and substantially deeper in the I-CXL 10min group. Confocal microscopy showed greater anterior stromal keratocyte decreases in the I-CXL 10min group than in the I-CXL 5min group at 3 and 6mo postoperatively (P<0.001); however, anterior stromal keratocytes and subbasal nerve density were not significantly different between the two groups at 12mo postoperatively.
CONCLUSION: I-CXL for 10min more effectively halts the progression of keratoconus than I-CXL for 5min after 12mo of follow-up. However, long-term studies are needed to evaluate the efficacy and safety of I-CXL.]]></description>
<pubDate>2019/1/3 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Kai Liao, Min Hu, Fen Chen, Pei Li, Peng Song and Qing-Yan Zeng]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Kai Liao, Min Hu, Fen Chen, Pei Li, Peng Song and Qing-Yan Zeng</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190206]]></guid><cfi:id>578</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Launching a paradigm for first and redo-surgery in primary congenital glaucoma: institutional experience]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190207]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the outcome of the initial and the redo-surgeries for primary congenital glaucoma (PCG) correlated to its degree of severity.METHODS: A retrospective study involved patients with PCG presented between 2010 and 2018. Medical records were reviewed to assess the degree of the preoperative severity according to the intraocular pressure (IOP), corneal diameter and corneal edema. Success and failure rates were calculated for both first and redo-surgeries at 6 and 12mo respectively then correlated to the severity of the cases.RESULTS: Complete records were retrieved for 272 eyes (153 patients) with PCG: 43 eyes were mild, 136 moderate and 93 severe. Combined trabeculotomy and trabeculectomy (CTT) had the highest success rate in moderate (96.4%) and severe cases (59.3%) while trabeculotomy had the highest success rate in mild cases (96.3%). Medical records of 88 eyes (63 patients) with recurrent PCG were analyzed, most with severe presentation (59 eyes). Ahmed glaucoma valve (AGV) was used in 67 (76%) eyes and augmented trabeculectomy in 21 (24%) eyes. At 12mo, there was no statistically significant difference between both surgeries in total success rate (P=0.256). For mild cases, success rate was 100% for both surgeries. Severe cases had higher success rates following AGV (87%) than augmented trabeculectomy (20%). Preoperative severity of the disease was an independent factor affecting the failure rate in secondary trabeculectomy but not in AGV. Patients younger than 24mo had higher probabilities of failure following both redo-surgeries with hazard ratio =1.325 and 0.37 for augmented trabeculectomy and AGV respectively.CONCLUSION: Preoperative assessment of the severity of eyes with PCG helps in the selecting the optimal primary and secondary surgery. For first surgery, trabeculotomy is more effective in mild cases whereas; CTT and augmented subscleral trabeculectomy (SST) are appropriate for moderate and severe cases. AGV proved to be superior to augmented SST in severe recurrent cases.]]></description>
<pubDate>2019/1/3 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Tharwat H. Mokbel, Eman M. El Hefney, Sherein M. Hagras, Amani E. Badawi, Manal A. Kasem, Ahmed A. Al Nagdy, Sherief E. El Khouly and Walid M. Gaafar]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Tharwat H. Mokbel, Eman M. El Hefney, Sherein M. Hagras, Amani E. Badawi, Manal A. Kasem, Ahmed A. Al Nagdy, Sherief E. El Khouly and Walid M. Gaafar</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190207]]></guid><cfi:id>577</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of subconjunctival injection with conbercept as an adjuvant to filtration surgery for open angle glaucoma: a prospective randomized interventional 6-month follow-up study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190208]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the safety and efficacy of subconjunctival injection with conbercept and 5-fluorouracil (5-FU) for open angle glaucoma (OAG) patients after filtration surgery.
METHODS: As a prospective randomized interventional trial, 36 eyes from 36 patients after OAG surgery were collected and divided randomly into conbercept and 5-FU groups. All patients were subconjunctivally injected with either conbercept (0.2 mL) or 5-FU (0.2 mL) on the 5th day post-operatively. The intraocular pressure (IOP), number of medications used, type of conjunctival bleb, and complications were recorded and analyzed pre-operatively and 1d, 1wk, 1, 3 and 6mo post-injection.
RESULTS: There were significant differences in IOP between the conbercept and 5-FU groups 1mo (conbercept group: 12.17±1.04 mm Hg; 5-FU group: 13.50±2.33 mm Hg, t=2.214, P=0.037), 3mo (conbercept group: 13.00±1.88 mm Hg; 5-FU group: 14.50±2.28 mm Hg, t=2.153, P=0.039), and 6mo post-injection (conbercept group: 13.28±2.95 mm Hg; 5-FU group: 15.22±2.49 mm Hg, t=2.140, P=0.040); however, in the number of medications, a prominent difference was not shown between groups on post-injection 6mo (t=1.312, P=0.200). Moreover, there was mild vascularity observed in the conbecept group than the 5-FU group 1d (3a, 3b, 3c: t=8.497, 6.693, 4.515, P=0.000), 1wk (3a, 3b, 3c: t=3.431, 6.408, 3.984, P=0.002, 0.000, 0.000), and 1mo post-injection (3a, 3b, 3c: t=2.466, 2.466, 2.503, P=0.019, 0.019, 0.017). Simultaneously, differences from other indicators between the two groups were not demonstrated. Also, there was a lower probability of corneal epithelial stripping in the conbercept group than the 5-FU group (χ2=4.500, P=0.034).
CONCLUSION: Subconjunctival injection of conbercept has a safe, effective, and tolerable profile for open angle glaucoma patients with distinct conjunctival congestion after filtration surgery.]]></description>
<pubDate>2019/1/3 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jing Zhang, Vikash Vikash, Ping Wang, Tian Zheng, Dong-Lai Chen, Qing Wang and Min Ke]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jing Zhang, Vikash Vikash, Ping Wang, Tian Zheng, Dong-Lai Chen, Qing Wang and Min Ke</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190208]]></guid><cfi:id>576</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Dual Scheimpflug imaging as a screening method for occludable angles-a comparison with gonioscopy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190209]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate dual Scheimpflug analyzer (Galilei) as a screening method for the diagnostic of gonioscopically narrow anterior chamber angles (ACA).METHODS: In 40 eyes of 40 patients with different ACA range, the ACA, anterior chamber volume (ACV) and anterior chamber depth (ACD) were analyzed using the dual Scheimpflug analyzer (Galilei G6 system). Correspondence between these parameters and Shaffer’s classification based on gonioscopy were studied. Receiving operator characteristic (ROC) curves and partition analysis were used to determine the efficacy of the Galilei system in screening for narrow angles. Agreement (Kappa statistics), sensitivity, and specificity for each eye, according to Galilei measures, were also assessed.RESULTS: Shaffer’s grade (from 0 to 4) were significantly associated with each of the measurements (P<0.001). In screening eyes with narrow angles with the Galilei, the area under the ROC curve was largest (0.90) when ACD was used as the reference, and partition analysis demonstrated that those eyes were most adequately partitioned with an ACD of 2.86 mm with 100% sensitivity and 80% specificity.CONCLUSION: The Galilei is a secure, repeatable and noncontact screening method for narrow angles. However it does not provide sufficient information about the ACA anatomy to be considered a substitute for gonioscopy.]]></description>
<pubDate>2019/1/3 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Natália Maes Bessa, Rebeca de Azevedo Souza, Marcony R. Santhiago, Haroldo Vieira Moraes Jr and Beatriz Fiuza Gomes]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Natália Maes Bessa, Rebeca de Azevedo Souza, Marcony R. Santhiago, Haroldo Vieira Moraes Jr and Beatriz Fiuza Gomes</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190209]]></guid><cfi:id>575</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical outcomes with large macular holes using the tiled transplantation internal limiting membrane pedicle flap technique]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190210]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report the surgical technique and efficacy of the tiled transplantation internal limiting membrane (ILM) pedicle flap technique after vitrectomy for 33 patients with large macular hole (MH).
METHODS: This study was a prospective noncontrolled interventional study. All patients were treated by vitrectomy, the tiled transplantation ILM pedicle flap and gas tamponade. All patients underwent visual acuity measurements and optical coherence tomography (OCT), during preoperative and the follow-up visits postoperative.
RESULTS: Two high-myopic patient had flap dislocation during surgery. The thorough closure of MH following the tiled transplantation ILM pedicle flap technique was ultimately achieved in 31 patients observed by OCT imaging (93.94%) 1wk after surgery. Visual acuity improved from 1.51±0.31 (logMAR) preoperative to 0.92±0.30 6mo after surgery (P=0.000). There were no significant changes in OCT finding during the follow-up period from 1mo to 6mo after surgery.
CONCLUSION: The tiled transplantation ILM pedicle flap technique provides bridge for retinal gliosis to achieve successful closures of the large MHs, and the microenvironment of this technique is more similar to the normal physiological conditions.]]></description>
<pubDate>2019/1/3 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Li-Ping Wang, Wen-Tao Sun, Chun-Ling Lei and Jin Deng]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Li-Ping Wang, Wen-Tao Sun, Chun-Ling Lei and Jin Deng</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190210]]></guid><cfi:id>574</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Intravitreal conbercept injection for neovascular age-related macular degeneration]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190211]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the efficacy and safety of intravitreal injection of conbercept in patients with neovascular age-related macular degeneration (AMD).
METHODS: Retrospective review of 66 eyes of 63 patients with neovascular AMD. All patients received 0.5 mg intravitreal injections of conbercept monthly for 3 consecutive months, and then pro re nata treatment was performed. The changes of best-corrected visual acuity (BCVA) and central macular thickness (CMT) were observed before and after treatments. Minimum follow-up time was 12mo. SPSS 22.0 statistical software was used for statistical analysis.
RESULTS: The mean BCVA and CMT of 66 eyes (63 patients) were 1.11±0.60, 533.20±219.95 μm at baseline, and were 0.68±0.38, 310.28±125.60 μm at 3mo. No subjects were lost during the first three months, the improvements were all significantly (P<0.05). During the whole follow-up time of 12mo, 15 subjects (18 eyes) were lost. The mean BCVA and CMT of the rest 48 eyes with the follow-up time at least 1y were 0.83±0.46 and 547.59±196.77 μm at baseline, after 3mo and 12mo of conbercept injections became 0.55±0.41, 318.24±141.29 μm and 0.55±0.51, 333.87±173.25 μm. The differences were significant (P<0.05). No serious complications were observed.
CONCLUSION: Intravitreal injection of conbercept appears to significantly improve visual acuity and anatomical outcomes in patients with neovascular AMD, no serious adverse reactions and complications are observed.]]></description>
<pubDate>2019/1/3 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Bing-Hui Wu, Bing Wang, Hui-Qin Wu, Qin Chang and Hui-Qin Lu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Bing-Hui Wu, Bing Wang, Hui-Qin Wu, Qin Chang and Hui-Qin Lu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190211]]></guid><cfi:id>573</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of topical nepafenac 0.1% with intravitreal dexamethasone implant for the treatment of Irvine-Gass syndrome]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190212]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare safety and efficacy of intravitreal dexamethasone (IVD) implant  with topical nepafenac (TN) 0.1% in previously untreated Irvine-Gass syndrome (IGS) in clinical practice.METHODS: This was a retrospective study of 62 eyes with IGS after phacoemulsification with posterior chamber intraocular lens (IOL) implantation. None of the patients used treatment before IVD or TN. Best-corrected visual acuity (BCVA) with Early Treatment Diabetic Retinopathy Study chart (ETDRS), slit-lamp, intraocular pressure (IOP) measurement, fundus examination, spectral-domain optical coherence tomography (OCT) and fundus florescein angiography were performed to all subjects at baseline, 1, 3 and 6mo.RESULTS: The mean BCVA of the IVD group was 49.3±6.8, and the mean BCVA of the TN group was 32.9±7.3 ETDRS letters in post-treatment month 6. The mean central macular thickness (CRT) of IVD group was 266.6±53.5 µm and the mean CRT of TN group was 364.9±56.3 µm in post-treatment month 6. Baseline BCVA has correlation with final BCVA in TN group however there was no correlation between baseline BCVA and final BCVA in IVD group.CONCLUSION: IVD is found to be better than TN in controlling pseudophakic macular edema and improving visual acuity. IVD group also has significantly lower CRT however IOP is not significantly different between two groups in post-treatment month 6.]]></description>
<pubDate>2019/1/3 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hande Guclu and Vuslat Pelitli Gurlu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hande Guclu and Vuslat Pelitli Gurlu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190212]]></guid><cfi:id>572</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Indicating and predicting role of the horizontal C/D ratio in preclinical diabetic retinopathy associated with chronic angle-closure glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190213]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To observe morphological optic disc characteristics in patients with preclinical diabetic retinopathy (DR) associated with chronic angle-closure glaucoma (CACG).
METHODS: Twenty-two cases (43 eyes) of preclinical DR associated with CACG were enrolled in group A; 24 preclinical DR cases (46 eyes) were enrolled in group B; 26 CACG cases (51 eyes) were enrolled in group C; and 49 normal controls (49 eyes) were enrolled in group D. All underwent optical coherence tomography to measure the horizontal C/D ratio (HCDR), C/D area ratio (CDaR), vertical C/D ratio (VCDR), rim area (RA), cup volume (CV), disc area (DA) and average retinal nerve fiber layer (RNFL) thickness.
RESULTS: The ages of groups A, B, C, and D were 67.60±3.36, 66.78±3.33, 65.98±3.83, and 67.54±3.17y, respectively. The HCDR values in groups A, B, and C were distinct relative to those in group D (P<0.0001, P<0.01, and P<0.05, respectively). The HCDR values in group A were higher compared with those in groups B (P<0.0001) and D (P<0.0001); while these values were virtually identical statistically between groups A and C (P>0.05). The CDaR values in group A were higher in comparison to those in groups B and D (P<0.0001 in both groups); while these values were virtually identical statistically between groups A and C (P>0.05). The RA values in group A were smaller relative to those in groups B and D (P<0.0001 in both groups); while groups A and C were not distinct statistically (P>0.05). The CV values in group A were greater in comparison to those in groups B and D (P<0.0001 in both groups); while groups A and C were not distinct statistically (P>0.05). DA was not distinct for comparisons of two groups among the four groups (P>0.05). HCDR value correlated with mean nasal RNFL thickness (r=-0.909, P<0.0001), mean superior RNFL thickness (r=-0.866, P<0.0001), mean inferior RNFL thickness (r=-0.650, P<0.001) and mean temporal RNFL thickness (r=-0.562, P<0.01) in group A.
CONCLUSION: The HCDR was a sensitive morphological parameter in detecting structural visual disc changes in preclinical DR associated with CACG, which can reflect optic nerve damage caused jointly by CACG and diabetes. A higher HCDR may predict optic nerve atrophy.]]></description>
<pubDate>2019/1/3 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ze-Long Zhong and Song Chen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ze-Long Zhong and Song Chen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190213]]></guid><cfi:id>571</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Relationship between contrast sensitivity and corneal shape following overnight orthokeratology]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190214]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the relationship between contrast sensitivity (CS) and corneal shape following overnight orthokeratology (OK).
METHODS: We conducted a retrospective clinical study of 80 lens-wearing myopia patients, all of whom had undergone OK and had been evaluated by Orbscan II topography. We measured the surface irregularity index (SIRI) of corneal topography at 3 and 5 mm, the size of the flattened central corneal curvature of OK lens (zone A), the size of the cornea altered by OK lens (zone B), the size of the pupillary area at the corneal level (zone C), the area of crossover between zones A and C (zone AC), the area of crossover between zones B and C (BC), the ratio of BC to B (BC/B), and the ratio of AC to C (AC/C). CS was evaluated using the CSV-1000 with spatial frequencies of 3, 6, 12, and 18 cycles/degree (CPD).
RESULTS: Multiple correlation analyses indicated significant negative correlations between CS, zone C, BC/B, and 3-mm SIRI (all P<0.01). There were no significant differences between CS, zone B, AC/A, or 5-mm SIRI (P=0.60, 0.94 and 0.11, respectively). Zone C was negatively correlated with 3, 6, 12, and 18 CPD. 5-mm SIRI were negatively correlated with 6, 12, and 18 CPD. BC/C was negatively correlated with 6 and 18 CPD. AC/C was positively correlated with 3 CPD.
CONCLUSION: Zone C, 3-mm SIRI and BC/B affect the CS following overnight OK.]]></description>
<pubDate>2019/1/3 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Li-Li Liu, Li-Ping Gong, Yue-Yuan Xu, Xuan Zhu, Kaddie Kwok Chen and Wei-Feng Liu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Li-Li Liu, Li-Ping Gong, Yue-Yuan Xu, Xuan Zhu, Kaddie Kwok Chen and Wei-Feng Liu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190214]]></guid><cfi:id>570</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[SMILE intraoperative complications: incidence and management]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190215]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report the intraoperative complications associated with small incision lenticule extraction (SMILE) and their management.METHODS: This was a retrospective consecutive interventional clinical study, carried out on patients with myopia and myopic astigmatism, who underwent SMILE procedure. Type of intraoperative complications and their management were recorded.RESULTS: Our study comprised 282 eyes of 141 patients who were enrolled for SMILE surgeries. The intraoperative complications included lost vacuum (18 eyes, 6.38%), treatment decentration (6 eyes, 2.12%), wound bleeding (21 eyes, 7.45%), incomplete bubble separation (black islands) (3 eyes, 1.06%), the epithelial defects (15 eyes, 5.32%). Incision tear (27 eyes, 9.57%), lenticule adherence to the cap (6 eyes, 2.12%), and cap perforation occurred in 2 eyes (0.7%).CONCLUSION: Although SMILE is a promising technique for the correction of myopia and myopic astigmatism with predictable, efﬁcient, safe refractive and visual outcomes, complications can occur. However, most of them are related to inexperience and are included in the learning curve of the technique. More studies with a bigger number of eyes are required to efficiently evaluate the intraoperative complications and standardize their management strategies.]]></description>
<pubDate>2019/1/3 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Abdelmonem M Hamed, Mohamed Amin Heikal, Tarek T. Soliman, Ahmed Daifalla and Khaled E Said-Ahmed]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Abdelmonem M Hamed, Mohamed Amin Heikal, Tarek T. Soliman, Ahmed Daifalla and Khaled E Said-Ahmed</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190215]]></guid><cfi:id>569</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Visual performance after implantation of two types of phakic foldable intraocular lenses for correction of high myopia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190216]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare Visian lens (model V4c) and Artiflex lens regarding quality (contrast sensitivity) and quantity (efficacy, predictability, safety and stability) of vision in correcting high myopia with recording and analysis of complications.METHODS: The comparative prospective study included 39 eyes of 23 patients with high myopia, 19 eyes had Visian lens implantation (model V4c) and 20 eyes had Artiflex lens implantation. The inclusion criteria were high myopia (higher than 6.0 D) and stable refraction (<0.5 D change over one year). Outcomes included assessment of safety and efficacy indices, predictability, stability, contrast sensitivity and analysis of complications at postoperative 1d, 1wk and 1, 3, 6 and 12mo. Selection of the type of phakic intraocular lens for patients was based on surgeons’ preferences, which was no specific selection criteria.RESULTS: After 12mo of follow up, difference in uncorrected and corrected distant visual acuity (CDVA) between both groups was statistically insigniﬁcant (UDVA for VisianV4c and Artiflex lens were 0.33±0.2 logMAR and 0.37±0.2 logMAR respectively, P=0.59, CDVA for VisianV4c and Artiflex lens were 0.155±0.1 logMAR and 0.147± 0.1 logMAR respectively, P=0.87). The efficacy index was 1.25 for VisianV4c lens and 0.8 for Artiflex lens, 78.9% of eyes were within one diopter spherical equivalent in Visian V4c lens group compared to 70% in the Artiflex lens group. No eye lost lines of CVDA proving a good safety index for both lenses (safety index was 1.67 for VisianV4c lens and 1.34 for Artiflex lens). Difference in contrast sensitivity between both groups was statistically insignificant (P=0.15, 0.88, 0.27, 0.32 and 0.82 at five spatial frequencies).CONCLUSION: Both Visian ICL V4c and Artiflex lenses are safe and effective with stable and predictable refraction and they have comparable contrast sensitivity outcomes with no vision threatening complications.]]></description>
<pubDate>2019/1/3 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Islam M. Rizk, Abd-Almonem A. Al-hessy, Sherief E. El-Khouly and Ashraf M. Sewelam]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Islam M. Rizk, Abd-Almonem A. Al-hessy, Sherief E. El-Khouly and Ashraf M. Sewelam</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190216]]></guid><cfi:id>568</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[One-year outcomes of intravitreal conbercept combined rescue therapy for polypoidal choroidal vasculopathy in a Chinese population: a real-life clinical data]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190108]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the real-life clinical outcomes of intravitreal injection of conbercept combined rescue therapy for polypoidal choroidal vasculopathy (PCV).
METHODS: This was an open label, single center, and interventional study. All enrolled patients were treated initially with three consecutive monthly intravitreal conbercept injections (0.5 mg). Additional conbercept injections were administered upon substantial polyp regression with improved visual acuity (VA). Eyes with partial or no polyp regression and poor VA were rescue treated with photodynamic therapy (PDT) for subfoveal polyps or thermal laser photocoagulation for extrafoveal polyps. Best-corrected visual acuity (BCVA), central foveal thickness (CFT) and polyp regression were observed as primary outcomes. Side effects were also collected during the follow-up period.
RESULTS: A total of 56 eyes (56 patients) with PCV were included. BCVA increased significantly from the baseline of 43.52±24.21 letters to 55.88±21.94 letters (P<0.001) at 12mo, while CFT decreased significantly from 457.41±207.86 μm to 247.98±127.08 μm (P<0.001). All patients showed polyp regression. Twenty-three eyes achieved complete polyp regression after the three initial injections, which increased to 44 eyes at 12mo. Seventeen eyes underwent rescue therapy, among which 2 eyes treated with PDT and 15 eyes treated with laser photocoagulation. A mean of 4.30±1.43 injections were given per eye. No intraocular inflammation, retinal or vitreous hemorrhage, or systemic complication occurred.
CONCLUSION: Conbercept is an effective and safe option for the treatment of PCV in Chinese population. The treatment regimen of three initial conbercept injections followed by additional injections or rescue therapies is efficacious for treating PCV.]]></description>
<pubDate>2019/1/3 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hui-Jun Qi, En-Zhong Jin and Ming-Wei Zhao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hui-Jun Qi, En-Zhong Jin and Ming-Wei Zhao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190108]]></guid><cfi:id>567</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Evaluation of spectral domain optical coherence tomography parameters in discriminating preperimetric glaucoma from high myopia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190109]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the diagnostic ability of macular ganglion cell-inner plexiform layer (GCIPL) thickness obtained by spectral-domain optical coherence tomography (SD-OCT) in discriminating non-highly myopic eyes with preperimetric glaucoma (PPG) from highly myopic healthy eyes.
METHODS: A total of 254 eyes, including 76 normal controls (NC), 116 eyes with high myopia (HM) and 62 non-highly myopic eyes with PPG were enrolled. The diagnostic ability of OCT parameters was accessed by the areas under the receiver operating characteristic (AUROC) curve in two distinguishing groups: PPG eyes with non-glaucomatous eyes including NC and HM (Group 1), and PPG eyes with HM eyes (Group 2). Differences in diagnostic performance between GCIPL and RNFL parameters were evaluated.
RESULTS: The minimum (AUROC curve of 0.782), inferotemporal (0.758) and inferior (0.705) GCIPL thickness were the top three GCIPL parameters in discriminating PPG from non-glaucomatous eyes, all of which had statistically significant lower diagnostic ability than average RNFL thickness (0.847). In discriminating PPG from HM, the best GCIPL parameter was minimum (0.689), statistically significant lower in diagnostic ability than average RNFL thickness (0.789) and three other RNFL thickness parameters of temporal and inferotemporal clock-hour sectors.
CONCLUSION: The minimum GCIPL thickness is the best GCIPL parameter to detect non-highly myopic PPG from highly myopic eyes, whose diagnostic ability is inferior to that of average RNFL thickness and RNFL thickness of several temporal and inferotemporal clock-hour sectors. The average RNFL thickness is recommended for discriminating PPG from highly myopic healthy eyes in current clinical practice in a Chinese population.]]></description>
<pubDate>2019/1/3 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xiao-Yu Xu, Hui Xiao, Jing-Yi Luo and Xing Liu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiao-Yu Xu, Hui Xiao, Jing-Yi Luo and Xing Liu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190109]]></guid><cfi:id>566</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[The prognosis of trabeculectomy in primary angle- closure glaucoma patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190110]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate whether the level of thrombospondin-1 (TSP-1) in aqueous humor can predict the prognosis of trabeculectomy in patients with primary angle-closure glaucoma (PACG).
METHODS: This case-control study involved 26 patients with PACG who experienced a failed trabeculectomy (case group) and 78 age- and sex-matched patients with PACG who underwent successful trabeculectomy (control group). Aqueous humor was collected at the time of trabeculectomy and tested for TSP-1 and TGF-β2 levels with an enzyme-linked immunosorbent assay method. Logistic regression modeling was used to assess the risk factors for failed trabeculectomy.
RESULTS: The mean TSP-1 aqueous concentrations were significantly higher in the case group (20.67±9.79 ng/mL) than the control group (5.17±2.29 ng/mL) (P<0.001). The transforming growth factor-β2 (TGF-β2) aqueous concentrations were significantly different between the case and control group, at 3633.25 and 1090.24 pg/mL, respectively (P<0.001). Logistic regression analysis revealed TSP-1 level as an independent risk factor for a failed trabeculectomy (OR=3.540; 95%CI=1.092-11.482).
CONCLUSION: The aqueous humor TSP-1 and TGF-β2 levels are higher in PACG eyes with failed trabeculectomy than with successful trabeculectomy at one year. The aqueous humor TSP-1 level is an independent risk factor associated with failed trabeculectomy.]]></description>
<pubDate>2019/1/3 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jun-Dong Zhu, Li-Lian Xie, Zhi-Yuan Li and Xiao-He Lu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jun-Dong Zhu, Li-Lian Xie, Zhi-Yuan Li and Xiao-He Lu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190110]]></guid><cfi:id>565</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of ring 1 parameters in 37-segment multifocal electroretinography between onset and offset conditions of ring 2 to 4 in normal subjects]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190111]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate whether the response of a central hexagonal element corresponding to the macular area in conventional multifocal electroretinography (mfERG) tests was the same as that of experimental mfERG using single central hexagonal element stimulation.
METHODS: Prospective, observational study. Thirty healthy subjects were included in this study. mfERG recordings were performed according to two protocols: stimulus with 37 hexagonal elements (protocol 1), and stimulus with a single central element created by deactivating the other 36 hexagonal elements (protocol 2). We compared differences between ring 1 parameters in each protocol.
RESULTS: In protocol 1, the first positive component (P1) implicit time and P1 amplitude were 37.8±1.8ms and 6.3±2.7 μV. After single element stimulation (protocol 2), double positive waves appeared. The implicit time and amplitude of P1 were 40.7±2.4ms (P<0.001) and 9.1±3.3 μV (P=0.001), respectively. The implicit time and amplitude of the second positive component (P2) were 68.0±4.5ms (P<0.001, compared with P1 in protocol 1) and 12.3±4.7 μV (P<0.001, compared with P1 in protocol 1), respectively. The amplitude of P2 in protocol 2 was about two times higher than that of P1 in protocol 1.
CONCLUSION: mfERG responses of a central hexagonal element in a single element stimulation protocol are different from those of multiple element stimulation. The positive wave is more enhanced compared to that of the conventional protocol and it elongated into two wavelets.]]></description>
<pubDate>2019/1/3 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jun Ho Yoo, Cheolmin Yun, Jaeryung Oh and Seong-Woo Kim]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jun Ho Yoo, Cheolmin Yun, Jaeryung Oh and Seong-Woo Kim</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190111]]></guid><cfi:id>564</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Fluorescein angiography of retinal vascular involution after intravitreal injection of ranibizumab for retinopathy of prematurity]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190112]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To describe the involution patterns of vessel growth of retina through fluorescein angiography (FA) of children, who had been under treatment up to 1y previously intravitreal ranibizumab (IVR) as monotherapy for retinopathy of prematurity (ROP).
METHODS: This is a retrospective study. The medical information and FA of 17 children (34 eyes) whose area of avascular retina from the ora serrata was more than two disc diameters (DD) were analyzed.
RESULTS: Among 34 eyes, all were the presence of finger-shaped vessels and arteriolar-venular shunts (100%, 34/34 eyes). Popcorn abnormalities were found in most of the eyes (94.1%, 32/34 eyes). Furthermore, in many cases (23.5%, 8/34 eyes), there were leakage persisting in the region of the junction between avascular and vascular retina. In contrast, just 2 eyes (5.9%) showed damage of retinal capillary bed and 3 eyes (8.8%) showed large area of retinal pigment epithelium (RPE) atrophy.
CONCLUSION: Although IVR can be very effective in ROP, we should remain cautious as infants may remain avascular peripheral retinas and abnormal vessel. FA allows accurate visualization of vessel abnormalities in eyes with ROP, which will be helpful to affect assessment of disease activity and therapeutic effect.]]></description>
<pubDate>2019/1/3 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yong Cheng, Tie-Gang Liu, Wei-Yi Li, Ming-Wei Zhao and Jian-Hong Liang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yong Cheng, Tie-Gang Liu, Wei-Yi Li, Ming-Wei Zhao and Jian-Hong Liang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190112]]></guid><cfi:id>563</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Evaluation of dynamic stereopsis in intermittent exotropia patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190113]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To delineate the characteristics of the dynamic stereopsis test and analyze related parameters in intermittent exotropia [X(T)] patients.
METHODS: Fifty-seven X(T) patients and 55 normal subjects were enrolled in this study. The normal and X(T) groups were used to test the reproducibility and reliability of the dynamic stereopsis test, and Bangerter filters with densities of 0.2 were then used to simulate suppression to test for traditional and dynamic stereopsis. In the X(T) group, the measurements included 1) dynamic stereopsis test comprising three parts: motion+disparity, motion only and disparity only; 2) ocular deviation angle; 3) Bagolini striated lens test; 4) disease course; and 5) Titmus stereopsis test.
RESULTS: The test-retest reliability of the dynamic stereopsis method was 0.901 in the normal and X(T) groups, and none of the X(T) patients were able to pass the static and dynamic stereopsis tests after using the 0.2 Bangerter filter. The accuracy rate was greater than 80% in the normal group and 31.81%, 36.36%, and 45.45% for the motion+disparity, motion-only and disparity-only components of the traditional test for X(T) patients diagnosed with stereoblindness via traditional tests, respectively. Patients with a long disease course (>1y) had worse dynamic stereopsis than those with a short disease course (<1y; P<0.05, Chi-square test). The deviation angle was not correlated with the motion+disparity, disparity-only, or the motion-only test components (all P>0.05, Chi-square test).
CONCLUSION: Dynamic stereopsis is preserved in certain X(T) patients diagnosed with stereoblindness via traditional tests. A long disease course was shown to be a negative factor for dynamic stereopsis in X(T) patients  which might be associated with worse progression, and provide good references clinically.]]></description>
<pubDate>2019/1/3 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jing Zhong, Da-Ming Deng, Zi-Dong Chen, Jin-Rong Li, Jun-Peng Yuan, Lei Feng, Ai-Hou Wang and Min-Bin Yu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jing Zhong, Da-Ming Deng, Zi-Dong Chen, Jin-Rong Li, Jun-Peng Yuan, Lei Feng, Ai-Hou Wang and Min-Bin Yu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190113]]></guid><cfi:id>562</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Management of tear trough deformity with and without tear trough-orbicularis retaining ligament complex release in transconjunctival blepharoplasty: a comparative study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190114]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the effect of releasing the orbicularis retaining ligament (ORL) complex of the tear trough combined with the transconjunctival blepharoplasty in the surgical management of tear trough deformity compared with the effect of blepharoplasty alone.
METHODS: A prospective, randomized (by closed envelope technique), controlled surgical trial which included 50 patients (100 eyes) with bilateral visible tear trough deformity and lower eyelid fat bulging, was divided into two groups where 25 patients (50 eyes) had tear trough-ORL release with blepharoplasty and 25 patients (50 eyes) didn’t. Qualitative and quantitative assessments of tear trough deformity were done at 6mo postoperatively, achieving grade 0 or 1 of Barton’s classification was considered a success. Standardized photographic documentation of each patient was done pre and postoperatively, also assessment of the patients’ satisfaction postoperatively was done and ranked as excellent, very good, good or fair.
RESULTS: There was statistically significant difference between the two groups in the overall aesthetic results postoperatively regarding the qualitative and quantitative analysis of the tear trough deformity, where patients who had tear trough-ORL complex release had more successful outcomes than those of the second group.
CONCLUSION: ORL release should be done in patients with tear trough deformity in order to release the tethering effect of this ligament which causes the prominence of the naso jugal groove.]]></description>
<pubDate>2019/1/3 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Tamer Ismail Gawdat, Engy Abd Eltawab Elsherif, Yomna Amr Alahmadawy and Yehia Salah Eldin Mostafa]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Tamer Ismail Gawdat, Engy Abd Eltawab Elsherif, Yomna Amr Alahmadawy and Yehia Salah Eldin Mostafa</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20190114]]></guid><cfi:id>561</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Dynamic profile of ocular refraction in pediatric cataract patients after lens surgeries]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191204]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To study the change in ocular refraction in patients with pediatric cataracts (PCs) after lens extraction.
METHODS: A total of 1258 patients who were undergoing cataract extraction with/without intraocular lens (IOL) implantation were recruited during preoperative examinations between Jan 2010 and Oct 2013. Patient ages ranged from 1.5mo to 14y. Follow-ups were conducted at 1wk, 1, and 3mo postoperatively and every 3mo in the first year, then 6mo thereafter. Ocular refraction [evaluated as spherical equivalent (SE)] and yearly myopic shift (YMS) were recorded and statistically analyzed among patients with age at surgery, baseline ocular refraction, gender, postoperative time and laterality (bilateral vs unilateral).
RESULTS: By Dec 31st 2015, 1172 participants had been followed for more than 2y. The median follow-up period was 3y. The critical factors affecting the ocular refraction of PC patients were baseline ocular refraction, postoperative time for both aphakic and pseudophakic eyes. YMS grew most rapidly in young childhood and early adolescence.
CONCLUSION: After lens surgeries, ocular refraction in PC patients shows an individual difference of change. Further concerns should be raising to monitor the rapid myopic shift at early adolescence of these patients.]]></description>
<pubDate>2019/11/6 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Zhen-Zhen Liu, Er-Ping Long, Duo-Ru Lin, Lei Ye, Yi-Fan Xiang, Wang-Ting Li, Xiao-Hang Wu, Xu-Tu Zhao, Xiao-Ping Liu, Lan-Qin Zhao, Xiu-Cheng Huang, Tong-Yong Yu, Hui Chen, Jing-Jing Chen, Ming-Xing Wu, Hao-Tian Lin, Wei-Rong Chen and Yi-Zhi Liu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zhen-Zhen Liu, Er-Ping Long, Duo-Ru Lin, Lei Ye, Yi-Fan Xiang, Wang-Ting Li, Xiao-Hang Wu, Xu-Tu Zhao, Xiao-Ping Liu, Lan-Qin Zhao, Xiu-Cheng Huang, Tong-Yong Yu, Hui Chen, Jing-Jing Chen, Ming-Xing Wu, Hao-Tian Lin, Wei-Rong Chen and Yi-Zhi Liu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191204]]></guid><cfi:id>560</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[The effects of implantable collamer lens implantation on higher order aberrations]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191205]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the changes in higher order aberrations (HOAs) after implantable collamer lens (ICL; Staar Surgical, Nidau, Switzerland) implantation.
METHODS: Totally 30 eyes of 18 patients with myopia were included in this study with an average age of 25.77y (min: 21, max: 40). Refraction, uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), HOAs (entire, corneal and internal) were evaluated preoperatively and three months postoperatively. Ocular aberrations were measured by using iTrace (Tracey Technology, Houston, Texas, USA). SPSS (IBM Corp. Released 2013. IBM SPSS Statistics for Windows, Version 22.0. Armonk, NY: IBM Corp) was used for the statistical analysis and the interpretation of the data. P values of less than 0.05 were considered statistically significant.
RESULTS: The preoperative mean spherical power was -9.01 D (min: -5.00, max: -13.00) and the mean cylindrical error was -2.40 D (min: -0.50, max: -4.75). The postoperative mean residual spherical power was -0.73 D (min: -0.20, max: -1.75) and the mean cylindrical error was -0.89 D (min: -0.18, max: -2.09). Analyses were made on root mean square (RMS) values of total HOAs (tHOAs), spherical aberration, coma and trefoil as entire, corneal and internal components. The differences in entire tHOAs and in internal tHOAs were significant. There was no significant change found in spherical aberrations. The differences in entire coma and in internal coma were significant. There was no significant change found in corneal coma. With respect to trefoil, the only significant difference was in internal trefoil.
CONCLUSION: The ICL implantation corrects the refractive error successfully and changes entire and internal HOAs of the eye.]]></description>
<pubDate>2019/11/6 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Belma Kayhan, Efekan Coskunseven, Onurcan Sahin and Ioannis Pallikaris]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Belma Kayhan, Efekan Coskunseven, Onurcan Sahin and Ioannis Pallikaris</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191205]]></guid><cfi:id>559</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Impact of corneal parameters on intraocular pressure measurements in different tonometry methods]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191206]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the impact of central corneal thickness (CCT) and corneal curvature on intraocular pressure (IOP) measurements performed by three different tonometers.
METHODS: IOP in 132 healthy eyes of 66 participants was measured using three different tonometry techniques: Goldmann applanation tonometer (GAT), Pascal dynamic contour tonometer (DCT), and ICare rebound tonometer (RT). CCT and corneal curvature were assessed.
RESULTS: In healthy eyes, DCT presents significantly higher values of IOP than GAT (17.34±3.69 and 15.27±4.06 mm Hg, P<0.0001). RT measurements are significantly lower than GAT (13.56±4.33 mm Hg, P<0.0001). Compared with GAT, DCT presented on average 2.51 mm Hg higher values in eyes with CCT<600 μm and 0.99 mm Hg higher results in eyes with CCT≥600 μm. The RT results were lower on average by 1.61 and 1.95 mm Hg than those obtained by GAT, respectively. Positive correlations between CCT in eyes with CCT<600 μm were detected for all IOP measurement techniques, whereas a similar relationship was not observed in eyes with thicker corneas. A correlation between IOP values and keratometry in the group with CCT<600 μm was not detected with any of the tonometry methods. In thicker corneas, a positive correlation was found for GAT and mean keratometry values (R=0.369, P=0.005).
CONCLUSION: The same method should always be chosen for routine IOP control, and measurements obtained by different methods cannot be compared. All analysed tonometry methods are dependent on CCT; thus, CCT should be taken into consideration for both diagnostics and monitoring.]]></description>
<pubDate>2019/11/6 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Aleksandra Zakrzewska, Marta P. Wi&#261;cek and Anna Machalińska]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Aleksandra Zakrzewska, Marta P. Wi&#261;cek and Anna Machalińska</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191206]]></guid><cfi:id>558</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Long-term observation of vitrectomy without subretinal hemorrhage management for massive vitreous hemorrhage secondary to polypoidal choroidal vasculopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191207]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To describe the long-term observation of vitrectomy without subretinal hemorrhage (SRH) management for massive vitreous hemorrhage (VH) secondary to polypoidal choroidal vasculopathy (PCV).
METHODS: This is a retrospective, consecutive case series. A total of 86 eyes of 86 patients with >14d of massive VH associated with PCV were included. All patients underwent vitrectomy without SRH management, followed by intravitreal ranibizumab injections and/or photodynamic therapy (PDT) as needed. The main outcome measures were best-corrected visual acuity (BCVA), postoperative adverse events and the recurrence of VH.
RESULTS: The average follow-up period was 25.5±9.2mo (range 12-35mo). Mean BCVA at baseline (2.16±0.39 logMAR) had improved significantly, both 3mo after surgery (1.42±0.66 logMAR, P<0.001) and by the last visit (1.23±0.74 logMAR, P<0.001). The common postoperative complications included macular subretinal fibrosis in 14 eyes (16.3%) and ciliary body detachment in 4 eyes (4.7%). Nineteen eyes (22.1%) received following treatment with ranibizumab injections without/with PDT, and 15 (17.4%) were resolved. Four eyes (4.7%) had recurrent hemorrhage during the follow-up period. In multiple regression analysis, thicker SRH (beta=0.33, P=0.025) in the preoperative B-scan and the presence of foveal subretinal fibrosis (beta=0.28, P=0.018) in the follow up were associated with poor postoperative BCVA.
CONCLUSION: Vitrectomy without SRH management for massive VH secondary to PCV improved/stabilized visual function in the long-term observation. Eyes presenting with thicker SRH preoperatively and forming foveal subretinal fibrosis in the follow-up period tended to have worse BCVA.]]></description>
<pubDate>2019/11/6 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Zhi-Xi Li, Yi-Jun Hu, Alp Atik, Lin Lu and Jie Hu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zhi-Xi Li, Yi-Jun Hu, Alp Atik, Lin Lu and Jie Hu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191207]]></guid><cfi:id>557</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Chorioretinal response to intravitreal aflibercept injection in acute central serous chorioretinopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191208]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate chorioretinal responses to intravitreal aflibercept injection (IAI) in patients with acute central serous chorioretinopathy (CSC).
METHODS: Seventy-one eyes from 71 patients with symptomatic CSC for less than six months were included. Thirty-five eyes received a single IAI and 36 eyes were observed without treatment. Best-corrected visual acuity (BCVA), central subfield foveal thickness (CSFT), and subfoveal choroidal thickness (SFCT) were assessed at baseline and at 1, 2, and 3mo.
RESULTS: The mean SFCT in the IAI group decreased at 1mo, rebounded at 2mo and remained stable at 3mo compared to the baseline, while significant change was not noted in the observation group. The mean CSFT decreased significantly during the 3-month study period in both groups, and was significantly lower in the IAI group at 1mo (P<0.001). A rebound of CSFT between 1 and 2mo was noted in 14 eyes (40.0%) in the IAI group and in 1 eye (2.8%) in the observation group (P<0.001). The significant visual improvement was achieved from 1mo in the IAI group, and from 2mo in the observation group. The rate of complete absorption of subretinal fluid at 3mo did not differ between the two groups. (45.7% vs 41.7%, P=0.813).
CONCLUSION: A single IAI for acute CSC induce a transient decrease in SFCT and CSFT, which implies that IAI may have a pharmacological effect on the underlying hyperpermeable choroid in acute CSC.]]></description>
<pubDate>2019/11/6 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Byung Ju Jung, Kook Lee, Jin Hyung Park and Jae Hyung Lee]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Byung Ju Jung, Kook Lee, Jin Hyung Park and Jae Hyung Lee</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191208]]></guid><cfi:id>556</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Epiretinal membrane following pars plana vitrectomy for rhegmatogenous retinal detachment repair]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191209]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the rate and possible contributors for post-pars plana vitrectomy (PPV) epiretinal membrane (ERM) in patients treated for rhegmatogenous retinal detachment (RRD).
METHODS: This prospective, nonrandomized study comprised 47 consecutive patients (47 eyes) with acute RRD treated with 23 G post-PPV. All participants were followed prospectively for 6mo for the development of ERM using spectral domain optical coherence tomography. Preoperative and intraoperative data were collected by questionnaires to surgeons. Main outcome measure was the percentage of the ERM formation following post-PPV for RRD.
RESULTS: ERM developed postoperatively in 23 eyes (48.9%), none necessitated surgical removal. There was a statistically significant difference between patients with and without ERM postoperatively in preoperative best corrected visual acuity (median logMAR 1.9 vs 0.3, respectively; P=0.003) rate of macula-off (69.6% vs 37.5%, respectively, P=0.028), and rate of ≥5 cryo-applications (55.6% and 18.8%, respectively, P=0.039). ERM developed mainly between the 1st and 3rd months of follow-up. Macula-off status increased the risk of ERM, with the odds ratio of 3.81 (P=0.031).
CONCLUSION: ERM is a frequent post RRD finding, and its development is associated with macula-off RRD.]]></description>
<pubDate>2019/11/6 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ruti Sella, Amir Sternfeld, Ivan Budnik, Ruth Axer-Siegel and Rita Ehrlich]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ruti Sella, Amir Sternfeld, Ivan Budnik, Ruth Axer-Siegel and Rita Ehrlich</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191209]]></guid><cfi:id>555</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of anti-inflammatory effects of intense pulsed light with tobramycin/dexamethasone plus warm compress on dry eye associated meibomian gland dysfunction]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191107]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the anti-inflammatory effects of intense pulsed light (IPL) with tobramycin/dexamethasone plus warm compress through clinical signs and cytokines in tears.
METHODS: Eighty-two patients with dry eye disease (DED) associated meibomian gland dysfunction (MGD) were divided into two groups. Group A was treated with IPL, and Group B was treated with tobramycin/dexamethasone plus warm compress. Ocular Surface Disease Index (OSDI), tear film breakup time (TBUT), corneal fluorescein staining (CFS), meibomian gland expressibility (MGE), meibum quality, gland dropout and tear cytokine levels were evaluated before treatment, 1wk and 1mo after treatment.
RESULTS: TBUT in Group A was higher (P=0.035), and MGE score was lower than Group B at 1mo (P=0.001). The changes of interleukin (IL)-17A and IL-1β levels in tears were lower in Group A compared with that in Group B at 1wk after treatment (P=0.05, P=0.005).
CONCLUSION: Treatment with IPL can improve TBUT and MGE and downregulate levels of IL-17A and IL-1β in tears of patients with DED associated MGD better than treatment with tobramycin/dexamethasone plus warm compress in one-month treatment period.]]></description>
<pubDate>2019/10/8 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yu-Fei Gao, Rong-Jun Liu, Ya-Xin Li, Chenmilu Huang, Yi-Yun Liu, Chen-Xi Hu and Hong Qi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yu-Fei Gao, Rong-Jun Liu, Ya-Xin Li, Chenmilu Huang, Yi-Yun Liu, Chen-Xi Hu and Hong Qi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191107]]></guid><cfi:id>554</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Accelerated versus standard corneal cross linking in the treatment of ectasia post refractive surgery and penetrating keratoplasty: a medium term randomized trial]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191108]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the clinical outcomes of the standard corneal cross linking (CXL) and the accelerated CXL in patients with progressive corneal ectasia post refractive surgery and penetrating keratoplasty.
METHODS: Totally 120 eyes of 83 patients scheduled to receive either standard CXL (3 mW/cm2 for a period of 30min) or accelerated CXL (18 mW/cm2 for a period of 5min). The main outcomes for comparison were the change in: maximum-K reading (K-max), manifest refractive spherical equivalent (SE), central corneal thickness (CCT), and the best corrected distance visual acuity (CDVA).
RESULTS: One hundred and eleven eyes completed the study. The main outcome measurement was the K-max reading. Both group showed significant improvement in the value postoperatively at 6 and 12mo. The mean change in the standard group was 1.21±0.11 D and in the accelerated group was 0.90±0.05 D at the end of 12mo postoperatively, with no statistically significant difference between the 2 groups. Similarly, CDVA improved significantly from their preoperative value in the standard group by 2.98±0.11 letters, and in the accelerated group by 2.20±0.06 letters, with no statistically significant difference between the two groups. Both of the SE, and CCT showed no statistically significant difference at the end of follow up period in each group.
CONCLUSION: Both standard CXL and accelerated CXL are safe and effective treatment in halting ectasia after corneal refractive surgery. The accelerated CXL results are comparable to the standard CXL with short time exposure of the cornea to ultraviolet irradiation, leading to reduced operation time, reduced operative ocular discomfort, and corneal haze.]]></description>
<pubDate>2019/10/8 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hany A. Khairy, Moataz F. Elsawy, Khaled Said-Ahmed, Marwa A. Zaki and Sameh S Mandour]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hany A. Khairy, Moataz F. Elsawy, Khaled Said-Ahmed, Marwa A. Zaki and Sameh S Mandour</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191108]]></guid><cfi:id>553</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Trocar opening: silicone oil removal with phacoemulsification and intraocular lens implantation]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191109]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the efficacy and safety of a modified technique [trocar opening (TO)] for silicone oil removal (SOR) in combination with phacoemulsification and intraocular lens (IOL) implantation.
METHODS: A total of 60 eyes of 60 patients with cataract and silicone oil-filled eyes were enrolled in this study. The patients were divided into two groups: the patients in the control group underwent 23-gauge pars plana active SOR surgery with phacoemulsi?cation and IOL implantation, while the patients in the TO group underwent TO methods during surgery. Best corrected visual acuity (BCVA), surgery time, intraocular pressure, and operative complications were observed 6mo after surgery.
RESULTS: There was no significant difference between the two groups in terms of age, gender, preoperative, intraocular pressure, or time of silicone oil stay. Prior to surgery, the mean BCVA for the control and TO groups was 1.34±0.44 and 1.36±0.42. At 6mo following surgery, the mean BCVA improved to 0.74±0.36 and 0.77±0.32, respectively (P<0.001). There was no significant difference between the two groups. The mean SOR time was 6.9±2.3min and 4.8±1.2min in the control and TO groups (P=0.008). The total operation time was 28.2±8.5min and 24.6±6.4min, respectively (P=0.035). Posterior capsule rupture occurred in four eyes of control and none of TO group (P<0.01). Late recurrent retinal detachment occurred in one eye in the control group (2mo after surgery) and in one eye in the TO group (4mo after surgery).
CONCLUSION: TO is a simple, effective, time-saving, and safe method for SOR combined with phacoemulsification and IOL implantation.]]></description>
<pubDate>2019/10/8 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xu Zhang, Ya-Jie Pan and Zheng-Yu Song]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xu Zhang, Ya-Jie Pan and Zheng-Yu Song</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191109]]></guid><cfi:id>552</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of contrast sensitivity based on the surgical results for intermittent exotropia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191110]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare contrast sensitivity (CS) based on the surgical results for intermittent exotropia (IXT) and to examine the relationship between CS and photophobia.
METHODS: Medical records of the patients who underwent bilateral lateral rectus muscle recession for IXT between 4 and 12 years old were reviewed retrospectively. They were categorized based on the surgical results; successful correction group (n=36) and overcorrection group (esotropia ≥10 PD at 3mo postoperatively, n=18). Using CGT-2000 test for CS was performed binocularly, and subjective reports of photophobia was investigated preoperatively and at 3mo postoperatively. Objective photophobia was defined as a significant decrease in CS in the presence of glare.
RESULTS: Preoperatively, there was no difference in CS between the groups. Postoperatively, under mesopic conditions, significant improvement of CS was observed at 6.3°, 4°, and 2.5° in the successful correction group and at 6.3° and 4° in the overcorrection group, regardless of glare. Under photopic conditions, at all visual angles except 0.64°, improvement in CS was noted in both groups while CS worsened significantly at 0.64° in the overcorrection group postoperatively. At all visual angles under photopic conditions postoperatively, regardless of glare, CS in the overcorrected group was significantly worse than that in the successful correction group, and CS was significantly decreased by addition of glare in both groups. All patients except one (96.4%) in the successful correction group and 8 patients (61.5%) in overcorrection group showed improvement of photophobia postoperatively, which correlated with CS under photopic conditions (P=0.001, 0.03).
CONCLUSION: After surgery for IXT, CS under photopic conditions improve at all visual angles except 0.64°, while CS is significantly worse in the overcorrection group postoperatively at 0.64°. Subjective photophobia have significant correlation with CS under photopic conditions, and may be used as an objective indicator of photophobia.]]></description>
<pubDate>2019/10/8 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hae Rang Kim and Soo Jung Lee]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hae Rang Kim and Soo Jung Lee</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191110]]></guid><cfi:id>551</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical features and treatment outcomes of primary ocular adnexal mucosa-associated lymphoid tissue lymphoma: a single center retrospective analysis of 64 patients in China]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191111]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the clinical features, treatment and prognosis of primary ocular adnexal mucosa-associated lymphoid tissue lymphoma (POAML).
METHODS: A retrospective analysis was performed on 64 patients with POAML who were admitted to the First Affiliated Hospital of Zhengzhou University from January 2006 to December 2018.
RESULTS: With a median follow-up of 61mo (range, 2-156mo), estimated overall survival (OS) rate and progression-free survival (PFS) rate at 10y reached 94.5% and 61.5%, respectively. Median OS time and PFS time were not reached. During this period, only 3 patients died, but none of them died directly due to disease progression. One patient (1.6%) developed transformation to diffuse large B-cell lymphoma (DLBCL). Of the 56 patients achieved complete remission after first-line treatment, 5 (8.9%) developed local and/or systemic relapse eventually. Patients ≥60y had significantly shorter PFS than younger patients (P=0.01). For patients with early stages (Ann Arbor stage I and stage II), univariate analysis confirmed that radiotherapy dose lower than 32 Gy were independently associated with shorter PFS (P=0.04). Other factors including gender, bone marrow involvement, the initial location of the disease, and the laterality were not associated with PFS.
CONCLUSION: The data from our center indicate that POAML has a slow clinical progression and has an excellent clinical outcome. Patients with POAML harbor a continual risk of relaps and transformation to aggressive subtype of lymphoma.]]></description>
<pubDate>2019/10/8 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hui Yu, Yu-Xin Du, Zhen-Chang Sun, Xiao-Rui Fu, Nan Tan, Wei-Feng Gong and Ming-Zhi Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hui Yu, Yu-Xin Du, Zhen-Chang Sun, Xiao-Rui Fu, Nan Tan, Wei-Feng Gong and Ming-Zhi Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191111]]></guid><cfi:id>550</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[The effect of intravenous high-dose glucocorticoids and orbital decompression surgery on sight-threatening thyroid-associated ophthalmopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191112]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report the effects of intravenous high-dose glucocorticoids (ivGC) and orbital decompression (OD) surgery for treatment of sight-threatening thyroid-associated ophthalmopathy (TAO).
METHODS: A retrospective review of medical records from patients with sight-threatening TAO [definite or highly suspected dysthyroid optic neuropathy (DON)] treated with ivGC (60 cases) and OD (25 cases) was conducted at the Zhongshan Ophthalmic Center between January 2001 and January 2009. Patients were initially treated with ivGC (ivGC group). If no significant improvement in visual function was obtained, they then received OD surgery (OD group). The pre- versus post-treatment efficacies of either ivGC or OD in these patients were assessed using several indices, including visual acuity, intraocular pressure, ocular alignment, ocular motility, and exophthalmos.
RESULTS: Nighty-one eyes had definite DON while 79 were considered to have highly suspected DON. In the ivGC group, 51 individuals (85.0%) eventually demonstrated normal vision, while 10 patients (16.7%) demonstrated a reduction in deviation (P<0.01), and 35 cases (58.3%) showed slight improvements in ocular motility (P<0.01). In OD group, visual acuity improved in 24 cases (96.0%, P<0.01) and all patients showed varying reductions of exophthalmos (mean: 4.35±1.13 mm, P<0.01). Eight cases (32.0%) experienced an 8-15 PD reduction of deviation and ocular motility improved in 12 cases (48.0%), while 3 patients (12.0%) developed new-onset strabismus with diplopia post-surgically (P<0.01). Patients were followed up at an average of 1.55±1.07y.
CONCLUSION: Both ivGC and OD show good therapeutic efficacy in the treatment of sight-threatening TAO. The presence of extremely poor eyesight (≥0.5logMAR) was corrected in some patients with ivGC alone, thus sparing these patients from subsequent OD surgery. In patients who were refractory to steroids, subsequent OD surgery often provided satisfactory outcomes, however, new-onset strabismus with diplopia was observed in 12.0% of these cases.]]></description>
<pubDate>2019/10/8 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yun Wen and Jian-Hua Yan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yun Wen and Jian-Hua Yan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191112]]></guid><cfi:id>549</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Analysis of the effect of repair materials for orbital blowout fracture on complications]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191113]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the effect of repair materials for orbital blowout fractures on the occurrence of postoperative complications.
METHODS: The clinical data and follow-up data of 54 subjects with orbital blowout fractures were retrospectively analyzed. The study was divided into three groups according to the used repair materials: titanium mesh (16 cases), Medpor (12 cases), and Medpor titanium mesh (26 cases). All test data were analyzed using the SPSS version 23.0 statistical software. The mean age and duration of disease between the groups were compared through one-way analysis of variance. The Chi-square (χ2) test was used to compare the number of males and females, different fracture types, and different surgical approaches among groups. The χ2 test was used to compare the frequencies for complications in each group.
RESULTS: The baseline characteristics of age and gender in each group were matched (F=1.763, P=0.172; χ2=0.026, P=0.987). In addition, there was no difference in the type of fracture and surgical approach (χ2=0.460, P=0.977; χ2=0.691, P=0.952), or the incidence of complications (χ2=0.081, P=0.960) between the three groups.
CONCLUSION: Although there is no difference in effect of various repair materials on the incidence of complications,  the effect of repair materials on postoperative complications of orbital blowout fractures should not be ignored.]]></description>
<pubDate>2019/10/8 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Qi-Hua Xu, Jin-Hai Yu, Yao-Hua Wang, An-An Wang and Hong-Fei Liao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Qi-Hua Xu, Jin-Hai Yu, Yao-Hua Wang, An-An Wang and Hong-Fei Liao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191113]]></guid><cfi:id>548</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of ocular parameters of two biometric measurement devices in highly myopic eyes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191005]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the differences and agreement of ocular biometric parameters in highly myopic eyes obtained by optical biometric measurement instruments, the OA-2000 and IOLMaster 500.
METHODS: Totally, 90 patients (90 eyes) were included. They were divided into high myopia group and control group. Ocular parameters, including axial length (AL), mean keratometry (Km), anterior chamber depth (ACD), and white to white (WTW), were obtained from the OA-2000 and IOLMaster 500.
RESULTS: For the control group, we applied Bland-Altman graphs to assess the 95% limits of agreement (LoA) for most parameters including AL, ACD, Km, and WTW (-0.24 to 0.29 mm, -0.22 to 0.45 mm, -0.39 to 0.31 D, and -0.90 to 0.86 mm, respectively). In high myopia patients, AL, ACD, Km values had wider 95% LoA (-0.34 to 0.32 mm, -0.36 to 0.34 mm, -0.57 to 0.47 D, respectively), except WTW (-0.80 to 0.68 mm). Differences were not statistically significant between these two instruments (P>0.05).
CONCLUSION: Most parameters obtained by the OA-2000 and IOLMaster 500 are comparable, including the AL, ACD, and K values. Among them, the agreement of the high myopia patients is poor compared to the patients without high myopia.]]></description>
<pubDate>2019/9/2 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xiao-Xiao Guo, Ran You, Shan-Shan Li, Xiu-Fen Yang, Lu Zhao, Fan Zhang, Yan-Ling Wang and Xi Chen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiao-Xiao Guo, Ran You, Shan-Shan Li, Xiu-Fen Yang, Lu Zhao, Fan Zhang, Yan-Ling Wang and Xi Chen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191005]]></guid><cfi:id>547</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Changes of tear film lipid layer thickness by 3% diquafosol ophthalmic solutions in patients with dry eye syndrome]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191006]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the quantitatively changes in lipid layer thickness (LLT) when 3% diquafosol eye drop is used for dry eye patients using the tear film interferometer.
METHODS: A total 124 participants (32 males, 92 females; mean age, 28.9y) diagnosed with dry eye disease (DED) received topical instillation of 4 ophthalmic solutions in one eye: diquafosol, normal saline, 0.1% sodium hyaluronate and 0.3% gatifloxacin, in a masked manner. LLT was measured using an interferometer at baseline and 20min after the instillation of each ophthalmic solutions.
RESULTS: Changes of LLT after instillation (nm, mean± standard error) were as follows: 12.6±2.0 for diquafosol (P<0.001), 1.2±2.2 for normal saline (P=0.301), 1.5±2.0 for hyaluronate (P=0.495), and 0.5±3.2 for gatifloxacin (P=0.884).
CONCLUSION: Topical instillation of diquafosol increases tear film LLT in DED patients. Diquafosol 3% eye drop might be effective treatment option of evaporative DED with meibomian gland dysfunction.]]></description>
<pubDate>2019/9/2 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Dong-Hyun Kang, Yong-Woo Lee, Kyu-Yeon Hwang, Kyung-Min Koh, Young-A Kwon, Byung-Yeop Kim, Sang-Wroul Song and Kook-Young Kim]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Dong-Hyun Kang, Yong-Woo Lee, Kyu-Yeon Hwang, Kyung-Min Koh, Young-A Kwon, Byung-Yeop Kim, Sang-Wroul Song and Kook-Young Kim</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191006]]></guid><cfi:id>546</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Accuracy of corneal astigmatism correction with two Barrett Toric calculation methods]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191007]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the prediction error between Barrett Toric calculator and the new online AcrySof Toric calculator which incorporated Barrett astigmatism algorithm in Chinese cataract eyes with normal axial length and anterior chamber depth (ACD).
METHODS: Prospective case-control study. All the cases had axial length (21-26 mm) with ACD no less than 2.4 mm. Keratometric values were measured by LenSTAR 900. The Barrett Toric calculator was used in group 1. In group 2, SRK-T formula was used to determine the spherical power of the Toric lens, and subsequent calculation of the cylinder type was performed using the new online Alcon Toric calculator. At 1 and 3mo after surgery, a comprehensive subjective optometry was performed. The predicted residual astigmatism calculated by the two calculators was compared with that obtained by postoperative refraction, and the difference was defined as the astigmatism correction error [error of refractive astigmatism (ERA)]. The error magnitude (EM) refers to the algebraic deviation of ERA, and the error vector (EV) indicates the vector deviation of ERA. The influence of the two calculation methods on the correction accuracy of toric IOL was quantitatively analyzed.
RESULTS: The |EM| obtained at 1mo after surgery were 0.21±0.12 D, 0.22±0.18 D in group 1 and group 2 respectively, and correspondingly turned to be 0.19±0.13 D, 0.20±0.19 D at 3mo after surgery, with no statistical difference (P=0.633, P=0.877). The vector analysis showed that |EV| values in two groups at 1mo after surgery were 0.29±0.14@105 (D@angle) and 0.35±0.20@113 (D@angle), respectively, whereas |EV| values 3mo after surgery were 0.27±0.16@86 (D@angle) and 0.32±0.23@102 (D@angle), respectively. The differences between the groups were not statistically significant (P=0.119, P=0.261).
CONCLUSION: The clinical effect of Barrett Toric calculator has a much more accurate tendency than that of new online AcrySof Toric calculator, but is not evident in cases with normal axial length and normal anterior posterior ratio.]]></description>
<pubDate>2019/9/2 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jun Yang, Hong Zhang, Xiao-Tong Yang, Fang Tian and Shao-Zhen Zhao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jun Yang, Hong Zhang, Xiao-Tong Yang, Fang Tian and Shao-Zhen Zhao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191007]]></guid><cfi:id>545</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Postoperative adjunctive bevacizumab versus placebo in primary trabeculectomy surgery for glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191008]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the effectiveness of postoperative adjunctive use of subconjunctival bevacizumab in altering the outcome of primary trabeculectomy in terms of sustained lowering of intraocular pressure (IOP) and reduction of postoperative bleb vascularization and fibrosis.
METHODS: A prospective, one center, randomized, placebo-control study. Fifty-nine patients (59 eyes) with uncontrolled IOP under maximal tolerated medical treatment (MTMT) were recruited. A primary trabeculectomy with mitomycin C (MMC) was done and the patients were randomized to either postoperative subconjunctival injection of bevacizumab (1.25 mg/0.05 mL) or balanced salt solution (BSS). Forty-seven patients (47 eyes) completed at least one year of follow up and were included in the study. The main outcome measure was the IOP, and secondary outcome measures include bleb morphology, vascularization, and fibrosis, as well as the need for glaucoma medications and 5-fluorouracil (5-FU) needling.
RESULTS: At 1-year follow up, there was no significant difference between groups for IOP (P=0.65), bleb morphology (P=0.65), and the need for glaucoma medications (P=0.65) or 5-FU needling requirements (P=0.11). However, the bevacizumab group had a higher rate of success results, lower use of glaucoma medications after surgery, and optimal bleb aspect in more patients, but more 5-FU needling procedures required.
CONCLUSION: A bigger sample size is needed in order to determine whether the differences found in the bevacizumab group are statistically significant.]]></description>
<pubDate>2019/9/2 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Sana’ Muhsen, Javiera Compan, Tze Lai, Christoph Kranemann and Catherine Birt]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Sana’ Muhsen, Javiera Compan, Tze Lai, Christoph Kranemann and Catherine Birt</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191008]]></guid><cfi:id>544</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Early outcomes of vision and objective visual quality analysis after cataract surgery with trifocal intraocular lens implantation]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191009]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the early outcomes of vision, objective visual quality and their correlation after cataract surgery with trifocal intraocular lens implantation.
METHODS: The visual examination and objective visual quality analysis using Optical Quality Analysis System (OQAS) at 1mo and 3mo, and defocus curve examination at 3mo were performed in 20 patients (27 eyes) after phacoemulsification combined with trifocal intraocular lens implantation surgery.
RESULTS: The uncorrected distant (UD), intermediate and near visual acuity (VA) were significantly improved after surgery (P<0.001). UDVA at 1mo after the surgery was slightly better than that after 3mo (P=0.026). The defocus curve after 3mo indicated that the peak of distant vision was close to 0 logMAR, and UDVA was lower than 0.3 logMAR in the range of -1.5 D to -3.0 D. The modulation transfer function (MTF) cutoff frequency, strehl ratio (SR), Optical Quality Analysis System values (OVs), includes OV100, OV20 and OV9 after the surgery were significantly better than before surgery (P<0.001), but the objective scattering index (OSI) was significantly decreased (P<0.001). UDVA at 3mo after the surgery had correlations with MTF cutoff, OSI, OV100 and OV20 (r=-0.400, 0.431, -0.437, -0.411, P=0.039, 0.025, 0.023, 0.033). The uncorrected intermediate VA after 3mo of the surgery had correlations with OSI and OV100 (r=0.478, -0.411, P=0.012, 0.033).
CONCLUSION: Trifocal intraocular lens implantation can provide good distant, intermediate and near VA, and the vision shows a well correlation with objective visual quality during early surgery.]]></description>
<pubDate>2019/9/2 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mei-Fang Chu, Na Hui, Cong-Yi Wang, Lei Yu, Bo Ma, Yan Li and Cheng Pei]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mei-Fang Chu, Na Hui, Cong-Yi Wang, Lei Yu, Bo Ma, Yan Li and Cheng Pei</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191009]]></guid><cfi:id>543</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Incomplete fluid-air exchange technique for idiopathic macular hole surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191010]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To explore an improved procedure involving incomplete fluid-air exchange for idiopathic macular hole (IMH), and the closure rate, visual function, and the visual field of macular holes (MHs) were evaluated.
METHODS: This prospective randomized controlled study, included 40 eyes of 40 patients with IMH who were treated with pars plana vitrectomy and peeling of the internal limiting membrane. They were grouped by random digital table. Twenty-one eyes underwent incomplete fluid-air exchange (IFA) and 19 eyes underwent traditional complete fluid-air exchange (CFA) as the control group. Outcomes included best-corrected visual acuity (BCVA), intraocular pressure, and optical coherence tomography, light adaptive electroretinography, and visual field evaluations.
RESULTS: All MHs <400 μm were successfully closed. BCVAs before and 6mo after surgery were 0.82±0.41 logMAR and 0.28±0.17 logMAR in IFA group and 0.86±0.34 logMAR and 0.34±0.23 logMAR in CFA group, respectively. The electroretinogram analysis of patients in IFA group revealed increases in b-wave amplitudes at 1, 3, and 6mo after surgery. Additionally, patients in IFA group showed an amplitude increase of 28.6% from baseline at 6mo (P<0.05), while no obvious improvements were noted in CFA group. Although there were no statistically significant improvements in either group, the IFA group showed a slight increase in mean sensitivity (P>0.05).
CONCLUSION: IFA is a reliable method that offers comparable closure rate to CFA and facilitates improvements in visual function.]]></description>
<pubDate>2019/9/2 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Bo-Jie Hu, Xue-Li Du, Wen-Bo Li, Yu-Wen Chang, Xing-Dong Shi, Teng Ma, Yong Wang, Yan-Hua He, Rui Niu and Wei-Na Cui]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Bo-Jie Hu, Xue-Li Du, Wen-Bo Li, Yu-Wen Chang, Xing-Dong Shi, Teng Ma, Yong Wang, Yan-Hua He, Rui Niu and Wei-Na Cui</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191010]]></guid><cfi:id>542</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Anatomical and functional changes after dexamethasone implant and ranibizumab in diabetic macular edema: a retrospective cohort study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191011]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the efficacy and safety of ranibizumab (RZB group) and dexamethasone implant (DEX group) intravitreal treatments in patients with treatment-na&iuml;ve center involved diabetic macular edema (DME) by means of functional and morphological assessments.
METHODS: This retrospective cohort study included 50 eyes of 50 patients with DME treated either with RBZ or DEX. Best-corrected visual acuity (BCVA) and microperimetry were evaluated at baseline and during a 6-month follow-up. In addition, central macular thickness (CMT) by means of structural optical coherence tomography (OCT) and retinal capillary plexus density and choriocapillary density by means of OCT angiography were assessed in all cases.
RESULTS: Functional and morphological parameters significantly improved during the study period in both groups. BCVA improved significantly in both groups with a greater increase in the DEX group compared to the RBZ group (P=0.030). Microperimetry significantly differed during follow-up between the two treatments (P=0.031). In both groups CMT significantly decreased (P<0.001) without statistically significant differences between the two groups. A statistically significant increase of deep capillary plexus density was detected in both groups at 30d after therapy. The retreatment rate was 0.70±0.10 and 0.65±0.10 in the RBZ group and 0.65±0.10 and 0.50±0.11 in DEX group at 120 and 180d respectively. Two out of 25 patients in DEX group showed intraocular pressure increase requiring hypotonic eye drops.
CONCLUSION: Both treatments are very effective for DME treatment during 6mo of follow-up with a lower retreatment rate in DEX group.]]></description>
<pubDate>2019/9/2 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Leonardo Mastropasqua, Silvio Di Staso, Rossella D’Aloisio, Alessandra Mastropasqua, Luca Di Antonio, Alfonso Senatore, Marco Ciancaglini, Marta Di Nicola, Giuseppe Di Martino, Daniele Tognetto and Lisa Toto]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Leonardo Mastropasqua, Silvio Di Staso, Rossella D’Aloisio, Alessandra Mastropasqua, Luca Di Antonio, Alfonso Senatore, Marco Ciancaglini, Marta Di Nicola, Giuseppe Di Martino, Daniele Tognetto and Lisa Toto</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191011]]></guid><cfi:id>541</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Association of urinary albumin excretion with central foveal thickness and intravitreal conbercept treatment frequency in patients with diabetic macular edema]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191012]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the effect of albuminuria on diabetic macular edema (DME) and the possible association between baseline urinary albumin excretion (UAE) and intravitreal conbercept (IVC) treatment frequency in DME patients.
METHODS: In this hospital-based retrospective study, a total of 350 in-patients with type 2 diabetes mellitus were recruited and their clinical records were reviewed. Thereafter, 52 patients identified with severe non-proliferative diabetic retinopathy (NPDR) combined with albuminuria were divided into the microalbuminuria (UAE 30-300 mg/24h) and macroalbuminuria (UAE>300 mg/24h) groups, which were compared and analyzed by both independent sample t-test and Chi-square test. Correlations between the systemic variables and the central foveal thickness (CFT) were evaluated using Spearman’s correlation and linear regression analyses. Of the 52 patients with center-involved DME, 43 received an initial combined injection of conbercept (0.5 mg/0.05 mL) and triamcinolone acetonide (1 mg/0.05 mL), followed by an IVC injection, as needed. The relationship between baseline UAE and number of IVC injections during the first year of treatment was analyzed using Spearman’s partial correlation.
RESULTS: Of 350 patients, a higher incidence of DME was observed in severe non-proliferative retinopathy (NPDR) patients than that observed in other groups. By dividing the 52 patients with severe NPDR into the micro- and macro-albuminuria subgroups, significant differences in CFT, systolic blood pressure, total cholesterol and serum creatinine levels, and UAE were revealed. Furthermore, a positive liner correlation between the UAE and CFT was found. Finally, the partial correlation coefficient adjusted for either the CFT or UAE indicated that both parameters directly correlated with the number of IVC injections administered during the 12mo of follow-up.
CONCLUSION: Generally, macular edema occurred in patients with severe NPDR, for whom the UAE is an independent risk predictor of DME. The baseline UAE and CFT predicted the treatment frequency of IVC injections administered in the first year for eyes with DME.]]></description>
<pubDate>2019/9/2 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Zi-Yao Liu, Xiao-Jie Ma, Ding-Ying Liao, Xin-Di Liu, Ling Bai, Jing Yao, Min Xu and Yu-Ping Zheng]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zi-Yao Liu, Xiao-Jie Ma, Ding-Ying Liao, Xin-Di Liu, Ling Bai, Jing Yao, Min Xu and Yu-Ping Zheng</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20191012]]></guid><cfi:id>540</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Crosslinked hyaluronic acid with liposomes and crocin for management symptoms of dry eye disease caused by moderate meibomian gland dysfunction]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200905]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To study the effect of uncrosslinked and crosslinked hyaluronic acid combined with other artificial tear components in patients with dry eye caused by moderate meibomian gland dysfunction.
METHODS: Prospective, single-blind, contralateral eye study. Fifty eyes (25 patients) were analyzed. Eye selection for each tear type was random, and the eye drop formulations, 0.4% uncrosslinked hyaluronic acid and 0.2% galactoxyloglucan (tear A) and 0.15% crosslinked hyaluronic acid, crocin, and liposomes (tear B) were used. The determined dosing schedule was three times a day for six weeks, and the study participants underwent a clinical examination before and 45d after lubricant treatment. The Schirmer test, tear breakup time (TBUT) test, and Ocular Surface Disease Index (OSDI) questionnaire were applied before and after instillation period with both types of artificial tears.
RESULTS: On the Schirmer test, a significant improvement was obtained with both tear A (P<0.01) and tear B (P<0.01). On the TBUT test, a significant improvement was obtained with tear A (P<0.01) and tear B (P<0.01). The OSDI score significantly decreased after instillation period with both artificial tear types (P<0.01).
CONCLUSION: Uncrosslinked hyaluronic acid combined with other components, such as tamarind seed polysaccharide, and crosslinked hyaluronic acid combined with liposomes and crocin are effective for management symptoms of dry eye disease.]]></description>
<pubDate>2020/7/21 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[José-María Sánchez-González, Concepción De-Hita-Cantalejo and María Carmen Sánchez-González]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>José-María Sánchez-González, Concepción De-Hita-Cantalejo and María Carmen Sánchez-González</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200905]]></guid><cfi:id>539</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A 5-year analysis of endothelial vs penetrating keratoplasty graft survival in Chinese patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200906]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine if there is any difference in long term graft survival between Descemet’s stripping endothelial keratoplasty (DSEK) and penetrating keratoplasty (PK).
METHODS: A retrospective 5-year cases analysis of bullous keratopathy secondary to Fuchs’ endothelial dystrophy or pseudophakic bullous keratopathy, receiving either DSEK or PK. A total of 42 DSEK cases and 25 PK cases were included in the analysis.
RESULTS: In the 5-year analysis, graft survival rates were very similar in the two groups (DSEK 77.1% vs PK 76.0%, P=0.918, 95%CI: -6.3 to 33.4). Sub-analyses at 1y (DSEK 81% vs PK 95%, P=0.085, 95%CI: -29 to 3.6) and 2y (DSEK 81% vs PK 88%, P=0.381, 95%CI: -25.9 to 11.8) show a trend towards lower survival rates of DSEK vs PK, but the results were not statistically significant.
CONCLUSION: Long term 5-year graft survival is similar between the DSEK and PK methods of corneal transplant in Chinese patients with bullous keratopathy.]]></description>
<pubDate>2020/7/21 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Anita Lai Wah Li, Rachel Pui Wai Kwok, Ka Wai Kam and Alvin Lerrmann Young]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Anita Lai Wah Li, Rachel Pui Wai Kwok, Ka Wai Kam and Alvin Lerrmann Young</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200906]]></guid><cfi:id>538</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Accuracy of eight intraocular lens power calculation formulas for segmented multifocal intraocular lens]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200907]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the accuracy of eight different intraocular lens (IOL) power calculation formulas for a segmented multifocal IOL.
METHODS: A total of 53 eyes of 41 adult cataract patients who underwent phacoemulsification and implantation with the SBL-3 segmented multifocal IOL between January 1, 2017 and January 31, 2019 were included in this retrospective study. Preoperative biometry measurements were obtained using an IOL Master. Manifest refraction was performed at least 4wk postoperatively. Accuracy of the eight formulas [Barrett Universal II, Emmetropia Verifying Optical (EVO), Haigis, Hill-RBF 2.0, Hoffer Q, Holladay 1, Kane, and SRK/T] was analyzed.
RESULTS: Using current lens constants, all formulas exhibited errors of slight myopic shift in refractive prediction. The Barrett Universal II formula had a significantly lower median absolute error (MedAE) than did Holladay 1 (P=0.02), Kane (P=0.001) and Hill-RBF 2.0 (P<0.001) formulas. The Haigis formula had a lower MedAE value than did the Hill-RBF 2.0 formula (P=0.005). Differences in MedAE values among SRK/T, EVO and Hoffer Q formulas were not significant. After optimizing lens constants, the MedAE values of all formulas were reduced; significant changes were noted for EVO (P=0.022), Haigis (P=0.048), Hill-RBF 2.0 (P=0.014), Holladay 1 (P=0.045) and Kane (P=0.022) formulas. All formulas performed equally well after optimization of lens constants (P=0.203).
CONCLUSION: All eight formulas tend to result in a myopic shift when using current lens constants. Optimized lens constants improve the accuracy of these formulas among adult Chinese patients.]]></description>
<pubDate>2020/7/21 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jing Zhao, Liang-Ping Liu, Huan-Huan Cheng, Jian-Bing Li, Xiao-Tong Han, Yu Liu and Ming-Xing Wu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jing Zhao, Liang-Ping Liu, Huan-Huan Cheng, Jian-Bing Li, Xiao-Tong Han, Yu Liu and Ming-Xing Wu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200907]]></guid><cfi:id>537</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Combined phacoemulsification and goniosynechialysis with or without endoscopic cyclophotocoagulation in the treatment of PACG with cataract]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200908]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the efficacy and safety of combined phacoemulsification and goniosynechialysis with or without endoscopic cyclophotocoagulation (PGE group and PG group) for the treatment of patients with coexisting primary angle-closure glaucoma (PACG) and cataracts.
METHODS: The clinical data of patients with PACG and cataract were retrospectively reviewed. There was a total of 88 eyes in the study and were divided into two groups, 42 eyes in PGE group and 46 eyes in PG group. Surgery success cumulative survival, preoperative and postoperative intraocular pressure (IOP), number of IOP-lowering medications, best corrected visual acuity (BCVA) in the two groups were observed for more than 12mo and compared within each group and between two groups.
RESULTS: The mean IOP in PGE group declined from 24.9 mm Hg preoperatively to 14.1 mm Hg at the first month after operation (P<0.001) and at the last visit 16.2 mm Hg (P<0.001). Meanwhile PG group also showed significant decrease, from 24.1 mm Hg preoperatively to 13.0 mm Hg at 1mo after operation (P<0.001) and 15.3 mm Hg at the last visit (P=0.004). The mean medications reliance reduced in both groups, in PGE group was reduced from 1.62 preoperatively to 0.13 at the last visit (P<0.001), in PG group from 0.87 to 0.10 (P<0.001). At the last visit, BCVA increased from 0.21 to 0.60 in PGE group (P<0.001) and from 0.24 to 0.67 in PG group (P<0.001). The success rate of PGE group at 1mo was 95.2%, then decreased to 70.7% at the last visit, whereas in PG group, the success rate at 1mo was 100%, at the last visit was 73.4%.
CONCLUSION: PGE shows promise for PACG patients with cataracts to reduce IOP, lighten the medication burden and improve visual acuity, and PG still has its value in specific patients.]]></description>
<pubDate>2020/7/21 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Wan-Shu Zhou, Wen-Xiang Lin, Yun-Yun Geng and Tao Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Wan-Shu Zhou, Wen-Xiang Lin, Yun-Yun Geng and Tao Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200908]]></guid><cfi:id>536</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Efficacy and safety of high-dose ultrasound cyclo-plasty procedure in refractory glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200909]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the efficacy and safety of high-dose ultrasound cyclo-plasty (UCP) for the treatment of refractory glaucoma in Chinese patients.
METHODS: In this 6-month retrospective study, 37 eyes of 37 patients suffering from severe glaucoma with uncontrolled intraocular pressure (IOP) of ≥21 mm Hg underwent 8-s ultrasonic cyclocoagulation with ten active piezoelectric elements. A complete ophthalmic examination was performed before and at 1d, 1, 3, 6mo after UCP. Therapeutic success was defined as IOP reduction from baseline ≥20% and IOP ≥5 mm Hg without adding new glaucoma medication compare to baseline at the 6-month follow-up visit. In addition to mean IOP at each follow-up visit, medications used and complications were also detected and compared to baseline.
RESULTS: After UCP procedure, the mean IOP was significantly reduced (P<0.01) from the preoperative 44.1±11.9 mm Hg to postoperative 26.7±11.8 mm Hg at 3mo, and 30.4±14.5 mm Hg at 6mo. The overall mean IOP reductions achieved at 3 and 6mo were 39% and 31% compared to baseline IOP. Sixty-one percent of patients responded well to UCP treatment with a mean IOP reduction of 48% at 3mo and 42% at 6mo. Ocular pain in most of patients were alleviated. No serious intraoperative or postoperative complications occurred.
CONCLUSION: High-dose UCP treatment is an effective and safe procedure to reduce IOP in Chinese patients with severe glaucoma.]]></description>
<pubDate>2020/7/21 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[He-Ting Liu, Qing Zhang, Zheng-Xuan Jiang, Yu-Xin Xu, Qian-Qian Wan and Li-Ming Tao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>He-Ting Liu, Qing Zhang, Zheng-Xuan Jiang, Yu-Xin Xu, Qian-Qian Wan and Li-Ming Tao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200909]]></guid><cfi:id>535</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Improved thickness measurement method for choroidal hyperpermeability in central serous chorioretinopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200910]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To observe choroidal thickness changes in the choroidal hyperpermeability area (CHA) in patients with central serous chorioretinopathy (CSC) after photodynamic therapy (PDT) using indocyanine green angiography (ICGA) combined with optical coherence tomography (OCT).
METHODS: This was a cohort study of 17 eyes (17 patients) with CSC. In all patients, the range of CHA was determined by ICGA. The patients were divided into two groups based on CHA covered the fovea (group A) or not (group B). All patients received half-dose verteporfin PDT over CHA in ICGA. Choroidal thickness was measured by OCT before, 1, and 3mo after treatment. The choroidal thickness values of the fovea and CHAs were obtained for each measurement. Secondary outcomes were changes in the best-corrected visual acuity (BCVA) and amount of subretinal fluid (SRF).
RESULTS: The differences in center choroidal thickness at baseline and at 1 and 3mo post-PDT were statistically significant in group A and all patients (both P<0.001). There was no significant difference in group B (P=0.059). The differences of thickness of CHA and BCVA at baseline and 1 and 3mo post-PDT were statistically significant in group A, group B, and all patients (all P<0.01). All patients showed complete SRF absorption at 3mo post-PDT.
CONCLUSION: Center choroidal thickness does not accurately reflect changes in CHA of patients whose CHA does not covered the fovea center. Using CHA as the observation target can make up for this limitation, expand the scope of application, and reduce bias.]]></description>
<pubDate>2020/7/21 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xing-Wang Chen, Fang-Yuan Han, Gang Su, Le Pan and Shan-Jun Cai]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xing-Wang Chen, Fang-Yuan Han, Gang Su, Le Pan and Shan-Jun Cai</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200910]]></guid><cfi:id>534</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Efficacy of the subthreshold micropulse yellow wavelength laser photostimulation in the treatment of chronic central serous chorioretinopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200911]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the efficacy and safety of subthreshold micropulse yellow laser (SMYL) in the treatment of chronic central serous chorioretinopathy (CCSC).
METHODS: The medical records of 58 eyes of 58 patients with CCSC were reviewed. A 577-nm SMYL system was used for the treatment. Fundus fluorescein angiography was used as the primary method of identifying CCSC, and resolution of subretinal fluid (SRF) evaluated by optical coherence tomography (OCT) and fundus autofluorescence. Central macular thickness (CMT), central macular volume (CMV), total macular volume (TMV), subfoveal choroidal thickness (SFCT), subretinal fluid height (SRFH), and subfoveal fluid basement diameter values were measured by spectral domain-OCT (SD-OCT) for all eyes.
RESULTS: The mean age of the patients was 42.4±9.9 (range: 20-72)y. The mean follow-up was 11.4±8.5 (range: 6-37)mo. Median BCVA at at the final follow up after treatment was statistically significant from the baseline. Complete SRF resolution was 12.1% of the eyes in the 1st month, 67.2% of the eyes in the 3rd month and 67.2% of the eyes in the last follow up. The initial median CMT, CMV, TMV, and SFCT values before treatment was significantly higher than 3rd month visit values (P<0.001). In the multivariate analysis performed, age and disease duration were found to be a risk factor for persistent SRF (P=0.017, P=0.016, respectively).
CONCLUSION: SMYL treatment provides a significant anatomical and functional improvement and is effective in eliminating SRF in eyes with CCSC.]]></description>
<pubDate>2020/7/21 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mehmed Ugur Isik, Mehmet Fatih Kagan Degirmenci and Ayhan Saglik]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mehmed Ugur Isik, Mehmet Fatih Kagan Degirmenci and Ayhan Saglik</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200911]]></guid><cfi:id>533</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Risk factors for an atherothrombotic event in patients with diabetic macular edema treated with intravitreal injections of bevacizumab]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200912]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To identify risk factors for an atherothrombotic event (ATE) among patients who were treated for diabetic macular edema (DME) with intravitreal bevacizumab injections.
METHODS: This retrospective study enrolled all consecutive patients with DME who were treated by intravitreal bevacizumab from 2009 through 2016 in a single center. They were divided into one group treated by bevacizumab and subsequently had an ATE and a second group also treated by bevacizumab and did not have an ATE.
RESULTS: A total of 455 patients with DME were enrolled. Seventy-two of the patients had an ATE. A multivariate model adjusted for age, gender, smoking, body mass index, hemoglobin A1c (HbA1c), duration of diabetes, creatinine, and blood pressure revealed an increased risk for ATE in the patients with diabetic duration of more than 13y, a systolic blood pressure over 153.5 mm Hg at first treatment, or having been treated by more than 4 intravitreal bevacizumab injections. Additionally, patients that had an ATE within 3mo from the last intravitreal treatment underwent more bevacizumab injections (5.2±3.4 vs 3.07±1.86; P<0.001).
CONCLUSION: The risk factors for an ATE identified in this study are systolic blood pressure >153.5 mm Hg, a history of diabetic mellitus for more than 13y, and treatment with more than 4 intravitreal bevacizumab injections. These factors need to be borne in mind when bevacizumab is being considered in the management of patients with DME.]]></description>
<pubDate>2020/7/21 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Alon Tiosano, Aviel Hadad and Noam Yanculovic]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Alon Tiosano, Aviel Hadad and Noam Yanculovic</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200912]]></guid><cfi:id>532</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Vitrectomy with air tamponade for surgical repair of rhegmatogenous retinal detachment by eye position guided fluid-air exchange]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200913]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To observe the efficacy and safety of pars plana vitrectomy (PPV) with eye position guided fluid-air exchange (FAX) and air tamponade in the treatment of rhegmatogenous retinal detachment (RRD).
METHODS: RRD patients without severe proliferative vitreoretinopathy (PVR) C1 or more were enrolled. All patients underwent PPV combining with air tamponade. During operation, the primary retinal break(s) were placed at lower site and subretinal fluid was aspirated through the break(s) at the same time when eye position guided FAX was proceeding. Sufficient laser spots were made to seal the retinal break(s) after FAX, and filtered air was left in vitreous cavity as tamponade agent finally. The main outcomes were primary and final success rates, best corrected visual acuity (BCVA), and the secondary outcomes were rate of postoperative cataract surgery and high intraocular pressure.
RESULTS: A total of 37 eyes (20 males and 17 females) with a follow-up time of ≥6mo were included. The range of RRD was 5.6±1.8h, and the number of retinal breaks was 1.9±1.2. The breaks located at inferior quadrants (between 3:00 and 9:00) in 5 cases (13.5%), and both superior and inferior breaks were found in 3 cases (8.1%). A total of 25 cases (67.6%) with macular detached involvement, 9 cases (24.3%) with intraocular lens, and 8 patients (21.6%) were treated with phacoemulsification and intraocular lens implantation together. The success rate of primary retinal reattachment was 100% (37/37). At 6mo postoperatively, BCVA (logMAR) was increased from 1.13±1.07 to 0.23±0.15 (P<0.001). Phacoemulsification combined with intraocular lens implantation was performed in 2 patients (5.4%), and one of them underwent macular epiretinal membrane peeling in addition (2.7%). Furthermore, high intraocular pressure was found in 4 cases (10.8%).
CONCLUSION: PPV with air tamponade by eye position guided FAX can achieve a high reattachment success rate in the management of patients with RRD, and it has the advantages of short postoperative prone time and fewer operative complications.]]></description>
<pubDate>2020/7/21 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yu-Hong Cheng, Hua Wang, Bo Li, Meng Ji, Qiang Shi, Yun Qi, Ya-Guang Hu, An-Ming Xie and Cheng Pei]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yu-Hong Cheng, Hua Wang, Bo Li, Meng Ji, Qiang Shi, Yun Qi, Ya-Guang Hu, An-Ming Xie and Cheng Pei</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200913]]></guid><cfi:id>531</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Umbilical cord derived mesenchymal stem cell implantation in retinitis pigmentosa: a 6-month follow-up results of a phase 3 trial]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200914]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the efficacy and the safety of umbilical cord derived mesenchymal stem cell (UC-MSC) implantation in patients with retinitis pigmentosa (RP).
METHODS: This prospective, single-center, phase 3 clinical study enrolled 124 eyes of 82 RP patients. The patients received 5 million UC-MSCs to the suprachoroidal area with a surgical procedure. Patients were evaluated on the 1st day, 1st, and 6th months postoperatively. Best corrected visual acuity (BCVA), anterior segment and fundus examinations, color photography, optical coherence tomography (OCT), and visual ?eld (VF) tests were carried out at each visit. Fundus ?uorescein angiography (FFA) and multifocal electroretinography (mfERG) recordings were performed at the end of the 6th month. Ocular and systemic adverse events of the surgical procedure were also noted.
RESULTS: All of the 82 patients completed the 6-month follow-up period. None of them had any serious systemic or ocular complications. There were statistically significant improvements in BCVA and VF during the study (all P<0.05). The amplitudes of the P1 waves in the central areas showed significant improvements in mfERG recordings. There were also significant increases in implicit times of P1 waves in the central areas.
CONCLUSION: Suprachoroidal administration of UC-MSCs has beneficial effect on BCVA, VF, and mfERG measurements during the 6-month follow-up period. Cell mediated therapy based on the secretion of growth factors (GFs) seems to be an effective and safe option for degenerative retinal diseases.]]></description>
<pubDate>2020/7/21 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Neslihan Sinim Kahraman and Ayse Oner]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Neslihan Sinim Kahraman and Ayse Oner</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200914]]></guid><cfi:id>530</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Choroidal changes in eyes treated with high-dose systemic corticosteroids for optic neuritis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200915]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyze the effect of systemic high-dose corticosteroid on the choroid in patients with unilateral optic neuritis.
METHODS: A retrospective comparative cohort study. Seventy-six eyes of 38 patients with unilateral optic neuritis that received systemic high-dose corticosteroid treatment were enrolled. Choroidal thickness (CT) and choroidal vascularity index (CVI) were measured in both affected and the fellow eyes at baseline, 1wk, 1 and 3mo. Changes in CT and CVI were analyzed in both eyes and compared between eyes.
RESULTS: The mean CT and CVI were 349 μm and 0.70 in the affected eyes and 340 μm and 0.69 in the fellow eyes at baseline (P=0.503 and 0.440, respectively). Decrement of CT and CVI at month 3 were significant in affected eyes (P=0.017 and P<0.001). Decreased CVI began 2wk after treatment whereas CT decreased from 1mo. The CVI also decreased significantly in fellow eyes at 3mo compared to the baseline (P=0.001).
CONCLUSION: A significant decrement in CT and CVI can appear after 3mo in optic neuritis patients treated with high-dose systemic corticosteroid treatment. The decrease in CVI appeared earlier than the decrease in CT, suggesting choroidal vasoconstriction caused by systemic steroid as a possible mechanism.]]></description>
<pubDate>2020/7/21 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jun Hyuk Lee, Ji Young Lee, Ho Ra, Nam Yeo Kang and Jiwon Baek]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jun Hyuk Lee, Ji Young Lee, Ho Ra, Nam Yeo Kang and Jiwon Baek</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200915]]></guid><cfi:id>529</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A new visual acuity test on touchpad for vision screening in children]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200916]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To validate a visual acuity (VA) test application on touchpad in the screening of pediatric population by comparing VA results obtained with conventional tests.
METHODS: A cohort of 101 patients, 44 girls and 57 boys with a median of 6.5 years old (3-10 years of age), presenting for eye examinations in Ophthalmology Department (Strasbourg, France) between November 1st, 2018, and February 1st, 2019 were enrolled. Monocular and binocular VA testing was performed on the subject using both a standard test and the touchpad application (Monoyer, “E” or, Pigassou depending of children’s capacities). Patients were excluded if they were physically or mentally unable to use the touchpad. The duration of each tests, the painfulness, the comprehension, the attention of children during the test and test’s preferences were also evaluated.
RESULTS: There was a good linear correlation and intra-class correlation coefficient [ICC=0.50 (0.34, 0.64) for binocular acuity, 0.74 (0.64, 0.82) for right eyes and 0.525 (0.37, 0.66) for left eye]. The standard errors of measurement were very low (0.08, 0.05, 0.08 for binocular VA, right eyes VA and left eyes VA, respectively). There was no difference between two tests for right eye (P=0.126), left eye (P=0.098) and binocular acuity (P=0.085). Non inferiority was proved for all binocular [-0.06 (-0.09, -0.03)], right eye [-0.04 (-0.07, -0.01)] and left eye [-0.06 (-0.09, -0.02)] VA. The sensitivity and specificity, which correspond to the ability for our app to detect amblyopia, were 92% and 80% respectively.
CONCLUSION: Our touchpad application represents an efficient and valid test of VA in children with a high specificity to detect visual impairment.]]></description>
<pubDate>2020/7/21 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Elsa Di Foggia, Noémie Stoll, Hélène Meunier, Adam Rimelé, Pascal Ance, Pierre-Henri Moreau, Claude Speeg-Schatz and Arnaud Sauer]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Elsa Di Foggia, Noémie Stoll, Hélène Meunier, Adam Rimelé, Pascal Ance, Pierre-Henri Moreau, Claude Speeg-Schatz and Arnaud Sauer</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200916]]></guid><cfi:id>528</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Anterior segment parameters associated with extramuscular manifestations in polymyositis and dermatomyositis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200917]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate detailed anterior segment parameters of patients with idiopathic inflammatory myopathies (IIM), including polymyositis (PM), and dermatomyositis (DM), and to clarify the associations between these data and clinical variables of IIM.
METHODS: Totally 57 PM, 41 DM patients and 62 controls were enrolled in this cross-sectional, observational, case-control study. All study participants underwent Pentacam evaluation. Laboratory investigations consisted of different antibody assays, while extramuscular clinical assessments included Raynaud’s phenomenon, dysphagia, interstitial lung disease, arthritis/arthralgia, and weight loss. Objective signs and subjective symptoms of dry eye disease (DED) were also evaluated.
RESULTS: All pachymetric parameters [center, apex, thinnest and maximal keratometry (Kmax)] and corneal volume (CV) of both sides of PM patients proved to be significantly lower. Some pachymetric data were also noticed as significantly decreased compared to those of controls. Several significant differences were traced between anterior segment values and extramuscular manifestations of myositis, largely in case of arthritis/arthralgia and weight loss, whereas associations between anterior segment parameters and antibodies were weak. Objective clinical tests of DED were also significantly decreased in IIM patients.
CONCLUSION: The results suggest that all IIM patients have thinner corneas compared with those of controls, and decreased corneal parameters are significantly associated with the occurrence of some extramuscular manifestations. In addition, IIM patients tend to develop objective signs of DED.]]></description>
<pubDate>2020/7/21 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Zoltan Griger, Katalin Danko, Gabor Nemeth, Ziad Hassan, Zsuzsa Aszalos, Katalin Szabo, Levente Bodoki, Rudolf Gesztelyi, Judit Zsuga, Peter Szodoray and Adam Kemeny-Beke]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zoltan Griger, Katalin Danko, Gabor Nemeth, Ziad Hassan, Zsuzsa Aszalos, Katalin Szabo, Levente Bodoki, Rudolf Gesztelyi, Judit Zsuga, Peter Szodoray and Adam Kemeny-Beke</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200917]]></guid><cfi:id>527</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparative 2-year outcomes of conventional and accelerated corneal collagen crosslinking in progressive keratoconus]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200807]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the safety and efficacy of conventional versus accelerated (9 mW/cm2) corneal collagen crosslinking (CXL) in progressive keratoconus at the 2-year follow-up.
METHODS: In this prospective study, consecutive progressive keratoconus patients were randomized to receive either conventional CXL (CCXL) or accelerated CXL (ACXL; using hydroxypropyl methylcellulose-assisted riboflavin imbibition for 10min at 9 mW/cm2). Visual, refractive, keratometric, topographic, and aberrometric outcomes and stromal demarcation line depth (DLD) measurements were compared at the end of a 2-year follow-up.
RESULTS: Thirty-two eyes from 32 patients in the CCXL and 27 eyes from 27 patients in the ACXL groups completed 2-year follow-up. At 2y post-CXL, both uncorrected and corrected visual acuities improved significantly in both groups. The improvements in keratometric readings, flattening rate (flattening of the maximum keratometry more than 1 D), 3 topographic indices, and vertical coma were significantly better in the CCXL group compared to the ACXL group (P<0.05). The DLD as measured by anterior segment optical coherence tomography or in vivo confocal microscopy was better detectable and significantly deeper in the CCXL group compared to the ACXL group. The deeper DLD was found to be significantly correlated with improvements in the mean keratometry measurements. Progression was noted in 11.1% of eyes in the ACXL group, whereas progression was not observed in any patient eye in the CCXL group.
CONCLUSION: In this prospective randomized study, ACXL is less effective in halting the progression of keratoconus at a 2-year follow-up compared to CCXL.]]></description>
<pubDate>2020/6/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Omur O. Ucakhan and Yagmur Seda Yesiltas]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Omur O. Ucakhan and Yagmur Seda Yesiltas</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200807]]></guid><cfi:id>526</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[CT and MR imaging findings of ocular adnexal mucosa-associated lymphoid tissue lymphoma associated with IgG4-related disease: multi-institutional case series]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200808]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report CT and MR imaging findings of ocular adnexal mucosa-associated lymphoid tissue lymphoma associated with IgG4-related disease (IgG4-MALT lymphoma), a rare but clinically important complication of ocular adnexal IgG4-related disease.
METHODS: We retrospectively reviewed all cases of histologically confirmed ocular adnexal IgG4-related disease at three tertiary and one secondary referral centers, between February 2003 and December 2016. Seven cases of histopathologically diagnosed IgG4-MALT lymphoma were identified. CT and MR images were analyzed by consensus of two experienced head and neck radiologists.
RESULTS: Lacrimal glands were the main site of involvement in all seven patients. The lesions typically showed well-demarcated margins, iso- to hyperattenuation on precontrast CT, T2 hypo- to isointensity, T1 isointensity, and homogenous internal architecture with homogenous enhancement pattern. Lesions were mostly hyperdense and isointense to normal extraocular muscles on postcontrast CT and MR images, respectively.
CONCLUSION: Unlike in typical ocular adnexal IgG4-related disease, T2 isointensity and hyperattenuation on precontrast CT images were noted in some IgG4-MALT lymphoma cases. Although the findings may be nonspecific, the possibility of accompanying MALT lymphoma may need to be considered, when ocular adnexal lesions in patients clinically suspected of having IgG4-related disease are refractory to glucocorticoids and show T2 isointensity and hyperattenuation on precontrast CT for the optimal management of the patients. However, this is a case series of a very rare complication of ocular adnexal IgG4-related disease, and thus caution is warranted to generalize the conclusion.]]></description>
<pubDate>2020/6/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Roh-Eul Yoo, Sun-Won Park, Jung Hyo Rhim, Ji Eun Kim, Soo Chin Kim, Ji-Young Choe, Ho-Kyung Choung, Sang In Khwarg, Ji-hoon Kim, Jeong Hyun Lee, Bo Eun Lee and Yeonah Kang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Roh-Eul Yoo, Sun-Won Park, Jung Hyo Rhim, Ji Eun Kim, Soo Chin Kim, Ji-Young Choe, Ho-Kyung Choung, Sang In Khwarg, Ji-hoon Kim, Jeong Hyun Lee, Bo Eun Lee and Yeonah Kang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200808]]></guid><cfi:id>525</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Endoscopic transnasal canaliculorhinostomy for refractory common canalicular obstruction with an unidentifiable lacrimal sac]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200809]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To describe the role of endoscopic transnasal canaliculorhinostomy (ETC) in refractory common canalicular obstruction (CCO) associated with an absent or unidentifiable lacrimal sac.
METHODS: The records of patients with refractory CCO who underwent ETC at the Eye Hospital of Wenzhou Medical University from October 2007 to December 2016 were retrospectively reviewed.
RESULTS: Fifty-six patients (56 eyes) with refractory CCO were recruited into the study. Eight patients were excluded due to the presence of a residual lacrimal sac or failure to complete the follow-up duration. The anatomic and functional success rates were both 85.4% (41/48) at a mean follow-up of 18.6mo. Five cases failed as a result of ostial synechia and two failed because of ostial obstruction by granulation. Postoperative complications included mild nasal bleeding in 5 cases, dried nasal feeling in 8 cases, and olfactory dysfunction in 4 cases.
CONCLUSION: Although being surgically challenging, ETC has comparable findings to its external approach counterpart or conjunctivodacryocystorhinostomy (CDCR) with Jones tube. And it may prove to be a novel alternate surgical technique for patients with refractory CCO without identifiable lacrimal sac.]]></description>
<pubDate>2020/6/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Zhao-Qi Pan, Jian-Ju Liu, Xian-Ke Jia, Jason Kian Seng Lee, Yun-Hai Tu, Jie-Liang Shi, Bo Yu, En-De Wu and Wen-Can Wu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zhao-Qi Pan, Jian-Ju Liu, Xian-Ke Jia, Jason Kian Seng Lee, Yun-Hai Tu, Jie-Liang Shi, Bo Yu, En-De Wu and Wen-Can Wu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200809]]></guid><cfi:id>524</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Agreement of corneal curvature and central corneal thickness obtained from a swept-source OCT and Pentacam in ectopia lentis patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200810]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the inter-device consistency of corneal curvature and central corneal thickness between Pentacam and a swept-source Fourier-domain anterior segment optical coherence tomography (AS-OCT) in ectopia lentis patients.
METHODS: Totally 72 eyes of ectopia lentis patients were recruited. Central corneal thickness (CCT), corneal curvature values and corneal astigmatism were obtained from both the Pentacam and AS-OCT (CASIA2). Repeatability was evaluated for both devices. The coefficient of repeatability (COR) and the relative COR was calculated. Bland-Altman plots were conducted to evaluate the inter-device agreement of measurement. Orthogonal linear regression was used to examine any proportional bias.
RESULTS: The mean difference of CCT, steep anterior corneal curvature (anterior KS), flat anterior corneal curvature (anterior Kf), anterior corneal astigmatism (ACA), steep posterior corneal curvature (posterior KS), flat posterior corneal curvature (posterior Kf), posterior corneal astigmatism (PCA), steep true net power (TNP KS), flat true net power (TNP Kf) and total corneal astigmatism (TCA) between Pentacam and CASIA2 were 7.03±9.70 μm, -0.19±0.41 D, -0.27±0.35 D, 0.04±0.47 D, -0.17±0.23 D, -0.11±0.11 D, -0.02±1.02 D -0.41±0.43 D, -0.52±0.46 D, and -0.15±0.96 D, respectively. For measurement of TNP Kf with the Pentacam and CASIA2, a mean difference of 0.52 D and COR of 0.90 with P=0.02 was detected. There was no significant difference in CCT (P=0.393), anterior Kf (P=0.107), anterior Ks (P=0.414), ACA (P=0.131), posterior Kf (P=0.286), posterior Ks (P=0.418), PCA (P=0.105), TNP Ks (P=0.054), and TCA (P=0.977) between Pentacam and CASIA2.
CONCLUSION: Our study reveals good agreement of CCT, corneal curvature and corneal astigmatism measured by CASIA2 and Pentacam in ectopia lentis patients. However, there was significant difference for CCT and corneal curvature values obtained by the two devices.]]></description>
<pubDate>2020/6/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Guang-Ming Jin, Bing Xiao, Yi-Jing Zhou, Yi-Yao Wang, Xue-Pei Li and Dan-Ying Zheng]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Guang-Ming Jin, Bing Xiao, Yi-Jing Zhou, Yi-Yao Wang, Xue-Pei Li and Dan-Ying Zheng</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200810]]></guid><cfi:id>523</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Efficacy and safety of XEN 45 gel stent alone or in combination with phacoemulsification in advanced open angle glaucoma patients: 1-year retrospective study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200811]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the effectiveness of the XEN 45 gel stent, either alone or combined with cataract surgery, in advanced stage open angle glaucoma (OAG) patients.
METHODS: Retrospective and single-center study conducted on consecutive OAG patients who underwent a XEN 45 gel stent implantation surgery, between July 2017 and September 2018. The primary efficacy end-point was the mean intraocular pressure (IOP) reduction at the end of the follow-up period. Success was defined as an IOP reduction of at least 20% and an IOP value ≤18 mm Hg without (complete) or with (qualified) hypotensive medication.
RESULTS: Seventy-four patients (80 eyes) were included in the study. In the overall study sample, XEN implant significantly reduced IOP from 21.0 (19.8 to 22.1) mm Hg at baseline to 9.3 (8.2 to 10.4), 10.7 (9.6 to 11.9), 13.4 (12.2 to 14.7), 14.5 (13.6 to 15.4), 14.7 (13.8 to 15.6), and 14.7 (13.9 to 15.4) mm Hg at 1d, 1wk, 1, 3, 6, and 12mo of follow-up, respectively (P<0.0001 each). In the overall study population, at the end of the study the mean IOP reduction was 27.4% (23.3% to 31.5%). Adjusted IOP reduction was similar in XEN and XEN+phacoemulsification groups [30.0 (23.4 to 36.4) mm Hg vs 24.8 (18.4 to 31.2) mm Hg, respectively, P=0.2939]. At the last follow-up visit, 52 (65.0%) eyes were considered success, 29 (36.3%) eyes as complete success and 23 (28.7%) as qualified success. Mean number of hypotensive medications was significantly reduced from 2.8 (2.7 to 3.0) at baseline to 1.1 (0.8 to 1.3), P<0.0001. Kaplan-Meier survival analysis did not find any difference in the success rate between XEN and XEN+PHACO, mean hazard ratio 0.56, 95%CI 0.26 to 1.23; P=0.1469. Needling was performed in 7 (8.8%) eyes at months 1 (n=3); 3 (n=2); 4 (n=1) and 11 (n=1). Eleven (13.8%) eyes presented adverse events.
CONCLUSION: XEN implant, either alone or in combination with phacoemulsification, significantly reduced the IOP and the number of hypotensive medications in patients with OAG in advanced stage.]]></description>
<pubDate>2020/6/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Teresa Laborda-Guirao, Juan M Cubero-Parra and Antonio Hidalgo-Torres]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Teresa Laborda-Guirao, Juan M Cubero-Parra and Antonio Hidalgo-Torres</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200811]]></guid><cfi:id>522</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Optical coherence tomography angiography assessment of 577 nm laser effect on severe non-proliferative diabetic retinopathy with diabetic macular edema]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200812]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To quantitatively evaluate the effect of the combined use of 577-nm subthreshold micropulse macular laser (SML) and multi-point mode pan retinal laser photocoagulation (PRP) on severe non-proliferative diabetic retinopathy (NPDR) with central-involved diabetic macular edema (CIDME) using optical coherence tomography angiography (OCTA).
METHODS: In this observational clinical study, 86 eyes of 86 NPDR patients with CIDME who underwent SML and PRP treatment were included. Images were obtained 1d before laser and post-laser (1d, 1wk, 1, 3, and 6mo) using AngioVue software 2.0. Best corrected visual acuity (BCVA, LogMAR), foveal avascular zone area (FAZ), choriocapillary flow area (ChF), parafoveal vessel density (PVD), capillary density inside disc (CDD), peripapillary capillary density (PCD), macular ganglion cell complex thickness (mGCCT), central macular thickness (CMT), and subfoveal choroidal thickness (ChT) were compared between pre- and post-laser treatment.
RESULTS: BCVA remained stable during 6mo post-laser therapy (pre-laser vs 6mo post-laser: 0.53±0.21 vs 0.5±0.15, P>0.05). PVD, ChF, ChT, CMT, and mGCCT significantly increased 1d post-laser therapy [pre-laser vs 1d post-laser: superficial PVD (%), 40.51±3.42 vs 42.43±4.68; deep PVD (%), 42.66±3.67 vs 44.78±4.52; ChF, 1.72±0.21 vs 1.9±0.12 mm2; ChT, 302.45±69.74 vs 319.38±70.93 μm; CMT, 301.65±110.78 vs 320.86±105.62 μm; mGCCT, 105.71±10.72 vs 115.46±9.64 μm; P<0.05]. However, PVD, ChF and ChT decreased to less than baseline level at 6mo post-laser therapy (pre-laser vs 6mo post-laser: superficial PVD (%), 40.51±3.42 vs 36.32±4.19; deep PVD (%), 42.66±3.67 vs 38.76±3.74; ChF, 1.72±0.21 vs 1.62±0.09 mm2; ChT, 302.45±69.74 vs 289.61±67.55 μm; P<0.05), whereas CMT and mGCCT decreased to baseline level at 6mo post-laser therapy (CMT, 301.65±110.78 vs 297.77±90.23 μm; mGCCT, 105.71±10.72 vs 107.05±11.81 μm; P>0.05). Moreover, FAZ continuously increased while CDD and PCD continuously decreased in 6mo after laser therapy. CMT and ChT had a significant positive correlation with ChF and PVD in most post-laser stages.
CONCLUSION: During a 6-month follow-up period after combined use of SML and PRP therapy, BCVA remained stable and there was a decreased trend in macular edema. Blood flow increased at 1d post-laser therapy and reduced at 6mo post-laser therapy.]]></description>
<pubDate>2020/6/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Zi-Jing Li, Jian-Hui Xiao, Peng Zeng, Rui Zeng, Xiang Gao, Yi-Chi Zhang and Yu-Qing Lan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zi-Jing Li, Jian-Hui Xiao, Peng Zeng, Rui Zeng, Xiang Gao, Yi-Chi Zhang and Yu-Qing Lan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200812]]></guid><cfi:id>521</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Predictive parameters on CT scan for dysthyroid optic neuropathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200813]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the value of parameters on CT scan in predicting dysthyroid optic neuropathy (DON) and to provide guidance for early diagnosis of DON accordingly.
METHODS: A total of 67 eyes of 35 patients with thyroid-associated ophthalmopathy (TAO) were included in this study. Patients were divided into 2 groups (DON group and non-DON group). Parameters were measured on high resolution CT, including muscle index (MI), superior ophthalmic vein (SOV) dilatation, extraocular muscle volume/orbit volume (MV/OV), and intracranial fat prolapsed, and be compared between these 2 groups. The relation between those parameters and visual function [visual acuity (VA) and visual field defect (VF defect)] were also evaluated.
RESULTS: MI and MV/OV were significantly higher in DON group (P=0.00035 and P=0.00026). No significant difference was detected regarding intracranial fat prolapse existence and SOV dilatation (P=0.37 and P=0.15). MV/OV was found to have significant negative correlation with both VF defect (R=-0.332, P=0.0273) and VA (R=-0.635, P=0.00) while MI was found to have negative linear correlation with VA only (R=-0.456, P=0.00017). The area under receiver operating characteristic curves was 0.82 for MV/OV and 0.75 for MI. The best performance in detecting DON was achieved when MV/OV is set at 0.20 with 72% sensitivity and 87% specificity and MI is set at 0.52 with 64% sensitivity and 80% specificity.
CONCLUSION: MI and MV/OV are predictive parameters for DON. Together with clinical manifestations, MV/OV≥0.2 can be used as a good indicator for DON in TAO patients.]]></description>
<pubDate>2020/6/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Bo Yu, Can Gong, Yuan-Fei Ji, Yu Xia, Yun-Hai Tu and Wen-Can Wu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Bo Yu, Can Gong, Yuan-Fei Ji, Yu Xia, Yun-Hai Tu and Wen-Can Wu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200813]]></guid><cfi:id>520</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Measurements of the parapapillary atrophy area and other fundus morphological features in high myopia with or without posterior staphyloma and myopic traction maculopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200814]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the affecting factors of parapapillary gamma and delta zones and other fundus morphological features in high myopia.
METHODS: Seventy high myopia patients were included in this retrospective observational study and 47 patients were female. Patients were divided into three groups: no posterior staphyloma (no PS), PS with myopic traction maculopathy (PS with MTM), and PS without MTM using 3-dimensional magnetic resonance imaging and optical coherence tomography. MTM patients were further classified into three types [epiretinal membrane, macular hole, and macular retinoschisis (MRS)]. Diameters of the gamma and delta zones were measured among other morphometric variables using fundus photographs.
RESULTS: Of the 70 individuals (127 eyes), the mean age was 57.46±13.56y. In univariate analysis, morphological features changed most dramatically in PS with MTM patients, who had the largest gamma zone diameters, the largest disk-fovea distance (DFD) and disk-fovea angle, and the smallest angle kappa and vertical distance of temporal arterial arcade. However, their horizontal delta zone diameter was smaller than in the patients with PS yet without MTM. In multivariate analysis, with axial length (AL) and age adjusted, the horizontal diameter in the delta zone of the PS without MTM group was still significantly larger than in the PS with MTM group (P=0.024). Comparing the three subtypes of MTM patients, the diameters of the gamma zone and DFD in MRS group were the largest.
CONCLUSION: The characteristics of the gamma and delta zones change inconsistently in different stages of high myopia. These changes may be associated with anatomical changes caused by local traction. Factors such as PS, AL and age play an important role. These findings may provide a hint about the pathogenesis of traction in high myopia.]]></description>
<pubDate>2020/6/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xiao-Xiao Guo, Xi Chen, Shan-Shan Li, Min Li, Xiu-Fen Yang, Lu Zhao, Ran You and Yan-Ling Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiao-Xiao Guo, Xi Chen, Shan-Shan Li, Min Li, Xiu-Fen Yang, Lu Zhao, Ran You and Yan-Ling Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200814]]></guid><cfi:id>519</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of excyclotorsion following graded inferior oblique recession for primary versus secondary inferior oblique overaction]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200815]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the changes in excyclotorsion after inferior oblique (IO) recession in patients with primary and secondary inferior oblique overaction (IOOA).
METHODS: We retrospectively analyzed the data obtained from patients with IOOA who underwent graded IO recession. The patients were followed up for at least 3mo after surgery. Fundus photographs were taken pre- and postoperatively, and the sum of the angles of torsion in both eyes was used to analyze changes in excyclotorsion. Patients were divided into two groups: those diagnosed with primary IOOA were enrolled in the 1’IOOA group, and those diagnosed with secondary IOOA caused by superior oblique palsy (SOP) were enrolled in the 2’IOOA group. Excyclotorsion before and after surgery were compared between the two groups.
RESULTS: A total of 78 patients were enrolled in this study: 34 eyes in the 1’IOOA group and 44 eyes in the 2’IOOA group. In the 78 patients, torsional angle significantly decreased from 15.31°±7.40° to 12.11°±6.53° after IO recession (P<0.001). Mean preoperative torsional angle was larger in the 2’IOOA group than in the 1’IOOA group (P=0.03). In both groups, excyclotorsion significantly decreased after IO recession (P=0.001 and P<0.001, respectively); however, there was no significant difference in the amounts of changes in excyclotorsion between the two groups.
CONCLUSION: Excyclotorsion is significantly larger in secondary IOOA than in primary IOOA, and a significant decrease in the torsional angle occurs after IO recession in both types of IOOA.]]></description>
<pubDate>2020/6/22 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Donghun Lee, Won Jae Kim and Myung Mi Kim]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Donghun Lee, Won Jae Kim and Myung Mi Kim</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200815]]></guid><cfi:id>518</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Objective optical quality and visual outcomes after the PresbyMAX monocular ablation profile]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200707]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess objective visual quality after presbyopia correction using the PresbyMAX monocular mode.
METHODS: This prospective, nonrandomized study included 28 eyes from 18 patients (mean age 50.4±5.6y) who underwent presbyopia correction with the PresbyMAX monocular mode. Monocular and binocular visual acuities were evaluated preoperatively, 1d, 1wk, 1, 3mo, and 1y after surgery. Optical quality was analyzed by Hartmann-Shack wavefront aberration supported cornea ablation. Modulation transfer function (MTF) cutoff frequency, Strehl ratio, and objective scattering index (OSI) were analyzed using an optical quality analysis system.
RESULTS: One year after surgery, 100% and 94.4% of patients achieved binocular uncorrected distance and near visual acuity of 20/25, respectively. At the last visit Spherical aberration and total higher aberration were higher than the corresponding preoperative levels (P<0.001); however, no significant difference was found in MTF, OSI, or Strehl ratio. Transient decreases in OSI and MTF mainly occurred in the nondominant eyes. There was no significant difference in optical quality between the dominant and nondominant eyes, except for spherical aberration and horizontal coma (P<0.05).
CONCLUSION: The PresbyMAX monocular mode is safe and effective for presbyopia correction. It has little effect on optical quality, though short-term degraded optical quality occurred mainly in the bi-aspheric ablated eyes.]]></description>
<pubDate>2020/5/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Dan Fu, Jing Zhao and Xing-Tao Zhou]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Dan Fu, Jing Zhao and Xing-Tao Zhou</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200707]]></guid><cfi:id>517</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Evaluation of chronic ocular sequelae in patients with symblepharon caused by ocular burns]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200708]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate chronic ocular sequelae in patients with symblepharon caused by ocular burns and propose an objective grading system.
METHODS: This was a retrospective, single-center clinical study. Patients with symblepharon caused by ocular burns at least six months later were assessed. Chronic ocular sequelae were classified into 3 categories (eyelid, conjunctiva, and cornea) and 9 chronic ocular sequelae [friction factors, exposure factors, conjunctival hyperemia, length of symblepharon, scope of adhesion, lacrimal area adhesion, loss of the palisades of Vogt (POV), corneal neovascularization, and corneal opacification]. Each ocular sequela was graded from 0 to 3, depending on the increasing severity. The 9 ocular sequelae were evaluated to obtain the total severity score for each eye. The total severity score was defined as Grade I (1-9), Grade II (10-18), and Grade III (19-27). Moreover, the correlation between the severity of chronic ocular sequelae and visual acuity, surgical strategy, and the prognosis was analyzed, respectively.
RESULTS: Cases of 79 eyes with symblepharon caused by ocular burns were included in this study. Of these, 20 (25.32%) were defined as Grade I, 43 (54.43%) as Grade II, and 16 (20.25%) as Grade III. Eyes with a high total severity score had reduced visual acuity, required complicated surgery strategies, and poor prognosis (P<0.001). Multivariate regression analysis showed that the scope of adhesion, corneal opacification, and corneal neovascularization significantly affected visual acuity, surgical strategy, and prognosis (all P<0.001).
CONCLUSION: The evaluation of chronic ocular sequelae enabled the development of an objective grading system for patients with symblepharon caused by ocular burns. This grading system can be applied to guide the treatment and predict the prognosis.]]></description>
<pubDate>2020/5/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Liang-Bo Chen, Si-Yi Zhang, Chen-Xi Yan, Qin-Ke Yao, Chun-Yi Shao and Yao Fu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Liang-Bo Chen, Si-Yi Zhang, Chen-Xi Yan, Qin-Ke Yao, Chun-Yi Shao and Yao Fu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200708]]></guid><cfi:id>516</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Medical treatment of inflammatory punctual stenosis monitored by anterior segment optical coherence tomography]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200709]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the role of medical treatment in the management of inflammatory punctum stenosis guided by spectral domain anterior segment optical coherence tomography (OCT).
METHODS: This prospective study included 60 patients complaining of epiphora due to inflammatory punctual stenosis. They were divided into two groups: Group A (30 patients) treated with a combination of preservative free hydrocortisone sodium phosphate 3.35 mg/mL eye drops, and preservative free artificial tears based on sodium hyaluronate, polyethylene and propylene Glycol; Group B (30 patients) treated with the same preservative free artificial tears only. Thirty normal subjects were included for comparison of pre-treatment anatomical parameters. Before starting treatment, all patients underwent anterior segment assessment including slit lamp examination, measurement of intraocular pressure (IOP), fluorescein dye disappearance test, and measurement of the outer punctum diameter (OPD) by Spectral domain anterior segment OCT. All assessments were repeated at each follow up done at 1 and 3mo later, together with subjective evaluation of patient’s satisfaction of the treatment outcome by simple rating questionnaire.
RESULTS: Punctual diameter increased significantly with treatment in both groups (P<0.0001); although the widening was more in Group A as compared to group B (16.2% vs 8% of the original punctual size, mean difference of 28.933 μm, P=0.0076). Subjective satisfaction with treatment outcome was also better in group A (70% vs 40%, Chi-square P=0.0397).
CONCLUSION: A combination of preservative free steroid eye drops and artificial tears causes significant widening of inflammed stenotic punctae and improvement of the associated epiphora.]]></description>
<pubDate>2020/5/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hanan Youssef Elalfy, Mahmoud A Elsamkary, Ahmed M Shafek Elridy, Tarek M Saad, Saad Mohamed Rashad and Samah M Fawzy]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hanan Youssef Elalfy, Mahmoud A Elsamkary, Ahmed M Shafek Elridy, Tarek M Saad, Saad Mohamed Rashad and Samah M Fawzy</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200709]]></guid><cfi:id>515</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Conjunctival flap advancement with or without scleral graft for hypotony maculopathy after trabeculectomy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200710]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the outcomes of adaptive conjunctival flap advancement surgical techniques with or without scleral graft for patients undergoing revision surgery after trabeculectomy.
METHODS: This retrospective study included 28 eyes of 28 subjects from December 2015 to April 2018. A group of 15 eyes underwent conjunctival advancement only while the other 13 eyes did conjunctival advancement with partial thickness scleral graft. In both study groups, we considered the intraocular pressure (IOP) as our primary outcome and visual acuity (VA) as our secondary outcome. Both were assessed pre- and post-operatively till the last follow-up possible point. Additionally, we classified the patients according to complete and qualified success criteria.
RESULTS: The mean age of the conjunctival advancement group was 36.87±19.25y, while it was 44.08±18.04 in the other group. In both study groups, the mean IOP significantly increased after revision surgery at 1, 2, 3mo and the last follow-up visit when compared to prior the surgery (P<0.001). Moreover, VA was significantly improved (P=0.03) in the final follow-up for both surgical techniques. When we compared the change from baseline in both groups, there was no significant difference between IOP improvement in 1mo (P=0.263), while the difference was significant in 2mo (P=0.03), 3mo (P=0.02) and in the final follow-up visit postoperatively. However, this difference was not significant regarding VA (P=0.5).
CONCLUSION: The both adaptive techniques of conjunctival advancement and conjunctival advancement with scleral graft are effective for treating patients with late-onset hypotony. Yet, more prospective studies are needed to assert upon these results.]]></description>
<pubDate>2020/5/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Abdelhamid Shaker Elhofi, Mohamed Fahmy Doheim and Amir AbouSamra]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Abdelhamid Shaker Elhofi, Mohamed Fahmy Doheim and Amir AbouSamra</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200710]]></guid><cfi:id>514</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Subconjunctival injections of triamcinolone acetonide to treat uveitic macular edema]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200711]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the efficacy and safety of subconjunctival triamcinolone acetonide (TA) injections for treating uveitic macular edema (UME).
METHODS: This retrospective case series study included patients with UME who received subconjunctival TA injections with a minimum follow-up period of 6mo. The main outcome measure was central macular thickness (CMT). The secondary outcome measures included best-corrected visual acuity (BCVA), recurrence rate and intraocular pressure (IOP).
RESULTS: In total, 65 patients (80 eyes), mainly including idiopathic uveitis in 33 patients (50.77%) and Vogt-Koyanagi-Harada (VKH) syndrome in 19 patients (29.23%), were enrolled in this study. The mean CMT decreased from 457.6±173.0 μm at baseline to 325.9±176.8, 302.7±148.2, 332.2±177.3 and 270.6±121.6 μm at 1-, 2-, 3- and 6-months postinjection, respectively (all P<0.001). BCVA increased from logMAR 0.5±0.3 at baseline to logMAR 0.4±0.3, 0.4±0.3, 0.4±0.4 and 0.4±0.3 at the 1-, 2-, 3- and 6-months postinjection visits, respectively (all P<0.001). Twenty-one (21/80, 26.25%) eyes underwent relapse of UME within 6mo. A total of 20/80 (25%) eyes exhibited elevated IOPs, of which 13 eyes were controlled with topical IOP-lowering agents and 7 eyes underwent surgical removal of subconjunctival TA deposit.
CONCLUSION: Subconjunctival TA injections appear to be safe and effective for UME.]]></description>
<pubDate>2020/5/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yi Qu, Xin-Shu Liu, An-Yi Liang, Jun-Yan Xiao, Chan Zhao, Fei Gao and Mei-Fen Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yi Qu, Xin-Shu Liu, An-Yi Liang, Jun-Yan Xiao, Chan Zhao, Fei Gao and Mei-Fen Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200711]]></guid><cfi:id>513</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Efficiency analysis by mfERG and OCT of intravitreal injection with ranibizumab on diabetic macular edema]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200712]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyze the clinical efficacy of intravitreal injection of ranibizumab (IVR) on diabetic macular edema (DME) with multifocal electroretinography (mfERG) and optical coherence tomography (OCT).
METHODS: A total of 41 patients (41 eyes) with DME were treated with IVR. The best corrected visual acuity (BCVA), mfERG results, and OCT were analyzed to compare to the baselines at 1wk, 1, and 3mo after operation.
RESULTS: The BCVA was significantly improved in all eyes at each time point (P<0.001). The macular area leakage and edema were reduced 1wk and 1mo after IVR, and the central fovea thickness (CFT) was significantly reduced compared to baseline (P<0.001). The mfERG, two-dimensional and three-dimensional images all showed that the macular fovea (1 ring) response density decreased, and the fovea and macular area spikes significantly decreased or disappeared. The amplitude density of the P1 wave was increased, and the latency of the P1 wave was shortened than preoperation (P<0.001). At 1wk and 1mo after the operation, there was a negative correlation between the amplitude density of P1 waves and CFT.
CONCLUSION: OCT and mfERG fully demonstrate the importance of IVR for DME patients from the macular morphology and function, especially the significance of mfERG in this disease.]]></description>
<pubDate>2020/5/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hong-Xia Bian, Meng-Ting Bian, Wei-Hong Liu, Rui-Ying Liu and Mi Guo]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hong-Xia Bian, Meng-Ting Bian, Wei-Hong Liu, Rui-Ying Liu and Mi Guo</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200712]]></guid><cfi:id>512</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Application of pediatric ocular trauma score in pediatric open globe injuries]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200713]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the predictive value of pediatric penetrating ocular trauma score (POTS) on the visual outcome in children with open globe injury.
METHODS: A retrospective study in 90 children (60 males and 30 females) aged 1-15y (average, 7.48±2.86y) with penetrating ocular trauma was performed. Each patient’s POTS was calculated. The effects of POTS on final visual acuity (FVA) were examined. Correlation between factors affecting POTS and the FVA was established.
RESULTS: All patients presented with single-eye trauma. The follow-up time was 3-21mo (average, 10.23±3.54mo). Among the 90 cases of penetrating wounds, 71 eyes (78.89%) were injured in Zone I (wound involvement limited to the cornea, including the corneoscleral limbus), 17 eyes (18.89%) were injured in Zone II (wound involving the sclera and no more posterior than 5 mm from the corneoscleral limbus), and 2 eyes (2.22%) were injured in Zone III (wound involvement posterior to the anterior 5 mm of the sclera). Analysis of POTS and FVA showed important correlation between them (r=0.414, P=0.000). Initial visual acuity (P=0.00), age (P=0.02), injury location (P=0.002), traumatic cataract (P=0.00), vitreous hemorrhage (P=0.027), retinal detachment (P=0.003), and endophthalmitis (P=0.03) were found to be statistically significant factors for the FVA outcome.
CONCLUSION: Ocular trauma presents serious consequences and poor prognosis in children. The POTS may be a reliable prognostic tool in children with open globe injury.]]></description>
<pubDate>2020/5/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Chao Xue, Li-Chun Yang and Yi-Chun Kong]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Chao Xue, Li-Chun Yang and Yi-Chun Kong</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200713]]></guid><cfi:id>511</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Different damage patterns of retinal nerve fiber layer and ganglion cell-inner plexiform layer between early glaucoma and non-glaucomatous optic neuropathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200606]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the damage pattern of the peripapillary retinal nerve fiber layer (pRNFL) and the macular ganglion cell-inner plexiform layer (mGCIPL) between early glaucomatous and non-glaucomatous optic neuropathy (EGON and NGON).
METHODS: It is a cross-sectional study. Thirty-eight healthy controls, 74 EGONs and 70 NGONs with comparable average pRNFL loss were included. The NGON group included 23 eyes of optic neuritis (ON), 13 eyes of hereditary optic neuropathy (HON), 19 eyes of toxic optic neuropathy (TON) and 15 eyes of compressive neuropathy (CON). The sectoral pRNFL and mGCIPL thickness obtained by high definition optical coherence tomography were analyzed.
RESULTS: Compared to normal controls, the pRNFL thickness in all quadrants showed a decrease in both EGON and NGON group (P<0.001), but the average pRNFL thickness of EGON group was not different to that of NGON group (P=0.94). The inferior and superior pRNFL was thinner in EGON group compared to NGON group (P<0.001). The temporal pRNFL was thinner in NGON group compared to EGON group (P<0.001). No statistically significant difference was found in nasal pRNFL between EGON and NGON. While the nasal pRNFL was thinner in CON than other three types of NGON (P=0.01), no statistically significant difference was found in other three quadrantal pRNFL among the four types of NGON (P>0.05). The mGCIPL of EGON and NGON group were thinner than control group (P<0.001). In EGON group the severest sites of mGCIPL reduction was located at inferotemporal and inferior sectors. While, compared to EGON group, the average mGCIPL of NGON group were significantly thinner, especially in superonasal and inferonasal sectors (P<0.001).
CONCLUSION: The damage pattern of pRNFL and mGCIPL caused by glaucoma is distinct from other NGON such as ON, TON, HON and CON, and this characteristic damage pattern is helpful in differentiating early glaucoma from other NGON.]]></description>
<pubDate>2020/4/28 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hui Xiao, Xing Liu, Ping Lian, Ling-Ling Liao and Yi-Min Zhong]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hui Xiao, Xing Liu, Ping Lian, Ling-Ling Liao and Yi-Min Zhong</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200606]]></guid><cfi:id>510</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Diagnosis of lacrimal punctum lesions using optical coherence tomography: a preliminary study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200607]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To study the imaging characteristics of lacrimal punctum lesion with optical coherence tomography (OCT), and provide imaging basis for the diagnosis and treatment of lacrimal punctum diseases.
METHODS: A total of 25 patients (28 eyes) with epiphora and lacrimal puncta lesions were enrolled. Lacrimal puncta lesions included: punctum membrane obstruction in 7 cases (9 eyes), punctum agenesis in 1 case (1 eye), a mass protruded from the punctum in 1 case (1 eye), slit puncta in 1 case (1 eye), peri-puncta mass in 2 cases (2 eyes), chronic dacryocystitis in 4 cases (4 eyes), and primary puncta stenosis in 9 cases (10 eyes; 3 eyes mild, 4 eyes moderate and 3 eyes severe). All patients were examined by slit lamp microscopy and OCT to observe the morphological characteristics of abnormal punctum.
RESULTS: Two types of complete membrane obstruction and incomplete membrane obstruction of puncta were observed in OCT images of 7 patients. No lacrimal punctum and lacrimal canalicular cavity were found in 1 case with punctum agenesis. OCT images showed that a narrow lumen remained in the lacrimal puncta in 1 patient with a mass protruded from the punctum. OCT of punctum in a patient with slit punctum after stent placement showed stent and abnormal lacrimal structure. No abnormal intraluminal structure was found in 2 cases of peri-puncta mass after OCT scan, and the lacunar space was narrower than that of the contralateral eye. OCT of puncta in 4 patients with chronic dacryocystitis showed that pus floated in tear with lump-like medium-low reflex. In 9 patients with primary lacrimal puncta stenosis, OCT image could clearly show the changes of puncta lumen in different degrees and shapes.
CONCLUSION: OCT is feasible for the examination of pathological punctum, and can provide imaging basis for the diagnosis and treatment of punctum disease.]]></description>
<pubDate>2020/4/28 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hai Tao, Ying-Shuang Wang, Fei Wang, Hai-Bin Wang, Wei-Li Dong, Fang Bai, Peng Wang, Xi-Bin Zhou, Li-Hua Wang and Chuan Liu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hai Tao, Ying-Shuang Wang, Fei Wang, Hai-Bin Wang, Wei-Li Dong, Fang Bai, Peng Wang, Xi-Bin Zhou, Li-Hua Wang and Chuan Liu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200607]]></guid><cfi:id>509</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Correlation between corneal demarcation line depth in epithelium-off and trans-epithelium accelerated corneal cross linking and keratoconus progression]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200608]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare corneal demarcation line (DL) depth in both accelerated epithelium-off and trans-epithelium cross linking (CXL) using anterior segment optical coherence tomography (AS-OCT) and its relation to maximum keratometry (Kmax) progression in both techniques.
METHODS: A prospective comparative interventional study where patients with mild to moderate keratoconus (KC) were classified into two groups: accelerated epithelium-off and trans-epithelium CXL based on corneal pachymetry. Assessment of corneal DL depth was carried out after 3mo by AS-OCT. Kmax readings were evaluated after one year follow up using the Scheimpflug imaging system.
RESULTS: Study included 74 eyes of 44 patients. Group A underwent epithelium-off CXL (41 eyes), while Group B underwent trans-epithelium CXL (33 eyes). At 3mo follow up, mean corneal DL depth in Group A was 219.9±58.4 μm while in Group B was 127.2±7.8 μm (P<0.05). The mean Kmax changed from 51.9±3.9 to 51.3±4.2 diopters in Group A and from 53.1±4.1 to 53.6±5 diopters in Group B with insignificant difference in Kmax changes in either group (P>0.05). In addition, no significant change in corneal pachymetry was found in both groups (mean change at 1y: 6.4±4.7 and -10.1±2.3 μm in Groups A and B respectively).
CONCLUSION: Despite a significantly deeper corneal DL depth created by accelerated epithelium-off CXL technique compared to accelerated trans-epithelium CXL, there is no significant impact on keratoconus progression.]]></description>
<pubDate>2020/4/28 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mahmoud Abdel-Radi, Zeiad Eldaly, Hazem Abdelmotaal, Reham Abdelrahman, Mohamed Sayed and Kamel Soliman]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mahmoud Abdel-Radi, Zeiad Eldaly, Hazem Abdelmotaal, Reham Abdelrahman, Mohamed Sayed and Kamel Soliman</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200608]]></guid><cfi:id>508</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Rainbow halos occur less following implantation of extended range of vision one-piece intraocular lenses vs diffractive bifocal intraocular lenses]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200609]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate clinical outcomes following implantation of an extended range of vision intraocular lens (IOL), the ZXR00, and a diffractive multifocal IOL with +2.75 diopters (D) add power, the ZKB00.
METHODS: Totally 30 patients who underwent either bilateral implantation of the ZXR00 IOL with intended emmetropia (ZXR00 emmetropia group: 20 eyes) and intended micromonovision (ZXR00 monovision group: 20 eyes), or bilateral implantation of the ZKB00 IOL with intended emmetropia (ZKB00 group: 20 eyes) were included in this study. Visual acuity at 4 m, 80, and 40 cm; and the types of halos (misty, fine, and rainbow) were analyzed at one and three months after surgery.
RESULTS: There were no significant differences in distance visual acuity among the three groups. The mean uncorrected intermediate visual acuity was better in the ZXR00 emmetropia and monovision groups (0.02 logMAR and 0.02 logMAR, respectively) than in the ZKB00 group (0.14 logMAR). The mean uncorrected near visual acuity was worse in the ZXR00 emmetropia group (0.26 logMAR) than in the ZXR00 monovision and ZKB00 groups (0.12 logMAR and 0.10 logMAR, respectively). There was an increased incidence of rainbow halos in the ZKB00 group vs in either ZXR00 group (P=0.033).
CONCLUSION: Implantation of the ZXR00 IOL with intended micromonovision provide superior visual acuity than implantation of the ZXR00 IOL with intended emmetropia. The ZXR00 IOLs tend to show a lower incidence of rainbow halos than did the ZKB00 IOL.]]></description>
<pubDate>2020/4/28 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jae-hyung Kim, Youngsub Eom, Seo Yeon Park, Soo Youn Choi, Ho Sik Hwang, Jun-Heon Kim, Jong Suk Song and Hyo Myung Kim]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jae-hyung Kim, Youngsub Eom, Seo Yeon Park, Soo Youn Choi, Ho Sik Hwang, Jun-Heon Kim, Jong Suk Song and Hyo Myung Kim</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200609]]></guid><cfi:id>507</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Agreement between IOLMaster? 500 and Pentacam? HR for keratometry assessment in type 2 diabetic and non-diabetic patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200610]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate inter-device agreement of anterior keratometry obtained by the IOLMaster&#174; 500 and Pentacam&#174; HR in type 2 diabetic and non-diabetic patients.
METHODS: Corneal measurements were sequentially performed in 60 diabetes mellitus (DM) and 48 age and sex-matched controls undergoing cataract surgery. Variables recorded included flat and steep keratometry, mean keratometry (Km), astigmatism magnitude, axis location, J0 and J45 components. Bland-Altman plots and intraclass correlation coefficients were used for examination of agreement. Subgroup analyses were performed for astigmatism magnitude, diabetes duration, hemoglobin A1c (HbA1c) levels and diabetic retinopathy (DR) stage.
RESULTS: Agreement for Km and astigmatism magnitude were considered good and moderate, with 95% limits of agreement (LoA) of -1.09 to 1.23 diopters (D) and -0.83 to 0.86 D in DM group, respectively; and -0.59 to 0.72 D and -0.98 to 0.75 D in non-DM group, respectively. In contrast, the 95% LoA for corneal axis exceeded the clinically relevant margins in both groups. In the total sample, only 41 eyes (38%) had a smaller than 5-degree difference. Diabetes duration, HbA1c levels and DR stage were not found to significantly affect agreement. Logistic regression showed that higher corneal power (P=0.021) and astigmatism magnitude (P=0.011) were associated with a decreased risk of having a difference in axis location greater than 10-degrees.
CONCLUSION: In both groups, IOLMaster and Pentacam agree well for corneal power and moderately for astigmatism. However, axis location disagreement is frequent in eyes with flatter corneas and small amounts of astigmatism.]]></description>
<pubDate>2020/4/28 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Joao N Beato, Joao Esteves-Leandro, David Reis, Rita Matos, Manuel Falcao, Vítor Rosas, Angela Carneiro and Fernando Falcao-Reis]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Joao N Beato, Joao Esteves-Leandro, David Reis, Rita Matos, Manuel Falcao, Vítor Rosas, Angela Carneiro and Fernando Falcao-Reis</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200610]]></guid><cfi:id>506</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Surgical stress and cytoskeletal changes in lens epithelial cells following manual and femtosecond laser-assisted capsulotomy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200611]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To study the effect of mechanical stress on the cytoskeleton in lens epithelial cells following conventional phacoemulsification surgery (CPS) and femtosecond laser-assisted cataract surgery (FLACS).
METHODS: The cytoskeleton of the epithelial cells of the anterior lens capsules (ALC) removed by CPS and FLACS was examined by immunohistochemistry. Expression of the intermediate filament, glial fibrillary acidic protein (GFAP), and glutamine synthetase (GS) immunoreactivity were detected. In order to map the actin network of cells, fluorescently labeled phalloidin was used. The samples were examined using confocal laser scanning microscopy.
RESULTS: GFAP expression was visible in a larger number of the epithelial cells after CPS compared to FLACS. In CPS sample’s epithelial cells, GFAP immunoreactivity indicated robust morphological change. Regarding the actin filaments, the presence of tubular elements connecting epithelial cells, regular actin pattern and marked cortical network after CPS were found. Following FLACS, the actin cytoskeleton of the epithelial cells remained densely structured, and the tubular elements were undetectable, however, the above-mentioned regular actin pattern and the marked cortical network were visible.
CONCLUSION: The conventional removal of the ALC induces more robust changes of the cytoskeleton of the lens epithelial cells.]]></description>
<pubDate>2020/4/28 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Andrea Krisztina Sükosd, Krisztina Szabadfi, Edina Szabó-Meleg, Beáta Gáspár, Pavel Stodulka, Gyorgy Sétáló Jr, Róbert Gábriel, Miklós Nyitrai, Zsolt Biró and Hajnalka Abrahám]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Andrea Krisztina Sükosd, Krisztina Szabadfi, Edina Szabó-Meleg, Beáta Gáspár, Pavel Stodulka, Gyorgy Sétáló Jr, Róbert Gábriel, Miklós Nyitrai, Zsolt Biró and Hajnalka Abrahám</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200611]]></guid><cfi:id>505</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Surgical management of uveitis-glaucoma-hyphema syndrome]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200612]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report outcomes of patients after intraocular lens (IOL) repositioning or exchange for the version of the uveitis-glaucoma-hyphema (UGH) syndrome that does not include closed loop anterior chamber IOL (nUGH).
METHODS: Chart review of patients with nUGH who underwent IOL repositioning or exchange by one surgeon were reviewed. The main outcome measures were best corrected visual acuity (BCVA) as a decimal fraction preoperatively and postoperatively after IOL repositioning or exchange. Clinical findings evaluated included the presence of uveitis, hyphema, elevated intraocular pressure (IOP), and other complications such as pigment dispersion or vitreous hemorrhage. The number of anti-inflammatory and glaucoma medications were assessed before and after IOL repositioning or exchange.
RESULTS: The study included 14 pseudophakic eyes. The median time at the onset of contemporary UGH after cataract extraction and IOL implantation (CE/IOL) was 7.5y. IOL repositioning or exchange was performed at a mean duration of 8.1±4.7mo (median: 4mo) after onset of UGH. The mean BCVA was improved from 0.45±0.26 preoperatively after onset of UGH syndrome to 0.76±0.22 (P=0.016) after IOL repositioning or exchange. Among the 14 eyes, uveitis, elevated IOP, and hyphema were present preoperatively in 13, 13, and 6 eyes, respectively. Uveitis and hyphema resolved in all cases after IOL surgery. The mean IOP was reduced from 26.4±4.5 mm Hg preoperatively to 14.7±4.9 postoperatively (P=0.01). The mean number of glaucoma medications used was reduced from 1.7±1.1 medications preoperatively to 0.8±1.08 (P=0.04) postoperatively.
CONCLUSION: IOL repositioning or exchange is an effective treatment in many cases for medically resistant contemporary UGH syndrome.]]></description>
<pubDate>2020/4/28 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Abdelrahman M. Elhusseiny, Richard K. Lee and William E. Smiddy]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Abdelrahman M. Elhusseiny, Richard K. Lee and William E. Smiddy</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200612]]></guid><cfi:id>504</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Performances of glaucoma operations with Kahook Dual Blade or iStent combined with phacoemulsification in Japanese open angle glaucoma patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200613]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare surgical outcomes of phacoemulsification combined with glaucoma surgical techniques performed with either Kahook Dual Blade (KDB) or iStent for Japanese patients with either primary open angle glaucoma or exfoliation glaucoma.
METHODS: We retrospectively evaluated the surgical outcomes of 129 eyes of 84 Japanese patients with glaucoma who underwent KDB or 44 eyes of 34 patients who underwent phacoemulsification with iStent procedures combined with cataract surgery. The primary outcome was surgical success or failure [with surgical failure being indicated by <20% reduction from preoperative intraocular pressure (IOP) or IOP>18 mm Hg as criterion A; IOP>14 mm Hg as criterion B on two consecutive study visits; or reoperation requirement]. In addition, we assessed the number of postoperative glaucoma medications and the resulting complications.
RESULTS: The probability of success was significantly higher in the KDB group than in the iStent group for criterion A (60.2% vs 46.4%, P=0.019). In the KDB group, the mean preoperative IOP of 19.8±7.3 mm Hg decreased significantly to 13.0±3.1 mm Hg (P<0.01), and the mean number of glaucoma medications at 2.5±1.4 decreased significantly to 1.6±1.6 (P<0.01) 12mo postoperatively. In the iStent group, the mean preoperative IOP of 17.8±2.9 mm Hg significantly decreased to 14.3±2.3 mm Hg (P<0.01), and the mean number of glaucoma medications at 2.2±1.1 decreased significantly to 0.9±1.4 (P<0.01) 12mo postoperatively. The overall IOP reduction percentage was higher in the KDB group (26.2%) than in the iStent group (19.0%) 12mo postoperatively (P=0.03). Hyphema occurred significantly more frequently in the KDB group (16.3%) than in the iStent group (2.3%, P=0.017).
CONCLUSION: KDB and iStent procedures combined with cataract surgery both result in significant IOP and glaucoma medication reductions after the 12-month follow-up. The patients in the KDB group have a higher success rate for the target IOP of less than 18 mm Hg and a higher complication rate than those in the iStent group.]]></description>
<pubDate>2020/4/28 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Kentaro Iwasaki, Yoshihiro Takamura, Yusuke Orii, Shogo Arimura and Masaru Inatani]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Kentaro Iwasaki, Yoshihiro Takamura, Yusuke Orii, Shogo Arimura and Masaru Inatani</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200613]]></guid><cfi:id>503</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Ocular hypertension and severe intraocular pressure elevation after posterior subtenon injection of triamcinolone acetonide for various diseases]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200614]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate and compare the incidences of ocular hypertension and severe intraocular pressure (IOP) elevation after posterior subtenon injection of triamcinolone acetonide (PSTA) for various diseases.
METHODS: Totally 179 eyes that had received PSTA for diabetic macular edema (n=108), pseudophakic cystoid macular edema (n=20), branch retinal vein occlusion (n=16), central retinal vein occlusion (CRVO, n=14), choroidal neovascularization (n=14) or noninfectious uveitis (n=7) were retrospectively enrolled. The primary outcomes included ocular hypertension defined as an IOP>21 mm Hg, and severe IOP elevation defined as a rise of 10 mm Hg or more in IOP compared with baseline. Cox regression models were used to analyze the hazard ratios (HRs) among different diseases.
RESULTS: After PSTA, the mean IOPs from month 1 to month 6 all significantly increased (P<0.05). Ocular hypertension occurred in 30.7% of eyes (median time: 8wk), and severe IOP elevation occurred in 16.2% of eyes (median time: 9wk). Patients receiving PSTA for CRVO or uveitis had a significantly higher risk for ocular hypertension (HR=3.049, P=0.004 for CRVO; HR=5.464, P=0.019 for uveitis) and severe IOP elevation (HR=2.913, P=0.034 for CRVO; HR=7.650, P=0.009 for uveitis).
CONCLUSION: IOP significantly increases within 6mo after PSTA, with the onset of ocular hypertension happening mostly at 2 to 3mo. Patients of CRVO or noninfectious uveitis have a higher risk of ocular hypertension or severe IOP elevation after PSTA and should be monitored for IOP more carefully.]]></description>
<pubDate>2020/4/28 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yun-Hsiang Yang, Hua-Hsuan Kuo, Wei-Cherng Hsu and Yi-Ting Hsieh]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yun-Hsiang Yang, Hua-Hsuan Kuo, Wei-Cherng Hsu and Yi-Ting Hsieh</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200614]]></guid><cfi:id>502</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[One-year follow-up evaluation of combined phacovitrectomy for idiopathic epiretinal membrane]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200615]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the therapeutic effect of combined phacovitrectomy with membrane peeling and intraocular lens (IOL) implantation in patients with severe idiopathic epiretinal membrane (iERM) and concurrent cataract.
METHODS: A total of 34 eyes from 34 patients who underwent phacovitrectomy and epiretinal membrane (ERM) peeling at the First Affiliated Hospital of Zhejiang University between 2015 and 2017. The best-corrected visual acuity (BCVA) and central foveal thickness (CFT) were measured preoperatively and at 1, 3, 6mo and 1y postoperatively. Temporal changes and bivariate correlations of these parameters were analyzed.
RESULTS: Mean logMAR BCVA improved and CFT decreased significantly (P<0.001) until 6mo after surgery. Correlation analysis revealed a positive correlation between preoperative and postoperative logMAR BCVA (r=0.716, P<0.001 at 1mo, r=0.417, P=0.014 at 3mo, r=0.359, P=0.037 at 6mo, and r=0.369, P=0.032 at 12mo post-op respectively), but preoperative CFT was neither associated with postoperative CFT nor with postoperative logMAR BCVA. There was a positive correlation between CFT and logMAR BCVA at 1mo (r=0.346, P=0.045), 6mo (r=0.347, P=0.045), and 12mo (r=0.342, P=0.048) post-operatively. The intra- and postoperative complications were relatively mild, and the incidences were generally low.
CONCLUSION: For severe iERM patients with significant visual symptoms, combined phacovitrectomy with membrane peeling and IOL implantation is safe and effective in improving BCVA and decreasing CFT. Early surgery in selected patients may help preserving better visual function.]]></description>
<pubDate>2020/4/28 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Feng Dong, Chen-Ying Yu, Ning Zhu and Ding-Hua Lou]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Feng Dong, Chen-Ying Yu, Ning Zhu and Ding-Hua Lou</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200615]]></guid><cfi:id>501</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Correlation of ischemic ophthalmopathy with lacunar infarction]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200616]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the correlation of ischemic ophthalmopathy (IO) with lacunar infarction (LI), an ischemic lesions in the cerebrovascular system.
METHODS: Totally 204 cases of IO without any nervous system symptom and previously diagnosed LI served as the observational group. All 204 cases without IO, nervous system symptoms and previous LI served as the control group. Age and sex between the two groups matched well. LI was diagnosed by magnetic resonance imaging (MRI) and the results of the two groups were statistically analyzed and compared.
RESULTS: IO included 174 eyes of 156 patients with non-arteritis anterior ischemic optic neuropathy (NAION), 42 eyes of 36 patients with central retinal artery occlusion (CRAO) or branch retinal artery occlusion (BRAO) and 12 eyes of 12 patients with ocular ischemia syndrome (OIS).The detection rate of LI (72.54%) in IO group was obviously higher than that (15.68%) in the control group (P<0.001). IO was positively correlated with LI (r=0.573, P<0.05). In addition, most infarction sites located in the basal ganglia (67.57%), which were not the vital areas of cerebrum and not easy to be found due to their small size. The majority  of those first visited IO patients (72.54%) without nervous system symptom and previously diagnosed LI had already suffered from LI.
CONCLUSION: According to our studies, there is a positive correlation between IO and LI. IO can be used as an important predictor for the present of LI, especially obvious signs of the patient.]]></description>
<pubDate>2020/4/28 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Min Wang, Yu-Fang Gao, Wei Chen, Rong Li, Li-Hua Hou and Jian-Ying Du]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Min Wang, Yu-Fang Gao, Wei Chen, Rong Li, Li-Hua Hou and Jian-Ying Du</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200616]]></guid><cfi:id>500</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical observations of iridociliary cysts and their changes after implantable collamer lens implantation in myopic patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200617]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To observe the characteristics of iridociliary cysts in myopic patients and evaluate the influences on the position and safety of implantable collamer lens (ICL) after surgery.
METHODS: Totally 270 eyes of 135 patients who underwent ICL surgery for the corrections of myopia were included in this study. Preoperative and postoperative morphology of iridociliary cysts were observed in ultrasonic biomicroscopy (UBM) image.
RESULTS: A total of 138 iridociliary cysts were found in 88 eyes of 50 patients among 270 eyes of 135 patients before surgery (37%). Twenty-five patients had cysts in one eye (50%) and 25 had cysts in both eyes (50%). The prevalence of iridociliary cysts was negatively correlated with age, but no gender difference (P>0.05). The incidence of iridociliary cysts was much less in eyes with myopia greater than -9.00 D (P<0.05). The diameter of the largest cyst was 1.96 mm and the smallest cyst was 0.24 mm, with a majority within the range of 0.5 to 1.0 mm. Most of the cysts were located in the inferior temporal quadrant. One year after ICL implantation, 51 iridociliary cysts (37%) remained unchanged, 47 cysts (34%) decreased in size, and 40 cysts (29%) disappeared. Most of cysts that changed after surgery were smaller than 1.0 mm (P<0.05) and located in the nasal and temporal sides around the haptics of implantable lens. All the ICL were in their original position.
CONCLUSION: Iridociliary cysts are commonly seen in myopic eyes. The cysts have no impact on the safety of ICL surgery. Some cysts may decrease in size or disappear after ICL implantation.]]></description>
<pubDate>2020/4/28 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Qian Chen, Meng-Ying Qi, Xiao-Hua Lei and Qing-Yan Zeng]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Qian Chen, Meng-Ying Qi, Xiao-Hua Lei and Qing-Yan Zeng</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200617]]></guid><cfi:id>499</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Visual outcomes after three different surgical procedures for correction of refractive error in patients with thin corneas]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200618]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate and compare the visual and refractive outcomes of small incision lenticule extraction (SMILE), laser assisted sub-epithelial keratomileusis (LASEK), and LASEK combined with corneal collagen cross-linking (LASEK-CXL) surgery in patients with less than 500 μm of central corneal thickness (CCT).
METHODS: The retrospective medical records review was conducted on the patients with CCT less than 500 μm treated with SMILE, LASEK, and LASEK-CXL. There was a total of 172 eyes, 76 eyes were in the SMILE group, 53 eyes in the LASEK group, and 43 eyes in the LASEK-CXL group. Uncorrected distance visual acuity (UDVA), spherical equivalent refraction (SE), and corneal haze were followed up in the three groups for 12mo.
RESULTS: At 12mo postoperatively, there were no statistically significant differences in UDVA and in the absolute value of SE between the three groups. The predictability within ±0.50 D in the SMILE group (85.5%) was significantly higher than in both the LASEK group (64.2%, P<0.01) and the LASEK-CXL group (69.8%, P=0.04). The efficacy index and safety index were not significantly different among the three groups. Corneal haze at 12mo postoperatively was higher in the LASEK-CXL group (27.9%) than in the SMILE group (2.6%, P<0.01) and in the LASEK group (7.5%, P<0.01).
CONCLUSION: In patients with CCT less than 500 μm, SMILE, LASEK, and LASEK-CXL appear to be effective for myopic correction. Among them, SMILE surgery shows the highest predictability.]]></description>
<pubDate>2020/4/28 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hye Seong Hwang, Hyun Jeong Lee, Seong Jun Lee and Jae-Hyung Kim]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hye Seong Hwang, Hyun Jeong Lee, Seong Jun Lee and Jae-Hyung Kim</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200618]]></guid><cfi:id>498</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical efficacy of the partial rectus muscle transportation procedure for paralytic strabismus]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200619]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyze the clinical efficacy of the partial rectus muscle transportation (PRT) procedure for paralytic strabismus due to single rectus muscle palsy.
METHODS: In total, 28 patients (31 eyes) who underwent the PRT procedure for paralytic strabismus due to single rectus muscle palsy were retrospectively examined. The following data were collected pre- and postoperatively: angle of deviation in the primary position, presence of diplopia in the primary position, presence of compensatory head posture, and motility of the affected eye. The follow-up period was 6mo.
RESULTS: Based on the preoperative and intraoperative findings, different operations were performed: 2 eyes were treated with PRT, 26 eyes were treated with PRT combined with the recession of the antagonist muscle (Am) of the paralytic rectus muscle, and 3 eyes were treated with PRT along with the recession of the Am and the yoke muscle (Ym). On the first day after the operation, 24 patients were found to be orthophoric in the primary position, without diplopia or abnormal head posture. Moreover, 2 patients with monocular lateral rectus muscle palsy had mild overcorrection to 5 prism diopters (PD) and 8 PD, respectively, whereas 2 patients with binocular lateral rectus muscle palsy had mild undercorrection to 8 PD and 10 PD, respectively. During the 6-month follow-up period, the mean deviation was rectified from 96.79±41.21 PD to 0.64±2.38 PD (t=12.48, P<0.001), whereas the deviations in the 2 patients with mild overcorrection were corrected to orthotropia. The mean preoperative limitation of motility improved from -4.55±0.51 to -2.65±0.61 (t=-15.13, P<0.001) after 6mo postoperatively.
CONCLUSION: PRT is an effective treatment for complete paralytic strabismus due to single rectus muscle palsy, and can achieve stable clinical efficacy.]]></description>
<pubDate>2020/4/28 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yan-Qiong Tu, Xiao-Ying Wu, Jie-Yue Wang and Feng-Yun Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yan-Qiong Tu, Xiao-Ying Wu, Jie-Yue Wang and Feng-Yun Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200619]]></guid><cfi:id>497</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of conventional and Hang-back methods of inferior oblique recession in V-pattern strabismus with inferior oblique overaction]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200620]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare outcomes of conventional and Hang-back methods of inferior oblique (IO) recession in V-pattern strabismus with inferior oblique overaction (IOOA).
METHODS: Comparative randomized study was conducted consisting of 50 patients, age 6 to 35y having V-pattern strabismus [>15 prism diopter (PD)] with IOOA. They were divided equally in two groups and underwent IO recession, group A by conventional method and group B by Hang-back method. Parameters evaluated were reduction in V-pattern and IOOA, shift in torsion, improvement in binocular status. Success was a residual V-pattern of less than 10 PD at 1y of follow up.
RESULTS: The mean V-pattern preoperatively and postoperatively at 1y was 24±5.4 PD and 4.2±3.51 PD in group A and 23.44±6.44 PD and 5.76±3.8 PD in group B respectively. The mean reduction in V-pattern was 20±6.78 PD in group A and 18.2±5.48 PD in group B. The mean correction of IOOA was 18.48±3.13 PD in group A and 16±2.93 PD in group B. Mean shift in extorsion was 3.08±1.8 degree in group A and 3.72±2.14 degree in group B.
CONCLUSION: Both the procedures achieve a significant and comparable reduction in V-pattern and IOOA. Hang-back recession being a landmark free surgery eliminates the need for intrascleral suturing thereby reducing the risk of scleral perforation with possible postoperative adjustment of muscle. It may be considered as a good alternative for IO recession in patients of V-pattern strabismus with mild to moderate amount of IOOA.]]></description>
<pubDate>2020/4/28 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Kamlesh Anand, Ankita Bharadwaj, Shweta Dhiman, Yashpal Goel, Anju Rastogi, Richa Agarwal, Manisha Mishra and Prateek Kumar]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Kamlesh Anand, Ankita Bharadwaj, Shweta Dhiman, Yashpal Goel, Anju Rastogi, Richa Agarwal, Manisha Mishra and Prateek Kumar</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200620]]></guid><cfi:id>496</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Analysis of choroidal morphology and comparison of imaging findings of subtypes of polypoidal choroidal vasculopathy: a new classification system]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200506]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To classify polypoidal choroidal vasculopathy (PCV) into 2 subtypes based on the subfoveal choroidal thickness (SFCT) and to further evaluate their multimodal image features.
METHODS: A retrospective observational case series study. Sixty-four eyes of 64 patients with PCV were enrolled and classified into 2 groups based on SFCT (thick-choroid group/thin-choroid group). Then further analyze the spectrum domain optical coherence tomography (SD-OCT) and indocyanine green angiography (ICGA) differences of the two subtypes. Imaging analysis included measurement of SFCT, maximum vascular diameter ratio (MVDR), choroidal vascularity index (CVI), central macular thickness (CMT), and the presence of pigment epithelial detachment (PED) on SD-OCT. Polypoidal lesions (polyps) number, branching vascular network (BVN) area, greatest linear dimension (GLD), and the choroidal vascular hyperpermeability (CVH) were analyzed by ICGA.
RESULTS: The distribution of SFCT was bimodal with two peaks at 195 and 285 μm, and a trough at 225 μm. The 225 μm was taken as the cutoff point for the following classification of thick/thin choroid groups. The PCV eyes in the thick-choroid group presented with greater MVDR, CVI within 3 and 6 mm of the fovea, but lower CMT, less PED, small PED diameters on SD-OCT scans, and fewer polyps, smaller BVN and GLD, but more frequency of CVH on ICGA.
CONCLUSION: The SFCT at 225 μm can be used as a readily available indicator for the classification of PCV subtypes. The thick-choroid group presents much apparent enlargement of the choroidal layer and vasculature expansion, which indicates different pathogenesis of the two subtypes.]]></description>
<pubDate>2020/3/30 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Zi-Yang Liu, Bing Li, Song Xia and You-Xin Chen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zi-Yang Liu, Bing Li, Song Xia and You-Xin Chen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200506]]></guid><cfi:id>495</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Diffractive multifocal intraocular lens implantation in patients with monofocal intraocular lens in the contralateral eye]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200507]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate clinical outcomes of unilateral implantation of a diffractive multifocal intraocular lens (IOL) in patients with contralateral monofocal IOL.
METHODS: Twenty-two patients who already had implantation of a monofocal IOL in unilateral eye underwent implantation of a diffractive multifocal IOL in contralateral eye were enrolled. After 1, 6, and 12mo, uncorrected and distant corrected distant visual acuity (UCDVA and DCDVA), uncorrected and distant corrected intermediate-visual acuity (UCIVA and DCIVA), uncorrected and distant corrected near visual acuity (UCNVA and DCNVA), and contrast sensitivity were obtained. Halo/glare symptoms, spectacle dependence, and patient satisfaction were also evaluated.
RESULTS: The mean age was 67.86±7.25y and the average interval between two IOL implantations was 645.82±878.44d. At 1mo, binocular UCDVA was lower than 0.20 logMAR in 76% of patients (mean 0.12±0.13 logMAR), which increased to 90% by 6 and 12mo. The binocular UCDVA was significantly better than the monocular results (P<0.05) at 1, 6, and 12mo. Additionally, UCNVA was lower than 0.40 logMAR in 82% of patients, increasing to 90% by 6 and 12mo. Mean UCNVA in the multifocal IOL implanted eye was statistically significantly better than that in the monofocal IOL implanted eye (P<0.05) at 1, 6, and 12mo. About 5% of patients at 1 and 6mo, reported “severe glare or halo”. Patient satisfaction rates were 95% and 91% at 6 and 12mo, respectively.
CONCLUSION: Unilateral implantation of multifocal IOL in patients with a contralateral, monofocal IOL implantation results in high patient satisfaction rate, with low severe glare or halo rate during follow-up. It can represent a good option for patients who have previously had a monofocal IOL implantation regardless of two year interval duration between two IOL implantations.]]></description>
<pubDate>2020/3/30 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jae Yong Kim, Yunhan Lee, Hun Jae Won, Hyerin Jeong, Jin Hyoung Park, Myoung Joon Kim and Hungwon Tchah]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jae Yong Kim, Yunhan Lee, Hun Jae Won, Hyerin Jeong, Jin Hyoung Park, Myoung Joon Kim and Hungwon Tchah</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200507]]></guid><cfi:id>494</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Optical coherence tomography angiography of the peripapillary region and macula in normal, primary open angle glaucoma, pseudoexfoliation glaucoma and ocular hypertension eyes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200508]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate and compare the peripapillary and retinal vasculature changes in primary open angle glaucoma (POAG), pseudoexfoliation glaucoma (PXG), ocular hypertension (OHT) and normal eyes using optical coherence tomography angiography (OCTA).
METHODS: A total of 114 POAG, PXG and OHT eyes of 60 patients and 46 eyes of 23 healthy control participants with good quality OCTA images were included. The PXG, POAG, OHT, and control groups (aged 68.17±6.30y, 61.11±10.26y, 58.1±8.9y, and 56.9±4.6y, respectively) contained of 46, 36, 32, and 46 eyes, respectively. Measurements of vessel density (VD) in the peripapillary region and macula, average retinal inner thickness, and retinal nerve fiber layer thickness (RNFLT) were compared among groups. In order to test the accuracy of differentiation between eyes with and without glaucoma, the area was calculated under the receiver operating characteristic (ROC) curves.
RESULTS: The VD in glaucomatous eyes was significantly lower than the control group in all peripapillary sectors (44.35%±6.78% vs 50.47%±1.83%, P<0.001), the superficial (44.08%±5.46% vs 51.28%±2.85%, P<0.001) and the deep (45.13%±8.55% vs 54.20%±5.44%, P<0.001) vascular plexus. There was a significant difference in peripapillary VD between glaucomatous and OHT eyes (44.35%±6.78% vs 49.86%±2.45%, P<0.001). The OHT group featured a lower super?cial (48.06%±4.32% vs 51.28%±2.85%, P=0.027) and deep plexus (48.70%±5.99% vs 54.20%±5.44%, P=0.013) whole image vessel density (wiVD) than did the control group. The average macular superficial plexus wiVD was significantly lower in eyes with PXG than in eyes with POAG (42.22%±5.36% vs 46.54%±5.56%, P=0.046).
CONCLUSION: OCTA can measure reduced peripapillary and macular VD in eyes with glaucoma and OHT, and these results are correlated to functional and structural glaucomatous alterations. Peripapillary and macular superficial plexus VD is lower in eyes with PXG than in eyes with POAG. Furthermore, the OHT eyes demonstrate impaired macular vasculature in both superficial and deep plexus.]]></description>
<pubDate>2020/3/30 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Helin Ceren Kose and Oya Tekeli]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Helin Ceren Kose and Oya Tekeli</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200508]]></guid><cfi:id>493</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Internal limiting membrane dragging and peeling: a modified technique for macular holes closure surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200509]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To introduce a modified technique of internal limiting membrane (ILM) centripetal dragging and peeling to treat idiopathic macular hole (IMH) and to observe the ILM-retina adhesive forces.
METHODS: Twenty-six consecutive patients with stage 3 to 4 IMH and followed up at least six months were enrolled. All patients underwent complete par plana vitrectomy, ILM dragging and peeling, fluid and gas exchange, 15% C3F8 tamponade and 2-week prone position. The best corrected visual acuity, macular hole evaluation by optical coherence tomography, and complications were evaluated.
RESULTS: The mean diameter of IMH was 524±148 μm (range: 201-683 μm), with 21 cases (80.8%) greater than 400 μm. ILM dragging and peeling were successfully performed in all cases. Most of the ILM-retina adhesive forces are severe (42.3%, 11/26), followed by mild (38.5%, 10/26), and moderate (19.2%, 5/26). The mean follow-up duration was 21.2±6.1mo. The IMH was closed in 25 (96.3%) eyes. Visual acuity (logMAR) improved significantly from 1.2±0.6 preoperatively to 0.7±0.5 postoperatively (P<0.001).
CONCLUSION: Preexisting ILM-retina adhesive force is found in IMH patients. With assistance of this force, this modified technique may help to release the IMH edges and improve the closure rate of large IMH.]]></description>
<pubDate>2020/3/30 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jie Peng, Li-Hua Zhang, Chun-Li Chen, Jing-Jing Liu, Xiu-Yu Zhu and Pei-Quan Zhao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jie Peng, Li-Hua Zhang, Chun-Li Chen, Jing-Jing Liu, Xiu-Yu Zhu and Pei-Quan Zhao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200509]]></guid><cfi:id>492</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Analysis of the rates of emulsification in intraocular silicone oil tamponades of differing viscosities]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200510]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the rates of emulsification in silicone oil (SO) tamponades of differing viscosities used during pars plana vitrectomy (PPV) in the treatment of complicated vitreoretinal diseases.
METHODS: This study was a prospective randomized clinical trial. Totally 290 cases with greater likelihoods of secondary detachment were included and randomly grouped into either Siluron 2000 (n=143) or Siluron 5000 (n=147) SO tamponades with 23-gauge PPV. Patient follow-ups and data analyses were conducted 1, 3, 6, and 12mo post-surgery.
RESULTS: The time of the SO emulsification ranged from 1 to 17mo, with a mean of 7.3±4.2mo. The Siluron 5000 group showed a slower emulsification rate in comparison to the Siluron 2000 group. The Siluron 2000 group took a shorter time to show signs of emulsification, necessitating earlier SO removal. However, there were no significant differences in the occurrence of complications, including secondary retinal detachment, cataract, corneal abnormality, high intraocular pressure and hypotony.
CONCLUSION: The Siluron 2000 SO tamponade shows a faster rate of emulsification than the Siluron 5000 SO, necessitating earlier removal. Both groups show similar results in terms of anatomical success and visual acuity outcome, and there is no significant difference between the SOs regarding the occurrence of complications.]]></description>
<pubDate>2020/3/30 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xiu-Juan Zhao, Ning-Ning Tang, Yu Lian, Bing-Qian Liu, Yong-Hao Li and Lin Lu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiu-Juan Zhao, Ning-Ning Tang, Yu Lian, Bing-Qian Liu, Yong-Hao Li and Lin Lu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200510]]></guid><cfi:id>491</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Foveal pit morphological changes in asymptomatic carriers of the G11778A mutation with Leber’s hereditary optic neuropathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200511]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the foveal pit morphology changes in unaffected carriers and affected Leber’s hereditary optic neuropathy (LHON) patients with the G11778A mutation from one family.
METHODS: This study was a prospective cross-sectional study. Both eyes from 16 family members (age from 9 to 47y) with the G11778A mutation were analyzed and compared with 1 eye from 20 normal control subjects. Eleven family members with the G11778A mutation but without optic neuropathy were classified as unaffected carriers (n=22 eyes). Five family members (n=10 eyes) expressed the LHON phenotype and were classified as affected patients. Retinal images of all the subjects were taken by optical coherence tomography (OCT), and an automatic algorithm was used to segment the retina to eight layers. Horizontal and vertical OCT images centered on the fovea were used to measure intra-retinal layer thicknesses and foveal morphometry.
RESULTS: Thicker foveal thickness, thinner foveal pit depth, and flatter foveal slopes were observed in unaffected carriers and affected LHON patients (all P<0.001). Further, the slopes of all four sectors in the LHON were flatter than those in the unaffected carriers (all P<0.001). Compared with the control group, affected LHON patients had a thinner retinal nerve fiber layer (RNFL), ganglion cell layer and inner plexiform layer (GCL+IPL), and total retina (all P<0.01). The retinal nerve fiber layer (RNFL) of affected patients was 38.0% thinner than that of controls while the GCL+IPL was 40.1% thinner.
CONCLUSION: The foveal pit morphology shows changes in both unaffected carriers and affects patients. RNFL and GCL+IPL are thinner in affected LHON patients but not in unaffected carriers.]]></description>
<pubDate>2020/3/30 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xin-Ting Liu, Mei-Xiao Shen, Chong Chen, Sheng-Hai Huang, Xi-Ran Zhuang, Qing-Kai Ma, Qi Chen, Fan Lu and Yi-Min Yuan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xin-Ting Liu, Mei-Xiao Shen, Chong Chen, Sheng-Hai Huang, Xi-Ran Zhuang, Qing-Kai Ma, Qi Chen, Fan Lu and Yi-Min Yuan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200511]]></guid><cfi:id>490</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of choroidal thickness in high myopic eyes after FS-LASIK versus implantable collamer lens implantation with swept-source optical coherence tomography]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200512]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the changes in choroidal thickness (CT) in high myopic eyes after femtosecond laser-assisted in situ keratomileusis (FS-LASIK) surgery or central hole implantable collamer lens (ICL V4c) implantation using swept-source optical coherence tomography (SS-OCT).
METHODS: We examined the right eyes of 116 patients with high myopia who were candidates for FS-LASIK surgery and ICL implantation. Sixty eyes underwent ICL V4c implantation and 56 eyes were subjected to FS-LASIK surgery. The CT was measured with SS-OCT. All data were recorded preoperatively and 2h, 1wk, 1 and 3mo postoperatively. Other demographic information was collected, including age, sex, uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), spherical equivalent (SE), intraocular pressure (IOP) and axial length (AL).
RESULTS: The UCVA improved in both groups and showed no significant differences between groups. There also were no significant differences between the two groups in postoperative BCVA and SE (P=0.581 and 0.203, respectively). The foveal CTs, inner nasal and outer nasal CTs were significantly thicker at 2h postoperatively in both groups (P<0.05) but returned to baseline levels in 1wk; after 1mo, no significant differences were found relative to the preoperative values. At 3mo in each group, nine regions showed variations in the CT as compared with preoperative thickening, but only the foveal and nasal area CTs preoperative differences were statistically significant (P<0.05). In addition, there was no significant difference in 9 regions of CT between the two groups at all follow-up times (P>0.05).
CONCLUSION: The CTs after ICL implantation and FS-LASIK surgery are significantly thicker than those before operation, especially in the foveal and nasal areas, but there is no significant difference between the two methods.]]></description>
<pubDate>2020/3/30 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jing Zhang, Fang-Lin He, Yan Liu and Xian-Qun Fan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jing Zhang, Fang-Lin He, Yan Liu and Xian-Qun Fan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200512]]></guid><cfi:id>489</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Changes in corneal biomechanics and intraocular pressure following Femto-LASIK using Goldman applanation tonometry and ocular response analyzer]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200513]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare intraocular pressure (IOP) measurements before and after laser in situ keratomileusis (LASIK) with a femtosecond laser for flap creation using ocular response analyzer (ORA) and Goldmann applanation tonometry, and to identify factors that may influence the preoperative and postoperative IOP.
METHODS: A prospective study conducted on myopic patients who underwent LASIK using a femtosecond laser for flap fashioning. Enrolled patients were evaluated preoperatively, 6wk and 3mo postoperatively for manifest refraction (MR), keratometric (K) readings and central corneal thickness (CCT) using a scheimpflug-based topography. Corneal resistance factor (CRF), corneal hysteresis (CH), Goldmann correlated IOP (IOPg) and corneal compensated IOP (IOPcc) were measured using ORA besides IOP assessment by Goldman applanation tonometry (GAT).
RESULTS: There was a statistically significant decrease in measures of IOPg by 3.35±0.83 mm Hg, followed by GAT which decreased by 2.2±0.44 mm Hg, and the least affected by operation was IOPcc which decreased only by 0.87±0.1 mm Hg after 6wk. After 3mo follow up there was a statistically significant decrease in IOPcc which decreased only by 0.76±0.4 mm Hg, followed by IOP GAT by 1.6±0.5 mm Hg, and the most affected by operation was IOPg which decreased by 2.3±0.3 mm Hg. Correspondingly, there was a statistically significant decrease in CH and CRF after 6wk and 3mo. At 3mo, the preoperative MR and preoperative GAT were prominent significant predictors of the postoperative GAT changes. The prediction equation was subsumed.
CONCLUSION: IOP measurements and corneal biomechanical factors reduce significantly after LASIK with a femtosecond laser for flap creation. The IOPcc values are less influenced by changes in corneal properties than IOPg and GAT, indicating that IOPcc may provide the most reliable measurement of IOP after this procedure.]]></description>
<pubDate>2020/3/30 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ahmed Yassin Hemida, Omar M Said, Asser A.E. Abdel-Meguid, Mohammed Iqbal and Amani E Badawi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ahmed Yassin Hemida, Omar M Said, Asser A.E. Abdel-Meguid, Mohammed Iqbal and Amani E Badawi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200513]]></guid><cfi:id>488</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Stability of the Barrett True-K formula for intraocular lens power calculation after SMILE in Chinese myopic eyes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200405]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the Barrett True-K formula with other formulas integrated in Lenstar 900 to predict intraocular lens (IOL) power after small-incision lenticule extraction (SMILE).
METHODS: A theoretical prospective study was performed to predict the ratio of equivalent IOL power before and after SMILE using the SRK/T (Sanders, Retzlaff, Kraff/theoretical), Holladay 1, Haigis, and Barrett True-K formulas and compare the stability of their predictions. The study included 54 eyes (54 cases) with a manifest refraction spherical equivalent (MRSE) of -4.99±1.45 D. They were divided into two groups: 27 eyes with axial length of 24-26 mm in Group A, and 27 eyes with axial length >26 mm in Group B. All subjects enrolled in this study were examined with the Lenstar 900 before and 6mo after SMILE including measurements of axial length, corneal curvature, and anterior chamber depth (ACD).
RESULTS: The prediction of equivalent IOL power of the two groups was more stable for the Barrett True-K formula, especially in long axial length eyes (Group B). The respective percentages for the SRK/T, Holladay 1, Haigis, and Barrett True-K formulas were 7.4%, 7.4%, 85.19%, and 88.89% for a margin of error within 0.5 D; 25.92%, 51.84%, 100%, and 100% for a margin of error within 1.0 D in Group A; 33.33%, 40.74%, 44.44%, and 81.48% for a margin of error within 0.5 D; and 44.44%, 59.26%, 66.66%, and 92.59% for a margin of error within 1.0 D in Group B. The respective percentages for Barrett True-K formulas were 100% for a margin of error within 2.0 D in Group B.
CONCLUSION: Theoretically, the Barrett True-K formula provides more stable predictions than other formulas for cataract eyes after SMILE.]]></description>
<pubDate>2020/3/3 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Wei Zhu, Feng-Ju Zhang, Yu Li and Yan-Zheng Song]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Wei Zhu, Feng-Ju Zhang, Yu Li and Yan-Zheng Song</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200405]]></guid><cfi:id>487</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of long-term results after manual and femtosecond assisted corneal trephination in deep anterior lamellar keratoplasty for keratoconus]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200406]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare long-term postoperative outcomes of manual and femtosecond assisted corneal trephination in deep anterior lamellar keratoplasty (FS-DALK) for keratoconus.
METHODS: In the retrospective study, 17 consecutive eyes that underwent vertical side cut incision FS-DALK and 22 eyes that underwent trephine incision DALK were collected over a 2-year period. Main measurements included postoperative uncorrected-visual acuity (UCVA), corrected distance visual acuity (CDVA), refractive sphere and cylinder, manifest refraction spherical equivalent (MRSE), flat and steep corneal keratometry (K1 and K2), endothelial cell density (ECD), and time of epithelium healing and suture removal.
RESULTS: Groups were comparable for diagnosis and preoperative visual acuity. Follow-up averaged 23mo (range, 12-36mo). At 12mo, the mean UCVA was better in the manual-DALK group (P=0.039), and the refractive sphere was lower in the FS-DALK group (P=0.040). MRSE between groups differed at 1, 6, and 12mo postoperatively (P=0.047, 0.025, 0.042, respectively). Mean CDVA, cylinder, K1, K2, corneal astigmatism, ECD, and time of epithelium healing were similar between groups. Stability of MRSE, ECD, and K1 returned sooner after FS-DALK. Initial loosened suture removal time was earlier in the manual-DALK group (P=0.042) while complete suture removal time was similar (P=0.122).
CONCLUSION: Manual and femtosecond assisted corneal trephination in DALK are options for advanced keratoconus. FS-DALK do not result in improved visual acuity but it is more stable during the follow-up period. FS-DALK in the present form show limited benefit, so surgical design and parameters still need to be optimized and explored.]]></description>
<pubDate>2020/3/3 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hua Li, Min Chen, Yan-Ling Dong, Jing Zhang, Xian-Li Du, Jun Cheng, Hua Gao and Li-Xin Xie]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hua Li, Min Chen, Yan-Ling Dong, Jing Zhang, Xian-Li Du, Jun Cheng, Hua Gao and Li-Xin Xie</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200406]]></guid><cfi:id>486</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Collagen crosslinking with photoactivated riboflavin in advanced infectious keratitis with corneal melting: Electrophysiological Study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200407]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the effect of photoactivated chromophore for keratitis crosslinking (PACK-CXL) in case of severe keratitis with melting on the electrophysiological function of the retina and the optic nerve.
METHODS: The study included 32 eyes of 32 patients with smear positive severe infectious keratitis with corneal melting. The patients were randomly divided into two groups. Group I (control group) included 16 eyes received systemic and topical antimicrobial drugs guarded by culture and sensitivity test. Group II underwent CXL and then continued their antimicrobial treatment. Full field electroretinogram (ERG) and flash visual evoked potential (VEP) were done for each patient in both groups basically and then 1wk, 1 and 3mo post-treatment to assess the changes in the electrophysiological function of the retina and optic nerve.
RESULTS: Healing of 10 eyes in group I in comparison to 14 eyes in group II was recorded. The mean duration of healing was 36.56±5.21d in group I vs 20.2±4.4d in group II (P<0.005). In group II, ERG showed an insignificant reduction of all parameters of ERG and VEP after CXL. The amplitude of scotopic rod response, oscillatory potential amplitude, flicker amplitude and photopic cone response were insignificantly decreased (P=0.4, 0.8, 0.1, and 0.3 respectively). There were insignificant prolongation of latencies of scotopic rod, oscillatory potential, flicker and photopic cone response (P=0.2, 0.7, 0.5 and 0.1). There was slight delay in latency of VEP without a significant reduction in amplitude.
CONCLUSION: CXL is an effective technique in treatment of severe infectious keratitis with melting as it halts the melting process with acceptable safety on the retinal and optic nerve function.]]></description>
<pubDate>2020/3/3 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Eman A. Awad, Mona Abdelkader, Ameera G. Abdelhameed, Walid M. Gaafar and Tharwat H. Mokbel]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Eman A. Awad, Mona Abdelkader, Ameera G. Abdelhameed, Walid M. Gaafar and Tharwat H. Mokbel</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200407]]></guid><cfi:id>485</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of intraocular lens implantation on visual field in glaucoma and comorbid cataracts]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200408]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the effects of intraocular lens (IOL) implantation on visual field (VF) in patients with glaucoma and comorbid cataracts (G&C) with different disease severities.
METHODS: Totally 56 eyes of 50 patients with primary G&C were included. All patients were divided into three groups based on the severity of the VF defect: the mild, moderate, and severe stage. Phacoemulsification was performed for cataract removal combined with IOL implantation. Visual acuity (VA) and VF tests were performed for all enrolled patients, up to 3mo after surgery. Changes in VF threshold and global VF index in various groups were also recorded before and after surgery. The mean light sensitivity (MS) values and the changes following surgery (DMS) were compared between the three groups. Advanced Glaucoma Intervention Study (AGIS) scoring was analyzed on all VF results for analysis of changes in VF before and after surgery.
RESULTS: Following surgery, the MS values of the three groups of G&C increased significantly, while the AGIS scores decreased statistically in all groups. The DMS values for the three zones in moderate and severe stage but not mild stage were statistically different between zones. The DMS value was significantly higher in zone I than those in zone II and III (zone I>zone II>zone III; P<0.05). The DMS was significantly higher in zone I than that in zone III in moderate stage patients (zone I>zone II>zone III; P<0.01), while the DMS values in the severe stage patients was significantly higher in zone I than those in zone II and III (zone I>zone II>zone III; P<0.01).
CONCLUSION: The mean VF sensitivity of glaucoma patients increased significantly after cataract removal and IOL implantation. Variations in the severity and distribution of characteristics of VF defects result in differences in postoperative VF improvements after cataract surgery. The magnitude of increase in VF sensitivity is associated with VF defect characteristic in glaucoma.]]></description>
<pubDate>2020/3/3 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Can Zhao, Qing Cun, Yi-Jin Tao, Wen-Yan Yang, Hua Zhong, Feng-Jie Li, Sean Tighe, Ying-Ting Zhu and Ting Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Can Zhao, Qing Cun, Yi-Jin Tao, Wen-Yan Yang, Hua Zhong, Feng-Jie Li, Sean Tighe, Ying-Ting Zhu and Ting Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200408]]></guid><cfi:id>484</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of capsular tension ring implantation on predicted refractive error after cataract surgery in patients with pseudoexfoliation syndrome]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200409]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the effect of capsular tension ring (CTR) implantation on predicted refractive error after cataract surgery in patients with pseudoexfoliation (PEX) syndrome.
METHODS: This double-blind randomized clinical trial was conducted on 60 patients with PEX syndrome referring to Imam Khomeini Hospital affiliated to Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran, for undergoing cataract surgery. The study population was divided into two groups, namely CTR group (n=30) and non-CTR group (control group; n=30). The refractive error and anterior chamber depth (ACD) were measured 1wk, 1mo, and 3mo after phacoemulsification (PE) surgery.
RESULTS: The results indicated no statistically significant difference between the two groups in terms of predicted refractive error (obtained by subtracting preoperative predicted refractive error from actual postoperative refractive error) 1wk (P=0.47), 1mo (P=0.30), and 3mo (P=0.06) after the PE surgery. Regarding the CTR group, the changes of ACD was statistically significant 1 and 3mo after the PE surgery, compared to those obtained 1wk post-surgery (P=0.005).
CONCLUSION: The CTR implantation in PEX cataractous patients without zonulysis has no statistically significant effect on the predicted refraction and ACD changes after PE. The predicted refraction error has a hyperopic shift in both groups. The results reveal the unnecessary of calculating modified IOL in CTR implantation.]]></description>
<pubDate>2020/3/3 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mohammad Malekahmadi, Sadegh Kazemi, Farideh Sharifipour, Farshad Ostadian, Atefeh Mahdian Rad and Mohammad Sadegh Mirdehghan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mohammad Malekahmadi, Sadegh Kazemi, Farideh Sharifipour, Farshad Ostadian, Atefeh Mahdian Rad and Mohammad Sadegh Mirdehghan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200409]]></guid><cfi:id>483</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Pentacam changes in primary angle-closure glaucoma after different lines of treatment]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200410]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the changes in the anterior chamber parameters using Pentacam following four different lines of treatment of primary angle-closure glaucoma (PACG).
METHODS: A retrospective comparative study included 126 patients (126 eye) presented within 24-48h after acute angle-closure glaucoma (AACG). Patients were divided into 2 groups: group A (68 eyes) with controlled intraocular pressure (IOP) ≤21 mm Hg, which included subgroup A1 (34 eyes) with clear lens underwent Nd:YAG laser peripheral iridotomy (LPI) and subgroup A2 (34 eyes) with cataract underwent standard phacoemulsification; and group B (58 eyes) with uncontrolled IOP, which included subgroup B1 (30 eyes) with clear lens underwent trabeculectomy and subgroup B2 (28 eyes) with cataract underwent combined phacoemulsification and trabeculectomy. Patients were followed up for at least 3mo. Primary outcomes were Pentacam anterior segment measurements [anterior chamber angle (ACA) and depth (ACD)]. Secondary outcomes were changes in IOP, visual acuity (VA) and recorded complications.
RESULTS: At the 3rd month, there was significant increase in the ACA values in all studied groups compared to preoperative values (P<0.001). The highest percent of increase in ACA was recorded in phacotrabeculectomy group B2 (128.40%). There was significant increase in ACD values at 3rd month compared with baseline values (P<0.001) for groups A1, A2, and B2; without change in B1 trabeculectomy group. The maximum deepening of ACD was noticed in group B2 with 94.27% increase. Significant decrease in postoperative IOP in groups A2, B1 and B2  (P<0.001, P=0.014, and P<0.001 respectively). In group A1  there was significant increase in 3rd month postoperative IOP from baseline values (P<0.001). The maximum decrease in IOP was noticed in group B2 with 59.54% decrease. VA improvement in 3rd month postoperative was recorded in all studied groups, maximum VA improvement was observed in group B2 up to 0.2 logMAR.
CONCLUSION: Pentacam can be a helpful tool in studying and comparing the effect of the different lines of management of PACG on the anterior chamber measures. Phacotrabeculectomy was proved to be an effective line for managing PACG with resultant significant increase in the anterior chamber parameters, IOP reduction as well as maximum VA improvement. LPI has only temporary effect on IOP with significant changes in ACA and ACD. Phacoemuslification alone can be an option in treating PACG. Trabeculectomy resulted in temporary increase in the anterior chamber parameter which subsequently returned to baseline values.]]></description>
<pubDate>2020/3/3 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Tharwat H. Mokbel, Abd-Elmonem Elhesy, Ahmed Alnagdy, Mohammed F. Elashri, Ahmed M. Eissa, Walid M. Gaafar and Sherein M. Hagras]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Tharwat H. Mokbel, Abd-Elmonem Elhesy, Ahmed Alnagdy, Mohammed F. Elashri, Ahmed M. Eissa, Walid M. Gaafar and Sherein M. Hagras</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200410]]></guid><cfi:id>482</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Elevated VEGF-A & PLGF concentration in aqueous humor of patients with uveal melanoma following Iodine-125 plaque radiotherapy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200411]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To measure the concentration of vascular endothelial growth factor-A (VEGF-A), and placental growth factor (PLGF) in aqueous humor of uveal melanoma patients before and after Iodine-125 plaque therapy (IPT), determine the postoperative fluctuation and evaluate associated factors in vivo.
METHODS: Participants were 18 Chinese patients with uveal melanoma who were elected to IPT. Undiluted aqueous humor samples were collected at Iodine plaque implant and removal time, then stored immediately at -80℃ until assayed. The concentration of VEGF-A, PLGF and other 7 cytokines comprising interleukin-2 (IL-2), IL-8, IL-10, interferon (IFN)-γ, programmed death (PD)-1, transforming growth factor (TGF)-β1 and insulin-like growth factor (IGF)-1 in aqueous humor was measured using Raybiotech immunoassay kit, a high throughput strategy. The VEGF-A and PLGF levels were compared across preoperation and postoperation subgroups, as well as those of other 7 interleukins. Correlation and grouped analyses were conducted to determine the independent effects of clinical parameters and other cytokines on VEGF-A and PLGF concentration or fluctuation. This study set a self-control design.
RESULTS: VEGF-A (P=0.038) and PLGF (P=0.026) were the only two increased cytokines after IPT. Preoperative and postoperative level of VEGF-A and PLGF (r=0.575, P=0.013; r=0.987, P<0.001) correlated with each other significantly. Level of VEGF-A (r=0.626, P=0.005; r=0.588, P=0.01) and PLGF (r=0.616, P=0.007; r=0.588, P=0.01) had positive correlation with tumor thickness consistently. Elevated VEGF-A or PLGF level were strong predictive factors of each other (P=0.007, OR=60.0). The elevated VEGF-A group showed a higher postoperative level of IFN-γ (P=0.005), IL-2 (P<0.001) and IL-10 (P=0.004) in aqueous humor. When the elevated PLGF group got similar results that a higher postoperative level of IFN-γ (P=0.007), IL-2 (P<0.001) and IL-10 (P=0.013) in aqueous humor.
CONCLUSION: This study reveals that VEGF-A and PLGF in aqueous humor significantly increased with tumor thickness and radiation process in uveal melanoma patients. VEGF-A and PLGF may be crucial in uveal melanoma genesis and radiotherapy reactions. Immune mediators comprised IFN-γ, IL-2 and IL-10 could play roles in the link between inflammation and angiogenesis in uveal melanoma when exposed to radiotherapy.]]></description>
<pubDate>2020/3/3 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Meng-Xi Chen, Yue-Ming Liu, Yang Li, Xuan Yang and Wen-Bin Wei]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Meng-Xi Chen, Yue-Ming Liu, Yang Li, Xuan Yang and Wen-Bin Wei</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200411]]></guid><cfi:id>481</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effects of intravitreal conbercept before panretinal photocoagulation on lipid exudates in diabetic macular documented by optical coherence tomography]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200412]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the effects of intravitreal conbercept (IVC) as adjunctive treatments before panretinal photocoagulation (PRP) to decrease hyperreflective dots (HRDs) in Chinese proliferative diabetic retinopathy (PDR) patients.
METHODS: Fifty-nine enrolled patients were categorized into 2 groups: single dose IVC (0.5 mg/0.05 mL) 1wk before PRP (Plus group) or PRP only (PRP group). Six months later, we measured the best corrected visual acuity (BCVA), central macula thickness (CMT) by optical coherence tomography and counted the number of HRDs in different retina layers.
RESULTS: The average CMT significantly decreased in Plus group but increased in PRP group. The average BCVA in the Plus group was also significantly better than that in the PRP group. Total HRDs decreased in the Plus group but increased in PRP group significantly. IVC pre-treatment has beneficial effects on reducing HRDs forming in the inner retina layer while the PRP alone increased the HRDs in the outer retina layer.
CONCLUSION: IVC is a promising adjunctive treatment to PRP in the treatment of PDR. Single dose IVC one week before PRP is suggested to improve retina blood-retina barrier, decrease lipid exudate and inhibit HRDs development in PDR.]]></description>
<pubDate>2020/3/3 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jing-Rong Shi, Quan Zhang, Ting Zhang, Hong Zhuang, Zhong-Cui Sun and Yao-Wu Qin]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jing-Rong Shi, Quan Zhang, Ting Zhang, Hong Zhuang, Zhong-Cui Sun and Yao-Wu Qin</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200412]]></guid><cfi:id>480</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Anatomic and functional results of idiopathic macular epiretinal membrane surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200413]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the impact of macular surgery on the functional and anatomic outcomes in patients with grade 2 epiretinal membrane (ERM), and the effect of internal limiting membrane (ILM) peeling on visual acuity and to analyze the long-term effect of pars plana vitrectomy (PPV) on intraocular pressure (IOP).
METHODS: Pseudophakic eyes (62 eyes) diagnosed as idiopathic grade 2 ERM with at least 6mo postoperative follow-up were included in this retrospective study. The fellow eye was nonvitrectomized. Patients were divided into two groups: group 1 (29 eyes) treated with ERM and ILM peeling and group 2 (33 eyes) with only ERM peeling. Preoperative and postoperative best corrected visual acuity (BCVA), slit-lamp, and a dilated fundus examination was performed. IOP was measured with Goldman applanation tonometer before, day 1 and first week and each visit after surgery. The incidence of significant IOP elevation was compared between vitrectomized eyes and nonvitrectomized fellow eyes.
RESULTS: Visual improvement was statistically significant and similar in both groups (P=0.008 in group 1, P=0.002 in group 2, P=0.09 inter-group). The amount of decrease in central macular thickness was statistically significant and similar in both groups (P=0.005 group 1, P=0.008 group 2, P=0.37 intergroup). At the final follow-up (14.1±9.6mo) the incidence of significant IOP elevation was 4% in vitrectomized eyes (three eyes) and 3% (two eyes) in the nonvitrectomized fellow eyes (P=0.12). Four eyes (12.1%) had recurrent ERM after a mean follow-up of 8.6±1.1mo in group 2, there was no recurrence in group 1 (P=0.01).
CONCLUSION: Recurrence of ERM may be decreased by ILM peeling during ERM surgery. However, it seems that ILM peeling do not affect the functional outcome and 23-gauge PPV alone do not have a significant effect on IOP.]]></description>
<pubDate>2020/3/3 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mehmet Ozgur Cubuk and Erkan Unsal]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mehmet Ozgur Cubuk and Erkan Unsal</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200413]]></guid><cfi:id>479</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Retinal vascular diameter changes assessed with a computer-assisted software after strabismus surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200414]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To quantitatively investigate the retinal vascular diameter changes, analyzing the early and long-term effects on the retinal circulation, with 6-month follow-up.
METHODS: Patients underwent horizontal strabismus surgery were enrolled prospectively. Retinal vessel diameters on color fundus photographs were assessed before and 1, 7d, 6mo after surgery, using a computer-assisted quantitative assessment software. To evaluate the retinal vascular caliber changes, retinal vascular diameters were calculated by means of the Parr–Hubbard formula as the central retinal arteriolar equivalent (CRAE) and central retinal venular equivalent (CRVE). The arteriovenous ratio (AVR) was calculated as CRAE divided by CRVE.
RESULTS: A total of 154 eyes of 104 consecutive patients were included. Compared with the data before surgery (121.55±24.67), the mean CRAE (131.18±28.29) significantly increased 1d after surgery (P=0.003), but went back to baseline level at 7d (118.89±30.35, P=0.15), and 6mo (123.22±15.32, P=0.60), so did the AVR (P<0.001, P=0.08, P=0.07). As for the mean CRVE, there was no significant difference between those four time points (172.43±33.25, 175.57±36.98, 174.03±40.18,  174.86±20.46, P=1.00).
CONCLUSION: Strabismus surgery on both lateral and media rectus muscles, or single media rectus muscle may increase retinal blood flow during the early postoperative period, but would return to normal later. The number of transected anterior ciliary arteries rather might be the main cause of retinal hemodynamic changes early after strabismus surgery.]]></description>
<pubDate>2020/3/3 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jin-Qiong Zhou, Jing Fu, Ji-Peng Li, Xiao-Zhen Wang, Wen-Ying Wang, Bo-Wen Zhao and Meng Qi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jin-Qiong Zhou, Jing Fu, Ji-Peng Li, Xiao-Zhen Wang, Wen-Ying Wang, Bo-Wen Zhao and Meng Qi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200414]]></guid><cfi:id>478</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Repeatability and agreement of two anterior segment OCT in myopic patients before implantable collamer lenses implantation]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200415]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the intra-operator repeatability of time domain and swept-source Fourier domain anterior segment optical coherence tomography (AS-OCT), namely, Visante AS-OCT and Casia SS-1000 OCT, in measuring the preoperative parameters of implantable collamer lens (ICL) in myopic eyes, as well as the agreement between the two devices.
METHODS: A total of 97 eyes from 49 myopes were investigated in this prospective case series study. The anterior chamber depth (ACD), angle-to-angle distance (ATA), pupil diameter (PD) and crystalline lens rise (CLR) in all subjects were measured for three times during one session by the same operator. The repeatability was evaluated using the within-subject standard deviation (Sw), repeatability limits and intraclass correlation coefficients (ICC). The agreement between the two systems was evaluated using the Bland-Altman plots and 95% limits of agreement (LoA).
RESULTS: The repeatability limits of Visante AS-OCT in measuring ACD, ATA, PD and CLR were 0.099, 0.141, 0.304, and 0.079 mm, respectively. The repeatability limits of Casia SS-1000 OCT in measuring ACD, ATA, PD, and CLR were 0.105, 0.127, 0.357, and 0.082 mm, respectively. Excellent repeatability could be attained in both devices, with the ICC>0.8 for all the measured variables. The interdevice agreement was excellent (P>0.05) for ACD and ATA, but poor (P<0.05) for PD and CLR.
CONCLUSION: Good repeatability can be attained by time domain and swept-source Fourier-domain OCT for all the measured variables. Moreover, interdevice agreement analysis suggests that interchangeable measurements between two devices can be achieved for ACD and ATA, but not for PD and CLR; but the differences in measurements were not clinically significant.]]></description>
<pubDate>2020/3/3 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xi-Fang Zhang, Meng Li, Yan Shi, Xiu-Hua Wan and Huai-Zhou Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xi-Fang Zhang, Meng Li, Yan Shi, Xiu-Hua Wan and Huai-Zhou Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200415]]></guid><cfi:id>477</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Three horizontal muscle surgery for large-angle esotropia: success rate and dose-effect ratio]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200416]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the moderate-term success and calculate the mean dose-effect ratio in large-angle esotropic patients who underwent three muscle surgery.
METHODS: In a retrospective study, we reviewed the medical records of 37 patients with large-angle esotropia who underwent bilateral medial rectus recession and one lateral rectus resection. Sex, age at surgery time, amount of recessed or resected muscles in millimeter (mm), pre- and postoperative alignment in prism diopter (D), dose/response ratio, and presence of amblyopia and other associated vertical deviations were recorded.
RESULTS: The mean age of subjects at surgery was 12.2±12.3y (range: 1-57). The mean preoperative deviation of 70.4±8.1 D (range: 60-85 D) decreased to a mean of 5.4±8.1 D (range: 0-30 D) postoperatively (P<0.005). Successful alignment was achieved in 30 of 37 patients (81%) at a mean follow-up of 15.7±20.1mo (range: 3-90). The mean amount of recession and resection was 17.59±1.29 mm, and a mean dose-response ratio of 3.79±81 (range: 2.83-4.66) was determined.
CONCLUSION: Three-muscle surgery for large-angle esotropia results in good moderate-term outcomes without high rates of overcorrection or undercorrection.]]></description>
<pubDate>2020/3/3 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Reza Nabie, Vahideh Manouchehri, Saba Salehpour, Banafsheh Kharrazi Ghadim and Erfan Bahramani]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Reza Nabie, Vahideh Manouchehri, Saba Salehpour, Banafsheh Kharrazi Ghadim and Erfan Bahramani</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200416]]></guid><cfi:id>476</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[The effects of simultaneous operation on dissociated vertical deviation with horizontal and torsional strabismus]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200417]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the therapeutic effects of simultaneous horizontal and vertical operations on dissociated vertical deviation (DVD) associated with other deviations.
METHODS: Forty-five cases of DVD with horizontal and torsional strabismus underwent combined operation were collected retrospectively. All clinical records were analyzed. All patients were followed up for 6 to 24mo. Wilcoxon signed-ranks test was performed to evaluate the changes of vertical and horizontal deviation. χ2 test was used to evaluate the changes of binocular visual function.
RESULTS: Forty-five cases included 36 patients with intermittent exotropia and binocular inferior oblique overaction (IOOA), 5 patients with concomitant esotropia and binocular IOOA, 4 patients with intermittent exotropia and monocular superior oblique palsy. The superior rectus recession (SRR) combined with horizontal rectus recession and the myectomy of inferior oblique or anterior transposition were operated simultaneously to correct all types of strabismus. There were 43 cases who achieved normal eye position in vertical direction, while 2 cases were with undercorrection of 5Δ to 6Δ. In patients with horizontal strabismus, 2 cases of exotropia were with overcorrection of 6Δ to 8Δ, 1 case of esotropia was with undercorrection of 6Δ, and 1 case of monocular superior oblique palsy with compensatory head posture was not significantly improved. The binocular visual function of most patients recovered after operation. The difference of the binocular visual function and eye position were significant compared with that before operation (P<0.05).
CONCLUSION: The simultaneous operation on DVD with horizontal and torsional strabismus is successful.]]></description>
<pubDate>2020/3/3 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Lu-Qin Wan, Xiao-Mei Wan, Hua-Qing Gong and Li-Xin Xie]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Lu-Qin Wan, Xiao-Mei Wan, Hua-Qing Gong and Li-Xin Xie</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200417]]></guid><cfi:id>475</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Noninvasive stiffness assessment of the human lens nucleus in patients with anisometropia using an ultrasound elastography system]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200305]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the significance of ultrasound elastography for evaluating stiffness of the human lens nucleus in patients with anisometropia.
METHODS: A total of 14 patients (28 eyes) with anisometropia were enrolled. The difference in refractive status between two eyes ≥-4.0 diopters (D) and the difference in axial length (AL) of the eyes was ≥3 mm. There were 5 males and 9 females with an average age of 62±3.3y. The test data of the long AL eye of each patient was included in group A (14 eyes), and test data of the eye with relative short AL was included in group B. Lens nuclear stiffness was measured with free-hand qualitative elastography by independent operators. Strain gray scale and color-coded elastography maps were recorded. In each case, three consecutive measurements were performed and strain ratio was used for statistical analysis. Photograph and sectional view of the lens were analyzed and archived by anterior segment image.
RESULTS: In the long AL group, the strain rate in the nucleus of the lens was 0.16%±0.08%; in the short AL group, the strain rate in the nucleus of the lens was 0.54%±0.16%. Independent sample t-test analyses showed that the long AL group lens had a significantly smaller nuclear strain rate than the relatively short AL group, P<0.05.
CONCLUSION: The relationship between human lens stiffness and different AL is demonstrated by ultrasound elastography. The long AL is associated with lower strain ratio and less resilience of the lens.]]></description>
<pubDate>2020/2/4 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hai-Yan Zhou, Hong Yan, Wei-Jia Yan, Xin-Chuan Wang and Qiao-Ying Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hai-Yan Zhou, Hong Yan, Wei-Jia Yan, Xin-Chuan Wang and Qiao-Ying Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200305]]></guid><cfi:id>474</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Traumatic endophthalmitis and the outcome after vitrectomy in young children]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200306]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To explore the traumatic endophthalmitis in young children and the outcome of pars plana vitrectomy (PPV).
METHODS: Twenty-two eyes of 22 cases of young children consecutive pediatric traumatic endophthalmitis treated and followed up between September 2014 and May 2018 were included. Aqueous humor or vitreous samples were taken for bacterial culture and sensitivity tests. Intravitreal antibiotics (norvancomycin and ceftazidime) injection, combined with 23-gauge PPV, were administered in 22 eyes. Silicone oil (SO; 5000 centistoke) tamponade or perfluoropropane gas (C3F8) was used in all patients. Main outcome measures were best-corrected visual acuity (BCVA) and retinal attachment, the ratio of penetrating injury, and the existence of intraocular foreign body.
RESULTS: The mean age of patients was 6.9±2.2 (range, 3-10)y. All injured eyes suffered from penetrating ocular injury with retained intraocular foreign body in one eye. Bacterial culture was positive in only 2 eyes. The mean follow-up time was 21.1±4.7 (range, 12-30)mo. In the primary PPV, intravitreal antibiotics was administrated in all eyes, SO in 18 eyes, and C3F8 in 4 eyes. The secondary operation of SO removal and C3F8 endotamponade was performed in 16 eyes and a second SO endotamponade due to emulsification of the oil and retinal detachment (RD) was operated in 7 eyes underwent 3 to 11.5mo after primary PPV. A third operation was done in 7 eyes. The final intraocular pressure (IOP) was 8.9±1.8 (range, 6.9-11.4) mm Hg. The final BCVAs were 20/200 or better in 5, counting fingers in 2, and light perception to hand movement in 8 eyes. Whose (66.7%) had retinal injury exhibited worse BCVA (P=0.019, Fisher’s exact test). Eyes underwent SO tamponade exhibited worse final BCVA than that with C3F8 in the primary PPV (P=0.026, Fisher’s exact test).
CONCLUSION: Traumatic endophthalmitis in children is generally more severe and associated with more complicated surgical procedures. Most patients have retinal injury need multiple operations and the final BCVA is poor. Prevention of ocular trauma, especially in children, is still critical.]]></description>
<pubDate>2020/2/4 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ya-Li Zhou, Yi-Xiao Wang, Teng-Teng Yao, Yuan Yang and Zhao-Yang Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ya-Li Zhou, Yi-Xiao Wang, Teng-Teng Yao, Yuan Yang and Zhao-Yang Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200306]]></guid><cfi:id>473</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Pars plana vitrectomy relieves the depression in patients with symptomatic vitreous floaters]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200307]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the depressive state among the patients with symptomatic vitreous floaters (SVF), as well as its change after SVF removal via vitrectomy surgery.
METHODS: Twenty-eight eyes of 28 patients who underwent 27-gauge pars plana vitrectomy (PPV) for SVF were included. Thirty-nine eyes of 39 age- and gender- matched healthy volunteers without SVF were also recruited as a healthy control. Center for Epidemiologic Studies Depression (CES-D) was used to assess volunteers and patients’ depression (before and 1wk after PPV).
RESULTS: The CES-D score was 18.3±8.6 for patients, and was 12.4±6.0 for healthy control (P=0.003). Patients were significantly more likely to be in a depressive state (53.6%, defined as CES-D score ≥16) than the healthy control (20.5%, P=0.005). For patients with SVF, the CES-D score was negatively correlated with their age (rs=-0.42, P=0.025). After PPV, both the CES-D score (11.9±5.4 vs 18.3±8.6, P<0.001) and proportion of depressive state (18.5% vs 53.6%, P=0.005) were significantly decreased.
CONCLUSION: This study suggests that symptoms of vitreous floaters have an apparently negative impact on patients’ psychological state. The PPV can effectively relieve the depressive state for patients with SVF.]]></description>
<pubDate>2020/2/4 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Rong-Han Wu, Jun-Hong Jiang, Yi-Fan Gu, Nived Moonasar and Zhong Lin]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Rong-Han Wu, Jun-Hong Jiang, Yi-Fan Gu, Nived Moonasar and Zhong Lin</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200307]]></guid><cfi:id>472</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Flicker defined form and RareBit measurements lack in specificity of visual pathways]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200308]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the different visual pathways represented by the Heidelberg Engineering Perimeter flicker defined form and RareBit (magnocellular and parvocellular respectively) in different age-groups and according to the fatigue.
METHODS: Totally 64 eyes of 32 healthy subjects were included in the prospective study. Each participant underwent screening—ophthalmic examination including best-corrected visual acuity, anterior and posterior segment assessment, and visual field examination with Heidelberg Edge Perimetry (HEP)-standard automated perimeter (SAP) 24-2. They were observed for 2y previously to the enrollment. This helped to define that the enrolled patients did not bear the glaucoma-developing potential. During the screening and after two years the HEP had been conducted in the standard protocol 24-2 and RareBit perimetry (RBP) in accordance with the manufacturer’s description. Participants were randomly assigned to the groups: flicker defined form (FDF)-first or RBP-first. This defined from which additional visual field test the participant started. Participants were additionally subdivided to younger and older study groups. The effect of subject variables was explored with Mann-Whitney U-test. Testing for the presence of correlations between parameters was performed using the Spearman Rank Order Correlations and confirmed by the parametric tests. For the influence of additional factors, the Kruskal-Wallis test was performed.
RESULTS: The positive correlation between mean deviation (MD) and mean hit rate (MHR) and pattern standard deviation (PSD) and standard deviation of MHR (±MHR) were found in younger study group (P=0.005, r=0.481 and P=0.0074, r=0.465), whereas in the older subgroup no correlation was observed. Additionally, the randomization protocol helped in defining the role of fatigue on the HEP-FDF results. Participant for whom the HEP-FDF was performed after RareBit had significantly worse results than those for whom the HEP-FDF was first. In the younger group, the MHR and ±MHR depend from age in that group (P<0.05, r=0.43 and r=-0.57 respectively) while no age-dependent differences were found in HEP-related parameters. On the contrary in the older group the MD and PSD varies with age (P<0.05, r=0.47 and r= -0.44 respectively) while the RBP parameters remained unchanged. The questionnaire showed that participants preferred RareBit over HEP-FDF in terms of a duration time, comfort, understanding of the test procedures, and ocular pain (P<0.05).
CONCLUSION: The influence of patient’s fatigue should be considered during HEP-FDF examination. An overlap hypothesis should be reevaluated after determining of other factors that affect HEP-FDF and RareBit results.]]></description>
<pubDate>2021/8/31 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Justyna Szkudlarek-Wodzińska, Joanna Przezdziecka-Dolyk, Olaf Fuchs, Ziemowit Poznański and Marta Misiuk-Hojlo]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Justyna Szkudlarek-Wodzińska, Joanna Przezdziecka-Dolyk, Olaf Fuchs, Ziemowit Poznański and Marta Misiuk-Hojlo</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200308]]></guid><cfi:id>471</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[High-dose ruthenium-106 plaque therapy for circumscribed choroidal hemangioma: a retrospective study of 25 Chinese patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200309]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the efficacy and safety of ruthenium-106 (106Ru) plaque radiotherapy at a dose (>50 Gy) higher than recommended (29-50 Gy) for treatment of circumscribed choroidal hemangioma (CCH) in Chinese patients.
METHODS: This retrospective study included 25 symptomatic CCH patients undergoing 106Ru plaque brachytherapy involving 25 eyes between January 2005 and August 2016. Ophthalmic examination was performed at the baseline and at each post-treatment follow-up visit, using best-corrected visual acuity (BCVA), dilated fundus examination, and B-scan ultrasonography. The primary efficacy outcome measures included the changes in BCVA and hemangioma dimensions at the last followup visit from the baseline.
RESULTS: The mean follow-up duration was 28.0±26.6 (range, 12-110)mo. All the hemangiomas were located in the posterior pole except for two involving the fovea. The mean apex dose of 106Ru plaque radiotherapy was 84.4±19.7 Gy. The mean BCVA improved from 41.4±29.3 (0-97) at the baseline to 53.0±33.8 (0-97) ETDRS letters at the last visit (P=0.01). The mean hemangioma height declined from 3.98±0.88 (2.40-5.50) mm to 0.84±1.63 (0-6.47) mm (P≤0.001), and the greatest linear diameter (GLD) reduced from 9.36±2.23 (6.80-15.00) to 7.40±2.45 (0-13.00) mm (P≤0.001). Hemangioma size increased in one (4%) eye with a worsened vision, and subretinal fluid completely resolved in all but one patient (4%). Radiation-related retinopathy was observed in two patients at post-treatment 9 and 11mo, respectively.
CONCLUSION: 106Ru plaque brachytherapy at a dose (>50 Gy) higher than recommended (29-50 Gy) is an effective treatment regimen for symptomatic CCH associated with significantly improved visual acuity and a favorable safety profile in Chinese patients.]]></description>
<pubDate>2020/2/4 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jing Li, En-Zhong Jin and Jian-Hong Liang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jing Li, En-Zhong Jin and Jian-Hong Liang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200309]]></guid><cfi:id>470</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Correlation of the history of stroke and the retinal artery occlusion: a nested case-control study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200310]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyze the systemic factors including stroke history related to the retinal artery occlusion (RAO).
METHODS: Patients with an exact diagnosis of RAO in the medical database of the Kailuan Corporation were identified as the case group. Five patients without RAO were added for each case from the Kailuan Study and matched for sex and age (age±2) as the control group. The Kailuan Study is a general population-based cohort study in northern China, in which a total of 101 510 individuals (81 110 men) aged 18-98y were recruited to participate in the study. And the participants were bi-annually re-examined. The database of both groups was from Kailuan study of 2010 cohort. All the information, including the demographic characteristics, lifestyle behaviors, medical comorbidities, medical history, family medical history, drug usage, anthropometric measurements, blood pressure measurement, blood sample laboratory assessment, urine tests, and other physical examinations were all collected. A retrospective nested case-control method was used for this study. Conditional multivariate logistic regression was used to analyze the risk factors with SPSS 13.0 software and SAS 9.3 software.
RESULTS: A total of 45 patients were included as the case group, and the control group included 225 patients. In the case group, 28 patients (62.2%) had a central retinal artery occlusion (CRAO), and 17 patients (37.8%) had a branch retinal artery occlusion (BRAO). A total of 18 patients (40.0%) had a stroke before the RAO (mean 4.04±3.88y before the RAO), and 31 patients (81.6%) had infarctions or malacia identified by the cranial computed tomography (CT) scans. The basal ganglia and centrum semiovale were the most frequently involved regions. Plaques in the common carotid artery were present in 32 patients (88.9%). Conditional multivariate logistic regression analysis showed that the RAO was found to be associated with the history of stroke (P=0.0023, OR=28.794; 95%CI: 3.322-249.586).
CONCLUSION: A history of stroke can significantly increase the incidence of RAO. Exists of plaque in the carotid artery is mean more than its severe stenosis for RAO.]]></description>
<pubDate>2020/2/4 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yue-Yan Xiao, Wen-Bin Wei, Ya-Xing Wang, Ai-Dong Lu, Shuo-Hua Chen, Lu Song and Shou-Ling Wu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yue-Yan Xiao, Wen-Bin Wei, Ya-Xing Wang, Ai-Dong Lu, Shuo-Hua Chen, Lu Song and Shou-Ling Wu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200310]]></guid><cfi:id>469</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Long-term effects of pattern scan laser pan-retinal photocoagulation on diabetic retinopathy in Chinese patients: a retrospective study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200206]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the long-term effects of pattern scan laser (PASCAL) pan-retinal photocoagulation (PRP) on diabetic retinopathy (DR) in Chinese patients.
METHODS: In this retrospective study, we evaluated clinical data of 29 patients (53 eyes) with severe non-proliferative DR (SNPDR) or proliferative DR (PDR) who received PRP and follow-up at our hospital from 2008 to 2013. Sixteen patients (29 eyes) received PASCAL PRP and 13 patients (24 eyes) received 100-ms conventional laser PRP.
RESULTS: After long-term follow-up (mean, min-max days: 719.8, 290-1666 for PASCAL PRP vs 743.5, 240-1348 for conventional PRP, P=0.569), patients receiving PASCAL PRP required fewer photocoagulation sessions than the conventional PRP group (2.6±1.0 vs 3.9±0.9, P<0.01). Best corrected visual acuity (BCVA) was reduced slightly in PASCAL PRP group while reduced significantly in conventional PRP group. At last visit, 24 eyes in the PASCAL group (88.9%) and 21 eyes in the conventional group (91.7%) were improved or stable. Two eyes in PASCAL PRP group (7.4%) and 3 eyes in the conventional PRP group (12.5%) developed vitreous hemorrhage or vitreous fibrovascular proliferation.
CONCLUSION: PASCAL PRP is as effective and may be more conducive to maintaining visual acuity with less treatment sessions for DR treatment compared to conventional laser PRP.]]></description>
<pubDate>2020/2/3 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Chuang-Xin Huang, Kun-Bei Lai, Li-Jun Zhou, Zhen Tian, Xiao-Jing Zhong, Fa-Bao Xu, Ya-Jun Gong, Lin Lu and Chen-Jin Jin]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Chuang-Xin Huang, Kun-Bei Lai, Li-Jun Zhou, Zhen Tian, Xiao-Jing Zhong, Fa-Bao Xu, Ya-Jun Gong, Lin Lu and Chen-Jin Jin</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200206]]></guid><cfi:id>468</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Outcomes of 1.8-3.0 mm incision phacoemulsification combined with trabeculectomy for primary angle-closure glaucoma with cataract]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200207]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare efficacy of coaxial microincisions (1.8 mm, 2.2 mm) and small incisions (3.0 mm) on phacoemulsification combined with trabeculectomy for primary angle-closure glaucoma (PACG) with cataract.
METHODS: Ninety-six patients (96 eyes) with PACG and cataract were recruited and randomly divided into three groups between January 2015 and June 2017. Group A (3.0 mm incision), B (2.2 mm incision), and C (1.8 mm incision) comprised 30, 34 and 32 eyes respectively. All cases were treated with clear corneal incision phacoemulsification combined with trabeculectomy. Data including best corrected visual acuity (BCVA), corneal astigmatism, corneal endothelial cell counts (CECC), intraocular pressure (IOP), and complications were collected before the operation, and at postoperative 1d, 1 and 3mo.
RESULTS: All the patients were successfully treated with surgery. The BCVA of groups B and C were significantly improved as compared to group A at postoperative 1d, 1 and 3mo (all P<0.05), but there was no difference between groups B and C at each time interval (all P>0.05). The corneal astigmatism of group A was statistically higher than that of group B (P=0.026); corneal astigmatism of group B was statistically higher than that of group C at postoperative 1d (P=0.006). The corneal astigmatism of group A at postoperative 3mo was significantly higher than that before operation (P=0.003). At postoperative 1 and 3mo, corneal astigmatism of groups B and C were significantly lower than that of group A (all P<0.05). The CECC in group B was significantly higher than that of group A (P=0.020), and CECC in group C was significantly higher than that of group B (P=0.034) at postoperative 1d. At postoperative 1 and 3mo, CECC of groups B and C were significantly higher than that of group A (all P<0.05). In each group, postoperative mean IOP at each time interval was significantly lower than preoperative IOP (all P<0.05).
CONCLUSION: Coaxial microincision phacoemulsification combined with trabeculectomy for PACG with cataract has better curative efficacy in reducing postoperative corneal astigmatism and corneal endothelial cell injury than traditional small incision combined surgery, and the 1.8 mm microincision has better curative efficacy than 2.2 mm microincision in the early postoperative period.]]></description>
<pubDate>2020/2/3 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Qing Wang, Zheng-Xuan Jiang and Rong-Feng Liao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Qing Wang, Zheng-Xuan Jiang and Rong-Feng Liao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200207]]></guid><cfi:id>467</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Impact of switching from ranibizumab to aflibercept on the number of intravitreous injection and follow up visit in wet AMD: results of real life ELU study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200208]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To study if one of the two molecules could lead to a lower number of follow up visits and intra-vitreous injection (IVI) with the same efficacy.
METHODS: ELU (or “elected” in French) study is a retrospective study conducted in real life in patients presenting suboptimal response after ranibizumab IVI (phase 1) and secondary switched to aflibercept (phase 2). The number of follow up visits and IVI were compared in both phases. Visual acuity (VA) evolution and “switching” reasons were secondary analyzed.
RESULTS: We retrospectively included data of 33 patients (38 eyes) with age-related macular degeneration (AMD; mean age: 77±7.7y). The number of monthly follow up visits [median (Q1; Q3)]: was significantly lower with aflibercept (phase 2), respectively 1.0 (0.81; 1.49) visits in phase 1, versus 0.79 (0.67; 0.86) visits in phase 2. The median number of monthly IVI also significantly decreased in phase 2, respectively 0.67 (0.55; 0.90) IVI in phase 1, versus 0.55 (0.45; 0.67) IVI in phase 2. The mean VA evolution (VA final-VA initial) was similar in both phases, (P>0.05). Whatever the reason for “switching” (loss of efficacy, tachyphylaxis, tolerance problems), there was no incidence on VA evolution over the time.
CONCLUSION: Our results show that switching from ranibizumab to aflibercept in “suboptimal” patients significantly reduce the number of follow up visits and IVI, with a comparable efficacy. This decrease in visit number could improve patients’ quality of life and reduce surgical risk by reducing the number of injections.]]></description>
<pubDate>2020/2/3 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Frederic Queguiner, Kristina Bezirganyan, Jean Christophe Courjaret, Laurence Curel, Guillaume Penaranda and Maud Righini Chossegros]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Frederic Queguiner, Kristina Bezirganyan, Jean Christophe Courjaret, Laurence Curel, Guillaume Penaranda and Maud Righini Chossegros</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200208]]></guid><cfi:id>466</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Combined intra-arterial chemotherapy and intravitreal melphalan for the treatment of advanced unilateral retinoblastoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200209]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the efficacy and safety of combined intra-arterial chemotherapy (IAC) and intravitreal melphalan (IVM) for the treatment of advanced unilateral retinoblastoma.
METHODS: This retrospective study involved 30 consecutive eyes from 30 Chinese patients with advanced unilateral retinoblastoma. All patients were initially treated with IAC combined with IVM. The clinical status and complications were recorded at each visit.
RESULTS: The International Intraocular Retinoblastoma Classification groups were D in 23 eyes and E in 7 eyes. All eyes showed severe cloud vitreous seeds at the first visit. The mean number of IAC cycles and intravitreal injections was 3.2 (range, 3-4) and 6 (range, 1-14), respectively. The median follow-up time was 29mo (range, 7-36mo). Treatment success with regression of the retinal tumor and vitreous seeds was achieved in 29 of 30 eyes (96.7%). Globe salvage was attained in 93.3% (28/30) eyes, and enucleation (n=2) was performed due to neovascular glaucoma and persistent vitreous hemorrhage. Complications included retinal pigment epithelium (RPE) atrophy (n=13; 43%), mild lens opacity (n=7; 23%), vitreous hemorrhage (n=5; 17%) and rhegmatogenous retinal detachment (n=1; 3%). No extraocular tumor extension or metastasis occurred.
CONCLUSION: Combined IAC and IVM is effective and safe for the treatment of advanced unilateral retinoblastoma.]]></description>
<pubDate>2020/2/3 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ting-Yi Liang, Xiu-Yu Zhu, Xu-Ming Hua, Xun-Da Ji and Pei-Quan Zhao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ting-Yi Liang, Xiu-Yu Zhu, Xu-Ming Hua, Xun-Da Ji and Pei-Quan Zhao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200209]]></guid><cfi:id>465</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Altered spontaneous brain activity pattern in patients with ophthalmectomy: an resting-state fMRI study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200210]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To use the voxel-wise degree centrality (DC) method to explore the underlying functional network brain-activity in patients with ophthalmectomy.
METHODS: A total of 32 ophthalmic surgery patients (10 women and 22 men), and 32 healthy subjects (10 women and 22 men) highly matched in gender, age, and the same operation method. Everyone experienced a resting-state functional magnetic resonance imaging scan. The spontaneous brain activity could be assessed by DC. Correlation analysis was used to explore the relationships between the average DC signal values and behavior performance in different regions. Receiver operating characteristic (ROC) curve analysis was utilized to differentiate between ophthalmectomy patients and healthy controls (HCs).
RESULTS: Compared with HCs, ophthalmectomy patients had greatly reduced DC values in left lingual gyrus, bilateral lingual lobe, left cingulate gyrus, and increased DC values of left cerebellum posterior lobe, left middle frontal gyrus1, right supramarginal gyrus, left middle frontal gyrus2, right middle frontal gyrus. However, we did not find that there was a correlation between the average DC values from various brain regions and clinical manifestations.
CONCLUSION: Dysfunction may be caused by ophthalmectomy in lots of cerebral areas, which may show the potential pathological mechanism of ophthalmectomy and it is beneficial to clinical diagnosis.]]></description>
<pubDate>2020/2/3 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Bing Zhang, Biao Li, Rong-Qiang Liu, Yong-Qiang Shu, You-Lan Min, Qing Yuan, Pei-Wen Zhu, Qi Lin, Lei Ye and Yi Shao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Bing Zhang, Biao Li, Rong-Qiang Liu, Yong-Qiang Shu, You-Lan Min, Qing Yuan, Pei-Wen Zhu, Qi Lin, Lei Ye and Yi Shao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200210]]></guid><cfi:id>464</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[One year results of presbyLASIK using hybrid bi-aspheric micro-monovision ablation profile in correction of presbyopia and myopic astigmatism]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200211]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyze one year clinical outcomes and subjective rating of hybrid bi-aspheric multifocal central presbyLASIK with micro-monovision for correction of presbyopia and myopic astigmatism.
METHODS: Seventy-four eyes of 37 patients consecutively treated with presbyLASIK were assessed. The mean age of the patients was 43.8±3.0y with a mean spherical equivalent refraction of -5.21±1.87 diopters (D) and mean astigmatism of -0.82±0.64 D. Visual acuity, manifest refraction, contrast sensitivity, aberrometry and patients’ subjective rating were evaluated pre- and postoperatively.
RESULTS: At 1y postoperatively (68 eyes of 34 patients), the mean spherical equivalent (SE) refraction in distance eyes was 0.06±0.05 D, whereas the achieved SE in near eyes was -0.83±0.05 D. Ninety-nine percent of eyes were within ±0.50 D of target correction of SE. The binocular mean uncorrected distance visual acuity (UDVA) was 0.00±0.18 logMAR (20/20). Sixty-four percent of patients achieved 0.0 logMAR (20/20) or better of UDVA and 0.1 logRAD or better of UNVA as well. There was a binocularly loss of one line CDVA after surgery for only one patient (3%, 1/34) and no patient lost 2 lines. The changes in binocular contrast sensitivity (CS) in all test conditions were not significant at any frequency after surgery. The changes of entire eye total higher order aberrations (tHOA) and spherical aberrations (SA) significantly higher in near eyes than in distance eyes. The overall satisfaction score for surgery was 93±8.
CONCLUSION: The hybrid bi-aspheric multifocal central presbyLASIK with micro-monovision appears to be an efficacious option for myopic presbyopes. One year postoperative outcomes in a relatively young presbyopia population indicate improvements in both far and near vision with high satisfaction.]]></description>
<pubDate>2020/2/3 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Fang Liu, Ting Zhang and Quan Liu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Fang Liu, Ting Zhang and Quan Liu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200211]]></guid><cfi:id>463</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Treatment modalities in Duane’s Retraction Syndrome]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200212]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To study the different treatment modalities needed in cases of Duane’s Retraction Syndrome (DRS).
METHODS: This prospective study undergone in more than four years, in Alexandria, included 238 patients of DRS, including type I, 162 patients (68%), type II 12 patients (5%) and type III 64 patients (27%). Surgery was indicated in 98 (41%) of them, to eliminate abnormal head posture, deviation of the eye in primary position, severe retraction of the globe or cosmetically unacceptable upshoot with attempted adduction.
RESULTS: Type I was the most common and type II was the least. Females were predominant in this study, constituting 125 patients (52.5%), and males 113 patients (47.5%). Left eye was more affected, in 110 patients (46.2%), right eye in 91 patients (38.2%) and bilateral in 37 patients (15.6%). Amblyopia was found in 27 patients (11.3%) and treated in 13 patients under 10 years of age, by patching the normal eye. Ninety-eight patients (41%) were operated, the results were most satisfactory and a nomogram is followed in the surgical plan.
CONCLUSION: The surgical management is needed in less than half of the cases and should be planned for every case individually according to the clinical findings, planned nomogram and modified intraoperatively according to the anatomical findings during surgery.]]></description>
<pubDate>2020/2/3 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Karim A Gaballah and Dalal Shawky]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Karim A Gaballah and Dalal Shawky</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200212]]></guid><cfi:id>462</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A computerized resolution visual acuity test in preschool and school age children]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200213]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To develop a novel approach called the Autoacuity Tester, and to evaluate its validity, especially the sensitivity and specificity for detecting amblyopia.
METHODS: Children aged from 3 to 12y (n=552) were enrolled in the study. The validity of the Autoacuity Tester was evaluated by comparing it to the Tumbling E Early Treatment Diabetic Retinopathy Study (ETDRS) acuity chart for school age children, and Lea Symbols and Teller acuity card (TAC) for preschool children. The repeatability was assessed by coefficient of repeatability (COR). The sensitivity and specificity for detecting amblyopia were calculated.
RESULTS: The mean difference (95% limits of agreement) between the Autoacuity Tester and the ETDRS tests were -0.03 (-0.24, 0.19) logMAR for the school age group. In preschool children, the mean difference was 0.04 (-0.14, 0.21) logMAR between the Autoacuity Tester and the TAC and 0.00 (-0.17, 0.18) logMAR between the Autoacuity Tester and the Lea Symbols. For the school age group, the COR was 0.20 logMAR for the Autoacuity Tester and 0.18 logMAR for the ETDRS. For the preschool group, the COR was 0.13 logMAR for the Autoacuity Tester and 0.21 logMAR for TAC. The Autoacuity Tester (88%) is more sensitive than TAC (72%) in detecting amblyopia (P=0.04), while had similar specificity (92% vs 90%, P=0.20).
CONCLUSION: The Autoacuity Tester provides a reliable alternative for assessing visual acuity, and offers advantage of higher testability and repeatability for preschool children.]]></description>
<pubDate>2020/2/3 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ying-Yan Qin, Zhen-Zhen Liu, Li-Yuan Zhu, Xuan Bao, Fu-Rong Luo, Yi-Zhi Liu, Young Tsau and Ming-Xing Wu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ying-Yan Qin, Zhen-Zhen Liu, Li-Yuan Zhu, Xuan Bao, Fu-Rong Luo, Yi-Zhi Liu, Young Tsau and Ming-Xing Wu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200213]]></guid><cfi:id>461</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical characteristics of asymptomatic Terson syndrome in the patients with aneurysmal subarachnoid hemorrhage]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200214]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate clinical characteristics of asymptomatic Terson syndrome and its clinical impact in patients with aneurysmal subarachnoid hemorrhage (SAH).
METHODS: This retrospective, interventional study included 31 patients with aneurysmal SAH, and the medical records were reviewed. In addition to baseline characteristics of the study population such as age, sex, and underlying medical history, multi-modal imaging analysis, including fluorescein angiography (FA), spectral domain optical coherence tomography (SD-OCT), were also reviewed. Glasgow Coma Scale (GCS), Hunt-Hess (HH) grade, and Fisher scale at the time of admission, and functional outcome by using modified Rankin Scale (mRS) at 6mo were compared.
RESULTS: Of the 31 patients, 10 patients (32.3%) were diagnosed with Terson syndrome. All the patients with Terson syndrome did not report visual symptoms at the time of ophthalmologic screening. FA showed microvascular changes of retinal capillaries and varying degrees of disc leakage. SD-OCT allowed intuitive anatomical localization of multi-layered retinal hemorrhages and assessment of ellipsoid zone integrity. The patients with Terson syndrome showed significantly worse GCS (P=0.047) and HH grade (P=0.025) than those without, except Ficher scale (P=0.385). There was no significant difference in the mRS (P=0.250) at 6mo. Among baseline factors, the HH grade was the only significant factor associated with Terson syndrome (B=1.079, P=0.016).
CONCLUSION: In our study, 32.3% of the patients have Terson syndrome without visual symptoms. The baseline HH grade is significantly correlated with Terson syndrome, and there is no significant difference in the functional outcome between the patients with and without Terson syndrome. Terson syndrome may develop without any visual symptoms as shown in our study, and ophthalmologic screening may be recommended to prevent further visual deterioration especially in the patients with poor HH grade at the time of aneurysmal SAH.]]></description>
<pubDate>2020/2/3 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hae Min Kang, Jin Mo Cho, So Yeon Kim and Jeong Hoon Choi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hae Min Kang, Jin Mo Cho, So Yeon Kim and Jeong Hoon Choi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200214]]></guid><cfi:id>460</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Different modes of foveal regeneration after closure of full-thickness macular holes by (re)vitrectomy and autologous platelet concentrate]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200106]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To describe using spectral-domain optical coherence tomography the regeneration of the foveal morphology after pars plana (re)vitrectomy surgery and gas tamponade combined with injection of autologous platelet concentrate to treat full-thickness macular holes, and to describe different anatomical outcome.
METHODS: A retrospective case series of 8 eyes of 8 patients was described.
RESULTS: In all cases investigated, the platelet-assisted closure of macular holes was associated with a rapid resolution of cystic cavities in the foveal walls. In two patients, there was a regular regeneration of the foveal morphology after hole closure; the regenerated central fovea had a regular structure with a foveola and photoreceptors. In three other patients, there was an irregular regeneration of the fovea; a foveola was not formed, photoreceptor cells were absent from the foveal center, and the center was composed of Müller and retinal pigment epithelial (RPE) cells. The foveal regeneration after hole closure may proceed with or without a temporary detachment of the foveal center from the RPE, and with or without a direct contact between the central outer nuclear layer (ONL) and the RPE. Contacts between the ONL and RPE were observed only in patients with an irregular foveal regeneration after hole closure.
CONCLUSION: The data show that there are different modes of foveal regeneration after closure of macular holes with (re)vitrectomy and platelet concentrate. It is suggested that the regular regeneration of the foveal morphology proceeds by Müller cell-mediated tissue movements without cell proliferation, whereas the irregular foveal regeneration proceeds in part by proliferation of Müller and RPE cells.]]></description>
<pubDate>2019/12/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Andreas Bringmann, Claudia Jochmann, Jan Darius Unterlauft, Renate Wiedemann, Matus Rehak and Peter Wiedemann]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Andreas Bringmann, Claudia Jochmann, Jan Darius Unterlauft, Renate Wiedemann, Matus Rehak and Peter Wiedemann</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200106]]></guid><cfi:id>459</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparative clinical outcomes of Tecnis toric IOL implantation in femtosecond laser-assisted cataract surgery and conventional phacoemulsification surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200107]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the short-term visual outcomes, residual refractive cylinder, and rotation stability after Tecnis toric intraocular lens (IOL) implantation during femtosecond laser-assisted cataract surgery (Femto phaco) and conventional phacoemulsification surgery (Conventional phaco).
METHODS: In a prospective cohort study, Conventional phaco and Femto phaco (anterior capsulotomy and lens fragmentation by a femtosecond laser) with Tecnis toric IOL implantation were performed in 40 eyes from 36 patients and 37 eyes from 33 patients, respectively. The uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), and manifest refraction were assessed during 1d, 1wk, and 1mo follow-ups. The orientation of the Tecnis Toric IOL was evaluated during 1wk and 1mo follow-ups.
RESULTS: There were no significant differences in UDCA or CDVA between two groups at 1mo postoperatively, though relatively more subjects had UDVA values of 20/25 or better in Femto phaco group than in the Conventional group (P>0.05). A lower but not significantly lower rate of having more than 5° of IOL rotation was observed in Femto phaco group at the 1-month follow-up, while a significant lower rate of residual astigmatism of ≤1 D was observed in Femto phaco group.
CONCLUSION: The Femto phaco group has significantly more subjects with the residual astigmatism of ≤1 D, but there are no significant differences in rotation stability and visual outcomes as compared with the Conventional phaco group after the application of the Tecnis toric IOL in this cohort.]]></description>
<pubDate>2019/12/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Kai-Ran Lai, Xiao-Bo Zhang, Yin-Hui Yu and Ke Yao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Kai-Ran Lai, Xiao-Bo Zhang, Yin-Hui Yu and Ke Yao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200107]]></guid><cfi:id>458</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Ocular bacterial infections at a tertiary eye center in China: a 5-year review of pathogen distribution and antibiotic sensitivity]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200108]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To provide statistical evidence for the use of antibiotics in ophthalmology by assessing the distribution and antibiotic sensitivity of bacterial isolates from ocular specimens with suspected microbial infections.
METHODS: This study applied a retrospective analysis of 3690 bacterial isolates from ocular specimens, which were obtained from the conjunctiva, cornea, aqueous humor, vitreous body, and other ocular sites of the patients at Shandong Eye Institute in northern China from January 2013 to December 2017. The parameters assessed mainly included the distribution of isolated bacteria and the results of susceptibility tests for antibiotics. In the analysis of antibiotic sensitivities, the bacteria were divided into four groups according to gram staining, and statistical methods were used to compare their antibiotic sensitivities.
RESULTS: Among the 3690 isolated bacterial strains, Staphylococcus epidermidis (2007, 54.39%) accounted for the highest proportion. As for the total isolates, their sensitivity rate to gatifloxacin was up to 90.01%, with four types of gram-stained bacteria being all highly sensitive to it, but their sensitivity rate to levofloxacin was only 51.91%. The sensitivity rate of gram-negative bacilli (G-B) to levofloxacin was 83.66%, significantly higher than the other three types of gram-stained bacteria (P<0.05). Gram-positive cocci (G+C, 97.95%) and gram-positive bacilli (G+B, 97.54%) were more sensitive to vancomycin than gram-negative cocci (G-C, 70.59%) and G-B (68.57%; P<0.05). For fusidic acid, the sensitivity rates of G+C (89.83%) and G+B (73.37%) were significantly higher than that of G-B (29.83%; P<0.05). The gram-negative bacteria’s sensitivity rate to cefuroxime was as low as 59.25%, but only G-B was less sensitive to cefuroxime (57.28%), while G-C was still highly sensitive (89.29%). The sensitivity rate of gram-positive bacteria to moxifloxacin was as high as 80.28%, but only G+C was highly sensitive to moxifloxacin (81.21%), while G+B was still less sensitive (32.00%).
CONCLUSION: Staphylococcus epidermidis is the predominant isolate in all ocular specimens with bacteria. Gatifloxacin is more suitable for topical prophylactic use than levofloxacin in ophthalmology when necessary. Vancomycin and fusidic acid both have better effects on gram-positive bacteria than gram-negative bacteria. More accurate antibiotic sensitivity analysis results can be obtained when a more detailed bacterial classification and more appropriate statistical methods are performed.]]></description>
<pubDate>2019/12/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Wen Gao, Tian Xia, Hua-Bo Chen, Xiao-Jing Pan, Yu-Sen Huang, Xin Wang, Yan-Ling Dong and Li-Xin Xie]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Wen Gao, Tian Xia, Hua-Bo Chen, Xiao-Jing Pan, Yu-Sen Huang, Xin Wang, Yan-Ling Dong and Li-Xin Xie</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200108]]></guid><cfi:id>457</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Accuracy of biometric formulae for intraocular lens power calculation in a teaching hospital]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200109]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the accuracy of three commonly used biometric formulae across different axial lengths (ALs) at one United States Veterans Affairs teaching hospital.
METHODS: A retrospective chart review was conducted from November 2013 to May 2018. One eye of each patient who underwent cataract surgery with a monofocal intraocular lens (IOL) was included. The range of postoperative follow-up period was from 3wk to 4mo. The Holladay 2, Barrett Universal II, and Hill-Radial Basis Function (Hill-RBF) formulae were used to predict the postoperative refraction for all cataract surgeries. For each formula, we calculated the prediction errors [including mean absolute prediction error (MAE)] and the percentage of eyes within ±0.25 diopter (D) and ±0.5 D of predicted refraction. We performed subgroup analyses for short (AL<22.0 mm), medium (AL 22.0-25.0 mm), and long eyes (AL>25.0 mm).
RESULTS: A total of 1131 patients were screened, and 909 met the inclusion criteria. Resident ophthalmologists were the primary surgeons in 710 (78.1%) cases. We found no statistically significant difference in predictive accuracy among the three formulae over the entire AL range or in the short, medium, and long eye subgroups. Across the entire AL range, the Hill-RBF formula resulted in the lowest MAE (0.384 D) and the highest percentage of eyes with postoperative refraction within ±0.25 D (42.7%) and ±0.5 D (75.5%) of predicted. All three formulae had the highest MAEs (>0.5 D) and lowest percentage within ±0.5 D of predicted refraction (<55%) in short eyes.
CONCLUSION: In cataract surgery patients at our teaching hospital, three commonly used biometric formulae demonstrate similar refractive accuracy across all ALs. Short eyes pose the greatest challenge to predicting postoperative refractive error.]]></description>
<pubDate>2019/12/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Kevin S Tang, Elaine M Tran, Allison J Chen, David R Rivera, Jorge J Rivera and Paul B Greenberg]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Kevin S Tang, Elaine M Tran, Allison J Chen, David R Rivera, Jorge J Rivera and Paul B Greenberg</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200109]]></guid><cfi:id>456</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Evaluation of functional outcome and stability of sutureless scleral tunnel fixated IOLs in children with ectopia lentis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200110]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate functional outcome of sutureless scleral tunnel intraocular lens (SSTIOL) in children with crystalline lens subluxation of more than 7 clock hours.
METHODS: A prospective interventional study was conducted consisting of 45 eyes of 44 children in age group 6-18y having >7 clock hours of lens subluxation who underwent lensectomy-vitrectomy followed by SSTIOL implantation. Primary outcome was improvement in best corrected visual acuity (BCVA) and secondary outcomes were assessment of intraocular lens (IOL) tilt using ultrasound biomicroscopy (UBM), mean change in astigmatism at last follow-up of 1y and associated complications.
RESULTS: The mean preoperative and postoperative BCVA was 1.05±0.28 and 0.64±0.45 (logMAR) respectively (P=0.001) at last follow-up. The mean astigmatism preoperatively and postoperatively was -4.17±2.69 D and -1.86±1.25 D respectively (P=0.011). Significant IOL tilt (>5 degrees) was present in 5 cases. The mean percentage endothelial loss was 3.65%±1.92%. The most serious complication encountered was retinal detachment seen in 2 cases.
CONCLUSION: SSTIOL implantation provides efficient visual rehabilitation in children provided there is stringent case selection. We recommend caution in children having white-to-white distance >12 mm and presence of peripheral retinal degenerations.]]></description>
<pubDate>2019/12/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Anju Rastogi, Prateek Kumar, Shweta Dhiman, Manisha Mishra, Kamlesh Anand and Ankita Bhardwaj]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Anju Rastogi, Prateek Kumar, Shweta Dhiman, Manisha Mishra, Kamlesh Anand and Ankita Bhardwaj</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200110]]></guid><cfi:id>455</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparisons of ganglion cell-inner plexiform layer loss patterns and its diagnostic performance between normal tension glaucoma and primary open angle glaucoma: a detailed, severity-based study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200111]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the patterns of macular ganglion cell-inner plexiform layer (GCIPL) loss in normal tension glaucoma (NTG) and primary open angle glaucoma (POAG) in a detailed, disease severity-matched way; and to assess the diagnostic capabilities of GCIPL thickness parameters in discriminating NTG or POAG from normal subjects.
METHODS: A total of 157 eyes of 157 subjects, including 57 normal eyes, 51 eyes with POAG and 49 eyes with NTG were enrolled and strictly matched in age, refraction, and disease severity between POAG and NTG groups. The average, minimum, superotemporal, superior, superonasal, inferonasal, inferior, and inferotemporal GCIPL thickness, and the average, superior, temporal, inferior, and nasal retinal nerve fiber layer (RNFL) thickness were obtained by Cirrus optical coherence tomography (OCT). The diagnostic capabilities of OCT parameters were assessed by area under receiver operating characteristic (AUROC) curves.
RESULTS: Among all the OCT thickness parameters, no statistical significant difference between NTG group and POAG group was found (all P>0.05). In discriminating NTG or POAG from normal subjects, the average and inferior RNFL thickness, and the minimum GCIPL thickness had better diagnostic capabilities. There was no significant difference in AUROC curve between the best GCIPL thickness parameter (minimum GCIPL) and the best RNFL thickness parameter in discriminating NTG (inferior RNFL; P=0.076) and indiscriminating POAG (average RNFL; P=0.913) from normal eyes.
CONCLUSION: Localized GCIPL loss, especially in the inferior and inferotemporal sectors, is more common in NTG than in POAG. Among all the GCIPL thickness parameters, the minimum GCIPL thickness has the best diagnostic performance in differentiating NTG or POAG from normal subjects, which is comparable to that of the average and inferior RNFL thickness.]]></description>
<pubDate>2019/12/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xiao-Yu Xu, Kun-Bei Lai, Hui Xiao, Yi-Quan Lin, Xin-Xing Guo and Xing Liu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiao-Yu Xu, Kun-Bei Lai, Hui Xiao, Yi-Quan Lin, Xin-Xing Guo and Xing Liu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200111]]></guid><cfi:id>454</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of different lens status on intraocular pressure elevation in patients treated with anti-vascular endothelial growth factor injections]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200112]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the effect of lens status on sustained intraocular pressure (IOP) elevation in patients treated intravitreally with anti-vascular endothelial growth factor (VEGF) agents.
METHODS: Data were retrospectively collected for all patients treated with intravitreal injections of anti-VEGF medication at a tertiary medical center in July 2015. Findings were analyzed by lens status during 6 months’ follow-up. The main outcome measure was a sustained increase in IOP (≥21 mm Hg or change of ≥6 mm Hg from baseline on ≥2 consecutive visits, or addition of a new IOP-lowering medication during follow-up).
RESULTS: A total of 119 eyes of 100 patients met the study criteria: 40 phakic, 40 pseudophakic, and 39 pseudophakic after Nd:YAG capsulotomy. The rate of sustained IOP elevation was significantly higher in the post-capsulotomy group (23.1%) than in the phakic/pseudophakic groups (8.1%; P=0.032), with no statistically significant differences among the 3 groups in mean number of injections, either total (P=0.82) or by type of anti-VEGF mediation (bevacizumab: P=0.19; ranibizumab: P=0.13), or mean follow-up time (P=0.70).
CONCLUSION: Nd:YAG capsulotomy appears to be a risk factor for sustained IOP elevation in patients receiving intravitreal anti-VEGF injections. This finding has important implications given the growing use of anti-VEGF treatment and the irreversible effects of elevated IOP.]]></description>
<pubDate>2019/12/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Amir Sternfeld, Rita Ehrlich, Dov Weinberger and Assaf Dotan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Amir Sternfeld, Rita Ehrlich, Dov Weinberger and Assaf Dotan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200112]]></guid><cfi:id>453</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Ocular flora in patients undergoing intravitreal injections: antibiotic resistance patterns and susceptibility to antiseptic picloxydine]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200113]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To study antibiotic resistance patterns and susceptibility to eye antiseptic picloxydine of conjunctival flora in patients undergoing intravitreal injections (IVIs).
METHODS: Conjunctival swabs were taken in 4 groups of patients, 20 patients in each group (n=80): without IVIs and ophthalmic operations in history (group N1; control group); with the first IVI and antibiotic eye drops Tobrex applied 3d before IVI and 5d after it (group N2); with 20 or more IVIs and repeated courses of antibiotic eye drops (group N3); with the first IVI and antiseptic eye drops Vitabact (picloxydine) applied 3d before IVI and 5d after it (group N4). In groups N2 and N4 swabs were taken at baseline and after the treatment. Efficacy of picloxydine in inhibition of growth of conjunctival isolates susceptible and resistant to antibiotic was studied in vitro. Minimal inhibition concentrations (MIC) were determined with microdilution test.
RESULTS: Two of the three patients who had to undergo the IVI procedure showed conjunctiva bacterial contamination. Along with few Staphylococcus aureus and Gram-negative isolates susceptible to most antibiotics, the majority (71%-77%) of causative agents were coagulase-negative Staphylococci (CoNS), 40%-50% of which were multidrug resistant (MDR). Eye disinfection in the operating room and peri-injection courses of Tobrex or Vitabact resulted in total elimination of isolates found at baseline. However, in 10% and 20% of patients, respectively, recolonization of the conjunctiva with differing strains occurred. In patients with repeated IVI and Tobrex/Maxitrol treatment, the conjunctival flora showed high resistance rates: 90% of CoNS were MDR. In the in vitro study, picloxydine showed bactericidal effect against Staphylococci isolates both antibiotic resistant and susceptible with MIC≥13.56 μg/mL. Incubation of bacteria for 15min in Vitabact eye drops, commercially available form of picloxydine, 434 μg/mL, showed total loss of colony forming units of all tested isolates including Pseudomonas aeruginosa.
CONCLUSION: The confirmed efficacy of eye antiseptic picloxydine against conjunctival bacterial isolates and the presence of its commercial form, 0.05% eye drops, convenient for use by patients before and after injection, make this eye antiseptic promising for prophylaxis of IVI-associated infectious complications.]]></description>
<pubDate>2019/12/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Maria V. Budzinskaya, Anait S. Khalatyan, Marina G. Strakhovskaya and Vladimir G. Zhukhovitsky]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Maria V. Budzinskaya, Anait S. Khalatyan, Marina G. Strakhovskaya and Vladimir G. Zhukhovitsky</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200113]]></guid><cfi:id>452</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of OCT and OCTA manifestations among untreated PCV, neovascular AMD, and CSC in Chinese population]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200114]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the qualitative and quantitative features among untreated polypoidal choroidal vasculopathy (PCV), neovascular age-related macular degeneration (nv-AMD) and central serous chorioretinopathy (CSC) using optical coherence tomography (OCT) and OCT angiography (OCTA).
METHODS: This retrospective study included 16 eyes with thin-choroid PCV, 18 eyes with thick-choroid PCV, 16 eyes with nv-AMD and 17 eyes with CSC, respectively. The indicators were obtained by OCT and OCTA.
RESULTS: Sub-foveal choroidal thickness (SFCT) in CSC was thicker compared to other groups (all P<0.05). SFCT in nv-AMD was thicker compared to thin-choroid PCV, but thinner compared with thick-choroid PCV (both P<0.05). As the ratio of thickness of Haller’s layer to thickness of SFCT, which of thin-choroid PCV was significantly higher than CSC (P<0.001). Likewise, thick-choroid PCV had significantly higher ratio than nv-AMD (P=0.016) or CSC (P<0.001). There were differences among them in pigment epithelium detachment (PED). The whole-superficial retinal vessel density (RVD), deep RVD and choroidal capillary vessel density (CCVD) in CSC were significantly higher compared to other three groups, respectively (all P<0.05). The whole CCVD in nv-AMD was higher compared to thick-choroid PCV (P=0.032). Cross-sectional local angiographic form was 87.50%, 83.33%, 0 and 35.29% in thin-choroid PCV, thick-choroid PCV, nv-AMD and CSC, respectively. Cross-sectional diffuse angiographic form was 12.50%, 16.67%, 100% and 5.88% in thin-choroid PCV, thick-choroid PCV, nv-AMD and CSC, respectively.
CONCLUSION: Combination of OCT and OCTA can effectively observe the significant alterations existed in PCV, CSC and nv-AMD, and there are distinctive differences among them. The pathogenesis is not exactly the same between PCV and nv-AMD, or PCV and CSC.]]></description>
<pubDate>2019/12/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ming-Zhen Yuan, Lu-Lu Chen, Jing-Yuan Yang, Ming-Yue Luo and You-Xin Chen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ming-Zhen Yuan, Lu-Lu Chen, Jing-Yuan Yang, Ming-Yue Luo and You-Xin Chen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200114]]></guid><cfi:id>451</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of two different treatment regimens’ efficacy in neovascular age-related macular degeneration in Turkish population—based on real life data-Bosphorus RWE Study Group]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200115]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare two different anti-vascular endothelial growth factor (anti-VEGF) treatment regimens’-a priori pro re nata (PRN) and PRN regimen following the loading phase-anatomical and functional results in neovascular age-related macular degeneration (nAMD) patients.
METHODS: Totally 544 nAMD patients followed and treated with aflibercept (n=135) and ranibizumab (n=409) at 9 different centers between 2013 and 2015 were enrolled into this retrospective multicenter study. Patients with initial best corrected visual acuity (BCVA) interval of 1.3-0.3 (logMAR) and a minimum follow-up of 12mo were included. Patients under two different regimens-a priori pro re nata (1+PRN) or 3 consecutive intravitreal injections followed by a PRN regimen (3+PRN)-were compared in BCVA at 3th, 6th and 12th months, and in central macular thickness (CMT) at 6th and 12th months. The total study group, intravitreal ranibizumab (IVR) and intravitreal aflibercept (IVA) groups were evaluated separately.
RESULTS: The mean CMT decreased in the 1+PRN (n=101) regimen from 407 to 358 and 340 μm and in the 3+PRN (n=443) group from 398 to 318 and finally to 310 μm at months 6 and 12, respectively. Anatomically, the CMT reduction at 6th month (48.5 vs 76.4; P<0.05) was statistically significant in favor of 3+PRN group. BCVA changed in 1+PRN group from 0.77 to 0.78, 0.75 and 0.75; in 3+PRN group from 0.81 to 0.69, 0.72, and 0.76 at months 3, 6, and 12, respectively. Visual gain was statistically better in 3+PRN group at 3th month (-0.01 vs 0.12; P<0.001). In IVR group, CMT reduction was in greater in 3+PRN at 6th (44 vs 72) and 12th month (61 vs 84), but statistically insignificant. The 3+PRN group revealed statistically better visual results at 3th month (-0.02 vs 0.11, P<0.05). In IVA group, although statistically insignificant, CMT reduction (61 vs 89, 6th month; 85 vs 97, 12th month) and visual gain (0.02 vs 0.16; 0.02 vs 0.14; 0.05 vs 0.11) was found in favor of 3+PRN group at all visits.
CONCLUSION: The loading dose of anti-VEGF treatments in nAMD leads to significantly better anatomical and functional results, regardless of the agent, specially in early follow-up interval.]]></description>
<pubDate>2019/12/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Burak Erden, Selim B&ouml;l&uuml;kba&scedil;&inodot;, Abdullah &Ouml;zkaya, Levent Karaba&scedil;, Cengiz Alag&ouml;z, Zeynep Alk&inodot;n, &Ouml;zg&uuml;r Artunay, Sad&inodot;k Etka Bayramo&gbreve;lu, G&ouml;khan Demir, Mehmet Demir, Ali Demircan, G&uuml;rkan Erdo&gbreve;an, Mehmet Erdo&gbreve;an, Erdem Eri&scedil;, Havva Kald&inodot;r&inodot;m, &Idot;smail Umut Onur, &Ouml;zen Ayranc&inodot; Osmanba&scedil;o&gbreve;lu, Sezin &Ouml;zdo&gbreve;an Erkul, Mine &Ouml;zt&uuml;rk, &Idot;rfan Perente, K&uuml;bra Sar&inodot;c&inodot;, Nihat Say&inodot;n, Dilek Ya&scedil;a, &Idot;hsan Y&inodot;lmaz and Zeynep Y&inodot;lmazabdurrahmano&gbreve;lu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Burak Erden, Selim B&ouml;l&uuml;kba&scedil;&inodot;, Abdullah &Ouml;zkaya, Levent Karaba&scedil;, Cengiz Alag&ouml;z, Zeynep Alk&inodot;n, &Ouml;zg&uuml;r Artunay, Sad&inodot;k Etka Bayramo&gbreve;lu, G&ouml;khan Demir, Mehmet Demir, Ali Demircan, G&uuml;rkan Erdo&gbreve;an, Mehmet Erdo&gbreve;an, Erdem Eri&scedil;, Havva Kald&inodot;r&inodot;m, &Idot;smail Umut Onur, &Ouml;zen Ayranc&inodot; Osmanba&scedil;o&gbreve;lu, Sezin &Ouml;zdo&gbreve;an Erkul, Mine &Ouml;zt&uuml;rk, &Idot;rfan Perente, K&uuml;bra Sar&inodot;c&inodot;, Nihat Say&inodot;n, Dilek Ya&scedil;a, &Idot;hsan Y&inodot;lmaz and Zeynep Y&inodot;lmazabdurrahmano&gbreve;lu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200115]]></guid><cfi:id>450</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Unilateral foveomacular retinitis resembling solar retinopathy among young soldiers in Korean army and associated multimodal imaging findings]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200116]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To describe the clinical features and multimodal images of unilateral foveomacular retinitis in young Korean soldiers.
METHODS: Ten patients having foveomacular retinitis were included. Fluorescein angiography, fundus autofluorescence (FAF), infrared reflectance (IR), and spectral-domain optical coherence tomography (SD-OCT) were analyzed.
RESULTS: All patients were young males experienced insidious visual decline without exposure to bright light. Initial and final vision ranged from hand movement to 20/20 (median 20/200) and 20/2000 to 20/20 (median 20/500), respectively. Vision decreased in 6 patients while improved in two. Typical macular abnormality was yellow granular spots. SD-OCT showed ellipsoid zone (EZ) or interdigitation zone (IZ) disruption of fovea. The degree of EZ/IZ damage correlated with vision. Lesions were clearly visualized through IR and matched with SD-OCT findings.
CONCLUSION: This is the first case series of foveomacular retinitis diagnosed with multimodal imaging. Foveomacular retinitis should be suspected in sudden unilateral visual decline especially in young soldiers. SD-OCT is the most important diagnostic modality.]]></description>
<pubDate>2019/12/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Chang Ki Yoon, Kyu Hyung Park and Se Joon Woo]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Chang Ki Yoon, Kyu Hyung Park and Se Joon Woo</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200116]]></guid><cfi:id>449</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Acute changes in ganglion cell layer thickness in ischemic optic neuropathy compared to optic neuritis using optical coherence tomography]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200117]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To elucidate the changes of different ganglion cell layer (GCL) thinning patterns between the optic neuritis (ON) and non-arteritic anterior ischemic optic neuropathy (NAION).
METHODS: A prospective, observational study was conducted to evaluate the timing of GCL changes between acute ON and NAION using optical coherence tomography.
RESULTS: Thinning on optical coherence tomography in the NAION group occurs as early as 11d after symptomatic onset of vision loss and follows an altitudinal pattern. The mean superior-inferior GCL thickness difference in the NAION cohort was clinically significant at 5.7 μm in the NAION cohort compared to controls of 0.8 μm (P=0.032), but not significant in the ON group compared to controls with both groups measuring 1.1 μm. Global thinning was significant for the ON group compared to controls at 7.2 μm (P=0.011) but not the NAION group compared to controls at 1.35 μm.
CONCLUSION: These findings suggest that future treatments for NAION should be given early, and possibly before 11d in order to prevent GCL and irreversible vision loss.]]></description>
<pubDate>2019/12/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Peter W. MacIntosh, S. Vijay Kumar, V.R. Saravanan and Virna M. Shah]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Peter W. MacIntosh, S. Vijay Kumar, V.R. Saravanan and Virna M. Shah</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200117]]></guid><cfi:id>448</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Newly onset indirect traumatic optic neuropathy-surgical treatment first versus steroid treatment first]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200118]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the efficacy and safety of the treatment of endoscopic trans-ethmosphenoid optic canal decompression (ETOCD) with combination of steroid in patients with newly onset indirect traumatic optic neuropathy (ITON) and compare the outcome between immediate ETOCD treatment and ETOCD with preoperative steroid treatment.
METHODS: Patients presented as newly onset ITON (suffered trauma within 3d) at a tertiary medical center between Mar 1st, 2016 and Mar 1st, 2018 were enrolled in this study. All patients were equally and randomly divided into 2 groups. Cases in group A were performed ETOCD immediately after admition while cases in group B were prescribed by methylprednisolone (20 mg/kg · d) for 3d before ETOCD. Methylprednisolone (20 mg/kg · d) was used after surgery for 6d in group A and 3d in group B. Follow-up was up to 3mo in all cases. Visual acuity (VA) before and after treatment between the two groups were taken into comparison.
RESULTS: Complete postoperative data were acquired from 34 patients in group A and from 32 patients in group B. Group A had significantly higher effective rate in VA than group B (χ2 =4.905, P=0.027).
CONCLUSION: For patients with newly onset ITON, combination treatment of ETOCD with high-dose steroid is an effective and safe way. Immediate surgery will lead to better prognosis for these cases.]]></description>
<pubDate>2019/12/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Bo Yu, Ying-Jie Ma, Yun-Hai Tu and Wen-Can Wu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Bo Yu, Ying-Jie Ma, Yun-Hai Tu and Wen-Can Wu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200118]]></guid><cfi:id>447</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical outcomes of transepithelial photorefractive keratectomy versus femtosecond laser assisted keratomileusis for correction of high myopia in South Egyptian population]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200119]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the safety and efficacy of transepithelial photorefractive keratectomy (t-PRK) with adjuvant mitomycin  C (MMC) versus femtosecond laser assisted keratomileusis  (Femto-LASIK) in correction of high myopia.
METHODS: Prospective randomized comparative study including 156 eyes of 156 patients with high myopia and a spherical equivalent refraction (SER) <-6.00 D. They were divided randomly into two groups: Group A included 72 eyes treated with t-PRK with adjuvant MMC and Group B included 84 eyes treated with Femto-LASIK. Visual acuity, SER, corneal topography, pachymetry and keratometry were assessed for 12mo postoperatively.
RESULTS: The preoperative mean SER was -8.86±1.81 and -9.25±1.70 D in t-PRK MMC group and Femto-LASIK respectively (P=0.99) which improved to -0.65±0.43 D and -0.69±0.50 D at 12mo follow up. Mean SER remained stable during the 12mo of follow-up, with no statistically significant difference between the two groups (P=0.64). In t-PRK MMC group, only six eyes needed retreatment after six months of follow up. And two eyes showed haze (one reversible haze grade 2, while the other had dense irreversible haze grade 4).
CONCLUSION: t-PRK MMC provides safe and satisfactory visual outcomes and acceptable risk as Femto-LASIK in patients with high myopia.]]></description>
<pubDate>2019/12/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Amr Mounir, Engy Mohamed Mostafa, Hatem Ammar, Osama Ali Mohammed, Alahmady Hamad Alsmman, Mahmoud Mohamed Farouk and Mohamed Gamal Elghobaier]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Amr Mounir, Engy Mohamed Mostafa, Hatem Ammar, Osama Ali Mohammed, Alahmady Hamad Alsmman, Mahmoud Mohamed Farouk and Mohamed Gamal Elghobaier</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20200119]]></guid><cfi:id>446</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of femtosecond laser-assisted steepest-meridian clear corneal incisions on preexisting corneal regular astigmatism at the time of cataract surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201208]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the clinical efficacy and safety of femtosecond laser-assisted steepest-meridian clear corneal incisions for correcting preexisting corneal astigmatism performed at the time of cataract surgery.
METHODS: This prospective case series study comprised consecutive age-related cataract patients with corneal regular astigmatism (range: +0.75 to +2.50 D) who had femtosecond laser-assisted steepest-meridian clear corneal incisions (single or paired). Corneal astigmatism was performed with the Pentacam preoperatively and 3mo postoperatively. Total corneal astigmatism and steepest-meridian measured in the 3-mm central zone were used to guide the location, size and number of clear corneal incision. The vector analysis of astigmatic change was performed using the Alpins method.
RESULTS: Totally 138 eyes of 138 patients were included. The mean preoperative corneal astigmatism was 1.31±0.41 D, and was significantly reduced to 0.69±0.34 D (equivalent to difference vector) after surgery (P<0.01). The surgically-induced astigmatism was 1.02±0.54 D. The correction index (ratio of target induced astigmatism and surgically-induced astigmatism: 0.72±0.36) as well as the magnitude of error (difference between surgically-induced astigmatism and target induced astigmatism: -0.29±0.51) represented a slight under correction. For angle of error, the arithmetic mean was 1.11±13.70, indicating no significant systematic alignment errors.
CONCLUSION: Femtosecond-assisted steepest-meridian clear corneal incision is a fast, customizable, adjustable, precise, and safe technique for the reduction of low to moderate corneal astigmatism during cataract surgery.]]></description>
<pubDate>2020/10/21 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Wei Chen, Min Ji, Jian Wu, Yong Wang, Jing Zhou, Rong-Rong Zhu, Hong Lu and Huai-Jin Guan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Wei Chen, Min Ji, Jian Wu, Yong Wang, Jing Zhou, Rong-Rong Zhu, Hong Lu and Huai-Jin Guan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201208]]></guid><cfi:id>445</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of nepafenac 0.1% on retinal thickness after cataract surgery in patients without risk factors for cystoid macular edema]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201209]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the effect of topical preoperative nepafenac 0.1% treatment on postoperative macular edema using optical coherence tomography (OCT) after uncomplicated cataract surgery.
METHODS: Ninety eyes of 90 patients without any risk factors were included in the study. The patients were assigned to three groups: group 1, treated with topical prednisolone acetate 1%; group 2, treated with topical nepafenac 0.1%   in addition to prednisolone acetate (1%); and group 3, those who started receiving nepafenac 0.1% treatment 3d prior to surgery and continued the treatment postoperatively in addition to prednisolone acetate (1%). Central retinal thickness (CRT) and macular volume values were recorded using OCT at weeks 3 and 6.
RESULTS: The increases in macular volume in the central 1 mm area after 3 and 6wk were significantly lower in patients who used prophylactic topical nepafenac preoperatively (group 3) compared with those in group 1 (P=0.028 and 0.008, respectively). No significant differences in the increase in macular volume and CRT were noted between groups 2 and 3 (P>0.05). In group 1, the increases in macular volume in the central 3 mm area at weeks 3 and 6 were significantly higher than that in group 2 and 3 (3rd week, P=0.004; 6th week, P=0.005).
CONCLUSION: Nepafenac 0.1% treatment in addition to topical steroids after uncomplicated cataract surgery reduce the increase in macular volume in the early postoperative period.]]></description>
<pubDate>2020/10/21 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Asena Keles Sahin, Ahmet Sahap Kükner, Fatih Ulas and Umit Dogan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Asena Keles Sahin, Ahmet Sahap Kükner, Fatih Ulas and Umit Dogan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201209]]></guid><cfi:id>444</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of complications after Ahmed versus Baerveldt implant in glaucoma patients: one year follow-up]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201210]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare surgical results of the Ahmed and Baerveldt implant procedures in glaucoma patients at 1y follow-up at Jakarta Eye Center (JEC) Eye Hospitals.
METHODS: This cohort retrospective study was conducted on glaucoma patients aged ≥18y who had undergone Ahmed and Baerveldt implant surgery. Intraocular pressure (IOP), visual acuity, glaucoma medication, success rate, early and late postoperative complications, and the number of resurgeries were analyzed.
RESULTS: A total of 351 eyes in the Ahmed group and 94 eyes in the Baerveldt group were included in this study. At 1y follow-up, the mean IOP was found to be significantly lower in the Baerveldt group (13±4.47 mm Hg) compared to the Ahmed group (15.02±5.73 mm Hg; P=0.025). Glaucoma medication was required in both the Ahmed and Baerveldt groups (58.92% vs 71.67%). Comparable success rate was found in both groups. The Ahmed group revealed a complete and qualified success of 86.82%, and failure of 13.17%. Similarly, the Baerveldt group showed complete and qualified success in 87.75% and failure in 12.25% cases. In the Ahmed group, 11.97% early complications, 26.06% late complications and 9.97% resurgeries were observed. In comparison, in the Baerveldt group, 23.40% early complications, 30.95% late complications and 11.70% resurgeries were observed.
CONCLUSION: Both groups of glaucoma implants show significant IOP reduction, however, the Baerveldt implant group demonstrates greater IOP reduction with more failure rates and complications than the Ahmed implant group.]]></description>
<pubDate>2020/10/21 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Sara Listyani Koentjoro, Widya Artini, Iwan Soebijantoro, Vira Wardhana Istiantoro, Emma Rusmayani, Rini Sulastiwaty, Zeiras Eka Djamal, Arini Safira Nurul Akbar and Muhammad Yoserizal]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Sara Listyani Koentjoro, Widya Artini, Iwan Soebijantoro, Vira Wardhana Istiantoro, Emma Rusmayani, Rini Sulastiwaty, Zeiras Eka Djamal, Arini Safira Nurul Akbar and Muhammad Yoserizal</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201210]]></guid><cfi:id>443</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Diagnostic performance of OCT and OCTA in less than 60-year-old patients with early POAG: a cross-sectional study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201211]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To observe and characterize imaging features of macular and optic disc areas in less than 60-year-old patients with early primary open angle glaucoma (POAG) by optical coherence tomography (OCT) and optical coherence tomography angiography (OCTA), and to evaluate the diagnostic value of OCT and OCTA.
METHODS: Totally 15 patients (23 eyes) with early POAG as observation group and 30 health people (30 eyes) as normal control group were enrolled in this cross-sectional study. OCTA-based superficial macula vessel density, superficial macula perfusion density, superficial optic disc vessel density, superficial optic disc perfusion density and spectral domain OCT (SD-OCT)-based macular area thickness, ganglion cell complex (GCC) thickness and retinal nerve fiber layer (RNFL) thickness were measured in the two groups. Independent t-test and receiver operating characteristic curve were used for analysis. Area under the receiver operating characteristic curves (AUROC) were used to measure the diagnostic utility.
RESULTS: Among all the parameters, the optimal diagnostic utility parameter was the superficial vessel density in the macular area (except the center of the macula), and the AUROC reached 0.98. The diagnostic utility of macular area perfusion density (except the center of the macula) was similar to that of superficial vessel density in the macular area, and the AUROC was above 0.97. Followed by the diagnostic utility of vessel density in the optic disc area, the best parameter was the inner ring of the vessel density, and its AUROC reached 0.97. The diagnostic utility of perfusion density in the optic disc area was slightly lower than that of vessel density in the optic disc area. The best parameter was the central optic disc perfusion density, and its AUROC was 0.95. The SD-OCT-based diagnostic utility parameters were generally lower than that mentioned above, the top three parameters were the inferior RNFL thickness (AUROC=0.919), the superior (AUROC=0.919) and the inferior GCC thickness (AUROC=0.9077).
CONCLUSION: The OCT-based diagnostic utility parameters are generally lower than the OCTA-based diagnostic utility parameters. OCTA has an important clinical application value in diagnosis and evaluation for less than 60-year-old patients with early POAG.]]></description>
<pubDate>2020/10/21 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yan-Jie Li, Wei-Shai Liu, Zi-Chao Bai, Rong-Xia Cao and Hai-Hua Ren]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yan-Jie Li, Wei-Shai Liu, Zi-Chao Bai, Rong-Xia Cao and Hai-Hua Ren</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201211]]></guid><cfi:id>442</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Study of corneal biomechanical properties in patients with childhood glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201212]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To study of corneal biomechanical properties and intraocular pressure (IOP) measured with Corvis Scheimpflug Technology (ST) in patients with childhood glaucoma (CG).
METHODS: Cross-sectional study in which 89 eyes were included 56 of them with CG. Only one eye per patient was included. The following variables were obtained from the clinical history and the ophthalmological examination: age, sex, IOP, number of surgeries, and the cup/disc ratio (CDR). The following parameters were recorded using Corvis ST: corrected by biomechanics IOP (bIOP), not corrected IOP (nctIOP), central corneal thickness (CCT), maximum concavity [radius, peak distance (PD) and deformation amplitude], applanation 1 and 2 (length and velocity). The mean age was 23±14.55 and 33±19.5 years old for the control group and CG group, respectively. Totally 36 were males and 53 were females. In the CG group, 7 patients were controlled only with medical treatment. Sixteen had at least one previous goniotomy, 19 had at least one trabeculectomy, and 11 had an Ahmed implant.
RESULTS: A significant and positive intraclass correlation coefficient was found between Goldman IOP and the IOP measured by Corvis in both groups. No differences were found between the IOP measured with Corvis and Goldman using a student t-test. Regarding biomechanical parameters, there were differences in the applanation length 2 (A-L2), in the applanation velocity 2 (A-V2) and in the PD. By sex, only the applanation length 1 (A-L1) was found to be different in control group. A positive and significant Pearson correlation was found between CDR and the A-L1.
CONCLUSION: Corneal biomechanical properties have shown differences between CG and healthy subjects and also between men and women.]]></description>
<pubDate>2020/10/21 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Sara Garcia Caride, Lucia Perucho González, Federico Sáenz Francés and Julián García Feijoo]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Sara Garcia Caride, Lucia Perucho González, Federico Sáenz Francés and Julián García Feijoo</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201212]]></guid><cfi:id>441</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Melanin change of retinal pigment epithelium and choroid in the convalescent stage of Vogt-Koyanagi-Harada disease]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201213]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To observe the melanin change of the retinal pigment epithelium (RPE) and choroid in the convalescent stage of Vogt-Koyanagi-Harada (VKH).
METHODS: A retrospective study was performed on 40 eyes of 20 patients in the convalescent stage of VKH. Fundus photography (FP), multi-spectral imaging (MSI), and optical coherence tomography (OCT) were performed.
RESULTS: In the VKH convalescent stage, focal RPE melanin accumulation (FRMA) was detected in 34 eyes (85%) on MSI and in 7 eyes (17.5%) on FP. FRMA was limited to the previous retinal detachment area in all 28 eyes (FRMA was detected in 34 eyes on MSI, which were enrolled, and 6 eyes lacked data in the acute stage). Sunset-glow fundus was detected in 20 eyes (50%) on FP. The mean density of FRMA in a 1-mm-diameter circular area of the fovea was 0.04±0.07 on MSI, which was significantly correlated with sunset-glow fundus (ρ=0.467, P=0.02).
CONCLUSION: In the VKH convalescent stage, FRMA is derived from the RPE melanin change, and sunset-glow fundus is derived from the choroid melanin change. A higher density of FRMA in the fovea and sunset-glow fundus represents more serious depigmentation of melanin.]]></description>
<pubDate>2020/10/21 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ying Huang, Ya-Ting Yang, Bing Lin, Sheng-Hai Huang, Zu-Hua Sun, Rong Zhou, Ying-Zi Li and Xiao-Ling Liu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ying Huang, Ya-Ting Yang, Bing Lin, Sheng-Hai Huang, Zu-Hua Sun, Rong Zhou, Ying-Zi Li and Xiao-Ling Liu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201213]]></guid><cfi:id>440</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical features and treatment outcomes of endogenous Klebsiella endophthalmitis: a 12-year review]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201214]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To identify the clinical features and treatment outcomes of endogenous Klebsiella pneumoniae endophthalmitis and investigate prognostic factors of poor visual outcome.
METHODS: The clinical records of all patients diagnosed with endogenous Klebsiella endophthalmitis between January 2007 to December 2018 in Prince of Wales Hospital, Hong Kong, China were retrospectively reviewed. Thorough ophthalmological examination findings were recorded in the case note, including visual acuity testing, slit-lamp examination, indirect ophthalmoscopy and B-scan ultrasonography if media opacity precluded fundus viewing.
RESULTS: A total of 18 eyes in 14 patients were identified. Bilateral involvement was noted in 4 patients (28.6%). Hepatobiliary sepsis was the source in 9 patients (64.3%). Culture of intraocular fluid was positive in 5 out of 18 eyes (27.8%). Mortality was noted in 2 patients (14.3%). Mean final visual acuity was 20/1500. Six out of 16 eyes had total loss of sight (37.5%) and 3 eyes required evisceration (18.8%). Multivariate linear regression revealed poor presenting visual acuity (P=0.031) and lack of fundus view due to vitritis (P=0.02) as prognostic factors of poor visual outcome.
CONCLUSION: Visual outcome of endogenous Klebsiella endophthalmitis is poor. Poor presenting visual acuity and lack of fundus view predict poor visual outcome. High index of suspicion for endophthalmitis is important in Klebsiella sepsis patients with complaints of ocular symptoms. Ophthalmological screening is recommended in non-communicable patients with Klebsiella sepsis.]]></description>
<pubDate>2020/10/21 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Chun Yue Mak, Mary Ho, Lawrence Pui-leung Iu, Helena Pui-yee Sin, Li Jia Chen, Grace Lui, Marten Erik Brelen and Alvin Lerrmann Young]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Chun Yue Mak, Mary Ho, Lawrence Pui-leung Iu, Helena Pui-yee Sin, Li Jia Chen, Grace Lui, Marten Erik Brelen and Alvin Lerrmann Young</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201214]]></guid><cfi:id>439</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Imageology of internal carotid artery siphon in non-arteritic anterior ischaemic optic neuropathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201215]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate whether narrowing of internal carotid artery siphon (ICAS) may increase the risk of developing non-arteritic anterior ischaemic optic neuropathy (NAION).
METHODS: Totally 30 consecutive patients who had unilateral NAION and 30 gender-matched control subjects were recruited in the present study. The diameter of ICAS of all the participants were measured using head-and-neck computed tomographic angiography (CTA). Color doppler flow imaging (CDI) was used to measure the haemodynamics parameters of ICAS and short posterior ciliary arteries (SPCAs) in all subjects. Comparison of parameters between the NAION patients and controls as well as between the two sides within the patients were performed. The correlation between the diameter of ICAS and NAION was analyzed.
RESULTS: A comparison of parameters between the affected side of the NAION patients and the controls, including the diameter of ICAS, the resistance index (RI) of ICAS, the blood flow velocities of SPCAs and RI of SPCAs, showed significantly difference (P<0.01), while there was no significant difference in terms of the mean blood flow velocity (Vm) of ICAS; Similar results were found while comparing all the measurements of the affected and unaffected side of patients (P for RI of SPCAs <0.05). No marked difference was detected in nearly all parameters except for RI of ICAS and SPCAs between the unaffected side of the NAION patients and the controls (P<0.05). The diameter of ICAS were significantly positive correlated with both peak systolic velocity (PSV) of SPCAs and end diastolic velocity (EDV) of SPCAs in patients with NAION (r=0.514, P<0.01 and r=0.418, P<0.05, respectively).
CONCLUSION: Narrowing of ICAS may increase the risk of developing NAION.]]></description>
<pubDate>2020/10/21 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Zhi-Yong Fu, Hong-Yang Li and Yan-Ling Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zhi-Yong Fu, Hong-Yang Li and Yan-Ling Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201215]]></guid><cfi:id>438</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Analysis of macular microvasculature and thickness after ICL implantation in patients with myopia using optical coherence tomography]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201216]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate changes in macular vessels and thickness in myopic eyes after intraocular collamer lens (ICL) implantation using quantitative optical coherence tomography angiography (OCTA).
METHODS: This retrospective included 73 myopic eyes of 73 patients (average age, 27.53±6.16y) who underwent ICL implantation (28 eyes were Toric ICL). Axial length (AL), uncorrected visual acuity (UCVA), refractive dioptre (RD), intraocular pressure (IOP) and OCTA were measured and compared with before and 1wk, 1, and 3mo after surgery. OCTA was used to image vessel density (VD) and skeleton density (SD) in both the superficial (SCP) and deep capillary plexus (DCP). Central retinal thickness (CRT) and ganglion cell-inner plexiform layer thickness (GCT) were also measured. Changes between pre- and postoperative measurements were analysed by repeated measures analysis of variance.
RESULTS: Compared with preoperative data, postoperative data on UCVA revealed significant improvements in all patients (P<0.05). However, there was no significant difference in IOP. After the operation, CRT and GCT exhibited significant changes (P<0.05). Among these measures, CRT was significantly higher at one and three months postoperative (all P<0.01). GCT was significantly higher at 1wk, 1, and 3mo postoperative (all P<0.01). Changes in VD and SD were nonsignificant in both the SCP and DCP. There was no difference in postoperative changes between the ICL and Toric ICL groups.
CONCLUSION: ICL and Toric ICL implantation both have good efficacy and safety for myopic eyes, but macular area changes that occur after surgery need attention.]]></description>
<pubDate>2020/10/21 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Qiu-Jian Zhu, Meng-Yu Wang, Peng Yu, Xiao-Suo Liang, Lie Ma, Hai-Xiang Xiao and You Yuan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Qiu-Jian Zhu, Meng-Yu Wang, Peng Yu, Xiao-Suo Liang, Lie Ma, Hai-Xiang Xiao and You Yuan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201216]]></guid><cfi:id>437</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Preliminary results of a new intrastromal corneal ring segment as a tissue saving procedure in photorefractive keratectomy to correct moderate to high myopia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201217]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the clinical results after implantation of a new intrastromal corneal ring segment (ICRS) associated with photorefractive keratectomy (PRK) to correct high myopia (HM) patients with thin corneas.
METHODS: We evaluated 42 eyes of 23 HM patients that had ICRS implantation followed by PRK. The mean age of patients was 29.1±7.12y (range 18 to 40 years old). Uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), keratometry, spherical equivalent, pachymetry, and aberrometry were compared using ANOVA with repeated measurements evaluated preoperatively and at last follow-up visit after the procedures. The refractive predictability and simulated/real corneal ablation were also assessed.
RESULTS: The mean follow-up time after PRK was 6.8±1.6mo. The mean preoperative UCVA improved from 20/800 preoperative to 20/100 after ICRS and 20/35 after PRK. The mean preoperative BCVA was 20/25 (range from 20/30 to 20/20) and remained unchanged after ICRS implantation. Following the PRK the mean BCVA was 20/25 (range from 20/30 to 20/20). The mean spherical equivalent decreased from -7.25±1.12 (range -5.00 to -9.00) preoperatively to -3.32±1.0 (range -2.00 to -5.00) postoperatively (P<0.001) after ICRS implantation and decreased from -2.44±1.51 preoperatively to 0.32±0.45 (range -0.625 to 0.875) postoperatively (P<0.001) after PRK. The change in BCVA and topographic astigmatism was statistically significant (P<0.0001).
CONCLUSION: ICRS in HM associated with PRK can be a tissue saving procedure and an alternative surgical option for correction of moderate to high myopia.]]></description>
<pubDate>2020/10/21 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Sandro Coscarelli, Pablo Rodrigues, Guilherme Rocha and Leonardo Torquetti]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Sandro Coscarelli, Pablo Rodrigues, Guilherme Rocha and Leonardo Torquetti</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201217]]></guid><cfi:id>436</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinicopathological analysis of 719 pediatric and adolescents’ ocular tumors and tumor-like lesions: a retrospective study from 2000 to 2018 in China]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201218]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To describe the clinicopathologic features and classification of pediatric and adolescent ocular tumors and tumor-like lesions
METHODS: A total of 719 cases of pathologically confirmed ocular tumors and tumor-like lesions in a pediatric population from two academic institutions over an 18-year period were retrospectively analyzed. The main outcome measures were the clinical and pathological features of the cases.
RESULTS: Benign tumors accounted for 92.1% of all cases while malignant tumors accounted for 7.9%. The most common ocular benign tumors were (epi-)dermoid cysts (19.8%), nevi (15.2%), corneal dermoid tumors (9.8%), and calcified epitheliomas (8.8%). The most common ocular malignant tumors were retinoblastoma (80.8%), and rhabdomyosarcoma (3.9%). Eyelid and ocular surface tumors comprised 73.3% of benign tumors while intraocular and orbital cavity comprised 94.2% of malignant tumors. For tumor site, the upper eyelid was up to 1.79 times more than lower eyelid (P<0.05). Age at surgery and sex also had an association with different lesions (P=0.006, P=0.035, respectively).
CONCLUSION: Most ocular tumors and tumor-like lesions in children and adolescents are benign. Pediatric ocular tumors are distinct from those in adults in terms of histological origin. (Epi-)dermoid cysts are the most common benign tumors while retinoblastomas the most common malignant tumors.]]></description>
<pubDate>2020/10/21 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xi-Zhe Dai, Lin-Yan Wang, Yi Shan, Jiang Qian, Kang Xue and Juan Ye]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xi-Zhe Dai, Lin-Yan Wang, Yi Shan, Jiang Qian, Kang Xue and Juan Ye</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201218]]></guid><cfi:id>435</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Poor prognostic factors in post-traumatic endophthalmitis following open globe injury]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201219]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To demonstrate prognostic factors for poor visual outcome in patients with post-traumatic endophthalmitis (PTE) following open globe injury.
METHODS: A retrospective study was conducted on 66 patients (66 eyes) with PTE following open globe injury from 2005 to 2015. Potential factors accounting for good and poor visual outcome were statistically analyzed by Chi-square test and Logistic regression model.
RESULTS: In 66 cases, 39 cases (59%) had a poor visual outcome. Univariate and multivariate Logistic regression analysis identified retained intraocular foreign body (IOFB) as the only factor significantly associated with poor visual outcome [adjusted odds ratio, 4.62; 95% confidence interval (1.04-20.53); P=0.04]. The most common causative agents were gram-positive organisms (83%), of which Bacillus cereus (33%), was the most common pathogen. All cases received intravitreal antibiotic injections. Oral ciprofloxacin was the most used systemic antibiotic (33%). Pars plana vitrectomy was performed in 83% (55/66) of cases. At 6mo follow-up, mean BCVA was 1.74±0.72 logMAR units.
CONCLUSION: In patients with PTE following open globe injury, the only predictor of poor visual outcome is the presence of IOFB. Bacillus cereus is the most isolated microorganism.]]></description>
<pubDate>2020/10/21 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Sukhum Silpa-archa, Akkaranisorn Dejkong, Kwanchanoke Kumsiang, Peranut Chotcomwongse, Janine M Preble and C. Stephen Foster]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Sukhum Silpa-archa, Akkaranisorn Dejkong, Kwanchanoke Kumsiang, Peranut Chotcomwongse, Janine M Preble and C. Stephen Foster</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201219]]></guid><cfi:id>434</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Local dry vitrectomy combined with segmental scleral buckling and viscoelastic tamponade for rhegmatogenous retinal detachment with vitreous traction]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201105]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To demonstrate local dry vitrectomy combined with segmental scleral buckling and viscoelastic tamponade for the treatment of partial rhegmatogenous retinal detachment (RRD) with local vitreous traction in patients at high-risk for proliferative vitreoretinopathy (PVR).
METHODS: Eleven eyes of 11 patients were retrospectively studied, including 5 retinal dialysis and 6 retinal detachment (RD; 5 eyes with peripheral retinal hole and 1 eye with giant tear). All patients exhibited partial RD and local vitreous traction. Combined local dry vitrectomy without conventional infusion and segmental scleral buckling was performed. Viscoelastic fluid was injected into the vitreous cavity if needed. Demographic information, preoperative and post-operative complications, and outcomes were recorded.
RESULTS: The mean age of the patients at presentation was 26.55±13.52y. All 11 patients obtained retinal reattachment after a single surgical intervention. Postoperative visual acuities were improved or remained stable in all patients. None of them developed complications, except for temporary mildly increased intraocular pressure in 3 cases.
CONCLUSION: Combined local dry vitrectomy and segmental scleral buckling are effective for patients of RRD with local vitreous traction. The technique avoids many complications associated with regular surgery and was minimally invasive to both the external and internal eye.]]></description>
<pubDate>2020/9/17 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ping Fei, Hai-Ying Jin, Qi Zhang, Jie Peng, Jia-Kai Li, Jiao Lyu, Tian Tian, Zu-Peng Lu, Jing Li and Pei-Quan Zhao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ping Fei, Hai-Ying Jin, Qi Zhang, Jie Peng, Jia-Kai Li, Jiao Lyu, Tian Tian, Zu-Peng Lu, Jing Li and Pei-Quan Zhao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201105]]></guid><cfi:id>433</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Fourier-domain optical coherence tomography-guided phototherapeutic keratectomy for the treatment of anterior corneal scarring]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201106]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the safety, visual and anatomic outcomes of fourier-domain optical coherence tomography (FD-OCT)-guided excimer laser phototherapeutic keratectomy (PTK) combined with photorefractive keratectomy (PRK) surgery in treating anterior corneal scarring.
METHODS: Clinical data of 23 eyes of 21 patients with anterior corneal scarring underwent FD-OCT-guided PTK and PRK from Dec. 2014 to Jul. 2016 were reviewed. Patients were assessed for preoperative and postoperative uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity (BSCVA), contrast sensitivity (CS), FD-OCT, corneal topography and colour figures of anterior segments.
RESULTS: The preoperative corneal pathologic conditions included viral keratitis (7 patients, 7 eyes), band keratopathy (2 patients, 4 eyes), corneal dystrophy (4 patients, 4 eyes), traumatic corneal disease (2 patients, 2 eyes) and corneal chemical injury (6 patients, 6 eyes). Mean follow-up time was 10.65 (range, 3-19)mo. UCVA (in logMAR) improved from a mean of 0.79 (95%CI, 0.28-1.29) preoperatively to a mean of 0.45 (95%CI, 0.29-0.62) postoperatively (P=0.021). BSCVA (in logMAR) improved from 0.57 (95%CI, 0.27-0.88) preoperatively to a mean of 0.28 (95%CI, 0.15-0.41) postoperatively (P=0.001). Corneal topographic indices postoperatively showed significant improvement in corneal cylinder (P=0.009), the surface regularity index (P=0.007) and surface asymmetry index (P=0.00). Postoperative spherical equivalent averaged -0.53 diopters (-1.49 to 0.42). No complications were associated with the treatment.
CONCLUSION: FD-OCT-guided PTK combined with PRK is safe and effective for the treatment of anterior corneal scarring by eliminating or reducing corneal opacities.]]></description>
<pubDate>2020/9/17 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yu-Li Yang, Qian Jian, Bo Liu, Ke Wang, Yu-Juan Chen, Lian Tan, Mei-Jun Pu and Yong Liu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yu-Li Yang, Qian Jian, Bo Liu, Ke Wang, Yu-Juan Chen, Lian Tan, Mei-Jun Pu and Yong Liu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201106]]></guid><cfi:id>432</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of visual quality after implantation of A1-UV and SN60WF aspheric intraocular lens]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201107]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the visual performance of pseudophakic eyes implanted with A1-UV and SN60WF aspheric intraocular lens (IOL), and to investigate the correlations between visual quality parameters and pupil size.
METHODS: This prospective comparative study included 105 eyes of 90 patients with age-related cataract who underwent uneventful phacoemulsification. The subjects were divided into two groups according to the implanted IOL type. Three months postoperatively, visual acuity and contrast sensitivity were measured, wave-front aberrations were assessed using a KR-1W aberrometer (Topcon), and objective optical quality parameters were performed using an optical quality analysis system-OQAS II (Visiometrics). Independent sample t-test and Spearman correlation analysis were used for data analysis.
RESULTS: There were no significant differences found in visual acuity, contrast sensitivity and visual quality parameters between the two groups (P>0.05). The measured intraocular spherical aberration (SA) in A1-UV IOL eyes of -0.19±0.05 μm was close to the designed SA value of -0.20 μm. The modulation transfer function cutoff, Strehl ratio and OQAS values were negatively correlated with pupil size in both groups (P<0.01).
CONCLUSION: The subjective and objective visual quality in pseudophakic eyes with A1-UV and SN60WF IOLs are comparable. For aspheric IOL eyes, visual quality decreases with increasing pupil size.]]></description>
<pubDate>2020/9/17 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xuan Liao, Ji-Yun Li, Qing-Qing Tan, Jing Tian, Jia Lin and Chang-Jun Lan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xuan Liao, Ji-Yun Li, Qing-Qing Tan, Jing Tian, Jia Lin and Chang-Jun Lan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201107]]></guid><cfi:id>431</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Association between islet autoantibodies and the prevalence of autoimmune uveitis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201108]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the predictive value of islet autoantibodies for the diagnosis of autoimmune uveitis (AU), as well as to characterize the association bet ween islet autoantibodies and AU.
METHODS: Totally 97 patients with AU and 100 healthy persons without any autoimmune diseases as the control group were recruited. Multiple serum islet autoantibodies were measured using commercial enzyme-linked immunosorbent assay kits (ELISA). A supplementary questionnaire was used to complement the subject’s demographics and clinical features. The level of glucose concentrations and white blood cells were measured. Conditional logistic regression was performed to estimate odds ratios (ORs), and 95% confidence intervals (CIs) of AU according to islet autoantibodies and to evaluate the predictive value of islet autoantibodies for AU diagnosis. Autoantibodies subgroups and other variables were included into analysis.
RESULTS: In AU patients, the prevalence of detecting at least one of the autoantibodies was 31.9% (31/97). The most frequent autoantibody was ZnT8A (30.9%), followed by GADA (11.3%), IA-2A (4.1%), ICA (2.1%) and IAA (2.1%). Islet autoantibodies were found to be correlated positively with AU diagnosis [OR (95%CI): 13.86 (3.28, 58.50), P<0.001]. Moreover, Zn-T8A was remarkably correlated with AU diagnosis [OR (95%CI): 6.13 (1.96, 19.17), P<0.001], In contrast, neither GADA nor other islet antibodies (IA-2A, ICA and IAA) showed any association with AU risk under an additive model.
CONCLUSION: The prevalence of islet antibodies, especially ZnT8A, in patients with AU is higher. Islet antibodies as well as novel biomarkers should be included in routine evaluation at AU and is a valuable biological marker to classify newly-diagnosed uveitis.]]></description>
<pubDate>2020/9/17 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yun Zhang, Ni Yan, Ya Li, Wei-Mei Ma, Hong-Li Liu, Jing-Ni Yu and Le Ma]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yun Zhang, Ni Yan, Ya Li, Wei-Mei Ma, Hong-Li Liu, Jing-Ni Yu and Le Ma</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201108]]></guid><cfi:id>430</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Newer trends in tubercular uveitis: a case series with systemic correlation]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201109]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the spectrum of uveitis, causes of visual loss in systemic tuberculosis (TB), role of investigations and outcome after anti-TB therapy (ATT).
METHODS: A retrospective study was conducted on 250 patients with systemic TB at a referral center in Chennai, South India from April 2016 to May 2019. Systemic workup comprised of Mantoux, chest X-ray, polymerase chain reaction (PCR) and QuantiFERON (QFT) TB Gold. Aqueous humor analysis by nested PCR or real time PCR (RT-PCR) and ancillary ophthalmic investigations such as fundus fluorescein angiography, optical coherence tomography were performed.
RESULTS: Multifocal choroiditis and vasculitis were the most common manifestations (39% and 24% respectively) together accounting for 61% of cases and they had a higher risk of recurrence (3%). Pulmonary tuberculosis (PTB) was more frequently associated with uveitis (18%). Among those with extra-pulmonary tuberculosis (EPTB), uveitis occured in miliary TB (2%), bone (1%) and abdominal TB (1%). Complications such as cystoid macular edema, choroidal neovascular membranes and macular scarring caused visual loss. Aqueous humor analysis detected mycobacterium TB antigen. Collectively, systemic investigations such as chest X-ray, Mantoux test and those performed on blood samples such as PCR and QFT were positive in 39% of patients. In inconclusive patients, nested PCR and/or RT-PCR were done on aqueous humor samples and were diagnostic in 96%. A combination of tests was diagnostic in 92%. ATT in isolation in 71% and combined with corticosteroids in 29% was used for treatment of which signs of resolution and improvement in vision started as early as 6wk in those who were started immediately on corticosteroids and ATT and longer than 3mo in those on ATT alone. Prompt treatment with ATT and corticosteroids improved vision in 23% of our patients within 2mo. Vitritis with choroiditis causes cystoid macular oedema and requires longer duration of ATT. Vision improved in 69%. Complete resolution occurred in 75% and worsening in 12%.
CONCLUSION: A combination of investigations guided by clinical suspicion helps in precise diagnosis. In diagnostic dilemmas analysis of ocular samples is reliable and confirmatory. Screening all patients and a multidisciplinary approach in TB (active, healed or during treatment) is recommended.]]></description>
<pubDate>2020/9/17 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Radha Annamalai, Meera Mohanakumar, Krishnima Raghu and Muthukumar Muthayya]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Radha Annamalai, Meera Mohanakumar, Krishnima Raghu and Muthukumar Muthayya</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201109]]></guid><cfi:id>429</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of postoperative anterior segment changes associated with pars plana vitrectomy with and without vitreous base shaving]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201110]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare changes in anterior segment topography and axial length (AL) evaluated with Pentacam and IOL Master after pars plana vitrectomy (PPV) performed with and without vitreous base shaving.
METHODS: This prospective study included patients who underwent PPV or phacoemulsification+PPV (Phaco+PPV) for various indications. Patients who underwent total posterior hyaloid detachment and excessive vitreous base shaving with scleral indentation were referred to as complete PPV (c-PPV). The patients whom posterior hyaloid was separated as far as the posterior arcades and vitreous base shaving with scleral depression was not performed were classified as the partial PPV (p-PPV) group. All patients underwent detailed ophthalmologic examinations preoperatively and 1wk, 1, and 3mo postoperatively. Changes in the anterior chamber depth (ACD), anterior chamber volume (ACV), iridocorneal angle (ICA), central corneal thickness (CCT), and keratometric measurements (K1 and K2) were evaluated with Pentacam HR. Changes in the AL measurements were analyzed with IOL Master.
RESULTS: A significant increase in ACD was observed in c-PPV cases (P=0.02), but this increase was not significant in the p-PPV group (P=0.053). In contrast, ICA increased significantly in the c-PPV group (P=0.02) but decreased in the p-PPV group (P=0.09). BCVA was significantly improved in the c-PPV group from week 1 (P<0.001) while the increase in the p-PPV group reached significance at 3mo (P=0.035). CCT increased in the first week and later returned to baseline in both groups. No significant differences in the other parameters were observed between the groups, and there were no significant changes in intraocular pressure, ACV, AL, K1 or K2 values (P>0.05 for all).
CONCLUSION: Incomplete posterior hyaloid excision and not removing the vitreous base in PPV surgeries may create a more stable anterior chamber, thus preventing the downward movement of the lens-iris diaphragm, and may cause ciliary body retraction, thereby reducing ICA. Awareness of these effects can provide some amount of guidance to physicians in selecting the appropriate PPV procedure and preempting surgical complications.]]></description>
<pubDate>2020/9/17 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Enes Toklu, Muhammed Altinisik, Ahmet Elbay and Arif Koytak]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Enes Toklu, Muhammed Altinisik, Ahmet Elbay and Arif Koytak</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201110]]></guid><cfi:id>428</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical features and changes of disease spectrum of zone II retinopathy of prematurity: a 10-year review]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201111]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report the clinical features and evolution of zone II retinopathy of prematurity (ROP).
METHODS: RetCam images of preterm infants with zone II ROP at our hospital between January 2009 and January 2019 were reviewed. The location, extent, and severity of ROP were recorded. Eyes were classified as type 1 zone II, type 2 zone II, and mild zone II ROP. The clinical features and evolution of zone II ROP were analyzed.
RESULTS: In total, 184 infants (302 eyes) were enrolled. Of these, 55 eyes (18%) developed type 1 zone II ROP, 39 eyes (13%) developed type 2 zone II ROP, and 208 eyes (69%) developed mild zone II ROP. The proportion of type 1 zone II ROP significantly decreased over the 10y. The onset of type 2 zone II and mild zone II ROP were 1wk earlier than type 1 zone II, and both regressed at 45wk. Isolated neovascular tuft (popcorn) and double track signs were characteristic manifestations of zone II ROP. Eighty-seven percent of type 1 zone II ROP regressed completely with an unfavorable outcome that emerged in seven eyes after laser treatment.
CONCLUSION: Zone II is an area with ROP disease at various risk levels. Zone II ROP has unique clinical presentations like popcorn and double track signs. Over time, the proportion of zone II ROP with high risk gradually decrease and respond well to therapy.]]></description>
<pubDate>2020/9/17 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ying-Qin Ni, Si-Si Xu, Ting Zhang and Xin Huang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ying-Qin Ni, Si-Si Xu, Ting Zhang and Xin Huang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201111]]></guid><cfi:id>427</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Efficacy of internal limiting membrane peeling for diabetic macular edema after preoperative anti-vascular endothelial growth factor injection]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201112]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To explore the efficacy of minimally invasive vitrectomy (MIV) with or without internal limiting membrane (ILM) peeling on the treatment of diabetic macular edema (DME) in proliferative diabetic retinopathy (PDR) combining with preoperative anti-vascular endothelial growth factor (anti-VEGF) injection.
METHODS: Totally 132 eyes (132 patients) diagnosed PDR with DME were included between June 2015 and June 2018 in Tianjin Eye Hospital. The single MIV treatment group included 68 eyes and the MIV combined with ILM peeling group included 64 eyes. Anti-VEGF drugs were injected intravitreally 1wk before the operation and the period of follow-up was 1 to 3y. Best-corrected visual acuity (BCVA), central retinal thickness (CRT), total macular volume (TMV), macular edema (ME) severity, intraocular pressure (IOP), and complications were recorded. Prognostic factors of visual acuity following ILM peeling were analyzed.
RESULTS: The BCVA was higher than preoperative values at 1, 3, 6, and 12mo after surgery in both groups (all P<0.05). At 6 and 12mo, the BCVA of the combined group was significantly higher than that of the MIV only group (0.52±0.23 vs 0.64±0.29 logMAR, P=0.011 in 6mo; 0.41±0.25 vs 0.52±0.25 logMAR, P=0.008 in 12mo). Mean CRT values postoperative were significantly lower than preoperative values in both groups from the 1st month (1mo 397.65±106.18 vs 451.94±118.88 μm in MIV only group; 388.88±108.68 vs 464.36±111.53 μm in combined group; both P<0.05) and decreased gradually. The differences between the two groups were statistically significant at 3, 6, and 12mo (P=0.004, 0.003, 0.00 respectively). The TMV was decreased from the 3rd month in the single treatment group (3mo 11.14±1.66 vs 12.20±2.09 mm3, P<0.05). At 12mo, the proportion of eyes with edema that had CRT more than 350 μm was significantly lower than before surgery (13.24% vs 77.94% in MIV only group; 1.56% vs 81.25% in combined group; both P<0.05). There was no significant difference in the recurrence incidence of macular epiretinal membrane, ME, transient IOP increase, vitreous rebleeding, or traction retinal detachment between the two groups. BCVA after ILM excision was positively correlated with the CRT and ME degree before and after surgery (r=0.430, 0.485, respectively; P<0.05).
CONCLUSION: MIV combined with ILM peeling accelerates the absorption of ME, improves vision, reduces the postoperative CRT and TMV, and reduces the recurrence rate of postoperative ME.]]></description>
<pubDate>2020/9/17 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jing Guo, Xue Bi, Shan-Na Chen, Song Chen, Guang-Hui He, Bin Wu, Wei Zhang and Jian Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jing Guo, Xue Bi, Shan-Na Chen, Song Chen, Guang-Hui He, Bin Wu, Wei Zhang and Jian Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201112]]></guid><cfi:id>426</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of intravitreal injection of conbercept and triamcinolone acetonide for macular edema secondary to branch retinal vein occlusion]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201113]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the safety and efficacy of the intravitreal injection of conbercept (IVC) and triamcinolone acetonide (IVTA) for macular edema (ME) secondary to branch retinal vein occlusion (BRVO).
METHODS: A prospective, randomized clinical study. Patients with ME secondary to BRVO were randomly assigned to either IVC group or IVTA group at a ratio of 2:1 and a 12-month follow-up was performed. The efficacy outcome measures included the mean changes and differences in best corrected visual acuity (BCVA) and the central retinal thickness (CRT). The safety profiles and the mean retreatment intervals were also compared.
RESULTS: There was no statistically significant difference of baseline between the two groups (IVC group, n=36; IVTA group, n=17). At 12mo, the BCVA letters improved by 27.31±18.36 in the IVC group, and 13.53±11.37 in the IVTA group (P=0.0004). CRT reduction was 253.33±163.69 and 150.24±134.32 μm, respectively (P=0.0034). The mean BCVA in the IVC group was superior to that of the IVTA group for months 6-12 (P<0.01). The mean CRT at 9 and 12mo were thinner in the IVC group compared to the IVTA group (P<0.01). The mean retreatment interval in the IVC group was longer than that in the IVTA group (97.40±36.27d vs 68.71±36.38d, P=0.0030). One eye in the IVC group and seven eyes in the IVTA group developed elevated intraocular pressure (IOP; P=0.0012). The proportion of eyes with cataract new-onset or progression were 19.44% in the IVC group and 64.71% in the IVTA group (P=0.0012).
CONCLUSION: IVC could maintain or improve BCVA and reduce CRT for a longer time and have longer retreatment interval than IVTA. In addition, patients treated with IVTA are more susceptible to IOP elevation and cataract progression.]]></description>
<pubDate>2020/9/17 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Miao Zhao, Ce Zhang, Xi-Mei Chen, Yan Teng, Tian-Wei Shi and Fei Liu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Miao Zhao, Ce Zhang, Xi-Mei Chen, Yan Teng, Tian-Wei Shi and Fei Liu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201113]]></guid><cfi:id>425</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Parafoveal retinal massage combined with autologous blood cover in the management of giant, persistent or recurrent macular holes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201114]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the efficacy and safety of parafoveal retinal massage combined with autologous whole blood cover in the treatment of refractory macular holes (MHs) and present the surgical procedure.
METHODS: Patients with giant (minimum diameter ≥800 μm), recurrent or persistent MHs who underwent PPV combined with parafoveal retinal massage and autologous whole blood cover using C3F8 as tamponade agent from February 2018 to May 2019 were enrolled in this retrospective study. After surgery, all patients were informed to maintain a prone position for at least 7d. Preoperative and postoperative best-corrected visual acuities (BCVAs) were compared and MH closure rate was measured as the main outcome.
RESULTS: A total of 13 MH patients consisted of 6 giant MHs, 4 persistent holes and 3 recurrent holes (5 men and 8 women; average age was 56.40±11.72y) were enrolled in this study. MH closure was achieved in 11 eyes by this modified surgical technique while 2 eyes failed. Revitrectomy with autologous neurosensory retinal patch transplantations was applied for those 2 patients and then both holes were closed. No intraoperative complications were observed. BCVA improved from 1.73 logMAR to 0.74 logMAR at 6mo postoperation. There was significant difference in BCVA before versus after the surgery (P<0.05). There were no adverse events occurred during the follow-up period.
CONCLUSION: With easier surgical procedure, parafoveal retinal massage combined with autologous whole blood cover is an effective addition to the surgical options for the management of refractory MHs.]]></description>
<pubDate>2020/9/17 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hua Wang, Meng Ji, Rong Di, Yun Qi, Cheng Pei, Shan Gao, Si-Wei Liu, An-Ming Xie and Yu-Hong Cheng]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hua Wang, Meng Ji, Rong Di, Yun Qi, Cheng Pei, Shan Gao, Si-Wei Liu, An-Ming Xie and Yu-Hong Cheng</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201114]]></guid><cfi:id>424</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of clinical outcomes after femtosecond laser in situ keratomileusis in eyes with low or high myopia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201115]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the clinical results of femtosecond (FS) laser in situ keratomileusis (LASIK) in high myopic patients and low myopic patients.
METHODS: This study included 212 myopic eyes undergoing LASIK using a VisuMax 500kHz FS laser. All treated eyes were assigned to one of two groups according to preoperative manifest spherical refraction: low myopia group (A, >?4.0 D) and high myopia group (B, ≤?4.0 D). Uncorrected and corrected distance visual acuity (UDVA, CDVA), refractive errors, and higher-order aberrations (HOAs) were measured preoperatively and 1wk, 1, 3 and 6mo postoperatively.
RESULTS: At 6mo of follow-up, 92% and 76% had a UDVA of 20/20 or better in group A and B, respectively (P=0.037) and UDVA was significantly different between two groups (P=0.042). Six and seven percentage lost one line of CDVA in group A and B, respectively (P=0.572) and no eyes in both groups lost more than two lines. Each group had 87% and 76% of treated eyes within ±0.5 D of the intended correction (P=0.186), and 13% and 43% with a change of >0.50 D in spherical equivalent from 1wk to 6mo postoperatively (P=0.005). In terms of postoperative astigmatism, each group had 89.1% and 76.6% within ±0.50 D, respectively and there was significant difference (P=0.006). Group A tends to induce smaller HOAs than group B.
CONCLUSION: FS LASIK is effective and safe for correcting high myopia as well as low myopia. However, high myopic eyes showed more postoperative astigmatism and HOAs which affect visual acuity.]]></description>
<pubDate>2020/9/17 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Su Hwan Park, Cheng-Ye Che, Sung Il Kim, Choul Yong Park, Jong Heon Lee, Young Hee Kim, Ji Won Jung, Jong Soo Lee and Ji Eun Lee]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Su Hwan Park, Cheng-Ye Che, Sung Il Kim, Choul Yong Park, Jong Heon Lee, Young Hee Kim, Ji Won Jung, Jong Soo Lee and Ji Eun Lee</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201115]]></guid><cfi:id>423</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effects of congenital ptosis on the refractive development of eye and vision in children]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201116]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the influence of unilateral congenital ptosis on the development of the eye and vision in children.
METHODS: In this prospective observational study, 41 patients with unilateral congenital ptosis were enrolled (age range 3-15y). The blepharoptosis was divided into 3 subgroups according to the margin reflex distance-1 (MRD-1), including mild group (MRD-1≥2 mm), moderate group (0≤MRD-1<2 mm), and severe group (MRD-1<0 mm). The fellow eyes served as controls. All subjects underwent ocular examinations, including axial length, keratometry, and refractive error.
RESULTS: The incidence of astigmatism (ptotic eyes: 58.5% vs fellow eyes: 24.4%, P=0.002) and magnitude of cylindrical power (ptotic eyes: -0.86±0.79 D vs fellow eyes: -0.43±0.63 D, P=0.003) differed significantly between the ptotic eyes and the fellow eyes. The spherical equivalent refraction (P=0.006), spherical power (P=0.01), cylindrical power (P=0.011), axial length-corneal radius (AL/CR) ratio (P=0.009), frequency of hyperopia (P=0.002) and astigmatism (P=0.004) were significantly different among the ptotic eye subgroups and the fellow eye group. In addition, in patients with congenital ptosis, the incidence of amblyopia is 43.9% and the incidence of anisometropia is 24.4%. More importantly, the ratio of AL/CR showed significantly positive correlation with the severity of ptosis (P=0.002).
CONCLUSION: Congenital ptosis may lead to a delayed eyeball development in the aspect of AL/CR. The risk of amblyopia is also increased due to visual deprivation and aggravated anisometropia, particularly in severe ptosis case.]]></description>
<pubDate>2020/9/17 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xiao-Yu Zeng, Jia-Xing Wang, Xiao-Li Qi, Xue Li, Shao-Zhen Zhao, Xiao-Long Li, Xue-Han Qian and Nan Wei]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiao-Yu Zeng, Jia-Xing Wang, Xiao-Li Qi, Xue Li, Shao-Zhen Zhao, Xiao-Long Li, Xue-Han Qian and Nan Wei</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201116]]></guid><cfi:id>422</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Pathologic comparisons of enucleated eyes with retinoblastoma after superselective ophthalmic arterial chemotherapy with or without intravenous chemotherapy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201117]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To describe and compare pathologic findings in eyes enucleated after superselective ophthalmic arterial chemotherapy (SOAC) or SOAC with intravenous chemotherapy (IVC) for retinoblastoma.
METHODS: Medical records between January 1st, 2014 and June 30th, 2017 were retrospectively analyzed, and pathologic findings were recorded. This study included 36 eyes from 22 (61.1%) male and 14 (38.9%) female patients. Nineteen of 36 (52.8%) eyes received SOAC (mean=3, range=1-7) as primary treatment, and 17 of 36 (47.2%) eyes received SOAC (mean=3.7, range=1-10) after IVC (mean=6.1, range=2-11). Tumor extension including choroidal invasion (n=9, 25%), optic nerve invasion (n=5, 13.9%) and anterior segment invasion (n=5, 13.9%) were recorded.
RESULTS: Histopathologic evidence of ischemic damage in the retina and choroid was found in 28 (77.8%) eyes. Thrombosed blood vessels were identified in 9 (25%) eyes, including orbital artery in the retrobulbar orbit (n=1), intrascleral vessels (n=4), and chorioretinal vessels (n=6). Fibrotic changes were found in extraocular muscles (n=5, 13.9%) and optic nerve (n=5, 13.9%). Varying degrees of scleral degeneration were found in all eyes. In statistical analysis, there was no significant difference in clinical and pathologic changes between SOAC group and SOAC with IVC group except for optic nerve invasion (P=0.047).
CONCLUSION: SOAC for retinoblastoma can result in ocular toxicity, and SOAC with IVC do not increase the toxicity but reduce the incidence of optic nerve invasion.]]></description>
<pubDate>2020/9/17 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xiu-Yu Zhu, Jing Li, Wen-Bin Guan, Chun-Li Chen, Xun-Da Ji and Pei-Quan Zhao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiu-Yu Zhu, Jing Li, Wen-Bin Guan, Chun-Li Chen, Xun-Da Ji and Pei-Quan Zhao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201117]]></guid><cfi:id>421</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Spectral-domain optical coherence tomography finding in cytomegalovirus retinitis in AIDS patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201118]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To observe the findings of spectral domain optical coherence tomography (SD-OCT) scan in cytomegalovirus retinitis (CMVR).
METHODS: Forty-six eyes of 33 patients with acquired immunodeficiency syndrome and CMVR were enrolled in the study. Complete ophthalmologic examinations, color fundus photography, SD-OCT and fundus autofluorescence (FAF) were performed for all patients at the first visit and each follow-up visit. Retinal necrosis in CMVR was analyzed on SD-OCT and classified into two types, the typical type and the atypical type.
RESULTS: Forty-one eyes of active CMVR and 4 eyes of recurrent CMVR were classified into typical type, and 4 eyes with graying retinal lesion without hemorrhage or only punctate hemorrhage were classified into atypical type. In active stage of CMVR, the retina in typical type was significant thickened with hyperreflective lesion and full-thickness disruption of retinal architecture with enlarged vessel; while in atypical type, the retina was also destroyed in all layers but without thickening or slightly thinned. The choroid, vitreous and retinal vessels were not significantly involved. In healed stage, the retina was thin with destroyed layers in both types. In typical type, FAF showed mottled hypofluorescence mixed with punctuate hyperfluorescence. In atypical type, the retina showed some “cavity” in outer nuclear layer, and FAF showed mild hyperfluorescence.
CONCLUSION: SD-OCT show different changes in the retina in typical type and atypical type of CMVR, which should be useful in assisting diagnosis and follow-up management of the disease.]]></description>
<pubDate>2020/9/17 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yan Sheng, Yong-Zheng Guo, Li-Jun Xu and Biao Zhu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yan Sheng, Yong-Zheng Guo, Li-Jun Xu and Biao Zhu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201118]]></guid><cfi:id>420</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Shifting hierarchy of the conjunctival florae in the patients employed a long-time topical fluoroquinolone]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201007]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To observe the shifting hierarchy of the conjunctival florae in the patients who employed a long-time topical fluoroquinolone and characterize the consequent variations of their antibiotic sensitivity and virulence.
METHODS: A total of 143 eyes (143 patients) who suffered from the non-infectious corneal ulcer and topically used fluoroquinolone more than 2wk were enrolled as the fluoroquinolone eye. The untreated fellow eye was considered as the contralateral eye. Seventy-five healthy subjects were selected as the control. The culture positivity and strains of the isolated conjunctival florae were observed. Their antibiotic susceptibility and expression of the virulence-related genes were detected.
RESULTS: Florae were recovered from 84.0%, 37.1%, and 57.3% of the conjunctival swabs in the control, fluoroquinolone eye, and contralateral eye, respectively. The most frequently isolated microorganisms were Staphylococcus epidermidis (34.9%) in the control, followed by Staphylococcus aureus (17.5%), Staphylococcus saprophyticus (14.3%), Micrococcus (9.5%), Propionibacterium acnes (7.9%). However, those orderly ranks shifted to Staphylococcus aureus (34.0%), Propionibacterium acnes (20.8%), Candida albicans (17.0%), Pseudomonas aeruginosa (9.4%) in the fluoroquinolone eye. A growing number of the fluoroquinolone-resistant florae survived in the fluoroquinolone eye, accompanied by an increased expression of the virulence-related genes.
CONCLUSION: A long-time topical fluoroquinolone leads to a shifting hierarchy of the conjunctival florae, accompanied by the consequent variations of the antibiotic sensitivity and virulence.]]></description>
<pubDate>2020/8/25 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xue-Hui Zhang, Ying Tian, Yi-Yi Wen and Shuang-Yong Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xue-Hui Zhang, Ying Tian, Yi-Yi Wen and Shuang-Yong Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201007]]></guid><cfi:id>419</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Three-year follow-up in advanced pediatric keratoconus: thin corneas may not have pachymetry properly assessed after crosslinking]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201008]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyze the crosslinking (CXL) effects in pediatric keratoconus, and to identify the patients’ corneal characteristics whose pachymetry could not be adequately evaluated by Scheimpflug method after procedure.
METHODS: Consecutive pediatric patients with progressive keratoconus underwent CXL were included. Best-corrected visual acuity (BCVA) and spheric equivalent (SE) were measured before and after CXL. After CXL, groups 1 and 2 were divided based on the posterior surface Pentacam quality specifications (QS): “OK” (Group 1) and “not OK” (Group 2). The mean (RmF and RmB) and minimum (RminF and RminB) radius of curvatures of the anterior and posterior corneal surfaces, and the thinnest pachymetry (Pmin) were measured preoperatively at 3, 6, 12, 24, and 36mo. Haze was annotated.
RESULTS: Twenty-six patients (14 men, mean age 14±1.8y) and median Kmax of 59.9 D initially and 61.4 D preoperatively were treated. BCVA was not different before and 24mo after CXL. Group 2 statistically differed to group 1 in that SE was more myopic before and with no difference 24mo after CXL; RmF and RmB were steeper and Pmin was thinner pre-surgically. Group 2, in which pachymetric changes could not be adequately evaluated after surgery, presented with significant RmF flattening, a shift to hyperopia, and more haze after CXL.
CONCLUSION: Patients whose pachymetry could not be adequately evaluated after CXL had steeper and thinner corneas before surgery. The predictive factors for impaired QS after CXL are RmF, RmB, and Pmin. In advanced keratoconus, alternative methods to analyze pachymetry and the posterior surface should be considered.]]></description>
<pubDate>2020/8/25 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Rosalia Antunes-Foschini and Sidney Júlio Faria-e-Sousa]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Rosalia Antunes-Foschini and Sidney Júlio Faria-e-Sousa</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201008]]></guid><cfi:id>418</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Trifocal toric intraocular lenses in eyes with low amount of corneal astigmatism]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201009]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the refractive and visual outcomes following cataract surgery and implantation of a trifocal toric intraocular lens (IOL) in eyes with low degrees of corneal astigmatism.
METHODS: Twenty-six eyes of 22 patients who underwent implantation a trifocal toric IOL (FineVision PODFT, PhysIOL s.a., Liege, Belgium) were enrolled. Phacoemulsification with femtosecond laser, capsular tension ring insertion and intraoperative aberrometry were performed in all cases. All IOLs used showed a cylinder power of 1.00 D. Main outcome measures were refractive error and corrected-distance visual acuity (CDVA) and uncorrected-distance visual acuity (UDVA) values. Eyes were evaluated at 4mo post-surgery.
RESULTS: Totally 50% of eyes showed a spherical equivalent (SE) within ±0.13 D and all of them within ±0.50 D. The mean SE and refractive cylinder were -0.02±0.23 and -0.16±0.22 D, respectively. Vector analysis revealed that 100% of eyes were within ±0.50 D for the SE and cylindrical components (J0 and J45). Refractive changes were not correlated with keratometric changes (P>0.05) showing that the reduction in astigmatism comes from the trifocal toric IOL. Of 81% and 96% of eyes showed UDVA and CDVA of 20/20, respectively. The postoperative mean values of monocular distance Snellen decimal UDVA and CDVA were 0.97±0.05 and 0.99±0.02 (about 20/20), respectively.
CONCLUSION: Our study suggests that the use of this trifocal toric IOL in patients with low amount of astigmatism provides accurate refractive outcomes and enables them to achieve excellent visual acuity.]]></description>
<pubDate>2020/8/25 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Paz Orts-Vila, Salvador Aguilar-Córcoles, Cristina Tello-Elordi, María Ramos-Alzamora, Robert Montés-Micó and Pedro Taná-Rivero]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Paz Orts-Vila, Salvador Aguilar-Córcoles, Cristina Tello-Elordi, María Ramos-Alzamora, Robert Montés-Micó and Pedro Taná-Rivero</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201009]]></guid><cfi:id>417</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A pilot study of the precision of digital intraocular pressure measurement during vitrectomy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201010]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the precision of digital intraocular pressure (IOP) measurement in silicone oil (SO) filled eyes during vitrectomy.
METHODS: This is a retrospective, single-blind study. Patients who were diagnosed with retinal detachment and scheduled for vitrectomy with SO injection were consecutively enrolled. During the vitrectomy, IOP was digitally measured and then by a rebound tonometer (IcarePRO). The rebound tonometer readings were masked to the surgeons. The digitally measured IOP and that of rebound tonometer were compared, and the inter-methods agreement was assessed. The absolute deviation in IOP values between these two methods (?IOP) was also calculated, and correlations between ?IOP and refractive status, lens status and levels of surgeons’ experience were analyzed.
RESULTS: A total of 131 patients (131 eyes) were recruited, with a mean age of 51.0±16.1y. There was no significant difference in IOPs between digital measurement and the rebound tonometer (15.6±4.3 vs 15.7±5.1 mm Hg; t=0.406, P=0.686). Intraclass correlation coefficients (ICC) analysis indicated a strong correlation between these two measurements (ICC=0.830, P<0.001). The mean ?IOP was 2.0±1.9 mm Hg (range: 0-12.8 mm Hg), with 98 eyes (74.8%) had the ?IOP within 3 mm Hg. ?IOP was found to be negatively correlated with levels of surgeons’ experience (r=-0.183; P=0.037), but not with the refractive status or lens status of the patients (both P>0.05).
CONCLUSION: For experienced surgeons, the digital IOP measurement may be an acceptable technique for IOP measurement in SO filled eyes during vitrectomy. However, its use by inexperienced surgeons should be taken with caution.]]></description>
<pubDate>2020/8/25 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Can-Can Xue, Shu-Shan Li, Jin-Hong Miao, Se-Fei Wu, Xue-Ling Tian and Chun Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Can-Can Xue, Shu-Shan Li, Jin-Hong Miao, Se-Fei Wu, Xue-Ling Tian and Chun Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201010]]></guid><cfi:id>416</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Central choroidal thickness in children and adolescents with anxiety disorders: enhanced depth imaging optical coherence tomography findings]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201011]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To measure the central choroidal thickness (ChT) in children and adolescents with anxiety disorders.
METHODS: Totally 41 anxiety patients (8-16y) and 35 healthy controls (age-matched) were evaluated. Complete ophthalmic examination was performed. Inclusion criteria were best corrected visual acuity ≥20/20, normal intraocular pressure (IOP; 10-21 mm Hg), and no systemic or ocular diseases according to history. The diagnosis of psychiatric disorders was determined using Schedule for Affective Disorders and Schizophrenia for School Aged Children Present-Lifetime Version (K-SADS-PL). Enhanced depth imaging optical coherence tomography (EDI-OCT) was used to measure the central ChT.
RESULTS: The mean age was 12.18±3.24y in the patient group and 12.86±3.15y in the control group. Age and gender distribution of the two groups was similar. Central ChT mean value was 353.26±31.9 μm in anxiety patients while 318.75±60.9 μm in the control group. Mean central ChT was statistically significantly higher in the children and adolescents with anxiety disorders than healthy controls (P=0.002).
CONCLUSION: The children and adolescents with anxiety disorders have significantly thicker central ChT than controls. In the larger sample, longitudinal studies will contribute to the use of choroidal differences as a clinical marker for monitoring anxiety disorders.]]></description>
<pubDate>2020/8/25 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Didem Ayyildiz and Taha Ayyildiz]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Didem Ayyildiz and Taha Ayyildiz</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201011]]></guid><cfi:id>415</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of intravitreal anti-vascular endothelial growth factor agents and treatment results in Irvine-Gass syndrome]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201012]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the efficacy of bevacizumab, ranibizumab, and aflibercept in pseudophakic cystoid macular edema (CME) patients with Irvine-Gass syndrome (IGS).
METHODS: This study is designed as retrospective consecutive case series. Those who developed postoperative pseudophakic CME that refractory to topical treatment and were treated with anti-vascular endothelial growth factor (VEGF) agents included in the study. Optical coherence tomography (OCT) examination including central macular thickness (CMT), total macular volume (TMV), retinal nerve fiber layer (RNFL), ganglion cell layer (GCL) and choroidal thickness (ChT) measurements at the baseline, 1st, 3rd and 6th month controls were performed.
RESULTS: Fifty-nine eyes of 59 patients with CME and other healthy eyes of the patients (Control group) were evaluated. There were 22 eyes of 22 patients in the bevacizumab group (group 1), 19 eyes of 19 patients in the ranibizumab group (group 2), and 18 eyes of 18 patients in the aflibercept group (group 3). There was no difference in terms of age, gender, axial length, IOP, and spherical equivalent values. The baseline subfoveal and mean ChT were higher in the IGS group. The difference between the baseline and sixth month values of subfoveal and mean ChT were compared in the CME groups, thinning was observed in all three groups. GCL was thinner in the patient group at the 6th month of treatment. The resolution time of CME was observed faster in group 1.
CONCLUSION: All three anti-VEGF agents seem to be effective in CME but bevacizumab appears to be slightly more cost-effective than the other two alternatives.]]></description>
<pubDate>2020/8/25 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Fahrettin Akay, Mehmed Ugur Isik, Berkay Akmaz and Yusuf Ziya Güven]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Fahrettin Akay, Mehmed Ugur Isik, Berkay Akmaz and Yusuf Ziya Güven</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201012]]></guid><cfi:id>414</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Correlation between optical coherence tomography, multifocal electroretinogram findings and visual acuity in diabetic macular edema]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201013]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyze the correlation between macular morphology and function in eyes with diabetic macular edema (DME).
METHODS: Fifty-five eyes with different visual acuity (VA) of 32 patients who suffered from DME were analyzed using multifocal electroretinography (mfERG) and optical coherence tomography (OCT). The parameters of mfERG including implicit times and response amplitude were compared to those of 50 normal eyes of 36 age-matched subjects. Correlation analysis was performed between VA, the parameters of mfERG including implicit times and response amplitude, and the central macular thickness (CMT).
RESULTS: The amplitude of N1 and P1 were significantly decreased and their latency were significantly increased in five ring regions of the retina in patients with DME. There was statistically significant correlation between logMAR BCVA and P1 amplitude densities in rings 1-4 (r=-0.306, -0.536, -0.470, -0.362; P=0.023, <0.01, <0.01, 0.007 respectively), N1 amplitude in ring 2 and ring 3 (r=-0.035, -0.286; P=0.019, 0.034 respectively). There was poor correlation between the CMT and best-corrected visual acuity (BCVA; r=0.288, P=0.033), but there was no significant correlation between CMT and amplitude or implicit time of N1 and P1 (P>0.05) in the central macular ring. Multiple stepwise regression analysis showed that P1 amplitude density in ring 2 was the only contributor to the VA.
CONCLUSION: It seems to be more appropriate of combining use of mfERG with OCT for the evaluation of macular function in eyes with DME.]]></description>
<pubDate>2020/8/25 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hong-He Xia, Jia-Lin Chen, Hao-Yu Chen and Hong-Jie Lin]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hong-He Xia, Jia-Lin Chen, Hao-Yu Chen and Hong-Jie Lin</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201013]]></guid><cfi:id>413</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Intravitreal dexamethasone implant in na?ve and previously treated patients with diabetic macular edema: a retrospective study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201014]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the effect of the intravitreal dexamethasone implant (DEX) Ozurdex on the best corrected visual acuity (BCVA) and central retinal thickness (CRT) in patients with diabetic macular edema (DME).
METHODS: Totally 43 eyes (24 na&#239;ve and 19 previously treated) were included in the study. Retrospective and single-center study involved patients with a clinical diagnosed of DME, who received treatment with DEX implant and had a follow-up of at least 12mo. Primary endpoints included changes in BCVA and CRT.
RESULTS: At month 12, mean improvement in BCVA from baseline was 20.4±20.8 letters and 6.8±6.9 letters in na&#239;ve and previously treated patients, respectively (P=0.0132). The na&#239;ve patients achieved the BCVA improvement significantly faster (2.4±1.5mo) than the previously treated ones (3.5±2.4mo, P=0.0298; Mann-Whitney test). The proportion of eyes gaining ≥15 letters was 54.2% and 21.1% in the non-previously treated and previously treated groups, respectively (P=0.0293). CRT was significantly reduced from 484.0±119.8 and 487.5±159.9 μm to 272.0±39.2 and 233.5±65.7 μm in the na&#239;ve and previously treated patients, respectively; P<0.0001 each, respectively. The presence of subretinal fluid was significantly associated with the proportion of patients achieving a BCVA improvement ≥5 letters [HR (95%CI), 1.23 (1.04 to 1.45), P=0.0145]; ≥10 letters [HR (95%CI), 1.75 (1.10 to 2.77), P=0.0182]; and ≥15 letters [HR (95% CI), 2.04 (1.03 to 4.02), P=0.0407]. Na&#239;ve patients received less DEX implants throughout the study than the previously treated ones (1.8±0.6 vs 2.3±0.6, P=0.0172, respectively). Totally 9 patients (20.9%) have developed ocular hypertension, which was successfully controlled with topical hypotensive drugs. Of the 23 phakic eyes at baseline, 5 eyes (21.7%) either had new onset lens opacity or progression of an existing opacity during the study follow-up. Four of them (2 in the na&#239;ve group and 2 in the previously treated one) required cataract surgery at months 4, 6, 6, and 6, respectively.
CONCLUSION: The results obtained in this study may support the early use of DEX Ozurdex as first line therapy in na&#239;ve patients.]]></description>
<pubDate>2020/8/25 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Marta Medina-Baena, Olga Cejudo-Corbalán, Juan Ignacio García-Pulido, María Jesús Huertos-Carrillo and Eloy Girela-López]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Marta Medina-Baena, Olga Cejudo-Corbalán, Juan Ignacio García-Pulido, María Jesús Huertos-Carrillo and Eloy Girela-López</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201014]]></guid><cfi:id>412</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Subthreshold micropulse laser versus intravitreal anti-VEGF for diabetic macular edema patients with relatively better visual acuity]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201015]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the effects of yellow (577 nm) subthreshold micropulse laser (SML) and intravitreal (IV) anti-vascular endothelial growth factor (VEGF) treatment in patients with diabetic macular edema (DME) with relatively better visual acuity [best corrected visual acuity (BCVA) ≤0.15 logMAR].
METHODS: The medical records of 76 eyes of 47 patients underwent IV (0.5 mg) anti-VEGF injection or SML for the DME with relatively better BCVA were reviewed. The IV group received three consecutive monthly IV anti-VEGF injections, then were retreated as needed. The laser treatment group was treated at baseline and 3mo, and then retreated at 6 and 9mo if needed. All participants were followed up for one year. The mean BCVA and mean central macular thickness (CMT) values changes over the follow-up were evaluated.
RESULTS: Twenty-four and 23 patients were assigned to the SML and IV subgroups, respectively. The mean number of treatments was 3.64±0.76 in SML group and 5.85±1.38 in IV group (P<0.05). The subgroups were similar with regard to the mean BCVA score at baseline and at the 1st and 3rd months, but the score of SML group was better than that of IV group at the 6th, 9th, and 12th months (P<0.05). The decrease in the mean CMT values from baseline values was higher in SML group at the 6th, 9th, and 12th months (P<0.05).
CONCLUSION: Yellow SML treatment is superior to IV anti-VEGF injection in DME patients with relatively better BCVA for increasing visual acuity and decreasing CMT at 6, 9, and 12mo. SML can be a good alternative first-line therapy for DME with BCVA ≤0.15 logMAR.]]></description>
<pubDate>2020/8/25 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Sezen Akkaya, Banu Acikalin, Yusuf Emre Dogan and Fatih Coban]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Sezen Akkaya, Banu Acikalin, Yusuf Emre Dogan and Fatih Coban</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201015]]></guid><cfi:id>411</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Complications of dexamethasone implants: risk factors, prevention, and clinical management]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201016]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate major complications after intravitreal injection of dexamethasone implants (Ozurdex) and their clinical management.
METHODS: In a retrospective observational study between 2014 and 2016 at two university hospitals, we reviewed the clinical records of 1241 consecutive macular edema patients treated with the dexamethasone implant, and separated severe adverse events in the injection procedure from those that were post-injection complications. We evaluated the cause and the outcomes in each case.
RESULTS: In twenty-one procedures (1.69%) we noticed significant complications during and after intravitreal injection of the dexamethasone implant. Complications related to the injection procedure were in one case, that a second implant was injected by mistake in the same eye on the same day. In another case, the implant lodged in the sclera during retraction of the injector needle. Leaking scleral tunnel at the injection site led to hypotony in another case. There were 10 cases of post-injection displacement of the implant into the anterior chamber and one case with a migrated and trapped device between the intraocular lens and an artificial iris. Displacement typically occurred in patients with preexisting risk factors: eyes with complicated intraocular lens implantation, iris reconstruction or iris defects or pseudophakic eyes after vitrectomy were prone to develop this complication. Displacement led to secondary corneal decompensation with pseudohypopyon. One case developed an endophthalmitis, and we observed four cases of retinal detachment. Two eyes presented with long-lasting hypotony due to ciliary insufficiency.
CONCLUSION: Treatment with the dexamethasone implant may cause various expected or unexpected complications that may have serious consequences for the patient and require further surgery. To reduce complications, clinicians should evaluate certain risk factors before scheduling patients for dexamethasone implant treatment and use proper injection techniques.]]></description>
<pubDate>2020/8/25 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Nil Celik, Ramin Khoramnia, Gerd. U Auffarth, Saadettin Sel and Christian S Mayer]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Nil Celik, Ramin Khoramnia, Gerd. U Auffarth, Saadettin Sel and Christian S Mayer</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201016]]></guid><cfi:id>410</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Natural history of persistent subretinal fluid following the successful repair of rhegmatogenous retinal detachment]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201017]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To provide a detailed description of the natural history of persistent subretinal fluid (SRF) after successful repair of rhegmatogenous retinal detachment (RRD) and its association with visual outcome.
METHODS: This was a prospective long-term follow-up for eyes undergoing scleral buckling (SB) surgery for macula-off RRD. Examinations were carried out preoperatively and postoperatively at 1, 3, 6, 9 and 12mo, until persistent SRF had completely resolved. One month postoperatively, optical coherence tomography (OCT) was used to classify SRF into three patterns: bleb-like loculated (BL), shallow-diffused (SD), and multiple blebs (MB). Serial OCT imaging was used to evaluate morphological changes in SRF until its complete disappearance. Patients were divided into two groups depending on the presence or absence of persistent SRF.
RESULTS: A total of 59 patients (59 eyes) were included. There were no statistical differences between two groups at baseline, except for the proportion of patients with high myopia and a younger age. One month after surgery, OCT detected persistent SRF in 49 eyes (83.1%). The 3 morphological patterns of SRF were observed in 27 eyes (55.1%) with BL, 13 eyes (26.5%) with SD, and 9 eyes (18.4%) with MB. The mean time for complete absorption differed significantly across the three SRF patterns (F=8.097, P=0.001), which was 8.8±6.1, 20.1±12.1, and 16.7±10.2mo in BL, SD, and MB, respectively. In 9 of the 13 eyes with SD, the pattern transformed into MB type. In cases involving MB, the size and number of blebs decreased gradually until they had been completely absorbed. Eyes with persistent SRF were more likely to demonstrate disruption of the ellipsoid zone (49.0% vs 10%, P=0.034). The final best-corrected visual acuity of two groups was 0.37±0.11 (with SRF) vs 0.34±0.12 (without SRF) logMAR (P=0.499), respectively.
CONCLUSION: High preoperative myopia and younger age are associated with persistent SRF. BL is the most commonly observed pattern with the shortest duration and gradually disappeared. Most cases involving SD SRF transform into MB type during resolution. The size and number of the MBs decrease gradually until they were completely absorbed. The absence of persistent SRF may contribute to slow visual recovery in the short-term but does not influence the final visual outcome.]]></description>
<pubDate>2020/8/25 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yan Fu, Song Chen, Zhao-Hui Gu, Yue-Ling Zhang, Li-Ying Li and Na Yang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yan Fu, Song Chen, Zhao-Hui Gu, Yue-Ling Zhang, Li-Ying Li and Na Yang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201017]]></guid><cfi:id>409</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Altered amplitude of low-frequency fluctuations and default mode network connectivity in high myopia: a resting-state fMRI study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201018]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyze changes in amplitude of low-frequency fluctuations (ALFFs) and default mode network (DMN) connectivity in the brain, using resting-state functional magnetic resonance imaging (rs-fMRI), in high myopia (HM) patients.
METHODS: Eleven patients with HM (HM group) and 15 age- and sex-matched non-HM controls (non-HM group) were recruited. ALFFs were calculated and compared between HM group and non-HM group. Independent component analysis (ICA) was conducted to identify DMN, and comparisons between DMNs of two groups were performed. Region-of-interest (ROI)-based analysis was performed to explore functional connectivity (FC) between DMN regions.
RESULTS: Significantly increased ALFFs in left inferior temporal gyrus (ITG), bilateral rectus gyrus (REC), bilateral middle temporal gyrus (MTG), left superior temporal gyrus (STG), and left angular gyrus (ANG) were detected in HM group compared with non-HM group (all P<0.01). HM group showed increased FC in the posterior cingulate gyrus (PCC)/precuneus (preCUN) and decreased FC in the left medial prefrontal cortex (mPFG) within DMN compared with non-HM group (all P<0.01). Compared with non-HM group, HM group showed higher FC between mPFG and bilateral middle frontal gyrus (MFG), ANG, and MTG (all P<0.01). In addition, HM patients showed higher FC between PCC/(preCUN) and the right cerebellum, superior frontal gyrus (SFG), left preCUN, superior frontal gyrus (SFG), and medial orbital of the superior frontal gyrus (ORB supmed; all P<0.01).
CONCLUSION: HM patients show different ALFFs and DMNs compared with non-HM subjects, which may imply the cognitive alterations related to HM.]]></description>
<pubDate>2020/8/25 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xue-Wei Zhang, Rong-Ping Dai, Gang-Wei Cheng, Wei-Hong Zhang and Qin Long]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xue-Wei Zhang, Rong-Ping Dai, Gang-Wei Cheng, Wei-Hong Zhang and Qin Long</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201018]]></guid><cfi:id>408</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of unilateral inferior oblique weakening on fundus torsion in bilateral eyes of children with congenital superior oblique palsy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201019]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To study the change of torsion in both eyes after unilateral inferior oblique (IO) weakening on children with congenital superior oblique palsy (SOP).
METHODS: This retrospective study enrolled all patients diagnosed with unilateral congenital superior oblique palsy (UCSOP) accompanied by inferior oblique overaction (IOOA). A total of 120 eyes of 60 patients were divided into group 1 (more extorted paretic eye) and group 2 (more extorted nonparetic eye). The degree of fundus torsion was evaluated before and 1mo after the IO weakening procedure. The torsion of the fundus was recorded by measuring the disk-foveal angle (DFA) using fundus photography.
RESULTS: Group 1 included 26 cases and group 2 included 34 cases, thus the rate of extorsion was insignificantly higher in the nonparetic eye (P=0.10). The preoperative DFA in the paretic and nonparetic eyes was 13.21±5.95, 7.97±4.25 in group 1, and 4.65±3.79, 13.16±5.35 in group 2 (both P<0.001). The postoperative DFA in the paretic and nonparetic eyes was 8.57±4.87, 7.32±4.27 in group 1 (P=0.24), and 3.85±6.00 and 9.94±5.45 in group 2 (P<0.001). The amount of postoperative reduction of the DFA in the paretic and nonparetic eyes was 4.64±3.90, 0.65±0.76 in group 1 (P=0.002), and 0.80±0.81, 3.21±5.50 in group 2 (P=0.01). The difference in the amount of reduction of DFA in the more extorted eye in group 1 (paretic eye) vs group 2 (nonparetic eye) was insignificant (P=0.30).
CONCLUSION: Excyclotorsion in the nonparetic eye has a similar probability in the paretic eye in UCSOP children, and weakening of the ipsilateral IO has a more obvious effect on the decrement of extorsion in the more extorted eye regardless of which eye is paretic.]]></description>
<pubDate>2020/8/25 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yuan Wang, Qian Wu, Jing-Jing Jiang, Hui Li, Wen Liu, Cheng Li, Xue-Qing Bai and Ning-Dong Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yuan Wang, Qian Wu, Jing-Jing Jiang, Hui Li, Wen Liu, Cheng Li, Xue-Qing Bai and Ning-Dong Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20201019]]></guid><cfi:id>407</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[One-step viscoelastic agent technique for ICL V4c implantation for myopia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210910]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the safety and efficacy of using a one-step viscoelastic agent technique for posterior chamber phakic implantable collamer lens with a central hole (ICL V4c) implantation for myopia correction.
METHODS: The one-step viscoelastic agent technique for ICL V4c implantation was used in 100 eyes of 52 patients. Refractive outcomes, intraocular pressure (IOP), corneal endothelial cell, and corneal densitometry values were evaluated at 1d, 1wk, 1 and 3mo postoperatively.
RESULTS: All the surgeries were uneventful. No corrected distance visual acuity was lost after 3mo. IOP was 16.12±3.18 mm Hg before surgery, and 14.74±3.08 mm Hg at 1d and 14.50±2.56 mm Hg at 3mo after surgery (P<0.05). Corneal endothelial cell density was 2580±242 cell/mm2, the coefficient of variation in cell size was 42.11%±7.92%, and the percentage of hexagonal cells was 40.98%±9.46% before surgery. No significant difference was found when these outcomes were compared between the studied time points (P>0.05). The corneal densitometry values of the central 2 mm and 2 to 6 mm areas showed similar regularities. After surgery, the values significantly increased at 1d, then decreased to the preoperative values at 1wk, and then continued to decrease at 3mo (P<0.05).
CONCLUSION: The one-step viscoelastic agent technique for ICL V4c implantation is found to be safe and effective for myopia correction and causes little disturbance to the cornea.]]></description>
<pubDate>2021/8/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hua-Mao Miao, Feng Zhao, Ling-Ling Niu, Jing Zhao, Xiao-Ying Wang and Xing-Tao Zhou]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hua-Mao Miao, Feng Zhao, Ling-Ling Niu, Jing Zhao, Xiao-Ying Wang and Xing-Tao Zhou</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210910]]></guid><cfi:id>406</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Five-year results of refractive outcomes and vision-related quality of life after SMILE for the correction of high myopia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210911]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the long-term visual, refractive outcomes and vision-related quality of life after small incision lenticule extraction (SMILE) for the correction of high myopia.
METHODS: Thirty patients (60 eyes) with high myopia who underwent SMILE more than 5y were selected as the SMILE group. Another 30 high myopia patients (60 eyes) who had worn corrective spectacles for more than 5y were selected as the control group. In SMILE group, the postoperative follow-up time were 3, 6mo, 1 and 5y. Uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), spherical equivalent (SE), and ocular axial length (AL) were analyzed. The Chinese version of the National Eye Institute Visual Function Questionnaire-25 (CHI-NEI-VFQ-25) was used to evaluate the vision-related quality of life in the SMILE group and the control group.
RESULTS: In SMILE group, the mean preoperative SE was -7.29±0.87 D (range -6.00 to -9.125 D). At 5-year follow up, the efficacy index and safety index of SMILE were 1.09±0.18 and 1.19±0.12, respectively. Five years postoperatively, 44 eyes (73%) obtained a visual acuity of 20/20 or better. There were no eyes with CDVA loss of one or more Snellen lines. Forty-nine eyes (82%) and 57 eyes (95%) were within ±0.50 and ±1.00 D of attempted correction at 5-year follow-up, respectively. Forty-eight eyes (80%) had astigmatism <0.50 D at 5-year follow-up. The postoperative mean SE values at 3, 6mo, 1, and 5y were 0.11±0.44, 0.07±0.45, -0.02±0.41, and -0.15±0.46 D, respectively. No significant change was observed in the ocular AL from before operation to 5y postoperatively (26.08±0.96 mm vs 26.01±0.94 mm, P=0.068). Compared to the control group, the SMILE group showed a significantly higher total score on the CHI-NEI-VFQ-25 (90.14 vs 81.43, P<0.001).
CONCLUSION: In the present study, in a long-term follow-up we demonstrate that correcting high myopia with SMILE is safe, effective, and predictable. Vision-related quality of life after SMILE is better in the SMILE group than in the control group who wore corrective spectacles.]]></description>
<pubDate>2021/8/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Min Lang, Kai-Wei Cao, Ting Liu, Ying Zhu and Jian Ye]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Min Lang, Kai-Wei Cao, Ting Liu, Ying Zhu and Jian Ye</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210911]]></guid><cfi:id>405</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Evaluation of a new nomogram for Ferrara ring segment implantation in keratoconus]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210912]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the short-term clinical outcomes of Ferrara rings in keratoconus using an optimized nomogram developed after several years of research and retrospective analysis of clinical data.
METHODS: This prospective longitudinal non-comparative clinical trial evaluated 88 eyes of 88 patients (age 18-62y) with keratoconus diagnosis from two Spanish centers. Ferrara ring segment (AJL Ophthalmic) implantation was performed in all cases, using the mechanical procedure in 25 eyes (28.4%) and a femtosecond laser-assisted procedure in 63 eyes (71.6%). The ring segments implanted in each case were selected using a new optimized nomogram that considered variables such as anterior corneal asphericity and astigmatism or the discrepancy among astigmatism and coma orientations. Visual, refractive, corneal topographic, aberrometric, and pachymetric changes after surgery were evaluated during a 3-month follow-up.
RESULTS: The implants induced a significant refractive change as well as an improvement in uncorrected (UDVA) and corrected distance visual acuity (CDVA; P<0.001). Postoperative CDVA of 0.10 logMAR or better was achieved in 28.4% and 46.5% of eyes, respectively. Two eyes (2.3%) lost two or more lines of CDVA whereas a total of 53.5% of eyes gained lines of CDVA. A significant central anterior and posterior corneal flattening was induced (P≤0.003), with a significant reduction of anterior (P<0.001) and posterior corneal astigmatisms (P=0.048), and a change in anterior asphericity (P<0.001). Total primary coma (6 mm pupil) change was also statistically significant (preoperative 3.66±3.04 μm vs postoperative 2.33±2.26 μm, P<0.001). No significant differences were found in the effect of ring segments between cases implanted using the mechanical and femtosecond techniques (P≥0.101).
CONCLUSION: The implantation of Ferrara rings based on the nomogram evaluated is safe and effective for promoting a visual rehabilitation in keratoconus, with a relevant control of primary coma aberration.]]></description>
<pubDate>2021/8/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Joaquín Fernández, Cristina Peris-Martínez, Antonio Pérez-Rueda, Sidi Mohamed Hamida Abdelkader, María José Roig-Revert and David P. Piñero]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Joaquín Fernández, Cristina Peris-Martínez, Antonio Pérez-Rueda, Sidi Mohamed Hamida Abdelkader, María José Roig-Revert and David P. Piñero</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210912]]></guid><cfi:id>404</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Anterior segment OCT application in quantifying posterior capsule opacification severity with varied intraocular lens designs]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210913]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the application of anterior segment-optical coherence tomography (AS-OCT) in posterior capsule opacification (PCO) severity assessment and analyse the relationship between PCO severity and intraocular lens (IOL) characters.
METHODS: PCO patients were prospectively recruited. Cross-sectional images of the anterior segment at horizontal and vertical meridians were acquired with AS-OCT. The area of the IOL-PC (posterior capsular) space and PCO severity (area, thickness, and density at 3 mm and 5 mm IOL optic regions) were measured. The relationship between PCO severity and visual acuity, comparisons of PCO severity and IOL-PC space using varied IOL designs were analysed.
RESULTS: One hundred PCO eyes were enrolled. IOL-PC space, PCO thickness and area were positively correlated with axial length. In addition, PCO area and thickness were positively correlated with visual acuity when it was ≤0.52 logMAR. The cut-off level of visual acuity should be 0.52 logMAR. With varied IOL designs, 3-piece C haptic IOL showed a smaller PCO area and thickness than the 1-piece 3 haptic IOL and 1-piece 4 haptic IOL. PCO area and thickness values for an IOL with a diameter ≤11.0 mm was greater than for an IOL with a diameter of 12.5 mm, and the differences were statistically significant. PCO area and thickness increased when IOL haptic angulation increased (from 0 to 12 degrees).
CONCLUSION: In PCO eyes, cut-off level of visual acuity is 0.52 logMAR. With more severe PCO, visual acuity maybe not enough to describe the visual function impairment. PCO severity and IOL-PC space are significantly correlated with axial length and IOL design and material.]]></description>
<pubDate>2021/8/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Sha-Sha Yu, Cheng-Zhe Lu, Ya-Wen Guo, Yun Zhao and Xiao-Yong Yuan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Sha-Sha Yu, Cheng-Zhe Lu, Ya-Wen Guo, Yun Zhao and Xiao-Yong Yuan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210913]]></guid><cfi:id>403</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Predictive value of retinal function by the Purkinje test in patients scheduled for cataract surgery in Kinshasa, DR Congo]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210914]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the retinal function in patients with dense cataracts in resource poor settings in Kinshasa, DR Congo.
METHODS: In a tertiary eye care center, the Purkinje entoptic test was performed as part of the ophthalmological examination in 98 eyes in patients with cataract, using a penlight. Totally 92 cataract patients including 86 patients suffered from unilateral and 6 from bilateral cataracts were included in the study. The investigator asked the patients about their perception of the vascular pattern most commonly described as a leafless or dead tree. Visual acuity≥6/60 was considered an indication of good visual function and visual acuity<6/60 of poor function. Following small incision cataract surgery, best corrected visual acuity (BCVA) was determined and compared with the preoperative findings.
RESULTS: Out of 98 eyes, there were 80 (81.6%) where the Purkinje entoptic phenomenon was reported by the patients. After cataract surgery, out of the 80 eyes, there were 75 (93.8%) with a BCVA of better than 6/60, whereas in 5 eyes (6.2%), BCVA was 6/60 or less. Out of the 18 eyes (18.4%) where no Purkinje tree was recognized, there were 14 (77.8%) with BCVA of better than 6/60, whereas in 4 (22.2%) BCVA was 6/60 or less.
CONCLUSION: The Purkinje entoptic test is successfully used for preoperative assessment of retinal function in patients with dense cataract. However, further investigation and refinement of the test is necessary to validate the method for use in sub-Saharan conditions.]]></description>
<pubDate>2021/8/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Serge Dinkulu, Ngoy Janvier Kilangalanga, Edith Mukwanseke, Longo Flavien Lutete, Adrian Hopkins, Rudolf Friedrich Guthoff and Thomas Stahnke]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Serge Dinkulu, Ngoy Janvier Kilangalanga, Edith Mukwanseke, Longo Flavien Lutete, Adrian Hopkins, Rudolf Friedrich Guthoff and Thomas Stahnke</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210914]]></guid><cfi:id>402</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Simultaneous pars plana vitrectomy, panretinal photocoagulation, cryotherapy, and Ahmed valve implantation for neovascular glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210915]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To describe and evaluate the efficacy of Ahmed glaucoma valve implantation (AGV) combined with pars plana vitrectomy (PPV) in a single surgical act for the treatment of advanced neovascular glaucoma (NVG).
METHODS: Retrospective observational case series included 51 eyes from 50 patients with severe NVG treated with PPV, AGV, and panretinal photocoagulation and/or cryotherapy in a single surgical act during a 13-year period (2005-2018). Preoperative, intraoperative and postoperative data at day 1 and months 1, 3, 6, 21, and 24 were systematically collected. Definition of surgical success was stablished at IOP between 6 and 21 mm Hg with or without topical treatment.
RESULTS: Main indications for surgery were NVG secondary to proliferative diabetic retinopathy (39.2%) and central retinal vein occlusion (37.3%). Mean (±SD) preoperative IOP was 42.0±11.2 mm Hg decreasing to 15.5±7.1 mm Hg at 12mo and 15.8±9.1 mm Hg at 24mo of follow up. Cumulative incidence of success of IOP control was 76.0% at first postoperative month, reaching 88.3% at 6mo. Prevalence of successful IOP control at long term was 74.4% at 12mo and 71.4% at 24mo. Eye evisceration for unsuccessful NVG management was required in 1 case (2.0%).
CONCLUSION: Combination of AGV implantation and PPV in a single act may be a suitable option for severe forms of NVG in a case-by-case basis for effective IOP control and a complete panretinal photocoagulation.]]></description>
<pubDate>2021/8/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Carolina Bernal-Morales, Marina Dotti-Boada, Alvaro Olate-Perez, Manuel J. Navarro-Angulo, Laura Pelegrín and Marc Figueras-Roca]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Carolina Bernal-Morales, Marina Dotti-Boada, Alvaro Olate-Perez, Manuel J. Navarro-Angulo, Laura Pelegrín and Marc Figueras-Roca</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210915]]></guid><cfi:id>401</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Long-term outcomes of focal laser photocoagulation for the treatment of polypoidal choroidal vasculopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210916]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the long-term effect and safety of focal laser photocoagulation treatment in eyes with polypoidal choroidal vasculopathy (PCV).
METHODS: Medical records of 13 eyes of 13 patients with PCV were followed-up for more than 2y after focal laser photocoagulation treatment. The patients were diagnosed with PCV using indocyanine green angiography, and eyes with other comorbid ocular diseases were excluded. The measurement outcomes of the study were the post-treatment regression and recurrence of polyps, complications, and changes in visual acuities. Paired t-test was performed to compare visual outcome before and after the treatment.
RESULTS: The mean age of the 13 patients was 70.2±5.5y, and the follow-up period was 72.3±31.0 (range, 25-118)mo. Three eyes had juxtafoveal polyps and 10 eyes had extrafoveal polyps. Of the 13 eyes, 9 eyes (69.2%) had regression of polyps 1.7±1.2 (range, 0.9-4)mo after focal laser photocoagulation. Five eyes (55.6%) showed recurrence of polyps during the follow-up periods, and the recurrence period was 12.8±18.9 (range, 1.9-48)mo. Mild subretinal hemorrhage occurred in two eyes (15.4%) 27 and 72d after laser treatment, respectively. There were no statistically significant differences in visual acuities at baseline; 1, 2, 3y post-treatment (all P>0.05); and last follow-up (0.63±0.5, 0.73±0.70, 0.67±0.57, 0.75±0.7, and 0.95±0.8 logMAR, respectively).
CONCLUSION: Focal laser photocoagulation is beneficial for early regression of polyps in eyes with PCV and does not result in significant submacular hemorrhage during the long-term follow-up. Furthermore, it can be primarily considered in eyes with PCV with extrafoveal or juxtafoveal polyps to regress risky polyps as well as to maintain visual acuity without serious hemorrhagic complications.]]></description>
<pubDate>2021/8/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Sooyeon Choe, Hyun Goo Kang, Kyu Hyung Park, Christopher Seungkyu Lee and Se Joon Woo]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Sooyeon Choe, Hyun Goo Kang, Kyu Hyung Park, Christopher Seungkyu Lee and Se Joon Woo</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210916]]></guid><cfi:id>400</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Displacement of the retina after idiopathic macular hole surgery with different internal limiting membrane peeling patterns]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210917]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To explore retinal displacement after surgical treatment for idiopathic macular hole (IMH) with different internal limiting membrane (ILM) peeling patterns.
METHODS: Totally 22 eyes from 20 patients with IMH were randomly allocated into two groups, N-T group (11 eyes) and T-N group (11 eyes). For patients in N-T group, ILM was peeled off from nasal to temporal retina. For patients in T-N group, ILM was peeled off from temporal to nasal retina. Preoperative, postoperative 1, 3, and 6mo, autofluorescence fundus images were collected for manual measurement of distances of fixed nasal (N), temporal (T), superior (S), and inferior (I) retinal points (bifurcation or crossing of retinal vessels) around the macula to the optic disc (OD). These were respectively defined as N-OD, T-OD, S-OD, and I-OD. The retinal displacement, macular hole closure rate, and best corrected visual acuity (BCVA) were compared between the two groups after surgery.
RESULTS: At postoperative 1, 3, and 6mo, the macula slipped toward the OD, manifested by the decreased T-OD, N-OD, S-OD, and I-OD (P<0.05). No significant difference was found in the T-OD, N-OD, S-OD, and I-OD between N-T group and T-N group. IMH closure rate was 100% both in N-T group and T-N group. There was no significant difference in BCVA between two groups (P<0.05).
CONCLUSION: The macula slips toward the OD after successful macular hole surgery. The two different ILM peeling pattern show similar visual outcome and retinal displacement, which means ILM peeling directions are not the influencing factor of postoperative retinal displacement.]]></description>
<pubDate>2021/8/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jin Liu, Zi-Zhong Hu, Xin-Hua Zheng, Yuan-Long Li, Jun-Long Huang, Er-Bing Cao, Song-Tao Yuan, Ping Xie and Qing-Huai Liu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jin Liu, Zi-Zhong Hu, Xin-Hua Zheng, Yuan-Long Li, Jun-Long Huang, Er-Bing Cao, Song-Tao Yuan, Ping Xie and Qing-Huai Liu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210917]]></guid><cfi:id>399</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Efficacy of topical dorzolamide 2% in diabetic cystoid macular edema]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210918]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To study the effect of topical dorzolamide 2% on macular thickness reduction in diabetic cystoid macular edema (CME).
METHODS: This was a prospective, non-randomized, open study including eyes with diabetic macular edema (DME). All eyes received topical dorzolamide 2% three times daily for one month. Changes in best-corrected visual acuity (BCVA), and central macular thickness (CMT) by optical coherence tomography) were evaluated at 1wk, 1, and 3mo post-treatment.
RESULTS: Ninety-three eyes (84 patients) were included. Mean±SD (logMAR) BCVA improved significantly from 1.08±0.26 pretreatment to 0.66±0.24 at 1mo and 0.87±0.26 at 3mo post-treatment (P<0.001 both). The mean±SD CMT was significantly reduced from 535.27±97.4 μm at baseline to 357.43±125.8 μm at 1mo and 376.23±114.5 μm at 3mo post-treatment (P<0.001 both). No significant ocular or systemic side effects were recorded.
CONCLUSION:  Topical dorzolamide 2% results in significant improvement of mean BCVA and reduction of  mean CMT at 3mo post-treatment. It can be used as an effective, affordable, and safe therapy for treatment of non-refractory diabetic CME.]]></description>
<pubDate>2021/8/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Amani E Badawi, Tharwat H. Mokbel, Eman M Elhefney, Sherein M. Hagras and Ameera G Abdelhameed]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Amani E Badawi, Tharwat H. Mokbel, Eman M Elhefney, Sherein M. Hagras and Ameera G Abdelhameed</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210918]]></guid><cfi:id>398</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Analogs of microgravity: the function of Schlemm’s canal, intraocular pressure and autonomic nervous during the head-down tilt test in healthy subjects]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210919]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the ocular outcomes and to elucidate possible mechanisms underlying intraocular pressure (IOP) change following the head-down tilt (HDT) test.
METHODS: The study included 21 participants at the Department of Ophthalmology of Tongji Hospital. Subjects received the test of I-care tonometry, enhanced depth imaging optical coherence tomography and heart rate variability (HRV) analysis before and after 15min HDT test. The lumen area of Schlemm’s canal (SCAR), IOP, HRV were calculated.
RESULTS: IOP increased significantly after 20° head down position from 14.0±3.0 to 17.0±3.3 mm Hg (P<0.001). SCAR decreased from 13449.0±5454.9 μm2 at sitting condition to 9576.6±4130.9 μm2 post 15min HDT test. High frequency (HF) indices increased significantly from 1462±865 Hz at baseline to 2128±824 Hz. Heart rate (HR) decreased significantly from 76±11.48 to 70±11.52 bpm after the HDT. The linear regression analysis showed that the difference of HF and SCAR significantly correlated with each other during the HDT (R2=20%, P=0.04).
CONCLUSION: These outcomes perform the first evidence of the activation of autonomic nervous system of HDT may cause the collapse of Schlemm’s canal lumen, which in turn leading to the increased IOP.]]></description>
<pubDate>2021/8/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Wei Chen, Zhi-Qi Chen, Yan Xiang, Chao-Hua Deng, Hong Zhang and Jun-Ming Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Wei Chen, Zhi-Qi Chen, Yan Xiang, Chao-Hua Deng, Hong Zhang and Jun-Ming Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210919]]></guid><cfi:id>397</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of vitamin B12 deficiency anemia on peripapillary retinal nerve fiber layer]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210920]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the effect of vitamin B12 deficiency anemia (BDA) on peripapillary retinal nerve fiber layer thickness (RNFLT) using spectral domain optical coherence tomography (SD-OCT), and to determine any correlation arising thereof.
METHODS: In this cross-sectional observational study, 99 eyes of 50 BDA patients of age 18-65y were compared with 100 eyes of 50 healthy control subjects. All subjects underwent comprehensive clinical, ophthalmic, and hematological evaluation, followed by peripapillary RNFLT assessment using SD-OCT.
RESULTS: The mean total, inferior, nasal, and temporal RNFLT were significantly lower in BDA group as compared to control group (P<0.05). The mean total, inferior and nasal RNFLT correlated significantly (P<0.05) with serum Hb%, B12 and mean corpuscular volume (MCV) level (r=0.310, 0.435, -0.386 for total; r=0.932, 0.481, -0.513 for inferior; r=0.344, 0.254, -0.233 for nasal; respectively), while temporal and superior RNFLT quadrant did not show any correlation with any of the hematological parameters (r=0.144, 0.167, -0.096; r=0.111, 0.070, -0.099; respectively). The mean total RNFLT showed progressive thinning at par with the progression of anemia, except in very severe BDA, where an inverse relationship was documented.
CONCLUSION: The mean total, inferior, nasal, and temporal peripapillary RNFLT was significantly thinner in BDA patients. Peripapillary RNFLT thinning seemed to proceed at par with the progression of severity of anemia, except in very sever grade. Early assessment of peripapillary RNFLT may be crucial in BDA patients to prevent potential blinding sequelae. Peripapillary RNFLT thinning in BDA patients should be considered in the differential diagnosis of other non-glaucomatous optic neuropathies, as well.]]></description>
<pubDate>2021/8/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Sushobhan Das Gupta, Tarannum Shakeel, Aeshwarya Dhawan and Aashish Kakkar]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Sushobhan Das Gupta, Tarannum Shakeel, Aeshwarya Dhawan and Aashish Kakkar</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210920]]></guid><cfi:id>396</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Conjunctival flap with auricular cartilage grafting: a modified Hughes procedure for large full thickness upper and lower eyelid defect reconstruction]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210805]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the suitability of a modified Hughes procedure, which consists of conjunctival flap with auricular cartilage grafting in reconstructing large full thickness upper and lower eyelid defect.
METHODS: Patients with full thickness eyelid carcinoma involving more than 50% margin length who underwent surgical resection were retrospectively reviewed in the study. The defects were reconstructed using conjunctival flap with auricular cartilage grafting, covered with myocutaneous flap above. Followed-up time ranged from 12 to 24mo. Outcomes were classified as “good”, “fair”, and “poor” by evaluating the margin appearance, eyelid appearance, and complications.
RESULTS: A total of 42 patients were enrolled in the study (26 males, 16 females, mean age, 68.6±7.7y, range: 53 to 82y). The mean defect widths measured 23.2±2.9 mm (range, 17 to 28 mm). The mean posterior lamellar defect height was 5.5±1.3 mm (4 to 8 mm). Thirty-seven patients had a “good” outcome (88.1%), 5 patients had a “fair” outcome (11.9%), and no one had a “poor” outcome.
CONCLUSION: Conjunctival flap with auricular cartilage grafting and myocutaneous flap grafting is an effective procedure in reconstructing large full thickness upper and lower eyelid defect. It can not only achieve satisfied reconstruction, but also preserve intact tarsal plate of the opposite eyelid, avoiding retraction or entropion.]]></description>
<pubDate>2021/6/28 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ben Chen, David Meng-da Woo, Jia Liu, Xiu-Ying Zhu, Yan-Yan Lin, Ying-Jie Ma and Xi Chen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ben Chen, David Meng-da Woo, Jia Liu, Xiu-Ying Zhu, Yan-Yan Lin, Ying-Jie Ma and Xi Chen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210805]]></guid><cfi:id>395</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Evaluating newer generation intraocular lens calculation formulas in manual versus femtosecond laser-assisted cataract surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210806]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the refractive accuracy of the Haigis, Barrett Universal II (Barrett), and Hill-radial basis function 2.0 (Hill-RBF) intraocular lens (IOL) power calculations formulas in eyes undergoing manual cataract surgery (MCS) and refractive femtosecond laser-assisted cataract surgery (ReLACS).
METHODS: This was a REB-approved, retrospective interventional comparative case series of 158 eyes of 158 patients who had preoperative biometry completed using the IOL Master 700 and underwent implantation of a Tecnis IOL following uncomplicated cataract surgery using either MCS or ReLACS. Target spherical equivalence (SE) was predicted using the Haigis, Barrett, and Hill-RBF formulas. An older generation formula (Hoffer Q) was included in the analysis. Mean refractive error (ME) was calculated one month postoperatively. The lens factors of all formulas were retrospectively optimized to set the ME to 0 for each formula across all eyes. The median absolute errors (MedAE) and the proportion of eyes achieving an absolute error (AE) within 0.5 diopters (D) were compared between the two formulas among MCS and ReLACS eyes, respectively.
RESULTS: Of the 158 eyes studied, 64 eyes underwent MCS and 94 eyes underwent ReLACS. Among MCS eyes, the MedAE did not differ between the formulas (P=0.59), however among ReLACS eyes, Barrett and Hill-RBF were more accurate (P=0.001). Barrett and Hill-RBF were both more likely to yield AE<0.5 D among both groups (P<0.001).
CONCLUSION: The Barrett and Hill-RBF formula lead to greater refractive accuracy and likelihood of refractive success when compare to Haigis in eyes undergoing ReLACS.]]></description>
<pubDate>2021/6/28 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Harrish Nithianandan, Soumya Sharma, Eric S. Tam, Hannah Chiu, Rajiv Maini and Sohel Somani]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Harrish Nithianandan, Soumya Sharma, Eric S. Tam, Hannah Chiu, Rajiv Maini and Sohel Somani</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210806]]></guid><cfi:id>394</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Progression rate to primary angle closure following laser peripheral iridotomy in primary angle-closure suspects: a randomised study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210807]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report the progression rate (PR) to primary angle closure (PAC) following laser peripheral iridotomy (LPI) in PAC suspects (PACS).
METHODS: Prospective, randomized controlled interventional clinical trial conducted at the Handan Eye Hospital, China. Totally 134 bilateral PACS, defined as non-visibility of the posterior trabecular meshwork for ≥180 degrees on gonioscopy were randomly assigned to undergo LPI in one eye. Gonioscopy and Goldmann applanation tonometry were performed prior to, on day 7 and 12mo post LPI.
RESULTS: Eighty of 134 patients (59.7%) could be followed up at one year. The mean intraocular pressure (IOP) in treated eyes was 15.9±2.6 mm Hg at baseline, 15.4±3.0 mm Hg on day 7; 16.5±2.9 mm Hg at one month, and 15.5±2.9 mm Hg at 12mo; the IOP in untreated eyes was similar (P=0.834). One or more quadrants of the angle opened in 93.7% of the LPI treated eyes, but 67.0% (53/79) remained closed in two or more quadrants. The PR to PAC in untreated eyes was 3.75% and one developed acute angle-closure glaucoma (AACG); the PR to PAC in treated eyes was 2.5% and none had developed peripheral anterior synechia (PAS) or AACG.
CONCLUSION: LPI can open some of the occludable angle in the majority of eyes with PACS, but 67% continue to have non-visibility of the trabecular meshwork for over 180 degrees.]]></description>
<pubDate>2021/6/28 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Da-Peng Mou, Yuan-Bo Liang, Su-Jie Fan, Yi Peng, Ning-Li Wang and Ravi Thomas]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Da-Peng Mou, Yuan-Bo Liang, Su-Jie Fan, Yi Peng, Ning-Li Wang and Ravi Thomas</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210807]]></guid><cfi:id>393</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of the SITA Faster–a new visual field strategy with SITA Fast strategy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210808]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare visual field defects using the Swedish Interactive Thresholding Algorithm (SITA) Fast strategy with SITA Faster strategy, a newly developed time-saving threshold visual field strategy.
METHODS: Ninety-three participants (60 glaucoma patients and 33 normal controls) were enrolled. One eye from each participant was selected randomly for the study. SITA Fast and SITA Faster were performed using the 24-2 default mode for each test. The differences of visual field defects between the two strategies were compared using the test duration, false-positive response errors, mean deviation (MD), visual field index (VFI) and the numbers of depressed test points at the significant levels of P<5%, <2%, <1%, and <0.5% in probability plots. The correlation between strategies was analyzed. The agreement between strategies was acquired by Bland-Altman analysis.
RESULTS: Mean test durations were 246.0±60.9s for SITA Fast, and 156.3±46.3s for SITA Faster (P<0.001). The test duration of SITA Faster was 36.5% shorter than SITA Fast. The MD, VFI and numbers of depressed points at P<5%, <2%, <1%, and <0.5% in probability plots showed no statistically significant difference between two strategies (P>0.05). Correlation analysis showed a high correlation for MD (r=0.986, P<0.001) and VFI (r=0.986, P<0.001) between the two strategies. Bland-Altman analysis showed great agreement between the two strategies.
CONCLUSION: SITA Faster, which saves considerable test time, has a great test quality comparing to SITA Fast, but may be not directly interchangeable.]]></description>
<pubDate>2021/6/28 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Chao-Xu Qian, Qin Chen, Qing Cun, Yi-Jin Tao, Wen-Yan Yang, Yue Yang, Zhong-Yin Hu, Ying-Ting Zhu and Hua Zhong]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Chao-Xu Qian, Qin Chen, Qing Cun, Yi-Jin Tao, Wen-Yan Yang, Yue Yang, Zhong-Yin Hu, Ying-Ting Zhu and Hua Zhong</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210808]]></guid><cfi:id>392</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Combined ab-interno trabeculectomy and cataract surgery induces comparable intraocular pressure reduction in supine and sitting positions]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210809]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyze the therapeutic effect of combined ab-interno trabeculectomy and cataract surgery on intraocular pressure (IOP) levels in supine and sitting postures during a 24-hour IOP profile.
METHODS: Twenty-six eyes of twenty-six patients receiving ab-interno trabeculectomy using electroablation of the trabecular meshwork combined with cataract surgery or stand-alone were included in this retrospective analysis. IOP change during 24-hour IOP profiles within two years postoperatively were analyzed for eyes receiving surgery (“study eyes”) and compared to fellow eyes, which had not received surgery. Clinical data including mean sitting IOP (siIOP), mean supine IOP (suIOP) and the number of topical antiglaucomatous medications (TAM) were extracted from patients’ files.
RESULTS: Preoperatively, siIOP was 17.6±5.3 mm Hg in study and 17.1±4.7 mm Hg in fellow eyes (P=0.347). Patients were treated with an average of 2.8±1.0 TAM. Best corrected visual acuity (BCVA) was significantly worse in study eyes (P<0.001), visual field function was marginally not significantly different (P=0.057). After surgery 9.6±6.8mo, study eyes had a mean siIOP of 14.5±3.6 mm Hg (IOP reduction: -3.2 mm Hg, P=0.009), a mean suIOP of 18.0±3.5 mm Hg, and an average of 1.3±1.34 TAM (P<0.001), while in fellow eyes, mean siIOP was 16.2±3.4 mm Hg and mean suIOP was 20.5±5.1 mm Hg. Postoperatively, the relative IOP increase between sitting and supine postures was approximately 30% in both study and fellow eyes (P=0.99).
CONCLUSION: IOP after ab-interno trabeculectomy shows a comparable relative reduction in both supine and sitting position. Classical trabeculectomy is known to lower suIOP overproportionally.]]></description>
<pubDate>2021/6/28 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Caroline Gietzelt, David Kiessling, Randolf A. Widder, Ludwig M. Heindl, Claus Cursiefen, Thomas S. Dietlein and Philip Enders]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Caroline Gietzelt, David Kiessling, Randolf A. Widder, Ludwig M. Heindl, Claus Cursiefen, Thomas S. Dietlein and Philip Enders</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210809]]></guid><cfi:id>391</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Mid-term results of patterned laser trabeculoplasty for uncontrolled ocular hypertension and primary open angle glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210810]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To describe the safety and efficacy of patterned laser trabeculoplasty (PLT) as an adjunctive treatment in primary open angle glaucoma (POAG) and ocular hypertension (OHT) after 18-month follow-up in Hispanic population.
METHODS: A single-center, retrospective study was conducted. All patients with OHT or POAG undergoing PLT from June 2016 to August 2016 were included in the study. Investigated parameters were intraocular pressure (IOP), the number of IOP-lowering medications, best corrected visual acuity (BCVA), laser parameters and postoperative adverse events. Primary efficacy outcome measures were the proportion of eyes achieving an IOP reduction ≥20% at 18mo versus baseline medicated IOP or a reduction in the number of medications while maintaining IOP values.
RESULTS: From 40 PLT-treated eyes (mean baseline IOP 20.3±1.7 mm Hg), 24 patients were analyzed (age 63.4±7.3y). The mean IOP reductions from baseline across visits (months 1, 3, 6, 9, 12, and 18) ranged from 14.1% to 20.8%. Success rate after 18-month follow-up was 61.7% with a mean IOP of 16±3.2 mm Hg (P<0.001). The number of glaucoma IOP-lowering medications per eye (preoperative 2.1±1.1 and postoperative 2.3±1.1, P=0.86) and the mean BCVA (preoperative 0.10±0.22 and postoperative 0.11±0.22 logMAR, P=0.42) remained stable. Adverse events comprised transitory IOP spikes in 4 eyes (10%) and peripheral anterior synechiae in 7 eyes (17.5%).
CONCLUSION: Mid-term results of PLT show that this procedure may be an efficacious and safe technique to approach medically uncontrolled OHT or POAG patients.]]></description>
<pubDate>2021/6/28 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Gustavo Espinoza, Yuly Andrea Castellanos-Castellanos, Angelica Pedraza-Concha, Ignacio Rodríguez-Una, Maria Fernanda Acuna and Juan Camilo Parra]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Gustavo Espinoza, Yuly Andrea Castellanos-Castellanos, Angelica Pedraza-Concha, Ignacio Rodríguez-Una, Maria Fernanda Acuna and Juan Camilo Parra</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210810]]></guid><cfi:id>390</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Macular density alterations in myopic choroidal neovascularization and the effect of anti-VEGF on it]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210811]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyse macular microvascular alterations in myopic choroidal neovascularization (mCNV) and the efficiency of anti-vascular endothelial growth factor (anti-VEGF) therapy for mCNV by optical coherence tomography angiography (OCTA).
METHODS: A total of 123 patients were included in this retrospective study, divided into mCNV group, high myopia (HM) group, and normal group at the Affiliated Eye Hospital of Wenzhou Medical University from January 2017 to January 2019. Superficial vessel density, deep capillary density, foveal avascular zone (FAZ) area, A-circularity index (AI) and vessel density around the 300 μm width of the FAZ region density (FD) and the area of choroidal neovascularization (CNV) lesion (only for mCNV group) were measured on 3×3 mm2 OCTA images. FAZ area was corrected for axial length. Central macular thickness (CMT) was measured on OCT in mCNV group. Compared the parameters on OCTA of 3 groups and pre-anti-VEGF and post-anti-VEGF at 1, 2, 3, and 6mo follow-up in mCNV group.
RESULTS: There were significant differences among 3 groups in superficial vessel density, deep capillary density and FD (P<0.05). FAZ area in HM group was smaller than normal group (P<0.05), but there was no significant difference between mCNV group and the other two group. AI increased in mCNV group (P<0.05). The mean CMT, area and flow area of CNV lesion decreased after treatment (P<0.05), while vessel density and FAZ didn’t change. The mean CMT, area and flow area of CNV lesion statistically decreased after anti-VEGF treatment in mCNV group (P<0.05), while superficial vessel density, deep capillary density and FAZ area, AI and FD didn’t change. The mean reduction ratio of lesions was 50.32% (7.07% to 100%).  Lesion regression 100% was observed in 2 cases (4.88%). There was a negative correlation between the CNV lesion area and reduction ratio (r=-0.380, P=0.042) and the flow lesion area and reduction ratio (r=-0.402, P=0.030).
CONCLUSION: Macular vessel density decreases, FAZ turns smaller and more irregular in mCNV eyes. Anti-VEGF therapy is efficient for mCNV without affecting vessel density and FAZ, but it is unable to completely eliminate CNV lesions in most cases. The bigger mCNV lesions have lower reduction ratio.]]></description>
<pubDate>2021/6/28 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jian-Bo Mao, Yi-Run Shao, Jia-Feng Yu, Xin-Yi Deng, Chen-Yi Liu, Yi-Qi Chen, Yun Zhang, Zhao-Kai Xu, Su-Lan Wu and Li-Jun Shen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jian-Bo Mao, Yi-Run Shao, Jia-Feng Yu, Xin-Yi Deng, Chen-Yi Liu, Yi-Qi Chen, Yun Zhang, Zhao-Kai Xu, Su-Lan Wu and Li-Jun Shen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210811]]></guid><cfi:id>389</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Choroidal structural changes determined by the binarization method after intravitreal aflibercept treatment in neovascular age-related macular degeneration]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210812]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the choroidal structural alterations after intravitreal injection of aflibercept in neovascular age-related macular degeneration (nAMD).
METHODS: Fifty eyes with treatment-na&#239;ve nAMD were evaluated at baseline, 3rd, and 12th month. Fifty eyes of 50 healthy subjects were also included as controls. Choroidal thickness (CT) was measured in the subfoveal region. Total circumscribed choroidal area (CA), luminal area (LA), stromal area (SA), and choroidal vascularity index (CVI) was calculated using Image J.
RESULTS: At baseline, subfoveal CT was increased in nAMD patients compared to controls (P=0.321). Eyes with nAMD had a significantly increased total circumscribed CA and SA (P=0.041, 0.005, respectively). The CVI was decreased (P=0.038). In the 3rd month, the subfoveal CT, LA, and CVI revealed a decrease (P=0.005, P=0.039, 0.043, respectively). In the 12th month, subfoveal CT, LA, and CVI were decreased in comparison to baseline measures (P<0.001, 0.006, 0.010, respectively).
CONCLUSION: Significant structural alterations are found after intravitreal aflibercept treatment during the 12-month follow-up, in particular at the third month, in eyes with nAMD.]]></description>
<pubDate>2021/6/28 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Emine Temel, Kemal Ornek and Nazife Asikgarip]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Emine Temel, Kemal Ornek and Nazife Asikgarip</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210812]]></guid><cfi:id>388</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Evaluation of axial length/total corneal refractive power ratio as a potential marker for ocular diagnosis of Marfan’s syndrome in children]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210813]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate whether the axial length (AL)/total corneal refractive power (TCRP) ratio is a sensitive and simple factor that can be used for the early diagnosis of Marfan’s syndrome (MFS) in children.
METHODS: The relationship between the AL/TCRP ratio and the diagnosis of MFS for 192 eyes in 97 children were evaluate. The biological characteristics, including age, sex, AL, and TCRP, were collected from medical records. Receiver operating characteristic (ROC) curve analysis was performed to investigate whether the AL/TCRP ratio effectively distinguishes MFS from other subjects. The Youden index was used to re-divide the whole population into two groups according to an AL/TCRP ratio of 0.59.
RESULTS: Of 96 subjects (mean age 7.46±3.28y) evaluated, 56 (110 eyes) had a definite diagnosis of MFS in childhood based on the revised Ghent criteria, 41 (82 eyes) with diagnosis of congenital ectopia lentis (EL) were included as a control group. AL was negatively correlated with TCRP, with a linear regression coefficient of -0.36 (R2=0.08). A significant correlation was found between age and the AL/TCRP ratio (P=0.023). ROC curve analysis showed that the AL/TCRP ratio distinguished MFS from the other patients at a threshold of 0.59. MFS patients were present in 24/58 (41.38%) patients with an AL/TCRP ratio of ≤0.59 and in 34/39 (87.18%) patients with an AL/TCRP ratio of >0.59.
CONCLUSION: An AL/TCRP ratio of >0.59 is significantly associated with the risk of MFS. The AL/TCRP ratio should be measured as a promising marker for the prognosis of children MFS. Changes in the AL/TCRP ratio should be monitored over time.]]></description>
<pubDate>2021/6/28 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Tian-Hui Chen, Ai-Zhu Miao, Yu-Liang Wang, Min Zhang, Jia-Hui Chen, Jia-Lei Zheng, Michael Deng, Ying-Hong Ji and Yong-Xiang Jiang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Tian-Hui Chen, Ai-Zhu Miao, Yu-Liang Wang, Min Zhang, Jia-Hui Chen, Jia-Lei Zheng, Michael Deng, Ying-Hong Ji and Yong-Xiang Jiang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210813]]></guid><cfi:id>387</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Role of artificial tears with and without hyaluronic acid in controlling ocular discomfort following PRK: a randomized clinical trial]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210814]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare outcomes of applying preservative free artificial tears (PFAT) with and without hyaluronic acid (HA) in early postoperative course following photorefractive keratectomy (PRK).
METHODS: In this triple-blinded randomized clinical trial, PRK procedure was performed on both eyes of 230 patients. Following PRK, patients were divided into three groups: the HA+ group, 44 patients PFAT containing HA; the HA- group, 71 patients PFAT without HA were administered 5 times per day (every 4h); the third group, 115 patients received no PFAT before lens removal. On the 1st and 4th postoperative day, Visual Analogue Score (VAS) was utilized to evaluate patient’s level of pain. Participants were asked to complete a questionnaire about the severity of eye discomfort ranked from 0 to 10 (0=no complaint; 10=most severe complaint experienced).
RESULTS: In eyes receiving PFAT with or without HA (Drop group), mean scores for epiphora, foreign body sensation, and blurred vision on the 1st postoperative day were statistically lower (P<0.05). Filamentous keratitis (FK) was detected in 11 (4.7%) eyes, and recurrent corneal erosion (RCE) was observed in 5 (2.1%) eyes. In the control group, FK was noted in 16 (6.9%) eyes while 13 (5.6%) eyes had RCE and 5 (2.1%) eyes had corneal haze. The rate of complications was statistically lower in Drop group (P=0.009). However, the aforementioned scores were not statically different between HA+ and HA- group one and two (P=0.29).
CONCLUSION: Following PRK, applying PFAT with and without HA yields faster visual recovery, decreases postoperative ocular discomfort and haze formation; however there is no additive effect for HA.]]></description>
<pubDate>2021/6/28 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mehrdad Mohammadpour, Masoud Khorrami-Nejad and Delaram Shakoor]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mehrdad Mohammadpour, Masoud Khorrami-Nejad and Delaram Shakoor</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210814]]></guid><cfi:id>386</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Factors associated with axial length elongation in high myopia in adults]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210815]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the association of axial length (AL) and ocular factors on AL elongation.
METHODS: A retrospective chart review of patients who underwent two or more AL examinations for more than two years. Totally 4 groups were divided according to initial AL (<24 mm, 24-26 mm, 26-28 mm, ≥28 mm). Initial fundus photograph was used to find risk factors associated AL elongation.
RESULTS: The mean age of the patients was 47.21±7.79y. AL remained almost unchanged in the groups with AL<24 mm and 24≤AL<26 mm. On the contrary, AL increased by 0.011 mm/y in the group with 26≤AL<28 mm and 0.035 mm/y in the group with AL≥28 mm (P<0.001). In high myopia, AL elongation increased in eye with longer AL (r=0.003, P=0.024), female gender (r=0.014, P=0.019), eye with larger peripapillary chorioretinal atrophic area (r=0.002, P=0.019), and smaller vascular arcade angle (r=-0.004, P=0.006). The risk of elongation 0.03 mm/y in high myopia was increased in female gender (P=0.040), and gradually increased in eye with large peripapillary chorioretinal atrophy area (P<0.01).
CONCLUSION: AL elongate significantly in the eye with longer AL, female gender, and the eye with larger atrophic area and smaller arcade angle on fundus photography.]]></description>
<pubDate>2021/6/28 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hong Kyu Kim and Sung Soo Kim]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hong Kyu Kim and Sung Soo Kim</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210815]]></guid><cfi:id>385</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of corneal biological parameters between transepithelial and epithelium-off corneal cross-linking in keratoconus]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210706]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the differences in corneal biological parameters between transepithelial and epithelium-off corneal cross-linking in keratoconus.
METHODS: In our prospective clinical trial, 40 patients (60 eyes) with progressive keratoconus were randomized to undergo corneal cross-linking with transepithelial (TE group, n=30) or epithelium-off (EO group, n=30) keratoconus. Examinations comprised topography, corneal biomechanical analysis and specular microscopy at 6mo postoperatively.
RESULTS: The keratometer values were not significantly different between the TE and EO corneal cross-linked groups in different periods (each P>0.05). The corneal thickness of the EO group was greater than that of the TE group at 1wk after the operation (each P<0.05). Regarding corneal biomechanical responses, the EO group showed a longer second applanation length than TE group (P=0.003). Regarding the corneal endothelial function, standard deviation of the endothelial cell size, and coefficient of variation in the cell area, the values of EO group were larger than those of TE group at 1wk (P=0.011, 0.026), and the percentage of hexagonal cells in EO group was lower than that in TE group at 1 and 6mo (P=0.018, 0.019).
CONCLUSION: Epithelium-off corneal cross-linking may strengthen corneal biomechanics better than TE procedure can. However, the TE procedure with a lower ultraviolet-A irradiation intensity would be safer for corneal endothelial function.]]></description>
<pubDate>2021/5/25 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Bo-Wen Ouyang, Hui Ding, Han Wang, Zhen-Duo Yang, Tan Zhong, Hong-Ming Fan and Xing-Wu Zhong]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Bo-Wen Ouyang, Hui Ding, Han Wang, Zhen-Duo Yang, Tan Zhong, Hong-Ming Fan and Xing-Wu Zhong</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210706]]></guid><cfi:id>384</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Influence of lens position as detected by an anterior segment analysis system on postoperative refraction in cataract surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210707]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To predict postoperative intraocular lens (IOL) position using the Sirius anterior segment analysis system and investigate the effect of lens position and IOL type on postoperative refraction.
METHODS: A total of 97 patients (102 eyes) were enrolled in the final analysis. An anterior segment biometry measurement was performed preoperatively with Sirius and Lenstar. The results of predicted lens position (PLP) and IOL power were automatically calculated by the software used by the instruments. Effective lens position (ELP) was measured manually using Sirius 3mo postoperatively. Pearson’s correlation analysis and linear regression analysis were used to determine the correlation of lens position to other parameters.
RESULTS: PLP and ELP were positively correlated to axial length (AL; r=0.42, P<0.0001 and r=0.49, P<0.0001, respectively). There was a weak correlation between the peLP (ELP-PLP) and the prediction error of spherical refraction (peSR; r=0.34, P<0.0001). The peLP of Softec HD IOL differed statistically from those of both the TECNIS ZCB00 and Sensor AR40E IOLs. Multiple linear regression was used to obtain the prediction formula: ELP=0.66+0.63× [aqueous depth (AQD)+0.6LT] (r=0.61, P<0.0001), and a new variable (AQD+0.6 LT) was found to have the strongest correlation with ELP.
CONCLUSION: The Sirius anterior segment analysis system is helpful to predict ELP, which reduces postoperative refraction error.]]></description>
<pubDate>2021/5/25 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jia-Ju Zhang, Jian-Qing Li, Chen Li, Yi-Hong Cao and Pei-Rong Lu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jia-Ju Zhang, Jian-Qing Li, Chen Li, Yi-Hong Cao and Pei-Rong Lu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210707]]></guid><cfi:id>383</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of IOL-Master 700 and IOL-Master 500 biometers in ocular biological parameters of adolescents]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210708]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the differences and consistency of IOL-Master 700 biometers applying swept optical coherence tomography with the conventional IOL-Master 500 applying partial coherence interference in terms of the ocular biological parameters in adolescents with ametropia.
METHODS: A total of 110 adolescents (110 eyes) with ametropia were collected, including 55 males and 55 females; age 10.69±2.81y. Ocular biological measurements were taken by IOL-Master 700 and IOL-Master 500 respectively to obtain biological parameters including axial length (AL), mean corneal anterior surface keratometry (Km), anterior chamber depth (ACD), and horizontal corneal diameter (WTW). Paired t-test was used to compare the differences between the two instruments. The intra-group correlation coefficient (ICC) and the Bland-Altman analysis were used to evaluate the consistency of parameter measurements between the two instruments for the four biological parameters.
RESULTS: Statistical analysis showed that there was no significant difference in the Km value measured by IOL-Master 700 and IOL-Master 500 (t=-1.644, P=0.116). The average differences of the AL, ACD, and WTW distances between the two instruments are 0.028, 0.101 and 0.064 mm respectively, and the differences are statistically significant (t=2.644, 12.505, 3.911, P<0.001). The consistency study results indicated high correlation in the measurement of AL, Km, ACD and WTW between the two instruments (ICC=0.994, 0.873, 0.927, 0.912).
CONCLUSION: The novel biometric instrument IOL-Master 700 makes no difference with IOL-Master 500 in the measurement of Km. There are some differences in the values of AL, ACD, and WTW. However, the two instruments show good consistency in these four biological measurements. The measured values of Km are interchangeable between the instruments. These two types of biometrics can be used as mutual reference in consideration of that the differences in AL, ACD, and WTW measurements are not sufficient to produce clinically meaningful differences.]]></description>
<pubDate>2021/5/25 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Qiang Shi, Guang-Yan Wang, Yu-Hong Cheng and Cheng Pei]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Qiang Shi, Guang-Yan Wang, Yu-Hong Cheng and Cheng Pei</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210708]]></guid><cfi:id>382</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Predictive value of pupillography on intraoperative floppy iris syndrome in preoperative period]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210709]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To present the frequency of intraoperative floppy iris syndrome (IFIS) in cataract patients who taking alpha 1-a receptor antagonist (ARA) drugs, and evaluate the predictive value of pupil diameter (PD) changes in IFIS patients.
METHODS: Male cataract patients who are under treatment with alpha-1a-ARAs (alfuzosin, tamsulosin) intraoperatively were evaluated and were grouped as with/without IFIS. The preoperative PD values were compared with controls. Also, the intraoperative manipulations and early/late complications were recorded.
RESULTS: A total of 77 patients (77 eyes) of 94 benign prostate hyperplasia (BPH) patients have been defined as IFIS (81.91%) and 40 patients (40 eyes) were taking tamsulosin and 37 patients (37 eyes) were taking alfuzosin. During the cataract surgery, the rate of posterior capsular rupture (P=0.754), vitreous loss (P=0.585), iris tears (P=0.004), and iris catching (P=0.000) were higher in IFIS group, but the difference was significant only in the iris catching. At the postoperative first-month visit, persistent IOP rise and iris stromal tears were more frequent in IFIS group, but the difference was not significant (P=0.311, P=0.146; respectively). In contrast, Descemet membrane detachment was insignificantly more frequent in controls (P=0.311). In IFIS and control patients, PDs were 9.54±1.78 and 9.72±1.57 mm (P=0.255) under scotopic illumination, 8.54±1.43 and 8.74±1.25 mm (P=0.289) under mesopic illumination, 6.99±1.35 and 7.27±1.39 mm (P=0.662) under photopic illumination, respectively. However PDs were lower in IFIS under all illumination degrees, no significant difference was detected between groups.
CONCLUSION: IFIS is a significant clinical syndrome with an increased intraoperative/postoperative complication ratio. The prediction of this syndrome is important because of prevention required precautions against possible complications. There is no association between IFIS and preoperative PD.]]></description>
<pubDate>2021/5/25 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Gozde Sahin Vural and Mehmet Vural]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Gozde Sahin Vural and Mehmet Vural</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210709]]></guid><cfi:id>381</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Quantitative analysis of retinal intermediate and deep capillary plexus in patients with retinal deep vascular complex ischemia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210710]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To quantitatively analyze the retinal intermediate and deep capillary plexus (ICP and DCP) in patients with retinal deep vascular complex ischemia (RDVCI), using 3D projection artifacts removal (3D PAR) optical coherence tomography angiography (OCTA).
METHODS: RDVCI patients and gender- and age-matched healthy controls were assessed and underwent OCTA examinations. The parafoveal vessel density (PFVD) of retinal deep vascular complex (DVC), ICP, and DCP were analyzed, and the percentage of reduction (PR) of PFVD was calculated.
RESULTS: Twenty-four eyes in 22 RDVCI patients (20 in acute phase and 4 in chronic phase) and 24 eyes of 22 healthy subjects were enrolled as the control group. Significant reduction of PFVD in DVC, ICP, and DCP was observed in comparison with the controls (DVC: acute: 43.59%±6.58% vs 49.92%±5.49%, PR=12.69%; chronic: 43.50%±3.33% vs 51.20%±3.80%, PR=15.04%. ICP: acute: 40.28%±7.91% vs 46.97%±7.14%, PR=14.23%; chronic: 41.48%±2.87% vs 46.43%±3.29%, PR=10.66%. DCP: acute: 45.44%±8.27% vs 51.51%±9.97%, PR=11.79%; chronic: 37.78%±3.48% vs 51.73%±5.17%, PR=26.97%; all P<0.05). No significant PR difference was found among DVC, ICP, and DCP of RDVCI in acute phase (P=0.812), but significant difference in chronic phase (P=0.006, DVC vs DCP, ICP vs DCP). No significant difference in PR between acute and chronic phases in the DVC (P=0.735) or ICP (P=0.681) was found, but significant difference in the DCP (P=0.041).
CONCLUSION: The PFVD of DVC, ICP, and DCP in RDVCI is significantly decreased in both acute and chronic phases. ICP impairment is stabilized from acute to chronic phase in RDVCI, whereas subsequent DCP impairment is uncovered and can be explained by ischemia-reperfusion damage.]]></description>
<pubDate>2021/5/25 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xin-Xin Li, Tian-Wei Qian, Ya-Nan Lyu, Xun Xu and Su-Qin Yu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xin-Xin Li, Tian-Wei Qian, Ya-Nan Lyu, Xun Xu and Su-Qin Yu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210710]]></guid><cfi:id>380</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Peripheral arterial filling time and peripheral retina fluorescence features in ultra-widefield angiography]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210711]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the peripheral arterial filling time (PAFT) and venous filling time (VFT) in eyes without known diseases that may influence filling process using ultra-widefield (UWF) fluorescein angiography (FA), and to review the peripheral retina fluorescence features.
METHODS: A total of 30 eyes of 30 patients were retrospectively reviewed in this observational study. UWF-FA was performed using Optos 200Tx. PAFT and VFT was recorded. The interval between the arterial or venous filling completion and the previous photo was documented. The appearance of the far peripheral retina was described as either granular background fluorescence or mottled fluorescent band or vascular leakage. Terminal vascular patterns was described as loop pattern or branching pattern. Microvascular abnormalities such as arteriovenous shunting, vessels crossing the horizontal raphe, right angle vessels, terminal networks, capillary nonperfusion, drusen or microaneurysms were evaluated.
RESULTS: The normal limits of PAFT was 3.397-8.984s and 4.399-11.753s for VFT. The appearance of the far peripheral retina, defined as granular background (63%), mottled fluorescence (20%), or vascular leakage (17%), was symmetrical between both eyes. Capillary nonperfusion (23%) and microaneurysms (40%) were more frequently found in eyes with loop pattern than in eyes with branching pattern. Other peripheral signs such as right-angle vessels (73%), and terminal networks (80%) were commonly seen on UWF-FA in the normal peripheral retina.
CONCLUSION: The main courses of retinal artery and vein filling time are overlapping with each other on UWF-FA. Notably, the arterial filling process is completed in the arteriovenous phase rather than the traditionally named arterial phase. There are various manifestations in the peripheral retina of normal eyes.]]></description>
<pubDate>2021/5/25 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hai-Cheng She, Xi-Fang Zhang, Yong-Peng Zhang, Xuan Jiao and Hai-Ying Zhou]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hai-Cheng She, Xi-Fang Zhang, Yong-Peng Zhang, Xuan Jiao and Hai-Ying Zhou</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210711]]></guid><cfi:id>379</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Atherogenic indices in non-arteritic ischemic optic neuropathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210712]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the atherogenic indices and the relationship with visual acuity and bilateral sequential involvement in patients with non-arteritic ischemic optic neuropathy (NAION).
METHODS: A total of 65 patients with NAION and 48 age-sex matched healthy individuals were included in this retrospective study. The demographic characteristics and laboratory findings of the patients and control subjects were obtained from the electronic medical records. The atherogenic indices were calculated using the lipid parameters. The association between visual acuity, bilateral sequential involvement, and atherogenic indices was investigated.
RESULTS: The mean age was 63.8±12.5y in the NAION group and 64.7±10.1y in control group (P=0.707). Although there were no significant differences in terms of total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-c) between two groups (P=0.089, 0.091), all the non-traditional serum lipid ratios were significantly higher in NAION group (P<0.05). In the NAION subgroup analysis, with visual acuity≤20/200 had higher TC/high-density lipoprotein cholesterol (HDL-c), LDL-c/HDL-c, and non-HDL-c/HDL-c values than the patients in the NAION group with visual acuity >20/200 (P=0.032, 0.025, 0.032, respectively). The values for the atherogenic indices were higher in NAION patients with bilateral sequential involvement in comparison to those with unilateral involvement (P=0.271, 0.127, 0.197, 0.128, 0.127, respectively).
CONCLUSION: The study reveals a relationship between NAION and the non-traditional lipid ratios. Atherogenic indices may predict the visual loss severity and second eye involvement in patients with NAION.]]></description>
<pubDate>2021/5/25 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Nurullah Kocak, Volkan Yeter, Mustafa Turunc, Merve Bayrambas, Bilge Eraydin and Inci Güngor]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Nurullah Kocak, Volkan Yeter, Mustafa Turunc, Merve Bayrambas, Bilge Eraydin and Inci Güngor</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210712]]></guid><cfi:id>378</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Evaluation of preoperative dry eye in people undergoing corneal refractive surgery to correct myopia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210713]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the incidence of preoperative dry eye and related factors in patients undergoing corneal refractive surgery to correct myopia.
METHODS: A total of 141 patients with myopia who underwent corneal refractive surgery were surveyed by questionnaires, tear film break-up time (BUT) test, Schimer I test (SIt), corneal fluorescein staining (FL) test and diagnosed according to the currently recognized domestic diagnostic criteria for dry eye. Correlation analysis of factors such as age, gender, regular wearing of contact lens (CL), diopter (spherical equivalent), corneal thickness, and corneal curvature that may affect the onset of dry eye was carried out to clarify the main influencing factors.
RESULTS: There were 64 patients (45.39%) diagnosed with dry eye. The male patients (20.31%) was significantly less than that of non-dry eye subjects (41.56%; χ2=7.260, P=0.007); the proportion of patients with dry eye wearing CL (81.25%) was significantly higher than that of non-dry eye subjects (51.95%; χ2=13.234, P<0.001); the median diopter level of dry eye patients was -6.59 (IQR: -8.87, -4.58) D, and the median diopter level of non-dry eye subjects was -5.69 (IQR: -7.15, -4.03) D. The diopter level of dry eye patients was significantly higher (Z=-2.086, P=0.019). However, the age, best corrected visual acuity, and intraocular pressure of dry eye patients were not statistically different from those of non-dry eye subjects (t=-0.257, -0.383 and 0.778, P=0.798, 0.702, and 0.438); the corneal thickness and corneal curvature (K1 and K2) were also not statistically different either (Z=-1.487, -1.036 and -1.707, P=0.137, 0.300, and 0.088). The research further analyzes the three significant factors in the single factor analysis (gender, CL wear, and diopter) in a multi-factor way: CL wear and diopter were the influencing factors of dry eye disease. Among them, CL wear increased the risk of dry eye by 2.934 times compared with no CL wear; for every 1 D increase in diopter, the risk of dry eye increased by 0.761 times.
CONCLUSION: Preoperative dry eye is relatively common in patients who undergo corneal refractive surgery to correct myopia, especially in patients who have a history of CL wear and a high diopter level before surgery. Therefore, it is necessary to carry out preoperative screening and timely treatment of dry eye to obtain the best treatment outcome and postoperative satisfaction.]]></description>
<pubDate>2021/5/25 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Peng-Fei Zhao, Yue-Hua Zhou, Ya-Bin Hu, Kai Cao, Ying Qi, Ning Guo, Xu Gao, Qing-Wei Zhang and Chang-Bin Zhai]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Peng-Fei Zhao, Yue-Hua Zhou, Ya-Bin Hu, Kai Cao, Ying Qi, Ning Guo, Xu Gao, Qing-Wei Zhang and Chang-Bin Zhai</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210713]]></guid><cfi:id>377</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Lag of accommodation predicts clinically significant change of spherical equivalents after cycloplegia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210714]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate related factors with the change of spherical equivalents (ΔSE) and determine the suitable predictor of clinically significant ΔSE (≥0.50 D) with cyclopentolate hydrochloride on Chinese children.
METHODS: A total of 145 right eyes of 145 children aged 4 to 15y were enrolled. Intraocular pressure, axial length and lag of accommodation (LOA) were assessed before cycloplegia induced by 3 drops of 1% cyclopentolate at 5-minute intervals. SE was measured before and 1h after the first drop of cyclopentolate. ΔSE was compared between different gender groups and among refractive groups. Multivariate linear regression analysis was performed to find related factors with ΔSE. ROC analysis was used to figure out the suitable predictor of clinically significant ΔSE.
RESULTS: For the total 145 eyes, the mean SE reached up to -0.70±1.86 D from -1.30±1.62 D, with the mean ΔSE of 0.60±0.55 D. The mean ΔSE were 0.63±0.55 D and 0.57±0.56 D respectively in the male and female group (P=0.40). The mean ΔSE was significantly different among different refractive groups (P<0.0001), with the ΔSE of hyperopia group (1.12±0.64 D) larger than that of the emmetropia (0.56±0.43 D, P=0.001) and myopia group (0.32±0.28 D, P<0.0001). The ΔSE was correlated with LOA (B=-0.54, P<0.0001), cycloplegic SE (B=0.10, P<0.0001) and age (B=-0.04, P=0.015). ROC curve indicated that LOA predicted clinically significant ΔSE by 82% [area under the curve (AUC)=0.82] alone, while the value was slightly improved to 85% (AUC=0.85) in combination with axial length and 86% (AUC=0.86) in association with axial length as well as age.
CONCLUSION: After cycloplegia with cyclopentolate, the ΔSE decreases with larger LOA, longer axial length and older age. Specifically, LOA plays a more vital role in predicting clinically significant ΔSE.]]></description>
<pubDate>2021/5/25 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Cheng-Cheng Jin, Ru-Xia Pei, Bei Du, Gui-Hua Liu, Nan Jin, Lin Liu and Rui-Hua Wei]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Cheng-Cheng Jin, Ru-Xia Pei, Bei Du, Gui-Hua Liu, Nan Jin, Lin Liu and Rui-Hua Wei</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210714]]></guid><cfi:id>376</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of vision loss on plasticity of the head and neck proprioception]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210715]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate whether head and neck proprioception and motor control could be compensatory enhanced by long-term vision loss or impairment.
METHODS: Individuals who were blind, low vision or sighted were included in the study, which would undergo the head repositioning test (HRT). The constant error (CE), absolute error (AE), variable error (VE) and root mean square error (RMSE) of each subject were statistically analyzed. Data were analyzed using the SAS 9.4. Tukey-Kramer for one-way ANOVA was used for comparison of blind, low vision, and sighted subjects, as well as to compare subjects with balanced vision, strong vision in the left eye and strong vision in the right eye. Independent sample t-test was used to compare subjects with congenital blindness and acquired blindness, as well as left and right hand dominance subjects.
RESULTS: A total of 90 individuals (25 blind subjects, 31 low vision subjects, and 34 sighted subjects) were included in the study. Among the blind subjects, 14 cases had congenital blindness and 11 cases had acquired blindness. Among the blind and low vision subjects, 21 cases had balanced binocular vision, 17 cases had strong vision in the left eye and 18 cases had strong vision in the right eye. Among all subjects, 11 cases were left hand dominance, and 79 cases were right hand dominance. There were significant differences in AE, VE, and RMSE in head rotation between blind, low vision, and sighted subjects (P<0.01), in AE, VE, and RMSE between blind and sighted (P<0.01), and in VE and RMSE between low vision and sighted (P<0.05). No significant difference between blind and low vision (P>0.05). Significant differences in CE and AE of head right rotation and CE of general head rotation between congenital and acquired (P<0.05). No significant differences between left and right hand dominance and in balance or not of binocular vision (P>0.05).
CONCLUSION: Long-term vision loss or impairment does not lead to compensatory enhancement of head and neck proprioception and motor control. Acquired experience contributes to HRT performance in the blind and has long-lasting effects on plasticity in the development of proprioception and sensorimotor control.]]></description>
<pubDate>2021/5/25 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Tian-Yu Jiang, Bin Shi, Dong-Mei Wu, Lin Zhang, Chang-Shui Weng and Li-Hai Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Tian-Yu Jiang, Bin Shi, Dong-Mei Wu, Lin Zhang, Chang-Shui Weng and Li-Hai Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210715]]></guid><cfi:id>375</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Foveal regeneration after resolution of cystoid macular edema without and with internal limiting membrane detachment: presumed role of glial cells for foveal structure stabilization]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210606]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To document with spectral-domain optical coherence tomography the morphological regeneration of the fovea after resolution of cystoid macular edema (CME) without and with internal limiting membrane (ILM) detachment and to discuss the presumed role of the glial scaffold for foveal structure stabilization.
METHODS: A retrospective case series of 38 eyes of 35 patients is described. Of these, 17 eyes of 16 patients displayed foveal regeneration after resolution of CME, and 6 eyes of 6 patients displayed CME with ILM detachment. Eleven eyes of 9 patients displayed other kinds of foveal and retinal disorders associated with ILM detachment.
RESULTS: The pattern of edematous cyst distribution, with or without a large cyst in the foveola and preferred location of cysts in the inner nuclear layer or Henle fiber layer (HFL), may vary between different eyes with CME or in one eye during different CME episodes. Large cysts in the foveola may be associated with a tractional elevation of the inner foveal layers and the formation of a foveoschisis in the HFL. Edematous cysts are usually not formed in the ganglion cell layer. Eyes with CME and ILM detachment display a schisis between the detached ILM and nerve fiber layer (NFL) which is traversed by Müller cell trunks. ILM detachment was also found in single eyes with myopic traction maculopathy, macular pucker, full-thickness macular holes, outer lamellar holes, and glaucomatous parapapillary retinoschisis, and in 3 eyes with Müller cell sheen dystrophy (MCSD). As observed in eyes with MCSD, cellophane maculopathy, and macular pucker, respectively, fundus light reflections can be caused by different highly reflective membranes or layers: the thickened and tightened ILM which may or may not be detached from the NFL, the NFL, or idiopathic epiretinal membranes. In eyes with short single or multiple CME episodes, the central fovea regenerated either completely, which included the disappearance of irregularities of the photoreceptor layer lines and the reformation of a fovea externa, or with remaining irregularities of the photoreceptor layer lines.
CONCLUSION: The examples of a complete regeneration of the foveal morphology after transient CME show that the fovea may withstand even large tractional deformations and has a conspicuous capacity of structural regeneration as long as no cell degeneration occurs. It is suggested that the regenerative capacity depends on the integrity of the threedimensional glial scaffold for foveal structure stabilization composed of Müller cell and astrocyte processes. The glial scaffold may also maintain the retinal structure after loss of most retinal neurons as in late-stage MCSD.]]></description>
<pubDate>2021/4/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Andreas Bringmann, Martin Karol, Jan Darius Unterlauft, Thomas Barth, Renate Wiedemann, Leon Kohen, Matus Rehak and Peter Wiedemann]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Andreas Bringmann, Martin Karol, Jan Darius Unterlauft, Thomas Barth, Renate Wiedemann, Leon Kohen, Matus Rehak and Peter Wiedemann</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210606]]></guid><cfi:id>374</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Reliability of Chinese web-based ocular surface disease index questionnaire in dry eye patients: a randomized, crossover study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210607]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the reliability of web-based version of ocular surface disease index in Chinese (C-OSDI) on clinically diagnosed dry eye disease (DE) patients.
METHODS: A total of 254 Chinese participants (51% male, 129/254; mean age: 27.90±9.06y) with DED completed paper- and web-based versions of C-OSDI questionnaires in a randomized crossover design. Ophthalmology examination and DED diagnosis were performed prior to the participants being invited to join the study. Participants were randomly designated to either group A (paper-based first and web-based second) or group B (web-based first and paper-based second). Final data analysis included participants that had successfully completed both versions of the C-OSDI. Demographic characteristics, test-retest reliability, and agreement of individual items, subscales, and total score were evaluated with intraclass correlation coefficients (ICC), Spearman rank correlation, Wilcoxon test and Rasch analysis.
RESULTS: Reliability indexes were adequate, Pearson correlation was greater than 0.8 and ICCs range was 0.827 to 0.982; total C-OSDI score was not statistically different between the two versions. The values of mean-squares fit statistics were very low compared to 1, indicating that the responses to the items by the model had a high degree of predictability. While comparing the favorability 72% (182/254) of the participants preferred web-based assessment.
CONCLUSION: Web-based C-OSDI is reliable in assessing DED and correlation with the paper-based version is significant in all subscales and overall total score. Web-based C-OSDI can be administered to assess individuals with DED as participants predominantly favored online assessment.]]></description>
<pubDate>2021/4/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xin-Mei Zhang, Lan-Ting Yang, Qing Zhang, Qing-Xia Fan, Can Zhang, Yue You, Chen-Guang Zhang, Tie-Zhu Lin, Ling Xu, Salissou Moutari, Jonathan E. Moore, Emmanuel E. Pazo and Wei He]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xin-Mei Zhang, Lan-Ting Yang, Qing Zhang, Qing-Xia Fan, Can Zhang, Yue You, Chen-Guang Zhang, Tie-Zhu Lin, Ling Xu, Salissou Moutari, Jonathan E. Moore, Emmanuel E. Pazo and Wei He</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210607]]></guid><cfi:id>373</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Surgical outcomes in acute dacryocystitis patients undergoing endonasal endoscopic dacryocystorhinostomy with or without silicone tube intubation]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210608]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To establish the necessity of silicone tube intubation in acute dacryocystitis (AD) patients undergoing endonasal endoscopic dacryocystorhinostomy (En-DCR).
METHODS: Patients presenting with unilateral AD were randomly assigned to two treatment groups. En-DCR procedures were performed following lacrimal abscess formation, with the operation being performed with silicone intubation for patients in group B but not group A. Functional success was defined by an absence of additional AD episodes, no epiphora, and ostium patency as established via endoscopic evaluation or fluorescein irrigation. Operative success rates and demographic variables were compared between treatment groups.
RESULTS: In total, 66 patients were analyzed in the present study (33 per group), with complete postoperative data having been successfully collected from 27 and 22 patients in group A and group B, respectively. All patients exhibited complete resolution of acute inflammation. Upon follow-up, granulation tissue was detected around the ostium at higher rates in group B (9/22, 40.9%) relative to group A (4/27, 14.8%). At the 12-month follow-up time point, patients in group A exhibited higher success rates (25/27, 92.6%) relative to patients in group B (20/22, 90.9%), but this difference was not significant. Cases of lacrimal passage reconstruction failure in both groups were attributed to excessive fibrous and/or granulation tissue formation proximal to the intranasal ostium.
CONCLUSION: Given that these two operative approaches are associated with similar rates of operative success and in light of differences in granulation tissue formation, cost, and operative duration, these data do not support the routine silicone intubation of AD patients following En-DCR surgery.]]></description>
<pubDate>2021/4/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Bo Yu, Yu Xia, Jia-Ying Sun, Qian Ye, Yun-Hai Tu, Guang-Ming Zhou and Wen-Can Wu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Bo Yu, Yu Xia, Jia-Ying Sun, Qian Ye, Yun-Hai Tu, Guang-Ming Zhou and Wen-Can Wu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210608]]></guid><cfi:id>372</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Rectangular 3-snip punctoplasty versus punch punctoplasty with silicone intubation for acquired external punctal stenosis: a prospective randomized comparative study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210609]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the effectiveness of rectangular 3-snip punctoplasty versus punch punctoplasty via Kelly punch with silicone intubation for the management of acquired external punctal stenosis (AEPS).
METHODS: A prospective, randomized, comparative study was performed on 123 eyes of 94 patients with AEPS. Patients were recruited into either group of rectangular 3-snip punctoplasty (group A) or group of punch punctoplasty with silicone intubation (group B). Outcomes measured were Munk score, grade of punctal stenosis, fluorescein dye disappearance time test (FDDT) and tear meniscus height (TMH) 6 and 12mo after surgery.
RESULTS: Twelve months after surgery, Munk score, FDDT and TMH significantly decreased in both groups compared with the baseline (all P<0.05), and grade of punctal stenosis increased significantly (P<0.05). The grade of punctal stenosis, Munk score, FDDT and TMH were better in group B compared with group A at 6 or 12mo (all P<0.05). There was a positive correlation between TMH and Munk score (R=0.655, P<0.001). At the last followed-up, anatomical success was noted in 96.7% eyes in group A and 98.4% eyes in group B (P=0.613).
CONCLUSION: Punch punctoplasty via Kelly punch with silicone intubation achieves better outcomes than rectangular 3-snip punctoplasty. The new technique is a simple, minimally invasive, with high anatomical and functional success in patients with AEPS.]]></description>
<pubDate>2021/4/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xin Cao, Zi-Zhong Hu, Ying Wu, Yu Song and Qing-Huai Liu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xin Cao, Zi-Zhong Hu, Ying Wu, Yu Song and Qing-Huai Liu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210609]]></guid><cfi:id>371</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Role of bevacizumab intraocular injection in the management of neovascular glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210610]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the long-term effects of intraocular bevacizumab (Avastin) injections as an adjunctive drug to manage patients with neovascular glaucoma (NVG).
METHODS: A retrospective study was conducted consisting of 34 eyes with secondary NVG caused by proliferative diabetic retinopathy (n=25), ischemic central retinal vein occlusion (n=8), and retinal ischemia resulting from persistent detachment (n=1) were managed by intraocular injections of bevacizumab (1.25 mg/0.05 mL), in addition to other treatments. The main outcome measure was the change in the degree of iris neovascularization. Secondary outcomes included intraocular pressure and the number of additional interventions or antiglaucoma medications administered after injection.
RESULTS: All patients were followed-up for at least 12mo. At the last follow-up, complete regression of rubeosis irides was detectable in 13 (38.2%) eyes and incomplete regression in 21 eyes (61.8%). The mean intraocular pressure was 45.32±7.185 mm Hg at baseline and significantly decreased to 26.15±5.679 mm Hg at the last follow-up visit (P=0.000005). Patients received an average of 4.97 injections. As additional treatments, 12 eyes (35%) received laser photocoagulation and 6 eyes (18%) underwent retinocryopexy. No further treatment was needed in 16 eyes (47.1%).
CONCLUSION: Intravitreal bevacizumab injection can have a favorable effect in controlling intraocular pressure and pain control in patients with NVG because it decreases the angiogenesis and helps to augment the results of conventional procedures. The primary cause of retinal ischemia should be always targeted.]]></description>
<pubDate>2021/4/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Fawaz Al Sarireh, Hamzeh Mohammad Alrawashdeh, Khalid Al Zubi and Khalil Al Salem]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Fawaz Al Sarireh, Hamzeh Mohammad Alrawashdeh, Khalid Al Zubi and Khalil Al Salem</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210610]]></guid><cfi:id>370</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Evaluation of retinal and choroidal changes in patients with Alzheimer’s type dementia using optical coherence tomography angiography]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210611]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the changes in fundus parameters in patients with Alzheimer’s type dementia (ATD) using optical coherence tomography angiography (OCTA), to record flash electroretinograms (ERG) using the RETeval system and to explore changes in retinal function.
METHODS: Twenty-nine patients with ATD and 26 age-matched normal subjects were enrolled. All subjects underwent OCTA scans to analyse the superficial retinal vessel parameters in the macular area, including the vessel length density, the vessel perfusion density and the area of foveal avascular zone (FAZ), as well as the choroidal thickness. The differences between the patients with ATD and the normal control group were compared and explored the relevant factors affecting vessel parameters. We also recorded the flash ERGs using the RETeval system and intended to explore changes in retinal function by analysing the ERG image amplitude in patients with ATD.
RESULTS: The vessel parameters [Pvessel length density=0.005 and Pvessel perfusion density=0.006) and average choroid thickness (P<0.001) in the macular area of the ATD group was less than the control group. The FAZ area was statistically significantly enlarged in the ATD group (P<0.001). These parameters were correlated with the Mini-Mental State Examination (MMSE) score and the Montreal Cognitive Assessment (MoCA).
CONCLUSION: Patients with ATD exhibit decreases in the parameters associated with fundus. In addition, these indicators significantly correlate with the MMSE score and the MoCA score. OCTA may be an adjunct tool with strong potential to track changes in the diagnosis and monitoring the progression of the disease.]]></description>
<pubDate>2021/4/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ze-Bing Li, Zhong-Jing Lin, Na Li, Huan Yu, Yan-Lin Wu and Xi Shen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ze-Bing Li, Zhong-Jing Lin, Na Li, Huan Yu, Yan-Lin Wu and Xi Shen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210611]]></guid><cfi:id>369</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Triamcinolone as an adjunct to the combination of anti-VEGF for the management of diabetic macular edema]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210612]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the efficacy of intravitreal triamcinolone (IVTA) as an adjunct to the combination of anti-vascular endothelial growth factor (VEGF) for the management of diabetic macular edema (DME).
METHODS: A total of 51 patients with visual disabilities causing by DME from two sites were retrospectively collected and assigned to two groups according to the therapeutic method: intravitreal conbercept (IVC) combined with focal laser (24 eyes) and IVC combined with focal laser and IVTA (27 eyes). Best-corrected visual acuity (BCVA), the required number of IVCs, central retinal thickness (CRT), the mean costs of treatment burden and safety were compared over 12mo.
RESULTS: From baseline to month 1 through month 12, IVC combined with focal laser and IVTA improved the mean average change in BCVA superior to IVC combined with focal laser (+5.20 vs +2.71 letters). At month 12, 20.83% of the IVC combined with focal laser and 37.04% of IVC combined with focal laser and IVTA arms gained more than 10 BCVA letters. During the period, the mean CRT decreased significantly in the IVC combined with focal laser and IVTA arm (-245.9 μm) compared to the IVC combined with focal laser arm (-98.45 μm). The average of 6.45 and 1.25 conbercept injections performed in the IVC combined with focal laser and IVC combined with focal laser and IVTA arms, respectively. The mean cost of treatment burden for 12mo was $6247.44±4069.18 in the IVC combined with focal laser arm and $1679.19±542.73 in the IVC combined with focal laser and IVTA arm, with a statistically significant difference. Apart from occasional minor subconjunctival hemorrhage, no other significant ocular adverse events (AEs) were observed in either group during the12-month period.
CONCLUSION: It is effective and cost-effective to treat DME by utilizing triamcinolone as an adjunct to the combination of anti-VEGF.]]></description>
<pubDate>2021/4/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ying-Ying Yu, Yong Cheng, Li-Bin Chang, Hui-Ka Xia and Xiao-Xin Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ying-Ying Yu, Yong Cheng, Li-Bin Chang, Hui-Ka Xia and Xiao-Xin Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210612]]></guid><cfi:id>368</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A decrease in macular microvascular perfusion after retinal detachment repair with silicone oil]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210613]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To observe whether silicone oil (SO) tamponade could decrease macular perfusion after retinal detachment repair.
METHODS: A prospective observational case-control study. Patients diagnosed with primary macular off rhegmatogenous retinal detachment undergoing successful retinal repair surgery with vitrectomy were strictly selected. Optical coherence tomography angiography findings were compared between SO and air tamponade groups. Two postoperative visiting points were set (1 and 3mo).
RESULTS: Totally 29 patients (29 eyes) were enrolled. Twenty cases had SO tamponade while 9 cases were with air tamponade. At the first visiting point, superficial parafoveal vessel density (PFSVD) significantly decreased in the SO group (P=0.0403), especially in the superior quadrant or superior-hemi area (P=0.0089, 0.0426, respectively). Parafoveal deep vessel density (PFDVD) had no difference between the two groups. At the second visiting point, all quadrants of PFSVD reduced significantly in the SO group (P=0.0256, 0.0001, 0.0031, <0.0001 in temporal, superior, nasal, and inferior area, respectively), but PFDVD remained no different. In the air group, all areas of PFSVD showed significantly improving from the first visit to the second one (P=0.0324, 0.0001, 0.0371, 0.0026, in temporal, superior, nasal, and inferior area, respectively); however, almost all quadrants of PFDVD showed no changes during this period. In the SO group, both PFSVD and PFDVD showed no obvious changes between the two visiting points. Besides, parafoveal full retinal thickness in the SO group reduced significantly at both visiting points over the air tamponade, while the foveal avascular zone area showed no difference in the two groups.
CONCLUSION: After retinal detachment surgery with vitrectomy and SO tamponade, superficial macular perfusion and full retinal thickness could decrease obviously when compared to air tamponade. This reduction process could persist throughout the tamponade period.]]></description>
<pubDate>2021/4/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Wei Fang, Jing Zhai, Jian-Bo Mao, Hai-Dong Li, Zhen-Bin Qian, Chao-Qiao Chen, Jia-Hao Xu, Li-Jun Shen and Yi-Qi Chen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Wei Fang, Jing Zhai, Jian-Bo Mao, Hai-Dong Li, Zhen-Bin Qian, Chao-Qiao Chen, Jia-Hao Xu, Li-Jun Shen and Yi-Qi Chen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210613]]></guid><cfi:id>367</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Evaluation of macular vessel density changes after vitrectomy with silicone oil tamponade in patients with rhegmatogenous retinal detachment]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210614]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate macular microvasculature changes in eyes after pars plana vitrectomy (PPV) and intraocular silicone oil (SO) tamponade for macula-off rhegmatogenous retinal detachment (RRD) using optical coherence tomography angiography (OCTA).
METHODS: Totally 19 eyes (19 patients) with macula-off RRD who underwent PPV and intraocular SO tamponade were retrospectively reviewed. The parafoveal superficial capillary plexus (SCP) vessel density (VD), deep capillary plexus (DCP) VD, choriocapillaris plexus (CCP) VD, and foveal macular thickness were evaluated using OCTA throughout 16wk postoperatively. The values of healthy fellow eyes were used as control.
RESULTS: The parafoveal SCP, DCP, and CCP VDs were significant increased over time in RRD eyes during the 12wk postoperatively, then decreased at 16wk postoperatively (all P<0.01). The ratios of RRD eyes and fellow healthy eyes (r/f ratios) of the SCP and DCP VDs were lower than those of the CCP VD postoperatively (all P<0.05). There were not significant differences in the r/f ratios between SCP and DCP VDs postoperatively (all P>0.05).
CONCLUSION: The parafoveal SCP, DCP, and CCP VDs gradually recover over time after PPV surgery with SO tamponade. Long-time SO tamponade might decrease postoperative macular VDs. Compared to parafoveal CCP VD, the parafoveal SCP and DCP VDs were more vulnerable in RRD eyes postoperatively.]]></description>
<pubDate>2021/4/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jian Jiang, Song Chen, Ya-Ding Jia, Rui Li, Jin-Xiu Zhou and Rui-Mei Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jian Jiang, Song Chen, Ya-Ding Jia, Rui Li, Jin-Xiu Zhou and Rui-Mei Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210614]]></guid><cfi:id>366</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Expression levels of pro-inflammatory interleukin-8 and certain antimicrobial peptides in concurrent with bacterial conjunctivitis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210505]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To detect the quantitative expression levels of the pro-inflammatory interleukin-8 (IL8), antimicrobial peptides human beta defense-2 (HBD2), and human beta defense-3 (HBD3) genes in bacterial conjunctivitis.
METHODS: The human conjunctival epithelial cells were obtained using the impression cytology technique from healthy controls and patients. The genes expression levels were determined utilizing a reverse transcription quantitative polymerase chain reaction (RT-qPCR). The contribution of causative agent type, the number of isolates and severity of clinical features, in the increase of genes expression was also determined.
RESULTS: The RT-qPCR showed that IL8, HBD2, and HBD3 expression increased in bacterial conjunctivitis as compared to healthy control (P<0.001). In gram-negative bacterial conjunctivitis, HBD2 was highly up-regulated (P<0.001) compared to other types of bacterial conjunctivitis. In mixed bacterial conjunctivitis, a direct correlation between HBD2 up-regulation and HBD3 up-regulation was observed (P<0.05). The severity of clinical features was related to the up-regulation of IL8 and HBD2 (P<0.05).
CONCLUSION: IL8, HBD2, and HBD3 are immune-effectors in infectious conjunctivitis. HBD2 is active during different bacterial conjunctivitis but is more released with gram-negative bacteria compared to gram-positive bacteria. HBD3 is an obvious defender in different bacterial conjunctivitis.]]></description>
<pubDate>2021/3/29 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Alaa El-Dien Shawky Hosny, Zeinab El-Demerdash El-Bazza, Mohammed Abdelhalim Ramadan, Maha Ahmed Shafik, Mahmoud Ahmed Shafeek and Rania Abdelmonem Khattab]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Alaa El-Dien Shawky Hosny, Zeinab El-Demerdash El-Bazza, Mohammed Abdelhalim Ramadan, Maha Ahmed Shafik, Mahmoud Ahmed Shafeek and Rania Abdelmonem Khattab</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210505]]></guid><cfi:id>365</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Iris manipulation during phacoemulsification: intraoperative and postoperative complications]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210506]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To quantify intraoperative and postoperative complications in complex phacoemulsification cataract extraction (phacoemulsification) with iris manipulation compared to non-complex and complex phacoemulsification without iris manipulation.
METHODS: All phacoemulsification cases at the University of Colorado between January 1, 2014, and June 30, 2017 were included. Exclusion criteria for the primary outcome of intraoperative complications were planned combination surgery and eyes with less than 28d follow-up. Exclusion criteria for the secondary outcomes of postoperative complications were unplanned additional surgery, and chronic steroid eye drop use prior to surgery. Data including sex, race/ethnicity, surgery length, visual acuity, intraoperative and postoperative complications, and intraocular pressures (IOP) were collected and analyzed utilizing general linear and Logistic regression modeling.
RESULTS: The medical records of 5772 eyes were reviewed (500 complex without iris manipulation, 367 with iris manipulation). The number of any intraoperative complication in the complex with iris manipulation and complex without iris manipulation groups was 15 (4.1%) and 26 (5.2%), respectively, compared to 41 (0.8%) in the non-complex group. Postoperative inflammation was found in 135 (2.8%) non-complex cases, 20 (4.1%) complex cases without iris manipulation, and 20 (5.6%) complex cases with iris manipulation. The adjusted odds ratio of postoperative inflammation in phacoemulsification with iris manipulation compared to non-complex was 2.3 (95%CI: 1.3-4.0, P=0.005). The rate of IOP spikes >10 mm Hg was significantly greater in cases with iris manipulation (P=0.001).
CONCLUSION: Complex cases have more intraoperative complications. However, only complex cases with iris manipulation led to increase rates of postoperative inflammation and IOP spikes >10 mm Hg.]]></description>
<pubDate>2021/3/29 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Eric R. Williams, Jennifer L. Patnaik, D. Claire Miller, Anne M. Lynch, Richard S. Davidson, Malik Y. Kahook and Leonard K. Seibold]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Eric R. Williams, Jennifer L. Patnaik, D. Claire Miller, Anne M. Lynch, Richard S. Davidson, Malik Y. Kahook and Leonard K. Seibold</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210506]]></guid><cfi:id>364</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparing corneal outcome between femtosecond laser-assisted cataract surgery and conventional phaco surgery in Fuchs’ endothelial dystrophy patients: a randomized pilot study with 6mo follow up]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210507]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the corneal outcome in Fuchs’ endothelial dystrophy (FED) patients between femtosecond laser-assisted cataract surgery (FLACS) and conventional phaco surgery (CPS).
METHODS: This was a randomized controlled study comparing one eye surgery by FLACS and the contralateral eye operated by CPS (stop and chop technique) in FED patients. Central corneal thickness, corneal light backscatter, corneal densitometry, and central corneal endothelial cell count and hexagonality (noncontact endothelial cell microscope), and corrected distance visual acuity (CDVA) were assessed preoperatively and at day 1, 40, and 180 postoperatively.
RESULTS: Totally 31 patients (16 women) were included. At day 40 postoperatively, the mean endothelial cell loss (ECL) was 23.67% by FLACS and 17.30% by CPS (P=0.53). At day 180 postoperatively, ECL was 25.58% in FLACS and 21.32% in CPS (P=0.69). Densitometry data in all layers and all annuli from anterior layer to posterior layer in annuli 0-2, 2-6, 6-10 and 10-12, total densitometry with all layers and all annuli was performed. A significant difference was found in 6-10 (posterior layer) at day 1 with -1.42 grayscale units (GSU; 95%CI: -2.66 to -0.19, P=0.02). In 10-12 (anterior layer, central layer and all layers) at day 40 were significant different with 7.7 (95%CI: 1.89 to 13.50, P=0.009), 3.97 (95%CI: 0.23 to 7.71, P=0.03), 4.73 GSU (95%CI: 0.71 to 8.75, P=0.02), respectively. In the remaining parameters we found no difference between the two groups (P>0.05). Three CPS eyes suffered from corneal decompensation.
CONCLUSION: There is no significant difference in corneal outcome between FLACS and CPS. Endothelial cell density and pentacam corneal outcome may be inadequate as outcome parameters in FED patients.]]></description>
<pubDate>2021/3/29 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Therese Krarup, Kathrine Rose, Aurore Marie-Laurence Akpé Mensah, Morten la Cour and Lars Morten Holm]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Therese Krarup, Kathrine Rose, Aurore Marie-Laurence Akpé Mensah, Morten la Cour and Lars Morten Holm</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210507]]></guid><cfi:id>363</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Addressing the MSICS learning curve: identification of instrument-holding techniques used by experienced surgeons]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210508]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To identify instrument holding archetypes used by experienced surgeons in order to develop a universal language and set of validated techniques that can be utilized in manual small incision cataract surgery (MSICS) curricula.
METHODS: Experienced cataract surgeons performed five MSICS steps (scleral incision, scleral tunnel, side port, corneal tunnel, and capsulorhexis) in a wet lab to record surgeon hand positions. Images and videos were taken during each step to identify validated hand position archetypes.
RESULTS: For each MSICS step, one or two major archetypes and key modifying variables were observed, including tripod for scleral incision, tripod-thumb bottom for scleral tunnel, underhand-index to thumb grip for side port, index-contact tripod for corneal entry, and tripod-forceps for capsulorhexis. Key differences were noted in thumb placement and number of fingers supporting the instrument, and modifying variables included index finger curvature and amount of flexion.
CONCLUSION: Identification of optimal hand positions and development of a formal nomenclature has the potential to help trainees adopt hand positions in an informed manner, influence instrument design, and improve surgical outcomes.]]></description>
<pubDate>2021/3/29 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Alexandra J. Berges, Zervin R. Baam, Angela Zhu, Shameema Sikder, Samuel Yiu, Ravilla D. Ravindran and Kunal S. Parikh]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Alexandra J. Berges, Zervin R. Baam, Angela Zhu, Shameema Sikder, Samuel Yiu, Ravilla D. Ravindran and Kunal S. Parikh</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210508]]></guid><cfi:id>362</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Optimizing the intraocular lens formula constant according to intraocular lens diameter]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210509]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine whether the different diameters of a specific intraocular lens (IOL) have significantly different optimized SRK/T A constants and whether these new A constants can improve refractive outcomes.
METHODS: Data were collected prospectively from Jan. 2011 to Dec. 2012 on all patients undergoing routine cataract surgery at a district general hospital in the UK. Patients were divided into three groups according to the size of the Akreos AO MI60 IOL used. A constants for the SRK/T formula were optimized according to the size of the IOL. These optimized A constants were then used to select future refractive outcomes.
RESULTS: A total of 2398 cataract operations were performed during the study period of which 1131 met the inclusion criteria. The three optimized A constants for the different sized IOLs were 118.98, 119.13, 119.32. The difference between them was highly significant (P≤0.0001). Two optimized A constants for three sizes of IOL led to an improvement in refractive outcomes (from 93.4% to 94.6% of refractive outcomes within 1.00 D of predicted spherical equivalent). The optimized A constant for the largest IOL was based on a small number of cases and was not used.
CONCLUSION: Optimizing the A constant for the three distinct sizes of the Bausch & Lomb Akreos MI60 lens lead to three significantly different A constants. In our practice, using two different optimized A constants for three different sized IOLs give the least refractive error, however, using three optimized A constants may give better results with a larger dataset.]]></description>
<pubDate>2021/3/29 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Abdul R El-Khayat and Paul Tesha]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Abdul R El-Khayat and Paul Tesha</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210509]]></guid><cfi:id>361</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Applications of the isolated-check visual evoked potential in primary open angle glaucoma with or without high myopia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210510]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To explore the diagnostic performance of isolated-check visual evoked potential (icVEP) for primary open angle glaucoma (POAG) in both highly myopic and non-highly myopic populations and compare it with those of optical coherence tomography (OCT) and Heidelberg retinal tomography (HRT) parameters.
METHODS: A total of 126 participants were recruited, including 31 highly myopic participants with POAG (HM-POAG), 36 non-highly myopic participants with POAG (NHM-POAG), 25 highly myopic participants without POAG (HM) and 34 controls without high myopia (Normal). All the participants underwent a complete ophthalmic examination. The signal-to-noise ratio (SNR) was used to assess the icVEP. Both qualitative and quantitative diagnostic performances of OCT, HRT and the icVEP were analyzed and compared.
RESULTS: Based on the criterion of SNR≤1, the diagnostic performance of the icVEP in highly myopic subjects [area under the receiver operating characteristic curve (AUC)=0.862] was better than that in non-highly myopic subjects (AUC=0.789), and the SNR had fairly good specificity. In distinguishing the HM-POAG and HM groups, the AUC of the SNR was not different from those of the OCT and HRT parameters (P>0.05) in either the qualitative or quantitative comparison. In the qualitative analysis, the icVEP showed good consistency with damage to the central 10° of the visual field (kappa=0.695-0.747, P<0.001).
CONCLUSION: The icVEP has the potential to discriminate individuals with and without POAG, especially in populations with high myopia.]]></description>
<pubDate>2021/3/29 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xia Wang, Ruo-Shi Li, Ya-Hui Wei, Yuan Fang, Tian Tian, Mei Li and Ying-Zi Pan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xia Wang, Ruo-Shi Li, Ya-Hui Wei, Yuan Fang, Tian Tian, Mei Li and Ying-Zi Pan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210510]]></guid><cfi:id>360</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Associations of lens thickness and axial length with outcomes of laser peripheral iridotomy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210511]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the association of axial length (AL), lens thickness (LT), and lens vault (LV) with postoperative anterior chamber angle metrics after laser peripheral iridotomy (LPI).
METHODS: Prospective observational study of 69 patients (97 eyes) were diagnosed as primary angle-closure suspect (PACS), primary angle closure (PAC) or primary angle-closure glaucoma (PACG). AL, LT, anterior central chamber depth (ACD), angle opening distance (AOD), trabecular iris angle (TIA), and angle recess area (ARA) were measured before and 1wk after LPI. The association between AL, LT, LV with ACD, AOD, TIA, ARA were analyzed by comparing the differences between preoperative and postoperative measurements for anterior segment biometric parameters.
RESULTS: ACD, AOD, TIA, and ARA were significantly increased after LPI (all P<0.05). Greater LT was significantly associated with greater postoperative increases in ACD, AOD, TIA, and ARA (all P<0.05). AL was not significantly associated with changes of anterior segment biometric parameters. Greater LV was significantly associated with greater postoperative increases in ACD, AOD, and TIA (all P<0.05), but was not significantly associated with changes of ARA.
CONCLUSION: Greater baseline LT and LV measurements are associated with greater increases in anterior segment biometric parameters after laser peripheral iridotomy. AL are not associated with the change of anterior segment biometric parameters.]]></description>
<pubDate>2021/3/29 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ya-Meng Liu, Die Hu, Long-Fang Zhou, Jie Lan, Cheng-Cheng Feng, Xiao-Yun Wang and Xiao-Jing Pan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ya-Meng Liu, Die Hu, Long-Fang Zhou, Jie Lan, Cheng-Cheng Feng, Xiao-Yun Wang and Xiao-Jing Pan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210511]]></guid><cfi:id>359</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comprehensive evaluation of intravitreal conbercept versus half-dose photodynamic therapy for chronic central serous chorioretinopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210512]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the safety and efficacy of conbercept intravitreal injection and half-dose photodynamic therapy (PDT) in treating chronic central serous chorioretinopathy (CSC).
METHODS: This study was retrospective. Thirty-seven patients (37 eyes) with chronic CSC received conbercept injections while 57 patients (57 eyes) were treated with half-dose PDT. All subjects were followed in 6mo. Outcome measures included change in best-corrected visual acuity (BCVA), central macular thickness (CMT), subfoveal choroidal thickness (SFCT), and resolution of subretinal fluid (SRF).
RESULTS: There was no adverse event observed in either treatment group. At the 6-month follow-up, 26 eyes (70.3%) in the conbercept group and 54 eyes (94.7%) in the half-dose PDT group (P<0.05) reached full resolution of SRF. The mean logarithm of the minimum angle of resolution (logMAR) BCVA significantly improved (P<0.001) in both treatment groups with better outcome at early phase in the half-dose PDT group (2wk, 1, and 2mo, P<0.05). All subjects experienced significant CMT improvement (P<0.001) with no statistical difference between the two groups (P>0.05). The SFCT also improved in all subjects (P<0.001) with better outcome in the half-dose PDT group (P<0.05).
CONCLUSION: Both intravitreal conbercept and half-dose PDT are safe to use in treating chronic CSC. By 6mo, both treatment groups are efficacious in improving BCVA, reducing CMT and SFCT, and resolving SRF in eyes with chronic CSC. Half-dose PDT may show better outcome at initial phase of treatment in chronic CSC. Longer follow-up period is necessary to study for long-term effect and safety.]]></description>
<pubDate>2021/3/29 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jian-Bo Mao, Cai-Yun Zhang, Chen-Yi Liu, Yun Zhang, Jing-Jing Lin, Zhao-Kai Xu, Yi-Qi Chen, Yuan-Yuan Fan, Shi-Xin Zhao and Li-Jun Shen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jian-Bo Mao, Cai-Yun Zhang, Chen-Yi Liu, Yun Zhang, Jing-Jing Lin, Zhao-Kai Xu, Yi-Qi Chen, Yuan-Yuan Fan, Shi-Xin Zhao and Li-Jun Shen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210512]]></guid><cfi:id>358</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with macular edema secondary to uveitis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210513]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the correlation between disorganization of the retinal inner layers (DRIL) and best-corrected visual acuity (BCVA) in patients with uveitis and macular edema (UME) who underwent systemic treatment using optical coherence tomography (OCT).
METHODS: A retrospective clinical study of 23 patients (30 eyes) with DRIL and 23 patients (31 eyes) without DRIL secondary to UME were included. All patients underwent comprehensive ophthalmic examinations at baseline, 3, 6, and 12mo after local and systemic treatment. The OCT-based parameters included foveal center point thickness (FCPT), mean thickness (MT), and diameters of DRIL in horizontal and vertical directions. BCVA and OCT-based parameters were compared between the two groups. The relationship between each OCT parameter and BCVA was evaluated using linear correlation and regression analysis.
RESULTS: At the initial visit, the mean baseline FCPT was 441.03±128.68 μm in the eyes with DRIL and 337.26±99.31 μm in the eyes without DRIL (P=0.001). No significant differences were observed in MT (P=0.357). The mean size of transverse and vertical diameters of DRIL was 684.07±267.51 and 267.07±104.61 μm at baseline, respectively. There was significant improvement in BCVA and OCT-based parameters at 3, 6, and 12mo in all cases (P<0.001 for each timepoint). In addition, significant differences were detected in BCVA and OCT parameters between eyes with and without DRIL at each time point (P<0.01 for each timepoint). A greater DRIL range at baseline was associated with a worse baseline BCVA (transverse diameter of DRIL: r=0.875, P<0.001; vertical diameter of DRIL: r=0.622, P<0.001). The transverse diameter of baseline DRIL was found to be significantly correlated with the final BCVA (P=0.003).
CONCLUSION: The improvement in BCVA is associated with DRIL in patients with UME. DRIL is an easy-to-determine and robust imaging biomarker that could help predict BCVA prognosis in eyes with UME.]]></description>
<pubDate>2021/3/29 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Zheng Liu, Qing-Qin Tao, Xiao-Rong Li and Xiao-Min Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zheng Liu, Qing-Qin Tao, Xiao-Rong Li and Xiao-Min Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210513]]></guid><cfi:id>357</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Short-term effects of intravitreal Conbercept injection combined with laser photocoagulation on macular edema secondary to ischemic retinal vein occlusion]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210514]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To observe changes in the best-corrected visual acuity (BCVA), central macular thickness (CMT), and central choroidal thickness (CCT) of patients with macular edema (ME) secondary to ischemic retinal vein occlusion (iRVO) following intravitreal Conbercept injection.
METHODS: This retrospective study included 33 eyes from 33 patients who received intravitreal injections of Conbercept for ME secondary to iRVO. Treatments were performed on a 3+pro re nata (3+PRN) basis. All of the patients were examined by fundus fluorescein angiography and spectral domain optical coherence tomography at the first visit. Laser photocoagulation was performed in the nonperfusion area of the retina of all eyes after the first injection. BCVA, CMT, and CCT were observed before and after 6mo of treatment. The number of injections necessary to achieve improved vision was also noted.
RESULTS: Following Conbercept treatment, the mean BCVA significantly improved from 0.81±0.39 at baseline to 0.41±0.25 and 0.43±0.29 logMAR in the third and sixth months, respectively (both P=0.000). The CMT of the patients at baseline was 556.75±98.57 μm; 304.78±68.53 and 306.85±76.77 μm 3 and 6mo after treatment, respectively (both P=0.000 vs baseline). The CCTs of the patients at baseline, 3 and 6mo after treatment were 304.63±57.83, 271.31±45.53, and 272.29±39.93 μm, respectively (P=0.026 and 0.035 vs baseline). No severe adverse event relevant to the therapy was noted, and the average number of injections delivered was 3.35.
CONCLUSION: Intravitreal Conbercept injection combined with laser photocoagulation appears to be a safe and effective treatment for ME secondary to iRVO in the short-term.]]></description>
<pubDate>2021/3/29 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Zheng-Feng Liu, Xing-Rong Wang, Xiao-Yan Zhang, Xue-Mei Pan, Rui-Xue Zhang, Hong-Sheng Bi and Ying Wen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zheng-Feng Liu, Xing-Rong Wang, Xiao-Yan Zhang, Xue-Mei Pan, Rui-Xue Zhang, Hong-Sheng Bi and Ying Wen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210514]]></guid><cfi:id>356</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Optical and visual quality comparison of implantable collamer lens and femtosecond laser assisted laser in situ keratomileusis for high myopia correction]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210515]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare clinical outcomes and refractive stability of implantable collamer lens (ICL) implantation and femtosecond laser assisted laser in situ keratomileusis (FS-LASIK) for high myopia correction.
METHODS: The Optical Quality Analysis System (OQAS) was used to evaluate clinical outcomes objectively after operation for high myopia correction. We compared the two procedures in terms of 1-year changes in uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), safety index, efficacy index, spherical equivalent, modulation transfer function (MTF) cutoff frequency, strehl ratio (SR) and objective scatter index (OSI).
RESULTS: At 1y postoperatively, the safety indices were 1.33±0.27 in ICL group, and 1.17±0.24 in FS-LASIK group. 39.58% in the ICL group and 27.59% in the FS-LASIK group gained CDVA in 2 lines or better than that in preoperative CDVA. The efficacy indices were 1.28±0.22 in ICL group, and 1.13±0.26 in FS-LASIK group. The changes of spherical equivalent from 1wk to 1y postoperatively was -0.12±0.37 D in ICL group, and -0.79±0.58 D in FS-LASIK group (P<0.05). Spherical equivalent within ±0.50 D was achieved in 97.92% in ICL group and 68.97% in FS-LASIK group. MTF cutoff frequency were higher with ICL as compared to FS-LASIK (P<0.05) at each postoperative follow-up stage; for postoperative 1mo later, SR was statistically significant difference between two groups (P<0.05); with no statistically significant difference in OSI between two groups (P>0.05) in postoperative 3mo later.
CONCLUSION: ICL implantation and FS-LASIK procedures both provide good safety and predictability in high myopia correction. ICL implantation provides better clinical outcomes and refractive stability than FS-LASIK.]]></description>
<pubDate>2021/3/29 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Zheng Jiang, Hua Wang, Dong-Qiang Luo and Jiao Chen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zheng Jiang, Hua Wang, Dong-Qiang Luo and Jiao Chen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210515]]></guid><cfi:id>355</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Transepithelial photorefractive keratectomy for myopia: effect of age and keratometric values]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210516]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate demographic and preoperative factors increasing the risk of ametropia following transepithelial photorefractive keratectomy (transPRK) in myopia and myopic astigmatism.
METHODS: This retrospective cohort study included myopic eyes (-0.50 to -8.75 D) with or without astigmatism (up to 3.50 D) enrolled at Dr. Yap Eye Hospital Yogyakarta. TransPRK was performed using Technolaz 217z100 excimer laser. Subjects were clustered into ametropia and emmetropia group based on uncorrected distance visual acuities (UDVA) 3mo post-operatively. Multiple preoperative and intraoperative parameters were analyzed using Logistic regression to obtain their effect on ametropia risk following transPRK.
RESULTS: A total of 140 eyes of 87 consecutive subjects were studied. Prevalence of ametropia following transPRK was 20 (14.29%) eyes. Subjects in ametropia group were significantly older than the emmetropia group (31.80±14.23 vs 18.88±2.41, respectively; P<0.001). Bivariate Logistic regression analysis showed that older age (OR=1.23), higher preoperative spherical equivalent (>-6 D; OR=12.78), steeper anterior keratometric readings (Kmax>45 D and mean K>44 D; OR=4.28 and 4.35, respectively) increased the risk of ametropia following transPRK. Adjusted multivariate Logistic regression analysis showed that age was the strongest predictor for the incidence of ametropia following transPRK. Complications of transPRK were overcorrection, suspected posterior keratoectasia and accommodation insuffiency.
CONCLUSION: Older age can be the strongest factor for increasing ametropia risk following transPRK. Cut-off points of Kmax and mean K at 45 and 44 D respectively  are proposed as the predictors for ametropia following transPRK.]]></description>
<pubDate>2021/3/29 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Amanda Nur Shinta Pertiwi, Indra Tri Mahayana, Agus Supartoto, Wasisdi Goenawan and Suhardjo]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Amanda Nur Shinta Pertiwi, Indra Tri Mahayana, Agus Supartoto, Wasisdi Goenawan and Suhardjo</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210516]]></guid><cfi:id>354</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Trabeculectomy with Ologen implant versus perfluoropropane gas bubble for open angle glaucoma in pseudophakic eyes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210405]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the safety and efficacy of augmented trabeculotomy with Ologen versus perfluoropropane in management of pseudophakic glaucoma.
METHODS: This is a comparative randomized study included 57 pseudophakic eyes of 57 patients with medically uncontrolled open angle glaucoma (OAG). Twenty-nine patients were allocated in group I (trabeculectomy with Ologen; trab-ologen group), while 28 patients were assigned in group II (trabeculectomy with perfluoropropane gas bubble; trab-C3F8 gas bubble group).
RESULTS: The intraocular pressure (IOP) was significantly reduced in both study groups at all postoperative follow up intervals (1wk, 3, 6, 12, 18, 24, 30 and 36mo, P&#x0026;#x003C;0.001). The differences between the mean IOP values of both groups remained statistically insignificance during the early 12 months of follow up. However, the trab-ologen group achieved a statistically significant reduction over the trab-C3F8 gas bubble group during the last 24 months of follow up.
CONCLUSION: Augmentation of trabeculectomy with either Ologen implant or perfluoropropane gas bubble are associated with strict long term IOP control and evident safety in medically-uncontrolled pseudophakic eyes with OAG.]]></description>
<pubDate>2021/2/25 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ahmed S Elwehidy, Tharwat Mokbel, Hossam Youssef Abouelkheir, Waleed Abou Samra, Faried M Wagdy and Amr Mohammed Elsayed Abdelkader]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ahmed S Elwehidy, Tharwat Mokbel, Hossam Youssef Abouelkheir, Waleed Abou Samra, Faried M Wagdy and Amr Mohammed Elsayed Abdelkader</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210405]]></guid><cfi:id>353</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical characteristics of progressive nonarteritic anterior ischemic optic neuropathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210406]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To study whether patients with progressive nonarteritic anterior ischemic optic neuropathy (NAION) present earlier than patients with stable NAION and to describe their clinical characteristics and visual outcome.
METHODS: This was a retrospective chart review. All patients with NAION seen during the acute stage from January 2012 to December 2018 were reviewed. Patients were included if they had documented disc edema and follow up of at least 3mo. Patients with progressive NAION were identified if they worsened in 2 out of 3 parameters: visual acuity ≥3 Snellen lines; Color vision ≥4 Ishihara plates; the visual field defect involved a new quadrant. The clinical characteristics, time from symptom onset to presentation, systemic risk factors and visual outcome were compared to patients with stable NAION.
RESULTS: Totally 122 NAION cases met the inclusion criteria. Mean age was 58.1y (range 22-74), 70% were men. Twenty cases (16.4%) had progressive NAION. Patients with progressive NAION did not differ from stable NAION in their demographics, systemic risk factors or in their initial visual deficit. At last follow up, median visual acuity was 1.0 logMAR (IQR 0.64-1.55) in patients with progressive NAION, vs 0.18 (IQR 0.1-0.63) in stable NAION (P&#x0026;#x003C;0.001). Median color vision testing was 0 plates correct (IQR 0-2.5%) vs 92% plates correct (IQR 50%-100%) in the stable NAION group (P&#x0026;#x003C;0.001). Patients with progressive NAION differed in the time from symptom onset to presentation (median 2d vs 5d, P=0.011).
CONCLUSION: We find no identifiable risk factors associated with progressive NAION. Progressors arrive earlier for ophthalmological evaluation.]]></description>
<pubDate>2021/2/25 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Omer Y. Bialer and Hadas Stiebel-Kalish]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Omer Y. Bialer and Hadas Stiebel-Kalish</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210406]]></guid><cfi:id>352</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of correcting myopia and astigmatism with SMILE or FS-LASIK and postoperative higher-order aberrations]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210407]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the effect of myopia and astigmatism correction and postoperative change in higher-order aberration as results of receiving small-incision lenticule extraction (SMILE) and femtosecond laser-assisted in situ keratomileusis (FS-LASIK).
METHODS: A prospective and non-randomized controlled study was conducted. The subjects are divided into two groups according to different operations received: 229 eyes of 116 patients in the SMILE group and 168 eyes of 86 patients in the FS-LASIK group. All subjects were followed up for 3mo by monitoring their uncorrected visual acuity (UCVA), best-corrected visual acuity (BCVA), spherical equivalent, higher-order aberrations, and the preoperative and postoperative complications.
RESULTS: At 1wk, 1, and 3mo post-surgery, 224 eyes (97.8%), 227 eyes (99.1%) and 229 eyes (100%) had UCVA≥20/20 in the SMILE group, while 165 eyes (98.2%), 167 eyes (99.4%) and 167 eyes (99.4%) had UCVA≥20/20 in the FS-LASIK group, respectively (χ2=0.146, 2.135, and 1.124; all P&#x0026;#x003E;0.05). BCVA reduction was not observed in both groups at 1 and 3mo of post-surgery (χ2=0.734 and 1.898, P&#x0026;#x003E;0.05). There was no statistically significant difference in the spherical equivalent between the two groups at 1 and 3mo post-surgery, though the percentage of the spherical equivalent within ±0.50 D at 3mo post-surgery was 98% in the SMILE group, which was higher than that of the FS-LASIK group (92%, χ2=1.872, P&#x0026;#x003E;0.05). The root mean square (RMS) values of total high-order aberration, coma, and spherical aberration of the two groups increased significantly in the early postoperative period and decreased after 3mo, but the values were still higher than the preoperative levels (P&#x0026;#x003C;0.05); there was no significant difference between the two groups in the RMS values of total higher-order aberrations and specific higher-order aberrations (P&#x0026;#x003E;0.05). The incidence of complications in the SMILE group was lower than that in the FS-LASIK group (χ2=14.52, P&#x0026;#x003C;0.05).
CONCLUSION: SMILE and FS-LASIK can effectively treat myopia, significantly improve visual acuity, and increase the total high-order aberration, spherical aberration, and coma. The incidence of complications after SMILE is relatively low.]]></description>
<pubDate>2021/2/25 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Peng-Fei Zhao, Ya-Bin Hu, Yue Wang, Cai-Yun Fu, Jing Zhang and Chang-Bin Zhai]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Peng-Fei Zhao, Ya-Bin Hu, Yue Wang, Cai-Yun Fu, Jing Zhang and Chang-Bin Zhai</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210407]]></guid><cfi:id>351</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical performance of presbyopia correction with a multifocal corneoscleral lens]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210408]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the clinical performance of a multifocal corneoscleral lens for the presbyopia correction.
METHODS: A prospective clinical trial of the Onefit? A multifocal corneoscleral lens was conducted with 40 participants with presbyopia. At 4wk of continuous wear of the corneoscleral lens, changes in the distance, intermediate, and near visual acuity (VA) were evaluated. The safety of the corneoscleral lens, central corneal thickness (CCT), corneal endothelial cell count, binocular stereopsis, tear film break-up time (BUT), corneal staining, corneal edema, corneal neovascularization (NV), and conjunctival hyperemia were examined. In addition, a subjective questionnaire addressing satisfaction (rated from 1 to 5 points) and discomfort (rated from 1 to 5 points) was administered.
RESULTS: Forty participants were enrolled in this study. Six participants were excluded because of poor compliance with lens fitting (n=2) and loss to follow-up (n=4). The mean age of the participants was 53.0±4.9y. At 4wk of continuous wear of the corneoscleral lens, the best corrected far, intermediate, and near VA was 0.08±0.11, 0.10±0.12, and 0.10±0.12 logMAR, respectively. These results were significant improvements over the baseline uncorrected VA (far: P=0.004; intermediate: P=0.004; near: P=0.002). CCT, corneal endothelial cell count, binocular stereopsis, BUT, corneal staining, corneal edema, corneal NV, and conjunctival hyperemia were not significantly different between baseline and after corneoscleral lens use. The average satisfaction scores for fit sensation; corrected far, intermediate, and near VA; and ease of handling were 4.1, 3.4, 3.6, 3.5, and 3.4, respectively. The average discomfort scores for dryness, irritation, foreign body sensation, redness, fogging, and halo were 1.7, 1.8, 1.5, 1.7, 1.7, and 1.3, respectively.
CONCLUSION: Far, intermediate, and near VA are improved in presbyopic patients with the multifocal corneoscleral lens compared to uncorrected baseline VA, without adverse ocular effects. This evidence supports the safety and effectiveness of presbyopia correction with multifocal corneoscleral lenses.]]></description>
<pubDate>2021/2/25 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Woo Chan Park, Chae Hoon Kim and Sang Wook Jin]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Woo Chan Park, Chae Hoon Kim and Sang Wook Jin</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210408]]></guid><cfi:id>350</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A comparison of visual acuity measured by ETDRS chart and Standard Logarithmic Visual Acuity chart among outpatients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210409]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the results of visual acuity (VA) measured by Early Treatment Diabetic Retinopathy Study (ETDRS) chart, 5 m Standard Logarithm Visual Acuity (5SL) chart, and 2.5 m Standard Logarithm Visual Acuity (2.5SL) chart in outpatients of age 12-80y.
METHODS: Each patient (totally 2000 outpatients) had both eyes tested with ETDRS chart at 4 m, 5SL chart at 5 m, and 2.5SL chart at 2.5 m in random order. The VA values of outpatients were categorized by ages. VA values were expressed by logMAR recording method.
RESULTS: The mean VA results of ETDRS charts, 5SL, and 2.5SL chart were 0.52±0.28, 0.50±0.30, and 0.46±0.28 logMAR, respectively. There was a statistically significant difference in the three eye charts in the whole group (P&#x0026;#x003C;0.001). For all subjects, the correlation of VA tested with three charts was statistically significant (Spearman correlation coefficient=0.944, 0.937, 0.946, all P&#x0026;#x003C;0.001). Bland–Altman analysis shows the 95% limits of agreement between the 5SL and 2.5SL chart were -0.182 to 0.210, -0.139 to 0.251, and -0.151 to 0.235 logMAR, respectively).
CONCLUSION: The agreement between the three eye charts is not high. The VA measured by 5SL chart is slightly better than that by ETDRS chart and 5SL chart would be a suitable alternative when ETDRS chart are not available in the clinical situation. The VA measured by 2.5SL chart is about 0.5 line better than VA tested with ETDRS chart, which may overestimate VA.]]></description>
<pubDate>2021/2/25 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Tao Wang, Pei-Jie Huang, Chen Chen, Ding-Wei Liu and Jing-Lin Yi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Tao Wang, Pei-Jie Huang, Chen Chen, Ding-Wei Liu and Jing-Lin Yi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210409]]></guid><cfi:id>349</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Spasm of the near reflex: a common diagnostic dilemma?]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210410]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report the clinical characteristics and diagnostic procedures used in patients with spasm of the near reflex (SNR), in order to present common investigation strategies and diagnostic pitfalls.
METHODS: Retrospective case series of twenty-two patients, mainly children, with SNR or accommodation spasm (AS). AS was diagnosed on the basis of blurred vision and a difference of &#x0026;#x003E;2 dioptres between manifest and cycloplegic retinoscopy. If esotropia and miosis were present, the patients were diagnosed with SNR. All patients underwent visual acuity testing, orthoptic evaluation, assessment of refraction before and after cycloplegia, and dilated fundoscopy. Additional diagnostic investigations, such as neuroimaging, lumbar puncture (LP), electrophysiology and blood tests, were also recorded. Screen use among children was assessed in hours per day.
RESULTS: There were 19 female and 3 male patients (age range 7-33y, median=10y). Seventeen patients had AS and 5 patients had SNR, with episodic blurry vision and headaches being the most common symptoms. Brain neuroimaging was performed in six patients (27%), although only one had a history of brain trauma. Two of those patients underwent visual evoked potentials and three also underwent LP and received intravenous steroid therapy. The majority of patients (90%) reported prolonged daily screen time (&#x0026;#x003E;2h/d), and in 55% of cases there were concurrent social problems or psychological triggers. Treatment consisted of careful explanation of the condition, atropine 1% eye drops and full cycloplegic correction by means of bifocal glasses.
CONCLUSION: The diagnosis of SNR and AS may be challenging, because symptoms are usually intermittent and nonspecific, and a large number of patients are often subjected to redundant and potentially time-consuming examinations and treatment, that may exaggerate the underlying psychological disorder. Hence, detailed clinical testing and assessment of psychosocial profile is necessary, in order to avoid unnecessary investigations. Neuroimaging should be performed only in selected cases. Finally, due to prolonged screen use SNR and AS may become more frequent in the future.]]></description>
<pubDate>2021/2/25 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Eleni Papageorgiou, Dimitrios Kardaras, Eftychia Kapsalaki, Efthymios Dardiotis, Asimina Mataftsi and Evangelia E. Tsironi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Eleni Papageorgiou, Dimitrios Kardaras, Eftychia Kapsalaki, Efthymios Dardiotis, Asimina Mataftsi and Evangelia E. Tsironi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210410]]></guid><cfi:id>348</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Similar therapeutic effects of 125I seed radiotherapy and γ-ray radiotherapy on lacrimal gland adenoid cystic carcinoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210411]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the survival outcomes of patients with lacrimal gland adenoid cystic carcinoma who underwent eye-sparing surgery combined with 125I seed implantation radiotherapy or local external γ-ray radiotherapy.
METHODS: In this retrospective comparative case series, the clinical records of 27 primary and 8 recurrent patients were reviewed. Univariate and multivariate analyses were used to identify risk factors associated with distant metastasis (DM), and the overall survival (OS) after the initial surgery was analyzed.
RESULTS: The median follow-up after radiotherapy was 36mo (range 6-120mo). At the last follow-up after radiotherapy, 26 (74.3%) patients had no evidence of disease, 7 (20%) patients had DM, 2 (5.9%) patients died of DM, and 1 patient with DM was lost to follow-up. Univariate analyses showed that duration of symptoms, bone destruction, T stage classification, and wide excision surgery were risk factors influencing DM (P&#x0026;#x003C;0.05). The 5-year and 10-year OS rates after the initial surgery were 95.8% and 79.9%, respectively. The 5-year DM-free survival and disease-free survival rates after radiotherapy were 66.4% and 52.7%, respectively.
CONCLUSION: 125I seed radiotherapy and local external γ-ray radiotherapy may have similar therapeutic effects in preventing DM. Patients with T1/T2 stage disease have a better prognosis than those with T3/T4 stage disease.]]></description>
<pubDate>2021/2/25 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Rui Liu, Ji-Tong Shi, Xin Ge, Ben-Tao Yang, Hong Zhang, Jing-Xue Zhang and Jian-Min Ma]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Rui Liu, Ji-Tong Shi, Xin Ge, Ben-Tao Yang, Hong Zhang, Jing-Xue Zhang and Jian-Min Ma</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210411]]></guid><cfi:id>347</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Visual performance of four types of diffractive multifocal intraocular lenses and a review of articles]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210304]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the clinical outcomes of a variety of multifocal intraocular lenses (MIOLs) in patients diagnosed with presbyopia or cataracts.METHODS: This clinical trial study included 141 patients (282 eyes) with different MIOLs implantation. The Symfony (60 eyes), the ReSTOR (100 eyes), the AT LISAtri (60 eyes), and the PanOptix (62 eyes) intraocular lenses were evaluated in this prospective interventional study. The near, intermediate, and distant visual acuities, contrast sensitivity, and defocus curve were measured as valid criteria. To statistically analyze the results, we used the Statistical Package for Social Science software, the non-parametric Wilcoxon signed-rank t, the one-way analysis of variance and the Tukey's post-hoc test in our analysis. Moreover, we conducted a detailed literature search on the PubMed database in English about MIOLs, in total 59 studies were included in this review article.RESULTS: The four approaches did not show any significant difference in the best-corrected distance visual acuity (P>0.05). The defocus curves at the contrast of 100% showed that trifocal IOLs had better intermediate performance than the bifocal IOL (P<0.05). There were no statistically significant differences between AT LISAtri and PanOptix lenses for visual acuity at all distances. The eyes with PanOptix, Symfony, and AT LISAtri IOL showed better contrast sensitivity than those ReSTOR at spatial frequencies of 1, 3, and 6 cpd in photopic and mesopic conditions (P<0.001).CONCLUSION: All four groups of the multifocal lenses were satisfying in terms of distance and near vision. Also, the group of trifocal lenses led to satisfactory outcomes in intermediate vision, without degradation in quality of vision.]]></description>
<pubDate>2021/2/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Farideh Doroodgar, Feizollah Niazi, Azad Sanginabadi, Farid Karimian, Sana Niazi, Cyrus Alinia and Mohammad Ali Javadi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Farideh Doroodgar, Feizollah Niazi, Azad Sanginabadi, Farid Karimian, Sana Niazi, Cyrus Alinia and Mohammad Ali Javadi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210304]]></guid><cfi:id>346</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Efficacy of wet-lab training versus surgical-simulator training on performance of ophthalmology residents during chopping in cataract surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210305]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyze whether wet-lab training (WLT) or surgical-simulator training (SST) is better for ophthalmology residents to master the chopping technique.METHODS: Sixty ophthalmology residents (in their second year) and three cataract surgeons participated in the study. The residents were randomly separated into two groups, WLT group and SST group. The residents in WLT group were asked to perform 10 trials of chopping using pig eyes and scored by the surgeons, and then they performed and scored using simulator for one time. The residents in SST group underwent 10 trials of chopping using simulator, and the simulator scored each trail. Then, this group were asked to perform the chopping using pig eyes and scored by the surgeons. At last, we investigated the residents' satisfaction about the training.RESULTS: The demographic characteristics had no significant differences between the two groups. Recorded by the simulator, the residents in SST group got significantly higher overall score (83.90±1.31) than WLT group (78.73±1.92, P=0.03). And the residents in SST group got less corner area injured, and they spend less time than WLT group (P<0.05). Moreover, the residents in WLT group used more ultrasonic energy value than SST group (P=0.03). However, scored by the surgeons, the residents in two groups got nearly the same overall score. The residents in WLT group performed better on the frequencies of posterior capsule torn and incisional stress (P=0.03, 0.008, respectively). In the survey, the residents in two groups held the same opinion that the training was helpful and they strongly recommended this training. And all of them enjoyed the training, and enjoyed being randomized in their own group. However, with respect to the realistic character, the residents thought that WLT was better than SST (P<0.001).CONCLUSION: Both of the Eyesi surgical-stimulator and the wet-lab improve the residents' chopping ability and each has its own advantages. The combination of the two training ways could be considered to be a part of the training curriculum for new residents.]]></description>
<pubDate>2021/2/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ya-Guang Hu, Qiu-Ping Liu, Ning Gao, Chang-Rui Wu, Jian Zhang, Li Qin and Jing-Ming Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ya-Guang Hu, Qiu-Ping Liu, Ning Gao, Chang-Rui Wu, Jian Zhang, Li Qin and Jing-Ming Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210305]]></guid><cfi:id>345</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Visual quality after implantation of trifocal intraocular lenses in highly myopic eyes with different axial lengths]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210306]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyze postoperative clinical results after implantation of trifocal intraocular lenses (IOLs) in highly myopic eyes with different axial lengths (ALs).METHODS: This retrospective study describes 61 eyes of 44 patients that were implanted with trifocal diffractive IOLs (AT LISA tri 839MP). Twenty-one eyes (15 patients) were included in the AL<26 mm group, 19 eyes (13 patients) in the AL≥26 mm and <28 mm group, and 21 eyes (16 patients) in the AL≥28 mm group. Postoperative outcomes, including corrected and uncorrected distance visual acuity (UDVA), intermediate and near visual acuity at 167 cd/m2 luminance, depth of focus at 85 cd/m2 luminance, and objective optical quality parameters assessed using the Optical Quality Analysis System (OQAS), were compared among the groups at 3mo.RESULTS: There were no significant differences in the mean UDVA, uncorrected intermediate visual acuity, uncorrected near visual acuity, corrected distance visual acuity, distance-corrected intermediate visual acuity, and distance-corrected near visual acuity (DCNVA) among the three groups (P>0.05). Better near and intermediate visual acuity (from -1.5 D to -3.0 D) were noted on the defocus curve of the AL<26 mm group (P<0.01 vs AL≥28 mm group). Significantly higher objective scatter index (OSI) values and lower modulation transfer function (MTF) cut-off values, Strehl ratio (SR), and OQAS values (OVs) were observed in the AL≥28 mm group (P<0.01 vs AL<26 mm group). All OQAS parameters had statistically significant correlations with DCNVA and visual acuity at the vergence of -2.5 D (P<0.05 to P<0.01).CONCLUSION: Implantation of trifocal IOLs provides good short-term visual and refractive outcomes in highly myopic eyes with different ALs. However, the near vision decreases in the extremely myopic eyes at lower luminance, which is associated with the lower objective optical quality in these eyes.]]></description>
<pubDate>2021/2/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hui Liu, Fang-Fang Li, Hai-Jun Xia and Jin Zhou]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hui Liu, Fang-Fang Li, Hai-Jun Xia and Jin Zhou</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210306]]></guid><cfi:id>344</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparative evaluation of rotational stability of toric IOLs with four-eyelet vs two-eyelet capsular tension rings in eyes with high myopia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210307]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the rotational stability of Toric intraocular lens (IOLs) implantation combined with four-eyelet or two-eyelet capsular tension rings (CTRs) in eyes with high myopia and cataract.METHODS: This prospective randomized controlled interventional study included 33 eyes which had preoperative corneal astigmatism ≥1.5 D and ocular axial length ≥25.5 mm. These eyes were randomly divided into two groups to undergo phacoemulsification and toric IOL implantation with either four-eyelet CTR implantation (group A, n=16) or two-eyelet CTR implantation (group B, n=17). Uncorrected visual acuity (UCVA), best-corrected visual acuity (BCVA), phoropter examination results, and toric IOL rotation degrees were tested 6mo after the surgery.RESULTS: In both groups, the toric IOL was in the capsular sac 6mo after surgery. The difference between the two groups in terms of visual outcome was not found to be statistically significant (P>0.05) at a follow-up of 6mo. The mean residual astigmatism values were 0.56±0.22 D and 0.92±0.24 D in A and B groups, respectively (P<0.001). The mean rotation degree of IOL was 1.00°±0.73° in group A and 3.53°±1.46° in group B (P<0.001).CONCLUSION: In cataract patients with high myopia and astigmatism, four-eyelet CTR can effectively increase the rotation stability of toric IOLs, achieving the desired goal of correcting corneal astigmatism.]]></description>
<pubDate>2021/2/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hui-Min Jiang, Kun Liang and Li-Ming Tao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hui-Min Jiang, Kun Liang and Li-Ming Tao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210307]]></guid><cfi:id>343</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[An Ex-Press implant versus trabeculectomy in a fibrotic bleb with late failure after previous trabeculectomy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210308]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the outcome of an Ex-Press implant and subscleral trabeculectomy (SST) in the management of glaucoma after previous trabeculectomy on a fibrotic bleb.METHODS: This randomized prospective study included 28 eyes from 28 patients (age range: 42-55y) with primary open angle glaucoma (POAG) presented with elevated intraocular pressure (IOP) with fibrotic bleb despite previous SST for more than 4mo. The eyes enrolled in the study were divided into two groups: group I (subjected to Ex-Press implant surgery) and group II [subjected to SST with mitomycin C (MMC)]. The follow-up continued one year after surgery to evaluate IOP, visual acuity (VA), visual field (VF), and postoperative complications.RESULTS: A significant decrease in IOP was found in both groups with a higher reduction in Ex-Press implant surgery with the mean IOP of 14.50 mm Hg (P=0.001), while the SST group recorded the mean IOP of 16.50 mm Hg (P=0.001) after one year. However, the difference between the two groups in terms of the decrease in IOP was insignificant. Fewer postoperative complications were recorded in the Ex-Press implant surgery and more cases requiring further anti-glaucomatous medications were seen in the SST group. Both groups showed stability in terms of VA and VF.CONCLUSION: Ex-Press implant surgery and SST with MMC are two surgical alternatives for controlling IOP in late failure that occurs more than 4mo after previous SST with a fibrotic bleb. However, Ex-Press shunt is a safer surgery with fewer complications.]]></description>
<pubDate>2021/2/25 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Faried Wagdy, Tharwat H. Mokbel, Hisham Elsorogy, Ahmed Alnagdy, Dina Abd Elfattah and Abd-Elmonem A. Elhesy]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Faried Wagdy, Tharwat H. Mokbel, Hisham Elsorogy, Ahmed Alnagdy, Dina Abd Elfattah and Abd-Elmonem A. Elhesy</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210308]]></guid><cfi:id>342</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Micropulse laser trabeculoplasty under maximal tolerable glaucoma eyedrops: treatment effectiveness and impact of surgical expertise]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210309]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the effectiveness of micropulse laser trabeculoplasty (MLT) for eyes with open angle glaucoma (OAG) under maximal tolerable glaucoma eyedrops and to assess the effect of expertise performing MLT on its clinical effectiveness.METHODS: Medical records of 42 consecutive eyes of 34 patients diagnosed with OAG who underwent MLT were retrospectively reviewed. The effectiveness was determined using the Kaplan-Meier survival analysis. Failure was defined as an intraocular pressure (IOP) reduction of <20% from baseline, an IOP >21 mm Hg during two consecutive follow-up visits, or surgical intervention for OAG. To determine the impact of MLT surgical expertise on clinical effectiveness, the eyes were divided into two groups according to whether the procedure was conducted by an experienced specialist (defined as a glaucoma specialist who had conducted at least ten MLT procedures) or a less experienced glaucoma specialist. The difference in expertise was determined using a log-rank test.RESULTS: MLT was conducted by three glaucoma specialists. The overall survival rates were 0.76, 0.48, and 0.44 at 1, 3, and 6mo, respectively. The survival rates for MLT performed by a less experienced glaucoma specialist were 0.62, 0.31, and 0.25 (n=21 eyes) at 1, 3, and 6mo, respectively, whereas the survival rates for MLT performed by an experienced glaucoma specialist were 0.90, 0.64, and 0.64 (n=21 eyes) at 1, 3, and 6mo, respectively. The log-rank test showed a significant difference in the survival curves of the two groups (P=0.0061).CONCLUSION: The 6-month effectiveness of MLT for controlling IOP is relatively limited in eyes with OAG using maximal tolerable glaucoma eyedrops. However, its effectiveness may be improved if performed by a glaucoma specialist with sufficient MLT experience.]]></description>
<pubDate>2021/2/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Shinji Kakihara, Takao Hirano, Akira Imai, Taihei Kurenuma, Yoshiaki Chiku and Toshinori Murata]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Shinji Kakihara, Takao Hirano, Akira Imai, Taihei Kurenuma, Yoshiaki Chiku and Toshinori Murata</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210309]]></guid><cfi:id>341</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[High interpretable machine learning classifier for early glaucoma diagnosis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210310]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To develop a classifier for differentiating between healthy and early stage glaucoma eyes based on peripapillary retinal nerve fiber layer (RNFL) thicknesses measured with optical coherence tomography (OCT), using machine learning algorithms with a high interpretability.METHODS: Ninety patients with early glaucoma and 85 healthy eyes were included. Early glaucoma eyes showed a visual field (VF) defect with mean deviation >-6.00 dB and characteristic glaucomatous morphology. RNFL thickness in every quadrant, clock-hour and average thickness were used to feed machine learning algorithms. Cluster analysis was conducted to detect and exclude outliers. Tree gradient boosting algorithms were used to calculate the importance of parameters on the classifier and to check the relation between their values and its impact on the classifier. Parameters with the lowest importance were excluded and a weighted decision tree analysis was applied to obtain an interpretable classifier. Area under the ROC curve (AUC), accuracy and generalization ability of the model were estimated using cross validation techniques.RESULTS: Average and 7 clock-hour RNFL thicknesses were the parameters with the highest importance. Correlation between parameter values and impact on classification displayed a stepped pattern for average thickness. Decision tree model revealed that average thickness lower than 82 µm was a high predictor for early glaucoma. Model scores had AUC of 0.953 (95%CI: 0.903- 0998), with an accuracy of 89%.CONCLUSION: Gradient boosting methods provide accurate and highly interpretable classifiers to discriminate between early glaucoma and healthy eyes. Average and 7-hour RNFL thicknesses have the best discriminant power.]]></description>
<pubDate>2021/2/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Carlos Salvador Fernandez Escamez, Elena Martin Giral, Susana Perucho Martinez and Nicolas Toledano Fernandez]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Carlos Salvador Fernandez Escamez, Elena Martin Giral, Susana Perucho Martinez and Nicolas Toledano Fernandez</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210310]]></guid><cfi:id>340</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparing posture induced intraocular pressure variations in normal subjects and glaucoma patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210311]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the posture-induced variations in intraocular pressure (IOP) between the primary open angle glaucoma (POAG) and non-glaucomatous eyes.METHODS: A case-controlled age matched study was conducted in 55 successive newly diagnosed POAG and 56 non-glaucomatous patients seen in glaucoma clinic and general outpatient eye clinic in the Alex Ekwueme University Teaching Hospital, Abakaliki. The IOPs of eligible correspondents were measured with Perkin's hand-held tonometer in the sitting, supine flat and supine with pillow positions respectively. Measurement of IOP in each position was done after 15min of assuming such posture.RESULTS: The IOP difference between the sitting and supine flat position was significantly higher in the POAG than non-glaucoma subjects (7.68±2.08 vs 4.03±0.13 mm Hg, P<0.001). The IOP difference between the sitting and supine with pillow positions was 2.61±1.49 mm Hg for POAG and 1.44±0.70 mm Hg in non-glaucoma (P<0.001), while difference between supine flat and supine with pillow positions was 5.07±2.24 mm Hg in POAG and 2.59±0.66 mm Hg in non-glaucomatous patients (P<0.001).CONCLUSION: Greater variations in posture induced IOP occurred in POAG patients than non-glaucomatous. The posture induced IOP variation is lowest in the sitting position and highest in the supine flat position. Evaluation of posture induced IOP changes may be an important tool in the management of glaucoma.]]></description>
<pubDate>2021/2/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Onyekachi Jane Ireka, Chimdia E Ogbonnaya, Obinna C Arinze, Nneka Ogbu and Chimdi M Chuka-Okosa]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Onyekachi Jane Ireka, Chimdia E Ogbonnaya, Obinna C Arinze, Nneka Ogbu and Chimdi M Chuka-Okosa</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210311]]></guid><cfi:id>339</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Role of home monitoring with iCare ONE rebound tonometer in glaucoma patients management]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210312]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate intraocular pressure (IOP) measurements and fluctuations using the iCare ONE rebound tonometer (RT-ONE), during home monitoring, in diagnosed and suspected glaucoma patients.METHODS: A retrospective case series of consecutive patients with known glaucoma or glaucoma suspects who were followed-up and treated between January 2016 and January 2017. The study included 80 eyes of 40 patients with a mean age of 59.1±14.6y (range, 24-78). All patients have undergone 4-5d of IOP home monitoring with RT-ONE at morning, noon, afternoon, and night time.RESULTS: Baseline mean IOP, as measured in the clinic (8 a.m.-12 p.m.), was 17.4±5.1 mm Hg, compared to RT-ONE home monitoring mean IOP of 15.6±4.1 mm Hg (P=0.002). Mean IOP was significantly lower at noon, afternoon and night times compared to clinic measured IOP and morning measurements (P=0.005). IOP peak measured during home monitoring was significantly higher compared to the clinic measured IOP (21.3±5.6 mm Hg and 17.4±5.1 mm Hg, P<0.001). IOP peaks during home monitoring demonstrated a majority of 47 peaks during morning measurements, compared to 23 at noon, 19 at afternoon and only 12 at night (P<0.001). The home monitoring results led to treatment modification of 44 eyes (55%), treatment regime was insufficient for 40 (50%) eyes.CONCLUSION: Home monitoring IOP with RT-ONE can provide good assessment of mean IOP, IOP fluctuations and peaks throughout the hours of the day, which lead to an accurate treatment for glaucoma patients.]]></description>
<pubDate>2021/2/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Eldar Rosenfeld, Gilad Rabina, Dana Barequet, Michael Mimouni, Naomi Fischer and Shimon Kurtz]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Eldar Rosenfeld, Gilad Rabina, Dana Barequet, Michael Mimouni, Naomi Fischer and Shimon Kurtz</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210312]]></guid><cfi:id>338</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Dynamic versus static ultra-widefield fluorescein angiography in eyes with diabetic retinopathy: a pilot prospective cross-sectional study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210313]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyze differences in ultra-widefield fluorescein angiography (UWFA) findings between dynamic and static images of eyes with diabetic retinopathy (DR).METHODS: This cross-sectional study included 28 eyes of 28 patients with DR undergoing UWFA. A series of UWFA images acquired from each patient were converted into a time-lapse video and used as a dynamic image. A single, clear, arteriovenous phase image was chosen as a static image. Non-perfusion index (NPI) and its correlation with vascular abnormalities in different zones were compared between dynamic and static UWFA imaging.RESULTS: NPI appeared to increase from the center to the far-periphery in both groups. Dynamic NPI was lower in the total retinal area (0.26 vs 0.29, P=0.009) and far-periphery (0.33 vs 0.36, adjusted P=0.042), which was contrary to the static NPI. Far-peripheral NPI was associated with intraretinal microvascular abnormality in the posterior area in both groups.CONCLUSION: Time-lapse dynamic UWFA imaging is a useful modality to differentially diagnose hypofluorescence in the most peripheral region. This modality could provide a reliable method for NPI measurement.]]></description>
<pubDate>2021/2/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hang-Qi Shen, Jing Wang, Tian Niu, Ji-Li Chen and Xun Xu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hang-Qi Shen, Jing Wang, Tian Niu, Ji-Li Chen and Xun Xu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210313]]></guid><cfi:id>337</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Real-world outcomes of two-year Conbercept therapy for diabetic macular edema]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210314]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the two-year outcomes of patients treated for diabetic macular edema (DME) with intravitreal Conbercept (IVC).METHODS: The clinical data of 30 DME patients (36 eyes) were retrospectively reviewed. The patients were treated with IVC for 3mo. Additional IVC was given at subsequent monthly visits, if needed (3+PRN). The patients were followed up for 24mo.RESULTS: The best-corrected visual acuity (BCVA) at 24mo significantly increased (66.7±15.3 letters) in comparison with the baseline (54.4±15.4 letters, P<0.0001). The mean improvement in BCVA was 11.0±2.9 letters. At 24mo, 44.1% of the eyes surveyed gained ≥15 letters, 52.9% of the eyes gained ≥10 letters, and 70.6% of the eyes gained ≥5 letters. No vision loss was noted in 96.8% of the eyes, and 5.9% of the eyes lost ≥5 letters, but ≤10 letters. The central retinal thickness (CRT) at 24mo was significantly reduced (277.1±122.9 μm) in comparison with the baseline (510.9±186.1 μm, P<0.0001). At 24mo, 43.3% of the patients had a CRT ≤250 μm. The mean number of injections over 24mo was 10.6±2.0. No severe eye or systemic adverse events related to either the drug or injection were noted.CONCLUSION: IVC is safe and effective for the treatment of DME.]]></description>
<pubDate>2021/2/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yong Cheng, Li Yuan, Ming-Wei Zhao and Tong Qian]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yong Cheng, Li Yuan, Ming-Wei Zhao and Tong Qian</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210314]]></guid><cfi:id>336</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Early visual function outcomes of topography-guided FS-LASIK and SMILE in treatment of myopia and myopic astigmatism]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210315]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the quality outcomes of vision at early phase after topography-guided femtosecond laser-assisted in situ keratomileusis (FS-LASIK-CV) and small incision lenticule extraction (SMILE) in treatment of myopia and myopic astigmatism.METHODS: Retrospective comparative analysis of 49 patients that underwent FS-LASIK (n=23) or SMILE (n=26) procedure for myopia and myopic astigmatism between April and September in 2019. Pre- and postoperative uncorrected visual acuity (UCVA), spherical equivalent refraction (SEQ), cylindrical refraction, contrast sensitivity function (CSF), and corneal higher-order aberrations (HOAs) were evaluated. Independent t-test was used for inter-group comparison, while repeated measures ANOVA was used to analyze changes at different time points.RESULTS: In both groups, 100% of the eyes obtained a UCVA of 20/20 or better at 1wk, 1, and 3mo postoperatively. At 1d and 3mo postoperatively, UCVA was better in FS-LASIK-CV group than in SMILE group. At 1wk postoperatively, SEQ was lower in SMILE group than in FS-LASIK-CV group (P=0.006). At 3mo postoperatively, the SEQ reached target refraction in both groups. The residual astigmatism was reduced in both groups without intergroup difference (P>0.05). At 3mo postoperatively, the spherical aberration and coma under 6 mm pupil size were  higher than preoperative levels in both groups (P<0.05). However, the increase in the corneal HOAs in the FS-LASIK-CV group was less than the SMILE group (P<0.05). At 3mo postoperatively, the logCS were better than preoperative levels under scotopic conditions without glare and scotopic conditions with glare in both groups (P<0.05). At 1 and 3mo postoperatively, under scotopic conditions without glare and scotopic conditions with glare, FS-LASIK-CV group showed more improvement in logCS at two spatial frequencies (12.0 c/d and 18.0 c/d; P<0.05).CONCLUSION: Both FS-LASIK-CV and SMILE demonstrate to be safe, effective, and predictable in treatment of myopia and myopic astigmatism. Early postoperative improvement in UCVA and CSF at high spatial frequency under scotopic conditions were better after FS-LASIK-CV than SMILE.]]></description>
<pubDate>2021/2/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Lin-Juan Yang, Xuan Liu, Sheng-Jian Mi, Le Sun and Meng-Xin Chen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Lin-Juan Yang, Xuan Liu, Sheng-Jian Mi, Le Sun and Meng-Xin Chen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210315]]></guid><cfi:id>335</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of healing patterns of different side-cut angulations after FS-LASIK]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210316]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate and evaluate healing patterns around flaps made with different side-cut angulations after femtosecond laser in situ keratomileusis (FS-LASIK).METHODS: Thirty-four patients (68 eyes) received a 90° side-cut (n=34) or a 120° side-cut flaps (n=34) made with a femtosecond laser. One day, 1wk, 1 and 3mo postoperatively, side-cut scar was evaluated under slit-lamp photography according to a new grading system (Grade 0=transparent scar, 1=faint healing opacity, and 2=evident healing opacity). In vivo corneal confocal microscopy and anterior segment optical coherence tomography (AS-OCT) were used to observe wound-healing patterns around flap margin in the two groups. Sirius Scheimpflug Analyzer was also used to analyze higher order aberrations 3mo after surgery.RESULTS: There were no significant differences in flap wound-healing patterns at each follow up between the two groups (P>0.05). Three months after surgery, the flap edge scar classified as Grade 0 had excellent apposition and rapid nerve regeneration. At 3 mm and 5 mm pupil diameters, there were significant differences in trefoil aberrations between the two groups (P<0.05), but no statistically significant differences were found in total higher order aberrations (HOAs), spherical aberrations or coma in any of the pupil size conditions (P>0.05).CONCLUSION: Flap edge scars classified as Grade 0 have excellent apposition and rapid nerve regeneration, and 120° side-cut angle flaps induce less trefoil aberrations after FS-LASIK.]]></description>
<pubDate>2021/2/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Wei Wei, Xi-Yu Sun, Di Shen, Xiao-Rui Wang, Yu-Qiang Ji and Chang-Ning Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Wei Wei, Xi-Yu Sun, Di Shen, Xiao-Rui Wang, Yu-Qiang Ji and Chang-Ning Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210316]]></guid><cfi:id>334</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Auricular cartilage versus donor sclera as a wrapping of hydroxyapatite orbital implants]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210317]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To retrospectively compare postoperative outcomes after primary enucleation and placement of a hydroxyapatite (HA) implant without wrapping, wrapped with auricular cartilage or donor sclera.METHODS: Medical records of patients presented as intraocular tumor or severe ocular injury were identified from the electronic medical record system. Cases underwent enucleation and HA orbital implantation were enrolled in this study and were divided into 3 groups according to the wrapping material of HA implant. Cases with autogenous cartilage caps were enrolled in group A (n=11), with donor sclera caps in group B (n=12), and without any wrapping material in group C (n=9). Follow-ups were set at 1, 2wk, 1, 3, 6, and 12mo after surgery.RESULTS: Altogether 32 cases finished the follow-up and were enrolled in this study. Three cases (27.27%) in group A, 4 cases (33.33%) in group B, and 4 cases (44.44%) in group C developed one complication each after surgery. In group A, no HA exposure occurred, but conjunctival inclusion cyst occurred in one and severe conjunctive chemosis in two cases. In group B, one HA exposure occurred, conjunctive inclusion cysts occurred in one, severe conjunctive chemosis occurred in one, and conjunctival granuloma occurred in one case. In group C, one HA exposure occurred, severe conjunctive chemosis occurred in two cases, and conjunctival granuloma occurred in one case. The case of exposure of none-wrapped implant was noted in the first 6mo after placement of the orbital implant. The case of exposure of donor sclera-wrapped implant was noted at the 12mo after placement of the orbital implant. Both exposure cases were treated successfully with conservative treatment.CONCLUSION: With low incidence of implant exposure and mild complications, auricular cartilage can be a good choice of alternative wrapping material of orbit implant with satisfied outcome.]]></description>
<pubDate>2021/2/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ying-Jie Ma, Xiu-Ying Zhu, Ben Chen, Yan-Yan Lin, Jia Liu and Xi Chen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ying-Jie Ma, Xiu-Ying Zhu, Ben Chen, Yan-Yan Lin, Jia Liu and Xi Chen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210317]]></guid><cfi:id>333</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Surgical correction of recurrent epiblepharon in Chinese children using modified skin re-draping epicanthoplasty]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210206]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the clinical efficacy of the modified skin re-draping epicanthoplasty procedure for correction of recurrent lower lid epiblepharon in Chinese children.
METHODS: From 2016 to 2018, 18 children (10 males and 8 females, average age 6.2±1.7y; 30 eyes) with recurrent epiblepharon who attended Beijing Children’s Hospital were included in the study. All the children had undergone lower eyelid surgery for epiblepharon. Surgical design included using an additional incision along the upper palpebral margin, to avoid vertical scarring on the upper lid. The re-draping method was used to correct recurrent epiblepharon. Follow-up ranged from 3 to 24mo. Postoperative surgical outcomes, complications, and subjective satisfaction were evaluated.
RESULTS: Complete correction of cilia touching the cornea was observed in all patients during an average follow-up of 7.1mo. No “dog ears” or obvious scars were formed after surgery. All parents were satisfied with the cosmetic results and none complained. Mean astigmatism decreased from 2.39±0.79 diopter (D) preoperatively to 2.19±0.79 D at 6mo after surgery; however, the difference was not significant. Best-corrected visual acuity improved, although the change in mean visual acuity was not significant. No recurrence occurred during the follow-up period.
CONCLUSION: This surgical modified skin re-draping technique is effective and highly satisfactory for correction of recurrent epiblepharon. The approach is characterized by a simple design, a straightforward procedure, inconspicuous scarring, and good postoperative appearance.]]></description>
<pubDate>2020/12/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Shou-Long Hu, Wen-Qing Shi, Ting Su, Qian-Min Ge, Qiu-Yu Li, Biao Li, Rong-Bin Liang, Pei-Wen Zhu and Yi Shao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Shou-Long Hu, Wen-Qing Shi, Ting Su, Qian-Min Ge, Qiu-Yu Li, Biao Li, Rong-Bin Liang, Pei-Wen Zhu and Yi Shao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210206]]></guid><cfi:id>332</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Expression and role of specificity protein 1 and collagen I in recurrent pterygial tissues]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210207]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the expression profiles of the transcription factor specificity protein 1 (Sp1) and collagen I in recurrent pterygial tissues. What is more, to compare the changes of Sp1 and collagen I among primary pterygial tissue, recurrent pterygial tissue and conjunctival tissue.
METHODS: In the prospective study, we collected the pterygial tissues of 40 patients who underwent resection of primary pterygial tissue and recurrent pterygial tissue, and the conjunctival tissues of 10 patients with enucleation due to trauma. The relative expression levels of Sp1 and collagen I were analyzed by reverse transcription quantitative-polymerase chain reaction and Western blot. Paired t-test was performed to compare the Sp1 and collagen I of recurrent pterygial tissues, as well as the primary pterygial tissues and conjunctival tissues. In further, Pearson’s hypothesis testing of correlation coefficients was used to compare the correlations of Sp1 and Collagen I.
RESULTS: The content of Sp1 and collagen I mRNA and protein was significantly greater in recurrent pterygial tissue than that was in primary and conjunctival tissue (P<0.05). There was a positive correlation between the mRNA and protein levels of Sp1 and collagen I in recurrent pterygial tissues (protein: r=0.913, P<0.05; mRNA: r=0.945, P<0.05).
CONCLUSION: Sp1 and collagen I are expressed in normal conjunctival, primary, and recurrent pterygial tissues, but expression is significantly greater in the latter. Sp1 and collagen I may be involved in the regulation of the development of recurrent pterygium.]]></description>
<pubDate>2020/12/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Chun-Sheng Shi, Yue Wu, Na Shu, Li-Li Jiang and Bo Jiang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Chun-Sheng Shi, Yue Wu, Na Shu, Li-Li Jiang and Bo Jiang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210207]]></guid><cfi:id>331</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Evaluation of corneal topographic, tomographic and biomechanical indices for detecting clinical and subclinical keratoconus: a comprehensive three-device study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210208]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the diagnostic ability of topographic and tomographic indices with Pentacam and Sirius as well as biomechanical parameters with Corvis ST for the detection of clinical and subclinical forms of keratoconus (KCN).
METHODS: In this prospective diagnostic test study, 70 patients with clinical KCN, 79 patients with abnormal findings in topography and tomography maps with no evidence on clinical examination (subclinical KCN), and 68 normal control subjects were enrolled. The accuracy of topographic, tomographic, and biomechanical parameters was evaluated using the area under the receiver operating characteristic curve (AUC) and cross-validation analysis. The Delong method was used for comparing AUCs.
RESULTS: In distinguishing KCN from normal, all parameters showed statistically significant differences between the two groups (P<0.001). Indices with the perfect diagnostic ability (AUC≥0.999) were Sirius KCN vertex of back (KVb), Pentacam random forest index (PRFI), Pentacam index of height decentration (IHD), and Corvis integrated tomographic/biomechanical index (TBI). In distinguishing subclinical KCN from normal, Sirius symmetry index of back (SIb; AUC=0.908), Pentacam inferior-superior difference (IS) value (AUC=0.862), PRFI (AUC=0.847), and Corvis TBI (AUC=0.820) performed best. There were no significant differences between the highest AUCs within keratoconic groups (DeLong, P>0.05).
CONCLUSION: In clinical KCN, all topographic, tomographic, and biomechanical indices have acceptable outcomes in terms of sensitivity and specificity. However, in differentiating subclinical forms of KCN from normal corneas, curvature-based parameters (SIb and IS value) followed by integrated indices (PRFI and TBI) are the most powerful tools for early detection of KCN.]]></description>
<pubDate>2020/12/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Zahra Heidari, Hassan Hashemi, Mehrdad Mohammadpour, Kazem Amanzadeh and Akbar Fotouhi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zahra Heidari, Hassan Hashemi, Mehrdad Mohammadpour, Kazem Amanzadeh and Akbar Fotouhi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210208]]></guid><cfi:id>330</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Ultrasound elastography for evaluating stiffness of the human lens nucleus with aging: a feasibility study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210209]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the significance of ultrasound elastography for evaluating stiffness of the human lens nucleus in volunteers with different ages.
METHODS: A total of 90 volunteers (lens transparency, uncorrected visual acuity ≥0.5, intraocular pressure: 14-19 mm Hg) were divided into 3 groups according to age: Group A (30 people, median age: 82±3.5y, mean axial lengths 23.7±0.5 mm); Group B (30 people, median age: 46±2.1y, mean axial lengths 23.9±0.4 mm); and Group C (30 people, median age: 22±3.5y, mean axial lengths 24.0±0.4 mm). Lens nuclear stiffness was measured by Free-hand qualitative elastography by independent operators. Strain gray scale and color-coded elastography maps were recorded. In each case, three consecutive detections were performed and strain ratio was used for statistical analysis.
RESULTS: Elastography analysis showed excellent diagnostic performance for lens sclerosis. Lens strain ratio was lowest (0.03±0.01)% in Group A and highest (2.03±0.43)% in Group C. Lens strain ratio was moderate (0.64±0.10)% in Group B. There were significant differences between these three groups (P<0.05). The lens nucleus strain rate changes with age. With aging, the lens nucleus strain rate and resilience decrease, demonstrating harder texture.
CONCLUSION: The relationship between human lens stiffness and age is demonstrated by ultrasound elastography. Older age is associated with lower strain ratio and less resilience of the lens.]]></description>
<pubDate>2020/12/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hai-Yan Zhou, Hong Yan, Wei-Jia Yan and Xin-Chuan Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hai-Yan Zhou, Hong Yan, Wei-Jia Yan and Xin-Chuan Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210209]]></guid><cfi:id>329</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Objective visual quality one year after toric IOL implantation for correction of moderate and high corneal astigmatism]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210210]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the objective visual quality after implantation of a toric intraocular lens (IOL) in order to correct moderate or high corneal astigmatism at the one year postoperative follow-up.
METHODS: From December 2017 to June 2018, 66 patients (90 eyes) with simple age-related cataract with regular corneal astigmatism greater than 1.5 D were enrolled in this prospective self-control study. The patients were implanted with Proming&#174; toric IOL (model: AT3BH-AT6BH). The subjects were divided into moderate astigmatism group (46 eyes, 1.5-2.5 D) and high astigmatism group (44 eyes, >2.5 D). The uncorrected distance visual acuity, residual astigmatism and axial position of IOL were observed before operation, 3, 6mo and 1y after operation. Modulation transfer function cutoff (MTF cutoff), Strehl ratio (SR), object scatter index (OSI) were observed by OQAS II to evaluate the objective visual quality of patients.
RESULTS: There was no significant difference in UCVA, residual astigmatism, axial deviation, MTF cutoff, SR and OSI between moderate and high astigmatism group (all P>0.05). After 3mo, UCVA, MTF cutoff and SR were significantly increased (all P<0.05), residual astigmatism and OSI were significantly decreased (all P<0.05). After 3mo, all the indexes remained stable.
CONCLUSION: Proming toric IOL can effectively treat age-related cataract patients with moderate-to-high regular corneal astigmatism, correcting corneal astigmatism, improving UCVA, ensuring long-term stability in the capsule, and providing patients with better visual quality.]]></description>
<pubDate>2020/12/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hui Zhong, Hong Qin, Hui-Juan Wang and Zhao-Yi Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hui Zhong, Hong Qin, Hui-Juan Wang and Zhao-Yi Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210210]]></guid><cfi:id>328</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Refractive outcomes after vitrectomy combined with phacoemulsification of idiopathic macular holes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210211]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report the refractive outcomes after vitrectomy combined with phacoemulsification and intraocular lens (IOL) implantation (phaco-vitrectomy) in idiopathic macular holes (IMH).
METHODS: A total of 56 eyes with IMH (IMH group) that underwent phaco-vitrectomy and 44 eyes with age-related cataract (ARC group) that underwent cataract surgery were retrospectively reviewed. The best corrective visual acuity (BCVA), predicted refractive error (PRE), actual refractive error (ARE), axial length (AL), were measured in both groups before and 6mo after operation. The power calculation of IOL and the predicted refractive error (PRE) were calculated according to the SRK/T formula. The difference of PRE and ARE between the two groups were compared and analyzed.
RESULTS: In the IMH group, the diameters of macular holes were 271.73±75.85 μm, the closure rate was 100%. The pre- and post-operative BCVA were 0.80±0.35 and 0.40±0.35 logMAR. The PRE of A-ultrasound and IOL Master in the IMH group was -0.27±0.25 and 0.10±0.66 D. The postoperative mean absolute prediction error (MAE) was observed to be 0.58±0.65 and 0.53±0.37 D in the IOL Master and A-ultrasound (P=0.758). The PRE and ARE of the IMH group were 0.10±0.66 D and -0.19±0.64 D (P=0.102). The PRE and ARE of the ARC group was -0.43±0.95 and -0.31±0.93 D (P=0.383). The difference between PRE and ARE was -0.33±0.81 and 0.09±0.64 D in the IMH and ARC groups (P=0.021). The proportion of myopic shift was 67.9% in the IMH group and 27.3% in the ARC group (P=0.004).
CONCLUSION: The myopic shift can be observed in patients with IMH after phaco-vitrectomy.]]></description>
<pubDate>2020/12/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Bo-Shi Liu, Wei-Na Cui, Rui Niu, Qiong Chen, Ze-Tong Nie, Jiao-Ting Wei and Bo-Jie Hu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Bo-Shi Liu, Wei-Na Cui, Rui Niu, Qiong Chen, Ze-Tong Nie, Jiao-Ting Wei and Bo-Jie Hu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210211]]></guid><cfi:id>327</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Association between risk factors and retinal nerve fiber layer loss in early stages of diabetic retinopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210212]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the changes of retinal nerve fiber layer (RNFL) among normal individuals, diabetic patients without diabetic retinopathy (NDR) and non-proliferative diabetic retinopathy (NPDR), and explore the possible risk factors of early diabetic retinopathy (DR).
METHODS: In this cross-sectional study, 107 participants were divided in three groups. Totally 31 normal individuals (control group), 40 diabetic patients without DR (NDR group) and 36 patients with NPDR (NPDR group) were included. Optical coherence tomography (OCT) was used to detect RNFL thickness and other optic disc parameters among different groups. The potential association between RNFL loss and systemic risk factors were assessed for DR, including diabetes duration, body mass index (BMI), hemoglobin A1c (HbA1c), serum lipids, and blood pressure.
RESULTS: The average and each quadrant RNFL thickness were thinner in NPDR group compared to control group of the right (P=0.00, P=0.01, P=0.01, P=0.02, P=0.04) and left eyes (P=0.00, P=0.00, P=0.00, P=0.03, P=0.04). The average, superior and inferior RNFL thickness were thinner in NDR group compared to the NPDR group of the right (P=0.00, P=0.02, P=0.03) and left eyes (P=0.00, P=0.00, P=0.01). Diabetic duration was negatively correlated with the superior, inferior, and average RNFL thickness of the right (r=-0.385, P=0.001; r=-0.366, P=0.001; r=-0.503, P=0.000) and left eyes (r=-0.271, P=0.018; r=0.278, P=0.015; r=-0.260, P=0.023). HbA1c was negatively correlated with the superior, inferior, and average RNFL thickness of the right (r=-0.316 P=0.005; r=-0.414, P=0.000; r=-0.418, P=0.000) and left eyes (r= -0.367, P=0.001; r=-0.250, P=0.030; r=-0.393, P=0.000). Systolic pressure was negatively correlated with the inferior and average RNFL thickness of the right eye (r=-0.402, P=0.000; r=-0.371, P=0.001) and was negatively correlated with the superior and average RNFL thickness of the left eye (r=-0.264, P=0.021; r=-0.233, P=0.043).
CONCLUSION: RNFL loss, especially in the superior and inferior quadrants, may be the earliest structural change of the retina in diabetic patients, and is also associated with diabetic duration, HbA1c, and systolic pressure.]]></description>
<pubDate>2020/12/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Zhong-Qi Wan, Yan Gao, Min Cui and Yong-Jie Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zhong-Qi Wan, Yan Gao, Min Cui and Yong-Jie Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210212]]></guid><cfi:id>326</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A pilot study on vitrectomy combined with scleral shortening for eyes with myopic macular retinoschisis—2y follow-up results]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210213]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the effect of vitrectomy combined with scleral shortening for eyes with myopic macular retinoschisis.
METHODS: Thirty-seven patients with myopic macular retinoschisis who underwent pars plana vitrectomy (PPV) combined with scleral shortening were reviewed. Axial length (AL), the height of macular retinoschisis, the height of retinal detachment if existed, the diameter of macular hole if existed and best corrected visual acuity (BCVA) were obtained. The preoperative and postoperative parameters were compared.
RESULTS: At postoperative 24mo, the mean AL and height of macular retinoschisis were reduced significantly by 0.79 mm and 256.51 μm (t=8.064, P<0.0001; Z=-5.086, P<0.0001) respectively. In addition, the mean height of retinal detachment and diameter of macular hole were also reduced significantly by 365.38 μm and 183.68 μm (Z=-4.457, P=0.000008; Z=-2.983, P=0.003) respectively. Meanwhile, the postoperative BCVA was improved markedly (Z=-2.126, P=0.033).
CONCLUSION: Vitrectomy combined with scleral shortening is an effective surgical method for eyes with myopic macular retinoschisis, whether or not macular hole and retinal detachment are present.]]></description>
<pubDate>2020/12/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Peng Zhang, Cun-Xi Ye, Ling-Xin Hou, Yu-Hua Hao, Kun Wang and Qing-Li Shang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Peng Zhang, Cun-Xi Ye, Ling-Xin Hou, Yu-Hua Hao, Kun Wang and Qing-Li Shang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210213]]></guid><cfi:id>325</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Diabetes onset at an earlier age and high HbA1c levels as risk factors of diabetic retinopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210214]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the effect of age at diabetes onset and uncontrollable high HbA1c levels on the development of diabetic retinopathy (DR) among Chinese type 2 diabetes mellitus (DM) patients.
METHODS: This was a cross-sectional survey of diabetic patients in Subei district, China. Data covering physical measurements, fasting blood-glucose (FBG), glycosylated hemoglobin (HbA1c), blood lipid, urinary albumin/creatinine ratio (UACR), ocular fundus examination, and diabetes treatment records were collected. An independent sample t-test were used to analyze differences. A Logistic regression analysis was applied to study the independent risk factors of DR.
RESULTS: A total of 1282 patients with type 2 DM were enrolled, and 191 cases had DR (14.9%). The age at diabetes onset, education level, alcohol consumption, HbA1c level, UACR level, and hypoglycemic drugs were independent influencing factors for DR. The older the onset of diabetes, the less likely to develop DR (OR: 0.958, 95%CI: 0.942-0.975, P=0.000). Patients were then divided in terms of age at diabetes onset as follows: <50y, 50-59y, 60-69y, and ≥70y. Compared with diabetes onset age <50y, 50-59y (OR: 0.463, 95%CI: 0.306-0.699, P=0.000), 60-69y (OR: 0.329, 95%CI: 0.203-0.535, P=0.000) and ≥70y (OR: 0.232, 95%CI: 0.094-0.577, P=0.002) were at a lower risk of DR. The prevalence of DR was highest in patients with diabetes onset age <50y (29.5%, P<0.05). The HbA1c level (8.67±1.97)% and proportion of insulin injection (52.5%) in patients with diabetes onset <40y were higher than in patients with older diabetes onset age (P<0.05).
CONCLUSION: Diabetes onset at an earlier age and uncontrollable high HbA1c level could be independent risk factors for DR.]]></description>
<pubDate>2020/12/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Rui-Fang Feng, Hai-Yang Liu, Ya-Lu Liu, Qing Xu, Lei Qiao, Chao-Ju Gong, Yi-Peng Zhang, Jie Li, Li-Na Guan, Wei Fan, Mei-Li Li, Wen-Jin Li and Su-Yan Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Rui-Fang Feng, Hai-Yang Liu, Ya-Lu Liu, Qing Xu, Lei Qiao, Chao-Ju Gong, Yi-Peng Zhang, Jie Li, Li-Na Guan, Wei Fan, Mei-Li Li, Wen-Jin Li and Su-Yan Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210214]]></guid><cfi:id>324</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effects of diode laser photocoagulation treatment on ocular biometric parameters in premature infants with retinopathy of prematurity]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210215]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the effects of diode laser treatment on ocular biometric parameters in premature infants with retinopathy of prematurity (ROP).
METHODS: Premature infants who received diode laser treatment for ROP (n=68) and premature infants with spontaneous regressed ROP without treatment (n=50) were performed longitudinal ocular biometric measurements including anterior chamber depth, lens thickness and axial length as follows: 1d prior to laser treatment, and 3, 6, 9, and 12mo after the laser treatment.
RESULTS: The mean birth weight, gestational age and initial examination time values were 936.53±302.07 g, 26.66±2.42wk, 36.26±2.73wk in the treatment group and 959.78±260.08 g, 27.28±2.10wk, 36.56±2.54wk in the control group. There was no statistically significant difference in these demographic characteristics of the groups. Anterior chamber depth, lens thickness and axial length demonstrated statistically significant linear increases during the study period in the two groups (P<0.001 for each). There were no statistically significant differences between the two groups in terms of anterior chamber depth after laser treatment. Measurements of the lens thickness at 9th and 12th months (9th month 3.70±0.22 vs 3.60±0.21 mm, P=0.017; 12th month 3.81±0.21 vs 3.69±0.22 mm, P=0.002) and the axial length at 12th month (19.35±0.79 vs 19.13±0.54 mm, P=0.031) after laser treatment were statistically higher in the treatment group.
CONCLUSION: Diode laser retinal photocoagulation treatment in premature infants seems to increase the lens thickness and axial length.]]></description>
<pubDate>2020/12/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Damla Erginturk Acar, Ugur Acar, Zuhal Ozen Tunay, Aysegul Arman and Anil Barak]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Damla Erginturk Acar, Ugur Acar, Zuhal Ozen Tunay, Aysegul Arman and Anil Barak</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210215]]></guid><cfi:id>323</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of early changes in ocular surface markers and tear inflammatory mediators after femtosecond lenticule extraction and FS-LASIK]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210216]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the short-term impacts of femtosecond lenticule extraction (FLEx) and femtosecond laser-assisted laser in situ keratomileusis (FS-LASIK) on ocular surface measures and tear inflammatory mediators.
METHODS: This prospective comparative nonrandomized clinical study comprised 75 eyes (75 patients). Totally 20 male and 15 female patients (age 21.62±3.25y) with 35 eyes underwent FLEx, and 26 male and 14 female patients (age 20.18±3.59y) with 40 eyes underwent FS-LASIK. Central corneal sensitivity, noninvasive tear breakup time, corneal fluorescein staining, Schirmer I test, tear meniscus height, and ocular surface disease index were evaluated in all patients. Tear concentrations of nerve growth factor (NGF), interleukin-1α (IL-1α), transforming growth factor-β1 (TGF-β1), tumor necrosis factor-α (TNF-α), interferon-γ (IFN-γ), and matrix metalloproteinase-9 (MMP-9) were assessed by multiplex antibody microarray. All measurements were performed preoperatively, and 1d, 1wk, and 1mo postoperatively.
RESULTS: Patients who underwent FLEx exhibited a more moderate reduction in central corneal sensation and less corneal fluorescein staining than those in the FS-LASIK group 1wk after the procedure (P<0.01). NGF was significantly higher 1d and 1wk after surgery in the FS-LASIK group than in the FLEx group (P<0.01). By contrast, compared to those in the FLEx group, higher postoperative values and slower recovery of tear TGF-β1, IL-1α, and TNF-α concentrations were observed in the FS-LASIK group (P<0.01). Tear concentrations of NGF, TGF-β1, TNF-α, and IL-1α were correlated with ocular surface changes after FLEx or FS-LASIK surgery.
CONCLUSION: There is less early ocular surface disruption and a reduced inflammatory response after FLEx than after FS-LASIK. NGF, TGF-β1, TNF-α, and IL-1α may contribute to the process of ocular surface recovery.]]></description>
<pubDate>2020/12/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Chi Zhang, Hui Ding, Hong He, He Jin, Liang-Ping Liu, Xiao-Wei Yang, Jun Yang and Xing-Wu Zhong]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Chi Zhang, Hui Ding, Hong He, He Jin, Liang-Ping Liu, Xiao-Wei Yang, Jun Yang and Xing-Wu Zhong</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210216]]></guid><cfi:id>322</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of axial length and anterior chamber depth on the peripheral refraction profile]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210217]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the effect of axial length (AL) and anterior chamber depth (ACD) on peripheral refractive profile in myopic patients compared to emmetropic participants.
METHODS: This cross-sectional study was conducted in right eyes of 58 participants of whom 38 were emmetropic and 20 were myopic. Central and peripheral refraction were measured at 10°, 20°, and 30° eccentricities in nasal and temporal fields using an open-field autorefractor. The Lenstar LS900 was used to measure ACD and AL. The participants were divided into three groups of short (<22.5 mm), normal (22.5-24.5 mm), and long eye (>24.5 mm) according to AL and three groups of low ACD (<3.00 mm), normal ACD (3.00-3.60 mm), and high ACD (>3.60 mm) according to ACD.
RESULTS: The mean age of the participants was 22.26±3.09y (range 18-30y). The peripheral mean spherical refractive error showed a hypermetropic shift in myopic and emmetropic groups although this shift was more pronounced in the myopic group. The results showed significant changes in the spherical equivalent, J0, and J45 astigmatism in all gazes with an increase in eccentricity (P<0.001). The pattern of refractive error changes was more noticeable in long and short eyes versus normal AL eyes. Moreover, the pattern of peripheral refractive changes was much more prominent in the high ACD group versus the normal ACD group and in the normal ACD group versus the low ACD group.
CONCLUSION: Peripheral refraction changes are greater in participants with AL values outside the normal range and deeper ACD values compared to participants with normal AL and ACD.]]></description>
<pubDate>2020/12/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Masoud Khorrami-Nejad, Raha Moradi, Alireza Akbarzadeh Baghban and Bahram Khosravi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Masoud Khorrami-Nejad, Raha Moradi, Alireza Akbarzadeh Baghban and Bahram Khosravi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210217]]></guid><cfi:id>321</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Exploratory study of non-invasive, high-resolution functional macular imaging in subjects with diabetic retinopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210108]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate a high-resolution functional imaging device that yields quantitative data regarding macular blood flow and capillary network features in eyes with diabetic retinopathy (DR).
METHODS: Prospective, cross-sectional comparative case-series in which blood flow velocities (BFVs) and non-invasive capillary perfusion maps (nCPMs) in macular vessels were measured in patients with DR and in healthy controls using the Retinal Functional Imager (RFI) device.
RESULTS: A total of 27 eyes of 21 subjects were studied [9 eyes nonproliferative diabetic retinopathy (NPDR), 9 eyes proliferative diabetic retinopathy (PDR) and 9 controls]. All diabetic patients were type 2. All patients with NPDR and 5 eyes with PDR also had diabetic macular edema (DME). The NPDR group included eyes with severe (n=3) and moderate NPDR (n=6), and were symptomatic. A significant decrease in venular BFVs was observed in the macular region of PDR eyes when compared to controls (2.61±0.6 mm/s and 2.92±0.72 mm/s in PDR and controls, respectively, P=0.019) as well as PDR eyes with DME compared to NPDR eyes (2.36±0.51 mm/s and 2.94±1.09 mm/s in PDR with DME and NPDR, respectively, P=0.01).
CONCLUSION: The RFI, a non-invasive imaging tool, provides high-resolution functional imaging of the retinal microvasculature and quantitative measurement of BFVs in visually impaired DR patients. The isolated diminish venular BFVs in PDR eyes compared to healthy eyes and PDR eyes with DME in comparison to NPDR eyes may indicate the possibility of more retinal vein compromise than suspected in advanced DR.]]></description>
<pubDate>2020/11/19 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Thalmon R. Campagnoli, Gábor Márk Somfai, Jing Tian, Delia Cabrera DeBuc and William E. Smiddy]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Thalmon R. Campagnoli, Gábor Márk Somfai, Jing Tian, Delia Cabrera DeBuc and William E. Smiddy</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210108]]></guid><cfi:id>320</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Visual outcomes of surgical and conservative treatment in children with small posterior polar cataracts and posterior lenticonus]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210109]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the visual outcomes of children with small (≤3 mm) posterior polar cataracts (PPC) and posterior lenticonus who had cataract extraction surgery with the visual outcomes of those who were managed conservatively.
METHODS: Children who initially had small PPC and posterior lenticonus who were followed up over 1-year period were retrospective reviewed in the study. Patients receiving surgery were compared with those receiving conservative therapy. The axial length, keratometry, refraction, best-corrected visual acuity (BCVA), and strabismus measurements were recorded. Lens morphology, i.e., the location, size, and depth of the cataract lesion, was measured with a Scheimpflug imaging system. To help control for baseline differences in the groups, patients were matched with controls by propensity score methodology.
RESULTS: The study evaluated 60 patients (30 in the surgery group and 30 in the conservative therapy group) after matching by propensity score. Patients who underwent cataract surgery showed greater BCVA improvements (0.36±0.24 logMAR) than patients who were treated without surgery (0.22±0.26 logMAR; P=0.036). Surgery was effective in patients with a rear projection length (RPL) less than 1.0 mm and a pretreatment BCVA worse than 0.52 logMAR.
CONCLUSION: Children with small PPC and posterior lenticonus who undergo cataract surgery experience greater BCVA improvements than those managed conservatively. Certain patients presenting with a RPL less than 1.0 mm and a pretreatment BCVA of 0.52 logMAR or worse may benefit from surgery.]]></description>
<pubDate>2020/11/19 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hui Chen, Wan Chen, Xiang-Hua Wu, Zhuo-Ling Lin, Jing-Jing Chen, Xiao-Yan Li, Wei-Rong Chen and Hao-Tian Lin]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hui Chen, Wan Chen, Xiang-Hua Wu, Zhuo-Ling Lin, Jing-Jing Chen, Xiao-Yan Li, Wei-Rong Chen and Hao-Tian Lin</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210109]]></guid><cfi:id>319</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Long-term follow-up of cataract surgery in eyes filled with silicone oil]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210110]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the refractive and long-term outcome of eyes filled with silicone oil (SO) undergoing phacoemulsification cataract surgery (PCS).
METHODS: This retrospective study evaluated patients with SO tamponade who were scheduled for PCS.
RESULTS: Subjects (n=26) were followed for 29.5±13.9mo after cataract surgery. The median spherical equivalent refraction (SER) was +5.3 D [interquartile range (IQR) +2.9 to +6.7] before PCS, and +3.4 D (IQR +2.0 to +4.4) after PCS. Within the follow-up period retinal reattachment after SO removal was achieved in 15 out of 26 eyes (57.7%). In 13 eyes assessment of refraction after SO-removal was possible, and showed a myopic shift of -4.6 D (IQR -2.9 to -7.3) in the SER. After SO removal, 5 of the 13 eyes (38.5%) were within ±1.0 D of the target refraction, while 9 out of the 13 eyes (69.2%) were within ±2.0 D.
CONCLUSION: In our study, the refraction after PCS for eyes filled with SO manifested low predictability, as did the myopic shift following SO removal. A significant percentage of the eyes that underwent SO administration required a long-term tamponade.]]></description>
<pubDate>2020/11/19 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Piotr Kanclerz, Christoph Leisser, Andrzej Grzybowski and Pawel Lipowski]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Piotr Kanclerz, Christoph Leisser, Andrzej Grzybowski and Pawel Lipowski</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210110]]></guid><cfi:id>318</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Early results of circularity and centration of capsulotomy prepared by three different methods]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210111]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the difference of capsulotomy produced by precision pulse capsulotomy (PPC), manual (M-CCC), and femtosecond laser assisted capsulotomy (FLAC) in relation to intraocular lens (IOL) centration, circularity and its effect on visual outcomes.
METHODS: Prospective, non-randomized comparative study conducted at LV Prasad Eye Institute, Hyderabad, India. Sixty eyes of 52 patients were grouped into 3 (FLAC, PPC and M-CCC) based on capsulotomy techniques used. Twenty consecutive eyes with uneventful phacoemulsification and with no comorbidities affecting the capsulotomy or visual outcome were included in each group. The main outcome measure was IOL centration in relation to capsulotomy and pupil. Secondary outcome measures were post-operative visual acuity, manifest refraction and aberration profile between groups.
RESULTS: At 5wk the visual, refractive outcomes and endothelial cell density were comparable between the 3 groups. The median circularity index of FLAC was statistically significantly different to M-CCC or PPC (1-10) groups (P<0.01) but PPC (11-20) was comparable to FLAC. Decentration of IOL center in relation to capsulotomy was seen only between the PPC (1-10) group and FLAC group (P=0.02). The IOL was well centered in relation to the pupil in all the groups (P=0.46). The quality of vision parameters like the higher order aberrations, spherical aberration, coma, trefoil, modular transfer function, and Strehl ratio were comparable between the groups.
CONCLUSION: Our study shows that despite differences in the morphology of capsulotomy produced by PPC, M-CCC, FLAC a well-centered IOL can be achieved. The measured capsular morphology parameters do not affect visual outcomes.]]></description>
<pubDate>2020/11/19 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jagadesh C. Reddy, Soumya Devta, Kiran Kumar Vupparaboina, Mohammad Hasnat Ali and Pravin K. Vaddavalli]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jagadesh C. Reddy, Soumya Devta, Kiran Kumar Vupparaboina, Mohammad Hasnat Ali and Pravin K. Vaddavalli</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210111]]></guid><cfi:id>317</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Leptin’s concentration in tears and dry eye: a clinical observational study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210112]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the concentration of leptin in tears and its correlation with dry eye symptoms and signs.
METHODS: The study enrolled individuals (n=39) responding to an advertising or dry eye patients (n=58) from the Ophthalmology Department. Tear samples were collected for leptin concentration measuring. Ocular Surface Disease Index (OSDI), tear meniscus height (TMH), tear break up time (TBUT), cornea fluorescein staining, Schirmer test (ST) and impression cytology (IC) were assessed. Leptin concentration in tears of dry eye patients and healthy controls, and its correlation with clinical features of dry eye disease (DED) were analyzed.
RESULTS: Age, body mass index (BMI), OSDI scores and cornea fluorescein staining scores showed a negative correlation with leptin concentration in tears (r=-0.340, P=0.001; r=-0.332, P=0.001; r=-0.258, P=0.011; r=-0.424, P<0.001, respectively). ST showed positive correlation with leptin concentration in tears (r=0.206, P=0.045). No significant difference was observed in leptin concentration between dry eye patients and controls (P=0.682). Multivariate linear regression analysis revealed that dry eye, OSDI, corneal fluorescein staining scores and ST correlated with leptin concentration in tears.
CONCLUSION: This is the first study measuring leptin concentration in tears. The correlation between leptin concentration and DED symptoms and signs reveal that leptin level correlated with the dry eye, potentially contributing to repair of ocular damage and dry eye improvement.]]></description>
<pubDate>2020/11/19 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ran Hao, Yan Liu and Xue-Min Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ran Hao, Yan Liu and Xue-Min Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210112]]></guid><cfi:id>316</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Corneal epithelial thickness analysis of forme fruste keratoconus with optical coherence tomography]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210113]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To explore the significance of corneal epithelial thickness analysis in diagnosing early keratoconus.
METHODS: There were 26 clinical keratoconus, 21 forme fruste keratoconus, 40 high corneal astigmatism (ΔK) and 40 low ΔK eyes involved in the study. Fourier-domain optical coherence tomography was used to measure the corneal epithelial thickness of four groups. The morphological features of topographic map and the thickness of corneal epithelial thinnest point were analyzed. The distribution curve of corneal epithelial thickness at 45°, 90°, and 135° axial directions that are through the pupil center was also analyzed. One-way ANOVA was performed to compare the data.
RESULTS: The topographic map of forme fruste keratoconus corneal epithelial thickness was uniformity shape; crater shape existed only in clinical keratoconus group; and central island shape mainly existed in high ΔK group. The thinnest point of corneal epithelial thickness of forme fruste keratoconus group was significantly lower than that of low ΔK group (P=0.022). The thickness of corneal epithelium in the forme fruste keratoconus at 90° was thinner than that in the low astigmatism group at -1, and -2 mm points (P-1 mm=0.015, P-2 mm=0.036).
CONCLUSION: The analysis of the thinnest point in forme fruste keratoconus corneal epithelium appears earlier than corneal epithelial remodeling. The topographic map of corneal epithelium in high ΔK eyes appears in central island shape, and can be used for the differential diagnosis of early keratoconus.]]></description>
<pubDate>2020/11/19 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xiao-Long Yang, Yun Wang, Bao-Gen Luo, Yue Xu and Xiao-Feng Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiao-Long Yang, Yun Wang, Bao-Gen Luo, Yue Xu and Xiao-Feng Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210113]]></guid><cfi:id>315</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Endogenous fungal endophthalmitis: risk factors, clinical course, and visual outcome in 13 patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210114]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyze the risk factors, ophthalmological features, treatment modalities and their effect on the visual outcome in patients with endogenous fungal endophthalmitis (EFE).
METHODS: Data retrieved from the medical files included age at presentation to the uveitis clinic, gender, ocular symptoms and their duration before presentation, history of fever, eye affected, anatomical diagnosis and laboratory evidence of fungal infection. Medical therapy recorded included systemic antifungal therapy and its duration, use of intravitreal antifungal agents and use of oral/intravitreal steroids. Surgical procedures and the data of ophthalmologic examination at presentation and at last follow-up were also collected.
RESULTS: Included were 13 patients (20 eyes, mean age 58y). Ten patients presented after gastrointestinal or urological interventions and two presented after organ transplantation. In one patient, there was no history of previous intervention. Diagnostic vitrectomy was performed in 16 eyes (80%) and vitreous cultures were positive in 10 of the vitrectomized eyes (62.5%). In only 4 patients (31%), blood cultures were positive. All patients received systemic antifungal therapy. Sixteen eyes (80%) received intravitreal antifungal agent with voriconazole being the most commonly used. Visual acuity (VA) improved from 0.9±0.9 at initial exam to 0.5±0.8 logMAR at last follow-up (P=0.03). A trend of greater visual improvement was noted in favor of eyes treated with oral steroids (±intravitreal dexamethasone) than eyes that were not treated with steroids. The most common complication was maculopathy. Twelve eyes (60%) showed no ocular complications.
CONCLUSION: High index of suspicion in patients with inciting risk factors is essential because of the low yield of blood cultures and the good general condition of patients at presentation. Visual prognosis is improved with the prompt institution of systemic and intravitreal pharmacotherapy and the immediate surgical intervention. Oral±local steroids could be considered in cases of prolonged or marked inflammatory responses in order to hasten control of inflammation and limit ocular complications.]]></description>
<pubDate>2020/11/19 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jamel Corredores, Itzhak Hemo, Tareq Jaouni, Zohar Habot-Wilner, Michal Kramer, Shiri Shulman, Haneen Jabaly-Habib, Ala'a Al-Talbishi, Michael Halpert, Edward Averbukh, Jaime Levy, Iris Deitch-Harel and Radgonde Amer]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jamel Corredores, Itzhak Hemo, Tareq Jaouni, Zohar Habot-Wilner, Michal Kramer, Shiri Shulman, Haneen Jabaly-Habib, Ala'a Al-Talbishi, Michael Halpert, Edward Averbukh, Jaime Levy, Iris Deitch-Harel and Radgonde Amer</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210114]]></guid><cfi:id>314</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Risk factors for persistent epiphora following successful canalicular laceration repair]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210115]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To identify the risk factors of epiphora in patients with anatomical patency after surgical repair of canalicular laceration.
METHODS: This retrospective case series included 178 cases of canalicular laceration repair from 2005 to 2012. Demographic data collected from each patient included age, sex, type of injury, distance from the distal lacerated end of the canaliculus to the punctum, the severity score for the structural abnormity of the medial canthus, the duration of stent placement, and the timing of surgery. The risk factors for epiphora were evaluated using Logistic regression models.
RESULTS: Among the 178 cases, 45 (25.3%) with lacrimal patency after irrigation had symptomatic epiphora at the final follow-up. Patients’ sex, age, type of injury, duration of stent placement, timing of surgery, and concurrent trauma were not found to be signi?cantly associated with symptomatic epiphora after surgical repair of the lacerated canaliculus (P>0.05). A distance of more than 5 mm from the distal cut end to the punctum was closely and significantly associated with symptomatic epiphora after surgical repair of the lacerated canaliculus (P<0.01). Symptomatic epiphora was significantly more frequent in patients with higher severity scores for structural abnormities of the medial canthus (P<0.01).
CONCLUSION: Our results indicate that the risk factors for postoperative symptomatic epiphora include a further distance between the distal cut end and the lacrimal punctum and a higher severity score for structural abnormities of the medial canthus. These findings could be used to prognosticate postoperative symptomatic epiphora.]]></description>
<pubDate>2020/11/19 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ying-Yan Qin, Zuo-Hong Li, Feng-Bin Lin, Yu Jia, Jun Mao, Cong-Yao Wang and Xuan-Wei Liang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ying-Yan Qin, Zuo-Hong Li, Feng-Bin Lin, Yu Jia, Jun Mao, Cong-Yao Wang and Xuan-Wei Liang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210115]]></guid><cfi:id>313</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Impact of binocular visual field loss on driving performance in glaucoma patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210116]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the driving performance in young and middle-aged Chinese glaucoma patients with mild to severe visual field loss compared to those without glaucoma by using a driving simulation test.
METHODS: Twenty-nine participants were included in this study: nine patients with glaucoma but pass the binocular Esterman visual field test, ten patients with glaucoma and fail the binocular Esterman visual field test, and ten age-matched healthy controls. A driving simulation test was designed as a frequency-based analysis of a lane-keeping task. The total performance error, the control-response amplitude and delay were calculated.
RESULTS: Esterman visual field test fail group showed the longest delay of control-response among three groups (P=0.02). And the delay in lane-keeping task was significantly associated with inferior field of better-eye (r=0.51, P=0.004) and integrated visual field (r=0.55, P=0.002).
CONCLUSION: Young and middle-aged glaucoma patients with binocular visual field loss suffered from a longer delay of response in driving simulation test, while inferior visual field having more impact than superior visual field.]]></description>
<pubDate>2020/11/19 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Zhen-Ying Jiang, Jing Chen, Jing Yao and Shao-Hong Qian]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zhen-Ying Jiang, Jing Chen, Jing Yao and Shao-Hong Qian</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20210116]]></guid><cfi:id>312</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical analysis of 109 cases of lacrimal gland pleomorphic adenoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211207]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To monitor the prognosis of patients with lacrimal gland pleomorphic adenoma (LGPA) following surgical resection within the past 10y. The factors affecting patient prognosis are analyzed and the experience of surgical treatment is summarized.
METHODS: In this retrospective, comparative case series, clinical records from 109 cases of LGPA treated chiefly at the same institution between November 2009 and May 2019 were reviewed. All 109 patients underwent surgery, histopathological examination, and imaging examination. For patients who underwent surgery for the first time, LGPA could be resected completely, including tumor and capsule tissues, using a surgical approach via the eyebrow arch or double eyelid crease.
RESULTS: The ratio of males to females was 1:1.60, the ages ranged from 19 to 74 years old with a mean age of 43.64±13.07 years old, and the ratio of left to right eyes was 1:1.37. A total of 109 patients underwent surgical excision and five of these received radiotherapy after malignant transformation. Of these patients, 15 were lost to follow up within the April 1, 2020 deadline and 1 was diagnosed as a recurring pathology. The 5-year recurrence rate for 86 patients who underwent initial surgery was 7.27%. Single factor analysis revealed that the course of disease, bone destruction, invasion of surrounding tissues, tumor size, capsule integrity, and expression of Ki-67 were statistically significant (P<0.05). Binomial Logistic regression analysis showed that capsule integrity was a risk factor influencing recurrence (P=0.008).
CONCLUSION: LGPA has a risk of recurrence and potential for malignant transformation. Complete removal of the tumor and capsule in the initial surgery is a key factor in preventing recurrence.]]></description>
<pubDate>2021/11/25 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Rui Liu, Nan Wang, Hong Zhang, Xin Ge and Jian-Min Ma]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Rui Liu, Nan Wang, Hong Zhang, Xin Ge and Jian-Min Ma</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211207]]></guid><cfi:id>311</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Decreased retinal microvasculature densities in pterygium]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211208]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the retinal vascular network alterations in eyes of patients with pterygium.
METHODS: Totally 18 left eyes from 18 female pterygium patients and 18 left eyes from 18 female healthy control subjects were enrolled. Optical coherence tomography angiography (OCTA) images were generated of the superficial retinal layer and deeper retinal layer of the macular retina for each eye. The microvascular (MIR) and macrovascular (MAR) densities were calculated and MIR, MAR, and total microvascular (TMI) density was compared in the healthy control and pterygium groups.
RESULTS: In pterygium group, in the superficial retinal layer, the vascular density in superficial MIR, superior right (SR), inferior right (IR), right (R), superficial central annuli (SC)1, SC2, and SC3 decreased significantly in the macular area (P<0.05). Furthermore, the vascular density in all those decreased regions except R, was significantly and negatively correlated with the disease course (r=-0.6038 to -0.7762, P=0.0008), and the area size of pterygium (r=-0.6043 to -0.9508, P<0.05). For the deeper retinal layer, the density of deep total microvessel (DTMI), deeper MIR, SR, IR, R, DC2, and DC3 decreased significantly in macular area of pterygium patients (P<0.05). Furthermore, the vascular density in all those decreased regions was significantly and negatively correlated with the disease course (r=-0.6901 to -0.7795, P=0.0015), and the area size of pterygium (r=-0.6043 to -0.9563, P<0.05). No statistically significant differences and correlation was found in other region density (|r|<0.47, P>0.05).
CONCLUSION: OCTA findings suggest that pterygium patients present with decreased retinal MIR density, and the major vascular alterations occurr mainly on the bitamporal side. The vascular density of the superficial SC1, SC2, SC3 adjacent to the foveal and deep layer of DC2, DC2 regions, significantly decreased.]]></description>
<pubDate>2021/11/25 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Feng Wang, Qian-Min Ge, Hui-Ye Shu, Xu-Lin Liao, Rong-Bin Liang, Qiu-Yu Li, Li-Juan Zhang, Gui-Ping Gao and Yi Shao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Feng Wang, Qian-Min Ge, Hui-Ye Shu, Xu-Lin Liao, Rong-Bin Liang, Qiu-Yu Li, Li-Juan Zhang, Gui-Ping Gao and Yi Shao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211208]]></guid><cfi:id>310</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of perioperative parameters in one-handed rotational phacoemulsification versus conventional phacoemulsification and femtosecond laser-assisted cataract surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211209]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare perioperative parameters of one-handed rotational phacoemulsification technique (one-handed phaco-roll) with each of other two techniques, “Divide et Conquer” and femtosecond laser-assisted cataract surgery (FLACS)
METHODS: In this retrospective and comparative cohort study, eyes with uncomplicated cataract (nuclear density grade 2 to 3) treated routinely with one-handed phaco-roll (n=23; Group 1) or “Divide et Conquer” (n=23; Group 2) or FLACS (n=23; Group 3) were enrolled. Intraoperative parameters including effective phaco-time (EPt), ultrasound time (USt), aspiration time, surgical time, phacoemulsification (phaco)-power, balanced salt solution (BSS) use, cumulative dissipated energy (CDE) were recorded and compared. Clinical outcomes including best corrected visual acuity (BCVA), corneal endothelial cell density (ECD), endothelial cell loss (ECL), central corneal thickness (CCT) and central macular thickness (CMT), were assessed and compared pre-operatively and at 1mo after surgery.
RESULTS: Aspiration and surgical time, and BSS used were lower in Group 1 (P<0.01) than other groups. EPt, phaco-power and CDE were lower in Group 1 (P<0.05) than Group 2 but not significantly different from Group 3. In Group 1, USt was lower (P<0.05) than Group 2 but higher (P<0.05) than Group 3. BCVA improved in all groups without significant difference between Group 1 and the other ones. No significant differences regarding all post-operative morphologic outcomes (ECD, ECL, CCT, CMT) were reported. No clinical complications occurred.
CONCLUSION: One-handed phaco-roll seems to be less time-consuming than “Divide et Conquer” and FLACS and less energy-consuming than “Divide et Conquer”. Furthermore, one-handed phaco-roll seems to have an equal safety profile compared to the other two techniques.]]></description>
<pubDate>2021/11/25 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Samuele Gigliola, Giancarlo Sborgia, Alfredo Niro, Carmela Palmisano, Pasquale Puzo, Gianluigi Giuliani, Luigi Sborgia, Dario Sisto, Valentina Pastore, Claudio Furino, Rossella Donghia, Alessandra Sborgia, Francesco Boscia and Giovanni Alessio]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Samuele Gigliola, Giancarlo Sborgia, Alfredo Niro, Carmela Palmisano, Pasquale Puzo, Gianluigi Giuliani, Luigi Sborgia, Dario Sisto, Valentina Pastore, Claudio Furino, Rossella Donghia, Alessandra Sborgia, Francesco Boscia and Giovanni Alessio</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211209]]></guid><cfi:id>309</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of trifocal toric and bifocal toric intraocular lens implantation in patients with cataract and high corneal astigmatism]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211210]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate and compare the quality of life, satisfaction, contrast sensitivity, glare, depth perception, and intraocular lens (IOL) rotation in patients who underwent trifocal toric and bifocal toric IOLs.
METHODS: A total of 80 eyes of 40 patients were included in this prospective study. Twenty patients in each group were implanted with trifocal toric and bifocal toric IOL, respectively. Preoperative and postoperative 6-month measurements were recorded for both patient groups. Comprehensive anterior and posterior segment examinations, distance-intermediate-near visual acuity values and the visual function scale questionnaire results were evaluated at these examinations. Patient satisfaction, contrast sensitivity, glare, intermediate-near and distance stereopsis and IOL rotation were also evaluated.
RESULTS: No significant difference was found between the groups in terms of distance and near visual acuities (P=0.269, P=0.451). Intermediate visual acuity was significantly increased in the trifocal toric group (P<0.001). The visual function scale results were increased after surgery in both groups (P=0.001 and P<0.001), with no difference determined between them (P=0.158 and P=0.691). The number of patients wearing glasses was low in both groups and there was no significant difference between the groups (P>0.05). The overall satisfaction in the trifocal toric group was significantly higher than in the bifocal toric group (P=0.03). The highest sensitivity was observed at 6 cpd spatial frequency in all patients under photopic conditions (1.80±0.24 logU, 1.74±0.20 logU). Distance-intermediate-near binocular depth perception results in both groups were higher in the trifocal toric group (P=0.02, 0.048, 0.003, respectively). Although there was no significant difference for 3 meters stereopsis, the trifocal toric group had higher depth perception (P=0.577). Mean rotation was 5.76°±3.93° in the trifocal toric group and 12°±7.1° in the bifocal toric group.
CONCLUSION: Better results in the middle distance are obtained in the trifocal toric group and less IOL rotation due to digital system-coordinated surgery. Moreover, the overall satisfaction in the trifocal toric group is significantly higher than in the bifocal toric group.]]></description>
<pubDate>2021/11/25 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Merve Bozkurt Gencer, Hikmet Basmak, Erdogan Yasar and Ozkan Onal]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Merve Bozkurt Gencer, Hikmet Basmak, Erdogan Yasar and Ozkan Onal</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211210]]></guid><cfi:id>308</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of imo and Humphrey field analyzer perimeters in glaucomatous eyes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211211]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the imo perimeter, a new portable head-mounted perimeter unit that enables both eyes to be examined quickly and simultaneously, with the Humphrey field analyzer (HFA) perimeter to investigate correlations and their diagnostic ability in glaucomatous eyes.
METHODS: The performance of the equipment in 128 glaucomatous eyes and 40 normal eyes were tested. We investigated the correlations of mean deviation, pattern standard deviation, visual field index, and the sensitivity.
RESULTS: Measurements of mean deviation (r=0.886, P<0.001), pattern standard deviation (r=0.814, P<0.001), and visual field index (r=0.871, P<0.001) in both perimeters were strongly and positively correlated. The sensitivities in the imo perimeter were 80.5% for mean deviation, 81.2% for pattern standard deviation, and 80.5% in visual field index; those in the HFA were 63.3% for mean deviation, 74.5% for pattern standard deviation, and 80.5% for visual field index. Both perimeters demonstrated high diagnostic ability.
CONCLUSION: The parameters by the imo and HFA in glaucomatous eyes show strong positive correlations with favorable sensitivity, specificity, and diagnostic ability. However, the difference between imo and HFA results increases with the increase in visual field disturbance.]]></description>
<pubDate>2021/11/25 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yoshinori Nakai, Kyoko Bessho, Yuko Shono, Kaori Taoka and Yoshihide Nakai]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yoshinori Nakai, Kyoko Bessho, Yuko Shono, Kaori Taoka and Yoshihide Nakai</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211211]]></guid><cfi:id>307</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Aqueous angiopoietin-like levels correlate with optical coherence tomography angiography metrics in diabetic macular edema]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211212]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To quantitatively detect aqueous levels of angiopoietin-like (ANGPTL)3, ANGPTL4, and ANGPTL6 and investigate their correlation with optical coherence tomography angiography (OCTA) findings in patients with diabetic macular edema (DME).
METHODS: This cross-sectional study included 23 patients (27 eyes) with type 2 diabetes and 16 control subjects (20 eyes). All patients underwent OCTA imaging and ultra-wide field fundus photography. Diabetic patients were categorized into two groups according to the presence or absence of diabetic retinopathy (DME group, 14 patients, 16 eyes); and non-diabetic retinopathy (NDR) group, 9 patients, 11 eyes, respectively. Aqueous levels of ANGPTL3, ANGPTL4, and ANGPTL6 were assessed using suspension array technology, and foveal-centered 3×3 mm2 OCTA scans were automatically graded to determine the central, inner, and full vessel density (CVD, IVD, FVD); central, inner, and full perfusion density (CPD, IPD, FPD), foveal avascular zone (FAZ) area, FAZ perimeter, and FAZ circularity index (FAZ-CI) on superficial capillary plexuses. Additionally, central subfield thickness (CST), cube volume (CV), and cube average thickness (CAT) were measured in a model of macular cube 512×128.
RESULTS: Aqueous ANGPTL3 levels were not significantly different among the three groups (P>0.05). ANGPTL4 levels were significantly higher in the DME group than the control and NDR groups (P<0.0001 and P<0.001), while ANGPTL6 levels were significantly higher in the DME group than the control group (P<0.05). In the whole cohort, the aqueous ANGPTL3 levels correlated negatively with the IVD, FVD, IPD, and FPD, and positively with the CV and CAT. The aqueous ANGPTL4 levels correlated negatively with the CVD, IVD, FVD, CPD, IPD, and FPD, and positively with the FAZ perimeter, CST, CV, and CAT. The aqueous ANGPTL6 levels correlated negatively with the IVD, FVD, IPD, FPD, FAZ-CI and positively with CST, CV, CAT.
CONCLUSION: ANGPTL4 and ANGPTL6 may be associated with vascular leakage in DME and may represent good targets for DME therapy. In addition, OCTA metrics may be useful for evaluating macular ischemia in DME.]]></description>
<pubDate>2021/11/25 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jie Yan, Wu-Jun Li, Ya-Zhou Qin, Xuan-Yu Qiu, Li Qin and Jing-Ming Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jie Yan, Wu-Jun Li, Ya-Zhou Qin, Xuan-Yu Qiu, Li Qin and Jing-Ming Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211212]]></guid><cfi:id>306</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Artificial intelligence can assist with diagnosing retinal vein occlusion]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211213]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assist with retinal vein occlusion (RVO) screening, artificial intelligence (AI) methods based on deep learning (DL) have been developed to alleviate the pressure experienced by ophthalmologists and discover and treat RVO as early as possible.
METHODS: A total of 8600 color fundus photographs (CFPs) were included for training, validation, and testing of disease recognition models and lesion segmentation models. Four disease recognition and four lesion segmentation models were established and compared. Finally, one disease recognition model and one lesion segmentation model were selected as superior. Additionally, 224 CFPs from 130 patients were included as an external test set to determine the abilities of the two selected models.
RESULTS: Using the Inception-v3 model for disease identification, the mean sensitivity, specificity, and F1 for the three disease types and normal CFPs were 0.93, 0.99, and 0.95, respectively, and the mean area under the curve (AUC) was 0.99. Using the DeepLab-v3 model for lesion segmentation, the mean sensitivity, specificity, and F1 for four lesion types (abnormally dilated and tortuous blood vessels, cotton-wool spots, flame-shaped hemorrhages, and hard exudates) were 0.74, 0.97, and 0.83, respectively.
CONCLUSION: DL models show good performance when recognizing RVO and identifying lesions using CFPs. Because of the increasing number of RVO patients and increasing demand for trained ophthalmologists, DL models will be helpful for diagnosing RVO early in life and reducing vision impairment.]]></description>
<pubDate>2021/11/25 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Qiong Chen, Wei-Hong Yu, Song Lin, Bo-Shi Liu, Yong Wang, Qi-Jie Wei, Xi-Xi He, Fei Ding, Gang Yang, You-Xin Chen, Xiao-Rong Li and Bo-Jie Hu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Qiong Chen, Wei-Hong Yu, Song Lin, Bo-Shi Liu, Yong Wang, Qi-Jie Wei, Xi-Xi He, Fei Ding, Gang Yang, You-Xin Chen, Xiao-Rong Li and Bo-Jie Hu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211213]]></guid><cfi:id>305</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[New technique for removal of perfluorocarbon liquid related sticky silicone oil and literature review]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211214]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the safety and efficacy of sticky silicone oil (SSO) removal using a 22-gauge vein detained needle and inner limiting membrane (ILM) wrap-and-peel technique.
METHODS: This retrospective consecutive case series reviewed the records of patients with a history of retinal detachment who had received silicone oil and perfluorocarbon liquid (PFCL) as intraocular tamponades. Patients were included in the analysis if they exhibited SSO remnants during silicone oil removal. The aspiration of most of the SSO remnants was performed by a 22-gauge vein detained needle. The small amounts of droplets adhered to the macula and epi-macular membrane were subsequently removed by the ILM warp-and-peel technique. The anatomical and functional outcomes, and postoperative complications were recorded. In vitro experiments were performed to simulate the formation of SSO remnants in four groups.
RESULTS: Of 711 patients who underwent silicone oil removal during the study period, 9 patients exhibited SSO remnants and underwent follow-up for at least 3mo. Seven eyes (78%) underwent the ILM wrap-and-peel technique to completely remove small droplets of SSO that were glued to the macula and epi-macular membrane. No obvious complications occurred. Postoperative optical coherence tomography revealed normal retinal structure in all patients. In vitro analyses showed that balanced salt solution and prolonged vibration (for 1wk) had the strongest effects on silicone oil and PFCL compound opacities.
CONCLUSION: SSO remnants could be removed in an intact manner and without complications, using a vein detained needle-assisted and ILM wrap-and-peel technique. The findings suggest that PFCL and infusion fluid should be completely removed before silicone oil injection to prevent SSO formation.]]></description>
<pubDate>2021/11/25 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hai-Shuang Lin, Yong-Ping Tang, Lu Zhang, En-Ze Liu, Ling-Ying Ye, Ming-Na Xu, Rong-Han Wu and Zhi-Xiang Hu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hai-Shuang Lin, Yong-Ping Tang, Lu Zhang, En-Ze Liu, Ling-Ying Ye, Ming-Na Xu, Rong-Han Wu and Zhi-Xiang Hu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211214]]></guid><cfi:id>304</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Surgical outcomes in inferior recurrences of rhegmatogenous retinal detachment]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211215]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyze the anatomical and functional outcomes in the inferior recurrences of rhegmatogenous retinal detachment (RRD) depending on the surgical approach.
METHODS: Eighty-one eyes of 81 patients (47 males and 34 females with a mean age of 54.8±14.1y) who demonstrated at least one inferior recurrence of RRD were included in this retrospective study. All patients were categorized as having received either circular scleral buckling (SB), pars plana vitrectomy (PPV), a combination of SB and PPV (SB+PPV), PPV with retinotomy (PPV+RT), or PPV+RT and short-term postoperative perfluorocarbon liquid tamponade (PPV+RT+pPFCL). All cases were followed up until successful retinal reattachment or third recurrence. The primary outcome measures were the achievement of the surgical goal without recurrence of RRD and best-corrected visual acuity (BCVA).
RESULTS: After the treatment of the first recurrence, the recurrence rate in the PPV+SB group was statistically significantly lower than that of the PPV (P=0.0012), PPV+RT (P=0.028), or PPV+RT+pPFCL (P=0.047) group. There was no statistically significant difference between PPV+SB, PPV+RT, and PPV+RT+pPFCL groups in the recurrence rate after treatment of the second recurrence (42 eyes). However, there was a statistically significant (P=0.016) trend towards a decrease of recurrence rate after PPV+RT+pPFCL. There was no statistically significant improvement of BCVA in either study group (P>0.05) after both first and second recurrence surgery. The mean time follow-up was 109.0±91.0d before the first recurrence and 210.0±186.6d between previous surgery at second recurrence.
CONCLUSION: Patients with first inferior recurrence of RRD may benefit from SB as an adjunct to PPV. RT and short-term pPFCL tamponade in the second recurrence may allow better anatomical outcomes, however, without functional improvement.]]></description>
<pubDate>2021/11/25 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Sergey V. Churashov, Tatiana N. Shevalova, Alexei N. Kulikov and Dmitrii S. Maltsev]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Sergey V. Churashov, Tatiana N. Shevalova, Alexei N. Kulikov and Dmitrii S. Maltsev</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211215]]></guid><cfi:id>303</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Quantitative analysis of retinal vasculature in normal eyes using ultra-widefield fluorescein angiography]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211216]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To quantify the area and density of retinal vascularity by ultra-widefield fluorescein angiography (UWFA).
METHODS: In a retrospective study, UWFA images were obtained using an ultra-widefield imaging device in 42 normal eyes of 42 patients. Central and peripheral steered images were used to define the edge of retinal vasculature by a certified grader. The length from the center of the optic disc to the edge of retinal vascularity (RVL) in each quadrant and the total retinal vascular perfusion area (RVPA) were determined by the grader using OptosAdvance software. The density of retinal vascularity (RVD) was quantified in different zones of central-steered images using Image J software.
RESULTS: Among 42 healthy eyes, the values for mean RVL in each quadrant were 19.007±0.781 mm (superior), 18.467±0.869 mm (inferior), 17.738±0.622 mm (nasal) and 24.241±1.336 mm (temporal). The mean RVPA was 1140.117±73.825 mm2. The mean RVD of the total retina was 4.850%±0.638%. RVD varied significantly between different retina zones (P<0.001), and significant differences existed in the RVD values for total retinal area in patients over 50 years old compared to those under 50 years old (P=0.033). No gender difference was found.
CONCLUSION: The UWFA device can be a promising tool for analyzing the overall retinal vasculature and may provide a better understanding of retinal vascular morphology in normal eyes. Aging may be related to lower RVD.]]></description>
<pubDate>2021/11/25 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jing-Wen Jiang, Zuo-Hui-Zi Yi, Xiao-Ling Wang, Jue-Jun Liu, Gong-Peng Sun and Chang-Zheng Chen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jing-Wen Jiang, Zuo-Hui-Zi Yi, Xiao-Ling Wang, Jue-Jun Liu, Gong-Peng Sun and Chang-Zheng Chen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211216]]></guid><cfi:id>302</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Outcomes of half-width vertical rectus transposition augmented with posterior fixation sutures for sixth cranial nerve palsy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211217]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To describe the experience with half-width vertical muscles transposition (VRT) augmented with posterior fixation sutures.
METHODS: The clinical charts of all patients, who underwent half-width VRT augmented with posterior fixation sutures for sixth cranial nerve palsy from January 2003 to December 2018, were retrospectively reviewed. For each patient, pre- and post-operatively, the largest measured angle was used for the calculations, usually resulting with the angle for distance, except in young infants, where measurements were made at near fixation using the Krimsky test.
RESULTS: Fifteen patients met the inclusion criteria for the study, of them 9 (60.0%) had also medial rectus muscle recession at the time of surgery. Mean follow-up period was 21.4±23.2mo (range 1.5-82mo). Preoperative mean esotropia was 51.3±19.7 prism diopter (PD; range 20-90 PD). Postoperative mean deviation on final follow-up was 7.7±20.2 PD (range -40 to 35 PD; P=0.018). In all patients with preoperative abnormal head position, improvement was noted. Ten (66.7%) patients had improvement in abduction and 10 (66.7%) patients reported improvement in their diplopia, by final follow-up. The addition of medial rectus recession was correlated with a larger change in postoperative horizontal deviation compared to baseline (P=0.026). Two (13.3%) patients developed a vertical deviation in the immediate postoperative period which had resolved in one of them.
CONCLUSION: Half-width VRT augmented with posterior fixation suture, with or without medial rectus muscle recession, is an effective and safe procedure for esotropia associated with sixth cranial nerve palsy. A major improvement in the angle of deviation is expected. Most patients will have improvement in their abnormal head position and diplopia.]]></description>
<pubDate>2021/11/25 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ortal Fogel-Tempelhof, Anat Bachar Zipori, Chaim Stolovitch and Oriel Spierer]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ortal Fogel-Tempelhof, Anat Bachar Zipori, Chaim Stolovitch and Oriel Spierer</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211217]]></guid><cfi:id>301</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Role of orthoptics and scoring system for orbital floor blowout fracture: surgical or conservative treatment]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211218]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the role of orthoptics in referring patients with orbital floor blowout fracture (OFBF) for conservative or surgical treatment and based on the results, to propose a scoring system for such decision making.
METHODS: A retrospective analysis of 69 patients with OFBF was performed (35 treated conservatively, 34 surgically). The role of orthoptics in referring to surgery or conservative treatment was retrospectively evaluated, the factors with the highest significance for decision making were identified, and a scoring system proposed using Logistic regression.
RESULTS: According to defined criteria, the treatment was unsuccessful in 2 (6%) surgically treated and only in one (3%) conservatively treated patient. The proposed scoring system includes the defect size and several values resulting from the orthoptic examination, the elevation of the eyebulb measured on Lancaster screen being the most significant.
CONCLUSION: The study demonstrates the benefits of orthoptic examination when making decisions on conservative or surgical treatment and for diagnosing ocular motility disorder (with or without binocular diplopia) in OFBF patients. The proposed scoring system could, following verification in a prospective study, become a valuable adjunctive tool.]]></description>
<pubDate>2021/11/25 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Juraj Timkovic, Jiri Stransky, Katerina Janurova, Petr Handlos and Jan Stembirek]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Juraj Timkovic, Jiri Stransky, Katerina Janurova, Petr Handlos and Jan Stembirek</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211218]]></guid><cfi:id>300</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Evaluation of the long-term effect of foldable capsular vitreous bodies in severe ocular rupture]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211219]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the long-term effect of foldable capsular vitreous body (FCVB) in the treatment of severe ocular rupture to provide a practical basis for clinical selection.
METHODS: A total of 26 patients (26 eyes), 23 men and 3 women, with severe ocular rupture who underwent FCVB implantation between March 2018 and September 2018 were retrospectively analysed. All open ocular wounds located in zone III, with preoperative visual acuity grade IV and above (Snellen less than 4/200). The best corrected visual acuity (BCVA), intraocular pressure (IOP), cornea, anterior chamber, iris, lens, choroid, and retina were evaluated before and after the surgery. The subjective feeling and the location of FCVB were also assessed.
RESULTS: The average age of the 26 patients was 36y (20-60y). Postoperative follow-up was from 10 to 14mo. At the end of follow up, BCVA was light perception (LP) in 10 cases, no light perception (NLP) in 13 cases, hand motions (HM) in 3 cases. IOP was 11±5 mm Hg. Corneal degeneration was in 3 cases and corneal endothelial dystrophy was in 7 cases. Shallow anterior chamber was in 8 cases and hyphema was in 8 cases. Organized membrane in the pupil was in 14 cases. Epiphora occurred in 3 cases. FCVB drainage tube exposed in 3 cases. All FCVBs were in their normal location and no rejection occurred.
CONCLUSION: FCVB implantation is a long-term effective treatment and may provide a practical selection for severe ocular rupture.]]></description>
<pubDate>2021/11/25 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jin Deng, Hu-Ping Song, Rong-Le Zhou, Tao Chen, Jian-Zhou Wang and Zhao-Liang Zhu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jin Deng, Hu-Ping Song, Rong-Le Zhou, Tao Chen, Jian-Zhou Wang and Zhao-Liang Zhu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211219]]></guid><cfi:id>299</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Establishment of a prediction tool for ocular trauma patients with machine learning algorithm]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211220]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To predict final visual acuity and analyze significant factors influencing open globe injury prognosis.
METHODS: Prediction models were built using a supervised classification algorithm from Microsoft Azure Machine Learning Studio. The best algorithm was selected to analyze the predicted final visual acuity. We retrospectively reviewed the data of 171 patients with open globe injury who visited the Pusan National University Hospital between January 2010 and July 2020. We then applied cross-validation, the permutation feature importance method, and the synthetic minority over-sampling technique to enhance tool performance.
RESULTS: The two-class boosted decision tree model showed the best predictive performance. The accuracy, precision, recall, F1 score, and area under the receiver operating characteristic curve were 0.925, 0.962, 0.833, 0.893, and 0.971, respectively. To increase the efficiency and efficacy of the prognostic tool, the top 14 features were finally selected using the permutation feature importance method: (listed in the order of importance) retinal detachment, location of laceration, initial visual acuity, iris damage, surgeon, past history, size of the scleral laceration, vitreous hemorrhage, trauma characteristics, age, corneal injury, primary diagnosis, wound location, and lid laceration.
CONCLUSION: Here we devise a highly accurate model to predict the final visual acuity of patients with open globe injury. This tool is useful and easily accessible to doctors and patients, reducing the socioeconomic burden. With further multicenter verification using larger datasets and external validation, we expect this model to become useful worldwide.]]></description>
<pubDate>2021/11/25 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Seungkwon Choi, Jungyul Park, Sungwho Park, Iksoo Byon and Hee-Young Choi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Seungkwon Choi, Jungyul Park, Sungwho Park, Iksoo Byon and Hee-Young Choi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211220]]></guid><cfi:id>298</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Ocular manifestation and visual outcomes in herpes zoster ophthalmicus: a prospective study from a tertiary hospital of Eastern India]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211221]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To estimate the magnitude of different ocular manifestation in clinically established herpes zoster ophthalmicus (HZO) patients and assessment of the visual outcome after two months of initial examination.
METHODS: An observational prospective study was conducted on 42 clinically diagnosed Tzanck smear positive cases HZO to observe the occurrence and frequency of different ocular manifestation and their visual outcome in 10-month period with 2mo follow up. Full ophthalmological examination using slit lamp, non-contact tonometry, applanation tonometry, direct and indirect ophthalmoscope were performed.
RESULTS: Out of 42 patients of HZO, 33 had one or more type of ocular manifestation staring from lid skin involvement to conjunctivitis, keratitis, uveitis, increased intraocular pressure (IOP) and optic neuritis but no retinal manifestation. More number of HZO cases and ocular manifestation were found with advancement of ages. Young HZO patients were more associated with human immunodeficiency virus (HIV) infection and HIV infected people with HZO infection had more ocular manifestation. Male to female ratio was 2:1 among HZO cases but ocular manifestation occurred more among males. Female with advanced age were involved more. Lid involvement (73.81%), conjunctivitis (69.05%), and keratitis (59.52%) were most common ocular manifestation followed by anterior uveitis (30.95%) and episcleritis (11.90%). Ocular hypertension (42.86%) was associated with almost every ocular manifestation. Among the cases of more than 45 years of age, 9.52% patients acquired 6/6 vision compared to 7.14% patients at and below 45 years of age after 8wk of follow up.
CONCLUSION: The visual outcomes are poor in HZO with advanced age group. Visual outcome of the affected eyes is poor than unaffected eyes. The loss of vision is mainly due to keratitis, anterior uveitis, posterior uveitis, and optic neuritis.]]></description>
<pubDate>2021/11/25 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mayukh Goswami, Santanu Bhattacharya and Manas Bandyopadhyay]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mayukh Goswami, Santanu Bhattacharya and Manas Bandyopadhyay</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211221]]></guid><cfi:id>297</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Altered spontaneous brain activity patterns in patients with hyperthyroidism exophthalmos using amplitude of low-frequency fluctuation: a resting-state fMRI study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211222]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess changed spontaneous brain activity in hyperthyroid exophthalmos (HE) patients by the amplitude of the low-frequency fluctuation (ALFF) method, and to analyze the correlation between brain activity and ALFF values in these patients.
METHODS: Totally 18 HE and 18 hyperthyroid non-exophthalmos (HNE) patients were enrolled. The participants were tested by resting-state functional magnetic resonance imaging, and receiver operating characteristic (ROC) curves were generated to classify the ALFF values of the study population. Pearson’s correlation analysis was utilized to evaluate the relationship between the ALFF values obtained from different brain areas and clinical manifestations.
RESULTS: Contrary to HNE patients, we observed lower ALFF values in the left calcarine fissure and surrounding cortex (LCFSC) in HE patients. In the ROC curve analysis of the LCFSC, the area under the curve reflected a high degree of accuracy. In addition, there was positive correlation between mean ALFF values of the LCFSC and the best-corrected visual acuity of the affected eyes.
CONCLUSION: The study displays abnormal brain activity in LCFSC in patients with HE, which might suggest pathological mechanism of visual impairment of HE patients.]]></description>
<pubDate>2021/11/25 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ling Ling, Wen-Feng Liu, Yu Guo, Rong-Bin Liang, Hui-Ye Shu, Li-Juan Zhang, Qiu-Yu Li, Qian-Min Ge, Yi-Cong Pan and Yi Shao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ling Ling, Wen-Feng Liu, Yu Guo, Rong-Bin Liang, Hui-Ye Shu, Li-Juan Zhang, Qiu-Yu Li, Qian-Min Ge, Yi-Cong Pan and Yi Shao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211222]]></guid><cfi:id>296</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Midterm outcomes of penetrating keratoplasty following allogeneic cultivated limbal epithelial transplantation in patients with bilateral limbal stem cell deficiency]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211107]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the midterm outcomes of penetrating keratoplasty (PK) following allogeneic cultivated limbal epithelial transplantation (CLET) for bilateral total limbal stem cell deficiency (LSCD).
METHODS: Ten patients (10 eyes) with bilateral LSCD were enrolled in this prospective noncomparative case series study. Each participant underwent PK approximately 6mo after a CLET. Topical tacrolimus, topical and systemic steroids, and oral ciclosporin were administered postoperatively. Best-corrected visual acuity (BCVA), intraocular pressure (IOP), ocular surface grading scores (OSS), corneal graft epithelial rehabilitation, persistent epithelial defect (PED), immunological rejection, and graft survival rate were assessed.
RESULTS: The time interval between PK and allogeneic CLET was 6.90±1.29 (6-10)mo. BCVA improved from 2.46±0.32 logMAR preoperatively to 0.77±0.55 logMAR post-PK (P<0.001). Kaplan-Meier analysis of mean graft survival revealed graft survival rates of 100% at 12 and 24mo and 80.0% at 36mo. PEDs appeared in 5 eyes at different periods post-PK, and graft rejection occurred in 4 eyes. The total OSS decreased from 12.4±4.4 before allogeneic CLET to 1.4±1.51 after PK.
CONCLUSION: A sequential therapy design of PK following allogeneic CLET can maintain a stable ocular surface with improved BCVA despite the relatively high graft rejection rate.]]></description>
<pubDate>2021/10/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jun-Fa Xue, Dong-Fang Li, Ya-Ni Wang, Chen Chen, Ru-Fei Yang, Qing-Jun Zhou, Ting Liu, Li-Xin Xie and Yan-Ling Dong]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jun-Fa Xue, Dong-Fang Li, Ya-Ni Wang, Chen Chen, Ru-Fei Yang, Qing-Jun Zhou, Ting Liu, Li-Xin Xie and Yan-Ling Dong</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211107]]></guid><cfi:id>295</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effects of dietary high dose DHA omega-3 supplement in dry eye with meibomian gland dysfunction]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211108]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the clinical efficacy of dietary supplement of high dose DHA omega-3 in dry eye with meibomian gland dysfunction (MGD).
METHODS: Prospective randomized double-masked, placebo-controlled clinical trial was conducted in mild to moderate dry eye patients with MGD. Patients have no history of taking any dietary omega-3 supplements before 3mo. Patients were divided into two groups: 24 patients in the omega-3 group and 26 patients in the placebo group. The omega-3 group received two capsules of Easyeye Dry&#174;, total containing 600 mg of EPA and 1640 mg of DHA, while the placebo group received two capsules containing 3000 mg of olive oil. All patients take two pills once a day. The examination of MGD scores, tear break-up time (TBUT), corneal staining test (NEI), strip meniscometry (SM tube), and ocular surface disease index (OSDI) scores were performed at baseline, after 4 and 8wk.
RESULTS: A total of 50 patients were included. There were no differences in baseline characteristics between the two groups, such as age, sex, and other ocular examination findings. The TBUT, NEI, and OSDI scores significantly improved after 4 and 8wk in both groups. While after 8wk TBUT (6.00±1.62s vs 5.08±1.28s, P=0.034) and MGD score (7.2±1.8 vs 8.1±2.6, P=0.033) in the omega-3 group was more significantly improved than that of the placebo group.
CONCLUSION: Dry eye with the MGD patient, a high dose of DHA omega-3 dietary supplement can improve TBUT and MGD score after 8wk, effective in stabilizing the tear film.]]></description>
<pubDate>2021/10/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yeon Ji Jo and Jong Soo Lee]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yeon Ji Jo and Jong Soo Lee</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211108]]></guid><cfi:id>294</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Changes in post-keratoplasty astigmatism after suture removal: refraction vs tomography vs aberrometry]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211109]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyse the changes in magnitude and orientation of astigmatism after suture removal (SR) in keratoplasty eyes as measured by refraction, tomography, and aberrometry.
METHODS: Twenty-six eyes of 25 patients after optical keratoplasty requiring SR to reduce the astigmatism during the follow-up period were prospectively included. Eyes with poor quality topography scans or if there were no sutures in the steepest semi meridian were excluded. Corrected distance visual acuity (CDVA), manifest refraction, corneal tomography and aberrometry were performed on all patients before and after SR.
RESULTS: The mean age of the patients was 40.8±14.4y. Penetrating keratoplasty was performed in 23 eyes (89%) and deep anterior lamellar keratoplasty was done in 3 eyes (11%). There was a statistically significant reduction in the magnitude of refractive, tomographic and aberrometry astigmatism after SR (P<0.001) at 2h after suture removal. The mean net reduction of the astigmatism was greater as measured by corneal tomography compared to refractive astigmatism (P<0.05). There was no statistically significant change in refractive astigmatism between 2h and 2mo after SR (P=0.55). Vector calculations demonstrated a greater amount of undercorrection in the tomography group and the rotational error was more towards counterclockwise direction. Mean monocular logMAR CDVA improved from 0.57 D to 0.49 D after SR (P=0.002).
CONCLUSION: The net reduction in the magnitude of astigmatism after SR is greater in the tomography and aberrometry groups. With one episode of SR, there is no difference in the aberration profile.]]></description>
<pubDate>2021/10/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Suraj Kumar Chaurasiya, Jagadesh C. Reddy, Pravin K. Vaddavalli and Christopher J. Rapuano]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Suraj Kumar Chaurasiya, Jagadesh C. Reddy, Pravin K. Vaddavalli and Christopher J. Rapuano</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211109]]></guid><cfi:id>293</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Indications for exchange or explantation of phakic implantable collamer lens with central port in patients with and without keratoconus]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211110]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the causes of phakic implantable collamer lens (ICL) exchange/explantation in patients with and without keratoconus (KC) at two tertiary hospitals in Riyadh, Saudi Arabia.
METHODS: A retrospective chart review of all patients who underwent ICL (model V4c with central port) exchange/explantation was performed using the electronic medical record systems. All available preoperative and postoperative data were documented for each patient.
RESULTS: Over 7y, 2283 ICL implantation procedures were performed; 46 implants (2%) required exchange (21 implants)/explantation (25 implants), of which 14 cases (30.4%) were patients with KC. Indications for ICL exchange/explantation in non-KC group were vault measurement, cataract formation, increased intraocular pressure, inaccurate refraction, and patient dissatisfaction in 22 (68.75%), 4 (12.5%), 3 (9.37%), 2 (6.25%), and 1 (3.12%) case, respectively. The most common indication for ICL exchange/explantation in the KC group was inaccurate vault sizing in 11 patients (78.57%), inaccurate refraction in 2 patients (14.28%), and patient dissatisfaction postoperatively in 1 (7.14%) case.
CONCLUSION: ICL implantation results in predictable refractive outcomes over the long term with exchange/explantation rates comparable to previous literature. Improper vault size is the most common cause of ICL exchange/explantation among patients with or without KC.]]></description>
<pubDate>2021/10/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Albanderi Alhamzah, Saad S. Alharbi, Fahad Alfardan, Tariq Aldebasi and Tariq Almudhaiyan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Albanderi Alhamzah, Saad S. Alharbi, Fahad Alfardan, Tariq Aldebasi and Tariq Almudhaiyan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211110]]></guid><cfi:id>292</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Individuals with and without normal tension glaucoma exhibit comparable performance on tests of cognitive function]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211111]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate aspects of cognition impacted by individuals with and without normal tension glaucoma.
METHODS: Fifty normal tension glaucoma (NTG) and 50 control patients ≥50y of age were recruited from the UCSF Department of Ophthalmology. Demographic data and glaucoma parameters were extracted from electronic medical records for both groups. Tests of executive function [Executive Abilities: Measures and Instruments for Neurobehavioral Evaluation and Research (EXAMINER)] and learning and memory [California Verbal Learning Test–Second Edition (CVLT-II)] were administered to both NTG and controls. Race, handedness, best-corrected visual acuity, maximum intraocular pressure, optic nerve cup-to-disc ratio, visual field and optic nerve optical coherence tomography parameters, and a measure of general health (Charlson Comorbidity Index) were compared between NTG and controls as well as within NTG subgroups. Multivariate linear regression was used to compare group performances on the EXAMINER battery and CVLT-II while controlling for age, sex, and years of education.
RESULTS: NTG and controls were comparable with respect to age, sex, race, education, handedness, and the Charlson Comorbidity Index (P>0.05 for all). Performance on the EXAMINER composite score and the CVLT-II did not differ between NTG and controls (P>0.05 for both).
CONCLUSION: This is the first prospective study in which the cognitive function of subject with NTG were evaluated using a comprehensive, computerized neurocognitive battery. Subjects with NTG do not perform worse than unaffected controls on tests of executive function, learning, and memory. Results do not support the hypothesis that individuals with NTG are at higher risk for cognitive dysfunction and/or dementia.]]></description>
<pubDate>2021/10/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Qi N. Cui, David Green, Mohit Jethi, Todd Driver, Travis C. Porco, Jane Kuo, Shan C. Lin, Robert L. Stamper, Ying Han, Cynthia S. Chiu, Saras Ramanathan, Michael E. Ward, Katherine Possin and Yvonne Ou]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Qi N. Cui, David Green, Mohit Jethi, Todd Driver, Travis C. Porco, Jane Kuo, Shan C. Lin, Robert L. Stamper, Ying Han, Cynthia S. Chiu, Saras Ramanathan, Michael E. Ward, Katherine Possin and Yvonne Ou</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211111]]></guid><cfi:id>291</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of intraocular pressure peak and fluctuations among Filipino patients with non-glaucomatous eyes and glaucoma suspects using water drinking test and diurnal intraocular pressure]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211112]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the intraocular pressure (IOP) peaks and fluctuations using water drinking tests (WDTs) and mean diurnal IOP among Filipino patients with normal eyes and glaucoma suspects
METHODS: This prospective study included normal and glaucoma suspect patients. Each patient underwent both WDT and mean diurnal examination on separate visits. For mean diurnal examination, IOP was recorded every 2h for 8h while in WDT, IOP was recorded prior to WDT, and post-WDT at 5, 15, 30, 45, and 60min. IOP peak was recorded as the highest IOP for both methods, and IOP fluctuation was recorded as highest IOP minus lowest IOP.
RESULTS: With the comparison of diagnostic tests, both normal eyes and glaucoma suspect groups, the peak IOP was caught at 15min. Comparative analysis of both groups also showed that the peak IOP measurements were statistically higher for the WDT compared to mean diurnal IOP (P=0.039, P=0.048 under normal group and P=0.032 and P=0.031 under glaucoma suspect group). Similarly, the WDT had a statistically higher mean IOP fluctuation score than the mean diurnal IOP method in both groups (P=0.003, P=0.011 under normal group; P=0.002 and P=0.005 under glaucoma suspect group).
CONCLUSION: This study shows that WDT is a comparable diagnostic exam in predicting IOP fluctuations than mean diurnal measurement. WDT is a promising diagnostic procedure for risk assessment in glaucoma.]]></description>
<pubDate>2021/10/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Anelisa Koh and Cynthia Verzosa]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Anelisa Koh and Cynthia Verzosa</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211112]]></guid><cfi:id>290</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Safety and effectiveness of an iris hook assisted phacoemulsification in vitrectomized eyes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211113]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To introduce a simple iris hook assisted phacoemulsification (PE) procedure and evaluate the safety and efficacy of it in completely vitrectomized eyes.
METHODS: A single centre study which included 65 previously completely vitrectomized eyes of 62 patients who underwent cataract surgery. Patients were randomly divided into 3 groups. Patients received PE, and intraocular lens (IOL) implantation with the assistance of iris hook (SynergetiesTM) as group A (25 eyes); patients who received PE assisted with a 25G pars plana irrigation as group B (20 eyes), and patients who received PE performed without the help of any instrument as group C (20 eyes). Main outcome measures were surgery duration, Ultrasound (U/S) total time, endothelial cell density (ECD), cumulative dissipated energy (CDE) and complications of the procedures.
RESULTS: With the help of iris hook, the patients in group A had the lowest ECD loss rate (0.07±0.03, 0.09±0.03, and 0.10±0.03, P<0.05), shortest CDE (12.2±4.1, 15.8±6.0, and 16.0±6.0, P<0.05) and U/S total time (36.6±13.0s, 46.3±16.4s, and 47.6±16.1s, P<0.05), and minimal incidence of complications. The longest surgery duration was in group B (19.4±1.6min) and maximum complications rate in group C (20% miosis, 10% posterior capsular tears, 5% zonular dialysis, 5% cystoid macular edema). While best-corrected visual acuity (BCVA), intraocular pressure (IOP) and ECD did not show a significant difference among the three groups.
CONCLUSION: Without prolonged surgery duration, the iris hook assistant method can minimize heat generation during surgery and incidence of complications, which transfer the challenged PE in vitrectomized eyes into a regular surgery. It does not need any change in the hydrodynamic parameters and in the bag PE technique, easy to operate even for junior surgeons.]]></description>
<pubDate>2021/10/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ling Bai, Yan-Fen Wang, Farheen Tariq, Yu-Ping Zheng, Hai-Xiao Feng, Feng Wang and Shu Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ling Bai, Yan-Fen Wang, Farheen Tariq, Yu-Ping Zheng, Hai-Xiao Feng, Feng Wang and Shu Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211113]]></guid><cfi:id>289</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Altered brain network centrality in patients with retinal vein occlusion: a resting-state fMRI study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211114]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To explore the intrinsic brain activity variations in retinal vein occlusion (RVO) subjects by using the voxel-wise degree centrality (DC) technique.
METHODS: Twenty-one subjects with RVO and twenty-one healthy controls (HCs) were enlisted and underwent the resting-state functional magnetic resonance imaging (rs-fMRI) examination. The spontaneous cerebrum activity variations were inspected using the DC technology. The receiver operating characteristic (ROC) curve was implemented to distinguish the DC values of RVOs from HCs. The relationships between DC signal of definite regions of interest and the clinical characteristics in RVO group were evaluated by Pearson’s correlation analysis.
RESULTS: RVOs showed notably higher DC signals in right superior parietal lobule, middle frontal gyrus and left precuneus, but decreased DC signals in left middle temporal gyrus and bilateral anterior cingulated (BAC) when comparing with HCs. The mean DC value of RVOs in the BAC were negatively correlated with the anxiety and depression scale.
CONCLUSION: RVO is associated aberrant intrinsic brain activity patterns in several brain areas including pain-related as well as visual-related regions, which might assist to reveal the latent neural mechanisms.]]></description>
<pubDate>2021/10/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Wen-Jia Dong, Ting Su, Chu-Qi Li, Yong-Qiang Shu, Wen-Qing Shi, You-Lan Min, Qing Yuan, Pei-Wen Zhu, Kang-Cheng Liu, Jing-Lin Yi and Yi Shao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Wen-Jia Dong, Ting Su, Chu-Qi Li, Yong-Qiang Shu, Wen-Qing Shi, You-Lan Min, Qing Yuan, Pei-Wen Zhu, Kang-Cheng Liu, Jing-Lin Yi and Yi Shao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211114]]></guid><cfi:id>288</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[An online diabetic retinopathy screening tool for patients with type 2 diabetes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211115]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To develop a useful diabetic retinopathy (DR) screening tool for patients with type 2 diabetes mellitus (T2DM).
METHODS: A DR prediction model based on the Logistic regression algorithm was established on the development dataset containing 778 samples (randomly assigned to the training dataset and the internal validation dataset at a ratio of 7:3). The generalization capability of the model was assessed using an external validation dataset containing 128 samples. The DR risk calculator was developed through WeChat Developer Tools using JavaScript, which was embedded in the WeChat Mini Program.
RESULTS: The model revealed risk factors (duration of diabetes, diabetic nephropathy, and creatinine level) and protective factors (annual DR screening and hyperlipidemia) for DR. In the internal and external validation, the recall ratios of the model were 0.92 and 0.89, respectively, and the area under the curve values were 0.82 and 0.70, respectively.
CONCLUSION: The DR screening tool integrates education, risk prediction, and medical advice function, which could help clinicians in conducting DR risk assessments and providing recommendations for ophthalmic referral to increase the DR screening rate among patients with T2DM.]]></description>
<pubDate>2021/10/27 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Wan-Yue Li, Ming Yang, Ya-Nan Song, Ling Luo, Chuang Nie and Mao-Nian Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Wan-Yue Li, Ming Yang, Ya-Nan Song, Ling Luo, Chuang Nie and Mao-Nian Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211115]]></guid><cfi:id>287</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical effectiveness of diquafosol ophthalmic solution 3% in Korean patients with dry eye disease: a multicenter prospective observational study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211007]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the effectiveness of diquafosol ophthalmic solution 3% administered in Korean patients with dry eye disease in real-world clinical settings.
METHODS: Diquafosol was administered for 8wk to 3 patient groups who received diquafosol as add-on therapy to existing medication (Add group, n=150); received diquafosol only (Monotherapy group, n=196); or discontinued part of their existing medication in favor of diquafosol (Switch group, n=11). Tear break-up time (TBUT), cornea and conjunctival staining based on National Eye Institute/Industry scoring scheme, subjective symptoms using the Ocular Surface Disease Index (OSDI) questionnaire, and meibum quality and expressibility were evaluated at baseline, week 4, and week 8.
RESULTS: The mean TBUT increased (from 3.46, 3.92, and 5.84s, respectively, to 5.15, 5.53, and 8.59s, respectively) and corneal staining score decreased (from 2.23, 2.24, and 3.09, respectively, to 0.85, 0.97, and 1.64, respectively) in a time-dependent manner from baseline to week 8 in all three groups. Conjunctival staining score, OSDI questionnaire, and meibum quality and expressibility improved over time from baseline to week 8 in the Add and Monotherapy groups, but differences were not statistically significant in the Switch group.
CONCLUSION: Diquafosol improves subjective symptoms and objective signs in patients treated with existing medicines combined with diquafosol and treated solely with diquafosol. Diquafosol can be used as an effective therapeutic agent for dry eye disease or additionally applied in patients who have insufficient response to existing medicines.]]></description>
<pubDate>2021/9/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Youngsub Eom and Hyo Myung Kim]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Youngsub Eom and Hyo Myung Kim</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211007]]></guid><cfi:id>286</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Assessment of anterior chamber angle changes after phacoemulsification with swept-source OCT]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211008]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the changes of anterior chamber angle in patients with shallow anterior chamber after phacoemulsification combined with intraocular lens (IOL) implantation, based on anterior segment swept-source optical coherence tomography (AS-SS-OCT) measurements.
METHODS: This was a prospective case control study; sixty eyes of sixty case were scheduled for cataract surgery with normal intraocular pressure (IOP). Based on anterior chamber depth (ACD) and gonioscopy findings, the eyes were divided into two groups: group of shallow anterior chamber and narrow angle (SAC group, 30 eyes); and group of normal anterior chamber group with wide angle (NAC group, 30 eyes). Measurements of ACD, anterior chamber volume (ACV), iris volume (IV), lens vault (LV), angle opening distance (AOD), angle recess area (ARA), trabecular iris space area (TISA), and trabecular iris angle (TIA) were conducted in each group before and 3mo after surgery.
RESULTS: There was no significant difference in age, axial length (AL), corneal curvature, corneal diameter, intraocular pressure, and IV between two groups before surgery, except for the LV (P=0.000). ACD and ACV were prominently larger in the NAC group than the SAC group 3mo after operation (3.69±0.38 vs 3.85±0.39 mm, P=0.025; 161.37±19.47 vs 178.26±20.30 mm3, P=0.002). AOD750, ARA750 in nasal and inferior quadrants, TISA750 in all quadrants except temporal, and TIA750 in all quadrants in SAC group were significantly smaller than those in NAC group after operation (all P<0.05).
CONCLUSION: Cataract surgery can deepen anterior chamber and increase the width of anterior chamber angle in Chinese subjects, but the angle related parameters including AOD750, ARA750, TISA750, TIA, TISA750, and ACV in patients with shallow anterior chamber and narrow angle do not reach the normal level.]]></description>
<pubDate>2021/9/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Qian Zheng, Man Hu, Zhang-Liang Li, Ping-Jun Chang and Yun-E Zhao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Qian Zheng, Man Hu, Zhang-Liang Li, Ping-Jun Chang and Yun-E Zhao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211008]]></guid><cfi:id>285</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Association of peripheral anterior synechia, intraocular pressure, and glaucomatous optic neuropathy in primary angle-closure diseases]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211009]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the association of peripheral anterior synechiae (PAS) with intraocular pressure (IOP) and glaucomatous optic neuropathy (GON) in primary angle closure (PAC) and primary angle-closure glaucoma (PACG).
METHODS: Totally 355 eyes (238 PAC and 117 PACG) of 181 patients were included in this retrospective analysis of baseline data from a randomized clinical trial. All patients had undergone a comprehensive ophthalmic examination. The extent of PAS in clock hours as determined on gonioscopy was documented. The independent effect of the extent of PAS on IOP and the prevalence of GON were determined using multivariable generalized estimating equation (GEE) models.
RESULTS: The frequency of GON increased with the extent of PAS and a higher IOP. PAS were more extensive (8 vs 1 clock hour, P<0.001) and IOP higher (28.01 vs 18.00 mm Hg, P<0.001) in PACG compared to PAC. The prevalence of GON among the PAS quartiles were 10.2% (PAS<0.5 clock hours), 16.9% (PAS≥0.5 and PAS<3 clock hours), 29.6% (PAS≥3 and PAS<7 clock hours), and 74.4% (PAS≥7 clock hours), respectively. After adjusting for IOP, age, gender, spherical equivalent, average Shaffer score and number of medications, the odds ratio (OR) for GON was 4.4 (95%CI: 1.5-13.0; P=0.007) with PAS≥3 clock hours and 13.8 (95%CI: 4.3-43.6; P<0.001) with PAS≥7 clock hours as compared to eyes with PAS<0.5 clock hours. The frequency of GON increased linearly with the extent of PAS. Extent of PAS was also associated with higher IOP. Eyes with both PAS≥6 clock hours and IOP≥21 mm Hg had the highest risk of GON compared to eyes with both PAS<6 clock hours and IOP<21 mm Hg (OR=18.0, 95%CI: 7.5-43.4; P<0.001).
CONCLUSION: The extent of PAS in PAC and PACG is an important predictor of higher IOP and is linearly associated with GON independent of IOP, suggesting other factors related to PAS formation may be involved in the development of GON in PACG.]]></description>
<pubDate>2021/9/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ming Zhang, Guang-Yun Mao, Cong Ye, Su-Jie Fan, Yuan-Bo Liang and Ning-Li Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ming Zhang, Guang-Yun Mao, Cong Ye, Su-Jie Fan, Yuan-Bo Liang and Ning-Li Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211009]]></guid><cfi:id>284</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Efficacy and safety of newly developed preservative-free latanoprost 0.005% eye drops versus preserved latanoprost 0.005% in open angle glaucoma and ocular hypertension: 12-week results of a randomized, multicenter, controlled phase III trial]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211010]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the therapeutic efficacy, safety and tolerability of newly developed preservative-free (PF) latanoprost generic [TJO-002] and compare it with benzalkonium chloride (BAK)-preserved latanoprost [Xalatan&#174;] in patients with primary open angle glaucoma (POAG) and ocular hypertension (OHT).
METHODS: Included patients were aged ≥19y with POAG/OHT. After a washout period, patients with IOP 21-35 mm Hg at 9 a.m. were enrolled. After a full ophthalmic and glaucoma examination, 144 patients with POAG and OHT participated in this study. Subjects were randomly assigned either PF latanoprost (74 eyes) or BAK-preserved latanoprost (70 eyes). All subjects were examined at 4, 8, and 12wk after first administration. At each follow-up visit, IOP was measured at 9 a.m. and 5 p.m. and compliance was assessed. Throughout the study, all adverse events were recorded and monitored by the masked investigators who measured IOP.
RESULTS: Both groups showed a statistically significant decrease of average diurnal IOP at 12wk compared to baseline (-7.21±3.10 mm Hg in the PF latanoprost group and -7.02±3.17 mm Hg in the BAK latanoprost group, both P<0.0001). There was no statistically significant diurnal IOP variation between the groups. In terms of tolerability, pruritus, burning/stinging, and sticky eye sensation, severity was significantly lower in the PF latanoprost group than in the BAK latanoprost group (P<0.05).
CONCLUSION: PF latanoprost has at least similar efficacy in terms of IOP reduction and better tolerability compared with BAK latanoprost.]]></description>
<pubDate>2021/9/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Joon Mo Kim, Kyung Rim Sung, Ji Woong Lee, Haksu Kyung, Seungsoo Rho and Chan Yun Kim]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Joon Mo Kim, Kyung Rim Sung, Ji Woong Lee, Haksu Kyung, Seungsoo Rho and Chan Yun Kim</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211010]]></guid><cfi:id>283</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effective treatment for secondary angle-closure glaucoma caused by traumatic lens subluxation: phacoemulsification with capsular-tension-ring implantation combined with ophthalmic endoscope-controlled goniosynechialysis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211011]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the safety and efficacy of phacoemulsification with capsular-tension-ring implantation and posterior chamber intraocular lens implantation combined with ophthalmic endoscope-controlled goniosynechialysis (Phaco-CTR-IOL-OE-GSL) for treating secondary angle-closure glaucoma induced by traumatic lens subluxation.
METHODS: A retrospective and descriptive study was performed on patients with lens subluxation, angle closure, goniosynechia, and evaluated intraocular pressure (IOP) that cannot be controlled with medication, who underwent Phaco-CTR-IOL-OE-GSL. The postoperative best-corrected visual acuity (BCVA), IOP, range of goniosynechia and complications were retrospectively observed.
RESULTS: Nine patients with secondary angle-closure glaucoma induced by traumatic lens subluxation were included. The follow-up period was 51.1±8.6mo. The preoperative range of zonule rupture was 158.2°±33.0°, and the range of goniosynechia was 220.0°±92.5°. The baseline BCVA was 0.9±1.0 logMAR, IOP was 30.7±17.3 mm Hg, and number of anti-glaucoma medication was 3.2±1.1. Mild intraoperative hyphaemia with 8 eyes (88.8%) in the anterior chamber, and was absorbed two days postoperatively. One eye (11.1%) had postoperative ciliary body detachment and was recovered after five days of topical drug treatment. BCVA was 0.2±0.2 logMAR at 3mo postoperatively. The average IOP at the last follow-up was 16.7±2.0 mm Hg, and no anti-glaucoma medications were used. The average range of recurrent goniosynechia was 54.9°±33° at the final postoperative gonioscopic examination.
CONCLUSION: Phaco-CTR-IOL-OE-GSL is safe and effective in the treatment of secondary angle-closure glaucoma induced by traumatic lens subluxation. The use of an endoscope provides a more direct and clear examination for GSL, and 360° dissection is easily achieved.]]></description>
<pubDate>2021/9/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Qi Dai, Lin Fu, Xin-Yi Liu and Wei-Hua Pan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Qi Dai, Lin Fu, Xin-Yi Liu and Wei-Hua Pan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211011]]></guid><cfi:id>282</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Impact of intraocular pressure fluctuations on progression of normal tension glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211012]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate short- and long-term intraocular pressure (IOP) fluctuations and further ocular and demographic parameters as predictors for normal tension glaucoma (NTG) progression.
METHODS: This retrospective, longitudinal cohort study included 137 eyes of 75 patients with NTG, defined by glaucomatous optic disc or visual field defect with normal IOP (<21 mm Hg), independently from therapy regimen. IOP fluctuation, mean, and maximum were inspected with a mean follow-up of 38mo [standard deviation (SD) 18mo]. Inclusion criteria were the performance of minimum two 48-hour profiles including perimetry, Heidelberg retina tomograph (HRT) imaging, and optic disc photographs. The impact of IOP parameters, myopia, sex, cup-to-disc-ratio, and visual field results on progression of NTG were analyzed using Cox regression models. A sub-group analysis with results from optical coherence tomography (OCT) was performed.
RESULTS: IOP fluctuations, average, and maximum were not risk factors for progression in NTG patients, although maximum IOP at the initial IOP profile was higher in eyes with progression than in eyes without progression (P=0.054). The 46/137 (33.5%) eyes progressed over the follow-up period. Overall progression (at least three progression confirmations) occurred in 28/137 eyes (20.4%). Most progressions were detected by perimetry (36/46). Long-term IOP mean over all pressure profiles was 12.8 mm Hg (SD 1.3 mm Hg); IOP fluctuation was 1.4 mm Hg (SD 0.8 mm Hg). The progression-free five-year rate was 58.2% (SD 6.5%).
CONCLUSION: Short- and long-term IOP fluctuations do not result in progression of NTG. As functional changes are most likely to happen, NTG should be monitored with visual field testing more often than with other devices.]]></description>
<pubDate>2021/9/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Susanne Hopf, Doris Schwantuschke, Irene Schmidtmann, Norbert Pfeiffer and Esther Maria Hoffmann]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Susanne Hopf, Doris Schwantuschke, Irene Schmidtmann, Norbert Pfeiffer and Esther Maria Hoffmann</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211012]]></guid><cfi:id>281</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Intraluminal stenting versus external ligation of Ahmed glaucoma valve in prevention of postoperative hypotony]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211013]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare intraluminal stenting and external ligation of Ahmed glaucoma valves (AGV) for refractory glaucoma management and postoperative hypotony prevention.
METHODS: This randomized prospective blind study included 30 eyes of 25 patients (age range: 44-56y) with refractory glaucoma. This study was conducted from September 2018 to January 2020. The study included two groups, AGV with intraluminal stenting group (n=15 eyes) and AGV with external ligation group (n=15 eyes). Follow-up period was one year postoperatively. The primary outcome was intraocular pressure (IOP) and its association with the number of postoperative glaucoma medications. IOP?≤?21 mm Hg without medications indicated complete success while IOP?≤?21 mm Hg with medications indicated qualified success; and IOP<6 mm Hg was defined as hypotony.
RESULTS: After a year of follow-up, IOP was significantly reduced in the intraluminal stenting group than in the external ligation group (11.67±0.89 vs 14.2±4.0 mm Hg, respectively, P=0.024). Postoperative hypotony was more common in the external ligation group (2 cases, 13.33%) than in the intraluminal stenting group (1 case, 6.67%).
CONCLUSION: Application of intraluminal stenting or external ligation during AGV surgery usually prevents postoperative hypotony (transient and persistent) that occurs in conventional AGV surgery.]]></description>
<pubDate>2021/9/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Dina Abd Elfattah, Faried Wagdy, Tharwat Mokbel, Hisham Elsorogy and Abd-Elmonem A. Elhesy]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Dina Abd Elfattah, Faried Wagdy, Tharwat Mokbel, Hisham Elsorogy and Abd-Elmonem A. Elhesy</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211013]]></guid><cfi:id>280</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Visual acuity after intravitreal ranibizumab with and without laser therapy in the treatment of macular edema due to branch retinal vein occlusion: a 12-month retrospective analysis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211014]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To identify factors contributing to visual improvement after treatment of macular edema (ME) secondary to branch retinal vein occlusion (BRVO), and to assess the interaction between laser therapy and intravitreal ranibizumab (IVR).
METHODS: We retrospectively reviewed the medical records of patients who had been treated for BRVO-related ME at our hospital. Records were traceable for at least 12mo, and evaluated factors included age, sex, medical history, smoking history, treatment methods, foveal hemorrhage, and change in visual acuity. Treatments included laser therapy, IVR, sub-Tenon’s capsule injection of triamcinolone (STTA), a combination, or no intervention. Multivariate logistic regression analysis and interaction terms were used to assess the clinical efficacy of the treatments, and odds ratios (OR) and 95% confidence intervals (CI) were calculated.
RESULTS: Seventy-three patients (34 men, 39 women; 73 eyes) with a mean age of 69.4±12.1y were included. Patients who underwent IVR monotherapy, laser monotherapy, and STTA+laser had significantly higher best corrected visual acuity at 12mo compared to baseline (P<0.001, <0.001, and 0.019, respectively). Logistic regression analysis without interaction terms found that IVR was a significant visual acuity recovery factor (adjusted OR: 3.89, 95%CI: 1.25-12.1, P=0.019). Adjusted OR using an interaction model by logistic regression was 16.6 (95%CI: 2.54-108.47, P=0.003) with IVR treatment, and 8.25 (95%CI: 1.34-50.57, P=0.023) with laser treatment. No interaction was observed (adjusted OR: 0.07, 95%CI: 0.01-0.75, P=0.029).
CONCLUSION: IVR contributes to improvements in visual acuity at 12mo in ME secondary to BRVO. No interaction is observed between laser therapy and IVR treatments.]]></description>
<pubDate>2021/9/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Reiko Umeya, Koichi Ono and Toshimitsu Kasuga]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Reiko Umeya, Koichi Ono and Toshimitsu Kasuga</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211014]]></guid><cfi:id>279</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Dexamethasone intravitreal implant (Ozurdex) in diabetic macular edema: real-world data versus clinical trials outcomes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211015]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the safety and efficacy of intravitreal dexamethasone implants (Ozurdex&#174;/DEX) in patients with diabetic macular edema (DME) either na&#239;ve or non-na&#239;ve to anti-VEGF therapies who switched to DEX implant independent of response to anti-vascular endothelial growth factors (anti-VEGFs).
METHODS: This was an audit retrospective review of medical records of patients with DME who switched to the DEX intravitreal implant. Patients were divided into 2 groups: patients na&#239;ve to antiangiogenic therapy and patients who were previously treated with anti-VEGFs. Data regarding demographics, changes in mean best-corrected visual acuity (BCVA), central macular thickness (CMT), and intraocular pressure (IOP) was collected over 6mo. The demographic data mean changes in BCVA, CMT, and IOP were compared. Six-month follow-up data of 47 patients (57 eyes), who either switched to DEX implant irrespective of response to previous treatments or were treatment na&#239;ve before receiving DEX implant, was collected.
RESULTS: Improvement in mean BCVA was observed from 1-4mo after injection with a decreased effect at month 6 as expected, with better outcomes in na&#239;ve compared to non-na&#239;ve patients. A statistically relevant decrease in mean CMT was observed during the follow-up period. An increase in mean IOP was observed in the first 2mo after DEX therapy. The mean number of injections of the overall population during the 6mo was 1.3. A subgroup analysis showed no relevant difference between phakic versus pseudophakic patients relative to measured outcomes. There was no cataract progression during the follow-up period and no adverse events reported.
CONCLUSION: This real-life setting study shows that intravitreal DEX implant is effective and safe. The timings of greater therapeutic impact are concordant with previous studies and suggest that earlier treatment with corticosteroids may have an additional benefit in na&#239;ve patients.]]></description>
<pubDate>2021/9/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Pedro Neves, Mário Ornelas, Inês Matias, Joao Rodrigues, Margarida Santos, Marco Dutra-Medeiros and David Martins]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Pedro Neves, Mário Ornelas, Inês Matias, Joao Rodrigues, Margarida Santos, Marco Dutra-Medeiros and David Martins</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211015]]></guid><cfi:id>278</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparative analysis of the clinical outcomes between wavefront-guided and conventional femtosecond LASIK in myopia and myopia astigmatism]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211016]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the clinical outcomes of wavefront guided femtosecond LASIK (WFG LASIK) and conventional femtosecond LASIK (NWFG LASIK) in eyes with myopia and myopia astigmatism.
METHODS: This was a retrospective, nonrandomized, comparative investigation enrolling 236 eyes of 122 patients (18-50y) with low & moderate and high myopia. The WFG group including 97 eyes (50 patients) undergone WFG LASIK and the NWFG group including 139 eyes (72 patients) undergone conventional LASIK. Mean efficacy index, high order aberrations (HOAs), pupil size and the quality of visual questionnaire were evaluated 6mo postoperatively.
RESULTS: There is no difference between WFG group (-0.054±0.049 in logMAR) and NWFG group (-0.040±0.056) in uncorrected distance visual acuity (UDVA) postoperatively. The myopia astigmatism is higher in WFG group than that in NWFG group (P<0.05). However, the mean efficacy index (MEI) in the WFG group (1.09±0.106) is better than that in the NWFG group (1.036±0.124; P<0.001). Increased HOAs were observed in NWFG group (0.30±0.196) than that in WFG group (0.146±0.188; P<0.001). The pupil size is larger in WFG group (5.15±0.76 mm) than that in NWFG group (4.32±0.52 mm). The patients are satisfied with the clinical surgery, yet WFG group showed better visual quality using the questionnaire survey. Meanwhile, high myopia would result in worse MEI, HOAs and visual quality than low & moderate myopia.
CONCLUSION: WFG and NWFG FS-LASIK are both effective and safe procedures to correct low & moderate and high myopia, but WFG FS-LASIK gives a better postoperative MEI, aberrometric control and predictable outcome. Meanwhile, WFG FS-LASIK is better than NWFG FS-LASIK in correction of myopia astigmatism. Low & moderate myopia allow better clinical outcomes than high myopia using any surgical method.]]></description>
<pubDate>2021/9/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xiao Gui, Rui Zhang, Sha Li, Na Zhao, Hao-Rui Zhang, Yu-Kun Zhou, Chen-Yang Huan, Chun-Yan Zhao, Hong-Ying Wang, Hong-Yuan Song, Wei Shen and Jian-Hua Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiao Gui, Rui Zhang, Sha Li, Na Zhao, Hao-Rui Zhang, Yu-Kun Zhou, Chen-Yang Huan, Chun-Yan Zhao, Hong-Ying Wang, Hong-Yuan Song, Wei Shen and Jian-Hua Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211016]]></guid><cfi:id>277</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Reliability of the ocular trauma score for the predictability of traumatic and post-traumatic retinal detachment after open globe injury]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211017]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To elucidate the question of whether the ocular trauma score (OTS) and the zones of injury could be used as a predictive model of traumatic and post traumatic retinal detachment (RD) in patients with open globe injury (OGI).
METHODS: A retrospective observational chart analysis of OGI patients was performed. The collected variables consisted of age, date, gender, time of injury, time until repair, mechanism of injury, zone of injury, injury associated vitreous hemorrhage, trauma associated RD, post traumatic RD, aphakia at injury, periocular trauma and OTS in cases of OGI.
RESULTS: Totally 102 patients with traumatic OGI with a minimum of 12mo follow-up and a median age at of 48.6y (range: 3-104y) were identified. Final best corrected visual acuity (BCVA) was independent from the time of repair, yet a statistically significant difference was present between the final BCVA and the zone of injury. Severe trauma presenting with an OTS score I (P<0.0001) or II (P<0.0001) revealed a significantly worse BCVA at last follow up when compared to the cohort with an OTS score >III. OGI associated RD was observed in 36/102 patients (35.3%), whereas post traumatic RD (defined as RD following 14d after OGI) occurred in 37 patients (36.3%). OGI associated RD did not correlate with the OTS and the zone of injury (P=0.193), yet post traumatic RD correlated significantly with zone III injuries (P=0.013).
CONCLUSION: The study shows a significant association between lower OTS score and zone III injury with lower final BCVA and a higher number of surgeries, but only zone III could be significantly associated with a higher rate of RD.]]></description>
<pubDate>2021/9/23 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Simon Dulz, Vasilis Dimopoulos, Toam Katz, Robert Kromer, Eileen Bigdon, Martin Stephan Spitzer and Christos Skevas]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Simon Dulz, Vasilis Dimopoulos, Toam Katz, Robert Kromer, Eileen Bigdon, Martin Stephan Spitzer and Christos Skevas</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20211017]]></guid><cfi:id>276</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of 0.01% atropine eyedrops on intraocular pressure in schoolchildren: a randomized clinical trial]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220904]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the effect of 0.01% atropine eye drops on intraocular pressure (IOP) in myopic children.METHODS: A placebo-controlled, double-masked, randomized study. Totally 220 children aged 6 to 12y with myopia ranging from -1.00 to -6.00 D in both eyes were enrolled. Children were randomized in a 1:1 ratio to either 0.01% atropine eye drops or a placebo group using generated random numbers. All participants underwent the examination of IOP and cycloplegic refraction at baseline, 6 and 12mo. The change of IOP and the proportion of subjects with increased IOP in atropine and placebo groups were compared.RESULTS: Of 220 children, 117 were boys (53.2%). A total of 159 (72.3%) participants completed the follow-up at the 1-year study. At baseline, the mean IOP was 15.74 mm Hg (95%CI, 15.13 to 16.34 mm Hg) for the 0.01% atropine group and 15.59 mm Hg (95%CI, 15.00 to 16.19 mm Hg) for placebo group (mean difference, 0.14 mm Hg; P=0.743) after adjusting for central corneal thickness at baseline. At one year follow-up, the mean change of IOP was 0.16 mm Hg (95%CI, -0.43 to 0.76 mm Hg) for the 0.01% atropine group and -0.11 mm Hg (95%CI, -0.71 to 0.50 mm Hg) for placebo group (mean difference, 0.27 mm Hg; P=0.525) after adjusting for central corneal thickness. The 51.4% of children have increased IOP in the 0.01% atropine group, compared with 45.9% in the placebo group (P=0.511).CONCLUSION: The 0.01% atropine eye drops do not significantly affect the risk of elevated IOP. It is relatively safer to use in the studies that try to minimize myopia progression. However, a further long-duration study is required to be validated.]]></description>
<pubDate>2022/9/1 14:00:52</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Javaria Bukhari, Shi-Fei Wei, Shi-Ming Li, Wen-Zai An, Jia-Ling Du, Xin-Tong Liang, Jia-He Gan, Jia-Xin Tian, Wei-Ling Bai, Zhi-Ning Cai, Lei Yin and Ning-Li Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Javaria Bukhari, Shi-Fei Wei, Shi-Ming Li, Wen-Zai An, Jia-Ling Du, Xin-Tong Liang, Jia-He Gan, Jia-Xin Tian, Wei-Ling Bai, Zhi-Ning Cai, Lei Yin and Ning-Li Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220904]]></guid><cfi:id>275</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Staged lensectomy and vitrectomy in the management of stage 5C retinopathy of prematurity with corneal opacification: long-term follow up]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220905]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To verify the feasibility and safety of staged lensectomy and vitrectomy in stage 5C retinopathy of prematurity (ROP) with corneal opacification.METHODS: This was a retrospective, interventional, consecutive case series. Twenty-two eyes of 18 stage 5C ROP patients with corneal opacification were included. Regular combined lensectomy and vitrectomy were not prescribed due to the invisible fundus. Staged lensectomy and posterior vitrectomy were performed. The anatomical and visual outcomes were reviewed at the final follow-up visit.RESULTS: The mean gestational age of ROP patients was 29.3±1.6wk (range: 27-32wk), comprising 8 males and 10 females. The average birth weight was 1363.0±300.0 g. All the eyes had corneal opacity and flat or disappeared anterior chambers pre-operatively. Two eyes had complicated cataract and 7 eyes had retrolental fibroplasia. Six eyes had posterior pupillary synechiae or membranes. Seven (31.8%) eyes had vascularly active retinas. The average interval between two procedures was 6.8±4.6mo (2.5-18.5mo). After surgeries, all the patients had normal anterior chambers. Fourteen eyes had clear corneas. The intraocular pressure of 3 eyes with glaucoma was controlled by medication. Two eyes had ocular phthisis. The retina was reattached in 3 eyes and partially attached in 11 eyes. Visual acuity ranged from no light perception to hand motion.CONCLUSION: Staged lensectomy and vitrectomy are procedures that can halt progression to further complications and preserve some useful eyesight in stage 5C ROP patients with corneal opacification. The earlier the lensectomy is performed, the better the prognosis is.]]></description>
<pubDate>2022/9/1 14:00:52</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ping Fei, Ting-Yi Liang, Jie Peng, Yu Xu, Jia Luo, Qi Zhang, Jia-Kai Li, Jiao Lyu and Pei-Quan Zhao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ping Fei, Ting-Yi Liang, Jie Peng, Yu Xu, Jia Luo, Qi Zhang, Jia-Kai Li, Jiao Lyu and Pei-Quan Zhao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220905]]></guid><cfi:id>274</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical value of phenylephrine testing in the upper and lower eyelids of patients with aponeurotic and congenital eyelid ptosis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220906]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To characterize the phenylephrine test in aponeurotic and congenital eyelid ptosis, to determine the appropriate timing of the phenylephrine test, and to assess the responses of the upper and lower eyelids.METHODS: This was a retrospective analysis of 140 eyes of 87 patients (mean age 52.29±16.45y; 22 males, 65 females) with upper eyelid ptosis. Totally 88.6% had aponeurotic and 11.4% had congenital ptosis. For the evaluation of the responses of the upper and lower eyelids to topical 2.5% phenylephrine, the scleral show height, the marginal reflex distance (MRD) between the inferior margin of the upper eyelid and pupillary light reflex (MRD1), and between the central portion of the lower eyelid and pupillary light reflex (MRD2) were measured at the 2nd, 5th, and 15th minutes. The changes of MRD1 and MRD2 with time (ΔMRD1 and ΔMRD2) were evaluated.RESULTS: The mean MRD1, MRD2, and scleral show heights increased within 5min after testing, remaining largely stable between the 5th-15th minutes. The percentage of eyes with a greater response in MRD1 increased with increased severity of ptosis (P<0.05). Eyes with aponeurotic ptosis were more responsive to phenylephrine testing than congenital ptosis. The mild ptosis group had lower scleral show measurements and higher ΔMRD2 values. The ΔMRD1 and ΔMRD2 values were poorly correlated in all measurement times.CONCLUSION: Performing the phenylephrine test 5min after instilling the reagent is adequate to assess the maximum response of the upper and lower eyelids. The upper and lower eyelid responses in phenylephrine testing are poorly correlated. However, the ΔMRD2 is related with baseline scleral show degree that may be a postoperative predictive factor. Further studies are necessary to determine the relationship between the responses of the lower eyelids to phenylephrine testing.]]></description>
<pubDate>2022/9/1 14:00:52</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ozgun Melike Gedar Totuk, Meltem Guzin Altinel, Ayse Yagmur Kanra and Umit Aykan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ozgun Melike Gedar Totuk, Meltem Guzin Altinel, Ayse Yagmur Kanra and Umit Aykan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220906]]></guid><cfi:id>273</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Morphological changes in the iridocorneal angle and their relationship with intraocular pressure after infantile cataract surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220907]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate morphological changes in the iridocorneal angle after pediatric cataract surgery.METHODS: Children who underwent primary infantile cataract surgery were included and 64 eyes from 41 children, including 18 with unilateral cataracts (18 eyes) and 23 with bilateral cataracts (46 eyes) were examined. All patients underwent two gonioscopic examinations to evaluate the iridocorneal angle, before the primary lens removal and before the secondary intraocular lens implantation. The anatomical changes in the iridocorneal angle and the relationship between intraocular pressure (IOP) and iridocorneal angle changes were also analyzed.RESULTS: The iridocorneal angle was wide in 64 eyes before and after surgery. The trabecular meshwork pigmentation, number of iris processes in every quadrant of the iridocorneal angle, and the width of the ciliary body band in the superior and inferior quadrants at the second gonioscopic examination were significantly increased compared to those at the first examination (P<0.001, P<0.05, P<0.05, and P<0.05, respectively). IOP gradually increased at 1mo after operation, and returned to the preoperative level at 3mo. However, IOP still increased significantly at 6 and 12mo.CONCLUSION: The main changes after pediatric cataract surgery include an increase in trabecular meshwork pigmentation and number of iris processes, IOP gradually increase and has positive correlation with trabecular meshwork pigmentation and anterior insertion of iris process.]]></description>
<pubDate>2022/9/1 14:00:52</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Dan-Dan Wang, Zhang-Liang Li, Bing Zhang, Zi-Yi Lu, Wei-Chen Guan and Yun-E Zhao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Dan-Dan Wang, Zhang-Liang Li, Bing Zhang, Zi-Yi Lu, Wei-Chen Guan and Yun-E Zhao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220907]]></guid><cfi:id>272</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparative analysis of visual quality between unilateral implantation of a trifocal intraocular lens and a rotationally asymmetric refractive multifocal intraocular lens]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220908]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare visual quality after unilateral cataract surgery with implantation of trifocal intraocular lens (IOL) and asymmetric refractive multifocal IOL.METHODS: The prospective nonrandom, comparative study consisted of 60 eyes of 60 patients suffering unilateral cataract surgery with implantation of two different IOLs: AT LISA tri 839MP (30 eyes; Carl Zeiss Meditec, Germany) and LS-313 MF30 (30 eyes; Oculentis GmbH, Germany). Visual acuity, refractive outcome, contrast sensitivity, defocus curves, quality of vision, and optical phenomena were evaluated at 3mo postoperatively.RESULTS: There were no statistical differences between groups in uncorrected distance visual acuity (P=0.13) and uncorrected near visual acuity (P=0.54). In contrast, uncorrected intermediate visual acuity was better in trifocal group compared to the refractive multifocal group (P=0.02). No significant statistical between-group difference was detected in cylinder (P=0.43). Compared to trifocal group, spherical refraction and spherical equivalent in refractive multi focal group were more myopic (P<0.01). Under photopic conditions, no significant statistical differences were found between groups in contrast sensitivity at 3 and 6 cycles per degree (cpd). The refractive multifocal group performed better at 12 and 18 cpd than the trifocal group (P=0.01, P=0.034, respectively). The questionnaires of quality of vision and optical phenomena showed no differences between groups.CONCLUSION: Trifocal IOL is superior to refractive multifocal IOL in intermediate visual acuity. Rotationally asymmetric refractive multifocal IOL is more myopic in automated refraction and significantly better for the photopic contrast sensitivity at high frequency.]]></description>
<pubDate>2022/9/1 14:00:52</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Na Hui, Mei-Fang Chu, Yan Li, Cong-Yi Wang, Lei Yu and Bo Ma]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Na Hui, Mei-Fang Chu, Yan Li, Cong-Yi Wang, Lei Yu and Bo Ma</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220908]]></guid><cfi:id>271</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Efficacy of haptic sutured in-the-bag intraocular lens for intraocular lens-capsule complex stability: a comparison of three insertion methods]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220909]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the efficacy and stability of haptic sutured in-the-bag intraocular lens (IOL) in eyes with zonular instability.METHODS: A total 60 eyes of 60 patients were included in this retrospective cohort study. Postoperative stability in three groups [haptic sutured IOL in the bag, IOL in the bag insertion with haptics oriented toward areas of zonulysis, IOL with capsular tension ring (CTR) in the bag insertion] were compared according to the IOL insertion methods. To evaluate the IOL stability, the changes of anterior chamber depth (ACD), refraction, contraction of anterior continuous curvilinear capsulotomy (CCC) area, and tilt of IOL were compared.RESULTS: There was no significant difference in change of ACD (-0.04±0.01 mm in group of haptic sutured IOL, -0.07±0.01 mm in group of CTR insertion) and refraction (0.05±0.05 D in group of haptic sutured IOL, 0.37±015 D in group of CTR insertion) between the group of haptic sutured IOL in the bag and CTR insertion group. But in comparison of CCC contraction and IOL tilt, CTR insertion group showed less contraction (1.00%±0.52%) and less IOL tilt (2.66°±0.11°) than the group of haptic sutured IOL in the bag (6.32%±1.36%, 3.47°±0.11°, respectively). The CTR insertion group showed the least CCC contraction and the least tilt.CONCLUSION: In eyes with zonular instability, the method of haptic sutured IOL in-the-bag shows comparable stability in ACD and refraction in comparison with IOL with CTR in the bag insertion. The method of IOL only in-the-bag insertion shows the largest contraction of CCC and the largest tilt of IOL.]]></description>
<pubDate>2022/9/1 14:00:53</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yang Kyung Cho, Andrew Thomson and Balamurali K Ambati]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yang Kyung Cho, Andrew Thomson and Balamurali K Ambati</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220909]]></guid><cfi:id>270</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Ultrasound biomicroscopic imaging demonstrate thinner ciliary body thickness in eyes with angle closure]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220910]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the ciliary body thickness between eyes with primary angle closure (PAC) and primary angle-closure glaucoma (PACG) with the normal eyes, and to investigate the association between ciliary body thickness and ciliary processes situation.METHODS: In this cross-sectional study, 57 patients with PAC/PACG were matched to 57 normal subjects after propensity score matching (PSM) adjusting for age and gender. All subjects underwent conventional ocular examinations and ultrasound biomicroscopy (UBM) examination, among which the patients with PAC/PACG performed the examinations one month after laser peripheral iridotomy (LPI). Quantitative parameters were measured, which included ciliary body thickness at the position of 1 mm posterior to the scleral spur (CBT1), trabecular-ciliary process distance (TCPD) and trabecular-ciliary process angle (TCA).RESULTS: Eyes with PAC/PACG presented significantly thinner CBT1, shorter TCPD and smaller TCA (P<0.001) than the normal eyes, both in comparison of the means of four quadrants and in comparisons of each quadrant. After removing images with peripheral anterior synechia (PAS), the same results were also found in comparisons between the two groups. Significant correlations were found between TCPD (R2=0.537, P<0.001) and TCA (R2=0.517, P<0.001) with CBT1.CONCLUSION: Eyes with PAC/PACG have thinner ciliary body thickness and more anteriorly situated ciliary processes. Thinner ciliary body thickness is associated with anterior situation of the ciliary processes.]]></description>
<pubDate>2022/9/1 14:00:53</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Shi-Yan Chen, Na He, Yu-Jie Yan, Xiang Fan and Ling-Ling Wu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Shi-Yan Chen, Na He, Yu-Jie Yan, Xiang Fan and Ling-Ling Wu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220910]]></guid><cfi:id>269</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Reproducibility of macular perfusion parameters in non-proliferative diabetic retinopathy patients by two different OCTA sweep modes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220911]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the reproducibility of macular perfusion parameters in non-proliferative diabetic retinopathy (NPDR) patients measured by different examiners and two different sweep modes of optical coherence tomography angiography (OCTA).METHODS: Ninety-eight (98 eyes) patients with NPDR were included in this study. All participates were performed three times using Cirrus OCTA with Angiography 3×3 mm2 and 6×6 mm2 sweep mode by two examiners. The macular foveal avascular zone (FAZ) and vessel density (VD) in the superficial retinal layer (SRL) were measured. The reproducibility of the measurements was evaluated with intraclass correlation coefficients (ICC) and coefficient of variation (CoV).RESULTS: The intra-mode ICCs of Angiography 3×3 mm2 and 6×6 mm2 sweep mode were 0.957 to 0.959 and 0.964 to 0.977, respectively; and the inter-mode ICCs were 0.962 to 0.970. The intra-examiner ICCs of macular perfusion parameters were >0.950; and the inter-examiner ICCs were 0.928 to 0.969. All CoVs were <1.0%.CONCLUSION: Cirrus OCTA can measure macular perfusion parameters in NPDR patients with excellent reproducibility. The measurements of FAZ and VD in the SRL determined by Angiography 3×3 mm2 and 6×6 mm2 sweep mode are highly consistent and both sweep modes are suitable for macular perfusion parameters measurement.]]></description>
<pubDate>2022/9/1 14:00:53</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Shen Qu, Ao Rong, Yun-Li Niu, Xin Liu, Yu-Shan Zhang, Chun-Yu Liu and Yan-Long Bi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Shen Qu, Ao Rong, Yun-Li Niu, Xin Liu, Yu-Shan Zhang, Chun-Yu Liu and Yan-Long Bi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220911]]></guid><cfi:id>268</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Peripapillary vessel density and retinal nerve fiber layer thickness changes in early diabetes retinopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220912]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To perform a quantitative analysis of the peripapillary vessel density (VD) and retinal nerve fiber layer (RNFL) thickness changes in patients with early stage of diabetic retinopathy (DR).METHODS: In this case-control study, swept-source optical coherence tomography angiography (SS-OCTA) imaging was used to examine diabetic and age-matched healthy subjects. The optic disc HD 6×6 mm2 blood flow imaging scan mode was selected. Automatic software was used to measure the peripapillary VD, capillary vessel density (CVD), and RNLF in an optic nerve head (ONH)  filed based on the Garway-Heath map. In addition, the correlation between peripapillary VD, CVD, and RNFL was further investigated.RESULTS: The cohort consisted of 32 healthy individuals and 72 patients with diabetes (34 eyes with no DR and 38 eyes with mild-moderate NPDR). Peripapillary VD decreased in the mild-moderate NPDR group compared to the control group in most regions (P<0.05). Peripapillary CVD and RNFL thickness were significantly lower in the mild-moderate NPDR group in the superior temporal (ST) quadrants (P=0.018, P=0.030). In the correlation analysis of each region, the RNFL thickness in the NS region was positively correlated with the peripapillary VD and CVD (r=0.233, P=0.05; r=0.288, P=0.015). In the TI region, the RNFL thickness was positively correlated with the peripapillary CVD (r=0.237, P=0.047).CONCLUSION: The measurement based on the ONH topographic map may be helpful in detecting functional and structural impairments in DR. The peripapillary VD, CVD and RNFL decrease in early DR, and the RNFL thickness altered in association with the CVD or/and VD in some regions.]]></description>
<pubDate>2022/9/1 14:00:53</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xiang-Ning Wang, Xuan Cai, Ting-Ting Li, Da Long and Qiang Wu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiang-Ning Wang, Xuan Cai, Ting-Ting Li, Da Long and Qiang Wu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220912]]></guid><cfi:id>267</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Inner limiting membrane peeling prevents secondary epiretinal membrane after vitrectomy for proliferative diabetic retinopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220913]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the role of internal limiting membrane (ILM) peeling in preventing secondary epiretinal membrane (ERM) formation in pars plana vitrectomy (PPV) for proliferative diabetic retinopathy (PDR).METHODS: This retrospective study analyzed the medical records of patients who underwent PPV for PDR and were followed up for minimum 3mo. ILM peeling was performed based on the intraoperative surgeons’ judgments. ERM was assessed by optical coherence tomography photography. The relationship between ILM peeling and postoperative ERM was analyzed.RESULTS: In total, 212 eyes from 197 patients were included in this study. The incidence of secondary ERM in the ILM non-peeling group was significantly higher than that in the ILM peeling group (37.0% vs 14.0%; P<0.001). Multivariate logistical regression revealed that ILM peeling was highly associated with the prevention of secondary ERM development [odds ratio 0.38; 95% confidence interval 0.17-0.86; P<0.05].CONCLUSION: ILM peeling during PPV for PDRs can effectively reduce the incidence of secondary ERM development and is worth consideration by vitreoretinal surgeons.]]></description>
<pubDate>2022/9/1 14:00:53</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Rong-Han Wu, Ming-Na Xu, Ke Lin, Ming-Xue Ren, Han Wen, Ke-Mi Feng, Hong-Jia Zhou, Nived Moonasar and Zhong Lin]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Rong-Han Wu, Ming-Na Xu, Ke Lin, Ming-Xue Ren, Han Wen, Ke-Mi Feng, Hong-Jia Zhou, Nived Moonasar and Zhong Lin</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220913]]></guid><cfi:id>266</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Various configuration types of the foveal avascular zone with related factors in normal Chinese adults with or without myopia assessed by swept-source OCT angiography]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220914]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To describe the morphological characteristics of foveal avascular zone (FAZ) in normal Chinese adults with or without myopia by swept-source optical coherence tomography angiography (SS-OCTA) and analyze the possible associated factors.METHODS: Normal Chinese adults with or without myopia aged between 18 and 60y were recruited into the study. One eye in each individual was randomly selected for scanning using SS-OCTA. FAZ parameters, central retinal thickness (CRT) and central choroidal thickness (CCT) were then analyzed. Correlations between systemic and ocular variables and FAZ parameters were subsequently evaluated. The subgroup analysis based on refractive error was also carried out.RESULTS: In total, 127 eyes out of 127 normal subjects were finally included in the study (mean age 29.5±8.22y, 61 males and 66 females). The pattern of FAZ was variable: round configuration in 28 eyes (22%), quadrilateral configuration in 23 eyes (18%), pentagonal configuration in 20 eyes (16%), oval configuration in 15 eyes (12%), triangular configuration in 6 eyes (5%) and irregular configuration in 35 eyes (28%). The mean area of FAZ was 0.37±0.12 mm2. Females had a larger FAZ (0.41±0.11 mm2 vs 0.32±0.11 mm2) compared with that of males (P<0.01). All myopic individuals showed smaller FAZ area and perimeter compared with that of normal individuals (P<0.01). There was no obvious correlation between age and FAZ. In the univariate regression analysis, both axial length (AL) and refractive error were significantly related to FAZ parameters. However, only CRT showed negative correlation with FAZ in the multivariate regression analysis.CONCLUSION: The pattern of FAZ configuration in normal Chinese adults with or without myopia is highly variable. Establishing quantitative parameters of FAZ would not only provide details of macular pathophysiology but could possibly contribute as a biomarker in disease staging.]]></description>
<pubDate>2022/9/1 14:00:54</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yan-Min Dong, Hai-Yan Zhu, Zhen-Hui Liu, Shu-Ying Fu, Ke Wang, Li-Ping Du and Xue-Min Jin]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yan-Min Dong, Hai-Yan Zhu, Zhen-Hui Liu, Shu-Ying Fu, Ke Wang, Li-Ping Du and Xue-Min Jin</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220914]]></guid><cfi:id>265</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Severe unilateral congenital ptosis with poor levator function: tarsoconjunctival mullerectomy plus levator resection vs frontalis sling procedure]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220805]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare frontalis sling and tarsoconjunctival mullerectomy plus levator resection (TCMLR) in subjects with severe unilateral congenital ptosis with poor levator function (LF).METHODS: A prospective non-randomized non-blinded single center clinical trial. Fifty patients with severe unilateral congenital ptosis with poor LF were recruited. The frontalis sling and TCMLR were performed and the functional, cosmetic outcomes, complications, and success rate were evaluated at 1, 3, and 6mo postoperatively. The t-test, Chi-square, Fishers exact, and nonparametric Mann-Whitney tests were used by SPSS software.RESULTS: Frontalis sling and TCMLR procedures were performed on 26 and 24 patients respectively. The mean age was 10.97±10.67y. LF was significantly better in the TCMLR group at months 1, 3, and 6 (P=0.002). Lagophthalmos was more common in the TCMLR group (no significant difference). At month 3, mild punctate epithelial erosions were observed more in the frontalis sling group (P=0.002). Significant complete success rate of 1st and 6th month for the frontalis sling vs TCMLR groups were 50% vs 20.8% (P=0.02), and 38.4% vs 50% (P=0.03) respectively.CONCLUSION: Complete success rate of TCMLR is higher in long-term follow-up in contrast with the frontalis sling in the short-term. Transient complications are more detected in mid-term follow-ups in both groups.]]></description>
<pubDate>2022/7/28 11:22:38</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Abolfazl Kasaee, Mostafa Aliabadi, Laily Najafi and Mansooreh Jamshidian-Tehrani]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Abolfazl Kasaee, Mostafa Aliabadi, Laily Najafi and Mansooreh Jamshidian-Tehrani</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220805]]></guid><cfi:id>264</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Methotrexate for chronic non-necrotizing anterior scleritis in Chinese patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220806]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the effectiveness and corticosteroid-sparing capabilities of methotrexate (MTX) in the treatment of chronic non-necrotizing anterior scleritis in Chinese patients.METHODS: A retrospective chart review of all patients with active anterior scleritis between January 2015 and June 2019 was conducted. All patients received 10 to 15 mg/wk MTX orally, and corticosteroids (10 to 40 mg/d prednisolone or equivalent methylprednisolone) with slow tapering. Topical corticosteroid eye drops (1% prednisolone actate, 0.1% dexmathosone or 0.1% fluoromethalone) were applied to control comorbid anterior uveitis at presentation or during follow up. The main outcomes were inflammation control and corticosteroid-sparing success, and secondary outcomes were reduction of immunosuppression load and best-corrected visual acuity (BCVA).RESULTS: Thirty-two eyes (22 patients) were included. The proportion of patients who achieved corticosteroid-sparing success was 50.0% at 3mo and 77.3% at 12mo [8 (36.4%) patients discontinued corticosteroid]. The proportion of eyes that achieved inflammation control was 59.4% at 3mo and 78.1% at 12mo. The immunosuppression load was 5.14±0.87 at presentation and 2.76±2.34 at 12mo (P<0.01). BCVA maintained unchanged or improved in 29 (90.6%) of all affected eyes. One patient discontinued MTX treatment because of an abnormal liver function test, and no other serious adverse effects were observed.CONCLUSION: According to this pilot study, low dose MTX appear to be a well-tolerated and effective treatment for chronic non-necrotizing anterior scleritis patients in the Chinese population.]]></description>
<pubDate>2022/7/28 11:22:38</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jun-Yan Xiao, An-Yi Liang, Fei Gao, Chan Zhao and Mei-Fen Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jun-Yan Xiao, An-Yi Liang, Fei Gao, Chan Zhao and Mei-Fen Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220806]]></guid><cfi:id>263</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Monitoring of central corneal thickness after phacoemulsification—comparison of statical and rotating Scheimpflug pachymetry, and spectral-domain OCT]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220807]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To explore the possibility of deploying three contactless devices (static and rotating Scheimpflug technology, spectral domain optical coherence tomography) for measuring central corneal thickness (CCT) in preoperative and postoperative examinations of cataract patients.METHODS: Totally 72 patients who had undergone surgery without complications were selected. The CCT was measured prior to the operation, as well as on the first, 5th-7th and 28th day following the operation using the Nidek NT 530-P, Sirius®, and Topcon OCT-2000 devices.RESULTS: A significant postoperative increase and subsequent decrease in CCT was identified with all three devices. The correlations were highly significant and thus reflect a very good degree of comparability at all times with the exception of the rotating Scheimpflug camera. The postoperative results from the latter differed significantly from the other devices. The correlations were Sirius/Topcon (P=0.010) and Sirius/Nidek (P<0.0005). No statistically significant difference could be identified in the comparison between Topcon and Nidek (P=0.056).CONCLUSION: All three devices are suitable for postoperative monitoring of CCT. The measurement results are only comparable to a limited extent and not interchangeable in the course of treating a single patient. This is due to the different imaging technology used in the devices and the resulting modalities for conducting the measurements.]]></description>
<pubDate>2022/7/28 11:22:38</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Daniel M. Handzel, Carsten H. Meyer and Alfred Wegener]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Daniel M. Handzel, Carsten H. Meyer and Alfred Wegener</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220807]]></guid><cfi:id>262</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Outcomes of chronic angle-closure glaucoma treated by phacoemulsification and endocyclophotocoagulation with or without endoscopically goniosynechialysis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220808]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the surgical outcomes of patients with chronic angle-closure glaucoma (CACG) treated with phacoemulsification (phaco)/endocyclophotocoagulation (ECP) with and without endoscopic goniosynechialysis (E-GSL).METHODS: A retrospective, nonrandomized, comparative case series was conducted. Patients with CACG who underwent phaco in combination with either ECP alone (ECP group) or GSL with ECP (E-GSL group) from 2018 to 2019 were followed for 12mo and reviewed. Clinical features and outcomes were identified and analyzed. The ECP and E-GSL groups were matched in age and baseline intraocular pressure (IOP). Changes in IOP, mean of visual acuity (VA), peripheral anterior synechiae (PAS) formation, and the number of glaucoma medications was examined.RESULTS: The ECP group included 32 eyes of 27 patients, and the E-GSL group included 32 eyes of 26 patients. The preoperative baseline IOP was 22.18±6.48 mm Hg in the ECP group and 22.95±6.71 mm Hg in the E-GSL group (P=0.644). The mean IOP reduction was 26.2% in the ECP group and 41.6% in the E-GSL group at 12mo. The mean postoperative VA (logMAR units) at 12mo was 0.47 in the ECP group and 0.36 in the E-GSL group. The reduction in PAS formation and the number of glaucoma medications was also higher in the ECP group than E-GSL group at 12mo.CONCLUSION: The phaco/ECP and phaco/E-GSL groups both achieve a significant reduction in IOP without complications associated with traditional glaucoma filtration surgeries.]]></description>
<pubDate>2022/7/28 11:22:38</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xing Wu, Ying Wang, Xi Liu, Zhao-Hui Li, Li-Qin Deng, Dai-Shi Chen and Da-Jiang Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xing Wu, Ying Wang, Xi Liu, Zhao-Hui Li, Li-Qin Deng, Dai-Shi Chen and Da-Jiang Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220808]]></guid><cfi:id>261</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Outcomes and predictors of vitrectomy and silicone oil tamponade in retinal detachments complicated by proliferative vitreoretinopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220809]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate outcomes and determine factors influencing the outcomes of vitrectomy with silicone oil (SO) endotamponade for the management of rhegmatogenous retinal detachment (RRD) complicated by advanced proliferative vitreoretinopathy (PVR).METHODS: This is a retrospective, interventional case series of eyes with PVR grade C associated RRD with or without prior surgery that underwent vitreoretinal surgery and SO tamponade. Eyes with a minimum follow-up of 6mo after SO extraction were included. Eyes were classified into three PVR subgroups according to severity and extension of proliferation. The influence of several preoperative, intraoperative and postoperative factors upon the functional and anatomical outcomes was assessed using multivariate logistic regression analysis.RESULTS: A hundred and one eyes of 101 patients that met the inclusion criteria were studied. Seventy-five of 101 eyes (74.3%) had successful retinal reattachment after one operation. Increased aqueous cell and flare at the first week exam had a statistically significant association with redetachment, recurrent membrane proliferation and keratopathy. Visual acuity improvement was significantly associated with faint postoperative aqueous inflammation values, primary vitrectomy and PVR outside of the posterior pole.CONCLUSION: Although encouraging anatomical and functional outcomes are achieved after vitrectomy and SO tamponade in eyes with RRD complicated by PVR, an increase in aqueous flare or cells at the first week follow-up is most likely to result in postoperative late complications. Primary vitrectomy, PVR associated with minimal posterior pole extension and absent to mild postoperative aqueous inflammation are associated with improved post-operative final visual acuity.]]></description>
<pubDate>2022/7/28 11:22:39</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Kenan Sonmez and Hilal Kilinc Hekimsoy]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Kenan Sonmez and Hilal Kilinc Hekimsoy</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220809]]></guid><cfi:id>260</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Changes in axial length after vitrectomy for rhegmatogenous retinal detachment combined with choroidal detachment]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220810]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report the postoperative axial length (AL) changes in rhegmatogenous retinal detachment combined with choroidal detachment (RRD-CD) patients.METHODS: The medical records of 97 consecutive patients from January 2015 to December 2018 were reviewed. Patients included were divided into RRD-CD and RRD only groups. All patients had received AL measurements before pars plana vitrectomy (PPV) and before silicone oil removal (SOR). The changes in AL of the two groups were compared. In addition, the potential factors related to AL changes were analyzed.RESULTS: AL elongation after PPV was 1.01 mm [interquartile range (IQR): 0.37, 1.79; P=0.02] in the RRD-CD group, which was greater than in RRD only group (0.15 mm, IQR: 0.04, 0.41; P<0.001). AL increased 0.06 mm per 1 mm Hg intraocular pressure changes in the RRD-CD group (R2=0.11, P=0.03). RRD-CD patient was 11.42 times (3.54-46.80) more likely to experience post-PPV AL elongation of more than 1 mm [P<0.001, Akaike information criterion (AIC)=92.33, area under the curve (AUC)=0.839].CONCLUSION: RRD-CD patients are very likely to have a postoperative elongation of AL. The primary intraoclular lens implantation using presurgery AL data may cause a significant refractive error in RRD-CD patients who underwent PPV.]]></description>
<pubDate>2022/7/28 11:22:39</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ji-Peng Li, Jun Xu and Meng Zhao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ji-Peng Li, Jun Xu and Meng Zhao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220810]]></guid><cfi:id>259</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Anti-VEGF reduces inflammatory features in macular edema secondary to retinal vein occlusion]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220811]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the anti-inflammatory effect of intravitreal injection of anti-vascular endothelial growth factor (anti-VEGF) in patients with macular edema secondary to retinal vein occlusion (RVO-ME).METHODS: Twenty-eight eyes from twenty-eight treatment-naïve patients (14 males and 14 females) with RVO-ME were included in this retrospective study. The retinal vein occlusion (RVO) was comprised of both central retinal vein occlusion (CRVO, n=14) and branch retinal vein occlusion (BRVO, n=14). Intravitreal injection of anti-VEGF reagents were administered monthly for three consecutive months, in which 18 patients were injected with ranibizumab and 10 patients were injected with conbercept. All eyes were imaged with optical coherence tomography angiography (OCTA) at baseline and 1wk after monthly intravitreal anti-VEGF injection. The visual acuity (VA), central macular thickness (CMT), the number of hyperreflective foci (HRF) recognized as an inflammatory sign in OCT images, and non-perfusion area (NPA), were compared before and after anti-VEGF treatments.RESULTS: The mean interval between baseline and follow-up was 29.4±0.79 (range, 27-48)d. Compared with the baseline, the VA improved (logMAR 1.5±0.1 vs 0.8±0.1, P<0.05) and CMT decreased (460±34.0 μm vs 268.8±12.0 μm, P<0.05), significantly, after anti-VEGF treatment. The number of HRF was decreased significantly (76.5±4.8 vs 47.8±4.3, P<0.05) after anti-VEGF treatment.CONCLUSION: Anti-VEGF therapy is effective in treating RVO-ME. The mechanisms for the decreased HRF and the reduction of NPA by anti-VEGF therapy merits further exploration.]]></description>
<pubDate>2022/7/28 11:22:39</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hai-Feng Qin, Fan-Jun Shi, Chao-Yang Zhang, Da-Wei Luo, Shi-Yue Qin, Jing Wu, Hai Xie, Jing-Ting Zhang, Qing-Hua Qiu, Kun Liu, Guo-Tong Xu, Guo-Xu Xu and Jing-Fa Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hai-Feng Qin, Fan-Jun Shi, Chao-Yang Zhang, Da-Wei Luo, Shi-Yue Qin, Jing Wu, Hai Xie, Jing-Ting Zhang, Qing-Hua Qiu, Kun Liu, Guo-Tong Xu, Guo-Xu Xu and Jing-Fa Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220811]]></guid><cfi:id>258</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of outcomes of idiopathic macular holes treated by vitrectomy with air or silicone oil tamponade based on the hole size]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220812]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the efficacy of vitrectomy combined with air or silicone oil in the treatment of idiopathic macular hole (IMH).METHODS: According to the results of high-definition optical coherence tomography (HD-OCT), 75 cases (75 eyes) of IMH in stage II-IV (Gass stage) in the General Hospital of Chinese PLA from January 2017 to December 2019 were collected for this retrospective study. The best corrected visual acuity (BCVA) and minimum diameter of IMH (MMHD) were measured. Eyes underwent vitrectomy combined with internal limiting membrane peeling operation, and were divided into disinfection air group (30 eyes) and silicone oil group (45 eyes) according to the intraocular tamponade. For MMHD≤400 μm (MMHD1), there were 23 eyes in air group and 16 eyes in silicone oil group. For MMHD2>400 μm (MMHD2), there were 7 eyes in air group and 29 eyes in silicone oil group. One month after surgery, the closure rates of IMH and BCVA were compared and analyzed. According to HD-OCT, the closure shape was graded with A (bridge closure) and B (good closure).RESULTS: The closure rates of air group and silicone oil group were 86.67% and 95.56% respectively with no significant difference (P>0.05); For MMHD1, those of air group and silicone oil group were 95.65% and 100% respectively with no significant difference (P>0.05); For MMHD2, those of air group and silicone oil group were 57.14% and 93.10% respectively, and those of the silicone oil group were higher than the air group (P<0.05). There was no significant difference in the closure shape grade between MMHD1 air group and silicone oil group (P>0.05). The proportion of Grade B in MMHD2 silicone oil group was higher than that in the air group (P<0.05). BCVA of each group after operation was better than that before operation, and there was no significant difference between air group and silicone oil group. While among them, MMHD1 air group was better than silicone oil group (P<0.05), and there was no significant difference between MMHD2 air group and silicone oil group (P>0.05).CONCLUSION: For smaller IMH (≤400 μm), the efficacy of vitrectomy combined with air should be considered better than silicone oil; for larger IMH (>400 μm), the efficacy of silicone oil may be better than air.]]></description>
<pubDate>2022/7/28 11:22:39</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Lan Yin, An-Qi Liu, Xin Jin, Liang Jia and Feng-Xiang Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Lan Yin, An-Qi Liu, Xin Jin, Liang Jia and Feng-Xiang Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220812]]></guid><cfi:id>257</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A algorithm for prediction of exudative retinal detachment risk of patients with pregnancy-induced hypertension]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220813]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the risk of exudative retinal detachment (ERD) morbidity in patients with pregnancy-induced hypertension (PIH) by using the logistic regression combined with the receiver operating characteristic (ROC) curve.METHODS: A total of 46 patients with ERD and 142 patients with non-ERD were diagnosed as PIH from January 2017 to February 2020. A retrospective comparison of the clinical manifestations and laboratory tests were conducted. The risk of ERD morbidity with PIH was predicted by using logistic regression combined with an ROC curve model.RESULTS: There was no significant difference in age and body mass index between the two groups before pregnancy (P>0.05). However, significant differences were found in gestational weeks, duration of hypertension, maximum and minimum systolic and diastolic blood pressure (BP), and plasma total protein (PTP) concentration between the two groups (P<0.05). Binary logistic regression analysis showed that the maximum systolic BP (OR=1.050, 95%CI: 1.016-1.085) and PTP concentration (OR=0.764, 95%CI: 0.702-0.832) were independent prediction risks of ERD in PIH. The sensitivities of maximum systolic BP, PTP concentration and combined diagnosis were 0.717, 0.870, and 0.870, respectively; the specificities were 0.617, 0.837, and 0.908, respectively; the area under the curve (AUC) was 0.707 (95%CI: 0.622-0.792), 0.917 (95%CI: 0.868-0.967), and 0.933 (95%CI: 0.890-0.975), respectively; the AUC of combined diagnosis was higher than that of single diagnosis (P<0.01).CONCLUSION: Logistic regression and ROC curve model combined with maximum systolic BP and PTP can improve the early identification of high-risk PIH patients in the hospital.]]></description>
<pubDate>2022/7/28 11:22:39</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Li Hu, Dong-Hao Li and Shuang-Yong Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Li Hu, Dong-Hao Li and Shuang-Yong Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220813]]></guid><cfi:id>256</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Nomogram model for predicting oculomotor nerve palsy in patients with intracranial aneurysm]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220814]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To explore the risk factors of oculomotor nerve palsy (ONP) in patients with intracranial aneurysm (IA) and develop a nomogram model for predicting ONP of IA patients.METHODS: A total of 329 IA patients were included. Logistic regression analysis was applied to identify independent factors, which were then integrated into the nomogram model. The performance of the nomogram model was evaluated by calibration curve, receiver operating curve (ROC), and decision curve analysis.RESULTS: Univariate and multivariate logistic regression analysis indicated posterior communicating artery (PCoA) aneurysm [hazard ratio (HR)=17.13, P<0.001] and aneurysm diameter (HR=1.31, P<0.001) were independent risk factors of ONP in IA patients. Based on the results of logistic regression analysis, a nomogram model for predicting the ONP in IA patients was constructed. The calibration curve indicated the nomogram had a good agreement between the predictions and observations. The nomogram showed a high predictive accuracy and discriminative ability with an area under the curve (AUC) of 0.863. The decision curve analysis showed that the nomogram was powerful in the clinical decision. PCoA aneurysm (HR=3.38, P=0.015) was identified to be the only independent risk factor for ONP severity.CONCLUSION: PCoA aneurysm and aneurysm diameter are independent risk factors of ONP in IA patients. The nomogram established is performed reliably and accurately for predicting ONP. PCoA aneurysm is the only independent risk factor for ONP severity.]]></description>
<pubDate>2022/7/28 11:22:39</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yuan-Yue Cui, Bin Wang, Bo Jiang and Shi-Hong Zhao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yuan-Yue Cui, Bin Wang, Bo Jiang and Shi-Hong Zhao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220814]]></guid><cfi:id>255</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Photopic pupil size change in myopic orthokeratology and its influence on axial length elongation]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220815]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To explore the photopic pupil size behavior in myopic children undergoing overnight orthokeratology (ortho-k) over 1-year period and its effects on the axial elongation.METHODS: A total of 202 Chinese myopic children were enrolled in this prospective clinical trial. Ninety-five subjects in ortho-k group and eighty-eight subjects in spectacle group completed the 1-year study. Axial length (AL) was measured before enrollment and every 6mo after the start of ortho-k. The photopic pupil diameter (PPD) was determined using the Pentacam AXL and measured in an examination room with lighting of 300-310 Lx. Stepwise multiple linear regression analysis was used to identify variables contribution to axial elongation.RESULTS: Compared with spectacle group, the average 1-year axial elongation was significantly slower in the ortho-k group (0.25±0.27 vs 0.44±0.23 mm, P<0.0001). In ortho-k group, PPDs significantly decreased from 4.21±0.62 mm to 3.94±0.53 mm after 1mo of lens wear (P=0.001, Bonferroni correction) and the change lasts for 3-month visit. No significantly change during the other follow-up visits was found (P>0.05, Bonferroni correction). The 4.81 mm PPD may be a possible cutoff point in the ortho-k group. Subjects with PPD below or equal to 4.81 mm tended to have smaller axial elongation compared to subjects with PPD above 4.81 mm after 1-year period (t=-3.09, P=0.003). In ortho-k group, univariate analyses indicated that those with older age, greater degree of myopia, longer AL, smaller baseline PPD (PPDbaseline) experienced a smaller change in AL. In multivariate analyses, older age, greater AL and smaller PPDbaseline were associated with smaller increases in AL. In spectacle group, PPD tended to be stable (P>0.05, Bonferroni correction) and did not affect axial growth.CONCLUSION: PPDs experience significantly decreases at 1-month and 3-month ortho-k treatment. Children with smaller PPD tend to experience slower axial elongation and may benefit more from ortho-k.]]></description>
<pubDate>2022/7/28 11:22:39</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Meng-Jun Zhu, Li Ding, Lin-Lin Du, Jun Chen, Xian-Gui He, Shan-Shan Li and Hai-Dong Zou]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Meng-Jun Zhu, Li Ding, Lin-Lin Du, Jun Chen, Xian-Gui He, Shan-Shan Li and Hai-Dong Zou</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220815]]></guid><cfi:id>254</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Simple method of measuring ocular rotation in supine position during small incision lenticule extraction]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220816]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To introduce a novel measurement method of static cyclotorsion in small incision lenticule extraction (SMILE) and to investigate the effect of preoperative parameters on cyclotorsion and the effect of cyclotorsion on postoperative outcomes.METHODS: The medical records of 242 patients and 484 eyes who underwent SMILE surgery were retrospectively reviewed. Preoperative intraocular pressure, refractive error, and corneal thickness were investigated. Refractive values and visual acuity were measured at 1d, 1, 3, and 6mo. Ocular cyclotorsion in the supine position was measured by calculating the location and angle of the incision site of the cornea in the anterior slit photograph taken after surgery.RESULTS: Of the total 484 eyes in 242 patients, preoperative mean spherical equivalent (SE) was -4.10±1.64 D, and the mean astigmatism was -0.82±0.74 D. Uncorrected distance visual acuity (UCVA) and SE improved significantly after the surgery. Moreover, 219 (45.2%) eyes had excyclotorsion, 235 (48.6%) eyes had incyclotorsion, and 30 (6.2%) eyes had no torsion. The right eyes tended to be excyclotorted, and the left eyes tended to be incyclotorted (P<0.01). The mean cyclotorsion was 1.18°±3.69°, and the mean absolute value of cyclotorsion was 3.14°±2.26°. The range of cyclotorsion was 0.5°–11.4°. It was found that the smaller the preoperative sphere, the higher the amount of cyclotorsion (r=0.11, P=0.016). There was no significant association between the amount of cyclotorsion and preoperative astigmatism. There was no correlation between sex, preoperative corneal thickness, preoperative intraocular pressure, amount of cyclotorsion, and direction of cyclotorsion. The ratio of right eye excyclotorsion and left eye incyclotorsion on 1d was higher than that at 1, 3, and 6mo (all P<0.01). There was no difference between the 1, 3, and 6mo results in the right and left eyes (P=0.15, P=0.16, respectively).CONCLUSION: The newly devised ocular cyclotorsion measurement method can be used to evaluate ocular cyclotorsion after SMILE. Preoperative SE is associated with the amount of cyclotorsion, however, cyclotorsion doesn’t have a significant effect on the results of SMILE surgery.]]></description>
<pubDate>2022/7/28 11:22:40</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jiho Song, Hwanho Lee, Moon Sun Jung and Jae-hyung Kim]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jiho Song, Hwanho Lee, Moon Sun Jung and Jae-hyung Kim</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220816]]></guid><cfi:id>253</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical features and treatment of near-work-related acquired esotropia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220817]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the characteristics of near-work-related esotropia and the clinical efficacy of botulinum toxin type A (BTXA) injection therapy on it.METHODS: A total of 107 patients aged 15-57y with near-work-related esotropia were taken as the BTXA-treated group, and 30 other peers without near-work-related esotropia were included in the control group. All participants were refractive corrected to analyse the clinical characteristics of near-work-related esotropia. All subjects were examined including Worth4 spot examination, stereoscopic vision, strabismus angle, accommodative convergence to accommodation ratio (AC/A), far and near positive and negative convergence, positive and negative fusion range, positive and negative relative accommodation. Clinical efficacy was evaluated at a period of 10mo follow-up.RESULTS: The distant and near stereopsis were found in 84.9% and 77.5% of patients in the BTXA-treated group, respectively. In the control group, all patients had distant and near stereopsis. The incidence of taking off one’s glasses to see close objects was significantly higher in the BTXA-treated group than in the control group (P<0.05). The BTXA-treated group showed a smaller range of in-fusion (9.84±5.72)° than the control group (22.04±8.71)° (P<0.05). The near esotropia angle of the BTXA-treated group (17.08±11.98)△ was significantly smaller than the distant esotropia angle (19.07±11.68)△ (P<0.05). Ten months after injection, the diplopia and esotropia of most patients underwent improvements after treatment (P<0.05).CONCLUSION: This study reveals that the accommodation function and the habit of near work without wearing spectacles are associated with near-work-related esotropia, while the length of time for near work and the onset time are independent of near-work-related esotropia. Additionally, BTXA injection therapy plays a vital role in relieving diplopia and restoring eye position.]]></description>
<pubDate>2022/7/28 11:22:40</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Rui-Lin Guo, Li-Kun Ai and Shi-Qiang Zhao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Rui-Lin Guo, Li-Kun Ai and Shi-Qiang Zhao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220817]]></guid><cfi:id>252</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Analysis of retinal vasculature changes in indirect traumatic optic neuropathy using optic coherence tomography angiography]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220818]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the retinal vasculature alterations in indirect traumatic optic neuropathy (ITON) patients following craniofacial trauma by optic coherence tomography angiography (OCTA).METHODS: Patients diagnosed of monocular ITON were recruited from August 2016 to May 2020. OCTA was performed using the AngioVue OCT-A system for two cube scans centered at the optic nerve head and fovea. OCTA data included thicknesses of peripapillary retinal nerve fiber layer (RNFL) and macular ganglion cell complex (GCC), as well as proportion of capillary perfusion and data were analyzed for correlation with post-injury timepoints: within 7, 8-30, 31-90, and 91-365d.RESULTS: A total of 73 ITON patients were studied. Significant thinning of RNFL and GCC layers and attenuation of microvascular perfusion were observed in ITON eyes as compared to contralateral unaffected eyes (for most of the analyzed sectors and quadrants, P<0.05). Without respect to surgical intervention and vision recovery, the decrease in retinal layer thicknesses and microvascular perfusion was time-dependent, and most significant within three months (P<0.001).CONCLUSION: ITON presents with time-dependent thinning of retinal layers and attenuation of microvasculature, indicating possible degeneration of retinal ganglion cells due to reduced retinal blood supply.]]></description>
<pubDate>2022/7/28 11:22:40</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Huan Ma, Yang Gao, Jin-Miao Li, Yue-Kun Bao, Cong Nie, Pan Yin, Xi Lyu, Xiao-Yan Ding and Rong Lu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Huan Ma, Yang Gao, Jin-Miao Li, Yue-Kun Bao, Cong Nie, Pan Yin, Xi Lyu, Xiao-Yan Ding and Rong Lu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220818]]></guid><cfi:id>251</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Predictive value and applicability of ocular trauma scores and pediatric ocular trauma scores in pediatric globe injuries]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220819]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the predictive value and applicability of Ocular Trauma Score (OTS) and Pediatric Ocular Trauma Score (POTS) for closed and open globe injuries in the pediatric group.METHODS: A retrospective study of closed and open globe injuries in children age of 0-18-year-old between 2012-2019 was conducted. Medical records were collected, and injuries were classified using Birmingham Eye Trauma Terminology System (BETTS). The predictive value and applicability of both OTS and POTS to final visual acuity (VA) were analyzed.RESULTS: Of 84 patients, 59 (70.2%) presented with closed globe injuries (CGI) and 25 (29.8%) with open globe injuries (OGI). The mean of initial VA was 0.832±0.904 logMAR. OTS and POTS was calculated. Initial VA (P<0.001) and traumatic cataract (P<0.001) were significantly associated with visual outcome, followed by organic/unclean wound (P=0.001), delay of surgery (P=0.001), iris prolapse (P=0.003), and globe rupture (P=0.008). A strong correlation between OTS and POTS and final VA (r=-0.798, P<0.001; r=-0.612, P<0.001) was found. OTS was more applicable in all age group of pediatric and in contrast to POTS, it was designed for 0-15 years old. POTS requires eleven parameters and OTS six parameters. Even though initial VA was not available, we could still calculate into POTS equation.CONCLUSION: OTS and POTS are highly predictive prognostic tools for final VA in CGI and OGI’s in children.]]></description>
<pubDate>2022/7/28 11:22:40</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yunia Irawati, Lily Silva Ardiani, Tjahjono Darminto Gondhowiardjo and Annette K. Hoskin]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yunia Irawati, Lily Silva Ardiani, Tjahjono Darminto Gondhowiardjo and Annette K. Hoskin</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220819]]></guid><cfi:id>250</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Ocular syphilis resurgence in an urban underserved community in the United States]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220820]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the clinical characteristics, demographics, and visual outcomes of patients with ocular syphilis at an urban hospital to increase awareness and assist in earlier diagnosis and treatment of the resurgent disease.METHODS: A retrospective chart review was performed on patients with ICD-9 and ICD-10 diagnosis codes correlating with syphilis or syphilis-related ocular diseases between 2010 and 2019. Variables evaluated included age, gender, race, vision, ocular findings, human immunodeficiency virus (HIV) status and men who have sex with men status, recreational drug and alcohol use.RESULTS: Ocular syphilis was diagnosed in 40 patients (53 eyes) of a total of 229 patients who tested positive for syphilis via serum and/or cerebrospinal fluid treponemal testing from 2010-2019. Among patients with ocular syphilis, most patients were males, aged 45 or above and Black, and had no diagnosed HIV infection. Approximately 50% patients had 20/40 vision or better. Nearly 50% had non-granulomatous anterior uveitis as their initial presentation, and 49% of patients had involvement of the posterior segment. Neovascular glaucoma (5.7%), papillitis (7.5%), vasculitis (5.7%), and retinal detachment (5.7%) were rarer presentations of the disease and were associated with a poorer visual prognosis.CONCLUSION: Given the increased prevalence and protean manifestations of syphilis, early diagnosis and treatment are paramount. More studies on ocular syphilis are warranted to understand this resurging disease.]]></description>
<pubDate>2022/7/28 11:22:40</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Emily K. Tam, Alexander Port, Diana Martin, Gabrielle Fridman, Steven Ness and Nicole H. Siegel]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Emily K. Tam, Alexander Port, Diana Martin, Gabrielle Fridman, Steven Ness and Nicole H. Siegel</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220820]]></guid><cfi:id>249</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Incidence and risk factors for vitreous loss in residents performing manual small-incision cataract surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220705]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the incidence of vitreous loss and associated risk factors in residents performing manual small-incision cataract surgery (MSICS).METHODS: The present retrospective record review study was performed on 490 patients who underwent MSICS performed between November 2018 and December 2019 by 7 third-year postgraduate residents. The study group comprised of patients having intraoperative vitreous prolapse. All the surgeries were performed under supervision of a trained assistant.RESULTS: The mean age of the participants at the time of surgery was 68.42±2.05y. Of the 490 patients, 250 patients were male, and 240 patients were female (P=0.23). A total of 215 (43.9%) eyes had mature white cataract, 185 (37.8%) eyes had brown cataract, and 90 (18.3%) eyes had immature senile cataract. The incidence of intraoperative vitreous loss among residents was 2% (10/490). Vitreous loss occurred during hydrodissection [1/10 (10%)], nucleus delivery [3/10 (30%)], irrigation and aspiration [5/10 (50%)], and intraocular lens insertion [1/10 (10%)]. Multivariate stepwise Logistic regression analysis confirmed immature senile cataract [odds ratio (OR)=3.99; P=0.02], irrigation and aspiration of cortical material (OR=3.07; P=0.03), and anterior capsular extension (OR=3.22, P=0.03) as independent risk factors for vitreous loss.CONCLUSION: Immature senile cataract, irrigation and aspiration of cortical material, and anterior capsular extension are independent risk factors for vitreous loss. Our findings may serve as a guide for future trainers or residents learning MSICS.]]></description>
<pubDate>2022/6/30 14:51:23</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Rajesh Subhash Joshi, Ashok Hukumchand Madan, Preeti Dashrath Wadekar, Nivedita Patil, Sonali Tamboli, Tanmay Surwade and Namrata Bansode]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Rajesh Subhash Joshi, Ashok Hukumchand Madan, Preeti Dashrath Wadekar, Nivedita Patil, Sonali Tamboli, Tanmay Surwade and Namrata Bansode</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220705]]></guid><cfi:id>248</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A new bleb-independent surgery namely penetrating canaloplasty for corticosteroid-induced glaucoma: a prospective case series]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220706]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report the outcomes of penetrating canaloplasty for corticosteroid-induced glaucoma in a case series.METHODS: Penetrating canaloplasty is a bleb-independent filtering surgery unifying canaloplasty and trabeculectomy. In this study, the surgery was performed to restore the natural outflow through surgically expanded Schlemm’s canal and generated trabeculum ostium. A total of 10 eyes of 8 patients were treated with penetrating canaloplasty for corticosteroid-induced glaucoma. Intraocular pressure (IOP) and the number of glaucoma medications at postoperative 3, 6, 12, 18, 24, 36, and 48mo were documented as primary endpoint. Complications after the surgery were recorded as secondary endpoint.RESULTS: Penetrating canaloplasty was accomplished successfully for all 10 eyes, with a mean follow-up of 20.4±13.0mo (range 6-48mo). The mean preoperative IOP and number of anti-glaucoma medications were 45.1±6.5 mm Hg and 3.3±0.5 respectively. The mean post-operative IOP at 3, 6, 12, 18, 24, 36, and 48mo were 15.8±6.0, 14.7±3.3, 15.3±2.0, 15.6±2.6, 17.5±1.8, 16.5±4.9, and 14.0 mm Hg. The number of anti-glaucoma medications at these time points were all 0. This surgery failed to control the IOP in 1 eye at 1mo after surgery. Hyphaema occurred in 3 eyes on the first day after surgery. Postoperative transient IOP increasing was encountered with in two eyes from 1wk to 1mo after surgery. Choroidal detachment developed in one eye but responded well to conservative treatment.CONCLUSION: Penetrating canaloplasty is effective for corticosteroid-induced glaucoma without serious complications, making it a viable or preferred alternative option.]]></description>
<pubDate>2022/6/30 14:51:24</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jing-Jing Hu, Hai-Shuang Lin, Shao-Dan Zhang, Wen-Qing Ye, Juan Gu, Yan-Qian Xie, Yi-Hua Tang and Yuan-Bo Liang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jing-Jing Hu, Hai-Shuang Lin, Shao-Dan Zhang, Wen-Qing Ye, Juan Gu, Yan-Qian Xie, Yi-Hua Tang and Yuan-Bo Liang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220706]]></guid><cfi:id>247</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of minimally invasive glaucoma surgery with trabecular micro-bypass stent and microhook ab interno trabeculotomy performed in conjunction with cataract surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220707]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the effectuality and safety of cataract surgery combined with either ab interno trabeculotomy by the microhook (μLOT) or a single iStent® trabecular bypass implantation (iStent) in eyes with cataract and mild-to-moderate glaucoma.METHODS: This study enrolled subjects with mild-to-moderate open angle glaucoma with visually significant cataract who used two or more ophthalmic antiglaucoma agents between 60 and 90y of age. Patients underwent cataract surgery cooperated with either implantation of an iStent (iStent-phaco) or excisional goniotomy with the μLOT (μLOT-phaco). Patients underwent μLOT-phaco in the eye with lower the mean deviation, according to the Humphrey field analyzer, while iStent-phaco was carried out on the other eye. Intraocular pressure (IOP) pre- and post-surgery, alterations in anterior chamber flare (ACF), and corneal endothelial cell density (ECD) were estimated.RESULTS: Twenty subjects were enrolled (mean age: 73.6±7.3y). The mean medicated preoperative IOP was 16.7 mm Hg in the μLOT and 16.2 mm Hg in the iStent eyes. The mean final IOP at 12mo was 13.6 mm Hg in the μLOT eyes and 13.6 mm Hg in the iStent eyes, representing a 17.8% and 17.2% reduction, respectively. The preoperative ACF in the μLOT eyes was 9.5 pc/ms and it returned to normal in 30d postoperatively, with a value of 11.4 pc/ms. In the iStent eyes, ACF was 9.6 pc/ms preoperatively and it returned to normal by 7d postoperatively (11.2 pc/ms at day 7), demonstrating that postoperative inflammation was less in the iStent eyes. The corneal ECD in both groups was not significantly decreased.CONCLUSION: In this study, iStent and μLOT are both effective through 12mo of follow-up. Safety is more favorable in the iStent eyes, based on early anterior chamber inflammation.]]></description>
<pubDate>2022/6/30 14:51:24</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Naoto Tokuda, Yasushi Kitaoka, Ayaka Tsukamoto, Yasuhiro Toyoda, Yusuke Yamada, Kana Sase and Hitoshi Takagi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Naoto Tokuda, Yasushi Kitaoka, Ayaka Tsukamoto, Yasuhiro Toyoda, Yusuke Yamada, Kana Sase and Hitoshi Takagi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220707]]></guid><cfi:id>246</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Impact of OCT scan-patterns in identifying morphological features of lamellar macular holes and macular pseudoholes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220708]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the impact of the optical coherence tomography (OCT) scan patterns on the detection of the features associated with lamellar macular hole (LMH) and macular pseudohole (MPH).METHODS: This is a retrospective analysis of 100 consecutive eyes with LMH (n=41) and MPH (n=59) having at least three of the following OCT features, which include mandatory criteria for the diagnosis of LMH and MPH: Epiretinal membrane, epiretinal proliferation, verticalization, intraretinal cystoid spaces, foveoschisis, irregular foveal contour, foveal cavity with undermined edges, and ellipsoid line disruption. Primary outcome measurement was the detection frequency of the features in three different OCT scan patterns: 1) volume scan; 2) six radial scans (R6); and 3) vertical and horizontal radial scans (R2).RESULTS: Of the total eight features, the maximal detection frequency was found as 4.45±1.45, 4.35±1.47, and 3.70±1.59, by the volume, R6 and R2, respectively. R2 was inferior to the other patterns in detection of the total features (P<0.001), whereas R6 and volume patterns were found comparable (P=0.312).CONCLUSION: The physician should be aware that the selection of the OCT-scan pattern may influence the detection of mandatory morphological criteria for the diagnosis of LMH and MPH.]]></description>
<pubDate>2022/6/30 14:51:24</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Osman Murat Uyar, Jonas Neubauer, Francoise Sadler, Eva-Maria Konrad and Faik Gelisken]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Osman Murat Uyar, Jonas Neubauer, Francoise Sadler, Eva-Maria Konrad and Faik Gelisken</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220708]]></guid><cfi:id>245</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Neuromyelitis optica spectrum disorders and anti-myelin oligodendrocyte glycoprotein positive optic neuropathies]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220709]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To describe the clinical characteristics and treatments associated with antibody positive optic neuropathies including anti-myelin oligodendrocyte glycoprotein (MOG) and anti-aquaporin 4 (AQP4), alongside diagnostic modalities, investigations, and outcomes.METHODS: A cross-sectional single-centre retrospective case series consisting of 16 patients including 12 anti-MOG positive patients and 4 anti-AQP4 positive patients. Each of these patients had clinical signs and symptoms of optic neuritis and consisted of all patients who had a positive blood antibody result in our centre. Clinical findings including presence of a relative afferent pupillary defect, colour vision and disc assessment were recorded. Structured clinical exam and multimodal imaging was undertaken sequentially on each. Optical coherence tomography (OCT) scanning was preformed to examine the correlation between ganglion cell layer (GCL) thickness and visual acuity (VA) at presentation and as a determinant of final visual outcome in both groups. Initial and long-term treatment is also summarised.RESULTS: A total of 16 patients were included in the study consisting of 12 anti-MOG and 4 anti-AQP4 positive patients. Nine of the 16 patients were female and the average age of onset was 29.2y in the MOG group and 42y in the AQP4 group. There was no statistically significant correlation (Pearson correlation) between GCL thickness and presenting and final VA [r(10)=0.081, P=0.08 and r(10)=0.089, P=0.34 respectively]. The same statistical analysis was performed for the correlation between retinal nerve fibre layer (RNFL) and VA and similar outcomes were observed [r(10)=0.04, P=0.22 and r(10)=0.09, P=0.04]. No correlation was seen for initial RNFL thickness and final visual outcome in this group either [r(2)=0.19, P=0.38]. Visual field testing and radiological findings for each group are described.CONCLUSION: No correlation between initial VA or RNFL and final visual outcome is identified. A broad range of visual field and radiographic findings are identified, a consensus on treatment of neuromyelitis optica spectrum disorders and anti-MOG positive optic neuropathies has yet to be accepted but initial high dose immunosuppression followed by low dose maintenance therapy is favoured.]]></description>
<pubDate>2022/6/30 14:51:24</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Patrick Murtagh, Amy Coman, Kirk Stephenson, Maria Gaughan, David Ryan, Graeme McNeill, Christopher McGuigan and Lorraine Cassidy]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Patrick Murtagh, Amy Coman, Kirk Stephenson, Maria Gaughan, David Ryan, Graeme McNeill, Christopher McGuigan and Lorraine Cassidy</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220709]]></guid><cfi:id>244</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Relative peripheral refraction and its role in myopia onset in teenage students]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220710]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To characterize peripheral refraction and its relationship with myopia development in a selected group of male teenage Chinese students.METHODS: This 2-year prospective cohort study randomly enrolled 85 non-myopic boys (age, 14-16y) from the Experimental Class of Air Force in China. Cycloplegic peripheral refraction was examined at 0°, ±10°, and ±20° along the horizontal visual field in the right eye at the baseline and 2-year follow-up.RESULTS: The incidence of myopia at the 2-year follow-up was 15.29% (13/85). The baseline central refraction (CR) and peripheral refraction at ±10° were significantly lower in students who developed myopia than in those who did not (P<0.05). Relative peripheral refraction (RPR) did not differ between students with and without myopia (P>0.05). At the 2-year follow-up, the RPR at ±10° and 20° nasal was significantly more hyperopic in the myopic group than in the non-myopic group. Multiple linear regression analysis indicated that the change in CR was significantly correlated with the changes in RPR at 20° nasal, 10° nasal, and 20° temporal. Multivariate Logistic regression analysis indicated that the baseline CR [odds ratio (OR): 0.092, 95% confidence interval (CI): 0.012-0.688, P=0.020] and the baseline RPR at 10° nasal (OR: 0.182, 95%CI: 0.042-0.799, P=0.024) were significantly correlated with incident myopia (Omnibus test, χ2=10.20, P=0.006).CONCLUSION: CR change is significantly correlated with changes in RPR, and students who develop myopia have more relative peripheral hyperopia. More baseline CR and relative peripheral hyperopia at 10° nasal are protective of myopia onset.]]></description>
<pubDate>2022/6/30 14:51:24</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Lin-Song Qi, Lu Yao, Xue-Feng Wang, Jin Zhao, Yong Liu, Teng-Yun Wu, Qing-Hong Yang, Chen Zhao and Zhi-Kang Zou]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Lin-Song Qi, Lu Yao, Xue-Feng Wang, Jin Zhao, Yong Liu, Teng-Yun Wu, Qing-Hong Yang, Chen Zhao and Zhi-Kang Zou</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220710]]></guid><cfi:id>243</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Virtual reality training improves accommodative facility and accommodative range]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220711]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the effects of virtual reality (VR) training on different parameters of vision.METHODS: Sixty individuals ranged 18-60 years old with asthenopia were randomly divided into short-term (n=40) and long-term (n=20) treatment groups. They were given a specially designed VR training device only once for 15min or 3-4 times a day for 15min each time for 1mo. The visual acuity, spherical equivalent, accommodative range, accommodative facility, pupil size, and visual fatigue were evaluated before (control) and after VR training.RESULTS: The visual acuity, accommodative range, and accommodative facility increased in subjects of the short-term treatment group, whereas their pupil size contracted significantly. No significant changes in spherical equivalent and visual fatigue were observed. The changes in distant vision and corrected visual acuity were positively correlated with those in pupil size, but not with spherical equivalent. The accommodative range and accommodative facility improved significantly in subjects of the long-term treatment group. No significant changes in visual acuity, spherical equivalent, pupil size, and visual fatigue were noted.CONCLUSION: VR training can improve the accommodative range and accommodative facility of human eyes. Although short-term VR training can transiently improve vision, which probably due to bright light adaptation, there is no evidence that it can improve myopia.]]></description>
<pubDate>2022/6/30 14:51:24</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Dong-Yu Guo, Yuan-Yuan Shen, Miao-Miao Zhu, Yang-Yang Zhan, Xia-Wei Wang, Jian-Hua Xia, Bo Jiang, Yang-Shun Gu and Yan Long]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Dong-Yu Guo, Yuan-Yuan Shen, Miao-Miao Zhu, Yang-Yang Zhan, Xia-Wei Wang, Jian-Hua Xia, Bo Jiang, Yang-Shun Gu and Yan Long</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220711]]></guid><cfi:id>242</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Short-term effect of 0.01% atropine sulphate eye gel on myopia progression in children]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220712]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the effect of 0.01% atropine sulphate eye gel on myopia progression and axial elongation in a 6-month treatment in children.METHODS: Totally 185 children aged 6-12y with binocular myopia of 3.0 D or less in both eyes were enrolled in this prospective cohort study. The atropine group (n=125) received one drop of 0.01% atropine sulphate eye gel in each eye before bedtime daily. The control group included 60 matched children without drug intervention during the same period. The spherical equivalent and axial length was recorded at baseline and the sixth month of treatment. The efficacy was evaluated by the change of the spherical equivalent and axial length. Adverse events were also recorded.RESULTS: The average spherical equivalent and axial length at baseline were not statistically significant between the atropine group (-1.64±0.80 D, 24.13±0.76 mm) and the control group (-1.59±0.94 D, 24.06±0.77 mm, P>0.05). After 6mo, there was significantly difference in the spherical equivalent progression between the atropine and the control group (-0.27±0.33 vs -0.60±0.35 D, P<0.001), with a relative reduction of 55.0% in myopia progression. The increase in axial elongation in the atropine group was significantly less than control group (0.19±0.14 vs 0.26±0.14 mm, P<0.001), with a relative reduction of 26.9% in axial length. The 84.4% and 38.4% of the eyes progressed by less than 0.50 D and remained stable in the atropine group, compared with 51.7% and 4.2% in the control group. No adverse events were observed.CONCLUSION: Atropine sulphate eye gel 0.01% can slow down myopia progression and axial elongation in children with a 6-month treatment.]]></description>
<pubDate>2022/6/30 14:51:25</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Shi-Yin Pan, Yang-Zheng Wang, Jun Li, Xue-Hui Zhang, Jin Wang, Xiu-Ping Zhu, Xiang-Hua Xiao and Jun-Tian Liu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Shi-Yin Pan, Yang-Zheng Wang, Jun Li, Xue-Hui Zhang, Jin Wang, Xiu-Ping Zhu, Xiang-Hua Xiao and Jun-Tian Liu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220712]]></guid><cfi:id>241</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Short and long term corneal biomechanical analysis after overnight orthokeratology]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220713]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the short and long term corneal biomechanical changes after overnight orthokeratology (OK) and compare them with those occurring in subjects not wearing contact lenses.METHODS: Retrospective case control study enrolling 54 subjects that were divided into three groups 18 subjects each: control group (CG), short term (15 nights) OK (STOK) group, and long term (more than 1y of OK wear) OK (LTOK) group. Corneal biomechanics were characterized using the CorVis® ST system (Oculus), recording parameters such as time [first/second applanation time (AT1, AT2)], speed [velocity of corneal apex at the first/second applanation time (AV1, AV2)], and amplitude of deformation (AD1, AD2) in the first and second corneal flattening, corneal stiffness (SPA1), biomechanically corrected intraocular pressure (bIOP) and corneal (CBI) and tomographic biomechanical indices (TBI).RESULTS: Significantly lower AD1 and standard deviate on of Ambrosio’s relational average thickness related to the horizontal profile (ARTh) values were found in the OK groups compared to CG (P<0.05). Likewise, significantly higher values of CBI were found in STOK and LTOK groups compared to CG (P<0.01). No significant differences between groups were found in integrated radius index (P=0.24), strain stress index (P=0.22), tomographic biomechanical index (P=0.91) and corneal stiffness parameter (SPA1, P=0.97). Significant inverse correlations were found between corneal thickness and CBI in STOK (r= -0.90, P<0.01) and LTOK groups (r=-0.71, P<0.01).CONCLUSION: OK does not seem to alter significantly the corneal biomechanical properties, but special care should be taken when analyzing biomechanical parameters influenced by corneal thickness such as amplitude of deformation, ARTh or CBI, because they change significantly after treatment but mainly due to the reduction and pachymetric progression induced by the corneal molding secondary to OK treatment.]]></description>
<pubDate>2022/6/30 14:51:25</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Amelia Nieto-Bona, Paloma Porras-Ángel, Adela Elena Ayllón-Gordillo, Gonzalo Carracedo and David P Piñero]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Amelia Nieto-Bona, Paloma Porras-Ángel, Adela Elena Ayllón-Gordillo, Gonzalo Carracedo and David P Piñero</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220713]]></guid><cfi:id>240</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Reduced choroidal peripapillary capillaries in thyroid-associated ophthalmopathy with early stage of dysthyroid optic neuropathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220714]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate whether the subtle change of choroidal/retinal vessel densities and volumes in thyroid-associated ophthalmopathy (TAO) could be an early sign to detect dysthyroid optic neuropathy (DON).METHODS: This was a retrospective cross-sectional study, and a total of 98 eyes from 50 subjects were enrolled under certain criteria. Thirty-four eyes of normal controls and 64 eyes of TAO, including 39 eyes of DON and 25 eyes of TAO without DON, underwent optical coherence tomography angiography (OCTA) scanning. All the tested parameters of OCTA scanning including choroid radial peripapillary capillaries (RPC), retinal nerve fiber layer (RNFL), and macular ganglion cell complex (GCC) were compared among groups, and the correlation between OCTA parameters and visual function parameters was also investigated.RESULTS: Whole choroidal RPC was significantly reduced in DON (48.24%±0.4978%) compared to normal (50.33%±0.3173%) and TAO without DON (49.16%±0.5463%; P=0.0041). The reduction of whole choroidal RPC was also correlated with visual field (VF) defect in DON (r=0.5422, n=39). Although vision acuity and VF were improved in all the patients with DON after being treated with medical and surgical decompression, the reduction of RPC density were not reversed.CONCLUSION: There is a notable reduction in choroidal RPC in DON, which is correlated with VF defect. The reduction of RPC density could not be reversed immediately by medical and surgical decompression even when vision and VF were improved. These findings suggest that choroidal RPC could be a useful parameter to diagnose and monitor early stage of DON.]]></description>
<pubDate>2022/6/30 14:51:25</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jia-Hui Wu, Li-Ying Luo, Hao Zhou, Ying Wu, Jian Zhang and Jin-Wei Cheng]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jia-Hui Wu, Li-Ying Luo, Hao Zhou, Ying Wu, Jian Zhang and Jin-Wei Cheng</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220714]]></guid><cfi:id>239</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Temporal retinal thinning might be an early diagnostic indicator in male pediatric X-linked Alport syndrome]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220715]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate temporal retinal thinning changes in retinal layers using spectral-domain optical coherence tomography (SD-OCT) in pediatric X-linked Alport syndrome (XLAS) patients.METHODS: A retrospective case-control study. SD-OCT scans of pediatric patients diagnosed with XLAS and age- and sex-matched healthy control participants were reviewed. Automated segmentation of SD-OCT scans was induced to analyze the retinal thickness (RT) of different layers. The temporal thinning index (TTI) was calculated for each layer and compared between the patients and the control group.RESULTS: Forty-three pediatric XLAS patients and 60 healthy controls were included. Temporal retinal thinning was present in 33 patients (76.74%), while 28 patients (65.11%) had severe pathological temporal retinal thinning and 5 patients (11.63%) had moderate thinning. The temporal inner sector RT (P<0.0001), the temporal outer sector RT (P<0.0001), and the nasal outer sector RT (P=0.0211) were significantly thinner in the XLAS male patients. The TTI of the total retina was significantly higher in the XLAS group than in the control group (P<0.0001). The TTI of the inner retina layers (P<0.0001), ganglion cell layer (P<0.0001), inner plexiform layer (P<0.0001), inner nuclear layer (P<0.0001), and outer nuclear layer (P<0.0001) were significantly higher in the XLAS group. The central RT of the XLAS group was significantly thinner than that of the control group (P<0.0001).CONCLUSION: Temporal retinal thinning appears early in XLAS patients, especially in male patients. The thinning is mainly caused by structural abnormalities of the inner retina. This suggests that temporal retinal thinning could be helpful for the early diagnosis and follow-up of XLAS with noninvasive SD-OCT examination.]]></description>
<pubDate>2022/6/30 14:51:25</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Rui-Lin Zhu, Liang Zhao, Xiao-Peng Gu, Ya-Di Zhang, Fang Wang, Yan-Qin Zhang and Liu Yang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Rui-Lin Zhu, Liang Zhao, Xiao-Peng Gu, Ya-Di Zhang, Fang Wang, Yan-Qin Zhang and Liu Yang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220715]]></guid><cfi:id>238</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Incidence of ocular manifestations in patients with graft versus host disease after allogeneic stem cell transplant in Riyadh, Saudi Arabia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220716]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the incidence and severity of ocular graft versus host disease (oGVHD) in patients who underwent allogeneic stem cell transplant (SCT) in King Abdul-Aziz Medical City, Saudi Arabia.METHODS: This is a retrospective cohort study conducted in King Abdul Aziz Medical City on patients who underwent allogeneic hematopoietic cell transplant (allo-HCT) from 2010 to 2017. The ocular examination findings including visual acuity, meibomian gland dysfunction, corneal and conjunctival staining with severity, corneal scarring, tear film meniscus and breakup time, anterior and posterior segment examination findings, intraocular pressure, treatment given, punctual plugs used or not, and follow up response were collected.RESULTS: The five years cumulative incidence of oGVHD among post-transplant patients was 56.98% (95%CI 38.6%-71.7%). The potential risk factors assessed for developing ocular manifestation were age, gender, donor’s age, donor gender mismatch CD3 and CD34 infusion, while none of the correlates were identified as statistically significant risk factors of developing ocular manifestation. However, the incidence was statistically significantly different between patients diagnosed with acute myelocytic leukemia and acute lymphocytic leukemia (P=0.038). The mean latent period to develop ocular symptoms was 20.5mo. All patients had variable degree of dry eyes. None of the patients developed any posterior segment complication.CONCLUSION: The incidence of oGVHD is low in King Abdul-Aziz Medical City. This can be attributed to the preconditioning and immunosuppressive regime.]]></description>
<pubDate>2022/6/30 14:51:26</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Tariq Aldebasi, Rabia Bashir, Shiji Gangadharan, Naila A. Shaheen, Basil Alhussain, Tariq Almudhaiyan and Bader Alahmari]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Tariq Aldebasi, Rabia Bashir, Shiji Gangadharan, Naila A. Shaheen, Basil Alhussain, Tariq Almudhaiyan and Bader Alahmari</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220716]]></guid><cfi:id>237</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[The binocular intraocular lens power difference in eyes with different axial lengths]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220609]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the binocular intraocular lens (IOL) power difference in eyes with short, normal, and long axial lengths (AL) using Lenstar LS 900 optical biometry.METHODS: A total of 716 (1432 eyes) participants were included. The groups were categorized into short (group A: AL&#x003C;22 mm), normal (group B: 22 mm≤AL≤25 mm), and long AL groups (group C: AL&#x003E;25 mm). The central corneal thickness (CCT), anterior chamber depth (ACD), lens thickness (LT), AL, anterior corneal keratometry, white-to-white (WTW), pupil diameter (PD), as well as IOL power calculated using embedded Barrett formula were assessed. Bland-Altman plots were used to test the agreement of the binocular parameters.RESULTS: In group A, the CCT of the right eye was significantly thinner than that of the left eye (P=0.044) with a difference of -2±8 μm [95% limits of agreement (LoA), -17.8 to 13.2 μm]. For group B, the PD and IOL power in the right eye were significantly lower than those of the left eye (P=0.001, &#x003C;0.001) with a difference of -0.05±0.32 mm (95%LoA, -0.68 to 0.58 mm) and -0.18±1.01 D (95%LoA, -2.2 to 1.8 D). The AL of right eye was longer than that of the left eye (P=0.002) with a difference of 0.04±0.25 mm (95%LoA, -0.45 to 0.52 mm). No significant difference was observed for all the binocular parameters in group C. The percentage of participants with binocular IOL power difference within ±0.5 D were 62% (31/50), 68.3% (339/496), and 38.8% (66/170) in groups A, B, and C, respectively.CONCLUSION: The binocular parameters related to IOL power are in good agreement, but the binocular IOL power difference of more than half of participants with long AL is more than 0.50 D.]]></description>
<pubDate>2022/5/31 14:47:11</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ming-Hui Deng, Xiao-Gang Wang, Song Chen and Xue-Feng Shi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ming-Hui Deng, Xiao-Gang Wang, Song Chen and Xue-Feng Shi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220609]]></guid><cfi:id>236</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Changes in the peripapillary vasculature and macular thickness after cataract surgery using two phacoemulsification systems with optical coherence tomography angiography]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220610]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the changes in the peripapillary vasculature and macular thickness after cataract surgery using two phacoemulsification systems with optical coherence tomography angiography (OCTA).METHODS: Fifty-two eyes of 52 patients with age-related cataract were randomized into two groups for phacoemulsification: Infiniti group (26 patients) using the Infiniti phacoemulsification system with gravity-fluidics and Centurion group (26 patients) using the Centurion phacoemulsification system with active-fluidics. The peripapillary vessel density (PVD) and macular thickness were examined using OCTA at baseline and at 1d, 1 and 3mo after cataract surgery.RESULTS: In the Infiniti group, the PVD was significantly reduced at 1d after the cataract surgery (P&#x003C;0.001). However, the retinal nerve fiber layer (RNFL) thickness showed no significant change during the follow-up. Change in PVD 1d postoperatively was significantly negatively correlated to the cumulative dissipated energy (CDE), estimated fluid usage (EFU), effective phacoemulsification time (EPT), intraocular pressure (IOP), and total operating time (TOT; P&#x003C;0.05). The macular thickness was significantly increased in all regions after the cataract surgery (P&#x003C;0.05). However, no significant changes were found in the macular vessel density (VD) during the follow-up (P&#x003E;0.05). In the Centurion group, the VD and thickness in the optic papilla and macula did not significantly change in all regions during the follow-up (all P&#x003E;0.05). The best-corrected visual acuity (BCVA) significantly improved in both groups postoperatively (P&#x003C;0.001).CONCLUSION: Using the Infiniti phacoemulsification system, OCTA provides a promising analysis of retinal vascular alterations, demonstrating a reduction of the PVD and an increase in the macular thickness. The Centurion phacoemulsification system can provide better retinal vasculature preservation during cataract surgery.]]></description>
<pubDate>2022/5/31 14:47:11</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Liang-Zhang Tan, Fang Tian, Lu Chen, Li-Na Sun, Xue Gong, Jing-Li Liang, Hong Zhang and Xiao-Rong Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Liang-Zhang Tan, Fang Tian, Lu Chen, Li-Na Sun, Xue Gong, Jing-Li Liang, Hong Zhang and Xiao-Rong Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220610]]></guid><cfi:id>235</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A novel mutation of CYP4V2 gene associated with Bietti crystalline dystrophy complicated by choroidal neovascularization]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220611]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the clinical characteristics and genetic features of a Bietti crystalline dystrophy (BCD) proband in a Chinese family.METHODS: A Chinese female diagnosed with BCD complicated by bilateral choroidal neovascularization (CNV) and her parents underwent complete ophthalmic examinations, including fundus autofluorescence (AF), fundus photography (FP), fundus fluorescein angiography (FFA), visual field testing, full-field electroretinography (ERG), optical coherence tomography (OCT) and optical coherence tomography angiography (OCTA). The sequencing of the CYP4V2 gene was performed to the whole family.RESULTS: Bilateral tiny glittering crystal-like deposits and differing extent of atrophy of the retinal pigment epithelium (RPE) were found in the posterior pole of her fundus. The diffuse hypo-fluorescence shown on AF images and window defects shown on FFA both indicated the atrophy of the RPE and choriocapillaris. OCT showed the thinning of the RPE and choriocapillaris layer, ellipsoid zone (EZ) band defect and CNV in both eyes. OCTA images proofed bilateral type 2 CNV. The visual field test showed central and paracentral scotoma. ERG showed a slightly decreased b-wave in scotopic ERG. Gene sequencing identified three mutations of the CYP4V2 gene, c.802_807del, c.810delT, and c.1388G&#x003E;A. The mutation c.1388G&#x003E;A was a novel substitution mutation.CONCLUSION: The novel mutation c.1388G&#x003E;A may be a possible cause that could induce the clinical phenotype of BCD.]]></description>
<pubDate>2022/5/31 14:47:12</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xin-Yao Han, Lin-Qi Zhang, Ji-Yang Tang, Lyu-Zhen Huang, Ran Tang and Jin-Feng Qu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xin-Yao Han, Lin-Qi Zhang, Ji-Yang Tang, Lyu-Zhen Huang, Ran Tang and Jin-Feng Qu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220611]]></guid><cfi:id>234</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Short-term outcomes of mitomycin C-augmented excisional bleb revision with capsulectomy for failed Ahmed glaucoma valve]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220612]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report short-term outcomes of mitomycin C-augmented excisional bleb revision with capsulectomy (ERC) after Ahmed glaucoma valve (AGV) failure.METHODS: Patients who underwent ERC procedures between January 2017 and December 2019 with a minimum follow-up of 6mo were evaluated retrospectively for indications of AGV and AGV implantation to ERC interval. The number of anti-glaucoma medications (AGMs), intraocular pressure (IOP) and best corrected visual acuity (BCVA) were recorded at baseline, 1, 7, 30, 90, and 180d. Intra- and postoperative complications were also recorded.  Positive outcome was defined as IOP≤21 mm Hg with or without AGMs.RESULTS: Fourteen eyes [14 patients, median age 69.5y, interquartile range (IQR) 61.3-80] were included. Pseudoexfoliative glaucoma (n=5, 36%) was the most common form of glaucoma. The median AGV implantation to ERC interval was 8.8mo (IQR 3.91-43.67). At 6mo, the median number of AGMs decreased from 3.0 (IQR 3.0-4.0) to 2.0 (IQR 1.5-3), the median IOP decreased from 26 mm Hg (IQR 22-29) to 16.5 mm Hg (IQR 13.75-20) and there was no significant change in BCVA. The success rate at 6mo was 92.9%. The Kaplan-Meier cumulative probability of survival was 93%, 79%, 64%, and 64% at 1wk, and 1, 3, and 6mo, respectively. No intraoperative complications were identified. Postoperative complications were identified in 5 eyes (36%), which were resolved spontaneously during the first week following ERC.CONCLUSION: ERC has a high success rate for short-term management of AGV failure. A longer follow-up study is required to determine long-term cumulative failure rates.]]></description>
<pubDate>2022/5/31 14:47:13</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Bar Davidov, Shimon Kurtz, Ilona Mohilevtseva, Michael Waisbourd and Rony Rachmiel]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Bar Davidov, Shimon Kurtz, Ilona Mohilevtseva, Michael Waisbourd and Rony Rachmiel</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220612]]></guid><cfi:id>233</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[iStent inject and cataract surgery for mild-to-moderate primary open angle glaucoma in Japan: a cost-utility analysis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220613]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the cost-utility of iStent inject® with cataract surgery vs cataract surgery alone in patients with mild-to-moderate primary open angle glaucoma (POAG) in the Japanese setting from a public payer's perspective.METHODS: A Markov model was adapted to estimate the cost-utility of iStent inject® plus cataract surgery vs cataract surgery alone in one eye in patients with mild-to-moderate POAG over lifetime horizon from the perspective of Japanese public payer. Japanese sources were used for patients' characteristics, clinical data, utility, and costs whenever available. Non-Japanese data were validated by Japanese clinical experts.RESULTS: In the probabilistic base case analysis, iStent inject® with cataract surgery was found to be cost-effective compared with cataract surgery alone over a lifetime horizon when using the ¥5 000 000/quality-adjusted life year (QALY) willingness-to-pay threshold. The incremental cost-utility ratio (ICUR) was estimated to be ¥1 430 647/QALY gained and the incremental cost-utility ratio (ICER) was estimated to be ¥12 845 154/blind eye avoided. iStent inject® with cataract surgery vs cataract surgery alone was found to increase costs (¥1 025 785 vs ¥933 759, respectively) but was more effective in increasing QALYs (12.80 vs 12.74) and avoiding blinded eyes (0.133 vs 0.141). The differences in costs were mainly driven by costs of primary surgery (¥279 903 vs ¥121 349). In the scenario analysis from a societal perspective, which included caregiver burden, iStent inject® with cataract surgery was found to dominate cataract surgery alone.CONCLUSION: The iStent inject® with cataract surgery is a cost-effective strategy over cataract surgery alone from the public payer's perspective and cost-saving from the societal perspective in patients with mild-to-moderate POAG in Japan.]]></description>
<pubDate>2022/5/31 14:47:13</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ataru Igarashi, Kyoko Ishida, Nobuyuki Shoji, Alice Chu, Heather Falvey, Ru Han, Maki Ueyama and Yoshie Onishi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ataru Igarashi, Kyoko Ishida, Nobuyuki Shoji, Alice Chu, Heather Falvey, Ru Han, Maki Ueyama and Yoshie Onishi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220613]]></guid><cfi:id>232</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Feasibility of telemedicine program using a hand-held nonmydriatic retinal camera in Panama]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220614]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the image quality of a telemedicine screening program for retinal disease using a nonmydriatic camera among rural island communities in Bocas del Toro, Panama.METHODS: In June 2018, a group of three medical students volunteered at clinics operated by the Floating Doctors in the province of Bocas del Toro, Panama. Non-mydriatic images of the retina were obtained using the Pictor Plus (Volk Optical, Mentor OH), randomized, and sent to two board-certified ophthalmologists at the University of California, Irvine for analysis using a modified version of the FOTO-ED scale. Inter-rater reliability was calculated using the kappa statistic.RESULTS: Seventy patients provided a total of 127 images. Average image quality was 3.31, and most frequent image quality was 4/5 on the FOTO-ED scale. Thirty patients had at least one eye image with ideal quality (42.86%), while only one patient had no adequate photos taken (1.43%). However, high quality images were obtained in both eyes in only 12 patients (17.14%). The inter-rater reliability between the two ophthalmologists was 0.614.CONCLUSION: Further improvements are necessary to acquire higher quality images more reliably. This may include further training and experience or mydriasis.]]></description>
<pubDate>2022/5/31 14:47:14</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Alexander S. Himstead, Janani Prasad, Sean Melucci, Kevin M. Gustafson, Paul E. Israelsen and Andrew Browne]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Alexander S. Himstead, Janani Prasad, Sean Melucci, Kevin M. Gustafson, Paul E. Israelsen and Andrew Browne</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220614]]></guid><cfi:id>231</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Structural-visual functional relationships detected by optical coherence tomography in varying age-cohorts’ patients with optic neuritis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220615]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the relationships of final best-corrected visual acuity (BCVA) and the optic nerve structural loss in varying age-cohorts of optic neuritis (ON) patients.METHODS: This is a retrospective, cross-sectional study. Totally 130 ON subjects (200 eyes) without ON onset within 6mo were included, who underwent BCVA assessment, peripapillary retinal nerve fibre layer (pRNFL) and macular segmented layers evaluation by optical coherence tomography (OCT).RESULTS: For the 0-18y cohort, the final BCVA (logMAR) was significantly better and less frequent recurrences than adult cohorts (P=0.000). The final BCVA (logMAR) in all age-cohorts of the ON patients had negative and linear correlations to the pRNFL thicknesses and macular retinal ganglion cell layer (mRGCL) volumes, when the pRNFL thicknesses were reduced to the thresholds of 57.2-67.5 µm or 0.691-0.737 mm3 in mRGCL volumes, respectively, with the strongest interdependence in the 19-40y cohort. The ON patients from varying age cohorts would be threatened by blindness when their pRNFL thicknesses dropped 36.7-48.3 µm or the mRGCL volumes dropped to 0.495-0.613 mm3.CONCLUSION: The paediatric ON has best prognosis and young adult ON exhibits perfectly linear correlations of final vision and structural loss. The pRNFL and the mRGCL could be potential structural markers to predict the vision prognosis for varying-age ON patients.]]></description>
<pubDate>2022/5/31 14:47:15</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Wei Shi, Hong-Tao Zhang, Hua-Xin Zuo, Si-Yuan Li, Pan-Pan Zheng, Quan-Gang Xu, Si-Yu Cai, Shi-Hui Wei, Li Li and Chun-Xia Peng]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Wei Shi, Hong-Tao Zhang, Hua-Xin Zuo, Si-Yuan Li, Pan-Pan Zheng, Quan-Gang Xu, Si-Yu Cai, Shi-Hui Wei, Li Li and Chun-Xia Peng</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220615]]></guid><cfi:id>230</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Long-term outcome of pathologic myopic foveoschisis treated with posterior scleral reinforcement followed by vitrectomy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220616]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report the long-term outcome of posterior scleral reinforcement (PSR) followed by vitrectomy for pathologic myopic foveoschisis (MF).METHODS: The records of 27 patients (44 eyes) treated with posterior scleral reinforcement (PSR) followed by vitrectomy for pathologic MF were retrospectively reviewed. The best-corrected visual acuity (BCVA), refractive error, axial length, and spectral-domain optical coherence tomography findings and complications were analyzed.RESULTS: Forty-four eyes of 27 patients were included in this study. The follow-up period was 47.98±18.23mo (24-83mo). The mean preoperative BCVA (logMAR) was 1.13±0.63, and the mean postoperative BCVA was 0.30±0.33 at the last visit. There showed a significant improvement in BCVA postoperatively (P&#x003C;0.001). Postoperative BCVA in 41 eyes (93%) was improved compared with the preoperative one. Forty-two eyes (95.45%) got total resolution of the MF after surgery. The remaining two eyes (4.55%) got partial resolution of foveoschisis. The preoperative foveal thickness was 610.45±217.11 μm and the postoperative foveal thickness at the last visit was significantly reduced to 177.64±55.40 μm (P&#x003C;0.001). The preoperative axial length was 29.60±1.71 mm, and the postoperative axial length was 29.74±1.81 mm at the last visit. There was no significant increase in axial length within 47.98±18.23mo of follow-up (P=0.562). There was no recurrence of foveoschisis or occurrence of full-thickness macular hole during the whole follow-up period.CONCLUSION: For pathologic MF, PSR followed by vitrectomy is an effective procedure to improve the visual acuity and the anatomical structure of macula. It can also stabilize the axial length for a long time.]]></description>
<pubDate>2022/5/31 14:47:15</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yao Huang, Yue Qi, Wen-Bin Wei and An-Li Duan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yao Huang, Yue Qi, Wen-Bin Wei and An-Li Duan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220616]]></guid><cfi:id>229</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Vector analysis of Contoura Vision for the correction of myopia and myopic astigmatism]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220617]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the visual outcomes of Contoura Vision (CV) with automatic eye tracking system in eyes with myopia and myopic astigmatism.METHODS: This prospective study included 160 eyes (80 patients) with moderate myopia and irregular astigmatism between January and August 2018. Subjects were randomly divided into CV group (80 eyes) that underwent CV femtosecond laser-assisted in situ keratomileusis (FS-LASIK) and a control group (80 eyes) that underwent wavefront-optimized FS-LASIK. Visual outcomes and astigmatic vector analysis were evaluated and compared between preoperatively and 3mo postoperatively.RESULTS: Basic details were similar in both groups (P&#x003E;0.05). At 3mo postoperatively, uncorrected distance visual acuity was 20/16, 20/20, and 20/25 in 24, 76, and 80 eyes of patients in CV group, respectively. The CV group was better in predictability of astigmatism correction at 3mo postoperatively. In CV group, 64 eyes had deviation of astigmatic axis within 15° and 28 eyes had deviation of astigmatic axis within 5°, both were better than those in the control group. The number of eyes with residual astigmatism within 0.5 D were less in CV group (48 eyes) than the control group (40 eyes). Compared with the preoperative, C7 significantly reduced to 0.056±0.030 in CV group at 3mo after the procedure (P&#x003C;0.05), and were significantly lower than those in the control group (P&#x003C;0.05).CONCLUSION: CV with automatic eye tracking system is safe and effective for the correction of myopia and myopic astigmatism.]]></description>
<pubDate>2022/5/31 14:47:16</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ying Lin, Huan-Jun Su, Mu-Zhi Yuan and Yong Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ying Lin, Huan-Jun Su, Mu-Zhi Yuan and Yong Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220617]]></guid><cfi:id>228</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Topography versus non-topography-guided photorefractive keratectomy with corneal cross-linking variations in keratoconus]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220505]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the visual results of non-topography-guided and topography-guided photorefractive keratectomy (PRK) applying sequential and simultaneous corneal cross-linking (CXL) treatment for keratoconus.METHODS: Interventional and comparative prospective study. Sixty-nine eyes (36 patients) suffering from keratoconus (stages 1 Amsler-Krumeich classification) were divided into four groups: sequential topography-guided photorefractive keratectomy with CXL, simultaneous topography-guided photorefractive keratectomy with CXL, simultaneous non-topography guided photorefractive keratectomy with CXL, and sequential non-topography guided photorefractive keratectomy with CXL. The main outcome measures were pre- and postoperative uncorrected distance visual acuity (UDVA), best corrected distance visual acuity (CDVA), manifest refraction, contrast sensitivity, and keratometry.RESULTS: All analyzed visual, contrast sensitivity, and refractive parameters showed a significant improvement in the four groups (all P<0.05). A noticeable improvement was seen in keratometry in all the groups, and a remarkable difference was observed between topography-guided groups in comparison to non-topography-guided groups (P<0.05). Interestingly, the improvement in all parameters showed a degree of stability to the end of the follow-up.CONCLUSION: The treatment priorities in all four groups are safety, efficacy, and predictability in the correction of the sphero-cylindrical errors in mild and moderate keratoconus. No significant differences among groups in the recorded objective outcomes were found.]]></description>
<pubDate>2022/4/27 14:07:15</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Sana Niazi, Jorge Alio del Barrio, Azad Sanginabadi, Farideh Doroodgar, Cyrus Alinia, Alireza Baradaran-Rafii, Feaizollah Niazi, Hossein Mohammad-Rabei, Mohammad Mehdi Sadoughi and Jorge L. Alio]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Sana Niazi, Jorge Alio del Barrio, Azad Sanginabadi, Farideh Doroodgar, Cyrus Alinia, Alireza Baradaran-Rafii, Feaizollah Niazi, Hossein Mohammad-Rabei, Mohammad Mehdi Sadoughi and Jorge L. Alio</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220505]]></guid><cfi:id>227</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A novel analysis of Scheimpflug total corneal refractive power following corneal cross-linking in mild to moderate keratoconus]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220506]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To detect an earlier improvement in mild to moderate keratoconus following corneal cross-linking (CXL) with total corneal refractive power (TCRP) using ray tracing method.METHODS: A total of 40 eyes of 30 consecutive patients who underwent CXL for progressive keratoconus were retrospectively enrolled. The following keratometric parameters provided by Pentacam HR, including maximum keratometry (Kmax), steepest keratometry (Ksteep), 3 mm zonal TCRP centered over corneal apex (TCRPapex,zone 3 mm), zonal mean keratometry and TCRP centered over corneal cone (Kmcone,zone and TCRPcone,zone 1, 2, 3 mm) were evaluated preoperatively and 1, 3, 6, and 12mo postoperatively. Groups 1 and 2 were defined based on Kmax at postoperative 1mo as improved (the initial improvement group) or worsen (the initial deterioration group) compared to the preoperative level.RESULTS: In the overall group, only keratometric parameters based on ray tracing method displayed significant improvement early at 3mo postoperatively, in which TCRPcone,zone 1 mm and 2 mm exhibited the largest flattening (0.57 D and 0.53 D, respectively). In Group 1, only Kmax, Kmcone,zone 2 mm and TCRPcone,zone 2 mm showed significant improvement initially at 1mo postoperatively, in which Kmax exhibited the largest improvement (1.05 D), followed by TCRPcone,zone 2 mm (0.82 D). In Group 2, only keratometric parameters based on ray tracing method and Kmcone,zone 3 mm showed slight but not significant improvement early at 3mo, in which TCRPcone,zone 3 mm displayed the most improvement (0.19 D), followed by TCRPcone,zone 2 mm (0.15 D).CONCLUSION: The findings indicate that a 2 mm zonal TCRP centered over Kmax could earlier detect keratometric improvement by CXL compared to other commonly used parameters in mild to moderate keratoconic eyes.]]></description>
<pubDate>2022/4/27 14:07:15</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Chao Pan, Wei-Na Tan, Dan Chen, Yu Liu, Hao-Yu Wang, Deng-Feng Liang, Yan-Jun Hua, Xiao-Hua Lei, Qing-Yan Zeng and Shao-Zhen Zhao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Chao Pan, Wei-Na Tan, Dan Chen, Yu Liu, Hao-Yu Wang, Deng-Feng Liang, Yan-Jun Hua, Xiao-Hua Lei, Qing-Yan Zeng and Shao-Zhen Zhao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220506]]></guid><cfi:id>226</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical application of a shape-preserving rapid corneal donor dehydrater]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220507]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To describe the design and clinical application of a corneal donor dehydrator which can quickly dehydrate corneas and keep its original shape.METHODS: The corneal donor material is placed on stainless steel beads with different diameters in the dehydrating box to make the cornea the same shape as the steel ball. Then, the cornea is placed inside the dehydrater for rapid dehydrating using the internal cleaning and ventilation system. Totally 83 eyes underwent deep anterior lamellar keratoplasty (DALK) using corneal donor tissue preserved with corneal dehydrater, and 60 patients (60 eyes) received DALK by the same surgeon using corneal donor tissue preserved with glycerol were included in the control group. The best corrected visual acuity (BCVA), the thickness and transparency of the corneal buttons were recorded.RESULTS: After the completion of dehydrating, all the donor corneas maintained a normal shape without any shrinkage or distortion, and the average intraoperative rehydration time was 43.3±12.1s during operation. The mean BCVA of the dehydrater group was 0.30±0.18 at 1wk and 0.32±0.16 at 1mo, which were statistically better than that of the control group (P<0.001). The score of corneal buttons transparency were lower than that of the control group with statistical difference (P<0.001). The thickness of corneal buttons at 1wk and at 1mo in the dehydrater group was significantly better than that of the control group respectively (P<0.001). One week after operation, no corneal button turbidity or edema was observed in both groups.CONCLUSION: The dehydrater can quickly dehydrate the corneal material in a clean and airtight environment and maintain the original shape of the corneal donor during the dehydrating process. This dehydrater is recommended for long-term high-quality preservation in areas where corneal materials cannot be used within a reasonable time period.]]></description>
<pubDate>2022/4/27 14:07:15</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yu Sun, Xiao-Lin Qi, Xiao Lin, Xiao-Yu Zhang, Li Gao and Hua Gao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yu Sun, Xiao-Lin Qi, Xiao Lin, Xiao-Yu Zhang, Li Gao and Hua Gao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220507]]></guid><cfi:id>225</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of preoperative simulated and postoperative real safety distances using anterior segment OCT in patients with phakic IOL according to iris configuration]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220508]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the simulated safe distance (SSD) preoperatively versus real safe distance (RSD) postoperatively in patients with iris-claw phakic intraocular lens (pIOL) implantation according to iris configuration.METHODS: Totally 60 eyes of 60 patients underwent pIOL implantation for surgical correction of myopia. Anterior chamber depth (ACD) was measured with the IOLMaster 700, and nasal and temporal safety distances (SD) were measured pre- and postoperatively using Anterior Segment Visante-OCT. SD was defined as a line measured between the edge of the optic or its simulated image to the endothelium. Eyes were divided into 3 groups: convex, concave, and plane according to preoperatory iris configuration. Statistical analysis was performed using the R program, for the comparison of independent groups and multiple comparisons, the Kruskal-Wallis test and the Dunn test were used respectively.RESULTS: Mean difference between nasal preoperative SSD and postoperative RSD was -0.36±0.38, -0.29±0.48, and -0.18±0.30 mm in the concave, convex, and plane group, respectively. Mean difference between temporal SSD and RSD was -0.36±0.37, -0.14±0.38, and -0.24±0.33 mm in the concave, convex, and plane group, respectively. There were statistically significant differences between SSD and RSS for both nasal and temporal sides in the concave and plane group (P<0.002).CONCLUSION: Preoperative SSD and postoperative RSD for iris-claw pIOL shows significant differences in patients with concave and plane iris.]]></description>
<pubDate>2022/4/27 14:07:15</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Maria A Henriquez, Maythe Camino-Quezada, Or Ben-Shaul and Luis Izquierdo Jr]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Maria A Henriquez, Maythe Camino-Quezada, Or Ben-Shaul and Luis Izquierdo Jr</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220508]]></guid><cfi:id>224</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Green tea—a new perspective of glaucoma prevention]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220509]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine how green tea and catechins can affect intraocular pressure (IOP) changes.METHODS: Totally 43 young volunteers were included in the study. The experiment was held between noon and 2 p.m. Two extracts—green tea and epigallocatechin gallate (EGCG, 400 mg capsules) and placebo (400 mg capsules) were used in the study. Participants were divided into three groups. Green tea extract group (GT group) had 17 subjects, EGCG extract group 17 subjects, control (placebo) group 9 subjects. IOP was measured with the Icare tonometer before and 30min, 1, 1.5, 2h after the consumption of each extract and placebo. Results were analyzed using the IBM SPSS program. Statistical confidence level P<0.05.RESULTS: The most significant reduction of IOP from the beginning of the experiment was measured after 2h in GT group (left 2.18±3.19 mm Hg, P=0.012; right 2.59±1.97 mm Hg, P<0.000) and after 1h in EGCG extract group (left 2.41±2.98 mm Hg, P<0.004; right 1.94±1.98 mm Hg, P<0.001). In control group no significant changes were measured.CONCLUSION: People who have increased IOP or risk factors for glaucoma development, could benefit from drinking green tea or its concentrated extracts in moderate doses.]]></description>
<pubDate>2022/4/27 14:07:15</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Kornelijus Gasiunas and Saulius Galgauskas]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Kornelijus Gasiunas and Saulius Galgauskas</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220509]]></guid><cfi:id>223</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Efficacy evaluation of intravitreal ranibizumab therapy for three types of retinopathy of prematurity]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220510]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate efficacy of intravitreal ranibizumab (IVR) therapy for aggressive posterior retinopathy of prematurity (ROP), threshold ROP disease and type 1 pre-threshold ROP.METHODS: A retrospective analysis was performed on 40 patients (76 eyes) who had IVR as the primary treatment for ROP from April 2017 to January 2018. According to disease pathogenic features, the 76 eyes were divided into three groups: aggressive posterior ROP (AP-ROP) group (16 eyes), threshold ROP group (28 eyes) and type 1 pre-threshold ROP group (32 eyes). The characteristics of patients and lesions situation before the first intravitreal injection, and posttreatment fundus outcomes determined by wide-angle RetCam fundus imaging were recorded.RESULTS: The birth weight and postmenstrual age of first IVR treatment in AP-ROP, threshold ROP, and type 1 pre-threshold ROP groups were significant difference (1087.50±246.78, 1103.75±168.30, 1257.03±210.82 g, P=0.005; 34.50±1.46, 36.89±2.97, 36.50±2.36wk, P=0.008), while the gestational age was not difference (28.00±2.00, 28.54±1.90, 28.59±1.43wk, P=0.510). The retina hemorrhage ratio (with/without: 14/2, 8/20, 5/27), iris neovascularization or vascular engorgement ratio (with/without: 12/4, 11/17, 6/26), and the zone I (inside/outside: 16/0, 2/26, 5/27) in AP-ROP, threshold ROP, and type 1 pre-threshold ROP group were difference significantly (all P<0.05). The regression rates were 37.5%, 92.86%, and 100%, and the recurrence rates were 62.5%, 7.14%, and 0 in AP-ROP, threshold ROP, and type 1 pre-threshold ROP group, respectively (both P<0.05). The recurrence eyes were cured by secondary IVR or retinal laser photocoagulation.CONCLUSION: IVR is an effective treatment for all types of ROP. The regression of AP-ROP is significantly lower than type 1 pre-threshold and threshold disease. Birth weight, retinal hemorrhage, iris neovascularization or vascular engorgement and lesions located in zone I may be associated with AP-ROP recurrence and retreatment, which should be noted in follow-up.]]></description>
<pubDate>2022/4/27 14:07:15</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Qiong Zou, Yan-Qiong Zhu, Feng-Jun Zhang and Qiu-Ping Liu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Qiong Zou, Yan-Qiong Zhu, Feng-Jun Zhang and Qiu-Ping Liu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220510]]></guid><cfi:id>222</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Amniotic membrane for covering high myopic macular hole associated with retinal detachment following failed primary surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220511]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the therapeutic effect of amniotic membrane (AM) for covering high myopic macular hole associated with retinal detachment following failed primary surgery.METHODS: Seventeen eyes of 17 patients whose axial length was more than 29 mm suffered from macular hole (MH) or MH associated with retinal detachment (RD), and had previously surgery of pars plana vitrectomy (PPV) with internal limiting membrane (ILM) peeling and silicone oil (SO) tamponade. Half a year after the surgery, optical coherence tomography (OCT) showed that MH did not heal in all 17 eyes and RD was still maintained in 13 eyes of these 17 eyes. We performed SO removal combined with AM covering on macular area and C3F8 tamponade, and phacoemulsification combined with intraocular lens implantation simultaneously cataract eyes. We followed up these patients for one year.RESULTS: In all 17 eyes, SO was removed successfully, MHs were healed and RDs were reattached. One eye (5.89%, 1/17) had AM shifted half a month after surgery and underwent a second surgery to adjust the position of the AM and supplement C3F8. After surgery, the visual acuity (VA) improved in 15 eyes (88.24%, 15/17), no change in two eyes (11.76%, 2/17). No serious complications occurred in all eyes.CONCLUSION: AM covering is helpful to rescue the previous failure surgery of high myopic MH.]]></description>
<pubDate>2022/4/27 14:07:16</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Gang Qiao, Xiao-Juan Zhang, Zi-Yan Tang, Qiang-Xing Zou, Chun-Mei He, Xian-Ming Lei, Long Zhao, Yu Quan, Hua-Qing Yang, Kui Cao and Wan-Jiang Dong]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Gang Qiao, Xiao-Juan Zhang, Zi-Yan Tang, Qiang-Xing Zou, Chun-Mei He, Xian-Ming Lei, Long Zhao, Yu Quan, Hua-Qing Yang, Kui Cao and Wan-Jiang Dong</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220511]]></guid><cfi:id>221</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Prophylactic juxtapapillary laser photocoagulation in pediatric morning glory syndrome]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220512]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the anatomic and visual outcomes of prophylactic juxtapapillary laser photocoagulation treatment alone in the prevention of retinal detachment (RD) in a cohort of pediatric patients diagnosed with morning glory syndrome (MGS).METHODS: A total of 24 eyes of 22 consecutive patients aged 0-15y diagnosed with MGS treated with prophylactic juxtapapillary laser photocoagulation alone were reviewed. Data including demographics, ocular examination, anatomic and visual outcomes, following treatment and complications were collected.RESULTS: Two patients had bilateral laser treatment and 20 had monocular laser treatment. The age at treatment of 13 (59.1%) patients was less than 12mo. The presenting symptoms included strabismus (6/22, 27.3%), decreased vision (2/22, 9.1%), and routine fundus screening (14/22, 63.6%). Fifteen (68.2%) patients underwent cranial magnetic resonance imaging (MRI) examinations, and 3 of those 15 (20.0%) had abnormal findings in the nervous system. Based on preoperative wide-field fundus photography and B-scan echography, all (100.0%) eyes had no obvious RD. On postoperative 1mo and 6mo and the following follow-ups, the anatomic outcomes of all eyes remained stable. The mean follow-up duration was 27.7±17.5mo. No severe complications were found. Preoperative visual acuity acquired from 2 (9.1%) patients ranged from light perception to 20/200. Postoperative acuity acquired from 11 (50.0%) patients ranged from light perception to 20/125.CONCLUSION: The preliminary anatomic and visual outcomes of prophylactic juxtapapillary laser treatment alone in pediatric MGS patients are relatively stable in a short-term follow-up. Further long-term clinical observation will be needed to confirm its efficacy and safety.]]></description>
<pubDate>2022/4/27 14:07:16</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yi-Hua Zou, Kai-Qin She, Jia-Ning Ren, Ting-Yi Liang, Ping Fei, Yu Xu, Jing Li, Xiang Zhang, Jie Peng and Pei-Quan Zhao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yi-Hua Zou, Kai-Qin She, Jia-Ning Ren, Ting-Yi Liang, Ping Fei, Yu Xu, Jing Li, Xiang Zhang, Jie Peng and Pei-Quan Zhao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220512]]></guid><cfi:id>220</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Neuroretinal dysfunction in patients affected by neurofibromatosis type 1]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220513]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To examine neuroretinal function by using the multifocal electroretinography (mfERG) test in patients with neurofibromatosis type 1 (NF1) without optic pathway gliomas (OPGs).METHODS: This study was conducted on 35 patients (35 eyes) with NF1 and 30 healthy subjects (30 eyes) for the control group. Each subject underwent a complete ophthalmological examination including spectral domain-optical coherence tomography (SD-OCT) and mfERG. The 1.5-Tesla magnetic resonance imaging (MRI) scan of the brain was performed in NF1 patients to assess the presence of OPGs. All participants were recruited having a best corrected visual acuity (BCVA) of no less than 20/20 in each eye. The amplitude and implicit time of the P1 wave (first-order Kernel component) were evaluated on mfERG. Data analysis was carried out in the two central degrees and in the four quadrants from two to 25 degrees of visual field.RESULTS: Statistically significant results were obtained for the P1 wave amplitudes in the 4 quadrants in NF1 patients compared to healthy controls, while the reduction was not significant in the 2 central degrees between the groups. A statistically significant difference was observed among the P1 wave amplitudes as recorded in the 4 quadrants within the NF1 group, with lower amplitudes detected in the nasal quadrants. No differences in the implicit times were recorded in the 2 central degrees and in the 4 quadrants as compared between NF1 patients and controls.CONCLUSION: Impaired neuroretinal function in NF1 patients is expressed in a decreased amplitude of the P1-wave between 2 and 25 central retinal degrees on mfERG. Altered intracellular signal transduction due to abnormal neurofibromin-mediated cyclic adenosine monophosphate (cAMP) generation, can be involved. The possible use of mfERG as subclinical retinal damage indicator has a potential utility in clinical practice for the follow-up of NF1 patients.]]></description>
<pubDate>2022/4/27 14:07:16</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Antonietta Moramarco, Luca Lucchino, Fabiana Mallone, Michela Marcelli, Ludovico Alisi, Vincenzo Roberti, Sandra Giustini, Alessandro Lambiase and Marcella Nebbioso]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Antonietta Moramarco, Luca Lucchino, Fabiana Mallone, Michela Marcelli, Ludovico Alisi, Vincenzo Roberti, Sandra Giustini, Alessandro Lambiase and Marcella Nebbioso</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220513]]></guid><cfi:id>219</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of clinical outcome of small-incision lenticule intrastromal keratoplasty and FS-LASIK for correction of moderate and high hyperopia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220514]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the clinical outcome of small-incision lenticule intrastromal keratoplasty (sLIKE) and femtosecond laser-assisted in situ keratomileusis (FS-LASIK) for correction of moderate and high hyperopia.METHODS: A case-controlled clinical study was performed. Twenty right eyes of 20 moderate and high hyperopia patients underwent sLIKE (sLIKE group) and 22 right eyes of 22 moderate and high hyperopia patients underwent FS-LASIK (FS-LASIK group) were enrolled in this study from October 2015 to October 2017. Visual acuity, refractive error, corneal thickness, and keratometry were compared between the groups before and 1y postoperatively.RESULTS: The postoperative uncorrected near visual acuity (UNVA) and uncorrected distance visual acuity (UDVA) were improved in the two groups. The UNVA reached J1 in 15 eyes (75.0%) in the sLIKE group and 5 eyes (22.7%) in the FS-LASIK group 1y after surgery (χ2=11.476, P=0.001). The UDVA was equal or better than the preoperative CDVA in 16 eyes (80.0%) in the sLIKE group and 8 eyes (36.4%) in the FS-LASIK group, respectively (X2=8.145, P=0.004). No eyes lost any line of best-corrected visual acuity (BCVA) in either group. The amount of postoperative residual hyperopia in the sLIKE group was significantly less than in the FS-LASIK group (Z=-2.841, P=0.004). The postoperative keratometry and corneal thickness were significantly higher in the sLIKE group than in the FS-LASIK group (t=4.411, 10.279, P<0.001). The SRI and SAI of the sLIKE group were significantly higher than that in the FS-LASIK group. There was no statistically significant difference in mean decentration between the two groups.CONCLUSION: sLIKE has better visual and refractive outcome than FS-LASIK for correction of moderate and high hyperopia.]]></description>
<pubDate>2022/4/27 14:07:16</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Li Zhang, Yue-Hua Zhou, Chang-Bin Zhai, Jing Zhang and Yan Zheng]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Li Zhang, Yue-Hua Zhou, Chang-Bin Zhai, Jing Zhang and Yan Zheng</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220514]]></guid><cfi:id>218</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Factors affecting single-step transepithelial photorefractive keratectomy outcome in the treatment of mild, moderate, and high myopia: a cohort study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220515]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the effect of preoperative factors on visual acuity, higher-order aberrations (HOAs), and index of success for spherical change (S.IOS) after transepithelial photorefractive keratectomy (t-PRK) for treating different grades of myopia.METHODS: This was a retrospective one-armed cohort study where patients with high, moderate, or mild myopia treated with single-step t-PRK using Amaris 500 Hz excimer laser were evaluated for visual acuity, refractive status, corneal topography, HOAs, S.IOS, and mean efficiency and safety index before and 6mo after surgery.RESULTS: A total of 154 eyes of 77 patients with mild (n=59), moderate (n=83), and high (n=12) myopia were reviewed. The efficiency and safety indices for vision recovery by single-step t-PRK were 98% and 100%, respectively. The achieved spherical equivalent (SE) was within 1 diopter (D) in 151 (98%) eyes. The median of the S.IOS was 1.18 [interquartile range (IQR) 1.0, 1.4]. The change in S.IOS was significantly correlated with age (P=0.007), 6.5 mm ablation zone (Mann-Whitney U test, P<0.01), and mild and moderate grade of myopia (Kruskal–Wallis test, P<0.001). Trefoil aberration, spherical aberration, and aberration coefficient types of HOA increased significantly (Wilcoxon test, P<0.001) 6mo post-surgery. There was a significant correlation between spherical aberration and aberration coefficient HOAs by myopia grades (P<0.05).CONCLUSION: Single-step t-PRK has promising short-term outcomes for refractive corrections and vision improvement to treat all three grades of myopia.]]></description>
<pubDate>2022/4/27 14:07:16</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mansour M. Al-Mohaimeed]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mansour M. Al-Mohaimeed</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220515]]></guid><cfi:id>217</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Accuracy of segmented measurement of axial length in ultra-high myopia filled with silicone oil using immersion B-scan ultrasonography]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220516]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the accuracy of segmented measurement of axial length (AL) in high myopia filled with silicone oil by immersion B-scan ultrasonography (immersion B-scan).METHODS: From June 2016 to June 2020, a total of 67 ultra-high myopia inpatients (67 eyes) who underwent silicone oil removal combined with cataract extraction and intraocular lens (IOL) implantation were retrospectively enrolled. The preoperative axial length (AL) of 31 patients with severe cataract were segmented measured using immersion B-scan (B-scan group) and another 36 patients with mild or moderate cataract were measured using IOLMaster 500 (IOLMaster group). The post-operative ALs in two groups were both measured using IOLMaster 500. The IOL power was calculated with Haigis formula. The differences in ALs between pre- and post-surgery, as well as the postoperative refractive spherical equivalent, absolute refractive error, the prediction deviation of postoperative refraction and best corrected visual acuity (BCVA) were compared.RESULTS: The pre- and post-operative ALs were 30.46±1.63 mm (range 28.09-33.51 mm) and 30.42±1.70 mm (range 28.03-33.90 mm) in B-scan group (t=0.644, P=0.542) and 30.51±1.21 mm (range 28.03-33.90 mm) and 30.43±1.27mm (range 28.54-33.50 mm) in IOLMaster group (t=1.843, P=0.074), respectively. Three months after surgery, BCVA were 0.45±0.13 (range 0.3-0.9) and 0.44±0.20 (range 0.2-1.0) in B-scan and IOLMaster group respectively (t=0.086, P=0.932). There was no significant difference of the postoperative spherical equivalent (-3.11±0.65 D vs -3.21±0.51 D, t=0.671, P=0.505) and the absolute refractive error (0.589±0.340 vs 0.470±0.245 D, t=1.615, P=0.112) between two groups. In B-scan group, absolute refractive error within ±0.50 D was found in 18 eyes (58.1%), within ±1.00 D in 26 eyes (83.9%), and within ±1.50 D in 31 eyes (100%). In IOLMaster group, absolute refractive error within ±0.50 D was found in 23 eyes (63.9%), within ±1.00 D in 34 eyes (94.4%), and within ±1.50 D in 36 eyes (Z=0.757, P=0.449).CONCLUSION: The segmented measurement of ALs by immersion B-scan shows comparable measurement accuracy with that of IOLMaster 500 in ultra-high myopia patients with severe cataract secondary to silicone oil filling and can obtain an ideal postoperative refractive state.]]></description>
<pubDate>2022/4/27 14:07:17</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Qing-Hua Yang, Hong-Tao Zhang, Xiao-Qi Li, Bing Chen, Zhao-Hui Li, Yi-Fei Huang, Xin Jin, Ying Zhang and Li-Qiang Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Qing-Hua Yang, Hong-Tao Zhang, Xiao-Qi Li, Bing Chen, Zhao-Hui Li, Yi-Fei Huang, Xin Jin, Ying Zhang and Li-Qiang Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220516]]></guid><cfi:id>216</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A randomized study of network-based perception learning in the treatment of amblyopia children]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220517]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the effectiveness of network-based perception learning (NBPL) and traditional training in the treatment of amblyopia children.METHODS: This randomized controlled clinical trial recruited 56 participants aged 4-12y with anisometropic and/or strabismic amblyopia. Participants were randomly divided into two groups: the NBPL group (n=28) who received patching and NBPL for 3mo, and the control group (n=28) who got 3mo of patching and traditional training. Best-corrected visual acuity (BCVA) in the amblyopic eye and stereoacuity were measured and compared at baseline, 1, 2, and 3mo post-randomization.RESULTS: There were no significant differences in age, gender ratio, and BCVA between the two groups at baseline. At 3mo, most patients gained lines (2 logMAR lines on average) of BCVA in both groups except one 11-year-old girl in the control group (P<0.05). But no significant difference in BCVA improvement of the amblyopic eye between the two groups was found (P=0.725), and amblyopia resolved (BCVA of 0.1 logMAR or better or within 1 logMAR line of the fellow eye) for 13 (46.4%) participants in both groups. The number of patients with improvement of stereoacuity was 25 and 13 in the NBPL group and control group (P=0.041), respectively,  and a significant difference exists in the distribution of stereopsis at 3mo between the two groups (P=0.015). Besides, in patients with measurable stereopsis improvement degree and space for improvement in the two groups, the NBPL group also achieved better stereoscopic improvement than the control group (10/11 vs 4/11, P<0.05).CONCLUSION: The NBPL system has a significant effect on the improvement of BCVA and stereoacuity of amblyopia children and is better than traditional training in terms of stereoacuity improvement. Perceptual learning visual training may play a more important role in the treatment of amblyopia in the future.]]></description>
<pubDate>2022/4/27 14:07:17</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Chang-Yue Zheng, Wei Xu, Shun-Qiang Wu and Dong-Xu Han]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Chang-Yue Zheng, Wei Xu, Shun-Qiang Wu and Dong-Xu Han</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220517]]></guid><cfi:id>215</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Outcomes of different lines of keratoconus management in a tertiary eye center in north China]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220407]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the treatment selections and outcomes of keratoconus and discuss the grading treatment of keratoconus.METHODS: Medical records of 1162 patients (1863 eyes) with keratoconus treated with rigid gas permeable (RGP), corneal collagen crosslinking, and keratoplasty were reviewed. The patients were grouped according to the CLEK Study. The advanced group was further divided into a <60 D group and >60 D group. The best-corrected visual acuity (BCVA) and topographic data before and after treatment were recorded.RESULTS: In the 761 eyes with steep K<52 D, nonsurgical management accounted for 83.4%, while in the 735 eyes with steep K>60 D, surgical management accounted for 90.6%. A total of 618 eyes had improved BCVA at the final follow-up point (>18mo, P<0.001). When steep K was <52 D, the BCVA in the RGP group was better than those with lamellar keratoplasty (LKP; P=0.028). When steep K was >52 D, the BCVA and topographic astigmatism outcomes showed no differences among the treatment groups. When steep K was >60 D, the BCVA in eyes treated with LKP was worse than those with steep K<60 D (P=0.025). The incidence of steep K progression in the RGP group was higher in advanced group (20.0% vs 10.8%, P=0.019). The probability of future keratoplasty in RGP was higher in advanced group (14.8% vs 7.0%, P=0.027). The incidence of steep K progression in the corneal collagen crosslinking (CXL) group was higher in advanced group (32.3% vs 8.5%, P=0.007). Multivariate logistic regression revealed the following related factors for treatment options: steep K [odds ratio (OR)=1.208, 95%CI: 1.052-1.387], TA (OR=1.171, 95%CI: 1.079-1.270), and TCT (OR=0.978, 95%CI: 0.971-0.984). The level of steep K, TA, and TCT all relates to the treatment choices of both keratoplasty and non-keratoplasty, while steep K provided the highest diagnostic accuracy (AUC=0.947, P<0.001).CONCLUSION: Steep K is an important grading treatment indicator. When steep K is <52 D, RGP lenses should be recommended. It is the best time for LKP when the steep K ranges from 52 to 60 D.]]></description>
<pubDate>2022/3/29 14:34:13</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jing Zhang, Xian-Li Du, Lei Wan, Yan-Ling Dong and Li-Xin Xie]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jing Zhang, Xian-Li Du, Lei Wan, Yan-Ling Dong and Li-Xin Xie</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220407]]></guid><cfi:id>214</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Factors associated with corneal astigmatism change after ptosis surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220408]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the predictive factors of postoperative corneal astigmatism change in ptosis patients who underwent ptosis surgical repair.METHODS: Patients who underwent levator resection at Oculoplastic service of the Department of Ophthalmology, Naresuan University Hospital, Thailand between September 2017 and August 2019 were retrospectively evaluated. Changes in degree and axis of corneal astigmatism after ptosis surgery were compared based on patient factors consisting of age at operation, sex, preoperative margin-reflex distance (MRD) 1, and preoperative degree and axis of corneal astigmatism.RESULTS: Forty-two eyes of 28 patients were included in the study. Wilcoxon signed ranks test showed a significant postoperative corneal astigmatism change only in a subgroup of eyes with preoperative astigmatism of ≥1.5 diopters (D; P=0.006). Furthermore, 72.2% (13/18) of the eyes with preoperative astigmatism of ≥1.5 D showed a reduction of astigmatism after eyelid surgery, with the mean astigmatic change of 0.65 D. Majority of preoperative eyes demonstrated with-the-rule astigmatism pattern (45.2%), of which 57.9% showed a reduced degree of astigmatism.CONCLUSION: In patients undergoing ptosis surgery, the data demonstrate for the first time the association between postoperative corneal astigmatism change and a preoperative corneal astigmatism of ≥1.5 D. Thus, we encourage considering severity of corneal astigmatism prior to cataract or refractive surgery planning in ptosis patients, especially with toric-intraocular lens, to avoid the possibility of calculation error.]]></description>
<pubDate>2022/3/29 14:34:14</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Natpatsorn Mongkolareepong, Nattapong Mekhasingharak and Oranicha Pimpha]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Natpatsorn Mongkolareepong, Nattapong Mekhasingharak and Oranicha Pimpha</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220408]]></guid><cfi:id>213</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparing surgical efficiencies between phacoemulsification systems: a single surgeon retrospective study of 2000 eyes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220409]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare under similar conditions intraoperative surgical efficiencies metrics between an active fluidics and a gravity based phacoemulsification systems.
METHODS: Adult patients who were diagnosed with a cataract that compromised visual acuity inferior to 20/40 were included in the study. Patients were excluded from the study if they had a history of severe retinal disorders, clinically significant corneal endothelial dystrophy or history of corneal disease. All phacoemulsification surgeries were performed by a single surgeon. Both phacoemulsification systems used the 0.9 mm 45-degree aspiration bypass system Intrepid Balanced tip and the 0.9 mm Intrepid Ultra infusion sleeve. All cataracts were classified using the Lens Opacities Classification System III, cumulative dissipated energy (CDE) and aspiration fluids were measured in each surgery.
RESULTS: Totally 2000 eyes were included in the study. Phacoemulsification was performed in 1000 (50%) eyes with an active fluid dynamics system and in 1000 (50%) eyes with a gravity-based fluidic system. Mean CDE until fracture of the lens was 1.1 and 1.9 percent-seconds and total mean CDE used was 5.6 and 7.2 percent-seconds using an active fluidics dynamics system and gravity-based fluidic system, respectively (P<0.001). Mean aspiration fluids used were 70 mL using an active fluidics dynamics system and 85 mL using a gravity-based fluidic system (P<0.001).
CONCLUSION: This study evidences that surgeries performed under similar conditions (same surgeon, phaco tip and sleeve) with the active fluidics dynamics system required significantly lower CDE and aspiration fluids.]]></description>
<pubDate>2022/3/29 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Luis Escaf-Jaraba, Jorge Escobar-DiazGranados and Bartolomé Valdemarín]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Luis Escaf-Jaraba, Jorge Escobar-DiazGranados and Bartolomé Valdemarín</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220409]]></guid><cfi:id>212</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Intraoperative complication rates in cataract surgery performed by resident trainees and staff surgeons in a tertiary eyecare center in Hungary]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220410]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the incidence of intraoperative complications during primary phacoemulsification (phaco) surgery between resident surgeons (residents) and staff surgeons (specialists) and to objectively determine the difficulty of stages in phaco surgery.METHODS: This retrospective study included cases of phaco cataract surgery performed between January and December 2019. There were no exclusion criteria. For each patient, demographics, clinical history, case complexity, type of surgeon, and operative details were reviewed. Primary outcomes included intraoperative complication rates and the objective measure of difficulty in the steps of the surgery performed by residents and specialists.RESULTS: A total of 3272 cases were included; 7.4% (n=241) of cases were performed by residents. The overall complication rate was 5.4% (n=177). The intraoperative complication rate was significantly higher (P<0.001) in residents (n=33, 13.7%) than in specialists (n=144, 4.8%). The most frequent complications were posterior capsule tear (n=85, 2.6%), anterior capsule tear (n=50, 1.53%), zonular fiber loss (n=45, 1.38%), and dropped nucleus (n=15, 0.46%). Objectively, the most difficult steps during surgery were phaco in 66 (60.0%), capsulorhexis in 21 (19.1%), irrigation/aspiration in 13 (11.8%), hydrodissection in 9 (8.2%), and intraocular lens (IOL) implantation in 1 (0.9%) case.CONCLUSION: Intraoperative complication rates are higher in residents than in specialists. The order of objective difficulty in phaco surgery steps is in line with the subjective findings of other surveys, revealing that the most challenging parts of phaco surgery are phaco and capsulorhexis.]]></description>
<pubDate>2022/3/29 14:34:14</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Márton Magyar, Gábor László Sándor, László Ujváry, Zoltán Zsolt Nagy and Gábor Tóth]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Márton Magyar, Gábor László Sándor, László Ujváry, Zoltán Zsolt Nagy and Gábor Tóth</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220410]]></guid><cfi:id>211</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Preoperative laser reduces silicone oil use in primary diabetic vitrectomy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220411]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To identify the predictive factors and laser photocoagulation associated with the use of silicone oil as endotamponade during primary diabetic vitrectomy.METHODS: The medical and surgical records of 690 patients (798 eyes) who underwent primary diabetic vitrectomy at a tertiary eye hospital in China from January 2018 to December 2018 were reviewed in this retrospective cohort study. The patients’ baseline characteristics and preoperative treatments were recorded. The binary Logistic regression model was used to evaluate the risk factors for the use of silicone oil as endotamponade agent during primary vitrectomy for proliferative diabetic retinopathy (PDR)-related complications.RESULTS: Among 690 patients with mean age of 52.1±10.5y (range: 18-85y), 299/690 (43.3%) were female. The 31.6% of the eyes received preoperative laser treatment, and 72.4% of the eyes received preoperative anti-VEGF adjuvant therapy. Non-clearing vitreous haemorrhage (VH) alone or combined with retinal detachment was the main surgical indication (89.5%) for primary vitrectomy. Silicone oil was used as endotamponade in 313 (39.2%) eyes. Lack of preoperative laser treatment [odds ratio (OR) 0.66, 95% confidence interval (CI): 0.48-0.92; P=0.015] and older age (OR 0.96, 95%CI: 0.95-0.98; P<0.001) were predictors of silicone oil tamponade during primary vitrectomy for PDR.CONCLUSION: The lack of preoperative laser treatment is a significant predictor of silicone oil tamponade during primary vitrectomy for PDR. However, the severity of PDR relevant to silicone oil use should be further evaluated.]]></description>
<pubDate>2022/3/29 14:34:14</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Wen-Bin Zheng, Xiao-Hu Ding, Kun-Bei Lai, Ji-Zhu Li, Yu-Qing Wu, Yuan Ma, Zi-Ye Chen, Shi-Da Chen, Sai-Nan Xiao, Bing-Qian Liu, Ying Lin and Tao Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Wen-Bin Zheng, Xiao-Hu Ding, Kun-Bei Lai, Ji-Zhu Li, Yu-Qing Wu, Yuan Ma, Zi-Ye Chen, Shi-Da Chen, Sai-Nan Xiao, Bing-Qian Liu, Ying Lin and Tao Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220411]]></guid><cfi:id>210</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[One-year outcomes and predictable factors for microhook ab interno trabeculotomy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220412]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the one-year outcomes and factors that influence the results of microhook ab interno trabeculotomy (μLOT).METHODS: The medical records of consecutive patients with open angle glaucoma who underwent μLOT (including combination of μLOT and cataract surgery) between February 2018 and July 2019 were retrospectively reviewed. Surgical success was defined as the following: an intraocular pressure (IOP)≤21 mm Hg or IOP≤preoperative IOP with a reduced number of glaucoma eye drops, without additional glaucoma surgery, and assessed using Kaplan-Meier survival analysis. A multivariate Cox proportional-hazards regression model was used to investigate the factors associated with surgical failure.RESULTS: The 59 eyes of 59 patients comprising 28 eyes with primary open angle glaucoma (POAG) and 31 with secondary open angle glaucoma (SOAG) were included. The mean IOP and number of glaucoma eye drops significantly decreased from 25.3±7.2 mm Hg and 3.9±1.1, preoperatively to 16.1±4.4 mm Hg (P<0.01) and 2.1±1.8 (P<0.01), respectively, 12mo postoperatively, with a cumulative success rate of 63.1%. The one-year success rate was significantly higher in POAG eyes than in SOAG eyes (80.0% vs 48.0%; P=0.011, log-rank test). Multivariate analyses revealed SOAG [P=0.017, adjusted hazard ratio (aHR): 3.468, 95%CI: 1.246-9.654] and the postoperative IOP spike (IOP>25 mm Hg within 2wk post-surgery; P<0.001, aHR: 5.382, 95%CI: 2.113-13.707) as independent factors associated with surgical failure.CONCLUSION: The μLOT is a good treatment option for POAG eyes. However, the postoperative course should be carefully followed in cases with postoperative IOP spike.]]></description>
<pubDate>2022/3/29 14:34:15</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Daiki Sakai, Masashi Fujihara, Satoshi Yokota, Makoto Nakamura and Yasuo Kurimoto]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Daiki Sakai, Masashi Fujihara, Satoshi Yokota, Makoto Nakamura and Yasuo Kurimoto</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220412]]></guid><cfi:id>209</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical characteristics and surgical treatment of idiopathic uveal effusion syndrome]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220413]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the clinical characteristics of idiopathic uveal effusion syndrome (IUES) and to identify effective surgical modalities for its treatment.METHODS: This retrospective analysis included clinical data of 33 eyes from 26 patients with IUES at Beijing Tongren Hospital. Records of eye examinations, ocular ultrasound, ocular ultrasound biomicroscopy (UBM), and follow-up surgical treatment were reviewed and analyzed.RESULTS: Of 26 patients, 17 (65.4%) were male and 9 (34.6%) were female. The average age of disease onset was 46.8y (range: 22-64y). Seven patients (26.9%) showed retinal detachment in both eyes at presentation. B-ultrasound showed the presence of retinal detachment in one eye or both eyes. All patients had binocular ciliary leakage and detachment. Eyes with retinal detachment underwent four-quadrantic partial-thickness sclerectomy and sclerostomy. Subretinal fluid resolution was achieved within 6mo. Recurrence was observed in three eyes and was resolved with re-operation.CONCLUSION: Ophthalmic ultrasound and UBM, among others, can be helpful in the diagnosis of IUES. Sclerectomy and sclerostomy are surgical modalities that can successfully treat the disease. Some patients may experience recurrence after surgery; reoperation remains safe and effective for them. Long-term follow-up is essential in such settings.]]></description>
<pubDate>2022/3/29 14:34:15</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Zhi-Jun Shen, Lin Shen and Hong Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zhi-Jun Shen, Lin Shen and Hong Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220413]]></guid><cfi:id>208</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Efficacy of conbercept after switching from bevacizumab/ranibizumab in eyes of macular edema secondary to central retinal vein occlusion]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220414]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To explore the efficacy of conbercept after switching from bevacizumab/ranibizumab in eyes of central retinal vein occlusion (CRVO) through optical coherence tomography angiography (OCTA).METHODS: Patients with prior treatment of a minimum of three consecutive intravitreal injections of either bevacizumab or ranibizumab, followed by injection of conbercept, were recruited. The minimal follow-up period after switching was 12mo. Central retinal thickness (CRT), best-corrected visual acuity (BCVA), the interval of injections was reviewed. Perfusion density (PD) and vascular length density (VLD) of superficial and deep capillary plexus were acquired from OCTA images before and after switching.RESULTS: Twenty-four eyes were included. CRT significantly decreased from 460.71±153.23 μm (before switching) to 283.92±38.27 μm at the end of follow-up (P<0.001). However, BCVA gained to some extent (from 0.98±0.33 to 0.76±0.42 logMAR) but the difference was not significant (P=0.070). After switching to conbercept the injection interval extended from 5.2±2.3wk to 8.3±3.9wk (P=0.012). At the end of follow-up, PD of deep retinal layer decreased significantly compared with before switching (from 34.62%±5.27% to 33.26%±5.82%, P=0.016), similar result was found in VLD of deep retinal layer but not in PD or VLD in superficial layer.CONCLUSION: In cases of refractory macular edema secondary to CRVO, switching to conbercept improves macular thickness and extends interval of injection. Retinal microvasculature cannot improve with treatment of conbercept.]]></description>
<pubDate>2022/3/29 14:34:15</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Tong Zhao, You Chen, Hong-Song Zhang, Yi Chen and Zhi-Jun Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Tong Zhao, You Chen, Hong-Song Zhang, Yi Chen and Zhi-Jun Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220414]]></guid><cfi:id>207</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Efficacy of intravitreal conbercept combined with panretinal photocoagulation for severe nonproliferative diabetic retinopathy without macular edema]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220415]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess efficacy of intravitreal conbercept (IVC) injection in combination with panretinal photocoagulation (PRP) vs PRP alone in patients with severe nonproliferative diabetic retinopathy (SNPDR) without macular edema (ME).METHODS: Forty-eight patients with SNPDR without ME (56 eyes) were divided into the PRP group and IVC+PRP group (the pulse group) in this retrospective clinical study. Conbercept was intravitreally administered to patients in the pulse group 1wk before treatment with PRP and followed up for 1, 3, and 6mo. The best-corrected visual acuity (BCVA, logMAR), center foveal thickness (CFT), visual acuity (VA) improvement, and adverse reactions were compared between groups.RESULTS: In the PRP group, the BCVA reduced at 1 and 3mo before improving at 6mo. In the pulse group, baseline BCVA decreased continuously at 1mo, increased at 3 and 6mo. BCVA in the pulse group was better than that in the PRP group at 1, 3, and 6mo. There was an increase in CFT in the PRP group during follow-up compared with baseline. In the pulse group, CFT was increased at 1mo relative to baseline, steadily decreased to the baseline level at 3 and 6mo. There was a more significant reduction in CFT in the pulse group during follow-up compared with the PRP group. The effective rates of VA in the PRP and the pulse groups were 81.48% and 100%, respectively.CONCLUSION: As PRP pretreatment, a single dose of IVC administration has beneficial effects for preventing PRP-induced foveal thickening and increasing VA in patients with SNPDR without ME.]]></description>
<pubDate>2022/3/29 14:34:15</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ning Zhao, Jian Guan, Na Cai and Ning-Ning Liu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ning Zhao, Jian Guan, Na Cai and Ning-Ning Liu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220415]]></guid><cfi:id>206</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A new handheld fundus camera combined with visual artificial intelligence facilitates diabetic retinopathy screening]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220416]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To explore the performance in diabetic retinopathy (DR) screening of artificial intelligence (AI) system by evaluating the image quality of a handheld Optomed Aurora fundus camera in comparison to traditional tabletop fundus cameras and the diagnostic accuracy of DR of the two modalities.METHODS: Overall, 630 eyes were included from three centers and screened by a handheld camera (Aurora, Optomed, Oulu, Finland) and a table-top camera. Image quality was graded by three masked and experienced ophthalmologists. The diagnostic accuracy of the handheld camera and AI system was evaluated in assessing DR lesions and referable DR.RESULTS: Under nonmydriasis status, the handheld fundus camera had better image quality in centration, clarity, and visible range (1.47, 1.48, and 1.40) than conventional tabletop cameras (1.30, 1.28, and 1.18; P<0.001). Detection of retinal hemorrhage, hard exudation, and macular edema were comparable between the two modalities, in principle, with the area under the curve of the handheld fundus camera slightly lower. The sensitivity and specificity for the detection of referable DR with the handheld camera were 82.1% (95%CI: 72.1%-92.2%) and 97.4% (95%CI: 95.4%-99.5%), respectively. The performance of AI detection of DR using the Phoebus Algorithm was satisfactory; however, Phoebus showed a high sensitivity (88.2%, 95%CI: 79.4%-97.1%) and low specificity (40.7%, 95%CI: 34.1%-47.2%) when detecting referable DR.CONCLUSION: The handheld Aurora fundus camera combined with autonomous AI system is well-suited in DR screening without mydriasis because of its high sensitivity of DR detection as well as its image quality, but its specificity needs to be improved with better modeling of the data. Use of this new system is safe and effective in the detection of referable DR in real world practice.]]></description>
<pubDate>2022/3/29 14:34:16</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Shang Ruan, Yang Liu, Wei-Ting Hu, Hui-Xun Jia, Shan-Shan Wang, Min-Lu Song, Meng-Xi Shen, Da-Wei Luo, Tao Ye and Feng-Hua Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Shang Ruan, Yang Liu, Wei-Ting Hu, Hui-Xun Jia, Shan-Shan Wang, Min-Lu Song, Meng-Xi Shen, Da-Wei Luo, Tao Ye and Feng-Hua Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220416]]></guid><cfi:id>205</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Artificial intelligence improves accuracy, efficiency, and reliability of a handheld infrared eccentric autorefractor for adult refractometry]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220417]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the accuracy, efficiency, and reliability of a handheld infrared eccentric autorefractor (hICA) with artificial intelligence (AI) by comparing its refraction measurements to those recorded using hICA and a clinical table-mounted automatic refractor (TAR).METHODS: A cross-sectional study using three optometers, including hICA with or without AI and TAR, for refractometry of adults (aged 19-49 years old) with no signs of ocular disease or trauma in the absence of cycloplegia. Right and left eye refraction data were recorded, including the spherical equivalent (SE), diopter of spherical power (DS), diopter of cylindrical power (DC) decomposed into vectors J0 and J45, and measurement times. To avoid analytical difficulties associated with the interdependence of observations between eyes from the same individual, the Generalized Estimation Equation was used to compare the SE, DS, J0 and J45 measurements, and the times thereof, among the different groups. The intraclass correlation coefficient (ICC) and Spearman’s rank correlation coefficient were used to evaluate correlations among the measurements recorded by the three different instruments. Bland-Altman were used to analyze the precision of the equipment by the agreement.RESULTS: A total of 70 patients (140 eyes; mean age: 31.37y; range: 19-49y) were assessed using refractometry. In a brightly lit environment, there was no significant difference between the mean SE recorded using TAR and that recorded using hICA with AI or without AI (both P>0.05). In an intense-light environment, hICA equipped with AI showed a better detection rate than without AI. Light intensity had a greater effect on dioptric measurements recorded using hICA without AI (P<0.001) than on those recorded using the one equipped with AI (P<0.05). Measurement times varied significantly between the different light intensities and instruments (P<0.05).CONCLUSION: For the normal human eyes, AI may improve the accuracy, efficiency, and reliability of measurements recorded using hICA in various light environments.]]></description>
<pubDate>2022/3/29 14:34:16</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yi-Ting Cao, Dan-Yang Che, Yi-Lei Pan, Yun-Li Lu, Chong-Yang Wang, Xiao-Li Zhang, Yun-Fei Yang, Ke-Ke Zhao and Ji-Bo Zhou]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yi-Ting Cao, Dan-Yang Che, Yi-Lei Pan, Yun-Li Lu, Chong-Yang Wang, Xiao-Li Zhang, Yun-Fei Yang, Ke-Ke Zhao and Ji-Bo Zhou</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220417]]></guid><cfi:id>204</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical characteristics of ocular toxocariasis in adults in north China]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220305]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the clinical features of adult patients with ocular toxocariasis (OT) in north China and to diagnose adults OT patients in early stage.METHODS: Clinical data of 24 adults with OT were retrospectively analyzed. Slit lamp photographs and fundus photographs and other imaging examinations of all the patients were reviewed. A questionnaire concerning the pet ownership and place of residence was completed to investigate the possible infection origin. Descriptive statistical analyses were performed on the demographic data, clinical features, funduscopic findings and ELISA results.RESULTS: Among the 24 patients diagnosed with OT by Toxocara IgG antibody in intraocular fluid, 16 (66.7%) eyes were right eye. The onset age of 12 eyes (50.0%) was between 30 and 40 years old, and 21 (87.5%) eyes were of peripheral granuloma type. The most common sign was vitreous opacity. Granulomas were detected in all the eyes, and 20 (83.3%) patients resided in rural area. In 4 patients, the concentration of anti-Toxocara antibody both in anterior humor and in vitreous humor were detected, and the results showed the concentration in vitreous humor was much higher than aqueous humor.CONCLUSION: Our study analyzes the clinical manifestation of OT in adults, which may have been under-recognized before. Eye side, residence, and detection of granuloma may help us in diagnosis of OT in patients with monocular vitreous opacity. For adult patients with presumed OT, negative results of anti-Toxocara antibody in anterior humor cannot rule out the possibility of OT, further detection of vitreous humor is suggested for final diagnosis.]]></description>
<pubDate>2022/3/1 14:57:54</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xiao-Feng Hu, Jing Feng, Hao Kang, Hui Wang, Xu-Hui Liu and Yong Tao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiao-Feng Hu, Jing Feng, Hao Kang, Hui Wang, Xu-Hui Liu and Yong Tao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220305]]></guid><cfi:id>203</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Evaluations of wavefront aberrations and corneal surface regularity in dry eye patients measured with OPD Scan III]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220306]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the wavefront aberrations and corneal surface regularity between dry eye (DE) patients and normal subjects and assess its diagnostic performance for DE measured with OPD Scan-III.METHODS: Fifty right eyes of 50 DE patients and 31 right eyes of normal subjects were included. The examinations for ocular surface including logarithm of the minimum angle of resolution best-corrected distance visual acuity (logMAR BCVA) the ocular surface disease index (OSDI), tear film break-up time (TBUT) and corneal fluorescein staining (CFS). OPD Scan-III was used to measure anterior corneal aberrations including total corneal aberrations, high order aberration (HOA), coma, trefoil, spherical aberration (SA), standard deviation of corneal power (SDP), surface regularity index (SRI) and surface asymmetry index (SAI). Statistical analysis were assessed with nonparametric tests and Spearman's correlations. All parameters were also analyzed for sensitivity, specificity, and receiver operating characteristics (ROC) curves.RESULTS: Wavefront aberrations parameters including total corneal aberrations, HOA, coma, trefoil, and SA in DE group were significantly higher than those in normal group (P&#x0026;#x003C;0.001). Corneal surface regularity parameters including SRI and SAI in DE group were significantly higher than both in normal group (P&#x0026;#x003C;0.05). All the wavefront aberrations parameters had significant correlations with ocular surface parameters (P&#x0026;#x003C;0.05). The logMAR BCVA had positive correlations with SAI and SRI (all P&#x0026;#x003C;0.001). CFS scores had positive correlations with SAI and SRI (all P&#x0026;#x003C;0.001). All the wavefront aberrations parameters showed good diagnosis sensitivity and specificity, however, the corneal regularity parameters showed only good specificity but poor sensitivity. The cut-off value selected for trefoil in diagnosis DE showed the highest area under the curve (AUC, 0.921) values as compared to the other parameters with sensitivity of 0.955 and specificity of 0.867.CONCLUSION: Wavefront aberrations and corneal surface regularity are increased in DE patients and also correlated with ocular surface parameters. Wavefront aberrations parameters have potential to be indicators to diagnosis and monitor DE.]]></description>
<pubDate>2022/3/1 14:57:55</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Rong-Jun Liu, Bai-Kai Ma, Yu-Fei Gao, Yi-Yun Liu and Hong Qi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Rong-Jun Liu, Bai-Kai Ma, Yu-Fei Gao, Yi-Yun Liu and Hong Qi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220306]]></guid><cfi:id>202</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Management of chronic dacryocystitis cases after failed external dacryocystorhinostomy using endoscopic technique with a novel lacrimal ostium stent]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220307]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To demonstrate the outcomes of endoscopic endonasal dacryocystorhinostomy (En-DCR) with an novel lacrimal ostium stent (LOS) which was performed in patients with recurrent epiphora after failed external dacryocystorhinostomy (Ex-DCR) and analyze the causes of failed Ex-DCR.METHODS: From September 2015 and December 2017, the clinic data of 29 cases suffered from recurrent epiphora after failed Ex-DCR was reviewed. The LOS were implanted into the ostium at the end of the revisional surgery. The causes of failed Ex-DCR were analyzed before revisional surgeries. Outcome of revisional surgeries with the new device were evaluated as well.RESULTS: The major causes of failure of the external approach were synechiae formation in the nasal ostium (29/29), followed by inadequate removal of the bony wall (21/29), nasal synechiae formation between lateral wall of nose and middle turbinate (11/29), and the bone opening was not in good location (7/29). The rate of success after revisional surgery was 82.76%. Re-obstruction of the ostiums were found in 5 failed cases.CONCLUSION: Endoscopic approach with a novel LOS may be an effective procedure to manage recurrent epiphora after previous failed Ex-DCR surgery. Synechiae formation in the nasal ostium and inadequate removal of the bony wall were the major causes of failure of Ex-DCR.]]></description>
<pubDate>2022/3/1 14:57:55</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Bo Yu, Yun-Hai Tu, Guang-Ming Zhou, Jie-Liang Shi, En-De Wu and Wen-Can Wu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Bo Yu, Yun-Hai Tu, Guang-Ming Zhou, Jie-Liang Shi, En-De Wu and Wen-Can Wu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220307]]></guid><cfi:id>201</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Association between axial length and toric intraocular lens rotation according to an online toric back-calculator]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220308]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the relationship between axial length (AL) and intraocular lens (IOL) rotation among eyes receiving a toric IOL and subsequently entered into an online toric back-calculator database.METHODS: Retrospective analysis of data collected online via astigmatismfix.com, a freely available online toric back-calculator where surgeons enter pre- and post-operative information to help manage residual postoperative astigmatism. Included records were deemed valid with entry of AL and IOL orientation between January 2017 and March 2019. Rotation was determined by a difference of ≥5° between pre-operative intended IOL orientation and actual post-operative IOL orientation. Frequency and magnitude of rotation are presented with means and associated standard deviation (SD). Linear regression models of this association are presented.RESULTS: Records of 6752 eyes were included in the analysis, of which 74.8% were determined to have a rotated IOL. The magnitude of rotation increased with each millimeter (mm) increase in AL with a mean rotation of 13.3° (SD: 12.8°) for eyes with AL 20-20.9 mm and a maximum mean rotation of 30.6° (SD: 30.3°) among eyes with AL 29-29.9 mm. General linear modeling demonstrated a significant association (P&#x0026;#x003C;0.0001) with a parameter estimate of 1.19 (standard error: 0.159) and R2 of 0.0083.CONCLUSION: Analysis from an online database indicates that toric IOLs inserted into eyes with longer AL are more likely to rotate and to rotate more degrees from the target axis. The findings from this study are clinically relevant for surgeons implanting toric IOLs.]]></description>
<pubDate>2022/3/1 14:57:55</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jennifer L. Patnaik, Malik Y. Kahook, John P. Berdahl, David R. Hardten, Brandie D. Wagner, Leonard K. Seibold and Brent A. Kramer]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jennifer L. Patnaik, Malik Y. Kahook, John P. Berdahl, David R. Hardten, Brandie D. Wagner, Leonard K. Seibold and Brent A. Kramer</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220308]]></guid><cfi:id>200</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Ocular development in children with unilateral congenital cataract and persistent fetal vasculature]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220309]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the ocular development of patients who had unilateral congenital cataract (CC) combined with persistent fetal vasculature (PFV).METHODS: This cross-sectional, observational study included patients who had unilateral CC and PFV and those with isolated unilateral CC. Axial length (AL), keratometry, anterior chamber depth (ACD), lens thickness, and vitreous length were obtained. The ocular biometric parameters of the affected eyes of patients with CC and PFV were compared with the fellow eyes and with the affected eyes of patients with isolated CC.RESULTS: A total of 110 patients were included and divided into 4 groups: group 1 (18 patients with CC and PFV, &#x0026;#x003C;24mo), group 2 (22 patients with CC and PFV, ≥24mo), group 3 (35 patients with CC, &#x0026;#x003C;24mo), and group 4 (35 patients with CC, ≥24mo). The ALs of the affected eyes were shorter than those of the fellow eyes in group 1 (20.02±1.06 vs 20.66±0.63 mm, P=0.025). While the ALs of the affected eyes were longer than those of the fellow eyes in group 2 (23.18±2.00 vs 22.31±1.06 mm, P=0.044) and group 4 (22.64±1.80 vs 22.02±1.01 mm, P=0.033). The keratometries of the affected eyes were steeper than those of the fellow eyes in group 2 (44.78±1.66 vs 43.83±1.38 D, P=0.041) and group 4 (43.76±1.91 vs 43.34±1.46 D, P=0.043). No difference of ACDs between two eyes was found in all groups (all P&#x0026;#x003E;0.05).CONCLUSION: Compared with the fellow eyes, the ALs of the eyes with unilateral CC and PFV are shorter in patients younger than 24mo and longer in those older than 24mo; the keratometries of the eyes with unilateral CC and PFV are steeper in patients older than 24mo and similar with those younger than 24mo. These findings provide further understanding of ocular development in patients with both CC and PFV.]]></description>
<pubDate>2022/3/1 14:57:55</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Shu-Yi Zhang, Hui Chen, Jing-Hui Wang, Wan Chen, Qi-Wei Wang, Jing-Jing Chen, Xiao-Shan Lin, Zhuo-Ling Lin, Duo-Ru Lin, Hao-Tian Lin and Wei-Rong Chen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Shu-Yi Zhang, Hui Chen, Jing-Hui Wang, Wan Chen, Qi-Wei Wang, Jing-Jing Chen, Xiao-Shan Lin, Zhuo-Ling Lin, Duo-Ru Lin, Hao-Tian Lin and Wei-Rong Chen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220309]]></guid><cfi:id>199</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Evaluation of the safety of anterior capsule staining with trypan blue under air: a retrospective analysis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220310]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the safety of using 0.03% trypan blue under air for anterior capsule staining in cataract surgery.METHODS: The current study involved a retrospective analysis of the medical records of 86 patients with vitreous hemorrhage, who underwent pars plana vitrectomy and cataract surgery. The patients were classified into two groups. The trypan blue group (n=45) comprised patients who underwent anterior capsule staining with 0.03% trypan blue under an air bubble. The control group (n=41) comprised of patients who underwent intracameral illuminator-assisted capsulorhexis. The status of endothelial cell density (ECD) in both the groups was analyzed.RESULTS: The trypan blue group displayed significant decline in ECD at 1mo (7.91% loss, P&#x0026;#x003C;0.001) and 3mo (9.65% loss, P&#x0026;#x003C;0.001) after the surgery, whereas no significant changes were observed in the control group. Moreover, the number of patients who did not display a postoperative decline in ECD was significantly higher in the control group (43.9%; 18 patients) than in the trypan blue group (17.1%; 7 patients, P=0.004).CONCLUSION: Anterior capsule staining with trypan blue under the air bubble would not be as safe as the intracameral illuminator. The ECD loss might be attributed to the air bubble rather than to the deleterious effects of 0.03% trypan blue. Further studies are required to clarify this.]]></description>
<pubDate>2022/3/1 14:57:55</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Young Min Park, Jong Soo Lee, Ji Eun Lee, Yeon Ji Jo, Ik Soo Byon and Sung Who Park]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Young Min Park, Jong Soo Lee, Ji Eun Lee, Yeon Ji Jo, Ik Soo Byon and Sung Who Park</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220310]]></guid><cfi:id>198</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Evaluation of Corvis ST tonometer with the updated software in glaucoma practice]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220311]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the agreement of biomechanically corrected intraocular pressure (b-IOP) and central corneal thickness (CCT) measurements obtained with the updated Corvis ST tonometer versus Goldmann applanation tonometry (GAT) and optical-based corneal pachymetry (OB-CCT) in controls, patients with ocular hypertension (OHT) and primary open angle glaucoma (POAG). Additionally, we examined the differences in corneal deformation parameters provided by the updated Corvis ST among the three groups.METHODS: For each participant, GAT IOP, OB-CCT and measurements with a Corvis ST with updated software were obtained. Bland-Altman analysis was used to assess the agreement between the two measurement methods.RESULTS: A consecutive series of 80 eyes from 80 participants (30 with POAG, 25 with OHT and 25 normal controls) were included in this prospective study. The mean GAT IOP of all eyes was 17.2±3.6 mm Hg, and the mean b-IOP was 15.9±3.7 mm Hg (Spearman's rho=0.767, P&#x0026;#x003C;0.001). The 95% limits of agreement (LoAs) ranged from -3.1 mm Hg to 5.5 mm Hg for GAT IOP and b-IOP. b-IOP was not correlated with OB-CCT (Spearman's rho=-0.13 P=0.917). Meanwhile there was a weak positive corelation between OB-CCT and GAT IOP–b-IOP difference (Spearman's rho=0.378, P=0.001). The mean OB-CCT was 549.5±36.4 µm, and the Corvis-CCT was 556.1±41.5 µm (Spearman's rho=0.900, P&#x0026;#x003C;0.001). No statistically significant difference in the new indices provided by the updated Corvis ST was detected among the three groups. Compared with control eyes, POAG eyes had a significantly reduced applanation time 2 after adjusting for OB-CCT and GAT IOP (P=0.048).CONCLUSION: Corvis b-IOP and CCT correlate well with GAT IOP and OB-CCT. b-IOP is not affected by CCT, which might be an advantage, especially in thick or thin corneas. Corvis ST yields shorter applanation time 2 measurements in patients with POAG, which might reflect altered corneal viscoelasticity.]]></description>
<pubDate>2022/3/1 14:57:56</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ioannis Halkiadakis, Vasilios Tzimis, Alexandros Gryparis, Ioannis Markopoulos, Vasiliki Konstadinidou, Elias Zintzaras and Michalis Tzakos]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ioannis Halkiadakis, Vasilios Tzimis, Alexandros Gryparis, Ioannis Markopoulos, Vasiliki Konstadinidou, Elias Zintzaras and Michalis Tzakos</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220311]]></guid><cfi:id>197</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Multimode imaging characteristics and treatment of uveal schwannoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220312]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To delineate the different imaging characteristics of uveal schwannoma from melanoma and discuss the optimal treatment strategy for intraocular schwannoma.METHODS: Case series of three patients diagnosed with intraocular schwannoma was collected at Zhongshan Ophthalmic Center, Guangzhou, China from July 2014 to December 2020. All the study patients underwent ultrasonography and magnetic resonance imaging (MRI). The clinical features, therapeutic strategies, and prognoses of all patients were reviewed.RESULTS: Ultrasonography of all three patients (all females, mean age, 39y, age range, 23-54y) showed low to medium reflectivity with a homogeneous internal structure. MRI of all three patients demonstrated isointensity on T1-weighted imaging spin-echo (T1WI SE) images and hypointense on fast spin-echo T2-weighted images (FSE T2WI) images with respect to the brain. Minimally invasive pars plana vitrectomy (PPV) and local resection of the tumor was performed for all patients, and the diagnosis of schwannoma was confirmed by histopathological examination.CONCLUSION: The present study indicates that ultrasonography and MRI features of uveal schwannoma may contribute to the differentiation of uveal schwannoma from melanoma, and the optimal therapy for intraocular schwannoma is minimally invasive PPV and local resection.]]></description>
<pubDate>2022/3/1 14:57:56</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ting Zhang, Lu-Jia Feng, You Wang, Yun-Hong Shi, Li Wang, Yi-Meng Sun, Yan-Tao Wei and Shao-Chong Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ting Zhang, Lu-Jia Feng, You Wang, Yun-Hong Shi, Li Wang, Yi-Meng Sun, Yan-Tao Wei and Shao-Chong Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220312]]></guid><cfi:id>196</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Plasma and aqueous humor levels of adiponutrin and pannexin 1 in patients with and without diabetic retinopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220313]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate plasma and aqueous levels of adiponutrin and pannexin 1 in patients with and without diabetic retinopathy.METHODS: The study included three age and gender-matched groups of 20 cataract patients with no diabetes or additional disease (Group C), 20 cataract patients with diabetes and no retinopathy (Group DM+C), and 20 cataract patients with diabetic retinopathy (Group DR+C). All the patients were examined with respect to body mass index (BMI), fasting plasma glucose, hemoglobin A1c (HbA1c), and lipid profile. Phacoemulsification and intraocular lens (Phaco+IOL) implantation were performed to all patients in all the groups, and aqueous samples were taken during the operation. The plasma and aqueous adiponutrin and pannexin 1 levels were analyzed using enzyme-linked immunosorbent assays.RESULTS: A statistically significant difference was determined between the groups with respect to BMI, fasting plasma glucose, and HbA1c levels (P&#x0026;#x003C;0.05 for all parameters tested). The plasma adiponutrin levels of Group DR+C were statistically significantly lower than those of Group C and Group DM+C (P&#x0026;#x003C;0.001, P=0.004). No statistically significant difference was determined in the aqueous adiponutrin levels in three groups. The plasma pannexin 1 levels of Groups DM+C and DR+C were statistically significantly lower than those of Group C (both P=0.001). The aqueous pannexin 1 levels of Group DR+C were statistically significantly higher than those of Group C and Group DM+C (P=0.001, P&#x0026;#x003C;0.001).CONCLUSION: Adiponutrin and pannexin 1, which play an important role in the pathophysiology of diabetes and obesity, and have a regulatory role in hyperglycemia and insulin resistance. The measurement of adiponutrin and pannexin 1 levels may support clinicians in determining the risk of DR development.]]></description>
<pubDate>2022/3/1 14:57:56</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Fatih Cem Gül, Sabiha Güngor Kobat, Fatih Celik, Süleyman Aydin and Ramazan Fazil Akkoc]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Fatih Cem Gül, Sabiha Güngor Kobat, Fatih Celik, Süleyman Aydin and Ramazan Fazil Akkoc</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220313]]></guid><cfi:id>195</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Gender as an effect modifier in the relationship between hypertension and reticular pseudodrusen in patients with early or intermediate age-related macular degeneration]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220314]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine whether the prevalence of treated hypertension is higher among males or females with early/intermediate (e/i) age-related macular degeneration (AMD) with and without bilateral reticular pseudodrusen (RPD).METHODS: Retrospective review of the records of patients with e/iAMD who were recruited into the University of Colorado AMD registry between July 2014 and November 2019. Images were classified using the Beckman Initiative criteria and presence/absence of RPD. Patients were categorized into three groups: 1) e/iAMD with RPD; 2) e/iAMD without RPD; 3) control patients who did not have AMD. Multinomial logistic regression analysis was used for adjusted analysis with odds ratios (OR) and confidence intervals (CI).RESULTS: There were 260 patients with e/iAMD of which 101 had bilateral RPD and 159 had no RPD, and 221 controls. Overall, 62% of patients were female and the three groups did not differ by gender. When stratified by gender, the female e/iAMD/RPD group had a higher prevalence of hypertension, 64.1% vs 45.2% for controls, OR=2.2 (95%CI: 1.2-4.0). The frequency of hypertension in the e/iAMD/no RPD group was 54.1% and did not significantly differ from the control group. Among males, prevalence rates of treated hypertension did not differ. There is a significant interaction of hypertension and gender for the e/iAMD/RPD group such that women with e/iAMD who had RPD were significantly more likely to have hypertension (P=0.042). This relationship was not significant in the e/iAMD/no RPD group (P=0.269).CONCLUSION: Among females treated hypertension is significantly higher among e/iAMD/RPD patients, whereas for males there is no significant association.]]></description>
<pubDate>2022/3/1 14:57:56</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Nathaniel Gelinas, Anne M. Lynch, Marc T. Mathias, Alan G. Palestine, Naresh Mandava, Karen L Christopher and Jennifer L. Patnaik; University of Colorado Retina Research Group]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Nathaniel Gelinas, Anne M. Lynch, Marc T. Mathias, Alan G. Palestine, Naresh Mandava, Karen L Christopher and Jennifer L. Patnaik; University of Colorado Retina Research Group</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220314]]></guid><cfi:id>194</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Macular Bruch’s membrane defects and other myopic lesions in high myopia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220315]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the ocular fundus features of highly myopic eyes with and without macular Bruch's membrane (BM) defects and investigate the associations between macular BM defects and other myopic lesions.METHODS: This retrospective, observational case series included 262 eyes (139 patients) with high myopia (HM) refractive error ≥-6.0 diopters (D) or axial length ≥26.5 mm from March 2019 to December 2019. The patients underwent a comprehensive ophthalmic examination, including swept-source optical coherence tomography (SS-OCT). The features of macular BM defects and other ocular fundus lesions were examined in OCT images.RESULTS: Totally 51 eyes (19.5%) were detected with macular BM defects, which were characterized by a lack of BM, retinal pigment epithelium (RPE), and an almost complete loss of photoreceptors or choriocapillaris. Eyes with macular BM defects had worse best-corrected visual acuity (BCVA) than those without (P&#x0026;#x003C;0.001). Dome-shaped macula (DSM, P=0.042), retinal cysts (P=0.006), choroidal neovascularization (CNV, P&#x0026;#x003C;0.001), choroidal defects and abnormality (P=0.003), scleral defects (P=0.015), scleral deformation (P=0.005), posterior staphyloma (P=0.011), and perforating vessels (P&#x0026;#x003C;0.001) occurred more frequently in eyes with macular BM defects. In multivariate analysis, the presence of macular BM defects remained the significant association with presence of DSM (P=0.013), scleral defects (P=0.015), posterior staphyloma (P=0.001), perforating vessels (P&#x0026;#x003C;0.001) and CNV (P=0.004).CONCLUSION: Macular BM defects has a prevalence of approximately 20% in HM and it has tight association with other myopic fundus lesions. BM might be crucial in the pathogenesis of myopic fundus lesions due to its biomechanical function. A comprehensive understanding of BM's role is useful for further researches about myopic lesions.]]></description>
<pubDate>2022/3/1 14:57:56</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Li-Hui Meng, Ming-Zhen Yuan, Xin-Yu Zhao and You-Xin Chen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Li-Hui Meng, Ming-Zhen Yuan, Xin-Yu Zhao and You-Xin Chen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220315]]></guid><cfi:id>193</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Long-term outcomes of drusenoid pigment epithelium detachment in intermediate AMD treated with 577 nm subthreshold micropulse laser: a preliminary clinical study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220316]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the long-term anatomical and visual outcomes of drusenoid pigment epithelial detachment (D-PED) in intermediate age-related macular degeneration (AMD) eyes treated with 577 nm yellow subthreshold micropulse laser (SML).METHODS: In this retrospective study, 21 eyes of 16 patients with D-PED in intermediate AMD were consecutively included and assessed. All the eyes were treated with 577 nm SML in several sessions according to D-PED growth status. The logarithm of the minimum angle of resolution (logMAR) best-corrected visual acuity (BCVA) were assessed at the initial visit and after treatment. Spectral-domain optical coherence tomography (SD-OCT) was performed to evaluate the D-PED lifecycle by volumetric calculations. Regression analysis was used to determine the breakpoint, growth, and collapse rate of the D-PED lesions. The progression to advanced AMD was also documented.RESULTS: All the eyes were treated with SML for 2.9±1.0 sessions. The mean follow-up period was 25.3±12.6mo. The BCVA was stable from the baseline to final visit. All the eyes were categorized into two groups according to the anatomical changes of the D-PED lesion: the collapse group (n=6, 28.6%) and non-collapse group (n=15, 71.4%). The change in logMAR BCVA did not differ significantly between the collapse group 0.00 (-0.31, 0.85) and non-collapse group 0.00 (0.00, 0.00; P=1). Regression analysis showed that the growth rate was significantly higher in the collapse group (0.090±0.095 mm3/mo) than in the non-collapse group (0.025±0.035 mm3/mo; P&#x0026;#x003C;0.001). One eye (4.8%) developed macular neovascularization at 11mo after SML treatment in the non-collapse group. Three eyes (14.3%) developed geographic atrophy (GA) in the collapse group.CONCLUSION: Compared to the natural course of D-PED reported by previous studies, our results preliminarily show that SML can alleviate visual loss and possibility of progression to advanced AMD in eyes with D-PED in intermediate AMD. A controlled clinical trial needs to further verify the benefit of the intervention.]]></description>
<pubDate>2022/3/1 14:57:56</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Zhen Huang, Kai-Yu Deng, Yu-Meng Deng, Yan-Nian Hui and Yan-Ping Song]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zhen Huang, Kai-Yu Deng, Yu-Meng Deng, Yan-Nian Hui and Yan-Ping Song</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220316]]></guid><cfi:id>192</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of oral citicoline therapy on retinal nerve fiber layer and ganglion cell-inner plexiform layer in patients with primary open angle glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220317]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the short-term effects of oral citicoline therapy on the retinal nerve fiber layer (RNFL) and the macular ganglion cell-inner plexiform layer (mGCIPL) in patients with primary open angle glaucoma (POAG).METHODS: Fifty-four eyes of 54 patients with POAG glaucoma included in the study. In addition to a topical hypotensive, 250-mg oral citicoline was administered to 27 patients, while 27 patients were assigned as the control group. RNFL and mGCIPL values were measured using optical coherence tomography (OCT) at 1d before treatment and 3mo after the initiation of treatment. At the third month visit, citicoline treatment was discontinued and drug-free control (wash-out) measurements were obtained at the fourth month in citicoline group.RESULTS: The average RNFL thickness was significantly higher at month 3 than the baseline (P=0.038) in citicoline group. However, this improvement partially regressed after a 1-month wash-out period. No statistically significant changes in RNFL were observed in the superior, nasal, temporal and inferior quadrants at months 3 and 4 (P&#x0026;#x003E;0.05). The change in the average and inferior quadrant RNFL thickness in the citicoline group at 3mo was significantly greater than the control group (P=0.006 and P=0.014, respectively). There were no significant differences between the groups according to the change in mGCIPL thickness and the superior, nasal and temporal quadrant RNFL thickness (P&#x0026;#x003E;0.05).CONCLUSION: With oral citicoline treatment, the loss in the average RNFL is prevented in POAG patients in the short-term. Study data show that citicoline may have a significant impact on slowing glaucoma progression, which could have a potential neuroprotective effect.]]></description>
<pubDate>2022/3/1 14:57:57</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Asena Keles Sahin, Hasan Burhanettin Kapti and Aslihan Uzun]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Asena Keles Sahin, Hasan Burhanettin Kapti and Aslihan Uzun</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220317]]></guid><cfi:id>191</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Efficacy of intravitreal conbercept injection on short- and long-term macular edema in branch retinal vein occlusion]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220318]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To observe the best-corrected visual acuity (BCVA) and central foveal thickness (CFT) repeatedly after the intravitreal injection of conbercept (IVC) for treating cystoid macular edema (CME) in branch retinal vein occlusion (BRVO) and explore the relationship between the duration of CME and visual outcome.METHODS: Subgroup analysis was performed to compare short-term (within 90d of CME onset) and long-term (over 90d of CME onset) macular edema in BRVO. After an initial IVC, a pro re nata (PRN) strategy was performed according to the recurrence of CFT or decrease of BCVA. Analysis of variance using repeated measurements, statistical analysis following indicators including BCVA and CFT collected at baseline and 1, 3, and 6mo after IVC.RESULTS: Among the 60 cases included in this retrospective study, 36 were short-term CME, and 24 were long-term CME. There were statistical significances between and within groups of the BCVAs at different time points (P&#x0026;#x003C;0.001). The interaction was found between group and time (P=0.006), indicating the difference in the speed of BCVA improvement between groups. In particular, the improvement speed of BCVA in the short-term CME group was faster than that in the long-term CME group. There were significant differences between and with groups of the CFT at different time points (P&#x0026;#x003C;0.001). However, the interaction between group and time in relation to CFT had no significant differences (P=0.59).CONCLUSION: IVC treatment for CME following BRVO is effective and safe. The duration of CME before treatment is a significant predictor of the visual outcomes of patients with BRVO. The improvement of vision might be faster with early IVC treatment than with delayed treatment.]]></description>
<pubDate>2022/3/1 14:57:57</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jing-Yi Bai, Wen-Ying Wang, Zhi-Zhi Dou, Bo-Chao Geng, Xiao-Yan Xu, Yuan-Zhang Zhu, Shan-Yao Zhao, Min Liu, Shao-You Jia and Wen-Juan Luo]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jing-Yi Bai, Wen-Ying Wang, Zhi-Zhi Dou, Bo-Chao Geng, Xiao-Yan Xu, Yuan-Zhang Zhu, Shan-Yao Zhao, Min Liu, Shao-You Jia and Wen-Juan Luo</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220318]]></guid><cfi:id>190</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Three-dimensional diabetic macular edema thickness maps based on fluid segmentation and fovea detection using deep learning]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220319]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To explore a more accurate quantifying diagnosis method of diabetic macular edema (DME) by displaying detailed 3D morphometry beyond the gold-standard quantification indicator-central retinal thickness (CRT) and apply it in follow-up of DME patients.METHODS: Optical coherence tomography (OCT) scans of 229 eyes from 160 patients were collected. We manually annotated cystoid macular edema (CME), subretinal fluid (SRF) and fovea as ground truths. Deep convolution neural networks (DCNNs) were constructed including U-Net, sASPP, HRNetV2-W48, and HRNetV2-W48+Object-Contextual Representation (OCR) for fluid (CME+SRF) segmentation and fovea detection respectively, based on which the thickness maps of CME, SRF and retina were generated and divided by Early Treatment Diabetic Retinopathy Study (ETDRS) grid.RESULTS: In fluid segmentation, with the best DCNN constructed and loss function, the dice similarity coefficients (DSC) of segmentation reached 0.78 (CME), 0.82 (SRF), and 0.95 (retina). In fovea detection, the average deviation between the predicted fovea and the ground truth reached 145.7±117.8 μm. The generated macular edema thickness maps are able to discover center-involved DME by intuitive morphometry and fluid volume, which is ignored by the traditional definition of CRT&#x0026;#x003E;250 μm. Thickness maps could also help to discover fluid above or below the fovea center ignored or underestimated by a single OCT B-scan.CONCLUSION: Compared to the traditional unidimensional indicator-CRT, 3D macular edema thickness maps are able to display more intuitive morphometry and detailed statistics of DME, supporting more accurate diagnoses and follow-up of DME patients.]]></description>
<pubDate>2022/3/1 14:57:57</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jing-Jing Xu, Yang Zhou, Qi-Jie Wei, Kang Li, Zhen-Ping Li, Tian Yu, Jian-Chun Zhao, Da-Yong Ding, Xi-Rong Li, Guang-Zhi Wang and Hong Dai]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jing-Jing Xu, Yang Zhou, Qi-Jie Wei, Kang Li, Zhen-Ping Li, Tian Yu, Jian-Chun Zhao, Da-Yong Ding, Xi-Rong Li, Guang-Zhi Wang and Hong Dai</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220319]]></guid><cfi:id>189</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparative study of objective visual quality between FS-LASIK and SMART in myopia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220320]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the changes in the objective visual quality of patients with low and moderate myopia postoperatively after transepithelial photorefractive keratectomy using the smart pulse technology (SMART) and femtosecond laser in situ keratomileusis (FS-LASIK).METHODS: Corneal higher-order aberrations (HOAs), horizontal coma, vertical coma and spherical aberration were measured using Pentacam, and cutoff for modulation transfer function (MTF cutoff), objective scatter index (OSI) and Strehl ratio (SR) was measured using an optical quality analysis system (OQAS-II), before and after operation at 1, 3, and 6mo, and data were analyzed by repeated measurement two-way analysis of variance.RESULTS: The difference in uncorrected distance visual acuity between SMART and FS-LASIK was statistically significant only 1wk postoperatively. Approximately 86.36% and 80.69% of patients with spherical equivalent (SE) in ±0.50 D were observed in the SMART and FS-LASIK groups, respectively. No significant difference was observed in SE between the two groups (P=0.509). The HOAs increased postoperatively compared with those before surgery in both groups (P&#x0026;#x003C;0.05). No significant difference in HOA, corneal horizontal coma, spherical aberration, ΔHOA, Δhorizontal coma, and Δspherical aberration were observed between the two group (P&#x0026;#x003E;0.05). Corneal vertical coma and Δcorneal vertical coma in the FS-LASIK group were higher than those in the SMART group (P&#x0026;#x003C;0.05). The OSI of both groups at 1mo after surgery was higher than that before surgery (P&#x0026;#x003C;0.05). At 3 and 6mo postoperatively, the OSI in the FS-LASIK group was slightly higher than that in the SMART group (P=0.040 and 0.047, respectively). At 6mo after surgery, the MTF cutoff was statistically significant different between the two groups (P=0.026). No significant difference in SR between the FS-LASIK and SMART groups was observed at 1, 3, and 6mo postoperatively (P&#x0026;#x003E;0.05).CONCLUSION: The HOAs increase and visual quality is delayed in both groups postoperatively, and the long-term objective visual quality after SMART is slightly better than that after FS-LASIK.]]></description>
<pubDate>2022/3/1 14:57:57</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yuan Wu, Yue Huang, Shu-Han Wang, Gui-Qin Wang, Ao-Miao Yu, Shao-Zhen Zhao, Rui-Hua Wei, Rui-Bo Yang and Chen Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yuan Wu, Yue Huang, Shu-Han Wang, Gui-Qin Wang, Ao-Miao Yu, Shao-Zhen Zhao, Rui-Hua Wei, Rui-Bo Yang and Chen Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220320]]></guid><cfi:id>188</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[One-step thermokeratoplasty for pain alleviating and pre-treatment of severe acute corneal hydrops in keratoconus]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220205]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To observe the efficacy of simplified one-step thermokeratoplasty for the treatment of severe acute corneal hydrops in keratoconus.METHODS: In this retrospective, noncomparative clinical study, 10 patients (10 eyes) with acute hydrops in keratoconus were treated with simplified one-step thermokeratoplasty. Pain, changes in the corneal curvature, thickness, and size and morphology of the Descemet membrane breaks were detected before and after surgery. Eight patients were successfully treated using modified deep anterior lamellar keratoplasty (DALK). Graft transparency, visual acuity, and immunological rejection were evaluated for 6 to 12mo.RESULTS: Pain and corneal oedema were promptly alleviated, and the intrastromal ruptures diminished within 3 to 6wk after thermokeratoplasty. At 3 to 6wk after corneal oedema was faded, Descemet membrane breaks and intrastromal ruptures were healed. Two patients did not undergo subsequent corneal transplantation after thermokeratoplasty. Eight patients underwent DALK successfully and safely after thermokeratoplasty, without corneal perforation. Central corneal opacity faded or disappeared within 6mo. The mean best-corrected visual acuity was increased to 20/30 at 12 mo after DALK. No one was observed with any immune rejection.CONCLUSION: One-step thermokeratoplasty can successfully and efficiently accelerate the absorption of prominent corneal oedema in severe acute hydrops patients. This simple procedure with no complications can be performed in the emergency department by residents. This method can improve the safety of DALK and obtain good postoperative vision. Long-term management of acute corneal hydrops using simplified one-step thermokeratoplasty seems promising.]]></description>
<pubDate>2022/1/26 9:59:37</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ran Hao and Yun Feng]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ran Hao and Yun Feng</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220205]]></guid><cfi:id>187</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Accuracy of optimized Sirius ray-tracing method in intraocular lens power calculation]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220206]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the accuracy and predictability of ray tracing-assisted intraocular lens (IOL) calculation function in Sirius internal software and further improve the accuracy by optimizing the calculation of predicted lens position (PLP).METHODS: This retrospective study recruited 52 eyes of 49 patients. All of the cases with cataract had undergone phacoemulsiﬁcation combined with IOL implantation. SRK-T, Haigis formula, and Sirius ray-tracing method were all used for each eye's IOL calculation. The mean absolute value of prediction error (prediction error=predicted refraction- postoperative refraction) was defined as mean absolute prediction error (MAPE) and was determined for each method. Calculation of PLP was optimized by effective lens position (ELP). Optimized PLP was entered to Sirius internal software again to verify whether the method was improved.RESULTS: Compared with SRK-T and Haigis formulas, less accuracy was shown in Sirius ray-tracing method (P=0.001). The ELP of the IOL moved forward compared to PLP (P&#x0026;#x0026;#x003C;0.001). The MAPE of the ELP-inputted Sirius ray-tracing method was reduced. ELP and PLP were well correlated. Taking ELP as y and PLP given by Sirius soft as x, a linear regression formula y=0.1637x+3.1741 was concluded (R²=0.1066, P=0.018). It was shown that the optimized Sirius ray-tracing method (optimized PLP entered), compared with SRK-T and Haigis formulas, worked with the same accuracy (P=0.038).CONCLUSION: The original Sirius ray tracing method is not satisfactory enough. However, in normal eyes, the optimized Sirius ray-tracing method in IOL calculation was as accurate as SRK-T and Haigis formulas.]]></description>
<pubDate>2022/1/26 9:59:37</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Li-Qing Wei, Ying-Hui Fu, Wei-Hua Pan, Li Nie, Yu Chen, Gui-Fang Liu and Zhen-Bin Qian]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Li-Qing Wei, Ying-Hui Fu, Wei-Hua Pan, Li Nie, Yu Chen, Gui-Fang Liu and Zhen-Bin Qian</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220206]]></guid><cfi:id>186</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Predictors of angle widening after laser iridotomy in Chinese patients with primary angle-closure suspect using ultrasound biomicroscopy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220207]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the predictive value of baseline parameters of ultrasound biomicroscopy (UBM) for angle widening after prophylactic laser peripheral iridotomy (LPI) in patients with primary angle-closure suspect (PACS).METHODS: Angle-opening distance (AOD), trabecular iris angle (TIA), iris thickness, trabecular-ciliary process angle, and trabecular-ciliary process distance were measured using UBM performed before and two weeks after LPI. Iris convexity (IC), iris insertion, angulation, and ciliary body (CB) size and position were graded. Uni- and multivariate regression analyses were used to determine factors predicting the change in AOD (ΔAOD500, calculated as an angle width change before and after LPI) in all quadrants and in subgroup quadrants based on IC.RESULTS: In 94 eyes of 94 patients with PACS, LPI led to angle widening with increases in AOD500 and TIA (P&#x0026;#x0026;#x003C;0.01). Multivariable regression analysis showed that IC (P&#x0026;#x0026;#x003C;0.001), CB position (P=0.007) and iris insertion (P=0.049) were significantly predictive for ΔAOD500. All quadrants were categorized into extreme IC (27.8%), moderate IC (62.3%), and absent IC (9.9%) subgroups. The AOD500 increased by 220% and no other predictive factor was found in the extreme IC quadrants. The AOD500 increased by 55%, and baseline iris angulation was predictive for smaller changes in ΔAOD500 in the moderate IC quadrants.CONCLUSION: In PACS patients, quadrants with greater iris bowing predict substantial angle widening after LPI. Quadrants with a flatter iris, anteriorly positioned CB, and basal iris insertion are associated with less angle widening after LPI. Quadrants with iris angulation as well as a flatter iris configuration predict a smaller angle change after LPI.]]></description>
<pubDate>2022/1/26 9:59:38</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xue-Ting Pei, Shu-Hua Wang, Xia Sun, Hong Chen, Bing-Song Wang, Shu-Ning Li and Tao Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xue-Ting Pei, Shu-Hua Wang, Xia Sun, Hong Chen, Bing-Song Wang, Shu-Ning Li and Tao Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220207]]></guid><cfi:id>185</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical research of EX-PRESS drainage device and modified trabeculectomy combined with intravitreal conbercept treatment for neovascular glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220208]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the efficacy and safety of modified trabeculectomy (experimental group) and implantation of EX-PRESS drainage device (control group), combined with intravitreal conbercept injection for neovascular glaucoma (NVG).METHODS: Totally 30 patients with NVG were selected from June 2014 to June 2017, and randomly divided into experimental group and control group. All patients were underwent intravitreal conbercept (0.5 mg/0.05 mL) treatment before surgery. Modified trabeculectomy was performed in MT group, while EX-PRESS drainage device implantation was performed in EX group. The success rates, best corrected visual acuity (BCVA), intraocular pressure (IOP), filtering bleb and complications were observed and compared.RESULTS: The differences of success rate, BCVA and filtering bleb were not statistically significant 12mo after the surgery (P&#x0026;#x0026;#x003E;0.05), however, the difference of IOP at 1d, 1wk, 1, 3, and 6mo after surgery was statistically significant (Ftime=390.64, Ptime&#x0026;#x0026;#x003C;0.0001) between two groups. The interactions between two groups in the given time showed no significant difference (Fintergroup×time=0.181, Pintergroup×time=0.57), and also there was no significant difference in IOP between the two groups (F=3.16, P=0.09). The results of pairwise comparison at each time point showed no significant difference in IOP between 1d and 1wk, 3 and 6, 3mo and 12mo after surgery (P&#x0026;#x0026;#x003E;0.05), while the results at other time point indicate statistical differences (P&#x0026;#x0026;#x003C;0.05).CONCLUSION: The modified trabeculectomy and the implantation of EX-PRESS drainage device have clinical application value in reducing IOP and postoperative complications of refractory NVG.]]></description>
<pubDate>2022/1/26 9:59:38</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Peng Li, Qing Liu, Xiao-Min Liu, Li Wang, Zhao-Jiang Du and Qian-Yan Kang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Peng Li, Qing Liu, Xiao-Min Liu, Li Wang, Zhao-Jiang Du and Qian-Yan Kang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220208]]></guid><cfi:id>184</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effects of perioperative managements on ocular surface microbiota in intravitreal injection patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220209]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the effects of on ocular surface microbiota in patients who received intravitreal injections.METHODS: Samples of ocular surface microbiota were obtained from 41 eyes of 41 patients who visited the Department of Ophthalmology. Patients were separated for three groups. Group A did not receive perioperative managements or intravitreal injection. Group B1 received only once and B2 received more than twice. In operating room, the samples were collected on the ocular surface. Operating taxonomic units (OTUs) clustering and alpha/beta diversity analysis was performed. The microbial 16S rRNA from samples were analyzed using the HiSeq 2500 platform.RESULTS: Alpha diversity did not differ in each group, and beta diversity differed in the B2 group. Beta diversity showed a significant difference between Group A and B2 (P=0.048). With the perioperative managements before intravitreal injection, the composition and relative abundance were altered. Top 10 microbiota on phylum and genus level, and then microbiota notably changed at genus level were listed. Gram-negative bacteria were varied more. Furthermore, Proteus was not found in Groups A and B1, but it was appeared after the patients received perioperative management and intravitreal injections in Group B2.CONCLUSION: With the perioperative managements, the balance of microbiota on the ocular surface is destroyed, and relative composition and abundance of microbiota on the ocular surface is obviously altered. The clinical doctors should pay more attention on the consequence of perioperative managements before intravitreal injection.]]></description>
<pubDate>2022/1/26 9:59:38</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ya-Guang Hu, Qiong Wu, Tian-Hui Li, Fang Sui, Ming Zhang, Zhen Zhang, Rui Shi, Na Hui, Li Qin and Li Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ya-Guang Hu, Qiong Wu, Tian-Hui Li, Fang Sui, Ming Zhang, Zhen Zhang, Rui Shi, Na Hui, Li Qin and Li Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220209]]></guid><cfi:id>183</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Combining robot-assisted surgical system and 3D visualization system for teaching minimally invasive vitreoretinal surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220210]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the feasibility of teaching minimally invasive vitreoretinal surgery with a robot-assisted surgical system and a three-dimensional (3D) visualization system.METHODS: Enucleated porcine eyes were established as an animal model for removing foreign bodies. Forty medical students were recruited to remove foreign bodies to compare the traditional microscope and the 3D system. One junior resident performed the surgical task with manual and robot-assisted operations on 20 porcine eyes for each group. One senior surgeon evaluated the retinal invasion by a graded injury degree. The learning curve for minimally invasive vitreoretinal surgery was described.RESULTS: Compared with the robot-assisted group, the injury degree was higher in the manual group. For the first ten surgeries, the manual and robot-assisted groups had injuries of 2.60±1.35 (4 to 0) and 1.80±1.62 (4 to 0), respectively. For the last ten surgeries, the injury degrees were 1.90±1.20 (3 to 0) and 0.80±0.42 (1 to 0). Considering the manual and robot-assisted groups together, 95%, 75% and 60% of the students considered surgical manipulation with the 3D visualization system to be more comfortable, easier and clearer, respectively.CONCLUSION: The robot-assisted surgical system and 3D visualization system may have value in teaching minimally invasive vitreoretinal surgery.]]></description>
<pubDate>2022/1/26 9:59:38</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yi-Qi Chen, Dan Cheng, Lin Zhu, Wei-Qian Gao, Jia-Feng Yu, Jun Wang, Xin-Yi Deng, Ji-Wei Tao, Jia Qu and Li-Jun Shen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yi-Qi Chen, Dan Cheng, Lin Zhu, Wei-Qian Gao, Jia-Feng Yu, Jun Wang, Xin-Yi Deng, Ji-Wei Tao, Jia Qu and Li-Jun Shen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220210]]></guid><cfi:id>182</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of fundus fluorescein angiography and fundus photography grading criteria for early diabetic retinopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220211]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the assessment outcomes of the characteristics of mild to moderate non-proliferative diabetic retinopathy (NPDR) established by fundus photography and fundus fluorescein angiography (FFA).METHODS: The fundus photos and FFA results of 260 patients with diabetes mellitus were reviewed. Diabetic retinopathy (DR) severity was graded based on the international classification standard. The microaneurysms, hemorrhages, and intraretinal microvascular abnormalities (IRMA) in FFA images of patients with mild to moderate NPDR were observed. The differences between the fundus photos and the FFA results were summarized, analyzed, and compared.RESULTS: The counting of intraretinal hemorrhages identified by FFA revealed that only 9 eyes (1.9%) had more than 20 intraretinal hemorrhages in all four quadrants; 15 eyes (3.1%) had more than 20 intraretinal hemorrhages in three quadrants; 26 eyes (5.4%) had over 20 intraretinal hemorrhages in two quadrants; and 37 eyes (7.7%) had more than 20 intraretinal hemorrhages in only one quadrant. Furthermore, the number of IRMAs appeared ≥4 in 17 eyes, 3 in 35 eyes, 2 in 69 eyes, and 1 in 93 eyes.CONCLUSION: FFA has higher detection accuracy of retinal angiopathy than fundus photography. FFA grading results are helpful for timely detection and proper treatment of lesions easily missed by fundus photography.]]></description>
<pubDate>2022/1/26 9:59:39</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xin-Yue Li, Shu Wang, Li Dong and Hong Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xin-Yue Li, Shu Wang, Li Dong and Hong Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220211]]></guid><cfi:id>181</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Image enhancement of color fundus photographs for age-related macular degeneration: the Shanghai Changfeng Study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220212]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To develop and evaluate a new fundus image optimization software based on red, green, blue channels (RGB) for the evaluation of age-related macular degeneration (AMD) in the Chinese population.METHODS: Fundus images that were diagnosed as AMD from the Shanghai Changfeng Study database were analyzed to develop a standardized optimization procedure. Image brightness, contrast, and color balance were measured. Differences between central lesion area and normal retinal area under different image brightness, contrast, and color balance were observed. The optimal optimization parameters were determined based on the visual system to avoid image distortion. A paired-sample diagnostic test was used to evaluate the enhancement software. Fundus optical coherence tomography (OCT) was used as the gold standard. Diagnostic performances were compared between original images and optimized images using McNemar's test.RESULTS: A fundus image optimization procedure was developed using 86 fundus images of 74 subjects diagnosed with AMD. By observing gray-scale images, choroid can be best displayed in red channel and retina in green channel was found. There was limited information in blue channel. Totally 104 participants were included in the paired sample diagnostic test to assess the performance of the optimization software. After the image enhancement, sensitivity increased from 74% to 88% (P=0.008), specificity decreased slightly from 88% to 84% (P=0.500), and Youden index increased by 0.11.CONCLUSION: The standardized image optimization software increases diagnostic sensitivity and may help ophthalmologists in AMD diagnosis and screening.]]></description>
<pubDate>2022/1/26 9:59:39</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jing-Jing Shen, Rui Wang, Li-Long Wang, Chuan-Feng Lyu, Shuo Liu, Guo-Tong Xie, Hai-Luan Zeng, Ling-Yan Chen, Min-Qian Shen, Xin Gao, Huan-Dong Lin and Yuan-Zhi Yuan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jing-Jing Shen, Rui Wang, Li-Long Wang, Chuan-Feng Lyu, Shuo Liu, Guo-Tong Xie, Hai-Luan Zeng, Ling-Yan Chen, Min-Qian Shen, Xin Gao, Huan-Dong Lin and Yuan-Zhi Yuan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220212]]></guid><cfi:id>180</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Secondary endoresection for previously treated choroidal melanomas with a non-responsive course and persistent exudative retinal detachment]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220213]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the results and complications of secondary endoresection via pars plana vitrectomy for choroidal melanoma and review the previously reported endoresection studies on the treatment of choroidal melanoma.METHODS: The medical records of 6 patients with choroidal melanoma who underwent secondary endoresection between March 2012 and March 2020 were retrospectively reviewed. The indications for secondary endoresection were progressive or recurrent tumor and severe exudative retinal detachment after previous treatment with plaque radiotherapy/Cyberknife radiosurgery/transpupillary thermotherapy (TTT).RESULTS: Before endoresection, 2 eyes had Iodine-125 plaque radiotherapy and TTT, 1 eye had Ruthenium-106 plaque radiotherapy and TTT, 1 eye had Cyberknife radiosurgery and TTT, 1 eye had Cyberknife radiosurgery, and 1 eye had TTT only. Preoperative visual acuity ranged from 20/63 to 20/1600 (Snellen) and from 0.5 to 1.9 (mean: 1.1) on the logMAR scale. The mean tumor base diameters were 9.5×8.7 mm and the mean tumor thickness was 5.4 mm. After secondary endoresection, transient vitreous hemorrhage developed in 2 (33.3%) eyes and retinal detachment in 1 (16.7%) eye. Cytopathological examination revealed epithelioid cell melanoma in 4 (66.7%) eyes and mixed cell melanoma in 1 (16.7%). Melanoma cell type was not specified in 1 (16.7%) eye. At a mean follow-up of 49.6mo (range: 16-90mo), mean visual acuity did not improve and 1 eye was enucleated due to tumor recurrence. Final visual acuity ranged from 20/63 to 20/1600 (Snellen) and from 0.5 to 1.9 (mean: 1.2) on the logMAR scale. Two patients with choroidal melanoma developed metastasis and eventually expired.CONCLUSION: Secondary endoresection seems to be an effective treatment option for globe salvage in choroidal melanoma not responsive to conventional treatment and displaying persistent exudative retinal detachment. There was no visual acuity increase among the treated eyes but globe salvage was possible in most cases in this study.]]></description>
<pubDate>2022/1/26 9:59:39</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ahmet Kaan Gündüz and Ibadulla Mirzayev]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ahmet Kaan Gündüz and Ibadulla Mirzayev</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220213]]></guid><cfi:id>179</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A novel surgical technique of internal limiting membrane peeling for high myopic foveoschisis: a wide range of whole piece consecutive peeling without preservation of epi-fovea]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220214]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To demonstrate an improved surgical technique of whole piece consecutive internal limiting membrane (ILM) peeling without preservation of the epi-fovea to treat high myopic foveoschisis (MF).METHODS: A 23-gauge 3-port pars plana vitrectomy was performed on 16 patients with high MF. A parallel arc line along the vascular arcades was scraped out with a curved membrane scraper DSP. Next, an ILM forceps was used to catch hold of the incisal edge of the ILM flap, and the action of releasing and separating was subsequently taken toward the direction of the macular fovea. Next, the ILM forceps was used to grasp the released area, and the whole area coherent ILM peeling covering the macular fovea was implemented thereafter. Finally, the ILM was folded backwards and peeled off in the arc direction.RESULTS: At the final visit, the average central macular thickness decreased remarkably from 423.76±177.67 to 178.24±66.21 μm. The mean logarithm of the minimum angle of resolution best-corrected visual acuity of 1.37±0.59 was significantly alleviated to 0.74±0.59.CONCLUSION: The wide range of whole piece consecutive ILM peeling without preservation of the epi-fovea is proven to be effective and significantly reduced the occurrence of retinal tear and macular hole.]]></description>
<pubDate>2022/1/26 9:59:39</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Shuai He, Tong Su, Zhong-Yi Zhou, Xiao-Meng Li, Wu Xu and Qing-Hua Qiu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Shuai He, Tong Su, Zhong-Yi Zhou, Xiao-Meng Li, Wu Xu and Qing-Hua Qiu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220214]]></guid><cfi:id>178</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Changes in Schlemm’s canal, trabecular meshwork, and relevant parameters in the early stage after SMILE of myopia patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220215]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To observe the changes in Schlemm's canal (SC), trabecular meshwork (TM), and anterior chamber relevant parameters after small incision lenticule extraction (SMILE) of myopia patients.METHODS: A total of 58 eyes from 30 patients who underwent SMILE were divided into a low and moderate myopia group (group A, 32 eyes) and a high myopia group (group B, 26 eyes). The diameter and area of the SC, the width and thickness of TM obtained by CIRRUS HD-OCT5000, and the related anterior chamber parameters obtained by Pentacam anterior segment analysis system, accommodation amplitude (AMP) were observed pre- and postoperatively. The preoperative intraocular pressure (IOP) and postoperative correction of intraocular pressure (IOPcc) were measured.RESULTS: The diameter and area of the SC in the two groups were significantly increased postoperatively (all P&#x0026;#x0026;#x003C;0.01). The TM width of the patients in the two groups were increased at 1mo after surgery (both P&#x0026;#x0026;#x003C;0.01), but the TM thickness did not change (P&#x0026;#x0026;#x003E;0.05). The corneal curvature, central anterior chamber depth, and anterior chamber volume decreased after SMILE surgery (all P&#x0026;#x0026;#x003C;0.01). There was a weak negative correlation between the SC area change and AMP change in group A (r=-0.362, P&#x0026;#x0026;#x003C;0.01). The postoperative IOP decreased after correction by Shah formula (P&#x0026;#x0026;#x003C;0.05).CONCLUSION: SC and TM in myopia patients change in the early postoperative stage of SMILE and the IOP is decline.]]></description>
<pubDate>2022/1/26 9:59:39</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Dan-Dan Yang, Zhi-Qi Chen, Wei Chen, He Yin, Jing-Kai Peng and Jun-Ming Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Dan-Dan Yang, Zhi-Qi Chen, Wei Chen, He Yin, Jing-Kai Peng and Jun-Ming Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220215]]></guid><cfi:id>177</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of efficacy of two different silicone hydrogel bandage contact lenses after T-PRK]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220216]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the efficacy between two different silicone hydrogel bandage contact lenses after transepithelial photorefractive keratectomy (T-PRK).METHODS: In this randomized controlled trial, a total of 89 patients (178 eyes) who underwent T-PRK at the Qingdao Eye Hospital from October to December 2019 were selected. One random eye wore a Senofilcon A bandage contact lens after surgery, and the other eye a Balafilcon A bandage contact lens. Pain scores, uncorrected visual acuity (UCVA), spherical equivalent (SE), corneal epithelial healing status, epithelial thickness, bandage lenses deposits, lenses movement, and ocular surface conditions were measured and compared.RESULTS: There were no differences between the two groups in UCVA, SE, corneal epithelial healing status, corneal epithelial thickness, tear river heights and tear film rupture time at each follow-up visit. However, postoperative pain scores in the Senofilcon A group were significantly lower than those of the Balafilcon A group (Fintergroups=67.833, P&#x0026;#x0026;#x003C;0.001; Ftime=383.773, P&#x0026;#x0026;#x003C;0.001; Finteraction=57.344, P&#x0026;#x0026;#x003C;0.001). The duration of pain in eyes in the Senofilcon A group was shorter than that of the Balafilcon A group (t=-3.326, P=0.001). The surface deposition scores and movement scores of Senofilcon A bandage lenses on the first and fourth days after surgery were lower than those of Balafilcon A bandage lenses (Z=-5.385, -6.782, P&#x0026;#x0026;#x003C;0.001; Z=-8.336, -8.906, P&#x0026;#x0026;#x003C;0.001).CONCLUSION: Both Senofilcon A and Balafilcon A bandage lenses have good efficacy after T-PRK. Senofilcon A lenses are associated with less pain and more comfort compared to Balafilcon A.]]></description>
<pubDate>2022/1/26 9:59:39</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hua Li, Ting Shao, Jia-Fan Zhang, Lin Leng, Sai Liu and Ke-Li Long]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hua Li, Ting Shao, Jia-Fan Zhang, Lin Leng, Sai Liu and Ke-Li Long</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220216]]></guid><cfi:id>176</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Multimodal therapy in the management of primary orbital mesenchymal chondrosarcoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220217]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the ophthalmic manifestations, radiographic features, and prognosis of Chinese patients with primary orbital mesenchymal chondrosarcoma (MCS).METHODS: The study included 6 cases with primary orbital MCS treated at Tianjin Eye Hospital from January 2009 to December 2019. Patitent ophthalmic manifestations, radiographic features, diagnosis, pathology, therapeutic regimens, and prognosis were retrospectively reviewed.RESULTS: Six patitents with primary orbital MCS were identified. The mean age at the first visit was 33y (range, 25-42y). All six patients displayed manifestations of exophthalmos, diplopia, limitation of eye displacement, upper eyelid oedema, decreased visual acuity and ptosis. The mean disease history and range were 5 and 2-8mo, respectively. The tumors were located in the superonasal extraconal compartment (2/6, 33.3%), intraconal compartment (2/6, 33.3%), and bitemporal extraconal compartment (2/6, 33.3%), respectively. Radiographic features were a well-defined, orbital mass with calcification and ossification on computed tomography (CT), and marked heterogenous enhancement on dynamic magnetic resonance imaging (MRI). Five patients were treated with tumor resection and one patient received orbital exenteration. Five patients in the cohort received postoperative radiation therapy, two patients received chemotherapy, and one patient did not receive postoperative adjuvant therapy because he refused. The histopathologic classification revealed a tumour composed of a mixture of mature chondroid tissue surrounded by small, round, and undifferentiated mesenchymal cells. Immunohistochemistry revealed Bcl-2, vimetin, CD99, and S-100 were expressed were expressed. After surgeries, two patients have developed a local recurrence. The median recurrence time of 58mo (52-64mo). One patient had distant recurrence included the lungs occurred 52mo after the initial surgery.CONCLUSION: The possibilty of orbital MCS need to be considered when a painless, slowly growing orbital mass with calcification and ossification. From our experience, trimodality treatment of radiation therapy, chemotherapy and surgery maybe the best option. Orbital MCS has a high tendency for late recurrence, regular long-term follow-up after complete excision is mandatory.]]></description>
<pubDate>2022/1/26 9:59:40</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yun Zhao, Jing-Wen Hui, Sha-Sha Yu, Jin-Yong Lin and Hong Zhao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yun Zhao, Jing-Wen Hui, Sha-Sha Yu, Jin-Yong Lin and Hong Zhao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220217]]></guid><cfi:id>175</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effectiveness of oral probiotics supplementation in the treatment of adult small chalazion]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220106]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To define the possible beneficial impact of probiotics oral supplementation on patients affected by chalazion.
METHODS: Prospective comparative pilot study on 20 adults suffering from chalazion randomly divided into two groups. The first group (n=10) received conservative treatment with lid hygiene, warm compression, and dexamethasone/tobramycin ointment for at least 20d. The second group (n=10), in addition to the conservative treatment, received a mixture of probiotic microorganisms of Streptococcus thermophilus ST10 (DSM 25246), Lactococcus lactis LLC02 (DSM 29536) and Lactobacillus delbrueckii (DSM 16606) once a day up to 3mo. Chalazia were classified according to their size into three groups: small (<2 mm), medium (≥2 to <4 mm), or large (≥4 mm). When conservative treatment with and without probiotics supplementation failed to resolve the lesion, invasive methods were used, intralesional steroid injection in medium size chalazion and surgical incision and curettage for the largest ones.
RESULTS: Medical treatment with or without probiotics supplementation was effective only on the small size chalazia. There was a significant difference in the time taken for complete resolution of small size chalazia between the two groups in favor of the patients receiving probiotics (38.50±9.04d vs 21.00±7.00d, P=0.039). Medium and large size chalazia did not respond to medical treatment with or without probiotics supplementation over the follow-up period (3mo). The treatment did not induce any complications in both groups and no recurrence of chalaziosis was recorded in both groups.
CONCLUSION: The considerable difference in time taken for complete resolution of small chalazia between the two groups in favor of the experimental one confirms the presence of a gut-eye axis.]]></description>
<pubDate>2021/12/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mariaelena Filippelli, Roberto dell'Omo, Angela Amoruso, Ilaria Paiano, Marco Pane, Pasquale Napolitano, Giuseppe Campagna, Silvia Bartollino and Ciro Costagliola]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mariaelena Filippelli, Roberto dell'Omo, Angela Amoruso, Ilaria Paiano, Marco Pane, Pasquale Napolitano, Giuseppe Campagna, Silvia Bartollino and Ciro Costagliola</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220106]]></guid><cfi:id>174</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Penetrating keratoplasty in children under 3 years old with congenital corneal opacities]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220107]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the graft rejection and visual outcomes after penetrating keratoplasty (PK) in the presence of various congenital corneal opacities in children.
METHODS: In this retrospective cohort study, children who underwent PK were then followed for 5y. The patient’s medical records were collected from June 2014 until June 2019 and analyzed in December 2019. All patients were children under three years old with congenital corneal opacities with or without microcornea who came to a pediatric ophthalmologist and underwent PK in Jakarta Eye Center (JEC). Beforehand, all children have participated in a thorough evaluation for PK. In the case of severe microcornea was not advised to undergo surgery. The visual outcomes and graft survival rate were described in percentages. The graft survival plot was presented with Kaplan-Meier, while the visual acuity was analyzed using the Wilcoxon signed ranks test.
RESULTS: Sixteen eyes from eleven patients (seven girls and four boys) underwent PK. The graft survival rate of the first 6, 12, and 18 mo later of keratoplasty was 100%, 83.3%, and 66.7%, respectively. The overall mean survival time is 22mo (standard error 2.419), and no significant difference between the patients underwent PK before and after 36mo of their age (P=0.52). The graft failure was 50%, and post-surgery complications included cataract 43.7%, band keratopathy 12.5%, and scleromalasia 6.25%. Wilcoxon test analysis of visual acuity post keratoplasty was not statistically significant (P=0.34), while overall showed 44% improvements of visual outcome for 5y of follow-up. With a good survival at one year up to 22mo (83.3%), the visual acuity could be achieved (63%), and showed improvements (44%) during follow-up.
CONCLUSION: The complications are frequent for pediatric PK. Thus, corneal surgery on infants requires careful case selection, adequate pre-operative evaluation, skilled surgery (optical correction), very close cooperation family–physician, intensive post-operation care, and amblyopia management in the future.]]></description>
<pubDate>2021/12/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Made Susiyanti, Burhana Mawarasti and Florence M. Manurung]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Made Susiyanti, Burhana Mawarasti and Florence M. Manurung</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220107]]></guid><cfi:id>173</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Twenty-four hours intraocular pressure in keratoconic eyes assessed by applanation tonometry and Tono-Pen AVIA]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220108]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess intraocular pressure (IOP) during the daily curve of intraocular pressure (DCPo) in keratoconic eyes and compare Goldmann applanation tonometer (GAT), without and with astigmatism correction (nGAT and cGAT) and Tono-Pen AVIA (TPA) assessment methods.
METHODS: Thirty-nine keratoconic eyes of 24 patients were assessed. DCPo was evaluated with five IOP measurements; four were performed with a GAT (nGAT and cGAT), and a Tono-Pen AVIA (TPA) at various times throughout the day.
RESULTS: Mean IOP DCPo values (mm Hg) were: nGAT, 9.9±2.6; cGAT, 11.3±2.6; TPA 12.3±3.1. Mean IOP DCPo differences (mm Hg) and Spearman’s correlation coefficients were as follows: cGATc-nGAT, 1.32±1.31, rs=0.879 (P<0.01); cGAT-TPA, -1.02±2.08, rs=0.723 (P<0.01); and nGAT-TPA, -2.35±2.23, rs=0.730 (P<0.01). Bland-Altman analysis for agreement between cGAT-TPA and nGAT-TPA mean IOP DCPo measurements revealed a mean difference of 1.02 (95%CI, 0.35-1.70) and 2.35 (95%CI, 1.62-3.07) mm Hg, respectively. Regression analysis yielded the following equation: TPA IOP=5.49+0.775×cGAT-0.015×ACD-0.299×corneal astig matism, which allowed us to infer TPA IOP values from other parameters.
CONCLUSION: In keratoconic eyes, IOP peaks of DCPo measurements are identified at 6 a.m., independent of the tonometer. The mean DCPo values are: TPA>cGAT>nGAT. IOP TPA measures are predictive of cGAT values, adjusted according to anterior chamber depth and corneal astigmatism.]]></description>
<pubDate>2021/12/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Rafael Vidal Merola, Sebastiao Cronemberger, Artur William Veloso and Alberto Diniz-Filho]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Rafael Vidal Merola, Sebastiao Cronemberger, Artur William Veloso and Alberto Diniz-Filho</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220108]]></guid><cfi:id>172</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Observation seasonal variation of intraocular pressure in young healthy volunteers]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220109]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate fluctuation of intraocular pressure (IOP) and seasonal variation of 24-hour IOP during one year in healthy participants
METHODS: Totally 13 young healthy volunteers participated in this study. IOP was measured with Canon TX-20 at about 8:00-9:00 a.m. from Monday to Friday every week for a whole year. They also underwent 24-hour IOP examination every three months. Blood pressure, heart rate, temperature, humidity, atmosphere pressure, sunshine duration and other environment parameters were recorded.
RESULTS: The yearly fluctuation curve showed IOP in the summer months were lower than other seasons. In the multivariable generalized estimating equation analysis, IOP had a negative correlation with both temperature and sunshine duration (P<0.05). There also was a seasonal effect on 24-hour IOP. However, all intraclass correlation coefficients values of minimum, maximum and average of the 24-hour IOP and each individual IOP were less than 0.30.
CONCLUSION: IOP is trend to be higher in cold days than warm days. IOP have negative association with both environmental temperature and duration of sunshine. On a season-to-season basis, 24-hour IOP is not highly reproducible in healthy volunteers.]]></description>
<pubDate>2021/12/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Na Liao, Yan-Qian Xie, Guang-Yun Mao, Fan-Jun Bao, Zhong Lin, Hui-Lyu Jiang and Yuan-Bo Liang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Na Liao, Yan-Qian Xie, Guang-Yun Mao, Fan-Jun Bao, Zhong Lin, Hui-Lyu Jiang and Yuan-Bo Liang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220109]]></guid><cfi:id>171</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effectiveness of surgical management of malignant glaucoma in phakic eyes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220110]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the effectiveness of core vitrectomy-phacoemulsification-intraocular lens (IOL) implantation-capsulo-hyaloidotomy in treating phakic eye at least 1mo after the onset of malignant glaucoma.
METHODS: A retrospective analysis were performed on malignant glaucoma patients treated in Zhongshan Ophthalmic Center between 2016 and 2018. Demographic and clinical data were described. The preoperative and postoperative visual acuity (VA), intraocular pressure (IOP), number of IOP-lowering medications used, and anterior chamber depth (ACD) of the case series were compared by Wilcoxon signed-rank test.
RESULTS: Thirteen phakic eyes with long time intervals between onset and surgery were identified in this case series. Core vitrectomy-phacoemulsification-IOL implantation-capsulo-hyaloidotomy reduced the IOP (P=0.046) and the number of IOP-lowering medications used (P=0.004), deepened the ACD (P=0.005). Complete success was achieved in 38.5% of the eyes, and anatomical success was achieved in 100% of the eyes without any recurrence. The only postoperative complication observed is corneal endothelial decompensation. It occurred in two cases.
CONCLUSION: Core vitrectomy-phacoemulsification-IOL implantation-capsulo-hyaloidotomy is safe and effective for treatment of long onset phakic malignant glaucoma.]]></description>
<pubDate>2021/12/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Qi-Wei Wang, Jing Li, Xiao-Shan Lin, Wan Chen, Qiao-Lin Zhu, Feng-Qi Zhou, Hao-Tian Lin and Wei-Rong Chen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Qi-Wei Wang, Jing Li, Xiao-Shan Lin, Wan Chen, Qiao-Lin Zhu, Feng-Qi Zhou, Hao-Tian Lin and Wei-Rong Chen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220110]]></guid><cfi:id>170</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Impact of systemic steroids combined with immunosuppressive treatment on glaucomatous features in patients with systemic lupus erythematosus]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220111]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the incidence of increased intraocular pressure (IOP) and glaucomatous changes in systemic lupus erythematosus (SLE) patients in comparison with systemic steroids and immunosuppressive treatment.
METHODS: Sixty-two women with SLE were divided into two groups: treated (n=47, 94 eyes) and not treated (n=15, 30 eyes) with systemic glucocorticosteroids (GC; GC-free). Twenty-one individuals in GC group were treated with immunosuppressive agents (immunomodulating and biologic). The visual acuity and IOP with ocular pulsatile amplitude (OPA) measurements, as well as scanning laser polarimetry (GDx) with nerve fiber index (NFI) measurement, spectral domain optical coherence tomography (SD-OCT) of the optic disk with retinal nerve fiber layer (RNFL) analysis and the macular region with ganglion cell analysis (GCA) were performed.&#160;
RESULTS: Mean IOP values in group with combined GC and immunosuppressive therapy was 15.8±2.56 mm Hg and was significantly lower than in individuals with exclusive GC treatment (17.63±4.38 mm Hg, P=0.043). Contrary, no differences in mean IOP values between GC-free group and individuals treated with combined GC and immunosuppressive therapy were detected (P=0.563). Similarly, mean IOP in GC was 17.14±3.94 mm Hg and in GC-free patients was equal to 16.67±3.45 mm Hg (P=0.671). According to treatment regimen no statistical differences in optic disk SD-OCT for RNFL thickness, RNFL symmetry, cupping volume and the C/D ratio were observed. Similarly, no statistical differences for the mean and minimal ganglion cell layer (GCL) thickness measured in macular SD-OCT or NFI in GDx were detected.
CONCLUSION: Combined immunosuppressive and systemic GC therapy in SLE patients may lower the risk of iatrogenic ocular hypertension. No relationship between treatment regimen and glaucomatous damage of optic nerve fibers in analyzed groups with SLE is detected.]]></description>
<pubDate>2021/12/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Marta P. Wiacek, Danuta Bobrowska–Snarska, Marek Brzosko, Wojciech Lubiński and Monika Modrzejewska]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Marta P. Wiacek, Danuta Bobrowska–Snarska, Marek Brzosko, Wojciech Lubiński and Monika Modrzejewska</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220111]]></guid><cfi:id>169</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Prevalence of focal lamina cribrosa defects in eyes with pachychoroid disease spectrum]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220112]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the prevalence of focal lamina cribrosa (LC) defect among patients with pachychoroid disease spectrum (PDS) in the absence of peripapillary retinoschisis.
METHODS: This retrospective, cross-sectional study comprised of 180 patients with PDS, including polypoidal choroidal vasculopathy (PCV), central serous chorioretinopathy, and pachychoroidal neovasculopathy. Medical records and optic nerve head evaluations conducted using spectral-domain optical coherence tomography with enhanced depth imaging were reviewed. As a control group, 236 patients who underwent ophthalmologic evaluation for vitreous floaters, without obvious ocular disease, were also included.
RESULTS: The mean age of the PDS group, which included 118 male patients (65.6%), was 57.4±11.1y. There was no significant difference between the two groups in age (P=0.710) or sex (P=0.248). Six patients (3.3%) in the PDS group and none in the control group showed focal LC defect (P=0.318). Among the six patients with focal LC defect in the PDS group, four eyes had PCV, one eye was the fellow eye of a PCV eye, and one eye had pachychoroidal neovasculopathy.
CONCLUSION: Focal LC defect can be defected in patients with PDS in the absence of peripapillary retinoschisis. However, the prevalence of focal LC defect was not different significantly between PDS patients and those who did not have PDS.]]></description>
<pubDate>2021/12/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hae Min Kang, Na Eun Lee, Jeong Hoon Choi, Hyoung Jun Koh and Sung Chul Lee]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hae Min Kang, Na Eun Lee, Jeong Hoon Choi, Hyoung Jun Koh and Sung Chul Lee</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220112]]></guid><cfi:id>168</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Corneal epithelial defects following vitreoretinal surgery: incidence and outcomes from the DISCOVER study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220113]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the incidence, risk factors, clinical course, and outcomes of corneal epithelial defects (CED) following vitreoretinal surgery in a prospective study setting.
METHODS: This was a post-hoc analysis of all participants in DISCOVER intraoperative optical coherence tomography study. Subjects with CED 1d after surgery without intraoperative corneal debridement was defined as the postoperative CED group. Subjects who underwent intraoperative debridement were defined as intraoperative debridement group. Eyes were matched 2:1 with controls (eyes without postoperative CED) for comparative assessment. The primary outcomes were the incidence of CED on postoperative day one and the incidence of required intraoperative debridement. Secondary outcomes included time to defect closure, delayed healing (>2wk), visual acuity (VA) and presence of scarring at one year and cornea consult.
RESULTS: This study included 856 eyes that underwent vitreoretinal surgery. Intraoperative corneal debridement was performed to 61 (7.1%) subjects and postoperative CED developed spontaneously in 94 (11.0%) subjects. Significant factors associated with postoperative CED included prolonged surgical duration (P=0.003), diabetes mellitus (P=0.04), postoperative ocular hypotension (P<0.001). Prolonged surgical duration was associated with intraoperative debridement. Delayed defect closure time (>2wk) was associated with corneal scar formation at the end of the 1y in all epithelial defect subjects (P<0.001). The overall rate of corneal scarring for all eyes undergoing vitrectomy was 1.8%.
CONCLUSION: Prolonged duration of surgery is the strongest factor associated with both intraoperative debridement and spontaneous postoperative CED. Delayed defect closure is associated with a greater risk of corneal scarring at one year. The overall rate of corneal scarring following vitrectomy is low at <2%.]]></description>
<pubDate>2021/12/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Kubra Sarici, Daniel Petkovsek, Alison Martin, Alex Yuan, Jeffrey M. Goshe, Sunil K. Srivastava, Jamie L. Reese and Justis P. Ehlers]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Kubra Sarici, Daniel Petkovsek, Alison Martin, Alex Yuan, Jeffrey M. Goshe, Sunil K. Srivastava, Jamie L. Reese and Justis P. Ehlers</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220113]]></guid><cfi:id>167</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Vitreous microparticles contain apoptotic signals suggesting a diabetic vitreopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220114]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate differences in microparticle profiles in  vitreous samples between diabetic and non-diabetic eyes undergoing vitrectomy.
METHODS: Un-masked cross-sectional series of 34 eyes undergoing vitrectomy. Vitreous specimens were collected and processed to evaluate for membrane integrity (DAPI), apoptosis (Annexin-V), and endothelial-cell origin (V-Cadherin). A BD LSR II flow cytometer was used for analysis and standardized sub-micron-sized beads were used for size comparison.
RESULTS: Thirty-four specimens underwent analysis. Greater levels of Annexin-V were found on microparticles from specimens in which blood had entered the vitreous (n=12) compared to those without blood (n=22; 52.3%±30.7% vs 19.6%±27.2%, P=0.002). Patients with diabetes having surgery with hemorrhage (n=7) had greater expression of Annexin-V than those without hemorrhage (n=8; 62.1%±31.7% vs 18.9%±20.9%, P=0.009). However, in patients with non-diabetic vitreous hemorrhage, the level of Annexin-V expression was not significantly different compared to other disease processes (38.6%±25.7%, n=5 vs 20.0%±30.9%, n=14, P=0.087).
CONCLUSION: Increased expression of the apoptotic marker, Annexin-V is detected on vitreous microparticles in diabetes-related vitreous hemorrhage. When evaluating vitreous hemorrhage in patients without diabetes, the apoptotic signal is not significantly different. Vitrectomy in patients with diabetes, and improvement in visual outcomes, may be related to the removal of a serum-derived, pro-apoptotic vitreous. Further investigation is warranted in order to identify the molecular characteristics of microparticles that regulate disease.]]></description>
<pubDate>2021/12/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Harris Sultan, Rithwick Rajagopal, Prabakar Kumar Rao, Kisha Deslee Piggott, Michael A Paley, Lynn Marisa Hassman, Albert S. Li, Brigid Marshall and Rajendra Shridhar Apte]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Harris Sultan, Rithwick Rajagopal, Prabakar Kumar Rao, Kisha Deslee Piggott, Michael A Paley, Lynn Marisa Hassman, Albert S. Li, Brigid Marshall and Rajendra Shridhar Apte</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220114]]></guid><cfi:id>166</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Characteristics of macular microvasculature before and after idiopathic macular hole surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220115]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the macular microvasculature before and after surgery for idiopathic macular hole (MH) and the association of preoperative vascular parameters with postoperative recovery of visual acuity and configuration.METHODS: Twenty eyes from 20 patients with idiopathic MH were enrolled. Optical coherence tomography angiography (OCTA) images were obtained before, 2wk, 1, and 3mo after vitrectomy with internal limiting membrane peeling. Preoperative foveal avascular zone (FAZ) area and perimeter and regional vessel density (VD) in both layers were compared according to the 3-month best-corrected visual acuity (BCVA).RESULTS: The BCVA improved from 0.98±0.59 (logMAR, Snellen 20/200) preoperatively to 0.30±0.25 (Snellen 20/40) at 3mo postoperatively. The preoperative deep VD was smaller and the FAZ perimeter was larger in the 3-month BCVA<20/32 group (all P<0.05). A significant reduction was observed in FAZ parameters and all VDs 2wk postoperatively. Except for deep perifoveal VD, all VDs recovered only to their preoperative values. The postoperative FAZ parameters were lower during follow-up. Decreases in preoperative deep VDs were correlated with worse postoperative BCVA (Pearson’s r=-0.667 and -0.619, respectively). A larger FAZ perimeter (Spearman’s r=-0.524) and a lower deep perifoveal VD preoperatively (Pearson’s r=0.486) were associated with lower healing stage.CONCLUSION: The status of the deep vasculature may be an indicator of visual acuity in patients with a closed MH. Except for the deep perifoveal region, VD recovers only to preoperative levels.]]></description>
<pubDate>2021/12/24 10:54:48</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Dan Cheng, Ji-Wei Tao, Xue-Ting Yu, Yi-Qi Chen, Mei-Xiao Shen, Min-Hui Wu, Jia-Feng Yu, Heng-Li Lian, Zhe Lu and Li-Jun Shen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Dan Cheng, Ji-Wei Tao, Xue-Ting Yu, Yi-Qi Chen, Mei-Xiao Shen, Min-Hui Wu, Jia-Feng Yu, Heng-Li Lian, Zhe Lu and Li-Jun Shen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220115]]></guid><cfi:id>165</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Foveal structure changes in infants treated with anti-VEGF therapy or laser therapy guided by optical coherence tomography angiography for retinopathy of prematurity]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220116]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate foveal vessel density (VD) and foveal thickness using optical coherence tomography angiography (OCTA) in retinopathy of prematurity (ROP) children treated with laser photocoagulation or anti-vascular endothelial growth factor (VEGF) injection. Additionally, we assessed the relationship between foveal microvascular anomalies and different therapies in ROP children.
METHODS: This was a single-center, retrospective study of patients with a diagnosis of type 1 ROP. Twenty-three eyes (14 patients) treated with anti-VEGF injection and twenty-nine eyes (17 patients) treated with laser coagulation were included in this study. The foveal VD, inner thickness and full thickness were measured at the central 0°, 2° to 8°, and 8° of the retina (centered on the fovea) using OCTA and cross-sectional OCT, respectively.
RESULTS: Foveal VD, inner thickness and full thickness were significantly smaller within the central 8° of the retina in ROP children treated with anti-VEGF injection than in those treated with laser photocoagulation (P=0.013, 0.009, 0.036, respectively). The full thickness was also smaller in the anti-VEGF group than in the laser group at the central 0° of the retina (P=0.010). The grade of foveal hypoplasia is lower in the anti-VEGF group than in the laser group (P=0.045). Multivariable analysis did not find any risk factors associated with visual acuity in our study.
CONCLUSION: In children with type 1 ROP, the better structural development of fovea in those who were treated with anti-VEGF injection compared with laser photocoagulation are identified. However, visual acuity outcomes are similar 70mo after the treatments.]]></description>
<pubDate>2021/12/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xun Deng, Yong Cheng, Xue-Mei Zhu, Dan-Dan Linghu, Hua Xu and Jian-Hong Liang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xun Deng, Yong Cheng, Xue-Mei Zhu, Dan-Dan Linghu, Hua Xu and Jian-Hong Liang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220116]]></guid><cfi:id>164</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Efficacy of long-term orthokeratology treatment in children with anisometropic myopia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220117]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To explore the efficacy of the orthokeratology lens for anisometropic myopia progression.
METHODS: A retrospective study was performed. Cycloplegic refraction and axial length (AL) were collected from 50 children (10.52±1.72y) who visited Peking University Third Hospital from July 2015 to August 2020. These children’s one eyes (Group A) received monocular orthokeratology lenses at first, after different durations (12.20±6.94mo), their contralateral eyes (Group B) developed myopia and receive orthokeratology as well. The data in 1-year of binocular period were recorded. AL growth rate (difference of follow-up and baseline per month) were compared between two groups by paired t test. Interocular differences of AL were compared by Wilcoxon test.
RESULTS: During monocular period, the AL growth rate of the Group A (0.008±0.022 mm/mo) was significantly slower than that of the Group B (0.038±0.018 mm/mo; P<0.0001). However, during binocular period, the AL growth rate of the Group A (0.026±0.014 mm/mo) was significantly faster than that of the Group B (0.016±0.015 mm/mo; P<0.0001). The AL difference between both eyes was 0.6 (0.46) mm, then significantly decreased to 0.22 (0.39) mm when started binocular treatment (P<0.0001). However, it was significantly increased to 0.30 (0.32) mm after a year (P<0.0001), but still significantly lower than baseline (P<0.0001).
CONCLUSION: The orthokeratology lens is efficient for control the AL elongation of monocular myopia eyes and reduce anisometropia. For the condition that the contralateral eyes develop myopia and receive orthokeratology lens later, there is no efficiency observed on control interocular difference of AL during binocular treatment.]]></description>
<pubDate>2021/12/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Kai-Yun Zhang, Hui-Bin Lyu, Jia-Rui Yang and Wei-Qiang Qiu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Kai-Yun Zhang, Hui-Bin Lyu, Jia-Rui Yang and Wei-Qiang Qiu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220117]]></guid><cfi:id>163</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Ophthalmic manifestations of Cryptococcus gattii species complex: a case series and review of the literature]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220118]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report 4 cases of Cryptococcus gattii (C. gattii) species complex infection with diverse ophthalmic manifestations, and to review the literature to examine pathobiology of disease, classical ophthalmic presentations and outcomes, and treatment modalities for this emerging pathogen.
METHODS: Cases of C. gattii meningoencephalitis with ophthalmic manifestations were identified via chart review at two institutions in Australia and one institution in the mid-west region of the United States and are reported as a case series. Additionally, a MEDLINE literature review was conducted to identify all reported cases of C. gattii with ophthalmic manifestations from 1990-2020. Cases were reviewed and tabulated, together with our series of patients, in this report.
RESULTS: Four cases of C. gattii with ophthalmic manifestations are presented; three from Australia and one from the USA. A literature review identified a total of 331 cases of C. gattii with visual sequelae. The majority of cases occurred in immunocompetent individuals. Blurred vision and diplopia were the most common presenting symptoms, with papilloedema the most common sign, reported in 10%-50% of cases. Visual loss was reported in 10%-53% of cases, as compared to rates of visual loss of 1%-9% in C. neoformans infection. Elevated intracranial pressure, cerebrospinal fluid (CSF) fungal burden, and abnormal neurological exam at presentation correlated with poor visual outcomes. The mainstays of treatment are anti-fungal agents and aggressive management of intracranial hypertension with serial lumbar punctures. CSF diversion procedures should be considered for refractory cases. Acetazolamide and mannitol are associated with high complication rates, and adjuvant corticosteroids have demonstrated higher mortality rates; these treatments should be avoided.
CONCLUSION: Permanent visual loss represents a devastating yet potentially preventable sequelae of C. gattii infection. Intracranial hypertension needs to be recognised early and aggressively managed. Referral to an ophthalmologist/neuro-ophthalmologist in all cases of cryptococcal infection independent of visual symptoms at time of diagnosis is recommended.]]></description>
<pubDate>2021/12/24 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Grace A. McCabe, Jack W. McHugh, Todd Goodwin, Douglas F. Johnson, Anthony Fok and Thomas G. Campbell]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Grace A. McCabe, Jack W. McHugh, Todd Goodwin, Douglas F. Johnson, Anthony Fok and Thomas G. Campbell</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20220118]]></guid><cfi:id>162</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical efficacy of 0.05% cyclosporine nano-emulsion in the treatment of dry eye syndrome associated with meibomian gland dysfunction]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221205]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the clinical efficacy of topical 0.05% cyclosporine nano-emulsion in the treatment of dry eye syndrome (DES) with meibomian gland dysfunction (MGD).METHODS: This prospective study included 64 patients with DES and MGD who were randomly assigned to three groups: Group 1 (n=24, conventional cyclosporine), Group 2 (n=21, nano-emulsion cyclosporine), and Group 3 (n=19, control). Lid margin telangiectasia (LMT), meibomian gland secretion (MGS), conjunctival injection (CI), corneal staining (CS), tear break-up time (TBUT), Schirmer test I (STI), Ocular Surface Disease Index (OSDI), and lipid layer thickness (LLT) was evaluated at 4, 8, and 12wk of treatment.RESULTS: In Group 3 (control), LMT, CS, and CI improved after 8wk, MGS, TBUT after 12wk of treatment. In Group 1 (conventional cyclosporine), LMT, MGS, and TBUT improved significantly after 4wk, whereas CS, CI, STI, and LLT improved significantly after 8wk, and OSDI at 12wk. In Group 2 (nano-cyclosporine), LMT, MGS, CS, CI, TBUT, and OSDI significantly improved after 4wk, and STI after 8wk. Especially, LLT was significantly higher than other groups after 4wk.CONCLUSION: Cyclosporine and nano-cyclosporine shows significant improvement in DES with MGD than the control group. In contrast, the nano-cyclosporine group shows more statistically improved CI and CS at 4wk, especially LLT at 4, 8, and 12wk compared to the conventional cyclosporine group.]]></description>
<pubDate>2022/11/22 10:48:18</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yeon Ji Jo, Ji Eun Lee and Jong Soo Lee]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yeon Ji Jo, Ji Eun Lee and Jong Soo Lee</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221205]]></guid><cfi:id>161</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Topographic tear film trend and new parameters for non-invasive break up time test]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221206]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the quantitative and qualitative results of the noninvasive tear film break-up time (NI-BUT) test and investigate the predictive ability of the new NI-BUT parameter in discriminating between normal Ocular Surface Disease Index (OSDI; scores ≤12) and abnormal OSDI (scores ≥13).METHODS: A total of 341 eyes of 341 volunteers who applied for routine eye outpatient control were included in the prospective study. All participants’ noninvasive first tear film break-up time (NIF-BUT), noninvasive average tear film break-up time (NIAvg-BUT) and average value of the first three break-up time (A3F-BUT) were analyzed. A3F-BUT, the new NI-BUT parameter, is calculated by adding the NIF-BUT value to the 2nd break-up time value that has a difference of at most 1 second from the NIF-BUT value and to the 3rd break-up time and then dividing the respective sum by 3. Receiver operating characteristic (ROC) curve and forward logistic regression analyses were performed to determine the parameter that had the best predictive ability between the OSDI groups.RESULTS: The NI-BUT values of 255 eyes of 255 volunteers included in the study were analyzed statistically. The mean NIF-BUT, NIAvg-BUT, and A3F-BUT values were calculated as 5.3±3.0, 8±3.1, and 5.8±3.0 seconds, respectively. All three parameters were found to be significantly lower in the abnormal OSDI group (P=0.014, 0.034, and 0.011, respectively). The area under the curve (AUC) of the A3F-BUT to predict abnormal OSDI was AUC=0.625 (0.529-0.720), P=0.011 and NIF-BUT was AUC=0.599 (0.502-0.696), P=0.043. The A3F-BUT parameter and NIF-BUT parameters were found to be significantly efficient in discriminating abnormal OSDI.CONCLUSION: The new parameter for the NI-BUT test has more predictive ability in the discrimination of OSDI groups.]]></description>
<pubDate>2022/11/22 10:48:18</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yakup Acet]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yakup Acet</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221206]]></guid><cfi:id>160</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of the position of the corneal lamella on the frequency of its detachment]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221207]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the influence of gaps [places where neither the donor’s nor the recipient’s Descemet’s membrane (DM) is present] and overlaps (places where the recipient’s DM is covered by the donor’s DM) on the frequency of postoperative detachment of DM endothelial keratoplasty (DMEK) lamellae.METHODS: Totally 64 eyes of 64 patients with Fuchs’ endothelial dystrophy or bullous keratopathy indicated for DMEK were randomly divided in two groups. The diameter of the implanted DMEK lamella was the same in both groups (8 mm), but we changed the diameter of the removed recipient DM. In the first group (32 eyes), the circular area was approximately 8.5 mm (gaps); in the second group (32 eyes), the diameter was 7.5 mm (overlaps). Postoperatively we noted all cases of detachment visible on the slit lamp and these cases we indicated for rebubbling. We also measured the uncorrected distance visual acuity (UDVA) as well as corrected distance visual acuity (CDVA) in decimal and postoperative endothelial cell density (ECD). The minimum follow-up time was 6mo.RESULTS: The number of rebubbling procedures in the entire group of patients was 13, i.e., 20.3%, with 6 eyes (18.7%) in the gap group, and 7 eyes (21.9%) in the overlap group. Lamella replacement (re-DMEK) was required in 3 (gap group) and 2 patients (overlap group), respectively. The difference between the groups was statistically insignificant. The UDVA was 0.54±0.21 in the gap group and 0.58±0.24 in the overlap group. The CDVA was 0.74±0.22 and 0.80±0.16, respectively. ECD was 1920±491 and 2149±570 cells/mm2. The small differences between both groups were not statistically significant.CONCLUSION: We do not notice any difference in the group of patients with overlaps or gaps of DM. The presence of small areas of gaps or overlaps does not affect the frequency of detachment of the DMEK lamellae.]]></description>
<pubDate>2022/11/22 10:48:18</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Pavel Studeny, Magdalena Netukova, Martina Nemcokova, Yun-Min Klimesova and Deli Krizova]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Pavel Studeny, Magdalena Netukova, Martina Nemcokova, Yun-Min Klimesova and Deli Krizova</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221207]]></guid><cfi:id>159</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Efficacy of scleral-fixated 3-looped haptics intraocular lens implantation for surgical management of microspherophakia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221208]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the safety and efficacy of scleral-fixated 3-looped haptics intraocular lens (IOL) implantation for surgical management of microspherophakia.METHODS: A retrospective case series include 10 microspherophakic patients (15 eyes) who underwent lens removal plus a modified surgical treatment of scleral-fixated 3-looped haptics IOL implantation. The primary outcomes involved visual acuity, intraocular pressure (IOP). Secondary outcomes were spherical equivalent (SE), anterior chamber depth (ACD), corneal endothelial cell density and postoperative complications.RESULTS: After a postoperative follow-up of 17.60±15.44mo, improved visual outcomes can be observed. The uncorrected distance visual acuity (UCVA) logMAR improved from 1.54±0.59 preoperatively to 0.51±0.35 postoperatively (P=0.001), and best corrected visual acuity (BCVA) logMAR improved from 0.97±0.91 preoperatively to 0.24±0.23 postoperatively (P=0.003). Moreover, the SE decreased from -9.58±7.47D preoperatively to -0.65±2.21 D postoperatively (P<0.001). In terms of safety profile, the average IOP decreased from 21.10±12.94 mm Hg preoperatively to 14.03±3.57 mm Hg postoperatively (P=0.044), and the previously elevated IOP of three eyes decreased to the normal range. The ACD increased from 2.25±1.45 mm preoperatively to 3.35±0.39 mm postoperatively (P=0.017). The density of corneal endothelial cells did not change significantly after surgery (P=0.140). The posterior chamber IOLs were well centered and no severe complications were found.CONCLUSION: Lens removal plus the modified surgical treatment of scleral-fixated 3-looped haptics IOL implantation can help in improvement of visual acuity, which can be regarded as a relative safe method for the surgical management of microspherophakia.]]></description>
<pubDate>2022/11/22 10:48:18</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xue-Wen Yu, Xian Ge, Wei-Jie Chen, Shuang Ni, Xue-Qi Lin, Si-Ting Sheng, Dan Chen and Wen Xu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xue-Wen Yu, Xian Ge, Wei-Jie Chen, Shuang Ni, Xue-Qi Lin, Si-Ting Sheng, Dan Chen and Wen Xu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221208]]></guid><cfi:id>158</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Deep sclerectomy-trabeculectomy with mitomycin C in treating glaucoma: postoperative long-term results]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221209]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the long-term postoperative outcomes of deep sclerectomy-trabeculectomy (DST) with mitomycin C (MMC) in the treatment of glaucoma.METHODS: Patients who underwent DST with MMC between 2010 and 2017 were included in this retrospective observational study. Complete success was defined as postoperative intraocular pressure (IOP) ≤21 mm Hg or 30% reduction of IOP from baseline without any topical IOP-lowering agent, and qualified success defined as IOP≤21 mm Hg or 30% reduction of IOP from baseline with/without single topical agent. We evaluated the surgical success rates and complication rates of this procedure, as well as described the IOP profiles, best corrected visual acuity (BCVA) profiles and mean deviations (MD) of Humphrey visual field (HVF) 24-2 performance at each follow-up time point. Mixed linear regression models were constructed to determine estimated predictive values of demographic data, use of topical IOP-lowering agents, baseline and postoperative IOP and optical profiles (e.g., BCVA and MD).RESULTS: Totally 98 eyes (mean postoperative follow-up 67.5mo) showed mean IOP reduction at every follow-up interval. Both median BCVA and MD of visual fields were maintained throughout the follow-up intervals when comparing to baseline. The number of IOP-lowering medications decreased from 2.8±0.8 to 0.3±0.7 (P=0.068). Totally 84 (85.7%) eyes achieved complete success at final follow-up. Transient hyphaema and transient choroidal effusion developed in 15 eyes (15.3%) and 11 eyes (11.2%) respectively. Other complications included shallow anterior chamber in 5 eyes (5.1%), bleb leak in 4 eyes (4.1%), bleb revision in 7 eyes (7.1%), bleb needling in 9 eyes (9.2%) and repeat trabeculectomy in 1 eye (1.0%). There was no endophthalmitis, blebitis or macular oedema. There was no significant correlation between postoperative IOP control and postoperative BCVA.CONCLUSION: DST with MMC demonstrates effective and sustained long-term outcomes in the treatment of glaucoma with no major complication.]]></description>
<pubDate>2022/11/22 10:48:18</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Chung Shen Chean, Li Jiang, Gayathri Kanchana Niroshani Pati Arambage and Punithawathy Ranjit]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Chung Shen Chean, Li Jiang, Gayathri Kanchana Niroshani Pati Arambage and Punithawathy Ranjit</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221209]]></guid><cfi:id>157</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Evaluation of the learning curve of laser peripheral iridectomy: the 20th case reaches the turning point]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221210]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To explore the learning curve for ophthalmologists at the start of laser peripheral iridectomy (LPI) training.METHODS: The learning curve of 4 doctor groups without previous LPI experience was studied. Three main parameters of LPI were reviewed: total energy, argon energy and neodymium-doped yttrium aluminum garnet (Nd:YAG) energy. Procedures were evaluated in cohorts of 20 cases to identify the turning points of the three variables.RESULTS: There was no significant difference in terms of age or eye among the 4 doctor groups. There were stable trends on the learning curve for the Doctor A and C groups regarding total energy and argon energy. In addition, the turning points on the learning curve were determined after the 20th procedure for the Doctor B and D groups regarding total energy and argon energy. Moreover, the Nd:YAG energy was relatively stable since the first procedure.CONCLUSION: It requires approximately 20 procedures for a beginner to reach a turning point on the learning curve regarding LPI. It can serve as a point of reference or guideline for training beginners to perform LPI.]]></description>
<pubDate>2022/11/22 10:48:18</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yao Liu, Yu-Ying Zhou, Cheng-Guo Zuo, Yun-Ru Liao, Jia-Wei Ren, Hui-Shan Lin, Xin-Bo Gao and Ming-Kai Lin]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yao Liu, Yu-Ying Zhou, Cheng-Guo Zuo, Yun-Ru Liao, Jia-Wei Ren, Hui-Shan Lin, Xin-Bo Gao and Ming-Kai Lin</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221210]]></guid><cfi:id>156</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Post-operative visual outcomes based on morphological staging of idiopathic epiretinal membranes on OCT]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221211]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the recently described optical coherence tomography (OCT) based classification of epiretinal membrane (ERM) and its usefulness in predicting the functional outcome.METHODS: A retrospective observational review of OCT scans of patients with the diagnosis of idiopathic ERM was carried out from January 2016 to June 2021. All consecutive images diagnosed with any stage of idiopathic ERM and fulfilled the eligibility criteria were included in the analysis. ERM was identified on OCT scans as a thin hyperreflective layer over the inner layers of retina. OCT scans of patients with ERM who underwent vitrectomy, were independently staged as per the new classification by two independent retinal surgeons to form a consensus on stage. Best corrected visual acuity (BCVA) in logMAR scale and central subfield thickness (CST) on pre- and post-operative spectral domain OCT scans were the variables noted for all patients at the time of diagnosis and at 6 and 12mo follow up visit after undergoing intervention. Partial correlation coefficient was computed between BCVA (logMAR) and CST by ERM stage adjusting by baseline measures.RESULTS: Clinical charts of 74 patients with idiopathic ERM were assessed. Clinically significant improvement in BCVA overtime was observed with significant difference in median visual acuity of patients with Stage II-IV ERM with P<0.001. The median CST of all patients with stage II-IV ERM showed similar consistent improvement with P<0.001 from baseline to 12th month. Our results showed not only gain in visual acuity but also shift from baseline to anatomical normalization of CST in stage II. We found a decrease in CST with difference of 166 μm and 151 μm in stage III and stage IV respectively. Our results remained consistent with the hypothesis of improved visual outcomes with all stages of ERM with adjusted moderate linear correlation between visual acuity and CST in stage II-IV (r>0.3).CONCLUSION: Equally significant visual outcomes of patients with ERM staged II-IV and therefore can be counselled for improved visual acuity after surgical removal of ERM with improvement up to 5 lines on Snellen’s chart from the baseline.]]></description>
<pubDate>2022/11/22 10:48:19</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Sehrish Nizar Ali Momin, Roha Ahmad Choudhary, M. A. Rehman Siddiqui, Shiraz Hashmi, Abdul Sami Memon and Haroon Tayyab]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Sehrish Nizar Ali Momin, Roha Ahmad Choudhary, M. A. Rehman Siddiqui, Shiraz Hashmi, Abdul Sami Memon and Haroon Tayyab</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221211]]></guid><cfi:id>155</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Long-term clinical effects of intravitreal injections of conbercept for the treatment of choroidal neovascularization in patients with pathological myopia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221212]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To observe the long-term clinical efficacy of intravitreal injections of conbercept, a novel vascular growth factor inhibitor, for the treatment of pathological myopia choroidal neovascularization (PM-CNV).METHODS: A total of 67 eyes (from 67 patients; mean age, 54.90±12.7y) with PM-CNV were retrospectively researched. Based on the different schemes used for the administration of the drug, the patients were divided into two groups: group A (n=35; average age, 53.31±13.6y; average diopter, 9.25±1.72 D), which received only one injection of pro re nata (PRN; 1+PRN regimen), and group B (n=32; average age, 56.49±11.8y; average diopter, 9.63±2.24 D), which received one injection per month for 3mo (3+PRN regimen). Best-corrected visual acuity (BCVA) analysis, intraocular pressure (IOP) examination, slit-lamp microscopy, fundus examination and optical coherence tomography were performed at each follow-up. The recurrence and treatment times of CNV were recorded. The patients were followed up for at least 12mo.RESULTS: The BCVA was increased in 29 eyes (82.9%) in group A and 30 eyes (93.75%) in group B; no increase or decrease was observed in 6 (17.1%) and 2 (6.25%) eyes in groups A and B, respectively. The BCVA (logMAR) values before treatment (0.67±0.48 and 0.71±0.56) were significantly higher than those 12mo after treatment (0.31±0.26 and 0.33±0.17) in groups A and B, respectively (P<0.05). The mean central macular thickness (CMT) values had significantly decreased from 346.49±65.99 and 360.10±82.31 μm at baseline to 257.29±40.47 and 251.97±48.26 μm in groups A and B, respectively, after 12mo of treatment. A total of 21 eyes in group A needed reinjection (60%; average number of injections, 2.51±0.98); the corresponding values in group B were 6 eyes (18.75%; average number of injections, 3.74±1.22). There were no adverse ocular and systemic complications during the treatment and follow-up.CONCLUSION: Intravitreal injection of conbercept with 1+PRN or 3+PRN improve the visual acuity, reduce macular edema and reduce the level of CMT in patients with PM-CNV. The 3+PRN regimen demonstrates a lower recurrence rate of CNV than the 1+PRN regimen, but requires more treatment. However, both treatment regimens demonstrate long-term safety and efficacy for the treatment of PM-CNV.]]></description>
<pubDate>2022/11/22 10:48:19</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Si Zhang, Zi-Fang He, Fei-Fei Chen, Wen-Wen Zhang, Ya-Jun Liu, Hui Chen and Zheng-Gao Xie]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Si Zhang, Zi-Fang He, Fei-Fei Chen, Wen-Wen Zhang, Ya-Jun Liu, Hui Chen and Zheng-Gao Xie</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221212]]></guid><cfi:id>154</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical feature and predictive factor analysis for spontaneous regression of retinopathy of prematurity in a Chinese population]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221213]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the ratio of spontaneous regression of retinopathy of prematurity (ROP) and to explore the possible relevant predictive factors.METHODS: A retrospective review of 405 infants who were diagnosed with ROP and mother during pregnancy were collected. Stage, zone, and duration of ROP were recorded. Statistical analysis was performed on 51 possible predictive factors.RESULTS: Totally 356 infants showed spontaneous regression. The incidence was 100%, 95.3%, and 22.7% in stage 1, 2, and 3, respectively. The 13.4% of the ROP with plus disease eventually resolved spontaneously. All affected eyes of aggressive posterior retinopathy of prematurity (AP-ROP) failed to spontaneously regress. The mean duration of ROP was 7.2wk in patients with spontaneous resolution of ROP. Days of mechanical ventilation (OR=0.981, 95%CI, 0.965-0.997, P=0.021), retinal hemorrhage (OR=0.173, 95%CI, 0.064-0.470, P=0.001), delivery pattern (OR=2.750, 95%CI, 1.132-6.681, P=0.025), maternal anemia in pregnancy (OR=0.142, 95%CI, 0.036-0.563, P=0.005), the stages (at initial diagnosis OR=0.183, 95%CI, 0.041-0.816, P=0.026; at final diagnosis OR=0.031, 95%CI, 0.006-0.167, P<0.001), and with plus disease or not (OR=0.005, 95%CI, 0.001-0.031, P<0.001) were independent predictive factors of the spontaneous regression of ROP.CONCLUSION: Most mild ROP can spontaneously resolve. Active treatment is still recommended for stage 3 ROP, zone I ROP, AP-ROP, and ROP with plus disease. Prolonged mechanical ventilation and concurrent retinal hemorrhage reduce the likelihood of spontaneous ROP resolution. The pattern of delivery and the mother’s anemia during pregnancy can also affect the prognosis of ROP.]]></description>
<pubDate>2022/11/22 10:48:19</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yi-An Li, Xiao-Hong Zhou, Xiao-Jing Cai and Chen-Hao Yang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yi-An Li, Xiao-Hong Zhou, Xiao-Jing Cai and Chen-Hao Yang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221213]]></guid><cfi:id>153</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Simultaneous screening and classification of diabetic retinopathy and age-related macular degeneration based on fundus photos—a prospective analysis of the RetCAD system]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221214]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the accuracy of an artificial intelligence (AI) based software (RetCAD, Thirona, The Netherlands) to identify and grade age-related macular degeneration (AMD) and diabetic retinopathy (DR) simultaneously based on fundus photos.METHODS: This prospective study included 1245 eyes of 630 patients attending an ophthalmology day-care clinic. Fundus photos were acquired and parallel graded by the RetCAD AI software and by an expert reference examiner for image quality, and staging of AMD and DR. Adjudication was provided by a second expert examiner in case of disagreement between the AI software and the reference examiner. Statistical analysis was performed on eye-level and on patient-level, by summarizing the individual image level-gradings into and eye-level or patient-level score, respectively. The performance of the RetCAD system was measured using receiver operating characteristics (ROC) analysis and sensitivity and specificity for both AMD and DR were reported.RESULTS: The RetCAD achieved an area under the ROC (Az) of 0.926 with a sensitivity of 84.6% at a specificity of 84.0% for image quality. On image level, the RetCAD software achieved Az values of 0.964 and 0.961 with sensitivity/specificity pairs of 98.2%/79.1% and 83.9%/93.3% for AMD and DR, respectively. On patient level, the RetCAD software achieved Az values of 0.960 and 0.948 with sensitivity/specificity pairs of 97.3%/73.3% and 80.0%/90.1% for AMD and DR, respectively. After adjudication by the second expert examiner sensitivity/specificity increases on patient-level to 98.6%/78.3% and 100.0%/92.3% for AMD and DR, respectively.CONCLUSION: The RetCAD offers very good sensitivity and specificity compared to manual grading by experts and is in line with that obtained by similar automated grading systems. The RetCAD AI software enables simultaneous grading of both AMD and DR based on the same fundus photos. Its sensitivity may be adjusted according to the desired acceptable sensitivity and specificity. Its simplicity cloud base integration allows cost-effective screening where routine expert evaluation may be limited.]]></description>
<pubDate>2022/11/22 10:48:19</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Christos Skevas, Hanah Weindler, Max Levering, Jonne Engelberts, Mark van Grinsven and Toam Katz]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Christos Skevas, Hanah Weindler, Max Levering, Jonne Engelberts, Mark van Grinsven and Toam Katz</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221214]]></guid><cfi:id>152</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Lag time, high-risk histopathological features, metastasis, and survival interrelation in retinoblastoma: a perspective from lower-middle income country]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221215]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the impact of lag time to metastasis and survival rates among patients with retinoblastoma.METHODS: This retrospective study was conducted with 52 patients from the Department of Ophthalmology and the Department of Pediatrics of Dr. Sardjito General Hospital, between 1st January 2014 and 31st December 2020. Lag time was defined as the time delay between the first sign of retinoblastoma to the diagnosis of retinoblastoma. The subjects with lag time > one year were included in the case group, while the subjects with lag time < one year were included in the control group.RESULTS: The lag time was significantly correlated with American Joint Committee on Cancer and Intraocular Classification of Retinoblastoma staging of retinoblastoma (P=0.005 and P=0.006, respectively). The lag time was also significantly correlated with both metastasis event [odds ratio (OR): 5.06, 95%Cl: 1.56-16.44, P=0.006] and mortality (OR: 4.54, 95%Cl: 1.37-15.07, P=0.011). The follow-up was continued for 32 subjects for 3y after initial diagnoses. Survival analysis revealed a significant difference among these two groups (P=0.021). Furthermore, lag time was significantly correlated with survival of retinoblastoma (r=-0.53, P=0.046).CONCLUSION: The study highlights the importance of lag time between the onset of first symptoms and the time of retinoblastoma diagnosis which significantly contribute to metastasis and mortality of patients with retinoblastoma. Examinations for the early detection of retinoblastoma should be performed for individuals at-risk to minimize lag time and improve the outcomes.]]></description>
<pubDate>2022/11/22 10:48:19</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Purjanto Tepo Utomo, Datu Respatika, Bambang Ardianto, Hanggoro Tri Rinonce, Didik Setyo Heriyanto, Banu Aji Dibyasakti, Irene Titin Darajati, Indra Tri Mahayana and Agus Supartoto]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Purjanto Tepo Utomo, Datu Respatika, Bambang Ardianto, Hanggoro Tri Rinonce, Didik Setyo Heriyanto, Banu Aji Dibyasakti, Irene Titin Darajati, Indra Tri Mahayana and Agus Supartoto</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221215]]></guid><cfi:id>151</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A modified 3D stereophotogrammetry-based distraction test for assessing lower eyelid tension]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221105]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the reliability of a modified three-dimensional distraction test (3D-DT) and three-dimensional pinch test (3D-PT) for assessing lower eyelid tension (LET).METHODS: A cross-sectional study was conducted among 97 volunteers including 97 eyelids with no history of trauma, tumor, or reconstructive surgeries. Six three-dimensional photographs were acquired for each participant, including two photographs obtained in a neutral position (NP), two using a modified 3D-DT with a 15.9-grammes stainless steel eyelid hook performed, and two using 3D-PT.RESULTS: The mean absolute differences between NP, 3D-DT, and 3D-PT measurements varied between 0.07 and 7.42, 0.10 and 13.10, and 0.07 and 15.97, respectively; technical error of measurement varied between 0.05 and 7.81, 0.09 and 10.19, and 0.07 and 12.47, respectively; and relative error measurements varied between 0.10% and 11.50%, 0.16% and 30.51%, and 0.11% and 38.75%, respectively. For intra-rater reliability, the intraclass correlation coefficients (ICCs) were more than 0.80 in seven out of eight measurements obtained in the NP and 3D-DT, whereas those obtained in the 3D-PT were as low as less than 0.30 by rater 1; the ICCs of all the measurements obtained in all the positions (NP, 3D-DT, and 3D-PT) were more than 0.80 by rater 2. For inter-rater reliability six out of eight NP and 3D-DT measurements had an ICC greater than 0.80, whereas those of 3D-PT measurements were less than 0.30. For intra-method reliability, the ICCs of all the NP measurements were more than 0.87, whereas those of the six 3D-DT measurements and four 3D-PT measurements were more than 0.80.CONCLUSION: Our study results prove that the modified 3D-DT, which involves the use of an eyelid hook, can be a highly reliable method for evaluating LET. Furthermore, this novel and simple method may be utilized as the basis for further investigation and routine pre- and postoperative clinical evaluation.]]></description>
<pubDate>2022/10/25 14:09:32</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xiao-Yi Hou, Alexander C. Rokohl, Marius M. Meinke, Sen-Mao Li, Ming Lin, Ren-Bing Jia, Yong-Wei Guo and Ludwig M. Heindl]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiao-Yi Hou, Alexander C. Rokohl, Marius M. Meinke, Sen-Mao Li, Ming Lin, Ren-Bing Jia, Yong-Wei Guo and Ludwig M. Heindl</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221105]]></guid><cfi:id>150</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Endoscopic dacryocystorhinostomy with mucosal anastomosing in chronic dacryocystitis with three categories of ethmoid sinuses]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221106]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the outcome of endoscopic dacryocystorhinostomy (En-DCR) with mucosal anastomosis in chronic dacryocystitis patients, with various categories of ethmoid sinuses.METHODS: Between July 2015 and September 2019, 1439 adult patients, representing 1623 affected eyes, presented with chronic dacryocystitis and were scheduled for En-DCR. The categories of ethmoid sinuses were preoperatively determined, using computed tomography-dacryocystography (CT-DCG), and were classified as category 1 (C1), category 2 (C2), and category 3 (C3). No sinuses anterior to the posterior lacrimal crest defined as C1. Sinuses found between the anterior edge of the lacrimal bone and the posterior lacrimal crest defined as C2. Sinuses found anterior to the lacrimal bone suture defined as C3. At the end of surgery, the dacryocyst and nasal mucosa were anastomosed in C1, and the dacryocyst mucosa and anterior ethmoid sinus were anastomosed in C2 and C3 ethmoid sinus patients. The surgical success rate and related complications, in patients with 3 categories of ethmoid cells, were monitored and documented.RESULTS: Postoperative data was obtained for 179 C1 affected eyes, 878 C2 affected eyes, and 432 C3 affected eyes. The overall success rate of En-DCR was 93.0% (1385/1489). Additionally, the success rates were comparable among the different ethmoid categories at 12mo post operation. We demonstrated that the major reason for surgical failure was intranasal ostial closure, due to granulation or scar tissue.CONCLUSION: En-DCR is a feasible and highly effective primary treatment for chronic dacryocystitis. To ensure surgical success, the surgery protocol must be designed in accordance with the category of ethmoid sinuses present in individual patient.]]></description>
<pubDate>2022/10/25 14:09:32</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yao-Hua Wang, Wen-Hao Jiang, Yun-Hai Tu, Guang-Ming Zhou, Wen-Can Wu and Bo Yu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yao-Hua Wang, Wen-Hao Jiang, Yun-Hai Tu, Guang-Ming Zhou, Wen-Can Wu and Bo Yu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221106]]></guid><cfi:id>149</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effects of rigid gas permeable contact lens on morphological parameters and vision-related quality of life in keratoconus patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221107]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the effect of rigid gas permeable contact lens (RGP-CL) on corneal morphological parameters and vision-related quality of life in keratoconus (KC) patients.METHODS: Totally 57 eyes of 30 KC patients who were followed-up for more than two years, including 17 RGP wearers (32 eyes) and 13 non-wearers (25 eyes) were retrospectively analyzed. Initial medical history and corneal topography were collected at baseline. Corneal topography, corneal aberration, optical coherence tomography, and vision-related quality of life questionnaires were performed at the last follow-up.RESULTS: According to corneal topography, increase of the flattest keratometric values was higher in RGP wearers than in non-wearers (P=0.038). The morphological parameters, including symmetry index of front corneal curvature (P=0.004) and Baiocchi-Calossi-Versaci index front (P=0.047), were lower in RGP wearers than in non-wearers. Vertical coma was smaller in RGP wearers than non-wearers in 3.0, 5.0, 6.0, and 7.0 mm pupil diameters, respectively (P<0.05). The environmental triggering domain of ocular surface disease index was worse in RGP wearers as compared to non-wearers (P=0.003). At the last follow-up, there were no significant differences in constituent ratios of KC progression, corneal thickness topography, epithelial thickness topography, morphological parameters of corneal topography, and other questionnaire scores between the two groups (all P>0.05).CONCLUSION: Long-term use of RGP does not worsen KC but may cause corneal epithelial remodeling to increase symmetry of corneal anterior surface, reduce corneal vertical coma and improve visual quality. However, RGP wearing causes a slight decrease in vision-related quality of life. The occurrence of ocular surface symptoms is mainly associated with environmental triggering factors.]]></description>
<pubDate>2022/10/25 14:09:32</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yue Xu, Yun Wang and Xiao-Feng Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yue Xu, Yun Wang and Xiao-Feng Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221107]]></guid><cfi:id>148</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Diagnostic evaluation of optical coherence tomography parameters in normal, preperimetric and perimetric glaucoma patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221108]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the diagnostic ability of glaucoma parameters measured by the optical coherence tomography (OCT) in normal, preperimetric glaucoma (PPG) and perimetric glaucoma (PG) patients.METHODS: This cross-sectional observational study includes 127 eyes of 127 subjects. Patients were divided into PPG (51 eyes), PG (46 eyes), and normal controls (30 eyes) based on clinical optic disc assessment and Humphrey visual field changes. The Heidelberg Spectralis OCT machine using Glaucoma Module Premium Edition software was used to measure the retinal nerve fiber layer (RNFL) and Bruch’s membrane opening-minimum rim width (BMO-MRW) to assess the optic nerve head and ganglion cell layer (GCL) thickness in the macula.RESULTS: RNFL, MRW, and GCL thickness were all significantly thinner in PG compared to PPG and the normal group. The BMO-MRW parameters showed better specificity (>70%) at 90% specificity compared to both RNFL and GCL parameters to discriminate normal, PPG, and PG patients. All BMO-MRW parameters showed higher area under curves (AUC) compared to RNFL and GCL parameters with the highest AUC observed in the superotemporal sector of the BMO-MRW (AUC=0.819 and and 0.897 between normal and PPG and PG groups respectively).CONCLUSION: While the BMO-MRW best discriminates PPG and PG against normal eyes, GCL parameters poorly differentiate the three groups.]]></description>
<pubDate>2022/10/25 14:09:32</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Aimy Mastura Zurairah Yusof, Othmaliza Othman, Seng Fai Tang, Mohd Rohaizat Hassan and Norshamsiah Md Din]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Aimy Mastura Zurairah Yusof, Othmaliza Othman, Seng Fai Tang, Mohd Rohaizat Hassan and Norshamsiah Md Din</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221108]]></guid><cfi:id>147</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Vision-related quality-of-life in Jamaican glaucoma patients at Kingston Public Hospital]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221109]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the vision-related quality-of-life of glaucoma patients and the association between clinical and socioeconomic factors, and vision-related quality-of-life.METHODS: This was a cross-sectional study. Consecutive patients with glaucoma were interviewed using a modified 25-item National Eye Institute Visual Function Questionnaire (VFQ-25) by a single interviewer. Statistical analysis was done to find associations between patient variables and vision-related quality-of-life scores. Confidentiality and anonymity were maintained.RESULTS: Ninety-six participants were recruited in the study. There were 44 males and the mean age for males and females was 65.7 and 69.5y, respectively. The mean composite score was 71.2 (with a maximum possible score of 100), with the highest mean score in the colour vision subscale (89.8) and the lowest mean score in the driving subscale (34.0). Worse visual acuity (P<0.001), longer duration of glaucoma (P<0.001) and higher number of glaucoma medications (P<0.001) were associated with a worse composite score. Female participants and those who lived in urban areas had significantly better scores than male participants (P=0.002) and those who lived in rural areas (P=0.017), respectively.CONCLUSION: The vision-related quality-of-life in Jamaican glaucoma patients is comparable to that of glaucoma patients in the Barbados Eye Study and other international studies using the VFQ-25 questionnaire. Worse quality-of-life scores are associated with poorer visual acuity, longer duration of glaucoma, more glaucoma medications, and sociodemographic factors such as male gender and rural residence.]]></description>
<pubDate>2022/10/25 14:09:33</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Valence A Jordan and Lizette L Mowatt]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Valence A Jordan and Lizette L Mowatt</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221109]]></guid><cfi:id>146</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of 24×20 mm2 swept-source OCTA and fluorescein angiography for the evaluation of lesions in diabetic retinopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221110]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare ultra-widefield (24×20 mm2) swept-source optical coherence tomography angiography (SS-OCTA) and fluorescein angiography (FA) in the evaluation of diabetic retinopathy (DR) lesions.METHODS: Forty-six eyes of 23 patients with treatment-naïve DR were included at Peking University People’s Hospital from September 1, 2021, until December 31, 2021, as well as 23 age and gender matched healthy controls. Quantitative assessments of DR lesions on FA and SS-OCTA (superficial capillary plexus, SCP, 24×20 mm2) were performed.RESULTS: Area of fovea avascular zone (FAZ) was larger in DR cases than controls (0.34±0.069 mm2 vs 0.287±0.108 mm2, P=0.006). In DR eyes, the mean FAZ area was 0.34±0.069 and 0.334±0.087 mm2 on SS-OCTA and FA, respectively (P=0.428), while the median FAZ perimeter was 2.382 (IQR, 2.201-2.59) and 2.333 (IQR, 2.138-2.6) mm on SS-OCTA and FA images (P=0.733). There was no significant difference in the size of the non-perfusion area (NPA) between the images on SS-OCTA and FA (12.389, IQR 4.96-28.3 and 11.125, IQR 5-28.31 mm2, P=0.197). The median total microaneurysm (MA) count was 35 (IQR, 19-46) and 73 (IQR, 43-93) on SS-OCTA and FA (P<0.001), respectively. No significant difference in intra-retinal microvascular abnormality (IRMA) and neovascularization (NV) count was found between the two techniques. The intraclass coefficient (ICCs) of all the parameters above indicated stable repeatability.CONCLUSION: Ultra-widefield SS-OCTA represents a reliable, noninvasive, and quantitative imaging technique in the assessment of microvasculature in DR, which offers a potential substitute for FA in DR evaluation.]]></description>
<pubDate>2022/10/25 14:09:33</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Qiao-Zhu Zeng, Si-Ying Li, Yu-Ou Yao, En-Zhong Jin, Jin-Feng Qu and Ming-Wei Zhao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Qiao-Zhu Zeng, Si-Ying Li, Yu-Ou Yao, En-Zhong Jin, Jin-Feng Qu and Ming-Wei Zhao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221110]]></guid><cfi:id>145</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Negative effects of enlarging internal limiting membrane peeling for idiopathic macular hole surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221111]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To observe the effects of the different extents of internal limiting membrane (ILM) peeling on the surgical success and anatomical and functional outcomes of idiopathic macular hole (IMH).METHODS: In this retrospective cohort study, 36 patients were reviewed and divided into two groups according to the extent of ILM peeling: group A (18 patients), with the peeling area within one-half of the optic disc macular distance as the radius; group B (18 patients), with the peeling area larger than that of group A but did not exceed the optic disc macular distance as the radius. The main outcomes included the best corrected visual acuity (BCVA), light-adaptive electroretinography, macular hole (MH) closure rate, central macular thickness (CMT), retinal nerve fiber layer (RNFL) and ganglion cell complex (GCC) thickness [nine regions based on the Early Treatment of Diabetic Retinopathy Study (ETDRS) ring] before and 1, 3, and 6mo after surgery.RESULTS: The closure rate was 94.4% (17/18) both in groups A and B. The BCVA in both groups improved significantly compared with the preoperative values, but there was no difference between the two groups. The b-wave amplitude of the electroretinogram analysis was significantly improved in both groups compared to that of the preoperative period, with a greater increase in group A than in group B at 6mo (P=0.017). The CMT in both groups gradually decreased after surgery, and there was no difference between the two groups. The RNFL thickness of the temporal outer ring region in group B was significantly lower than that in group A at 3 and 6mo after surgery (P=0.010, 0.032). The GCC thickness of the temporal outer ring region in group B was significantly lower than that in group A at 6mo after surgery (P=0.038).CONCLUSION: Enlarging the extent of ILM peeling doesn’t affect the IMH closure rate and visual acuity recovery, but the greater the extent of peeling, the greater the damage to the inner retinal structures.]]></description>
<pubDate>2022/10/25 14:09:33</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ze-Tong Nie, Bo-Shi Liu, Yong Wang, Qiong Chen, Jiao-Ting Wei, Meng Yang, Shao-Fang Pang, Xiao-Rong Li and Bo-Jie Hu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ze-Tong Nie, Bo-Shi Liu, Yong Wang, Qiong Chen, Jiao-Ting Wei, Meng Yang, Shao-Fang Pang, Xiao-Rong Li and Bo-Jie Hu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221111]]></guid><cfi:id>144</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Real-world outcomes of anti-vascular endothelial growth factor therapy for retinal vascular vein occlusion in Tibet, China]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221112]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the outcomes of intravitreal anti-vascular endothelial growth factor (anti-VEGF) agents for patients with retinal vein occlusion (RVO) related-macular edema (ME) in Tibetan.METHODS: A retrospective, observational, single-center study. The demographic and clinical data of 90 RVO Tibetan patients (93 eyes) treated with either ranibizumab or conbercept in Tibet Autonomous Region People’s Hospital from Jan 2018 to December 2019 were collected.RESULTS: The mean patient age was 56.8±10.6y, 45 (50%) of them were female. The mean living altitude was 3867.8±567.9 m. At the last visit, the best-corrected visual acuity (BCVA) significantly increased (52.2±21.8 letters) in comparison with the baseline (38.2±24.1 letters, P<0.001); while the central retinal thickness (CRT) significantly reduced (245.5±147.6 μm) in comparison with the baseline (504.1±165.2 μm, P<0.001). The 43.0% of the eyes gained ≥15 letters, 60.2% of the eyes gained ≥10 letters, and 78.5% of the eyes gained ≥5 letters. No vision loss was noted in 92.5% of the eyes, 4 eyes lost more than 10 letters during follow-up period. The mean number of injections was 2.4±1.8. No severe ocular or systemic adverse events related to either the drug or injection were noted.CONCLUSION: Anti-VEGF therapy is effective and safe in Tibetan patients for the treatment of RVO related ME.]]></description>
<pubDate>2022/10/25 14:09:34</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xue-Mei Zhu, Ying-Ying Yu, Sina Zhuoga, Xiao Dawa, Yong-Kang Zhou, Ouzhu Wangmu, Deji Yangzong, Fang An, Heng Miao and Ming-Wei Zhao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xue-Mei Zhu, Ying-Ying Yu, Sina Zhuoga, Xiao Dawa, Yong-Kang Zhou, Ouzhu Wangmu, Deji Yangzong, Fang An, Heng Miao and Ming-Wei Zhao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221112]]></guid><cfi:id>143</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of FFP2/N95 facemask wear on retinal and choroidal thickness profile in healthy subjects]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221113]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the influence of non-oil 95 (N95)/filtering facepiece 2 (FFP2) facemask wear on retinal thickness, choroidal thickness (CT), retinal nerve fiber layer thickness (RNFLT), and ganglion cell layer thickness (GCLT) in healthy subjects.METHODS: In this prospective study, 53 healthy participants who used FFP2/N95 facemask were enrolled. Participants underwent optical coherence tomography imaging before and at 1 and 4h following FFP2/N95 facemask wear. The last imaging session was performed 1h after FFP2/N95 removal. Retinal thickness, CT, RNFLT, and GCLT were assessed at each session. Vital parameters were also assessed.RESULTS: The pulse rate of the subjects significantly decreased at 1 and 4h compared to baseline values (P<0.05). No significant changes in retinal thickness, RNFLT, and GCLT were observed in the study. CT profile showed a significant increase at all measured locations except 1-mm temporal, 1-mm inferior and 2-mm inferior points following FFP2/N95 wear which turned to baseline values after FFP2/N95 removal. Pulse rate and CT changes at 4h were significantly correlated (P<0.05).CONCLUSION: Parasympathetic activation during FFP2/N95 facemask wear might have a role on elevated CT measurements in healthy individuals by virtue of increased choroidal blood flow.]]></description>
<pubDate>2022/10/25 14:09:34</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Betul Onal Gunay, Irfan Akalin, Ahmet Kalkisim, Cenap Mahmut Esenulku and Elif Betul Turkoglu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Betul Onal Gunay, Irfan Akalin, Ahmet Kalkisim, Cenap Mahmut Esenulku and Elif Betul Turkoglu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221113]]></guid><cfi:id>142</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Factors associated with diabetic retinopathy screening and regular eye checkup practice among diabetic patients attending Felege Hiwot Specialized Hospital]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221114]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To identify associated factors of diabetic retinopathy (DR) screening and ey e check-up practice among diabetes mellitus (DM) patients attending Felege Hiwot Specialized Hospital.METHODS: An institution-based cross-sectional study was applied from October 4, 2019 to January 12, 2020 at Felege Hiwot Specialized Hospital. A systematic random sampling technique was used to recruit participants and an interviewer-administered questionnaire was employed to collect the data. The collected data were entered into Epi Info version 7 and transposed to SPSS version 24 for statistical analysis. Descriptive statistics were executed and associated factors were identified using binary logistic regression. The strength of association between the independent and the outcome variable was determined using an adjusted odds ratio (AOR) with 95% confidence interval (CI).RESULTS: Four hundred and six participants partake with a response rate of 95.7% and a mean age of 47±11.5y. The magnitude of DR screening was 308 (75.9%, 95%CI: 71.5%, 79.8%). Higher educational level (AOR=3.25; 95%CI: 1.40, 8.78), good knowledge of DR (AOR=2.50; 95%CI: 1.55, 4.46), and family history of DM (AOR=2.15; 95%CI: 1.41, 3.85) were significantly associated with DR screening. On the other side, rural residence [AOR=3.11 (1.89, 5.02)] and undesirable attitudes toward DR [AOR=5.65 (3.14, 8.76)] were significantly associated with poor regular eye checkup practice.CONCLUSION: Most of the participants are screened for DR. Higher education, family history, and good knowledge are associated with DR screening. In addition, rural residence and undesirable attitudes toward DR are associated with regular eye checkup practice.]]></description>
<pubDate>2022/10/25 14:09:35</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Sofonias Addis Fekadu, Mohamed Abdu Seid, Yonas Akalu, Yibeltal Yismaw Gela, Mengistie Diress, Mihret Getnet, Baye Dagnew and Yitayeh Belsti]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Sofonias Addis Fekadu, Mohamed Abdu Seid, Yonas Akalu, Yibeltal Yismaw Gela, Mengistie Diress, Mihret Getnet, Baye Dagnew and Yitayeh Belsti</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221114]]></guid><cfi:id>141</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Changes on optical coherence tomography angiography and fluorescein angiography in eyes with neovascular age-related macular degeneration]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221115]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the changes on optical coherence tomography angiography (OCTA) and fluorescein angiography (FA) and their correlation in neovascular age-related macular degeneration (nAMD) before and after intravitreal aflibercept injections (IAIs).METHODS: In 43 treatment-naïve patients with nAMD, choroidal neovascularization (CNV) in OCTA were morphologically and quantitatively analyzed before and after IAIs to determine whether they are correlated with leakage on FA or not. By combining CNV in OCTA and leakage in FA, lesions were characterized as three types: L+C+ (with both CNV and leakage), L-C+ (with CNV but without leakage), or L+C- lesion (with leakage outside CNV).RESULTS: Before IAI, while 27 eyes had L+C+ lesion only, 16 eyes had both L+C+ and L-C+ lesions simultaneously. Tiny capillaries and anastomosis in CNV were more developed in L+C+ lesion, at 86.0% and 58.1%, respectively, relative to 9.3% and 9.3% in L-C+ lesions (P<0.001). After IAIs in 33 eyes, tiny capillaries and anastomosis were decreased in the lesions with cessation of leakage on FA (P<0.001 and P=0.001, respectively). In quantitative analysis, neovascularization length and numbers of junctions and endpoints were also significantly decreased.CONCLUSION: Leakage on FA is associated with CNV morphology in OCTA and remained so after IAIs. Therefore, by carefully assessing the morphological and quantitative changes of CNV in OCTA before and after treatment, activity of nAMD is expected even though CNV on OCTA is not completely matched with fluorescein leakage.]]></description>
<pubDate>2022/10/25 14:09:35</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[So Min Ahn, Mihyun Choi, Cheolmin Yun, Seong-Woo Kim and Jaeryung Oh]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>So Min Ahn, Mihyun Choi, Cheolmin Yun, Seong-Woo Kim and Jaeryung Oh</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221115]]></guid><cfi:id>140</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical efficacy of botulinum toxin type A on acute acquired comitant esotropia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221116]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the effects of micro-injection of botulinum toxin A (BTXA) on acute acquired comitant esotropia (AACE).METHODS: A total of 33 AACE patients who underwent BTXA micro-injection at Renmin Hospital of Wuhan University from September 1st, 2019 to July 1st, 2021 were retrospective analyzed. Esotropia, eye alignment, stereopsis, and complications were examined at baseline (except complications), 1wk, 1, 3, and 6mo after injection.RESULTS: The average angle of deviation before injection was (+20.24±6.80)Δ at near and (+24.76±6.43)Δ at distance, while (+5.15±5.85)Δ at near and (+7.30±6.17)Δ at distance 6mo after treatment (P<0.05). Six months after injection, the stereopsis of patients had improved. The number of patients having no stereopsis (>800 seconds of arc) decreased from 11 to 3. The number of patients having peripheral stereopsis (300-800 seconds of arc), macular stereopsis (70-200 seconds of arc) and central concave stereopsis (≤60 seconds of arc) increased from 10 to 11, 10 to 12, and 2 to 7, respectively. At the follow-ups at 1wk, 1, 3, and 6mo after injection, success rates were 96.97%, 96.97%, 93.94% and 87.88%, respectively. One week after injection, two patients (6.07%) showed subconjunctival hemorrhage; three patients (9.09%) showed limited eye movement and one patient (3.03%) showed mild vertical strabismus. All the symptoms disappeared by the final follow-up.CONCLUSION: Micro-injection of BTXA can reduce diplopia and improve binocular vision function of AACE patients. Furthermore, the operation is relatively safe with few complications, making it an ideal treatment modality for AACE.]]></description>
<pubDate>2022/10/25 14:09:35</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xiao-Qi Huang, Xue-Min Hu, Yi-Jia Zhao, Mei-Hong Ye, Bei-Xi Yi and Lian-Hong Zhou]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiao-Qi Huang, Xue-Min Hu, Yi-Jia Zhao, Mei-Hong Ye, Bei-Xi Yi and Lian-Hong Zhou</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221116]]></guid><cfi:id>139</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Lacrimal sac lymphoma: a case series and literature review]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221004]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To study the clinical and pathological characteristics of the lacrimal sac lymphoma, which is rare but it is the major type of non-epithelial malignant tumor in the lacrimal sac region.METHODS: Sixty-four cases of malignant lacrimal sac tumors in our hospital from 1986 to 2020 were retrospectively reviewed. Eight cases of lacrimal sac lymphoma were carefully reviewed.RESULTS: There were five mucosal-associated lymphoid tissue (MALT) lymphomas, one diffused large B-cell lymphoma, one NK/T cell lymphoma, and one mantle cell lymphoma. All eight patients represented symptoms of epiphora with swelling in the lacrimal sac for a certain period of time and showed no signs of systemic involvement at the first time of clinical visits. They had received either chemotherapy or radiotherapy after surgery. Long-term follow-up (from 11 to 220mo) showed that, except one patient with MALT lymphoma died for unknown reasons at 104mo after surgery, the other 7 patients were all alive with no signs of local recurrence, neither in other organs.CONCLUSION: Non-epithelial malignant tumors of the lacrimal sac are rare and lymphoma is the major subtype.]]></description>
<pubDate>2022/9/21 16:28:47</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Feng-Xi Meng, Han Yue, Yi-Qun Yuan, Rui Zhang, Yi-Fei Yuan, Ying-Wen Bi and Jiang Qian]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Feng-Xi Meng, Han Yue, Yi-Qun Yuan, Rui Zhang, Yi-Fei Yuan, Ying-Wen Bi and Jiang Qian</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221004]]></guid><cfi:id>138</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Age-related changes of lens thickness and density in different age phases]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221005]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To explore the changes in lens thickness and density with age.METHODS: A Chinese population-based retrospective study was performed. A total of 497 individuals (490 right eyes and 495 left eyes), ranging from 3 to 69 years old were included. Lens images obtained from IOL Master 700 were used to measure lens thickness and density. Piecewise regression model was chosen to illustrate the relationship of lens thickness and density with age.RESULTS: The proportion of people aged 3-18, 19-40, over 40 was 38.6%, 50.9% and 10.5% respectively. The whole lens thickness decreased with age during the first 7 years of life, kept stable from 8 to 16 years old, and then increased at the rate of about 27 µm per year. The thickness of the lens cortex and nucleus tended to decrease first and then increase with age, which was dependent on age stages. The whole lens density also decreased with age until 7 years old. The increasing rate of lens density was different in different age groups. The whole lens density increased rapidly from 7 to 22 years old and slowed down after 22 years old. Similarly, the changing tendency of lens cortical and nuclear density differed in different age phases.CONCLUSION: Both lens thickness and density are significantly associated with age, whereas they do not change linearly with age. Moreover, it is necessary to increase the population over 40 years old and conduct further research.]]></description>
<pubDate>2022/9/21 16:28:47</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yin-Hao Wang, Jing Zhong and Xue-Min Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yin-Hao Wang, Jing Zhong and Xue-Min Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221005]]></guid><cfi:id>137</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Therapeutic potential of pupilloplasty combined with phacomulsification and intraocular lens implantation against uveitis-induced cataract]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221006]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the therapeutic effect of pupilloplasty combined with phacomulsification and intraocular lens implantation (PPI) in uveitis-induced cataract.METHODS: Total 28 patients with uveitis-induced cataract were enrolled. Within 3mo before the PPI, 7 cases accompanied with glaucoma maintained carteolol hydrochloride for lowering intraocular pressure, and 1 case maintained glucocorticoid for anti-inflammation. The baseline characteristics, treatment processes, and outcomes of enrolled cases were retrospectively analyzed. Hematoxylin and eosin (HE) staining was performed to reveal the histopathological changes of iris tissues.RESULTS: Iris hemorrhage was the only intraoperative complication observed in 2 cases. After the surgery, normal intraocular pressure, right position of intraocular lens, and improved visual gain [best corrected visual acuity (BCVA)>0.5] were achieved. Postoperative keratic precipitates was observed in 2 cases, which was recovered within 1wk. During the follow-up of 5-10y, no recurrence of uveitis was found in 27 cases (96.43%). Uveitis only recurred in one case with the onset of ankylosing spondylitis. HE staining showed iris stroma (all samples), pigment cell hyperplasia in pigment epithelium (n=9) and stroma (n=19), inflammatory cell infiltration in iris (n=7), and neovascularization in iris surface (n=2).CONCLUSION: PPI improves the visual gain and prevents the long-term recurrence of uveitis in patients with uveitis-induced cataract, including those with preoperative intraocular pressure abnormality (glaucoma) and inflammation (active uveitis). Uveitis presents stroma atrophy, pigment cell hyperplasia, and inflammatory cell infiltration, even in a quiet state.]]></description>
<pubDate>2022/9/21 16:28:48</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hui Lu, Dou-Dou Chen and Si-Quan Zhu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hui Lu, Dou-Dou Chen and Si-Quan Zhu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221006]]></guid><cfi:id>136</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Efficacy of microcatheter-assisted trabeculotomy on secondary glaucoma after congenital cataract surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221007]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate efficacy of microcatheter-assisted trabeculotomy (MAT) in eyes with secondary glaucoma after congenital cataract surgery and explore its correlation with the different degree of trabeculotomy.METHODS: A retrospective analysis was conducted on patients who underwent the said procedure between September 2019 and September 2020. The patients were classified into two groups according to the degree of trabeculotomy (group 1: ≤240-degree; group 2: 240–360-degree). The intraocular pressure (IOP) and anti-glaucoma drugs before and after operation was collected during the 12-month follow-up.RESULTS: Totally 27 eyes of 25 patients were included: 11 (40.7%) eyes in group 1 and 16 (59.3%) eyes in group 2. The mean IOP of all patients was 34.67±9.18 mm Hg preoperatively and 8.74±4.32, 9.95±5.65, 14.39±5.30, 16.02±4.37, 15.82±3.28, and 16.19±3.56 mm Hg 1d, 1wk, 1, 3, 6, and 12mo after surgery, respectively. In all patients, there were significant differences in IOP at each time point (F=65.614, P<0.01). In each group, IOP after surgery was lower than that before surgery (all P<0.01), but there was no difference in the rate of IOP reduction between the two groups (P=0.246). Furthermore, the amount of anti-glaucoma medications reduced to 0.30±0.67 (0–2) at 12mo from 2.63±0.49 (2–3) preoperatively (P<0.01), and there was no difference between the two groups (P>0.05). At the end of follow-up, the partial success rate was 81.8% in group 1 vs 93.75% in group 2 (P=0.549). Various amount of intraoperative and postoperative hyphema occurred in all eyes, which spontaneously absorbed or cleaned through paracentesis and irrigation. No other serious complications was observed.CONCLUSION: MAT can effectively reduce IOP in patients with secondary glaucoma after congenital cataract surgery with a high success rate and safety. And it can be used as the first choice for the treatment of secondary glaucoma after surgery for congenital cataracts.]]></description>
<pubDate>2022/9/21 16:28:48</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Wen-Jing Zhang, Ying Qi, Xue-Tao Huang and Ren-Jie Yao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Wen-Jing Zhang, Ying Qi, Xue-Tao Huang and Ren-Jie Yao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221007]]></guid><cfi:id>135</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Prophylaxis with intraocular pressure lowering medication and glaucomatous progression in patients receiving intravitreal anti-VEGF therapy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221008]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate whether pretreatment with pressure-lowering medication prior to anti-vascular endothelial factor (VEGF) injections had an effect on glaucomatous progression in patients with preexisting glaucoma or ocular hypertension (OHT).METHODS: A total of 66 eyes from 54 patients with a preexisting diagnosis of glaucoma or OHT, treated with six or more anti-VEGF injections were selected for chart review. Primary outcome measures were rate of visual field loss in dB/year, rate of change in retinal nerve fiber layer (RNFL) thickness in microns/year, and need for additional glaucoma intervention.RESULTS: The number of eyes requiring additional glaucoma medication was 5 of 20 (25.0%) and 14 of 46 (30.4%) for the pretreated and non-pretreated groups, respectively. The number of eyes requiring glaucoma laser or surgery was 4 of 20 (20.0%) and 13 of 46 (28.3%) for the pretreated and non-pretreated groups, respectively. Estimated mean rate of pattern standard deviation decline was not significant in either group (P>0.073), with no difference between groups (P=0.332). Although both groups showed significant RNFL change from baseline (P<0.011), no difference was detected between groups (P=0.467).CONCLUSION: Pretreatment has no detectable effect on structural or functional glaucomatous progression. Patients receiving repeated injections may be at risk for glaucomatous complications requiring invasive intervention.]]></description>
<pubDate>2022/9/21 16:28:48</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jeanette Du, James T Patrie, Xiao-Yu Cai, Bruce E Prum and Yevgeniy Shildkrot]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jeanette Du, James T Patrie, Xiao-Yu Cai, Bruce E Prum and Yevgeniy Shildkrot</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221008]]></guid><cfi:id>134</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Optimal timing of preoperative intravitreal anti-VEGF injection for proliferative diabetic retinopathy patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221009]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyze concentrations of vascular endothelial growth factor (VEGF) and fibrosis-related factors in vitreous fluid of proliferative diabetic retinopathy (PDR) patients pre-treated with intravitreal anti-VEGF injections (IVI) at different time periods prior to pars plana vitrectomy (PPV), and their correlation with the degree of vitreoretinal fibrosis and explore the optimal timing of preoperative IVI.METHODS: The prospective case-control study from January 2019 to July 2020 included 31 eyes with PDR-related complications (PDR group) and 21 eyes with non-diabetic ocular disease (control group) requiring PPV. PDR eyes were divided into four groups based on timing of PPV: 3d after IVI (3-day group); 5d after IVI (5-day group); 7 or more days after IVI (≥7-day group); and no IVI. Vitreous fluid samples (0.5-1.0 mL) were collected prior to switching on the infusion before routine 23-G PPV. Concentrations of VEGF, basic fibroblast growth factor (bFGF), periostin (PN), interleukin (IL)-6, IL-8, and tumor necrosis factor (TNF)-α were measured by immunoassay, and concentration differences for each cytokine were compared among the groups. The degree of vitreoretinal fibrosis was graded intraoperatively, and the correlation between the changes in cytokine levels and the severity of vitreoretinal fibrosis was analyzed by univariate ordinal logistic regression analysis.RESULTS: PDR eyes without IVI had significantly higher VEGF, bFGF, PN, and IL-6 concentrations than non-diabetic eyes (all P<0.05), and had a significantly higher concentration of VEGF (P<0.05) and a significantly lower concentration of IL-8 (P<0.05) than PDR eyes with IVI. Statistically significant differences were also observed for concentrations of VEGF, bFGF, PN, IL-6, and IL-8 among 3-day, 5-day, and ≥7-day groups (all P<0.05); meanwhile there was no significant difference in TNF-α among groups (P=0.226). The 5-day group had the lowest concentration of VEGF and the ≥7-day group had the highest concentration of bFGF and PN. The degree of vitreoretinal fibrosis was significantly higher in the ≥7-day group compared to the 3-day (P=0.015) and 5-day group (P=0.039), and vitreoretinal fibrosis correlated significantly with concentrations of bFGF, PN, IL-6, and IL-8 (all P<0.05). Univariate ordinal logistic regression analysis showed that bFGF was an independent risk factor for the severity of vitreoretinal fibrosis in PDR patients pre-treated with IVI.CONCLUSION: The vitreous concentrations of VEGF, bFGF, PN, IL-6, and IL-8 change after pretreatment with IVI before PPV in PDR patients. The degree of vitreoretinal fibrosis is higher in patients with a longer time between IVI treatment and PPV, which may be related to the angio-fibrosis switch. The results suggest that PPV should be performed 5d after IVI administration in PDR patients.]]></description>
<pubDate>2022/9/21 16:28:48</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yue Xu, Chi Xie, Yan Fang, Yan Yu and Cui Qiu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yue Xu, Chi Xie, Yan Fang, Yan Yu and Cui Qiu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221009]]></guid><cfi:id>133</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Prognosis value of Chinese Ocular Fundus Diseases Society classification for proliferative diabetic retinopathy on postoperative visual acuity after pars plana vitrectomy in type 2 diabetes]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221010]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the postoperative visual acuity among eyes with proliferative diabetic retinopathy (PDR) of different stages after pars plana vitrectomy (PPV) in type 2 diabetic patients.METHODS: A retrospective study was conducted for PDR eyes undergoing PPV in type 2 diabetic patients. All patients were divided into three groups based on Chinese Ocular Fundus Diseases Society (COFDS) classification for PDR: Group A (primary vitreous hemorrhage), Group B (primary fibrovascular proliferation) and Group C (primary vitreous hemorrhage and/or fibrovascular proliferative combined with retinal detachment). The postoperative visual acuity and the change between postoperative and preoperative visual acuity were compared among three groups. The associated risk factors for postoperative visual acuity were analyzed in the univariate and multiple linear aggression.RESULTS: In total, 195 eyes of 195 patients were collected in this study, including 71 eyes of 71 patients in Group A, 75 eyes of 75 patients in Group B and 49 eyes of 49 patients in Group C. The eyes in Group A got better postoperative best-corrected visual acuity (BCVA) compared to the eyes in Group B and C (0.48±0.48 vs 0.89±0.63, P<0.001; 0.48±0.48 vs 1.04±0.67, P<0.001; respectively). The eyes in Group A got more improvement of BCVA compared to the eyes in Group B and C (1.07±0.70 vs 0.73±0.68, P=0.004; 1.07±0.70 vs 0.77±0.78, P=0.024; respectively). In the multiple linear regression analysis, primary fibro-proliferative type (β=0.194, 95%CI=0.060-0.447, P=0.01), retinal detachment type (β=0.244, 95%CI=0.132-0.579, P=0.02), baseline logMAR BCVA (β=0.192, 95%CI=0.068-0.345, P=0.004), silicone oil tamponade (β=0.272, 95%CI=0.173-0.528, P<0.001) was positively correlated with postoperative logMAR BCVA. Eyes undergoing phacovitrectomy had better postoperative BCVA (β=-0.144, 95%CI=-0.389 to -0.027, P=0.025).CONCLUSION: PDR eyes of primary vitreous hemorrhage type usually have better visual acuity prognosis compared to primary fibrovascular proliferation type and retinal detachment type. COFDS classification for PDR may have a high prognostic value for postoperative visual outcome and surgical management indications.]]></description>
<pubDate>2022/9/21 16:28:48</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Tie-Zhu Lin, Yan Kong, Cheng Shi, Emmanuel Eric Pazo, Guang-Zheng Dai, Xian-Wei Wu, Ling Xu and Li-Jun Shen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Tie-Zhu Lin, Yan Kong, Cheng Shi, Emmanuel Eric Pazo, Guang-Zheng Dai, Xian-Wei Wu, Ling Xu and Li-Jun Shen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221010]]></guid><cfi:id>132</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Risk factors for the long-term prognosis and recurrence of HIV-negative cytomegalovirus retinitis in North China]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221011]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To demonstrate the clinical features, the risk factors, the visual prognosis and the recurrence of cytomegalovirus (CMV) retinitis (CMVR) in HIV-negative patients.METHODS: HIV-negative patients with CMVR were involved in this study. Best corrected visual acuity (BCVA), intraocular pressure (IOP), CMV-DNA load in aqueous and/or serum samples, treatment, follow-up time, recurrence and complications were recorded. Ocular characteristics were evaluated by fundus photographs. Association between ocular factors and visual prognosis were analyzed by regression analysis.RESULTS: Twenty-five eyes of 16 patients were included. All 25 eyes underwent intravitreal injections of anti-viral agents. The mean logMAR BCVA improved from 0.94±0.98 (0.98-0.78) initially to 0.77±0.73 (0.82-0.68) at last visit, but not significantly. After antiviral treatment, the aqueous CMV DNA load significantly reduced to (3.42±1.47)×102 copies/mL (P=0.001), compared with (2.51±3.11)×105 copies/mL at baseline. Macular involvement (R2=0.475, P=0.049) and initial visual acuity (R2=0.475, P=0.017) were significantly associated with the poor visual prognosis (BCVA<20/400). The extent of retinal lesions (R2=0.064, P=0.04) was significant associated with the risk of recurrence of CMVR.CONCLUSION: Intravitreal injection of anti-viral agents offers a safe and effective treatment for CMVR. Macular involvement and initial visual acuity significantly associate with visual prognosis. The extent of retinal lesions is significantly associated with the recurrence of CMVR. These ocular factors can be used as predictive risk factors for long term visual prognosis in HIV-negative CMVR patients.]]></description>
<pubDate>2022/9/21 16:28:48</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yan-Hong Shi, Hui Wang, Hao Kang, Jing Feng, Xiao-Feng Hu, Yun Li, Zhu-Yun Qian and Yong Tao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yan-Hong Shi, Hui Wang, Hao Kang, Jing Feng, Xiao-Feng Hu, Yun Li, Zhu-Yun Qian and Yong Tao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221011]]></guid><cfi:id>131</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Visual field defects and retinal nerve fiber layer damage in buried optic disc drusen: a new insight]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221012]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the association between buried optic disc drusen (BODD) location using spectral-domain optical coherence tomography (SD-OCT) and the location of associated visual field defects (VFD) using the Garway-Heath mapping.METHODS: This monocentric retrospective cross-sectional study was led at the authors’ institution. Adult patients diagnosed with BODD who had complete records with a reliable Humphrey® 24-2 visual field, macular, and papillary OCT were enrolled. Fisher’s exact test was used to measure the association between BODD location and VFD distribution according to Garway-Heath’s mapping.RESULTS: Totally 20 eyes of 15 patients were included (60% females). The median age (interquartile range) was 63 (43)y and the median best corrected visual acuity (BCVA) was -0.08 (0.08) log MAR. BODD were mostly located in zones A, E, and F. The minimal rim width (MRW) was globally preserved. The retinal nerve fiber layer (RNFL) was predominantly altered in zones D, E, and F. There was a significant correlation between BODD location and that of RNFL alterations in zones D (P=0.03) and E (P=0.025); Moreover, the presence of BODD in the E zone was significantly related to damaged RNFL in the neighbouring sectors D and F (P=0.012; P=0.02 respectively). Sixty-three percent (12/19) of visual fields were abnormal and there was a significant match (Phi=0.7, P=0.009) between drusen location and VFD only in zone D.CONCLUSION: BODD do not only affect young patients and can be more harmful than usually expected, as we found VFD in 63% of cases. There is a correspondence between BODD location, RNFL damage, and VFD distributions. The presence of BODD induces the overestimation of MRW, thereby disrupting its sensitivity as an early indicator of ganglion fibers damage.]]></description>
<pubDate>2022/9/21 16:28:48</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Brenda Nana Wandji, Artémise Dugauquier and Adèle Ehongo]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Brenda Nana Wandji, Artémise Dugauquier and Adèle Ehongo</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221012]]></guid><cfi:id>130</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical observation of vitrectomy combined with endolaser photocoagulation at the edge of posterior scleral staphyloma for macular hole retinal detachment in high myopia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221013]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To observe the clinical effect of pars plana vitrectomy (PPV) and silicone oil filling surgery combined with intraoperative posterior scleral staphyloma (PS) marginal retinal photocoagulation in the treatment of high myopic macular hole retinal detachment (MHRD) with PS.METHODS: This was a retrospective clinical study. From May 2017 to March 2020, 62 MHRD patients with PS (62 eyes) were enrolled in the study. Patients were divided into 23G PPV combined with PS marginal retina intraoperative photocoagulation group (combined group) and conventional surgery group (conventional group), with 31 eyes in each. Triamcinolone acetonide and indocyanine green were used to remove the epiretinal membrane and the posterior macular inner limiting membrane (ILM). In the combined group, 2 to 3 rows of retinal photocoagulation were performed on the edge of the PS. The patients were followed up for an average of 8.34±3.21mo. The first retinal reattachment rate, macular hole closure rate, Duration of silicone oil tamponade, best corrected visual acuity (BCVA) and average number of operations were observed and compared between the two groups.RESULTS: The first retinal reattachment rates of the eyes in the combined group and the conventional group were 96.7% (29/31) and 67.7% (21/31), respectively (χ2=6.613, P=0.010). The macular hole closure rates in the combined group and the conventional group were 74.2% (23/31) and 67.7% (21/31), respectively (χ2=0.128, P=0.721). The Duration of silicone oil tamponade of the patients in the combined group was lower than that of the routine group (t=-41.962, P≤0.001). Postoperative logMAR BCVA values of patients in the combined group and the conventional group were 1.27±0.12 and 1.26±0.11, compared with the logMAR BCVA before surgery, each group was improved (t=19.947, t=-19.517, P≤0.001, P≤0.001). There was no significant difference in the logMAR BCVA between the eyes of the two groups (t=-0.394, P=0.695). The average numbers of operations on the eyes in the conventional group and the combined group were 2.39±0.62 and 2.06±0.25 times, the combined group had fewer operations on average (t=-2.705, P=0.009).CONCLUSION: Intraoperative PPV treatment of MHRD with PS combined with PS marginal endolaser photocoagulation can effectively increase the rate of retinal reattachment after the first operation, reduce the number of repeated operations, and reduce the postoperative duration of silicone oil tamponade.]]></description>
<pubDate>2022/9/21 16:28:49</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xiao-Tian Zhang, Jing-Xian Wang and Song Chen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiao-Tian Zhang, Jing-Xian Wang and Song Chen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221013]]></guid><cfi:id>129</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Association of sleep quality with myopia based on different genetic risk levels]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221014]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyse the association of sleep quality with myopia under different genetic risk (GR) levels.METHODS: A cross-sectional survey of students aged 9-14y in Wenzhou, China, was conducted. Refraction without cycloplegia and ocular parameters were measured. Sleep quality was assessed with the Pittsburgh Sleep Quality Index (PSQI). Seventeen single nucleotide polymorphisms (SNPs) were replicated by association analysis and used to compute the GR score (GRS). Possible confounders were assessed by a questionnaire that collected information about the children and their parents. Generalized linear models were used to analyse the sleep quality, the GR, and their interaction effects on the risk of myopia.RESULTS: Out of 1354 children included in this study, 353 (26.07%) had sleep disturbances. The GRS ranged from 4.49 to 12.89 with a mean of 7.74±1.23, and the participants were divided into a low GR group, a moderate GR group and a high GR group according to the GRS quartile. In the generalized linear model, the children with sleep disturbances and high GR had a higher risk of myopia than those without sleep disturbances and with low GR (OR=1.59, 95%CI: 1.12-2.25; OR=1.88, 95%CI: 1.23-2.88, respectively). Compared to those with low GR and SDs, children with high GR with or without SDs had a higher risk of myopia (OR=4.88, 95%CI: 2.03-11.71; OR=1.70, 95%CI: 1.06-2.72, respectively).CONCLUSION: The prevalence of sleep disturbances in elementary school students in Wenzhou was 26.07%. There is a significant interaction between sleep disturbances and a high GR of myopia, suggesting that a high GR of myopia may increase children’s sensitivity to sleep disturbances. This study indicates that children with a high GR of myopia need to achieve adequate sleep duration and excellent sleep quality.]]></description>
<pubDate>2022/9/21 16:28:49</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Juan He, Yao-Yao Lin, Jie Chen, Bing Sun, Yan-Hui Wang, Dan-Dan Jiang, Lin-Jie Liu, Shu-Dan Lin and Yan-Yan Chen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Juan He, Yao-Yao Lin, Jie Chen, Bing Sun, Yan-Hui Wang, Dan-Dan Jiang, Lin-Jie Liu, Shu-Dan Lin and Yan-Yan Chen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221014]]></guid><cfi:id>128</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Botulinum toxin augmented bilateral lateral rectus recession versus three muscles surgery in large-angle intermittent exotropia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221015]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report the surgical outcomes of correcting large angle intermittent exotropia in adult patients by bilateral lateral rectus muscle recession with intraoperative use of botulinum toxin and to compare the results with those of bilateral lateral rectus muscle recession and unilateral medial rectus resection.METHODS: The medical records of patients who underwent surgical correction of large angle intermittent exotropia [exotropia >50 prism dioptre (PD)] were retrospectively reviewed. Two groups of patients were identified; Group I (21 patients) had bilateral lateral recti recession augmented with intraoperative botulinum toxin A (BTA) injection into the recessed muscles and group II (30 patients) were treated by bilateral lateral recti recession with unilateral medial rectus muscle resection. Preoperative data were extracted for age, gender, refraction, type of exotropia, angle of stereopsis and angle of deviation. The main outcome measures were the postoperative angle of deviation and stereoacuity angle by Titmus test measured at the end of one year of postoperative follow up.RESULTS: By the end of the first postoperative year, 10 patients in group I (47.6%) and 20 patients in group II (66.7%) achieved esotropia/esophoria <5 PD or exotropia/exophoria <10 PD. The difference in surgical success rate was not statistically significant (P=0.1) but there was a statistically significant higher rate of undercorrection in group I (P=0.03). On the other hand, 3 patients in group I (14.3%) and 5 patients in group II (16.7%) had improved stereopsis; this difference in the sensory outcome was not statistically significant (P=0.8). In the BTA augmented surgery group, good stereoacuity and smaller preoperative angle of deviation were associated with significantly higher surgical success rate (P=0.004, 0.01 respectively).CONCLUSION: BTA augmented bilateral lateral recti recession is associated with higher rate of undercorrection as compared to bilateral lateral recti recession with unilateral medial rectus resection in the correction of large angle intermittent exotropia. The surgical success rate in BTA augmented surgery group is observed to be higher in patients with preoperative smaller angle of deviation and in patients with good stereoacuity.]]></description>
<pubDate>2022/9/21 16:28:49</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hala Kamal Mattout, Sameh Mosaad Fouda and Wael M El-Haig]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hala Kamal Mattout, Sameh Mosaad Fouda and Wael M El-Haig</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221015]]></guid><cfi:id>127</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Refractive outcomes and optical quality of PRESBYOND laser-blended vision for presbyopia correction]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221016]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the one-year refractive outcomes and optical quality following PRESBYOND laser-blended vision (LBV).METHODS: This retrospective study included 20 patients who underwent PRESBYOND treatment between Jan 2019 and Aug 2020. The patients were asked to attend a follow-up outpatient visit one year after surgery. Distance and near visual acuity as well as subjective refraction were examined. Optical quality was assessed using wavefront-supported custom ablation. A questionnaire evaluating optical quality and satisfaction was completed at the last visit.RESULTS: The average patient age was 48.1±7.4y (range, 41 to 58y). The mean preoperative spherical equivalent was -7.59±2.39 D. At the one-year follow-up, two eyes (both dominant eyes) lost one line of corrected distance visual acuity (CDVA), while the remaining eyes (38/40) maintained or gained lines of CDVA. The average binocular uncorrected distance visual acuity improved from 0.15±0.03 to 0.90±0.26 (decimal vision; P<0.001). The average binocular uncorrected near visual acuity increased from 0.34±0.28 to 0.97±0.07 (P<0.001). The spherical aberration was 0.04±0.06 μm in the nondominant eye and 0.09±0.09 μm in the dominant eye (P=0.02). All patients were satisfied with or accepted the outcomes of the surgery. The primary complaints were related to disturbances in night vision and relatively inferior near vision.CONCLUSION: Over the one-year observation period, PRESBYOND is a safe and effective option for presbyopia correction. The optical quality and near vision deserve further investigation.]]></description>
<pubDate>2022/9/21 16:28:49</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Dan Fu, Aruma Aruma, Ye Xu, Tian Han, Fei Xia and Xing-Tao Zhou]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Dan Fu, Aruma Aruma, Ye Xu, Tian Han, Fei Xia and Xing-Tao Zhou</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221016]]></guid><cfi:id>126</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Microbial spectrum and risk factors of endogenous endophthalmitis in a tertiary center of Northern China]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221017]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To study the clinical features, microbial spectrum, associated factors and prognosis of endogenous endophthalmitis (EE) in a group of Chinese patients.METHODS: The medical records from 32 eyes of 29 patients diagnosed with EE in Peking Union Medical College Hospital from January 2009 to October 2019 were reviewed.RESULTS: The initial visual acuity (VA) of 30 eyes in this study was worse than 20/400. Twenty-three eyes were diagnosed with fungal endophthalmitis and nine with bacterial endophthalmitis. The most common fungal and bacterial isolates were Candida and Klebsiella pneumoniae, respectively. Several rare fungi and bacteria species were also isolated from our patients, including Cryptococcus, Paecilomyces, Brucella, and Bacillus licheniformis. The leading risk factor for EE was diabetes. The most common extraocular infection locus was genitourinary tract. Vitrectomy was performed on twenty-nine eyes. Eight eyes achieved final VA of 20/400 or better. EE caused by Candida had a better prognosis.CONCLUSION: The visual outcome of EE is based on pathogens and prompt intervention. Early vitrectomy and antimicrobial treatment are beneficial for EE.]]></description>
<pubDate>2022/9/21 16:28:49</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Lin-Yang Gan, Jun-Jie Ye, Hui-Ying Zhou, Han-Yi Min and Lin Zheng]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Lin-Yang Gan, Jun-Jie Ye, Hui-Ying Zhou, Han-Yi Min and Lin Zheng</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221017]]></guid><cfi:id>125</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Globe penetration during loco-regional anesthesia: prevalence and review of cases]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221018]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To describe prevalence and different clinical signs and management of cases with penetrating eye injuries during loco-regional anesthesia for ophthalmic surgery.METHODS: A retrospective review of clinical records was carried out, identifying cases of globe penetration secondary to peribulbar anesthesia injection during 5y activity in Centro de Oftalmología Barraquer.RESULTS: A total of 17 460 needle-based ocular anesthesia procedures were performed in our centre and 4 cases of globe penetration were recorded with an estimated prevalence of 0.024%. Globe penetrations were always detected in the first 24h after surgery. Vitreous haemorrhage was found in all the cases. Two eyes presented retinal detachment and two eyes choroidal detachment (CD). The initial surgical approach was performed within the first 48h. Silicone oil was used as tamponade in three eyes and the fourth case remained only with air. Detachments were solved successfully in all the cases. Functional results varied among cases, depending on ocular remarkable antecedent and globe penetration with or without retinal or CD.CONCLUSION: Prevalence of globe penetration during loco-regional anesthesia is low in our centre. Physicians should consider the possibility of globe penetration in eyes with postoperative atypical appearance after loco-regional anesthesia. Immediate B-scan ultrasonography is recommended in suspicious cases with a dense vitreous haemorrhage. An early vitrectomy surgery in conjunction with laser or cryotherapy at the penetration sites is essential for good anatomical and functional results.]]></description>
<pubDate>2022/9/21 16:28:49</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Alba Gómez-Benlloch, Maximiliano Olivera, Jeroni Nadal, Gemma Julio and Javier Elizalde]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Alba Gómez-Benlloch, Maximiliano Olivera, Jeroni Nadal, Gemma Julio and Javier Elizalde</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20221018]]></guid><cfi:id>124</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Long-term outcomes of laser dacryoplasty combined with intubation using a new silicon tube in patients with lacrimal duct obstruction]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230914]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the 15-year outcomes of laser dacryoplasty (LDP) in patients with lacrimal duct obstruction; and to evaluate LDP combined with intubation using a new silicone tube to treat complicated cases.METHODS: Patients with lacrimal duct obstruction and treated with LDP between April 2000 and April 2005 were investigated retrospectively. Totally 116 eyes with completed 15-year follow-up records were included in this study. For complicated cases (52 eyes of 52 patients), both LDP and intubation using a self-made silicon tube were performed. For patients with uncomplicated obstruction (64 eyes of 61 patients), only LDP was performed. Outcomes were assessed based on results of lacrimal irrigation and degree of symptoms during follow-up.RESULTS: At the follow-up time of 15y, 81 eyes achieved full success (69.8%); 21 eyes got improved (18.1%); and 14 eyes were considered failure (12.1%). The success rate was 71.2% (37/52 eyes) for complicated cases; and 68.8% (44/64 eyes) for uncomplicated cases. No statistically significant difference between two groups was observed (P=0.961). No postoperative complication was observed.CONCLUSION: LDP is a well-tolerated, simple, and effective procedure with satisfactory long-term outcomes in selected patients, which make it a good alternative to conventional dacryocystorhinostomy. In addition, intubation with the self-made mono-canalicular silicone tube facilitates the management of complicated cases with few complications.]]></description>
<pubDate>2023/8/22 11:33:43</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yi-Meng Fan, Xiu-Xia Yin, Ning Gao, Zhao Liu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yi-Meng Fan, Xiu-Xia Yin, Ning Gao, Zhao Liu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230914]]></guid><cfi:id>123</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[In vivo quantification of human aqueous veins by enhanced depth imaging optical coherence tomography and optical coherence tomography angiography images]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230915]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the aqueous vein in vivo by using enhanced depth imaging optical coherence tomography (EDI-OCT) and optical coherence tomography angiography (OCTA).METHODS: In this cross-sectional comparative study, 30 healthy participants were enrolled. Images of the aqueous and conjunctival veins were captured by EDI-OCT and OCTA before and after water loading. The area, height, width, location depth and blood flow of the aqueous vein and conjunctival vein were measured by Image J software.RESULTS: In the static state, the area of the aqueous vein was 8166.7±3272.7 μm2, which was smaller than that of the conjunctival vein (13 690±7457 μm2, P&#x003C;0.001). The mean blood flow density of the aqueous vein was 35.3%±12.6%, which was significantly less than that of the conjunctival vein (51.5%±10.6%, P&#x003C;0.001). After water loading, the area of the aqueous vein decreased significantly from 8725.8±779.4 μm2 (baseline) to 7005.2±566.2 μm2 at 45min but rose to 7863.0±703.2 μm2 at 60min (P=0.032). The blood flow density of the aqueous vein decreased significantly from 41.2%±4.5% (baseline) to 35.4%±3.2% at 30min but returned to 45.6%±3.6% at 60min (P=0.021).CONCLUSION: The structure and blood flow density of the aqueous vein can be effectively evaluated by OCT and OCTA. These may become biological indicators to evaluate aqueous vein changes and aqueous outflow resistance under different interventions in glaucoma patients.]]></description>
<pubDate>2023/8/22 11:33:43</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Zhi-Qi Chen, Wei Chen, Chao-Hua Deng, Jing-Min Guo, Hong Zhang, Jun-Ming Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zhi-Qi Chen, Wei Chen, Chao-Hua Deng, Jing-Min Guo, Hong Zhang, Jun-Ming Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230915]]></guid><cfi:id>122</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical efficacy and changes of serum VEGF-A, VEGF-B, and PLGF after conbercept treating neovascular age-related macular degeneration]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230916]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the clinical efficacy and systemic safety profile of conbercept in clinical practice on vascular endothelial growth factor (VEGF)-A, VEGF-B, and placental growth factor (PLGF) levels after intravitreal injections for the neovascular age-related macular degeneration (AMD).METHODS: Thirty-five patients (35 eyes) with neovascular AMD received intravitreal injections of conbercept treatment with pro re nata protocol. Best-corrected visual acuity (BCVA) and central retinal thickness (CRT) were detected before the intravitreal injection and at 1, 3, and 12mo after conbercept treatment. The levels of serum VEGF-A, VEGF-B, and PLGF were measured by enzyme-linked immunosorbent assay before the injection and 1 and 12mo after conbercept treatments.RESULTS: At baseline, the mean BCVA score was 39.89±14.64 letters. The mean BCVA scores were 51.03±15.78, 56.71±14.38, and 52.49±10.16 letters at 1, 3, and 12mo after conbercept treatment, and the BCVA improvements were all significant, respectively (P&#x003C;0.05). At baseline, the mean CRT was 436.7±141.9 µm. At 1, 3, and 12mo after conbercept treatment, the mean CRT values were 335.1±147.8, 301.1±116.5, and 312.2±98.22 µm, and the CRT improvements were all significant, respectively (P&#x003C;0.05). At baseline, 1 and 12mo after conbercept treatment, the mean levels of serum VEGF-A were 1013.8±454.3, 953.1±426.4, and 981.5±471.7 pg/mL, the mean levels of serum VEGF-B were 46.93±24.76, 42.99±19.16, and 45.32±18.76 pg/mL, the mean levels of serum PLGF at these points were 251.7±154.9, 241.3±166.7, and 245.6±147.2 pg/mL, respectively. Compared with the baseline, the levels of serum VEGF-A, VEGF-B, and PLGF did not significantly change at 1 and 12mo after conbercept treatment, respectively (P&#x003E;0.05).CONCLUSION: Conbercept intravitreal injection leads to BCVA and CRT improvement, however, it does not significantly affect systemic serum VEGF-A, VEGF-B, and PLGF levels at 1 and 12mo after intravitreal injection treating neovascular AMD.]]></description>
<pubDate>2023/8/22 11:33:43</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xiao-Dong Chen, Chan Li, Guo-Long Ding, Yan Suo, Yu-Sheng Zhu, Hui-Qin Lu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiao-Dong Chen, Chan Li, Guo-Long Ding, Yan Suo, Yu-Sheng Zhu, Hui-Qin Lu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230916]]></guid><cfi:id>121</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[One-year outcomes of resveratrol supplement with aflibercept versus aflibercept monotherapy in wet age-related macular degeneration]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230917]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the one-year outcomes of resveratrol oral supplement in patients suffering from wet age-related macular degeneration (AMD).METHODS: Fifty naïve and previously untreated patients suffering from wet AMD, were randomly assigned in two subgroups of 25 patients each. All the participants were treated with 3 monthly intravitreal injections of 2.0 mg aflibercept (IAIs) followed by injections “according to need”, while in one group the patients also received daily two tablets of resveratrol oral supplement. Prior to treatment initiation, a complete ophthalmological examination, including best corrected visual acuity (BCVA) and contrast sensitivity evaluation, optical coherence tomography (OCT) scans, fundus autofluorescence (FAF), fluorescein angiography, indocyanine green angiography, and OCT angiography (OCTA), was performed to every participant, while all of them completed the Hospital Anxiety and Depression Scale (HADS) questionnaire, in order to assess their quality of life (QoL) status. The patients were assessed monthly for 1y with FAF, and OCT or OCTA; the main endpoints were the number IAIs, the changes in BCVA, in contrast sensitivity, and in patients' QoL status.RESULTS: No significant differences were present between the groups regarding the baseline demographic and clinical data. Over the 12-month period, a similar number of IAIs was applied in both groups (4.52±1.00 vs 4.28±0.90, P=0.38), while the rest of the clinical data also did not differ significantly after the completion of the study period. However, for HADS Depression (11.88±2.51 vs 8.28±1.54, P&#x003C;0.001) and HADS Anxiety (11.92±2.52 vs 7.76±1.51, P&#x003C;0.001) questionnaires values, the score was significantly better in patients who received resveratrol supplements. Moreover, a statistically significant difference was detected in the mean change from baseline values of contrast sensitivity (0.17±0.19 vs 0.35±0.24, P=0.005), HADS Depression (0.08±1.38 vs -3.88±1.48, P&#x003C;0.001), and HADS Anxiety (0.36±1.98 vs -5.12±2.70, P&#x003C;0.001) scores, in favour of the patients treated with resveratrol supplements.CONCLUSION: The resveratrol oral supplement is a complementary treatment in cases of wet AMD, highlighting its effectiveness in improving patients' QoL status.]]></description>
<pubDate>2023/8/22 11:33:43</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ioannis Datseris, Nikolaos Bouratzis, Charalambos Kotronis, Iordanis Datseris, Malvina-Efthimia Tzanidaki, Alexandros Rouvas, Nikolaos Gouliopoulos]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ioannis Datseris, Nikolaos Bouratzis, Charalambos Kotronis, Iordanis Datseris, Malvina-Efthimia Tzanidaki, Alexandros Rouvas, Nikolaos Gouliopoulos</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230917]]></guid><cfi:id>120</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Epiretinal membrane related vascular changes in diabetic eyes evaluated with optical coherence tomography angiography]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230918]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the retinochoroidal microvascular circulation and anatomical structure of diabetic and non-diabetic patients with epiretinal membrane (ERM) with the help of optical coherence tomography angiography (OCT-A) and compare them with healthy control subjects.METHODS: In this prospective, cross-sectional study, a total of 165 eyes were evaluated, including 50 eyes of patients with diabetic ERM, 54 eyes of idiopathic ERM (iERM) patients, and 61 eyes of healthy controls. Macula and disc angiography was performed by OCT-A. Macular vessel density (VD) ratio was evaluated by dividing the VD of the foveal region by the VD of the parafoveal region. Statistical calculations were evaluated at the 95% confidence interval.RESULTS: Macula superficial VD values of ERM cases were lower than that in the control group, while foveal VD was higher in ERM cases. Macula deep VD values of ERM cases were lower in all quadrants, except the fovea. The width of the foveal avascular zone (FAZ) area was significantly lower in the ERM groups, and the FAZ width was lowest in iERM group. Macula superficial VD ratio was significantly higher in the ERM groups, but there was no significant difference between ERM groups. Macula deep VD ratio was significantly higher in the iERM group than in the control group.CONCLUSION: Diabetic and idiopathic ERMs differ in their mechanism of formation and clinical presentation, as well as their effect on retinal vascular structures. If the relationship of increase of retinal thickness with vascular integrity can be demonstrated with OCT-A, then, OCT-A can be used as a guide for ERM prognosis.]]></description>
<pubDate>2023/8/22 11:33:43</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Umay Guvenc, Guner Uney, Nurten Unlu, Mehmet Akif Acar, Dicle Hazırolan, Ozlem Candan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Umay Guvenc, Guner Uney, Nurten Unlu, Mehmet Akif Acar, Dicle Hazırolan, Ozlem Candan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230918]]></guid><cfi:id>119</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Changes of retinal vessel density in low to moderate myopic eyes with orthokeratology evaluated by optical coherence tomography angiography]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230919]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To explore the effect of orthokeratology (OK) fitting on retinal vessel density in low to moderate myopia adolescents by using optical coherence tomography angiography.METHODS: Children aged 10 to 14y with a cycloplegic spherical equivalent refraction of −0.50 diopter (D) to −5.00 D and astigmatism with more than −1.50 D were recruited. The enrolled adolescents were divided into OK group and spectacle group. During regular follow-up, adolescents were measured respectively at pre-wear, 1, 3, and 6mo after treatment. The follow-up included uncorrected distance visual acuity (UDVA), axial length (AL), superficial capillary plexus density (SCPD), deep capillary plexus density (DCPD), central retinal thickness (CRT), foveal avascular zone area (FAZ-A), foveal avascular zone perimeter (FAZ-P) and foveal vessel density in a 300-µm-wide region around foveal avascular zone (FD-300). The collected data were analyzed using statistical methods.RESULTS: By one month, SCPD significantly increased in the fovea and superior retina, and DCPD significantly increased inferiorly in OK group compared to spectacle group (P&#x003C;0.05). By three months, there were significant increases in SCPD in the fovea and inferior retina, and DCPD in the parafovea, superior, and inferior retina in OK group (P&#x003C;0.05), while the increase in SCPD and DCPD in the fovea were observed by six months (P&#x003C;0.05). The FD-300 significantly increased at every follow-up in OK group compared to spectacle group (P&#x003C;0.05). No significant differences in the CRT, FAZ-A and FAZ-P and FD-300 were observed between two groups (P&#x003E;0.05). OK group showed a significant improvement in UDVA after wearing OK, compared to spectacle group (P&#x003C;0.01), while the AL did not show a significant difference between two groups (P&#x003E;0.05).CONCLUSION: Short-term OK worn can increase local retinal vessel density in adolescents with low-to-moderate myopia.]]></description>
<pubDate>2023/8/22 11:33:44</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jia-Hui Shi, Yi-Ping Zhao, Gang Liu, Xin-Yi Huang, Li-Li Lang, Wan-Cheng Jia, Ji-Li Chen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jia-Hui Shi, Yi-Ping Zhao, Gang Liu, Xin-Yi Huang, Li-Li Lang, Wan-Cheng Jia, Ji-Li Chen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230919]]></guid><cfi:id>118</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Retrolaminar migration as a complication of intraocular silicone oil injection detected on unenhanced CT]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230920]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To describe the clinical and radiologic features of retrolaminar migration silicone oil (SiO) and observe the dynamic position of ventricular oil accumulation in supine and prone.METHODS: For this retrospective study, 29 patients who had a history of SiO injection treatment and underwent unenhanced head computed tomography (CT) were included from January 2019 to October 2022. The patients were divided into migration-positive and negative groups. Clinical history and CT features were compared using Whitney U and Fisher's exact tests. The dynamic position of SiO was observed within the ventricular system in supine and prone. CT images were visually assessed for SiO migration along the retrolaminar involving pathways for vision (optic nerve, chiasm, and tract) and ventricular system.RESULTS: Intraocular SiO migration was found in 5 of the 29 patients (17.24%), with SiO at the optic nerve head (n=1), optic nerve (n=4), optic chiasm (n=1), optic tract (n=1), and within lateral ventricles (n=1). The time interval between SiO injection and CT examination of migration-positive cases was significantly higher than that of migration-negative patients (22.8±16.5mo vs 13.1±2.6mo, P&#x003C;0.001). The hyperdense lesion located in the frontal horns of the right lateral ventricle migrated to the fourth ventricle when changing the position from supine to prone.CONCLUSION: Although SiO retrolaminar migration is unusual, the clinician and radiologist should be aware of migration routes. The supine combined with prone examination is the first-choice method to confirm the presence of SiO in the ventricular system.]]></description>
<pubDate>2023/8/22 11:33:44</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Fan-Fan Zhao, Ya-Ling Pan, Hui Jin, Yang-Yang Wu, Yu-Ting Yan, Yu Meng, Xiang-Yang Gong]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Fan-Fan Zhao, Ya-Ling Pan, Hui Jin, Yang-Yang Wu, Yu-Ting Yan, Yu Meng, Xiang-Yang Gong</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230920]]></guid><cfi:id>117</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Endoscopic dacryocystorhinostomy with bicanalicular silicone tube intubation for treating chronic dacryocystitis secondary to nasolacrimal duct stent incarceration]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230805]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the feasibility of endoscopic dacryocystorhinostomy (En-DCR) with bicanalicular silicone tube intubation for treating chronic dacryocystitis secondary to nasolacrimal duct stent (NDS) incarceration.METHODS: En-DCRs were performed on 44 chronic dacryocystitis patients (46 eyes) secondary to NDS incarceration from April 2016 to October 2022. The granuloma and scar tissues were separated, and the removal of NDS incarceration was achieved during the surgery; the flap of the lacrimal sac was trimmed and anastomosed with nasal mucosal, a bicanalicular silicone tube was implanted, and lacrimal size and condition were assessed. The tube was removed 3mo after surgery. During the final follow-up of 12mo when the surgery was completed, the complications and the rates of surgical success were assessed.RESULTS: This study covered 40 patients (42 eyes). Intraoperatively, it was found that the lacrimal sac became small, and the sac wall had granulation and scar tissue attached to the incarcerated NDS in all eyes. At 12mo after surgery completed, the rates of the functional and anatomical success reached 80.95% (34/42) and 83.33% (35/42), respectively. Under the effect of intranasal ostial closure, seven eyes failed to achieve anatomical success. No serious complications (e.g., visual impairment, sinusitis, and orbital fat prolapse) was observed.CONCLUSION: With the success rate over 80% and no serious complications, En-DCR with bicanalicular silicone tube implantation is effective in treating chronic dacryocystitis secondary to NDS incarceration.]]></description>
<pubDate>2023/7/25 10:38:15</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Shan Lan, Jin-Qiang Yu, Feng Ke, De-Kun Li, Bo Yu and Zhen-Kai Liu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Shan Lan, Jin-Qiang Yu, Feng Ke, De-Kun Li, Bo Yu and Zhen-Kai Liu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230805]]></guid><cfi:id>116</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Investigation of lacrimal sac space-occupying lesions using color doppler ultrasound, computed tomography, and computed tomography dacryocystography]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230806]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To observe the imaging features of color Doppler ultrasound (CDU) and computed tomography (CT) or computed tomography dacryocystography (CT-DCG) in different types of lacrimal sac space-occupying lesions (SOLs).METHODS: This retrospective case series study included 21 patients with lacrimal sac SOLs who underwent lacrimal sac surgery between January 2018 and March 2022. The imaging features of CDU and CT or CT-DCG in these patients were extracted from the examination cloud system. The images were observed and analyzed.RESULTS: The detection rate of lacrimal SOLs between CDU (21/21, 100%) and CT or CT-DCG (20/21, 95.2%) had no statistically significant difference (P=1.0). CDU could detect the blood flow signals in all SOLs except mucocele and mucopeptide concretion. Among them, polyps had characteristic imaging changes on CDU and CT-DCG. The mucoceles and mucopeptide concretions had characteristic imaging changes on CDU, which could provide more information for differential diagnosis.CONCLUSION: The morphology and internal blood flow signals of lacrimal sac SOLs can be observed using CDU. CT or CT-DCG has advantages in observing structural damage around the lacrimal sac mass. Therefore, CDU may be used as a routine examination to exclude lacrimal sac SOLs before dacryocystorhinostomy in the absence of preoperative CT or CT-DCG.]]></description>
<pubDate>2023/7/25 10:38:15</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Zhen-Bin Qian, Bo Yu, Ye Yang, Wei Fang, Jian-Li Dong and Li-Qing Wei]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zhen-Bin Qian, Bo Yu, Ye Yang, Wei Fang, Jian-Li Dong and Li-Qing Wei</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230806]]></guid><cfi:id>115</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Rotational stability of plate haptic toric intraocular lenses after combined 25-gauge vitrectomy and cataract surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230807]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the postoperative intraocular lens (IOL) rotational stability and residual refractive astigmatism following combined 25-gauge vitrectomy and cataract surgery with implantation of a plate haptic toric IOL.METHODS: In this retrospective case series, 32 eyes of 32 patients underwent a combined 25-gauge vitrectomy and phacoemulsification for vitreoretinal diseases and cataract with regular corneal astigmatism of at least 1 diopter (D). A plate haptic toric IOL (AT Torbi 709M, Carl Zeiss Meditec AG) was implanted in all eyes. The outcome measures were rotational stability and refractive astigmatism up to 6mo postoperatively as well as the best corrected visual acuity (BCVA).RESULTS: Preoperative refractive astigmatism was 2.14±1.17 D, which was significantly reduced to 0.77±0.37 D six to eight weeks postoperatively and remained stable throughout the observation period (0.67±0.44 D at three months and 0.75±0.25 D at six months; for all groups: P<0.0001 compared to baseline). BCVA improved significantly from 0.36±0.33 logMAR preoperatively to 0.10±0.15 logMAR following surgery (P=0.02). Mean IOL axis deviation from the target axis was 3.4°±2.9° after six to eight weeks and significantly decreased over time (2.4°±2.6° six months after surgery; P=0.04).  In one patient IOL, re-alignment was performed.CONCLUSION: Corneal astigmatism is significantly reduced following combined 25-gauge vitrectomy and cataract surgery. The plate haptic toric IOL position and axis remain stable during the observation period of six months.]]></description>
<pubDate>2023/7/25 10:38:15</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Lara Buhl, Julian Langer, Stefan Kassumeh, Thomas C. Kreutzer, Wolfgang J. Mayer and Siegfried G. Priglinger]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Lara Buhl, Julian Langer, Stefan Kassumeh, Thomas C. Kreutzer, Wolfgang J. Mayer and Siegfried G. Priglinger</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230807]]></guid><cfi:id>114</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A new software for automated counting of glistenings in intraocular lenses in vivo]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230808]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the performance of a bespoke software for automated counting of intraocular lens (IOL) glistenings in slit-lamp images.METHODS: IOL glistenings from slit-lamp-derived digital images were counted manually and automatically by the bespoke software. The images of one randomly selected eye from each of 34 participants were used as a training set to determine the threshold setting that gave the best agreement between manual and automatic grading. A second set of 63 images, selected using randomised stratified sampling from 290 images, were used for software validation. The images were obtained using a previously described protocol. Software-derived automated glistenings counts were compared to manual counts produced by three ophthalmologists.RESULTS: A threshold value of 140 was determined that minimised the total deviation in the number of glistenings for the 34 images in the training set. Using this threshold value, only slight agreement was found between automated software counts and manual expert counts for the validating set of 63 images (κ=0.104, 95%CI, 0.040-0.168). Ten images (15.9%) had glistenings counts that agreed between the software and manual counting. There were 49 images (77.8%) where the software overestimated the number of glistenings.CONCLUSION: The low levels of agreement show between an initial release of software used to automatically count glistenings in in vivo slit-lamp images and manual counting indicates that this is a non-trivial application. Iterative improvement involving a dialogue between software developers and experienced ophthalmologists is required to optimise agreement. The results suggest that validation of software is necessary for studies involving semi-automatic evaluation of glistenings.]]></description>
<pubDate>2023/7/25 10:38:15</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Nick Stanojcic, Christopher C. Hull, Eduardo Mangieri, Nathan Little and David O’Brart]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Nick Stanojcic, Christopher C. Hull, Eduardo Mangieri, Nathan Little and David O’Brart</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230808]]></guid><cfi:id>113</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Efficacy and safety of latanoprost/timolol fixed combination dosed twice daily compared to once daily in patients with primary open angle glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230809]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate whether latanoprost/timolol fixed combination (LTFC) dosed twice daily may provide further intraocular pressure (IOP) reduction and evaluate the safety profile at this dose.METHODS: This is an open-labeled, randomized, prospective crossover study on fourty primary open angle glaucoma patients. Two weeks of washout period were followed by randomization to either once daily (OD, group A) or twice daily dosing (BD, group B) of LTFC for 4wk. After another 2-week washout period, the patients’ treatment dose was crossed-over for another 4wk. IOP reduction alongside ocular and systemic side effects were evaluated.RESULTS: Mean baseline IOP was 18.57±2.93 and 17.8±3.01 mm Hg before OD and BD dose respectively, (P=0.27). Mean IOP after BD dose was statistically lower (12.49±1.59 mm Hg) compared to OD (13.48±1.81 mm Hg, P=0.017). Although IOP reduction after BD dose was more (5.32±3.24 mm Hg, 29.89%) than after OD dosing (5.04 mm Hg, 27.14%), it did not reach statistical significance (P=0.68). Patients switched from OD to BD (group A) showed mean IOP reduction by 0.69 mm Hg [95% confidence interval (CI): -0.09 to 1.48 mm Hg, P=0.078]; but patients switched from BD to OD (group B) had significantly higher mean IOP by 1.25 mm Hg (95%CI: -2.04 to -0.46 mm Hg, P=0.006). BD dose had more ocular side effects albeit mild.CONCLUSION: Mean IOP after LTFC dosed twice daily is statistically lower, with additional mild side effects.]]></description>
<pubDate>2023/7/25 10:38:15</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Anis Baidura Azal, Siti Husna Hussein, Seng Fai Tang, Othmaliza Othman and Norshamsiah Md Din]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Anis Baidura Azal, Siti Husna Hussein, Seng Fai Tang, Othmaliza Othman and Norshamsiah Md Din</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230809]]></guid><cfi:id>112</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Syphilitic uveitis in HIV-positive patients: report of a case series, treatment outcomes, and comprehensive review of the literature]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230810]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report the clinical characteristics, treatment and outcomes of active syphilitic uveitis in human immunodeficiency virus (HIV) positive patients and compare them with the previously published data.METHODS: Retrospective analysis of the case series from an infectious disease center in southern China was conducted. Comprehensive review of previously published cases of HIV positive syphilitic uveitis was conducted using the PubMed and Web of Science databases and the references listed in the identified articles.RESULTS: Twelve HIV positive patients with active syphilitic uveitis were collected. All were male, with age of 36.3y (range 27 to 53y). Five (41.7%) had a history of syphilis, and three of them had received anti-syphilis treatment. Ocular manifestations included corneal epithelial defect (13%), complicated cataract (17.4%), vitreous opacity (82.6%), optic disc edema (26.1%), macular edema (30.4%), neuro-retinitis (43.5%), and retinal hemorrhage (26.1%). After standardized syphilitic treatment, intraocular inflammation was reduced and vision improved in all cases. The literature review summarizes 105 previously reported cases of HIV positive syphilitic uveitis. High serum rapid plasma regain (RPR) titers may be associated with severe uveitis and poor vision. Treatment with penicillin, ceftriaxone sodium, or penicillin plus benzylpenicillin instead of using benzylpenicillin alone can significantly improve best-corrected visual acuity (BCVA) in HIV positive ocular syphilis patients.CONCLUSION: For HIV positive syphilitic uveitis patients, prompt diagnosis and appropriate treatment and follow-up are paramount. In our series, the clinical manifestations are diverse. Syphilis patients treated by penicillin G or long-acting penicillin before may still develop syphilitic uveitis. Patients who relapse after long-term penicillin treatment can still benefit from penicillin G.]]></description>
<pubDate>2023/7/25 10:38:16</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ning Xu, Jia-Guo Yuan, Qin-Jin Dai, Chao Yuan, Yan He, Ting-Shuai Jiang and Jie Zhu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ning Xu, Jia-Guo Yuan, Qin-Jin Dai, Chao Yuan, Yan He, Ting-Shuai Jiang and Jie Zhu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230810]]></guid><cfi:id>111</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Correlation between diabetic retinopathy and Helicobacter pylori infection: a cross-sectional retrospective study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230811]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To explore the correlation between diabetic retinopathy (DR) and Helicobacter pylori (Hp) infection, based on data from a physical examination population.METHODS: This cross-sectional retrospective analysis included data of 73 824 health examination participants from December 2018 to December 2019. Participants were divided into the diabetic group and non-diabetic group, non-diabetic retinopathy (NDR) group, non-proliferative diabetic retinopathy (NPDR) group, proliferative diabetic retinopathy (PDR) group, and Hp infection group. Gender, age, body mass index (BMI), systolic blood pressure (SBP), diastolic blood pressure (DBP), fasting plasma glucose (FPG), glycated hemoglobin A1c (HbA1c), triglycerides (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and Hp data were recorded to compare the degree of DR lesions and Hp infection. Logistic regression analysis was used to evaluate the correlation between DR and Hp infection.RESULTS: There was a statistically significant difference between the diabetic and non-diabetic group (χ2=94.17, P<0.0001). Logistic regression analysis showed that male sex, age, BMI, SBP, TG, LDL-C, and Hp infection were independent risk factors for DR. There was no correlation between the degree of DR lesions and Hp infection (ρ=-0.00339, P=0.7753). Age [odds ratio (OR)=1.035, 95%CI: 1.024, 1.046, P<0.0001] and SBP (OR=1.009, 95%CI: 1.004, 1.015, P=0.0013) were independent risk factors for the degree of DR.CONCLUSION: There is a significant correlation between DR and Hp infection in the physical examination population. Hp infection is a risk factor for DR, and there is no significant difference between Hp infection and DR of different pathological degrees. Actively eradicating Hp may be of help to prevent DR.]]></description>
<pubDate>2023/7/25 10:38:16</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Zhen-Rong Liu, Ting Bao, Gui-Jun Xue, Qiao-Yun Xu, Yun-Xia Gao and Ming Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zhen-Rong Liu, Ting Bao, Gui-Jun Xue, Qiao-Yun Xu, Yun-Xia Gao and Ming Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230811]]></guid><cfi:id>110</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Identification of retinal thickness and blood flow in age-related macular degeneration with reticular pseudodrusen]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230812]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate thickness characteristics and vascular plexuses in retinas with reticular pseudodrusen (RPD) as an early detection strategy for age-related macular degeneration (AMD).METHODS: This retrospective study included 24 subjects (33 eyes) with RPD and 25 heathy control subjects (34 eyes). The superficial capillary plexus (SCP) and the deep capillary plexus (DCP) of the retinal posterior poles were investigated with optical coherence tomography angiography (OCTA). Retinal thicknesses and vessel densities were analyzed statistically.RESULTS: The general retinal thicknesses of RPD eyes were significantly decreased (95%CI -14.080, -0.655; P=0.032). The vessel densities of DCP in RPD eyes were significantly increased in the global (95%CI 1.067, 7.312; P=0.027), parafoveal (95%CI 0.417, 5.241; P=0.022), and perifoveal (95%CI 0.181, 6.842; P=0.039) quadrants. However, the vessel densities of the SCP were rarely increased in the eyes with RPD.CONCLUSION: The thinning of retinas in the RPD group suggests a reduction in the number of cells. Additionally, the increased vessel density of the DCP in retinas with RPD indicates a greater demand for blood supply, possibly due to the hypoxia induced RPD compensation caused by RPD in the outer retina. This study highlights the pathological risks associated with RPD and emphasizes the importance of early intervention to retard the progression of AMD.]]></description>
<pubDate>2023/7/25 10:38:16</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yong-Zhao Wei, Hao Huang, Xiang Zhang, Hong-Hua Yu, Bao-Yi Liu, Yu-Yao Diao, Lu Cheng and Hao Cheng]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yong-Zhao Wei, Hao Huang, Xiang Zhang, Hong-Hua Yu, Bao-Yi Liu, Yu-Yao Diao, Lu Cheng and Hao Cheng</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230812]]></guid><cfi:id>109</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical and genetic characteristics of retinoblastoma patients in a single center with four novel RB1 variants]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230813]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the clinical and genetic characteristics of children diagnosed with retinoblastoma (RB) at Gazi University Faculty of Medicine’s Department of Pediatric Oncology.METHODS: All cases diagnosed with RB and received treatment and follow-up in the Ophthalmology and Pediatric Oncology Department, October 2016 to May 2021 were evaluated retrospectively. The RB1 gene was analyzed by next-generation sequencing (NGS) technique in DNAs obtained from peripheral blood samples of the patients.RESULTS: This study included 53 cases with 67 RB-affected eyes during the study period. The mean age was 24.6 (median: 18.5, range: 3–151)mo. There were 15 (22.3%) Group D eyes and 39 (58.2%) Group E eyes. The RB1 gene was sequenced by the NGS method in 19 patients. Heterozygous RB1:NM_000321.3: c.54_76del (p.Glu19AlafsTer4) variant was detected in a 15-month-old female with bilateral RB. Heterozygous RB1:NM_000321.3: c.1814+3A>T variant was detected in a 5.5-month-old male with bilateral RB. The intronic RB1:NM_000321.3: c.1332+4A>G variant was detected in patient 14, a 13-month-old male with unilateral RB. The RB1:NM_000321.3: c.575_576del (p.Lys192SerfsTer10) variant was found in an 18-month-old female with an allele frequency of 37%. These variants have not been reported in the literature and mutation databases.CONCLUSION: Four novel variants are described and one of them is found in two different patients. This data is crucial for assessing prognosis. It serves as a guide for estimating the long-term risk of secondary malignancy as well as the short-term risk of developing additional malignancies in the same eye and the other eye.]]></description>
<pubDate>2023/7/25 10:38:16</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Özge Vural, Hatice Tuba Atalay, Gulsum Kayhan, Bercin Tarlan, Merve Oral, Arzu Okur, Faruk Güçlü Pınarlı and Ceyda Karadeniz]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Özge Vural, Hatice Tuba Atalay, Gulsum Kayhan, Bercin Tarlan, Merve Oral, Arzu Okur, Faruk Güçlü Pınarlı and Ceyda Karadeniz</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230813]]></guid><cfi:id>108</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[One-year clinical efficacy evaluation of selective corneal wavefront aberration-guided FS-LASIK correction in patients with high myopia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230814]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the effectiveness, safety, predictability, precision and changes of higher-order aberrations (HOAs) on corneal front surface of selective corneal wavefront aberration-guided femtosecond laser-assisted in situ keratomileusis (CW-FS-LASIK) in patients with high myopia 1-year postoperatively.METHODS: Totally 74 eyes of 37 patients with high myopia or myopic astigmatism in both the eyes who underwent the CW-FS-LASIK procedure in Xi’an Gaoxin Hospital from January 2021 to June 2021 were included. The changes of uncorrected distance visual acuity (UDVA), best corrected visual acuity (BCVA), spherical equivalent refraction (SER), astigmatism, HOAs and Strehl ratio (SR) on the anterior surface of the cornea after 1y of the surgery were analyzed.RESULTS: At postoperative 1y, the UDVA (logMAR) of 74 eyes (100%) reached 0 or better, including 0 in 8 eyes (10.81%), -0.1 in 45 eyes (60.81%), and -0.2 in 21 eyes (28.38%). The effectiveness index was 1.29±0.134. There was no decrease in postoperative BCVA compared with preoperative BCVA in all patients. Postoperative BCVA was the same in 44 eyes (59.46%) as preoperative BCVA, increased by 1 line in 23 eyes (31.08%) and increased by 2 lines in 7 eyes (9.46%) compared with preoperative BCVA. The safety index was 1.11±0.159. The estimated corrected SER before surgery was (-7.76±1.21) D, and the actual corrected SER was (-7.83±1.25) D (Y=0.9811X+0.2156, R2=0.9084). There was a high correlation between the estimated corrected SER and the actual corrected SER. The postoperative SER in 74 eyes (100%) was within ±0.75 D. The postoperative astigmatism of all was within -0.75 D to 0. Root mean square (RMS) HOAs of spherical aberration and SR within 5 mm of the corneal front surface were all increased compared with those before operation (P<0.01). The total coma, horizontal coma and vertical coma were all decreased compared with those before operation (P<0.01). There was no statistically significant difference in horizontal trefoil and vertical trefoil compared with preoperative ones (P>0.05).CONCLUSION: Selective CW-FS-LASIK for correction of high myopia is effective, safe, predictive, and accurate. For patients with preoperative RMS HOAs over 0.25 defocus equivalent, postoperative coma aberration can be significantly reduced, and SR value can be increased, thus corneal imaging quality can be improved.]]></description>
<pubDate>2023/7/25 10:38:17</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Zhong-Ji Li, Su-Han Liu, Chen Yang, Jiao Guo and Yu-Hui Duan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zhong-Ji Li, Su-Han Liu, Chen Yang, Jiao Guo and Yu-Hui Duan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230814]]></guid><cfi:id>107</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of changing mesopic and photopic light conditions on visual functions]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230815]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the effects of change in light conditions on refractive error and visual functions including visual acuity, stereopsis and contrast sensitivity.METHODS: This cross-sectional study was conducted in the optometry clinic of the Shahid Beheshti School of Rehabilitation on 48 students in 2021-2022. All of them had eye health and normal visual function and could have refractive errors or not. Light intensity of 4 lx was considered equivalent to photopic light condition and light intensity of 1 lx was considered to be equivalent to mesopic light condition. The amount of refractive error was checked by auto refractometer and its changes in mesopic light condition were subjectively measured. Also, visual acuity, stereopsis and contrast sensitivity (in five spatial frequencies of 1.5, 3, 6, 12, and 18 cycles per degree), were measured first in photopic light condition and then in mesopic light condition, by Snellen control vision chart, stereo butterfly test and the M&S technology monitor test respectively.RESULTS: In the 48 student subjects with an average age of 22.69±3.56y, mean of refractive error as sphere equivalent, visual acuity and stereopsis were -1.25±1.74 diopters, 0 logMAR, 44.37±13.03 seconds of arc, respectively in photopic light condition while in mesopic light was equal to -1.56±1.75 diopters, 0.12±0.09 logMAR and 50.62±33.35 seconds of arc, respectively. The mean of contrast sensitivity measured at spatial frequencies of 1.5, 3, 6, 12, and 18 cycles per degree in photopic condition was equal to 2.38±0.04, 2.37±0.07, 2.04±0.21, 1.27±0.32, 0.82±0.27 logarithm of contrast sensitivity, respectively and in mesopic lighting condition was equal to 2.34±0.12, 2.30±0.16, 1.84±0.28, 1.02±0.28, 0.63±0.24 logarithm of contrast sensitivity, respectively. Statistical analysis showed a significant difference between the two lighting conditions in all evaluated variables [refractive error (P<0.001), visual acuity (P<0.001), stereopsis (P=0.008) and contrast sensitivity (P<0.001)].CONCLUSION: The refractive error of the student subjects in mesopic light condition change towards myopia, and its amount is clinically significant. Also, the examination and comparison of the factors of visual acuity, stereopsis and contrast sensitivity in these two lighting conditions show that the decrease in brightness level to the mesopic level causes a decrease in the aforementioned visual functions.]]></description>
<pubDate>2023/7/25 10:38:17</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Fatemeh Mosayebi, Seyyed Mehdi Tabatabaee, Haleh Kangari and Saeed Rahmani]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Fatemeh Mosayebi, Seyyed Mehdi Tabatabaee, Haleh Kangari and Saeed Rahmani</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230815]]></guid><cfi:id>106</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Orbital liposarcoma: a retrospective, single-center study of thirteen patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230816]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To explore the clinical and pathological characteristics of thirteen patients with orbital liposarcoma.METHODS: The clinical history data of thirteen patients diagnosed as orbital liposarcoma at Beijing Tongren Hospital, from 2006 to 2021 were collected and analyzed. The data includes age, gender, affected orbital side, course of disease, status of disease (primary or recurrent), clinical manifestations, preoperative visual acuity, operative treatment, the relations between liposarcoma and surrounding tissue, longest diameter of liposarcoma, histological subtype, immunohistochemical indicators, follow-up treatment and prognosis.RESULTS: The initial symptoms are diverse. Proptosis is the most frequent chief complaint and the others included vision loss, epiphora, diplopia, and eyelid palpable mass. Results of imaging examination [computed tomography (CT) or magnetic resonance imaging (MRI)] showed orbital mass. In terms of treatment, 10 patients received tumor resection, and the mean longest diameter of the tumor was 3.39±1.36 cm. The other 3 patients had optic nerve invaded, so they received orbital exenteration. Pathological examination results confirmed the diagnose of liposarcoma for 13 patients. Six patients displayed as myxoid type, and three patients in each type of dedifferentiated and well-differentiated type. One patient was verified as pleomorphic, which was a rare type of liposarcoma. All of the patients showed Vimentin positive, and most showed CD34 and S-100 positive. Besides, four patients showed smooth muscle actin positive. All thirteen patients were alive.CONCLUSION: Orbital liposarcoma is a rare disease and it has no specific clinical manifestation. The diagnosis of liposarcoma should be considered when proptosis and orbital mass occurred in orbit. It is recommended to perform pathological examination to achieve early detection and early treatment.]]></description>
<pubDate>2023/7/25 10:38:17</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ning Gao, Xin Ge, Cheng Pei, Jian-Min Ma and Ya-Guang Hu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ning Gao, Xin Ge, Cheng Pei, Jian-Min Ma and Ya-Guang Hu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230816]]></guid><cfi:id>105</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Differential analysis of aqueous humor cytokine levels in patients with macular edema secondary to diabetic retinopathy or retinal vein occlusion]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230706]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the difference and the correlation between the concentrations of cytokines in the aqueous humor of eyes with macular edema secondary to diabetic retinopathy (DR) or retinal vein occlusion (RVO).METHODS: This is a retrospective case control study. The aqueous humor samples were collected during intravitreal injection of anti-vascular endothelial growth factor (VEGF) for patients diagnosed with macular edema secondary to DR (DME) or RVO (RVO-ME) at Xijing Hospital from August 2021 to July 2022. Meanwhile, aqueous humor samples during vitrectomy from patients with idiopathic macular hole (IMH) were also collected and served as controls. The aqueous humor concentrations of VEGF, platelet-derived factor (PDGF), interleukin (IL)-6, IL-8, IL-18, tumor necrosis factor-α (TNF-α) and monocyte chemoattractant protein 1 (MCP-1) were measured with Human Premixed Multi-Analyte Kit (Luminex). The difference of the aqueous cytokines and the correlation between the two diseases were analyzed.RESULTS: A total of 40 eyes of 38 patients were enrolled in the study, including 13 eyes of 11 DME patients (DME group), 16 eyes of 16 RVO-ME patients (RVO-ME group) and 11 eyes of 11 IMH patients (control group). The VEGF, PDGF, IL-6, IL-8, and MCP-1 levels of the aqueous humor were higher in both DME and RVO-ME groups compared with the control group (all P<0.05), the levels of TNF-α was higher in the DME group than in the control group (P<0.05). The VEGF, IL-6, MCP-1, and TNF-α levels in the aqueous humor were significantly higher in the DR group than those in the RVO group (all P<0.05). Correlation analyses revealed that there were complex positive correlations between IL-6, IL-8, IL-18, MCP-1, and TNF-α levels in the aqueous humor of eyes with two diseases.CONCLUSION: Although ischemic and inflammatory factors are similarly involved in the pathogenesis of DME and RVO-ME, the roles of these factors are more significant or more likely to be activated in DR patients, suggesting different treatment strategies should be considered for the two diseases.]]></description>
<pubDate>2023/6/27 16:00:21</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ke-Ke Hu, Chao-Wei Tian, Man-Hong Li, Tong Wu, Min Gong, Xin-Li Wei, Yu-Ru Du, Yan-Nian Hui and Hong-Jun Du]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ke-Ke Hu, Chao-Wei Tian, Man-Hong Li, Tong Wu, Min Gong, Xin-Li Wei, Yu-Ru Du, Yan-Nian Hui and Hong-Jun Du</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230706]]></guid><cfi:id>104</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Subcutaneous pedicled propeller flap technique for microscopic reconstruction of eyelid defects]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230707]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To describe the subcutaneous pedicled propeller flap technique for the microscopic reconstruction of eyelid defects and evaluate its outcomes.METHODS: The clinical data of 23 patients (23 eyes) who underwent microscopic reconstruction of eyelid defects with the subcutaneous pedicled propeller flap technique were retrospectively analyzed. All patients underwent eyelid tumor resection and one-stage microscopic reconstruction with the subcutaneous pedicled propeller flap for anterior- or posterior-layer eyelid defects. The survival rate of the propeller flap, eyelid function and appearance, tumor recurrence rate, and patient satisfaction were evaluated after the surgery.RESULTS: The patients consisted of 12 men and 11 women, aged 31–82y (mean, 58.9y). The longest follow-up time was 5y, and the shortest was 3mo. All the propeller flaps survived well. There was no significant difference in color and luster between the flap and adjacent tissues, and there was no dog ear phenomenon. No obvious scarring was observed. There were no obvious abnormalities of eyelid morphology or function, and no adverse complications such as exposure keratitis, entropion, ectropion, ptosis, and eyelid retraction. No tumor recurrence was found at the time of the last follow-up. All patients were satisfied with the surgical results.CONCLUSION: The subcutaneous pedicled propeller flap technique for the microscopic reconstruction of eyelid defects has satisfactory outcomes in terms of eyelid function and esthetics, and merits clinical application.]]></description>
<pubDate>2023/6/27 16:00:21</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Lei Zhong, Qian-Yi Lu and Pei-Rong Lu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Lei Zhong, Qian-Yi Lu and Pei-Rong Lu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230707]]></guid><cfi:id>103</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Lid scrubbing with a gel combining natural extracts for dry eye treatment]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230708]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the effect of lid scrubbing using a gel combining different natural extracts on ocular signs and symptoms of dry eye patients.METHODS: A retrospective study was performed on 19 dry eye patients (51.1±16.0y). Non-invasive tear break-up time, tear meniscus height, meibomian gland loss, lipid layer thickness, conjunctival redness, corneal staining, ocular surface disease index (OSDI), and ocular pain intensity were measured before (baseline), 1wk, and 2mo after lid scrubbing with a gel containing different natural extracts (okra extract, aloe vera leaf juice, hydrolysed soy protein, caffeine, citrus unshiu peel extract, and raspberry seed oil).RESULTS: Compared with the baseline, there was a statistically significant improvement in both first (P=0.048) and average (P=0.026) non-invasive tear break-up time 2mo after treatment, as well as in corneal staining (P=0.043, 0.012), OSDI (P<0.001), and ocular pain intensity (P<0.001) after 1wk and 2mo. In addition, there was no correlation between ocular signs and symptoms.CONCLUSION: The lid scrubbing with a gel combining different natural extracts show beneficial effects on tear film stability, corneal damage, and ocular symptoms, which is the reason why this therapeutic procedure is proposed as an alternative for dry eye management. However, it is not possible to attribute this beneficial effect solely to the presence of the natural extracts in the gel, primarily due to the absence of a negative control group.]]></description>
<pubDate>2023/6/27 16:00:22</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Blanca Diaz-Vega, Carlos Rodriguez-Fabuel, Sofia Vitores-Mate and Carlos Carpena-Torres]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Blanca Diaz-Vega, Carlos Rodriguez-Fabuel, Sofia Vitores-Mate and Carlos Carpena-Torres</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230708]]></guid><cfi:id>102</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of intubation in patients with functional epiphora after endoscopic dacryocystorhinostomy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230709]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the effect of bicanalicular silicone tube intubation (BSTI) in the treatment of functional epiphora after endoscopic dacryocystorhinostomy (En-DCR).METHODS: Clinical data of 84 patients (95 eyes) with functional epiphora after En-DCR were retrospectively analyzed. Functional epiphora was confirmed as persistent or recurrent epiphora by fluorescein dye disappearance test (FDDT), lacrimal irrigation test, as well as endoscopic examination. Secondary BSTIs were recommended for patients with functional epiphora. These tubes were removed 1mo after surgery. Functional success and associated complications were assessed after 2y of follow-up.RESULTS: Seven patients (9 eyes) refused intervention, 5 patients (6 eyes) did not complete postoperative follow-up, and 1 patient (1 eye) developed tube prolapse within 1mo after surgery. Seventy-one patients (79 eyes) were included at last. Functional success ratios at six months, one year, as well as two years post-operation were 94.9% (75/79), 92.4% (73/79), and 91.1% (72/79), respectively. Three eyes presented with punctal slitting (2 eyes without epiphora), 1 eye with proximal canaliculus slitting, 1 eye with canaliculus stenosis and 4 eyes with still present functional epiphora without detectable abnormal at the last follow-up.CONCLUSION: Secondary intubation is an effective procedure with low recurrence probability for functional epiphora after En-DCR. Punctal and canaliculus injury are the main tube-associated complications after secondary intubation.]]></description>
<pubDate>2023/6/27 16:00:22</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xue-Mei Han, Wen-Hao Jiang, Wen-Can Wu and Bo Yu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xue-Mei Han, Wen-Hao Jiang, Wen-Can Wu and Bo Yu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230709]]></guid><cfi:id>101</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Two-step strategy—conjunctival flap covering surgery combined with secondary deep anterior lamellar keratoplasty for the treatment of high-risk fungal keratitis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230710]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate whether the two-step strategy [conjunctival flap covering surgery (CFCS) combined with secondary deep anterior lamellar keratoplasty (DALK)] is effective for patients with high-risk fungal keratitis (FK).METHODS: In this noncomparative, retrospective case series, 10 subjects (6 males, 4 females) with a mean age of 56.5±7.1 (range 47-72)y with high-risk FK undergone the two-step strategy were included. Reported outcome measures were healing of the corneal ulcer, recurrence of FK, reject reaction, improvement in best corrected visual acuity (BCVA) and relevant complications.RESULTS: The average diameter of corneal infiltrates was 7.50±0.39 mm, ranging from 6.94 to 8.13 mm. The mean depth of corneal infiltrates was 422.4±77.1 μm, ranging from 350 to 535 μm. The mean corneal thickness was 597.4±117.3 μm, ranging from 458 to 851 μm. Hypopyon and endothelial plaques were presented in all patients. The period between the two steps was 3.65±0.9 (ranging from 3 to 5)mo. The graft diameter was 7.75±0.39 mm. At the last follow-up (average 9.25±3.39, ranging from 5.5 to 17mo), no fungal recurrence or graft rejection appeared, and all patients showed improvement of BCVA. One patient suffered from liver function impairment due to oral voriconazole for 4wk and recovered spontaneously after 1wk of drug withdrawal.CONCLUSION: The two-step strategy is safe and effective in the treatment of high-risk FK by transforming intentional therapeutic penetrating keratoplasty during acute infection to later optical DALK. It is a practical strategy, especially in areas lacking fresh donor corneas and eye bank services.]]></description>
<pubDate>2023/6/27 16:00:22</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yu-Chen Wang, Jia-Song Wang, Bei Wang, Xi Peng, Hua-Tao Xie and Ming-Chang Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yu-Chen Wang, Jia-Song Wang, Bei Wang, Xi Peng, Hua-Tao Xie and Ming-Chang Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230710]]></guid><cfi:id>100</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Posterior scleral application of a mitomycin C-soaked sponge during trabeculectomy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230711]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the safety and efficacy of posterior scleral application (a modified technique) of an antimetabolite mitomycin C-soaked sponge in trabeculectomy for patients with glaucoma.METHODS: This retrospective study included 101 patients (115 eyes) with glaucoma (aged 12–83y) who underwent trabeculectomy using a modified mitomycin C-soaked sponge placement method. A piece of 3.5×10 mm2 sponge was placed vertically and posteriorly with the long side perpendicular to the limbus. The mitomycin C concentration and exposure time were 0.2–0.5 mg/mL and 1–5min, respectively. Intraocular pressure, best-corrected visual acuity, and hypotensive medications were recorded at baseline and at the final visit. Complications, interventions required, and bleb morphology were recorded postoperatively. The primary outcome was trabeculectomy safety, including complications and bleb morphology; the secondary outcome was the trabeculectomy success rate.RESULTS: At the final follow-up [median 28mo, range 7–67mo and interquartile range (IQR) 13mo], the qualified (cumulative) success rate was 93.0% and the complete success rate was 60.0%. No bleb-related complications were observed. The mean height, extent, and vascularity grades were 0.6±0.9, 1.1±0.4, and 2.4±0.9, respectively. All Seidel tests were negative. The mean posteriority grade was 0.8±0.4.CONCLUSION: Trabeculectomy with the long side of a mitomycin C-soaked sponge placed perpendicular to the corneal limbus is safe and effective.]]></description>
<pubDate>2023/6/27 16:00:22</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Kun Hu, Yun-He Song, Feng-Bin Lin, Ying-Zhe Zhang, Ling Jin, Meng-Yin Liang, Robert N. Weinreb and Xiu-Lan Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Kun Hu, Yun-He Song, Feng-Bin Lin, Ying-Zhe Zhang, Ling Jin, Meng-Yin Liang, Robert N. Weinreb and Xiu-Lan Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230711]]></guid><cfi:id>99</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Technique of using Cionni-modified capsular tension ring in the management of severely traumatic lens subluxation]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230712]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the effect of Cionni-modified capsular tension ring (CTR) implantation in patients with severely traumatic subluxated cataracts.METHODS: All patients who totally had traumatic cataracts and lost zonule support and underwent cataract surgery were retrospectively analyzed. Corrected distance visual acuity (CDVA), extent of zonulysis, intraocular lens (IOL) position, intraoperative presentation, and complications were assessed. The primary outcomes included IOL centration stability and other postoperative complications.RESULTS: Twenty patients (20 eyes) were included in this study. The mean age in this study was 58.0±11.3y, and the average follow-up time was 17.3±12.8mo. Capsule bags were saved by Cionni-modified CTR. Nine eyes (45%) underwent simultaneously anterior vitrectomy due to the presence of vitreous in the anterior chamber. The preoperative mean CDVA was 0.83±0.24 logMAR, and the postoperative average CDVA was 0.23±0.30 logMAR (P<0.05). The horizontal and vertical IOL decentration after surgery was 0.27±0.12 mm and 0.41±0.19 mm, respectively; the vertical and horizontal IOL tilt after surgery was 5.5°±2.5° and 6.1°±2.2°, respectively. None of the eyes had obvious IOL decentration during the follow-up time. Eight eyes (40%) had posterior capsule opacification (PCO) that was severe enough to cause poor vision. Neodymium: YAG laser capsulotomy were performed on these eyes when the CTR was stabilized.CONCLUSION: With the help of Cionni-modified CTR, capsular bag preservation and better IOL concentration can be achieved without major complications in patients with severely traumatic subluxated cataracts.]]></description>
<pubDate>2023/6/27 16:00:22</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hao Jiang, Wei Zhang and Yan-Hua Chu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hao Jiang, Wei Zhang and Yan-Hua Chu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230712]]></guid><cfi:id>98</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Corneal astigmatic outcomes after femtosecond laser-assisted cataract surgery combined with surface penetrating arcuate keratotomies]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230713]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate corneal astigmatic outcomes of femtosecond laser-assisted arcuate keratotomies (FAKs) combined with femtosecond-laser assisted cataract surgery (FLACS) over 12mo follow-up.METHODS: Totally 145 patients with bilateral cataracts and no ocular co-morbidities were recruited to a single-centre, single-masked, prospective randomized controlled trial (RCT) comparing two monofocal hydrophobic acrylic intraocular lenses. Eyes with corneal astigmatism (CA) of >0.8 dioptres (D) received unpaired, unopened, surface penetrating FAKs at the time of FLACS. Visual acuity, subjective refraction and Scheimpflug tomography were recorded at 1, 6, and 12mo. Alpins vectoral analyses were performed.RESULTS: Fifty-one patients (61 eyes), mean age 68.2±9.6y [standard deviation (SD)], received FAKs. Sixty eyes were available for analysis, except at 12mo when 59 attended. There were no complications due to FAKs. Mean pre-operative CA was 1.13±0.20 D. There was a reduction of astigmatism at all post-operative visits (residual CA 1mo: 0.85±0.42 D, P=0.0001; 6mo: 0.86±0.35 D, P=0001; and 12mo: 0.90±0.39, P=0.0001). Alpins indices remained stable over 12mo. Overall, the cohort was under-corrected at all time points. At 12mo, 61% of eyes were within ±15 degrees of pre-operative astigmatic meridian.CONCLUSION: Unpaired unopened penetrating FAKs combined with on-axis phacoemulsification are safe but minimally effective. CA is largely under-corrected in this cohort using an existing unmodified nomogram. The effect of arcuate keratotomies on CA remained stable over 12mo.]]></description>
<pubDate>2023/6/27 16:00:22</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Nick Stanojcic, David O’Brart, Chris Hull, Vijay Wagh, Elodie Azan, Mani Bhogal, Scott Robbie and Ji-Peng Olivia Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Nick Stanojcic, David O’Brart, Chris Hull, Vijay Wagh, Elodie Azan, Mani Bhogal, Scott Robbie and Ji-Peng Olivia Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230713]]></guid><cfi:id>97</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Rare manifestation of familial vitreous amyloidosis caused by Gly103Arg transthyretin]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230714]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To identify and analyze the genotype of the patients with special ocular manifestations of familial vitreous amyloidosis (FVA) in a Chinese Han family.METHODS: Pars plana vitrectomy (PPV) surgery was performed on a 52-year-old Chinese woman presented with vitreous amyloidosis and progressive visual impairment, without evidence of cardiac, renal, gastrointestinal, central nervous system or peripheral nervous system dysfunction. During the surgery, the patient presented with a gray-white dense and thick cotton wool-like change in the vitreous body, accompanied by complete retinal detachment. Additionally, hard, free and movable yellow-white deposits were observed in the posterior pole and surrounding retina, the vitreous and subretinal deposits were examined by Congo red staining and immunohistochemical pathological examination, and whole exome sequencing was performed on blood samples from the patient and her cousin.RESULTS: During the operation, it was discovered that there was a complete detachment of the retina and a significant amount of hard, free-floating yellow-white deposits were observed beneath the posterior pole and surrounding retina. This is an exceedingly rare ocular manifestation. Pathological examination of the vitreous and subretinal deposit specimens revealed positive Congo red staining, as well as elevated vascular endothelial growth factor (VEGF) expression in vascular endothelial cells within the sediment specimens upon immunohistochemical examination. The patient and her cousin both exhibited a heterozygous mutation in Glyl03Arg within the transthyretin (TTR) gene, resulting in a substitution of glycine (Gly) at position 103 with arginine (Arg).CONCLUSION: FVA may present with various ocular manifestations, but panretinal detachment is a rare occurrence. In cases where retinal detachment persists for an extended period of time, amyloid deposits may form under the retina through retinal tears, leading to subretinal deposits that can impede retinal reattachment and negatively impact visual prognosis. Elevated levels of VEGF in the eyes of FVA patients may indicate an overexpression state, necessitating careful postoperative follow-up. The heterozygous mutation Gly103Arg may represent a unique pathogenic site in Chinese individuals.]]></description>
<pubDate>2023/6/27 16:00:23</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yan-Bing Feng, Yan-Bo Shi, Yan-Yan He, Zhen-Yi Ma, Yi-Xing Zhu and Wen-Qing Weng]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yan-Bing Feng, Yan-Bo Shi, Yan-Yan He, Zhen-Yi Ma, Yi-Xing Zhu and Wen-Qing Weng</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230714]]></guid><cfi:id>96</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Structural measurements and vessel density of spectral-domain optic coherence tomography in early, moderate, and severe primary angle-closure glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230715]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the macular ganglion cell-inner plexiform layer (GCIPL) thickness, retinal nerve fiber layer (RNFL) thickness, optic nerve head (ONH) parameters, and retinal vessel density (VD) measured by spectral-domain optical coherence tomography (SD-OCT) and analyze the correlations between them in the early, moderate, severe primary angle-closure glaucoma (PACG) and normal eyes.METHODS: Totally 70 PACG eyes and 20 normal eyes were recruited for this retrospective analysis. PACG eyes were further separated into early, moderate, or severe PACG eyes using the Enhanced Glaucoma Staging System (GSS2). The GCIPL thickness, RNFL thickness, ONH parameters, and retinal VD were measured by SD-OCT, differences among the groups and correlations within the same group were calculated.RESULTS: The inferior and superotemporal sectors of the GCIPL thickness, rim area of ONH, average and inferior sector of the retinal VD were significantly reduced (all P<0.05) in the early PACG eyes compared to the normal and the optic disc area, cup to disc ratio (C/D), and cup volume were significantly higher (all P<0.05); but the RNFL was not significant changes in early and moderate PACG. In severe group, the GCIPL and RNFL thickness were obvious thinning with retinal VD were decreasing as well as C/D and cup volume increasing than other three groups (all P<0.01). In the early PACG subgroup, there were significant positive correlations between retinal VD and GCIPL thickness (except superonasal and inferonasal sectors, r=0.573 to 0.641, all P<0.05), superior sectors of RNFL thickness (r=0.055, P=0.049). More obvious significant positive correlations were existed in moderate PACG eyes between retinal VD and superior sectors of RNFL thickness (r=0.650, P=0.022), and temporal sectors of RNFL thickness (r=0.740, P=0.006). In the severe PACG eyes, neither GCIPL nor RNFL thickness was associated with retinal VD.CONCLUSION: The ONH damage and retinal VD loss appears earlier than RNFL thickness loss in PACG eyes. As the PACG disease progressed from the early to the moderate stage, the correlations between the retinal VD and RNFL thickness increases.]]></description>
<pubDate>2023/6/27 16:00:23</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Wei Jiang, Nan Jiang, Gui-Bo Liu, Jing Lin, Cui Li and Gui-Qiu Zhao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Wei Jiang, Nan Jiang, Gui-Bo Liu, Jing Lin, Cui Li and Gui-Qiu Zhao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230715]]></guid><cfi:id>95</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Predictive factors of epiretinal membrane in complicated rhegmatogenous retinal detachment tamponaded with silicone oil]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230716]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the incidence and predictive factors for epiretinal membrane (ERM) formation in eyes with complicated primary rhegmatogenous retinal detachment (RRD) tamponaded with silicone oil (SO).METHODS: This retrospective case-control study included 141 consecutive patients with (51 eyes) and without (90 eyes) ERM formation after primary pars plana vitrectomy (PPV) and SO tamponade for complicated RRD. The risk factors for ERM were assessed using logistic regression analysis.RESULTS: The prevalence of postoperative ERM was 36.2% (51/141). Multivariate logistic regression analysis showed that the risk factors for ERM in SO-tamponaded eyes included preoperative proliferative vitreoretinopathy [PVR; odds ratio (OR), 2.578; 95% confidence interval (CI) 1.580–4.205, P<0.001], preoperative choroidal detachment (OR, 4.454; 95%CI 1.369–14.498, P=0.013), and photocoagulation energy (OR, 2.700; 95%CI 1.047–6.962, P=0.040). The duration of the preoperative symptoms, intraocular SO tamponade time, giant retinal tear, preoperative vitreous hemorrhage, preoperative best-corrected visual acuity, number of breaks, quadrants of RRD, axial length, and photocoagulation points were not predictive factors for ERM formation.CONCLUSION: Preoperative PVR, choroidal detachment, and photocoagulation energy are risk factors of ERM formation after complicated RRD repair. Better ophthalmic care as well as patient education are necessary for such patients with risk factors.]]></description>
<pubDate>2023/6/27 16:00:23</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yuan-Jie Qian, Wu Xiang, Yi-Meng Sun, Alfira Mijit, Zhi-Hao Jiang and Yan-Tao Wei]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yuan-Jie Qian, Wu Xiang, Yi-Meng Sun, Alfira Mijit, Zhi-Hao Jiang and Yan-Tao Wei</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230716]]></guid><cfi:id>94</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of total corneal power measurements obtained with different devices after myopic keratorefractive surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230717]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyze the differences, agreements, and correlation among total corneal power parameters generated by different instruments after myopic keratorefractive surgery.METHODS: The prospective cross-sectional study included patients who underwent myopic keratorefractive surgery and received measurements of corneal power 3mo after surgery. Automated keratometer was used for the measurement of simulated keratometry (SimK), swept-source optical coherence tomography (SS-OCT) based biometer for total keratometry (TK), anterior segment-OCT for real keratometry (RK), and Scheimpflug keratometer for the true net power (TNP), the total corneal refractive power (TCRP) and equivalent K-readings (EKR). The differences among these parameters were analyzed, and the agreements and correlation between SimK and other total corneal power parameters were investigated.RESULTS: A total of 70 eyes of 70 patients after myopic keratorefractive surgery were included. The evaluated corneal power parameters were as follows: SimK 38.32±1.93 D, TK 37.54±2.12 D, RK 36.64±2.09 D, TNP 36.56±1.97 D, TCRP 36.70±2.01 D, and EKR 37.55±2.00 D. Pairwise comparison showed that there were significant differences (P<0.001) among all parameters except for between TK and EKR, RK and TNP, RK and TCRP (P=1.000, 1.000, 1.000, respectively). The limits of agreement between SimK and TK, RK, TNP, TCPR, and EKR were 1.08, 1.08, 1.43, 1.48, and 1.73 D, respectively. All parameters showed good correlation with SimK, and the correlation coefficients were 0.995, 0.994, 0.983, 0.982, and 0.975.CONCLUSION: Among the corneal power parameters after myopic keratorefractive surgery, the value of SimK is the largest, followed by TK and EKR, with TCRP, RK, and TNP being the smallest. The differences among the parameters may be attributable to the different calculation principles. Correct understanding and evaluation of corneal power parameters can provide a theoretical basis for taking advantage of the total corneal power to improve the accuracy of intraocular lens calculation after keratorefractive surgery.]]></description>
<pubDate>2023/6/27 16:00:23</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Zi-Yang Wang, Yan-Zheng Song, Wen-Li Yang, Qian Liu, Yi-Feng Li, Rui Cui, Lin Shen and Chang-Bin Zhai]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zi-Yang Wang, Yan-Zheng Song, Wen-Li Yang, Qian Liu, Yi-Feng Li, Rui Cui, Lin Shen and Chang-Bin Zhai</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230717]]></guid><cfi:id>93</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Long-term observation on safety and visual quality of implantable collamer lens V4c implantation for myopia correction: a 5-year follow-up]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230718]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To elucidate the safety and visual quality of implantable collamer lens with central hole (ICL V4c) implantation for correcting moderate and high myopia for at least 5y.METHODS: This retrospective study was conducted on 58 patients (114 eyes) who were followed up for at least 5y after ICL V4c implantation. The observation was done before and on 1d, 1mo, 1 and 5y or more after the surgical procedure. The visual acuity, subjective refraction, intraocular pressure, vault, axial length, central hole position, pupil diameter, visual quality, and adverse events were analyzed. The visual quality includes aberration, the modulation transfer function cutoff frequency (MTF cutoff), objective scattering index (OSI), Stroller’s ratio (SR), and visual quality questionnaire.RESULTS: The average follow-up period was 69.25±3.80mo (range 60–82mo) and the preoperative spherical equivalent (SE) was -8.66±1.97 D. At 5y after operation, the safety index was 1.01±0.02 and the efficacy index was 0.99±0.42 and SE was -0.65±0.63 D. The 59.6% of the eyes achieved an uncorrected distance visual acuity of 20/20, 76.3% of the eyes had SE within ±1.0 D at the last visit. The axial length increased by 0.29±0.71 mm 5y after the surgery (t=-3.843, P<0.001). The mean vault at the last follow-up was 510.59±245.61 μm. The central hole was on the temporal side in 80 eyes (84.2%). The visual quality questionnaire showed that 98.2% patients were satisfied with the surgical procedure. Adverse events occurred in 4 eyes (3.5%), including the posttraumatic toric ICL rotation (2 eyes), iris incarceration (1 eye), and posttraumatic ICL displacement (1 eye) at the last follow-up.CONCLUSION: Long-term ICL V4c implantation is safe, effective, and stable for correcting moderate and to high myopia, and the visual quality with patients is excellent and satisfactory, but the progression of axial length still needs attention after surgery.]]></description>
<pubDate>2023/6/27 16:00:23</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xiao Chen, Li Li, Jing Rao, Yue-Xi Chen, Yang Gao, Rui-Xue Huang and Qi-Zhi Zhou]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiao Chen, Li Li, Jing Rao, Yue-Xi Chen, Yang Gao, Rui-Xue Huang and Qi-Zhi Zhou</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230718]]></guid><cfi:id>92</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical features, radiological imaging, and treatment strategies of nonmetallic intraorbital foreign bodies: a retrospective analysis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230719]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To provide comprehensive data on nonmetallic intraorbital foreign bodies (IOFBs) by summarizing and analyzing material types, clinical manifestations, imaging features, and treatment strategies.METHODS: Totally 28 nonmetallic IOFB cases treated at Shengjing Hospital of China Medical University from 2012 to 2020 were retrospectively reviewed. The types of foreign bodies, clinical features, imaging manifestations, and treatment outcomes were analyzed.RESULTS: Among all cases, 67.8% (19/28) of the foreign bodies were organic. The top three entrances were the upper eyelid skin (7/28), lower fornix conjunctiva (6/28), and lower eyelid skin (4/28). In most cases (11/28, 39.3%), foreign bodies remained in the medial orbits. The major clinical manifestations included eyelid redness and swelling (20/28, 71.4%), conjunctival congestion and edema (17/28, 60.7%), and ophthalmoptosis (15/28, 53.6%). Infection was the main complication, which occurred in 57.1% (16/28) of all cases. Computerized tomography (CT) values differed for different foreign bodies and varied in the different periods after injury. The plant- and grease-derived foreign bodies and the surrounding pus cysts showed different signals on magnetic resonance imaging (MRI). The prognosis varied with different foreign body types, surgery timing, and intraoperative management.CONCLUSION: The majority of nonmetallic IOFBs are organic and often remain in the superior, medial, and inferior areas of the orbit. Clinical manifestations vary owing to their different textures. CT and MRI facilitate the identification of foreign body materials. Plant-derived foreign bodies should be completely removed, and surgical treatment is a complicated process.]]></description>
<pubDate>2023/6/27 16:00:24</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Guang-Rui Chai, Ming Chen, Zi-Xun Song and Lu Liu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Guang-Rui Chai, Ming Chen, Zi-Xun Song and Lu Liu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230719]]></guid><cfi:id>91</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Ocular manifestations and quality of life in patients after hematopoietic stem cell transplantation]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230720]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To explore the relationship between ocular and systemic conditions and the impact of ocular complications on the quality of life (QOL) in patients after allogeneic hematopoietic stem cell transplantation (ALLO-HSCT).METHODS: Forty-four patients with severe hematopoietic disease were enrolled after ALLO-HSCT at our center from July 2018 to October 2020. They completed two questionnaires: the Ocular Surface Disease Index (OSDI) and the quality-of-life scale for Chinese patients with visual impairment (SQOL-DV1). Ocular conditions and systemic conditions were also assessed.RESULTS: Eye damage was correlated with total bilirubin (P=0.005), and gamma-glutamyl transferase (GGT) (P=0.021). There was no significant correlation between the overall QOL score and OSDI (P=0.8226) or SQOL-DV1 (P=0.9526) scores. The OSDI and the overall QOL score were not correlated with ocular conditions, including best-corrected visual acuity (BCVA), intraocular pressure, Schirmer tear test II, sodium fluorescein staining, tear film breakup time, and tear meniscus height. SQOL-DV1 was correlated with BCVA (P=0.0007), sodium fluorescein staining (P=0.007), and tear film breakup time (P=0.0146).CONCLUSION: In some patients, early ocular symptoms are not evident after ALLO-HSCT, while ocular surface complications can be observed after a comprehensive ophthalmological examination. Especially for those with elevated total bilirubin or GGT, regular ophthalmic follow-up visits are essential to diagnose and treat ocular graft versus host disease (oGVHD), especially for patients with elevated total bilirubin or GGT.]]></description>
<pubDate>2023/6/27 16:00:24</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Shu-Xian Fan, Wen-Hui Wang, Peng Zeng, Ke-Zhi Huang, Yu-Xin Hu, Jing Wang, Yi-Qing Li and Jian-Hui Xiao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Shu-Xian Fan, Wen-Hui Wang, Peng Zeng, Ke-Zhi Huang, Yu-Xin Hu, Jing Wang, Yi-Qing Li and Jian-Hui Xiao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230720]]></guid><cfi:id>90</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Assessment of the effects of intrastromal injection of adipose-derived stem cells in keratoconus patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230605]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the efficacy and safety of intrastromal transplantation of adipose-derived stem cells (ASCs) in keratoconus patients.METHODS: This study was conducted on 8 eyes of 8 patients with moderate to severe keratoconus. In the patients, ophthalmic assessments including visual acuity, refraction, slit lamp examination, fundoscopy, corneal topography, and confocal microscopy were performed. Autologous stem cells were used. The isolated stem cells were injected into the corneal stroma by using femtosecond laser. Surgical procedure was similar to intracorneal ring implantation. All patients were re-assessed 1, 3, and 6mo after surgery.RESULTS: The baseline mean visual acuity was 0.48±0.18 and improved to 0.66±0.17 after surgery and final acuity increased by 1.85±0.80 lines (P=0.001). The mean spherical refraction of patients improved 0.34±0.35 D (P=0.039), and the mean cylindrical refraction of patients improved 0.84±0.23 D (P=0.016). The mean flat keratometry decreased 0.78±0.71 D (P=0.017), and the mean steep keratometry decreased 0.59±0.68 D (P=0.023). The mean central corneal thickness of patients improved of 6.29±4.47 μm (P=0.03). The mean keratocyte density at the anterior and middle stroma of cornea increased (P<0.05) but remained stable at the posterior stroma after 6mo. All patients had no complications and their corneas remained transparent.CONCLUSION: Intrastromal transplantation of ASCs has positive effects on vision and refractive parameters in most patients with keratoconus. After six months, visual acuity improved moderately, corneal parameters reduced slightly, and stromal keratocytes density increased. This modality is safe, and patients do not have any complications.]]></description>
<pubDate>2023/5/30 14:30:32</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Shahrokh Ramin, Ali Abbasi, Masoumeh Ahadi, Lina Moallemi Rad and Farzad Kobarfad]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Shahrokh Ramin, Ali Abbasi, Masoumeh Ahadi, Lina Moallemi Rad and Farzad Kobarfad</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230605]]></guid><cfi:id>89</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Subconjunctival conbercept for the treatment of corneal neovascularization]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230606]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the effectiveness and safety of subconjunctival injection of conbercept in the treatment of corneal neovascularization (CNV).METHODS: The data on 10 consecutively recruited patients with CNV who received a subconjunctival conbercept (1 mg) once, and measured the area, length, and diameter of neovascularization before and after (1d, 1, 2wk, and 1mo) treatment as well as the occurrence of systemic and ocular complications after treatment were analyzed.RESULTS: There was a statistically significant reduction in the area of CNV one day after treatment (mean±SD: 38.46±11.36 mm2), compared with before treatment (42.46±12.80 mm2, P<0.01). There was also a statistically significant reduction in the length (3.86±1.80 mm vs 4.64±1.77 mm, P<0.01) and diameter (0.044±0.022 vs 0.060±0.026, P<0.05) of CNV, one week after treatment comparing to before treatment. The reduction in all three parameters was maximized at two weeks after treatment (area: 29.49±8.83 mm2, P<0.001; length: 3.50±1.88 mm, P<0.001; and diameter: 0.038±0.017 mm, P<0.01). No severe systemic or ocular complication was observed during the study.CONCLUSION: During the observation period of one-month, subconjunctival injection of conbercept is an effective and safe method for the reduction of CNV. It may be effective as a preoperative drug for neovascular corneal transplantation.]]></description>
<pubDate>2023/5/30 14:30:32</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Cun Sun, Fang Ruan, Shang Li, Jian-Qiang Zhang and Ying Jie]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Cun Sun, Fang Ruan, Shang Li, Jian-Qiang Zhang and Ying Jie</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230606]]></guid><cfi:id>88</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Different serum levels of IgG and complements and recurrence rates in IgG4-positive and negative lacrimal gland benign lymphoepithelial lesion]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230607]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyze the differences in immune indicators and prognosis between IgG4-positive and negative lacrimal gland benign lymphoepithelial lesion (LGBLEL).METHODS: This was a single-center retrospective clinical study including 105 cases of IgG4-positive LGBLEL and 41 cases of IgG4-negative LGBLEL. Basic information, related indicators of peripheral venous blood samples using immunoscattering turbidimetry, treatment (partial surgical excision and glucocorticoid therapy) and prognosis (recurrence and death) were collected. Survival curves for recurrence were created using the Kaplan-Meier analysis. Univariate analysis and multivariate regression analysis were used to analyze prognostic factors.RESULTS: The mean age was 50.10±14.23y and 44.76±11.43y (P=0.033) in IgG4-positive and negative group respectively. The serum C3 and C4 was lower in IgG4-positive group (P=0.005, P=0.002), while the serum IgG and IgG2 was higher in IgG4-positive group (P=0.000 and P=0.008). Twenty-one cases had recurrence in IgG4-positive group and 3 cases recurrence in IgG4-negative group. The 5-year recurrence-free cumulative percentages of IgG4-positive group was 81.85%, and 83.46% in the IgG-negative group (P=0.216). The history of preoperative glucocorticoid therapy, serum C4, IgG1 and IgG2 were the factors affecting recurrence in IgG4-positive group, while serum C4, and IgG1 were the factors affecting recurrence of LGBLEL.CONCLUSION: Serum C4 and IgG1 are the factors affecting recurrence of LGBLEL, while the IgG4 does not affect recurrence of LGBLEL.]]></description>
<pubDate>2023/5/30 14:30:32</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Rui Liu, Nan Wang, Jin-Jin Wang, Jing Li, Xin Ge, Jing-Xue Zhang and Jian-Min Ma]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Rui Liu, Nan Wang, Jin-Jin Wang, Jing Li, Xin Ge, Jing-Xue Zhang and Jian-Min Ma</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230607]]></guid><cfi:id>87</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Evaluation of optic nerve head vessels density changes after phacoemulsification cataract surgery using optical coherence tomography angiography]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230608]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate optic nerve head (ONH) vessel density (VD) changes after cataract surgery using optical coherence tomography angiography (OCTA).METHODS: This was a prospective observational study. Thirty-four eyes with mild/moderate cataracts were included. ONH scans were obtained before and 3mo after cataract surgery using OCTA. Radial peripapillary capillary (RPC) density, all VD, large VD and retinal nerve fiber layer thickness (RNFLT) in total disc, inside disc, and different peripapillary sectors were assessed and analyzed. Image quality score (QS), fundus photography grading and best-corrected visual acuity (BCVA) were also collected, and correlation analyses were performed between VD change and these parameters.RESULTS: Compared with baseline, both RPC and all VD increased in inside disc area 3mo postoperatively (from 47.5%±5.3% to 50.2%±3.7%, and from 57.87%±4.30% to 60.47%±3.10%, all P<0.001), but no differences were observed in peripapillary area. However, large VD increased from 5.63%±0.77% to 6.47%±0.72% in peripapillary ONH region (P<0.001). RPC decreased in inferior and superior peripapillary ONH parts (P=0.019, <0.001 respectively). There were obvious negative correlations between RPC change and large VD change in inside disc, superior-hemi, and inferior-hemi (r=-0.419, -0.370, and -0.439, P=0.017, 0.044, and 0.015, respectively). No correlations were found between VD change and other parameters including QS change, fundus photography grading, postoperative BCVA, and postoperative peripapillary RNFLT.CONCLUSION: RPC density and all VD in the inside disc ONH region increase 3mo after surgery in patients with mild to moderate cataract. No obvious VD changes are found in peripapillary area postoperatively.]]></description>
<pubDate>2023/5/30 14:30:33</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ze-Hui Zhu, Yin-Ying Zhao, Rui Zou, Han Zou, Jia-Yan Fang, Ping-Jun Chang and Yun-E Zhao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ze-Hui Zhu, Yin-Ying Zhao, Rui Zou, Han Zou, Jia-Yan Fang, Ping-Jun Chang and Yun-E Zhao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230608]]></guid><cfi:id>86</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Stability of neodymium:YAG laser posterior capsulotomy in eyes with capsular tension rings]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230609]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the stability of neodymium (Nd):YAG laser posterior capsulotomy in eyes with capsular tension rings (CTRs).METHODS: A total of 60 eyes that underwent cataract surgery and laser posterior capsulotomy postoperatively were included in this retrospective cohort study. To evaluate the safety and stability of capsulotomy, changes in the size of posterior capsulotomy and anterior chamber depth (ACD) in three groups: the group without CTR, the group with 12 mm CTRs, and the group with 13 mm CTRs, at 1wk, 3, 12, and 15mo after capsulotomy, were compared.RESULTS: In the group without CTR and the group with 12 mm CTR, there was no significant change in ACD at every post-laser follow-up. In the group with 13 mm CTR, the ACD change was significant until 3mo after capsulotomy. In all groups, there was a significant increase in the area of capsulotomy between 1wk and 3mo post-laser. Between 3 and 12mo post-laser, only the group with 13 mm CTR showed a significant increase in the area of capsulotomy (P<0.01).CONCLUSION: Laser posterior capsulotomy is safe in all three groups. The capsulotomy and ACD become stabilized and have not shown significant changes since 1y post-laser, even with larger CTRs. The maintenance of centrifugal capsular tension can last longer with larger CTRs, and the stability of the capsulotomy site can be reached about 12mo after capsulotomy in pseudophakic eyes with larger CTRs.]]></description>
<pubDate>2023/5/30 14:30:33</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yang Kyung Cho and Min Sun Kim]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yang Kyung Cho and Min Sun Kim</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230609]]></guid><cfi:id>85</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of the efficacy and safety of ultrasonic cycloplasty vs valve implantation and anti-VEGF for the treatment of fundus disease-related neovascular glaucoma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230610]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the clinical efficacy and safety of ultrasonic cycloplasty (UCP) vs Ahmed glaucoma drainage valve implantation (ADV) in addition to intravitreal anti-vascular endothelial growth factor (VEGF) for treatment of fundus disease-related neovascular glaucoma (NVG).METHODS: A total of 43 patients (45 eyes) with NVG secondary to fundus diseases underwent anti-VEGF combined with UCP or ADV from August 2020 to March 2022 were enrolled in this retrospective cohort study. Of them, 14 patients (15 eyes) were treated with both UCP and anti-VEGF as the UCP group and 29 patients (30 eyes) treated with both ADV and anti-VEGF as the ADV group. The success of the treatment was defined as intraocular pressure (IOP) between 11-20 mm Hg with or without using IOP-lowering drugs. IOP measurement, IOP lowering drugs at baseline and follow-ups period and complications were recorded.RESULTS: The average age was 63.03±9.95 and 52.27±12.89y in ADV and UCP groups, respectively (P=1.947). The fundus pathology included proliferative diabetic retinopathy in 42 eyes and retinal vein occlusion in 3 eyes. All eyes in both groups achieved successful treatment at 3mo. While the success rate was 90.0% (27/30) in the ADV group and 86.7% (13/15) in the UCP group at the last follow-up of 6mo (P>0.05). IOP was significantly lower with reduction of drug use than the baseline in both groups (both P<0.05). And the ADV group needed fewer anti-glaucoma drops than the UCP group from 1d to 3mo. The comfort scores of patients in the ADV group were significantly lower than those in the UCP group in the first week after the operation (P<0.05).CONCLUSION: UCP is an alternative to the ADV with the same efficacy but non-invasive for the treatment of NVG.]]></description>
<pubDate>2023/5/30 14:30:33</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Fang-Fang Fan, Xing Ge, Dan-Dan Liu, Teng-Yu Xu, Rui-Xue Wang, Xiao-Ya Chen and Su-Yan Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Fang-Fang Fan, Xing Ge, Dan-Dan Liu, Teng-Yu Xu, Rui-Xue Wang, Xiao-Ya Chen and Su-Yan Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230610]]></guid><cfi:id>84</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Efficacy of ripasudil in reducing intraocular pressure and medication score for ocular hypertension with inflammation and corticosteroid]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230611]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the efficacy of ripasudil, a Rho kinase inhibitor, in reducing intraocular pressure (IOP) and medication scores of anti-glaucoma drugs in patients with ocular hypertension with inflammation and corticosteroid.METHODS: The study included 11 patients diagnosed with ocular hypertension with inflammation and corticosteroid, all of whom were prescribed ripasudil eye drops and followed up for at least 2y after the initiation of treatment. IOP was measured using a non-contact tonometer before enrollment and at each follow-up visit. The medication score of glaucoma eye drops was calculated for each patient.RESULTS: The mean IOP (26.4±2.9 mm Hg before treatment) significantly decreased after ripasudil therapy (13.7±3.3 mm Hg at 3mo) and remained stable in the low-teens during the 2-year follow-up period (P<0.0001). A significant decrease in the medication score was observed at 12mo or later after the initiation of ripasudil therapy (P<0.05). Both baseline medication scores and glaucomatous optic disc change rates were significantly higher in the five eyes that required glaucoma surgery during the 2-year observation period than the 10 eyes that did not require surgery.CONCLUSION: Our results demonstrate the efficacy of ripasudil, in reducing IOP and the medication score over a 2-year treatment period in patients with ocular hypertension with inflammation and corticosteroid. Our findings also suggest that ripasudil could reduce the IOP in uveitic glaucoma patients with both lower baseline medication score and lower glaucomatous optic disc change rate.]]></description>
<pubDate>2023/5/30 14:30:33</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ryoji Yanai, Sho-Hei Uchi, Masaaki Kobayashi, Tomohiko Nagai, Shinichiro Teranishi, Makiko Wakuta and Kazuhiro Kimura]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ryoji Yanai, Sho-Hei Uchi, Masaaki Kobayashi, Tomohiko Nagai, Shinichiro Teranishi, Makiko Wakuta and Kazuhiro Kimura</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230611]]></guid><cfi:id>83</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Volumetric fluid analysis of fixed monthly anti-VEGF treatment in patients with neovascular age-related macular degeneration]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230612]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate visual outcomes and changes in fluid after administering monthly anti-vascular endothelial growth factor (VEGF) injections to treat neovascular age-related macular degeneration (nAMD) with subretinal fluid (SRF) and pigment epithelial detachment (PED).METHODS: This prospective study included eyes with nAMD previously treated with as-needed anti-VEGF injections. The patients were treated with six monthly intravitreal injections of ranibizumab. Quantitative volumetric segmentation analyses of the SRF and PED were performed. The main outcome measures included best-corrected visual acuity (BCVA), and SRF and PED volumes.RESULTS: Twenty eyes of 20 patients were included in this study. At the 6-month follow-up, BCVA and PED volume did not change significantly (P=0.110 and 0.999, respectively) but the mean SRF volume decreased from 0.53±0.82 mm3 at baseline to 0.08±0.23 mm3 (P=0.002). The absorption rate of the SRF volume was negatively correlated with the duration of previous anti-VEGF treatment (P=0.029). Seven of the 20 eyes (35%) showed a fluid-free macula and significant improvement in BCVA (P=0.036) by month 6.CONCLUSION: Quantifying the SRF can precisely determine the patient’s responsiveness to anti-VEGF treatment of nAMD.]]></description>
<pubDate>2023/5/30 14:30:33</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Bo Hee Kim, In Boem Chang, Hyeong Gon Yu and In Hwan Hong]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Bo Hee Kim, In Boem Chang, Hyeong Gon Yu and In Hwan Hong</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230612]]></guid><cfi:id>82</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Time in range as a useful marker for evaluating retinal functional changes in diabetic retinopathy patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230613]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To elucidate the relationship between macular sensitivity and time in range (TIR) obtained from continuous glucose monitoring (CGM) measures in diabetic patients with or without diabetic retinopathy (DR).
METHODS: This was a cross-sectional study including 100 eyes of non-DR patients and 60 eyes of DR patients. An advanced microperimetry was used to quantitate the retinal mean sensitivity (MS) and fixation stability in central macula. TIR of 3.9-10.0 mmol/L was evaluated with CGM. Pearson coefficient analysis and multiple linear regression analysis were used to assess the correlation between TIR and retinal sensitivity.
RESULTS: In a comparison of non-DR patients, significant differences (P<0.05) were found in HbA1c, TIR, coefficient of variation (CV), standard deviation of blood glucose (SDBG) and mean amplitude of glucose excursion (MAGE) values in DR patients. Besides, those DR patients had significantly poor best-corrected visual acuity (BCVA, logMAR, P=0.001). In terms of microperimetry parameters, retinal mean sensitivity (MS) and the percentages of fixation points located within 2° and 4° diameter circles were significantly decreased in the DR group (P<0.001, P<0.001, P=0.02, respectively). The bivariate contour ellipse area (BCEA) encompassing 68.2%, 95.4%, 99.6% of fixation points were all significantly increased in the DR group (P=0.01, P=0.006, P=0.01, respectively). Correlation analysis showed that MS were significantly correlated with HbA1c (P=0.01). TIR was positively correlated with MS (r=0.23, P=0.01). SDBG was negatively correlated with MS (r=-0.24, P=0.01) but there was no correlation between CV and MAGE with MS (P>0.05). A multivariable linear regression analysis was performed to prove that TIR and SDBG were both independent risk factors for MS reduction in the DR group.
CONCLUSION: TIR is correlated with retinal MS reduction in DR patients, suggesting a useful option for evaluating DR progression.]]></description>
<pubDate>2023/5/30 0:00:00</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Dan-Dan Zhu, Xuan Wu, Xin-Xuan Cheng and Ning Ding]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Dan-Dan Zhu, Xuan Wu, Xin-Xuan Cheng and Ning Ding</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230613]]></guid><cfi:id>81</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Efficacy and safety of subthreshold micropulse laser in the treatment of acute central serous chorioretinopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230614]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyze the efficacy and safety of subthreshold micropulse laser (SML) in the treatment of acute central serous chorioretinopathy (CSC).METHODS: This is a retrospective case analysis study. Totally 58 eyes of 58 patients were enrolled, and they were divided into different groups. And 39 patients were treated with SML (SML group) and 19 patients were only observed (observation group). The follow-up period was 3mo after diagnosis. The best corrected visual acuity (BCVA), central retinal thickness (CRT), superficial retinal vascular density (SRVD), deep retinal vascular density (DRVD), the superficial and deep foveal avascular zone (FAZ) area, retinal light sensitivity (RLS), perfusion area of choroidal capillary layer (CCL), subfoveal choroidal thickness (SFCT) and fundus autofluorescence (FAF) were investigated.RESULTS: The BCVA, CRT, SRVD, DRVD, the superficial and deep FAZ area, RLS, SFCT of SML group were significantly improved at 3mo (all P<0.05). In the observation group, only CRT, DRVD and SFCT were improved (all P<0.05). Other research items in the observation group were not significantly different from baseline (all P>0.05). At the last follow-up, the BCVA and RLS in the SML group were better than those in the observation group, and CRT was lower, SRVD and DRVD, perfusion area of CCL were larger (all P<0.05). On FAF, no change of treatment spots was found after treatment. No structural laser damage was observed on optical coherence tomography (OCT) and optical coherence tomography angiography (OCTA), and no choroidal neovascularization was observed.CONCLUSION: SML treatment of acute CSC can improve BCVA, RLS, and perfusion area of CCL, reduce CRT, increase SRVD and DRVD, and is safe.]]></description>
<pubDate>2023/5/30 14:30:34</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jian-Jie Guo, Xiu-Juan Li and Jing-Jing Wan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jian-Jie Guo, Xiu-Juan Li and Jing-Jing Wan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230614]]></guid><cfi:id>80</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Photoreceptor changes in Leber hereditary optic neuropathy with m.G11778A mutation]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230615]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the functional and structural changes of photoreceptors in patients and asymptomatic carriers with Leber hereditary optic neuropathy (LHON) using full-field electroretinography (FERG) and optical coherence tomography (OCT).METHODS: Individuals diagnosed with LHON at the Renmin Hospital of Wuhan University and their family members were included in this cross-sectional observational study. The FERG a-wave amplitude of affected patients and asymptomatic carriers was analyzed. The thickness of the outer nuclear layer (ONL), inner and outer segment (IS/OS) and total photoreceptors in the macular fovea and parafovea were measured.RESULTS: This study included 14 LHON patients (mean age: 20.00±9.37y), 12 asymptomatic carriers (mean age: 39.83±6.48y), and 14 normal subjects (mean age: 24.20±1.52y). The FERG results showed that the dark-adapted 3.0 electroretinography and light-adapted 3.0 electroretinography a-wave amplitudes of patients and carriers were significantly decreased (P<0.001). The ONL and photoreceptors layers were slightly thicker in patients than in normal subjects (P<0.05), whereas they were thinner in carriers (P<0.05). There were no differences in IS/OS thickness among the groups (P>0.05).CONCLUSION: Photoreceptors function is significantly impaired in LHON-affected patients and asymptomatic carriers. Meanwhile, photoreceptors morphology is slightly altered, mainly manifesting as a change in ONL thickness.]]></description>
<pubDate>2023/5/30 14:30:34</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Qing-Mei Miao, Yu-Fang Cheng, Hong-Mei Zheng, Jia-Jia Yuan and Chang-Zheng Chen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Qing-Mei Miao, Yu-Fang Cheng, Hong-Mei Zheng, Jia-Jia Yuan and Chang-Zheng Chen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230615]]></guid><cfi:id>79</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Vision rehabilitation using microperimetric biofeedback training in age-related macular degeneration]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230616]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the impact of microperimetric biofeedback training (MBFT) on the quality of vision in patients with age-related macular degeneration (AMD).METHODS: This study was a prospective, interventional, comparative study with subjects of patients diagnosed with AMD in the National Eye Center Cicendo Eye Hospital, Indonesia. Patients were randomly divided into two groups, intervention and non-intervention with 18 patients in each group. The intervention group would receive six MBFT training sessions of 10-minute time duration each.RESULTS: A statistically significant improvement of best corrected visual acuity (BCVA) was found after the intervention, from 1.24±0.416 to 0.83±0.242 (logMAR; P<0.001). A statistically significant improvement for near vision acuity (NVA) was also observed, from 1.02±0.307 logMAR to 0.69±0.278 logMAR (P<0.001). In addition, reading rate increased, from 40.83±30.411  to 65.06±31.598 words/min (P<0.001). Similarly, a comparison of changes in BCVA, NVA, and reading rate between intervention and non-intervention groups showed a significant difference (P<0.001).CONCLUSION: MBFT significantly and positively impacts visual acuity, NVA, and reading rate in patients with AMD.]]></description>
<pubDate>2023/5/30 14:30:34</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Sri Hudaya Widihastha, Erwin Iskandar, Karmelita Satari, Irawati Irfani, Rova Virgana and Primawita Oktarima Amiruddin]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Sri Hudaya Widihastha, Erwin Iskandar, Karmelita Satari, Irawati Irfani, Rova Virgana and Primawita Oktarima Amiruddin</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230616]]></guid><cfi:id>78</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[0.05% atropine on control of myopia progression in Chinese school children: a randomized 3-year clinical trial]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230617]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the effect of 0.05% atropine on the control of myopia for 2y (phase I) and on spherical equivalent refraction (SER) progression for 1y (phase II) after its withdrawal in Chinese myopic children.METHODS: Totally 142 children with myopia were randomly assigned to the 0.05% atropine group or to the placebo group. In phase I, children received 1 treatment for each eye daily. In phase II, the patients received no treatment. Axial length (AL), SER, intraocular pressure (IOP) and atropine-related side effects were assessed at 6 months’ intervals.RESULTS: During phase I, the mean change of SER was -0.46±0.30 D in the atropine group, compared to -1.72±1.12 D in the placebo group (P<0.001). The mean change of AL in the atropine group (0.26±0.30 mm) was significantly shorter than that in the placebo group (0.76±0.62 mm, P=0.002). In addition, in phase II (12mo after the withdrawal of atropine), there was no significant difference in AL change from the atropine group, when compared with that from the placebo group (0.31±0.25 mm vs 0.28±0.26 mm, P>0.05). Furthermore, the change in SER from the atropine group was 0.50±0.41 D, which was significantly lower than 0.72±0.60 D from placebo group, (P<0.05). Finally, there were no statistically significant differences in IOP between the treatment and control groups at any stages (all P>0.05).CONCLUSION: The use of 0.05% atropine for two consecutive years may effectively control elongation of AL and thus progression of myopia, without significant SER progression 1y after atropine withdrawal. Therefore, treatment with 0.05% atropine daily for 2y is effective and safe.]]></description>
<pubDate>2023/5/30 14:30:34</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Qin Zhu, Guang-Yong Tang, Zhi-Juan Hua, Li-Ping Xue, Yuan Zhou, Jie-Ying Zhang, Ying-Ting Zhu and Xiao-Fan Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Qin Zhu, Guang-Yong Tang, Zhi-Juan Hua, Li-Ping Xue, Yuan Zhou, Jie-Ying Zhang, Ying-Ting Zhu and Xiao-Fan Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230617]]></guid><cfi:id>77</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Chronic hypotony management using endoscopy-assisted vitrectomy after severe ocular trauma or vitrectomy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230618]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report outcomes of endoscopy-assisted vitrectomy (EAV) in patients with chronic hypotony following severe ocular trauma or vitrectomy.METHODS: This was a retrospective, noncomparative case series. Ciliary bodies were evaluated using ultrasound biomicroscopy pre-operatively and direct visualisation intraoperatively. All selected individuals (seven patients/seven eyes) underwent EAV. Removal of ciliary membrane and traction, gas/silicone oil tamponade (GT/SOT), and scleral buckling (SB) were performed in selected eyes. Outcome measurements mainly included intraocular pressure (IOP) and best-corrected visual acuity (BCVA).RESULTS: Seven eyes from 7 male aphakic patients with a mean age of 45 (range, 20-68)y were included in this study; the average follow-up time was 12 (9-15)mo. GT was performed in 2 eyes; membrane peeling (MP) and SOT in 2 eyes; and MP, SOT, and SB in 3 eyes. The mean pre- and post-operative IOP were 4.5 (range, 4.0±0.11 to 4.8±0.2) mm Hg and 9.9 (range, 5.6±0.17 to 12.1±0.2) mm Hg at 52wk (12mo), respectively. BCVA improved in six eyes; one eye still showed light perception, and no bulbi phthisis was observed.CONCLUSION: Endoscopy offers improved judgment and recognition and has an improved prognosis for chronic hypotony. Therefore, endoscopy can be an effective and promising operative technique for chronic traumatic hypotony management.]]></description>
<pubDate>2023/5/30 14:30:34</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yong-Zhen Yu, Xiu-Lan Zou, Xuan-Ge Chen, Chu Zhang, Yang-Yang Yu, Meng-Yi Zhang and Yu-Ping Zou]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yong-Zhen Yu, Xiu-Lan Zou, Xuan-Ge Chen, Chu Zhang, Yang-Yang Yu, Meng-Yi Zhang and Yu-Ping Zou</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230618]]></guid><cfi:id>76</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Cost analysis of childhood glaucoma surgeries using the US Medicaire allowable costs]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230505]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyze and calculate the relative cost of various childhood glaucoma surgical interventions per mm Hg intraocular pressure (IOP) reduction ($/mm Hg).METHODS: Representative index studies were reviewed to quantitate the reduction of mean IOP and glaucoma medications for each surgical intervention in childhood glaucoma. A US perspective was adopted, using Medicare allowable costs to calculate cost/mm Hg IOP reduction ($/mm Hg) at 1y postoperatively.RESULTS: At 1y postoperatively, the cost/mm Hg IOP reduction was $226/mm Hg for microcatheter-assisted circumferential trabeculotomy, $284/mm Hg for cyclophotocoagulation, $288/mm Hg for conventional ab-externo trabeculotomy, $338/mm Hg for Ahmed glaucoma valve, $350/mm Hg for Baerveldt glaucoma implant, $351/mm Hg for goniotomy, and $400/mm Hg for trabeculectomy.CONCLUSION: Microcatheter-assisted circumferential trabeculotomy is the most cost-efficient surgical method to lower IOP in childhood glaucoma, while trabeculectomy is the least cost-efficient surgical method.]]></description>
<pubDate>2023/4/27 14:30:44</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Abdelrahman M. Elhusseiny, Mohamed M. Khodeiry, Nicolas A. Yannuzzi, Ta C. Chang, Richard K. Lee and William E. Smiddy]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Abdelrahman M. Elhusseiny, Mohamed M. Khodeiry, Nicolas A. Yannuzzi, Ta C. Chang, Richard K. Lee and William E. Smiddy</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230505]]></guid><cfi:id>75</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Predicting the prognosis of primary orbital lymphoma by clinical characteristics and imaging features]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230506]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyze the 5-year disease-free survival (DFS) of primary orbital lymphoma (POL) by clinical characteristics and imaging features.METHODS: A total of 72 patients, 43 males and 29 females, with histologically confirmed POL, were retrospectively recruited between January 2012 and May 2017. The information on clinical characteristics, imaging features, and 5-year DFS was obtained. Univariate and multivariate forward logistic regression analyses were used to identify the variables significantly associated with 5-year DFS. Kaplan-Meier was applied for survival analysis.RESULTS: Univariate analysis revealed that uni- or bilateral orbital involvement, single or multiple lesions, treatment methods, and contrast enhancement pattern on images were significant for 5-year DFS (P=0.022, 0.042, <0.001, and 0.028, respectively), while in multivariate logistic regression analysis, only uni- or bilateral orbital involvement, treatment methods and contrast enhancement pattern on images were significant (r=0.453, 0.897, and 0.556, P=0.038, <0.001 and 0.022, respectively). The survival curves for DFS were obtained.CONCLUSION: The majority of POL are B-cell lymphomas. Unilateral orbital involvement, homogeneous contrast enhancement on images, and the appropriate treatment schemes result to be significant factors for a good prognosis for POL.]]></description>
<pubDate>2023/4/27 14:30:45</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jian-Bo Zhu, Bin Li, Hong-Mei Zhang and Ning-Li Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jian-Bo Zhu, Bin Li, Hong-Mei Zhang and Ning-Li Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230506]]></guid><cfi:id>74</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Guidelines from an expert panel for the management of diabetic macular edema in the Malaysian population]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230507]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To derive a Malaysia guideline and consensus as part of the Malaysia Retina Group’s efforts for diagnosis, treatment, and best practices of diabetic macular edema (DME). The experts’ panel suggests that the treatment algorithm to be divided into groups according to involvement the central macula. The purpose of DME therapy is to improve edema and achieve the best visual results with the least amount of treatment load.METHODS: On two different occasions, a panel of 14 retinal specialists from Malaysia, together with an external expert, responded to a questionnaire on management of DME. A consensus was sought by voting after compiling, analyzing and discussion on first-phase replies on the round table discussion. A recommendation was deemed to have attained consensus when 12 out of the 14 panellists (85%) agreed with it.RESULTS: The terms target response, adequate response, nonresponse, and inadequate response were developed when the DME patients’ treatment responses were first characterized. The panelists reached agreement on a number of DME treatment-related issues, including the need to classify patients prior to treatment, first-line treatment options, the right time to switch between treatment modalities, and side effects associated with steroids. From this agreement, recommendations were derived and a treatment algorithm was created.CONCLUSION: A detail and comprehensive treatment algorithm by Malaysia Retina Group for the Malaysian population provides guidance for treatment allocation of patients with DME.]]></description>
<pubDate>2023/4/27 14:30:45</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Nor Fariza Ngah, Nor Asiah Muhamad, Shelina Oli Mohamed, Roslin Azni Abdul Aziz, Nur Hasnah Ma’amor, Nor Azita Ahmad Tarmidzi, Hanizasurana Hashim, Hamisah Ishak, Wan Norliza Wan Muda, Rosiah Muda, Azian Adnan, Rafidah Md Saleh, Wong Hon Seng, Nurfahzura Mohd Jamil, Tara Mary George and Adrian Koh]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Nor Fariza Ngah, Nor Asiah Muhamad, Shelina Oli Mohamed, Roslin Azni Abdul Aziz, Nur Hasnah Ma’amor, Nor Azita Ahmad Tarmidzi, Hanizasurana Hashim, Hamisah Ishak, Wan Norliza Wan Muda, Rosiah Muda, Azian Adnan, Rafidah Md Saleh, Wong Hon Seng, Nurfahzura Mohd Jamil, Tara Mary George and Adrian Koh</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230507]]></guid><cfi:id>73</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Analysis of postoperative ocular surface changes and intervention effect after pars plana vitrectomy in meibomian gland dysfunction dry eye patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230508]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To observe ocular surface changes after phacovitrectomy in patients with mild to moderate meibomian gland dysfunction (MGD)-type dry eye and track clinical treatment response using a Keratograph 5M and a LipiView interferometer.METHODS: Forty cases were randomized into control group A and treatment group B; the latter received meibomian gland treatment 3d before phacovitrectomy and sodium hyaluronate before and after surgery. The average non-invasive tear film break-up time (NITBUTav), first non-invasive tear film break-up time (NITBUTf), non-invasive measured tear meniscus height (NTMH), meibomian gland loss (MGL), lipid layer thickness (LLT) and partial blink rate (PBR) were measured preoperatively and 1wk, 1 and 3mo postoperatively.RESULTS: The NITBUTav values of group A at 1wk (4.38±0.47), 1mo (6.76±0.70), and 3mo (7.25±0.68) were significantly lower than those of group B (7.45±0.78, 10.46±0.97, and 11.31±0.89; P=0.002, 0.004, and 0.001, respectively). The NTMH values of group B at 1wk (0.20±0.01) and 1mo (0.22±0.01) were markedly higher than those of group A (0.15±0.01 and 0.15±0.01; P=0.008 and P<0.001, respectively); however, there was no difference at 3mo. The LLT of group B at 3mo [91.5 (76.25-100.00)] significantly exceeded that of group A [65.00 (54.50-91.25), P=0.017]. No obvious intergroup difference was found in MGL or PBR (P>0.05).CONCLUSION: Mild to moderate MGD dry eye worsens in the short term after phacovitrectomy. Preoperative cleaning, hot compresses, and meibomian gland massage as well as preoperative and postoperative sodium hyaluronate promote the rapid recovery of tear film stability.]]></description>
<pubDate>2023/4/27 14:30:45</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Bo-Shi Liu, Jiao-Ting Wei, Ze-Tong Nie, Meng Yang, Shao-Fang Pang, Wen-Bo Li, Xiao-Rong Li and Bo-Jie Hu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Bo-Shi Liu, Jiao-Ting Wei, Ze-Tong Nie, Meng Yang, Shao-Fang Pang, Wen-Bo Li, Xiao-Rong Li and Bo-Jie Hu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230508]]></guid><cfi:id>72</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A sutureless technique for securing leaking sclerotomies with viscoelastic substances in 23-gauge microincision vitrectomy surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230509]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To introduce and evaluate the clinical efficacy of a new technique, the use of viscoelastic substances (VS) to close leaking sclerotomy in 23G microincision vitrectomy, and to observe its effect on the visual acuity and intraocular pressure (IOP) of patients.METHODS: Patients who underwent 23G vitrectomy in Ningbo Eye Hospital before the use of VS technique (June 2019 to September 2020) and after the use of VS technique (October 2020 to December 2021) were selected as the subjects of this study. The above cases underwent operation by the same surgeon and were retrospectively analyzed. VS technique was used as the alternative to suturing, in which a small amount of VS was injected at the leaking sclerotomy and then gently massaged to confirm leaking sclerotomy closure.RESULTS: A total of 174 eyes were covered in the study, including 84 eyes in the control group (before the use of VS technique) and 90 eyes in the VS technique group. The number of eyes that needed to be sutured decreased considerably from 42.9% in the control group to 3.3% in the VS technique group, and the proportion of subconjunctival hemorrhage at 1-2d after surgery decreased remarkably from 35.7% in the control group to 2.2% in the VS technique group. No substantial differences in the incidence of mean IOP and low IOP were found between 1-2 and 3-20d after surgery in the VS technique group. No major complications associated with VS technique were identified during the study.CONCLUSION: In 23G microincision vitrectomy, VS technique is a safe, simple, and effective method to close leaking sclerotomy.]]></description>
<pubDate>2023/4/27 14:30:45</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Meng Li, Quan-Yong Yi, Jing-Hai Mao, Yan-Hong Liao, Yan-Yan Wang, Qin-Kang Lu and Yan Gong]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Meng Li, Quan-Yong Yi, Jing-Hai Mao, Yan-Hong Liao, Yan-Yan Wang, Qin-Kang Lu and Yan Gong</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230509]]></guid><cfi:id>71</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Flapless one-knot suture: a novel surgical technique for transscleral fixation of C-loop intraocular lenses]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230510]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To describe a novel suture approach for transscleral fixation of C-loop intraocular lenses (IOL) and to compare the surgical outcomes with the four-haptics posterior chamber (PC)-IOL technique.METHODS: We retrospectively analyzed 16 eyes of 16 patients who underwent transscleral fixation of C-loop PC-IOLs using a flapless one-knot suture technique, which were followed up for longer than 17mo. In this technique, the capsulorless IOL was suspended using a single suture for transscleral fixation of four feet. Then we compared its surgical outcomes and complications with the four-haptics PC-IOLs using the Student’s t test and Chi-square test.RESULTS: Sixteen patients of 16 eyes with a mean age of 58.3±10.1y (42-76y) who received transscleral C-loop IOL implantation due to trauma, vitrectomy, or cataract surgery with inadequate capsule support showed improved visual acuity. The difference was not significant between two IOLs except the surgery time (P>0.05). The mean operation times of C-loop IOL surgery was 24.1±1.83min and 31.3±4.47min of the four-haptics PC-IOL method (P<0.0001). In the C-loop IOLs group, there was statistical difference between the preoperative and the postoperative UCVA (logMAR, 1.20±0.50 vs 0.57±0.32, P=0.0003). There was no statistical difference between the preoperative and the postoperative BCVA (logMAR, 0.66±0.46 vs 0.40±0.23, P=0.056). However, there was no statistically significant difference in postoperative UCVA and BCVA between the two IOLs (P>0.05). We did not detect any optic capture, IOL decentration or dislocation, suture exposed, or cystoid macular edema in patients underwent C-loop IOLs surgery.CONCLUSION: The novel flapless one-knot suture technique for transscleral fixation of C-loop IOL is a simple, reliable, and stable technique.]]></description>
<pubDate>2023/4/27 14:30:46</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Qing-Qing Long and Bao-Jiang Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Qing-Qing Long and Bao-Jiang Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230510]]></guid><cfi:id>70</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Assessment of iris volume in glaucoma patients with type 2 diabetes mellitus by AS-OCT]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230511]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To examine the change of iris volume measured by CASIA2 anterior segment optical coherence tomography (AS-OCT) in glaucoma patients with or without type 2 diabetes mellitus (T2DM) and explore if there is a correlation between hemoglobin A1c (HbA1c) level and iris volume.METHODS: In a cross-sectional study, 72 patients (115 eyes) were divided into two groups: primary open angle glaucoma (POAG) group (55 eyes) and primary angle-closure glaucoma (PACG) group (60 eyes). Patients in each group were separately classified into patients with or without T2DM. Iris volume and glycosylated HbA1c level were measured and analyzed.RESULTS: In the PACG group, diabetic patients’ iris volume was significantly lower than those of non-diabetics (P=0.02), and there was a significant correlation between iris volume and HbA1c level in the PACG group (r=-0.26, P=0.04). However, diabetic POAG patients’ iris volume was noticeably higher than those of non-diabetics (P=0.01), and there was a significant correlation between HbA1c level and iris volume (r=0.32, P=0.02).CONCLUSION: Diabetes mellitus impact iris volume size, as seen by increased iris volume in the POAG group and decreased iris volume in the PACG group. In addition, iris volume is significantly correlated with HbA1c level in glaucoma patients. These findings imply that T2DM may compromise iris ultrastructure in glaucoma patients.]]></description>
<pubDate>2023/4/27 14:30:46</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ying Su, Qing-Shu Ge, Zong-Yi Li, Qian-Wen Bu, Die Hu, Long-Fang Zhou and Xiao-Jing Pan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ying Su, Qing-Shu Ge, Zong-Yi Li, Qian-Wen Bu, Die Hu, Long-Fang Zhou and Xiao-Jing Pan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230511]]></guid><cfi:id>69</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Microstructural morphology and visual acuity outcome in eyes with epiretinal membrane before, during, and after membrane peeling in intraoperative optical coherence tomography assisted macular surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230512]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To measure the difference of intraoperative central macular thickness (CMT) before, during, and after membrane peeling and investigate the influence of intraoperative macular stretching on postoperative best corrected visual acuity (BCVA) outcome and postoperative CMT development.METHODS: A total of 59 eyes of 59 patients who underwent vitreoretinal surgery for epiretinal membrane was analyzed. Videos with intraoperative optical coherence tomography (OCT) were recorded. Difference of intraoperative CMT before, during, and after peeling was measured. Pre- and postoperatively obtained BCVA and spectral-domain OCT images were analyzed.RESULTS: Mean age of the patients was 70±8.13y (range 46-86y). Mean baseline BCVA was 0.49±0.27 logMAR (range 0.1-1.3). Three and six months postoperatively the mean BCVA was 0.36±0.25 (P=0.01 vs baseline) and 0.38±0.35 (P=0.08 vs baseline) logMAR respectively. Mean stretch of the macula during surgery was 29% from baseline (range 2%-159%). Intraoperative findings of macular stretching did not correlate with visual acuity outcome within 6mo after surgery (r=-0.06, P=0.72). However, extent of macular stretching during surgery significantly correlated with less reduction of CMT at the fovea centralis (r=-0.43, P<0.01) and 1 mm nasal and temporal from the fovea (r=-0.37, P=0.02 and r=-0.50, P<0.01 respectively) 3mo postoperatively.CONCLUSION: The extent of retinal stretching during membrane peeling may predict the development of postoperative central retinal thickness, though there is no correlation with visual acuity development within the first 6mo postoperatively.]]></description>
<pubDate>2023/4/27 14:30:46</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Melanie Weschta, Moritz Pettenkofer, Julian E. Klaas, Nikolaus Feucht, Chris P. Lohmann and Mathias Maier]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Melanie Weschta, Moritz Pettenkofer, Julian E. Klaas, Nikolaus Feucht, Chris P. Lohmann and Mathias Maier</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230512]]></guid><cfi:id>68</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical and multimodal imaging features of acute macular neuroretinopathy lesions following recent SARS-CoV-2 infection]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230513]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To describe the clinical characteristics of eyes using multimodal imaging features with acute macular neuroretinopathy (AMN) lesions following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.METHODS: Retrospective case series study. From December 18, 2022 to February 14, 2023, previously healthy cases within 1-week infection with SARS-CoV-2 and examined at Tianjin Eye Hospital to confirm the diagnosis of AMN were included in the study. Totally 5 males and 9 females [mean age: 29.93±10.32 (16-49)y] were presented for reduced vision, with or without blurred vision. All patients underwent best corrected visual acuity (BCVA), intraocular pressure, slit lamp microscopy, indirect fundoscopy. Simultaneously, multimodal imagings fundus photography (45° or 200° field of view) was performed in 7 cases (14 eyes). Near infrared (NIR) fundus photography was performed in 9 cases (18 eyes), optical coherence tomography (OCT) in 5 cases (10 eyes), optical coherence tomography angiography (OCTA) in 9 cases (18 eyes), and fundus fluorescence angiography (FFA) in 3 cases (6 eyes). Visual field was performed in 1 case (2 eyes).RESULTS: Multimodal imaging findings data from 14 patients with AMN were reviewed. All eyes demonstrated different extent hyperreflective lesions at the level of the inner nuclear layer and/or outer plexus layer on OCT or OCTA. Fundus photography (45° or 200° field of view) showed irregular hypo-reflective lesion around the fovea in 7 cases (14 eyes). OCTA demonstrated that the superficial retinal capillary plexus (SCP) vascular density, deep capillary plexus (DCP) vascular density and choriocapillaris (CC) vascular density was reduced in 9 case (18 eyes). Among the follow-up cases (2 cases), vascular density increased in 1 case with elevated BCVA; another case has vascular density decrease in one eye and basically unchanged in other eye. En face images of the ellipsoidal zone and interdigitation zone injury showed a low wedge-shaped reflection contour appearance. NIR image mainly show the absence of the outer retinal interdigitation zone in AMN. No abnormal fluorescence was observed in FFA. Corresponding partial defect of the visual field were visualized via perimeter in one case.CONCLUSION: The morbidity of SARS-CoV-2 infection with AMN is increased. Ophthalmologists should be aware of the possible, albeit rare, AMN after SARS-CoV-2 infection and focus on multimodal imaging features. OCT, OCTA, and infrared fundus phase are proved to be valuable tools for detection of AMN in patients with SARS-CoV-2.]]></description>
<pubDate>2023/4/27 14:30:46</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yang-Chen Liu, Bin Wu, Yan Wang and Song Chen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yang-Chen Liu, Bin Wu, Yan Wang and Song Chen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230513]]></guid><cfi:id>67</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Quantitative study of peripapillary retinal nerve fiber layer thickness and peripapillary vessel density in patients with different stages of Parkinson’s disease]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230514]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To observe the changes in the thickness of peripapillary retinal nerve fiber layer (pRNFL) and peripapillary vessel density (pVD) in patients with different stages of Parkinson’s disease (PD).METHODS: Totally 47 patients (47 eyes) with primary PD were divided into the mild group and the moderate-to-severe group according to Hoehn & Yahr (H&Y) stage. Among them, there were 27 cases (27 eyes) in mild group and 20 cases (20 eyes) in moderate-to-severe group. And 20 cases (20 eyes) who were included in the control group were healthy people who came to our hospital for health screening at the same time. All participants underwent optical coherence tomography angiography (OCTA) examinations. The pRNFL thickness, total vessel density (tVD) and capillary vessel density (cVD) of the optic disc in average, superior half, inferior half, superior nasal (SN), nasal superior (NS), nasal inferior (NI), inferior nasal (IN), inferior temporal (IT), temporal inferior (TI), temporal superior (TS), and superior temporal (ST) were measured. One-way ANOVA was used to compare the differences of optic disc parameters among the three groups, and Pearson and Spearman correlations were used to analyze the correlation between pRNFL, pVD and the disease duration, H&Y stage and UPDRS-III score in patients with PD, respectively.RESULTS: There were significant differences in pRNFL thickness in average, superior half, inferior half, SN, NS, IN, IT and ST quadrants among the three groups (P<0.05). In PD group, the pRNFL thickness in average, superior half, inferior half, NS and IT quadrants were negatively correlated with H&Y stage and UPDRS-III score, respectively (P<0.05). There were statistically significant differences in the cVD of whole image, inferior half, NI and TS quadrants, the tVD of the whole image, inferior half, and peripapillary among the three groups (P<0.05). In PD group, the tVD of whole image and the cVD of NI and TS quadrants were negatively correlated with the H&Y stage, respectively (P<0.05); the cVD of TS quadrant was negatively correlated with UPDRS-III score (P<0.05).CONCLUSION: The thickness of pRNFL in PD patients is significantly decreased, and it is negatively correlated with H&Y stage and UPDRS-III score. With the increase of the severity of the disease, the pVD parameters in PD patients increase at first in the mild group, and then decrease in the moderate-to-severe group, and negatively correlate with H&Y stage and UPDRS-III score.]]></description>
<pubDate>2023/4/27 14:30:46</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ting-Yu Yang, Tian-Qi Zhang, Lai-Qing Xie, Ying Zhang, Shi-Mei Liu, Xin-Wei Zeng, Wei-Feng Luo and Guo-Xu Xu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ting-Yu Yang, Tian-Qi Zhang, Lai-Qing Xie, Ying Zhang, Shi-Mei Liu, Xin-Wei Zeng, Wei-Feng Luo and Guo-Xu Xu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230514]]></guid><cfi:id>66</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Orthokeratology with increased compression factor in adolescent myopia control: a 2-year prospective randomized clinical trial]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230515]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To explore the long-term efficacy, safety, and optical mechanism of orthokeratology with increased compression factor in adolescent myopia control.METHODS: A prospective, double-masked, and randomized clinical trial was performed from May 2016 to June 2020. Subjects aged between 8 and 16y, with myopia (-5.00 to -1.00 D), low astigmatism (≥-1.50 D) and anisometropia (≤1.00 D), were stratified into low (-2.75 to -1.00 D) and moderate (-5.00 to -3.00 D) myopia groups. Then they were randomly assigned to wear either increased compression factor (ICF; 1.75 D) orthokeratology or conventional compression factor (CCF; 0.75 D) orthokeratology. The data were recorded including axial length (AL), spherical equivalent (SE), best corrected visual acuity (BCVA), near visual acuity (NVA), corneal staining (using Efron grading scales), corneal hysteresis (CH), corneal resistance factor (CRF), higher-order aberrations (HOAs, expressed as root mean square, RMSh), and subfoveal choroidal thickness (SFChT) in the 2-year follow-up period. Pearson’s correlation coefficient was conducted to analyze the association between the changes in AL and RMSh, SFChT.RESULTS: At the 2-year visit, there were no statistical differences in all the parameters between the ICF group and the CCF group in low myopia subjects (P>0.05). For the moderate myopia subjects, the ICF group had shorter AL elongation (0.23±0.08 vs 0.30±0.11 mm, P=0.015), higher RMSh (1.94±0.50 vs 1.65±0.51 μm, P=0.041), and higher SFChT (279.04±35.72 vs 254.08±29.60 μm, P=0.008) than those in CCF group. The change in AL was negatively correlated with RMSh (r=-0.687, P<0.001) and SFChT (r=-0.464, P=0.013).CONCLUSION: ICF orthokeratology can control the progression of moderate myopia more effectively, which might be related to greater RMSh and SFChT.]]></description>
<pubDate>2023/4/27 14:30:46</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Wen-Ting Tang, Li Zhang, Hui-Dan Zhang, Shi-Bei Li and Hao Liang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Wen-Ting Tang, Li Zhang, Hui-Dan Zhang, Shi-Bei Li and Hao Liang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230515]]></guid><cfi:id>65</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Residual refractive errors in pseudophakic eyes and related factors: a population-based study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230516]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine residual refractive error after cataract surgery in pseudophakic eyes and its relationship with age, sex, and axial length (AL).METHODS: In this population-based cross-sectional study, the sampling was performed on individuals aged 60y and above in Tehran, Iran using a multi-stage stratified random cluster sampling method. Pseudophakic eyes with a best-corrected visual acuity of 20/32 or better were analyzed and their refractive results were reported.RESULTS: The mean spherical equivalent (SE) refraction was -0.34±0.97 diopters (D) and the mean absolute SE was 0.72±0.74 D with a median of 0.5 D. Moreover, 32.68% (n=546, 95%CI: 30.27%-35.08%), 53.67% (n=900, 95%CI: 51.23%-56.1%), 68.99% (n=1157, 95%CI: 66.96%-71.02%), and 79.73% (n=1337, 95%CI: 77.69%-81.76%) of the eyes had a residual SE within ±0.25, ±0.50, ±0.75, and ±1.00 D of emmetropia, respectively. According to the multiple logistic regression model, increasing age was associated with a statistically significant decrease in predictability for all cut points. Moreover, the predictability based on all cut points was significantly lower in individuals with an AL longer than 24.5 mm than in those with an AL between 22 to 24.5 mm.CONCLUSION: Based on the results, the accuracy of intraocular lens (IOL) power calculation is lower for those who underwent cataract surgery during the last 5y in Tehran, Iran. Among the most important influential factors, the choice of IOL or it’s power disproportionate to eye conditions and age can be mentioned.]]></description>
<pubDate>2023/4/27 14:30:47</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hassan Hashemi, Alireza Jamali, Farhad Rezavn, Alireza Hashemi and Mehdi Khabazkhoob]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hassan Hashemi, Alireza Jamali, Farhad Rezavn, Alireza Hashemi and Mehdi Khabazkhoob</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230516]]></guid><cfi:id>64</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Ocular manifestations of children with atopic dermatitis in Saudi Arabia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230517]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To examine the incidence of ocular abnormalities in children with atopic dermatitis (AD) in Saudi Arabia and its association with the severity of AD.METHODS: This is a cross-sectional study on 50 children with AD who were between 5 and 16 years of age. The severity of AD was evaluated using the SCORing Atopic Dermatitis (SCORAD) index. All the children underwent slit lamp exams, visual acuity assessment, intraocular pressure measurement, and corneal topography. The children were considered to have an ophthalmic abnormality if one or more of the following signs were present: glaucoma, keratoconus suspicion, in addition to lid, conjunctival, corneal, lenticular, or retinal abnormalities.RESULTS: Based on the SCORAD severity index, 14% of children had mild AD (7/50), 38% had moderate AD (19/50), and nearly half had severe AD. More than half the children exhibited facial involvement, and half had peri-orbital signs. The mean SCORAD index was 35.75. The mean age was 10.48±3.6y, and the cohort showed a slight male predominance (54% males). Both eyes of the 50 children in the cohort were studied. Based on the ocular examinations, 92% of the patients showed ocular abnormalities: lid abnormalities (27/50) followed by keratitis (22/50). Four patients had moderate risk for keratoconus in one eye and eight patients were suspected to have keratoconus. However, SCORAD severity index was not associated with age, sex, or the number or presence of ophthalmic abnormalities.CONCLUSION: This is the first study in Saudi Arabia to evaluate the prevalence of ocular manifestations in children with AD. The results indicate that the majority of children with AD have ocular abnormalities that mainly include lid abnormalities. Based on these findings, larger scale studies are needed to affirm whether regular screening for ophthalmic abnormalities would be beneficial for children with AD in terms of early intervention and prevention of sight-threatening complications.]]></description>
<pubDate>2023/4/27 14:30:47</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Lina Hassan Raffa, Tala Musa Roblah, Nasser Talal Balbaid, Bader Sameer Zimmo and Mahmood Jameel Showail]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Lina Hassan Raffa, Tala Musa Roblah, Nasser Talal Balbaid, Bader Sameer Zimmo and Mahmood Jameel Showail</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230517]]></guid><cfi:id>63</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Primary lacrimal sac lymphoma: a case-based retrospective study in a Chinese population]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230406]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the clinical characteristics, pathological types, tumor markers, treatments, and outcomes of Chinese patients with primary lacrimal sac lymphoma.METHODS: This case-based retrospective study analyzed 15 Chinese patients with primary lacrimal sac lymphoma. The clinical data collected included gender, age at diagnosis, symptoms, imaging examination results, pathologic diagnosis, pathogen identification, tumor markers, treatments, follow-up, and prognosis. Descriptive statistics were used to characterize the patients. Progression-free survival (PFS) was defined as the time from surgery to the last follow-up, first record of tumor recurrence, or death.RESULTS: There were 7 males and 8 females with unilateral primary lacrimal sac lymphoma in the left eye (n=6) or right eye (n=9). The initial symptom in 13 patients was epiphora, and 2 patients had redness and swelling in the lacrimal sac area. All patients ultimately developed epiphora, and 12 had masses in the lacrimal sac area. Analysis of preoperative plasma tumor markers indicated 14 patients had elevated homocysteine, 9 had elevated β2-microglobulin, and 2 had elevated lactate dehydrogenase (LDH); 2 patients had elevations of all three markers, and 1 patient had no elevation of any marker. All patients underwent surgical resection and 12 patients received postoperative chemotherapy. The pathological types were DLBCL (n=8), MALT lymphoma (n=5), and NK/T-cell lymphoma, nasal type (n=2). The mean follow-up time was 25.8mo (range: 4-41) and 2 patients died. Seven patients who underwent mass excision combined with dacryocystorhinostomy (DCR) had no postoperative epiphora. Eight patients who only underwent mass excision had varying degrees of postoperative epiphora. Preoperative LDH elevation and NK/T-cell lymphoma, nasal type were associated with poor prognoses.CONCLUSION: Early diagnosis and treatment can lead to a good prognosis for most patients with primary lacrimal sac lymphoma. Mass resection combined with DCR can reduce the occurrence of post-surgical epiphora. The pathology type and tumor marker status are associated with prognosis.]]></description>
<pubDate>2023/3/30 16:20:46</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Fang Bai, Hai Tao, Xi-Bin Zhou, Fei Wang, Peng Wang, Li-Hua Wang and Hong-Yang Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Fang Bai, Hai Tao, Xi-Bin Zhou, Fei Wang, Peng Wang, Li-Hua Wang and Hong-Yang Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230406]]></guid><cfi:id>62</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Preliminary study on the efficacy of lacrimal duct reconstruction with pedicled conjunctival flap in the treatment of severe lacrimal canalicular obstruction with conjunctivochalasis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230407]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the efficacy and safety of pedicled conjunctival lacrimal duct reconstruction in the treatment of severe obstruction of superior and inferior lacrimal canaliculi with conjunctivochalasis.METHODS: This study was performed as a retrospective analysis of patients who received conjunctival dacryocystorhinostomy with pedicled conjunctival flap reconstruction combined with tube intubation due to severe superior and inferior lacrimal canalicular obstruction with conjunctivochalasis from January 2019 to October 2019. The clinical data included the degree of preoperative epiphora and postoperative relief, preoperative examination of lacrimal duct computed tomography and ultrasound biomicroscopy, postoperative evaluation of lacrimal duct function by chloramphenicol taste and fluorescein dye disappearance test, etc. Syringing was carried out to determine the reconstruction and patency of the lacrimal duct.RESULTS: All 9 patients (9 eyes) had severe canalicular obstruction with conjunctivochalasis. The patients included 4 males and 5 females aged between 47–65y with an average age of 52.2±6.7y. At 3mo follow-up, the tube was removed and the patients were followed for a further 3mo. After tube removal, 6 patients showed no epiphora. These patients also had positive chloramphenicol tastes and normal fluorescein dye disappearance test results. Two patientshad epiphora. Also, syringing showed partial patency of the reconstructed lacrimal duct. One patient had no improvement in epiphora with negative chloramphenicol taste and fluorescein dye disappearance test results and obstruction of the reconstructed lacrimal duct. The total effective rate of the operation was 8/9, with no serious complications.CONCLUSION: Pedicled conjunctival lacrimal duct reconstruction conjunctival dacryocystorhinostomy is safe and effective for superior and inferior canalicular obstruction with conjunctivochalasis.]]></description>
<pubDate>2023/3/30 16:20:47</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Gao-Xiang Ouyang, Fang Bai and Hai Tao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Gao-Xiang Ouyang, Fang Bai and Hai Tao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230407]]></guid><cfi:id>61</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Treatment of corneal dermoid with lenticules from small incision lenticule extraction surgery: a surgery assisted by fibrin glue]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230408]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To observe the clinical efficacy of the combined use of small incision lenticule extraction (SMILE)-derived lenticule patches in corneal dermoid excision, with fixation of the lenticule patches assisted by fibrin glue.METHODS: Seventeen eyes of 17 patients with corneal dermoid were treated with dermoid removal combined with SMILE-derived lenticule transplantation. All lenticule patches were fixed by fibrin glue. Ocular changes were assessed using slit lamp microscopy and anterior-segmental optical coherence tomography. The best-corrected visual acuity (BCVA) and ocular dioptric variations were examined preoperatively and postoperatively. Intraocular pressure (IOP) was also monitored in all visited time.RESULTS: Totally, 18 lenticule patches were used on 17 eyes of 17 cornea dermoid patients. The mean follow-up time was 11.47±5.28mo. All lenticule patches were successfully glued, kept on its location and maintained transparent during the follow-up time, with a consecutive epithelial cover for 1wk. Nine of the patients could coordinate visual and optometry exam well. Their preoperative BCVA is 0.60±0.35 in decimal, significantly improved to 0.80±0.26 in decimal at 6mo postoperatively (Z=-2.392, P=0.017), but the changes of their corneal astigmatism diopters showed no significance, with 2.22±1.91 D preoperatively, and 2.28±1.31 D at 6mo postoperatively (Z=-0.135, P=0.893). Limbal pannus formation occurred in 4 (23.52%) cases and decreased with the application of tacrolimus eyedrops. IOP increased in 2 (11.76%) cases, but well decreased by timolol maleate eyedrops. All the adult patients or guardians of minor patients were satisfied with the cosmetic improvement.CONCLUSION: Dermoid excision combined with transplantation of SMILE-derived lenticule patches using fibrin glue is a safe and effective novel tectonic keratoplasty procedure for corneal dermoid.]]></description>
<pubDate>2023/3/30 16:20:47</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jiao-Lian Liu, Jia-Yue Ji, Qing Ye, Liu-Qing Wei, Xin Zhong, Lin-Zhi Jiang and Jing Zeng]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jiao-Lian Liu, Jia-Yue Ji, Qing Ye, Liu-Qing Wei, Xin Zhong, Lin-Zhi Jiang and Jing Zeng</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230408]]></guid><cfi:id>60</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Axial length, vitreoretinal pathology, and anterior chamber depth can predict postoperative refractive outcomes in phacovitrectomy/silicone oil removal]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230409]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the postoperative refractive prediction error (PE) and determine the factors that affect the refractive outcomes of combined pars plana vitrectomy (PPV) or silicone oil removal (SOR) with cataract surgery.METHODS: The study is a retrospective, case-series study. Totally 301 eyes of 301 patients undergoing combined PPV/SOR with cataract surgery were enrolled. Eligible individuals were separated into four groups according to their preoperative diagnoses: silicone oil-filled eyes after PPV (group 1), epiretinal membrane (group 2), macular hole (group 3), and primary retinal detachment (RD; group 4). The variables affecting postoperative refractive outcomes were analyzed, including age, gender, preoperative best-corrected visual acuity (BCVA), axial length (AL), keratometry average, anterior chamber depth (ACD), intraocular tamponade, and vitreoretinal pathology. The outcome measurements include the mean refractive PE and the proportions of eyes with a PE within ±0.50 diopter (D) and ±1.00 D.RESULTS: For all patients, the mean PE was -0.04±1.17 D, and 50.17% of patients (eyes) had a PE within ±0.50 D. There was a significant difference in refractive outcomes among the four groups (P=0.028), with RD (group 4) showing the least favorable refractive outcome. In multivariate regression analysis, only AL, vitreoretinal pathology, and ACD were strongly associated with PE (all P<0.01). Univariate analysis revealed that longer eyes (AL>26 mm) and a deeper ACD were correlated with hyperopic PE, and shorter eyes (AL<26 mm) and a shallower ACD were correlated with myopic PE.CONCLUSION: RD patients have the least favorable refractive outcome. AL, vitreoretinal pathology, and ACD are strongly associated with PE in the combined surgery. These three factors affect refractive outcomes and thus can be used to predict a better postoperative refractive outcome in clinical practice.]]></description>
<pubDate>2023/3/30 16:20:47</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xu Chen, He Zhao, Jia-Yun Ren, Lu Wang, Jun-Li Wan, Bo Liu, Nan Wu, Xi Liu and Yong Liu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xu Chen, He Zhao, Jia-Yun Ren, Lu Wang, Jun-Li Wan, Bo Liu, Nan Wu, Xi Liu and Yong Liu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230409]]></guid><cfi:id>59</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Influencing factors of fear of falling among glaucoma patients in west China: a cross-sectional study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230410]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the current situation and influencing factors of fear of falling in glaucoma patients in western China.METHODS: In this cross-sectional study, glaucoma patients treated in the Ophthalmology Department of West China Hospital of Sichuan University were conducted to investigate the demographic data, visual acuity, visual field, activities of daily living, risk of falling, fear of falling and psychological states. Generalized linear model was used for multivariate analysis with fear of falling as dependent variable and other factors as independent variables.RESULTS: The mean score of the Chinese version modified Fall Efficacy Scale (MFES) was 7.52±2.09 points. Univariate analysis and multivariate analysis showed that the history of falls within one year, visual acuity, visual field, risk of falling, activities of daily living and psychological states had statistically difference on fear of falling (P<0.05).CONCLUSION: Glaucoma patients in west China have relatively high risk of fear of falling. History of falling within 1y, severe visual function impairment, high risk of falling, incapable of independence of daily living, and abnormal psychological state are risk factors of fear of falling among glaucoma patients.]]></description>
<pubDate>2023/3/30 16:20:47</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jie Ren, Xin Zhang, Hong Lin and Ji-Hong Zeng]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jie Ren, Xin Zhang, Hong Lin and Ji-Hong Zeng</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230410]]></guid><cfi:id>58</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of anterior segment parameters of the eye between type 2 diabetic with and without diabetic retinopathy and non-diabetic]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230411]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare anterior segment parameters between two groups of type 2 diabetic with and without diabetic retinopathy (DR) and non-diabetic elderly subjects based on hemoglobin A1c (HbA1c) levels and status of DR.METHODS: This study was conducted on 997 residents aged 60y or over in Tehran, Iran. Diabetic group had HbA1c level ≥6.4% with no other systemic problems. The non-diabetic participants had normal eye findings and no systemic diseases. K1, K2, mean K, Q-value, anterior, central, posterior, and total corneal densitometric findings, anterior chamber volume (ACV), anterior chamber depth (ACD), corneal volume (CV), and pachymetry were measured by Pentacam AXL.RESULTS: A total of 678 non-diabetic (39% male) and 319 diabetic (35% male) subjects with mean age of 66.31±5.23 and 67.22±4.96y were examined, respectively. No statistically significant difference was found in anterior segment parameters between non-diabetic and diabetic groups (all P>0.05). However, middle, posterior, and total corneal densitometric values were statistically different between two groups after controlling the effects of confounders (P=0.014, 0.007, and 0.042, respectively). Corneal densitometric values in all layers, ACD, and ACV were different between diabetic subjects with and without DR (all P<0.05). In the diabetic group, only corneal densitometric values had a negative relationship with fasting blood sugar (P<0.001). ACD and ACV had a negative correlation with HbA1c levels (all P<0.05, r=-0.129 and -0.146, respectively). However, the relationships were not observed after controlling the confounders (P=0.938, 0.466, respectively).CONCLUSION: Considering the higher densitometric values of the cornea and lower ACD and ACV in diabetic subjects with DR, it is suggested that the examiners should perform comprehensive retinal examinations when faced with such conditions.]]></description>
<pubDate>2023/3/30 16:20:47</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Foroozan Narooie-Noori, Amir Asharlous, Ali Mirzajani, Ebrahim Jafarzadehpur, Mehdi Behnia and Mehdi Khabazkhoob]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Foroozan Narooie-Noori, Amir Asharlous, Ali Mirzajani, Ebrahim Jafarzadehpur, Mehdi Behnia and Mehdi Khabazkhoob</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230411]]></guid><cfi:id>57</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Detection of macular ganglion cell complex loss and correlation with choroidal thickness in chronic and recurrent central serous chorioretinopathy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230412]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the association of ganglion cell complex thickness (GCCt), global loss volume percentage (GLV%), and focal loss volume percentage (FLV%) with structural and functional findings among patients with chronic central serous chorioretinopathy (CCSC) and recurrent central serous chorioretinopathy (RCSC) by optical coherence tomography (OCT).METHODS: Among 29 patients with monocular affected central serous chorioretinopathy (CSC), 15 had CCSC, and 14 had RCSC. The GCCt, FLV%, GLV%, and subfoveal choroidal thickness (SFCT) and sublesional choroidal thickness (SLCT) values were determined using OCT, and the association of these characteristics with neural structure parameters, choroidal morphology, features and functional alterations were estimated for the CCSC and RCSC patients.RESULTS: In CCSC, the affected eyes had significantly lower GCCt values than the fellow eyes in the macular regions (all P<0.05), with the highest GCCt observed in the inferior area. A significant association was found between the GCCt in different regions and the change in best corrected visual acuity (BCVA; r=-0.696; -0.695; -0.694, P<0.05) in CCSC patients. A statistically significant moderate negative correlation indicated that long-term CCSC was associated with greater differences in the GCCt in different regions between affected and fellow eyes (r=-0.562; r=-0.556; r=0.525, P<0.05). Additionally, observation of thickened SFCT was associated with a worse FLV% (r=0.599; r=0.546, P<0.05) in both groups. Similarly, thickened SLCT was associated with FLV% in RCSC patients (r=0.544, P<0.05).CONCLUSION: The distribution and GCCt are associated with the duration and visual outcomes of CCSC, whereas there is no correlation among RCSC patients. FLV% may be instrumental in differentiating the various outer choroidal vessels (pachyvessels) in long-term CSC. These results suggest that neural structure parameters may aid in estimating and predicting the recovery of altered morphology and function in CCSC and RCSC patients.]]></description>
<pubDate>2023/3/30 16:20:48</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yang-Chen Liu, Bin Wu, Yan Wang and Song Chen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yang-Chen Liu, Bin Wu, Yan Wang and Song Chen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230412]]></guid><cfi:id>56</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Development of Knowledge, Attitude and Practice Questionnaire for age-related macular degeneration patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230413]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To develop and validate a questionnaire to evaluate knowledge, attitude and practice of patients diagnosed with age-related macular degeneration (AMD) who have undergone intravitreal injection treatment.METHODS: This study was conducted among patients diagnosed with AMD in Kuala Lumpur. The generation of the instrument included four phases which included item and domains development, content, face validity and exploratory factor analysis. Content validity and modified Kappa was used for validation of knowledge domain. Exploratory factor analysis was used for validation of both attitude and practice domains. Face validity was conducted in 12 patients, content validity was ascertained in 120 patients and test-retest reliability was determined in 39 patients with AMD.RESULTS: Content validity index (CVI) and modified kappa showed excellent values for most items in the knowledge domain with CVI for item (I-CVI) values between 0.78-1.0 and Kappa values of >0.74. The Kaiser-Meyer-Olkin (KMO) sampling adequacy showed acceptable scores of 0.70 and 0.75 for both attitude and practice domains respectively and Bartlett’s Test of sphericity were significant (χ2=0.00, P<0.001). Factor analysis resulted in five factors with thirty items for attitude domain and four factors with twenty items for practice domain. The Cronbach’s alpha showed acceptable values for all items in knowledge, attitude and practice domain with values >0.70 and good test-retest reliability. The final version of the questionnaire consisted of 93 items from four sections consisting of demographic details, knowledge, attitude and practice.CONCLUSION: The findings of this validation and reliability study show that the developed questionnaire has a satisfactory psychometric property for measuring KAP of patients diagnosed with AMD undergoing intravitreal injection treatment.]]></description>
<pubDate>2023/3/30 16:20:48</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mohd Harimi Abd Rahman, Prashanti Amirtharatnam, Sharanjeet Sharanjeet-Kaur, Sumithira Narayanasamy, Hanif Farhan Mohd Rasdi and Mae-Lynn Catherine Bastion]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mohd Harimi Abd Rahman, Prashanti Amirtharatnam, Sharanjeet Sharanjeet-Kaur, Sumithira Narayanasamy, Hanif Farhan Mohd Rasdi and Mae-Lynn Catherine Bastion</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230413]]></guid><cfi:id>55</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Assessment of the effects of induced anisometropia on binocularity with glasses-free 3D technique]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230414]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the effect of experimentally induced anisometropia on binocularity in normal adults with glasses-free three-dimensional (3D) technique.METHODS: Totally 54 healthy medical students with normal binocularity in the cross-sectional study were enrolled. Anisometropia was induced by placing trail lenses over the right eye, in 0.5 D steps including lenses of -0.5, -1, -1.5, -2, -2.5 D (hyperopic anisometropia) and lenses of +0.5, +1, +1.5, +2, +2.5 D (myopic anisometropia). The glasses-free 3D technique was used to evaluated not only fine stereopsis, but also coarse stereopsis, dynamic stereopsis, foveal suppression, and peripheral suppression in these subjects. One-way analysis of variance was used to compare quantitative data such as fine stereopsis, coarse stereopsis. Pearson’s Chi-square test was performed to compare categorical data such as dynamic stereopsis, foveal suppression and peripheral suppression.RESULTS: The subjects showed a statistically significant decline in fine stereopsis, coarse stereopsis, and dynamic stereopsis with increasing levels of anisometropia (P<0.001). Binocularity was affected when induced anisometropia was more than 1 D (P<0.05). Foveal suppression and peripheral suppression were evident and increased in proportion to anisometropia (P<0.001).CONCLUSION: The relatively low degrees of anisometropia may have a potentially significant effect on high-grade binocular interaction. The mechanisms underlying the defect of binocularity seem to involve not only foveal suppression, but also peripheral suppression.]]></description>
<pubDate>2023/3/30 16:20:48</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xu-Bo Yang, Wei-Dong Huang and Yong-Chuan Liao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xu-Bo Yang, Wei-Dong Huang and Yong-Chuan Liao</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230414]]></guid><cfi:id>54</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A 3-month comparison study of subjective and objective visual quality of small incision lenticule extraction and transepithelial photorefractive keratectomy in patients with low and moderate myopia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230415]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the subjective and objective visual quality between small incision lenticule extraction (SMILE) and transepithelial photorefractive keratectomy (tPRK) in patients with low and moderate myopia.METHODS: Patients undertaking SMILE or tPRK for the correction of low and moderate myopia were consecutively recruited in this prospective cohort study with a 3-month follow-up period. Objective evaluation [visual acuity test, manifest refraction, wavefront aberrations, the total cut-off value of the total modulation transfer function (MTFcut-off), and Strehl ratio (SR)] and subjective evaluation of visual quality (quality-of-life questionnaire) were conducted before surgery and at days 1, 7, 30, and 90 after surgery.RESULTS: A total of 47 patients (94 eyes) with SMILE and 22 patients (22 eyes) with tPRK were enrolled. The uncorrected visual acuity (UCVA) was better in SMILE patients on day 7 after surgery (1.13±0.13 vs 0.99±0.17, t=4.85, P<0.001) but was comparable at days 30 and 90. At day 90, the SMILE group had a lower spherical equivalent (SE) than the tPRK group (0.04±0.31 vs 0.19±0.43, t=2.08, P=0.042). Total higher order aberrations (HOAs) were induced in both surgical types, which were more evident in the tPRK group with 3-mm pupil diameter (0.16±0.07 vs 0.11±0.05, t=4.27, P<0.001) and 5-mm pupil diameter (0.39±0.17 vs 0.36±0.11, t=2.33, P=0.022). The MTFcut-off and SR showed a trend of improvement in both SMILE and tPRK patients but were statistically better in the SMILE group with both pupil diameters. There was a significant improvement of contrast sensitivity (CS) over baseline levels at the spatial frequency of 18 cycles/degree (c/d) in the SMILE group (F=2.72, P=0.033) and at 3 c/d (F=3.03, P=0.031), 12 c/d (F=3.72, P=0.013), and 18 c/d (F=4.62, P=0.004) in the tPRK group. The subjective quality of life questionnaire showed a steady improvement in the SMILE group (F=8.31, P<0.001) but not the tPRK group.CONCLUSION: SMILE and tPRK are both safe and effective ways to correct low and moderate myopia. A generally better and quicker recovery of visual quality favors the application of SMILE in qualified patients.]]></description>
<pubDate>2023/3/30 16:20:48</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Li-Xiang Wang, Xiao-Li Wang, Jing Tang, Ke Ma, Hong-Bo Yin and Ying-Ping Deng]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Li-Xiang Wang, Xiao-Li Wang, Jing Tang, Ke Ma, Hong-Bo Yin and Ying-Ping Deng</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230415]]></guid><cfi:id>53</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Accuracy between clinical and radiological diagnoses compared to surgical orbital biopsies]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230416]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the concordance between diagnosing orbital lesions by clinical examination, orbital imaging, and histological evaluation, in order to help guide future research and clinical practice.METHODS: A retrospective analysis was undertaken at a large regional tertiary referral centre of all surgical orbital biopsies performed over a 5-year period, from 1st January 2015 until 31st December 2019. Accuracy and concordance between clinical, radiological and histological diagnoses are reported as percentage sensitivity and positive predictive value.RESULTS: A total of 128 operations involving 111 patients were identified. Overall, sensitivities of 47.7% for clinical and 37.3% for radiological diagnoses were found when compared to the histological gold standard. Vascular lesions that have characteristic clinical and radiological features had the highest sensitivity at 71.4% and 57.1%, respectively. Inflammatory conditions showed the lowest sensitivity in both clinical (30.3%) and radiological (18.2%) diagnoses. The PPV for inflammatory conditions were 47.6% for clinical and 30.0% for radiological diagnoses.CONCLUSION: Accurate diagnoses are difficult to reach by relying on clinical examination and imaging alone. Surgical orbital biopsy with histological diagnosis should remain the gold standard approach for definitively identifying orbital lesions. Although larger scale prospective studies would help further refine concordance and guide future research avenues.]]></description>
<pubDate>2023/3/30 16:20:48</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Audrey Tang, Helen Hoi-Lam Ng, Taras Gout, Bernard Chang, Nabil El-Hindy and George Kalantzis]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Audrey Tang, Helen Hoi-Lam Ng, Taras Gout, Bernard Chang, Nabil El-Hindy and George Kalantzis</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230416]]></guid><cfi:id>52</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Receded near point of convergence as a predictor of mild cognitive impairment in the general geriatric population: results from a population-based study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230417]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the relationship between near point of convergence (NPC) and mild cognitive impairment (MCI) in the general elderly population.METHODS: The present report is a part of the Tehran Geriatric Eye Study (TGES): a population-based cross-sectional study conducted on individuals 60 years of age and above living in Tehran, Iran using the multi-stage stratified random cluster sampling method. Cognitive status was assessed using the Persian version of the Mini-Mental State Examination (MMSE). All study participants underwent complete ocular examination including measurement of uncorrected and best-corrected visual acuity, objective and subjective refraction, cover testing, NPC measurement, and slit-lamp biomicroscopy.RESULTS: The data of 1190 individuals were analyzed for this report. The mean age of the participants analyzed was 66.82±5.42 (60-92y) and 728 (61.2%) of them were female. Patients with MCI had a significantly more receded NPC compared to subjects with normal cognitive status (10.89±3.58 vs 7.76±2.71 cm, P<0.001). In the multivariable logistic regression model and in the presence of confounding variables, a receded NPC was statistically significantly associated with an increased risk of MCI (odds ratio: 1.334, 95% confidence interval: 1.263 to 1.410, P<0.001). According to receiver operating characteristic (ROC) analysis, a cut point NPC> 8.5 cm (area under the curve: 0.764, P<0.001) could predict the presence of MCI with a sensitivity and specificity of 70.9% and 69.5%, respectively.CONCLUSION: A receded NPC can be clinically proposed as a predictor of MCI in older adults. It is recommended that elderly with a receded NPC>8.50 cm undergo detailed cognitive screening for a definite diagnosis of MCI. In this case, the necessary interventions can be carried out to slow down MCI progression to dementia.]]></description>
<pubDate>2023/3/30 16:20:48</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Asgar Doostdar, Hassan Hashemi, Payam Nabovati, Amir Asharlous and Mehdi Khabazkhoob]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Asgar Doostdar, Hassan Hashemi, Payam Nabovati, Amir Asharlous and Mehdi Khabazkhoob</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230417]]></guid><cfi:id>51</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Surgical outcomes of complicated cataract with pediatric trematode granulomatous uveitis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230304]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To describe the clinical characteristics and surgical outcomes of complicated cataract with pediatric trematodal granulomatous uveitis (TGU).METHODS: Patients of cataract with TGU in the membranous (inactive) stage underwent cataract surgery with intraocular lens (IOL) implantation. Preoperative history and ophthalmic examination were conducted for all cases, whereas Schimphlug imaging and corneal topography were done for some patients. Postoperative follow up was done on the 1st, 2nd, and 5th postoperative days after surgery. Then, it was done at least at one, three, and six months postoperatively. Intraoperative and postoperative complications and the methods of their management were reported.RESULTS: Twelve eyes of 12 male children were included in this study ranging from 8 to 16y. The mean best corrected Snellen visual acuity (BCVA) was significantly improved from 0.09±0.06 preoperatively to 0.37±0.11 at the final visit 6mo postoperatively (P&#x003C;0.001). Schimphlug imaging and corneal topography showed flattening of the anterior surface of the inferior cornea. Intraoperative difficulties and complications included the poor dilatability of the drown down pupil, strong posterior synechia between the anterior lens capsule and the iris at the site of the inferior retrocorneal vascularized membrane and hyphema. All cases underwent primary hydrophobic IOL implantation.CONCLUSION: Surgery for this type of cataract is relatively safe and effective. It is associated with some specific difficulties and complications that should be considered during surgery and follow up.]]></description>
<pubDate>2023/3/2 15:56:07</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mahmoud M. Farouk, Amr Mounir, Mortada Ahmed Abozaid, Engy Mohamed Mostafa and Marwa Mahmoud Abdellah]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mahmoud M. Farouk, Amr Mounir, Mortada Ahmed Abozaid, Engy Mohamed Mostafa and Marwa Mahmoud Abdellah</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230304]]></guid><cfi:id>50</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Combination of cataract surgery with intravitreal injection of dexamethasone intravitreal implant (Ozurdex) for uveitis-induced cataract]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230305]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the long-term results of patients with chronic uveitis-induced cataract by phacoemulsification with IOL implantation and intravitreal injection of dexamethasone (DEX) intravitreal implant (Ozurdex).METHODS: The study included 32 eyes of 26 patients treated with DEX implant due to chronic uveitis-induced cataract and followed up for at least a year. Best-corrected visual acuity (BCVA), intraocular pressure (IOP), anterior chamber reaction, central macular thickness (CMT), intraoperative and postoperative complications and uveitis recurrence were analyzed retrospectively.RESULTS: A successful surgery was performed in all patients. The average follow-up period was 12mo. The female/male ratio was 13/13. Mean age was 45.65±3.83y (range 26 to 65y). Etiologically, rheumatic arthritis occurred in 6 patients (18.75%), ankylosing spondylitis in 4 (12.50%), HLA-B27 associated uveitis in 3 (9.38%), Vogt-Koyanagi-Harada-associated uveitis in 4 (12.50%) , Behcet's disease in 2 (6.25%), and 7 (21.88%) suffered from unknown diseases. All 32 eyes had varying degrees of improvement at 12mo after surgery, with 2 eyes showing BCVA of 0.1 or below (6.25%), 6 having 0.1-0.5 (18.75%), 18 of 0.5-1.0 (56.25%), and 6 of 1.0 or above (18.75%). No cases with increased IOP were observed. The values of mean CMT was increased at day 1, decreased at 1, 3mo after surgery and increased at 6, 12mo after surgery. No severe uveitis reactions, such as fibrinous exudates in the anterior chamber and exudative membrane formation on the anterior surface of the IOL, were observed after surgery.CONCLUSION: The present studies show that intravitreal injection of Ozudex during cataract operation can provide a new option for the clinical treatment of uveitis-induced cataract.]]></description>
<pubDate>2023/3/2 15:56:07</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jin Deng, Wen-Tao Sun, Hua Ai and Li-Ping Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jin Deng, Wen-Tao Sun, Hua Ai and Li-Ping Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230305]]></guid><cfi:id>49</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Outcomes and risk factors for failure of trabeculectomy in glaucomatous patients in Southwest China: a 325 eyes analysis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230306]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the outcomes and elucidate the failure factors for trabeculectomy with mitomycin C (MMC) in Southwest Chinese patients.METHODS: A retrospective correlational study was conducted on the glaucomatous patients who underwent initial trabeculectomy with MMC in Southwest Hospital and had been followed up for 1-3y. A complete success for surgery is defined as a postoperative intraocular pressure (IOP) &#x003E;5 and ≤21 mm Hg and 20% reduction of IOP compared to preoperative, without IOP-lowering medications. A qualified success for surgery is defined as the abovementioned postoperative IOP with or without IOP-lowering medications. The primary outcomes were IOP, the number of IOP-lowering medications, and cumulative success rate. The secondary outcomes included best corrected visual acuity (BCVA), mean deviation (MD) of visual field, major complications, and risk factors for surgical failure.RESULTS: A total of 325 eyes of 261 glaucomatous patients had been included in our study. Both the mean IOP and the number of IOP-lowering medications were significantly decreased from 32.9±12.0 to 16.4±5.7 mm Hg (P&#x003C;0.0001) and 3.0±0.9 to 0.9±1.0 (P&#x003C;0.0001), respectively, at the last visit. The cumulative complete success rate and qualified success rate were 77.8% and 92.0% at 1-year follow-up, and 47.2% and 77.7% at 3-year follow up. There were no significant differences in surgical outcomes between primary angle-closure glaucoma (PACG) and primary open angle glaucoma (POAG). In PACG patients, the success rates of trabeculectomy were comparable with those of phacotrabeculectomy. Hypertension (HR=1.904, P=0.011), encapsulated bleb (HR=2.756, P&#x003C;0.001), and more preoperative topical medications (HR=2.475, P=0.008) were risk factors for surgical failure.CONCLUSION: The qualified success rate of trabeculectomy with MMC in glaucomatous patients in the cohort is 92.0% at 1-year, and 77.7% at 3-year follow up. Hypertension, encapsulated bleb, and more preoperative topical medications are associated with surgical failure.]]></description>
<pubDate>2023/3/2 15:56:07</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Zuo-Xin Qin, Xi Ying, Qing Han, Lu Wang, Lian Tan, Yu-Fei Xu, Qiu-Xiang You, Nan Wu and Yong Liu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zuo-Xin Qin, Xi Ying, Qing Han, Lu Wang, Lian Tan, Yu-Fei Xu, Qiu-Xiang You, Nan Wu and Yong Liu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230306]]></guid><cfi:id>48</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Transpalpebral intraocular pressure measurement by Diaton compared to Goldman applanation tonometer in myopic eyes before and after transepithelial photorefractive keratectomy in Saudi Arabia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230307]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare intraocular pressure (IOP) measured via the trans palpebral IOP (tpIOP) method using a Diaton or with a Goldman applanation tonometer (GAT) and study the determinants of IOP difference in eyes undergoing transepithelial photorefractive keratectomy (TPRK) for myopia.METHODS: This cross-sectional validation study was held in 2020 in an eye hospital in Saudi Arabia. IOP was measured by Diaton and GAT before treatment, after one week, and one month of TPRK. It is considered if IOP difference by Diaton and GAT was less than ±2 mm Hg acceptable. The IOP difference was tested if correlated to spherical equivalent (SE), central corneal thickness (CCT), age, gender, or tpIOP.RESULTS: Totolly 200 myopic eyes of 100 patients were included in the study. The mean difference of IOP measured by two methods before TPRK, 1wk, and 1mo after TPRK were 0.790, -0.790, and -0.920 mm Hg, respectively (P&#x003C;0.001). Diaton could measure IOP effectively 89.5% eyes before TPRK and 82% and 84% at 1wk and 1mo after TPTK, respectively. At week 1, IOP differences were significantly correlated to baseline CCT (P=0.02) and tpIOP at week 1 (P&#x003C;0.001). One month after TPRK, only tpIOP was significantly correlated to the difference in IOP (P&#x003C;0.001).CONCLUSION: Diaton is a good screening tool for IOP before TPRK. It helps in monitoring IOP after surgery. Although more practical, it is less efficient than GAT. In eyes with high myopia and low tpIOP before surgery, IOP post-TPRK by Diaton and GAT could differ.]]></description>
<pubDate>2023/3/2 15:56:07</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Sultan Alzuhairy]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Sultan Alzuhairy</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230307]]></guid><cfi:id>47</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Analysis of clinical and pathological features of ciliary body medulloepithelioma]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230308]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyze and summarize the clinical and pathological features of ciliary body medulloepithelioma.METHODS: The clinical and pathological data of 11 patients (11 eyes) who were diagnosed with ciliary body medulloepithelioma at Beijing Tongren Hospital, Capital Medical University, from 2007 to 2021 were retrospectively analyzed.RESULTS: The initial symptoms of 11 patients included vision loss (6 eyes), atrophia bulbi (1 eye), proptosis (2 eyes), and leukocoria (2 eyes). Most patients suffered with corneal opacity, anterior chamber flare and hyphema. Iris neovascularization and synechia, complicated cataract, and secondary glaucoma occurred in several cases. Three patients even had lens subluxation and retinal detachment. B-scan ultrasonography showed vitreous opacity and a medium-high uneven echo mass in the eyeball. Ultrasound biomicroscopy examination showed a spherical or hemispherical ciliary body mass with uneven internal echoes and irregular cystic spaces. All of the 11 patients were diagnosed with malignant ciliary body medulloepithelioma by pathological evidence. In this study, 6 patients had enucleation (2 patients had systemic chemotherapy after surgery), and the other 5 patients had local tumor resection (1 patient had plaque radiotherapy after surgery).CONCLUSION: Ciliary body medulloepithelioma is a rare intraocular tumor and may be easily confused with retinoblastoma. Analyzing the clinical and pathological features of ciliary body medulloepithelioma is useful to further understand ciliary body medulloepithelioma, and can make an accurate diagnosis and better treatment.]]></description>
<pubDate>2023/3/2 15:56:07</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jing He, Cheng Pei, Xin Ge, Jian-Min Ma and Ya-Guang Hu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jing He, Cheng Pei, Xin Ge, Jian-Min Ma and Ya-Guang Hu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230308]]></guid><cfi:id>46</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Application of immersion B-scan ultrasonography in diagnosis of complex retinal detachment, persistent hyperplastic primary vitreous and intraocular tumors]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230309]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the diagnostic value of panoramic immersion B-scan ultrasonography (Pano-immersion B-scan, PIB) in complex retinal detachment (RD), persistent hyperplastic primary vitreous (PHPV) and intraocular tumors.METHODS: The clinical data of 44 patients collected from May 2012 to December 2019 in Chinese PLA General Hospital was retrospectively studied. All of these patients underwent PIB of the eye, because it was difficult to diagnose by routine ocular fundus examination, conventional ultrasound or/and ultrasonic biomicroscope (UBM) due to opacity of refractive media, pupillary occlusion, large involvement or special location of the lesion. The imaging features of difficult cases in PIB were analyzed. The diagnosis accuracy rating of PIB were evaluated and contrasted with conventional ultrasound or UBM by the standard of intraoperative diagnosis or/and pathological results.RESULTS: According to intraoperative diagnosis or pathological results as gold standard, among the 44 cases, there were 19 cases missed diagnosis, misdiagnosed or difficult-to-diagnose by conventional ultrasound or UBM, including 4 cases of long-standing RD difficult to diagnose, 4 cases misdiagnosed, and 11 cases incompletely observed or miss diagnosed. The diagnostic accuracy rate of PIB and conventional ultrasound or UBM were 100% (44/44) and 56.82% (25/44), and the sensitivity of them were 100% and 56.82%. All the patients underwent PIB and were diagnosed as RD (15 cases), retinal and choroidal detachment (4 cases), subchoroidal hematocele (1 case), vitreous opacity and/or organic membrane formation (4 cases), PHPV (12 cases), iris and/or ciliary body tumors (3 cases), and choroidal tumors (6 cases). According to the intraoperative diagnosis or pathological results, the diagnostic coincidence rate of PIB was 100%, which was significantly higher than conventional ultrasound and UBM.CONCLUSION: PIB can help to accurately diagnose complex RD, PHPV, and intraocular masses with special location or/and excessive size. It has important diagnostic value for patients with equivocal findings at conventional ultrasound examination.]]></description>
<pubDate>2023/3/2 15:56:08</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Qing-Hua Yang, An-Qi Liu, Ying-Xin Qu, Hong-Tao Zhang, Bing Chen, Yan Li, Liang Jia and Li-Qiang Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Qing-Hua Yang, An-Qi Liu, Ying-Xin Qu, Hong-Tao Zhang, Bing Chen, Yan Li, Liang Jia and Li-Qiang Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230309]]></guid><cfi:id>45</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effectiveness of modified inferior oblique muscle belly transposition for V-pattern exotropia combined with mild to moderate inferior oblique muscle overaction]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230310]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the effectiveness of a modified inferior oblique muscle belly transposition for treatment of V-pattern exotropia combined with mild to moderate inferior oblique muscle overaction.METHODS: Thirteen cases (23 affected eyes) of V-pattern exotropia with inferior oblique muscle overaction (+ or ++) who underwent the modified inferior oblique muscle belly transposition procedure were retrospectively reviewed. The amount of V-pattern, grade of inferior oblique overaction, degree of vertical strabismus, abnormal head posture, and the fovea-disc angle were evaluated before and after surgery.RESULTS: The V-pattern was corrected in all cases, and the amount of V-pattern reduced by 17.85±5.13 prism diopter (PD) on average (t=16.07, P&#x003C;0.001). The surgical cure rate for mild to moderate inferior oblique muscle overaction was 87.0% (20/23). The degree of the fovea-disc angle has a mean reduction of 5.45°±2.87° (t=3.95, P=0.003) after surgery. The mean vertical deviation in 5 cases with a small-angle hypertropia (5.23±3.06 PD) in the primary position reduced by 3.15±1.86 PD (t=6.10, P&#x003C;0.001). No serious complications were observed.CONCLUSION: The modified inferior oblique muscle belly transposition procedure can effectively treat mild to moderate inferior oblique overaction and relieve the V-pattern, which is safe and easy to perform.]]></description>
<pubDate>2023/3/2 15:56:08</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yang Hao, Ming Zhang, Yue Bian, Jing-Ming Li and Li Qin]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yang Hao, Ming Zhang, Yue Bian, Jing-Ming Li and Li Qin</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230310]]></guid><cfi:id>44</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Adjuvant therapy for orbital non-rhabdomyosarcoma soft tissue sarcoma: comparison of long-term outcome between radiotherapy and chemotherapy]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230311]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To illustrate clinicopathological features of orbital non-rhabdomyosarcoma soft tissue sarcoma (NRSTS), and to compare the treatment outcome between postoperative radiotherapy (RT) and chemotherapy in a retrospective analysis nearly 20y.METHODS: A retrospective cohort study of 56 patients with orbital NRSTS were reviewed, 34 of whom received postoperative RT, and 22 received postoperative chemotherapy. The clinicopathological features, local recurrence, metastases, and survival data were recorded. Survival analysis was performed using the Kaplan-Meier method.RESULTS: During follow-up (111.8mo, ranged 8-233mo) for 56 patients, 19 patients of them developed local recurrence, and 7 patients developed distant metastases. Fifteen patients died during follow-up period. Overall survival rates considering the whole study group was 78.57% at 5y, and 72.16% at 10y after the initial diagnosis. Compared with chemotherapy, RT was associated with lower risk of local recurrence [hazard ratio for RT vs chemotherapy, 0.263, 95% confidence interval (CI), 0.095-0.728, P=0.0015]; with lower risk of distant metastasis (hazard ratio for RT vs chemotherapy, 0.073, 95%CI, 0.015-0.364, P=0.0014); and with lower risk of death from disease (hazard ratio for RT vs chemotherapy, 0.066, 95%CI, 0.022-0.200, P&#x003C;0.0001). The 5-year survival rate in RT group was 97.06% compared to 50% in chemotherapy group.CONCLUSION: In patients with orbital NRSTS, postoperative RT provides better control of local recurrence, distant metastasis, and death from disease than chemotherapy. RT is the more preferrable adjuvant therapy compared to chemotherapy possibly.]]></description>
<pubDate>2023/3/2 15:56:08</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Xiao-Feng Li, Rui-Qi Ma, Xue Wu, Lu Gan, Zhi-Yu Peng and Jiang Qian]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Xiao-Feng Li, Rui-Qi Ma, Xue Wu, Lu Gan, Zhi-Yu Peng and Jiang Qian</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230311]]></guid><cfi:id>43</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Difference of anterior and posterior orbital development in patients with congenital microphthalmia: a retrospective cohort study from China]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230312]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate volume differences between anterior and posterior orbit and demographic characteristics of Chinese patients with congenital microphthalmia.METHODS: A retrospective cohort study, involving 169 unilateral congenital microphthalmia patients aged between 1 and 57 years old was conducted. Three-dimensional images of the orbit were generated from past CT scans, and digital orbital volume comprehensive measurement was done. The measured data included orbital volume (OBV), posterior orbital volume (POV), orbital width (OBW), orbital height (OBH), orbital depth (OBD), and posterior orbital area ratio.RESULTS: Significant differences were observed among OBV, POV, OBW, OBH, and OBD of the affected and unaffected eyes in different age-based groups (all P&#x003C;0.001). Among them, OBH had the greatest different. The mean microphthalmic to contralateral ratio (MCR) of OBV, POV, OBW, and OBH continuously increased from 1 to 3 years old, whereas the MCR of POV decreased from 3 to 17 years old. The MCR of OBD was not found to be correlated to age. There was no significant difference between OBV, POV, OBW, and OBH in ages from 13 years old to adulthood (all P&#x003E;0.05). The difference in posterior orbital area ratio between the affected and unaffected groups was not statistically significant (P&#x003E;0.05).CONCLUSION: OBH is maximally affected, whereas OBD is minimally affected by microphthalmia. Posterior orbital retardation began 2y prior to orbital retardation and occurred at 3 years old in the affected eye, suggesting that intervention therapy should be done before the age of 4.]]></description>
<pubDate>2023/3/2 15:56:08</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ju Zhang, Zhi-Jia Hou, Jun-Fang Xian, Qing-Lin Chang and Dong-Mei Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ju Zhang, Zhi-Jia Hou, Jun-Fang Xian, Qing-Lin Chang and Dong-Mei Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230312]]></guid><cfi:id>42</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Should ocular Demodex be checked and treated in refractory keratitis patients without blepharitis?]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230205]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the correlation between Demodex infestation and keratitis, and to assess demodicosis using a simple approach.METHODS: A modified slit lamp illumination (at 40× magnification) was used to observe Demodex tails in 40 patients with refractory keratitis and 80 healthy controls. Bacterial smear and culture of the conjunctival sac and corneal lesion were performed to identify the pathogen. Tea tree oil ointment (TTOO) was added as a Demodex killing agent for lid scrubs to the treatment when Demodex infestation was confirmed.RESULTS: Demodex tails were found in all patients compared to 42/80 of the controls (P<0.01). Seventeen patients presented blepharitis, while 23 were free of scales and inflammation at the lid margin. The demodicosis was mild, moderate, and severe in 8, 19, and 13 patients, respectively, compared to mild in 42 controls (P<0.01). The keratitis was mild, moderate, and severe in 13, 19, and 8 patients, respectively. The severity of Demodex infestation was not correlated to the severity of keratitis (P=0.126). The growth of Staphylococcus was revealed in nine patients who did not react to antibiotic eye drops prior to the TTOO treatment. Patients’ signs and symptoms got resolved after the lid scrub with TTOO.CONCLUSION: Ocular Demodex needs to be checked and treated in refractory keratitis patients with or without blepharitis. A slit-lamp illumination under high magnification favors the judgment of the severity of Demodex infestation.]]></description>
<pubDate>2023/2/2 15:59:15</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ying-Ying Gao, Ting Wang, Yu-Ting Jiang, Ming-Jun Yang, Xiu-Hai Lu, Ling Zheng, Shu-Ting Wang and Wei-Yun Shi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ying-Ying Gao, Ting Wang, Yu-Ting Jiang, Ming-Jun Yang, Xiu-Hai Lu, Ling Zheng, Shu-Ting Wang and Wei-Yun Shi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230205]]></guid><cfi:id>41</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Trends in operating room-based glaucoma procedures at a single eye center from 2016–2020]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230206]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate trends in glaucoma procedures at the Peking University Eye Center in 2016–2020.METHODS: A retrospective search of all glaucoma procedures performed at our institution were performed. Data were analyzed by calculating the absolute numbers and relative weightage of each procedure per year.RESULTS: The average age of glaucoma patients undergoing surgical procedures was 62.33±17.87y, and 55% were women. From 2016 to 2019, the number of surgical procedures performed in glaucoma patients showed an overall upward trend from 749 to 1460, although it decreased slightly in 2020 (n=1393), probably due to the COVID-19 pandemic. The number of trabeculectomies did not change significantly in 2016 (n=161) to 2018 (n=164) but decreased in 2019 (n=139) to 2020 (n=121), indicating a reduction in its relative weightage among glaucoma procedures (from 21.50% to 8.69%). The number of glaucoma drainage device implantations and minimally invasive glaucoma surgeries both increased (50 and 58 respectively in 2019), except in 2020. The number of transscleral cyclophotocoagulation procedures was relatively stable, increasing until 2017 (n=218) and then decreasing. Cataract surgeries with or without glaucoma procedures accounted for a large number of the total surgeries, increasing from 247 (32.97%) in 2016 to 967 (69.42%), among which cataract extraction combined with goniosynechialysis was the most frequent.CONCLUSION: The overall increase in the number of operating room-based surgical procedures is significant. Trabeculectomy is one of the most commonly performed procedures, despite the relative decline in its weightage. Other procedures, including use of glaucoma drainage devices and mini shunts and minimally invasive glaucoma surgeries, are gaining greater acceptance. Notably, lens-related surgery plays an important role in glaucoma management.]]></description>
<pubDate>2023/2/2 15:59:16</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Di Zhang, Jin-Hong Miao, Ling-Ge Suo, Ya-Nan Li, Xu-Hao Chen, De-Fu Wu, Qian-Ru Wu and Chun Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Di Zhang, Jin-Hong Miao, Ling-Ge Suo, Ya-Nan Li, Xu-Hao Chen, De-Fu Wu, Qian-Ru Wu and Chun Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230206]]></guid><cfi:id>40</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Nomogram for predicting non-proliferative vitreoretinopathy probability after vitrectomy in eyes with rhegmatogenous retinal detachment]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230207]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To identify the risk factors for postoperative proliferative vitreoretinopathy (PVR) in patients with primary rhegmatogenous retinal detachment (RRD) and develop a nomogram for predicting postoperative PVR-free probability.METHODS: A total of 741 patients (741 eyes) diagnosed with primary RRD who underwent first surgery in the same hospital were retrospectively reviewed and randomly assigned with 521 to the training set and 220 to the validation set. Univariate and multivariate logistic regression analyses were performed in the training cohort to determine risk factors to construct a nomogram for predicting the 3-, 4-, 5-, and 6-month postoperative PVR-free probabilities. Nomogram performance was estimated by the concordance index (C-index), calibration plot, and the area receiver operating characteristic (ROC) curve.RESULTS: A nomogram was constructed based on the preoperative PVR, silicone oil tamponade time (SOTT), photocoagulation energy (PE), retinal tear size (RTS), and hypertension. In the training set, the C-index of the nomogram was 0.896, 0.936, 0.961, and 0.972 at 3, 4, 5, and 6mo, respectively. The C-index values in the validation set were 0.860, 0.936, 0.951, and 0.965 at 3, 4, 5, and 6mo, respectively. Decision-curve analysis indicated that only the 4-, 5-, and 6-month nomograms had significant net benefits over a large threshold probabilities interval.CONCLUSION: Preoperative PVR, SOTT, PE, RTS, and hypertension are significant risk factors for postoperative PVR formation in patients with primary RRD. The proposed nomogram can effectively predict the 4-, 5-, and 6-month PVR-free probabilities after surgery and assist in making clinical decisions during follow-up.]]></description>
<pubDate>2023/2/2 15:59:16</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Zhi-Qiang Gao, Pei-Yu Wu, Jing Zhang, Zhi-Sheng Ke, Xu-Ting Hu, Zhao-Liang Zhang, Jing-Wei Zheng, Zong-Duan Zhang and Qin-Tuo Pan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zhi-Qiang Gao, Pei-Yu Wu, Jing Zhang, Zhi-Sheng Ke, Xu-Ting Hu, Zhao-Liang Zhang, Jing-Wei Zheng, Zong-Duan Zhang and Qin-Tuo Pan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230207]]></guid><cfi:id>39</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Retinal neurodegeneration in metabolic syndrome: a spectral optical coherence tomography study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230208]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the effects of metabolic syndrome (MetS) on retinal neurodegeneration by optical coherence tomography (OCT).METHODS: Patients diagnosed as MetS were compared with the age and sex-matched healthy control group (CG). Waist circumference measurements, fasting serological biochemical tests, and systemic blood pressures of all participants were evaluated. The MetS group was divided into 3 subgroups according to the number of MetS components: hypertension, diabetes mellitus, dyslipidemia (low-, high-density lipoprotein, hypertriglyceridemia), and visceral obesity findings; 3-component MetS3, 4-component MetS4, and all-component MetS5. All patients underwent complete eye examination and spectral OCT retinal imaging.RESULTS: Totally 58 eyes of 58 patients were included in the MetS group and 63 eyes of 63 age and sex-matched healthy subjects were included in CG. MetS group was composed of 22 subjects in MetS3, 21 subjects in MetS4, and 15 subjects in the MetS5 subgroup. Mean foveal thickness (MetS, 218.7±23.1 µm vs CG, 228.8±21.9 µm, P=0.015), mean inferior (MetS, 283.4±17.0 µm vs CG, 288.7±38.4 µm, P=0.002), superior (MetS, 287.0±18.5 µm vs CG 297.3±17.1 µm, P=0.001), nasal (MetS 287.3±16.7 µm vs CG 297.9±13.9 µm, P=0.000) and temporal (274.5±17.6 µm vs CG 285.6±13.6 µm, P=0.000) thickness in the 3 mm Early Treatment of Diabetic Retinopathy Study (ETDRS) circle was significantly lower in the MetS group. There was no statistically significant difference in the mean inferior, superior, nasal, and temporal thickness of 6 mm ETDRS circle, total macular volume, peripapillary and macular retinal nerve fiber layer, macular ganglion cell layer with inner plexiform layer, and ganglion cell complex. No statistically significant difference was found in these values ​​between the MetS3, MetS4, and the MetS5 groups.CONCLUSION: A significant reduction in central macular region thickness in MetS is detected and macular thickness is more susceptible to MetS induced neurodegeneration than peripapillary retinal nerve fiber layer.]]></description>
<pubDate>2023/2/2 15:59:16</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Evrim Polat, Ekrem Celik, Mesut Togac and Afsun Sahin]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Evrim Polat, Ekrem Celik, Mesut Togac and Afsun Sahin</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230208]]></guid><cfi:id>38</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Optical coherence tomography enhanced depth imaging of chorioretinal folds in patients with orbital tumors]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230209]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To characterize spectral-domain optical coherence tomography (SD-OCT) features of chorioretinal folds in orbital mass imaged using enhanced depth imaging (EDI).METHODS: Prospective observational case-control study was conducted in 20 eyes of 20 patients, the uninvolved eye served as a control. All the patients underwent clinical fundus photography, computed tomography, EDI SD-OCT imaging before and after surgery. Two patients with cavernous hemangiomas underwent intratumoral injection of bleomycin A5; the remaining patients underwent tumor excision. Patients were followed 1 to 14mo following surgery (average follow up, 5.8mo).RESULTS: Visual acuity prior to surgery ranged from 20/20 to 20/200. Following surgery, 5 patients’ visual acuity remained unchanged while the remaining 15 patients had a mean letter improvement of 10 (range 4 to 26 letters). Photoreceptor inner/outer segment defects were found in 10 of 15 patients prior to surgery. Following surgical excision, photoreceptor inner/outer segment defects fully resolved in 8 of these 10 patients.CONCLUSION: Persistence of photoreceptor inner/outer segment defects caused by compression of the globe by an orbital mass can be associated with reduced visual prognosis. Our findings suggest that photoreceptor inner/outer segment defects on EDI SD-OCT could be an indicator for immediate surgical excision of an orbital mass causing choroidal compression.]]></description>
<pubDate>2023/2/2 15:59:16</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Zhi-Yu Peng, Lu Gan, Kang Xue, Akrit Sodhi, Xiao-Feng Ye, Hui Ren and Jiang Qian]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zhi-Yu Peng, Lu Gan, Kang Xue, Akrit Sodhi, Xiao-Feng Ye, Hui Ren and Jiang Qian</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230209]]></guid><cfi:id>37</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparative study of functional optical zone: small incision lenticule extraction versus femtosecond laser assisted excimer laser keratomileusis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230210]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the size of functional optical zone (FOZ) after small incision lenticule extraction (SMILE) versus femtosecond laser assisted excimer laser keratomileusis (FS-LASIK) for myopia correction and potential associated factors for FOZ.METHODS: A total of 133 patients who received corneal refractive surgery in our hospital between November 2018 and July 2021 were retrospectively enrolled. There were 63 patients (123 eyes) in SMILE group and 70 patients (139 eyes) in FS-LASIK group. The size of FOZ was measured using Pentacam 3-dementional anterior segment analyzer before and 3mo after surgery, so as to analyze postoperative achieved functional optical zone (AFOZ) and its contributing parameters.RESULTS: When planned functional optical zone (PFOZ) was 6.5 mm for both groups, AFOZ was 1.45±0.27 and 1.67±0.25 mm smaller than preoperative FOZ in SMILE group and FS-LASIK group 3mo after surgery. AFOZ in SMILE group was significantly larger than that in FS-LASIK group (P<0.001). Variation of FOZ was negatively correlated with preoperative spherical equivalent (SE) and positively correlated with variation of mean keratometry value (△Km), variation of spherical aberration (△SA), and variation of Q-value (△Q, all P<0.001) in both groups. Multiple variable linear regression equations were △FOZ=1.354-0.1×pre-SE+0.336×△Q+1.462×△SA in SMILE group and △FOZ=1.512+0.137×△Q+0.468×△SA in FS-LASIK group.CONCLUSION: AFOZ is significantly smaller than preoperative FOZ in both SMILE and FS-LASIK groups. With the same PFOZ, larger AFOZ is achieved in SMILE group than in FS-LASIK group.]]></description>
<pubDate>2023/2/2 15:59:16</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yao-Wen Song, Meng-Fan Cui, Yi Feng, Min Qu, Yan Gao and Rui He]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yao-Wen Song, Meng-Fan Cui, Yi Feng, Min Qu, Yan Gao and Rui He</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230210]]></guid><cfi:id>36</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effects of slanted bilateral lateral recession vs conventional bilateral lateral recession on convergence insufficiency intermittent exotropia: a prospective study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230211]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To observe the surgical effects of slanted bilateral lateral recession (S-BLR) versus conventional bilateral lateral recession (C-BLR) in convergence insufficiency intermittent exotropia (CI-IXT).METHODS: Using a randomized, double-blind, prospective design, 22 patients with CI-IXT who were admitted to Renmin Hospital of Wuhan University from July 2019 to December 2020 were included. Patients were randomly divided into either S-BLR or C-BLR group for their subsequent strabismus surgery. All patients were followed up for 12mo. Near deviation, distant deviation, and near-distance difference (NDD) were measured in all patients.RESULTS: Twelve months after surgery, NDD improvement was 10 (8, 13) prismatic degrees (PD) in S-BLR group and 3 (1, 6) PD in C-BLR group (P=0.011). The near deviation of S-BLR group was 0 (-2, 2) PD, while that of C-BLR group was -4 (-6, -3) PD (P=0.005). Before and after surgery, the difference in the distant deviation between the two groups was not statistically significant. There was no statistically significant difference in near stereopsis between the two groups (P=0.380) at 12mo. The success rate at 12mo after operation was 90.91% and 72.73% in the two groups (P=0.280).CONCLUSION: CI-IXT patients treated with S-BLR have better surgical outcomes than those treated with C-BLR, which indicates S-BLR is a safe and effective operation pattern.]]></description>
<pubDate>2023/2/2 15:59:17</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yuan-Jin Li, Xiao-Qi Huang, Bei-Qian Yi, Yi-Jia Zhao, Die-Wen-Jie Hu, Run-Ting Ma, Wen-Ping Li, Mei-Hong Ye and Lian-Hong Zhou]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yuan-Jin Li, Xiao-Qi Huang, Bei-Qian Yi, Yi-Jia Zhao, Die-Wen-Jie Hu, Run-Ting Ma, Wen-Ping Li, Mei-Hong Ye and Lian-Hong Zhou</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230211]]></guid><cfi:id>35</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Destructive effects on endothelial cells of grafts in cytomegalovirus DNA-positive patients after keratoplasty]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230108]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate corneal graft survival rate and endothelial cell density (ECD) loss after keratoplasty in cytomegalovirus (CMV) positive patients.METHODS: This was a retrospective cohort study. We analyzed the clinical data of patients who underwent viral DNA detection in aqueous humor/corneal tissue collected during keratoplasty from March 2015 to December 2018 at the Peking University Third Hospital, Beijing, China. To further evaluate the effect of CMV on graft survival rate and ECD loss, patients were divided into three groups: 1) CMV DNA positive (CMV+) group; 2) viral DNA negative (virus-) group, comprising virus- group eyes pairwise matched to eyes in the CMV+ group according to ocular comorbidities; 3) control group, comprising virus- group eyes without ocular comorbidities. The follow-up indicators including graft survival rate, ECD, ECD loss, and central corneal thickness (CCT), were analyzed by Tukey honestly significant difference (HSD) test.RESULTS: Each group included 29 cases. The graft survival rate in CMV+ group were lowest among the three groups (P=0.000). No significant difference in donor graft ECD was found among three groups (P=0.54). ECD in the CMV+ group was lower than the virus- group at 12 (P=0.009), and 24mo (P=0.002) after keratoplasties. Furthermore, ECD loss was higher in the CMV+ group than in the virus- group in the middle stage (6-12mo) post-keratoplasty (P=0.017), and significantly higher in the early stage (0-6mo) in the virus- group than in the control group (P=0.000).CONCLUSION: CMV reduces the graft survival rate and exerts persistent detrimental effects on the ECD after keratoplasty. The graft ECD loss associate with CMV infection mainly occurrs in the middle stage (6-12mo postoperatively), while ocular comorbidities mainly affects ECD in the early stage (0-6mo postoperatively).]]></description>
<pubDate>2022/12/23 15:16:43</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yun-Xiao Zang, Rong-Mei Peng, Han-Zhi Ben, Jing-Hao Qu, Ge-Ge Xiao, Li-Xue Shuai, Pei Zhang, Li-Na Feng and Jing Hong]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yun-Xiao Zang, Rong-Mei Peng, Han-Zhi Ben, Jing-Hao Qu, Ge-Ge Xiao, Li-Xue Shuai, Pei Zhang, Li-Na Feng and Jing Hong</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230108]]></guid><cfi:id>34</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Clinical observation of recombinant human nerve growth factor in the treatment of neurotrophic keratitis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230109]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To characterize changes of corneal nerve morphology and tear indices in patients with neurotrophic keratitis (NK) treated with recombinant human nerve growth factor (rhNGF).METHODS: In a prospective observational study, six patients (nine eyes) were locally treated with rhNGF. Visual acuity, corneal fluorescein staining score, the heights of the tear river, lipid layer thickness (LLT), tear ferning (TF) test, conjunctival impression cytology (CIC) examination, the densities of cornea subbasal nerve fibers were determined before and after treatment.RESULTS: Compared with baseline, there was a significant difference in corneal fluorescence staining scores (P<0.01); all patient corneal epithelial defects recovered completely within 8wk, but there was no significant improvement in the height of the tear river (P=0.202). LLT was significantly increased when compared with baseline (P=0.042); however, the function of conjunctival goblet cells and mucin content did not significantly improve using the TF test and CIC examination (P=0.557, P=0.539). After 8wk of treatment, the average corneal subbasal nerve fiber density increased significantly (P<0.01), as did the number of corneal nerve fiber branches (P=0.001).CONCLUSION: RhNGF can increase the density of corneal subbasal nerve fibers, promote the healing of persistent corneal epithelial defects and corneal ulcers in patients with NK, also improving tear function partially.]]></description>
<pubDate>2022/12/23 15:16:43</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mi Hao, Yan Cheng, Jie Wu, Yu Cheng and Jing Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mi Hao, Yan Cheng, Jie Wu, Yu Cheng and Jing Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230109]]></guid><cfi:id>33</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Efficacy of custom-made soft keratoconus lenses on corneal aberrations and photic phenomena in patients with keratoconus: a corneal topography imaging based study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230110]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the efficacy of custom-made soft keratoconus (KC) lenses on corneal aberrations and photic phenomena in two different optical zones in patients with KC.METHODS: Sixty eyes of 42 patients with KC were examined at baseline and after fitting HydroCone (Toris K) soft silicone hydrogel lenses. Best spectacle-corrected visual acuity (BSCVA) and contact lens-corrected visual acuity (CLCVA) were recorded. Lower- and higher-order corneal aberrations (LOAs and HOAs) were measured with and without Toris K lenses and compared in central 4.5 mm and 7 mm zones. Mesopic pupil diameter and subjective photic phenomena were also assessed.RESULTS: Mean CLCVA was significantly improved compared to BSCVA (P<0.0001). Corneal curvature and refractive measurements were found to be significantly reduced by the use of Toris K lenses, except for posterior corneal curvature values. In the 4.5 mm central optical zone, all wavefront aberrations decreased significantly after lens fitting (P<0.0001). In contrast, in the 7 mm (peripheral) optical zone, values for HOAs, spherical and residual aberrations, and optical path differences were increased, while LOAs, trefoil, and quadrifoil coefficients were decreased. The rate of photic phenomena was significantly higher in participants with a pupil size >6.00 mm (85.7%).CONCLUSION: Toris K lenses provide good visual results and a significant reduction in central corneal aberrations in patients with KC but could cause an increase in peripheral aberrations. This practical and nonsurgical approach appears to be an effective method for the visual management of KC.]]></description>
<pubDate>2022/12/23 15:16:43</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Aysegul Penbe, Hatice Selen Kanar, Aysu Karatay Arsan and Sevda Aydın Kurna]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Aysegul Penbe, Hatice Selen Kanar, Aysu Karatay Arsan and Sevda Aydın Kurna</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230110]]></guid><cfi:id>32</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of success rate and intraocular pressure spikes between selective laser trabeculoplasty and micropulse laser trabeculoplasty in African American and Hispanic patients]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230111]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To examine the efficacy and safety of micropulse laser trabeculoplasty (MLT) versus selective laser trabeculoplasty (SLT) in a large cohort of primarily African American and Hispanic patients.METHODS: A single center retrospective comparative cohort review conducted at Cook County Health facilities that included patients with a diagnosis of open angle glaucoma or ocular hypertension who received an SLT or MLT procedure between January 2017 and May 2021.RESULTS: Totally 131 eyes of 99 patients were analyzed. The 77 eyes received SLT and 54 received MLT. Seven out of 77 eyes in the SLT group (9.1%) and 1 out of 54 eyes in the MLT group (1.9%) had an IOP spike (defined as > 5 mm Hg) at either 1h or 1wk after procedure (P=0.05, Chi-squared test with Haldane-Anscombe correction). The procedure failure rate at one year was 50% for SLT and 48% for MLT (P=0.31).CONCLUSION: MLT has a significantly lower incidence of pressure spikes and a similar treatment failure rate at 1-year post-procedure, demonstrating that it is a reasonable alternative compared to SLT.]]></description>
<pubDate>2022/12/23 15:16:43</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Alexander Z Robin, Palwasha Syar, Dana Darwish, Catherine Thomas, N.M. Pfahler, Agni Kakouri, Thomas Patrianakos and Michael Giovingo]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Alexander Z Robin, Palwasha Syar, Dana Darwish, Catherine Thomas, N.M. Pfahler, Agni Kakouri, Thomas Patrianakos and Michael Giovingo</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230111]]></guid><cfi:id>31</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Macular vascularisation changes analysed using OCT angiography after successful rhegmatogenous retinal detachment repair]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230112]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyse the macular vascularisation changes analysed using optical coherence tomography angiography (OCTA) after successful rhegmatogenous retinal detachment (RRD) repair by comparing gas vs silicone oil and macula-on vs macula-off.METHODS: This retrospective data collection included 77 eyes with RRD that underwent pars plana vitrectomy (PPV) and gas or silicone oil tamponade. We performed an OCTA during the postoperative control between 6 and 24mo after the last surgery and evaluated the main parameters measured by OCTA: foveal avascular zone (FAZ) and parafoveolar vascular density (PVD) in the superficial capillary plexus. The patients were divided into four groups: RRD with macular involvement treated with gas tamponade, RRD without macular involvement treated with gas tamponade, RRD with macular involvement treated with silicone oil tamponade and RRD without macular involvement treated with silicone oil tamponade. A one-way ANOVA test combined with post hoc Bonferroni corrections compared FAZ sizes and PVD in all four groups.RESULTS: The FAZ size was statistically significantly larger in eyes with RRD involving the macula than in those not involving it (P=0.005). There was no statistically significant difference in the FAZ sizes of the eyes treated with silicone oil tamponade compared to those treated with gas tamponade (P=0.54). There was no statistically significant difference in the PVD comparing all four groups.CONCLUSION: Despite the known risks associated with silicone oil, our findings suggest that the type of tamponade used during PPV to treat an RRD has no significant effect on the future integrity of the PVD or the size of the FAZ in the superficial capillary plexus as measured by OCTA.]]></description>
<pubDate>2022/12/23 15:16:43</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Marie Hartmann, Alaa Din Abdin, Doris Fraenkel, Christian Munteanu, Berthold Seitz and Shady Suffo]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Marie Hartmann, Alaa Din Abdin, Doris Fraenkel, Christian Munteanu, Berthold Seitz and Shady Suffo</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230112]]></guid><cfi:id>30</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Morphological and functional changes in the macular area in diabetic macular edema after a single intravitreal injection of aflibercept]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230113]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the changes in macular morphology and function after a single intravitreal injection of aflibercept in diabetic macular edema (DME) using optical coherence tomography angiography (OCTA) and MP-3 microperimetry.METHODS: Twenty-eight patients (42 eyes) diagnosed with DME were treated with intravitreal injection of aflibercept. The changes in best corrected visual acuity (BCVA), central retinal thickness (CRT), foveal avascular zone (FAZ) area, vessel density of superficial retinal capillary plexus (SVD), vessel density of deep retinal capillary plexus (DVD), mean light sensitivity (MLS), 2° fixation rate (P1), 4° fixation rate (P2), and other indicators 1mo after treatment were compared; of these, BCVA was converted into logarithm of the minimum angle of resolution (logMAR), and the correlation among the factors was analyzed.RESULTS: After treatment, logMAR BCVA was 0.47±0.24, which was significantly better than that before treatment (0.63±0.28, P<0.001). The CRT was 359.21±107.87 μm after treatment, which was significantly lower than before treatment (474.10±138.20 μm, P<0.001). The FAZ area, SVD, and DVD were not significantly changed after treatment compared with the baseline. MLS was 22.16±4.20 dB after treatment, which was significantly higher than before treatment (19.63±4.23 dB, P<0.001). P2 significantly increased after treatment than before treatment (P=0.007). P1 had no significant change after treatment than before treatment (P=0.086).CONCLUSION: A single intravitreal injection of aflibercept effectively reduces macular edema and improves retinal sensitivity, fixation stability, and visual acuity, possibly without causing significant changes in the retinal vascular condition in a short time.]]></description>
<pubDate>2022/12/23 15:16:43</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Chuan-He Zhang, Bin Gong, Chao Huang, Xiang-Wen Shu, Tian-Yu Chen, Xuan Chen, Chang-Long Wu and Yu Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Chuan-He Zhang, Bin Gong, Chao Huang, Xiang-Wen Shu, Tian-Yu Chen, Xuan Chen, Chang-Long Wu and Yu Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230113]]></guid><cfi:id>29</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Recurrence risk factors of intravitreal ranibizumab monotherapy in retinopathy of prematurity: a retrospective study at one center]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230114]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To identify risk factors of recurrence of this disorder after intravitreal ranibizumab (IVR) monotherapy.METHODS: Totally 33 eyes of 19 patients who underwent initial IVR treatments for type 1 retinopathy of prematurity (ROP) at our center were retrospectively reviewed between April 1, 2016 and December 31, 2017. Patient demographics, the side of ROP, multiple gestations, Apgar scores, zone, stage, plus disease, postmenstrual age at injection, surfactant therapy, blood transfusion therapy, hemorrhage before IVR, hemorrhage after IVR, gestational diabetes mellitus, pregnancy-induced hypertension, anemia, intraventricular hemorrhage, sepsis, respiratory distress syndrome, carbohemia, and congenital heart defects were recorded. Adjusted hazard ratios (HRs) and 95% confidence intervals were determined after adjusting for potential confounders using multivariate proportional Cox regression.RESULTS: Of the 33 eyes, 12 (36.4%) had ROP recurrences 45.3 (5.1, 50.9)mo after initial IVR treatments. The independent risk factors for ROP recurrences were zone (¢ò vs ¢ñ, HR: 0.056, P=0.003) and gestational diabetes mellitus (no vs yes, HR: 0.095, P<0.001). The mean uncorrected visual acuity for four recurrence eyes was 0.46 logMAR (0.13, 0.70) at 55.0 (51.0, 58.9) mo after the initial IVR treatment. The mean uncorrected visual acuity for 10 eyes without recurrence was 0.46 logMAR (0.19, 0.63) at 48.0 (43.8, 58.4) mo after the initial IVR treatment.CONCLUSION: Two independent risk factors for type 1 ROP recurrence after IVR treatment involving zone¢ñand gestational diabetes mellitus are identified, and the mean uncorrected visual acuity is 0.46 logMAR at 51.0 (44.0, 58.9)mo. The findings of this study are important for follow-up management and for improving the visual function of ROP patients.]]></description>
<pubDate>2022/12/23 15:16:44</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Feng-Yue Wu, Wen-Ting Yu, Dai-Xin Zhao, Wei Pu, Xue Zhang and Chun-Liu Gai]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Feng-Yue Wu, Wen-Ting Yu, Dai-Xin Zhao, Wei Pu, Xue Zhang and Chun-Liu Gai</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230114]]></guid><cfi:id>28</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Changes of optic nerve head microcirculation in high myopia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230115]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyze the correlation of age, spherical equivalent (SE), and axial length (AL) with the microcirculation of optic nerve head (ONH) in high myopia (HM).METHODS: In this cross-sectional clinical study, 164 right eyes were included. Optical coherence tomography angiography (OCTA) was used to detect ONH vessel density. Eyes were classified based on age, SE, and AL. Groups of Age1, Age2, and Age3 were denoted for age classification (Age1<20y, 20y≤Age2<30y, Age3≥30y); Groups SE1, SE2, and SE3 for the SE classification (-9≤SE1<-6 D, -12≤SE2<-9 D, SE3<-12 D); Groups AL1, AL2, AL3, and AL4 for the AL classification (AL1<26 mm, 26≤AL2<27 mm, 27≤AL3<28 mm, AL4≥28 mm).RESULTS: No significant difference was observed in vessel density among the Age1, Age2, and Age3 groups (all P>0.05) and the SE1, SE2, and SE3 groups (all P>0.05). No significant difference was observed in the intrapapillary vascular density (IVD) among AL1, AL2, AL3, and AL4 groups (P>0.05). However, a significant decrease was found in the peripapillary vascular density (PVD) in the AL1, AL2, AL3, and AL4 groups (F=3.605, P=0.015), especially in the inferotemporal (IT; F=6.25, P<0.001), temporoinferior (TI; F=2.865, P=0.038), and temporosuperior (TS; F=6.812, P<0.001) sectors. The IVD was correlated with age (r=-0.190, P<0.05) but not with SE or AL (P>0.05). The PVD was correlated with AL (r=-0.236, P<0.01) but not with age or SE (P>0.05).CONCLUSION: With the increase of AL, the IVD remains stable while the PVD decreases, especially in the three directions of temporal (IT, TI, and TS). The main cause of microcirculation reduction may be related to AL elongation rather than an increase in age or SE.]]></description>
<pubDate>2022/12/23 15:16:44</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Wen-Quan Tang, Yu-Lin Luo, Xi-Lang Wang and Xuan-Chu Duan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Wen-Quan Tang, Yu-Lin Luo, Xi-Lang Wang and Xuan-Chu Duan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20230115]]></guid><cfi:id>27</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of visual performance with iTrace analyzer following femtosecond laser-assisted cataract surgery with bilateral implantation of two different trifocal intraocular lenses]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231106]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the postoperative binocular visual performance with an iTrace analyzer following femtosecond laser-assisted cataract surgery (FLACS) combined with bilateral implantation of two different types of diffractive trifocal intraocular lenses (IOL).METHODS: During this retrospective observational study, patients who received bilateral FLACS combined with implantation of two different types of diffractive trifocal IOLs were evaluated. According to the IOLs’ different types and design, the patients were divided into AT LISA tri839MP group (tri839 group) and AcrySof PanOptix TFNT00 group (TFNT group). Study parameters included preoperative and postoperative uncorrected distance visual acuity (UDVA) at 5 m, uncorrected near visual acuity (UNVA) at 30 cm and 40 cm, uncorrected intermediate visual acuity (UIVA) at 60 cm and 80 cm, postoperative refractive status, objective visual qualities and total high order aberrations (HOAs) postoperatively. The postoperative complications were also recorded.RESULTS: Totally 56 eyes of 28 patients (tri839 group, n=26; TFNT group, n=30) were included. Preoperative baseline characteristics between groups were not statistically significantly different. UDVA was not significantly different between groups except for 1wk follow-up due to the postoperative corneal edema. TFNT group showed statistically significant better UNIA at 60 cm than tri839 group at the 1wk (0.05±0.19 vs 0.15±0.10 logMAR, P=0.013), 1mo (0.05±0.12 vs 0.15±0.09 logMAR, P=0.001) and 3mo (0.04±0.12 vs 0.15±0.11 logMAR, P=0.001) follow-up, while tri839 group showed statistically significant better UNIA at 80 cm than TFNT group at the 1d (0.14±0.15 vs 0.20±0.14 logMAR, P=0.041) and 1mo (0.09±0.07 vs 0.14±0.10 logMAR, P=0.042) follow-up. Postoperative refractive status showed stable at every visit. Modulated transfer function (MTF) values and strehl ratio (SR) values were improved and HOAs were lower significantly after surgery.CONCLUSION: FLACS with bilateral implantations of both tri839 and TFNT00 can achieve satisfactory natural whole-course vision, high postoperative refractive stability and good visual quality but without significantly difference. iTrace aberration instrument can accurately evaluate the visual quality under different status.]]></description>
<pubDate>2023/10/25 10:43:19</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Rui-Hong Ju, Hao-Kun Qu, Zhe-Ming Wu, Yun Chen, Li-Nan Wu, Yuan Long, Zheng Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Rui-Hong Ju, Hao-Kun Qu, Zhe-Ming Wu, Yun Chen, Li-Nan Wu, Yuan Long, Zheng Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231106]]></guid><cfi:id>26</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of three fundus inspection methods during phacoemulsification in diabetic white cataract]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231107]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate whether Wild Field Imaging System (WFIS SW-8000), 25G endoilluminator, and intraoperative optical coherence tomography (iOCT) can perform real-time screening and diagnosing in patients with suspicious diabetic retinopathy (DR) during phacoemulsification, especially in cases of white cataract.METHODS: A cross-sectional study was carried out. A total of 204 dense diabetic cataractous eyes of 204 patients with suspected DR treated from April 2020 to March 2021 were included. Phacoemulsification combined with intraocular lens implantation was performed. Following the removal of the lens opacity, the 25G endo-illuminator, fundus photography, and iOCT were performed successively. Optical coherence tomography (OCT) and/or fundus fluorescein angiography (FFA) were used to verify the fundus findings postoperatively. Intraoperative and postoperative results were compared to verify the accuracy of intraoperative diagnosis in each group.RESULTS: Intraoperative and postoperative examinations revealed 58 and 62 eyes with DR, respectively (positive rate, 28.43% and 30.39%, respectively). During the phacoemulsification, WFIS SW-8000 detected 44 eyes with DR (the detection rate, 70.97%); 25G endo-illuminator found 56 eyes with DR (the detection rate, 90.32%); iOCT found 46 eyes with DR (the detection rate, 74.19%); and 58 eyes with DR were found by combining the three methods (the detection rate, 93.55%). There were statistically significant differences in the diagnostic sensitivity for DR among the methods (χ2=16.36, P=0.001).CONCLUSION: WFIS SW-8000, 25G endo-illuminator, iOCT, and especially their combination can be used to inspect the fundus and detect DR intraoperatively; they are helpful for the timely diagnosis and treatment of DR in patients with dense cataract.]]></description>
<pubDate>2023/10/25 10:43:20</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Shu Su, Jian Wu, Min Ji, Yu Guan, Yao Shen, Huai-Jin Guan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Shu Su, Jian Wu, Min Ji, Yu Guan, Yao Shen, Huai-Jin Guan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231107]]></guid><cfi:id>25</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Pupillary capture following sutureless scleral-fixated intraocular lens in children with Marfan syndrome]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231108]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the clinical outcomes between two approaches for sutureless scleral-fixated intraocular lens (SFIOL) in children with Marfan syndrome (MFS).METHODS: The study included 15 children (26 eyes) with lens subluxation due to MFS. These children underwent lensectomy, anterior vitrectomy, and sutureless SFIOL. According to the position of placement of intraocular lens (IOL) haptics, two study groups were reviewed for best corrected visual acuity (BCVA) and postoperative complications: group A, 14 eyes with haptics fixated at 2.0 mm from the limbus; group B, 12 eyes with the haptics fixated at 2.5 mm from the limbus.RESULTS: The mean axial length for all patients was 25.66±2.35 mm. Postoperative BCVA in logMAR were significant improved in both groups (0.77±0.32 to 0.17±0.12 in group A, 0.66±0.25 to 0.24±0.12 in group B, both P<0.001) while no significant difference between two groups (P>0.05). Pupillary capture was main postoperative complication, occurring between 3d and 18mo. It occurred in 7 eyes in group A and one eye in group B (P=0.02).CONCLUSION: Sutureless SFIOL is an effective treatment approach for lens subluxation in children with MFS. Pupillary capture is the main postoperative complication. Fixated IOL haptics at 2.5 mm from the limbus can reduce the occurrence of pupillary capture.]]></description>
<pubDate>2023/10/25 10:43:20</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Dong-Mei Qi, Shu-Jia Huo, Tao Yu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Dong-Mei Qi, Shu-Jia Huo, Tao Yu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231108]]></guid><cfi:id>24</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Transient vacuolar changes of the crystalline lens in patients using a dispersive ophthalmic viscosurgical device]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231109]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To report the clinical prognosis and pathological findings of accidental lens vacuolar changes in eyes with intraoperative exposure to a dispersive ophthalmic viscosurgical device (OVD).METHODS: Two patients who developed transient lens vacuolar changes during uneventful persistent pupillary membrane (PPM) removal surgery were presented and followed up. This event was speculated to be associated with an intraoperative dispersive OVD DisCoVisc (hyaluronic acid 1.6%-chondroitin sulfate 4.0%) exposure. Then, to provide the pathological basis for our speculation, another four cataract patients were randomly exposed to different OVDs, and their anterior lens capsules were investigated with transmission electron microscopy (TEM).RESULTS: After months, the subcapsular vacuoles in both PPM cases were gradually disappeared without visual deterioration. For the cataract patients, similar lens changes were observed intraoperatively in those exposed to a dispersive DisCoVisc but not a cohesive OVD IVIZ (sodium hyaluronate gel 1.0%). In addition, marked ultrastructural changes, including chromatin condensation, extensive cytoplasmic vacuoles, and obvious intercellular space between lens epithelial cells in the anterior lens capsules of all eyes exposed to DisCoVisc, were observed by TEM.CONCLUSION: The lens vacuolar changes may be associated with a dispersive OVD exposure. Therefore, it is not preferable to use dispersive OVDs in patients with transparent lenses or without the intention of lens extraction. In addition, close follow-ups instead of immediate lens extraction are recommended for the occurrence of similar lens lesions.]]></description>
<pubDate>2023/10/25 10:43:20</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yue Zhou, Wan Chen, Yu Zhang, Zhuo-Ling Lin, Jing Li, Hui Chen, Wei-Rong Chen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yue Zhou, Wan Chen, Yu Zhang, Zhuo-Ling Lin, Jing Li, Hui Chen, Wei-Rong Chen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231109]]></guid><cfi:id>23</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Long-term efficacy and safety of YAG laser vitreolysis for vision degrading myodesopsia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231110]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the long-term efficacy and safety of yttrium-aluminum garnet (YAG) laser vitreolysis for vision degrading myodesopsia (VDM) caused by posterior vitreous detachment (PVD).METHODS: This retrospective study reviewed VDM patients of PVD type undergoing YAG laser vitreolysis. The baseline demographic information, the patterns of floaters, the number of floaters, and the subjective improvement of floater sympotoms (ranging from 0 to 100%) from medical records were collected. Significant improvement was defined as a relief of floater symptoms of ≥50% at the final visit. The long-term efficacy and safety of YAG laser vitreolysis were analyzed. The risk factors linked to significant improvement of floater symptoms were defined using univariate and multivariate logistic regression analyses.RESULTS: The final analysis included 221 patients with VDM. The mean age of patients was 61.08±7.74y, and the mean length of follow-up was 21.38±5.61mo. Totally 57.01% of patients experienced a significant improvement in their floater symptoms after YAG laser therapy, and none of them developed delayed retinal abnormalities such as retinal tears or detachments. Age (OR=1.049, 95%CI=1.007-1.092, P=0.021) was identified as a significant risk factor for significant improvement in VDM.CONCLUSION: YAG laser vitreolysis is an effective and secure treatment for PVD-type VDM, and patients of advanced age are more likely to get favorable outcomes.]]></description>
<pubDate>2023/10/25 10:43:20</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Tie-Zhu Lin, Cheng Shi, Xing Yang, Emmanuel Eric Pazo, Yan-Nian Hui, Li-Jun Shen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Tie-Zhu Lin, Cheng Shi, Xing Yang, Emmanuel Eric Pazo, Yan-Nian Hui, Li-Jun Shen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231110]]></guid><cfi:id>22</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Efficacy and safety of deep sclerectomy with uveoscleral implant plus collagen matrix implant overcoming the superficial scleral flap in glaucoma surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231111]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the efficacy and safety of non-penetrating deep sclerectomy (NPDS) with uveoscleral implant plus subconjunctival and intrascleral collagen matrix overcoming the superficial scleral flap lips (modified deep sclerectomy technique, DS) and minimal use of mitomycin C in glaucoma surgery.METHODS: A retrospective review of 47 consecutive glaucoma patients who underwent NPDS with DS between January 2017 and May 2018. Best-corrected visual acuity, intraocular pressure (IOP), post-operative need for glaucoma medications, visual field mean deviation (MD), re-interventions, needling revisions and laser goniopuncture were noted. Absolute success was defined as IOP≤18 mm Hg without topical medication. Relative success was defined as the same criteria but with the addition of any antihypertensive medication. IOP over 18 mm Hg on two consecutive follow-up visits was considered as a failure.RESULTS: Fifty-two eyes of 47 patients were evaluated. Mean preoperative IOP was 25.37±6.47 mm Hg, and decreased to 15.04±4.73 at 12mo and 12.21±4.1 at 24mo (all P<0.0001). Requirement for topical medications dropped from a mean of 3.06±0.25 per patient to 0.51±0.99 and 1.11±1.23 respectively after 12 and 24mo (all P<0.0001). No medications were required in 45.5% of patients after 24mo. Relative and absolute success rate at 24mo were 85.5%±5% and 48.5%±7.4%, respectively.CONCLUSION: DS is a safe and effective non-penetrating glaucoma surgery variation. It aims to retain the patency of all pathways created for aqueous humor drainage: the intrascleral bleb, the supraciliary space and the open communication between intrascleral and subconjunctival compartments.]]></description>
<pubDate>2023/10/25 10:43:20</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jéssica Botella-García, Marta Balboa, Pau Romera-Romero, Theo Stijnen, Adrián Sánchez-Fortún, Karl Mercieca, Jordi Loscos-Arenas]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jéssica Botella-García, Marta Balboa, Pau Romera-Romero, Theo Stijnen, Adrián Sánchez-Fortún, Karl Mercieca, Jordi Loscos-Arenas</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231111]]></guid><cfi:id>21</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Choroidal thickness measurements in young Saudi adult population: a cross-sectional study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231112]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To determine the choroidal thickness (CT) in young healthy Saudi adults using spectral-domain optical coherence tomography (SD-OCT) with an automated CT segmentation software.METHODS: Fifty-eight young adults (total of 116 eyes), 39 males and 19 females participated in this study between the ages of 18 and 38y (mean 22.65±3.9y). All participants underwent ophthalmic screening examination, including the SD-OCT for measurements of CT in each quadrant egmented into five eccentric regions starting from the foveal region up to 4.5 mm towards the periphery.RESULTS: The choroid was thickest in the foveal region (central 1 mm, 300±60 µm) and began to progressively thinner beyond the parafovea (1.5–2.5 mm, 284±67 µm) towards the peripheral region (3.5–4.5 mm from the fovea, 254±83 µm). The superior choroid showed the thickest profile (309±57 µm), while the nasal choroid exhibited the thinnest (229±76 µm). The rate of the thinning with increasing eccentricity was more predominant in the nasal choroid, which thinned from the foveal region (294±58 µm) to the peripheral region (158±55 µm). The superior and inferior choroid did not show a statistically significant thinning with eccentricity (all P>0.05). There was no statistically significant difference in the CT between gender, age, and laterality of the eyes (all P>0.05). A significant association of myopia with thinner subfoveal choroid was observed (Pearson’s, r=0.37), and regression analysis showed that a 10.3 µm choroidal thinning for each diopter increase of myopia.CONCLUSION: CT profile depends on eccentric and the quadrant. The CT profile across the measured area in the young Saudi adult population is comparable to other previous reports. Refractive error is critical for CT evaluation.]]></description>
<pubDate>2023/10/25 10:43:21</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mohammed M Althomali, Ahmed A Alharbi, Nouf M Albnayan, Abdulaziz M Alkhudhair, Muteb K Alanazi]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mohammed M Althomali, Ahmed A Alharbi, Nouf M Albnayan, Abdulaziz M Alkhudhair, Muteb K Alanazi</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231112]]></guid><cfi:id>20</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[First contact investigations and compliance to treatment in patients with uveitis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231113]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To ascertain the pattern of investigations at first contact in uveitic patients and evaluate compliance to treatment.METHODS: An observational study comprised of 201 uveitic patients presenting for the first time to our centre from January 2019 to June 2020. Detailed information regarding systemic investigations undertaken by specialists at the time of first contact and the cost of these investigations were reviewed on the first visit to our centre. Compliance with the treatment was determined and reasons behind non-compliance were evaluated on the first follow-up in patients who had no improvement in clinical signs and symptoms.RESULTS: The mean age of the study group was 35.35±14.1y and gender composition was 59.7% males and 40.3% females. Anterior uveitis was observed in 45.3% of patients, intermediate uveitis in 31.8% of patients, posterior uveitis in 14.9% of patients and panuveitis in 8.0% of patients. Association with a systemic disease was evident in 17.9% of patients. When compared with standard guidelines and uveitis patterns, systemic investigations were identified to be relevant only in 38.3% of patients. Non-compliance to treatment was documented in 22.4% of patients. Common reasons for non-compliance were inadequate counselling by the treating physician about treatment in 26.7% of patients and a busy schedule at work/school in 22.2% of patients.CONCLUSION: Significant number of investigations performed at first contact is found to be contrary to standard guidelines and are not contributory to the care. About a quarter of patients in this study are found to be non-compliant with the treatment. Compliance is more challenging to achieve in school-going children and working adults. The availability of comprehensive, periodically updated, evidence-based guidelines on the role of investigations and the use of trained counsellors may help to channelize proper evaluation and improve compliance to treatment, respectively, in patients with uveitis.]]></description>
<pubDate>2023/10/25 10:43:21</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Anuja Patil, Sanjeev Gupta, Pradeep Venkatesh, Mousumi Banerjee, Vinod Kumar, Rohan Chawla, Shorya Vardhan Azad, Atul Kumar]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Anuja Patil, Sanjeev Gupta, Pradeep Venkatesh, Mousumi Banerjee, Vinod Kumar, Rohan Chawla, Shorya Vardhan Azad, Atul Kumar</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231113]]></guid><cfi:id>19</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Retinal pigment epithelium–Bruch’s membrane volume in grading of age-related macular degeneration]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231114]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the agreement of optical coherence tomography (OCT) algorithm-based retinal pigment epithelium –Bruch’s membrane complex volume (RBV) with fundus photograph-based age-related macular degeneration (AMD) grading.METHODS: Digital color fundus photographs (CFPs) and spectral domain OCT images were acquired from 96 elderly subjects. CFPs were graded according to Age-Related Eye Disease Study (AREDS) classification. OCT image segmentation and RBV data calculation were done with OrionTM software. Univariate and multivariate analyses were performed to find out whether AMD lesion features associated with higher RBVs.RESULTS: RBV correlated with AMD grading (rs=0.338, P=0.001), the correlation was slightly stronger in early AMD (n=52; rs=0.432, P=0.001). RBV was higher in subjects with early AMD compared with those with no AMD lesions evident in fundus photographs (1.05±0.20 vs 0.96±0.13 mm3, P=0.023). In multivariate analysis higher RBVs were associated significantly with higher total drusen (β=0.388, P=0.027) and pigmentation areas (β=0.319, P=0.020) in fundus photographs, whereas depigmentation area (β=-0.295, P=0.015) associated with lower RBV.CONCLUSION: RBV correlate with AMD grading status, with a stronger association in patients with moderate, non-late AMD grades. This effect is driven mostly by lesions with drusen or pigmentation. Lesions with depigmentation tend to have lower values. RBV is more comprehensive measurement of the key area of AMD pathogenesis, compared to sole drusen volume analysis. RBV measurements are independent on grader variations and offer a possibility to quantify early and middle grade AMD lesions in a research setting, but may not substitute fundus photograph-based grading in the whole range of AMD spectrum.]]></description>
<pubDate>2023/10/25 10:43:21</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Fabian Kananen, Ilkka Immonen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Fabian Kananen, Ilkka Immonen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231114]]></guid><cfi:id>18</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Changes in corneal biomechanics and posterior corneal surface elevation after FS-LASIK]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231115]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the changes in corneal biomechanics and posterior corneal surface elevation after femtosecond laser-assisted in situ keratomileusis (FS-LASIK).METHODS: Totally 197 eyes of 100 patients who underwent the FS-LASIK from April 2022 to November 2022 were included. They were divided into three groups according to the ratio of residual corneal stroma thickness/corneal thickness (RCST/CT): Group I (50%≤RCST/CT<55%, 63 eyes of 32 patients), Group II (55%≤RCST/CT<60%, 67 eyes of 34 patients), and Group III (RCST/CT≥60%, 67 eyes of 34 patients). The intraocular pressure (IOP), corneal compensated IOP (IOPcc), corneal hysteresis (CH) and corneal resistance factor (CRF) were measured immediately, 1, and 3mo postoperatively by ocular response analyzer (ORA) and the posterior elevation difference (PED) was measured by Pentacam.RESULTS: After operation, IOP, CH, CRF, and PED were statistically different among the three groups (F=12.99, 31.148, 23.998, all P<0.0001). There was no statistically significant difference in IOPcc among the three groups (F=0.603, P>0.05). The IOP, IOPcc, CH, and CRF were statistical changed after surgery (F=699.635, 104.125, 308.474, 640.145, all P<0.0001). The PED of Group I was significantly higher than that of Group II (P<0.05), and Group II was significantly higher than that of Group III (P<0.05). The PED value of 3mo after surgery decreased in each group compared with 1mo after surgery, but there was no statistical difference (Group I: t=0.82, P=0.41; Group II: t=0.17, P=0.87; Group III: t=1.35, P=0.18). The correlation analysis of corneal biomechanical parameter changes with PED at 1mo and 3mo after surgery showed that ΔIOP, ΔIOPcc, ΔCH, and ΔCRF were not correlated with PED value in three groups (P>0.05).CONCLUSION: The smaller the RCST/CT, the greater effect on corneal biomechanics and posterior surface elevation. There is no correlation between changes in corneal biomechanics and posterior corneal surface elevation in the range of RCST/CT≥50%.]]></description>
<pubDate>2023/10/25 10:43:21</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Zhong-Ji Li, Chen Yang, Su-Han Liu, Jiao Guo, Yu-Hui Duan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Zhong-Ji Li, Chen Yang, Su-Han Liu, Jiao Guo, Yu-Hui Duan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231115]]></guid><cfi:id>17</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effectiveness and the nomogram of small incision lenticule extraction in the correction of myopic anisometropia in adults]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231116]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the safety, effectiveness, and predictability of small incision lenticule extraction (SMILE) for the treatment of anisometropia, and to explore the personalized design scheme of SMILE in correcting adult myopia anisometropia based on the nomogram.METHODS: It’s a prospective cohort study. Patients with anisometropic myopia of refractive difference ≥ 2.0 diopters (D) who underwent SMILE between September 2020 and March 2021 were enrolled. Clinical features and visual function were assessed preoperatively and at 1wk, 1, 3, and 6mo after the operation. The examination included tests for uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), refractive errors, effectiveness index (preoperative CDVA/postoperative UDVA), safety index (postoperative CDVA/preoperative CDVA), nomogram and stereoscopic function. Paired t-test, Wilcoxon signed-rank test and repeated-measures analyses of variance were used for continuous variables, and Pearson Chi-squared test was used for categorical variables.RESULTS: The study involved 45 consecutive patients (average age: 25.0±6.9y; 82 out of 90 eyes underwent SMILE, while 8 eyes were not operated). The average preoperative spherical equivalent (SE) was -4.74±0.22 D. Six months after surgery, the effectiveness index was 1.05±0.12, and the safety index was 1.09±0.11. Seventy eyes (85.4%) exhibited SE correction error within ±0.5 D. The percentage of eyes with Titmus stereoscopic function equal to or less than 200” significantly increased from 55.6% preoperatively to 88.9% postoperatively (P<0.05). There was statistically significant difference between higher myopia eyes and contralateral eyes in average nomogram value/spherical refraction ratio.CONCLUSION: SMILE is safe, effective and predictable in correcting myopic anisometropia, and it improves stereoscopic visual function of anisometropia patients. The precise and individualized design of the nomogram is a vital element to ensure the balance of both eyes after SMILE.]]></description>
<pubDate>2023/10/25 10:43:21</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Tong Zhang, Lu Zhu, Hang-Jia Zuo, Zhi-Jun Chen, Yan Ji, Xin Yang, Xiao-Rong Lu, Qiong Wu, Qing Wang, Jiu-Yi Xia, Meng Li, Chun-Jiang Zhou, Yao Wang, Ke Hu, Wen-Juan Wan]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Tong Zhang, Lu Zhu, Hang-Jia Zuo, Zhi-Jun Chen, Yan Ji, Xin Yang, Xiao-Rong Lu, Qiong Wu, Qing Wang, Jiu-Yi Xia, Meng Li, Chun-Jiang Zhou, Yao Wang, Ke Hu, Wen-Juan Wan</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231116]]></guid><cfi:id>16</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effectiveness of toric soft contact lenses for vision correction in patients with different degrees of astigmatism: a real-world study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231117]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the visual correction of patients with different degrees of astigmatism with toric soft contact lenses (TSC).METHODS: It was a real-world study with prospective and single-arm design. A total of 384 patients with astigmatism who came for TSC fitting and alignment from November 2022 to January 2023 were included. According to the difference in astigmatism, patients were divided into groups A (cylinder degree: -0.75 to -0.50 D), B (cylinder degree: -1.75 to -1.00 D) and C (cylinder degree ≤ -2.00 D), and followed up on the day of wear, 1wk, 1 and 3mo, mainly to observe visual acuity, refraction, lens fit, visual quality and comfort at 1wk after wear. The visual acuity success rate and the overall success rate of the fitting were evaluation indicators (taking into account the four dimensions of visual acuity, fitting, quality of vision and comfort). The visual acuity success rate was calculated by taking “corrected visual acuity with contact lenses is no less than 1 line or better than best spectacle-corrected visual acuity” (i.e. corrected visual acuity with contact lenses is 1 line below, equal to, one line above or more than best spectacle-corrected visual acuity) as the criterion for visual success, and the the overall success rate of the fitting was calculated by using the comprehensive indicators (visual acuity, fit, visual quality, comfort) to meet certain conditions as the judgment criteria for successful fitting.RESULTS: After 1wk of wearing TSC, the visual acuity success rates of patients were 100% (207/207), 98.58% (139/141) and 97.22% (35/36) in the three groups, respectively, with residual cylinder closed to 0. The acceptability of the lens fitting was over 95%; the incidence of adverse visual symptoms was within 10% and the comfort acceptability was over 97%. The overall success rate of fitting for patients with high, medium and low astigmatism was 93.72% (194/207), 90.78% (128/141) and 88.89% (32/36), respectively.CONCLUSION: TSC (model: G&G POP·CT) are effective in correcting astigmatism in patients with different degrees of astigmatism.]]></description>
<pubDate>2023/10/25 10:43:22</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Guo-Yun Zhang, Lu Ye, Wen-Jun Wang, Yi-Ming Guo, Jun-Han Wei, Mei-Xia Ren]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Guo-Yun Zhang, Lu Ye, Wen-Jun Wang, Yi-Ming Guo, Jun-Han Wei, Mei-Xia Ren</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231117]]></guid><cfi:id>15</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Analysis of independent risk factors for acute acquired comitant esotropia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231118]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To explore the risk factors for acute acquired comitant esotropia (AACE).METHODS: A retrospective cohort study was conducted by analyzing 83 patients (case group) with AACE who underwent strabismus correction surgery from January 1, 2021 to June 30, 2022. Totally 73 outpatient volunteers were recruited during the same period as the normal control group. The case group’s binocular vision time, near and distance esotropia angle, and near stereo vision function were recorded, and the age, gender, refractive status, and best-corrected visual acuity (BCVA) of both groups were analyzed. Additionally, multiple logistic regression analysis was conducted using an eye usage condition questionnaire to determine the independent risk factors for AACE.RESULTS: In the case group, 61 patients (73.49%) had myopia, with a mean equivalent spherical power (SE) of -3.35±3.31 D (range: +2.75 to -10.62 D) of the right eye and -2.87±3.35 D (range: +2.75 to -11.12 D) of the left eye. The average duration of diplopia in the case group was 29.83±35.72mo, of which 80 patients (96.39%) were primarily with distance diplopia. The near and distance esotropia angle after wearing glasses were 52.36±20.95 prism degree (PD) and 56.71±19.54 PD, respectively, and there was no statistically significant difference between the two (t=1.38, P=0.169). The incidence of improper glasses wearing and unhealthy eye habits in the case group was significantly higher than those in the control group (P<0.05). Close-up work without glasses [β=2.30, odds ratio (OR)=10, 95% confidence interval (CI) 2.35-42.51, P=0.002] and near work in supine position (β=1.80, OR=6.02, 95%CI 3.29-11.02, P<0.001) were independent risk factors for AACE.CONCLUSION: Patients with AACE mainly present with distance diplopia, and there is a high degree of variation in myopia. Near work without wearing glasses and in supine position are independent risk factors for AACE.]]></description>
<pubDate>2023/10/25 10:43:22</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jie Cai, Wei-Xia Lai, Xia Li, Qin Li, Ying Cai, Jin-Mao Chen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jie Cai, Wei-Xia Lai, Xia Li, Qin Li, Ying Cai, Jin-Mao Chen</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231118]]></guid><cfi:id>14</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Retinal thickness and fundus blood flow density changes in chest pain subjects with dyslipidemia]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231119]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the retinal thickness and fundus blood flow density changes in chest pain patients with dyslipidemia using optical coherence tomography angiography (OCTA).METHODS: All subjects with chest pain as the main symptom accepted a comprehensive ophthalmological examination. According to the serum lipid levels, the participants were divided into the control group and the dyslipidemia group. The retina thickness and fundus blood flow density were determined using OCTA.RESULTS: The study enrolled 87 left eyes from 87 adults with dyslipidemia and 87 left eyes from age- and sex-matched participants without dyslipidemia. The retina of dyslipidemia subjects was significantly thinner than that of the controls in the inferior (P=0.004 and P=0.014, respectively) and temporal (P=0.015 and P=0.019, respectively) regions, both inner and outer layers. In terms of blood flow density in the macula or optic disk, there was a decreasing trend in the dyslipidemia group compared with the control group, especially in the inferior and temporal regions.CONCLUSION: Dyslipidemia may contribute to the decrease in retinal thickness and fundus blood flow density. Further validation of the association between abnormal lipid metabolism and fundus microcirculation alterations needs to be carried out in chest pain patients.]]></description>
<pubDate>2023/10/25 10:43:22</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jin Wang, Yu-Cen Wang, Pei Zhang, Xin Wang, Rong-Rong Zong, Jing Jiang, Yu Zhang, Yi-Wen Qian, Qing-Jian Li, Zhi-Liang Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jin Wang, Yu-Cen Wang, Pei Zhang, Xin Wang, Rong-Rong Zong, Jing Jiang, Yu Zhang, Yi-Wen Qian, Qing-Jian Li, Zhi-Liang Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231119]]></guid><cfi:id>13</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Development of a new 17-item Asthenopia Survey Questionnaire using Rasch analysis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231120]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To develop the 17-item Asthenopia Survey Questionnaire (ASQ)-17 by Rasch analysis, and to generate a predictiveness score.METHODS: Totally 739 participants were recruited and 680 were involved in the result analysis in this prospective, cross-sectional study. Three rounds of Rasch analysis were used to analyze the psychometric characteristics of items and options.RESULTS: Phase 1 assessed the original ASQ-19, adjusted the item scoring mode to a four-point Likert response rating scale and combined the 18th and 19th items into a new item. Phase 2 deleted the 11th item. Phases 3 and 4 assessed the new ASQ-17. All the evaluation indexes of ASQ-17 were acceptable. The Infit and Outfit MnSq values of items were 0.67-1.48, the variance explained by the principal component and the unexplained variance explained by the first contrast were 53.90%-59.40% and 1.50-1.80 in three dimensions. The curve peaks of scores in each dimension were separated and in the same order. The PSR and PSI values were 2.80 and 0.89, respectively. The mean scores of dimensions A (9.5±4.1 vs 3.5±3.2), B (7.3±3.3 vs 2.5±2.7), C (4.3±2.2 vs 1.4±2.0) and total (21.1±8.1 vs 7.4±7.0) in asthenopia participants were significantly higher than those without asthenopia (all P<0.001). The area under the curve in two groups was 0.899 (P<0.001). Youden’s index was up to the maximum value of 0.784 when the cut-off value was 12.5.CONCLUSION: ASQ-17 has stronger option sorting and suitability than ASQ-19. It is an effective assessment tool for asthenopia with an optimal cut-off threshold value of 12.5, which is suitable for diagnosis and curative effect evaluation.]]></description>
<pubDate>2023/10/25 10:43:23</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Na Lin, Xiao-Man Li, Mao-Yuan Yang, Li Tian, Zhi-Hua Li, Jie-Li Mao, Jia-Fang Zhang, Jie Chen, Fan Lyu, Ru-Zhi Deng]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Na Lin, Xiao-Man Li, Mao-Yuan Yang, Li Tian, Zhi-Hua Li, Jie-Li Mao, Jia-Fang Zhang, Jie Chen, Fan Lyu, Ru-Zhi Deng</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231120]]></guid><cfi:id>12</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Agreement of intraocular pressure measurement with Corvis ST, non-contact tonometer, and Goldmann applanation tonometer in children with ocular hypertension and related factors]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231007]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To access the agreement of intraocular pressure (IOP) values obtained from biomechanically corrected tonometer [Corvis ST (CST)], non-contact tonometer (NCT), and Goldmann applanation tonometer (GAT) in children with NCT measured-IOP (NCT-IOP) values of 22 mm Hg or more, and related factors.METHODS: A total of 51 eyes with NCT-IOP≥22 mm Hg in children aged 7 to 14y were examined and IOP was measured by CST, NCT, and GAT. Based on GAT measured IOP (GAT-IOP), ocular hypertension (OHT) group (≥22 mm Hg, 24 eyes) and the non-OHT group (<22 mm Hg, 27 eyes) were defined. We compared the agreement of the three measurements, i.e., CST measured IOP (CST-IOP), GAT-IOP, and NCT-IOP, and further analyzed the correlation between the differences in tonometry readings, central corneal thickness (CCT), axial length (AL), optic disc rim volume, and age.RESULTS: Compared with the OHT group, thicker CCT, larger rim volume, and higher differences between NCT-IOP and GAT-IOP, were found in the non-OHT group. The differences between CST-IOP and GAT-IOP were lower than the differences between NCT-IOP and GAT-IOP in both groups. The mean differences in CST-IOP and GAT-IOP were 1.26 mm Hg (95% limit of agreement ranged from 0.1 to 2.41 mm Hg, OHT group) and 1.20 mm Hg (95% limit of agreement ranged from -0.5 to 3.00 mm Hg, non-OHT group), and the mean differences in NCT and GAT were 3.90 mm Hg (95% limit of agreement ranged from -0.19 to 9.70 mm Hg, OHT group) and 6.00 mm Hg (95% limit of agreement ranged from 1.50 to 10.50 mm Hg, non-OHT group). The differences between CST-IOP and GAT-IOP were not related to CCT, age, and AL in both groups; while the differences between NCT-IOP and GAT-IOP were related to CCT in the OHT group (r=0.93, P<0.001) and to CCT and AL in the non-OHT group (r=0.66, P<0.001, r=-0.81, P<0.001).CONCLUSION: The accuracy of NCT in the diagnosis of pediatric OHT is low. The agreement of CST-IOP and GAT-IOP was significantly higher in children with and without OHT than in those with NCT-IOP and GAT-IOP. Therefore, CST can be used as a good alternative for IOP measurement in children. The impacts of CCT and AL on NCT measurement need to be fully considered when managing childhood IOP.]]></description>
<pubDate>2023/9/19 15:49:12</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Hou-Gang Li, Yan-Hui Chen, Fang Lin, Si-Yu Li, Qing-Hua Liu, Chun-Ge Yin, Xi-Yue Chen, Xin-Jie Zhang, Yue Qu, Yan-Nian Hui]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Hou-Gang Li, Yan-Hui Chen, Fang Lin, Si-Yu Li, Qing-Hua Liu, Chun-Ge Yin, Xi-Yue Chen, Xin-Jie Zhang, Yue Qu, Yan-Nian Hui</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231007]]></guid><cfi:id>11</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Dry eye disease among patients infected with the SARS-CoV-2 Omicron variant: a cross-sectional study]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231008]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To investigate the incidence of dry eye disease (DED) and relevant risk factors among patients infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant.METHODS: This cross-sectional, observational analysis included 993 patients with corona virus disease 2019 (COVID-19) treated at the National Exhibition and Convention Center (Shanghai) Fangcang Shelter Hospital, from April 10 to May 26, 2022. Totally 944 uninfected control participants were recruited. All participants completed ocular surface disease index (OSDI) questionnaires, and DED symptoms were determined using OSDI scores. The demographic characteristics, length of hospital stay and in nasopharyngeal swabs were performed using questionnaires. SARS-CoV-2 Omicron variant infection was confirmed by nucleic acid-based detection in nasopharyngeal swabs using a 2019-nCoV nucleic acid detection kit. The risk factors for DED symptoms among patients with COVID-19 and control participants were determined by logistic regression analysis.RESULTS: Patients with COVID-19 showed a higher incidence of DED than controls (64.9% vs 55.1%, P<0.001). SARS-CoV-2 infection [odds ratios (ORs) (95%CI): 1.271 (1.038, 1.556)], use of contact lenses [ORs (95%CI): 9.350 (3.676, 23.783)], history of corneal refractive surgery [ORs (95%CI): 2.047 (1.494, 2.804)], poor sleep quality [ORs (95%CI): 2.657 (2.029, 3.480)], and video display terminal (VDT) use for more than 8h per day [ORs (95%CI): 6.348 (4.720, 8.538)] were found to be risk factors for DED symptoms in patients with COVID-19 as well as controls. For patients with COVID-19, the length of hospital stay [ORs (95%CI): 1.196 (1.134, 1.262)], use of contact lenses [ORs (95%CI): 20.423 (2.680, 155.632)], history of corneal refractive surgery [ORs (95%CI): 2.166 (1.321, 3.553)], poor sleep quality [ORs (95%CI): 3.650 (2.381, 5.597)], and VDT use for more than 8h per day [ORs (95%CI): 7.740 (4.918, 12.180)] were significant risk factors for DED symptoms.CONCLUSION: Patients with COVID-19 are more prone to develop symptomatic DED. SARS-CoV-2 infection and length of hospital stay are important risk factors for DED symptoms.]]></description>
<pubDate>2023/9/19 15:49:13</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Qi-Fang Chen, Juan Yu, Han Chu, Pan Hu, Li Chen, Ting Liu, Chong-Yi Li]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Qi-Fang Chen, Juan Yu, Han Chu, Pan Hu, Li Chen, Ting Liu, Chong-Yi Li</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231008]]></guid><cfi:id>10</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A combined treatment for patients with dry eye and associated laryngopharyngeal reflux: a real-life approach]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231009]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the efficacy and tolerability of administering a combined therapy in patients with dry eye syndrome (DES) and associated laryngopharyngeal reflux (LPR).METHODS: The study was retrospective, open, observational, and conducted in a real-life setting. Patients had pathological symptom assessment in dry eye (SANDE) and reflux symptom index (RSI) at baseline. Patients were re-assessed after 1mo and at the end of treatment. The treatment consisted of a three-month course based on the combined therapy: Gastroftal eye drops, one drop three times a day, and Gastroftal tablets, two tablets after lunch and two tablets after dinner. Tear break-up-time (TBUT) test, Schirmer test, RSI, and SANDE questionnaire were evaluated.RESULTS: The study included 253 patients. The mean age was 58±11.19y. TBUT test score and Schirmer’s test significantly increased (both P<0.001) after 1mo and at the end of treatment. The RSI score and SANDE scores significantly decreased (both P<0.001) after 1mo and at the end of treatment.CONCLUSION: The current, retrospective, and open study shows that combined therapy using Gastroftal eye drops and tablets could represent a valuable option in managing patients with DES associated with LPR.]]></description>
<pubDate>2023/9/19 15:49:13</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Giorgio Ciprandi, Stefano Bonini, Irene Schiavetti, Valerio Damiani, Study Group on Dry-Eye Pragmatical Management]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Giorgio Ciprandi, Stefano Bonini, Irene Schiavetti, Valerio Damiani, Study Group on Dry-Eye Pragmatical Management</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231009]]></guid><cfi:id>9</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparative outcomes of the pathogen in cultured Jones tubes used in lacrimal bypass surgery according to follow up periods]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231010]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To evaluate the pathogens in cultured Jones tubes used in lacrimal bypass surgery according to the postoperative periods and to obtain data for the prevention of infection of functional lacrimal stent invention.METHODS: Totally 71 patients (81 eyes) who underwent the removal of Jones tubes were enrolled in study. All the removed Jones tubes were cultured for bacterial and fungal identification and tested for bacterial antibiotic sensitivity. The results were analyzed according to the duration of the inserted Jones tube after lacrimal bypass surgery.RESULTS: Of the 81 eyes, bacteria were isolated from 69 eyes (85.2%) and fungi from 6 eyes (7.4%). Among 69 eyes, 40.6% showed Staphylococcus aureus (S. aureus), 11.6% were Pseudomonas aeruginosa (P. aeruginosa). Gram-positive bacteria were isolated more than Gram-negative bacteria, but Gram-negative bacteria showed a higher incidence in the Jones tube implanted for over 10y (P=0.035). The antibiotic sensitivity test showed that 46.4% of S. aureus were resistant to oxacillin. In terms of antibiotics commonly used in ocular clinical practice, vancomycin was sensitive to S. aureus and Streptococcus pneumoniae (S. pneumoniae), amikacin responded to P. aeruginosa and Proteus mirabilis (P. mirabilis). Trimethoprim/sulfamethoxazole (TMP/SMX) was all sensitive to S. aureus, S. pneumoniae and P. mirabilis except P. aeruginosa.CONCLUSION: S. aureus is the most commonly found organism in the Jones tube after lacrimal bypass surgery, and 46.4% of them are methicillin-resistant S. aureus (MRSA), sensitive to vancomycin. Especially, P. mirabilis responded with amikacin is dominantly detected in the Jones tubes implanted for more than 10y.]]></description>
<pubDate>2023/9/19 15:49:13</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Bo Hyun Park, Hui Kyung Kim, Yeon Ji Jo, Jong Soo Lee]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Bo Hyun Park, Hui Kyung Kim, Yeon Ji Jo, Jong Soo Lee</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231010]]></guid><cfi:id>8</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Differential expression of antimicrobial peptides in human fungal keratitis]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231011]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To analyze a series of antimicrobial peptides (AMPs) in corneal tissue from individuals with fungal keratitis (FK) during the active phase of the fungus infection and after healing.METHODS: Patients undergone lamellar keratoplasty for the treatment of severe FK or corneal scar had their corneal buttons sampled. Quantitative real-time polymerase chain reaction (PCR) was used to ascertain the gene expression of human beta-defensin (HBD)-1, -2, -3, -9, S100A7, 8, 9, and LL-37.RESULTS: All AMPs’ messenger ribonucleic acid (mRNA) expression was considerably elevated in all samples (n=12). In contrast to controls, where HBD-2, -3, and S100A7 mRNAs were expressed at very low levels, it was discovered that HBD-1, -9, S100A8, S100A9, and LL-37 were constitutively expressed in all healed samples (n=4). HBD-1, -2 -3, S100A7, and LL-37 mRNAs were significantly increased in all active FK samples (n=8). The levels of HBD-9, S100A8, and S100A9 mRNAs were moderately upregulated in all active FK samples. Subgroup comparison showed that HBD-2 was significantly increased in Fusarium keratitis samples (n=5), and LL-37 mRNAs were significantly enhanced in Aspergillus keratitis samples (n=3). Whereas there was not significantly increased of HBD-1, -3, -9, S100A7, 8, 9 mRNA in Aspergillus keratitis samples compared with Fusarium keratitis samples.CONCLUSION: AMPs expression is increased in active FK, but not all AMPs are equally expressed. HBD-2 and LL-37 expression levels are the highest, showing some specificity of AMP expression related to FK. Human AMPs, particularly HBD-2 may play a significant role in Fusarium keratitis and LL-37 might be the key player in Aspergillus keratitis.]]></description>
<pubDate>2023/9/19 15:49:13</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Jia-Song Wang, Xi Peng, Zhao Zhao, Chao Wang, Hua-Tao Xie, Ming-Chang Zhang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Jia-Song Wang, Xi Peng, Zhao Zhao, Chao Wang, Hua-Tao Xie, Ming-Chang Zhang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231011]]></guid><cfi:id>7</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Evaluation of corneal backward light scattering in type 2 diabetes mellitus]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231012]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To compare the corneal backward light scattering values in type 2 diabetes mellitus (DM) patients with those of age and sex-matched healthy controls.METHODS: The study included 30 patients (30 eyes) with type 2 DM and 30 control subjects (30 eyes). Duration of diabetes, most recent hemoglobin A1c levels, along with the status of diabetic retinopathy, and existing medical treatment of all subjects were recorded. All subjects underwent a complete ophthalmologic examination. In addition, backward light scattering (densitometry) was measured to assess changes in corneal transparency using tomography (Pentacam HR).RESULTS: The type 2 DM patients included 12 males and 18 females and control subjects included 16 males and 14 females. The age was 50.40±7.80y (range: 40-68y) of the diabetic group and 49.30±9.50y (rang: 40-73y) of control group. The diabetic group demonstrated significantly higher mean densitometry values of the anterior (6-10 mm) zone (P=0.047), the total anterior layer (P=0.036) and the total cornea (P=0.043) than control group. The corneal densitometry of the diabetic eyes demonstrated no significant correlation with hemoglobin A1c levels and DM duration.CONCLUSION: Diabetic group has higher densitometry in anterior corneal (6-10 mm) zone, total anterior cornea, and total cornea and with no correlation with hemoglobin A1c levels and DM duration.]]></description>
<pubDate>2023/9/19 15:49:14</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Amira Elagamy, Najd Abaalhassan, Mohamed Berika]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Amira Elagamy, Najd Abaalhassan, Mohamed Berika</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231012]]></guid><cfi:id>6</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Long-term outcomes of anti-VEGF treatment with 5+PRN regimen for macular edema due to central retinal vein occlusion]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231013]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To assess the long-term outcomes of treating macular edema (ME) associated with central retinal vein occlusion (CRVO) with a regimen of “5+pro re nata (PRN)”.METHODS: This retrospective study included 27 eyes of 27 patients with ME associated with non-ischemic CRVO (non-iCRVO group, n=15) and ischemic CRVO (iCRVO group, n=12). The eyes were treated with five consecutive intravitreal injections of conbercept or ranibizumab, followed by reinjections as needed or PRN. Retinal laser photocoagulation or intravitreal dexamethasone implants (DEX) were implemented in both groups when necessary. The best-corrected visual acuity (BCVA, logMAR) and central retinal thickness (CRT) were recorded at baseline, at 1, 2, 3, 4, 5, 6, and 12mo, and at the final visit. The efficacy rates of BCVA and CRT before and after treatment were calculated. The number of injections at each visit and the incidence of adverse events were also recorded.RESULTS: The patients, aged 59.4±15.1y, were followed up for 24.7±8.8mo (range: 15-42mo). After treatment, BCVA improved significantly from 1.04±0.56 logMAR at baseline to 0.59±0.36 logMAR (P=0.038) at the final visit in all patients. Both the non-iCRVO and the iCRVO groups achieved improved BCVA compared to the baseline at all visit points, but there was no statistical significance (P=0.197 and 0.33, respectively). The mean CRT was statistically reduced compared to baseline at all visit points in all the eyes and in both groups (all P<0.001). The apparent effective rate was 22.22% for BCVA and 37.04% for CRT after the first injection, 48.15% for BCVA and 62.96% for CRT after 5 consecutive injections, and 74.08% for BCVA and 100% for CRT at the end of follow up. The average number of injections in all patients was 9.0±2.4 at 12mo and 14.9±8.1 finally with no statistical significance between both groups (P>0.05). Laser treatment was applied to all eyes in the iCRVO group, while only 5 patients in the non-iCRVO group. Six patients in the non-iCRVO group and 3 patients in the iCRVO group had a drug switch. DEX was applied to 4 eyes in the non-iCRVO group and 5 eyes in the iCRVO group.CONCLUSION: The 5+PRN anti-vascular endothelial growth factor (VEGF) regimen is found to be safe and effective for both iCRVO and non-iCRVO, especially in the iCRVO group. The best regimen for such patients needs to be further investigated. Adjuvant laser therapy and DEX are necessary in some cases.]]></description>
<pubDate>2023/9/19 15:49:14</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Ya Ye, Yu-Meng Deng, Zhen Huang, Qiao-Wei Wu, Yan-Nian Hui, Yan-Ping Song]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Ya Ye, Yu-Meng Deng, Zhen Huang, Qiao-Wei Wu, Yan-Nian Hui, Yan-Ping Song</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231013]]></guid><cfi:id>5</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Comparison of anatomical and functional outcomes of different surgical techniques in myopic macular hole without retinal detachment]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231014]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To define the anatomic and functional outcomes of pars plana vitrectomy (PPV) with internal limiting membrane (ILM) peeling, inverted ILM flap and free ILM patch graft technique for the treatment of myopic macular hole (MH) without retinal detachment.METHODS: Sixty-four eyes of 64 patients who underwent PPV for myopic MH were included. Group 1 consists of patients underwent ILM peeling (n=26), and Groups 2 and 3 consists of patient underwent free ILM patch graft (n=20) and inverted ILM flap procedure (n=18) respectively. Outcomes following surgery were MH closure and best corrected visual acuity (BCVA) in logMAR at 6mo.RESULTS: Closure of MH was obtained in 20 eyes (76.9%) of the Group 1, in 16 eyes (80%) of the Group 2 and in 16 eyes (88.9%) of the Group 3. The mean preoperative and postoperative BCVA was 1.60±0.53 logMAR and 1.27±0.58 logMAR, respectively (P<0.05). There was no significant difference in the postoperative BCVA and anatomical closure rates in the three groups. Although the anatomical closure rate did not differ significantly in the groups, closure of MH tended to be better in the inverted ILM flap technique group at 6mo.CONCLUSION: Different surgical techniques may provide favorable visual and anatomical results for myopic MH surgery. ILM flap techniques offer higher closure rates compared to ILM peeling technique. However, in terms of visual outcomes, the study reveals no difference in three surgical techniques.]]></description>
<pubDate>2023/9/19 15:49:14</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Merve Ozbek, Sehnaz Ozcaliskan, Cengiz Alagoz, Ozgur Artunay]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Merve Ozbek, Sehnaz Ozcaliskan, Cengiz Alagoz, Ozgur Artunay</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231014]]></guid><cfi:id>4</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effect of visual perception training on binocular visual function reconstruction in patients after strabismus surgery]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231015]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To explore the effect of visual perception learning software training (VPT) on binocular visual function reconstruction in children with intermittent exotropia after strabismus surgery.METHODS: Ninety children with intermittent exotropia admitted to our hospital from June 2018 to December 2018 were included, and randomly divided into VPT and control groups. Children in the control group received basic binocular vision training, while those in the VPT group received VPT after strabismus surgery. Tertiary visual function, visual perception function, Newcastle Control Score (NCS), and ocular position retraction rate were compared at 3 and 12mo after the surgery.RESULTS: At 3 and 12mo after the surgery, the proportion of simultaneous perception, binocular fusion version and binocular stereo vision in the VPT group was conspicuously higher than that in the control group (P<0.05). After the vision training, the binocular visual perception functions of children in both groups were significantly improved compared with that before training (P<0.05). Interestingly, the grating sharpness, texture perception and texture motion perception in the VPT group were dramatically better than control group (P<0.01). The NCS in the VPT group was significantly lower than that in the control group (P<0.05). The ocular position retraction rate in the VPT group was significantly lower than that in the control group at 12mo (8.89% vs 26.67%, P=0.03).CONCLUSION: VPT effectively promotes binocular visual function reconstruction in intermittent exotropia children after strabismus surgery and reduces the strabismus severity and ocular position retraction rate.]]></description>
<pubDate>2023/9/19 15:49:14</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Yu Su, Fei Wang, Tao Wang, Qin-Mei Wang]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Yu Su, Fei Wang, Tao Wang, Qin-Mei Wang</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231015]]></guid><cfi:id>3</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Visual resolution under photopic and mesopic conditions in patients with Sjögren's syndrome]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231016]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To focus on different visual resolution tasks under photopic and mesopic conditions in Sjögren’s syndrome patients compared to age-matched healthy controls.METHODS: The visual resolution measurements included high and low visual acuities and contrast sensitivity functions. These tests were conducted under photopic and then mesopic conditions. Twenty-one Sjögren’s syndrome patients and 21 aged-matched healthy volunteers completed all the measurements in this study.RESULTS: Sjögren’s syndrome patients have greater impairment in contrast sensitivity than standardized visual acuity. This reduction was significant under the mesopic condition. Also, Sjögren’s syndrome patients treated with pilocarpine suffer more than patients without pilocarpine treatment under low light conditions.CONCLUSION: Sjögren’s syndrome patients shows greater impairment in different visual resolution tasks due to dry eye symptoms.]]></description>
<pubDate>2023/9/19 15:49:14</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Mosaad Alhassan, Amal Aldarwesh, Issa Alessa, Rafif Alhijji, Reema Alduhayan, Ali Almustanyir]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Mosaad Alhassan, Amal Aldarwesh, Issa Alessa, Rafif Alhijji, Reema Alduhayan, Ali Almustanyir</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231016]]></guid><cfi:id>2</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effects of obstructive sleep apnea on retinal microvasculature]]></title>
<link><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231017]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[AIM: To detect retinal microvascular variations in obstructive sleep apnea syndrome patients.METHODS: This prospective, observational case-control study included healthy controls and patients with mild, moderate, and severe obstructive sleep apnea syndrome. Vascular parameters, foveal avascular area, and flow areas in macula-centered, 6.00×6.00 mm2 scan size optical coherence tomography angiography images were compared.RESULTS: The control group had the highest whole image, parafoveal, and perifoveal vessel density among the groups in both superficial and the deep capillary plexus (all P<0.05). Rapid eye movement sleep apnoea-hypopnoea index was reversely correlated with whole (Rho=-0.195, P=0.034), parafoveal (Rho=-0.242, P=0.008), perifoveal (Rho=-0.187, P=0.045) vessel density in the superficial capillary plexus, and whole (Rho=-0.186, P=0.046), parafoveal (Rho=-0.260, P=0.004), perifoveal (Rho=-0.189, P=0.043) vessel density in the deep capillary plexus, though the mean and non-rapid eye movement sleep apnoea-hypopnoea index related with only parafoveal vessel density in the superficial capillary plexus (Rho=-0.213, P=0.020; Rho=-0.191, P=0.038) and the deep capillary plexus (Rho=-0.254, P=0.005; Rho=-0.194, P=0.035).CONCLUSION: This study shows decreased vessel density and its reverse correlation with the apnoea-hypopnoea index in patients with obstructive sleep apnea syndrome.]]></description>
<pubDate>2023/9/19 15:49:14</pubDate>
<category><![CDATA[Clinical Research]]></category>
<author><![CDATA[Müjdat Karabulut, Semai Bek, Sinem Karabulut, Aylin Karalezli, Gülnihal Kutlu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Müjdat Karabulut, Semai Bek, Sinem Karabulut, Aylin Karalezli, Gülnihal Kutlu</atom:name>
</atom:author>
<guid><![CDATA[http://www.ijo.cn/gjyken/article/abstract/20231017]]></guid><cfi:id>1</cfi:id><cfi:read>true</cfi:read></item>
</channel>
</rss>